title,datetime,impact_score,sentiment,summary,article
Hello Group Inc. Announces Unaudited Financial Results for the Fourth Quarter and Fiscal Year 2023,2024-03-14T08:12:00.000Z,Neutral,Neutral,"Hello Group Inc. (NASDAQ: MOMO) reports financial results for Q4 2023 and full year 2023. Net revenues decreased, but net income and non-GAAP net income increased. Monthly Active Users on Tantan app decreased, while paying users for Momo app and Tantan decreased slightly. The company's Chairman and CEO, Yan Tang, expressed satisfaction with the progress made in 2023 despite challenges.","Hello Group Inc. Announces Unaudited Financial Results for the Fourth Quarter and Fiscal Year 2023 Rhea-AI Impact (Neutral) Rhea-AI Sentiment (Neutral) Tags earnings Rhea-AI Summary Hello Group Inc. (NASDAQ: MOMO) reports financial results for Q4 2023 and full year 2023. Net revenues decreased, but net income and non-GAAP net income increased. Monthly Active Users on Tantan app decreased, while paying users for Momo app and Tantan decreased slightly. The company's Chairman and CEO, Yan Tang, expressed satisfaction with the progress made in 2023 despite challenges. Positive Increase in net income and non-GAAP net income for Q4 2023 compared to the same period in 2022. Decrease in net revenues for both Q4 2023 and full year 2023 compared to the previous year. Reduction in Monthly Active Users on Tantan app and paying users for Momo app and Tantan in Q4 2023. Declaration of a special cash dividend and amendment to the Share Repurchase Program. Business outlook for Q1 2024 forecasts a decrease in total net revenues. Positive comments from Chairman and CEO Yan Tang regarding the company's performance in 2023. Negative Decrease in net revenues for Q4 2023 and full year 2023. Reduction in Monthly Active Users and paying users for Momo and Tantan apps. Forecasted decrease in total net revenues for Q1 2024. Financial Analyst The financial results reported by Hello Group Inc. show a mixed picture, with net revenues declining by 6.5% year over year in Q4 2023 and by 5.5% for the full year, which may raise concerns about the company's top-line growth. However, the increase in net income, both GAAP and non-GAAP, suggests that the company has effectively managed costs and improved profitability despite revenue headwinds. This could indicate a stronger operational efficiency that investors may view favorably. The decrease in costs and expenses, particularly in revenue sharing with broadcasters and virtual gift recipients, as well as optimized personnel costs, contributed to the increased profitability.Furthermore, the declaration of a special cash dividend and the expansion and extension of the share repurchase program reflect confidence by the board in the company's cash position and future prospects. These actions typically signal to the market that the company believes its stock is undervalued and that it is committed to delivering value to shareholders. The special dividend and share buybacks could potentially support the stock price in the short term.However, the forecasted decline in revenues for Q1 2024 suggests that the company anticipates continued challenges. Investors should consider whether the improved profitability is sustainable in the face of persistent revenue declines and what strategies the company has in place to return to revenue growth. Market Research Analyst The reported decrease in Monthly Active Users (MAU) on the Tantan app and the decline in total paying users for both Momo and Tantan apps are concerning trends. These metrics are crucial for evaluating the company's engagement and monetization capabilities. The decline in MAUs and paying users could be indicative of increased competition in the social and entertainment space, changes in user preferences, or challenges in user acquisition and retention strategies.On the positive side, the growth in mobile marketing revenues and the mention of new standalone apps contributing to revenue growth suggest that the company is diversifying its revenue streams. This diversification could help mitigate the impact of declining revenues in its core services. It will be important to monitor the performance of these new initiatives and their contribution to the overall financial health of the company.The company's efforts to pivot away from less dating-centric live video services and to improve the Momo app's ecosystem are strategic moves that could pay off in the long term if they lead to a more engaged and monetizable user base. However, the short-term impact of these product adjustments on revenue should be carefully assessed. Economist The macroeconomic context in which Hello Group Inc. operates has been highlighted as a factor affecting consumer sentiment and, consequently, the company's revenues. The soft consumer sentiment could be a result of broader economic challenges, such as slowing growth, trade tensions, or regulatory changes in China's tech sector. Such external factors can have a significant impact on discretionary consumer spending, which is critical for entertainment and social platforms.Despite these challenges, Hello Group's ability to improve cost efficiency and profitability in a difficult economic environment is commendable. The company's proactive adjustments to operations and cost control strategies have shown resilience, which may be seen as a positive indicator of management's capability to navigate through economic headwinds.Investors should also consider the potential risks of regulatory changes and the impact of international expansion as the company seeks to invest more resources abroad. While diversification into overseas markets could offer growth opportunities, it also introduces new risks and uncertainties that need to be managed. 03/14/2024 - 04:12 AM BEIJING, March 14, 2024 /PRNewswire/ -- Hello Group Inc. (NASDAQ: MOMO) (""Hello Group"" or the ""Company""), a leading mobile social and entertainment platform in China, today announced its unaudited financial results for the fourth quarter and the full year ended December 31, 2023. Fourth Quarter of 2023 Highlights Net revenues decreased by 6.5% year over year to RMB3,002.9 million (US$423.0 million*) in the fourth quarter of 2023.Net income attributable to Hello Group Inc. increased to RMB452.5 million (US$63.7 million) in the fourth quarter of 2023, from RMB398.0 million in the same period of 2022.Non-GAAP net income attributable to Hello Group Inc. (note 1) increased to RMB514.7 million (US$72.5 million) in the fourth quarter of 2023, from RMB487.9 million in the same period of 2022.Diluted net income per American Depositary Share (""ADS"") was RMB2.32 (US$0.33) in the fourth quarter of 2023, compared to RMB2.01 in the same period of 2022.Non-GAAP diluted net income per ADS (note 1) was RMB2.63 (US$0.37) in the fourth quarter of 2023, compared to RMB2.46 in the same period of 2022.Monthly Active Users (""MAU"") on Tantan app were 13.7 million in December 2023, compared to 18.4 million in December 2022.For the Momo app total paying users was 7.4 million for the fourth quarter of 2023, compared to 7.8 million for the same period last year. Tantan had 1.2 million paying users for the fourth quarter of 2023 compared to 1.7 million from the year ago period.Full Year 2023 Highlights Net revenues decreased by 5.5% year over year to RMB12,002.3 million (US$1,690.5 million) for the full year of 2023.Net income attributable to Hello Group Inc. was RMB1,957.6 million (US$275.7 million) for the full year of 2023, compared to RMB1,484.3 million during the same period of 2022.Non-GAAP net income attributable to Hello Group Inc. (note 1) was RMB2,224.7 million (US$313.3 million) for the full year of 2023, compared to RMB1,885.8 million during the same period of 2022.Diluted net income per ADS was RMB9.84 (US$1.39) for the full year of 2023, compared to RMB7.31 during the same period of 2022.Non-GAAP diluted net income per ADS (note 1) was RMB11.17 (US$1.57) for the full year of 2023, compared to RMB9.20 during the same period of 2022.""2023 was a busy, yet fruitful year. Despite many changes and challenges in the external environment, our team made steady progress against our strategic priorities."" Commented Yan Tang, Chairman and CEO of Hello Group. ""With solid improvement in cost efficiency, we were able to meaningfully improve the profitability of the company against economic headwinds. I am also pleased to see that our new endeavors in the overseas market have started bearing fruits, which gives us more confidence to invest more resources and take bigger strides to explore wider markets abroad."" * This press release contains translations of certain Renminbi amounts into U.S. dollars at specified rate solely for the convenience of readers. Unless otherwise noted, all translations from Renminbi to U.S. dollars, in this press release, were made at a rate of RMB7.0999 to US$1.00, the effective noon buying rate for December 29, 2023 as set forth in the H.10 statistical release of the Federal Reserve Board. Fourth Quarter of 2023 Financial Results Net revenues Total net revenues were RMB3,002.9 million (US$423.0 million) in the fourth quarter of 2023, a decrease of 6.5% from RMB3,212.7 million in the fourth quarter of 2022. Live video service revenues were RMB1,523.9 million (US$214.6 million) in the fourth quarter of 2023, a decrease of 11.6% from RMB1,724.2 million during the same period of 2022. The decrease was primarily attributable to a soft consumer sentiment in the current macro environment and our proactive operation adjustments to de-emphasise large scale competition events in the Momo app, and to a lesser degree, Tantan pivoting away from the less dating-centric live video service. Value-added service revenues mainly include virtual gift revenues and membership subscription revenues. Total value-added service revenues were RMB1,424.9 million (US$200.7 million) in the fourth quarter of 2023, a decrease of 1.7% from RMB1,449.5 million during the same period of 2022. The decrease was primarily due to the impact of the macro economy on consumer sentiment as well as our product adjustments to improve Momo app's ecosystem, and to a lesser extent, the decline in Tantan's paying users that resulted from a reduction in channel investment, the anti-spam campaign and the adjustments to subscription renewals. The decrease was partially offset by the rapid revenue growth from the new standalone apps. Mobile marketing revenues were RMB44.9 million (US$6.3 million) in the fourth quarter of 2023, an increase of 36.4% from RMB32.9 million during the same period of 2022. Mobile games revenues were RMB5.4 million (US$0.8 million) in the fourth quarter of 2023, an increase of 2.4% from RMB5.3 million in the fourth quarter of 2022. Net revenues from the Momo segment decreased from RMB2,865.8 million in the fourth quarter of 2022 to RMB2,728.7 million (US$384.3 million) in the fourth quarter of 2023, primarily due to the decrease in net revenues from value-added service and live video service on Momo app. The decrease was partially offset by the revenue growth of the new standalone apps. Net revenues from the Tantan segment decreased from RMB346.7 million in the fourth quarter of 2022 to RMB272.2 million (US$38.3 million) in the fourth quarter of 2023, mainly due to the decrease in net revenues from live video service, and to a lesser extent, the decrease from value-added service. Cost and expenses Cost and expenses were RMB2,431.8 million (US$342.5 million) in the fourth quarter of 2023, a decrease of 11.2% from RMB2,738.3 million in the fourth quarter of 2022. The decrease was primarily attributable to: (a) a decrease in revenue sharing with broadcasters related to live video service on the Momo app and on the Tantan app, and a decrease in revenue sharing with virtual gift recipients of virtual gift service on the Momo app. The decrease was partially offset by an increase in revenue sharing with virtual gift recipients for new standalone apps; (b) a decrease in salary expenses and share-based compensation expenses, due to our continuous optimization in personnel costs and the newly granted share options which had lower fair value; (c) a decrease in sales and marketing expenses due to our initiatives to control cost and optimize Tantan's channel marketing strategy and, to a lesser extent, Momo's strategy to trim inefficient channel marketing spend. Non-GAAP cost and expenses (note 1) were RMB2,369.5 million (US$333.7 million) in the fourth quarter of 2023, a decrease of 10.5% from RMB2,648.3 million during the same period of 2022. Other operating income (loss), net Other operating income was RMB30.8 million (US$4.3 million) in the fourth quarter of 2023, compared to a loss of RMB65.2 million during the fourth quarter of 2022. The other operating loss in the fourth quarter of 2022 mainly included a contingent loss accrual of RMB92.9 million related to an ongoing investigation of the alleged illegal activity on the source of the funding consumed on Momo's platform. Income from operations Income from operations was RMB602.0 million (US$84.8 million) in the fourth quarter of 2023, compared to RMB409.2 million during the same period of 2022. Income from operations of the Momo segment was RMB576.9 million (US$81.3 million) in the fourth quarter of 2023, which increased from RMB435.8 million in the fourth quarter of 2022. Income from operations of the Tantan segment was RMB26.8 million (US$3.8 million) in the fourth quarter of 2023, compared to a loss from operations of RMB21.7 million in the fourth quarter of 2022. Non-GAAP income from operations (note 1) was RMB664.2 million (US$93.6 million) in the fourth quarter of 2023, compared to RMB499.2 million during the same period of 2022. Non-GAAP income from operations of the Momo segment was RMB638.9 million (US$90.0 million) in the fourth quarter of 2023, which increased from RMB519.2 million in the fourth quarter of 2022. Non-GAAP income from operations of the Tantan segment was RMB27.0 million (US$3.8 million) in the fourth quarter of 2023, compared to a non-GAAP loss from operations of RMB15.2 million in the fourth quarter of 2022. Income tax expenses Income tax expenses were RMB183.4 million (US$25.8 million) in the fourth quarter of 2023, compared to RMB109.4 million in the fourth quarter of 2022. The increase in income tax expenses was primarily due to the higher profit in the fourth quarter of 2023. Net income Net income was RMB452.5 million (US$63.7 million) in the fourth quarter of 2023, compared to RMB397.0 million during the same period of 2022. Net income from the Momo segment was RMB430.0 million (US$60.6 million) in the fourth quarter of 2023, compared to RMB397.1 million in the same period of 2022. Net income from the Tantan segment was RMB24.2 million (US$3.4 million) in the fourth quarter of 2023, compared to RMB4.7 million in the fourth quarter of 2022. Non-GAAP net income (note 1) was RMB514.7 million (US$72.5 million) in the fourth quarter of 2023, compared to RMB487.0 million during the same period of 2022. Non-GAAP net income from the Momo segment was RMB492.1 million (US$69.3 million) in the fourth quarter of 2023, which increased from RMB480.5 million in the fourth quarter of 2022. Non-GAAP net income of the Tantan segment was RMB24.4 million (US$3.4 million) in the fourth quarter of 2023, compared to RMB11.3 million in the fourth quarter of 2022. Net income attributable to Hello Group Inc. Net income attributable to Hello Group Inc. was RMB452.5 million (US$63.7 million) in the fourth quarter of 2023, compared to RMB398.0 million during the same period of 2022. Non-GAAP net income (note 1) attributable to Hello Group Inc. was RMB514.7 million (US$72.5 million) in the fourth quarter of 2023, compared to RMB487.9 million during the same period of 2022. Net income per ADS Diluted net income per ADS was RMB2.32 (US$0.33) in the fourth quarter of 2023, compared to RMB2.01 in the fourth quarter of 2022. Non-GAAP diluted net income per ADS (note 1) was RMB2.63 (US$0.37) in the fourth quarter of 2023, compared to RMB2.46 in the fourth quarter of 2022. Cash and cash flow As of December 31, 2023, the Company's cash, cash equivalents, short-term deposits, long-term deposits, short-term investments, short-term restricted cash and long-term restricted cash totaled RMB13,478.5 million (US$1,898.4 million), compared to RMB13,398.8 million as of December 31, 2022. Net cash provided by operating activities in the fourth quarter of 2023 was RMB415.9 million (US$58.6 million), compared to RMB538.7 million in the fourth quarter of 2022. Full Year 2023 Financial Results Net revenues for the full year of 2023 were RMB12,002.3 million (US$1,690.5 million), a decrease of 5.5% from RMB12,704.2 million in the same period of 2022. Net income attributable to Hello Group Inc. was RMB1,957.6 million (US$275.7 million) for the full year of 2023, compared to RMB1,484.3 million during the same period of 2022. Non-GAAP net income attributable to Hello Group Inc. (note 1) was RMB2,224.7 million (US$313.3 million) for the full year of 2023, compared to RMB1,885.8 million during the same period of 2022. Diluted net income per ADS was RMB9.84 (US$1.39) during the full year of 2023, compared to RMB7.31 in the same period of 2022. Non-GAAP diluted net income per ADS (note 1) was RMB11.17 (US$1.57) during the full year of 2023, compared to RMB9.20 in the same period of 2022. Net cash provided by operating activities was RMB2,277.2 million (US$320.7 million) during the full year of 2023, compared to RMB1,226.9 million in the same period of 2022. Recent Development Declaration of a special cash dividend Hello Group's board of directors has declared a special cash dividend in the amount of US$0.54 per ADS, or US$0.27 per ordinary share. The cash dividend will be paid on April 30, 2024 to shareholders of record at the close of business on April 12, 2024. The ex-dividend date will be April 11, 2024. The aggregate amount of cash dividends to be paid is approximately US$103 million, which will be funded by available cash on the Company's balance sheet. Share repurchase program On June 7, 2022, Hello Group's board of directors authorized a share repurchase program under which the Company may repurchase up to US$200 million of its shares up to June 6, 2024 (the ""Share Repurchase Program""). As of March 14, 2024, the Company has repurchased 16.2 million ADSs for US$86.1 million on the open market under this program, at an average purchase price of US$5.31 per ADS. On March 14, 2024, Hello Group's board of directors approved to amend the Share Repurchase Program to (i) extend the term of the Share Repurchase Program up to June 30, 2026, and (ii) upsize the Share Repurchase Program so that the Company is authorized to, from time to time, acquire up to an aggregate of US$286.1 million worth of its shares in the form of ADSs and/or the ordinary shares of the Company in the open market and through privately negotiated transactions, in block trades and/or through other legally permissible means, depending on market conditions and in accordance with applicable rules and regulations. Business Outlook For the first quarter of 2024, the Company expects total net revenues to be between RMB2.45 billion to RMB2.55 billion, representing a decrease of 13.1% to 9.5% year over year. This forecast reflects the Company's current and preliminary views on the market and operational conditions, which are subject to change. Note 1: Non-GAAP measures To supplement our consolidated financial statements presented in accordance with U.S. generally accepted accounting principles (""GAAP""), we, Hello Group, use various non-GAAP financial measures that are adjusted from the most comparable GAAP results to exclude share-based compensation. Reconciliations of our non-GAAP financial measures to our U.S. GAAP financial measures are shown in tables at the end of this earnings release, which provide more details about the non-GAAP financial measures. Our non-GAAP financial information is provided as additional information to help investors compare business trends among different reporting periods on a consistent basis and to enhance investors' overall understanding of the historical and current financial performance of our continuing operations and our prospects for the future. Our non-GAAP financial information should be considered in addition to results prepared in accordance with GAAP, but should not be considered a substitute for or superior to the GAAP results. In addition, our calculation of the non-GAAP financial measures may be different from the calculation used by other companies, and therefore comparability may be limited. Our non-GAAP information (including non-GAAP cost and operating expenses, income (loss) from operations, net income (loss), net income attributable to Hello Group Inc., and diluted net income per ADS) is adjusted from the most comparable GAAP results to exclude share-based compensation. A limitation of using these non-GAAP financial measures is that share-based compensation has been and will continue to be for the foreseeable future significant recurring expenses in our results of operations. We compensate for such limitation by providing reconciliations of our non-GAAP measures to our U.S. GAAP measures. Please see the reconciliation tables at the end of this earnings release. Conference Call Hello Group's management will host an earnings conference call on Thursday, March 14, 2024, at 8:00 a.m. U.S. Eastern Time (8:00 p.m. Beijing / Hong Kong Time on March 14, 2024). Participants can register for the conference call by navigating to: https://s1.c-conf.com/diamondpass/10037219-7ww6gf.html. Upon registration, each participant will receive details for the conference call, including dial-in numbers, conference call passcode and a unique access PIN. Please dial in 10 minutes before the call is scheduled to begin. A telephone replay of the call will be available after the conclusion of the conference call through March 21, 2024. The dial-in details for the replay are as follows: U.S. / Canada: 1-855-883-1031 Hong Kong: 800-930-639 Passcode: 10037219 Additionally, a live and archived webcast of the conference call will be available on the Investor Relations section of Hello Group's website at https://ir.hellogroup.com. About Hello Group Inc. We are a leading player in China's online social and entertainment space. Through Momo, Tantan and other properties within our product portfolio, we enable users to discover new relationships, expand their social connections and build meaningful interactions. Momo is a mobile application that connects people and facilitates social interactions based on location, interests and a variety of online recreational activities. Tantan, which was added into our family of applications through acquisition in May 2018, is a leading social and dating application. Tantan is designed to help its users find and establish romantic connections as well as meet interesting people. We also operate a number of other applications to serve different social and entertainment demands from our users. For investor and media inquiries, please contact: Hello Group Inc. Investor RelationsPhone: +86-10-5731-0538Email: ir@hellogroup.com Christensen In China Ms. Xiaoyan SuPhone: +86-10-5900-1548E-mail: Xiaoyan.Su@christensencomms.com In U.S. Ms. Linda BergkampPhone: +1-480-614-3004Email: linda.bergkamp@christensencomms.com Safe Harbor Statement This news release contains ""forward-looking"" statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and as defined in the Private Securities Litigation Reform Act of 1995. These forward-looking statements include but are not limited to our management quotes, our financial outlook for the first quarter of 2024, as well as the amount of, timing, methods and funding sources for repurchases of our shares under the share repurchase program. Our forward-looking statements are not historical facts but instead represent only our belief regarding expected results and events, many of which, by their nature, are inherently uncertain and outside of our control. Our actual results and other circumstances may differ, possibly materially, from the anticipated results and events indicated in these forward-looking statements. Announced results for the fourth quarter of 2023 are preliminary, unaudited and subject to audit adjustment. In addition, we may not meet our financial outlook for the first quarter of 2024 and may be unable to grow our business in the manner planned. We may also modify our strategy for growth. Moreover, there are other risks and uncertainties that could cause our actual results to differ from what we currently anticipate, including those relating to our ability to retain and grow our user base, our ability to attract and retain sufficiently trained professionals to support our operations, our ability to anticipate and develop new services and enhance existing services to meet the demand of our users or customers, the market price of the Company's stock prevailing from time to time, the nature of other investment opportunities presented to the Company from time to time, the Company's cash flows from operations, general economic conditions, and other factors. For additional information on these and other important factors that could adversely affect our business, financial condition, results of operations, and prospects, please see our filings with the U.S. Securities and Exchange Commission. All information provided in this press release and in the attachments is as of the date of the press release. We undertake no obligation to update any forward-looking statement, whether as a result of new information, future events or otherwise, after the date of this release, except as required by law. Such information speaks only as of the date of this release. Hello Group Inc. Unaudited Condensed Consolidated Statement of Operations (All amounts in thousands, except share and per share data) Three months Year Ended December 31 Ended December 31 2022 2023 2023 2022 2023 2023 RMB RMB US$ RMB RMB US$ Net revenues: Live video service 1,724,228 1,523,885 214,635 6,510,460 6,072,871 855,346 Value-added service 1,449,537 1,424,893 200,692 6,007,018 5,752,571 810,233 Mobile marketing 32,927 44,915 6,326 124,956 133,677 18,828 Mobile games 5,316 5,441 766 55,732 19,610 2,762 Other services 650 3,798 535 6,006 23,594 3,323 Total net revenues 3,212,658 3,002,932 422,954 12,704,172 12,002,323 1,690,492 Cost and expenses: Cost of revenues (1,916,050) (1,770,117) (249,316) (7,421,419) (7,025,394) (989,506) Research and development (272,657) (231,445) (32,598) (1,006,219) (884,590) (124,592) Sales and marketing (407,075) (304,696) (42,916) (2,073,617) (1,414,949) (199,291) General and administrative (142,492) (125,498) (17,676) (596,006) (502,479) (70,773) Total cost and expenses (2,738,274) (2,431,756) (342,506) (11,097,261) (9,827,412) (1,384,162) Other operating (loss) income, net (65,158) 30,821 4,341 20,632 130,105 18,325 Income from operations 409,226 601,997 84,789 1,627,543 2,305,016 324,655 Interest income 88,118 124,354 17,515 368,879 436,253 61,445 Interest expense (10,955) (20,552) (2,895) (83,530) (62,223) (8,764) Other gain or loss, net - (31,250) (4,401) 118,325 (26,685) (3,759) Income before income tax and share of income on equity method investments 486,389 674,549 95,008 2,031,217 2,652,361 373,577 Income tax expenses (109,421) (183,377) (25,828) (562,281) (630,023) (88,737) Income before share of income on equity method investments 376,968 491,172 69,180 1,468,936 2,022,338 284,840 Share of income (loss) on equity method investments 20,040 (38,703) (5,451) 11,073 (70,643) (9,950) Net income 397,008 452,469 63,729 1,480,009 1,951,695 274,890 Less: net loss attributable to non-controlling interest (986) - - (4,274) (5,886) (829) Net income attributable to the shareholders of Hello Group Inc. 397,994 452,469 63,729 1,484,283 1,957,581 275,719 Net income per share attributable to ordinary shareholders Basic 1.05 1.2 0.17 3.8 5.18 0.73 Diluted 1.01 1.16 0.16 3.65 4.92 0.69 Weighted average shares used in calculating net income per ordinary share Basic 377,841,986 376,317,036 376,317,036 390,176,367 377,639,399 377,639,399 Diluted 406,152,757 390,956,175 390,956,175 423,810,279 401,833,328 401,833,328 Hello Group Inc. Unaudited Condensed Consolidated Statement of Comprehensive Income (All amounts in thousands, except share and per share data) Three months Year Ended December 31 Ended December 31 2022 2023 2023 2022 2023 2023 RMB RMB US$ RMB RMB US$ Net income 397,008 452,469 63,729 1,480,009 1,951,695 274,890 Other comprehensive income (loss), net of tax: Foreign currency translation adjustment 54,041 (95,774) (13,489) (274,791) 20,414 2,875 Comprehensive income 451,049 356,695 50,240 1,205,218 1,972,109 277,765 Less: comprehensive (loss) income attributed to the non-controlling interest (7,154) (5,020) (707) 10,556 357 50 Comprehensive income attributable to Hello Group Inc. 458,203 361,715 50,947 1,194,662 1,971,752 277,715 Hello Group Inc. Unaudited Condensed Consolidated Balance Sheets (All amounts in thousands, except share and per share data) December 31 December 31 December 31 2022 2023 2023 RMB RMB US$ Assets Current assets Cash and cash equivalents 5,018,129 5,620,466 791,626 Short-term deposits 5,300,000 1,270,626 178,964 Restricted cash 97,706 10,147 1,429 Short-term investments 300,240 - - Accounts receivable, net of allowance for doubtful accounts of RMB5,870 and RMB12,780 as of December 31, 2022 and 2023, respectively 188,711 201,517 28,383 Amounts due from related parties 55 7,258 1,022 Prepaid expenses and other current assets 819,706 723,364 101,884 Total current assets 11,724,547 7,833,378 1,103,308 Long-term deposits 2,600,000 3,924,975 552,821 Long-term restricted cash 82,766 2,652,299 373,569 Right-of-use assets, net 115,520 109,572 15,433 Property and equipment, net 172,984 659,033 92,823 Intangible assets, net 22,203 17,086 2,407 Rental deposits 20,737 12,962 1,826 Long-term investments 893,988 786,911 110,834 Amounts due from RPT-non current - 20,000 2,817 Other non-current assets 162,499 180,052 25,360 Deferred tax assets 34,343 31,741 4,471 Total assets 15,829,587 16,228,009 2,285,669 Liabilities and equity Current liabilities Accounts payable 617,022 616,681 86,857 Deferred revenue 484,775 442,805 62,368 Accrued expenses and other current liabilities 797,504 630,617 88,821 Amounts due to related parties 9,178 4,314 608 Lease liabilities due within one year 88,352 60,008 8,452 Income tax payable 68,765 94,719 13,341 Deferred consideration in connection with business acquisitions 26,483 27,261 3,840 Long-term borrowings, current portion - 215,615 30,369 Convertible senior notes-current 2,646,168 - - Total current liabilities 4,738,247 2,092,020 294,656 Deferred tax liabilities 22,011 24,987 3,519 Convertible Senior Notes - 19,571 2,757 Long-term borrowings - 1,938,385 273,016 Lease liabilities 33,281 52,171 7,348 Other non-current liabilities 105,410 114,085 16,069 Total liabilities 4,898,949 4,241,219 597,365 Shareholder's equity (i) 10,930,638 11,986,790 1,688,304 Total liabilities and shareholder's equity 15,829,587 16,228,009 2,285,669 (i): As of December 31, 2023, the number of ordinary shares outstanding was 375,085,192. Hello Group Inc. Unaudited Condensed Consolidated Statement of Cash Flows (All amounts in thousands, except share and per share data) Three months Year Ended December 31 Ended December 31 2022 2023 2023 2022 2023 2023 RMB RMB US$ RMB RMB US$ Cash flows from operating activities: Net income 397,008 452,469 63,729 1,480,009 1,951,695 274,890 Adjustments to reconcile net income to net cash provided by operating activities: Depreciation of property and equipment 23,908 15,394 2,168 107,015 74,492 10,492 Amortization of intangible assets 1,279 1,279 180 5,116 5,116 721 Share-based compensation 89,944 62,224 8,765 401,484 267,101 37,620 Share of (income) loss on equity method investments (20,040) 38,703 5,451 (11,073) 70,643 9,950 Gain on repurchase of convertible senior notes - - - (129,575) (4,565) (643) Loss on long-term investments - 31,250 4,401 11,250 31,250 4,401 Cash received on distributions from equity method investments - - - 1,708 2,067 291 Gain or loss on disposal of property and equipment 4 2 - (779) (518) (73) Provision of (income) loss on receivable and other assets (75) 1,553 219 (528) 11,624 1,637 Changes in operating assets and liabilities: Accounts receivable 4,643 (11,392) (1,605) 20,338 (21,308) (3,001) Prepaid expenses and other current assets (36,784) (13,492) (1,900) (52,928) 84,802 11,944 Amounts due from related parties (55) (144) (20) (55) (27,203) (3,831) Rental deposits - 5,524 778 1,399 7,776 1,095 Deferred tax assets 1,493 1,728 243 507 2,600 366 Other non-current assets (15,907) 16,033 2,258 60,913 (11,606) (1,635) Accounts payable (8,992) (25,118) (3,538) (115,384) 13,707 1,931 Income tax payable (6,081) 5,456 768 (57,004) 25,952 3,655 Deferred revenue 17,504 (31,253) (4,402) (56,387) (42,390) (5,971) Accrued expenses and other current liabilities 121,638 (11,586) (1,632) (182,708) (183,772) (25,884) Amount due to related parties (265) 639 90 4,162 (4,865) (685) Deferred tax liabilities (15,367) (130,345) (18,359) (187,119) (147) (21) Other non-current liabilities (15,159) 6,953 979 (73,470) 24,710 3,480 Net cash provided by operating activities 538,696 415,877 58,573 1,226,891 2,277,161 320,729 Cash flows from investing activities: Purchase of property and equipment (10,053) (316,847) (44,627) (80,445) (576,310) (81,172) Payment for long-term investments (15,000) (9,750) (1,373) (70,343) (18,750) (2,641) Purchase of short-term deposits - - - (1,700,000) (1,028,556) (144,869) Cash received on maturity of short-term deposits 1,700,000 800,000 112,678 5,410,000 6,209,820 874,635 Payment for short term investments (300,000) - - (300,000) - - Cash received from sales of short-term investment - 308,550 43,458 - 308,550 43,458 Cash received on investment income distribution - - - 3,523 1,517 214 Purchase of long-term deposits (200,000) (361,165) (50,869) (2,750,000) (4,210,025) (592,970) Cash received on maturity of long-term deposits - - - 1,200,000 1,700,000 239,440 Cash received from sales of long-term investment - 10,000 1,408 - 25,000 3,521 Other investing activities 7 1 - 3,110 1,823 257 Net cash provided by investing activities 1,174,954 430,789 60,675 1,715,845 2,413,069 339,873 Cash flows from financing activities: Deferred payment for business acquisition - - - (21,421) - - Proceeds from exercise of share options 112 31 4 163 601 85 Repurchase of ordinary shares (104,684) (150,191) (21,154) (392,374) (212,195) (29,887) Repurchase of subsidiary's share options (1,076) - - (40,943) (4,319) (608) Dividends payment - (20,803) (2,930) (840,997) (958,052) (134,939) Proceeds from long-term borrowings - - - - 2,154,000 303,385 Payment for redemption of convertible bonds - - - (2,136,987) (2,679,942) (377,462) Net cash used in financing activities (105,648) (170,963) (24,080) (3,432,559) (1,699,907) (239,426) Effect of exchange rate changes (30,706) (34,609) (4,872) 41,390 93,988 13,240 Net increase (decrease) in cash and cash equivalents 1,577,296 641,094 90,296 (448,433) 3,084,311 434,416 Cash, cash equivalents and restricted cash at the beginning of period 3,621,305 7,641,818 1,076,328 5,647,034 5,198,601 732,208 Cash, cash equivalents and restricted cash at the end of period 5,198,601 8,282,912 1,166,624 5,198,601 8,282,912 1,166,624 Hello Group Inc. Reconciliation of Non-GAAP financial measures to comparable GAAP measures (All amounts in thousands, except per share data) 1. Reconciliation of Non-GAAP cost and operating expenses, income from operations, and net income to comparable GAAP measures. Three months Three months Three months Ended December 31, 2022 Ended December 31, 2023 Ended December 31, 2023 GAAP Share-based compensation Non-GAAP GAAP Share-based compensation Non-GAAP GAAP Share-based compensation Non-GAAP RMB RMB RMB RMB RMB RMB US$ US$ US$ Cost of revenues (1,916,050) 1,707 (1,914,343) (1,770,117) 1,909 (1,768,208) (249,316) 269 (249,047) Research and development (272,657) 22,145 (250,512) (231,445) 13,375 (218,070) (32,598) 1,884 (30,714) Sales and marketing (407,075) 8,480 (398,595) (304,696) 8,653 (296,043) (42,916) 1,219 (41,697) General and administrative (142,492) 57,612 (84,880) (125,498) 38,287 (87,211) (17,676) 5,393 (12,283) Cost and operating expenses (2,738,274) 89,944 (2,648,330) (2,431,756) 62,224 (2,369,532) (342,506) 8,765 (333,741) Income from operations 409,226 89,944 499,170 601,997 62,224 664,221 84,789 8,765 93,554 Net income attributable to Hello Group Inc. 397,994 89,944 487,938 452,469 62,224 514,693 63,729 8,765 72,494 Reconciliation of Non-GAAP financial measures to comparable GAAP measures (All amounts in thousands, except per share data) 1. Reconciliation of Non-GAAP cost and operating expenses, income from operations, and net income to comparable GAAP measures-continued. Year Year Year Ended December 31, 2022 Ended December 31, 2023 Ended December 31, 2023 GAAP Share-based compensation Non-GAAP GAAP Share-based compensation Non-GAAP GAAP Share-based compensation Non-GAAP RMB RMB RMB RMB RMB RMB US$ US$ US$ Cost of revenues (7,421,419) 14,195 (7,407,224) (7,025,394) 6,307 (7,019,087) (989,506) 888 (988,618) Research and development (1,006,219) 88,797 (917,422) (884,590) 64,561 (820,029) (124,592) 9,093 (115,499) Sales and marketing (2,073,617) 38,432 (2,035,185) (1,414,949) 29,066 (1,385,883) (199,291) 4,094 (195,197) General and administrative (596,006) 260,060 (335,946) (502,479) 167,167 (335,312) (70,773) 23,545 (47,228) Cost and operating expenses (11,097,261) 401,484 (10,695,777) (9,827,412) 267,101 (9,560,311) (1,384,162) 37,620 (1,346,542) Income from operations 1,627,543 401,484 2,029,027 2,305,016 267,101 2,572,117 324,655 37,620 362,275 Net income attributable to Hello Group Inc. 1,484,283 401,484 1,885,767 1,957,581 267,101 2,224,682 275,719 37,620 313,339 Hello Group Inc. Unaudited Condensed Segment Report (All amounts in thousands, except share and per share data) Three months Ended December 31, 2023 Momo Tantan QOOL Total Total RMB RMB RMB RMB US$ Net revenues: Live video service 1,423,730 100,155 - 1,523,885 214,635 Value-added service 1,264,358 160,535 - 1,424,893 200,692 Mobile marketing 33,395 11,520 - 44,915 6,326 Mobile games 5,441 - - 5,441 766 Other services 1,760 - 2,038 3,798 535 Total net revenues 2,728,684 272,210 2,038 3,002,932 422,954 Cost and expenses (ii): Cost of revenues (1,638,915) (130,237) (965) (1,770,117) (249,316) Research and development (180,343) (51,102) - (231,445) (32,598) Sales and marketing (244,043) (58,444) (2,209) (304,696) (42,916) General and administrative (117,923) (6,882) (693) (125,498) (17,676) Total cost and expenses (2,181,224) (246,665) (3,867) (2,431,756) (342,506) Other operating income 29,442 1,301 78 30,821 4,341 Income (loss) from operations 576,902 26,846 (1,751) 601,997 84,789 Interest income 124,294 57 3 124,354 17,515 Interest expense (20,552) - - (20,552) (2,895) Other gain or loss, net (31,250) - - (31,250) (4,401) Income (loss) before income tax and share of income on equity method investments 649,394 26,903 (1,748) 674,549 95,008 Income tax expenses (180,669) (2,708) - (183,377) (25,828) Income (loss) before share of income on equity method investments 468,725 24,195 (1,748) 491,172 69,180 Share of loss on equity method investments (38,703) - - (38,703) (5,451) Net income (loss) 430,022 24,195 (1,748) 452,469 63,729 (ii) Share-based compensation was allocated in cost of revenues and operating expenses as follows: Three months Ended December 31, 2023 Momo Tantan QOOL Total Total RMB RMB RMB RMB US$ Cost of revenues 1,905 4 - 1,909 269 Research and development 13,194 181 - 13,375 1,884 Sales and marketing 8,653 - - 8,653 1,219 General and administrative 38,279 8 - 38,287 5,393 Total cost and expenses 62,031 193 - 62,224 8,765 Hello Group Inc. Reconciliation of GAAP and NON-GAAP Results of Unaudited Segment Report (All amounts in thousands, except share and per share data) Three months Ended December 31, 2023 Momo Tantan QOOL Total Total RMB RMB RMB RMB US$ Income (loss) from operations 576,902 26,846 (1,751) 601,997 84,789 Share-based compensation 62,031 193 - 62,224 8,765 Non-GAAP income (loss) from operations 638,933 27,039 (1,751) 664,221 93,554 Net income (loss) 430,022 24,195 (1,748) 452,469 63,729 Share-based compensation 62,031 193 - 62,224 8,765 Non-GAAP net income (loss) 492,053 24,388 (1,748) 514,693 72,494 Hello Group Inc. Unaudited Condensed Segment Report (All amounts in thousands, except share and per share data) Three months Ended December 31, 2022 Momo Tantan QOOL Total Total RMB RMB RMB RMB US$[1] Net revenues: Live video service 1,561,332 162,896 - 1,724,228 249,990 Value-added service 1,265,693 183,844 - 1,449,537 210,164 Mobile marketing 32,927 - - 32,927 4,774 Mobile games 5,316 - - 5,316 771 Other services 483 - 167 650 93 Total net revenues 2,865,751 346,740 167 3,212,658 465,792 Cost and expenses (iii): Cost of revenues (1,722,675) (192,748) (627) (1,916,050) (277,801) Research and development (200,740) (71,917) - (272,657) (39,532) Sales and marketing (307,166) (98,209) (1,700) (407,075) (59,020) General and administrative (131,844) (7,899) (2,749) (142,492) (20,659) Total cost and expenses (2,362,425) (370,773) (5,076) (2,738,274) (397,012) Other operating (loss) income, net (67,499) 2,339 2 (65,158) (9,447) Income (loss) from operations 435,827 (21,694) (4,907) 409,226 59,333 Interest income 87,799 253 66 88,118 12,776 Interest expense (10,955) - - (10,955) (1,588) Income (loss) before income tax and share of income on equity method investments 512,671 (21,441) (4,841) 486,389 70,521 Income tax (expenses) benefits (135,602) 26,181 - (109,421) (15,865) Income (loss) before share of income on equity method investments 377,069 4,740 (4,841) 376,968 54,656 Share of income on equity method investments 20,040 - - 20,040 2,906 Net income (loss) 397,109 4,740 (4,841) 397,008 57,562 (iii) Share-based compensation was allocated in cost of revenues and operating expenses as follows: Three months Ended December 31, 2022 Momo Tantan QOOL Total Total RMB RMB RMB RMB US$ Cost of revenues 1,689 18 - 1,707 247 Research and development 15,907 6,238 - 22,145 3,211 Sales and marketing 8,473 7 - 8,480 1,229 General and administrative 57,350 262 - 57,612 8,353 Total cost and expenses 83,419 6,525 - 89,944 13,040 [1] All translations from RMB to U.S. dollars are made at a rate of RMB6.8972 to US$1.00, the effective noon buying rate for December 30, 2022 as set forth in the H.10 statistical release of the Federal Reserve Board. Hello Group Inc. Reconciliation of GAAP and NON-GAAP Results of Unaudited Segment Report (All amounts in thousands, except share and per share data) Three months Ended December 31, 2022 Momo Tantan QOOL Total Total RMB RMB RMB RMB US$ Income (loss) from operations 435,827 (21,694) (4,907) 409,226 59,333 Share-based compensation 83,419 6,525 - 89,944 13,040 Non-GAAP income (loss) from operations 519,246 (15,169) (4,907) 499,170 72,373 Net income (loss) 397,109 4,740 (4,841) 397,008 57,562 Share-based compensation 83,419 6,525 - 89,944 13,040 Non-GAAP net income (loss) 480,528 11,265 (4,841) 486,952 70,602 Hello Group Inc. Unaudited Condensed Segment Report (All amounts in thousands, except share and per share data) Year Ended December 31, 2023 Momo Tantan QOOL Total Total RMB RMB RMB RMB US$ Net revenues: Live video service 5,567,894 504,977 - 6,072,871 855,346 Value-added service 5,085,541 667,030 - 5,752,571 810,233 Mobile marketing 109,125 24,552 - 133,677 18,828 Mobile games 19,610 - - 19,610 2,762 Other services 16,337 - 7,257 23,594 3,323 Total net revenues 10,798,507 1,196,559 7,257 12,002,323 1,690,492 Cost and expenses (iv): Cost of revenues (6,404,042) (599,348) (22,004) (7,025,394) (989,506) Research and development (664,340) (220,250) - (884,590) (124,592) Sales and marketing (1,138,505) (268,652) (7,792) (1,414,949) (199,291) General and administrative (467,537) (26,482) (8,460) (502,479) (70,773) Total cost and expenses (8,674,424) (1,114,732) (38,256) (9,827,412) (1,384,162) Other operating income 125,318 4,411 376 130,105 18,325 Income (loss) from operations 2,249,401 86,238 (30,623) 2,305,016 324,655 Interest income 435,451 713 89 436,253 61,445 Interest expense (62,223) - - (62,223) (8,764) Other gain or loss, net (26,685) - - (26,685) (3,759) Income (loss) before income tax and share of income on equity method investments 2,595,944 86,951 (30,534) 2,652,361 373,577 Income tax expenses (623,844) (6,179) - (630,023) (88,737) Income (loss) before share of income on equity method investments 1,972,100 80,772 (30,534) 2,022,338 284,840 Share of loss on equity method investments (70,643) - - (70,643) (9,950) Net income (loss) 1,901,457 80,772 (30,534) 1,951,695 274,890 (iv) Share-based compensation was allocated in cost of revenues and operating expenses as follows: Year Ended December 31, 2023 Momo Tantan QOOL Total Total RMB RMB RMB RMB US$ Cost of revenues 6,167 140 - 6,307 888 Research and development 49,987 14,574 - 64,561 9,093 Sales and marketing 29,061 5 - 29,066 4,094 General and administrative 167,135 32 - 167,167 23,545 Total cost and expenses 252,350 14,751 - 267,101 37,620 Hello Group Inc. Reconciliation of GAAP and NON-GAAP Results of Unaudited Segment Report (All amounts in thousands, except share and per share data) Year Ended December 31, 2023 Momo Tantan QOOL Total Total RMB RMB RMB RMB US$ Income (loss) from operations 2,249,401 86,238 (30,623) 2,305,016 324,655 Share-based compensation 252,350 14,751 - 267,101 37,620 Non-GAAP income (loss) from operations 2,501,751 100,989 (30,623) 2,572,117 362,275 Net income (loss) 1,901,457 80,772 (30,534) 1,951,695 274,890 Share-based compensation 252,350 14,751 - 267,101 37,620 Non-GAAP net income (loss) 2,153,807 95,523 (30,534) 2,218,796 312,510 Hello Group Inc. Unaudited Condensed Segment Report (All amounts in thousands, except share and per share data) Year Ended December 31, 2022 Momo Tantan QOOL Total Total RMB RMB RMB RMB US$ Net revenues: Live video service 5,966,323 544,137 - 6,510,460 943,928 Value-added service 5,183,302 823,716 - 6,007,018 870,936 Mobile marketing 124,956 - - 124,956 18,117 Mobile games 55,732 - - 55,732 8,080 Other services 4,781 - 1,225 6,006 871 Total net revenues 11,335,094 1,367,853 1,225 12,704,172 1,841,932 Cost and expenses (v): Cost of revenues (6,704,020) (714,936) (2,463) (7,421,419) (1,076,005) Research and development (737,380) (268,839) - (1,006,219) (145,888) Sales and marketing (1,346,692) (721,889) (5,036) (2,073,617) (300,646) General and administrative (547,798) (33,234) (14,974) (596,006) (86,413) Total cost and expenses (9,335,890) (1,738,898) (22,473) (11,097,261) (1,608,952) Other operating income 8,753 11,830 49 20,632 2,991 Income (loss) from operations 2,007,957 (359,215) (21,199) 1,627,543 235,971 Interest income 368,051 544 284 368,879 53,482 Interest expense (83,530) - - (83,530) (12,111) Other gain or loss, net 118,325 - - 118,325 17,156 Income (loss) before income tax and share of income on equity method investments 2,410,803 (358,671) (20,915) 2,031,217 294,498 Income tax (expenses) benefits (586,663) 24,382 - (562,281) (81,523) Income (loss) before share of income on equity method investments 1,824,140 (334,289) (20,915) 1,468,936 212,975 Share of income on equity method investments 11,073 - - 11,073 1,605 Net income (loss) 1,835,213 (334,289) (20,915) 1,480,009 214,580 (v) Share-based compensation was allocated in cost of revenues and operating expenses as follows: Year Ended December 31, 2022 Momo Tantan QOOL Total Total RMB RMB RMB RMB US$ Cost of revenues 7,166 7,029 - 14,195 2,058 Research and development 67,659 21,138 - 88,797 12,874 Sales and marketing 38,202 230 - 38,432 5,572 General and administrative 259,669 391 - 260,060 37,705 Total cost and expenses 372,696 28,788 - 401,484 58,209 Hello Group Inc. Reconciliation of GAAP and NON-GAAP Results of Unaudited Segment Report (All amounts in thousands, except share and per share data) Year Ended December 31, 2022 Momo Tantan QOOL Total Total RMB RMB RMB RMB US$ Income (loss) from operations 2,007,957 (359,215) (21,199) 1,627,543 235,971 Share-based compensation 372,696 28,788 - 401,484 58,209 Non-GAAP income (loss) from operations 2,380,653 (330,427) (21,199) 2,029,027 294,180 Net income (loss) 1,835,213 (334,289) (20,915) 1,480,009 214,580 Share-based compensation 372,696 28,788 - 401,484 58,209 Non-GAAP net income (loss) 2,207,909 (305,501) (20,915) 1,881,493 272,789 View original content:https://www.prnewswire.com/news-releases/hello-group-inc-announces-unaudited-financial-results-for-the-fourth-quarter-and-fiscal-year-2023-302089170.html SOURCE Hello Group Inc. What were the net revenues for Hello Group Inc. in Q4 2023? Net revenues were RMB3,002.9 million (US$423.0 million) in Q4 2023, a decrease of 6.5% from the same period in 2022. How did the net income change for Hello Group Inc. in Q4 2023 compared to Q4 2022? Net income increased to RMB452.5 million (US$63.7 million) in Q4 2023 from RMB398.0 million in Q4 2022. What was the Monthly Active Users count for Tantan app in December 2023? MAU on Tantan app were 13.7 million in December 2023, compared to 18.4 million in December 2022. How many total paying users did Momo app have in Q4 2023? Momo app had 7.4 million total paying users in Q4 2023, compared to 7.8 million in the same period in 2022. What was the net income attributable to Hello Group Inc. for the full year of 2023? Net income attributable to Hello Group Inc. was RMB1,957.6 million (US$275.7 million) for the full year of 2023, compared to RMB1,484.3 million in 2022."
Futu Announces Fourth Quarter and Full Year 2023 Unaudited Financial Results,2024-03-14T08:00:00.000Z,Neutral,Neutral,"Futu Holdings Limited announced its unaudited financial results for Q4 and full year 2023. The company saw a 15.0% increase in paying clients, totaling 1.7 million. Total client assets rose to HK$485.6 billion. However, total trading volume declined by 12.5% in Q4 2023. Financially, total revenues increased by 4.1% in Q4 and 31.4% for the full year 2023. Net income decreased by 8.6% in Q4 but increased by 46.2% for the full year.","Futu Announces Fourth Quarter and Full Year 2023 Unaudited Financial Results Rhea-AI Impact (Neutral) Rhea-AI Sentiment (Neutral) Tags earnings Rhea-AI Summary Futu Holdings Limited announced its unaudited financial results for Q4 and full year 2023. The company saw a 15.0% increase in paying clients, totaling 1.7 million. Total client assets rose to HK$485.6 billion. However, total trading volume declined by 12.5% in Q4 2023. Financially, total revenues increased by 4.1% in Q4 and 31.4% for the full year 2023. Net income decreased by 8.6% in Q4 but increased by 46.2% for the full year. Positive Strong growth in paying clients with a 15.0% increase to 1.7 million. Total client assets reached HK$485.6 billion, a 16.3% year-over-year increase. Decline in total trading volume by 12.5% in Q4 2023. Total revenues increased by 4.1% in Q4 and 31.4% for the full year 2023. Net income decreased by 8.6% in Q4 but increased by 46.2% for the full year. Negative None. Financial Analyst The financial results of Futu Holdings Limited indicate a mixed performance, with a notable increase in total revenues and net income on an annual basis but a decline in net income for the fourth quarter. The growth in paying clients and client assets reflects a positive trend in user acquisition and asset retention, which is crucial for the company's revenue model that relies on trading volumes and margin financing. However, the decrease in total trading volume and DARTs suggests a potential reduction in user trading activity, which could impact future revenue streams.From an investment perspective, the expansion into new markets, such as Malaysia and the strategic focus on reducing friction in the account opening process are promising signs of Futu's growth strategy. These moves could potentially offset the sluggish trading volumes observed in the Hong Kong market. Investors should monitor the company's ability to maintain client growth and asset accumulation, as these are critical drivers for sustained revenue growth in the brokerage industry. Market Research Analyst Futu's performance in various geographic markets provides insight into the company's strategic positioning. The decline in client acquisition in Hong Kong due to poor market performance contrasts with the sustained growth in Singapore and the rapid expansion in Japan and Malaysia. This geographical diversification could mitigate risks associated with market-specific downturns and is indicative of Futu's adaptive market entry strategies.Furthermore, the company's focus on leveraging technology to streamline account opening and targeted marketing efforts are indicative of a user-centric approach, which is essential in the competitive fintech space. The increase in margin financing and securities lending balance suggests a growing trust in Futu's platform and services, which could enhance customer lifetime value and contribute to long-term profitability. Economist The performance of Futu Holdings in the context of global economic trends shows resilience amidst market volatility. The increase in client assets and margin financing indicates a robust demand for wealth management and trading services. However, the decline in trading volumes and DARTs may reflect broader economic uncertainties affecting investor behavior. As the company expands into new markets, it will need to navigate varying economic conditions and investor sentiment, which could influence its operational success.The contrast between the year-over-year increase in revenues and the quarterly decline in net income could be indicative of rising costs or increased competition affecting profit margins. The company's future performance will depend on its ability to manage these challenges while capitalizing on growth opportunities in emerging markets and new investment products. 03/14/2024 - 04:00 AM HONG KONG, March 14, 2024 (GLOBE NEWSWIRE) -- Futu Holdings Limited (Futu or the Company) (Nasdaq: FUTU), a leading tech-driven online brokerage and wealth management platform, today announced its unaudited financial results for the fourth quarter and full year ended December 31, 2023. Fourth Quarter and Full Year 2023 Operational Highlights Total number of paying clients1 increased 15.0% year-over-year to 1,710,106 as of December 31, 2023.Total number of registered clients2 increased 10.2% year-over-year to 3,561,966 as of December 31, 2023.Total number of users3 increased 10.5% year-over-year to 21.6 million as of December 31, 2023.Total client assets increased 16.3% year-over-year to HK$485.6 billion as of December 31, 2023.Daily average client assets were HK$470.3 billion in the fourth quarter of 2023, an increase of 22.8% from the same period in 2022.Total trading volume in the fourth quarter of 2023 decreased by 12.5% year-over-year to HK$956.6 billion, in which trading volume for U.S. stocks was HK$704.6 billion, trading volume for Hong Kong stocks was HK$237.7 billion, and trading volume for stocks under the Stock Connect was HK$10.7 billion. Total trading volume in 2023 declined 12.8% year-over-year to HK$4.2 trillion.Daily average revenue trades (DARTs)4 in the fourth quarter of 2023 declined 22.2% year-over-year to 369,729. DARTs in 2023 declined 27.2% year-over-year to 428,745.Margin financing and securities lending balance increased 24.2% year-over-year to HK$33.1 billion as of December 31, 2023. Fourth Quarter 2023 Financial Highlights Total revenues increased 4.1% year-over-year to HK$2,373.3 million (US$303.8 million).Total gross profit increased 0.1% year-over-year to HK$1,939.8 million (US$248.3 million).Net income decreased 8.6% year-over-year to HK$876.4 million (US$112.2 million).Non-GAAP adjusted net income5 decreased 6.3% year-over-year to HK$950.5 million (US$121.7 million). Full Year 2023 Financial Highlights Total revenues increased 31.4% year-over-year to HK$10,008.4 million (US$1,281.3 million).Total gross profit increased 28.0% year-over-year to HK$8,472.2 million (US$1,084.7 million).Net income increased 46.2% year-over-year to HK$4,278.9 million (US$547.8 million).Non-GAAP adjusted net income increased 45.9% year-over-year to HK$4,569.8 million (US$585.1 million). Mr. Leaf Hua Li, Futus Chairman and Chief Executive Officer, said, In 2023, we added over 220 thousand paying clients, bringing the total number of paying clients to 1.7 million, up 15.0% year-over-year. We acquired over 59 thousand paying clients in the fourth quarter, down 8.6% quarter-over-quarter. In Hong Kong, client acquisition trended down due to sluggish Hong Kong stock market performance. In Singapore, client acquisition sustained the momentum in the third quarter as clients continued to demonstrate heightened interest in money market funds. Our efforts to reduce friction in the account opening process, combined with targeted marketing, led to an increase in client acquisition in Japan towards year-end, which further accelerated in the first quarter owing to the Japan stock market's exceptional performance. We officially launched our brokerage business in Malaysia on February 26th, 2024. Leveraging the high brand awareness we garnered in the region through our rapid share gain in Singapore, we added over 30,000 clients within just one week of official launch, the fastest growth we have seen in any new market. Overall, we saw strong paying client growth across all markets in the first quarter as U.S. equities continued to post new highs and sentiments around Chinese equities rebounded. We are confident about client acquisition in 2024 and are guiding for 350 thousand net new paying clients. Total client assets increased by 16.3% year-over-year and 3.7% quarter-over-quarter to HK$485.6 billion, driven by robust net asset inflow across all regions and market appreciation of our clients U.S. stock holdings. Notably, client assets in Singapore grew 25% sequentially as we continued to attract higher quality clients with our richer product portfolio and growing brand awareness. Margin financing and securities lending balance increased by 2.1%. Total trading volume decreased by 12.2% quarter-over-quarter to HK$956.6 billion. Hong Kong stock trading volume fell by 12.8% sequentially to HK$237.7 billion against weak market performance. U.S. stock trading volume declined by 12.4% quarter-over-quarter to HK$704.6 billion due to lower turnover of the key U.S. technology names, partially offset by resilient trading turnover of leveraged and inverse ETFs. Wealth management asset balance was HK$57.6 billion, up 82.3% year-over-year and 10.9% quarter-over-quarter. Clients bond holdings jumped by over 60% sequentially given robust demand for U.S. Treasury bills. In Hong Kong, we enriched our structured note offerings for professional investors. In Singapore, we entered into an exclusive distribution agreement with Fullerton Fund Management for its SGD-denominated money market fund, the first and only SGD T+0 money market fund for retail investors in Singapore. We had 414 IPO distribution and IR clients as of quarter end, up 24.3% year-over-year. We underwrote 37 Hong Kong IPOs in 2023 and ranked first among all brokers, according to Wind. In the quarter, we acted as joint bookrunners for several high-profile HK IPOs, including those of J&T Express and UBTech. Fourth Quarter 2023 Financial Results Revenues Total revenues were HK$2,373.3 million (US$303.8 million), an increase of 4.1% from HK$2,280.7 million in the fourth quarter of 2022. Brokerage commission and handling charge income was HK$904.0 million (US$115.7 million), a decrease of 13.8% from the fourth quarter of 2022. This was mainly due to lower trading volume. Interest income was HK$1,331.9 million (US$170.5 million), an increase of 17.1% from the fourth quarter of 2022. The increase was mainly driven by higher interest income from bank deposits and higher margin financing income due to an increase in daily average margin balance. Other income was HK$137.3 million (US$17.6 million), an increase of 45.6% from the fourth quarter of 2022. The increase was primarily attributable to higher fund distribution service income. Costs Total costs were HK$433.5 million (US$55.5 million), an increase of 26.7% from HK$342.2 million in the fourth quarter of 2022. Brokerage commission and handling charge expenses were HK$59.2 million (US$7.6 million), a decrease of 7.5% from the fourth quarter of 2022. This decline was roughly in line with the decrease of our brokerage commission and handling charge income. Interest expenses were HK$270.8 million (US$34.7 million), an increase of 48.8% from the fourth quarter of 2022. The increase was primarily due to higher expenses associated with our securities borrowing and lending business and higher margin financing interest expenses. Processing and servicing costs were HK$103.5 million (US$13.3 million), an increase of 7.6% from the fourth quarter of 2022. The increase was primarily due to higher cloud service fee for new markets and higher system usage fee. Gross Profit Total gross profit was HK$1,939.8 million (US$248.3 million), an increase of 0.1% from HK$1,938.5 million in the fourth quarter of 2022. Gross margin was 81.7%, as compared to 85.0% in the fourth quarter of 2022. Operating Expenses Total operating expenses were HK$916.0 million (US$117.3 million), an increase of 12.0% from HK$817.9 million in the fourth quarter of 2022. Research and development expenses were HK$363.1 million (US$46.5 million), an increase of 8.6% from the fourth quarter of 2022. This was primarily due to an increase in research and development headcount to support new product offerings in new markets, though the magnitude of the headcount growth decelerated throughout 2023. Selling and marketing expenses were HK$182.5 million (US$23.4 million), an increase of 19.2% from HK$153.1 million in the fourth quarter of 2022. This was driven by a 41% year-over-year increase in net new paying clients, offset by lower client acquisition costs. General and administrative expenses were HK$370.4 million (US$47.4 million), an increase of 12.1% from the fourth quarter of 2022. The increase was primarily due to an increase in general and administrative personnel, partially offset by lower professional service fees. Income from Operations Income from operations decreased by 8.6% to HK$1,023.8 million (US$131.1 million) from HK$1,120.7 million in the fourth quarter of 2022. Operating margin declined to 43.1% from 49.1% in the fourth quarter of 2022. Net Income Net income decreased by 8.6% to HK$876.4 million (US$112.2 million) from HK$958.7 million in the fourth quarter of 2022. Net income margin for the fourth quarter of 2022 declined to 36.9% from 42.0% in the year-ago quarter. Non-GAAP adjusted net income decreased by 6.3% to HK$950.5 million (US$121.7 million) from the fourth quarter of 2022. Non-GAAP adjusted net income is defined as net income excluding share-based compensation expenses. For further information, see ""Use of Non-GAAP Financial Measures"" at the bottom of this press release. Net Income per ADS Basic net income per American Depositary Share (ADS) was HK$6.40 (US$0.82), compared with HK$6.88 in the fourth quarter of 2022. Diluted net income per ADS was HK$6.31 (US$0.81), compared with HK$6.80 in the fourth quarter of 2022. Each ADS represents eight Class A ordinary shares. Full Year 2023 Financial Results Revenues Total revenues were HK$10,008.4 million (US$1,281.3 million), an increase of 31.4% from HK$7,614.0 million in 2022. Brokerage commission and handling charge income was HK$3,944.8 million (US$505.0 million), a decrease of 1.6% from HK$4,007.6 million in 2022. This was mainly due to lower trading volume, largely offset by higher blended commission rate. Interest income was HK$5,536.4 million (US$708.8 million), an increase of 72.2% from HK$3,214.3 million in 2022. The increase in interest income was mainly driven by higher interest income from bank deposits and securities borrowing and lending business. Other income was HK$527.2 million (US$67.5 million), an increase of 34.5% from HK$392.1 million in 2022. The increase was primarily attributable to higher fund distribution service income. Costs Total costs were HK$1,536.2 million (US$196.7 million), an increase of 54.2% from HK$996.1 million in 2022. Brokerage commission and handling charge expenses were HK$249.6 million (US$32.0 million), a decrease of 24.3% from HK$329.8 million in 2022. This was attributable to lower trading volume and cost savings from our U.S. self-clearing business. Interest expenses were HK$910.8 million (US$116.6 million), an increase of 211.4% from HK$292.5 million in 2022. The increase was mainly driven by higher expenses associated with our securities borrowing and lending business. Processing and servicing costs were HK$375.9 million (US$48.1 million), an increase of 0.6% from HK$373.8 million in 2022. Gross Profit Total gross profit was HK$8,472.2 million (US$1,084.7 million), an increase of 28.0% from HK$6,617.9 million in 2022. Gross profit margin declined from 86.9% in 2022 to 84.7% in 2023. Operating Expenses Total operating expenses were HK$3,464.7 million (US$443.6 million), an increase of 13.6% from HK$3,049.0 million in 2022. Research and development expenses were HK$1,440.9 million (US$184.5 million), an increase of 17.9% from HK$1,222.1 million in 2022. The increase was primarily due to an increase in research and development headcount. Selling and marketing expenses were HK$710.3 million (US$90.9 million), a decrease of 20.7% from HK$895.8 million in 2022. The decrease was mainly due to slower paying client growth and lower customer acquisition costs. General and administrative expenses were HK$1,313.5 million (US$168.2 million), an increase of 41.1% from HK$931.1 million in 2022. The increase was primarily due to an increase in headcount for general and administrative personnel, especially in new markets. Income from Operations Income from operations increased by 40.3% to HK$5,007.5 million (US$641.1 million) from HK$3,568.9 million in 2022. Operating margin increased to 50.0% from 46.9% in 2022 primarily due to strong topline growth and operating leverage. Net Income Net income increased by 46.2% to HK$4,278.9 million (US$547.8 million) from HK$2,926.9 million in 2022. Non-GAAP adjusted net income increased by 45.9% to HK$4,569.8 million (US$585.1 million) from HK$3,131.4 million in 2022. Non-GAAP adjusted net income is defined as net income excluding share-based compensation expenses. For further information, see ""Use of Non-GAAP Financial Measures"" at the bottom of this press release. Net Income per ADS Basic net income per American Depositary Share (ADS) was HK$31.00 (US$3.97), compared with HK$20.55 in 2022. Diluted net income per ADS was HK$30.59 (US$3.92), compared with HK$20.34 in 2022. Each ADS represents eight Class A ordinary shares. New Share Repurchase Program The Company announced its US$500 million share repurchase program in March 2022, and by 2023 year-end, the expiration date, the Company had repurchased an aggregate of 11 million ADSs with approximately US$365 million in open market transactions. In addition, the Company's board of directors has authorized a new share repurchase program under which the Company may repurchase up to US$500 million worth of its ADSs, until December 31, 2025. The Company plans to fund the repurchases from its existing cash balance. Under the new share repurchase program, Futu may repurchase its ADSs from time to time in the open market at prevailing market prices, in privately negotiated transactions, in block trades and/or through other legally permissible means, depending on market conditions and in accordance with applicable rules and regulations. Futu's board of directors will review the share repurchase program periodically, and may modify, suspend or terminate the share repurchase program at any time. Conference Call and Webcast Futu's management will hold an earnings conference call on Thursday, March 14, 2023, at 7:30 AM U.S. Eastern Time (7:30 PM on the same day, Beijing/Hong Kong Time). Please note that all participants will need to pre-register for the conference call, using the link https://register.vevent.com/register/BI6ca5f071faa5463a85ad66444ee71849. It will automatically lead to the registration page of ""Futu Holdings Ltd Fourth Quarter and Full Year 2023 Earnings Conference Call"", where details for RSVP are needed. Upon registering, all participants will be provided in confirmation emails with participant dial-in numbers and personal PINs to access the conference call. Please dial in 10 minutes prior to the call start time using the conference access information. Additionally, a live and archived webcast of this conference call will be available at https://ir.futuholdings.com/. About Futu Holdings Limited Futu Holdings Limited (Nasdaq: FUTU) is an advanced technology company transforming the investing experience by offering fully digitalized financial services. Through its proprietary digital platforms, Futubull and moomoo, the Company provides a full range of investment services, including trade execution and clearing, margin financing and securities lending, and wealth management. The Company has embedded social media tools to create a network centered around its users and provide connectivity to users, investors, companies, analysts, media and key opinion leaders. The Company also provides corporate services, including IPO distribution, investor relations and ESOP solution services. Use of Non-GAAP Financial Measures In evaluating the business, the Company considers and uses non-GAAP adjusted net income, a non-GAAP measure, as a supplemental measure to review and assess its operating performance. The presentation of the non-GAAP financial measure is not intended to be considered in isolation or as a substitute for the financial information prepared and presented in accordance with U.S. GAAP. The Company defines non-GAAP adjusted net income as net income excluding share-based compensation expenses. The Company presents the non-GAAP financial measure because it is used by the management to evaluate the operating performance and formulate business plans. Non-GAAP adjusted net income enables the management to assess the Company's operating results without considering the impact of share-based compensation expenses, which are non-cash charges. The Company also believes that the use of the non-GAAP measure facilitates investors' assessment of its operating performance. Non-GAAP adjusted net income is not defined under U.S. GAAP and is not presented in accordance with U.S. GAAP. This non-GAAP financial measure has limitations as analytical tools. One of the key limitations of using non-GAAP adjusted net income is that it does not reflect all items of expense that affect the Company's operations. Share-based compensation expenses have been and may continue to be incurred in the business and are not reflected in the presentation of non-GAAP adjusted net income. Further, the non-GAAP measure may differ from the non-GAAP information used by other companies, including peer companies, and therefore their comparability may be limited. The Company compensates for these limitations by reconciling the non-GAAP financial measure to the nearest U.S. GAAP performance measure, all of which should be considered when evaluating the Company's performance. For more information on this non-GAAP financial measure, please see the table captioned ""Unaudited Reconciliations of Non-GAAP and GAAP Results"" set forth at the end of this press release. Exchange Rate Information This announcement contains translations of certain HK dollars (HK$) amounts into U.S. dollars (""US$"") at specified rates solely for the convenience of the reader. Unless otherwise stated, all translations from HK$ to US$ were made at the rate of HK$7.8109 to US$1.00, the noon buying rate in effect on December 29, 2023 in the H.10 statistical release of the Federal Reserve Board. The Company makes no representation that the HK$ or US$ amounts referred could be converted into US$ or HK$, as the case may be, at any particular rate or at all. Safe Harbor Statement This announcement contains forward-looking statements. These statements are made under the ""safe harbor"" provisions of the United States Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as ""will,"" ""expects,"" ""anticipates,"" ""future,"" ""intends,"" ""plans,"" ""believes,"" ""estimates"" and similar statements. Among other things, the quotations from the management team of the Company, contain forward-looking statements. Futu may also make written or oral forward-looking statements in its periodic reports to the SEC, in its annual report to shareholders, in press releases and other written materials and in oral statements made by its officers, directors or employees to third parties. Statements that are not historical facts, including statements about Futu's beliefs and expectations, are forward-looking statements. Forward-looking statements involve inherent risks and uncertainties. A number of factors could cause actual results to differ materially from those contained in any forward-looking statement, including but not limited to the following: Futu's goal and strategies; Futu's expansion plans; Futu's future business development, financial condition and results of operations; Futu's expectations regarding demand for, and market acceptance of, its credit products; Futu's expectations regarding keeping and strengthening its relationships with borrowers, institutional funding partners, merchandise suppliers and other parties it collaborates with; general economic and business conditions; and assumptions underlying or related to any of the foregoing. Further information regarding these and other risks is included in Futu's filings with the SEC. All information provided in this press release and in the attachments is as of the date of this press release, and Futu does not undertake any obligation to update any forward-looking statement, except as required under applicable law. For investor inquiries, please contact: Investor RelationsFutu Holdings Limitedir@futuholdings.com _________________________ 1 The number of paying clients refers to the number of clients with assets in their trading accounts with Futu.2 The number of registered clients refers to the number of users with one or more trading accounts with Futu.3 The number of users refers to the number of user accounts registered with Futu.4 The number of Daily Average Revenue Trades (DARTs) refers to the number of average trades per day that generate commissions or fees.5 Non-GAAP adjusted net income is defined as net income excluding share-based compensation expenses. FUTU HOLDINGS LIMITEDUNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS(In thousands, except for share and per share data) As of December 31, As of December 31, 2022 2023 2023 HK$ HK$ US$ASSETS Cash and cash equivalents5,028,898 4,937,538 632,134Cash held on behalf of clients50,685,472 44,369,310 5,680,435Restricted cash1,215 1,232 158Term deposit5,860 5,540 709Short-term investments675,064 3,114,613 398,752Securities purchased under agreements to resell32,000 133,039 17,032Loans and advances-current (net of allowance of HK$27,840 thousand and HK$45,949 thousand as of December 31, 2022 and December 31, 2023, respectively)26,676,358 32,528,421 4,164,491Receivables: Clients513,358 293,505 37,576Brokers5,914,963 5,189,155 664,348Clearing organizations3,066,953 4,244,793 543,445Fund management companies and fund distributors79,086 151,691 19,420Interest254,310 268,504 34,376Prepaid assets28,507 54,691 7,002Other current assets102,258 135,479 17,345Total current assets93,064,302 95,427,511 12,217,223 Operating lease right-of-use assets196,864 224,092 28,690Long-term investments239,694 238,556 30,541Loans and advances-non-current36,765 18,934 2,424Other non-current assets965,205 1,226,754 157,055Total non-current assets1,438,528 1,708,336 218,710Total assets94,502,830 97,135,847 12,435,933 LIABILITIES Amounts due to related parties52,725 69,018 8,836 Payables: Clients57,209,066 48,762,263 6,242,848 Brokers11,815,274 15,648,286 2,003,391 Clearing organizations51,867 24,096 3,085 Fund management companies and fund distributors90,801 175,575 22,478 Interest9,864 44,109 5,647 Borrowings2,480,532 5,651,565 723,549 Lease liabilities-current109,416 114,682 14,682 Accrued expenses and other current liabilities1,706,159 1,939,004 248,243 Total current liabilities73,525,704 72,428,598 9,272,759 Lease liabilities-non-current101,727 123,335 15,789 Other non-current liabilities13,620 12,183 1,560 Total non-current liabilities115,347 135,518 17,349 Total liabilities73,641,051 72,564,116 9,290,108 SHAREHOLDERS EQUITY Class A ordinary shares68 71 9 Class B ordinary shares29 27 3 Additional paid-in capital18,154,442 18,456,438 2,362,908 Treasury Stock(4,324,565) (5,199,257) (665,641)Accumulated other comprehensive loss(47,846) (49,433) (6,329)Retained earnings7,079,416 11,360,890 1,454,492 Total shareholders' equity20,861,544 24,568,736 3,145,442 Non-controlling interest235 2,995 383 Total equity20,861,779 24,571,731 3,145,825 Total liabilities and equity94,502,830 97,135,847 12,435,933 FUTU HOLDINGS LIMITEDUNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME(In thousands, except for share and per share data) For the Three Months Ended For the Twelve Months Ended December 31,2022 December 31,2023 December 31,2023 December 31,2022 December 31,2023 December 31,2023 HK$ HK$ US$ HK$ HK$ US$Revenues Brokerage commission and handling charge income1,048,592 903,999 115,736 4,007,642 3,944,779 505,035 Interest income1,137,843 1,331,945 170,524 3,214,327 5,536,422 708,807 Other income94,284 137,318 17,580 392,058 527,217 67,498 Total revenues2,280,719 2,373,262 303,840 7,614,027 10,008,418 1,281,340 Costs Brokerage commission and handling charge expenses(63,994) (59,166) (7,575) (329,789) (249,567) (31,951)Interest expenses(181,978) (270,784) (34,667) (292,503) (910,759) (116,601)Processing and servicing costs(96,198) (103,539) (13,256) (373,840) (375,904) (48,126)Total costs(342,170) (433,489) (55,498) (996,132) (1,536,230) (196,678)Total gross profit1,938,549 1,939,773 248,342 6,617,895 8,472,188 1,084,662 Operating expenses Research and development expenses(334,464) (363,132) (46,490) (1,222,077) (1,440,893) (184,472)Selling and marketing expenses(153,080) (182,461) (23,360) (895,772) (710,348) (90,943)General and administrative expenses(330,342) (370,397) (47,421) (931,144) (1,313,464) (168,158)Total operating expenses(817,886) (915,990) (117,271) (3,048,993) (3,464,705) (443,573) Income from operations1,120,663 1,023,783 131,071 3,568,902 5,007,483 641,089 Others, net8,880 (16,749) (2,144) (210,295) 33,442 4,281 Income before income tax expense and share of loss from equity method investments1,129,543 1,007,034 128,927 3,358,607 5,040,925 645,370 Income tax expense(166,390) (125,812) (16,107) (413,962) (748,479) (95,825)Share of loss from equity method investments(4,428) (4,836) (619) (17,752) (13,497) (1,728) Net income958,725 876,386 112,201 2,926,893 4,278,949 547,817 Attributable to: Ordinary shareholders of the Company958,776 878,225 112,436 2,926,944 4,281,474 548,140 Non-controlling interest(51) (1,839) (235) (51) (2,525) (323) 958,725 876,386 112,201 2,926,893 4,278,949 547,817 Net income per share attributable to ordinary shareholders of the Company Basic0.86 0.80 0.10 2.57 3.88 0.50 Diluted0.85 0.79 0.10 2.54 3.82 0.49 Net income per ADS Basic6.88 6.40 0.82 20.55 31.00 3.97 Diluted6.80 6.31 0.81 20.34 30.59 3.92 Weighted average number of ordinary shares used in computing net income per share Basic1,115,322,083 1,097,155,166 1,097,155,166 1,139,377,763 1,104,899,411 1,104,899,411 Diluted1,127,497,510 1,112,774,804 1,112,774,804 1,151,021,697 1,119,653,571 1,119,653,571 Net income958,725 876,386 112,201 2,926,893 4,278,949 547,817 Other comprehensive income/(loss), net of tax Foreign currency translation adjustment2,802 81,589 10,446 (123,840) (1,587) (203)Total comprehensive income961,527 957,975 122,647 2,803,053 4,277,362 547,614 Attributable to: Ordinary shareholders of the Company961,560 959,786 122,879 2,803,086 4,279,887 547,937 Non-controlling interest(33) (1,811) (232) (33) (2,525) (323) 961,527 957,975 122,647 2,803,053 4,277,362 547,614 FUTU HOLDINGS LIMITEDUNAUDITED RECONCILIATIONS OF NON-GAAP AND GAAP RESULTS(In thousands) For the Three Months Ended For the Twelve Months Ended December 31,2022 December 31,2023 December 31,2023 December 31,2022 December 31,2023 December 31,2023 HK$ HK$ US$ HK$ HK$ US$ Net income958,725 876,386 112,201 2,926,893 4,278,949 547,817Add: Share-based compensation expenses55,824 74,077 9,484 204,529 290,831 37,234Adjusted net income1,014,549 950,463 121,685 3,131,422 4,569,780 585,051 Non-GAAP to GAAP reconciling items have no income tax effect. How many paying clients did Futu Holdings have at the end of 2023? Futu Holdings had 1,710,106 paying clients as of December 31, 2023. What was the total client assets for Futu Holdings as of December 31, 2023? Futu Holdings' total client assets were HK$485.6 billion as of December 31, 2023. How did the total trading volume change in Q4 2023 compared to the previous year? The total trading volume decreased by 12.5% year-over-year in Q4 2023. What was the percentage change in total revenues for Futu Holdings in Q4 2023? Total revenues for Futu Holdings increased by 4.1% year-over-year in Q4 2023. How did the net income of Futu Holdings change in Q4 2023 compared to the previous year? Net income decreased by 8.6% year-over-year for Futu Holdings in Q4 2023."
"TotalEnergies SE: Convening of the Annual Shareholders Meeting on May 24, 2024",2024-03-14T07:00:00.000Z,Low,Positive,"TotalEnergies SE announces the convening of the Ordinary and Extraordinary Shareholders Meeting on May 24, 2024, renewals of directorships, and approval of the Sustainability & Climate  2024 Progress Report.","TotalEnergies SE: Convening of the Annual Shareholders Meeting on May 24, 2024 Rhea-AI Impact (Low) Rhea-AI Sentiment (Positive) Tags Rhea-AI Summary TotalEnergies SE announces the convening of the Ordinary and Extraordinary Shareholders Meeting on May 24, 2024, renewals of directorships, and approval of the Sustainability & Climate  2024 Progress Report. Positive The Board of Directors of TotalEnergies SE has scheduled the Shareholders Meeting for May 24, 2024. Renewals of directorships, including Mr. Patrick Pouyann, were proposed for approval at the meeting. The Sustainability & Climate  2024 Progress Report will be presented at the meeting, reflecting the Company's commitment to sustainable development and energy transition. The Board of Directors aims to ensure governance continuity and strategic stability for TotalEnergies. Mrs. Marie-Ange Debon's appointment as a director for a three-year term will be proposed at the meeting. The Company's efforts towards reducing emissions and contributing to a sustainable energy transition will be highlighted in the 2024 Progress Report. Negative None. 03/14/2024 - 03:00 AM PARIS--(BUSINESS WIRE)-- Regulatory News: The Board of Directors of TotalEnergies SE (Paris:TTE) (LSE:TTE) (NYSE:TTE) met on March 13, 2024 under the chairmanship of Mr. Patrick Pouyann, Chairman and Chief Executive Officer. It has decided to convene the Ordinary and Extraordinary Shareholders Meeting of the Company on Friday, May 24, 2024. The Notice of Meeting will be published soon in France's BALO (Bulletin des Annonces Lgales et Obligatoires) and will be available on the Company's website. The Board of Directors also approved the documents that will be submitted to shareholders at the Annual Meeting, including the Management Report. Company Governance The directorships of Mr. Patrick Pouyann, Mr. Jacques Aschenbroich, Mr. Glenn Hubbard as well as of Mrs. Anne-Marie Idrac expire at the end of the Annual Shareholders' Meeting on May 24, 2024. It is reminded that at its meeting of September 21, 2023, the Board unanimously decided that the renewal of the mandate of Mr. Patrick Pouyann will be proposed to the Shareholders Meeting on May 24, 2024. In the frame of the balanced governance implemented since 2015, it has also unanimously decided to propose the renewal of the mandate of Mr. Jacques Aschenbroich, who has held the position of Lead Independent Director since May 26, 2023. While reaffirming its support to the quality and the relevance of the strategy implemented since 2020, the Board of Directors considers as appropriate to ensure the continuity of the Companys governance and leadership. Since 10 years, Patrick Pouyann has done an extraordinary job leading TotalEnergies in a complex environment, delivering outstanding financial results and engaging the Company in the energy transition more quickly and consistently than its peers. The Board of Directors unanimously looks forward to his continued leadership and his strategic vision to continue TotalEnergies transition, with determination and consistency, relying on two pillars: Oil & gas on the one hand, Electricity and Renewables on the other hand. This vision, which creates value in the medium and long term, and this strategic stability are an asset and a differentiating factor for TotalEnergies compared with its peers. Furthermore, on the proposal of the Governance and Ethics Committee, the Board of Directors decided to submit to the Shareholders Meeting on May 24, 2024 the renewal for a period of three years of the directorships of Mr. Glenn Hubbard. In light of her seniority on the Board of Directors, Mrs. Anne-Marie Idrac will no longer be considered an independent director under the AFEP-MEDEF Code in May 2024 and therefore the renewal of her mandate will not be proposed. The Board of Directors thanks Mrs. Anne-Marie Idrac for her invaluable contribution, in particular within the Governance and Ethics Committee, the Compensation Committee and the Strategy & CSR Committee, from which it will continue to benefit until the end of her mandate. The Board of Directors has decided to propose to the Shareholders Meeting the appointment of Mrs. Marie-Ange Debon as a director for a three-year term. Mrs. Marie-Ange Debon, a French national, is graduated from the French cole des hautes tudes commerciales (HEC) and from the French cole nationale de ladministration (ENA) and holds a masters degree in law. Chairwoman of the Keolis Group Executive Board, she acquired an extensive experience in administration and then in large international groups in the environmental and transport sectors and she will be able in particular to make the Board benefit from her skills in financial, regulatory and governance matters for large companies. Mrs. Marie-Ange Debon indicated that she will not seek the renewal of her mandate as a director in Technip Energies which will expire in May 2024. At the end of the Shareholders Meeting on May 24, 2024, if the proposed resolutions are approved, the Board of Directors will be composed of 14 members representing 7 nationalities. The proportion of independent directors as defined by the AFEP-MEDEF Code will stand at 82%, in line with best standards. The proportion of women and men will be 45% and 55% respectively. Opinion on the Sustainability & Climate  2024 Progress Report In the context of the resolution approved by shareholders in May 2023 concerning TotalEnergies' ambition for sustainable development and an energy transition towards carbon neutrality, the Board of Directors committed to report to shareholders on the progress made in implementing this ambition. To this end, the Board of Directors approved the Company's Sustainability & Climate  2024 Progress Report, which will be presented on March 21, 2024 and submitted to an advisory vote at the Shareholders Meeting on May 24, 2024. This report sets out the implementation of the strategy and the progress made in 2023 with regard to the 2030 objectives. In particular, it reports on the results achieved in terms of reducing the Company's emissions and its contribution to a just, orderly and equitable energy transition for all of its stakeholders. Other resolutions The Board of Directors will also submit to the Shareholders Meeting for approval resolutions on the compensation of corporate officers, the appointment of the auditors as sustainability auditors as well as financial resolutions. *** About TotalEnergies TotalEnergies is a global multi-energy company that produces and markets energies: oil and biofuels, natural gas and green gases, renewables and electricity. Our more than 100,000 employees are committed to energy that is ever more affordable, more sustainable, more reliable and accessible to as many people as possible. Active in nearly 130 countries, TotalEnergies puts sustainable development in all its dimensions at the heart of its projects and operations to contribute to the well-being of people. @TotalEnergies - TotalEnergies - TotalEnergies - TotalEnergies Cautionary Note The terms TotalEnergies, TotalEnergies company or Company in this document are used to designate TotalEnergies SE and the consolidated entities that are directly or indirectly controlled by TotalEnergies SE. Likewise, the words we, us and our may also be used to refer to these entities or to their employees. The entities in which TotalEnergies SE directly or indirectly owns a shareholding are separate legal entities. This document may contain forward-looking information and statements that are based on a number of economic data and assumptions made in a given economic, competitive and regulatory environment. They may prove to be inaccurate in the future and are subject to a number of risk factors. Neither TotalEnergies SE nor any of its subsidiaries assumes any obligation to update publicly any forward-looking information or statement, objectives or trends contained in this document whether as a result of new information, future events or otherwise. Information concerning risk factors, that may affect TotalEnergies financial results or activities is provided in the most recent Registration Document, the French-language version of which is filed by TotalEnergies SE with the French securities regulator Autorit des Marchs Financiers (AMF), and in the Form 20-F filed with the United States Securities and Exchange Commission (SEC). View source version on businesswire.com: https://www.businesswire.com/news/home/20240314973768/en/ TotalEnergies Contacts Media Relations: +33 (0)1 47 44 46 99 l presse@totalenergies.com l @TotalEnergiesPR Investor Relations: +33 (0)1 47 44 46 46 l ir@totalenergies.com Source: TotalEnergies SE When is the Ordinary and Extraordinary Shareholders Meeting of TotalEnergies SE scheduled? The Shareholders Meeting is set to take place on May 24, 2024. Who chairs the Board of Directors of TotalEnergies SE? Mr. Patrick Pouyann serves as the Chairman and Chief Executive Officer of TotalEnergies SE. What will be presented at the Shareholders Meeting related to sustainability and climate? The Sustainability & Climate  2024 Progress Report will be presented, reflecting the Company's progress in implementing sustainable development and energy transition goals. Who is proposed for a renewal of directorship at the meeting? Mr. Patrick Pouyann, Mr. Jacques Aschenbroich, and Mr. Glenn Hubbard are proposed for the renewal of their directorships. What is the educational background of Mrs. Marie-Ange Debon, the proposed director? Mrs. Marie-Ange Debon is a French national with a background in business and law, holding degrees from HEC and ENA."
EdgeTI to Present at 2024 TechConnect World Innovation Conference and Expo,2024-03-14T07:01:00.000Z,Low,Neutral,Edge Total Intelligence Inc. (UNFYF) selected to present at the 2024 TechConnect World Innovation Conference to discuss how Digital Twins accelerate value and overcome obstacles. The company's edgeCore platform showcased at the event. Digital Twins are projected to drive significant revenue growth in the coming years.,"EdgeTI to Present at 2024 TechConnect World Innovation Conference and Expo Rhea-AI Impact (Low) Rhea-AI Sentiment (Neutral) Tags conferences Rhea-AI Summary Edge Total Intelligence Inc. (UNFYF) selected to present at the 2024 TechConnect World Innovation Conference to discuss how Digital Twins accelerate value and overcome obstacles. The company's edgeCore platform showcased at the event. Digital Twins are projected to drive significant revenue growth in the coming years. Positive None. Negative None. 03/14/2024 - 03:01 AM Session to Discuss How EdgeCore Digital Twin Accelerates Value and Dodges RoadblocksArlington, Virginia--(Newsfile Corp. - March 14, 2024) - Edge Total Intelligence Inc. (TSXV: CTRL) (OTCQB: UNFYF) (FSE: Q5I) (""edgeTI"", ""Edge Technologies"", ""Company""), a leading provider of real-time digital operations software, announces that it has been selected to present in the Innovation category at 2024 TechConnect World Innovation Conference and Expo held June 17 - 19th at National Harbor, MD.edgeTI's Jacques Jarman, a frequent speaker at TechConnect World, will present how Digital Twins are in everyone's future and how to dodge roadblocks to achieve success. The presentation will be part of several innovative sessions on AI and Digital Transformation held throughout the conference. edgeTI is also providing in-person demonstrations of edgeCore to attendees in Booth 429. For more than 20 years, the TechConnect World Innovation Conference and Expo has connected top applied research and early-stage innovations from universities, labs, and startups. The 2024 TechConnect World Innovation event incorporates smaller events focused on Small Business, AI, and Nanotech. This year's challenge is the Modular Open System Approach (MOSA), an integrated technical and business strategy for managing and sustaining systems and fleets of systems by employing modular and open principles - an integrated strategy the edgeCore platform is incredibly adept at putting into operation. ""We are pleased to be selected again to present at the innovation sessions and look forward to meeting with fellow innovators and customers,"" said Jacques Jarman, CRO of edgeTI. ""Digital Twins have an interesting role to play in putting the right information in the hands of decision makers at the speed of relevance.""Digital Twins help people see across systems and focus on what's important via virtual replicas and intuitive data models of real-world systems and operations. According to Markets and Markets a global analysts firm, Digital Twin global revenues are estimated to grow at over 61.3 % CAGR from 2023 to 2028. About edgeTIedgeTI helps customers sustain situational awareness and accelerate action with its real-time digital operations software, edgeCore that unites multiple software applicates and data sources into one immersive experience called a Digital Twin. Global enterprises, service providers, and governments are more profitable when insight and action are united to deliver fluid journeys via the platform's low-code development capability and composable operations. With edgeCore, customers can improve their margins and agility by rapidly transforming siloed systems and data across continuously evolving situations in business, technology, and cross-domain operations - helping them achieve the impossible.Website: https://edgeti.com LinkedIn: www.linkedin.com/company/edgeti YouTube: www.youtube.com/user/edgetechnologies Twitter: www.twitter.com/edge_suite For more information, please contact:Nick Brigman, Analyst and Press RelationsPhone: 888-771-3343 Email: ir@edgeti.com Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.Forward-Looking Information and Statements Certain statements in this news release are forward-looking statements or information for the purposes of applicable Canadian and US securities law. Forward-looking statements consist of statements that are not purely historical, including any statements regarding beliefs, plans, expectations, or intentions regarding the future. Such information can generally be identified by the use of forwarding-looking wording such as ""may"", ""expect"", ""estimate"", ""anticipate"", ""intend"", ""believe"" and ""continue"" or the negative thereof or similar variations. The reader is cautioned that assumptions used in the preparation of any forward-looking information may prove to be incorrect. Events or circumstances may cause actual results to differ materially from those predicted, as a result of numerous known and unknown risks, uncertainties, and other factors, many of which are beyond the control of the Company, including but not limited to business, economic and capital market conditions.Such statements and information are based on numerous assumptions regarding present and future business strategies and the environment in which the Company will operate in the future, including the demand for its products, anticipated costs, and the ability to achieve goals. Factors that could cause the actual results to differ materially from those in forward-looking statements include the competition and general economic, and market or business conditions. Forward-looking statements contained in this news release are expressly qualified by this cautionary statement. The reader is cautioned not to place undue reliance on any forward-looking information. The forward-looking statements contained in this news release are made as of the date of this news release. Except as required by law, the Company disclaims any intention and assumes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.To view the source version of this press release, please visit https://www.newsfilecorp.com/release/201654 What event is Edge Total Intelligence Inc. (UNFYF) participating in? Edge Total Intelligence Inc. (UNFYF) is presenting at the 2024 TechConnect World Innovation Conference and Expo. Who will be presenting at the conference from Edge Total Intelligence Inc. (UNFYF)? Jacques Jarman, CRO of edgeTI, will be presenting at the conference. What is the focus of the presentation by Edge Total Intelligence Inc. (UNFYF) at the conference? The presentation will discuss how Digital Twins accelerate value and avoid obstacles. What is the projected revenue growth rate for Digital Twins according to Markets and Markets? Markets and Markets estimate a revenue growth rate of over 61.3% CAGR for Digital Twins from 2023 to 2028. Where can attendees see demonstrations of edgeCore by Edge Total Intelligence Inc. (UNFYF) at the conference? Attendees can see demonstrations of edgeCore at Booth 429 during the conference."
Transaction in Own Shares,2024-03-14T06:30:00.000Z,Low,Negative,"Endeavour Mining plc announces the purchase of 8,000 of its own ordinary shares, with details on prices and volume. Following the repurchase, the Company will have no shares in treasury and 245,111,155 ordinary shares in issue.","Transaction in Own Shares Rhea-AI Impact (Low) Rhea-AI Sentiment (Negative) Tags Rhea-AI Summary Endeavour Mining plc announces the purchase of 8,000 of its own ordinary shares, with details on prices and volume. Following the repurchase, the Company will have no shares in treasury and 245,111,155 ordinary shares in issue. Positive None. Negative None. 03/14/2024 - 02:30 AM ENDEAVOUR ANNOUNCES TRANSACTION IN OWN SHARES London, 14 March 2024  Endeavour Mining plc (LSE:EDV, TSX:EDV) (the Company) announces it has purchased the following number of its ordinary shares of USD 0.01 each from Stifel Nicolaus Europe Limited. Aggregated information Dates of purchase: 13 March 2024 Aggregate number of ordinary shares of USD 0.01 each purchased: 8,000 Lowest price paid per share (GBp): 1,434.00 Highest price paid per share (GBp): 1,445.00 Volume weighted average price paid per share (GBp): 1,438.50 Following the cancellation of the repurchased shares, the Company will have no ordinary shares in treasury and 245,111,155 ordinary shares in issue. Therefore the total voting rights in the Company will be 245,111,155. This figure for the total number of voting rights may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules. These share purchases form part of the Company's buy-back programme announced on 20 March 2023. Transaction details In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (the Market Abuse Regulation), the table below contains detailed information of the individual trades made by Stifel Nicolaus Europe Limited as part of the buyback programme. Schedule of purchases Shares purchased: Endeavour Mining plc (ISIN: GB00BL6K5J42) Dates of purchases: 13 March 2024 Investment firm: Stifel Nicolaus Europe Limited Individual transactions Transaction date and time Volume Price (GBp) Trading Venue 13 Mar 2024, 08:14 AM 1,000 1,443.00 LSE 13 Mar 2024, 08:29 AM 500 1,439.00 LSE 13 Mar 2024, 08:29 AM 500 1,439.00 LSE 13 Mar 2024, 08:30 AM 1,000 1,439.00 LSE 13 Mar 2024, 09:09 AM 1,000 1,440.00 LSE 13 Mar 2024, 09:25 AM 1,000 1,434.00 LSE 13 Mar 2024, 10:22 AM 1,000 1,434.00 LSE 13 Mar 2024, 11:01 AM 1,000 1,434.00 LSE 13 Mar 2024, 01:08 PM 588 1,445.00 LSE 13 Mar 2024, 01:08 PM 412 1,445.00 LSE CONTACT INFORMATION For Investor Relations Enquiries: For Media Enquiries: Jack Garman Brunswick Group LLP in London Vice President of Investor Relations Carole Cable, Partner +44 203 011 2723 +44 7974 982 458 investor@endeavourmining.com ccable@brunswickgroup.com ABOUT ENDEAVOUR MINING PLC Endeavour Mining is one of the worlds senior gold producers and the largest in West Africa, with operating assets across Senegal, Cote dIvoire and Burkina Faso and a strong portfolio of advanced development projects and exploration assets in the highly prospective Birimian Greenstone Belt across West Africa. A member of the World Gold Council, Endeavour is committed to the principles of responsible mining and delivering sustainable value to its employees, stakeholders and the communities where it operates. Endeavour is admitted to listing and to trading on the London Stock Exchange and the Toronto Stock Exchange, under the symbol EDV. For more information, please visit www.endeavourmining.com. CAUTIONARY NOTE REGARDING FORWARD-LOOKING INFORMATION This document contains ""forward-looking statements"" within the meaning of applicable securities laws. All statements, other than statements of historical fact, are forward-looking statements, including but not limited to, statements with respect to Endeavour's plans and operating performance, the estimation of mineral reserves and resources, the timing and amount of estimated future production, costs of future production, future capital expenditures, the success of exploration activities, the anticipated timing for the payment of a shareholder dividend and statements with respect to future dividends payable to the Companys shareholders, the completion of studies, mine life and any potential extensions, the future price of gold and the share buyback programme. Generally, these forward-looking statements can be identified by the use of forward-looking terminology such as ""expects"", ""expected"", ""budgeted"", ""forecasts"", ""anticipates"", believes, plan, target, opportunities, objective, assume, intention, goal, continue, estimate, potential, strategy, future, aim, may, will, can, could, would and similar expressions . Forward-looking statements, while based on management's reasonable estimates, projections and assumptions at the date the statements are made, are subject to risks and uncertainties that may cause actual results to be materially different from those expressed or implied by such forward-looking statements, including but not limited to: risks related to the successful completion of divestitures; risks related to international operations; risks related to general economic conditions and the impact of credit availability on the timing of cash flows and the values of assets and liabilities based on projected future cash flows; Endeavours financial results, cash flows and future prospects being consistent with Endeavour expectations in amounts sufficient to permit sustained dividend payments; the completion of studies on the timelines currently expected, and the results of those studies being consistent with Endeavours current expectations; actual results of current exploration activities; production and cost of sales forecasts for Endeavour meeting expectations; unanticipated reclamation expenses; changes in project parameters as plans continue to be refined; fluctuations in prices of metals including gold; fluctuations in foreign currency exchange rates; increases in market prices of mining consumables; possible variations in ore reserves, grade or recovery rates; failure of plant, equipment or processes to operate as anticipated; extreme weather events, natural disasters, supply disruptions, power disruptions, accidents, pit wall slides, labour disputes, title disputes, claims and limitations on insurance coverage and other risks of the mining industry; delays in the completion of development or construction activities; changes in national and local government legislation, regulation of mining operations, tax rules and regulations and changes in the administration of laws, policies and practices in the jurisdictions in which Endeavour operates; disputes, litigation, regulatory proceedings and audits; adverse political and economic developments in countries in which Endeavour operates, including but not limited to acts of war, terrorism, sabotage, civil disturbances, non-renewal of key licenses by government authorities, or the expropriation or nationalisation of any of Endeavours property; risks associated with illegal and artisanal mining; environmental hazards; and risks associated with new diseases, epidemics and pandemics. Although Endeavour has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking statements, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements. Please refer to Endeavour's most recent Annual Information Form filed under its profile at www.sedarplus.ca for further information respecting the risks affecting Endeavour and its business. The declaration and payment of future dividends and the amount of any such dividends will be subject to the determination of the Board of Directors, in its sole and absolute discretion, taking into account, among other things, economic conditions, business performance, financial condition, growth plans, expected capital requirements, compliance with the Company's constating documents, all applicable laws, including the rules and policies of any applicable stock exchange, as well as any contractual restrictions on such dividends, including any agreements entered into with lenders to the Company, and any other factors that the Board of Directors deems appropriate at the relevant time. There can be no assurance that any dividends will be paid at the intended rate or at all in the future. Attachment Transaction in own shares How many ordinary shares did Endeavour Mining plc purchase? Endeavour Mining plc purchased 8,000 of its own ordinary shares. What was the lowest price paid per share by Endeavour Mining plc? The lowest price paid per share by Endeavour Mining plc was 1,434.00 GBp. What was the highest price paid per share by Endeavour Mining plc? The highest price paid per share by Endeavour Mining plc was 1,445.00 GBp. How many ordinary shares will be in issue after the repurchase? After the repurchase, Endeavour Mining plc will have 245,111,155 ordinary shares in issue. What is the total voting rights in Endeavour Mining plc after the repurchase? The total voting rights in Endeavour Mining plc after the repurchase will be 245,111,155. When were the shares purchased by Endeavour Mining plc? The shares were purchased on 13 March 2024."
Embraer Selects Dassault Systmes Simulation Technology to Support Quieter eVTOL Aircraft Development for Eve Air Mobility,2024-03-14T06:00:00.000Z,Low,Positive,"Dassault Systmes and Embraer utilize simulation technology to optimize eVTOL aircraft aerodynamics and aeroacoustics. SIMULIA fluid dynamics applications predict real-world conditions, aiding in noise reduction and design optimization. Eve Air Mobility's eVTOL production facility in Brazil is underway, with deliveries expected in 2026.","Embraer Selects Dassault Systmes Simulation Technology to Support Quieter eVTOL Aircraft Development for Eve Air Mobility Rhea-AI Impact (Low) Rhea-AI Sentiment (Positive) Tags Rhea-AI Summary Dassault Systmes and Embraer utilize simulation technology to optimize eVTOL aircraft aerodynamics and aeroacoustics. SIMULIA fluid dynamics applications predict real-world conditions, aiding in noise reduction and design optimization. Eve Air Mobility's eVTOL production facility in Brazil is underway, with deliveries expected in 2026. Positive None. Negative None. Aerospace Engineer The collaboration between Dassault Systmes and Embraer represents a significant advancement in the aerospace industry's approach to designing eVTOL aircraft. The use of SIMULIA PowerFLOW for fluid dynamics simulation is a testament to the industry's shift towards more sustainable and efficient design processes. By virtually testing propeller aerodynamics and aeroacoustics, engineers can iterate designs rapidly, reducing the need for costly physical prototypes and mitigating potential design flaws early in the development cycle.From an engineering perspective, the ability to predict real-world operating conditions is crucial for the success of eVTOLs in urban environments. Noise pollution is a critical concern and the emphasis on aeroacoustics simulation underscores the industry's commitment to minimizing the acoustic footprint of these new aircraft. Moreover, the human-centered design approach ensures that the comfort and safety of passengers and the surrounding community are prioritized.The move towards electrically powered aircraft aligns with global sustainability goals and could lead to a reduction in carbon emissions from the aerospace sector. However, the successful integration of eVTOLs into urban airspaces hinges on regulatory approval and public acceptance, which are influenced by factors such as noise levels and safety records. Market Research Analyst Embraer's strategic decision to partner with Dassault Systmes for eVTOL development is likely to have a positive impact on their market positioning in the burgeoning Urban Air Mobility (UAM) sector. As traditional aerospace manufacturers face increasing competition from startups and technology companies in the eVTOL space, collaborations that leverage advanced simulation technologies can provide a competitive edge.The announcement of Eve's production facility in Brazil and the timeline for delivery and service commencement by 2026 offers investors and stakeholders a clear roadmap of Embraer's UAM initiatives. This transparency in progress can contribute to investor confidence, particularly as the UAM market is still in its nascent stages and carries significant investment risks.Given the potential of eVTOLs to disrupt the transportation industry, particularly in congested urban areas, Embraer's progress in this area could be a signal to investors of the company's long-term growth prospects. The emphasis on sustainability and noise reduction also aligns with increasing regulatory and consumer demand for environmentally friendly transportation solutions. Environmental Sustainability Analyst The integration of eVTOLs into urban transportation systems presents an opportunity to alleviate traffic congestion and reduce the environmental impact of commuting. Embraer's focus on electric propulsion in their eVTOL design is a significant step towards a more sustainable aviation future. By optimizing the aerodynamics and aeroacoustics of eVTOLs, the company is addressing two of the most pressing environmental concerns associated with urban air mobility: energy efficiency and noise pollution.While the environmental benefits of electrically powered aircraft are clear, the long-term sustainability of eVTOLs will depend on the sources of electricity used to charge their batteries. If the energy comes from renewable sources, the environmental impact will be substantially lower compared to traditional fossil fuel-powered aircraft. Additionally, the reduction in noise pollution is not only beneficial for urban inhabitants but also contributes to a higher quality of urban life.As urban air mobility evolves, it will be important to monitor the lifecycle environmental impact of these aircraft, including their manufacturing, operation and end-of-life disposal. The development of sustainable materials and recycling processes for eVTOLs will be crucial in ensuring that the industry's growth does not come at the expense of environmental health. 03/14/2024 - 02:00 AM Dassault Systmes SIMULIA fluid dynamics simulation applications optimize eVTOL propeller aerodynamics and aeroacoustics Engineering team has been accurately performing virtual tests of real-world operating conditions VELIZY-VILLACOUBLAY, France--(BUSINESS WIRE)-- Dassault Systmes (Euronext Paris: FR0014003TT8, DSY.PA) and Embraer (NYSE: ERJ; B3: EMBR3) announced today that Dassault Systmes simulation technology has been utilized to simulate, analyze and test virtually Eve Air Mobilitys (NYSE: EVEX) electric vertical take-off and landing (eVTOL) aircraft. Dassault Systmes SIMULIA PowerFLOW application has provided robust and industry-proven fluid dynamics simulation to predict real-world operating conditions, allowing Embraer and Eves engineers to evaluate how the aircraft flies and test its sound emission. One of the main advantages of eVTOL aircraft is that they are electrically powered and a more sustainable option than combustion-powered aircraft. However, they are meant to operate in urban areas, making noise reduction a key driver in their design. SIMULIA fluid dynamics applications will enable Embraer and Eve to experience and optimize the most critical parts of their eVTOL aircraft in a virtual environment, said David Ziegler, Vice President, Aerospace & Defense Industry, Dassault Systmes. Embraer and Eve have been working in collaborative efforts with global partners in line with the commitment to safely provide more reliable, affordable, sustainable, integrated and human-centric Urban Air Mobility (UAM) solutions. Numerical validated models have demonstrated accuracy when compared with experimental results and have helped accelerate product definition, said Micael Gianini, Interiors, Noise and Vibration Senior Manager at Embraer. The human-centered design ensures the safety, accessibility, and comfort of passengers, the pilot, and the community by minimizing noise. In July 2023, Embraer and Eve announced that Eves first eVTOL production facility will be located in the city of Taubat, in the state of So Paulo, Brazil. The company has begun assembly of its first full-scale eVTOL prototype, which will be followed by a test campaign in 2024. Eves eVTOL is scheduled to begin deliveries and enter into service in 2026. Social media: Share this on X, formerly known as Twitter: The worlds third largest commercial aircraft manufacturer @embraer selects @Dassault3DS @SIMULIA to design quieter eVTOL aircraft #3DEXPERIENCE Connect with Dassault Systmes on X Facebook LinkedIn YouTube For more information: Dassault Systmes industry solution experiences for the aerospace & defense industry: https://www.3ds.com/industries/aerospace-defense/aerospace-defense-solutions Dassault Systmes 3DEXPERIENCE platform, 3D design software, 3D Digital Mock Up and Product Lifecycle Management (PLM) solutions: http://www.3ds.com ### About Dassault Systmes Dassault Systmes, the 3DEXPERIENCE Company, is a catalyst for human progress. We provide business and people with collaborative virtual environments to imagine sustainable innovations. By creating virtual twin experiences of the real world with our 3DEXPERIENCE platform and applications, our customers can redefine the creation, production and life-cycle-management processes of their offer and thus have a meaningful impact to make the world more sustainable. The beauty of the Experience Economy is that it is a human-centered economy for the benefit of all consumers, patients and citizens. Dassault Systmes brings value to more than 300,000 customers of all sizes, in all industries, in more than 150 countries. For more information, visit www.3ds.com  Dassault Systmes. All rights reserved. 3DEXPERIENCE, the 3DS logo, the Compass icon, IFWE, 3DEXCITE, 3DVIA, BIOVIA, CATIA, CENTRIC PLM, DELMIA, ENOVIA, GEOVIA, MEDIDATA, NETVIBES, OUTSCALE, SIMULIA and SOLIDWORKS are commercial trademarks or registered trademarks of Dassault Systmes, a European company (Societas Europaea) incorporated under French law, and registered with the Versailles trade and companies registry under number 322 306 440, or its subsidiaries in the United States and/or other countries. About Eve Air Mobility Eve is dedicated to accelerating the Urban Air Mobility ecosystem. Benefitting from a start-up mindset, backed by Embraer S.A.s more than 50-year history of aerospace expertise, and with a singular focus, Eve is taking a holistic approach to progressing the UAM ecosystem, with an advanced eVTOL project, comprehensive global services and support network and a unique air traffic management solution. Since May 10, 2022, Eve is listed on the New York Stock Exchange where its shares of common stock and public warrants trade under the tickers EVEX and EVEXW. For more information, please visit www.eveairmobility.com. About Embraer A global aerospace company headquartered in Brazil, Embraer has businesses in Commercial and Executive aviation, Defense & Security and Agricultural Aviation. The company designs, develops, manufactures and markets aircraft and systems, providing Services & Support to customers after-sales. Since it was founded in 1969, Embraer has delivered more than 8,000 aircraft. On average, about every 10 seconds an aircraft manufactured by Embraer takes off somewhere in the world, transporting over 145 million passengers a year. Embraer is the leading manufacturer of commercial jets up to 150 seats and the main exporter of high value-added goods in Brazil. The company maintains industrial units, offices, service and parts distribution centers, among other activities, across the Americas, Africa, Asia and Europe. View source version on businesswire.com: https://www.businesswire.com/news/home/20240313360850/en/ Dassault Systmes Press Contacts Corporate / France Arnaud MALHERBE arnaud.malherbe@3ds.com +33 (0)1 61 62 87 73 North America Natasha LEVANTI natasha.levanti@3ds.com +1 (508) 449 8097 EMEA Virginie BLINDENBERG virginie.blindenberg@3ds.com +33 (0) 1 61 62 84 21 China Grace MU grace.mu@3ds.com +86 10 6536 2288 India Kriti ASHOK kriti.ashok@3ds.com +91 9741310607 Japan Wen YANG wen.yang@3ds.com +81 3 4321 6549 Korea Jeemin JEONG jeemin.jeong@3ds.com +82 2 3271 6653 Media Contact: Eve Air Mobility: media@eveairmobility.com Source: Dassault Systmes How are Dassault Systmes and Embraer using simulation technology? Dassault Systmes' SIMULIA PowerFLOW application is being utilized to simulate, analyze, and test Eve Air Mobility's eVTOL aircraft. What is the significance of noise reduction in eVTOL aircraft design? Noise reduction is crucial as eVTOL aircraft are meant to operate in urban areas. SIMULIA fluid dynamics applications aid in optimizing noise levels. Where will Eve Air Mobility's eVTOL production facility be located? Eve's first eVTOL production facility will be in Taubat, Brazil, with assembly of the prototype already underway. When is Eve's eVTOL aircraft expected to enter service? Eve's eVTOL is scheduled to begin deliveries and enter into service in 2026."
Norsk Hydro: Eivind Kallevik appointed CEO of Hydro,2024-03-14T06:00:00.000Z,Low,Very Positive,"Eivind Kallevik appointed as President and CEO of Norsk Hydro ASA, succeeding Hilde Merete Aasheim. Kallevik brings over 30 years of experience in finance and industry to lead Hydro towards 2030 and beyond.","Norsk Hydro: Eivind Kallevik appointed CEO of Hydro Rhea-AI Impact (Low) Rhea-AI Sentiment (Very Positive) Tags Rhea-AI Summary Eivind Kallevik appointed as President and CEO of Norsk Hydro ASA, succeeding Hilde Merete Aasheim. Kallevik brings over 30 years of experience in finance and industry to lead Hydro towards 2030 and beyond. Positive None. Negative None. 03/14/2024 - 02:00 AM Eivind Kallevik has been appointed President and CEO of Norwegian aluminium and renewable energy company Norsk Hydro ASA. Kallevik succeeds Hilde Merete Aasheim, who has decided to step down after five years. The appointment will be effective May 13, 2024. ""I am pleased to announce that Eivind Kallevik has accepted the job as President and CEO of Hydro. Throughout his more than 30 years of experience from Norwegian and international finance and industry, Eivind has a strong track record of developing the business, capturing opportunities, and maneuvering the industrial landscape and markets. I am confident Eivind has what it takes to lead Hydro towards 2030 and beyond,"" says Dag Mejdell, chairperson of Hydro's Board of Directors. Kallevik is currently Executive Vice President and Head of Hydro's Aluminium Metal business area, a position he has held since 2019. From 2013 to 2019 he held the position as CFO in Hydro. Prior to this, Kallevik held several senior management positions in Hydro, including the Bauxite & Alumina business area and the downstream aluminium business. ""I am excited to take the next step for Hydro together with our 32,000 competent and engaged employees, with our strategic direction towards 2030 as a strong foundation. Our low-carbon efforts throughout our value chain are placing Hydro in a leading position in the green transition and providing a platform to accelerate our strategic partnerships. Strong control of our cost position and continuous improvement efforts will remain the backbone of Hydros operations, combined with our unique capabilities to develop innovative technologies and commercial opportunities,"" says Kallevik. Hilde Merete Aasheim has been working in Hydro for 17 years and will leave the company end of June, 2024. ""Hilde Merete Aasheim has led the company through a period where we have seen significant changes in the world around us. She has demonstrated a strong ability to manage short-term challenges, while positioning the company for long-term opportunities together with the rest of the organization. During her tenure, Hydro has strengthened profitability and significantly lifted the sustainability agenda, says Mejdell. Investor contact: Martine Rambl Hagen +47 91708918 Martine.Rambol.Hagen@hydro.com Media contact: Halvor Molland +47 92979797 Halvor.Molland@hydro.com This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading Act Who is appointed as the new President and CEO of Norsk Hydro ASA? Eivind Kallevik has been appointed as the new President and CEO of Norsk Hydro ASA, effective May 13, 2024. Who is Eivind Kallevik and what is his background? Eivind Kallevik has over 30 years of experience in Norwegian and international finance and industry. He has held various senior management positions within Hydro, including CFO and Executive Vice President. Who is stepping down as President and CEO of Norsk Hydro ASA? Hilde Merete Aasheim has decided to step down as President and CEO of Norsk Hydro ASA after five years. She will leave the company by the end of June 2024. What are Eivind Kallevik's plans for Hydro's future? Eivind Kallevik aims to lead Hydro towards 2030 and beyond by focusing on low-carbon efforts, strategic partnerships, cost control, continuous improvement, and developing innovative technologies. How has Hilde Merete Aasheim contributed to Norsk Hydro ASA during her tenure? Hilde Merete Aasheim has led Hydro through significant changes, strengthened profitability, and lifted the sustainability agenda during her 17-year tenure."
Mattr Announces Fourth Quarter and Full Year 2023 Results,2024-03-14T05:27:00.000Z,Neutral,Neutral,"Mattr Corp. reported its operational and financial results for Q4 2023, showcasing a strategic shift towards harsh-environment infrastructure products. Despite challenges, Continuing Operations saw a 16% YoY increase in Adjusted EBITDA, with revenue hitting $925.3 million. The sale of the Pipeline Performance Group to Tenaris for $225 million concluded the strategic review. The Company anticipates net cash proceeds of $278.5 million post-working capital adjustments. With total net cash of $334.1 million, Mattr's financials remain robust.","Mattr Announces Fourth Quarter and Full Year 2023 Results Rhea-AI Impact (Neutral) Rhea-AI Sentiment (Neutral) Tags earnings Rhea-AI Summary Mattr Corp. reported its operational and financial results for Q4 2023, showcasing a strategic shift towards harsh-environment infrastructure products. Despite challenges, Continuing Operations saw a 16% YoY increase in Adjusted EBITDA, with revenue hitting $925.3 million. The sale of the Pipeline Performance Group to Tenaris for $225 million concluded the strategic review. The Company anticipates net cash proceeds of $278.5 million post-working capital adjustments. With total net cash of $334.1 million, Mattr's financials remain robust. Positive Continuing Operations achieved a 16% YoY growth in Adjusted EBITDA, reaching $165.1 million for full year 2023. Revenue for the full year 2023 stood at $925.3 million, with operating income from Continuing Operations at $81.5 million. The sale of the Pipeline Performance Group to Tenaris for $225 million marked the completion of the strategic review process. Total net cash as of December 31, 2023, was $334.1 million, with a Net Debt-to-Adjusted EBITDA ratio of approximately (0.26) times. Consolidated Net Income for 2023 was $87.2 million, with Consolidated Adjusted EBITDA at $388.0 million. Q4 2023 saw revenue of $210.8 million generated by Continuing Operations, with Adjusted EBITDA at $32.8 million, a 21% decrease YoY. The Composite Technologies segment's revenue decreased by 19% in Q4 to $112.5 million, with Adjusted EBITDA at $18.8 million. The Connection Technologies segment saw a 4% increase in revenue to $79.0 million in Q4, with Adjusted EBITDA at $14.7 million. Discontinued Operations in Q4 generated revenue of $265.1 million, operating income of $105.4 million, and Adjusted EBITDA of $104.9 million. Mattr repurchased 2.9 million common shares in Q4 for $41.9 million and completed the maximum repurchases permitted under its NCIB. The Company was renamed to Mattr Corp. post-Q4 2023, changing its US OTC ticker symbol from SAWLF to MTTRF. Negative Fourth quarter Adjusted EBITDA from Continuing Operations decreased by 21% YoY. Composite Technologies segment's Q4 revenue decreased by 19% compared to the prior year's quarter. Fourth quarter Adjusted EBITDA for the Composite Technologies segment decreased by 31% YoY. An impairment charge of $18.5 million was associated with the closure of a production facility in Q4 2023. Q4 2023 saw a Net Loss of $23.0 million on a total consolidated basis. The Company made a net repayment of $30.0 million on the Credit Facility in Q4. Fourth quarter Adjusted EBITDA for the Connection Technologies segment remained relatively flat compared to the prior year. Mattr reported a Net Loss of $23.0 million in Q4 on a total consolidated basis. 03/14/2024 - 01:27 AM TORONTO, March 14, 2024 (GLOBE NEWSWIRE) -- Mattr Corp. (Mattr or the Company) (TSX: MATR) reported today its operational and financial results for the three and twelve months ended December 31, 2023. This press release should be read in conjunction with the Companys Management Discussion and Analysis (MD&A) and audited consolidated financial statements for the years ended December 31, 2023 and 20221, which are available on the Companys website and at www.sedarplus.com. During the fourth quarter of 2023, Mattr continued to execute on its strategy to deliver long-term growth, margin expansion and volatility reduction, completing the sale of a substantial part of our legacy pipe coating business, which concludes our strategic review process and firmly positions the Company as a harsh-environment infrastructure products provider, delivering high-value solutions to customers as they expand and renew critical infrastructure around the world, said Mike Reeves, President & CEO of Mattr. In 2023, Mattrs Continuing Operations delivered year-over-year Adjusted EBITDA growth of approximately 16%, with Adjusted EBITDA margin expanding by 140 basis points in the same period. This was accomplished while also completing a fundamental business transformation and despite unfavorable interest rates, slowing North American oilfield activity, US infrastructure permitting challenges and automotive sector labor disruption. Highlights include1: Full year Continuing Operations revenue was $925.3 million and operating income from Continuing Operations was $81.5 million. Adjusted EBITDA from Continuing Operations was $165.1 million, a 16% increase compared to $141.8 million for full year 2022. The results from 2023 included $2.6 million of one-time costs associated with the Companys North American manufacturing footprint Modernization, Expansion and Optimization (MEO) program, which encompasses the Companys growth and efficiency improvement initiatives;The Company completed the sale of a substantial part of its Pipeline Performance Group (PPG) business, reported as Discontinued Operations, to Tenaris S.A. (Tenaris) on November 30, 2023, for a contractual purchase price of $225 million ($166 million USD), subject to a customary working capital adjustment, concluding the Companys strategic review process. The Company currently anticipates receiving aggregate net cash proceeds of approximately $278.5 million, consisting of the cash provided to the Company by operating activities from Discontinued Operations between signing and closing of this transaction, plus the contractual purchase price, net of its aggregate transaction fees and expenses and the currently estimated working capital adjustment. The Company expects the parties to finalize the net working capital adjustment during the second quarter of 2024;As at December 31, 2023, the Company had total net cash of $334.1 million and a Net Debt-to-Adjusted EBITDA2 ratio (using a trailing twelve-month consolidated Adjusted EBITDA2) of approximately (0.26) times;For the full year ended December 31, 2023, Consolidated Net Income was $87.2 million, Consolidated Adjusted EBITDA was $388.0 million, fully diluted Consolidated EPS was $1.25 and fully diluted Adjusted Consolidated EPS was $3.43;Fourth quarter revenue generated by Continuing Operations was $210.8 million and fourth quarter operating income from Continuing Operations was $2.3 million. Fourth quarter Adjusted EBITDA from Continuing Operations was $32.8 million, a 21% decrease compared to fourth quarter of 2022. Fourth quarter 2023 results included $1.7 million of one-time costs associated with the Companys MEO program and a non-cash impairment charge of $18.5 million associated with a production facility closure as discussed in further detail below;Composite Technologies segment fourth quarter revenue decreased by 19% to $112.5 million compared to $139.6 million in the prior years quarter. Fourth quarter Adjusted EBITDA for the Composite Technologies segment was $18.8 million, which included $1.5 million of one-time costs associated with the Companys MEO program, decreased by 31% from prior years fourth quarter;Subsequent to the end of the fourth quarter of 2023, and consistent with its MEO program, the Composite Technologies segment discontinued the production of fiberglass reinforced plastic (FRP) tanks within its Anaheim, California facility and took steps to exit the site, which is expected to be complete by year end. Once completed, this action is expected to lower annualized segment fixed costs in its Composite Technologies segment by approximately $2.5 million, elevate overall production footprint efficiency and substantially lower its exposure to potential environmental, employment and other regulatory risks associated with business operations within the State of California. This action is not expected to alter previously shared revenue growth potential and related returns expectations tied to the segments MEO program. Consequently, the Company has reported a related non-cash impairment charge of $18.5 million during the fourth quarter of 2023 and expects to report a related non-recurring charge during the first quarter of 2024;Connection Technologies segment fourth quarter revenue increased by 4% to $79.0 million compared to $76.0 million in the prior years quarter. Fourth quarter Adjusted EBITDA for the Connection Technologies segment was $14.7 million, which included $0.2 million of one-time costs associated with the Companys MEO program, was relatively flat compared to the fourth quarter of prior year;For the fourth quarter, Discontinued Operations generated revenue of $265.1 million, operating income of $105.4 million and Adjusted EBITDA of $104.9 million;On a total consolidated basis (consisting of both Continuing Operations and Discontinued Operations), for the fourth quarter Mattr reported Net Loss of $23.0 million, Adjusted EBITDA (Consolidated Adjusted EBITDA) of $137.7 million, fully diluted Earnings (Losses) Per Share (Consolidated EPS) of $(0.34) and fully diluted Adjusted Consolidated EPS of $1.51 during the fourth quarter;The Company generated $101.4 million in cash in the fourth quarter from operating activities from Continuing Operations and Discontinued Operations on a consolidated basis (Consolidated Total Operating Activities), compared to $163.0 million of cash generated from Consolidated Total Operating Activities during the fourth quarter of 2022, while investing approximately $19 million under the 2023 portion of its previously announced capital investment program to support longer-term growth in its Composite and Connection Technologies segments;A net repayment of $30.0 million was made on the Credit Facility (as defined herein) bringing the outstanding balance to zero;The Company remained active under its normal course issuer bid (NCIB) repurchasing 2.9 million of its common shares during the fourth quarter for an aggregate repurchase price of $41.9 million and completing the maximum number of repurchases of common shares permitted under its current NCIB, which is eligible for renewal starting in June 2024; andSubsequent to the end of the fourth quarter of 2023, the Company was renamed to Mattr Corp. and changed its US OTC ticker symbol from SAWLF to MTTRF. 1 The Companys consolidated financial statements for the year ended December 31, 2023, report Continuing Operations as the Companys Composite Technologies and Connection Technologies reporting segments and Discontinued Operations as the Companys PPS reporting segment. Total consolidated figures include figures from both Continuing Operations and Discontinued Operations. 2 Adjusted EBITDA, Adjusted EBITDA margin, and Adjusted EPS are non-GAAP measures. Non-GAAP measures do not have standardized meanings prescribed by GAAP and are not necessarily comparable to similar measures provided by other companies. See Section 5.0  Reconciliation of Non-GAAP Measures for further details and a reconciliation of these non-GAAP measures. Mr. Reeves continued, Each of our continuing operating segments achieved new record annual revenue and annual Adjusted EBITDA results for 2023. Connection Technologies delivered its largest ever premium wire and cable order and significantly expanded its US infrastructure market participation, while Composite Technologies increased fuel storage tank revenue by over 7%, reached a new annual water products revenue record and saw larger diameter Flexpipe product revenue rise by nearly 70% versus the prior year. In parallel, the Company repurchased over 4.4 million shares during 2023 and deployed nearly $76.3 million of organic growth capital, with four substantial, high return, North American production facility additions remaining on-time, on-budget and scheduled for first production between mid-2024 and early 2025. In these last twelve months the employees of Mattr have achieved a long list of extraordinary outcomes and have done so while setting a new safety performance record. I could not be prouder of this organization and the many talented, creative and committed people who work here. During the fourth quarter of 2023, our ongoing actions to lower fixed costs and enhance production efficiency enabled Continuing Operations to maintain Adjusted EBITDA margins1 in excess of 15%, as Connection Technologies delivered year-over-year revenue growth, partially offsetting the previously anticipated impacts of lower North American onshore oilfield activity and temporarily reduced fuel tank production and shipment activity, both of which weighed on our Composite Technologies segment. Notwithstanding its sale at the end of November, our Discontinued Operations delivered substantial revenue growth, both year-over-year and on a sequential basis, driven by continued strong operational execution on the Southeast Gateway Pipeline (SGP) project and around the world, a testament to the capabilities and professionalism of the entire pipe coating organization. Mr. Reeves concluded, Entering 2024, normal seasonality combined with flat early-year North American oilfield activity is anticipated to cause Adjusted EBITDA in the first quarter of the year to be modestly below the fourth quarter of 2023, before an expected significant upwards shift in the second quarter of 2024. Our businesses serve large and growing end markets, we have a robust balance sheet, significant opportunities for investment in high return organic growth and the capacity to seek and complete meaningful, accretive acquisitions. Consequently, management believes Mattr is well positioned to deliver substantial value creation for shareholders over the coming years. While we will be impacted by one-time costs tied to our North American production footprint MEO activities during 2024, we believe that full year 2024 revenue and underlying profitability will be higher than 2023, and that our Company is poised to meet our stated growth, profitability and free-cash-flow conversion objectives in the years that follow. Selected Financial Highlights (in thousands of Canadian dollars, except per share amounts and percentages)Three Months EndedYear Ended December 31December 31 2023 2022 2023 2022 $%$%$%$% Revenue210,767 225,751 925,271 861,786 Gross profit65,873 31%69,551 31%296,43932%258,230 30% Income from Continuing Operations(a)2,319 1%12,383 5%81,5429%110,971 13% Net Income from Continuing Operations2,336 13,489 55,859 93,347 Net (Loss) Income from Discontinued Operations(25,342) (80,299) 31,360 (124,323) Net (Loss) Income for the period(23,006) (66,810) 87,219 (30,976) (Loss) Earnings per share: Basic (0.34) (0.94) 1.26 (0.43) Diluted(0.34) (0.94) 1.25 (0.43) Adjusted EBITDA from ContinuingOperations (b) (c)32,787 16%41,413 18%165,07818%141,823 16% Adjusted EBITDA from Discontinued Operations(b) (c)104,933 40%15,044 13%222,88427%9,910 3% Total Adjusted EBITDA from Operations (b) (c)137,720 29%56,457 16%387,96222%151,733 12% Total Adjusted EPS from Operations: (b) Basic1.52 0.44 3.46 1.01 Diluted1.51 0.43 3.43 1.01 (a)Operating income for the three months ended December 31, 2023, includes $18.5 million impairment charges, $1.7 million gain on sale of land and other and $2.5 million restructuring costs and other, net; while operating income for the three months ended December 31, 2022, includes no gain on sale of land and other, $2.2 million in impairment charges and $4.1 million in restructuring costs and other, net. Operating income for the year ended December 31, 2023, includes impairment charges of $27.2 million, $1.7 million gain on sale of land and other and $2.5 million restructuring costs and other, net; while operating income for the year ended December 31, 2022, includes $43.0 million in gain on sale of land and other, $9.5 million in impairment charges and $9.7 million in restructuring costs and other, net.(b)Adjusted EBITDA and Adjusted EPS are non-GAAP measures. Non-GAAP measures do not have standardized meanings prescribed by GAAP and are not necessarily comparable to similar measures provided by other companies. See Section 5.0  Reconciliation of Non-GAAP Measures for further details and a reconciliation of these non-GAAP measures.(c)Adjusted EBITDA is adjusted for all periods presented as the Company updated this non-GAAP measure in the first quarter of 2023 to include adjustments for share-based incentive compensation cost and foreign exchange (gain) loss. See Section 5.0  Reconciliation of Non-GAAP Measures for further details on the changes in the composition in Adjusted EBITDA. The amounts presented above reflect restated figures for all prior periods to align with the current presentation. 1.0 FOURTH QUARTER HIGHLIGHTS The fourth quarter of 2023 saw the Companys Composite Technologies segment revenue and Adjusted EBITDA decrease compared to the same quarter of 2022, as the segment navigated sequentially lower average North American oilfield activity, normal seasonal slowing of underground storage tank installation activity and the first of two quarters of lowered underground fuel tank production in response to transient customer permitting challenges encountered earlier in 2023. The segment also sold its Oilfield Asset Management (OAM) business during Q4 2022 and therefore the Q4 2023 results did not reflect any contributions from the OAM business line. In parallel, the Companys Connection Technologies segment delivered fourth quarter revenue and Adjusted EBITDA similar to the same quarter of 2022, with sales growth in North American infrastructure markets offsetting continued slowness in the Canadian distribution sector and US automotive labor disruption effects. The Company delivered operating income from Continuing Operations of $2.3 million and Adjusted EBITDA1 from Continuing Operations of $32.8 million in the fourth quarter of 2023, a decrease of $10.1 million and $8.6 million, respectively, compared to the fourth quarter of 2022. Operating income from Continuing Operations in the fourth quarter included impairment charges of $18.5 million booked in connection with the closure of the Xerxes Anaheim manufacturing facility and restructuring costs of $2.5 million, whereas the comparable period for the prior year included $2.1 million of impairment charges and $4.1 million of restructuring costs. Additionally, share-based incentive compensation of $2.1 million was recorded against operating income from Continuing Operations during the fourth quarter of 2023, while operating income from Continuing Operations in the prior years fourth quarter included a $12.9 million share-based incentive compensation expense. The Company continued to execute on its portfolio optimization strategy during the fourth quarter. On November 30, 2023, the Company completed the sale of its PPG pipe coating business to Tenaris. The Company has received gross proceeds of $241.2 million (USD $177.6 million) which include the agreed-upon purchase price of $225.4 million (USD$166 million) and initial working capital adjustments. The final net cash proceeds received by the Company in satisfaction of the contractual purchase price for the sale of the PPG business remains subject to completion of a customary final true up of the estimated working capital calculation as provided in the definitive purchase and sale agreement in respect of the transaction. The Company expects the parties to finalize the net working capital adjustment during the second quarter of 2024 and the Company currently anticipates its net cash outflow to settle the working capital adjustment will be approximately $32.0 million. The completion of this transaction concludes the Companys previously announced strategic review and portfolio transformation process. As at December 31, 2023, the Company had cash and cash equivalents totaling $334.1 million, an increase from the $98.0 million as at September 30, 2023 (December 31, 2022  $264.0 million). The increase in cash compared to the third quarter of 2023 was largely attributable to $241.2 million of gross sale proceeds received from the sale of PPG and $101.4 million of cash provided by consolidated operating activities (including Discontinued Operations). This was offset by (i) repayment of $30.0 million of the Companys syndicated credit facility (the Credit Facility), (ii) an aggregate of $41 million of share acquisitions under the Companys NCIB in the fourth quarter of 2023, (iii) $18.8 million of growth and maintenance capital expenditures for its Continuing Operations and (iv) $6.6 million spent on repayment of lease liabilities during the fourth quarter of 2023. Since the beginning of 2021 and up to December 31, 2023, the Company has repaid $291.5 million against the Credit Facility. The Company will continue to focus on maximizing the conversion of operating income into cash, optimizing its capital structure, investing in organic and inorganic growth opportunities, and enhancing shareholder value. 1 EBITDA, Adjusted EBITDA, Adjusted EPS, and net debt-to-Adjusted EBITDA are non-GAAP measures. Non-GAAP measures do not have standardized meanings under GAAP and are not necessarily comparable to similar measures provided by other companies. See Section 5.0  Reconciliation of Non-GAAP Measures for further details and a reconciliation of these non-GAAP measures. Adjusted EBITDA is adjusted for all periods presented as the Company updated this non-GAAP measure to include adjustments for share-based incentive compensation cost and foreign exchange (gain) loss. See Section 5.0  Reconciliation of Non-GAAP Measures for further details on the changes in composition of Adjusted EBITDA. The amounts presented above reflect restated figures for all prior periods to align with the current presentation. The Company expects the current calculation methodology of Adjusted EBITDA to be consistently applied in future periods. Selected Segment Financial Highlights (in thousands of Canadian dollars, except percentages)Three Months EndedYear Ended December 31December 31 2023 2022 2023 2022 $ %$ %$ %$ % Revenue Composite Technologies112,489 139,599 535,549 529,151 Connection Technologies78,982 76,053 344,980 315,245 Financial, Corporate, and Others19,296 10,099 44,742 17,390 Revenue from Continuing Operations210,767 225,751 925,271 861,786 Revenue from Discontinued Operations265,125 119,707 829,641 393,503 Operating (loss) income Composite Technologies(4,369)(3.9%)15,205 10.9%67,416 12.6%53,346 10.1% Connection Technologies11,795 14.9%11,594 15.2%60,356 17.5%55,237 17.5% Financial and Corporate(5,103) (14,424) (46,230) 2,388 Operating income from Continuing Operations2,319 12,383 81,542 110,971 Operating Income (loss) from Discontinued Operations 105,356 39.7%(1,352)(1.1%)196,271 23.7%(42,019)(10.7%) Adjusted EBITDA Composite Technologies18,837 16.7%27,343 19.6%112,821 21.1%97,687 18.5% Connection Technologies14,699 18.6%14,512 19.1%69,504 20.1%62,745 19.9% Financial and Corporate(749) (442) (17,247) (18,609) Adjusted EBITDA from Continuing Operations (a)32,787 15.6%41,413 18.3%165,078 17.8%141,823 16.5% Adjusted EBITDA from Discontinued Operations (a)104,933 39.6%15,044 12.6%222,884 26.9%9,910 2.5% (a)Adjusted EBITDA is a non-GAAP measure. Non-GAAP measures do not have a standardized meaning prescribed by GAAP and are not necessarily comparable to similar measures provided by other companies. See Section 5.0  Reconciliation of Non-GAAP Measures for further details and a reconciliation of these non-GAAP measures. Adjusted EBITDA is adjusted for all periods presented as the Company updated this non-GAAP measure in the first quarter of 2023 to include adjustments for share-based incentive compensation cost and foreign exchange (gain) loss. See Section 5.0  Reconciliation of Non-GAAP Measures for further details on the changes in composition for Adjusted EBITDA. The amounts presented above reflect restated figures for all prior periods to align with the current presentation. Composite Technologies segment revenue in the fourth quarter of 2023 was $112.5 million, a decrease of $27.1 million, or 19.4%, compared to the fourth quarter of 2022. Operating loss in the fourth quarter of 2023 was $4.4 million compared to operating income of $15.2 million in the fourth quarter of 2022. The segment's 2023 fourth quarter results included air permit and equipment non-cash impairment charges of $18.5 million booked in connection with the closure of the Xerxes Anaheim manufacturing facility. Excluding impacts from the OAM business (which was sold in November 2022 and generated no revenue or operating income in the fourth quarter of 2023 compared to revenue of $6.2 million and operating income of $0.2 million in the comparative period), the impact of the previously discussed impairment charge and the impact of $1.5 million in MEO costs associated with the establishment of the segments two new North American production sites during the period (no MEO costs were incurred during the prior year period), the segment's revenue decreased by $21 million and the operating income increased by $0.6 million. Excluding the impacts discussed above, the decrease in revenue was mostly attributable to lower demand for the Companys Flexpipe product line due to lower drilling and completion activity levels by North American oil and gas operators, and lower production and shipment of FRP tanks due to normal seasonal slowing in project execution compounded by the lingering impact of customer permitting delays experienced earlier in 2023. Despite these revenue reducing factors, the segment continued to optimize its cost base and delivered growth over the comparable period in sales of its large diameter Flexpipe products and established a new quarterly revenue record for its Xerxes stormwater product line. Adjusted EBITDA1 in the fourth quarter of 2023 was $18.8 million, a decrease of $8.5 million compared to $27.3 million in the fourth quarter of 2022. The Connection Technologies segment delivered revenue of $79 million in the fourth quarter of 2023 which was an increase of $2.9 million compared to the fourth quarter of 2022. This was primarily driven by an increase in wire and cable product shipments into infrastructure applications in North America. Its operating income in the fourth quarter of 2023 was $11.8 million, a modest increase from $11.6 million reported in the prior year period. The segment incurred MEO costs of approximately $0.2 million associated with the relocation of its North American footprint during the quarter. The segment delivered Adjusted EBITDA1 of $14.7 million during the fourth quarter of 2023, a 1.2% increase versus the prior year quarter. Discontinued Operations, which consists of the businesses formerly reported under the PPS segment (excluding the entities not within the perimeter of the transaction with Tenaris), generated revenue of $265.1 million in the fourth quarter of 2023, representing an increase of 121.5% versus the same quarter of 2022. Operating income in the fourth quarter of 2023 was $105.4 million which represented an increase of $106.7 million versus the fourth quarter of 2022 operating loss of $1.4 million. This significant increase was a result of strong performance in pipe coating facilities across all regions, bolstered by 2 full months of coating activity within the SGP project. Discontinued Operations generated $104.9 million of Adjusted EBITDA1 in the fourth quarter of 2023, a substantial increase from the $15 million reported in the prior years fourth quarter. Execution efficiency and favourable revenue mix resulted in Adjusted EBITDA margins1 of 39.6% during the quarter, compared to a 12.6% Adjusted EBITDA margin1 in the prior years fourth quarter. The Company has recognized a $105.0 million loss on the sale of PPG to Tenaris in Discontinued Operations in the consolidated statements of income (loss). The loss includes a non-cash Cumulative Translation Adjustment of $13.0 million that reflects the impact of foreign exchange rate fluctuations on the sold business. The PPG business, which has historically comprised the vast majority of the Companys bid and budgetary estimates and total order backlog, was sold in November 2023 and as a result the Company will no longer report these supplementary financial measures as the Company does not believe that going forward such measures will provide investors with useful information to understand or evaluate the Companys Continuing Operations or its respective performance and prospects. 2.0 OUTLOOK The Company expects to experience a modest sequential increase in consolidated revenue within its Continuing Operations during the first quarter of 2024, driven by broadly higher activity levels in its Connection Technologies segment and higher sales of composite pipe products into international markets within the Composite Technologies segment, partially offset by lower production and shipment of FRP tanks and lower pipe coating activity within its Brazilian operations. The Composite Technologies segments first quarter revenue outlook is primarily driven by expectations that North American onshore drilling and completion activity levels, and therefore North American demand for Flexpipe products, will be similar to those observed during the fourth quarter of 2023, while shipments of Flexpipe products to support international projects will move sequentially up. This is coupled with the normal seasonal low point for FRP tank installation activity as unfavorable weather and ground conditions are experienced across much of North America. The first quarter of 2024 is also anticipated to see the segment continue to limit FRP tank production activity to control customer-owned inventory levels which elevated over the course of 2023 in the face of permitting delay issues faced by some North American customers. This is the last quarter in which the Company anticipates this action will be necessary, as most customers have adapted their permit application strategies and are indicating greater confidence that permits will be available for projects in 2024 and beyond. First quarter revenue outlook within the Connection Technologies segment is primarily driven by expected sequential strengthening of demand within North American industrial and infrastructure markets. Despite an expectation of modest favorable movement in revenue generation in the first quarter of 2024, the Company anticipates some margin compression as a result of its MEO activities and the specific mix of product sales. During the second quarter of 2023, the Company detailed several planned 2023 and 2024 capital investments into high-return growth and efficiency improvement opportunities in both segments. These investments and other MEO activities, which are currently progressing on time and on budget, include: The addition of two new manufacturing facilities and elimination of one aging manufacturing facility within its Composite Technologies network, namely: a new Xerxes FRP tank production site in Blythewood, South Carolina that is expected to commence production in mid-2024; anda new Flexpipe composite pipe production site in Rockwall, Texas that is expected to commence production in mid-2024; andthe shut-down and exit of a Xerxes FRP tank production site in Anaheim, California that is expected to be largely complete by the end of 2024. The replacement of its Rexdale, Canada facility and expansion of its Connection Technologies North American manufacturing footprint via: a new heat-shrink tubing production site in Fairfield, Ohio that is expected to commence production in late 2024; anda new wire and cable production site in Vaughan, Ontario that is expected to commence production in late 2024. The Company expects to continue to make sizeable organic investments throughout 2024 to modernize, expand capacity in targeted geographies and improve efficiency within the North American production network of its Composite Technologies and Connection Technologies segments. Given the anticipated timing of these MEO actions, the Company continues to expect to recognize meaningful MEO costs throughout 2024, with these costs weighted towards optimization and growth activities within the Composite Technologies segment during the first half of 2024 and weighted towards the modernization and growth activities within the Connection Technologies segment during the second half of 2024. In aggregate, once completed, these planned investments are expected to result in the Company creating at least $150 million per year of incremental revenue generating capacity with comparable margins to those realized in its Composite Technologies and Connection Technologies segments. These levels of output are expected to be realized over the 35 year period following completion, as the facilities reach efficient utilization levels in accordance with their currently expected timelines. The Company does not expect the recently announced shut-down of the Xerxes production site in Anaheim, California, to alter the output expectations. In managements view, the underlying mid and long-term market trends for all of Mattrs core businesses remain favourable. Despite elevated interest rates, demand for products in support of critical infrastructure renewal and expansion is expected to remain robust; its fuel tank customers have made adjustments to accommodate elongated permitting timelines which are anticipated to result in a return to more normal FRP tank shipment patterns during the second quarter of 2024; and anticipated stable oil and gas commodity prices combined with a new annual capital spending cycle for North American oil and gas producers is expected to provide opportunities for market share gains by the Companys Flexpipe business, particularly within its recently commercialized larger diameter product portfolio, moving through the year. More broadly, management expects that demand for its differentiated products designed to withstand harsh environments will continue to rise in the coming years as a result of the global need to renew and expand critical infrastructure, including energy generation and distribution, electrification, transportation network enhancement and storm water management. The Company continues to closely monitor raw material and labour costs and accordingly, will continue to ensure its pricing appropriately reflects the value of its products and its cost inputs. The Company continues to take an all of the above approach to capital allocation, skewed towards investment in organic and inorganic acquisition and investment opportunities viewed as having the highest risk-adjusted return on investment potential. With substantial capacity to deploy capital and the expectation to deploy available capital over the next several quarters, the Company continues to elevate focus on inorganic opportunities, including opportunities of meaningful scale, particularly related to differentiated wire & cable sectors and water products, where long-term tailwinds are expected. The Company remains focused on ensuring any capital investments provide superior returns (both near and long-term) to shareholders in light of all available options, including the return of capital to shareholders. We expect to apply to renew our NCIB and continue to repurchase the Companys common shares on an opportunistic basis. Opportunities also exist to further enhance the Companys organic growth trajectory. 1 EBITDA, Adjusted EBITDA, adjusted EBITDA margins and net debt-to-Adjusted EBITDA are non-GAAP measures. Non-GAAP measures do not have standardized meanings under GAAP and are not necessarily comparable to similar measures provided by other companies. See Section 5.0  Reconciliation of Non-GAAP Measures for further details and a reconciliation of these non-GAAP measures. Adjusted EBITDA is adjusted for all periods presented as the Company updated this non-GAAP measure in the first quarter of 2023 to include adjustments for share-based incentive compensation cost and foreign exchange (gain) loss. See Section 5.0  Reconciliation of Non-GAAP Measures for further details on the changes in composition of Adjusted EBITDA. The amounts presented above reflect restated figures for all prior periods to align with the current presentation. The Company expects the current calculation methodology of Adjusted EBITDA to be consistently applied in future periods. Composite Technologies Segment While the Company anticipates continued year-over-year expansion of its stormwater products business, Composite Technologies segment performance in the first half of 2024 will largely be driven by three factors: production and shipment of FRP tanks into North American fuel station applications; baseline volumes of Flexpipe product consumption driven by North American oilfield activity levels; and continued market share gains by the Companys larger diameter Flexpipe products in North America and internationally. Production and shipment of Xerxes FRP tanks will be at their seasonal low point during the first quarter, as weather and ground conditions across much of North America remain largely unfavorable to fuel station construction activities, before normal seasonal construction activity rises in the second quarter of 2024. The first quarter of 2024 is also anticipated to see the segment continue to limit FRP tank production activity to control customer owned FRP tank inventory levels, which elevated over the course of 2023 in the face of permitting delay issues faced by some North American customers. This is the last quarter in which the Company anticipates this action will be necessary, as most customers have adapted their permit application strategies and are indicating greater confidence that permits will be available for projects in 2024 and beyond. Consequently, the Company anticipates a substantial increase in FRP tank production and shipments in the second quarter of 2024, and currently expects full year 2024 Xerxes revenues to expand compared to 2023. The Company anticipates North American onshore oil and gas drilling and completion activity will remain relatively flat throughout the first half of 2024, as generally stable commodity prices and the favorable impact of new calendar year customer capital budgets are offset by broad, large-scale, customer consolidation events which typically result in temporarily lower activity levels within the impacted organizations. Normal seasonality effects are expected to occur, with robust first quarter Canadian oilfield activity anticipated to move lower in the second quarter of 2024, due to weather and ground conditions, while US completion activity is anticipated to move higher in the second quarter, as weather and ground conditions become more favorable. The Company currently anticipates a substantial increase in North American Flexpipe revenue moving from the first quarter to the second quarter of 2024, as continued adoption of its recently commercialized larger diameter products enhance normal seasonal cycles. Overlaying North American oilfield trends, the Company has been successful in securing multiple Flexpipe orders, including larger diameter product orders, for delivery into international projects during the first half of 2024, and expects these deliveries to enhance first quarter and, more substantially, second quarter performance. The Company currently anticipates full year 2024 Flexpipe revenues to expand compared to 2023. The segment continues to execute the establishment of two new US production sites, with its Rockwall, Texas Flexpipe and Blythewood, South Carolina Xerxes facilities progressing on-time and on-budget. First production is expected from both sites during the third quarter of 2024. In addition, the segment has taken steps to lower its fixed cost and operating risk base by ceasing production of FRP tanks from its aging Anaheim, California facility, and will fully exit the site by year end. In combination, the actions taken to modernize, expand and optimize the segments North American production footprint are expected to lower average production costs, increase total production capacity and position the segment to deliver meaningful growth and margin expansion in subsequent years. The Company continues to expect MEO costs will lower segment EBITDA margins during the first half of 2024. The Company expects that there will be sufficient incremental revenues from these new facilities to absorb incremental fixed costs during the ramp up periods, and both new facilities have sufficient physical space to enable further production line additions in future years. The segment continues to closely monitor raw material and labour costs and, as a result, will continue to ensure its pricing appropriately reflects the value of its products and its cost inputs. Connection Technologies Segment The Company is expecting demand for its Connection Technologies segment products to rise in the first quarter of 2024 to levels similar to those observed in the prior years quarter, despite the non-recurrence of a large aerospace wire and cable order which favorably impacted Q1-2023 results, before moving further upwards in the second quarter of 2024. Profitability in the first and second quarters is expected to be modestly impacted by one-time costs associated with the Companys MEO activities, although the majority of MEO costs for the segment are expected to be recognized during the second half of 2024. The Company continues to monitor recessionary concerns and broad supply chain impacts. Its outlook does not incorporate any expectation of meaningful growth in total global vehicle output within the automotive end markets, which represented approximately 29% of the segments revenue in the fourth quarter of 2023. The Company does not anticipate any material impact from the continuing stabilization of EV demand and production. Despite the macroeconomic backdrop, demand for the Companys automotive products is expected to continue to outpace overall automotive production as a result of electronic content growth in premium, hybrid and full electric vehicle markets, particularly in the Asia Pacific and Europe, Middle East and Africa regions. The Company is expecting to benefit from continued infrastructure spending in 2024 and beyond as new and upgraded utility and communication networks are constructed, nuclear refurbishments continue in Canada, and federal stimulus package impacts persist. The segment continues to execute the establishment of two new production sites, with its Vaughan, Ontario and Fairfield, Ohio facilities progressing on-time and on-budget. First production from both sites is expected during the second half of 2024. The Company expects that there will be sufficient incremental revenues from these new facilities to absorb incremental fixed costs during the ramp up periods, and both new facilities have sufficient physical space to enable further production line additions in future years. The segment continues to closely monitor raw material and labour costs, particularly copper, and, as a result, will continue to ensure its pricing appropriately reflects the value of its products and its cost inputs. Strategic Review Update On November 30, 2023, the Company completed the sale of its PPG operating unit, a substantial part of its legacy pipe coating business, which concluded its strategic review process that was initially announced on September 12, 2022 (the Strategic Review) to review strategic alternatives for its PPG, SPS, and OAM operating units. Pursuant to the Strategic Review, the Company considered and explored a range of options for each of these operating units, including the sale of such units. To date, the Strategic Review process (including the sale of a non-material business unit preceding the formal launch of the Strategic Review) has resulted in the successful completion of the following: the sale of its Lake Superior Consulting business (which formed part of what was previously the PPS segment) in September 2022;the sale of its OAM business (which formed part of the Composite Technologies segment) in November 2022;the sale of its Socotherm subsidiary (which formed part of what was previously the PPS segment) in December 2022;the sale of its specialty pipe coating facility in Ellon, Scotland (which formed part of what was previously the PPS segment) in the second quarter of 2023;the sale of its SPS business (which formed part of what was previously the PPS segment) at the end of May 2023;the sale of its facility in Pozzallo, Italy (which formed part of what was previously the PPS segment) in fourth quarter of 2023;the sale of one of its real estate assets in western Canada; andthe sale of the substantial majority of its PPG operating unit (which formed the majority of what was previously the PPS segment), at the end of November 2023. In connection with the Strategic Review, the Company announced its official re-brand to Mattr in June 2023, and then completed its legal name change from Shawcor Ltd to Mattr Corp in January 2024, reflecting its transformation from an energy services organization to a material technologies company providing differentiated, high-performance products to critical infrastructure markets around the world. During the fourth quarter and prior to the completion of its sale to Tenaris in November of 2023, the PPG business generated significant revenue, Adjusted EBITDA and cash from operating activities for the Company. The Company benefitted from this significant generation of cash, but consequently this has resulted in the incurrence of related income tax and other liabilities for the PPG business which will require settlement with Tenaris as part of a customary working capital adjustment process. As such, the final net cash proceeds received by the Company in satisfaction of the contractual purchase price for the sale of the PPG business remains subject to completion of a customary final true up of the estimated working capital calculation as provided in the definitive purchase and sale agreement in respect of the transaction. The Company expects the parties to finalize the net working capital adjustment during the second quarter of 2024 and the Company currently anticipates its net cash outflow to settle the working capital adjustment will be approximately $32.0 million. The Company continues to explore options to divest of its Brazilian pipe coating operations (Thermotite), formerly part of the PPG operating unit, which was excluded from the perimeter of the transaction completed in November of 2023. While the Company does not anticipate Thermotites financial results to be material to the organization, the business is fully booked throughout 2024 and is expected to deliver increased full year 2024 financial performance when compared to 2023. The Company remains committed to divest of this entity and considers its Strategic Review to be substantially complete. 3.0 CONFERENCE CALL AND ADDITIONAL INFORMATION Mattr will be hosting a Shareholder and Analyst Conference Call and Webcast on Thursday, March 14th, 2024 at 9:00 AM ET, which will discuss the Companys Fourth Quarter 2023 Financial Results. To participate via telephone, please register at https://register.vevent.com/register/BI7d6d639108f6417e87ebf3c247fc115e and a telephone number and pin will be provided. Alternatively, please go to the following website address to participate via webcast: https://edge.media-server.com/mmc/p/66rbwdc2 . The webcast recording will be available within 24 hours of the live presentation and will be accessible for 90 days. About Mattr Mattr is a growth-oriented, global materials technology company broadly serving critical infrastructure markets, including transportation, communication, water management, energy and electrification. The Company operates through a network of fixed manufacturing facilities. Its two business segments, Composite Technologies and Connection Technologies, enable responsible renewal and enhancement of critical infrastructure while lowering risk and environmental impact. For further information, please contact: Meghan MacEachernDirector, External Communications & ESGTel: 437-341-1848Email: meghan.maceachern@mattr.comWebsite: www.mattr.com Source: Mattr Corp.Mattr.ER4.0 FORWARD-LOOKING INFORMATION This news release includes certain statements that reflect managements expectations and objectives for the Companys future performance, opportunities and growth, which statements constitute forward-looking information and forward-looking statements (collectively forward-looking information) under applicable securities laws. Such statements, other than statements of historical fact, are predictive in nature or depend on future events or conditions. Forward-looking information involves estimates, assumptions, judgements and uncertainties. These statements may be identified by the use of forward-looking terminology such as may, will, should, anticipate, expect, believe, predict, estimate, continue, intend, plan and variations of these words or other similar expressions. Specifically, this news release includes forward-looking information in the Outlook Section and elsewhere in respect of, among other things, the ability of the Company to deliver higher returns to all shareholders; the market dynamics during 2024; the favourability of underlying business trends of the Company; the Companys ability to execute on its portfolio optimization strategy; the Companys ability to execute projects under contract; the Companys ability to execute on its business plan and strategies, including the pursuit, execution and integration of potential organic and inorganic growth opportunities, as applicable; the timing of the finalization of the net working capital adjustment for the sale of the PPG business; the anticipated net cash outflow amount to settle the working capital adjustment for the sale of the PPG business; the level of financial performance throughout 2024; expected increased revenue within Continuing Operations in the first quarter of 2024; the gradual increase in demand for oilfield products in the first half of 2024; the demand for, and activity in, the Companys products in the Composite Technologies and the Connection Technologies segments of the Companys business; the Companys investments throughout 2024 to expand capacity within the Composite Technologies and Connection Technologies segments; North American onshore drilling and completion activity; the continued permitting delay impacts on fuel storage tank shipments; the anticipated results and timing of the Company's capital expenditures investments and the expected impact on the Company's revenue generating capacity, operational efficiencies, margin profile enhancement, and financial results; increased shipments of Flexpipe products; FRP tank production activity; the end to delays faced by North American customers due to permit application strategies; availability for permits for projects in 2024 and beyond; the impact of MEO activities on the Companys financial performance; the impact of MEO costs on financial measures in the first half of 2024; timing for completion of new facilities, and timing of achievement of anticipated production levels; the seasonal impacts to, and demand in, the Companys Composite Technologies and Connection Technologies segments; the impact of increased normal seasonality and stable North American oilfield activity in the first quarter of 2024; the anticipated normalized product shipment patterns during the second quarter of 2024; the anticipated demand for the Companys Flexpipe product line; the growth in premium, hybrid and full electric vehicle markets and the impact thereof on the Companys financial performance; the impact of continued infrastructure spending, including in the areas of water management, communication networks and nuclear refurbishment on the Companys financial performance; the Companys management of raw material and labour costs; the impact of global economic activity on the demand for the Company's products; the level, and impact of the demand for oil and gas; the impact of global oil and gas commodity prices and the annual capital spending cycle for North American oil and gas producers; the global need to renew and expand critical infrastructure; the impact of changing energy demand, supply and prices; the ability of the Company to fund its operating and capital requirements; the ability of the Company to comply with its debt covenants; and the ability to finance increases in working capital. Forward-looking information involves known and unknown risks and uncertainties that could cause actual results to differ materially from those predicted by the forward-looking information. Readers are cautioned not to place undue reliance on forward-looking information as a number of factors could cause actual events, results and prospects to differ materially from those expressed in or implied by the forward-looking information. Significant risks facing the Company include but are not limited to: the risks and uncertainties described in the Companys Management Discussion and Analysis under Risks and Uncertainties and in the Companys Annual Information Form under Risk Factors. These statements of forward-looking information are based on assumptions, estimates and analysis made by management in light of its experience and perception of trends, current conditions and expected developments as well as other factors believed to be reasonable and relevant in the circumstances. These assumptions include those in respect of the Companys ability to manage supply chain disruptions and other business impacts caused by, among other things, current or future geopolitical events, conflicts, or disruptions, such as the conflict in Ukraine and related sanctions on Russia; the impact of the Russia and Ukraine conflict on the Companys demand for products and the strength of its and its customers supply chains; the current escalating Israel-Palestine conflict; increased activity levels in the Connection Technologies segment; higher sales of composite pipe products into international markets; a similar level of North American onshore drilling and completion activity levels to those observed during the fourth quarter of 2023; demand for Flexpipe products will be similar to those observed during the fourth quarter of 2023; increased shipment of Flexpipe products to support international projects; strengthening demand within the North American industrial and infrastructure markets seasonal impacts on the Companys FRP tanks business due to North American weather and ground conditions; the changing demand for the Companys FRP tanks and water and stormwater storage and treatment systems; seasonal impacts to the Companys composite pipe business due to spring break-up conditions; the trend of international sales for composite pipe products ;expected demand for the Companys products in the Composite Technologies segment, including the ability to grow such demand over the timeline expected to complete such facilities and achieve desired operational levels; the Company being able to complete the construction and commissioning of these facilities on their expected timeline and budget, as applicable, and its ability to achieve and maintain necessary production and efficiency levels once operational; expectations regarding the Companys ability to attract new customers and develop and maintain relationships with existing customers; the continued availability of funding required to meet the Companys anticipated operating and capital expenditure requirements over such time; continued competitive intensity in the segments in which the Company operates consistent with levels experienced in 2023; no significant legal or regulatory developments, other shifts in economic conditions, or macro changes in the competitive environment affecting our business activities; key interest rates remaining relatively stable throughout 2024 to 2026; expectations regarding the Companys ability to continue to manage its supply chain and any future disruptions; the increased demand for the Companys products within the Connection Technologies markets; heightened demand for electric and hybrid vehicles and for electronic content within those vehicles; the growth in demand for water and storm water storage and treatment systems; heightened infrastructure spending in Canada, including in respect of commercial and municipal water projects, nuclear plant refurbishment and upgraded communication and transportation networks, communication networks and nuclear refurbishments; sustained health of oil and gas producers; the continued global need to renew and expand critical infrastructure including energy generation and distribution, electrification, transportation network enhancement and storm management; enhanced overall market activity; the continued recovery of the global economy; the Companys ability to execute projects under contract; the Companys continuing ability to provide new and enhanced product offerings to its customers; that the Company will continue to be able to optimize its portfolio and identify and successfully execute on opportunities for acquisitions or investments; the higher level of investment in working capital by the Company; the easing of supply chain shortages and the continued supply of and stable pricing or the ability to pass on higher prices to its customers for commodities used by the Company; the availability of personnel resources sufficient for the Company to operate its businesses; the maintenance of operations by the Company in major oil and gas producing regions; the adequacy of the Companys existing accruals in respect of environmental compliance and in respect of litigation and tax matters and other claims generally; the impact of adoption of artificial intelligence and other machine learning on competition in the industries which the Company operates; the Companys ability to meet its financial objectives; the ability of the Company to satisfy all covenants under its Credit Facility (as defined herein) and other debt obligations and having sufficient liquidity to fund its obligations and planned initiatives; the ability to develop, access or implement some or all of the technology necessary to efficiently and effectively achieve the Companys ESG goals and ambitions, including its greenhouse gas targets; the availability, commercial viability and scalability of the Companys greenhouse gas emission reduction strategies and related technology and products; and the anticipated costs and impacts on the Companys operations and financial results of adopting these technologies or strategies. The Company believes that the expectations reflected in the forward-looking information are based on reasonable assumptions in light of currently available information. However, should one or more risks materialize, or should any assumptions prove incorrect, then actual results could vary materially from those expressed or implied in the forward-looking information included in this document and the Company can give no assurance that such expectations will be achieved. When considering the forward-looking information in making decisions with respect to the Company, readers should carefully consider the foregoing factors and other uncertainties and potential events. The Company does not assume the obligation to revise or update forward-looking information after the date of this document or to revise it to reflect the occurrence of future unanticipated events, except as may be required under applicable securities laws. To the extent any forward-looking information in this document constitutes future oriented financial information or financial outlooks, within the meaning of securities laws, such information is being provided to demonstrate the potential of the Company and readers are cautioned that this information may not be appropriate for any other purpose. Future oriented financial information and financial outlooks, as with forward-looking information generally, are based on the assumptions and subject to the risks noted above. 5.0 RECONCILIATION OF NON-GAAP MEASURES The Company reports on certain non-GAAP measures that are used to evaluate its performance and segments, as well as to determine compliance with debt covenants and to manage its capital structure. These non-GAAP measures do not have standardized meanings under IFRS and are not necessarily comparable to similar measures provided by other companies. The Company discloses these measures because it believes that they provide further information and assist readers in understanding the results of the Companys operations and financial position. These measures should not be considered in isolation or used in substitution for other measures of performance prepared in accordance with GAAP. The following is a reconciliation of the non-GAAP measures reported by the Company. EBITDA and Adjusted EBITDA In an effort to reduce the volatility of the Adjusted EBITDA metric imposed by factors outside of the Companys control and to provide enhanced comparability of the Companys results from its principal business activities with those of the Companys peer group, the Company has modified the composition of Adjusted EBITDA. Beginning in the first quarter of 2023, Adjusted EBITDA includes adjustments for share-based incentive compensation costs and foreign exchange (gains) losses. Share-based incentive compensation costs have recently experienced a high degree of volatility derived from movements in the market value of the Companys shares and the related impact on such plans. Given the Companys global presence and its exposure to several foreign currency rates, the Company experiences fluctuation from foreign exchange gains or losses outside of its control. The Company believes this modified composition will present a more accurate representation of the Companys results from principal business activities. The amounts presented below reflect restated figures for prior periods as needed to align with the updated definition. EBITDA is a non-GAAP measure defined as earnings before interest, income taxes, depreciation and amortization. Adjusted EBITDA is also a non-GAAP measure defined as EBITDA adjusted for items which do not impact day to day operations. Adjusted EBITDA is calculated by adding back to EBITDA the sum of impairments, costs associated with refinancing of long-term debt and credit facilities, gain on sale of land and other, gain on sale of investment in associates, gain on sale of operating unit, acquisition costs, restructuring costs, share-based incentive compensation cost, foreign exchange (gain) loss and other, net and hyperinflationary adjustments. The Company believes that EBITDA and Adjusted EBITDA are useful supplemental measures that provide a meaningful indication of the Companys results from principal business activities prior to the consideration of how these activities are financed or the tax impacts in various jurisdictions and for comparing its operating performance with the performance of other companies that have different financing, capital or tax structures. The Company presents Adjusted EBITDA as a measure of EBITDA that excludes the impact of transactions that are outside the Companys normal course of business or day to day operations. Adjusted EBITDA is used by many analysts as one of several important analytical tools to evaluate financial performance and is a key metric in business valuations. It is also considered important by lenders to the Company and is included in the financial covenants of the Credit Facility. (in thousands of Canadian dollars) Year Ended December 31, 2023 2022 Net Income from Continuing Operations $55,859 $93,347 Add: Income tax expense (recovery) 5,401 (4,155)Finance costs, net 20,282 20,452 Amortization of property, plant, equipment, intangible and ROU assets 36,861 37,628 EBITDA from Continuing Operations $118,403 $147,272 Share-based incentive compensation cost 18,307 26,011 Foreign exchange loss (gain) 2,243 (7,871)Gain on sale of land and other (1,655) (43,017)Loss on sale of Subsidiaries - 1,327 Curtailment of defined benefit plan (1,889) - 2019 ZCL Composites Inc. purchase trust - (1,059)Impairment 27,195 9,457 Restructuring costs and other, net 2,474 9,703 Adjusted EBITDA from Continuing Operations $165,078 $141,823 Three Month Ended March 31, June 30, September 30, December 31, (in thousands of Canadian dollars) 2023 2023 2023 2023 Net Income from Continuing Operations$20,708 $14,670 $18,145 $2,335 Add: Income tax expense (recovery) 4,585 3,327 2,486 (4,997)Finance costs, net 4,984 4,974 5,344 4,980 Amortization of property, plant, equipment, intangible and ROU assets 9,021 9,170 9,785 8,885 EBITDA from Continuing Operations$39,298 $32,141 $35,760 $11,203 Share-based incentive compensation (recovery) cost (42) 18,668 (2,414) 2,096 Foreign exchange loss (gain) 1,210 (45) 952 126 Gain on sale of land and other - - - (1,655)Curtailment of defined benefit plan - - (1,889) - Impairment - - 8,652 18,544 Restructuring costs and other, net - - - 2,474 Adjusted EBITDA from Continuing Operations$40,466 $50,764 $41,060 $32,787 Three Month Ended March 31, June 30, September 30, December 31, (in thousands of Canadian dollars) 2022 2022 2022 2022 Net Income from Continuing Operations$10,017 $40,629 $29,211 $13,489 Add: Income tax expense (recovery) 249 7,006 (4,446) (6,963)Finance costs, net 3,948 5,934 6,040 4,530 Amortization of property, plant, equipment, intangible and ROU assets 9,464 9,998 9,102 9,064 EBITDA from Continuing Operations$23,678 $63,567 $39,907 $20,120 Share-based incentive compensation cost 2,346 2,584 8,182 12,899 Foreign exchange (gain) loss (2,625) (351) (5,664) 769 Gain on sale of land and other - (43,017) - - Loss on sale of Subsidiaries - - - 1,327 2019 ZCL Composites Inc. purchase trust - - (1,059) - Impairment - 7,292 - 2,165 Restructuring costs and other, net 1,075 2,420 2,075 4,133 Adjusted EBITDA from Continuing Operations$24,474 $32,495 $43,442 $41,413 Composite Technologies Segment (in thousands of Canadian dollars) Year Ended December 31, 2023 2022 Operating Income $67,416 $53,347 Add: Amortization of property, plant, equipment, intangible and ROU assets 27,043 29,758 EBITDA $94,459 $83,104 Share-based incentive compensation cost 1,812 4,468 Gain on sale of land and other (1,995) (3,820)Impairment 18,544 9,458 Restructuring costs and other, net - 4,477 Adjusted EBITDA $112,821 $97,687 Three Month Ended March 31, June 30, September 30, December 31, (in thousands of Canadian dollars) 2023 2023 2023 2023 Operating Income (Loss)$20,722 $25,580$25,483 $(4,369) Add: Amortization of property, plant, equipment, intangible and ROU assets 6,627 6,762 7,398 6,257 EBITDA$27,349 $32,342$32,881 $1,888 Share-based incentive compensation (recovery) cost (601) 2,449 (435) 399 Gain on sale of land and other - - - (1,995)Impairment - - - 18,544 Restructuring costs and other, net - - - - Adjusted EBITDA$26,748 $34,791$32,446 $18,837 Three Month Ended March 31, June 30, September 30, December 31,(in thousands of Canadian dollars) 2022 2022 2022 2022 Operating Income$6,874$9,521 $21,747$15,205 Add: Amortization of property, plant, equipment, intangible and ROU assets 7,409 7,910 7,189 7,250 EBITDA$14,283$17,431 $28,936$22,455 Share-based incentive compensation cost 278 293 1,173 2,724Gain on sale of land and other - (3,820) - -Impairment - 7,293 - 2,164Restructuring costs and other, net 423 1,967 2,088 -Adjusted EBITDA$14,984$23,164 $32,197$27,343 Connection Technologies Segment (in thousands of Canadian dollars) Year Ended December 31, 2023 2022 Operating Income $60,356$55,237 Add: Amortization of property, plant, equipment, intangible and ROU assets 5,752 4,363EBITDA $66,107$59,600 Share-based incentive compensation cost 2,649 3,064Restructuring costs and other, net 747 81Adjusted EBITDA $69,504$62,745 Three Month Ended March 31, June 30, September 30, December 31,(in thousands of Canadian dollars) 2023 2023 2023 2023 Operating Income$17,650$17,005$13,910 $11,791 Add: Amortization of property, plant, equipment, intangible and ROU assets 1,333 1,349 1,356 1,713EBITDA$18,983$18,354$15,266 $13,505 Share-based incentive compensation (recovery) cost 26 2,224 (48) 448Restructuring costs and other, net - - - 747Adjusted EBITDA$19,009$20,578$15,218 $14,699 Three Month Ended March 31, June 30, September 30, December 31,(in thousands of Canadian dollars) 2022 2022 2022 2022 Operating Income$14,887$14,832$13,915$11,603 Add: Amortization of property, plant, equipment, intangible and ROU assets 1,085 1,059 1,076 1,143EBITDA$15,972$15,891$14,991$12,746 Share-based incentive compensation cost 209 270 820 1,766Restructuring costs and other, net 27 54 - -Adjusted EBITDA$16,208$16,214$15,811$14,512 Discontinued Operations (in thousands of Canadian dollars) Year Ended December 31, 2023 2022 Net Income (loss) from Discontinued Operations $31,360 $(124,323) Add: Income tax expense (recovery) 52,660 (15,123)Finance costs, net 1,247 1,263 Amortization of property, plant, equipment, intangible and ROU assets 27,524 33,788 EBITDA from Discontinued Operations $112,791 $(104,395) Share-based incentive compensation (recovery) cost 236 5,480 Foreign exchange (gain) (2,612) (1,842)Loss on sale of Subsidiaries 111,004 83,424 Hyperinflation adjustment for Argentina - 12,774 Impairment - 12,975 Restructuring costs and other, net 1,465 1,495 Adjusted EBITDA from Discontinued Operations $222,884 $9,910 Three Month Ended March 31, June 30, September 30, December 31, (in thousands of Canadian dollars) 2023 2023 2023 2023 Net Income (loss) from Discontinued Operations$4,521 $(1,648)$53,829 $(25,342) Add: Income tax expense 672 2,831 23,769 25,388 Finance costs, net 160 554 400 133 Amortization of property, plant, equipment, intangible and ROU assets 10,209 10,860 6,480 (25)EBITDA from Discontinued Operations$15,562 $12,596 $84,478 $157 Share-based incentive compensation (recovery) cost (561) 3,296 (498) (2,002)Foreign exchange (gain) loss (939) (3,120) 1,310 138 Loss on sale of Subsidiaries - 3,738 2,089 105,177 Restructuring costs and other, net - - - 1,465 Adjusted EBITDA from Discontinued Operations$14,062 $16,510 $87,379 $104,933 Three Month Ended March 31, June 30, September 30, December 31, (in thousands of Canadian dollars) 2022 2022 2022 2022 Net (Loss) from Discontinued Operations$(17,133)$(20,682)$(6,208)$(80,299) Add: Income tax expense (recovery) 1,988 (807) (13,919) (2,386)Finance costs, net 397 128 455 284 Amortization of property, plant, equipment, intangible and ROU assets 8,008 7,485 7,340 10,955 EBITDA from Discontinued Operations$(6,740)$(13,876)$(12,332)$(71,447) Share-based incentive compensation cost 339 138 1,284 3,719 Foreign exchange (gain) loss (411) (1,155) (921) 645 Loss on sale of Subsidiaries - - 5,932 77,492 Hyperinflation adjustment for Argentina 1,890 1,533 5,510 3,842 Impairment - 12,974 - - Restructuring costs and other, net 131 576 (6) 794 Adjusted EBITDA from Discontinued Operations$(4,790)$190 $(532)$15,044 Total Consolidated Mattr (Continuing and Discontinued Operations) Year Ended December 31,(in thousands of Canadian dollars) 2023 2022 Total Consolidated Mattr Net Income (loss) $87,219 $(30,976) Add: Income tax expense (recovery) 58,061 (19,278)Finance costs, net 21,529 21,715 Amortization of property, plant, equipment, intangible and ROU assets 64,385 71,416 Total Consolidated Mattr EBITDA $231,195 $42,876 Share-based incentive compensation cost 18,541 31,488 Foreign exchange (gain) (369) (9,712)Gain on sale of land and other (1,655) (43,017)Loss on sale of Subsidiaries 111,004 84,751 Curtailment of defined benefit plan (1,889) - 2019 ZCL Composites Inc. purchase trust - (1,059)Hyperinflation adjustment for Argentina - 12,774 Impairment 27,197 22,433 Restructuring costs and other, net 3,938 11,199 Total Consolidated Mattr Adjusted EBITDA $387,962 $151,733 Three Month Ended March 31, June 30, September 30, December 31, (in thousands of Canadian dollars) 2023 2023 2023 2023 Total Consolidated Mattr Net Income (Loss)$25,229 $13,023 $71,974 $(23,006) Add: Income tax expense 5,257 6,158 26,255 20,391 Finance costs, net 5,144 5,528 5,744 5,113 Amortization of property, plant, equipment, intangible and ROU assets 19,230 20,030 16,265 8,859 Total Consolidated Mattr EBITDA$54,860 $44,737 $120,238 $11,357 Share-based incentive compensation (recovery) cost (603) 21,963 (2,912) 94 Foreign exchange loss (gain) 271 (3,165) 2,262 263 Gain on sale of land and other - - - (1,655)Loss on sale of Subsidiaries - 3,738 2,089 105,178 Curtailment of defined benefit plan - - (1,889) - Impairment - - 8,652 18,544 Restructuring costs and other, net - - - 3,938 Total Consolidated Mattr Adjusted EBITDA$54,528 $67,274 $128,440 $137,720 Three Month Ended March 31, June 30, September 30, December 31, (in thousands of Canadian dollars) 2022 2022 2022 2022 Total Consolidated Mattr Net (Loss) Income$(7,117)$19,947 $23,003 $(66,810) Add: Income tax expense (recovery) 2,237 6,199 (18,365) (9,349)Finance costs, net 4,345 6,062 6,495 4,813 Amortization of property, plant, equipment, intangible and ROU assets 17,472 17,483 16,442 20,019 Total Consolidated Mattr EBITDA$16,937 $49,691 $27,575 $(51,327) Share-based incentive compensation cost 2,685 2,722 9,466 16,616 Foreign exchange (gain) loss (3,036) (1,506) (6,585) 1,414 Gain on sale of land and other - (43,017) - - Loss on sale of Subsidiaries - - 5,932 78,819 Hyperinflation adjustment for Argentina 1,889 1,531 5,510 3,843 2019 ZCL Composites Inc. purchase trust - - (1,059) - Impairment - 20,269 - 2,164 Restructuring costs and other, net 1,206 2,996 2,070 4,927 Total Consolidated Mattr Adjusted EBITDA$19,681 $32,686 $42,908 $56,457 Adjusted EBITDA Margin Adjusted EBITDA margin is defined as Adjusted EBITDA divided by revenue and is a non-GAAP measure. The Company believes that Adjusted EBITDA margin is a useful supplemental measure that provides meaningful assessment of the business results of the Company and its Operating Segments from principal business activities excluding the impact of transactions that are outside of the Companys normal course of business. See reconciliation above for the changes in composition of Adjusted EBITDA, as a result of which the applicable tables reflect restated figures for the prior year quarter to align with current presentation. Operating Margin Operating margin is defined as operating (loss) income divided by revenue and is a non-GAAP measure. The Company believes that operating margin is a useful supplemental measure that provides meaningful assessment of the business performance of the Company and its Operating Segments. The Company uses this measure as a key indicator of financial performance, operating efficiency and cost control based on volume of business generated. Adjusted Net Income (attributable to shareholders) Adjusted Net Income (attributable to shareholders) is a non-GAAP measure defined as Net Income (attributable to shareholders) adjusted for items which do not impact day to day operations. Adjusted Net Income (attributable to shareholders) is calculated by adding back to Net Income (attributable to shareholders) the after tax impact of the sum of impairments, costs associated with repayment of long-term debt and credit facilities, gain on sale of land and other, gain on sale of investment in associates, gain on sale of operating unit, acquisition costs, restructuring costs, share-based incentive compensation cost, foreign exchange (gain) loss and other, net and hyperinflationary adjustments. The Company believes that Adjusted Net Income (attributable to shareholders) is a useful supplemental measure that provides a meaningful indication of the Companys results from principal business activities for comparing its operating performance with the performance of other companies that have different financing, capital or tax structures. Adjusted Earnings Per Share (Adjusted EPS) Adjusted EPS (basic) is a non-GAAP measure defined as Adjusted Net Income (attributable to shareholders) divided by the number of common shares outstanding. Adjusted EPS (diluted) is a non-GAAP measure defined as Adjusted Net Income (attributable to shareholders) divided by the number of common shares outstanding, further adjusted for potential dilutive impacts of outstanding securities which are convertible to common shares. The Company presents Adjusted EPS as a measure of Earning Per Share (EPS) that excludes the impact of transactions that are outside the Companys normal course of business or day to day operations. Adjusted EPS indicates the amount of Adjusted Net Income the Company makes for each share of its stock and is used by many analysts as one of several important analytical tools to evaluate financial performance and is a key metric in business valuations. Total Consolidated Mattr Adjusted EPS (Continuing and Discontinued Operations) (in thousands of Canadian dollars except for per share amounts)Year EndedDecember 31,December 31,20222023 Earnings Per Share Earnings Per Share BasicDiluted BasicDilutedTotal Consolidated Mattr Net Income (Loss) (a)$87,187 1.261.25$(29,989)(0.43)(0.43) Adjustments (before tax): Share-based incentive compensation cost 18,542 31,489 Foreign exchange (gain) loss (369) (9,712) Gain on sale of land and other (1,655) (43,017) Loss on sale of Subsidiaries 111,004 84,751 Hyperinflation adjustment for Argentina - 12,776 Curtailment of defined benefit plan (1,889) - Impairment 27,197 22,433 Restructuring costs and other, net 3,938 11,199 Tax effect of above adjustments (4,300) (8,787) Adjusted Net Income (non-GAAP) (a) 239,655 3.463.43 71,143 1.01 1.01 (a) attributable to Shareholders of the Company (in thousands of Canadian dollars except for per share amounts) Three Months EndedDecember 31,December 31,20232022 Earnings Per Share Earnings Per Share BasicDiluted BasicDilutedTotal Consolidated Mattr Net (Loss) (a)$(23,022)(0.34)(0.34)$(66,413)(0.94)(0.94) Adjustments (before tax): Share-based incentive compensation cost 94 16,618 Foreign exchange (gain) loss 263 1,414 Gain on sale of land and other (1,655) - Loss on sale of Subsidiaries 105,178 78,819 Hyperinflation adjustment for Argentina - 3,843 Curtailment of defined benefit plan - - Impairment 18,544 2,164 Restructuring costs and other, net 3,939 4,927 Tax effect of above adjustments (464) (10,625) Adjusted Net Income (non-GAAP) (a) 102,877 1.52 1.51 30,746 0.44 0.43 (a) attributable to Shareholders of the Company Total Net debt-to-Adjusted EBITDA Total Net debt-to-Adjusted EBITDA is a non-GAAP measure defined as the sum of long-term debt, current lease liabilities and long-term lease liabilities, less cash and cash equivalents, divided by the Consolidated (Continuing and Discontinued Operations) Adjusted EBITDA, as defined above, for the trailing twelve-month period. The Company believes Total Net debt-to-Adjusted EBITDA is a useful supplementary measure to assess the borrowing capacity of the Company. Total Net debt-to-Adjusted EBITDA is used by many analysts as one of several important analytical tools to evaluate how long a company would need to operate at its current level to pay of all its debt. It is also considered important by credit rating agencies to determine the probability of a company defaulting on its debt. See discussion above for the changes into the composition of Adjusted EBITDA. The table below reflects restated figures for the prior year quarters to align with current presentation. (in thousands of Canadian dollars except Net debt-to-EBITDA ratio) 2023 2022 Long-term debt $144,201 $210,832 Lease liabilities 88,263 59,439 Cash and Cash equivalents (334,061) (263,990)Total Net Debt $(101,597)$6,281 Q1 2022 Adjusted EBITDA $- $19,682 Q2 2022 Adjusted EBITDA - 32,688 Q3 2022 Adjusted EBITDA - 42,908 Q4 2022 Adjusted EBITDA - 56,458 Q1 2023 Adjusted EBITDA 54,528 - Q2 2023 Adjusted EBITDA 67,274 - Q3 2023 Adjusted EBITDA 128,440 - Q4 2023 Adjusted EBITDA 137,721 - Trailing twelve-month Adjusted EBITDA $387,963 $151,736 Total Net debt-to-Adjusted EBITDA (0.26) 0.04 Total Interest Coverage Ratio Total Interest Coverage Ratio is a non-GAAP measure defined as Consolidated Adjusted EBITDA (Continuing and Discontinued Operations), as defined above, for the trailing twelve-month period, divided by finance costs, net, for the trailing twelve-month period. The Company believes Total Interest Coverage Ratio is a useful supplementary measure to assess the Companys ability to honor its debt payments. Total Interest Coverage Ratio is used by many analysts as one of several important analytical tools to judge a companys ability to pay interest on its outstanding debt. It is also considered important by credit rating agencies to determine a companys riskiness relative to its current debt or for future borrowing. (in thousands of Canadian dollars except Interest Coverage ratio) 2023 2022 Q1 2022 Adjusted EBITDA $-$19,682Q2 2022 Adjusted EBITDA - 32,688Q3 2022 Adjusted EBITDA - 42,908Q4 2022 Adjusted EBITDA - 56,458Q1 2023 Adjusted EBITDA 54,528 -Q2 2023 Adjusted EBITDA 67,274 -Q3 2023 Adjusted EBITDA 128,440 -Q4 2023 Adjusted EBITDA 137,721 -Trailing twelve-month Adjusted EBITDA $387,963$151,736 Q1 2022 Finance costs, net $-$4,345Q2 2022 Finance costs, net - 6,062Q3 2022 Finance costs, net - 6,495Q4 2022 Finance costs, net - 4,813Q1 2023 Finance costs, net 5,144 -Q2 2023 Finance costs, net 5,528 -Q3 2023 Finance costs, net 5,744 -Q4 2023 Finance costs, net 5,113 -Trailing twelve-month finance cost, net $21,529$21,715Total Interest Coverage Ratio 18.02 6.99 Order Backlog and Bid and Budgetary Estimates The PPG business, which has historically comprised the vast majority of the Companys bid and budgetary estimates and total order backlog, was sold in November 2023 and as a result the Company will no longer report these supplementary financial measures as the Company does not believe that going forward such measures will provide investors with useful information to understand or evaluate the Companys Continuing Operations or their respective performance and prospects. 6.0 Additional Information Additional information relating to the Company, including its AIF, is available on SEDAR+ at www. sedarplus.com and on the Investors Centre page of the Companys website at: https://investors.Mattr.com/Investor-Center/default.aspx. What was Mattr Corp.'s revenue for the full year 2023? Mattr Corp.'s revenue for the full year 2023 was $925.3 million. What was the Net Debt-to-Adjusted EBITDA ratio as of December 31, 2023? As of December 31, 2023, the Net Debt-to-Adjusted EBITDA ratio was approximately (0.26) times. How much did Mattr Corp. receive from the sale of its Pipeline Performance Group to Tenaris? Mattr Corp. received $225 million from the sale of its Pipeline Performance Group to Tenaris. What was the revenue generated by Continuing Operations in Q4 2023? Continuing Operations generated revenue of $210.8 million in Q4 2023. What was the Adjusted EBITDA for the Composite Technologies segment in Q4? The Adjusted EBITDA for the Composite Technologies segment in Q4 was $18.8 million. How many common shares did Mattr Corp. repurchase in Q4? Mattr Corp. repurchased 2.9 million common shares in Q4. What was the Net Loss reported by Mattr Corp. in Q4 on a total consolidated basis? Mattr Corp. reported a Net Loss of $23.0 million in Q4 on a total consolidated basis."
Prospera Energy Inc. Announces a 508% increase in the 2023 Proven Developed Producing (PDP) Reserve Valuation,2024-03-14T06:00:00.000Z,Neutral,Neutral,"Prospera Energy Inc. announces a significant increase in its proven developed producing reserve value by 508% to 27MM$, with a total 2P reserve value of 133MM$. The company's reserves were independently assessed by InSite Petroleum Consultants Ltd., showcasing a current recovery rate of 9% using a combination of vertical and horizontal wells in key assets in Saskatchewan. PEI's 2023 Reserves Report highlights a substantial increase in reserves, with plans to exploit additional core properties in 2024, expecting significant future upside.","Prospera Energy Inc. Announces a 508% increase in the 2023 Proven Developed Producing (PDP) Reserve Valuation Rhea-AI Impact (Neutral) Rhea-AI Sentiment (Neutral) Tags Rhea-AI Summary Prospera Energy Inc. announces a significant increase in its proven developed producing reserve value by 508% to 27MM$, with a total 2P reserve value of 133MM$. The company's reserves were independently assessed by InSite Petroleum Consultants Ltd., showcasing a current recovery rate of 9% using a combination of vertical and horizontal wells in key assets in Saskatchewan. PEI's 2023 Reserves Report highlights a substantial increase in reserves, with plans to exploit additional core properties in 2024, expecting significant future upside. Positive None. Negative None. 03/14/2024 - 02:00 AM CALGARY, Alberta, March 14, 2024 (GLOBE NEWSWIRE) -- Prospera Energy Inc. (Prospera or the Company) (TSX.V: PEI, OTC: GXRFF, FRA: OF6B, OF6B.SG, OF6B.F, OF6B.BE). Prospera Energy Inc. (PEI) is pleased to announce a 508% increase to its proven developed producing reserve value of 27MM$, reflecting the success of PEIs 2023 development program. In addition, the companys proven plus probable (2P) reserve value increased by over 60MM$ to a total of 133MM$  largely driven by the undeveloped reserve value increase from 58MM$ to $98MM$. PEIs December 31, 2023, year-end reserves were independently assessed by InSite Petroleum Consultants Ltd. (InSite) in accordance with COGEH standards. The Insite report confirmed a current recovery rate of 9% (of 397 MMbbl discovered OOIP) using a combination of vertical and horizontal wells, primarily in core assets located in Southwest and West-Central Saskatchewan (>42,000 acres). PEIs 2P reserve value only reflects a portion of the remaining recoverable reserves and does not include the development of the largest core property in Saskatchewan (282 MMbbl OOIP) that is scheduled to commence exploitation in 2024. Also, there have been no improved recovery method benefits applied to these fields to date, yet. These upcoming development and enhanced recovery methods are expected to provide substantial steady upside to PEIs future reserves valuation. The 2023 Reserves Report demonstrates substantial upside for PEI, with highlights as follows: PDP reserves increased 508% from 4.4MM$ to 27.1MM$ at a discount rate of 10%.2P reserves increased by 60.8MM$ from 72.5MM$ to 133.3MM$ at a discount rate of 10%.Total proved and probable reserves value increased by 25% from 4,306 to 5,403 Mboe (97% liquids).The reserve life index increased by 6% from 28 to 30 years.PEI elected to apply modest price of 79$/bbl (WCS) for NPV estimation, allowing for substantial NPV appreciation if oil price sustains.2024 TPP F&D costs of $5.7/boe (4.3x recycle ratio).Net asset value per share: TP of $0.21 & TPP of $0.31 NI 51-101 Table 2.1.1The following table discloses, in the aggregate, the Corporations gross and net proved and probable reserves estimated using forecast prices and costs by product type. Forecast prices and costs means future prices and costs in the InSite Report that are generally accepted as being a reasonable outlook of the future or fixed or currently determinable future ,prices or costs to which the Corporation is bound. Prospera Energy Inc.Summary of Oil and Gas Reserves as of December 31, 2023Reserves CategoryLight and Medium Oil (Mbbl)Heavy Oil(Mbbl)Solution Gas(MMcf)Gas(MMcf)GrossNetGrossNetGrossNetGrossNetProved Developed Producing2322001,04499450197065Proved Developed Non-Producing232030530125195854Proved Undeveloped99801,9341,8553232 Total Proved3543003,2833,14910669128119Total Probable2662181,3641,2313020555498Total Proved + Probable6205184,6474,38013689683617 Gross reserves are the working interest share only. Net reserves are the working interest gross reserves plus all royalty interest reserves receivable less all royalty burdens payable. Conventional natural gas (solution) includes all gas produced in association with light, medium and heavy crude oil. Remaining ReservesRemaining reserves of oil and gas have been determined as of December 31, 2023. A summary of property gross and total company reserves follows: Prospera Energy Inc.Summary of Reserves as of December 31, 2023 Proved Developed Producing Total Proved Plus Probable Oil  Mbbl Property Gross1,748 7,311 Company WI1,276 5,267 Company Net1,194 4,898 Gas  MMcf Property Gross145 987 Company WI120 819 Company Net84 706 BOEs  MBOE Property Gross1,772 7,476 Company WI1,296 5,403 Company Net1,208 5,015 Product PricesThe InSite base product price forecast, effective January 1, 2024, was used for this evaluation, a copy of which is included in the InSite Report. To estimate actual received prices, adjustments were made to crude oil and by-products prices for quality and transportation tariffs. Similarly, adjustments were made to gas prices for heating value and transportation. It is assumed that the adjustment factors and increments will remain constant throughout the forecasts. Revenue data provided by the Company was used to quantify price adjustments. If such data was unavailable, typical values for the area were used to estimate price adjustments. Risks of political and economic uncertainties could affect future results and could cause results to differ materially from those expressed in this evaluation. Economic ResultsSummarized as follows is the NPV of the Corporations future net revenue attributable to the reserves categories previously tabulated, estimated using forecast prices and costs, before deducting future income tax expenses, and without discount and using discount rates of 5%, 10%, 15% and 20%. Future net revenue includes all resource income and is after capital investments, operating expenses, and royalties. Prospera Energy Inc.NPV of Future Net Revenue as of December 31, 2023NPV before Income Taxes (M$C) Proved Developed Producing Total Proved Proved Plus Probable Undiscounted0%30,905 131,261 209,549 Discounted5%29,857 108,092 164,900 10%27,051 89,920 133,312 15%24,407 76,147 110,652 20%22,196 65,581 93,893 Future operating costs are based on historical data. Wherever unavailable, they were estimated from analogous operations in the vicinity of the properties. The inflation of capital and operating costs is assumed to be 2.0% per annum after 2024. InSite has included cost estimates of well abandonment and reclamation for all existing wells, regardless of reserves assignment, and undeveloped locations assigned reserves. Estimates have been prepared based on historical costs and published guidance from provincial liability management or rating. It is understood that all abandonment and reclamation costs of wells and facilities have been accounted for by the Company. After Tax ResultsAs mandated by NI 51-101, after tax results are shown in the various tables of the InSite Report. After-tax calculations at the company level incorporated tax legislation and tax pool details for the Company, complying with the guidelines and philosophy of NI 51-101 in all material aspects. All future capital cost estimates herein have been categorized by tax pool definitions and used to supplement the year-end tax pool information provided by the Company. The year-end tax pool, as provided by the Company, is summarized below: Canadian Oil and Gas Property Expense (COGPE) $11,902,793Canadian Development Expense (CDE) $19,743,881Capital Cost Allowance (CCA Class 8,10,13,41,45) $2,274.Non-Capital Losses (100%) $8,846,004 QualificationTo prepare their evaluation, a technical presentation of properties was made by the Company to InSite. Data required by them was sourced from the Company, industry references and regulatory bodies. Neither field inspection nor environmental review of these properties were conducted by InSite, nor deemed necessary. Generally accepted engineering methods were employed to estimate reserves and forecast production. The InSite Report follows the Practice Standards and Guidelines of the Association of Professional Engineers and Geoscientists of Alberta (APEGA) and adheres in all material aspects to the business practices, evaluation procedures, and reserve definitions contained within NI 51-101 and the COGEH Handbook. Production & Development As per the Corporate Production Diagram (above) Prospera attained peaks rates of approximately 1,800 boepd in late December 2023. Additional production was shut-in to complete the drilling program. A combination of shut-in and new production from horizontal wells provided the capacity at an estimated 2,200 boepd. However, in January (as shown), the freezing weather conditions reduced existing production to an average of 900 boepd and curtailed shut-in and new well production. Compared to 2022, 2023 corporate production rebounded much quicker from these wintry weather conditions due to infrastructure improvements. Currently Prospera is producing 1,200 boepd with an additional 500 boepd to bring online. The success from PEIs 2023 drilling program supports the 2024 robust development plan to drill vertical / directional / horizontal wells in the medium oil property and horizontals in the core Saskatchewan assets. Furthermore, PEI also has planned to pilot a pressure support scheme to further improve recovery. The 2024 development plan is to be funded through a combination of cash flow and non-dilutive credit facilities to be secured against the 27MM$ of PDP reserves value. PEIs robust 2024 capital development and acquisition plan is to achieve a 2024 year-end exit target rate of 5,000 boepd. About ProsperaProspera Energy Inc. (TSX.V: PEI, OTC: GXRFF, FRA: OF6B) is a publicly traded energy company based in Western Canada, specializing in the exploration, development, and production of crude oil and natural gas. Prospera is primarily focused on optimizing hydrocarbon recovery from legacy fields through environmentally safe and efficient reservoir development methods and production practices. Prospera was restructured in the first quarter of 2021 to become profitable and in compliance with regulatory, environmental, municipal, landowner, and service stakeholders. The company is in the midst of a three-stage restructuring process aimed at prioritizing cost effective operations while appreciating production capacity and reducing liabilities. Prospera has completed the first phase by optimizing low hanging opportunities, attaining free cash flow, while bringing operation to safe operating condition, all while remaining compliant. Currently, Prospera is executing phase II of the restructuring process, the horizontal transformation intended to accelerate growth and capture the significant oil in place (400 million bbls). These horizontal wells allow PEI to reduce its environmental and surface footprint by eliminating the numerous vertical well leases along the lateral path. Phase III of Prosperas corporate redevelopment strategy is to optimize recovery through EOR applications. Furthermore, Prospera will pursue its acquisition strategy to diversify its product mix and expand its core area. Its goal is to attain 50% light oil, 40% heavy oil and 10% gas. PEI continues to apply efforts to minimize its environmental footprint. Also, efforts to reduce and eventually eliminate emissions, alongside pursuing innovative ESG methods to enhance API quality, thereby achieving higher margins and eliminating the need for diluents. For Further Information: Shawn Mehler, PR Email: investors@prosperaenergy.comWebsite: www.prosperaenergy.com FORWARD-LOOKING STATEMENTSThis news release contains forward-looking statements relating to the future operations of the Corporation and other statements that are not historical facts. Forward-looking statements are often identified by terms such as will, may, should, anticipate, expects and similar expressions. All statements other than statements of historical fact included in this release, including, without limitation, statements regarding future plans and objectives of the Corporation, are forward-looking statements that involve risks and uncertainties. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. Although Prospera believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because Prospera can give no assurance that they will prove to be correct. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. Actual results could differ materially from those currently anticipated due to a number of factors and risks. These include, but are not limited to, risks associated with the oil and gas industry in general (e.g., operational risks in development, exploration and production; delays or changes in plans with respect to exploration or development projects or capital expenditures; the uncertainty of reserve estimates; the uncertainty of estimates and projections relating to production, costs and expenses, and health, safety and environmental risks), commodity price and exchange rate fluctuations and uncertainties resulting from potential delays or changes in plans with respect to exploration or development projects or capital expenditures. The reader is cautioned that assumptions used in the preparation of any forward-looking information may prove to be incorrect. Events or circumstances may cause actual results to differ materially from those predicted, as a result of numerous known and unknown risks, uncertainties, and other factors, many of which are beyond the control of Prospera. As a result, Prospera cannot guarantee that any forward-looking statement will materialize, and the reader is cautioned not to place undue reliance on any forward- looking information. Such information, although considered reasonable by management at the time of preparation, may prove to be incorrect and actual results may differ materially from those anticipated. Forward-looking statements contained in this news release are expressly qualified by this cautionary statement. The forward-looking statements contained in this news release are made as of the date of this news release, and Prospera does not undertake any obligation to update publicly or to revise any of the included forward-looking statements, whether as a result of new information, future events or otherwise, except as expressly required by Canadian securities law. Neither TSXV nor its Regulation Services Provider (as that term is defined in the policies of the TSXV) accepts responsibility for the adequacy or accuracy of this release. Photos accompanying this announcement are available at:https://www.globenewswire.com/NewsRoom/AttachmentNg/1f5bbad9-207d-4acf-ba37-888fb01c7b1e https://www.globenewswire.com/NewsRoom/AttachmentNg/f70f9e28-3e34-45bc-83f0-e2780a4ccbfe What is the proven developed producing reserve value increase announced by Prospera Energy Inc.? Prospera Energy Inc. announced a 508% increase in its proven developed producing reserve value to 27MM$. Who independently assessed Prospera Energy Inc.'s reserves? PEI's reserves were independently assessed by InSite Petroleum Consultants Ltd. What is the current recovery rate mentioned in the PR? The current recovery rate of 9% was mentioned in the PR. What are the key assets where vertical and horizontal wells were primarily used by Prospera Energy Inc.? Vertical and horizontal wells were primarily used in core assets located in Southwest and West-Central Saskatchewan. What is the total 2P reserve value of Prospera Energy Inc.? The total 2P reserve value of PEI is 133MM$."
Oracle Helps Organizations Effectively Manage Sustainability Initiatives,2024-03-14T08:00:00.000Z,No impact,Positive,"Oracle introduces Oracle Cloud EPM for Sustainability, a solution in Oracle Fusion Cloud EPM to help organizations efficiently measure and manage sustainability initiatives. The new solution empowers business leaders to connect data, plans, and targets to optimize outcomes and comply with reporting standards.","Oracle Helps Organizations Effectively Manage Sustainability Initiatives Rhea-AI Impact (No impact) Rhea-AI Sentiment (Positive) Tags Rhea-AI Summary Oracle introduces Oracle Cloud EPM for Sustainability, a solution in Oracle Fusion Cloud EPM to help organizations efficiently measure and manage sustainability initiatives. The new solution empowers business leaders to connect data, plans, and targets to optimize outcomes and comply with reporting standards. Positive Oracle Cloud EPM for Sustainability helps organizations efficiently measure and manage sustainability initiatives. The solution enables direct connections and file-based uploads to consolidate disparate data sources for reporting standards compliance. Embedded scenario modeling capabilities allow organizations to run multiple scenarios simultaneously to make informed decisions. Built-in process management tools improve data clarity and error identification for better reporting accuracy. Negative None. 03/14/2024 - 04:00 AM New sustainability capabilities in Oracle Cloud EPM help business leaders efficiently plan, track, and report on initiatives and comply with new reporting standards LONDON, March 14, 2024 /PRNewswire/ -- Oracle CloudWorld -- Oracle today announced Oracle Cloud EPM for Sustainability, a new solution in Oracle Fusion Cloud Enterprise Performance Management (EPM) that helps organizations efficiently measure and effectively manage sustainability initiatives. The new solution will help business leaders gain the insights they need to make progress on sustainability goals by connecting data, plans, and targets across their organization, and by modeling multiple scenarios to optimize outcomes. Environmental data is sourced from many locations, business units, and systems within an organization and from suppliers and business partners. It is often manually consolidated in spreadsheets, so reporting and analyzing this data can be a slow, inefficient, and error-prone process. To address these challenges, improve the reporting process, and efficiently and accurately compile the information needed for emerging reporting guidelines, organizations need to leverage a purpose-built solution with embedded automation, AI, and machine learning. ""Many organizations are beginning to treat sustainability reporting requirements with the same rigor, governance, and technical expertise as financial reporting,"" said Hari Sankar, group vice president, Product Management at Oracle. ""With Oracle Cloud EPM for Sustainability, our customers can leverage a trusted solution that embeds AI and other advanced technologies to help improve efficiency, deliver insights, promote compliance, and effectively manage their progress on sustainability initiatives."" Oracle Cloud EPM for Sustainability helps organizations accelerate their sustainability efforts. The new solution enables organizations to: Collect, Connect, and Transform Data: Direct connections and file-based uploads enable organizations to consolidate disparate data sources to help meet International Financial Reporting (FRS) and Global Reporting Initiative (GRI) standards. For example, organizations can align energy use, fleet mileage, procurement data, and other applicable data sources to meet the requirements of the relevant frameworks and standards. In addition, built-in process management tools help capture all data, which not only improves the clarity of calculations, but also enables errors to be identified and discrepancies to be reconciled.Model Different Scenarios: Embedded scenario modeling capabilities enable organizations to run an unlimited number of scenarios simultaneously to determine the best path forward. With an enhanced understanding of the risks and opportunities for each initiative, organizations can make smarter decisions about sustainability initiatives and drive greater impact.Explore AI-Powered Insights: Built-in pattern recognition capabilities provide automated alerts on anomalies and variances, while self-service capabilities for filtering, sorting, and visualization enable users to drill into the data in a safe, effective manner. With purpose-built dashboards and automated analysis, organizations can monitor progress and take corrective action in a timely manner.Create Intelligent Plans: Predictive planning enables organizations to create and validate forecasts and predict future performance. In addition, embedded AI and machine learning helps business leaders continuously improve plans.Report and Act on Goals: Narrative reporting capabilities help business leaders align data with relevant reporting standards and produce reports with contextual detail that can be shared with key stakeholders. Timely, accurate, and insightful reports help organizations identify areas for improvement and quickly take action to reduce environmental impact.Part of Oracle Fusion Cloud Enterprise Resource Planning (ERP), Oracle Cloud EPM offers a comprehensive set of enterprise performance management capabilities that help organizations align financial and operational planning, close the books faster, and manage enterprise master data. About OracleOracle offers integrated suites of applications plus secure, autonomous infrastructure in the Oracle Cloud. For more information about Oracle (NYSE: ORCL), please visit us at oracle.com. TrademarksOracle, Java, MySQL, and NetSuite are registered trademarks of Oracle Corporation. NetSuite was the first cloud company--ushering in the new era of cloud computing. View original content to download multimedia:https://www.prnewswire.com/news-releases/oracle-helps-organizations-effectively-manage-sustainability-initiatives-302088876.html SOURCE Oracle How does Oracle Cloud EPM for Sustainability help organizations? Oracle Cloud EPM for Sustainability helps organizations efficiently measure and manage sustainability initiatives. What capabilities does the new solution offer? The new solution offers direct connections and file-based uploads to consolidate data sources, scenario modeling capabilities, and process management tools for improved reporting accuracy. What standards can organizations meet with Oracle Cloud EPM for Sustainability? Organizations can meet International Financial Reporting (FRS) and Global Reporting Initiative (GRI) standards with the solution. How does the solution improve data clarity and error identification? Built-in process management tools in Oracle Cloud EPM for Sustainability improve data clarity and error identification for better reporting accuracy."
Oracle Adds New Generative AI Capabilities to Oracle Fusion Cloud Applications Suite,2024-03-14T08:00:00.000Z,Low,Very Positive,"Oracle announces new generative AI capabilities in the Oracle Fusion Cloud Applications Suite to enhance decision making, employee, and customer experience. Over 50 embedded AI use cases respect customer data privacy and security, improving productivity and reducing costs.","Oracle Adds New Generative AI Capabilities to Oracle Fusion Cloud Applications Suite Rhea-AI Impact (Low) Rhea-AI Sentiment (Very Positive) Tags AI Rhea-AI Summary Oracle announces new generative AI capabilities in the Oracle Fusion Cloud Applications Suite to enhance decision making, employee, and customer experience. Over 50 embedded AI use cases respect customer data privacy and security, improving productivity and reducing costs. Positive None. Negative None. Market Research Analyst The integration of generative AI capabilities within Oracle's Fusion Cloud Applications Suite signifies a strategic enhancement that could potentially reshape the competitive landscape for enterprise resource planning (ERP) and supply chain management (SCM) software. By embedding over 50 AI use cases, Oracle is positioning itself as a leader in the next generation of cloud applications, which may attract new customers and retain existing ones by offering advanced, AI-powered solutions.From a market perspective, the ability to improve decision-making, enhance employee and customer experiences and increase productivity while reducing costs could result in increased market share and revenue growth for Oracle. The emphasis on data privacy and security in the AI implementations could also alleviate customer concerns about data sharing and usage, which is a significant competitive advantage in the current data-conscious business environment. Financial Analyst The announcement from Oracle regarding the new generative AI capabilities is likely to have a positive impact on their financial performance. The advanced features such as insight narratives, predictive forecast explanations and project plan generation can streamline operations and offer cost-saving benefits to users. These enhancements may lead to an increase in subscription renewals and attract new customers looking for sophisticated ERP solutions, potentially boosting Oracle's recurring revenue streams.Furthermore, the investment in AI technology demonstrates Oracle's commitment to innovation, which could positively influence investor confidence. However, the actual financial impact will depend on the adoption rate of these new features by existing customers and the ability to attract new clients. Technology Analyst Oracle's move to enhance its Oracle Fusion Cloud Applications Suite with generative AI capabilities is a significant technological advancement. The use of role-based security to embed these capabilities into workflows respects user entitlements and could set a new standard for the integration of AI within enterprise applications.The customizability of these AI tools to meet industry-specific needs indicates a flexible and forward-thinking approach. This could lead to wider adoption across various sectors, as companies look for tailored AI solutions that can integrate seamlessly with their existing systems and processes. 03/14/2024 - 04:00 AM New capabilities for finance, supply chain, HR, customer experience, and beyond help organizations be more competitive, boost productivity, and reduce cost of doing business LONDON, March 14, 2024 /PRNewswire/ -- Oracle CloudWorld -- Oracle today announced new generative AI capabilities within the Oracle Fusion Cloud Applications Suite that will help customers improve decision making and enhance the employee and customer experience. The latest AI additions include new generative AI capabilities embedded in existing business workflows across finance, supply chain, HR, sales, marketing, and service, as well as an expansion of the Oracle Guided Journeys' extensibility framework to enable customers and partners to incorporate more generative AI capabilities to support their unique industry and competitive needs. ""We are committed to delivering innovation that matters to our customers, and the combination of OCI, Fusion Applications, and the thousands of customers that use these applications daily enables us to continually improve our services and deliver best-in-class AI,"" said Steve Miranda, executive vice president of applications development, Oracle. ""We have been using AI in our applications for several years and now we are introducing more ways for customers to take advantage of generative AI across the suite. With additional embedded capabilities and an expanded extensibility framework, our customers can quickly and easily take advantage of the latest generative AI advancements to help increase productivity, reduce costs, expand insights, and improve the employee and customer experience."" 50+ Embedded Generative AI CapabilitiesBuilt on Oracle Cloud Infrastructure (OCI) and leveraging its leading AI services, Oracle supports over 50 generative AI use cases that are embedded within Oracle Fusion Applications and designed to respect customers' enterprise data, privacy, and security. With OCI Generative AI Service, no customer data is shared with large language model (LLM) providers or seen by other customers. In addition, an individual customer is the only entity allowed to use custom models trained on its data. To further protect sensitive information, role-based security is embedded directly into Oracle Fusion Applications workflows that only recommends content that end users are entitled to view. Newly embedded generative AI capabilities include: Oracle Fusion Cloud Enterprise Resource Planning (ERP): Insight narratives: Help identify anomalies, variances, and biases based on pattern recognition. With AI-generated narratives, based on a single insight or multiple related insights in Oracle's Intelligent Performance Management (IPM) Insight, organizations gain richer context and actionable explanations to drive smarter decisions. Management reporting narratives: Help finance professionals explain variances and trends impacting the business. With generative AI-powered management reporting narratives and contextual collaboration for finance and operating functions, organizations can improve productivity and efficiently develop accurate reports. Predictive forecast explanations: Help finance professionals generate contextual commentary to explain forecasts produced by predictive models and key factors driving the prediction. With generative AI-powered explanations, organizations can help demystify the inner workings of predictive models, build trust and confidence in forecasts, and enable broader adoption of predictive forecasting models.Project program status summary generation: Helps program managers generate executive summaries using details drawn from projects and sub-programs. With generative AI-powered status summaries, organizations can improve project transparency by surfacing key insights and outliers and reduce time spent on preparing status reports.Project plan and proposal generation: Helps project managers generate tailored project plans based on opportunity details, similar past projects, and best practices. With generative AI providing key points and narratives to include in plans and proposals, organizations can reduce time needed to develop plans and improve operational efficiency.Oracle Fusion Cloud Supply Chain & Manufacturing (SCM): Item description generation: Helps product specialists quickly generate standardized product descriptions that highlight SEO keywords. With generative AI support for item descriptions in Oracle Product Lifecycle Management, organizations can save time, reduce errors, and improve the overall quality of product descriptions to increase customer engagement and boost sales. Supplier recommendations: Help procurement professionals quickly and efficiently add suppliers to their organization's supply chain. With generative AI-powered supplier recommendations embedded in Oracle Procurement, organizations can use information such as product descriptions and purchase categories to identify suppliers, improve sourcing efficiency, help lower costs, and reduce supplier risk.Negotiation summaries: Help procurement professionals quickly generate a customized cover page summary for a specific negotiation. With generative AI-powered assisted authoring embedded in Oracle Procurement, organizations can accelerate negotiations, increase savings, reduce risk, and maximize supplier outcomes.Oracle Fusion Cloud Human Capital Management (HCM): Job category landing pages: Help career site administrators quickly build high-quality landing pages for different job categories. With richer generative AI-built career sites in Oracle Recruiting, organizations can deliver tailored experiences for candidate audiences and increase candidate engagement.Job match explanations: Help candidates spend less time determining if a job opening is best suited for their background and career goals by presenting them with a summary of how well they fit a job. With generative AI providing immediate feedback in Oracle Recruiting, candidates can better understand where they may best fit within an organization.Candidate assistant: Helps candidates find answers to common questions about the company, benefits, and job-specific requirements in a simple conversational experience. With generative AI providing immediate answers in Oracle Recruiting, organizations can keep candidates engaged while reviewing career sites and job opportunities.Manager survey generation: Helps managers generate quick surveys for their teams with manager-defined structure and formatting. With generative AI in Oracle Cloud HCM's Manager Activity Center, organizations can get timely employee feedback to quickly inform actions and decisions.Oracle Fusion Cloud Customer Experience (CX): Service webchat summaries: Help call center agents generate intelligent, concise, and clear summaries of customer chat sessions based on the transcription of the engagement. With generative AI creating high-quality summaries of chat interactions in Oracle Service, organizations can accurately track ongoing issues, reduce manual tasks for service agents, and improve the customer and employee experience.Assisted authoring for sales content: Helps salespeople improve productivity by generating customer success stories from closed-won account history. With generative AI quickly producing relevant supporting content in Oracle Sales, organizations can close new deals faster.Assisted authoring and recommendations for marketing collateral: Helps marketers improve productivity by providing subject line recommendations, email and landing page copy, and design recommendations that improve audience engagement. With generative AI supporting the development of assets in Oracle Marketing, organizations can improve the speed and relevance of marketing campaigns and optimize performance.Generative AI Extensibility with Oracle Guided JourneysOracle Guided Journeys now provides an extensibility framework that allows Oracle Cloud HCM and Oracle Cloud SCM customers and partners to add their own generative AI capabilities that complement and seamlessly integrate with their existing Oracle Fusion Applications investments. As part of this framework, organizations can choose a preferred LLM provider to support their unique industry and competitive needs. With Oracle Guided Journeys extensibility, customers and partners can help accelerate innovation and respond to changing market conditions with greater speed. Oracle Fusion Applications' generative AI services are powered by OCI, which hosts both prebuilt and custom models. Leveraging OCI Supercluster, which includes bare metal compute instances, ultra-low latency RDMA networking, and high-performance storage, OCI helps accelerates LLM training with the highest performance at the lowest cost. This allows Oracle to deliver the fastest AI innovation in the industry and attract the best enterprise-focused innovators, including Cohere, to build on OCI, further contributing to the innovation feedback cycle. About OracleOracle offers integrated suites of applications plus secure, autonomous infrastructure in the Oracle Cloud. For more information about Oracle (NYSE: ORCL), please visit us at www.oracle.com. Future Product DisclaimerThe preceding is intended to outline our general product direction. It is intended for information purposes only, and may not be incorporated into any contract. It is not a commitment to deliver any material, code, or functionality, and should not be relied upon in making purchasing decisions. The development, release, timing, and pricing of any features or functionality described for Oracle's products may change and remains at the sole discretion of Oracle Corporation. TrademarksOracle, Java, MySQL and NetSuite are registered trademarks of Oracle Corporation. NetSuite was the first cloud companyushering in the new era of cloud computing. View original content to download multimedia:https://www.prnewswire.com/news-releases/oracle-adds-new-generative-ai-capabilities-to-oracle-fusion-cloud-applications-suite-302088577.html SOURCE Oracle What are the new generative AI capabilities announced by Oracle in the Oracle Fusion Cloud Applications Suite? Oracle announced new generative AI capabilities embedded in existing business workflows across finance, supply chain, HR, sales, marketing, and service, as well as an expansion of the Oracle Guided Journeys' extensibility framework. How many generative AI use cases are supported by Oracle within Oracle Fusion Applications? Oracle supports over 50 generative AI use cases that are embedded within Oracle Fusion Applications and designed to respect customers' enterprise data, privacy, and security. What role does Oracle Cloud Infrastructure (OCI) play in supporting generative AI capabilities? Oracle Cloud Infrastructure (OCI) is leveraged by Oracle to support over 50 generative AI use cases within Oracle Fusion Applications, ensuring customer data privacy and security. What are some examples of newly embedded generative AI capabilities in Oracle Fusion Cloud ERP? Examples of newly embedded generative AI capabilities in Oracle Fusion Cloud ERP include insight narratives, management reporting narratives, predictive forecast explanations, project program status summary generation, and project plan and proposal generation. How does generative AI support product specialists in Oracle Fusion Cloud SCM? Generative AI helps product specialists in Oracle Fusion Cloud SCM quickly generate standardized product descriptions that highlight SEO keywords, improving product quality and customer engagement. What assistance does generative AI provide in Oracle Fusion Cloud HCM for job categories? Generative AI in Oracle Fusion Cloud HCM helps career site administrators build high-quality landing pages for different job categories, delivering tailored experiences for candidate audiences and increasing candidate engagement."
AI-Powered Analytics Help Oracle Fusion Applications Customers Achieve Better Business Outcomes,2024-03-14T08:00:00.000Z,Low,Positive,"Oracle announces new AI capabilities in Oracle Fusion Data Intelligence to enhance decision-making and action implementation for customers. These AI features provide advanced machine learning insights for finance, supply chain, HR, and customer service within Oracle Fusion Cloud Applications. The integration of AI-powered analytics aims to optimize operations and improve business outcomes.","AI-Powered Analytics Help Oracle Fusion Applications Customers Achieve Better Business Outcomes Rhea-AI Impact (Low) Rhea-AI Sentiment (Positive) Tags AI Rhea-AI Summary Oracle announces new AI capabilities in Oracle Fusion Data Intelligence to enhance decision-making and action implementation for customers. These AI features provide advanced machine learning insights for finance, supply chain, HR, and customer service within Oracle Fusion Cloud Applications. The integration of AI-powered analytics aims to optimize operations and improve business outcomes. Positive None. Negative None. Financial Analyst The introduction of advanced AI capabilities into Oracle Fusion Data Intelligence presents a significant opportunity for Oracle's clientele. By enhancing decision-making processes and enabling rapid action based on insights, these new features could lead to improved operational efficiency and financial performance for users. As organizations seek to leverage data for a competitive edge, Oracle's integration of predictive analytics and machine learning directly into enterprise applications like ERP, SCM, HCM and CX is particularly noteworthy.From a financial perspective, the ability to predict payment risks, optimize inventory and forecast sales with greater accuracy can translate into tangible benefits such as improved cash flow management, reduced capital tied up in inventory and higher sales conversion rates. These outcomes could potentially result in a positive impact on Oracle's revenue, as satisfied customers are likely to increase their investment in Oracle's cloud services and potentially attract new customers seeking similar benefits.Moreover, the integration with Oracle Fusion Accounting Hub suggests a strategic move to provide a more comprehensive solution, thereby increasing the value proposition of Oracle's offerings. This can be seen as an attempt to drive up the adoption rates of Oracle's ERP Analytics, which could enhance the company's competitive position in the cloud analytics market. Market Research Analyst Oracle's announcement aligns with the broader market trend of integrating AI and machine learning into business intelligence platforms. The market for AI in business analytics is rapidly growing and Oracle's move to enhance its Fusion Data Intelligence with new AI capabilities is strategic in maintaining relevance and competitiveness. By offering prebuilt AI models tailored for specific business functions, Oracle is reducing the barrier to entry for organizations that may lack the expertise to develop these capabilities in-house.The focus on predictive insights across various domainsfinance, supply chain, HR and customer experienceindicates a deep understanding of the diverse needs of modern enterprises. As businesses increasingly demand real-time, actionable insights, Oracle's solution could gain traction, potentially influencing market dynamics by setting a new standard for integrated AI analytics solutions.Furthermore, the emphasis on prebuilt analytical models and managed data pipelines highlights the importance of ease of use and scalability, which are critical factors for businesses when selecting a cloud analytics provider. Oracle's enhancements could shift customer expectations in the industry, prompting competitors to accelerate similar integrations to meet market demands. Legal Expert One of the notable AI capabilities introduced is the model that surfaces hidden biases in hiring, internal mobility and compensation practices. This feature not only has the potential to improve HR processes but also addresses a growing legal and ethical concern within the business community regarding workplace discrimination. By providing tools to identify and mitigate such biases, Oracle is proactively contributing to the creation of more equitable workplaces.These enhancements could also have legal implications for Oracle's clients, as they may help in ensuring compliance with various regulations concerning fair hiring practices and equal pay. Companies using Oracle's AI-powered analytics could leverage this technology to demonstrate due diligence in their efforts to prevent discriminatory practices, which could be beneficial in the event of legal scrutiny.It is important for Oracle and its customers to ensure that the AI models themselves are free from biases and that their use complies with data privacy regulations. As AI becomes more integrated into business processes, the legal landscape will likely evolve and Oracle will need to continuously update its offerings to align with new regulatory requirements. 03/14/2024 - 04:00 AM New AI capabilities in Oracle Fusion Data Intelligence help improve decision-making and quickly turn insights into action LONDON, March 14, 2024 /PRNewswire/ -- Oracle CloudWorld -- Oracle today announced new artificial intelligence (AI) capabilities in Oracle Fusion Data Intelligence that will help Oracle Fusion Cloud Applications customers improve decision making by combining data-driven insights with intelligent actions. Oracle Fusion Data Intelligence is a next-generation data, analytics, and AI solution powered by Oracle Cloud Infrastructure (OCI) services including Oracle Autonomous Database, OCI Data Lake, and Oracle Analytics Cloud. With the help of these new AI capabilities, organizations can make better decisions and improve business outcomes. ""Collecting, analyzing, and contextualizing data can be a time-consuming, error-prone process,"" said T.K. Anand, executive vice president, Analytics, Oracle. ""With Oracle Fusion Data Intelligence, our customers can optimize this process by taking advantage of a comprehensive analytics offering that brings together data, ready-to-use analytics, and prebuilt AI models in the right business context. The new AI capabilities we are adding can help customers further improve decision making and rapidly turn insights into action."" The new AI capabilities in Oracle Fusion Data Intelligence are designed to expand existing services with analytics that go beyond day-to-day transactional reporting. Advanced machine learning capabilities provide insights and predict outcomes on specific questions for finance, supply chain, HR, and customer service. The Oracle-managed data pipelines and prebuilt analytical models help ensure that data is always current for robust predictive model training and accurate predictions. AI-powered analytics integrated directly into Oracle Fusion Applications include: ERP Analytics: Help finance teams improve decision-making with insights into operational and financial metrics across the organization. New AI capabilities will help Oracle Fusion Cloud Enterprise Resource Planning (ERP) customers analyze collection history to better predict risk and payment timing, gain deeper insights into business spend to identify appropriate classifications, and automatically detect and flag expense anomalies. One of these available models flags customers that are at risk of paying invoices late using historic data from aging receivables. Another new model identifies the risk of paying vendors late in order to maximize discounts and improve vendor relationships.SCM Analytics: Help supply chain leaders optimize their supply chain with insights from across their operations as well as external market data. New AI capabilities can help Oracle Fusion Cloud Supply Chain & Manufacturing (SCM) customers predict the actions needed to ensure on-time delivery, reduce supplier risks, optimize inventory management, and improve warehouse efficiency. By leveraging prebuilt analytics, organizations can connect insights from different areas of their supply chain and respond to changes faster.HCM Analytics: Help HR teams improve recruitment, talent retention, and growth while increasing the likelihood that resources are aligned with business needs. New AI capabilities can help Oracle Fusion Cloud Human Capital Management (HCM) customers predict staffing needs, identify next steps to close skills gaps, analyze workforce diversity, and provide actionable insights to improve time-to-hire. One of these available models surfaces hidden biases in hiring, internal mobility, and compensation practices across gender, age, and ethnicity. Another new model automatically identifies skill gaps to drive improvements in workforce planning.CX Analytics: Help sales teams efficiently engage customers with relevant offers that drive revenue and minimize customer churn. New AI capabilities can help Oracle Fusion Cloud Customer Experience (CX) customers to more accurately forecast sales, identify optimal pricing strategies, predict customer churn rates, and deliver data-driven recommendations for product pricing and sales strategies. One of these available models enables teams to leverage a single prebuilt, extensible analytical model for sales, marketing, contract, service, and subscription data for a 360-degree view of revenue and to further expand analysis with back-office ERP data.In addition to the new AI capabilities, Oracle Fusion Data Intelligence now features an integration with and prebuilt analytics for Oracle Fusion Accounting Hub, part of Oracle Cloud ERP. Available as an add-on SKU to Oracle Fusion ERP Analytics, this integration enables customers to combine and analyze financial data from multiple accounting systems. Users can now discover correlations and irregularities across balances, journals, and sub-ledger transaction details, spanning accounting data from Oracle Cloud ERP and other systems. Fusion Data Intelligence is an evolution of the Oracle Fusion Analytics Warehouse product that delivers business data-as-a-service with automated data pipelines, 360-degree data models for key business entities, rich interactive analytics, AI/ML models, and intelligent applications. To learn more about Oracle Fusion Data Intelligence, please visit: www.oracle.com/business-analytics/fusion-data-intelligence-platform About OracleOracle offers integrated suites of applications plus secure, autonomous infrastructure in the Oracle Cloud. For more information about Oracle (NYSE: ORCL), please visit us at www.oracle.com. TrademarksOracle, Java, MySQL and NetSuite are registered trademarks of Oracle Corporation. NetSuite was the first cloud companyushering in the new era of cloud computing. View original content to download multimedia:https://www.prnewswire.com/news-releases/ai-powered-analytics-help-oracle-fusion-applications-customers-achieve-better-business-outcomes-302088848.html SOURCE Oracle What are the new AI capabilities announced by Oracle in Oracle Fusion Data Intelligence? Oracle announced new AI capabilities in Oracle Fusion Data Intelligence to enhance decision-making and action implementation for customers. Which areas within Oracle Fusion Cloud Applications will benefit from the advanced machine learning capabilities provided by the new AI features? Finance, supply chain, HR, and customer service will benefit from the advanced machine learning capabilities within Oracle Fusion Cloud Applications. How can organizations leverage the new AI capabilities in Oracle Fusion Data Intelligence to improve business outcomes? Organizations can leverage the new AI capabilities to make better decisions, predict outcomes, optimize supply chain operations, and enhance customer engagement. What is the main goal of integrating AI-powered analytics into Oracle Fusion Cloud Applications? The main goal is to optimize operations, improve business outcomes, and provide actionable insights for finance, supply chain, HR, and customer service."
Innate Pharma Announces Conference Call and Webcast for Full Year 2023 Financial Results,2024-03-14T06:00:00.000Z,Low,Neutral,"Innate Pharma SA (IPH; IPHA) announced a conference call on March 21, 2024, to discuss financial results for the full year ending December 31, 2023. Key participants include the CEO, CMO, COO, CFO, and President of US Operations. The event will be live webcasted and accessible via telephone. A replay will be available on the company's website for 90 days.","Innate Pharma Announces Conference Call and Webcast for Full Year 2023 Financial Results Rhea-AI Impact (Low) Rhea-AI Sentiment (Neutral) Tags earnings Rhea-AI Summary Innate Pharma SA (IPH; IPHA) announced a conference call on March 21, 2024, to discuss financial results for the full year ending December 31, 2023. Key participants include the CEO, CMO, COO, CFO, and President of US Operations. The event will be live webcasted and accessible via telephone. A replay will be available on the company's website for 90 days. Positive None. Negative None. 03/14/2024 - 02:00 AM MARSEILLE, France--(BUSINESS WIRE)-- Regulatory News: Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (Innate or the Company), today announced that the Company will hold a conference call on Thursday, March 21, 2024 at 2 p.m. CET / 9 a.m. EDT, following the release of its financial results for the full year ending December 31, 2023. Participants during the call will be: Herv Brailly, Chief Executive Officer Sonia Quaratino, Executive Vice President, Chief Medical Officer Yannis Morel, Executive Vice President, Chief Operating Officer Frdric Lombard, Senior Vice President, Chief Financial Officer Arvind Sood, Executive Vice President, President of US Operations Details for the Virtual Event The live webcast will be available at the following link: https://events.q4inc.com/attendee/435604632 Participants may also join via telephone using the following registration link: https://registrations.events/direct/Q4I409542 This information can also be found on the Investors section of the Innate Pharma website, www.innate-pharma.com. A replay of the webcast will be available on the Company website for 90 days following the event. About Innate Pharma Innate Pharma S.A. is a global, clinical-stage biotechnology company developing immunotherapies for cancer patients. Its innovative approach aims to harness the innate immune system through therapeutic antibodies and its ANKET (Antibody-based NK cell Engager Therapeutics) proprietary platform. Innates portfolio includes lead proprietary program lacutamab, developed in advanced form of cutaneous T cell lymphomas and peripheral T cell lymphomas, monalizumab developed with AstraZeneca in non-small cell lung cancer, as well as ANKET multi-specific NK cell engagers to address multiple tumor types. Innate Pharma is a trusted partner to biopharmaceutical companies such as Sanofi and AstraZeneca, as well as leading research institutions, to accelerate innovation, research and development for the benefit of patients. Headquartered in Marseille, France with a US office in Rockville, MD, Innate Pharma is listed on Euronext Paris and Nasdaq in the US. Learn more about Innate Pharma at www.innate-pharma.com and follow us on Twitter and LinkedIn. Information about Innate Pharma shares ISIN code Ticker code LEI FR0010331421 Euronext: IPH Nasdaq: IPHA 9695002Y8420ZB8HJE29 Disclaimer on forward-looking information and risk factors This press release contains certain forward-looking statements, including those within the meaning of the Private Securities Litigation Reform Act of 1995. The use of certain words, including believe, potential, expect and will and similar expressions, is intended to identify forward-looking statements. Although the company believes its expectations are based on reasonable assumptions, these forward-looking statements are subject to numerous risks and uncertainties, which could cause actual results to differ materially from those anticipated. These risks and uncertainties include, among other things, the uncertainties inherent in research and development, including related to safety, progression of and results from its ongoing and planned clinical trials and preclinical studies, review and approvals by regulatory authorities of its product candidates, the Companys commercialization efforts and the Companys continued ability to raise capital to fund its development. For an additional discussion of risks and uncertainties which could cause the company's actual results, financial condition, performance or achievements to differ from those contained in the forward-looking statements, please refer to the Risk Factors (Facteurs de Risque"") section of the Universal Registration Document filed with the French Financial Markets Authority (AMF), which is available on the AMF website http://www.amf-france.org or on Innate Pharmas website, and public filings and reports filed with the U.S. Securities and Exchange Commission (SEC), including the Companys Annual Report on Form 20-F for the year ended December 31, 2022, and subsequent filings and reports filed with the AMF or SEC, or otherwise made public, by the Company. This press release and the information contained herein do not constitute an offer to sell or a solicitation of an offer to buy or subscribe to shares in Innate Pharma in any country. View source version on businesswire.com: https://www.businesswire.com/news/home/20240313490063/en/ For additional information, please contact: Investors Innate Pharma Henry Wheeler Tel.: +33 (0)4 84 90 32 88 Henry.wheeler@innate-pharma.fr Media Relations NewCap Arthur Rouill Tel.: +33 (0)1 44 71 00 15 innate@newcap.eu Source: Innate Pharma SA When is the conference call announced by Innate Pharma (IPHA) scheduled to take place? The conference call by Innate Pharma (IPHA) is scheduled for Thursday, March 21, 2024, at 2 p.m. CET / 9 a.m. EDT. Who are the key participants in the conference call announced by Innate Pharma (IPHA)? The key participants in the conference call announced by Innate Pharma (IPHA) include the CEO, CMO, COO, CFO, and President of US Operations. How can participants join the conference call by Innate Pharma (IPHA)? Participants can join the conference call by Innate Pharma (IPHA) via live webcast at the provided link or through telephone registration. Where can participants find information about the conference call by Innate Pharma (IPHA)? Participants can find information about the conference call by Innate Pharma (IPHA) on the Investors section of the company's website, www.innate-pharma.com. For how long will the replay of the webcast from the conference call by Innate Pharma (IPHA) be available? The replay of the webcast from the conference call by Innate Pharma (IPHA) will be available on the company's website for 90 days following the event."
Gap Widens Between Leaders and Non-Leaders as Digital Transformation in Financial Services Reaches New Level of Maturity,2024-03-14T08:00:00.000Z,Low,Neutral,"Broadridge Financial Solutions, Inc. study reveals 75% of executives confident in tech transformation with a growing digital maturity gap. Leaders prioritize cybersecurity, GenAI, and talent development. AI-centric customer experiences and innovation culture key to success. Financial institutions to increase cybersecurity investments by 28% in the next two years.","Gap Widens Between Leaders and Non-Leaders as Digital Transformation in Financial Services Reaches New Level of Maturity Rhea-AI Impact (Low) Rhea-AI Sentiment (Neutral) Tags Rhea-AI Summary Broadridge Financial Solutions, Inc. study reveals 75% of executives confident in tech transformation with a growing digital maturity gap. Leaders prioritize cybersecurity, GenAI, and talent development. AI-centric customer experiences and innovation culture key to success. Financial institutions to increase cybersecurity investments by 28% in the next two years. Positive 75% of executives confident in tech transformation roadmap. Leaders prioritize cybersecurity, GenAI, and talent development. AI investments in customer interaction crucial for meaningful engagement. Financial institutions to increase cybersecurity investments by 28% in the next two years. Negative None. Market Research Analyst The insights from the Broadridge Financial Solutions study underscore a pivotal trend in the financial sector: the aggressive investment in technology and the intensifying competition for digital talent. The distinction between digital 'leaders' and 'non-leaders' is particularly noteworthy, as it suggests a widening digital maturity gap. This gap could have significant implications for market dynamics, potentially leading to shifts in competitive advantage and influencing investor sentiment towards companies that are perceived as either innovators or laggards in digital transformation.From a market perspective, the increased investment in cybersecurity and cloud platforms is a response to the growing threat landscape and the need for scalable infrastructure. The 28% projected increase in cybersecurity investment reflects the urgency of protecting digital assets, which could influence the performance and valuation of cybersecurity firms. The focus on AI, including GenAI, quantum computing and blockchain, indicates a shift towards more sophisticated technology solutions, which could foster new revenue streams and enhance operational efficiency for adopters.Moreover, the emphasis on customer-centric digital experiences driven by AI investments highlights a broader industry trend of leveraging technology to enhance client engagement and satisfaction. This could potentially lead to increased customer retention and acquisition, contributing to the top-line growth of financial institutions that successfully implement these technologies. Human Resources Expert The study's findings on the war for talent align with the broader narrative of a skills shortage in the technology sector, particularly in emerging technologies such as AI and blockchain. The disparity in digital skills and talent strategy between leaders (71%) and non-leaders (12%) is a critical factor that could impact the ability of firms to execute their digital transformation agendas. Firms with advanced digital talent strategies are likely to have a competitive edge in innovation and operational agility.As firms vie for top tech talent, the impact on human capital management and recruitment strategies will be profound. Companies that foster a culture of innovation and prioritize skills development are more likely to attract and retain the talent necessary for sustainable growth. This focus on human capital could have long-term benefits, such as increased productivity and innovation, which are essential for driving enterprise value and investor confidence. Cybersecurity Analyst The projected increase in cybersecurity investment reflects a strategic response to the heightened risk environment in the financial sector. As digital transformation accelerates, so does the attack surface for potential cyber threats. The prioritization of cybersecurity by executives not only affects internal security protocols but also shapes the expectations and selection criteria for third-party technology vendors.This trend has a dual impact: it drives demand for cybersecurity solutions, potentially benefiting providers in this space and it influences the operational risk profile of financial institutions. Investors may look favorably upon firms that demonstrate robust cybersecurity measures, as these are critical for maintaining trust and ensuring the continuity of digital services. The focus on cybersecurity as a top capability expected from technology vendors could also lead to industry-wide improvements in security standards, further shaping the competitive landscape. 03/14/2024 - 04:00 AM Firms pacing investments in core technologies and cyber while promise of GenAI and the war for talent becomes the next battleground NEW YORK, March 14, 2024 /PRNewswire/ -- As the digital revolution accelerates, financial institutions are racing to create enterprise value by investing heavily through the economic cycle, according to a new study by Broadridge Financial Solutions, Inc. (NYSE: BR). The study found that 75% of executives are confident in their tech transformation roadmap, but a digital maturity gap is growing between leaders and non-leaders. While more than two-thirds say they have made meaningful progress in modernizing their core IT platforms, organizations must make progress against multiple tech and talent frontiers as they grapple with new technologies like GenAI, rising cybersecurity challenges, and accelerating needs for seamless digital customer experiences. The 2024 Digital Transformation and Next-Gen Tech Study gauges the perspectives of 500 global C-suite and senior executives across the buy side and sell side, illuminating the forces driving the industry's technology modernization. The study categorized firms as digital ""leaders"" versus ""non-leaders,"" based on their advancement levels across ten essential aspects of digital transformation, including modernized core IT, the use of automation tools, innovation culture, data management, and digital customer experiences, among others. When it comes to areas of focus, more than 80% of all executives indicate that they are making the biggest day-to-day investments in cybersecurity technology and building an advanced IT cloud platform. Meanwhile the majority also expect to maintain or increase their investment in next-gen technologies like AI, quantum computing, crypto/digital assets, and blockchain over the next two years. ""It's no surprise that we are seeing significant momentum in the adoption of next-generation technology like GenAI from financial services firms looking to solve their most pressing business challenges, while they're also gaining measurable value from more established technologies including AI, blockchain, cloud and core infrastructure platforms,"" said Chris Perry, President of Broadridge. ""Focusing on the human aspect of digital transformation  attracting and retaining digital talent and fostering a culture of innovation  has proven to be just as critical to ensuring these initiatives succeed. Our study also revealed that firms with a decentralized approach to innovation are more likely to be leaders in transformation."" AI-Centric Customer Experiences Anticipated to Be the New Norm Personalized and seamless digital customer experiences have become an expectation in the financial services industry. In fact, 40% of respondents indicate that being customer obsessed with priorities deeply rooted in client needs is the top accelerator of digital transformation. Fueling many of these changes in the customer experience paradigm is AI. Seventy percent of leaders (52% overall) indicate that they are prioritizing their AI investments in customer interaction to fuel stronger and more meaningful customer engagement. When it comes to Generative AI, leaders are more likely to be making large or moderate investments in the technology (44%), more than twice the level of non-leaders. Despite the higher levels of investment by leaders, the lower cost of entry to deploy GenAI may allow non-leaders to get in on the action more easily, enabling them to catch up in their efforts to deploy the technology to both customer-focused and internal use cases. Focus on Talent and Culture for Innovation Initiatives to Succeed There have been significant IT advancements year-over year, however there is still work to be done in enterprise-wide skills development. Only 28% of all executives surveyed have reached the advanced stages of implementing a digital skills and talent strategy, a year-on-year increase of 4%. In addition to the technology aspects of transformation, digital leaders have not neglected the human side. Seventy-one percent of leaders have reached the advanced stages of implementing digital skills and talent strategy, compared with 12% of non-leaders. A further 85% say they have created an advanced innovation culture versus 24% of non-leaders. Cyber Risks are Still a Top Challenge As financial organizations accelerate digital customer experiences, they continue to put enormous effort into strengthening trust and security. Over the next two years, financial institutions plan to boost their investments in cybersecurity by 28% on average; impacting their internal security protocols, but also how they engage with third-party technology vendors. According to the study, cybersecurity is the top capability executives say they expect from their technology vendors, outpacing their ability to deliver projects on time and on budget and building next-generation technologies into their solutions. Executives also cited cybersecurity risks as the top challenge currently inhibiting the pace of digital transformation at their company. Tech executives, who often understand the risks of an insecure environment more than other senior leaders, tend to care more about cybersecurity than business executives. The full 2024 Digital Transformation and Next-Gen Tech Study can be found here. Methodology This Broadridge survey was conducted by ThoughtLab Group to understand how financial services companies are digitally transforming and adopting next-gen technologies. C-suite executives and their direct reports from 500 financial institutions globally on the buy side and sell side were surveyed, with fielding completed in Nov 2023. The total assets or AUM of companies in the sample ranged from $1 billion to over $250 billion. The study scored firms on a range of factors related to progress with digital transformation. Firms were then categorized as digital leaders or non-leaders in the Broadridge Digital Transformation Maturity Framework. For further details on survey methodology, please contact a Broadridge media representative. About Broadridge Broadridge Financial Solutions (NYSE: BR), a global Fintech leader with over $6 billion in revenues, provides the critical infrastructure that powers investing, corporate governance, and communications to enable better financial lives. We deliver technology-driven solutions that drive business transformation for banks, broker-dealers, asset and wealth managers and public companies. Broadridge's infrastructure serves as a global communications hub enabling corporate governance by linking thousands of public companies and mutual funds to tens of millions of individual and institutional investors around the world. Our technology and operations platforms underpin the daily trading of more than $10 trillion of equities, fixed income and other securities globally. A certified Great Place to Work, Broadridge is part of the S&P 500 Index, employing over 14,000 associates in 21 countries. For more information about us, please visit www.broadridge.com. Broadridge Contacts: Investors:Edings ThibaultHead of Investor Relations, Broadridgebroadridgeir@broadridge.com Media:Gregg RosenbergGlobal Head of Corporate CommunicationsGregg.Rosenberg@broadridge.com View original content to download multimedia:https://www.prnewswire.com/news-releases/gap-widens-between-leaders-and-non-leaders-as-digital-transformation-in-financial-services-reaches-new-level-of-maturity-302087815.html SOURCE Broadridge Financial Solutions, Inc. What percentage of executives are confident in their tech transformation roadmap according to the study? 75% of executives are confident in their tech transformation roadmap according to the study. What are the key areas of focus for executives in terms of investments? Executives are focusing on cybersecurity technology and building an advanced IT cloud platform. What are the top priorities for leaders in terms of AI investments? Leaders prioritize AI investments in customer interaction to fuel stronger and more meaningful customer engagement. How much do financial institutions plan to increase their investments in cybersecurity in the next two years? Financial institutions plan to increase their investments in cybersecurity by 28% in the next two years."
"SBM Offshore and Technip Energies sign a Partnership Agreement to form EkWiL, a Floating Offshore Wind Joint Venture",2024-03-14T06:00:00.000Z,Low,Neutral,"SBM Offshore and Technip Energies form a joint venture, EkWiL, to provide innovative solutions in the Floating Offshore Wind market. The 50/50 JV combines expertise, technologies, and delivery capabilities to enhance execution certainty and cost competitiveness. The collaboration aims to become a leading contractor in developing floating offshore wind infrastructures.","SBM Offshore and Technip Energies sign a Partnership Agreement to form EkWiL, a Floating Offshore Wind Joint Venture Rhea-AI Impact (Low) Rhea-AI Sentiment (Neutral) Tags partnership Rhea-AI Summary SBM Offshore and Technip Energies form a joint venture, EkWiL, to provide innovative solutions in the Floating Offshore Wind market. The 50/50 JV combines expertise, technologies, and delivery capabilities to enhance execution certainty and cost competitiveness. The collaboration aims to become a leading contractor in developing floating offshore wind infrastructures. Positive None. Negative None. 03/14/2024 - 02:00 AM March 14, 2024 Highlights Two global leaders in Floating Offshore Wind join forces to provide new energy solutions The combination of proven technologies, engineering know-how and recognized delivery expertise will enhance the confidence in the emerging floating offshore wind market SBM Offshore and Technip Energies are pleased to announce the signing of a Memorandum of Understanding for the creation of a joint venture entity, EkWiL. The new company will be a Floating Offshore Wind (FOW) pure player, capable of proposing a wide range of solutions to clients. EkWiL will combine the people expertise, engineering and delivery capabilities, and complementary technologies of Technip Energies and SBM Offshore, creating integrated floating solutions and leading delivery offerings for the Floating Offshore Wind market. This unique positioning will enhance execution certainty and cost competitiveness to these innovative projects. The 50/50 JV will operate as a fully integrated team, bringing together knowledge, innovation and capacities to develop the two leading-edge technologies (Semi-submersible INO15 by T.EN and Tension Leg Platform Float4Wind) covering a large spectrum of the Floating Offshore Wind market, and bring them to commercial deployment.  Bruno Chabas, CEO of SBM Offshore, commented: Our aim is to become a recognized leading contractor in developing floating offshore wind infrastructures. Collaboration is fundamental to position our ambitions sustainably while managing the pace of infrastructure development and the challenging economics of these pioneering systems. We are pleased to share our experience with the right partner, broadening the range of solutions and reinforcing our energy transition commitment.""  Arnaud Pieton, CEO of Technip Energies, commented: Joining forces and collaborating are necessary to capture the potential of the nascent floating offshore wind market. By leveraging the synergies of complementary technologies and supply chain experience, EkWiL will increase predictability to meet market demand and deliver on our ambition to provide new energy solutions. As is customary for transactions such as these, there are a number of matters that Parties will attend to for completion of the transactions, which includes satisfactory conclusion of due diligence, engagement with employee representative bodies to complete relevant consultations, and having in place all necessary regulatory approvals. SBM Offshore Evelyn Tachau BrownGroup Communications & Change DirectorTel: +377 (0) 6 40 62 30 34Email: evelyn.tachau-brown@sbmoffshore.com Wouter HoltiesCorporate Finance & Investor Relations ManagerTel: +31 (0) 6 23 34 37 64Email: wouter.holties@sbmoffshore.com Technip Energies Jason HyonnePress Relations & Social Media ManagerTel: +33 1 47 78 22 89Email: Jason Hyonne Phil LindsayVice-President Investor RelationsTel: +44 20 7585 5051Email: Phillip Lindsay About SBM Offshore SBM Offshore designs, builds, installs, and operates offshore floating facilities for the offshore energy industry. As a leading technology provider, we put our marine expertise at the service of a responsible energy transition by reducing emissions from fossil fuel production, while developing cleaner solutions for alternative energy sources. More than 7,400 SBMers worldwide are committed to sharing their experience to deliver safe, sustainable, and affordable energy from the oceans for generations to come. For further information: www.sbmoffshore.com About Technip Energies Technip Energies is a leading Engineering & Technology company for the energy transition, with leadership positions in Liquefied Natural Gas (LNG), hydrogen and ethylene as well as growing market positions in blue and green hydrogen, sustainable chemistry and CO2 management. The company benefits from its robust project delivery model supported by extensive technology, products and services offering. Operating in 34 countries, our 15,000 people are fully committed to bringing our clients innovative projects to life, breaking boundaries to accelerate the energy transition for a better tomorrow. Technip Energies is listed on Euronext Paris with American depositary receipts (ADRs). For further information: www.ten.com Market Abuse RegulationThis press release may contain inside information within the meaning of Article 7(1) of the EU Market Abuse Regulation. SBM Offshore Disclaimer Some of the statements contained in this release that are not historical facts are statements of future expectations and other forward-looking statements based on managements current views and assumptions and involve known and unknown risks and uncertainties that could cause actual results, performance, or events to differ materially from those in such statements. These statements may be identified by words such as expect, should, could, shall and similar expressions. Such forward-looking statements are subject to various risks and uncertainties. The principal risks which could affect the future operations of SBM Offshore N.V. are described in the Impact, Risk and Opportunity Management section of the 2023 Annual Report. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results and performance of the Companys business may vary materially and adversely from the forward-looking statements described in this release. SBM Offshore does not intend and does not assume any obligation to update any industry information or forward-looking statements set forth in this release to reflect new information, subsequent events or otherwise. Nothing in this release shall be deemed an offer to sell, or a solicitation of an offer to buy, any securities. The companies in which SBM Offshore N.V. directly and indirectly owns investments are separate legal entities. In this release SBM Offshore and SBM are sometimes used for convenience where references are made to SBM Offshore N.V. and its subsidiaries in general. These expressions are also used where no useful purpose is served by identifying the particular company or companies. ""SBM Offshore"", the SBM logomark, Fast4Ward, emissionZERO and Float4Wind are proprietary marks owned by SBM Offshore. Technip Energies | Important Information for Investors and Securityholders Forward-Looking Statement This Press Release contains forward-looking statements that reflect Technip Energies (the Company) intentions, beliefs or current expectations and projections about the Company's future results of operations, anticipated revenues, earnings, cashflows, financial condition, liquidity, performance, prospects, anticipated growth, strategies and opportunities and the markets in which the Company operates. Forward-looking statements are often identified by the words believe, expect, anticipate, plan, intend, foresee, should, would, could, may, estimate, outlook, and similar expressions, including the negative thereof. The absence of these words, however, does not mean that the statements are not forward-looking. These forward-looking statements are based on the Companys current expectations, beliefs and assumptions concerning future developments and business conditions and their potential effect on the Company. While the Company believes that these forward-looking statements are reasonable as and when made, there can be no assurance that future developments affecting the Company will be those that the Company anticipates. All of the Companys forward-looking statements involve risks and uncertainties, some of which are significant or beyond the Companys control, and assumptions that could cause actual results to differ materially from the Companys historical experience and the Companys present expectations or projections. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those set forth in the forward-looking statements. For information regarding known material factors that could cause actual results to differ from projected results, please see the Companys risk factors set forth in the Companys 2022 Annual Financial report filed on March 10, 2023, with the Dutch Authority for the Financial Markets (AFM) and the French Autorit des Marchs Financiers which include a discussion of factors that could affect the Company's future performance and the markets in which the Company operates. Please also see Section 1.3 (Principal Risks and Uncertainties) of the Company's 2023 Half-Year Report which was filed with the AFM and the AMF on July 27, 2023. Forward-looking statements involve inherent risks and uncertainties and speak only as of the date they are made. The Company undertakes no duty to and will not necessarily update any of the forward-looking statements in light of new information or future events, except to the extent required by applicable law. Attachment SBM Offshore and Technip Energies sign a Partnership Agreement to form EkWiL, a Floating Offshore Wind Joint Venture What is the joint venture entity created by SBM Offshore and Technip Energies? The joint venture entity created by SBM Offshore and Technip Energies is EkWiL, a Floating Offshore Wind pure player. What are the technologies covered by EkWiL for the Floating Offshore Wind market? EkWiL covers two leading-edge technologies, Semi-submersible INO15 by T.EN and Tension Leg Platform Float4Wind, offering a wide range of solutions. Who is the CEO of SBM Offshore and what is his comment on the collaboration? Bruno Chabas is the CEO of SBM Offshore. He mentioned that collaboration is fundamental to position their ambitions sustainably in developing floating offshore wind infrastructures. Who is the CEO of Technip Energies and what is his comment on the collaboration? Arnaud Pieton is the CEO of Technip Energies. He stated that joining forces and collaborating are necessary to capture the potential of the floating offshore wind market."
Allegiant Air Elevates Inflight Experience with Spring Menu Updates,2024-03-14T08:00:00.000Z,Low,Very Positive,"Allegiant Travel Company (NASDAQ: ALGT) introduces new Spring inflight menu options, including spiced rum, flavored water, and signature cocktails. The airline aims to enhance the onboard experience by offering a mix of familiar favorites and exciting new choices. Passengers can enjoy discounts on snack packs and contribute to charity through their purchases.","Allegiant Air Elevates Inflight Experience with Spring Menu Updates Rhea-AI Impact (Low) Rhea-AI Sentiment (Very Positive) Tags Rhea-AI Summary Allegiant Travel Company (NASDAQ: ALGT) introduces new Spring inflight menu options, including spiced rum, flavored water, and signature cocktails. The airline aims to enhance the onboard experience by offering a mix of familiar favorites and exciting new choices. Passengers can enjoy discounts on snack packs and contribute to charity through their purchases. Positive None. Negative None. 03/14/2024 - 04:00 AM Passengers can now enjoy more familiar favorites and brand new offerings LAS VEGAS, March 14, 2024 /PRNewswire/ -- Allegiant Travel Company (NASDAQ: ALGT) invites passengers to indulge in its new Spring inflight menu options. This update, designed to enhance the onboard experience, includes familiar favorites and brand-new offerings, ensuring a delightful journey for travelers. ""Our goal with this menu update is to strike a perfect balance between beloved staples and exciting new discoveries,"" said Keny Wilper, Allegiant's chief operating officer. ""We know onboard sales plays a critical role in enhancing customer experience and view our menu as a competitive differentiator. Often, we are at the forefront of inflight snack and beverage offerings across the industry."" New additions to the menu include spiced rum, flavored water and signature cocktails crafted to entice the taste buds. Passengers can now enjoy new options such as the signature Coronarita, Captain Morgan spiced rum and refreshing Lemon Perfect  a zero-sugar flavored water beverage enriched with organic lemons. Not to be missed is the exclusive Don Julio Limonada, a delightful fusion of Don Julio tequila and Lemon Perfect. In addition to the new beverage options, Allegiant introduces a special Wingz Snack Pack deal. Passengers can enjoy $5 off the Wingz Kids Box with an $11 purchase. The specially branded Wingz Snack Pack is a symbol of the airline's dedication to making air travel accessible to all. For each purchase made, the company donates $1 to Make-A-Wish. Allegiant has revamped its snack pack selections, ensuring a diverse variety of options to cater to every palate. From savory to sweet, there is something for everyone to enjoy at 30,000 feet. Allegiant's dedicated internal team works tirelessly to curate a menu that reflects passengers' preferences and enhances their overall inflight experience. With more than two decades of experience spearheading such initiatives, the airline remains steadfast in its commitment to prioritizing customer satisfaction. To view Allegiant's full inflight menu, click here. Allegiant  Together We FlyTM Las Vegas-based Allegiant (NASDAQ: ALGT) is an integrated travel company with an airline at its heart, focused on connecting customers with the people, places and experiences that matter most. Since 1999, Allegiant Air has linked travelers in small-to-medium cities to world-class vacation destinations with all-nonstop flights and industry-low average fares. Today, Allegiant serves communities across the nation, with base airfares less than half the cost of the average domestic roundtrip ticket. For more information, visit us at Allegiant.com. Media information, including photos, is available at http://gofly.us/iiFa303wrtF Media Contact Phone: 702-800-2020Email: mediarelations@allegiantair.com Category: NewsCategory: Inflight View original content to download multimedia:https://www.prnewswire.com/news-releases/allegiant-air-elevates-inflight-experience-with-spring-menu-updates-302088946.html SOURCE Allegiant Travel Company What are the new additions to Allegiant's Spring inflight menu? The new menu includes spiced rum, flavored water, and signature cocktails like the Coronarita, Captain Morgan spiced rum, and Lemon Perfect. What special deal does Allegiant offer on the Wingz Snack Pack? Passengers can get $5 off the Wingz Kids Box with an $11 purchase. Additionally, for each purchase, Allegiant donates $1 to Make-A-Wish. How does Allegiant ensure a diverse selection in their snack pack offerings? Allegiant has revamped its snack pack selections to cater to every palate, offering a variety of options from savory to sweet. What is Allegiant's main goal with the menu update? Allegiant aims to strike a balance between beloved staples and new discoveries to enhance the overall inflight experience for travelers. How does Allegiant view onboard sales in relation to customer experience? Allegiant sees onboard sales as crucial in enhancing customer experience and considers their menu a competitive differentiator."
Pharming Group reports fourth quarter and full year 2023 financial results,2024-03-14T06:00:00.000Z,Neutral,Neutral,"Pharming Group N.V. reports a strong financial performance in 2023 with total revenues increasing by 19% to US$245.3 million. RUCONEST revenues grew by 10% to US$227.1 million, and Joenja (leniolisib) saw a successful launch with revenues of US$18.2 million. The company has a strong cash position of US$215.0 million and has provided a revenue guidance of US$280 million  US$295 million for 2024.","Pharming Group reports fourth quarter and full year 2023 financial results Rhea-AI Impact (Neutral) Rhea-AI Sentiment (Neutral) Tags earnings Rhea-AI Summary Pharming Group N.V. reports a strong financial performance in 2023 with total revenues increasing by 19% to US$245.3 million. RUCONEST revenues grew by 10% to US$227.1 million, and Joenja (leniolisib) saw a successful launch with revenues of US$18.2 million. The company has a strong cash position of US$215.0 million and has provided a revenue guidance of US$280 million  US$295 million for 2024. Positive Total revenues increased by 19% to US$245.3 million in 2023. RUCONEST revenues grew by 10% to US$227.1 million. Joenja (leniolisib) had a successful launch with revenues of US$18.2 million in 2023. Cash and marketable securities increased to US$215.0 million by the end of 2023. Pharming provided a revenue guidance of US$280 million  US$295 million for 2024. Negative None. Financial Analyst The reported increase in total revenues by 19% to US$245.3 million for the full year 2023, with a notable 10% increase in RUCONEST revenues, is a strong indicator of the company's growth trajectory. The introduction of Joenja (leniolisib) and its subsequent uptake, with 81 patients on paid therapy in the U.S. and full year revenues of US$18.2 million, demonstrates the company's successful market penetration and diversification strategy. The overall increase in cash and marketable securities to US$215.0 million provides a cushion for future R&D investment and operational flexibility.Looking ahead, the 2024 revenue guidance of US$280 million  US$295 million, which represents 14%  20% growth, suggests confidence in the continued demand for RUCONEST and the expansion of leniolisib's market presence. This forecast could be a positive signal for investors, indicating sustainable growth potential. However, it is essential to monitor the progress of ongoing regulatory reviews and commercialization efforts in additional geographies, as they will be crucial in achieving this growth. The successful expansion of leniolisib for additional primary immunodeficiencies (PIDs) could further drive long-term value creation. Medical Research Analyst The mention of leniolisib's development for activated phosphoinositide 3-kinase delta (PI3K) syndrome (APDS) in additional geographies and pediatric patients, as well as its indication expansion to other PIDs, is indicative of the company's commitment to address unmet medical needs in rare diseases. The APDS patient finding initiatives and VUS resolution are critical for increasing the patient base eligible for treatment, which could directly impact future revenues and market share.Moreover, the orphan drug designation (ODD) by Japan for leniolisib and the initiation of pediatric clinical trials are strategic moves to broaden the treatment's label and market reach. The company's engagement with regulatory authorities like the US FDA and EMA and its submissions for marketing authorization in various countries, reflect a proactive approach to securing approval in multiple markets, potentially leading to a diversified and stable revenue stream. Market Research Analyst The competitive landscape of the Hereditary Angioedema (HAE) market and the rare disease sector, in general, is highly specialized, with significant barriers to entry due to the complexity of drug development and the necessity for targeted patient finding strategies. Pharming's strong performance with RUCONEST in the HAE market and its strategic initiatives to identify and diagnose APDS patients position it favorably within this niche market. The company's ability to grow its prescriber base and patient enrollments, despite the competitive environment, indicates effective marketing and sales strategies.Furthermore, the company's plans to develop leniolisib for additional PIDs based on the PI3K signaling pathway showcase its intent to leverage its expertise and existing platforms to tap into new market segments. This could potentially lead to the creation of new revenue streams and increase the company's market share within the rare disease space. However, the success of these initiatives will depend on the outcomes of clinical trials and regulatory approvals, which are inherently uncertain and can impact market expectations. 03/14/2024 - 02:00 AM Full year 2023 total revenues increased by 19% to US$245.3 millionRecord fourth quarter RUCONEST revenues of US$73.3 million resulted in a 10% increase in full year 2023 RUCONEST revenues to US$227.1 millionStrong start to Joenja (leniolisib) launch with 81 patients on paid therapy in the U.S. nine months following launch and full year 2023 revenues of US$18.2 millionOverall cash and marketable securities increased to US$215.0 million at the end of 2023 from US$208.7 million at the end of 2022 Progressed leniolisib development for APDS in additional geographies and for pediatric patients, and leniolisib indication expansion to primary immunodeficiencies (PIDs) with immune dysregulation linked to PI3K signaling2024 total revenue guidance of US$280 million  US$295 million (14%  20% growth)Pharming to host a conference call today at 13:30 CET (8:30 am EDT) Leiden, The Netherlands, March 14, 2024: Pharming Group N.V. (Pharming or the Company) (Euronext Amsterdam: PHARM / Nasdaq: PHAR) presents its preliminary (unaudited) financial report for the three months and full year ended December 31, 2023. Chief Executive Officer, Sijmen de Vries commented: We are pleased to have delivered an excellent year in which we transformed Pharming into a multi-product, commercial rare disease biopharmaceutical company. We grew RUCONEST revenues by 10% in 2023. This demonstrates the continued need for, and importance of, RUCONEST as a trusted cornerstone of treatment in the competitive HAE market. We launched Joenja (leniolisib) for APDS in the U.S. in April 2023, shortly after FDA approval, and saw meaningful initial uptake for what is the first and only FDA approved treatment for APDS. We have identified and confirmed over 840 APDS patients in global markets, including over 200 in the U.S. We have started family genetic testing initiatives, important since the majority of APDS patients will have family members also afflicted with the disease. In addition we have commenced studies to determine which of more than 1,100 patients in the U.S., with inconclusive genetic testing results showing a variant of uncertain significance (VUS), have genetic variants that cause hyperactivity in the PI3K pathway and can, therefore, be classified as APDS disease causing. This allows for an important APDS diagnosis for these patients, who could potentially be eligible for and offered treatment with Joenja. We also made strong progress preparing for the commercialization of leniolisib in key global markets. We have been receiving requests for individual treatment on a named patient basis, in markets outside of the U.S., and provided the first patients with leniolisib around year-end 2023. Numerous regulatory reviews are ongoing and we are preparing for commercialization in key global markets including Europe, the U.K., Japan, Asia Pacific, Middle East, and Canada. These results reflect Pharmings dedication to developing and delivering therapies to unserved rare disease patients. Looking to 2024, we remain focused on our goals of identifying additional APDS patients globally, continuing the momentum for Joenja revenue in the U.S., to obtaining regulatory approvals and bringing leniolisib to APDS patients in need of treatment in additional global markets and to further developing our rare disease pipeline and footprint. We are also seeking to significantly expand the leniolisib market opportunity and revenue growth by pursuing development of leniolisib for additional primary immunodeficiencies (PIDs) beyond APDS, and have advanced plans to start a Phase 2 proof of concept clinical trial in PIDs with immune dysregulation linked to PI3K signaling. Fourth quarter and full year 2023 highlights Commercialized assetsRUCONEST marketed for the treatment of acute HAE attacks RUCONEST performed strongly in the fourth quarter of 2023, with record revenues of US$73.3 million, a 34% increase compared to the fourth quarter of 2022. RUCONEST revenues for the full year 2023 were US$227.1 million, a 10% increase compared to 2022. The U.S. market contributed 97% of 2023 revenues, while the EU and Rest of World contributed 3%. The RUCONEST revenue acceleration in the second half of 2023 can be attributed to strong performance in leading key revenue indicators in the U.S. including new physicians prescribing RUCONEST, new patient enrollments including high frequency attack patients, and the total number of patients. We achieved over 70 RUCONEST new patient enrollments for four quarters in a row. Total enrollments in 2023 were up 25% vs. 2022 and were a significant driver of the strong RUCONEST revenue growth. We also increased the RUCONEST physician prescriber base by 13% during the year, in many cases adding previously unknown HAE prescribers. Joenja (leniolisib) marketed in the U.S. - the first and only approved disease modifying treatment for APDS Joenja (leniolisib) received U.S. FDA approval in late March 2023 for the treatment of activated phosphoinositide 3-kinase delta (PI3K) syndrome (APDS) in patients 12 years of age and older, and first commercial shipments to patients took place in April 2023. During the nine months following launch, Pharming made strong and rapid progress transitioning known patients onto commercial therapy. Revenues increased to US$7.9 million in the fourth quarter of 2023, driven by the continued increase in patients on paid therapy, and revenues were US$18.2 million for 2023. As of December 31, 2023, we have 92 APDS patients enrolled in the U.S., of which 81 patients are on paid therapy. APDS patient finding Based on available literature, Pharming estimates APDS prevalence of 1.5 patients per million. Our U.S. and global APDS patient finding efforts progressed during the year and as of December 31, 2023, Pharming has identified over 840 diagnosed APDS patients of all ages in global markets, including over 200 patients in the U.S. Of the identified patients in the U.S., approximately 75% are 12 years of age or older, the majority of whom are currently eligible for treatment with Joenja. Over 730 patients are in the U.S., Europe, the U.K., Japan, Asia Pacific, Middle East, and Canada, key markets for Pharming with estimated total prevalence of ~2000 APDS patients. Pharming advanced several initiatives during 2023 to diagnose additional APDS patients, including a sponsored genetic testing program in the U.S., partnerships with several genetic testing companies who undertake their own testing efforts and family testing programs. We have initiated a number of programs collaborating with clinicians and patients to aid in reducing the barriers and allowing the appropriate testing in families with APDS, to help identify family members of APDS patients who may also be affected by this disease. APDS is an inherited genetic disease and Pharming believes that many of the over 200 APDS patients already identified in the U.S. are likely to have family members who remain undiagnosed. APDS patient finding - Variant of Uncertain Significance (VUS) resolution APDS is diagnosed based on clinical symptoms, assessment of immune cell function and genetic testing. For a patient to receive a definitive APDS diagnosis, a genetic test revealing a disease-causing (pathogenic or likely pathogenic) variant in either the PIK3CD or PIK3R1 genes is required. Patients with clinical symptoms compatible with APDS frequently receive inconclusive genetic variant test results, i.e. previously unseen variants in the PIK3CD or PIK3R1 genes. It is important to determine if these Variants of Uncertain Significance (VUS) cause APDS. As of December 31, 2023, Pharming has identified more than 1,100 patients in the U.S. with a number of VUSs in the PIK3CD or PIK3R1 genes and is setting up validation studies with various laboratories to confirm which of these variants should be classified as APDS. As results become available, patients with validated variants could be diagnosed with APDS and, therefore, potentially be eligible for Joenja treatment. Completion of these studies is expected during the fourth quarter of 2024. Leniolisib highlights - regulatory, clinical and commercial strategy updates Leniolisib for APDS Pharming made continued progress in the fourth quarter of 2023 on leniolisib regulatory filings for APDS patients 12 years of age and older in key global markets. In addition, Pharming progressed ongoing clinical trials to support regulatory filings for approval in Japan and pediatric label expansion in key global markets. Pharmings strategy is to make leniolisib commercially available for APDS patients in additional key markets in Europe, U.K., Japan, Asia Pacific, Middle East, and Canada. Pharming intends to market leniolisib directly in most of these markets following regulatory approval. We currently have 96 patients on leniolisib therapy as part of an Expanded Access Program (compassionate use) or an ongoing clinical study. In addition, Pharming makes leniolisib available on a named patient basis to ensure that physicians can request leniolisib on behalf of individual patients living with APDS, who meet the eligibility criteria and receive local health authority authorization, in certain countries where leniolisib is not commercially available. European Economic Area (EEA) As part of the review process of the Marketing Authorisation Application (MAA) for leniolisib for patients 12 years of age and older, Pharming submitted its response to the European Medicines Agencys (EMA) Committee for Human Medicinal Products (CHMP) Day 180 list of outstanding issues (LoOI) in October 2023. In November 2023, Pharming received a Day 180 Second LoOI from the CHMP. The CHMP consulted an Ad-Hoc Expert Group (AEG) at a meeting held at the end of November. Pharming is working closely with the CHMP to address the remaining outstanding issues and we are now awaiting CHMPs opinion on the leniolisib MAA. United Kingdom In November 2023, Pharming announced its intention to file an MAA with the U.K. Medicines and Healthcare products Regulatory Agency (MHRA) through the International Recognition Procedure (IRP) which replaced the European Commission Decision Recognition Procedure (ECDRP) from January 1, 2024. Pharming submitted an MAA for leniolisib on the basis of the US FDA approval on March 12, 2024. Japan clinical trial In May 2023, leniolisib was granted orphan drug designation (ODD) by the Ministry of Health, Labour and Welfare of Japan (MHLW) for the treatment of APDS. In August 2023, Pharming announced that the first patient was enrolled in a Phase III clinical trial in Japan evaluating leniolisib for the treatment of APDS in adult and pediatric patients 12 years of age and older. Patient enrollment in this study is now complete. The single-arm, open-label clinical trial will evaluate the safety, tolerability, and efficacy of leniolisib in three patients, 12 years of age and older, who have a confirmed APDS diagnosis. The studys primary efficacy endpoints and secondary endpoints mirror those used to evaluate the clinical outcomes of the earlier leniolisib APDS trials. Pharming plans to file an application for the approval of leniolisib with Japans Pharmaceuticals and Medical Devices Agency (PMDA), following completion of the appropriate clinical trials. An approval decision would be expected in nine months based on priority review of the application due to ODD. Eligible patients enrolled in the trial will continue to receive the investigational drug for at least an additional year through an open-label extension trial. Additional markets Pharming filed regulatory submissions in Canada and Australia in the third quarter of 2023, and Israel in the second quarter. These submissions are progressing as expected and we anticipate regulatory action in 2024 for Canada, Australia, and Israel. Pediatric clinical trials In 2023, Pharming initiated two pediatric clinical trials, for children ages 4 to 11 and ages 1 to 6 years old, at sites in the U.S., Japan, and the EU. The single-arm, open-label, multinational clinical trials will evaluate the safety, tolerability, and efficacy of leniolisib in 15 children, per clinical trial, who have a confirmed APDS diagnosis. The primary efficacy endpoints and secondary endpoints of the studies mirror those used to evaluate the clinical outcomes in the previous leniolisib Phase II/III APDS trials for patients aged 12 and older. Pharming is nearing completion of enrollment in the clinical trial for children ages 4 to 11 years old. In November 2023, the first patient was dosed in the clinical trial for children ages 1 to 6 years old. Enrollment in the study is continuing as planned. Leniolisib for additional indications (PI3K platform) - Primary immunodeficiencies (PIDs) beyond APDS As we continue to work towards regulatory approvals of leniolisib for APDS in additional geographies and pediatric label expansion, we have also commenced work to identify and prioritize other indications where leniolisib has the potential to deliver value for patients. PI3K has been identified as an important player in a variety of disease states, and leniolisib has demonstrated an attractive, long-term efficacy, safety and tolerability profile in clinical trials conducted in both healthy volunteers and APDS patients. This provides a solid basis for our plans for the investigation and investment in further leniolisib indications. In December 2023, Pharming announced the expansion of its rare disease pipeline with plans to develop leniolisib for additional primary immunodeficiencies (PIDs) with greater prevalence than APDS. Pharming has engaged with and received feedback from the US FDA on its plans to develop leniolisib for PID disorders with immune dysregulation. Primary immunodeficiencies (PIDs) with immune dysregulation Leniolisib, by reducing PI3K activity, could help rebalance immune dysregulation in PIDs, positively impacting clinical manifestations including lymphoproliferation and autoimmunity. Pharming is now in the final stages of preparation for the start of an initial Phase 2, proof of concept, clinical trial in targeted PID genetic disorders with immune dysregulation linked to PI3K signaling in lymphocytes, with similar clinical phenotypes and unmet medical need to APDS. These PID disorders include ALPS-FAS, CTLA4 haploinsufficiency and PTEN deficiency. The epidemiology of these targeted PID genetic disorders suggests a prevalence of approximately five patients per million. The Phase 2 clinical trial is a single arm, open-label, dose range-finding study to be conducted in approximately 12 patients. The objectives for the trial will be to assess safety and tolerability, pharmacokinetics, pharmacodynamics, and explore clinical efficacy of leniolisib in this new PID population. The trial has been designed to inform a subsequent Phase 3 program. Organizational highlights During 2023 our new Chairman, Dr. Richard Peters, was elected, succeeding Paul Sekhri, who came to the end of his maximum term (eight years). Dr. Peters is a highly respected and proven industry leader, who brings extensive medical and commercial acumen for difficult-to-treat and rare diseases, from development stage to large global biopharmaceutical companies, to Pharming. We also strengthened our Executive Committee with the appointment of a Chief Business Officer, Dr. Alexander Breidenbach, who has more than 20 years of partnering, R&D and management experience in biosciences and, in this newly created position, is tasked with the development and execution of Pharmings growth strategy. Financial Summary Amounts in US$m except per share data 4Q 2023 4Q 2022 2023 2022 Consolidated Statement of Income Revenue - RUCONEST 73.3 54.6 227.1 205.6 Revenue - Joenja 7.9 0.0 18.2 0.0 Total Revenues 81.2 54.6 245.3 205.6 Cost of sales (7.1) (6.3) (25.2) (17.6) Gross profit 74.1 48.3 220.1 188.1 Other income 0.5 (1.1) 23.3 14.5 Research and development (11.6) (10.9) (68.9) (52.5) General and administrative (24.0) (17.6) (55.9) (46.0) Marketing and sales (37.9) (29.0) (124.0) (85.8) Operating profit (loss) 1.1 (10.2) (5.4) 18.2 Fair value gain (loss) on revaluation (0.9) (1.2) (0.9) (1.2) Other finance income 1.6 (4.8) 3.7 4.5 Other finance expenses (4.5) (1.5) (9.1) (5.5) Share of net profits in associates using the equity method 0.7 (0.4) (0.3) (1.1) Profit (loss) before tax (2.0) (18.1) (12.0) 15.0 Income tax credit (expense) (0.7) 3.5 1.9 (1.3) Profit (loss) for the period (2.7) (14.6) (10.1) 13.7 Share Information Basic earnings per share (US$) (0.004) (0.022) (0.015) 0.021 Diluted earnings per share (US$) (0.004) (0.022) (0.015) 0.019 Amounts in US$m December 31, 2023 December 31, 2022 Balance Sheet Cash and cash equivalents, restricted cash and marketable securities 215.0 208.7 Current assets 316.3 277.5 Total assets 461.4 425.8 Current liabilities 76.1 59.7 Equity 219.2 204.6 Financial highlightsFourth quarter 2023 Revenues in the fourth quarter of 2023 increased to US$81.2 million compared to US$54.6 million in the fourth quarter of 2022 and US$66.7 million in the third quarter of 2023. This growth was primarily due to a 34% increase in net sales for RUCONEST compared to the same period last year, as well as an 18% increase compared to the third quarter of 2023. Additionally, Joenja revenues in the fourth quarter were US$7.9 million, a 21% increase compared to the third quarter. Gross profit in the fourth quarter of 2023 increased by US$25.8 million compared to the fourth quarter of 2022. This growth was driven by higher revenues, although it was partially offset by increased RUCONEST production costs and royalty payments to Novartis on Joenja sales. Operating expenses increased by US$16.1 million in the fourth quarter compared to last year. US$8.3 million of this increase is directly related to research and development expenses for leniolisib and marketing and sales expenses for Joenja. Pharmings expansion efforts, driven by preparations for the launch and further commercialization of Joenja, led to a US$7.1 million increase in payroll expenses. In the fourth quarter of 2023, an operating profit of US$1.1 million was realized, in contrast to an operating loss of US$10.2 million in the fourth quarter of 2022. This improvement was primarily driven by the rise in gross profit, partially offset by the increase in operating expenses. Full year 2023 In 2023, Pharming revenues increased by 19% to US$245.3 million. However, operating profit declined to a loss of US$5.4 million, compared to a profit of US$18.2 million in 2022. Similarly, net profit decreased to loss of US$10.1 million, down from a profit of US$13.7 million in 2022. This section will further elaborate on Pharming's financial performance in 2023. Revenues and Gross Profit The 19% increase in revenues was a result of higher unit sales volumes, supported by a price increase below CPI, of RUCONEST in the U.S. market (US$221.2 million in 2023 compared to US$200.1 million in 2022) and the initial sales of Joenja (US$18.2 million in 2023) following the launch in April 2023. Revenues in Europe and the rest of the world increased by 12% to US$6.2 million in 2023. Cost of sales increased by 44% from US$17.6 million in 2022 to US$25.2 million in 2023. Cost of sales related to product sales in 2023 amounted to US$23.5 million compared to US$17.4 million in 2022. In addition to the higher unit sales volume, the rise was primarily attributed to rising production costs for RUCONEST and royalty payments to Novartis on Joenja sales. The remainder of cost of sales in 2023 (US$1.7 million) stem from impairment charges on inventory (2022: US$0.2 million). Gross profit increased by US$32.0 million, or 17%, to US$220.1 million for the year 2023. The main reasons for this increase were higher sales of RUCONEST and the launch of Joenja. Operating Profit (loss) and Other Operating Costs For 2023, operating profit (loss) decreased by US$23.6 million to US$(5.4) million compared with US$18.2 million for the prior year. This decrease was driven by increased operating costs (US$64.5 million) and offset by increased gross profit (US$32.0 million) as mentioned above and increased other income (US$8.8 million). Of the US$64.5 million increase in operating costs, US$10.4 million is attributed to milestone payments for Joenja following its first commercial sale in the second quarter of 2023. An additional US$25.7 million in expenses is directly related to research and development expenses for leniolisib and marketing and sales expenses for Joenja. Pharmings expansion efforts, driven by preparations for the launch and further commercialization of Joenja, led to a US$24.2 million increase in payroll expenses. Finally, Pharming incurred additional impairment expenses related to our DSP facility at Pivot Park in Oss, the Netherlands, amounting to US$4.7 million in 2023 compared to US$3.9 million in 2022. In 2023, other income increased by US$8.8 million to US$23.3 million as a result of the definitive agreement to sell the Rare Pediatric Disease Priority Review Voucher (PRV) to Novartis for a pre-agreed, one-time payment of US$21.3 million. Pharming was granted the PRV by the FDA in March 2023 in connection with the approval of Joenja. The amount differs from the previously disclosed US$21.1 million in the press release of the second quarter of 2023 due to currency fluctuations throughout the year. In 2022, Pharming reduced its minority stake in BioConnection from 43.85% to 22.98%. As a result of this one-off transaction, Pharming had recognized a gain of US$12.2 million in 2022. Finance income and expenses Other finance income decreased by US$0.8 million, to US$3.7 million in 2023. This decrease was caused by fluctuations in the exchange rate between the U.S. Dollar and the Euro during 2022 and 2023, which primarily impacts our net cash position. In 2022, the U.S. Dollar strengthened against the Euro, resulting in other finance income of US$4.4 million. However, in 2023, the U.S. Dollar weakened relative to the Euro, leading to other finance expenses of US$3.0 million. This decrease in other finance income was for largely offset by increased interest income from US$0.1 million in 2022 to US$3.7 million in 2023. This was driven by general interest rate hikes as well as investments in short-term readily convertible S&P AAA-rated government treasury certificates using excess cash. Other finance expenses increased by US$3.6 million, from US$5.5 million in, 2022 to US$9.1 million in 2023, mainly caused by foreign currency fluctuations as mentioned earlier. The fair value loss on revaluation (US$0.9 million) relates to fair value adjustments in the BioConnection preference share. This share is included in Pharming's balance sheet as an investment in debt instruments designated at the fair value through the statement of profit and loss (FVTPL). Income tax credit (expense) Income tax credit (expense) shifted from a US$1.3 million expense for the year ending December 31, 2022, to a US$1.9 million credit for the year ending December 31, 2023. This change occurred due to incurring a net loss before tax in 2023, as opposed to a net profit before tax in 2022. Profit (loss) for the year The total net loss in 2023 amounted to US$10.1 million, compared to a total net profit of US$13.7 million in 2022. This decrease was primarily caused by higher operating costs, due to Pharmings growth trajectory and investments in its product pipeline. In addition, fluctuations in foreign exchange rates adversely impacted the foreign currency results in the statement of income. These increased costs were partially offset by an increase in gross profit and other income. Intangible assets In 2023, intangible assets decreased by US$3.8 million, from US$75.1 million in 2022 to US$71.3 million in 2023. This decrease primarily resulted from regular amortization (amounting to US$5.9 million), partially offset by foreign currency effects (equivalent to US$2.2 million). The amortization relates to regular amortization of software and the existing re-acquired rights related to the acquisition of all North American commercialization rights from Bausch Health in 2016 and the acquisition of all European commercialization and distribution rights from Swedish Orphan International AB (Sobi) in 2020. In addition to the aforementioned, the amortization of the Joenja license commenced, following the FDA approval per March 24, 2023. Amortization is charged based on the economic lifetime of the intangible asset. The economic lifetime of the North American commercialization rights from Bausch Health is 20 years, where the economic lifetime of the European commercialization and distribution rights from Swedish Orphan International AB is 12 years. These estimates did not change compared to the previous year. The economic lifetime of the Joenja license is established at 14 years. Property, plant and equipment The value of property, plant and equipment decreased from US$10.4 million in 2022 to US$9.7 million in 2023. This decline was primarily driven by regular depreciation (amounting to US$2.4 million), partially offset by capital expenditures (totaling US$1.4 million), which were mainly associated with acquiring new machinery and equipment for Pharming's production process. Right-of-use assets The right-of-use assets decreased from US$28.8 million in 2022 to US$23.8 million in 2023. This decline was primarily driven by regular depreciation (amounting to US$4.2 million) and an additional impairment related to the DSP facility at Pivot Park in Oss, the Netherlands (totaling US$4.7 million). Pharming remains exploring alternative utilization possibilities for this asset. The decrease in the right-to-use assets is partially offset by investments in buildings (US$1.9 million) and cars (US$1.4 million). The 2023 building investments were related to adjustments in the existing right-of-use assets to account for inflation-related higher lease payments. Investments Investments increased by US$0.7 million, reaching US$10.4 million as of December 31, 2023. This growth was primarily driven by a US$1.6 million increase in the equity investment in Orchard, which is designated at fair value through the statement of other comprehensive income (FVTOCI). The rise in value was primarily triggered by the announcement that Orchard had entered into a definitive agreement with Japanese company Kyowa Kirin Co. LTD for the acquisition of Orchard at a premium over the prevailing share price. This transaction was successfully completed on January 24, 2024. Additionally, the overall investments saw a US$0.3 million increase due to favorable currency exchange movements. The increase in investments was partially offset by Pharmings share of US$0.3 million in the net loss of BioConnection, which is accounted for using the equity method. Furthermore, the investments were impacted by a fair value decrease of US$0.9 million in the preference share in BioConnection, carried at fair value through the statement of profit and loss (FVTPL). Inventories Inventories increased from US$42.3 million for the year ended December 31, 2022 to US$56.8 million for the year ended December 31, 2023. This was largely due to an increase in finished goods and work in progress inventory. Cash and cash equivalents and marketable securities Cash and cash equivalents alone decreased by US$145.8 million to US$61.5 million, as of December 31, 2023. This decline was primarily driven by negative cash flows from operating activities (totaling US$17.5 million) and net-purchases of marketable securities (amounting to US$149.2 million). This decrease was largely offset by the aforementioned PRV sale of US$21.3 million. In 2023, the Company invested in euro-denominated readily convertible S&P AAA-rated government treasury certificates with a maturity of six months or less from the date of acquisition. As of year-end 2023, these marketable securities amount to US$151.7 million. The combined total of cash and cash equivalents, together with restricted cash and marketable securities increased from US$208.7 million at year-end 2022 to US$215.0 million at year-end 2023. In addition to the movements mentioned earlier, this increase is partially attributable to favorable currency exchange fluctuations. Equity The equity position increased by US$14.5 million from US$204.6 million for the year ended December 31, 2022 to US$219.2 million for the year ended December 31, 2023. This increase was primarily driven by transactions recognized directly in equity relating to share based compensation and exercised options (totaling US$17.4 million) as well as other comprehensive income relating to the currency translation reserve (amounting to US$5.9 million) and fair value changes on investments designated as fair value through the statement of other comprehensive income (contributing US$1.2 million). This increase was partially offset by a net loss of US$10.1 million for the year. Convertible bond The convertible bond has increased by US$5.0 million to US$138.4 million at year-end 2023, moving from US$133.4 million as of December 31, 2022. This increase was mainly driven by foreign currency effects. During 2023, a total of US$4.0 million of interest was paid on the bond. Lease liabilities Lease liabilities decreased by US$0.2 million, moving from US$33.3 million as of December 31, 2022 to US$33.1 million as of December 31, 2023. This decrease was primarily driven by monthly or quarterly lease payments of US$5.1 million. However, it was partially offset by new leases (amounting to US$3.2 million), regularly accrued interest expenses (equivalent to US$1.2 million) and foreign exchange effects (totaling US$0.8 million). Outlook/Summary For 2024, the Company anticipates: Total revenues between US$280 million and US$295 million (14% to 20% growth), with quarterly fluctuations expected. Continued progress finding additional APDS patients in the U.S., supported by family testing and VUS validation efforts, and subsequently converting patients to paid Joenja (leniolisib) therapy.Increasing ex-U.S. revenues leniolisib - from commercial availability or through our Named Patient Program and other funded early access programs in key global markets.Completion of leniolisib clinical trials to support regulatory filings for approval in Japan and pediatric label expansion in key global markets.Progress towards regulatory approvals for leniolisib in the EEA, the U.K., Canada, Australia, and Israel.Initiate and advance a Phase 2 clinical trial for leniolisib in PIDs with immune dysregulation linked to PI3K signaling to significantly expand the long-term commercial potential of leniolisib.Continued operating cost investments to accelerate future revenue growth. Our current cash on hand and the continued cash flow from product revenues are expected to be sufficient to fund these investments. No material cash burn is expected prior to the impact of potential acquisition or in-licensing transactions.Continued focus on potential acquisitions and in-licensing of clinical stage opportunities in rare diseases. Financing, if required, would come via a combination of our strong balance sheet and access to capital markets. No further specific financial guidance for 2024 is provided. Additional informationPresentation The conference call presentation is available on the Pharming.com website from 07:30 CET today. Conference Call The conference call will begin at 13:30 CET/08:30 am EDT on Thursday, March 14. A transcript will be made available on the Pharming.com website in the days following the call. Please note, the Company will only take questions from dial-in attendees. Webcast Link: https://edge.media-server.com/mmc/p/5wi4ajdm Conference call dial-in details: https://register.vevent.com/register/BIc993931aa2d54aa89d594b2cad5ed972 Additional information on how to register for the conference call/webcast can be found on thePharming.com website. Financial Calendar 2024 Annual Report and 20-F 2023 April 41Q 2024 financial results May 8Annual General Meeting of Shareholders May 212Q/1H 2024 financial results August 13Q 2024 financial results October 24 For further public information, contact: Pharming Group N.V., Leiden, The NetherlandsMichael Levitan, VP Investor Relations & Corporate Communications T: +1 (908) 705 1696E: investor@pharming.com FTI Consulting, London, UKVictoria Foster Mitchell/Alex ShawT: +44 203 727 1000 LifeSpring Life Sciences Communication, Amsterdam, The NetherlandsLeon MelensT: +31 6 53 81 64 27E: pharming@lifespring.nl About Pharming Group N.V. Pharming Group N.V. (EURONEXT Amsterdam: PHARM/Nasdaq: PHAR) is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating, and life-threatening diseases. Pharming is commercializing and developing an innovative portfolio of protein replacement therapies and precision medicines, including small molecules, biologics, and gene therapies that are in early to late-stage development. Pharming is headquartered in Leiden, Netherlands, and has employees around the globe who serve patients in over 30 markets in North America, Europe, the Middle East, Africa, and Asia-Pacific. For more information, visit www.pharming.com and find us on LinkedIn. Risk profile We continue to closely monitor and manage the key risks and opportunities, and will respond appropriately to any emerging risk. We will issue a full overview of our risk profile in our Annual report 2023 to be published on April 4, 2024. Related party transactions There are no material changes in the nature, scope, and (relative) scale in this reporting period compared to last year. Auditors involvement The Condensed Consolidated Interim Financial Statements have not been audited by the Companys statutory auditor. Forward-looking Statements This press release may contain forward-looking statements. Forward-looking statements are statements of future expectations that are based on managements current expectations and assumptions and involve known and unknown risks and uncertainties that could cause actual results, performance, or events to differ materially from those expressed or implied in these statements. These forward-looking statements are identified by their use of terms and phrases such as aim, ambition, anticipate, believe, could, estimate, expect, goals, intend, may, milestones, objectives, outlook, plan, probably, project, risks, schedule, seek, should, target, will and similar terms and phrases. Examples of forward-looking statements may include statements with respect to timing and progress of Pharming's preclinical studies and clinical trials of its product candidates, Pharming's clinical and commercial prospects, and Pharming's expectations regarding its projected working capital requirements and cash resources, which statements are subject to a number of risks, uncertainties and assumptions, including, but not limited to the scope, progress and expansion of Pharming's clinical trials and ramifications for the cost thereof; and clinical, scientific, regulatory and technical developments. In light of these risks and uncertainties, and other risks and uncertainties that are described in Pharming's 2022 Annual Report and the Annual Report on Form 20-F for the year ended December 31, 2022, filed with the U.S. Securities and Exchange Commission, the events and circumstances discussed in such forward-looking statements may not occur, and Pharming's actual results could differ materially and adversely from those anticipated or implied thereby. All forward-looking statements contained in this press release are expressly qualified in their entirety by the cautionary statements contained or referred to in this section. Readers should not place undue reliance on forward-looking statements. Any forward-looking statements speak only as of the date of this press release and are based on information available to Pharming as of the date of this release. Pharming does not undertake any obligation to publicly update or revise any forward-looking statement as a result of new information, future events or other information. Inside Information This press release relates to the disclosure of information that qualifies, or may have qualified, as inside information within the meaning of Article 7(1) of the EU Market Abuse Regulation. Pharming Group N.V. Condensed Consolidated Financial Statements in U.S. Dollars (unaudited) For the year ended 31 December 2023 Condensed consolidated statement of incomeCondensed consolidated statement of comprehensive incomeCondensed consolidated balance sheetCondensed consolidated statement of changes in equityCondensed consolidated statement of cash flow CONDENSED CONSOLIDATED STATEMENT OF INCOME For the year ended 31 December Amounts in US$ 000 2023 2022 Revenues 245,316 205,622 Costs of sales (25,212) (17,562) Gross profit 220,104 188,060 Other income 23,349 14,523 Research and development (68,914) (52,531) General and administrative (55,877) (46,016) Marketing and sales (124,049) (85,803) Other Operating Costs (248,840) (184,350) Operating profit (loss) (5,387) 18,233 Fair value gain (loss) on revaluation (930) (1,185) Other finance income 3,663 4,485 Other finance expenses (9,069) (5,463) Finance result, net (6,336) (2,163) Share of net profits (loss) in associates using the equity method (289) (1,083) Profit (loss) before tax (12,012) 14,987 Income tax expense 1,893 (1,313) Profit (loss) for the year (10,119) 13,674 Basic earnings per share (US$) (0.015) 0.021 Diluted earnings per share (US$) (0.015) 0.019 CONDENSED CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME For the year ended 31 December Amounts in US$ 000 2023 2022 Profit (loss) for the year (10,119) 13,674 Currency translation differences 5,913 (10,349) Items that may be subsequently reclassified to profit or loss 5,913 (10,349) Fair value remeasurement investments 1,167 (705) Items that shall not be subsequently reclassified to profit or loss 1,167 (705) Other comprehensive income (loss), net of tax 7,080 (11,054) Total comprehensive income (loss) for the year (3,039) 2,620 CONDENSED CONSOLIDATED BALANCE SHEET As at 31 December Amounts in US$ 000 2023 2022 Non-current assets Intangible assets 71,267 75,121 Property, plant and equipment 9,689 10,392 Right-of-use assets 23,777 28,753 Long-term prepayments 92 228 Deferred tax assets 28,332 22,973 Investment accounted for using the equity method 2,285 2,501 Investments in equity instruments designated as at FVTOCI 2,020 403 Investment in debt instruments designated as at FVTPL 6,093 6,827 Restricted cash 1,528 1,099 Total non-current assets 145,083 148,297 Current assets Inventories 56,760 42,326 Trade and other receivables 46,157 27,619 Restricted cash 222 213 Marketable securities 151,683  Cash and cash equivalents 61,519 207,342 Total current assets 316,341 277,500 Total assets 461,424 425,797 Share capital 7,669 7,509 Share premium 478,431 462,297 Other reserves (2,080) (8,737) Accumulated deficit (264,834) (256,431) Shareholders equity 219,186 204,638 Non-current liabilities Convertible bonds 136,598 131,618 Lease liabilities 29,507 29,843 Total non-current liabilities 166,105 161,461 Current liabilities Convertible bonds 1,824 1,768 Trade and other payables 70,693 54,465 Lease liabilities 3,616 3,465 Total current liabilities 76,133 59,698 Total equity and liabilities 461,424 425,797 CONDENSED CONSOLIDATED STATEMENT CHANGES IN EQUITY For the period ended 31 December Attributable to owners of the parent Amounts in US$ 000 Share capital Share premium Other reserves Accumulated deficit Total equity Balance at January 1, 2022 7,429 455,254 3,400 (273,167) 192,916 Profit (loss) for the year    13,674 13,674 Other comprehensive income (loss) for the year   (11,054)  (11,054) Total comprehensive income (loss) for the year   (11,054) 13,674 2,620 Other reserves   (1,083) 1,083  Income tax benefit from excess tax deductions related to share-based payments    430 430 Share-based compensation    6,392 6,392 Options exercised / LTIP shares issued 80 7,043  (4,843) 2,280 Total transactions with owners, recognized directly in equity 80 7,043 (1,083) 3,062 9,102 Balance at December 31, 2022 7,509 462,297 (8,737) (256,431) 204,638 Profit (loss) for the year    (10,119) (10,119) Other comprehensive income (loss) for the year   7,080  7,080 Total comprehensive income (loss) for the year   7,080 (10,119) (3,039) Other reserves   (423) 423  Income tax benefit from excess tax deductions related to share-based payments    203 203 Share-based compensation    9,251 9,251 Options exercised / LTIP shares issued 160 16,134  (8,161) 8,133 Total transactions with owners, recognized directly in equity 160 16,134 (423) 1,716 17,587 Balance at December 31, 2023 7,669 478,431 (2,080) (264,834) 219,186 CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS For the year ended 31 December Amounts in $000 2023 2022 Profit (loss) before tax (12,012) 14,987 Adjustments to reconcile net profit (loss) to net cash used in operating activities: Depreciation, amortization, impairment of non-current assets 15,925 13,188 Equity settled share based payments 9,251 6,392 Gain on disposal of investment in associate 0 (12,242) Fair value gain (loss) on revaluation 930 1,185 Gain on disposal from PRV sale (21,279) 0 Other finance income (3,663) (4,485) Other finance expenses 9,069 5,463 Share of net profits in associates using the equity method 289 1,083 Other (1,080) (1,576) Operating cash flows before changes in working capital (2,570) 23,995 Changes in working capital: Inventories (14,434) (15,016) Trade and other receivables (18,538) 2,364 Payables and other current liabilities 16,228 11,992 Restricted cash (438) 273 Total changes in working capital (17,182) (387) Interest received (paid) 2,883 85 Income taxes received (paid) (655) (1,235) Net cash flows generated from (used in) operating activities (17,524) 22,458 Capital expenditure for property, plant and equipment (1,437) (1,376) Proceeds on PRV sale 21,279 0 Investment intangible assets (27) (601) Proceed from sale of Investment associate 0 7,300 Purchases of marketable securities (382,014) 0 Proceeds from sale of marketable securities 232,811 0 Net cash flows generated from (used in) investing activities (129,388) 5,323 Payment of lease liabilities (5,126) (3,311) Interests on loans and leases (4,046) (3,952) Settlement of share based compensation awards 8,133 2,281 Net cash flows generated from (used in) financing activities (1,039) (4,982) Increase (decrease) of cash (147,951) 22,799 Exchange rate effects 2,128 (7,381) Cash and cash equivalents at January 1 207,342 191,924 Total cash and cash equivalents at December 31 61,519 207,342 ---ENDS--- What was the total revenue growth for Pharming Group N.V. in 2023? Total revenues increased by 19% to US$245.3 million in 2023. How much did RUCONEST revenues grow by in 2023? RUCONEST revenues grew by 10% to US$227.1 million. What were the revenues for Joenja (leniolisib) in 2023? Joenja (leniolisib) had revenues of US$18.2 million in 2023. What was the cash position of Pharming Group N.V. at the end of 2023? Pharming had a cash and marketable securities position of US$215.0 million by the end of 2023. What revenue guidance did Pharming provide for 2024? Pharming provided a revenue guidance of US$280 million  US$295 million for 2024."
Shell publishes Annual Report and Accounts,2024-03-14T07:00:00.000Z,Low,Neutral,"Shell plc released its Annual Report and Accounts for 2023, to be presented at the Annual General Meeting on May 21, 2024. The report can be accessed online or downloaded in pdf format. Printed copies will be available from April 17, 2024. Shell plc is also filing its Form 20-F with the US SEC. The report includes unedited full text information for transparency and compliance.","Shell publishes Annual Report and Accounts Rhea-AI Impact (Low) Rhea-AI Sentiment (Neutral) Tags Rhea-AI Summary Shell plc released its Annual Report and Accounts for 2023, to be presented at the Annual General Meeting on May 21, 2024. The report can be accessed online or downloaded in pdf format. Printed copies will be available from April 17, 2024. Shell plc is also filing its Form 20-F with the US SEC. The report includes unedited full text information for transparency and compliance. Positive None. Negative None. Financial Analyst Shell plc's publication of its Annual Report and Accounts is a significant disclosure that provides investors and stakeholders with a comprehensive overview of the company's financial health and operational performance over the past year. Analysis of this report is crucial as it contains key financial metrics such as revenue, profit margins, cash flow and debt levels. These metrics are fundamental indicators of the company's ability to generate value and sustain operations. Additionally, the report may offer insights into Shell's strategic initiatives and capital allocation which can influence future growth prospects and competitiveness in the energy sector.From a financial analysis perspective, the report's data will enable a thorough evaluation of Shell's financial ratios against industry benchmarks, providing an understanding of its relative performance. The submission of the report to regulatory bodies like the AFM and the adherence to DTRs ensures transparency and compliance, which is vital for maintaining investor trust. The availability of the report in multiple formats, including the Form 20-F filing with the US SEC, makes the information accessible to a global investor audience, which is particularly important for a company with Shell's international presence. Market Research Analyst The energy sector is subject to volatile market conditions and regulatory changes, making the analysis of Shell's Annual Report and Accounts critical for understanding the company's adaptability and strategic positioning. The report provides market research professionals with data to assess Shell's market share, the effectiveness of its operations and its response to global energy trends such as the transition towards renewable energy sources. It also allows for the evaluation of Shell's performance in different geographical markets and segments, which can inform predictions about future market dynamics and potential shifts in consumer demand.Furthermore, the report's insights into Shell's research and development investments can signal the company's commitment to innovation and its potential to capitalize on emerging technologies. Such information can be pivotal for stakeholders to understand the long-term market implications of Shell's current business decisions and investments. Economist Shell's Annual Report and Accounts are not only a reflection of the company's financial standing but also serve as an economic indicator for the broader energy industry and the global economy. Economists can utilize this report to gauge the health of the energy sector, which is a significant component of global economic activity. The report can provide insights into capital expenditure trends, which have implications for economic growth and employment within the sector.Additionally, Shell's financial performance and strategic outlook can reflect broader economic conditions, such as the impact of fluctuating oil prices, geopolitical tensions and trade policies on international businesses. The report's information on Shell's operational efficiencies and cost management strategies can also shed light on how major corporations are navigating economic challenges and what this means for the future economic landscape. 03/14/2024 - 03:00 AM Shell plc published Annual Report and AccountsMarch 14, 2024 Shell plc published its Annual Report and Accounts for the year ended December 31, 2023. The 2023 Annual Report and Accounts will be submitted to the Annual General Meeting to be held on May 21, 2024. The 2023 Annual Report and Accounts can be viewed online or downloaded in pdf format at www.shell.com/news-and-insights/annual-reports-and-publications. In compliance with Listing Rule 9.6.1, on March 14, 2024, a copy of the 2023 Annual Report and Accounts was submitted to the National Storage Mechanism. This document will shortly be available for inspection at https://data.fca.org.uk/#/nsm/nationalstoragemechanism. In compliance with section 5:25m(5) Financial Markets Supervision Act, the Annual Report and Accounts was submitted to the Dutch Authority for the Financial Markets (AFM). The AFM publishes the report in its public register. Printed copies of the 2023 Annual Report and Accounts will be available from April 17, 2024, and can be requested, free of charge, at www.shell.com/news-and-insights/annual-reports-and-publications/order-printed-annual-reports. Shell plc will also file its Form 20-F for the year ended December 31, 2023, with the US Securities and Exchange Commission today. The Form 20-F will be available for download from www.shell.com/investors/financial-reporting/sec-filings.html or www.sec.gov. This announcement is made in accordance with DTR 6.3.5R(1A). Additional InformationFor the purposes of complying with the Disclosure Guidance and Transparency Rules (DTRs) and the requirements imposed on issuers though the DTRs, information required to be communicated in unedited full text was included in the 2023 Annual Report and Accounts. This was submitted to the National Storage Mechanism in unedited full text on March 14, 2024, and will shortly be available for inspection. Furthermore, the 2023 Annual Report and Accounts are available at www.shell.com/annual-report. Enquiries Shell Media Relations International: +44 20 7934 5550 Americas: +1 713 241 4544LEI number of Shell plc: 21380068P1DRHMJ8KU70Classification: Annual financial and audit reports Where can I view Shell plc's 2023 Annual Report and Accounts? You can view Shell plc's 2023 Annual Report and Accounts online or download it in pdf format at www.shell.com/news-and-insights/annual-reports-and-publications. When will the 2023 Annual Report and Accounts be available for inspection at the National Storage Mechanism? The 2023 Annual Report and Accounts will be available for inspection at the National Storage Mechanism shortly after being submitted on March 14, 2024. Where can I request printed copies of the 2023 Annual Report and Accounts? Printed copies of the 2023 Annual Report and Accounts will be available from April 17, 2024, and can be requested for free at www.shell.com/news-and-insights/annual-reports-and-publications/order-printed-annual-reports. What is Shell plc filing with the US SEC? Shell plc is filing its Form 20-F for the year ended December 31, 2023, with the US Securities and Exchange Commission. The form will be available for download at www.shell.com/investors/financial-reporting/sec-filings.html or www.sec.gov. What information is included in the 2023 Annual Report and Accounts for transparency? The 2023 Annual Report and Accounts include unedited full text information required for compliance with the Disclosure Guidance and Transparency Rules (DTRs)."
AirNet Regains Compliance with Nasdaq Minimum Bid Price Requirement,2024-03-14T08:00:00.000Z,Low,Neutral,"AirNet Technology Inc. (ANTE) received a Notification Letter from Nasdaq stating compliance with the minimum bid price requirement after facing non-compliance issues in November 2023. The Company's ADS closing bid price has been at $1.00 or above for the last 10 consecutive business days, ensuring compliance with Nasdaq rules.","AirNet Regains Compliance with Nasdaq Minimum Bid Price Requirement Rhea-AI Impact (Low) Rhea-AI Sentiment (Neutral) Tags Rhea-AI Summary AirNet Technology Inc. (ANTE) received a Notification Letter from Nasdaq stating compliance with the minimum bid price requirement after facing non-compliance issues in November 2023. The Company's ADS closing bid price has been at $1.00 or above for the last 10 consecutive business days, ensuring compliance with Nasdaq rules. Positive None. Negative None. Financial Analyst Regaining compliance with Nasdaq's minimum bid price requirement is a significant financial milestone for AirNet Technology Inc. It directly influences investor perception and can affect the liquidity of the shares. The company's ability to maintain a bid price above the $1 threshold over the consecutive 10-day period demonstrates a recovery in investor confidence and potentially an improved financial outlook.For stakeholders, the immediate benefit is the continued listing on the Nasdaq, which is crucial for access to capital markets and institutional investors. However, the underlying reasons for the stock's appreciation are paramount. If the price increase is due to fundamental improvements in the company's operations or financials, the long-term outlook may be positive. Conversely, if the increase is driven by speculative trading or temporary factors, the company may face future risks of non-compliance. Market Research Analyst From a market perspective, the compliance with Nasdaq's minimum bid price signals a stabilization in AirNet's market valuation. This could attract additional analysis from brokerage firms and market researchers, which in turn can lead to higher visibility among potential investors. However, it is essential to monitor the company's subsequent trading patterns and market performance to ensure that the stock price reflects its intrinsic value and is not subject to volatility.A critical analysis should include the company's market position, competitive landscape and growth potential. Any discrepancies with industry norms, such as revenue growth, profit margins, or return on equity, should be closely examined to assess the sustainability of AirNet's stock price recovery. 03/14/2024 - 04:00 AM BEIJING, March 14, 2024 /PRNewswire/ -- AirNet Technology Inc., formerly known as AirMedia Group Inc. (""AirNet"" or the ""Company"") (Nasdaq: ANTE), today announced that it received a notification letter (the ""Notification Letter on Compliance"") from the Listing Qualifications Department of The Nasdaq Stock Market Inc. (""Nasdaq"") on March 13, 2024, indicating that the Company has regained compliance with the minimum bid price requirement set forth in Rule 5550(a)(2) of the Nasdaq Listing Rules. As previously announced, on November 27, 2023, the Nasdaq notified the Company of its non-compliance with the Nasdaq's minimum bid price requirement because, as of November 24, 2023, the Company's closing bid price per American depositary share (""ADS"") was less than US$1.00 per ADS over the previous 30 consecutive business days. Pursuant to Rule 5810(c)(3)(A) of the Nasdaq Listing Rules, the Company has a compliance period of 180 calendar days, or until May 28, 2024, to regain compliance with Nasdaq's minimum bid price requirement. According to the Notification Letter on Compliance, the staff of Nasdaq has determined that for the last 10 consecutive business days, from February 28 through March 12, 2024, the closing bid price of the Company's ADSs had been at $1.00 per ADS or greater, and the Company has regained compliance with Rule 5550(a)(2) of the Nasdaq Listing Rules. Forward-Looking Statements This announcement contains forward-looking statements within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as ""will,"" ""expects,"" ""is expected to,"" ""anticipates,"" ""aim,"" ""future,"" ""intends,"" ""plans,"" ""believes,"" ""are likely to,"" ""estimates,"" ""may,"" ""should"" and similar expressions. The Company may also make written or oral forward-looking statements in its reports filed with, or furnished to, the U.S. Securities and Exchange Commission, in its annual reports to shareholders, in press releases and other written materials and in oral statements made by its officers, directors or employees to third parties. Forward-looking statements are based upon management's current expectations and current market and operating conditions, and involve inherent risks and uncertainties, all of which are difficult to predict and many of which are beyond the Company's control, which may cause its actual results, performance or achievements to differ materially from those in the forward-looking statements. Further information is included in the Company's filings with the U.S. Securities and Exchange Commission. All information provided in this announcement is as of the date of this announcement, and the Company does not undertake any obligation to update any forward-looking statement as a result of new information, future events or otherwise, except as required under law. View original content:https://www.prnewswire.com/news-releases/airnet-regains-compliance-with-nasdaq-minimum-bid-price-requirement-302088853.html SOURCE AirNet Technology Inc. What did AirNet Technology Inc. (ANTE) announce regarding Nasdaq compliance? AirNet Technology Inc. (ANTE) announced that it received a Notification Letter from Nasdaq indicating compliance with the minimum bid price requirement after facing non-compliance issues previously. When did Nasdaq notify AirNet Technology Inc. (ANTE) of its non-compliance? Nasdaq notified AirNet Technology Inc. (ANTE) of its non-compliance on November 27, 2023. What was the closing bid price of the Company's ADSs during the specified period mentioned in the Notification Letter on Compliance? The closing bid price of AirNet Technology Inc.'s (ANTE) ADSs was $1.00 or greater for the last 10 consecutive business days from February 28 through March 12, 2024. What is the compliance period given to AirNet Technology Inc. (ANTE) by Nasdaq to regain compliance with the minimum bid price requirement? AirNet Technology Inc. (ANTE) has a compliance period of 180 calendar days, until May 28, 2024, to regain compliance with Nasdaq's minimum bid price requirement."
u-blox Takes an Important Step Forward and Publishes Its Sustainability Report For 2023 In Accordance with The GRI Standards,2024-03-14T06:20:00.000Z,No impact,Very Positive,"u-blox (UBLXF) releases its 2023 Sustainability Report in line with Global Reporting Initiative Standards, emphasizing sustainability as a core strategy.","u-blox Takes an Important Step Forward and Publishes Its Sustainability Report For 2023 In Accordance with The GRI Standards Rhea-AI Impact (No impact) Rhea-AI Sentiment (Very Positive) Tags Rhea-AI Summary u-blox (UBLXF) releases its 2023 Sustainability Report in line with Global Reporting Initiative Standards, emphasizing sustainability as a core strategy. Positive None. Negative None. 03/14/2024 - 02:20 AM THALWIL, SWITZERLAND / ACCESSWIRE / March 14, 2024 / u-blox (SIX:UBXN), a global provider of leading positioning and wireless communication technologies and services, has taken an important step forward on its sustainability program and published today its 2023 Sustainability Report in accordance with the Global Reporting Initiative (GRI) Standards .Sustainability is an integral part of u-blox strategy. Reporting in accordance with GRI Standards is an important step for u-blox as it helps to efficiently inform about u-blox's sustainability activities and approach to environmental, social, and governance (ESG) activities.Based on a materiality assessment, u-blox has identified a roadmap to reach its targets based on five focus areas:Business Ethics, Privacy, and Data SecurityPeople and CommunitiesEnvironmental ResponsibilityResponsible Supply Chainu-blox Innovationsu-blox has set specific environmental, social, and governance short, medium, and long-term targets based on measurable performance indicators for each pillar.u-blox estimates that its technologies positively impact 13 out of 17 UN SDGs. The company added a new pillar and target to its sustainability strategy in 2023 to shape the social and environmental impact of its innovations. Consequently, u-blox has set a target to assess their product portfolio of modules and chips for their contribution to the SDGs by the end of 2025.Stephan Zizala, Chief Executive Officer of u-blox, commented: ""Sustainability is an integral part of our strategy, and applications contributing to sustainability are major growth drivers for u-blox. We are fortunate to be able to create solutions that make the world a better place. The u-blox Sustainability Report for 2023 shows our contribution and our measurable targets for a more sustainable future.""The u-blox Sustainability Report for 2023 is accessible online here.For further information, please contact:SustainabilityGitte JensenPhone: +41 44 722 74 86gitte.jensen@u-blox.comInvestor RelationsRafael DuartePhone: +41 79 966 89 12rafael.duarte@u-blox.comMediaNatacha SeitzPhone: +41 76 436 07 88natacha.seitz@u-blox.comAbout u-bloxublox (SIX:UBXN) provides semiconductor chips, modules, and IoT services that reliably locate and connect every thing. Our cutting-edge solutions drive innovation for the car of the future and the Internet of Things. Headquartered in Thalwil (Zurich), Switzerland, we have a presence of 1,400 experts who enable our customers to build solutions for a precise, smart, and sustainable future.(www.ublox.com)Join us on social media - X, Facebook, YouTube, LinkedIn, and Instagram.SOURCE: u-blox AGView the original press release on accesswire.com What did u-blox (UBLXF) publish recently? u-blox (UBLXF) published its 2023 Sustainability Report in accordance with the Global Reporting Initiative (GRI) Standards. What is u-blox's (UBLXF) core strategy according to the PR? Sustainability is highlighted as an integral part of u-blox's strategy in the released report. What standards did u-blox (UBLXF) follow for its sustainability report? u-blox (UBLXF) followed the Global Reporting Initiative (GRI) Standards for its 2023 Sustainability Report."
"Empresa Municipal de Transportes de Madrid awards Lleida.net the messaging service contract on mobile devices for a total amount of 104,519 euros.",2024-03-14T06:45:00.000Z,Low,Neutral,"Lleida.net (LLEIF) secures a messaging service contract with EMT for 104,519 euros, reinforcing its position in the technology services industry. The contract spans 14 months, highlighting the company's role in the Spanish economy and its strong intellectual property portfolio. Lleida.net, a key player in certified electronic signature services, has a global presence with listings on multiple stock exchanges.","Empresa Municipal de Transportes de Madrid awards Lleida.net the messaging service contract on mobile devices for a total amount of 104,519 euros. Rhea-AI Impact (Low) Rhea-AI Sentiment (Neutral) Tags Rhea-AI Summary Lleida.net (LLEIF) secures a messaging service contract with EMT for 104,519 euros, reinforcing its position in the technology services industry. The contract spans 14 months, highlighting the company's role in the Spanish economy and its strong intellectual property portfolio. Lleida.net, a key player in certified electronic signature services, has a global presence with listings on multiple stock exchanges. Positive None. Negative None. 03/14/2024 - 02:45 AM Madrid, March 14th. Empresa Municipal de Transportes de Madrid (EMT) has awarded Lleida.net (BME:LLN) (OTCQX:LLEIF) (EPA:ALLLN), a listed technology services company, the messaging service contract for mobile devices for a total amount of 104,519 euros. The resolution of the tender accredits Lleida.net as EMT's messaging management provider for a period of 14 months. EMT is a public company under the Madrid City Council, which is responsible for the management and operation of urban public transport services within the municipality of Madrid. Sisco Sapena, CEO of the technology company added that ""The award of this contract with one of Madrid's public companies crucial in the mobility system of the Spanish capital, is an important milestone to continue demonstrating the role of our technology among important players in the Spanish economy."" Lleida.net is one of the leading companies in Europe in the certified electronic signature, notification and contracting industry. It has more than 300 patents received from more than 60 countries internationally, and has one of the strongest intellectual property portfolios in the industry. Lleida.net, founded in 1995, first went public in Madrid in 2015. It subsequently executed a dual listing on Euronext Growth Paris in 2018 and on OTC Markets in New York in 2020. Its securities are also traded on the Frankfurt and Stuttgart stock exchanges. SAFE HARBOR STATEMENTThis press release contains statements regarding the future of the company and its innovations. Statements regarding the future may be accompanied by words such as ""anticipate"", ""believe"", ""estimate"", ""wait"", ""anticipate"", ""pretend"", ""power"", ""plan"", ""potential"", the use of future time and other terms of similar meaning. No undue reliance should be placed on these claims. These statements involve risks and uncertainties that could cause actual results to differ materially from those reflected in such statements, including uncertainty of the company's commercial success, ability to protect our intellectual property rights, and other risks. These statements are based on current beliefs and forecasts and refer only to the date of this press release. The company assumes no obligation to publicly update its forward-looking statements, regardless of whether new information, future events or any other circumstance arise. What contract did Lleida.net secure with EMT? Lleida.net secured a messaging service contract with EMT for a total amount of 104,519 euros. For how long is Lleida.net the messaging management provider for EMT? Lleida.net is the messaging management provider for EMT for a period of 14 months. What industry is Lleida.net a leading company in? Lleida.net is a leading company in the certified electronic signature, notification, and contracting industry. When did Lleida.net first go public? Lleida.net first went public in Madrid in 2015. How many patents does Lleida.net have internationally? Lleida.net has more than 300 patents received from more than 60 countries internationally."
Oracle Helps Organizations Build Smart and Efficient Operations,2024-03-14T08:00:00.000Z,Low,Neutral,"Oracle introduces Smart Operations capabilities in Oracle Cloud SCM to enhance productivity, quality, and visibility for manufacturing and maintenance operations, aiming to help organizations navigate supply chain challenges and increase efficiency.","Oracle Helps Organizations Build Smart and Efficient Operations Rhea-AI Impact (Low) Rhea-AI Sentiment (Neutral) Tags Rhea-AI Summary Oracle introduces Smart Operations capabilities in Oracle Cloud SCM to enhance productivity, quality, and visibility for manufacturing and maintenance operations, aiming to help organizations navigate supply chain challenges and increase efficiency. Positive None. Negative None. Supply Chain Management Expert The introduction of Oracle Smart Operations within its Cloud SCM suite represents a significant advancement in supply chain management technology. By integrating AI to enhance productivity and reduce downtime, Oracle is addressing key pain points in the industry such as labor shortages and supply disruption. This strategic move not only bolsters Oracle's product offering but also potentially reshapes the competitive landscape by setting a new standard for operational efficiency in supply chain management.From a supply chain perspective, the ability to predict and mitigate unplanned downtime is invaluable. The predictive maintenance features could lead to a reduction in operational costs and an increase in asset utilization for Oracle's customers. Furthermore, the real-time data analytics and recommendations could empower businesses to make more informed decisions, optimizing their supply chain networks and potentially improving their bottom line. Manufacturing Operations Analyst Oracle's new capabilities within its Cloud Manufacturing and Maintenance sectors are poised to transform manufacturing operations. The Operator Workbench and Digital Work Instructions aim to streamline production processes, which could translate to tangible improvements in manufacturing throughput and product quality. These enhancements could lead to a reduction in manual errors and an increase in production consistency, which are critical factors for manufacturers aiming to meet high industry standards and customer expectations.By enabling a more autonomous manufacturing environment, Oracle is facilitating a shift towards 'lights out' manufacturing. This shift could significantly reduce labor costs and human error while increasing production speed and consistency. However, it is crucial to assess the ease of integration of these systems into existing workflows and the training required for the workforce to adapt to these new tools. Technology Investment Analyst Oracle's announcement is likely to be of considerable interest to investors, as it signals the company's continued investment in innovation and its commitment to maintaining a competitive edge in the cloud services market. The enhancements to Oracle Cloud SCM could attract new customers and increase loyalty among existing ones, potentially leading to increased revenue streams.Investors should monitor customer adoption rates and feedback following the rollout of these new capabilities. Positive reception and successful case studies could serve as indicators of Oracle's potential market growth and its ability to capture a larger share of the supply chain management market. It is also important to consider the competitive responses from other major players in the industry, as they may launch similar initiatives to counter Oracle's advancements. 03/14/2024 - 04:00 AM New Smart Operations capabilities in Oracle Cloud SCM help customers increase productivity, enhance quality, reduce downtime, expand production visibility, and improve factory output LONDON, March 14, 2024 /PRNewswire/ -- Oracle CloudWorld -- To help organizations increase the efficiency of global supply chain operations, Oracle today announced Oracle Smart Operations, new supply chain execution capabilities in Oracle Fusion Cloud Supply Chain & Manufacturing (SCM). Powered by advanced technologies like artificial intelligence (AI), the new capabilities within Oracle Fusion Cloud Manufacturing and Oracle Fusion Cloud Maintenance can help customers improve factory output by increasing productivity, enhancing quality, reducing unplanned downtime, and improving visibility across operations. With on-going labor shortages, supply chain disruptions, ever-fluctuating demand, and volatile market needs, organizations are under pressure to do more with less. To remain competitive, manufacturing and asset-intensive organizations need smart and agile processes that increase the efficiency of factories, reduce the risk of unplanned downtime, and expand visibility across operations. Oracle Smart Operations offers connected, intelligent, and automated capabilities that enable Oracle Cloud Manufacturing and Oracle Cloud Maintenance customers to improve efficiency and make better business decisions with agile execution. ""As organizations look to insulate their operations from ongoing disruptions, many leaders are turning to technology to increase output, improve quality, and build resiliency,"" said Chris Leone, executive vice president of applications development, Oracle. ""With Oracle Cloud SCM, organizations can connect and automate end-to-end supply chain processes and move toward a lights out manufacturing model. The new smart manufacturing and maintenance capabilities can help our customers reduce inefficient manual recording and monitoring processes, increase safety, improve quality, and optimize operations."" Smart Operations for ManufacturingThe new capabilities within Oracle Cloud Manufacturing enable customers to combine data from connected equipment, the workforce, and supply chain processes to deliver real-time recommendations, autonomously adjust production, and execute on high-value manufacturing decisions. New capabilities include: Operator Workbench: Provides customers with a single user interface to capture and access information and insights as they complete day-to-day operations, such as operation start/stop, time tracking, materials and tools required, and production exception reporting. With a simple and user-friendly environment and automated data capture, machine operators have clear visibility into their daily tasks, and assembly workers gain more autonomy to execute orders and quickly track and record production.Digital Work Instructions: Help customers simplify complex assembly operations, including manual and automated assemblies, and enforce procedures to improve quality and consistency. With simple, intuitive work instructions, machine operators and assembly workers can improve productivity, quality, and safety, while addressing compliance.Smart Operations for Maintenance The new capability within Oracle Cloud Maintenance enables customers to combine maintenance data with real-time asset information, workforce, and supply chain data to enable continuous monitoring and predictive maintenance. The new capability includes: Maintenance Technician Workbench: Helps maintenance technicians to quickly and easily access relevant work based on assignment or skill, while also providing insights into service history and supporting seamless collaboration with other workers. With a single mobile user interface for all technician work execution, customers can make faster maintenance decisions that increase productivity, reduce downtime, ensure more frequent first-time fixes, optimize backup inventory, and enhance asset reliability.""Being a premium player in the automotive aftermarket industry places a critical focus on our manufacturing and maintenance operations. Our customers expect a consistently high-quality product and an on-time delivery, which is increasingly challenging with the continuous supply chain disruptions around the world,"" said Stefano Mariani, head of IT, Alcar Ruote. ""With these new capabilities in Oracle Cloud Manufacturing and Oracle Cloud Maintenance, our production operators will be better able to work with speed and accuracy, while capturing all of the key data associated with that work. This will help us improve the quality of our products, reduce costs, and increase the output of our operations."" Oracle Cloud SCM helps organizations seamlessly connect supply chain processes and quickly respond to changing demand, supply, and market conditions. With new features added every quarter, Oracle Cloud SCM helps customers create a resilient supply network and processes that can outpace change. For additional information on Oracle Cloud SCM applications, visit oracle.com/scm. About OracleOracle offers integrated suites of applications plus secure, autonomous infrastructure in the Oracle Cloud. For more information about Oracle (NYSE: ORCL), please visit us at www.oracle.com. Future Product DisclaimerThe preceding is intended to outline our general product direction. It is intended for information purposes only, and may not be incorporated into any contract. It is not a commitment to deliver any material, code, or functionality, and should not be relied upon in making purchasing decisions. The development, release, timing, and pricing of any features or functionality described for Oracle's products may change and remains at the sole discretion of Oracle Corporation. TrademarksOracle, Java, MySQL and NetSuite are registered trademarks of Oracle Corporation. NetSuite was the first cloud companyushering in the new era of cloud computing. View original content to download multimedia:https://www.prnewswire.com/news-releases/oracle-helps-organizations-build-smart-and-efficient-operations-302088571.html SOURCE Oracle What are the new capabilities introduced by Oracle in Oracle Cloud SCM? Oracle introduced Smart Operations capabilities in Oracle Cloud SCM to enhance productivity, quality, reduce downtime, and improve visibility for manufacturing and maintenance operations. How can Oracle Smart Operations help customers in the manufacturing industry? Oracle Smart Operations can help manufacturing customers by providing real-time recommendations, autonomous production adjustments, and high-value manufacturing decisions through connected equipment, workforce, and supply chain processes. What benefits do the new capabilities in Oracle Cloud Manufacturing offer? The new capabilities in Oracle Cloud Manufacturing offer benefits such as the Operator Workbench for data capture and access, and Digital Work Instructions to simplify assembly operations and improve quality and consistency. What is the purpose of the Maintenance Technician Workbench in Oracle Cloud Maintenance? The Maintenance Technician Workbench in Oracle Cloud Maintenance helps technicians access relevant work, service history, and collaborate seamlessly, leading to faster maintenance decisions, increased productivity, and enhanced asset reliability. How do the new capabilities in Oracle Cloud SCM benefit organizations? The new capabilities in Oracle Cloud SCM help organizations connect supply chain processes, respond to changing demand, supply, and market conditions, and create a resilient supply network to outpace change."
Regenx Announces Online Presentation,2024-03-14T06:00:00.000Z,Neutral,Neutral,"Regenx Tech Corp. plans to distribute a presentation to address shareholder inquiries, provide strategic direction insight, and showcase recent achievements. The presentation by Kara Wood will be available on March 21 on the company's website and social platforms. Questions can be submitted until March 18.","Regenx Announces Online Presentation Rhea-AI Impact (Neutral) Rhea-AI Sentiment (Neutral) Tags Rhea-AI Summary Regenx Tech Corp. plans to distribute a presentation to address shareholder inquiries, provide strategic direction insight, and showcase recent achievements. The presentation by Kara Wood will be available on March 21 on the company's website and social platforms. Questions can be submitted until March 18. Positive None. Negative None. 03/14/2024 - 02:00 AM EDMONTON, Alberta, March 14, 2024 (GLOBE NEWSWIRE) -- Regenx Tech Corp., (the ""Company"" or ""Regenx"") (CSE: RGX) (OTCQB: RGXTF) (FSE: YRS WKN:A2DSW3) is pleased to announce it plans on distributing a presentation during which the Company is going to take the opportunity to answer shareholder inquiries, provide insight into strategic direction and to showcase recent achievements. This presentation will be hosted by Kara Wood, Corporate Communications for Regenx Tech Corp. and will be available to view on the Regenx Website and social platforms on Thursday, March 21. Shareholders and interested parties are urged to submit their questions by March 18th, 2024, at the latest via this online form or by email: shawn@regenx.tech. About Regenx Tech Corp Regenx is positioned for growth in the Clean Tech sector through the development and commercialization of its environmentally friendly processing technologies for the recovery of precious metals. Initial focus is the extraction of platinum and palladium from diesel catalytic converters with its business partner Davis Recycling. For further information visit www.regenx.tech For further information contact Regenx Tech Corp.Greg PenduraCEO 780-800-0726investors@regenx.tech Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release. When will Regenx Tech Corp. distribute the presentation? Regenx Tech Corp. plans to distribute the presentation on March 21. Who will host the presentation? The presentation will be hosted by Kara Wood, Corporate Communications for Regenx Tech Corp. How can shareholders and interested parties submit questions? Questions can be submitted by March 18 via an online form or by email to shawn@regenx.tech. Where will the presentation be available to view? The presentation will be available on the Regenx Website and social platforms."
Microsoft and Oracle expand partnership to satisfy global demand for Oracle Database@Azure,2024-03-14T08:00:00.000Z,Low,Very Positive,"Microsoft Corp. and Oracle are expanding their collaboration to bring Oracle Database@Azure to five more regions globally, totaling 15 regions planned this year. This partnership aims to streamline workload migration to the cloud, offering customers the best of Oracle with Microsoft's cloud services like Azure AI.","Microsoft and Oracle expand partnership to satisfy global demand for Oracle Database@Azure Rhea-AI Impact (Low) Rhea-AI Sentiment (Very Positive) Tags partnership Rhea-AI Summary Microsoft Corp. and Oracle are expanding their collaboration to bring Oracle Database@Azure to five more regions globally, totaling 15 regions planned this year. This partnership aims to streamline workload migration to the cloud, offering customers the best of Oracle with Microsoft's cloud services like Azure AI. Positive None. Negative None. Market Research Analyst The expansion of Oracle Database@Azure into new regions represents a strategic move to capitalize on the increasing demand for cloud services. This collaboration between Microsoft and Oracle is a significant step in the multicloud strategy, which allows customers to leverage the strengths of multiple cloud providers. The inclusion of regions such as Germany, Australia, Brazil and others is indicative of a targeted approach to capture diverse markets, each with unique regulatory and data sovereignty requirements.From a market research perspective, this news suggests that the cloud services market is highly competitive and that partnerships between tech giants can be a powerful way to address customer needs for integrated solutions. The ability to run Oracle's database services on Microsoft's Azure platform simplifies the cloud migration process for enterprises, potentially increasing the adoption rate of cloud technologies. This move could also influence the competitive dynamics, prompting other cloud service providers to seek similar partnerships or to innovate in order to maintain market share. Financial Analyst The announcement is likely to have positive financial implications for both Microsoft and Oracle. By expanding the availability of Oracle Database@Azure to 15 regions, both companies are poised to capture a larger segment of the cloud market, which could lead to increased revenues. The synergy between Oracle's database services and Microsoft's cloud infrastructure, including Azure AI, can create a comprehensive offering that may drive sales and improve customer retention.For investors, this expansion could be seen as a growth indicator for both companies' cloud segments. It's important to note, however, that the costs associated with the expansion and the time needed to realize returns on investment should be considered. As the service is now available in key regions, monitoring the uptake and customer feedback will be crucial in assessing the financial success of this initiative. IT Infrastructure Expert The technical implications of Oracle Database@Azure's expansion are considerable. The service promises high performance, scale and availability, which are critical factors for enterprises when migrating mission-critical workloads to the cloud. The mention of feature and pricing parity with Oracle Cloud Infrastructure (OCI) suggests that customers will not face a premium for the multicloud flexibility.Moreover, the integration of Oracle's database services with Azure's development and AI services could facilitate the creation of new, cloud-native applications, presenting a significant opportunity for innovation. Enterprises stand to benefit from a unified operating environment that reduces latency and security concerns, which are often hurdles in cloud migration. The ability to maintain consistency with on-premises deployments could also minimize the need for extensive rearchitecting, thereby reducing the complexity and cost of cloud transitions. 03/14/2024 - 04:00 AM Powerful cloud database service now in Germany and announcing five additional cloud regions for a total of 15 regions planned this year REDMOND, Wash., and AUSTIN, Texas, March 14, 2024 /PRNewswire/ -- Microsoft Corp. and Oracle are expanding our collaboration to meet growing customer demand for Oracle Database@Azure around the world. Oracle Database@Azure will expand to five more regions, which brings the total planned multicloud availability footprint to 15 regions globally. ""Bringing Oracle Database@Azure to Europe will enable customers in the region to locally employ Oracle database services running on OCI hardware deployed in Azure datacenters for the first time,"" said Microsoft CVP Azure Infrastructure Product and Design Erin Chapple. ""The expansion of our collaboration with Oracle demonstrates our mutual commitment to help customers streamline the migration of workloads to the cloud so they can combine the best of Oracle with the breadth of Microsoft cloud services, like Azure AI, to empower business innovation."" ""We have embraced the tremendous global customer demand for Oracle Database@Azure and are hence announcing five additional regions to the road map today,"" said Karan Batta, senior vice president, Oracle Cloud Infrastructure. ""We are energized by the Global 500 companies in financial services, healthcare, manufacturing, oil and gas, pharmaceuticals, and more that are already utilizing Oracle Database@Azure. The increased uptick in demand and emerging and unified use cases across OCI and Microsoft Azure demonstrate just how important the multicloud deployments are for our joint customers."" Customers can now place orders for Oracle Database@Azure in the Microsoft Azure Germany West Central region in Frankfurt. This marks the debut of Oracle Database@Azure in Europe, and the second region after Microsoft Azure East US general availability in December 2023. To meet the growing customer demand this year, the service will further run in the Australia East, Brazil South, Canada Central, France Central, Central India, Italy North, Japan East, Southeast Asia, Sweden Central, United Kingdom South, Central United States, South Central United States, and United Arab Emirates North cloud regions. ""Enterprises that use offerings from multiple vendors are having a hard time moving their workloads to the cloud,"" said Holger Mueller, vice president and principal analyst, Constellation Research. ""Effectively CxOs need to pick the better offering and then live with the integration cost and risk going forward. The Microsoft and Oracle partnership is an innovative departure from this challenge, by allowing enterprises to even deliver their Oracle services through Azure's console. It is no surprise that Microsoft and Oracle are now doubling down on the customer momentum and expanding their partnership with more locations. This will give more enterprises the chance to move their mission-critical workloads to the cloud."" With Oracle Database@Azure running on OCI in Azure datacenters, customers benefit from: Flexible options to simplify and accelerate migrating their Oracle databases to the cloud, including compatibility with proven migration tools such as Oracle Zero-Downtime MigrationThe highest level of Oracle database performance, scale and availability, along with feature and pricing parity with OCIThe simplicity, security and latency of a unified operating environment (datacenter) within AzureConsistency with on-premises deployments of Oracle Database and Oracle Exadata to reduce the need to rearchitect or refactor solutionsThe ability to build new cloud-native applications using OCI and Azure technologies, including the rich set of Azure development and AI servicesUnified customer experience and support from Oracle and MicrosoftSimplified purchasing via the Azure Marketplace, and the ability to leverage Oracle and Microsoft licenses, commitments and discount programsThe assurance of a unified service and architecture that are tested and supported by two of the most trusted names in the cloudAdditional resources Learn more about Oracle Database@AzureRead more about the Oracle database services running on OCI in Azure datacentersLearn more about the Oracle and Microsoft partnershipRead the First Principles blog about powering applications with Oracle Database@AzureLearn more about Oracle database services, Oracle Autonomous Database, Oracle Exadata Database Service and Oracle Base Database ServiceLearn about innovating with Oracle and AzureAbout OracleOracle offers integrated suites of applications plus secure, autonomous infrastructure in the Oracle Cloud. For more information about Oracle (NYSE: ORCL), please visit us at www.oracle.com. About MicrosoftMicrosoft (Nasdaq ""MSFT"" @microsoft) enables digital transformation for the era of an intelligent cloud and an intelligent edge. Its mission is to empower every person and every organization on the planet to achieve more. TrademarksOracle, Java, MySQL and NetSuite are registered trademarks of Oracle Corporation. NetSuite was the first cloud company  ushering in the new era of cloud computing. View original content:https://www.prnewswire.com/news-releases/microsoft-and-oracle-expand-partnership-to-satisfy-global-demand-for-oracle-databaseazure-302088855.html SOURCE Microsoft Corp.; Oracle How many regions are Microsoft and Oracle planning to expand Oracle Database@Azure to this year? Microsoft and Oracle are planning to expand Oracle Database@Azure to a total of 15 regions globally this year. What are the benefits of running Oracle Database@Azure on OCI in Azure datacenters? Running Oracle Database@Azure on OCI in Azure datacenters provides customers with flexible migration options, high Oracle database performance, scale, and availability, feature and pricing parity with OCI, simplicity, security, and latency of a unified operating environment within Azure. Where can customers now place orders for Oracle Database@Azure in Europe? Customers can now place orders for Oracle Database@Azure in the Microsoft Azure Germany West Central region in Frankfurt, marking the debut of Oracle Database@Azure in Europe. What is the significance of the Microsoft and Oracle partnership for enterprises using offerings from multiple vendors? The Microsoft and Oracle partnership allows enterprises to deliver Oracle services through Azure's console, simplifying workload migration to the cloud and reducing integration costs and risks for enterprises using offerings from multiple vendors. What tools are available to simplify and accelerate migrating Oracle databases to the cloud? Customers can benefit from flexible migration options, including compatibility with proven migration tools such as Oracle Zero-Downtime Migration, to simplify and accelerate migrating Oracle databases to the cloud."
BlackBerry Reports 1 Million Attacks on Global Financial Sector in 120 Days,2024-03-14T04:01:00.000Z,Low,Negative,"BlackBerry Limited released its Global Threat Intelligence Report, highlighting a surge in novel malware attacks targeting critical industries. The report reveals a 27% increase in new malicious samples per minute compared to the previous period, with 31 attacks prevented every minute.","BlackBerry Reports 1 Million Attacks on Global Financial Sector in 120 Days Rhea-AI Impact (Low) Rhea-AI Sentiment (Negative) Tags Rhea-AI Summary BlackBerry Limited released its Global Threat Intelligence Report, highlighting a surge in novel malware attacks targeting critical industries. The report reveals a 27% increase in new malicious samples per minute compared to the previous period, with 31 attacks prevented every minute. Positive BlackBerry's AI-powered cybersecurity solutions successfully prevented 31 attacks per minute, marking a 19% increase from the previous reporting period. 62% of industry-related attacks focused on critical sectors like government, financial, healthcare, and communications industries. Threat actors are increasingly using novel malware to target high-value data, indicating specific motivations towards particular attack targets. Commercial enterprises, including retail, manufacturing, automotive, and professional services, were targeted by 33% of all threats, with a focus on information-stealing malware. Ransomware gangs are exploiting new Zero Day vulnerabilities, posing a significant threat to vulnerable targets and motivating profiteer groups. The BlackBerry Threat Intelligence team predicts a rise in attacks on critical infrastructure and supply chain cyberattacks in 2024, with an increase in APAC attacks from China and North Korea. Negative None. Cybersecurity Expert The revelation of the increased frequency of novel malware attacks, particularly targeting the financial sector, is a significant concern for cybersecurity professionals. The reported 27 percent increase in new malicious samples per minute intercepted by BlackBerry's AI-powered solutions is indicative of the escalating arms race between threat actors and cybersecurity defenses. The shift towards AI as a tool for both offense and defense in cyber warfare is particularly noteworthy. The implication here is that organizations must continually adapt their cybersecurity strategies, incorporating advanced technologies like AI and machine learning to identify and mitigate threats more effectively. This trend is likely to influence cybersecurity budgets and priorities, with a possible surge in demand for AI-driven security products and services. Financial Analyst For investors, BlackBerry's report underscores the company's pivotal role in a sector that is experiencing exponential growth in threat activity. The increased attack rate of 31 attacks every minute stopped by BlackBerry solutions suggests that their products are critical in combating these threats. This performance could positively influence the company's stock as it demonstrates the effectiveness and necessity of their cybersecurity offerings. However, investors should also consider the broader market implications, as the report indicates a growing risk to critical infrastructure and commercial enterprises. This could lead to increased volatility in the stock prices of companies within these sectors, as they may face higher costs associated with bolstering their cybersecurity defenses. Risk Management Specialist The report's focus on the potential for increased attacks on critical infrastructure and the rapid weaponization of CVEs (Common Vulnerabilities and Exposures) by ransomware gangs highlights a significant risk management challenge. Organizations in the targeted sectors must prioritize identifying and mitigating these vulnerabilities to prevent potentially crippling cyberattacks. This could involve reassessing risk management frameworks and investing in more proactive and predictive security measures. The anticipated rise in supply chain attacks further emphasizes the need for comprehensive risk assessments that extend beyond an organization's immediate network and include third-party vendors and partners. 03/14/2024 - 12:01 AM Continued Increase in Novel Malware Fuels 3.7 Attacks per Minute WATERLOO, ON, March 14, 2024 /PRNewswire/ -- BlackBerry Limited (NYSE: BB; TSX: BB) today released its latest Global Threat Intelligence Report, revealing threat actors focusing efforts on targeting high-value data held by the global financial sector, with one million attacks logged over the 120 day period. This ""death by a million cuts"" is revealed to be using mainly commodity malware, which indicates a large number of independent actors targeting the industry in pursuit of financial gain. Critical infrastructure attacks, including those targeting government, financial, healthcare and communications industries, altogether accounted for 62 percent of industry-related attacks over the report period, September to December 2023. The BlackBerry Threat Research and Intelligence team registered a 27 percent uptick in novel malware to 3.7 new malicious samples per minute prevented by its AI-powered cybersecurity solutions, compared to 2.9 per minute in the previous reporting period. Overall, BlackBerry cybersecurity solutions stopped 31 attacks every minute, a 19 percent increase on the last reporting period. ""We're consistently seeing increased volumes of attack in highly lucrative industries using novel malware,"" said Ismael Valenzuela, Vice President of Threat Research and Intelligence at BlackBerry. ""Novel malware typically indicates specific motivations from threat actors towards particular attack targets with intent to evade defenses, which are often based on static signatures. We've reached a pivotal point where traditional detection methods alone are not enough to combat this increasingly complex problem. AI is already being weaponized by malicious entities, so it must equally be the dominant tool for detection and defense."" Highlights from the latest BlackBerry Global Threat Intelligence Report include: 62 percent of industry-related attacks targeted critical industries: Digitization and the prospect of debilitating national infrastructure attracted notorious gangs and Malware-as-a-Service (MaaS) groups who attempt to exploit security misconfigurations and vulnerabilities for varying motives.Commercial enterprises also under attack: 33 percent of all threats targeted commercial enterprises (including retail, manufacturing, automotive and professional services), with the majority (53 percent) of those deploying information-stealing (Infostealer) malware with the aim of accessing highly sensitive data.Rapid weaponization of CVEs by Threat Actors: Ransomware gangs observed taking advantage of new Zero Day vulnerabilities and mass mobilizing against potentially vulnerable targets, with zero-day exploits motivating profiteer groups.Based on its data analysis, the BlackBerry Threat Intelligence and Research team predicts that 2024 will bring an increase in attacks targeting critical infrastructure and other profitable segments. VPN appliances will likely remain desirable targets for nation-state-level threat actors and it is anticipated that there will be a continued increase in supply chain cyberattacks targeting hardware and software vulnerabilities. Further, APAC will likely see an increase in attacks from China and North Korea, particularly financially-motivated attacks. Download a copy of BlackBerry's Global Threat Intelligence Report at BlackBerry.com, and register to attend our Global Threat Intelligence Report Deep Dive webinar on March 26 to discover more. About BlackBerryBlackBerry (NYSE: BB; TSX: BB) provides intelligent security software and services to enterprises and governments around the world. The company's software powers over 235M vehicles. Based in Waterloo, Ontario, the company leverages AI and machine learning to deliver innovative solutions in the areas of cybersecurity, safety, and data privacy solutions, and is a leader in the areas of endpoint management, endpoint security, encryption, and embedded systems. BlackBerry's vision is clear - to secure a connected future you can trust. For more information, visit BlackBerry.com and follow @BlackBerry. Trademarks, including but not limited to BLACKBERRY and EMBLEM Design, are the trademarks or registered trademarks of BlackBerry Limited, and the exclusive rights to such trademarks are expressly reserved. All other trademarks are the property of their respective owners. BlackBerry is not responsible for any third-party products or services. Media Contacts:BlackBerry Media Relations+1 (519) 597-7273mediarelations@BlackBerry.com View original content to download multimedia:https://www.prnewswire.com/news-releases/blackberry-reports-1-million-attacks-on-global-financial-sector-in-120-days-302087432.html SOURCE BlackBerry Limited How many attacks were prevented every minute by BlackBerry's cybersecurity solutions? BlackBerry's cybersecurity solutions prevented 31 attacks every minute, marking a 19% increase from the previous reporting period. What percentage of industry-related attacks targeted critical industries? 62% of industry-related attacks focused on critical sectors like government, financial, healthcare, and communications industries. What type of malware was predominantly used in attacks on commercial enterprises? Commercial enterprises were targeted by information-stealing (Infostealer) malware, with a majority of 53% deploying this type of malware. What are threat actors increasingly using to target high-value data? Threat actors are increasingly using novel malware to target high-value data, indicating specific motivations towards particular attack targets. What are ransomware gangs exploiting according to the report? Ransomware gangs are exploiting new Zero Day vulnerabilities, posing a significant threat to vulnerable targets and motivating profiteer groups."
ICL Files 2023 Annual Report on Form 20-F,2024-03-14T07:04:00.000Z,Neutral,Negative,"ICL files its annual report on Form 20-F for the fiscal year 2023, emphasizing climate-related financial disclosures and carbon footprint reduction efforts.","ICL Files 2023 Annual Report on Form 20-F Rhea-AI Impact (Neutral) Rhea-AI Sentiment (Negative) Tags Rhea-AI Summary ICL files its annual report on Form 20-F for the fiscal year 2023, emphasizing climate-related financial disclosures and carbon footprint reduction efforts. Positive None. Negative None. 03/14/2024 - 03:04 AM TEL AVIV, Israel--(BUSINESS WIRE)-- ICL (NYSE: ICL) (TASE: ICL), a leading global specialty minerals company, today announced the filing of its annual report on Form 20-F for the fiscal year ended December 31, 2023, with the U.S. Securities and Exchange Commission (SEC). Included, for the third year in a row, are Task Force on Climate-related Financial Disclosures (TCFD), which provide information on what ICL is doing to mitigate the risks of climate change and reduce its carbon footprint. The 2023 annual report can be accessed by visiting either the SECs website at www.sec.gov or the companys website at www.icl-group.com. In addition, shareholders may receive a hard copy of the companys complete audited financial statements free of charge, by requesting a copy from Investor Relations. About ICL ICL Group is a leading global specialty minerals company, which creates impactful solutions for humanity's sustainability challenges in the food, agriculture and industrial markets. ICL leverages its unique bromine, potash and phosphate resources, its global professional workforce, and its sustainability focused R&D and technological innovation capabilities, to drive the company's growth across its end markets. ICL shares are dual listed on the New York Stock Exchange and the Tel Aviv Stock Exchange (NYSE and TASE: ICL). The company employs more than 12,500 people worldwide, and its 2023 revenues totaled approximately $7.5 billion. For more information, visit ICL's website at icl-group.com. To access ICL's interactive CSR report, visit icl-group-sustainability.com. You can also learn more about ICL on Facebook, LinkedIn, YouTube, Twitter and Instagram. Forward Looking Statements This announcement contains statements that constitute forward-looking statements, many of which can be identified by the use of forward-looking words such as anticipate, believe, could, expect, should, plan, intend, estimate and potential, among others. Forward-looking statements appear in this press release and include, but are not limited to, statements regarding the companys intent, belief or current expectations. Forward-looking statements are based on managements beliefs and assumptions and on information currently available to management. Such statements are subject to risks and uncertainties, and actual results may differ materially from those expressed or implied in the forward-looking statements due to various factors, including, but not limited to: estimates, forecasts and statements as to management's expectations with respect to, among other things, business and financial prospects, financial multiples and accretion estimates, future trends, plans, strategies, positioning, objectives and expectations, general economic, market and business conditions, supply chain and logistics disruptions, energy storage and electric vehicle growth, the potential for new COVID-19 variants, global unrest and conflict, governmental and regulatory requirements and actions by governmental authorities, including changes in government policy, changes in environmental, tax and other laws or regulations and the interpretation thereof, and war or acts of terror and/or political, economic and military instability in Israel and its region, including the current state of war declared in Israel and any resulting disruptions to our supply and production chains. As a result of the foregoing, readers should not place undue reliance on the forward-looking statements contained in this press release concerning the timing of the transaction, or other more specific risks and uncertainties facing ICL, such as those set forth in the Risk Factors section of its Annual Report on Form 20-F filed on March 14, 2024, as such risk factors may be updated from time to time in its Current Reports on Form 6-K and other filings ICL makes with the U.S. Securities and Exchange Commission from time to time. Forward-looking statements refer only to the date they are made, and the company does not undertake any obligation to update them in light of new information or future developments or to publicly release any revisions to these statements in order to reflect later events or circumstances or to reflect the occurrence of unanticipated events. View source version on businesswire.com: https://www.businesswire.com/news/home/20240313773921/en/ Investor and Press Contact  Global Peggy Reilly Tharp VP, Global Investor Relations +1-314-983-7665 Peggy.ReillyTharp@icl-group.com Investor and Press Contact - Israel Adi Bajayo ICL Spokesperson +972-3-6844459 Adi.Bajayo@icl-group.com Source: ICL Group LTD What form did ICL file for the fiscal year ended December 31, 2023? ICL filed its annual report on Form 20-F. What does the Task Force on Climate-related Financial Disclosures (TCFD) provide in the annual report? TCFD provides information on ICL's actions to mitigate climate change risks and reduce its carbon footprint. Where can shareholders access the 2023 annual report? Shareholders can access the report on the SEC's website or ICL's website. How can shareholders obtain a hard copy of ICL's complete audited financial statements? Shareholders can request a free copy from Investor Relations."
Shell publishes Energy Transition Strategy 2024,2024-03-14T07:10:00.000Z,Neutral,Neutral,Shell announces Energy Transition Strategy 2024 with ambitious emission reduction targets and significant investments in low-carbon energy solutions.,"Shell publishes Energy Transition Strategy 2024 Rhea-AI Impact (Neutral) Rhea-AI Sentiment (Neutral) Tags Rhea-AI Summary Shell announces Energy Transition Strategy 2024 with ambitious emission reduction targets and significant investments in low-carbon energy solutions. Positive None. Negative None. Energy Market Analyst Shell's commitment to halving emissions from its operations by 2030 and the subsequent investment in low-carbon energy solutions is a strategic pivot that aligns with global decarbonization trends. The energy sector is under increasing pressure to transition to sustainable practices and Shell's update indicates a significant shift in capital allocation towards cleaner energy. This transition not only responds to regulatory pressures but also to a growing consumer demand for sustainable energy sources. The investment of $10-15 billion earmarked for low-carbon solutions over the next few years is poised to position Shell as a leader in the energy transition, potentially creating new revenue streams and mitigating long-term risks associated with fossil fuels.Furthermore, the reduction in net carbon intensity of energy products sold by Shell suggests an improvement in operational efficiency and a portfolio shift towards less carbon-intensive products. This could lead to a competitive advantage as carbon pricing mechanisms become more prevalent, potentially increasing operating costs for less proactive competitors. However, the transition also involves risks, such as the potential for stranded assets and the challenge of maintaining profitability while investing in emerging technologies with uncertain returns. Environmental Policy Expert Shell's energy transition strategy is indicative of the broader industry movement towards meeting the goals of the Paris Agreement, particularly the ambition to limit global warming to 1.5C. The company's focus on reducing Scope 3 emissionsthose produced by customers using its productsis particularly noteworthy, as these emissions typically represent the largest share of an oil and gas company's carbon footprint. By setting a target to reduce customer emissions by 15-20% by 2030, Shell is acknowledging its responsibility in addressing downstream emissions and is likely to influence consumer behavior and choices towards low-carbon alternatives.The strategy also reflects an understanding of the need for a 'balanced and orderly transition' to ensure energy security and affordability. This approach is crucial to avoid potential negative social and economic impacts, such as energy shortages or price spikes. However, the success of this strategy will depend on the company's ability to effectively implement new technologies and to navigate the complex regulatory environments that govern energy markets globally. Sustainability Investment Analyst From an investment perspective, Shell's update on its energy transition strategy can be seen as a proactive measure to future-proof its business model against the backdrop of a changing energy landscape. By diversifying its portfolio and investing in low-carbon technologies, Shell is not only reducing its environmental impact but also potentially enhancing its appeal to sustainability-focused investors. This could lead to improved access to capital and possibly a re-rating of the company's stock as it transitions from a traditional oil and gas company to an integrated energy provider.It is important to monitor Shell's progress towards these targets, as well as the company's ability to balance shareholder returns with the significant capital expenditures required for this transition. Investors will be looking for evidence of Shell's commitment to these goals, such as the development of renewable energy projects, carbon capture initiatives and partnerships in the electric mobility sector. The company's performance in these areas will be a key indicator of its long-term viability and success in a low-carbon economy. 03/14/2024 - 03:10 AM Shell publishes Energy Transition Strategy 2024 Shell will continue its drive to halve emissions from its operations (Scope 1 and 2) by 2030, compared with 2016 on a net basis. By the end of 2023, Shell had achieved more than 60% of this target. Shell also reduced the net carbon intensity of the energy products it sells by 6.3% compared with 2016, the third consecutive year it hit its target.To help drive the decarbonisation of the transport sector, Shell has set a new ambition to reduce customer emissions from the use of its oil products by 15-20% by 2030 compared with 2021 (Scope 3, Category 11). [A]Shell confirms it will invest $10-15 billion between 2023 and the end of 2025 in low-carbon energy solutions, making Shell a significant investor in the energy transition. London, 14 March 2024  Shell plc (Shell) has published its first energy transition update since the launch of its Powering Progress strategy in 2021. At our Capital Markets Day in June 2023, we outlined how our strategy delivers more value with less emissions, emphasising the more value part. In this energy transition update, we are focusing on how the same strategy delivers less emissions. Our target to achieve net-zero emissions by 2050 across all our operations and energy products is transforming our business. We believe this target supports the more ambitious goal of the Paris Agreement to limit global warming to 1.5C above pre-industrial levels. Shells strategy supports a balanced and orderly transition away from fossil fuels to low-carbon energy solutions to maintain secure and affordable energy supplies. Energy has made an incredible contribution to human development, allowing many people around the world to live more prosperous lives. Today, the world must meet growing demand for energy while tackling the urgent challenge of climate change. I am encouraged by the rapid progress in the energy transition in recent years in many countries and technologies, which reinforces my deep conviction in the direction of our strategy, said Wael Sawan, Shells Chief Executive Officer. Shell has a very important role to play in providing the energy the world needs today, and in helping to build the low-carbon energy system of the future. Our focus on performance, discipline and simplification is driving clear choices about where we can have the greatest impact through the energy transition and create the most value for our investors and customers. We believe this focus makes it more, not less, likely that we will achieve our climate targets. By providing the different kinds of energy the world needs, we believe we are the investment case and the partner of choice through the energy transition, said Sawan. Our energy transition plans cover all our businesses. Liquefied natural gas (LNG) is a critical fuel in the energy transition, and we are growing our world-leading LNG business with lower carbon intensity. We are cutting emissions from oil and gas production while keeping oil production stable, and growing sales of low-carbon energy solutions while gradually reducing sales of oil products such as petrol, diesel and jet fuel. As one of the worlds largest energy traders, we can connect the supply of low-carbon energy to demand, as we have done for many years with oil and gas. We have made good progress against our climate targets: By the end of 2023, we had achieved more than 60% of our target to halve emissions from our operations by 2030, compared with 2016. This goes above and beyond the targets set by signatories to the Oil and Gas Decarbonization Charter agreed at COP28.We continue to be an industry leader in reducing methane emissions. We were one of the first companies to set a target to achieve near-zero methane emissions by 2030. In 2023, we achieved 0.05% methane emissions intensity  significantly below our target of 0.2%. And in 2023 we also contributed to the World Banks Global Flaring and Methane Reduction Fund  further supporting industry-wide action to drive down methane emissions and flaring. In 2023, we achieved our target to reduce the net carbon intensity of the energy products we sell, with a 6.3% reduction compared with 2016  the third consecutive year we hit our target. As Shell transforms into a net-zero emissions energy business, we aim to take the lead in the energy transition where we have competitive strengths, see strong customer demand, and identify clear regulatory support from governments. To help drive the decarbonisation of the transport sector, we have set a new ambition to reduce customer emissions from the use of our oil products by 15-20% by 2030 compared with 2021 (Scope 3, Category 11).[A] Our focus on where we can add the most value has led to a strategic shift in our integrated power business. We plan to build our power business, including renewable power, in places including Australia, Europe, India and the USA, and have withdrawn from the supply of energy directly to homes in Europe. In line with this shift to prioritising value over volume in power, we will focus on select markets and segments. This includes selling more power to commercial customers, and less to retail customers. Given this focus on value, we expect lower total growth of power sales to 2030, which has led to an update to our net carbon intensity target. We are now targeting a 15-20% reduction by 2030 in the net carbon intensity of the energy products we sell, compared with 2016, against our previous target of 20%. We will continue to transparently report our progress against our targets and ambitions every year. Driving towards a net-zero future We are investing $10-15 billion between 2023 and the end of 2025 in low-carbon energy solutions, making us a significant investor in the energy transition. And in 2023, we invested $5.6 billion on low-carbon solutions, more than 23% of our total capital spending. These investments include electric vehicle charging, biofuels, renewable power, hydrogen and carbon capture and storage. Our investments in new technologies are helping to reduce emissions for Shell and our customers. We aim to help scale new technologies to make them an affordable choice for our customers and are focusing our advocacy on key areas which we believe are critical to the energy transition: policies that support national net-zero ambitions including carbon pricing, supplying the secure energy the world needs, driving changes in demand and growing low-carbon solutions. [A] Customer emissions from the use of our oil products (Scope 3, Category 11) were 517 million tonnes carbon dioxide equivalent (CO2e) in 2023 and 569 million tonnes CO2e in 2021. ENDS Notes to Editors For full details of updates to our climate targets, ambitions and performance please read the full report, online here: www.shell.com/ets2024pdf Shareholders will have an advisory vote on the Energy Transition Strategy at Shells 2024 AGM. Shells net carbon intensity is the average intensity, weighted by sales volume, of the energy products sold by Shell. It is tracked, measured and reported using our Net Carbon Footprint (NCF) methodology. We have set a new ambition to reduce customer emissions from the use of our oil products by 15-20% by 2030 compared with 2021 (Scope 3, Category 11). That is more than 40% compared with 2016 reported emissions. Customer emissions from the use of our oil products (Scope 3, Category 11) were 517 million tonnes carbon dioxide equivalent (CO2e) in 2023, 569 million tonnes CO2e in 2021 and 819 million tonnes CO2e in 2016. Of the 40% reduction by 2030, around 8 percentage points are related to volumes associated with additional contracts being classified as held for trading purposes, impacting reported volumes from 2020 onwards.Reducing the net carbon intensity of the products we sell requires action by both Shell (Scope 1 and 2 emissions) and our customers (Scope 3 emissions). While we can encourage the uptake of low-carbon products and solutions, we cannot control the final choices customers make. Support from governments and policymakers is essential to create the right conditions for changes in demand. In 2023, we invested $5.6 billion in low-carbon energy solutions, more than 23% of our total capital spending. This includes the acquisition of Nature Energy, which makes Shell one of the largest producers of renewable natural gas in Europe. And our ongoing investment in Sprng Energy, one of Indias leading renewable power platforms, demonstrates our determination to invest in growing renewable capacity in areas that play to our strengths and add most value. We are also pioneering efforts to scale up low-carbon solutions, such as by starting construction in late 2022 of Holland Hydrogen 1 in Rotterdam, which is anticipated to become one of the largest renewable hydrogen plants in Europe. Find out more about Shells 2023 Capital Markets Day online : www.shell.com/ets2024pdf EnquiriesUK / International Media Relations: +44 20 7934 5550 Shell plc  Energy Transition Strategy Chair's message This energy transition update marks an important moment for Shell. It comes three years after we launched our Powering Progress strategy, and builds on our Capital Markets Day in June 2023 when we set out our plans to create more value with less emissions. Our target to become a net-zero emissions energy business by 2050 remains at the heart of our strategy and is transforming our operations and energy products. We believe this target supports the more ambitious goal of the Paris Agreement, to limit the rise in the global average temperature to 1.5C above pre-industrial levels. As we work towards net zero, we are reducing emissions from our operations and energy products while becoming an increasingly successful organisation. Our energy transition plans cover all our businesses: Integrated Gas, Upstream and Downstream, Renewables and Energy Solutions. In this publication, we set out pathways to net zero for our two biggest customer sectors  transport and industry  based on where we believe we have the competitive advantages to provide our customers with the products they need through the transition. Helping reduce emissions for our customersWe want to lead in the decarbonisation of transport using the strength of our brand, deep customer relationships and global reach. We aim to grow our public charging network for electric vehicles, and remain one of the worlds largest blenders and distributors of biofuels [A]. As the energy transition progresses, we expect to sell more low-carbon products and solutions, and less oil products including petrol and diesel. To measure our progress, we have set a new ambition to reduce customer emissions from the use of our oil products by 15-20% by 2030 compared with 2021 (Scope 3, Category 11) [B]. Includes volumes from our joint venture RazenCustomer emissions from the use of our oil products (Scope 3, Category 11) were 517 million tonnes carbon dioxide equivalent (CO2e) in 2023 and 569 million tonnes CO2e in 2021. The world needs a balanced and orderly transition away from fossil fuels to maintain secure energy supplies, while accelerating the transition to affordable low-carbon solutions. We are growing our world-leading liquefied natural gas (LNG) business so that we can continue to provide a critical fuel in the energy transition. Our investments in carbon capture and storage, hydrogen and renewable energy will help us produce LNG with lower carbon intensity in the future. Through our world-class trading business, we can connect the supply of low-carbon energy to demand, as we have done for many years with oil, gas and LNG. As we work towards net zero, we are making clear choices about where we can add most value for our investors and customers. We expect renewable power will be critical for helping our commercial customers decarbonise, and plan to build our integrated power business in places including Australia, Europe, India and the USA. We have withdrawn from the supply of energy directly to homes in Europe because we do not believe we have a competitive position there. Technologies of the futureWe are increasing our investments in research and development, and investing in the fuels of the future. We aim to scale up new technologies to create affordable options for our customers into the 2030s. We are building Holland Hydrogen 1, one of the largest renewable hydrogen plants in Europe, close to our Energy and Chemicals Park Rotterdam in the Netherlands. We are also investing in carbon capture and storage technology to reduce emissions from our own operations such as refineries and LNG plants, and, in the longer term, to help our industrial customers reduce their emissions too. I saw first-hand the potential of some of the exciting new technologies we are developing when I visited Oman in January 2024. We are part of a group exploring a project to produce green ammonia and liquefied synthetic gas from renewable hydrogen. These technologies are still in the early stages, but they could help to decarbonise industry and commercial road transport in the future. More value with less emissionsAt our Capital Markets Day, we said we would deliver more value with less emissions. We have made good progress in our first year under our new Chief Executive Officer Wael Sawan. In 2023, we returned 42% of our cash flow from operations to our shareholders, the upper end of our 30-40% range through the cycle. We also reduced carbon emissions from our operations by 31% compared with 2016 levels, putting us well on the way towards our target of a 50% reduction by 2030 on a net basis. We achieved our short-term target to reduce the net carbon intensity of the energy products we sell, with a 6.3% reduction against our target of 6-8% compared with 2016. Transparency and shareholder supportIn 2021, 89% of our shareholders voted in support of our Energy Transition Strategy. Since then, we have published two progress reports, which our shareholders have also supported. Along with other Board members, I met with many of Shell's largest institutional shareholders following those votes. I appreciate their time and feedback and look forward to our next engagement in April 2024. The publication of our Energy Transition Strategy brings increased transparency, and better dialogue with our institutional investors. We heard that following Capital Markets Day, for example, some wanted us to be clearer about how we will deliver both more value and less emissions, and we are showing exactly that in this update. This year, we are again asking our shareholders to vote at our Annual General Meeting on our Energy Transition Strategy. As before, this vote is purely advisory, and not binding for our shareholders. The legal responsibility for approving or objecting to Shell's strategy lies with the Board and Executive Committee. We believe our strategy will transform Shell into a net-zero emissions energy business, creating value for our shareholders, customers and wider society. We will offer shareholders an advisory vote at the 2024 Annual General Meeting based on the energy transition plans described in this publication and our Annual Report and Accounts 2023. The Board recommends that shareholders vote in favour of the Resolution asking them to support those plans. Sir Andrew Mackenzie Chair Chief Executive Officer's introduction This is our first update to the Energy Transition Strategy that we published in 2021. It is an opportunity to take stock of our progress, to reflect on what we have learned, and to look forward as we transform Shell into a net-zero emissions energy business by 2050. Over the past three years we have seen the critical importance of secure and affordable energy for economies and people's lives. As the world's population grows by an estimated 2 billion people by 2050, and the benefits of energy are extended to the hundreds of millions who do not have it today, demand for energy will only grow. At the same time, the world must achieve an orderly transition away from fossil fuels to low-carbon energy to achieve net-zero emissions. Today, fossil fuels meet around 80% of global energy demand, with an even greater reliance in many developing countries. We support a balanced energy transition, one that maintains secure and affordable energy supplies as the world moves to net zero. I am encouraged by the rapid progress in the energy transition in many countries and technologies in recent years, including the continued growth in demand for liquefied natural gas (LNG), a critical fuel in the energy transition, and for low-carbon energy solutions such as solar and wind power, and electric vehicles. This progress reinforces my deep conviction in the direction of our strategy. Shell has an important role to play in providing the energy the world needs today, and in helping to build the low-carbon energy system of the future. There are exciting opportunities to use the strength of our innovation capabilities in the areas where we can have the greatest impact. Our purpose  to provide more and cleaner energy solutions  sets the direction for everything we do. Progress towards our targetsSince we launched our Powering Progress strategy, we have made good progress against our climate targets, and learned where we have competitive strengths. By the end of 2023, we had achieved more than 60% of our target to halve emissions from our operations by 2030, compared with 2016. We achieved this by adapting our portfolio, including by repurposing refineries, and making changes to our operations such as powering some oil and gas platforms with renewable energy. We continue to be one of the leaders in reducing emissions of methane, a potent greenhouse gas that can be released during oil, gas and LNG production. We were one of the first companies to set a target to achieve near-zero methane emissions by 2030. In 2023, we continued to keep our methane emissions intensity well below 0.2%. We made good progress towards our target to eliminate routine flaring from our upstream operations, compared with 2016 [A]. We also met our short-term target to reduce the net carbon intensity of the energy products we sell, with a 6.3% reduction against our target of 6-8% compared with 2016. More value, less emissionsAt our Capital Markets Day in June 2023, we outlined how our Powering Progress strategy delivers more value with less emissions, emphasising the ""more value"" part of our strategy. In this energy transition update, we are focusing on how the same strategy delivers ""less emissions"". Our energy transition plans cover all our businesses. In Integrated Gas, we are growing our world-leading LNG business with lower carbon intensity. In Upstream, we are reducing emissions from oil and gas production. In Downstream and Renewables and Energy Solutions, we are growing sales of low-carbon products and solutions such as biofuels, electric vehicle charging and renewable power, while investing in hydrogen and other fuels of the future. Our focus on performance, discipline and simplification is driving clear choices about where we can create the most value for our investors and customers through the energy transition. Our ability to raise and invest capital depends on delivering strong returns to shareholders, shaping the role that Shell can play on the journey to net zero. We believe this focus makes it more, not less, likely that we will achieve our climate targets and ambitions. Reducing emissions from productionWe believe the world will continue to need oil and gas for many years -- produced with much lower emissions -- alongside cleaner energy such as advanced biofuels, renewable power and hydrogen. We expect LNG will play a critical role in the transition. It continues to provide a secure supply of energy in many European countries. It also offers flexibility to electricity grids as wind and solar power grow, and opportunities to lower carbon emissions from industries such as cement and steel by replacing coal. In the future, by powering our LNG plants with renewable electricity, and adding carbon capture and storage, we aim to lower the carbon intensity of our LNG plants. Our LNG joint venture in Canada (Shell interest 40%), for example, the largest private-sector investment in the country's history, will use natural gas and renewable electricity to reduce emissions from the plant by more than one-third compared with the worlds best performing facilities. The Vito platform in the Gulf of Mexico (Shell interest 63.1%) is reducing emissions from oil and gas production. The platform started production in 2023 and is expected to produce around 80% less carbon dioxide emissions over its operating life, compared with the original design. We are using the same concept for two more platforms in the Gulf of Mexico, Whale (Shell interest 60%) and Sparta (Shell interest 51%). Supporting our customers as they decarboniseWe aim to lead in the energy transition where we have competitive strengths, see strong customer demand, and identify clear regulatory support from governments. The transport sector is a good example. We are building on our customer relationships and expertise to help drive the decarbonisation of passenger cars, heavy-duty trucks, planes and ships. We aim to grow our public charging network for electric vehicles, and stay a leader in biofuels including sustainable aviation fuels or renewable diesel made from waste. By repurposing our remaining integrated refineries to focus on four regional energy and chemicals parks, we are creating the low-carbon production hubs of the future. As we grow sales of low-carbon fuels we expect to reduce sales of oil products such as petrol and diesel. We have set a new ambition to measure our progress, to reduce customer emissions from the use of our oil products by 15-20% by 2030 compared with 2021 (Scope 3, Category 11) [B]. Our ambition is in line with the European Union's climate goals for transport, which are among the most progressive in the world. Our focus on value has led to a strategic shift in our power business towards select markets and segments. One example is selling more power to commercial customers, including renewable power, and less to retail customers. As a result, we expect lower growth in sales of power overall. We have updated our net carbon intensity target to reflect that change, with a 15-20% reduction by 2030, compared with 2016, against 20% previously. Towards net zeroIn total, we invested $5.6 billion in low-carbon solutions in 2023, which was 23% of our capital spending. We are spending $10-15 billion on low-carbon solutions between 2023 and 2025, making us a significant investor in the energy transition. With our focused approach, we believe our investments will have an important impact, allowing us to develop low-carbon solutions at increasingly affordable prices for our customers. Shell will provide the different kinds of energy the world needs. We will invest in producing LNG with lower carbon intensity, in reducing emissions from oil and gas production, and in providing cleaner energy solutions. As we transform Shell into a net-zero emissions energy business, we believe we are the investment case and the partner of choice through the energy transition. Wael SawanChief Executive Officer Subject to the completion of the sale of Shell Petroleum Development Company of Nigeria Limited (SPDCCustomer emissions from the use of our oil products (Scope 3, Category 11) were 517 million tonnes carbon dioxide equivalent (CO2e) in 2023 and 569 million tonnes CO2e in 2021. Our Energy Transition Strategy 2024 Our key beliefs have informed our strategy, enabled our progress, and will allow us to deliver on our updated targets and ambitions. 1 Today, the world must meet growing demand for energy while tackling the urgent challenge of climate change. There needs to be a balanced and orderly transition away from fossil fuels to low-carbon energy solutions to maintain secure and affordable energy supplies. 2 Our target to achieve net-zero emissions by 2050 across all our operations and energy products is transforming our business. We believe this target supports the more ambitious goal of the Paris Agreement, to limit the rise in the global average temperature to 1.5C above pre-industrial levels. 3 At our Capital Markets Day in June 2023, we outlined how our Powering Progress strategy delivers more value with less emissions, emphasising the ""more value"" part of our strategy. In our Energy Transition Strategy 2024, we are focusing on how the same strategy delivers ""less emissions"". 4 By the end of 2023, we had achieved more than 60% of our target to halve Scope 1 and 2 emissions from our operations by 2030, compared with 2016, and reduced our total methane emissions by 70%. 5 We believe liquefied natural gas (LNG) will play a critical role in the energy transition, replacing coal in heavy industry. It also has a continued role in displacing coal in power generation, helping to reduce local air pollution and carbon emissions. LNG helps to provide the flexibility the power system needs, at a time when renewable generation is growing rapidly. 6 Investment in oil and gas will be needed because demand for oil and gas is expected to drop at a slower rate than the natural decline rate of the worlds oil and gas fields, which is 4-5% a year. 7 We expect rapid growth in electric vehicles, including electric trucks, and believe biofuels and natural gas will also play a role in reducing emissions from heavy-duty transport. To help drive the decarbonisation of transport, we have set a new ambition to reduce customer emissions from the use of our oil products by 15-20% by 2030 compared with 2021 (Scope 3, Category 11).That is more than 40% compared with 2016 reported emissions. [A] Customer emissions from the use of our oil products (Scope 3, Category 11) were 517 million tonnes carbon dioxide equivalent (CO2e) in 2023, 569 million tonnes CO2e in 2021 and 819 million tonnes CO2e in 2016. Of the 40% reduction by 2030, around 8 percentage points are related to volumes associated with additional contracts being classified as held for trading purposes, impacting reported volumes from 2020 onwards. 8 We believe carbon abatement technologies such as carbon capture and storage will be needed for the world to reach net-zero emissions. We believe once key regulations, technologies and standards are in place, a large-scale business for carbon credits will emerge. 9 Our focus on performance, discipline and simplification is driving clear choices about where we can create the most value for our investors and customers. We believe renewable energy will be an essential part of a net-zero world. In line with our strategic shift to prioritise value over volume in power, we are concentrating on select markets and segments. As a result, we expect lower growth of power sales overall. We are now targeting a 15-20% reduction in the net carbon intensity of the energy products we sell by 2030, compared with 2016, against 20% previously. 10 We are investing $10-15 billion in low-carbon energy solutions between 2023 and the end of 2025, making us a significant investor in the energy transition. By providing the different kinds of energy the world needs, we believe we are the investment case and the partner of choice through the energy transition. Our journey towards net zero 2023 Invested $5.6 billion in low-carbon solutions, of our total capital spending of $24.4 billion in 2023. This included the acquisition of Nature Energy, one of the largest producers of renewable natural gas in Europe.Our Timi platform in Malaysia, mainly powered by solar and wind energy, started production. The Vito platform in the US Gulf of Mexico also started production, with 80% less CO2 emissions expected over its lifetime compared with the original design.The Hollandse Kust Noord wind park off the coast of the Netherlands became operational.Shells management team hosted its first Capital Markets Day in New York and set out Shells strategy to deliver more value with less emissions.Achieved our target to reduce the net carbon intensity of the energy products we sell by 6-8% by the end of 2023 compared with 2016.Reduced our operational emissions (Scope 1 and 2) by 31% by the end of 2023 compared with 2016, more than halfway towards our target to reduce them by 50% by 2030 on a net basis.Won majority shareholder support (80% of votes) for our energy transition progress at our Annual General Meeting. 2022 Completed the acquisition of renewable power company Sprng Energy, and took a final investment decision on Holland Hydrogen 1 and LNG expansion projects in Qatar.Introduced three new metrics in the annual bonus scorecard to reflect Shells role in the energy transition. Simplified our share structure, allowing us to manage our portfolio with greater agility through the energy transition. 2021 Completed the divestment of our Permian assets in the USA and bought solar company Savion in the USA.Offered shareholders an advisory vote on our energy transition strategy. The strategy was overwhelmingly supported. Introduced target to become a net-zero emissions energy business by 2050, and a target to halve Scope 1 and 2 under our operational control by 2030 on a net basis (2016 reference year). 2020 Announced ambition to become a net-zero emissions energy business by 2050. Extended the energy transition performance metric to around 16,500 employees through the Performance Share Plan (PSP). 2019Published our first Industry Associations Climate Review, which reviewed alignment between Shells climate-related policy positions and 19 key industry associations. 2018Signed a joint statement with Climate Action 100+ investor group announcing steps taken by Shell demonstrated alignment with the goals of the Paris Agreement. 2017Announced ambition to reduce the carbon intensity of the energy products we sell by around half by 2050 (Scope 1, 2 and 3). Our updated targets and ambitions Net-zero emissions by 2050 (Scopes 1, 2 and 3) Emissions from our own operations (Scope 1 and 2) TargetHalving Scope 1 and 2 emissions by 2030 [A] under operational control (2016 reference year) TargetEliminating routine flaring from Upstream operations by 2025 [B] TargetMaintain methane emissions intensity below 0.2% and achieve near-zero methane emissions by 2030 Emissions from the products we sell (Scope 3) TargetUpdated Net carbon intensity (NCI) Introducing a range of 15-20% for our target to reduce NCI by 2030 (2016 reference year) AmbitionNew Oil products ambition Reduce customer emissions from the use of our oil products by 15-20% by 2030, Scope 3 Category 11 [C] (2021 reference year) On a net basis.Subject to completion of the sale of SPDC.Customer emissions from the use of our oil products (Scope 3, Category 11) were 517 million tonnes carbon dioxide equivalent (CO2e) in 2023 and 569 million tonnes CO2e in 2021. Carbon performance at a glance Reducing Scope 1 and 2 emissions under our operational control Scope 1 and 2 operational emissions [A]Million tonnes CO2e 2016 [B] 2021 2022 2023 2030 2050 83 68 58 57 41 0 50% target reduction by 2030 2023: More than 60% of our 2030 target Methane emissions intensity [A] [E]% 2016 2021 2022 2023 Assets with marketed gas [F] 0.1 0.06 0.05 0.05 Assets without marketed gas [g] 0.03 0.01 0.01 0.001 Total routine flaring [A] [H] Million tonnes of hydrocarbons flared 2016 2021 2022 2023 1.1 0.2 0.1 0.1 Reducing emissions associated with our customers use of energy products Net carbon intensity (NCI) [C]g CO2e/MJ [C] 2016 [B] 2021 2022 2023 2024 2025 2030 2050 79 -2.5% -3.8% -6.3% -9-12% -9-13% -15-20% -100% 2021, 2022, 2023: NCI target achieved for third year in a row [D] Customer emissions from the use of our oil products (Scope 3, Category 11) [I]million tonnes CO2e 2021 [B] 2023 2030 569 -9% -15-20% We believe our total absolute emissions peaked in 2018 at 1.73 gigatonnes of carbon dioxide equivalent (GtCO2e). Operational control boundary. Scope 1 and 2 target is on a net basis.Reference year.Shell's NCI is the average intensity, weighted by sales volume, of the energy products sold by Shell. Estimated total greenhouse gas (GHG) emissions included in NCI correspond to well-to-wheel emissions associated with energy products sold by Shell, on an equity boundary, net of carbon credits. This includes the well-to-tank emissions associated with the manufacturing of energy products by others that are sold by Shell. Emissions associated with the manufacturing and use of non-energy products are excluded.2021 target 2-3%, 2022 target 3-4%, 2023 target 6-8%, all achieved. Acknowledging uncertainty in the pace of change in the energy transition, we have also chosen to retire our 2035 target of a 45% reduction in net carbon intensity.Our target is to maintain methane emissions intensity below 0.2% and achieve near-zero methane emissions by 2030.Methane emissions intensity from all oil and gas assets for which Shell is the operator that market their gas (including LNG and GTL assets), defined as the total volume of methane emissions in normal cubic meter (Nm3) per total volume of gas available for sale in Nm3.Methane emissions intensity from all oil and gas assets for which Shell is the operator that do not market their gas (e.g. where gas is reinjected) defined as the total mass of methane emissions in tonnes per total mass of oil and condensate available for sale in tonnes.Our target is to eliminate routine gas flaring from upstream operations by 2025, subject to the completion of the sale of SPDC.We have set a new ambition to reduce absolute emissions related to the use of our oil products by 15-20% by 2030, compared with 2021 (Scope 3 Category 11). Customer emissions from the use of our oil products (Scope 3, Category 11) were 517 million tonnes carbon dioxide equivalent (CO2e) in 2023 and 569 million tonnes CO2e in 2021. The energy system: our beliefs Today, fossil fuels meet around 80% of the world's primary energy use. There is even greater reliance in many developing countries where security of supply and stable prices are critical to their development. The world's primary energy demand is just over 300 million barrels of oil equivalent per day (mboe/d); with around 250 mboe/d from fossil fuels. Of this, 100 mboe/d is from oil, 80 mboe/d is from coal and 70 mboe/d is from gas. As demand for energy continues to grow, driven by rising populations and increased prosperity, the world must transition from fossil fuels to low-carbon energy in a balanced way to achieve net-zero emissions. The transition to net zero will not be linear, as different countries take different approaches and move at different paces. Public policy, developments in technology and infrastructure, and a functioning carbon market are essential to create the demand signals for the private sector to invest at scale. This will require collaboration between policymakers, customers and private organisations like Shell that have the financial strength, experience and capabilities to help build the new energy system. Developing our beliefs We have developed our beliefs through our engagements with customers, policymakers, scientists and thought leaders from around the world. We have used research from our technology programmes, along with work carried out by the International Energy Agency, the Intergovernmental Panel on Climate Change and several other external bodies. We have also drawn from the expertise in our own energy security scenarios, Sky 2050 and Archipelagos, which we published last year. Although our scenarios are not expressions of our strategy and are not our business plans, they help inform our beliefs. Our scenarios are quantified by our World Energy Models, which are supplemented with climate analysis done in conjunction with Massachusetts Institute of Technology. We will continue to challenge our own beliefs as technology, policy and customer preferences evolve. Increasing demandSince 2000, annual air mileage has tripled, passenger road mileage has doubled, and production of steel has more than doubled. We expect continued growth in the transport and industrial sectors, driven by rising populations and higher living standards in emerging and developing countries, where more than a quarter of the world's population still lack basic energy provisions. Oil demand has grown from 57 million barrels a day (mb/d) to almost 100 mb/d in the last 40 years, with occasional annual declines in recessions, and the notable decline caused by the Covid pandemic. In all cases, demand has rebounded. However, we believe growth in oil demand is set to slow in the second half of this decade, and could start falling in the 2030s because of increasing vehicle efficiency and growth in electric vehicles. Population, GDP, demand and consumption of energy 2000-2040 2000-2040 Population x1.5 GDP x3.4 Aviation (passenger km) x5.3 Passenger road (vehicle km) x3.1 Marine (tonne km) x2.2 Heavy industry (tonne steel equivalent) x2.6 Source: Shell analysis and IEA's Extended energy balances 2023). Demand for natural gas has also seen steady growth over the last 40 years, adding an average of about 60 billion cubic metres (bcm) of new demand a year. Demand for liquefied natural gas (LNG) has grown much faster, from about 30 million tonnes per annum (mtpa) in 1983 to more than 400 mtpa in 2023. Today, LNG makes up around 13% of the global gas market, a figure expected to exceed 20% by 2040. The global LNG market will continue growing at least through the 2030s, mostly driven by industrial decarbonisation in China, and strengthening demand in other Asian countries. LNG can help displace the use of coal in industry and power generation, and can top up supply in regions of declining domestic gas production such as Europe. The prospects for LNG demand are increasingly independent of pipeline natural gas because the fuel can be transported at short notice, and can also be used as a substitute for higher-carbon liquid fuels in shipping. Global demand for coal rose by 3.6% from 2013 to the end of 2023, when it reached a new high. This increase was fuelled by strong demand in developing economies. Coal demand increased by 35% in India and by 13% in China during this10-year period, due to rising demand for electricity and weak hydropower output. We believe replacing coal with natural gas, LNG and renewable power will be a key factor in reducing emissions. Primary energy demand by region and energy source, 2023 (exajoule) Middle East China Other Asia Pacific Americas India Rest of World Europe Oil 43% 19% 34% 37% 23% 30% 34% Natural Gas 55% 8% 20% 32% 5% 32% 22% Coal 1% 58% 25% 8% 45% 14% 11% Nuclear & electric renewables [A] 1% 11% 11% 15% 5% 7% 20% Bioenergy [B] 0% 4% 10% 8% 21% 17% 12% [A] Electric renewables are dominated hydroelectricity, wind, and solar. Some of these sources are also used to generate heat instead of electricity.[B] Electric renewables include hydroelectricity, solar and wind.Source: Shell analysis of IEA Extended Energy Balances (2023). Energy investment Significant investment will be required to keep supplying oil and gas while low-carbon alternatives are developed and made commercially available. This continued investment is needed because demand for oil and gas is expected to drop at a slower rate than the natural decline of the world's oil and gas fields, which is at 4% to 5% a year. Worldwide oil and gas production, outside North America, has been at around 120 mboe/d from 2013 until the end of 2023, despite cumulative oil and gas investment of more than $2 trillion over the same period. Current global investment in low- and zero-carbon energy is around $1.7 trillion a year. To reach net zero by 2050, scenarios suggest that $3-4 trillion of commercially viable investment in low-carbon energy is required each year. Final energy demand by sector and energy carrier, 2023 (exajoule) Marine Non-energy use Aviation commercial road Passenger road Heavy industry Light industry [C] Buildings Liquids (fossil) [A] 99% 52% 97% 91% 3% 18% 4% Solids (fossil) [A] 0% 7% 0% 0% 0% 29% 9% 3% Gaseous (fossil) [A] 0% 40% 0% 3% 4% 30% 21% 29% Electricity 0% 0% 0% 0% 1% 26% 38% 34% Heat 0% 0% 0% 0% 0% 6% 3% 6% Bioenergy [B] 1% 1% 3% 4% 4% 5% 10% 24% [A] Gaseous is mostly natural gas; Solids is mostly coal; Liquids is mostly oil. However, crossovers exist, such as LPG (gaseous oil product) and CTL (liquified coal).[B] Bioenergy includes traditional and modern uses of biomass, biofuels and biogas.[C] Includes rail, less than 5% of this category.Source: Shell analysis and IEAs Extended energy balances (2023). Global greenhouse gas emissions in 2023Carbon dioxide (CO2) emissions from the energy system amounted to almost three-quarters of global greenhouse gas emissions in 2023. Tighter government policies will help to reduce carbon emissions at a rate consistent with the temperature goals of the Paris Agreement. Even without these policies, we expect that the global demand for fossil fuels would fall from today's level of around 80% to below 70% by 2040. If the world follows a path to net-zero emissions by 2050, the figure could go down to 50%. This will be driven by electrification and the scaling-up of renewable energy generation. Estimated net global greenhouse gas emissions, 2023 % Heavy industry [A] 20 Light industry [B] 14 Passenger road transport 7 Freight road transport 4 Aviation 2 Marine 1 Buildings [C] 17 Other greenhouse gases [D] 28 Land-use change [E] 7 [A] Includes emissions from industrial processes, 18% of total.[B] Includes rail, 3.5% of total.[C] Emissions for operation of buildings - not construction (which is in industry sectors).[D] 70% methane, from agriculture and fossil production and use; 23% nitrous oxide; 7% others.[E] land use, land-use change emissions and forestry (LULUCF).Source: Shell analysis and IEAs Extended energy balances (2023). Industry Industry makes up 44% of the world's final energy use, with oil, gas and coal meeting almost 64% of this demand. Today, industry also uses substantial amounts of power generated by fossil fuels. The sector includes heavy industry, light industries such as manufacturing, mining and agriculture, and non-energy use feedstocks in chemicals. Heavy industryHeavy industry includes the energy-intensive production of steel and cement, which use high-temperature processes that can be hard and expensive to electrify. This sector represents 17% of final energy use, mainly in the form of coal, gas and electricity. Higher standards of living are built on the output of heavy industry. For example, the in-use stock per capita of steel in OECD countries ranges from 10-15 tonnes per person (t/p) compared with a world average of around 4 t/p [A]. Since 2000, OECD countries have seen a modest decline in energy demand as industrial output has plateaued. Innon-OECD countries, demand has nearly tripled, driven by industrialisation. Much of this increase in demand comes from China, which currently produces around half the world's steel and cement. The use of coal in heavy industry has fuelled much of the industrial growth in non-OECD countries over the last two decades, while OECD countries use far less coal and proportionally more gas and power. In non-OECD countries, gas and electricity have increased their market share against coal, and we expect this trend to continue. We believe natural gas and LNG will play an important role in replacing coal in high-temperature heavy industry applications. They can help address both local air emissions and wider climate considerations. More plentiful and affordable renewable electricity will also play a role in decarbonising this sector. Once electrification has taken place, gas will have a back-up role because many industrial processes require a high reliability of power supply. We also see potential for hydrogen in the long-term when it becomes cost competitive. Light industryLight industry constitutes around 17% of final energy use. Its energy requirements vary from fuel for heavy equipment to medium-level heat and electricity for manufacturing facilities. The energy mix for light industry includes coal, oil, gas, electricity and some commercial biomass. Many areas of light industry have already switched to electrification. We see this trend continuing with more action needed to increase efficiency. Supportive government policies are also needed to decarbonise the sector. Non-energy useNon-energy use is dominated by petroleum feedstocks and natural gas, and some coal in Asia. It represents about 10%of final energy use, but there are limited emissions as the feedstocks are transformed into material goods such as lubricants, plastics and fertilisers. Many of these products indirectly help reduce emissions when used in insulation in buildings or in plastics which reduce the weight of vehicles. We believe bio-feedstocks and recycling will grow in importance in this sector. Source: International Energy Agency. Iron and Steel Technology Roadmap reserved. Energy consumption in heavy industry (Exajoule/year) OECD Non-OECD 2000 2023 2000 2023 Solid (fossil) 13.12 11.96 38.04 32.34 Electricity from coal [A], [B] 11.24 6 10.09 17.85 Electricity from other [A] 12.62 16.54 7.99 10.44 Electricity from natural gas [A] 5.23 9.4 8.8 7.48 Gaseous (fossil) 38.45 40.5 21.83 26.31 Other [C] 19.35 15.61 13.25 5.59 [A] Includes heat.[B] Consists of nuclear, renewables and oil.[C] Includes liquid fossil fuels and bioenergy.Source: Shell analysis of IEA's Extended Energy Balances (2023). Transport sector The transport sector represents nearly 30% of final energy use, with oil products meeting more than 90% of this demand. The remainder is mostly met by LNG, compressed natural gas and biofuels. Global CO2 emissions from transport amount to around 8 gigatonnes (GT) a year, which is about one-seventh of global emissions. Oil products dominate transport because of their high energy density, convenience and cost competitiveness. In some markets, such as Europe and the USA, alternative transport fuels like ethanol are mandated. In Europe, where road transport fuel taxes are high, electric vehicles are increasingly cost competitive. However, in marine and aviation alternatives remain expensive. Bio-alternatives are at least twice the cost of oil products, and synthetic fuels manufactured from hydrogen can be up to eight times more expensive. Relative cost of transportation fuels, 2023 USD/boe Low Blank Tax Delta Aviation E-Kerosene 610 244 Biojet fuel [B] 214 92 Jet Fuel [B] 107 31 Marine E-ammonia 366 183 Bio-LNG [B] 183 153 Bunker fuel [B] 61 49 Commercial road transport [A] Biodiesel [B] 0 130 212 122 Electricity [C] 166 166 Diesel [B] 0 111 110 54 Passenger road transport [A] Electricity [C] 195 195 Gasoline [B] 0 101 238 54 [A] Noth-west European retail prices.[B] Beyond production costs, taxes significantly increase the price customers pay for biodiesel, diesel and gasoline.[C] Electric costs (0.2-0.6$kWh) adjusted for 2.4x higher efficiency of electric versus international combustion engine vehicles. Range shown is home/deport charging to highway fast charging.Source: Shell Scenario team interpretations of 2023 market data when Brent crude oil prices averaged $83/barrel Passenger road transportToday, there are around 1.3 billion cars on the road, consuming around 25 million barrels of oil per day (mb/d), which is a quarter of the world's oil production. Biofuels such as ethanol are used in some markets but currently amount to less than 5% of demand. We expect a rapid growth in electric vehicles, including plug-in hybrids. Today there are around 40 million such vehicles on the roads, with up to 275 million expected by 2030. The availability of charging points will be critical for the growth in electric vehicles. The share of electric cars in new car sales has increased from less than 3% in 2018 to 18% in 2023. The most rapid growth is in China, the world's largest car market, followed by Europe and the USA. In China, there are a wide range of vehicles for sale at under $40,000, while in other markets electric vehicles generally sell at above this price before government subsidies are applied. Commercial road transportCommercial road transport, which includes 70 million trucks, uses 16 mb/d. We believe the shift of commercial road transport towards low-carbon solutions is less than a decade behind that of passenger cars. We expect that biofuels and renewable natural gas will keep playing a role in reducing emissions from trucks. In the long term, we expect electricity or hydrogen to become the main paths to decarbonisation, depending on advances in technology, government policy and customer preferences. AviationDemand for aviation fuel has rebounded from its Covid lows and is now at about 7 mb/d. Sustainable aviation fuel (SAF) made from used cooking oils and other feedstocks is seen as a credible alternative to jet fuel. Today, SAF represents less than 0.1% of total demand, but we expect its market share to grow with support from governments. Around 11 markets have SAF targets, including Europe and Singapore. Some 25 airlines representing a combined 35% of global aviation emissions also have SAF targets. Government mandates are essential to increase demand for SAF because it costs consumers between two and four times more than conventional aviation fuel. There is limited evidence that passengers will voluntarily pay a premium to cover the extra cost. In the long term, advances in technology may create opportunities to use synthetic fuels such as e-kerosene, but further research and development is required. ShippingShipping represents about 6 mb/d of oil demand. About 5% of shipping gross tonnage in operation today is fuelled by LNG, which can reduce emissions by up to 23% compared with conventional fuels. Of the new ships on order, about 25% of gross tonnage is being designed for LNG. A significant number of the ships in operation today already have dual fuel capabilities, giving them the flexibility to run on alternatives. We believe demand for LNG in shipping will grow, including for liquefied biomethane. Fuels such as methanol and ammonia could be options for shipping in the long term, but we see challenges with both of them. Buildings Residential and commercial buildings represent just under 30% of final energy use. This energy is used to heat the buildings and power electrical devices, and around two-thirds of it comes from low-carbon sources. The global building stock has become about 75% more efficient in the last 40 years due to improved building standards, better insulation, and more efficient appliances. Electrification has helped to decarbonise this sector and we see this continuing, with an increased use of electric heat pumps and cookers, reducing demand for natural gas in homes. Supportive policies will be key to continuing this trend. Information technology services, including data centres, artificial intelligence and cryptocurrencies, are a rapidly growing part of the building sector. We believe global electricity demand in this area could double from 2023 to 2026. Power Power is the most rapidly decarbonising part of the energy system. More than 40% of electricity is now generated from renewables and nuclear. There has been rapid growth in wind and solar generation in the last 10 years, expanding from 3.5% of total power generation in 2013 to nearly 18% in 2023. Around 22% of final energy use was electrified by the end of 2023, up from around 18% in 2010. We think this trend is accelerating, aided by the adoption of electric vehicles and heat pumps. Electrification of final energy use could reach 30-40% by 2040. We expect that wind and solar will continue to dominate power generation growth as governments rightly support their scale-up, which will also require significant expansion of national electricity grids. We see natural gas having a continued role in displacing coal in power generation, which helps reduce local air pollution and carbon emissions. Natural gas also helps provide the flexibility the power system needs, at a time when renewables are growing rapidly, and its role is especially crucial in managing seasonal fluctuations in supply and demand. Carbon abatement We believe carbon abatement will be an important tool to reach net-zero emissions. Once key regulations and standards are in place, a large-scale business for carbon credits could emerge. Carbon credits may be used to compensate for emissions in line with the mitigation hierarchy of avoid, reduce and compensate. The cost of carbon abatement can be split into three tranches. Abatement for less than $100 a tonne of CO2 includes efficiency measures in industry and buildings, changes in agriculture, forestry and other land use practices, and some switching from coal to gas or renewables in power generation. The middle tranche of abatement costs between $100 a tonne and $200 a tonne and includes the use of carbon capture and storage (CCS) in power generation and industry. The highest abatement costs are at more than $200 a tonne. These include parts of the transport and industry sectors, and directly capturing carbon from the atmosphere. Carbon removals are likely to become an important way to limit the long-term temperature rise. Both of Shell's energy security scenarios envisage the need for multi-billion tonne a year carbon removals, which will need to be financed by emitters purchasing carbon credits. Demand for carbon credits in the voluntary carbon market is expected to grow significantly. CCS also has the potential to make a meaningful reduction in CO2 emissions. While there are only around 50 million tonnes per annum (mpta) of CCS in operation today, there are around 300 mtpa of projects under consideration [A]. Many net-zero scenarios show the industry growing to more than 1,000 mtpa by the mid-2030s. Global CCS Institute, 2023. The Global Status of CCS: 2023. Australia Shell's strategy to 2030 Our strategy transforms Shell into a net-zero emissions business by 2050 by delivering more value with less emissions. It supports our purpose to provide more and cleaner energy solutions Our beliefs inform our strategy. While the energy transition will move at different paces in different countries, we expect global growth in demand for oil will slow this decade, and is likely to start declining in the following decade. We also expect global demand for LNG will continue to grow at least through the 2030s. We believe the world needs a balanced energy transition, one that maintains secure energy supplies, while accelerating the transition to affordable low-carbon solutions. Our strategy supports a balanced transition by providing the oil and gas people need today, while helping to build the energy system of the future. As we implement our strategy, we are becoming a multi-energy business offering our customers more and cleaner energy solutions. We are reducing emissions from our operations, and helping our customers move to cost-competitive and cleaner energy. Our energy transition plans cover all our businesses: Integrated Gas - Growing our world-leading LNG business with lower carbon intensity.Upstream - Cutting emissions from oil and gas production while keeping oil production stable.Downstream, Renewables and Energy Solutions  Transforming our businesses to offer more low-carbon solutions while reducing sales of oil products. Delivering more value less emissions CFFO NZE Grow leading LNG position ~70% Leading Integrated Gas ~25% Achieve near-zero methane emissions Keep oil production flat ensuring cash flow longevity Advantaged Upstream Eliminate routine flaring High-grade portfolio ~30% Differentiated Downstream, Renewables and Energy Solutions ~75% Decarbonise our operations Apply value over volume Reduce oil product sales Pursue selective growth Grow low-carbon offerings Help customers decarbonise Decarbonise our operations Trading and optimisation capabilities [A] Net absolute emissions cover the Scope 1, 2 and 3 emissions from our energy products; these are calculated by product and allocated to businesses based on final point of sales, so emissions associated with upstream production are largely included under downstream as point of sale. Today, around 70% of our cash flow comes from our Integrated Gas and Upstream businesses, with the remaining 30% generated by our Downstream, Renewables and Energy Solutions businesses. The opposite is true for emissions. Around 75% of Shell's recorded emissions come from our Downstream, Renewables and Energy Solutions businesses, with the vast majority generated when our customers use our products. The remaining emissions are generated within Integrated Gas and Upstream, with a large proportion also coming from when our customers use our products. Across all our businesses, more than 90% of our emissions are reported as Scope 3. Shell will reduce emissions over time as our product mix evolves to meet changing customer demand. We will continue to produce LNG and oil with less emissions, while the mix of our sales will move more towards low-carbon solutions such as biofuels, renewable energy and hydrogen, and away from oil products such as petrol, diesel and jet fuel into the 2030s. Estimated share of energy sales 2016-2030 [A] 2016 2023 2030 Oil products [B] 57% 48% 39% LNG 14% 22% 26% Pipeline gas 25% 21% 21% Electricity 3% 7% 11% Biofuels 1% 2% 3% [A] Share of energy products sold, aggregated on energy basis (lower heating value) in final energy equivalents.[B] Oil products includes gas-to-liquids (GTL). Leading Integrated Gas Growing our world-leading LNG business with lower carbon intensity We plan to grow our LNG business by 20-30% by 2030 compared with 2022. We are developing new projects with lower carbon intensity by using renewable power and carbon abatement technology in the form of carbon capture and storage. Beyond our own production, we will continue to add scale and flexibility to our portfolio by buying LNG from others. Our LNG business will remain a key priority for Shell, meeting continued strong demand especially in Asia where we send most of our shipments today. As we grow our LNG business we will be targeting opportunities which have an internal rate of return of 11% or higher. Market outlook of LNG demand by region Million tonnes per annum 2022 2040 China 64 127 Japan, South Korea and Taiwan 139 113 South East Asia 19 116 South Asia 31 123 Europe 121 119 Rest of work 11 39 Middle East and North Arica 7 14 391 651 Source: Shell internal analysis LNG in the energy transitionLNG provides both energy security and flexibility because it can be easily transported to places where it is needed most. It continued to play a vital role in providing energy security in Europe in 2023. LNG is also a critical fuel in the energy transition. It is the lowest-carbon fossil fuel, producing around 50% less carbon emissions than coal when used to generate electricity, according to the International Energy Agency. Compared with coal, LNG emits far lower amounts of sulphur dioxide, nitrogen oxide and other compounds that contribute to local air pollution. Air pollution from gas-fired power plants versus coal-fired power plants coal emissions natural gas emissions Sulphur dioxide 0.67 0.01 nitrogen dioxide 0.7 0.02 particulate matter 0.09 0 Source: US Department of Energy National Enerfy Technology Laboratory 2015 There are many opportunities for industries to cut carbon emissions by switching from coal to natural gas and LNG. Coal accounts for more than 60% of the energy used across Asia to power heavy industries such as steel. External analysis forecasts renewables, supported by gas, will reduce coal's role in South Asia Coal Gas Nuclear Renewables Hydro Other % coal share % gas share 2022 217.7562 51.90026 10.05807 94.57961 57.00562 23.39897 0.660437 0.078663 2030 274.95 56.33033 26.056 246.7605 77.28263 29.93112 0.593944 0.054019 2035 298.448 60.00566 60.00566 394.2921 98.74457 35.70659 0.498706 0.047734 2040 317.593 75.56766 62.288 563.4911 100.1202 36.49179 0.394158 0.053103 Source; Shell interpretation of Wood Mackenzie data. LNG is the lowest-carbon marine fuel available at scale today and offers significant greenhouse gas (GHG) emissions reductions compared with conventional fuels. LNG also offers a long-term decarbonisation pathway through bio-LNG when the supply is scaled up. Shell has developed the world's largest LNG fuelling network of ports and bunker vessels on key trading routes, enabling more customers to choose LNG. To deliver the full GHG benefits of LNG, methane emissions must be minimised. We are working with partners, industry and universities to develop and implement technologies that reduce methane emissions associated with the use of LNG. Reducing methane emissionsMethane emissions from natural gas and LNG contribute to global warming. Methane is a potent GHG and reducing emissions of methane is considered one of the most effective near-term actions to keep the more ambitious 1.5C goal of the Paris Agreement within reach. As we grow our LNG business, we continue to make the reduction of methane emissions a priority. We were one of the first companies to set a target to achieve near-zero methane emissions by 2030 across all our operations. Through our more efficient new plants, and projects to reduce methane emissions from existing assets and our shipping fleet, we aim to deliver LNG with some of the lowest methane emissions in our industry. We are working with others to increase transparency on methane emissions, improve accuracy of reporting and drive reductions in methane emissions across our industry. We have been enhancing the accuracy of our reported emissions through the implementation of the United Nations Environment Programme (UNEP) Oil and Gas Methane Partnership (OGMP) 2.0 reporting framework in our operated and non-operated assets. In 2023, Shell received UNEP's recognition for being on track to achieve OGMP 2.0's gold standard of reporting in its operated assets by the end of 2023 and non-operated assets by 2025. This would be the third consecutive year that Shell has achieved this highest standard. Working with others Shell is a signatory of the Oil and Gas Decarbonisation Charter launched at COP28, which focuses on driving down Scope 1 and 2, flaring and methane emissions. We led the development of the Methane Guiding Principles Coalition which brings together industry and civil society to drive reductions in methane emissions from the natural gas supply chain. Signatories of the Methane Guiding Principles are engaging with governments and industry in 20 countries to inform policies and regulations and disseminate best practice. Shell is a contributor to the OGMP 2.0 Methane Reporting Framework which is the only measurement -based international framework for methane emissions in the oil and gas sector. We are also a member of the Oil & Gas Climate Initiative which has launched the Aiming for Zero Methane Emissions by 2030 initiative. Role of LNG in the energy transition Supporting renewable energy: Using LNG for power generation offers flexibility and the ability to quickly ramp up or down. LNG will be essential for maintaining grid stability as the share of renewables increases. Reducing air pollution: Gas-fired power generation can help significantly reduce air pollution when compared to the emissions released by coal-fired plants. Industrial and high-temperature applications: Gas and LNG are important for sectors where electrification is challenging, such as high-temperature industrial processes. They provide the necessary energy intensity and reliability that renewables currently cannot match, helping industries like cement and steel on their decarbonisation journeys. Market view of India gas demand by sector Billion cubic metres Industry Transport Power Residential and Commercial 2023 50 7 7 1 2030 70 16 7 3 2040 91 25 10 6 Source: Shell interpretation of Kpler, S&P Global Commodity Insights and FGE data, Wood Mackenzie and FGW data. Energy security: While displacement of coal by renewables is expected to be dominant in the power sector, gas and LNG will also have an important role. They will continue to provide the flexibility electricity grids will need, and energy security in the coming decades in developed countries. Climate policy and emissions trading: In regions with stringent climate policies and emissions trading systems, such as the European Union, gas and LNG can help meet emissions targets by replacing more carbon-intensive fuels. Lower-carbon fuel for transport: In some of the slower-to-abate transport sectors, such as long-distance commercial road transport and marine, LNG can help with their decarbonisation journeys. It is a solution that is both available and more affordable today when compared with other low-carbon products, and reduces emissions when compared with oil-based products. Gas displacement of coal in US power generation is helping to drive CO2 emissions lower 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 Coal TWh 1,986 1,756 1,847 1,733 1,514 1,581 1,582 1,352 1,239 1,206 1,149 965 773 898 832 Natural Gas TWh 883 921 988 1,014 1,226 1,125 1,127 1,335 1,379 1,298 1,472 1,589 1,627 1,579 1,687 Solar & Wind TWh 56 75 96 122 145 177 199 216 263 308 336 368 427 493 578 CO2 Emissions Mtpa 2,484 2,270 2,389 2,287 2,157 2,174 2,168 2,031 1,928 1,850 1,872 1,725 1,554 1,652 1,650 Source: US Energy Information Administration. Advantaged Upstream Cutting emissions from oil and gas production while keeping oil production stable We continue to focus on more value and less emissions, and expect that our oil production will remain stable through to 2030. The oil we are producing will increasingly come from our world-class deep-water business. Through innovative designs, our deep-water platforms are producing higher-margin and lower-carbon barrels. Maintaining oil production this decadeOur oil production peaked in 2019, and by the end of 2023 had fallen by around 20%. We believe that continued investment will be needed to maintain oil supplies as existing fields naturally decline faster than reductions in demand. To keep production of crude oil and natural gas liquids stable to 2030 at 1.4 million barrels per day, we are focusing exploration on our existing positions and basins where hydrocarbons have been discovered already. This includes our high-margin deep-water positions. Across our upstream portfolio we are targeting an internal rate of return of 15% or higher. We do not anticipate any new frontier exploration entries after 2025 [A]. From the beginning of 2023 until the end of 2025, we will have started projects with a total peak production of more than 500,000 barrels of oil equivalent a day. Around 40% of these projects are in deep water. They include the US Gulf of Mexico, where we are the leading operator and have one of the lowest GHG intensities in the world for oil production. As we continue to meet the world's demand, we will build on the strengths of our current portfolio to continue to deliver lower-carbon barrels with higher margins. A frontier entry refers to Shell participating in new exploration activities (seismic activities, exploratory drilling) outside countries where hydrocarbons have been discovered already (by Shell or other companies). More value: Shell deep-water unit CFFO exluding working capital compared with peers 2019 2020 2021 2022 Shell deep water 31.5 15.7 37.5 57.9 Peer Range Higher 21.6 12.2 25.9 39.3 Peer Range Lower 17.6 8.7 17.5 36.4 Less emissions: intensity of Shell deepwater assets compared to peers [B] Emissions 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 Shell deep water 15.1 14.9 13.1 13.5 14 14 13.9 12.7 12.8 12.7 12.5 12.8 13 13.6 Top 10% 13.2 12.4 13.1 13.5 13.2 11 12.4 12 11.1 10 9.4 10.4 10 10.1 Average Emissions 23.8 23.5 24.1 21.8 20.2 19.5 18.9 17.8 17.6 16.4 15.9 15.7 15 15 Bottom 10% 37.9 39.4 39.7 39 38.5 38.1 37.7 39.1 39.6 41.1 40.6 40.9 40.7 41.1 [A] Peer range comprises BP, TotalEnergies, ExxonMobil, Chevron and represents all Integrated Gas and Upstream related activities. based on external reporting and Shell internal analysis including peer working capital assumptions.[B] Shell internal analysis of Woodmac Lens data. Shell deep water includes both deep-water and ultra-deep-water positions. Peers are the majors, large- and mid-cap companies and represent all Integrated Gas and Upstream related activities. Decarbonising our operationsAs a responsible energy producer, we are implementing carbon management plans and reducing carbon emissions from our assets. We are looking at ways to electrify our offshore oil facilities, and using wind and solar power to reduce operational emissions. We see carbon capture and storage (CCS) as a core technology to further capture emissions from our facilities, reusing our own depleted oil and gas fields where possible. We are working towards our target to eliminate routine flaring from our upstream operations by 2025, five years ahead of the World Bank's initiative [A]. Routine flaring burns gas that is not used or reinjected into wells, which is inefficient and contributes to climate change. Subject to completion of the sale of SPDC Demonstrating progress on eliminating routine flaring million tonnes of hydrocarbons flared (reduction 91%) 2016 1.1 2021 0.2 2022 0.1 2023 0.1 Differentiated Downstream, Renewables and Energy Solutions Transforming our businesses to offer morelow-carbon solutions while reducing salesof oil products We are reshaping our Downstream, Renewables and Energy Solutions businesses with a more focused geographic portfolio of products to deliver more value with less emissions. We aim to lead in the energy transition in areas where we have competitive strengths, see strong customer demand, and identify clear regulatory support from governments. We are starting from a place of strength. Our global customer reach, and our supply and trading capabilities in low-carbon products, mean we are well placed to profitably deliver the low-carbon solutions people and businesses need. We are also able to identify changes in demand for products so that we can respond quickly. In the transport sector, for example, we see attractive growth opportunities in charging for electric vehicles and in biofuels for cars, trucks, planes and ships. We are strengthening these businesses to support our customers as they decarbonise and move from oil products to lower-carbon alternatives. As the energy transition evolves, we expect that growth in demand for oil products for transport will slow, and then decline. We are transforming our refinery portfolio and targeting value over volume in our marketing business. As a result, we will sell less oil products and more low-carbon products. Our strategy is to: Repurpose our remaining integrated refineries to focus on four regional energy and chemicals parks, providing cleaner molecules such as biofuels and hydrogen to help our customers decarbonise.Transform our marketing business by gradually reducing exposure to oil products used for transport, while changing our product mix by investing in areas such as electric vehicle charging, biofuels, and integrated power.Use technology and innovation to develop the business models and fuels of the future. The strength of our trading capabilities, coupled with our own production, will help us deliver affordable and low-carbon solutionsfor our customers. Focused on developing low-carbon solutions for today, tomorrow and the future Delivery today: Repurposing energy and chemical parks, Mobility and lubricant offeringsBuilding for tomorrow (2025+): Electric vehicle charging, low-carbon fuelsPreparing for the future (2030+): Hydrogen, Carbon removal and storageSupported and enabled by Integrated Power, trading and optimisation Delivering today Today, we are repurposing our remaining integrated refineries to focus on four regional energy and chemicals parks, which we are transforming into the low-carbon hubs of the future. As part of this process, we have completed the strategic review of our Energy and Chemicals Park Singapore with divestment as our preferred option. We are also high-grading our European energy and chemicals parks. This means retiring certain units and continuing with some divestments we have already announced. We are looking to strengthen our global retail and lubricants marketing businesses as the energy transition evolves, meeting the changing needs of our customers, and making value-driven choices region by region. That means growing our portfolio of low-carbon fuels and charging for electric vehicles in markets that meet our investment criteria such as China, Europe and the USA, and reducing our presence in others. As an example, we have signed an agreement to sell our shareholding in Shell Pakistan. Oil for lubricants and chemicals Most of the oil products sold by Shell are used in the transport sector. We estimate that 15-20% of the total oil products we sell are used for non-energy products such as lubricants and chemical products. Chemicals are used in many parts of modern life, from cosmetics to household goods. Lubricants are needed for virtually every machine and engine in operation. As these products are not combusted, their use does not cause Scope 3, Category 11 emissions. In 2023, Shell invested $2.3 billion in producing non-energy products including lubricants, chemicals, convenience retailing, agriculture and forestry, construction and road. We are upgrading our retail network, with expanded electric vehicle charging and convenience offers, in response to changing customer needs. In total, we plan to divest around 500 Shell-owned sites (including joint ventures) a year in 2024 and 2025. We are growing our premium lubricants portfolio to supply key energy transition sectors such as transformer oils used for offshore wind parks, and cooling fluids to support the development of electric vehicle car batteries. Supply, logistics and trading play a crucial role in ensuring we meet our customers' needs and generate strong returns. Our world-leading trading and optimisation business generates additional value by connecting supply and demand, for both conventional and low-carbon fuels across our global businesses. We will continue to grow our trading business in low-carbon molecules, carbon credits and power as the energy transition accelerates. Building for tomorrow (2025+) To build the businesses of tomorrow, we continue to strengthen our offer of low-carbon solutions where we see a significant increase in customer demand and supportive government policies. Between now and 2030, we are focusing on three areas where we have the potential to positively impact the energy transition by reducing the cost for our customers  electric vehicle charging, biofuels and integrated power. Electric vehicle charging We are growing our electric vehicle charging business to support customers who choose to change from a petrol or diesel vehicle to an electric one. We are focusing on offering our customers choices where we see increasing demand, such as in the fast-growing electric mobility markets of China and Europe. We aim to increase the number of public charge points we operate to around 200,000 by 2030, from around 54,000 today. Scaling our network of public EV charging points Thousands 2020 2021 2022 2023 2025 2030 Other 0.5 0.002 0.022 0.021 ~70 ~200 Asia 0.5 0.068 0.27 1.002 China 0 1.964 17.55 32.576 Europe 0 5.021 8.937 16.579 Americas 0 0.044 0.07 3.605 We are focusing on public charging, rather than home charging, because we believe it will be needed most by our customers. We have a major competitive advantage in terms of locations, as our global network of service stations is one of the largest in the world. We have other competitive advantages, such as our convenience retail offering which allows us to offer our customers coffee, food and other convenience items as they charge their cars. As we grow our business offering charging for electric vehicles, we expect an internal rate of return of 12% or higher. Biofuels We are expanding our world-leading biofuels business to meet growing customer demand and where we can use the strength of our supply and trading positions. Aviation and shipping remain some of the slower-to-decarbonise sectors and will require low-carbon molecular solutions such as biofuels and synthetic hydrogen-based fuels at scale in the future. Shell is already one of the world's largest energy traders and blenders of biofuels selling significantly more low-carbon fuels than we produce. We expect to continue to grow both our own production and sales of biofuels in the coming years. We are focusing on producing premium biofuels such as sustainable aviation fuel, renewable diesel and renewable natural gas (RNG). These fuels will help to reduce emissions in commercial road transport. To support our production of biofuels, we are investing in new feedstocks through investments and partnerships while using the strength of our trading business to expand sales beyond our production volumes. Through our Razen joint venture in Brazil we are already the largest producer of second-generation ethanol and the leading sugar-cane ethanol producer globally. To support growing demand for biofuels this decade, we are developing more second-generation technologies. We are also developing technologies and feedstocks that aim to allow continued and sustainable growth in biofuels while minimising impacts on the environment and food supplies. Following the 2023 acquisition of Nature Energy, one of the largest producers of RNG in Europe, we have a strong position in RNG. We are actively looking for more opportunities to meet emerging demand for RNG, especially in north-west Europe. We expect to generate an internal rate of return of more than 12% from our new investments in low-carbon fuels. Integrated power We will continue to grow our integrated power business with selective investments in renewable power generation. We will also use the strength of our trading and optimisation capabilities to meet the growing need for flexible power storage solutions such as batteries. We already have a significant presence in battery and storage through both our ventures programme and investments in research and development. We are making disciplined choices to create value from our power portfolio, stepping back from activities that do not fit our strategy or that do not generate enough returns. We have exited renewable projects in Ireland and France, and sold our home energy businesses in the UK and Germany. We are focusing on selling power, including renewable power, to business customers. We are also using renewable power to decarbonise our own operations. Over time, we will also use our renewable power capacity to produce low-carbon molecules such as hydrogen. We expect returns from power generation to be in line with the market, at around 6-8% ungeared, with opportunities to create higher returns from areas such as trading and optimisation. Flexible power generation capacity demand is projected to grow significantly 2025 2030 2035 2040 2045 2050 Gas 2.1 2.2 2.4 2.6 2.9 3.4 Hydrogen 0 0.1 0.3 0.5 0.7 1 Batteries 0.2 0.4 0.5 0.8 1.1 1.7 Other 0.4 0.3 0.3 0.4 0.4 0.5 [A] Gas includes both open-cycle and combined-cycle gas turbine power generation.Source: McKinsey Energy Solutions Global Energy Perspective 2023. Preparing for the future (2030+) This decade, we are also focusing on developing integrated energy hubs, select carbon capture and removal businesses, such as CCS, and fuels of the future, such as hydrogen, to prepare to meet our customers' needs after 2030. We plan to create integrated energy hubs around our energy and chemicals parks in North America and north-west Europe, and other locations where we see significant potential for high growth in demand in the future. These include Australia, Brazil, China and India. We will be focusing our investments in these hubs as we integrate our businesses and trading capabilities to deliver affordable low-cost solutions to our customers. We are researching the development of fuels such as liquefied synthetic gas (LSG), which is produced when renewable hydrogen is combined with captured carbon dioxide (CO2) to create natural gas, which is then liquefied. This low-carbon gas can be directly used in existing gas networks and infrastructure, including LNG plants. Carbon capture and removal We are developing technologies related to carbon capture and storage (CCS) and carbon removals, which are necessary to reduce emissions where there are few low-carbon alternatives. For the rest of this decade, we will direct most of our investments in CCS towards decarbonising our own operations. We are also looking to turn this into a profitable business for Shell by helping other companies decarbonise their operations in the future. However, in many countries CCS still lacks a clear business model. To address this challenge, Shell advocates policy mechanisms to enable CCS, and supports industry partnerships dedicated to the growth of commercially viable CCS projects. Direct air capture (DAC) technology can also play a key role in the energy transition. We are aiming to make it more affordable and scalable through several pilot projects. DAC extracts CO2 from the air to provide a carbon feedstock for synthetic products, or when coupled with transport and storage, to enable it to be stored underground. In combination with carbon capture and removal technologies, a functioning global carbon market will be a critical enabler of an accelerated energy transition. We are actively participating in carbon markets, and building and managing a diverse portfolio of high-quality carbon credits, including nature-based and non-nature based solutions, to help our customers decarbonise. Our transitions plans cover all our businesses Leading Integrated Gas Advantaged Upstream Differentiated Downstream, Renewables and Energy Solutions Focused decarbonisation pathwaysWe have identified pathways to net zero for our two biggest customer sectors, transport and industry. These two sectors make up more than 70% of global final energy demand and more than 55% of global carbon emissions today. Our pathways are based on where we believe we have the competitive advantages to provide our customers with the affordable productions they need though the transition. Passenger road transport:Between now and 2030: Oil products, Biofuel solutions and electric charging Between 2030 & 2040: Electric charging, biofuel solutions and oil products From 2040 onwards: Electric charging and oil products Commercial road transport:Between now and the mid 2030s: Oil products, Biofuel solutions, liquified natural gas and electric charging From the mid 2030s onwards: Biofuel solutions, electric charging, oil products and green hydrogen Aviation:Between now and the end of the 2030s: Oil products, biofuels solutions and synthetic fuels From the end of the 2030s onwards: Biofuel solutions, synthetic fuels and oil products Marine:Between now and the mid 2030s: Oil products, liquified natural gas and biofuel solutions From the mid 2030s onwards: Oil products, biofuel solutions, liquified natural gas and hydrogen and derivatives Industry and Services:Pathway 1: Between now and the mid 2030s: Liquified natural gas with carbon capture and storage and renewable natural gas. From the mid 2030s onwards: liquified natural gas with carbon capture and storage, renewable natural gas and hydrogen and derivatives Pathway 2: Between 2030 and 2040: Blue hydrogen. From 2040 onwards: Blue hydrogen and green hydrogen Pathway 3:Direct electrification and batteries and flex storage Carbon abatement and removal: Between now and 2030: Nature based solutions and carbon capture and storage From 2030 onwards: Carbon capture and storage, nature based solutions and direct air capture Note: The order of each item within the pathway sections above indicate their likely relative prominence within that section of that pathway. Significant uncertainty remains on the shape of these future pathways. Leading to our strategic decarbonisation areas for this decadeElectric vehicle charging Biofuels infrastructure Integrated power positions Co2 capture and removal value chains Enabled by our strengths and competitive advantages Trading capabilities and infrastructure networks Technology and innovation Policy and advocacy More value with less emissions: our actions Putting our strategy into action across all our businesses Our beliefs about the energy transition inform our strategy to deliver more value with less emissions. Our strategy is based on the areas where Shell has unique competitive strengths, allowing us to be a successful business through the energy transition. Growing our world-leading LNG business with lower carbon intensityAs we grow our world-leading liquefied natural gas (LNG) business by 20-30% by 2030, we will continue to reduce the carbon intensityof our operations. Our LNG joint venture in Canada (Shell interest 40%,non-operated) will use natural gas and renewable electricity to reduce emissions from the plant by more than one-third compared with the worlds best performing facilities when it starts up. The commissioning process is expected to begin in 2024 and will continue into 2025. In Qatar, Shell is a partner in the North Field Expansion, the largest LNG project in the world. It comprises the North Field East (Shell interest 6.25%) and North Field South (Shell interest 9.375%) projects. By using carbon capture and storage, these projects will help provide LNG with a lower-carbon footprint to our customers. Shell's share of these projects will be around 3.5 million tonnes per annum (mtpa) of LNG when production starts later this decade. Shell is working with shipping companies to help decarbonise the marine sector. Parts of the marine sector uses LNG to power some of its ships, with the aim of switching to liquefied biomethane or liquefied e-methane, a hydrogen-based fuel, in the longer term. Artificial intelligence for LNG Artificial intelligence (AI) is helping us reduce carbon emissions at LNG plants by using information from sensors to calculate the most efficient settings for equipment. At one LNG facility, we estimate these technology developments are reducing carbon dioxide emissions by around 340,000 tonnes a year. We have used these automation and optimisation technologies to reduce emissions at multiple LNG facilities. Reducing methane emissions We continue to enhance the accuracy of our reported methane emissions and reduce emission sources across Shell-operated assets. By the end of 2023, around 80% of fugitive-emission sources at our operated oil, gas and LNG production facilities used leak detection and repair programmes to tackle leaks and monitor equipment. Shell works with others to share our learnings and drive industry-wide action on methane operations. We are a founding signatory of the Oil and Gas Methane Partnership (OGMP) 2.0 reporting framework and have been implementing the framework in our operated and non-operated assets, engaging with our non-operated joint-venture partners to achieve improved accuracy or reporting beyond our operations. We test and use latest technologies to monitor our emissions. In 2023, we successfully completed a pilot with GHGSat, a pioneer in methane detection, to test satellite capabilities for monitoring methane emissions from offshore facilities. The aim is to use this technology more widely in the future. We have also been using drones and satellites to monitor the methane emitted during the production and processing of natural gas, and the export of LNG. This has helped us reduce wells maintenance periods and carefully control gas dryness during processing to limit venting. We have reduced vented methane emissions at our QGC business in Queensland by more than 2,800 tonnes since 2017. Consistently ahead of the industry leading average [A] Methane emissions intensity % 2018 2019 2020 2021 2022 2023 Industry leading average 0.25 0.23 0.21 0.18 0.15 Shell [B] 0.08 0.08 0.06 0.06 0.05 0.05 [A] Aggregated average performance of Oil and Gas Climate initiative companies.[B] Methane emissions intensity from all oil and gas assets for which Shell is the operator that market their gas (including LNG and GTL assets) defined as the total volume of methane emissions in normal cubic meter (Nm3) per total volume of gas available for sale in Nm3) Cutting emissions from oil and gas production in our Upstream business In our Upstream operations, we are cutting emissions from oil and gas production to meet our targets, which are some of the most ambitious in our industry. Reducing operational emissions is a key factor in the development of new projects. Our Vito deep-water platform (Shell interest 63.1%) in the Gulf of Mexico is one of our newest platforms and has a peak production of 100,000 barrels of oil equivalent a day. The platform is expected to reduce carbon dioxide (CO2) emissions by around 80% over its operating life, compared with its original design. In addition to the reduced emissions, Vito also cost 70% less than the anticipated cost of the original design, an example of creating more value with less emissions. Vito's design is being replicated in two other deep-water platforms in the Gulf of Mexico: Whale and Sparta. The Shell-operated Whale project (Shell interest 60%) is expected to start production towards the end of 2024 and is expected to operate with less emissions than Vito. A final investment decision for the Sparta project (Shell interest 51%) was announced in December 2023, with production due to begin in 2028. Shell will use the experience of the Vito and Whale projects to enhance the design and energy efficiency capabilities of Sparta. We are reducing the carbon intensity of new projects elsewhere. Timi in Malaysia (Shell interest 75%) is our first wellhead platform to be powered by a solar and wind hybrid power system. This unmanned platform, which delivered its first gas in August 2023, is around 60% lighter than a conventional tender-assisted drilling wellhead platform, helping to reduce the emissions needed to develop the project. Reducing routine flaring We are working to reduce routine flaring, which is inefficient and contributes to climate change. Our target is to eliminate routine flaring from our upstream operations by 2025 [A]. This commitment challenges us to move faster than the World Bank's Zero Routine Flaring by 2030 initiative. In 2023, around 10% of our greenhouse gas emissions from flaring occurred at facilities where there was no infrastructure to capture the gas, which is similar to the 2022 figure. Overall flaring decreased to 2.8 million tonnes of carbon dioxide equivalent (CO2e) in 2023 from 3 million tonnes of CO2e in 2022. Subject to the completion of the sale of SPDC. In Norway, Shell is the operator of the Ormen Lange gas field (Shell interest 17.8%). This is an underwater facility connected to Nyhamna, an onshore processing and export plant. The Ormen Lange is powered by renewable hydroelectricity provided by the Norwegian grid. This same source of renewable hydroelectricity provides around 93% of the energy needed for Nyhamna. We are installing further underwater compression units to increase gas recovery from the Ormen Lange field, which will also be powered by the same renewable hydroelectricity. Within our Upstream portfolio we have made divestments, including the sale of our interest in the Malampaya gas field in the Philippines in 2022 and our Permian business in the USA in 2021. These sales were strategic moves, which also resulted in reducing our Scope 1 and 2 emissions. Downstream, Renewables and Energy Solutions businesses: offering more low-carbon solutions We are reducing emissions associated with our refineries by transforming them into energy and chemicals parks. This transformation is under way at Norco in the USA, Scotford in Canada, Pernis in the Netherlands and Rheinland in Germany. In January 2024, we took a final investment decision to convert the hydrocracker of the Wesseling site at the Energy and Chemicals Park Rheinland into a production unit for Group III base oils to produce high-quality engine and transmission oils. The repurposing of this refinery is a significant step towards serving our growing lubricant customer base with premium base oils, delivering more value with less emissions. The Wesseling site will stop processing crude oil into petrol,jet fuel and diesel by 2025. When it starts operations in the second half of this decade, the production unit will be highly electrified and is expected to cut Shell's Scope 1 and 2 emissions by around 620,000 tonnes a year. This is the latest development in the transformation of Rheinland, which includes investments in a 10-megawatt electrolyser to produce renewable hydrogen and a biomethane liquefaction plant. BiofuelsWe are developing biofuels such as sustainable aviation fuel, renewable diesel and renewable natural gas (RNG) to help our customers decarbonise without having to change their cars, trucks, planes or ships. Shell is one of the world's largest traders and blenders of biofuels, meeting around 6% of global demand. In 2023, around 9.7 billion litres of biofuels went into our petrol and diesel worldwide, compared with 9.5 billion litres in 2022. Razen, our joint venture in Brazil (Shell interest 44%), is one of the world's biggest bioethanol producers, delivering some of the lowest carbon intensity biofuels available today. The majority of the ethanol and cellulosic ethanol produced by Razen is sold unblended to international customers in markets such as Europe, Japan and the USA. It is used in the transport, pharmaceutical and manufacturing industries, among others. Razen produced around 3.12 billion litres of ethanol in 2023, up from around 3 billion in 2022. Razen's Costa Pinto plant produced 30 million litres of second-generation ethanol made from inedible agricultural waste in 2023, up from 26 million in 2022. In 2023, the joint venture also commissioned the first of eight advanced biofuel plants which it aims to build in Brazil. In February 2023, we completed the nearly $2 billion acquisition of Nature Energy, making us one of the largest producers of renewable natural gas (RNG) in Europe. RNG, produced by turning organic material such as agricultural waste into renewable energy, is a low-carbon fuel that can power trucks and ships. With our partners, Nature Energy owns and operates 13 biogas plants in Denmark and one plant in the Netherlands. The biofuels plant at the Shell Energy and Chemicals Park Rotterdam in the Netherlands is expected to be one of Europe's biggest once operational in the latter half of the decade. It is expected to be capable of producing 820,000 tonnes of biofuels from waste each year. This facility will have the capacity to produce enough renewable diesel to avoid 2.8 million tonnes of carbon emissions a year. Sustainable aviation fuel (SAF) could account for more than half of the plant's biofuels capacity, with the rest being renewable diesel. Shell can adjust this mix to meet changing customer demand. SAF currently accounts for less than 0.1% of global aviation fuel. Shell's investment will help increase SAF production, which is vital if aviation is to cut carbon emissions. To support our biofuel production capacity, we are also investing in new feedstocks for biofuels. In 2022, Shell acquired waste recycling company EcoOils which produces advanced biofuels feedstock at its facilities in Malaysia and Indonesia. This will enable the production and supply of low-carbon fuels like SAF to customers. We also invested in agroforestry company Investancia Group (Shell interest 30%) in 2022. Together, Shell and Investancia are using degraded cattle land in Paraguay to plant pongamia oil trees to grow sustainable feedstock to make biofuels. Lower-carbon race fuel for Scuderia Ferrari Shell has developed a race fuel containing 10% of second-generation bioethanol for Scuderia Ferrari to use in its Formula 1 racing cars. We use digital simulation to predict the combustion behaviour and performance of each fuel blend to significantly reduce the development time, and maximise performance and efficiency. The team is now working on a 100% sustainable race fuel, which includes several different sustainable fuel components, to meet requirements for the 2026 Formula 1 season. Electric vehicle chargingShell is well positioned to become a profitable leader in public charging for electric vehicles, meeting the growing demand from drivers who need to charge on the go. At the end of 2023, we had around 54,000 public charge points for electric vehicles at Shell forecourts, on streets and at locations such as supermarkets. This was up from 27,000 in 2022. We expect to have around 70,000 public charge points by 2025 and around 200,000 by 2030. Shell Recharge, our public charging network, currently operates in around 33 countries. We opened our largest electric vehicle charging station in the world in China, the world's largest market for EVs, in September 2023. The 258 fast-charging points at the Shell Recharge Shenzhen Airport EV Station serve thousands of drivers every day. The charging points are partially powered by rooftop solar panels with the capacity to generate 300,000 kilowatt hours of renewable electricity a year. The charging station, a joint venture between Shell and Chinese electric car manufacture BYD (Shell share 80%), has a utilisation rate of two-and-a-half-times the local average. China is one of the most important growth markets for our Mobility business. In March 2023, we completed the acquisition of Volta Inc. in the USA. We now operate one of the largest public electric vehicle charging networks in the country, with more than 3,000 charge points across 31 states and more than 3,400 additional charge points in development. Integrated power positionsOur power business brings together our expertise in generation, trading and marketing. We are making selective investments in renewable generation, batteries and other grid-flexibility technologies, to provide low-carbon solutions to our commercial and industrial customers, and to decarbonise our own operations. We aim to profitably deliver more renewable power solutions, by growing our portfolio in select markets such as Australia, Europe, India and the USA. At the end of 2023, we had around 2.5 gigawatts (GW) of renewable capacity in operation, 4.1 GW under development and around 40 GW of potential capacity in our pipeline globally, including utility-scale solar and integrated wind-to-hydrogen projects. In 2023, Shell sold around 279 terawatt-hours (TWh) of electricity, which is more than enough to meet the annual needs of Australia. In the USA, the solar, wind and battery company Savion, which we acquired in 2021, has started to develop new solar plants. Once operational, they will generate around 500 megawatts (MW) of renewable power. We are also investing in growing our renewable energy capacity elsewhere. In 2022, we acquired Sprng Energy in India and in 2023 we acquired Isemaren in Spain. We are also developing our own positions, such as our Pottendijk and Koegorspolder solar farms in the Netherlands. In 2023 in the Netherlands, the Hollandse Kust Noord offshore wind farm (Shell interest 79.9%), which has a generating capacity of 759 MW, became operational. Hollandse Kust Noord will eventually produce the equivalent of almost 3% of electricity demand in the Netherlands. Ecowende (Shell interest 60%), our joint venture with Eneco, announced plans to develop a 760 MW wind farm nearby called Hollandse Kust West. We are also developing utility-scale battery storage systems in select markets. In March 2023, we entered into a partnership to deliver a battery storage system in Australia. Shell will have access to 100% of the battery system's offtake over a 20-year period. Completion of the project is expected in late 2024. HydrogenWe continue to invest in the production of hydrogen, looking for ways to expand the technology and reduce costs so that it becomes an affordable and available low-carbon option for the future. To deliver the full low-carbon potential of hydrogen, we continue to learn about where emissions, including methane, can occur during production and use. We are also identifying opportunities to address them in collaboration with others. We see a role for hydrogen as a feedstock, for example to make synthetic fuels, and as an energy carrier across industry and transport. At the end of 2022, we started to build Holland Hydrogen 1 in the Netherlands, which will be one of the largest renewable hydrogen plants in Europe when it becomes operational in the second half of the decade. The 200 MW electrolyser will be powered by renewable energy from the Hollandse Kust (noord) offshore wind farm. Holland Hydrogen 1 will help to decarbonise the production of our petrol, diesel and aviation fuel at the Shell Energy and Chemicals Park Rotterdam. In the longer term, the plant could also supply hydrogen to help reduce emissions in transport and industry. In Oman, we acquired a 35% interest in Green Energy Oman, which will produce hydrogen from seawater, powered by up to 25 GW of solar and wind energy. Shell is the lead operating partner. The project is expected to be operational by the early part of the next decade and aims to produce around 1.8 million tonnes of hydrogen a year at full capacity. As a founding member of the H2 Accelerate consortium, Shell continues to work with partners to enable the use of hydrogen to decarbonise long-haul road transport across Europe. The consortium is trying to develop a programme to make hydrogen a commercially viable fuel for the trucking sector. Carbon capture and storage (CCS)Shell continues to work with governments, customers and partners to unlock the potential of CCS to reduce emissions where there are few low-carbon alternatives. CCS technologies are necessary to meet the temperature goals of the Paris Agreement. However, in many countries CCS lacks a clear business model. To address this challenge, Shell advocates for policy mechanisms and supports industry partnerships dedicated to the growth of commercially viable CCS projects. By the end of 2023, the Quest CCS facility at the Scotford upgrader in Canada (Shell interest 10%) had captured and safely stored more than 8.8 million tonnes of CO2 since it began operating in 2015. We are exploring the possibility of increasing CCS capacity at Quest, initially by 750,000 tonnes a year. Our Northern Lights CCS project (Shell interest 33.3%) in Norway signed contracts in 2023 to transport and safely store 1.2 million tonnes of CO2 a year. The CO2 will be shipped from two of rsted's biomass power plants in Denmark and a Yara ammonia and fertiliser plant in the Netherlands. It will then be stored 2,600 metres below the seabed in the North Sea. In Australia, the Gorgon CCS project (Shell interest 25%, operated by Chevron) reported it had stored more than 9 million tonnes of CO2 equivalent by the end of 2023. In addition to these significant emission reductions, Chevron has confirmed it had acquired and surrendered carbon credits to address historical injection shortfalls. The project started operating in 2019 and is the largest CCS operation in the world. Construction of Porthos, Europe's largest CCS facility, will begin at the port of Rotterdam in 2024. Shell will be the biggest customer, supplying 1 million tonnes of CO2 a year. The captured CO2 will be transported to empty gas fields under the North Sea around 20 kilometres off the Dutch coast. This will reduce the Netherlands' annual CO2 emissions by around 2% for 15 years from 2026. In 2023, Shell and Esso were jointly awarded three licences in the UK's first-ever carbon storage licensing round. The joint venture (Shell interest 50%) will evaluate three sites in the North Sea for the potential storage of CO2 captured and transported from industrial facilities in the UK. Also in 2023, Shell's CANSOLV carbon capture technology won a bid for deployment at a CCS plant in Abu Dhabi, UAE. The plant will capture and permanently store 1.5 million tonnes of CO2 a year. Direct air capture Shell's research programmes have been developing technology to directly remove carbon from the atmosphere for several years. In 2023, we took the decision to build a direct air capture (DAC) demonstration unit at our technology research centre in Houston, Texas, USA. The aim of the project, which has a targeted start-up date of 2025, is to prove the viability of Shell's solid sorbent technology. The unit is being developed by a diverse team of Shell scientists, engineers and technical experts across the globe. Integrated energy hubs As part of our approach to the energy transition, we are developing integrated energy hubs to reduce our own emissions and those of the products we sell. At our Energy and Chemicals Park Rotterdam in the Netherlands, for example, we are integrating biofuels, hydrogen and CCS into our existing facilities. We have started to build Holland Hydrogen 1 which will help to decarbonise fuel production at the nearby energy and chemicals park once operational. The hydrogen plant will be powered by renewable energy from the Hollandse Kust (noord) offshore wind farm. Some of the emissions from the energy hub will be captured and stored under the North Sea by two CCS projects once they are in operation. These are Porthos, where we are the biggest customer, and Aramis, a joint venture. As the market develops, we will seek opportunities for future projects and use our customer relationships to meet increasing demand for low-carbon solutions. Holland Hydrogen 1Power: Hollandse Kusst (noord) wind farm - 759MW to Data centres and Shell Holland Hydrogen 1 - 200MW C02: Shell Energy and Chemicals Park Rotterdam to Aramis CCS- 5 mpta store and Porthos CCS- 2.5 mpta store Hydrogen: From Shell holland Hydrogen 1 200MW to Shell Carbon creditsCarbon credits can make an important contribution to our target to become a net-zero emissions energy business. They may be used by Shell and its customers to compensate emissions in line with the mitigation hierarchy of avoid, reduce and compensate. We are clear that carbon credits need to have a robust carbon benefit and deliver a positive impact on ecosystems and communities. We work closely with local partners to ensure that the carbon credits projects we invest in are of a high quality. We select projects that are certified under credible and independent carbon credit standards. These include the Verified Carbon Standard, Gold Standard and the American Carbon Registry. We do this to ensure that the carbon credits are real and verifiable, and that issues such as permanence, additionality and leakage have been adequately considered. We also help develop and buy carbon credits generated by other nature-based projects and by technologies. We carefully source and screen the credits we purchase and retire from the market. In 2023, Shell's net carbon intensity (NCI) accounted for 20 million carbon credits, of which 4 million were linked to the sale of energy products. Of the 20 million tonnes of carbon credit retirements included in Shell's NCI metric for 2023, 85% were certified by Verra, 9% by the American Carbon registry, 6% by Gold Standard, and less than 1% via Australian Carbon Credit Units. Tracking SAF with blockchain We are using new technologies to power our Upstream and Downstream assets, improve our trading and supply operations, and deliver compelling new materials and molecules. Avelia, a business model developed in partnership with Accenture and American Express Global Business Travel, uses blockchain to help our customers securely and transparently track emissions reductions and the environmental attributes of the sustainable aviation fuel they acquire, tracing it from production through to delivery into aviation fuelling networks. Technology and innovationBuilt on more than 125 years of technological innovation, our company's future performance depends on the successful development, demonstration and commercial deployment of new technologies and new products. In 2023, research and development expenditure on projects that contributed to decarbonisation was around $628 million, up from around $440 million in 2022. The 2023 figure represents around 49% of our total expenditure on research and development, up from around 41% in 2022. A leading investor in research and development (R&D) [A] % EBITDA spend on R&D (average 2021-2022) Peer 1 1.6 Shell 1.3 Peer 2 1.2 Peer 3 0.8 Peer 4 0.6 [A] Shell analysis of data published by peer companies (TotalEnergies, ExxonMobil, BP and Chevron) in annual reports with the note that definitions of R&D vary between companies. Our technology and innovation portfolio helps to deliver Shell's strategy by: Achieving more value with less emissions across our core businesses today. For example, the Just Add Water System, developed by Shell, uses a software system to reduce fuel costs for marine vessels and the GHG emissions they emit.Creating the low-carbon products and solutions of tomorrow, such as our CANSOLV carbon capture technology which will be deployed on the world's largest CCS plant in Abu Dhabi.Exploring the transformative technologies of the future, such as renewable hydrogen, direct air capture, and heat and power storage solutions. The technologies and business models we are developing will shape the products and services we offer our customers in the transport and industry sectors. At our Zhuhai plant in China, which produces lubricants and greases, we have introduced a thermal energy storage system. This system replaces diesel fuel with renewable electricity to generate the process steam required for manufacturing lubricants. The storage system will optimise steam production and is expected to reduce the use of diesel by 300 tonnes and CO2 emissions by more than 900 tonnes a year. By demonstrating the benefits of this type of system on a Shell facility, we are in a position to encourage and support the decarbonisation of our customers. We invest in the latest energy technologies through our partnerships with start-ups and leading academic institutions. For example, we are working with Imperial College London in the UK to develop new technologies, with a particular focus on electric vehicles, lubricants, energy storage, CCS, and materials. Powering industry through investments Shell Ventures invests in start-ups and bigger companies that seek to electrify energy systems, decarbonise transport, gain data-based insights and provide innovative customer solutions. In 2023, we invested in a German company called Kraftblock, which has created energy storage systems to help the industry sector switch from fossil fuels to renewable energies. The technology also allows customers to recycle waste heat. Shell Ventures is a partner with Norwegian company Corvus Energy, a leading supplier of safe, innovative and reliable energy storage solutions for the maritime industry. The company's battery storage systems replace diesel and bunkering oil, thereby reducing emissions. The storage systems are used on vessels in Shell's operations in the Gulf of Mexico. Climate policy engagement Comprehensive, coherent and consistent policies are a crucial part of the journey to net zero. With the right policy and regulatory conditions, we can profitably increase our investments through the energy transition. We advocate robust policies, legislation and regulations in areas where we can best support the decarbonisation of our customers and reduce our own emissions. Our advocacy, directly to governments, and indirectly through industry associations and coalitions, is a key part of our strategy. Shell engages with governments, regulators and policymakers in different ways to help shape policy, legislation and regulation. Our public policy positions serve as a framework for our advocacy with governments, international organisations, industry associations, and other stakeholders, globally, regionally and within countries. In using the positions, we recognise that the pace of the energy transition will vary around the world. In the table below, we show how our advocacy focuses on four key areas which we believe are critical to the energy transition and will support Shell's strategy. Policy and advocacy Advocacy Themes: A Achieving net-zero emissions Cross-sector policies that support the achievement of national net-zero ambitions through comprehensive policy frameworks and carbon pricing, and which seek to ensure a just transition B Supplying the secure energy the world needsPolicies that support energy security, such as clear and predictable regulatory frameworks that enable the production of hydrocarbons with lower emissions C Driving changes in demandPolicies that support changes in customer demand in transport and industry, such as vehicle standards, mandates for sustainable aviation fuel, and demand for low-carbon products D Growing low-carbon solutionsPolicies that encourage the development of low-carbon solutions, including incentives for biofuels, flexibility in feedstock choices, and effective regulatory frameworks for hydrogen and carbon capture and storage (CCS) Sector Policy Positions Advocacy Theme Cross cutting themes Translate targets into net-zero policy frameworks to achieve national net-zero emissions goals A Put a price on direct carbon emissions, integrate credits into carbon markets and support international cooperation A Regulatory frameworks that enable the production of hydrocarbons with lower emissions and the responsible management of end-of-project liabilities B Aim for near-zero methane emissions and an end to routine flaring as soon as possible and no later than 2030 B Recognise the role of gas in facilitating the energy transition and in securing stable and flexible energy supplies B Maintain liberalised power markets, enable uptake of power purchase agreements, and accelerate permitting and grid connections D Drive demand for low-carbon fuels through mandates and fuel standards, and allow flexibility in feedstock choice while meeting strong sustainability standards D Transport Road transport Establish policy frameworks for road transport that support the widespread adoption of low-emission vehicles and support investment in infrastructure through simplified and faster permitting and grid connections C Aviation Incentivise production of sustainable aviation fuel and set mandates to drive demand C Marine Establish a global carbon intensity standard for marine fuels to drive lower-carbon fuel uptake C Industry and services Encourage low-carbon energy use in industry through mandates and low-carbon product demand, and support investment in infrastructure networks and industrial hubs C Support production and demand for low-carbon hydrogen and accelerate infrastructure planning and investment D Carbon abatement and removal Recognise the role of carbon credits and ensure quality and integrity through standards and frameworks A Provide incentives for CCS, ensure efficient permitting and licensing of CCS infrastructure, and create regulatory frameworks that support storage and international transport and trading of CO2 D Read more about our policy positions on Shell.com/advocacy-and-political-activity Advocacy in action Advocating policies that encourage demand for and incentivise investment in low-carbon solutions is a key part of our engagement with governments and regulators. In the USA, for example, we advocate permits for projects to be granted faster and with fewer hurdles. Delays, caused in part by prolonged litigation, negatively impact the delivery of projects. We believe reform of the permit system will help to deliver new projects relating to the Infrastructure Investment and Jobs Act and the Inflation Reduction Act. To achieve this reform, we have constructively engaged in legislative negotiations in the House of Representatives and Senate to advance bipartisan legislative solutions. In the EU, Shell is advocating policies to enable commercial investments in the energy transition, notably the creation of demand for low-carbon solutions. We supported the Fit for 55 package, including binding targets for the use of renewable hydrogen and advanced biofuels. We supported policies to accelerate the electrification of road transport and frameworks that help the business case for carbon abatement and removal. In Brazil, we advocate the establishment of a national emissions trading system (ETS), which is a form of carbon pricing. We believe this would incentivise decarbonisation at the lowest cost, and support the long-term development of a global carbon market. The ETS is awaiting a final review by the Federal Senate, after which it is expected to be written into law. In the Asia-Pacific region, Shell is working with local and national governments to develop policy and regulatory frameworks for CCS. The creation of cross-border CCS hubs in the region could benefit multiple industries across the region. In 2024, Shell and ExxonMobil were selected to work with the Singapore government as lead developers for a cross-border CCS project that could store at least 2.5 million tonnes of carbon dioxide a year by 2030. Energy transition in action Selection of portfolio developments [A] Country Development Leading Integrated Gas Canada LNG Canada T1-2 Indonesia Masela PSC/Abadi divestment Nigeria NLNG T7 Qatar QatarEnergy LNG NFE(2) Advantaged Upstream Brazil Mero-2 start-up Mero-3 Mero-4 Malaysia Marjoram/Rosmari United Kingdom Pierce redevelopment Jackdaw USA Aera Energy divestment Sparta FID Vito start-up Whale Malaysia Baram Delta divestment Timi start-up Nigeria Nigerian onshore (SPDC) divestment agreed Differentiated Downstream, Renewables and Energy Solutions China EV growth Denmark Nature Energy acquisition Germany FID to repurpose Energy and Chemicals Park Rheinland Shell home energy retail divestment India Sprng Energy investment funnel Netherlands CrossWind/HKN HEFA Biofuels Plant Rotterdam Holland Hydrogen I Ecowende/HKW Norway Northern Lights JV (Phase 1) Pakistan Shell Pakistan Limited divestment agreed Singapore Aspired divestment of Energy and Chemicals Park Singapore United Kingdom Shell home energy retail divestment Acorn CCS Three CCS licenses USA Volta acquisition Savion investment funnel Renewable natural gas investments Atlantic Shores - Project 1 These developments include acquisitions, investments, projects, divestments and withdrawals, at various stages of maturity and with different levels of Shell interest from minority investment to full ownership. Targets, ambitions and performance Our target is to become a net-zero emissions energy business by 2050 It includes net-zero emissions from our operations, as well as net-zero emissions from the end-use of all the energy products we sell. In the short and medium term, we have set climate targets for emissions that we are able to control, namely our Scope 1 and 2 emissions, methane emissions, and flaring. We have also set climate targets and ambitions for emissions that are outside our control. These include our ambition to reduce the Scope 3, Category 11 customer emissions from the use of our oil products, and our target to reduce the net carbon intensity of all the energy products we sell. Targets and ambitions Net-zero emissions by 2050 (Scopes 1, 2 and 3) Emissions from our own operations (Scope 1 and 2) TargetHalving Scope 1 and 2 emissions by 2030 [A] under operational control (2016 reference year) TargetEliminating routine flaring from Upstream operations by 2025 [B] TargetMaintain methane emissions intensity below 0.2% and achieve near-zero methane emissions by 2030 Emissions from the products we sell (Scope 3) TargetUpdated Net carbon intensity (NCI) Introducing a range of 15-20% for our target to reduce NCI by 2030 (2016 reference year) AmbitionNew Oil products ambition Reduce customer emissions from the use of our oil products by 15-20% by 2030, Scope 3 Category 11 [C] (2021 reference year) On a net basis.Subject to completion of the sale of SPDC.Customer emissions from the use of our oil products (Scope 3, Category 11) were 517 million tonnes carbon dioxide equivalent (CO2e) in 2023 and 569 million tonnes CO2e in 2021. Reducing our absolute Scope 1 and 2 emissions In October 2021, we set a target to halve the emissions from our operations (Scope 1), plus the energy we buy to run them (Scope 2), by 2030 compared with 2016 levels on a net basis. To decarbonise our operations, we are focusing on: making portfolio changes such as acquisitions and investments in new, low-carbon projects. We are also decommissioning plants, divesting assets, and reducing our production through the natural decline of existing oil and gas fields;improving the energy efficiency of our operations;transforming our remaining integrated refineries intolow-carbon energy and chemicals parks, which involves decommissioning plants;using more renewable electricity to power our operations; anddeveloping carbon capture and storage (CCS) for our facilities. If required, we may choose to use high-quality carbon credits to offset any remaining emissions from our operations, in line with the mitigation hierarchy of avoid, reduce, and compensate. The chart below shows our progress since 2016 in reducing our Scope 1 and 2 emissions and gives an indication of how we expect to achieve our target in 2030. The actions we will take to achieve our target will depend on the evolution of our asset portfolio and the continued development of technologies that reduce carbon emissions. We expect that on a net portfolio basis, new investments across our portfolio will increase our Scope 1 and 2 emissions between 2024 and 2030, but this increase will be outweighed by planned divestments and natural decline. Our investments in producing low-carbon energy such as biofuels will increase our Scope 1 and 2 emissions, while reducing the net carbon intensity of the products we sell. Subsequent reductions in our emissions are reflected in the mechanisms outlined below and reflect an expected path to meeting our target in 2030. Working to reduce our absolute Scope 1 and 2 emissionsScope 1 and 2 emissions in million tonnes per annum [A], [B] Scope 1 Scope 2 Target 2016 72 11 2020 63 8 2021 60 8 2022 51 7 2023 50 7 Portfolio changes -1.4 Efficiency improvements -3.33 Energy and chemicals park transformation -0.58 Use of renewable power -1.73 Carbon capture and storage -6.3 Carbon credits [C] -1.6 2030 41 The 2016 baseline was not recalculated in 2023. The 2016 baseline may be recalculated in future years if an acquisition or a divestment has an impact of more than 10% on the total Scope 1 and 2 emissions. Operational control boundary.Including nature-based solutions. Our direct GHG emissions (Scope 1, operational control boundary) decreased from 51 million tonnes of carbon dioxide equivalent (CO2e) in 2022 to 50 million tonnes CO2e in 2023, driven by several factors including: divestments in 2022 (e.g. Deer Park and Mobile refinery, Tunisia Miskar concession, offshore Baram Delta Operations (BDO) PSC and Block SK307 PSC in the Philippines) and handover of operations in OML 11 in Nigeria in 2022; unplanned downtime (e.g. Deer Park Chemicals); reduced flaring from assets including Shell Nigeria Exploration and Production Company (SNEPCo); reduction activities and purchase of renewable electricity. These decreases were partly offset by Shell Polymers Monaca having more units online in 2023 and higher emissions from our Pearl gas-to-liquids plant and our Prelude floating liquefied natural gas facility with increased production. Our Annual Report and Accounts 2023 provides more details of how we reduced our Scope 1 and 2 emissions. Methane emissionsMethane emissions include those from unintentional leaks, venting and incomplete combustion, for example in flares and turbines. Our target to maintain methane emissions intensity below 0.2% continued to be met in 2023. Shell's overall methane emissions intensity was at 0.05% for facilities with marketed gas and 0.001% for facilities without marketed gas. We believe our methane emissions are quantified according to industry best practice. This target covers all Shell-operated oil and gas assets in our Upstream and Integrated Gas businesses. By the end of 2023, we reduced our total methane emissions by 70% since 2016. In 2023, Shell's total methane emissions were 41 thousand tonnes compared with 40 thousand tonnes in 2022. The increase was due to venting (for example, the maintenance of our Prelude asset and operational issues in assets operated by Sarawak Shell Berhad) and an increase in reported emissions from integrated gas assets in Canada resulting from the adoption of enhanced source level measurements in line with OGMP reporting requirements. Methane emissions intensity [A], [D] 2023 2022 2021 2016 Methane emissions intensity - assets with marketed gas [B] % 0.05 % 0.05 % 0.06 % 0.10 % Methane emissions intensity - assets without marketed gas [C] % 0.001 % 0.01 % 0.01 % 0.03 % Methane emissions [D] thousand tonnes 41 40 55 138 Our target is to maintain methane emissions intensity below 0.2% and achieve near zero methane emissions by 2030Methane emissions intensity from all oil and gas assets for which Shell is the operator that market their gas (incl. LNG and GTL assets), defined as the total volume of methane emissions in normal cubic metre (Nm3) per total volume of gas available for sale in Nm3. Methane emissions intensity from all oil and gas assets for which Shell is the operator that do not market their gas (e.g. where gas is reinjected) defined as the total mass of methane emissions in tonnes per total mass of oil and condensate available for sale in tonnes.Total methane emissions for all assets under Shell operational control including Integrated Gas and Upstream and Downstream and Renewables Energy Solutions assets, quantified according to industry best practice. Routine flaringWe are working to reduce flaring, which is inefficient and contributes to climate change. Routine flaring of gas occurs during normal oil production when it is not possible to use the gas or reinject it into the well. In 2021, we brought forward our target to eliminate routine flaring from our upstream operations to 2025 [A] from 2030. This accelerates our commitment of 2015 to end routine flaring as a signatory to the World Bank's Zero Routine Flaring by 2030 initiative. Total routine flaring from our upstream oil and gas assets remained relatively stable in 2023 compared with 2022 at 0.1 million tonnes, having reduced from 1.1 million tonnes in 2016. Around 50% of total routine and non-routine flaring in our Integrated Gas and Upstream facilities in 2023 occurred in assets operated by the SPDC and Shell Nigeria Exploration and Production Company (SNEPCo). On January 16, 2024, Shell reached an agreement to sell SPDC to a consortium of five companies, subject to approvals by the Federal Government of Nigeria and other conditions. Subject to completion of the sale of SPDC. Reducing net carbon intensityWe have set targets to reduce the net carbon intensity (NCI) of the energy products we sell by 9-12% by 2024, 9-13% by 2025, 15-20% by 2030, and 100% by 2050. The intended use of the NCI metric is to track progress in reducing the overall carbon intensity of the energy products sold by Shell. Net carbon intensity measures emissions associated with each unit of energy we sell, compared with a 2016 baseline. It reflects changes in sales of oil and gas products, and changes in sales of low and zero-carbon products- such as biofuels, hydrogen and renewable electricity. Unlike Scope 1 and 2 emissions, reducing the net carbon intensity of the products we sell requires action by both Shell and our customers, with the support of governments and policymakers to create the right conditions for change. Our focus on where we can add the most value has led to a strategic shift in our power business. We plan to build our integrated power business, including renewable power, in places such as Australia, Europe, India and the USA. We have withdrawn from the supply of energy directly to homes in Europe because we do not believe that is where our strengths lie. In line with our shift to prioritising value over volume in power, we are concentrating on select markets and segments. One example is our focus on commercial customers more than retail customers. Given this focus on value, we expect growth in total power sales to 2030 will be lower than previously planned. This has led to an update to our net carbon intensity target. We are now targeting a 15-20% reduction by 2030 in the net carbon intensity of the energy products we sell, compared with 2016, against our previous target of a 20% reduction. Acknowledging uncertainty in the pace of change in the energy transition, we have also chosen to retire our 2035 target of a 45% reduction in net carbon intensity. The biggest driver for reducing our net carbon intensity is increasing the sales of and demand for low-carbon energy. The chart on the next page illustrates how changes in the volume of products and services we sell could result in net carbon intensity reductions through to 2030. The change in our sales of these products and services will also reflect the development and adoption of new technologies and infrastructure, and the adoption of public policies designed to encourage the energy transition. In 2023, Shell's NCI was 74 grams of carbon dioxide equivalent per megajoule of energy (gCO2e/MJ), a 2.6% decrease from the previous year and a 6.3% reduction compared with 2016, the base year. The decrease in Shell's NCI in 2023 was mainly achieved through a reduction in the average intensity of power sold and the use of carbon credits. The power intensity reduction was driven mainly by progress in grid decarbonisation in key markets such as the USA and Europe, and partly by increased sales of renewable power, including the retirement of Renewable Energy Certificates. Working to reduce our net carbon intensity (NCI)NCI in gCO2e/MJ [A] Actual Target 2016 79 2021 77 2022 76 2023 74 Hydrocarbon sales [B] -1.1 Power sales [C] -7.4 Grow power sales Low-carbon fuels sales [D] -0.8 Grow biofuels, develop hydrogen Carbon capture and storage [E] 0.4 Develop Carbon capture and storage Carbon credits [F] -0.6 High-quality carbon credits 2030 -15-20% Grams of carbon dioxide equivalent per megajoule.Hydrocarbon sales reflect the effect of lower sales of oil products, and higher sales of natural gas. Emissions associated with gas are lower than those of oil products. Power sales show the expected growth of our integrated power business and increasing sales of renewable power. Sales of low-carbon fuels reflect higher sales of biofuels and hydrogen, which are low- and zero-carbon products. CCS reduces carbon emissions by capturing them at source. Carbon credits such as nature-based solutions can be used to offset remaining carbon emissions, particularly in hard-to-abate sectors such as aviation and industries including cement and steel. We undertake external verification of our GHG emissions annually. Our Scope 1 and 2 GHG emissions from assets and activities under our operational control and emissions associated with the use of our energy products (Scope 3) included in our NCI have been verified to a level of limited assurance. Ambition to reduce customer emissions from the use of our oil products We have set a new ambition to reduce customer emissions from the use of our oil products by 15-20% by 2030 compared with 2021 (Scope 3, Category 11). That is more than 40% compared with 2016 reported emissions. [A] This level of ambition is in line with the European Union's climate goals in the transport sector, among the most progressive in the world. Achieving this ambition will mean reducing sales of oil products, such as petrol and diesel, as we support customers as they move to electric mobility and lower-carbon fuels, including natural gas, LNG and biofuels. [A] Customer emissions from the use of our oil products (Scope 3, Category 11) were 517 million tonnes carbon dioxide equivalent (CO2e) in 2023, 569 million tonnes CO2e in 2021 and 819 million tonnes CO2e in 2016. Of the 40% reduction by 2030, around 8 percentage points are related to volumes associated with additional contracts being classified as held for trading purposes, impacting reported volumes from 2020 onwards.. Scope 3, Category 11 emission by product Diesel [A] 204.63378 Gasoline 186.18788 LNG [B] 185.42407 Natural gas 175.32567 Kerosene 73.598994 Fuel oil 44.459623 LPG [C] 7.5833652 [A] Including blending GLT[B] Liquefied natural gas[C] Liquefied petroleum Paris alignment The Paris Agreement aims to strengthen the global response to the threat of climate change by ""holding the increase in the global average temperature to well below 2C above pre-industrial levels and pursuing efforts to limit the temperature increase to 1.5C above pre-industrial levels"". Shell supports the more ambitious goal of the Paris Agreement, which is to limit the rise in global average temperature this century to 1.5C above pre-industrial levels. There is no established standard for aligning an energy supplier's decarbonisation targets and ambitions with the 1.5C temperature goal of the Paris Agreement. For this reason, we have defined our net carbon intensity target using 1.5C scenarios developed for the Intergovernmental Panel on Climate Change (IPCC) Sixth Assessment Report (AR6). We start with the complete set of 1.5C scenarios [A] and then exclude scenarios which are too reliant on carbon removals or use of bioenergy before removing outliers. We then calculate an emissions intensity for each scenario which is comparable to our own net carbon intensity. Finally, we produce a 1.5C pathway based on the reductions in emissions intensity over time. We have chosen to use a range instead of any individual scenario to better reflect the uncertainty of the energy transition. These are the AR6 scenarios which have a greater than 50% likelihood of limiting warming to 1.5C with no or limited overshoot (C1) or of returning warming to 1.5C after a high overshoot (C2). Overshoot describes how much the global temperature in a scenario exceeds 1.5C before returning. We believe that using this pathway to set our targets demonstrates that they are aligned with the more ambitious 1.5C goal of the Paris Agreement. This is illustrated in the chart below. Shell's Paris-aligned targets Shell historical 2016 2017 2018 2019 2020 2021 2022 2023 100% 100% 100% 99% 95% 97% 96% 94% 2021 2030 2035 2040 2045 2050 IEA APS 97% 87% 73% 61% 49% 40% IEA NZE 97% 77% 50% 27% 11% 0% Shell targets Year 2024 2024 2025 2025 2030 2030 2050 Range 91% 88% 91% 87% 85% 80% 0% Read more about our approach at shell.com/sustainability/our-climate-target/our-climate-target-faqs Shell net zero by 2050 We are committed to our target to become a net-zero emissions energy business by 2050. To achieve net zero, we will reduce emissions from our own operations, change the mix of the energy products we sell and grow new carbon removal and abatement businesses. At the same time, we will work to help advance the critical factors required for the world to achieve net zero. Critical factors on the path to net zeroThe scale of the energy transition requires fundamental change in both supply and demand. It will take supportive government policies, advances in technology and investments by companies across all parts of the economy to achieve this. We advocate policies, legislation and regulations in areas where we can best support the decarbonisation of our customers, reduce our own emissions and help accelerate the energy transition. To help stimulate demand, we are investing in scaling up low-carbon solutions so that they become an affordable choice for our customers. Through partnerships with start-ups and leading academic institutions, we are also helping to develop the technologies of the future that will be critical to achieving net zero such as direct air capture, renewable hydrogen and heat and power storage solutions. Multi-energy businessThere remains significant uncertainty around the shape of the future energy system. As a result, we are developing a multi-energy portfolio that has the flexibility to respond to uncertainty, and that will allow us to remain a successful business and achieve net-zero emissions. By 2050, we expect that low-carbon products and solutions will have grown to become a material part of our portfolio. These solutions will be in the form of sustainable biofuels as well as liquid synthetic products, such as synthetic kerosene for aviation, that will be created through new technologies. At the same time, we will have focused our oil and gas businesses on projects with higher margins and lower carbon emissions, while pairing these projects with carbon capture and storage to further reduce emissions. In addition to our energy sales, a core part of our future business will be helping customers to decarbonise in the sectors where we have competitive advantages, including by capturing carbon and storing it, or by using the carbon to produce low-carbon products such as hydrogen. While the journey to net zero will include significant challenges, it also presents many opportunities. Through the actions we are taking today, we are positioning Shell to deliver more value with less emissions as we transform into a net-zero emissions energy business. Share of global primary energy mix (%) 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 Hydrocarbon 0.82 0.83 0.83 0.82 0.82 0.82 0.82 0.81 0.81 0.81 0.8 0.81 0.8 Electricity 0.09 0.08 0.08 0.08 0.09 0.09 0.09 0.09 0.09 0.1 0.1 0.1 0.1 Low Carbon Molecules 0.09 0.09 0.09 0.09 0.09 0.09 0.09 0.09 0.09 0.09 0.1 0.1 0.1 Arch (H) 0.8 Arch (E) 0.1 Arch (L) 0.1 Sky (H) 0.8 Sky (E) 0.1 Sky (L) 0.1 IPCC C2 (H) 0.8 IPCC C2 (E) 0.1 IPCC C2 (L) 0.1 IPCC C1 (H) 0.8 IPCC C1 (E) 0.1 IPCC C1 (L) 0.1 IEA NZE (H) 0.79 IEA NZE (E) 0.1 IEA NZE (L) 0.1 IEA APS (H) 0.79 IEA APS (E) 0.1 IEA APS (L) 0.1 2025 2026 2027 2028 2029 2030 2031 2032 2033 2034 2035 2036 2037 Hydrocarbon Electricity Low Carbon Molecules Arch (H) 0.79 0.79 0.78 0.78 0.77 0.77 0.76 0.75 0.75 0.74 0.73 0.72 0.71 Arch (E) 0.11 0.11 0.12 0.12 0.13 0.13 0.14 0.15 0.15 0.16 0.17 0.18 0.19 Arch (L) 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 Sky (H) 0.78 0.77 0.76 0.74 0.73 0.71 0.7 0.68 0.66 0.64 0.62 0.6 0.58 Sky (E) 0.12 0.13 0.14 0.15 0.17 0.18 0.2 0.22 0.23 0.25 0.27 0.29 0.31 Sky (L) 0.1 0.1 0.1 0.1 0.1 0.11 0.11 0.11 0.11 0.11 0.11 0.11 0.12 IPCC C2 (H) 0.79 0.74 0.65 IPCC C2 (E) 0.1 0.14 0.21 IPCC C2 (L) 0.11 0.12 0.14 IPCC C1 (H) 0.76 0.64 0.54 IPCC C1 (E) 0.12 0.2 0.29 IPCC C1 (L) 0.13 0.16 0.18 IEA NZE (H) 0.63 IEA NZE (E) 0.24 IEA NZE (L) 0.13 IEA APS (H) 0.7 IEA APS (E) 0.18 IEA APS (L) 0.12 2038 2039 2040 2041 2042 2043 2044 2045 2046 2047 2048 2049 2050 Hydrocarbon Electricity Low Carbon Molecules Arch (H) 0.7 0.7 0.68 0.67 0.66 0.65 0.64 0.63 0.62 0.61 0.6 0.59 0.58 Arch (E) 0.19 0.2 0.21 0.22 0.23 0.24 0.25 0.26 0.27 0.28 0.29 0.3 0.31 Arch (L) 0.1 0.1 0.1 0.1 0.1 0.11 0.11 0.11 0.11 0.11 0.11 0.11 0.11 Sky (H) 0.56 0.54 0.52 0.49 0.47 0.45 0.43 0.41 0.39 0.37 0.35 0.33 0.31 Sky (E) 0.33 0.34 0.37 0.39 0.41 0.43 0.45 0.47 0.49 0.51 0.53 0.55 0.57 Sky (L) 0.12 0.12 0.12 0.12 0.12 0.12 0.12 0.12 0.12 0.12 0.12 0.12 0.12 IPCC C2 (H) 0.57 0.46 0.4 IPCC C2 (E) 0.27 0.35 0.39 IPCC C2 (L) 0.16 0.19 0.21 IPCC C1 (H) 0.45 0.37 0.32 IPCC C1 (E) 0.35 0.41 0.45 IPCC C1 (L) 0.2 0.22 0.23 IEA NZE (H) 0.44 0.3 0.16 IEA NZE (E) 0.39 0.52 0.65 IEA NZE (L) 0.16 0.18 0.18 IEA APS (H) 0.6 0.5 0.37 IEA APS (E) 0.26 0.34 0.46 IEA APS (L) 0.14 0.15 0.17 Just transition and governance A just transition A successful energy transition depends on more than financial investment and technological advances. It also needs to be a just transition, which means a fairer distribution of the costs and benefits of the world's transition to a net-zero emissions energy system. Shell aims to contribute to a just and inclusive transition by making a positive economic and social impact on communities, workers and customers. Closing the energy access gapToday, around 675 million people do not have access to electricity and 2.3 billion lack access to clean cooking facilities, according to the UN Department of Economic and Social Affairs. Shell has pledged $200 million as part of a broader initiative to help people get access to energy in the near and medium term. The initiative aims to help millions of people in underserved communities in sub-Saharan Africa, India and South-east Asia get access to electricity and improved cooking conditions. Skills for the futureAs more jobs are created in renewable energy, it is important to provide workers with the opportunity to learn new skills. This requires robust dialogue and collaboration between governments, businesses and the workforce. We are aiming to help 15,000 people in the UK get jobs with a focus on the energy transition by 2035. Shell, together with its partners, is supporting the creation of two energy transition skills hubs in Scotland and one in Wales. The facilities, which are expected to open in 2024 and 2025, aim to provide people with skills for the future, such as in wind turbine maintenance and heat pump installation. In 2023, around 6,900 Shell employees  up from around 4,000 in 2022  completed courses linked to the energy transition, including hydrogen production, carbon capture and storage, and greenhouse gas and energy management. We use our existing structures to expand social dialogue with employees, employee representative bodies, relevant local government agencies and communities to address the social aspects of the energy transition and to advance human rights and labour rights. Equal opportunitiesEquality of opportunity for groups that have been traditionally under-represented in energy is an important element of a just transition. Shell has set an ambition to become one of the most diverse and inclusive organisations in the world. This is embedded in our company strategy and applies to all parts of our business. We currently prioritise four areas: gender, race and ethnicity, LGBT+ and disability inclusion and enablement. CommunitiesAt our Pottendijk wind and solar power park in the Netherlands, which opened in 2023, we are sharing the proceeds from the renewable energy we generate. Over the next 16 years we expect to pay around $2 million into a community fund, which the municipality of Emmen will use as the community sees best. In Nigeria, Shell-funded investment company All On has agreed to invest $11 million in 25 mini-grid projects across the country. The company plans to supply affordable solar energy to communities that need it the most. Human rights, governments and industryRespecting human rights is an essential element of a just transition. Shell is committed to respecting human rights, as set out in the United Nations Universal Declaration of Human Rights and the International Labour Organization's Declaration on Fundamental Principles and Rights at Work. Read more about our approach at shell.com/justtransition Climate governance Our governance framework is designed to effectively deliver on the energy transition ambitions and targets of our Powering Progress strategy, which seeks to deliver more value with less emissions. The Board reviews our energy transition strategy periodically and oversees its implementation and delivery. In 2023, the Board considered climate-related matters throughout the year, including the assessment of climate-related risks and the effectiveness of corresponding risk management activities. The Board also challenged and endorsed business plans, including consideration of major capital expenditures, acquisitions and divestments. Our remuneration policies are designed to challenge and support the Executive Committee (EC) to reduce net carbon emissions, while generating shareholder value. Energy transition targets were part of the 2023 annual bonus scorecard (15% weighting), applicable to the majority of Shell's employees, as well as the 2023 Long-term Incentive Plan (LTIP) awards for senior executives (25% weighting) and the 2023 Performance Share Plan (PSP) awards for other employees (12.5% weighting), both vesting in 2026. Carbon management framework (CMF) We employ several processes across our organisation to ensure that management teams can effectively monitor and manage climate-related matters, including the delivery of Group carbon targets. These processes are supported by a combination of carbon management standards in projects, business growth forums where portfolio decisions are made, and capability development programmes. To drive delivery of carbon targets in the 2023 operating plan cycle, our net carbon intensity targets were translated into net absolute emissions budgets for each business. This enabled trade-offs within those budgets between emitting carbon and generating shareholder value. We also use carbon metrics (profitability per unit of carbon emitted) in decision-making when comparing different growth opportunities against each other. For the 2024 LTIP and PSP awards, ""Shell's journey in the energy transition"" performance condition retains the same weightings as for 2023. The extent to which awards will vest will be based on a holistic assessment of progress towards reducing emissions from our operations and supporting our customers to reduce their emissions. This will be based on our journey to net-zero targets for our own operations of: Halving Scope 1 and 2 emissions by 2030 under operational control on a net basis (2016 baseline); Eliminating routine flaring from upstream operations by 2025 [A]; andMaintaining methane emissions intensity below 0.2% and achieving near-zero methane emissions by 2030. It will also be based on progress in developments that support the energy transition to 2030 and beyond, such as the development of our power business (including renewables), lower-carbon LNG, biofuels, electric vehicle charging, hydrogen and carbon capture and storage (CCS). Subject to completion of the sale of SPDC. We will take into account progress towards achieving a 15-20% reduction in NCI by 2030 (2016 baseline) and a 15-20% reduction in customer emissions from the use of our oil products by 2030 (2021 baseline) [A]. We will also take into account Shells wider performance in accelerating the energy transition, for example by demonstrating leadership and advocacy in standard setting, alongside any other factors that are considered material. In 2024, we have adjusted the energy transition measure in our annual scorecard in light of our energy transition strategy update. By doing this, we continued to align to Shells strategic objective of becoming a net-zero emissions energy business by 2050, supporting a balanced energy transition by responsibly delivering the oil and gas people need today, while helping to build the clean energy system of the future. The metric ""Shell's journey in the energy transition"" in the annual bonus scorecard represents: LNG volumes  equity liquefaction;Reducing operational emissions  operational actions to reduce emissions in support of our target to achieve a 50% reduction in Scope 1 and 2 emission by 2030, on a net basis; andSupporting customer decarbonisation  electric vehicle charge point roll-out. Customer emissions from the use of our oil products (Scope 3, Category 11) were 517 million tonnes CO2e in 2023 and 569 million tonnes CO2e in 2021. For further details see ""Governance of climate-related risks and opportunities"" in our Annual Report and Accounts 2023. Energy transition and advisory votes Shell offered its first Energy Transition Strategy for submission to a shareholder advisory vote at the 2021 Annual General Meeting. The vote offered shareholders an opportunity to engage with and support Shell's energy transition plans. Shell was one of the first companies in the world to introduce such a vote. In 2022 and 2023, Shell also offered an advisory vote on its progress in putting its energy transition plans into action in the previous year. Following engagements with institutional investors, we found that expectations around issues such as the inclusion of an absolute Scope 3 target influenced the voting decisions of many investors, rather than the progress report itself. As a result, going forward, the energy transition progress report will be part of the Annual Report and Accounts without an advisory vote, while the Energy Transition Strategy (this publication) will be updated and offered for an advisory vote at least every three years. Climate litigation Climate litigation Environmental activists continue to bring litigation against governments and companies for the effects of climate change on individuals and communities around the world. In the Netherlands, Shell is appealing a decision from the District Court of The Hague ordering us to reduce worldwide aggregate carbon emissions across Scope 1, 2 and 3 by net 45% by 2030, compared with 2019 levels. The order states that reductions in Scope 2 and 3 emissions should be on a ""significant best efforts basis"". We are appealing the decision because we do not believe this is the right solution for the energy transition. By focusing on one company, and only on the supply of energy rather than the demand for it, we believe the ruling is ineffective and even counterproductive in addressing climate change. It is not clear how Shell can be ordered to reduce the emissions it does not control from customers, who are not under a similar legal obligation to reduce their emissions. The court is also asking Shell to reduce emissions significantly faster than the EU, which has one of the most ambitious pathways in the world. Shell believes that by working together, with effective government policies, the world can help shift consumer demand to low-carbon products and develop the infrastructure and technology needed for the energy transition, while maintaining a secure and affordable supply of energy. Shell's appeal will be heard by the Dutch Court of Appeal in April 2024. As we wait for the outcome of the appeal, Shell is taking active steps to comply with the ruling. Climate standards and benchmarks Climate initiatives and benchmarks play a role in supporting Shell's efforts in the energy transition. They promote an ongoing dialogue between interested parties and highlight areas of progress against externally established criteria. Doing business in a clear, open way is a commitment we work hard to keep, and we promote transparency where possible throughout our industry. We continue to learn as we work to provide relevant information to key stakeholders groups. In doing so we work with a number of stakeholders including regulators, auditors, investors and non-governmental organisations. Our strategy and progress in the energy transition, as well as our efforts to increase transparency, are recognised across environmental, social and governance (ESG) frameworks. Over the years, our performance scores have improved consistently, as evidenced by the assessment done by various external parties, including the most recent analysis from the Carbon Tracker Initiative [A] which highlights Shells good practices and key improvements in the financial related climate disclosures. ESG rating agencies [B] 2020 2021 2022 2023 MSCI A AA AA AA Sustainalytics 36.8 H 35.1 H 34.7 H 33.7 H ISS C C+ C+ C+ ISSThe ISS ESG net zero alignment model evaluates whether companies have a credible decarbonisation strategy, including interim greenhouse gas emissions targets and substantiated commitments to achieving net zero by 2050. Shell is one of eight companies in the oil and gas sector that received a net zero overall alignment status of ""aligning"" in 2023. Flying Blind: In a Holding Pattern, Carbon Tracker Initiative, February 2024MSCI: A score of AA and AAA indicates the company is leading its industry in managing the most significant ESG risks and opportunities. Sustainalytics: A lower score indicates a lower risk of experiencing material financial impacts from ESG factors. ISS: Companies are rated on a 12-point scale from A+ (best) to D-(worst). Climate InitiativesTransition Pathway InitiativeThe Transition Pathway Initiative (TPI) is a global, asset-owner led initiative which assesses companies' preparedness for the transition to a low-carbon economy. TPI assess a companies' performance and progress in the energy transition against internationally agreed benchmark. TPI's assessment is divided into two parts: management quality and carbon performance. Management quality describes a companys carbon management practices and governance, with a higher score indicating better performance. Carbon performance compares a companys emissions pathway against different climate scenarios consistent with the Paris Agreement. The carbon performance scores indicate whether a company's targets and plans are aligned in the short-term (2025), medium term (2035), and long-term (2050). In terms of management quality, in 2023, we received the highest score of four (strategic assessment) for the management of our greenhouse gas emissions, and of risks and opportunities related to the low-carbon transition. This exceeds the average score of 3.2 across all assessed companies in the oil and gas sector (90) In relation to carbon performance, although Shell's goal of becoming a net-zero emissions energy business by 2050 remains unchanged, TPI no longer considers this target to be aligned with its 1.5C benchmark. This is the result of TPI's approach to accounting for customer mitigation actions. Climate Action 100+Climate Action 100+ is an investor-led initiative that drives corporate action on climate change, representing investors with assets of around $68 trillion. Its net zero company benchmark assesses companies against three high-level goals set by investors: emissions reduction, governance, and climate-related disclosures. It tracks business alignment with a net-zero emissions future and the Paris Agreement goal of limiting global temperature rise to 1.5C. The disclosure framework evaluates the adequacy of corporate disclosure in relation to key actions companies can take to align with the goals of the Paris Agreement, and is assessed by the Transition Pathway Initiative. The latest results for Shell are shown below, based on publicly disclosed information as of May 29, 2023. Disclosure framework 2022 2023 Yes, meets all criteria 5 2 Partial, meets some criteria 3 7 No, does not meet any criteria 1 1 We are disappointed to see that our ratings have deteriorated in some areas in the latest assessment, which is largely due to annual updates to the methodology used. We have a strong governance and commitment to transparency so that investors can continue to assess our climate strategy and compare our progress with that of other companies. We will continue our engagement with CA100+ and TPI with the aim of ensuring that our current targets and disclosures are reflected in their benchmark and hope we can continue to improve the outcome in their assessment. Task Force on Climate-related Financial DisclosuresSince 2017, Shell has supported the recommendations of the Task Force on Climate-related Financial Disclosures (TCFD). The TCFD is a global initiative to get companies across all sectors to assess climate-related risks and opportunities. It recommends disclosure of qualitative and quantitative information aligned to its four core elements: governance, strategy, risk management, and metrics and targets. Our climate-related financial disclosures are consistent with all the TCFD's Recommendations and Recommended Disclosures. Please refer to our Annual Report and Accounts 2023 for more details. Shell's disclosures related to recommendations by the TCFD are set out in the ""Our journey to achieving net zero"" section of the Annual Report. Cautionary note The companies in which Shell plc directly and indirectly owns investments are separate legal entities. In this report ""Shell"", ""Shell Group"" and ""Group"" are sometimes used for convenience where references are made to Shell plc and its subsidiaries in general. Likewise, the words ""we"", us"" and ""our' are also used to refer to Shell plc and its subsidiaries in general or to those who work for them. These terms are also used where no useful purpose is served by identifying the particular entity or entities. ""Subsidiaries"", ""Shell subsidiaries"" and ""Shell companies"" as used in this report refer to entities over which Shell plc either directly or indirectly has control. The term joint venture, ""joint operations"", ""joint arrangements"", and ""associates"" may also be used to refer to a commercial arrangement in which Shell has a direct or indirect ownership interest with one or more parties. The term ""Shell interest"" is used for convenience to indicate the direct and/or indirect ownership interest held by Shell in an entity or unincorporated joint arrangement, after exclusion of all third-party interest. Forward-looking statementsThis report contains forward-looking statements (within the meaning of the U.S. Private Securities Litigation Reform Act of 1995) concerning the financial condition, results of operations and businesses of Shell. All statements other than statements of historical fact are, or may be deemed to be, forward-looking statements. Forward-looking statements are statements of future expectations that are based on management's current expectations and assumptions and involve known and unknown risks and uncertainties that could cause actual results, performance or events to differ materially from those expressed or implied in these statements. Forward-looking statements include, among other things, statements concerning the potential exposure of Shell to market risks and statements expressing management's expectations, beliefs, estimates, forecasts, projections and assumptions. These forward-looking statements are identified by their use of terms and phrases such as ""aim"", ""ambition"", ""anticipate"", ""believe"", ""could"", ""estimate"", ""expect"", ""goals"", ""intend"", ""may"", ""milestones"", ""objectives"", ""outlook"", ""plan"", ""probably"", ""project"", ""risks"", ""schedule"", ""seek"", ""should"", ""target"", ""will"" and similar terms and phrases. There are a number of factors that could affect the future operations of Shell and could cause those results to differ materially from those expressed in the forward-looking statements included in this report, including (without limitation): (a) price fluctuations in crude oil and natural gas; (b) changes in demand for Shell's products; (c) currency fluctuations; (d) drilling and production results; (e) reserves estimates; (f) loss of market share and industry competition; (g) environmental and physical risks; (h) risks associated with the identification of suitable potential acquisition properties and targets, and successful negotiation and completion of such transactions; (i) the risk of doing business in developing countries and countries subject to international sanctions; (j) legislative, judicial, fiscal and regulatory developments including regulatory measures addressing climate change; (k) economic and financial market conditions in various countries and regions; (l) political risks, including the risks of expropriation and renegotiation of the terms of contracts with governmental entities, delays or advancements in the approval of projects and delays in the reimbursement for shared costs; (m) risks associated with the impact of pandemics, such as the COVID-19 (coronavirus) outbreak, regional conflicts, such as Russia's invasion of Ukraine, and a significant cybersecurity breach; and (n) changes in trading conditions. No assurance is provided that future dividend payments will match or exceed previous dividend payments. All forward-looking statements contained in this report are expressly qualified in their entirety by the cautionary statements contained or referred to in this section. Readers should not place undue reliance on forward-looking statements. Additional risk factors that may affect future results are contained in Shell plc's Form 20-F for the year ended December 31, 2023 (available at shell.com/investors/news-and-filings/sec-filings.html and sec.gov). These risk factors also expressly qualify all forward-looking statements contained in this report and should be considered by the reader. Each forward-looking statement speaks only as of the date of this report, March 14, 2024. Neither Shell plc nor any of its subsidiaries undertake any obligation to publicly update or revise any forward-looking statement as a result of new information, future events or other information. In light of these risks, results could differ materially from those stated, implied or inferred from the forward-looking statements contained in this report. Shell's net carbon intensityAlso, in this report we may refer to Shell's ""net carbon intensity"", which includes Shell's carbon emissions from the production of our energy products, our suppliers' carbon emissions in supplying energy for that production and our customers' carbon emissions associated with their use of the energy products we sell. Shell only controls its own emissions. The use of the term Shell's ""net carbon intensity"" is for convenience only and not intended to suggest these emissions are those of Shell plc or its subsidiaries. Shell's net-zero emissions targetShell's operating plan, outlook and budgets are forecasted for a ten-year period and are updated every year. They reflect the current economic environment and what we can reasonably expect to see over the next ten years. Accordingly, they reflect our Scope 1, Scope 2 and Net Carbon Intensity (NCI) targets over the next ten years. However, Shell's operating plans cannot reflect our 2050 net-zero emissions target, as this target is currently outside our planning period.In the future, as society moves towards net-zero emissions, we expect Shell's operating plans to reflect this movement. However, if society is not net zero in 2050, as of today, there would be significant risk that Shell may not meet this target. Forward-looking non-GAAP measuresThis report may contain certain forward-looking non-GAAP measures such as [cash capital expenditure] and [divestments]. We are unable to provide a reconciliation of these forward-looking Non-GAAP measures to the most comparable GAAP financial measures because certain information needed to reconcile those non-GAAP measures to the most comparable GAAP financial measures is dependent on future events some of which are outside the control of Shell, such as oil and gas prices, interest rates and exchange rates. Moreover, estimating such GAAP measures with the required precision necessary to provide a meaningful reconciliation is extremely difficult and could not be accomplished without unreasonable effort. Non-GAAP measures in respect of future periods which cannot be reconciled to the most comparable GAAP financial measure are calculated in a manner which is consistent with the accounting policies applied in Shell plc's consolidated financial statements. The contents of websites referred to in this report do not form part of this report. We may have used certain terms, such as resources, in this report that the United States Securities and Exchange Commission (SEC) strictly prohibits us from including in our filings with the SEC. Investors are urged to consider closely the disclosure in our Form 20-F, File No 1-32575, available on the SEC website sec.gov. Additional informationAs used in this Report, ""accountable"" is intended to mean: required or expected to justify actions or decisions. The accountable person does not necessarily implement the action or decision (implementation is usually carried out by the person who is Responsible) but must organise the implementation and verify that the action has been carried out as required. This includes obtaining requisite assurance from Shell companies that the framework is operating effectively. ""Responsible"" is intended to mean: required or expected to implement actions or decisions. Each Shell company and Shell-operated venture is responsible for its operational performance and compliance with the Shell General Business Principles, Code of Conduct, Statement on Risk Management and Risk Manual, and Standards and Manuals. This includes responsibility for the operationalisation and implementation of Shell Group strategies and policies. CO2 compensation does not imply that there is no environmental impact from the production and use of the product as associated emissions remain in the atmosphere. CO2 compensation is not a substitute for switching to lower emission energy solutions or reducing the use of fossil fuels. Shell businesses focus first on emissions that can be avoided or reduced and only then, compensate the remaining emissions. ""carbon neutral"" or ""CO2 compensated"" indicates that Shell will engage in a transaction where an amount of CO2 equivalent to the value of the remaining CO2e emissions associated with the raw material extraction, transport, production, distribution and usage /end-of-life (if Lubricants or other non-energy product) of the product are compensated through the purchase and retirement of carbon credits generated from CO2 compensation projects. Although these carbon credits have been generated in accordance with international carbon standards, the compensation may not be exact. CO2e( CO2 equivalent) refers to CO2, CH4, N2O. LEI Number: 21380068P1DRHMJ8KU70Published: March 14, 2024Classification: Additional Regulated Information required to be disclosed under the laws of the United Kingdom What emission reduction targets has Shell set for its operations by 2030? Shell aims to halve emissions from its operations (Scope 1 and 2) by 2030 compared to 2016 on a net basis. How much has Shell achieved towards its emission reduction target by the end of 2023? By the end of 2023, Shell had achieved over 60% of its emission reduction target. What is Shell's new ambition to reduce customer emissions from the use of its oil products by 2030? Shell aims to reduce customer emissions from the use of its oil products by 15-20% by 2030 compared to 2021. How much will Shell invest in low-carbon energy solutions between 2023 and the end of 2025? Shell will invest $10-15 billion in low-carbon energy solutions between 2023 and the end of 2025."
Kinetik Announces Pricing of Secondary Offering of Common Stock,2024-03-14T04:39:00.000Z,Low,Neutral,"Kinetik Holdings Inc. (NYSE: KNTK) announced a secondary offering of 11,373,801 shares of its Class A common stock by Apache Midstream LLC at $33.75 per share. The Company will not receive proceeds from the sale. The underwriters have an option to purchase additional shares. CEO to purchase 14,814 shares at the public offering price.","Kinetik Announces Pricing of Secondary Offering of Common Stock Rhea-AI Impact (Low) Rhea-AI Sentiment (Neutral) Tags offering Rhea-AI Summary Kinetik Holdings Inc. (NYSE: KNTK) announced a secondary offering of 11,373,801 shares of its Class A common stock by Apache Midstream LLC at $33.75 per share. The Company will not receive proceeds from the sale. The underwriters have an option to purchase additional shares. CEO to purchase 14,814 shares at the public offering price. Positive None. Negative None. Financial Analyst From a financial perspective, the secondary offering of 11,373,801 shares by Apache Midstream LLC, a subsidiary of Apache Corporation, is a significant liquidity event that merits attention. At a price of $33.75 per share, the offering represents a substantial capitalization event for the Selling Stockholder. It is noteworthy that Kinetik Holdings Inc. will not receive any proceeds from this transaction, which implies that the company's capital structure and operating funds remain unaffected. However, investors should consider the potential dilutive effect of the additional 1,706,070 shares that may be purchased by the underwriters within the 30-day option period.Furthermore, the CEO's decision to purchase 14,814 shares at the public offering price could be interpreted as a signal of confidence in the company's future prospects. This action may influence investor sentiment and potentially affect the stock's performance in the short term. The involvement of prominent financial institutions as book-running managers and co-managers indicates a high level of interest and confidence in the offering, which could have positive implications for the stock's liquidity and future price stability. Market Research Analyst Examining the market implications, the secondary offering by Kinetik Holdings Inc. is indicative of Apache Midstream's strategic financial management, potentially aimed at reallocating capital within its portfolio or realizing gains from its investment in Kinetik. This move may signal to the market Apache's assessment of Kinetik's valuation or a shift in Apache's investment strategy.For Kinetik, the offering could have various market implications. While the company's equity base is expanding, the sale does not directly benefit Kinetik's financial position since the proceeds do not go to the company. Market response to such offerings can be mixed, as existing shareholders may be concerned about the dilution of their shares, while potential investors might see an opportunity to invest in the company at a set price. The CEO's share purchase can be seen as a commitment to the company's performance and may mitigate some dilution concerns. Legal Expert Legally, the secondary offering is conducted under a registration statement that became effective upon filing, which suggests compliance with the Securities and Exchange Commission (SEC) regulations. The preliminary prospectus supplement provides essential details about the offering and must be scrutinized for legal accuracy and completeness. It is essential for potential investors to review these documents thoroughly to understand the terms of the offering and the risks involved.The legal framework governing such transactions is designed to protect investors by ensuring transparency and the provision of all material information. The role of the underwriters is also critical as they are responsible for the distribution of shares and must adhere to both regulatory requirements and due diligence processes to ensure the success of the offering. 03/14/2024 - 12:39 AM HOUSTON & MIDLAND, Texas--(BUSINESS WIRE)-- Kinetik Holdings Inc. (NYSE: KNTK) (Kinetik or the Company) announced today the pricing of an underwritten secondary offering of 11,373,801 shares of its Class A common stock (the Offering) by Apache Midstream LLC (the Selling Stockholder), a subsidiary of Apache Corporation, at a price of $33.75 per share. Kinetik is not selling any shares of Class A common stock in the Offering and will not receive the proceeds from any sale of shares by the Selling Stockholder. The Selling Stockholder has granted to the underwriters a 30-day option to purchase up to an additional 1,706,070 shares of Kinetiks Class A common stock. In connection with the Offering, the Companys Chief Executive Officer has agreed to purchase an aggregate of 14,814 shares of Class A common stock from the underwriters at the public offering price. Goldman Sachs & Co. LLC, BofA Securities, J.P. Morgan and Mizuho are acting as joint lead book-running managers for the Offering. Citigroup, HSBC, Morgan Stanley, MUFG, Scotiabank, Truist Securities, Barclays, RBC Capital Markets and TD Securities are acting as joint book-running managers for the Offering. Capital One Securities, PNC Capital Markets LLC, Raymond James and Regions Securities LLC are acting as co-managers for the Offering. The Offering is being made only by means of a prospectus supplement. When available, a copy of the prospectus supplement and the accompanying base prospectuses may be obtained from Goldman Sachs & Co. LLC, Prospectus Department, 200 West Street, New York, NY 10282, by telephone at (866) 471-2526, by facsimile at (212) 902-9316 or by emailing Prospectus-ny@ny.email.gs.com; J.P. Morgan, c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, NY 11717, by telephone at (866) 803-9204; BofA Securities, Inc., NC1-022-02-25, 201 North Tryon Street, Charlotte, NC 28255-0001, Attn: Prospectus Department, Email: dg.prospectus_requests@bofa.com; Mizuho Securities USA LLC, 1271 Avenue of the Americas, 3rd Floor, New York, New York 10020, Attn: Equity Capital Market, telephone at +1 (212) 205-7600. The offering is being conducted pursuant to a registration statement, filed with the SEC on March 13, 2024, that became automatically effective upon filing, and corresponding prospectus included therein. A preliminary prospectus supplement thereto was filed with the SEC. Before investing, prospective investors should read the prospectus supplement, accompanying base prospectus and the documents incorporated by reference therein for more complete information about the Company and the Offering. An electronic copy of the prospectus supplement and accompanying base prospectus is available from the U.S. Securities and Exchange Commissions website at www.sec.gov. This news release does not constitute an offer to sell or a solicitation of an offer to buy any securities, nor shall there be any sale of any securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction. About Kinetik Holdings Inc. Kinetik is a fully integrated, pure-play, Permian-to-Gulf Coast midstream C-corporation operating in the Delaware Basin. Kinetik is headquartered in Midland, Texas and has a significant presence in Houston, Texas. Kinetik provides comprehensive gathering, transportation, compression, processing and treating services for companies that produce natural gas, natural gas liquids, crude oil and water. Forward-looking statements This news release includes certain statements that may constitute forward-looking statements for purposes of the federal securities laws. Forward-looking statements include, but are not limited to, statements that refer to projections, forecasts or other characterizations of future events or circumstances, including any underlying assumptions. The words anticipate, believe, continue, could, estimate, expect, intends, may, might, plan, seeks, possible, potential, predict, project, prospects, guidance, outlook, should, would, will, and similar expressions may identify forward-looking statements, but the absence of these words does not mean that a statement is not forward-looking. These statements include, but are not limited to, statements regarding the Offering. While forward-looking statements are based on assumptions and analyses made by us that we believe to be reasonable under the circumstances, whether actual results and developments will meet our expectations and predictions depend on a number of risks and uncertainties which could cause our actual results, performance, and financial condition to differ materially from our expectations. See Part I, Item 1A. Risk Factors in our Annual Report on Form 10-K for the year ended December 31, 2023. Any forward-looking statement made by us in this news release speaks only as of the date on which it is made. Factors or events that could cause our actual results to differ may emerge from time to time, and it is not possible for us to predict all of them. We undertake no obligation to publicly update any forward-looking statement, whether as a result of new information, future development, or otherwise, except as may be required by law. View source version on businesswire.com: https://www.businesswire.com/news/home/20240313776231/en/ Kinetik Investors: (713) 487-4832 Maddie Wagner (713) 574-4743 Alex Durkee Source: Kinetik Holdings Inc. What is the ticker symbol for Kinetik Holdings Inc.? The ticker symbol for Kinetik Holdings Inc. is KNTK. How many shares are being offered in the secondary offering? 11,373,801 shares of its Class A common stock are being offered in the secondary offering. At what price are the shares being offered? The shares are being offered at a price of $33.75 per share. Who is the Selling Stockholder in the Offering? Apache Midstream LLC, a subsidiary of Apache Corporation, is the Selling Stockholder in the Offering. Will Kinetik Holdings Inc. receive proceeds from the sale of shares in the Offering? Kinetik Holdings Inc. will not receive the proceeds from any sale of shares by the Selling Stockholder. Which underwriters are involved in the Offering? Goldman Sachs & Co. LLC, BofA Securities, J.P. Morgan, and Mizuho are acting as joint lead book-running managers for the Offering. What is the option granted to the underwriters in the Offering? The underwriters have a 30-day option to purchase up to an additional 1,706,070 shares of Kinetiks Class A common stock. Where can investors obtain the prospectus supplement for the Offering? Investors can obtain the prospectus supplement from various institutions including Goldman Sachs & Co. LLC, J.P. Morgan, BofA Securities, and Mizuho Securities USA LLC."
Nextracker and Orrcon Steel to Deliver Sovereign Capability in Australia,2024-03-14T02:00:00.000Z,Low,Neutral,"Nextracker (NXT) partners with Orrcon Steel to manufacture critical components for smart solar trackers in Australia, with the first delivery to ACCIONA Energias 480MWp Aldoga Solar Farm. The collaboration aims to support the local supply chain, create new manufacturing jobs, and enhance clean energy accessibility in Australia.","Nextracker and Orrcon Steel to Deliver Sovereign Capability in Australia Rhea-AI Impact (Low) Rhea-AI Sentiment (Neutral) Tags Rhea-AI Summary Nextracker (NXT) partners with Orrcon Steel to manufacture critical components for smart solar trackers in Australia, with the first delivery to ACCIONA Energias 480MWp Aldoga Solar Farm. The collaboration aims to support the local supply chain, create new manufacturing jobs, and enhance clean energy accessibility in Australia. Positive None. Negative None. Market Research Analyst The partnership between Nextracker and Orrcon Steel, facilitated by BlueScope Steel's investment, is a strategic move within the renewable energy sector in Australia. This collaboration not only enhances the supply chain resilience by localizing production but also aligns with the growing demand for renewable energy infrastructure. The creation of a facility capable of producing critical steel components for solar trackers domestically is expected to shorten lead times and reduce logistical costs, potentially improving Nextracker's market position in Australia.Furthermore, the investment in local manufacturing is likely to have a ripple effect on the economy, creating jobs and supporting the government's clean energy initiatives. The production capacity of up to 50,000 tonnes of torque tubes indicates a significant scale, which could cater to multiple large-scale solar projects. The commitment to sustainability and the transition to renewable energy sources is also a positive signal to stakeholders and may enhance the corporate image of the companies involved. Environmental Economist From an economic perspective, the establishment of the manufacturing facility for solar tracker components represents a forward-thinking approach to energy production and consumption. By focusing on reducing the carbon footprint through local manufacturing, the initiative supports Australia's transition to a low-carbon economy. This move can be seen as a proactive response to climate change, which is increasingly becoming a factor in investment decisions and consumer preferences.Additionally, the investment in renewable energy technology manufacturing could lead to long-term cost savings for the solar energy industry, as well as for end-users, by reducing dependency on imported materials. This aligns with the broader economic trend towards sustainable development and may provide a competitive edge as global markets increasingly favor environmentally responsible products and practices. Financial Analyst The announcement has direct implications for the financial performance of the companies involved. For BlueScope Steel, the investment in the facility represents a strategic diversification into the renewable energy sector, which could open new revenue streams and provide a hedge against the volatility of traditional steel markets. For Nextracker, the ability to deliver high-quality products faster to its customers in Australia could translate into increased sales and market share, as evidenced by Rystad's data indicating Nextracker's leadership in the Australian solar tracker system market.The financial impact on BlueScope Steel's stock (ASX:BSL) and Nextracker's stock (Nasdaq: NXT) will depend on the operational efficiency of the new facility, the uptake of solar energy projects in Australia and the companies' ability to capitalize on the growing renewable energy market. The strategic nature of this investment suggests a positive outlook for both companies, provided they can maintain quality and meet the anticipated demand from the renewable energy sector. 03/13/2024 - 10:00 PM The first project scheduled to receive delivery of Australian made steel components from the facility is ACCIONA Energias 480MWp Aldoga Solar Farm to be built near Gladstone BRISBANE, Australia--(BUSINESS WIRE)-- Nextracker (Nasdaq: NXT), a global market leader of solar tracker and software solutions, and Orrcon Steel, a leading Australian manufacturer of tube and pipe, and distributor of steel products and wholly owned business of BlueScope Steel (ASX:BSL), announced an agreement today to manufacture and deliver Australian made critical components for Nextrackers smart solar tracker used on distributed generation and utility-scale solar farms. The first project scheduled to receive delivery of Australian made steel components from the facility is ACCIONA Energias 480MWp Aldoga Solar Farm to be built near Gladstone. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240313484617/en/Nextracker's critical steel components manufacturing facility at BlueScope Steel's Orrcon Steel facility, QLD, Australia (Photo: Nextracker) Critical steel components will be produced from BlueScopes steel coil at Orrcon Steels Salisbury Tube mill in Brisbane and finished at its Northgate site by Baojia, Nextrackers global manufacturing partner for delivery to engineering procurement contractors (EPCs). The new manufacturing facility was officially opened today by Queensland Minister for Energy and Clean Economy Jobs, Mick de Brenni MP; Tania Archibald, Chief Executive BlueScope Australian Steel Products; Tony Schreiber, Chair of the Australian Steel Institute and General Manager of Orrcon Steel; and Peter Wheale, General Manager of Nextracker Australia, Southeast Asia, New Zealand. This foundation strengthens Nextrackers commitment to deliver energy security to Australians with a local supply chain and new manufacturing jobs to make clean energy affordable and accessible. We support Queenslands Energy and Jobs Plan and applaud their ambitions to create jobs for the clean energy economy, said Peter Wheale, Nextracker GM for Australia, Southeast Asia, and New Zealand. In addition to reducing our carbon footprint by manufacturing critical tracker components in Australia, the manufacturing facility in Queensland will accelerate Nextrackers ability to deliver faster to our customers in Australia and support large solar farms with quality, high performing solar tracker systems. Tania Archibald, Chief Executive of BlueScope Australian Steel Products, said, As one of Australias largest manufacturers, BlueScope continues to invest in our Australian operations, with more than $2 billion currently committed to secure our future as a vibrant, modern and sustainable manufacturer with a clear role to play in enabling Australias energy transition. As part of this program, weve been undertaking a range of climate related initiatives  not just in progressing our own ambitions for lower emissions steelmaking  but focusing on supplying our high-quality steel products that support our customers and the Australian industry more broadly participate in the energy transition. Tony Schreiber, Chair of the Australian Steel Institute and General Manager of Orrcon Steel, said, Orrcon Steel is one step closer to achieving our ambition to be a significant participant in Australias renewable energy supply chain. Our investment also includes a large tubular mill at Unanderra NSW, tooling to produce solar torque tubes and increased warehouse capacity, positioning our business as a key supplier of products for the rapidly expanding renewable energy sector. The collaboration with Nextracker and Baojia is another example of how were making a difference in the utility scale solar industry with an Australian made, high quality product. The manufacturing facility has been commissioned and 16 new jobs have been created to produce up to 50,000 tonnes of torque tubes, the equivalent of over 2.5GW of utility scale solar farms. According to industry analyst, Rystad, Nextracker is the market leader for solar tracker systems in Australia with 7.45 GWdc installed or under fulfilment in 13.5 GWdc of utility-scale PV assets. Nextrackers award-winning technology has also been used on some of the countrys largest projects: New England Solar Farm (521 MWd), Stubbo Solar Farm (520 MWd) and Western Downs (460 MWd). About Nextracker Nextracker is a leading provider of intelligent, integrated solar tracker and software solutions used in utility-scale and distributed generation solar projects around the world. Its products enable solar panels to follow the suns movement across the sky and optimise plant performance. With plants operating in more than thirty countries worldwide, Nextracker offers solar tracker technologies that increase energy production while reducing costs for significant plant ROI. For more information, visit nextracker.com. About Orrcon Steel Orrcon Steel, a wholly owned business of BlueScope, provides high-quality steel products and solutions. We locally manufacture steel, tube and pipe supplying a customer base that includes resellers, stockists, and distributors. The tubular products are utilised by steel fabricators, furniture and trailer body manufacturers, housing and construction companies, pipeline and infrastructure engineering firms, renewables and more. Orrcon Steel Distribution in addition to local tubular products, provides a range of hot dipped gal pipe, hot rolled structural steel, fencing and roofing through its network of branches Australia wide. We employ over 600 Australians who use their steel industry knowledge and experience to produce and supply reliable steel products. About Baojia Baojia is a leading OEM manufacturer specialising in the design, fabrication, and supply of high-quality steel structures for solar trackers. With a commitment to innovation, reliability, and sustainability, we play a pivotal role in the renewable energy sector by providing robust and efficient solutions for solar tracking systems. With over decades of experience and expertise in engineering and manufacturing steel structures tailored for solar trackers, our dedicated team of professionals ensure that our products meet the highest industry standards, providing our clients with reliable and durable products for their solar trackers. View source version on businesswire.com: https://www.businesswire.com/news/home/20240313484617/en/ Kristan Kirsh +1 650 814 1273 Kkirsh@nextracker.com Gabriel Wong (on behalf of Nextracker Australia Pacific) +61 432 177 005 gabriel@positivegood.com.au Source: Nextracker What is Nextracker's (NXT) partnership with Orrcon Steel about? Nextracker has partnered with Orrcon Steel to manufacture critical components for smart solar trackers in Australia. Which solar farm is set to receive the first delivery of Australian made steel components from the facility? ACCIONA Energias 480MWp Aldoga Solar Farm near Gladstone is scheduled to receive the first delivery. How many new jobs have been created by the manufacturing facility? The facility has created 16 new jobs to produce up to 50,000 tonnes of torque tubes. What is the equivalent capacity of the torque tubes produced by the facility? The 50,000 tonnes of torque tubes produced equate to over 2.5GW of utility-scale solar farms. According to industry analyst Rystad, what is Nextracker's position in the Australian market for solar tracker systems? Rystad reports that Nextracker is the market leader in Australia with 7.45 GWdc installed or under fulfillment."
"Solidion Technology, Inc. Announces Pricing of $3.85 Million Private Placement",2024-03-14T01:08:00.000Z,Low,Neutral,"Solidion Technology, Inc. announces a private placement to raise $3.85 million through the issuance of 5,133,332 units and pre-funded units. The net proceeds will be used for general working capital and administrative purposes. The private placement is expected to close on March 14, 2024.","Solidion Technology, Inc. Announces Pricing of $3.85 Million Private Placement Rhea-AI Impact (Low) Rhea-AI Sentiment (Neutral) Tags Rhea-AI Summary Solidion Technology, Inc. announces a private placement to raise $3.85 million through the issuance of 5,133,332 units and pre-funded units. The net proceeds will be used for general working capital and administrative purposes. The private placement is expected to close on March 14, 2024. Positive None. Negative None. Financial Analyst The capital raise by Solidion Technology, Inc. through a private placement is significant as it indicates the company's need for additional working capital and its strategy for growth. The amount of $3.85 million, while not substantial for large corporations, can be quite impactful for a smaller company like Solidion. The use of proceeds for general working capital and administrative purposes suggests that the company might be looking to scale operations or invest in research and development activities that are not specified in detail. This move could be a response to the competitive environment in the advanced battery technology sector, which is rapidly evolving and requires continuous investment.From a financial perspective, the issuance of units and pre-funded units with warrants attached provides investors with the potential for future equity at a predetermined price. The structure of this deal, particularly the low exercise price of the warrants, could dilute existing shareholders but also reflects the company's current valuation and the risk appetite of the investors. The involvement of a reputable placement agent like EF Hutton could add credibility to the offering and possibly attract institutional investors looking for exposure in the tech sector, particularly in sustainable and advanced energy solutions. Legal Expert The securities being offered by Solidion have not been registered under the Securities Act of 1933, which is a common practice in private placements targeting accredited investors. This exemption allows the company to raise capital more quickly than through a public offering, though it limits the pool of potential investors. The commitment to file one or more registration statements for the resale of the shares indicates a future transition to public tradability of these securities, which is an important consideration for investors regarding liquidity.It's also noteworthy that the company has engaged two law firms for the private placement, which underscores the complexity and importance of the transaction. Benesch Friedlander Coplan & Aronoff LLP and Loeb & Loeb LLP's involvement in this transaction ensures adherence to regulatory requirements and the structuring of the securities in a manner that is compliant with the law. Market Research Analyst The advanced battery technology market is a high-growth area, driven by the increasing demand for electric vehicles and renewable energy storage solutions. Solidion's capital raise could signal a strategic move to capitalize on market trends and position itself competitively. The company's performance and ability to utilize the raised funds effectively will be critical in determining their market position in the future.Investors may view this capital infusion as a positive development, provided Solidion can translate the additional resources into revenue-generating projects or technological advancements. However, the potential dilutive effect of the warrants and the reliance on future stockholder approval for the warrants' exercise could introduce volatility to the stock's performance. Monitoring the company's subsequent regulatory filings and performance metrics will be essential in assessing the impact of this capital raise on its market valuation and growth trajectory. 03/13/2024 - 09:08 PM DALLAS, TEXAS, March 13, 2024 (GLOBE NEWSWIRE) -- Solidion Technology, Inc., (the Company, ""Solidion, we, our or us), an advanced battery technology solutions provider, today announced that it has entered into a securities purchase agreement with institutional investors to raise approximately $3.85 million in aggregate cash proceeds, before deducting fees to the placement agent and other offering expenses payable by the Company. The closing of the private placement is expected to occur on March 14, 2024, subject to the satisfaction of certain customary closing conditions set forth in the securities purchase agreement. In connection with the private placement, the Company will issue an aggregate of 5,133,332 units and pre-funded units. The pre-funded units will be sold at the same purchase price as the units, less the pre-funded warrant exercise price of $0.0001. Each unit and pre-funded unit will consist of one share of common stock (or pre-funded warrant), two common warrants each exercisable for one share of common stock at an exercise price of $0.75 per share and one common warrant at an exercise price of $0.0001 to purchase such amount of shares of common stock as will be determined on the Reset Date (as defined in the Series B common warrant). The common warrants will be exercisable upon issuance and will have a term of 5.5 years from the stockholder approval date. The number of securities issued under the units is subject to adjustment as described in more detail in the Current Report on Form 8-K to be filed in connection with the private placement. The Company intends to use the net proceeds from the private placement primarily for general working capital and administrative purposes. EF Hutton is acting as exclusive placement agent for the offering. Benesch Friedlander Coplan & Aronoff LLP and Loeb & Loeb LLP are serving as counsel to the Company for the private placement. Winston & Strawn LLP is serving as counsel to the placement agent. The shares of common stock and warrants described above have not been registered under the Securities Act of 1933, as amended, and may not be offered or sold in the United States absent registration with the Securities and Exchange Commission (the SEC) or an applicable exemption from such registration requirements. The securities were offered only to accredited investors. Pursuant to a registration rights agreement with the investors, the Company has agreed to file one or more registration statements with the SEC covering the resale of the shares of common stock and the shares issuable upon exercise of the pre-funded warrants and warrants. This press release shall not constitute an offer to sell or the solicitation of an offer to buy any of the securities described herein, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction. About Solidion Technology, Inc. Headquartered in Dallas, Texas with pilot production facilities in Dayton, Ohio, Solidions core business includes manufacturing of battery materials and components, as well as development and production of next-generation batteries for energy storage systems and electric vehicles for ground, air, and sea transportation. Solidion offers two lines of battery products: (i) advanced anode materials (ready for production expansion); and (ii) three classes of solid-state batteries, including Silicon-rich all-solid-state lithium-ion cells (Gen 1), anodeless lithium metal cells (Gen 2), and lithium-sulfur cells (Gen 3), all featuring an advanced polymer- or polymer/inorganic composite-based solid electrolyte that is process-friendly. Solidions solid-state batteries can be manufactured at scale using current lithium-ion cell production facilities; this feature enables fastest time-to-market of safe solid-state batteries. Solidion batteries are designed to deliver significantly extended EV range, improved battery safety, lower cost per KWh, fastest time-to-market, and next-gen cathodes (potential to replace expensive nickel and cobalt with sulfur (S) and other more abundant elements). Cautionary Note Regarding Forward-Looking Statements: This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Solidion Technology Inc., (NASDAQ: STI) (the Company, ""Solidion, we, our or us) desires to take advantage of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 and is including this cautionary statement in connection with this safe harbor legislation. The words ""forecasts"" ""believe,"" ""may,"" ""estimate,"" ""continue,"" ""anticipate,"" ""intend,"" ""should,"" ""plan,"" ""could,"" ""target,"" ""potential,"" ""is likely,"" ""expect"" and similar expressions, as they relate to us, are intended to identify forward-looking statements. We have based these forward-looking statements primarily on our current expectations and projections about future events and financial trends that we believe may affect our financial condition, results of operations, business strategy, and financial needs. Important factors that could cause actual results to differ from those in the forward-looking statements include (i) the lack of a third party valuation in determining to pursue the business combination, (ii) the effect of the announcement or closing of the business combination on Solidions business relationships, operating results and business generally, (iii) risks that the business combination disrupts current plans and operations of Solidion and potential difficulties in Solidion employee retention as a result of the transaction, (iv) the outcome of any legal proceedings that may be instituted against Honeycomb Battery Company or against Nubia Brand International Corp. (Nubia) related to the transaction, (v) the ability to maintain the listing of Solidions securities on a national securities exchange, (vi) volatility of the price of Solidions securities due to a variety of factors, including changes in the competitive and highly regulated industries in which Solidion operates, variations in operating performance across competitors, changes in laws and regulations affecting Solidions business and changes in the combined capital structure, (vi) the ability to implement business plans, forecasts, and other expectations after the completion of the transaction, and identify and realize additional opportunities, and (vii) the risk of downturns and a changing regulatory landscape in the highly competitive EV battery industry, and the Risk Factors contained within our filings with the SEC, including Nubias definitive proxy statement filed with the SEC November 8, 2023. Any forward-looking statement made by us herein speaks only as of the date on which it is made. Factors or events that could cause our actual results to differ may emerge from time to time, and it is not possible for us to predict all of them. We undertake no obligation to publicly update any forward-looking statements, whether as a result of new information, future developments or otherwise, except as may be required by law. Solidion Technology Inc. Contacts For Investors: ir@solidiontech.com For Media: press@solidiontech.com What is Solidion Technology, Inc. announcing in the press release? Solidion Technology, Inc. announced a private placement to raise approximately $3.85 million. How many units and pre-funded units will be issued by the company? The company will issue a total of 5,133,332 units and pre-funded units. What will the net proceeds from the private placement be used for? The net proceeds from the private placement will primarily be used for general working capital and administrative purposes. When is the closing of the private placement expected to occur? The closing of the private placement is expected to occur on March 14, 2024. Who is acting as the exclusive placement agent for the offering? EF Hutton is acting as the exclusive placement agent for the offering."
Permex Petroleum Provides Update Regarding Management Cease Trade Order,2024-03-14T02:41:00.000Z,Neutral,Negative,"Permex Petroleum Corporation provides an update on the management cease trade order issued by the British Columbia Securities Commission due to delayed annual financial filings. The company cites lack of funds as the reason for the delay but is in the process of engaging its auditor to rectify the situation. Permex intends to follow the Alternative Information Guidelines and aims to file the Annual Filings by March 29, 2024.","Permex Petroleum Provides Update Regarding Management Cease Trade Order Rhea-AI Impact (Neutral) Rhea-AI Sentiment (Negative) Tags Rhea-AI Summary Permex Petroleum Corporation provides an update on the management cease trade order issued by the British Columbia Securities Commission due to delayed annual financial filings. The company cites lack of funds as the reason for the delay but is in the process of engaging its auditor to rectify the situation. Permex intends to follow the Alternative Information Guidelines and aims to file the Annual Filings by March 29, 2024. Positive None. Negative Delayed annual financial filings due to lack of funds leading to a management cease trade order by the BCSC. Uncertainty regarding the company's ability to engage its auditor and file the Annual Filings on time. 03/13/2024 - 10:41 PM Vancouver, British Columbia--(Newsfile Corp. - March 13, 2024) - Permex Petroleum Corporation (CSE: OIL) (OTC Pink: OILCF) (FSE: 75P) (""Permex"" or the ""Company"") is providing an update with respect to the management cease trade order (""MCTO"") issued by the British Columbia Securities Commission (the ""BCSC"") on January 30, 2024, as previously announced by the Company in news releases dated January 31, 2024, February 19, 2024 and February 28, 2024. The MCTO was issued by the BCSC in connection with the delay by the Company in filing its audited annual financial statements and accompanying management's discussion and analysis, with related CEO and CFO certificates for the financial year ended September 30, 2023 (collectively, the ""Annual Filings"").The completion of such Annual Filings was delayed due to a lack of funds, which prevented the Company from being able to engage its auditor. The Company is in the process of engaging its auditor. The Company is providing this status update in accordance with National Policy 12-203 - Management Cease Trade Orders (""NP 12-203""). The Company intends to follow the provisions of the Alternative Information Guidelines set out in NP 12-203, including the issuance of bi-weekly default status reports in the form of news releases, for as long as the Company remains in default. The Company confirms, as of the date of this news release, that there has been no material change in the information contained in the default announcement issued January 31, 2024, and the default status reports issued on February 19, 2024 and February 28, 2024, and there is no other material information concerning the affairs of the Company that has not been generally disclosed. The Company anticipates filing the Annual Filings and remedying its default on or before March 29, 2024. About Permex Petroleum CorporationPermex Petroleum is a uniquely positioned junior oil and gas company with assets and operations across the Permian Basin of West Texas and the Delaware Sub-Basin of New Mexico. The Company focuses on combining its low-cost development of Held by Production assets for sustainable growth with its current and future Blue-Sky projects for scale growth. The Company, through its wholly owned subsidiary, Permex Petroleum US Corporation, is a licensed operator in both states, and owns and operates on private, state and federal land. For more information, please visit www.permexpetroleum.com.Contact InformationPermex Petroleum CorporationMehran EhsanPresident, Chief Executive Officer & Director(469) 804-1306Gregory MontgomeryChief Financial Officer (469) 804-1306Or for investor relations, please contact:Renmark Financial Communications Inc.Steve Hosein: shosein@renmarkfinancial.comTel.: (416) 644-2020 or (212)-812-7680www.renmarkfinancial.comForward-Looking StatementsCautionary Note Regarding Forward-Looking Statements: This release includes certain statements and information that may constitute forward-looking information within the meaning of applicable Canadian securities laws. Forward-Looking statements relate to future events or future performance and reflect the expectations or beliefs of management of the Company regarding future events. Generally, forward-looking statements and information can be identified using forward-looking terminology such as ""intends"" or ""anticipates"", or variations of such words and phrases or statements that certain actions, events or results ""may"", ""could"", ""should"", ""would"" or ""occur"". This information and these statements, referred to herein as ""forwardlooking statements"", are not historical facts, are made as of the date of this news release and include without limitation, statements regarding discussions of future plans, estimates and forecasts and statements as to management's expectations and intentions with respect to, among other things, management expectations regarding the Company's ability to file the Annual Filings within the time period described herein.These forwardlooking statements involve numerous risks and uncertainties and actual results might differ materially from results suggested in any forward-looking statements. These risks and uncertainties include, among other things: the Company being unable to file the Annual Filings in the proposed timeframe; recent market volatility; and the state of the financial markets for the Company's securities.In making the forward-looking statements in this news release, the Company has applied certain material assumptions, including without limitation, that: the Company will be able to file the Annual Filings in the proposed time frame.Although management of the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking statements or forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements and forward-looking information. Readers are cautioned that reliance on such information may not be appropriate for other purposes. The Company does not undertake to update any forward-looking statement, forward-looking information or financial outlook that are incorporated by reference herein, except in accordance with applicable securities laws. We seek safe harbor.To view the source version of this press release, please visit https://www.newsfilecorp.com/release/201705 Why was the management cease trade order issued by the BCSC for Permex Petroleum Corporation (OILCF)? The management cease trade order was issued due to the company's delay in filing its audited annual financial statements and accompanying management's discussion and analysis. What caused the delay in filing the Annual Filings for Permex Petroleum Corporation (OILCF)? The delay was attributed to a lack of funds, which prevented the company from engaging its auditor. What steps is Permex Petroleum Corporation (OILCF) taking to rectify the situation? The company is in the process of engaging its auditor and intends to follow the Alternative Information Guidelines to remedy the default. When does Permex Petroleum Corporation (OILCF) aim to file the Annual Filings? The company anticipates filing the Annual Filings and resolving its default on or before March 29, 2024."
JetBlue Flights to the Emerald Isle Taking Off Today,2024-03-14T01:21:00.000Z,Neutral,Very Positive,"JetBlue (Nasdaq: JBLU) expands transatlantic offerings with new nonstop flights from New York and Boston to Dublin, reinforcing its disruptive presence in the industry. The airline introduces award-winning Mint and core products, offering limited roundtrip fares starting at $399, $499, 399, 499 in Core and $1999, $2499, 1999, 2499 in Mint. JetBlue aims to provide low fares and great service on popular routes, with plans for further European expansion.","JetBlue Flights to the Emerald Isle Taking Off Today Rhea-AI Impact (Neutral) Rhea-AI Sentiment (Very Positive) Tags Rhea-AI Summary JetBlue (Nasdaq: JBLU) expands transatlantic offerings with new nonstop flights from New York and Boston to Dublin, reinforcing its disruptive presence in the industry. The airline introduces award-winning Mint and core products, offering limited roundtrip fares starting at $399, $499, 399, 499 in Core and $1999, $2499, 1999, 2499 in Mint. JetBlue aims to provide low fares and great service on popular routes, with plans for further European expansion. Positive None. Negative None. 03/13/2024 - 09:21 PM Daily Nonstop Seasonal Service from New York and Boston to Dublin Introduces the Airlines Award-Winning Mint and Core Product Offerings to its Fourth Transatlantic Market To Celebrate Launches, Limited Roundtrip Fares Starting at $399, $499, 399, 499 in Core and $1999, $2499, 1999, 2499 in Mint Available NEW YORK--(BUSINESS WIRE)-- JetBlue (Nasdaq: JBLU) announced it has expanded its transatlantic offerings with new, nonstop flights taking off from New York and Boston today. Daily summer-seasonal service from New Yorks John F. Kennedy International Airport (JFK) and Boston Logan International Airport (BOS) to Dublin Airport (DUB) will operate through September 30, 2024 and reinforce JetBlues role as a disruptor in the industry as it brings low fares and great service to these popular routes. JetBlue has disrupted the transatlantic market since it first launched flights to London in 2021 offering a fresh, innovative, customer-focused experience without the historically high fares of legacy carriers. Since then, JetBlue has expanded its portfolio to include Paris, Amsterdam and now Dublin, and will continue its growth in Europe with seasonal flights to Edinburgh and additional frequencies to Paris later this spring. JetBlues entrance into Dublin is set to introduce a new era of low fares and great service between Ireland and the Northeast, said Joanna Geraghty, chief executive officer, JetBlue. We look forward to introducing our award-winning Mint and core service to business and leisure customers traveling to and from Dublin just in time for Saint Patricks Day and the summer holiday season. Travelers from the U.S. account for nearly 20% of all overseas tourism to Ireland, and Dublin has been among the most requested European destinations previously not served by JetBlue. With a strong, historic connection between Ireland and the United States  especially JetBlues Northeast focus cities, New York and Boston  that draws millions of travelers each way annually, JetBlue continues to deliver on its commitment to bring customers to the places they most want to go. Customers traveling from Dublin can conveniently connect to other destinations JetBlue serves from New York and Boston across the U.S., the Caribbean, and Latin America. The arrival of JetBlue to Dublin Airport is very good news for both passengers and Ireland and these new direct routes between Dublin and New York and Boston are going to prove really popular. Demand for transatlantic travel has never been higher, with stronger than ever business links continuing to grow between Ireland and the US. These new services from JetBlue will mean greater choice and value for our passengers and the Dublin Airport looks forward to working with JetBlue tonight ensure they are a flying success, said Gary McLean, Managing Director, Dublin Airport. We are delighted that JetBlue has chosen to initiate new nonstop services to Ireland. The introduction of the new routes from New York and Boston to Dublin is exciting news for tourism to the island of Ireland. We look forward to working closely with JetBlue to maximize the promotion of these services. Direct, convenient, and competitive access is critical to tourism, said Alice Mansergh, Tourism Ireland CEO. Tourism Ireland is committed to working with airline partners like JetBlue and other key partners to drive demand for these new routes, and, through our multi-faceted campaigns, to communicate to consumers the ease and convenience of traveling from the East Coast to Ireland and the great experiences and warm welcome that awaits. With this new destination, JetBlue is once again disrupting transatlantic service with an elevated experience specially designed for its Airbus A321neo with Mint aircraft. The airlines Mint premium experience offers customers fully lie-flat private suites with a sliding door and a custom-designed seat cushion developed by innovative mattress company Tuft & Needle. In addition to countless intuitive design touches, every customer will feel at home in the air with the newly launched Mint amenity kits. Tucked into a stylish and reusable foldable backpack designed by Caraa, the new amenity kits contain popular wellness products from New York-based brands Dr. Denis Gross and Plus Ultra, in addition to Tuft & Needle sleep amenities. Mint customers enjoy delicious, restaurant-style small plates curated by Delicious Hospitality Groups (DHG) popular New York City restaurants Legacy Records, Charlie Bird and Pasquale Jones. Their inventive culinary style and hospitality expertise brings the best inflight dining experience to Mint tray tables. JetBlues industry-leading core experience offers a new level of service to customers who generally fly coach but still want a great experience at an attractive fare. Core customers enjoy a boutique-style experience no matter where they sit with the most legroom in coach(a) as well as innovative, fresh meals crafted specifically for the A321neo with Mint aircraft. JetBlue worked with NYC-based culinary partner DIG to design an innovative and high-quality menu that more closely aligns with the beloved culinary experience on JetBlues A321 Long Range transatlantic routes. Upon launch, options for core customers will include crepes with smoked turkey, brie and caramelized onion jam; herb and cheese frittata; pesto pasta salad with grilled chicken; and sesame noodles with ginger garlic tofu, carrots and daikon. All customers stay connected throughout the flight with fast, free and unlimited high-speed Fly-Fi(b) and have access to a wide selection of entertainment, including exclusive content from Peacock. To honor the new destination, JetBlues seatback screens will also offer a curated catalog of Irish entertainment, including films such as Belfast, Once and Brooklyn, and specially-curated audio stories about Ireland from travel storytelling platform Autio. All customers are able to enjoy a multi-screen experience onboard  just like they do at home. For more details on JetBlues transatlantic service, visit: https://www.jetblue.com/flying-with-us/uk-and-europe. Schedule between New York (JFK) and Dublin (DUB) Daily seasonal service starting March 13 (Eastbound) & March 14 (Westbound) (through September 30, 2024) *all times local JFK- DUB Flight #841 DUB - JFK Flight #842 8:47 p.m.  9:00 a.m. (+1) 10:45 a.m.  1:22 p.m. Schedule between Boston (BOS) and Dublin (DUB) Daily seasonal service starting March 13 (Eastbound) & March 14 (Westbound) (through September 30, 2024) *all times local BOS - DUB Flight #353 DUB - BOS Flight #354 8:42 p.m.  8:20 a.m. (+1) 10:55 a.m.  12:57 p.m. Flights to Dublin will operate daily on JetBlues Airbus A321neo with Mint aircraft with 16 redesigned Mint Suite seats, 144 core seats and Airbus Enhanced Cabin with XL Bins. The A321neo with Mint features a 20 percent increase in fuel efficiency and up to 500 nautical miles in additional range. To celebrate the launch, seats on the Dublin routes are on sale starting today with low fares for U.S.-originating travelers starting at $399 roundtrip from Boston and $499 from New York for the airlines award-winning core experience and starting at $1999 and $2499 for JetBlues premium Mint experience. Ireland originating travelers can enjoy special introductory roundtrip fares starting at 399 ($439) to Boston and 499 ($549) to New York for core and 1999 ($2179) and 2499 ($2729) for Mint available only on jetblue.com (c). JetBlues Commitment to Sustainability JetBlues dedication to the communities it serves is exemplified by its industry-leading climate commitments. Aligned with the Paris Agreement, the airlines science-based target aims to effectively cut aircraft emissions in half on a per-seat basis by 2035 from 2019 levels. The airline is working to achieve this through a combination of external partnerships and advocacy for industry advances in sustainability along with internal efforts to drive additional operational efficiencies. Through this strategy, JetBlues goal is to reach net zero carbon emissions by 2040, ten years ahead of broader industry targets. JetBlue believes sustainable aviation fuel (SAF) is the most meaningful way the industry can significantly address its emissions and is proud to support the growing SAF market with three currently-producing SAF suppliers in the U.S., along with multiple partnerships and investments for future SAF and new SAF technologies. JetBlue has sourced Neste SAF for its inaugural Irish flights, delivered into Dublin Airport in partnership with American Express Global Business Travel and UKG, as the airline continues to explore additional SAF opportunities in its transatlantic destinations and we all work together to build a more sustainable future of flight. Book Better with JetBlue Customers who book directly through jetblue.com are guaranteed to find our best and lowest fares, and enjoy additional benefits including access to all of JetBlues fare options, as well as fare sales and promotions, some of which may not be available through other third parties; the ability to earn 2x TrueBlue points and participate in Points Pooling; seamless seat selections and upgrades to Even More Space; 24/7 direct access to JetBlues customer service channels; and more. About JetBlue JetBlue is New York's Hometown Airline, and a leading carrier in Boston, Fort Lauderdale-Hollywood, Los Angeles, Orlando and San Juan. JetBlue, known for its low fares and great service, carries customers to more than 100 destinations throughout the United States, Latin America, the Caribbean, Canada and Europe. For more information and the best fares, visit jetblue.com. a) Based on baseline seat pitch of transatlantic aircraft. b) Fly-Fi is available on all JetBlue-operated flights. Coverage area may vary by aircraft. Details on inflight wi-fi and entertainment: https://www.jetblue.com/flying-with-us c) New York (JFK) and Boston (BOS) to Dublin (DUB) requires roundtrip purchase & Sat. night stay. Book by 3/15/2024. Travel 3/19/2024-5/8/2024. 3-day advanced purchase required. Terms apply. Price is based on a dollar-to-euro conversion as of 2/20/2024. View source version on businesswire.com: https://www.businesswire.com/news/home/20240313707997/en/ JetBlue Corporate Communications Tel: +1.718.709.3089 corpcomm@jetblue.com Source: JetBlue What are the limited roundtrip fares for JetBlue's new nonstop flights to Dublin? Limited roundtrip fares start at $399, $499, 399, 499 in Core and $1999, $2499, 1999, 2499 in Mint. What is the ticker symbol for JetBlue? The ticker symbol for JetBlue is JBLU. What are the destinations JetBlue has expanded to in Europe? JetBlue has expanded its portfolio to include Paris, Amsterdam, and now Dublin, with plans for seasonal flights to Edinburgh and additional frequencies to Paris. What is the duration of the daily summer-seasonal service from New York and Boston to Dublin? The service will operate through September 30, 2024. What percentage of overseas tourism to Ireland is accounted for by travelers from the U.S.? Travelers from the U.S. account for nearly 20% of all overseas tourism to Ireland."
Asep Medical Confirms the Use of AI - Enables Improved Treatments for Common Biofilm Infections and Rapid Sepsis Diagnostics,2024-03-14T00:11:00.000Z,Neutral,Neutral,"Asep Medical Holdings Inc. presented groundbreaking AI technology for developing new biofilm infection treatments and a blood-based gene expression test for sepsis. AI methods predicted improved peptides with high biofilm activity, leading to potential new treatments. The SepsetER test, developed using AI, accurately predicts sepsis onset with just 6 genes. AI simplified the complexity of sepsis, identifying patient groupings with different immune defects. Asep aims to address antibiotic failure by developing antimicrobial peptides using AI, showing promising results.","Asep Medical Confirms the Use of AI - Enables Improved Treatments for Common Biofilm Infections and Rapid Sepsis Diagnostics Rhea-AI Impact (Neutral) Rhea-AI Sentiment (Neutral) Tags AI Rhea-AI Summary Asep Medical Holdings Inc. presented groundbreaking AI technology for developing new biofilm infection treatments and a blood-based gene expression test for sepsis. AI methods predicted improved peptides with high biofilm activity, leading to potential new treatments. The SepsetER test, developed using AI, accurately predicts sepsis onset with just 6 genes. AI simplified the complexity of sepsis, identifying patient groupings with different immune defects. Asep aims to address antibiotic failure by developing antimicrobial peptides using AI, showing promising results. Positive None. Negative None. 03/13/2024 - 08:11 PM VANCOUVER, BC, March 13, 2024 /PRNewswire/ - In a recent presentation to the US Biophysical Society in Philadelphia1, Asep Medical Holdings Inc. (""Asep Inc."" or the ""Company"") (CSE: ASEP) (OTCQB: SEPSF) (FSE: JJ8) CEO Dr. Bob Hancock announced how the ground-breaking use of artificial intelligence (AI) has allowed the development of new and improved treatments for biofilm infections. Biofilms are communities of bacteria that infect surfaces and cause 65% of all infections. They are very hard to treat, highly resistant to all antibiotics and no FDA-approved treatment for biofilms has been developed. Asep Medical's peptides have very potent activity against biofilms and thus have the potential to replace current sub-optimal treatments, including physical removal and combinations of antibiotics. Neural network artificial intelligence (AI) methods were applied to predict improved peptides based on the company's extensive stock of proprietary peptides and, in company-sponsored studies, have been shown to enable the prediction of improved peptides with substantially higher activity against biofilms2. This has allowed the company to enhance both activity and ability to suppress inflammation (the primary pathology of biofilm infections) and to explore the diverse markets impacted by biofilms, which cost global health care an estimated $368 billion annually3. These markets include oral health (dental) care4, wounds5 and chronic rhinosinusitis6, all addressed by Asep peptides that show excellent activity in model infections. Asep's first-generation product will be an oral irrigant/rinse for preventing biofilm infections in the oral cavity, which can lead to infections and erosion of teeth and dental implants. Another use for AI technology (LASSO regression) is in the development of the SepsetER blood-based gene expression test that is preparing to enter 510(k) regulatory approval studies in the USA. This test was developed at the University of British Columbia (UBC) under the guidance of Prof. Robert E. W. Hancock and analyzes the dysfunctional immune responses involved in sepsis7. Artificial intelligence8,9 was used to identify the minimum set of genes involved in a process termed cellular reprogramming (one of the types of immune dysfunction in sepsis), and it was shown that the expression of just 6 genes can accurately predict whether a patient will acquire sepsis and associated multi-organ failure. ""We have harnessed AI to diagnose sepsis. Sepsis is a severe disease responsible for one in five deaths worldwide1 and essentially all deaths from pandemic microbes like COVID-19,"" says Dr. Hancock, Chair and CEO of Asep Inc. ""It is critical to identify sepsis as early as possible due to the 7.6% increased risk of death10 for every hour of delay in diagnosis and initiation of appropriate treatment. No conventional assay exists that accurately predicts sepsis onset in the first hours after a patient enters the hospital. Asep scientists have found that SepsetER can predict whether a patient will subsequently acquire sepsis in 9 out of 10 patients in the ICU and 7 of 10 patients in the emergency department, based on analysis of company and published data"". AI was also used to simplify the extreme complexity7 of sepsis, which has limited treatments to date. In clinical studies of patients from 4 countries/4 continents published by the Lancet Journal EBioMedicine8 and the Nature Journal Scientific Reports9, LASSO regression AI methods were applied. Five groupings (endotypes) of patients were identified as showing major differences in the underlying immune defects in each group8. These endotypes could be assessed using simple gene assays that were 89-97% accurate8. ""Deciphering the underlying immune defects of sepsis patients is key to devising precision treatments tailored to the specific type of sepsis in patients,"" stated Asep CSO Dr. Evan Haney, ""This will form the basis of a second test in development."" OVERCOMING ANTIBIOTIC FAILUREThe failure of antibiotics11 due to delayed diagnosis of sepsis, the high prevalence of recalcitrant biofilm infections and increased antibiotic resistance, compounded by declining antibiotic discovery, are among society's most pressing health issues. As described above, Dr. Hancock and his team have applied AI to discover a host of antimicrobial peptides (strings of a dozen or so amino acids), representing a promising new class of antibiotics. Asep Inc. has adapted these AI methods to address antibiotic failure associated with biofilms (a multi-cellular growth state of bacteria adaptively resistant to conventional antibiotics)12,13. Dr. Hancock's team used peptide array technology to prepare large random peptide libraries created using the amino acid composition of the most active peptides. The resultant data was used with an AI technique called artificial neural networks to develop quantitative in-silico models of antibiotic activity2,12. Random tests proved remarkably effective in predicting the activity of 100,000 virtual peptides. The best peptides, representing the top quartile of predicted activities, were effective against a broad array of multidrug-resistant ""Superbugs"" with activities that were equal to or better than four highly used conventional antibiotics, more effective than the most advanced clinical candidate antimicrobial peptide, and protective against Staphylococcus aureus infections in animal models. Similar methods were used to derive excellent antibiofilm peptides. Asep is preparing to take the best of these peptides to the clinic. ""We use AI daily as a valuable tool in the battle against antibiotic failure to solve problems that have defied conventional methods. While others are trying to figure out how AI can be best used, we are already using it with amazing success in diagnostics and therapeutics. Asep Inc. is dedicated to leveraging AI's power to improve human health,"" said Dr. Evan Haney, Chief Scientific Officer of Asep. ABOUT ASEP MEDICAL HOLDINGS INC.Asep Medical Holdings Inc. (asepmedical.com) is dedicated to addressing the global issue of antibiotic failure by developing novel solutions for significant unmet medical needs in human medicine. The Company is a consolidation of three existing private companies, all with technology in advanced development  Sepset Biosciences Inc. (proprietary diagnostic tools to enable the early and timely identification of sepsis), ABT Innovations Inc. (broad-spectrum therapeutic agents to address multi-drug resistant biofilm infections), and SafeCoat Medical Inc. (an antimicrobial peptide, anti-fouling medical device coating technology). Sepset Biosciences Inc. (sepset.ca) is developing a diagnostic technology that involves a patient gene expression signature that predicts the development of severe sepsis, one of the significant diseases leading to antibiotic failure, since antibiotics are the primary treatment for sepsis. Sepsis was responsible for nearly 20% of all deaths on the planet in 2017 and essentially all deaths due to COVID-19 and other pandemics. The SepsetER test is a blood-based gene expression assay that is straightforward to implement, and results are obtained in about an hour after taking a blood sample in the emergency room or intensive care unit. This proprietary diagnostic technology differs from current diagnostic tests in enabling the diagnosis of severe sepsis within 60 minutes of initiating the test. Bacterial culture, the gold standard, provides a diagnosis after ~15 hours but can be as long as three days. Asep Inc. believes its test will enable physicians to make critical early decisions regarding appropriate therapies and thus reduce overall morbidity and mortality due to sepsis. ABT Innovations Inc.'s (abtinnovations.ca) peptide technology covers a broad range of therapeutic applications, including bacterial biofilm infections (medical device infections, chronic infections, lung, bladder, wound, dental, skin, ear-nose and throat, sinusitis, orthopaedic, etc.), anti-inflammatories, anti-infective immune-modulators and vaccine adjuvants. The company is in the pre-clinical development phase with promising data. SafeCoat Medical Inc.'s (safecoatmedical.com) technology incorporates self-assembling biocompatible polymers that can be combined with conjugated antimicrobial peptides and applied to virtually any surface as stable antimicrobial and/or anti-fouling coatings. Of particular interest is the application of this versatile antimicrobial coating to various medical devices and implants that often become contaminated with biofilm infections. SafeCoat is optimizing methods to manufacture and apply these anti-bacterial coatings to a host of surfaces and can tailor the composition of the coating and associated peptide sequences for any desired application. FORWARD-LOOKING STATEMENTS This news release contains certain ""forward-looking statements"" within the meaning of such statements under applicable securities law. Forward-looking statements are frequently characterized by words such as ""anticipates,"" ""plan,"" ""continue,"" ""expect,"" ""project,"" ""intend,"" ""believe,"" ""anticipate,"" ""estimate,"" ""may,"" ""will,"" ""potential,"" ""proposed,"" ""positioned"" and other similar words, or statements that certain events or conditions ""may"" or ""will"" occur. These statements include but are not limited to the successful clinical testing of our Sepsis diagnostic test and its intended filing for regulatory approval; the Company not receiving regulatory approval as planned or at all; the undertaking of pre-clinical studies on our lead therapeutic, with the expectation that this will lead to fast-track clinical trials; the timeframe for diagnosis of sepsis with the company's products; the potential opportunities for the generation of revenue; the therapeutic benefits of the company's products; and other statements regarding the company's proposed business plans. Various assumptions were used in drawing conclusions or making the predictions contained in the forward-looking statements throughout this news release. Forward-looking statements are based on the opinions and estimates of management at the date the statements are made and are subject to a variety of risks including the risk that the company's products may not perform as expected; that the company may not receive the requisite regulatory approvals or results of testing; the Company's testing of the products may not be successful and approvals may not be obtained in the estimated timelines or at all; the company may not be able to generate revenue from its products as expected or at all; the market for the company's products may not be as described in this news release; and various other risk factors identified in the Asep Medical Inc.'s prospectus dated November 9, 2021, and in the company's management discussion and analysis, available for review under the Company's profile at www.sedar.com and uncertainties and other factors that could cause actual events or results to differ materially from those projected in the forward-looking statements. Asep Medical Inc. is under no obligation and expressly disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as expressly required by applicable law. ENDNOTES 1 https://www.biophysics.org/2024meeting#/ 2 Haney, E.F., Y. Brito-Snchez, M.J. Trimble, S.C. Mansour, A. Cherkasov, and R.E.W. Hancock. 2018. Computer-aided discovery of peptides that specifically attack bacterial biofilms. Sci. Reports 8:1871. 3 Cmara et al. (2022) npj Biofilms and Microbiomes. 8:42. 4 Hu, J., J. Yu, H. Liu, Z. Wang, M. Haapasalo, E.F. Haney, R.E.W. Hancock, S. Deng, and Y. Shen. 2023. Dynamic killing effectiveness of mouth rinses and a d-enantiomeric peptide on oral multispecies biofilms grown on dental restorative material surfaces. J. Dentistry. 134:104552. 5 Wu, B.C., E.F. Haney, N. Akhoundsadegh, D. Pletzer, M.J. Trimble, A.E. Adriaans, P.H. Nibbering and R.E.W. Hancock. 2021. Human organoid biofilm model for assessing antibiofilm activity of novel agents. NPJ Biofilms and Microbiomes 7:8. 6 Alford, M.A., K.-Y.G. Choi, M.J. Trimble, H. Masoudi, P. Kalsi, D. Pletzer, R.E.W. Hancock. 2021. Murine models of sinusitis infection for screening antimicrobial and immunomodulatory therapies. Frontiers Cell. Infect. Microbiol. 11:621081. 7 Rudd, K. E. et al. Global, regional, and national sepsis incidence and mortality, 1990-2017: analysis for the Global Burden of Disease Study. Lancet 395, 200211 (2020).8 Baghela, A., O.M. Pena, A.H. Lee, B. Baquir, R. Falsafi, A. An, S.W. Farmer, A. Hurlburt, A. Mondragon-Cardona, J.D. Rivera, A. Baker, U. Trahtemberg, M. Shojaei, C.E. Jimenez-Canizales, C.C. dos Santos, B. Tang, H.R. Bouma, G.V. Cohen Freue, and R.E.W. Hancock. 2022. Predicting sepsis severity at first clinical presentation: the role of endotypes and mechanistic signatures. eBiomedicine 75:103776.9 Baghela, A., A. An, P. Zhang, E. Acton, J. Gauthier, E. Brunet-Ratnasingham, T. Blimkie, G. Cohen Freue, D. Kaufmann, A.H.Y. Lee, R.C. Levesque, and R.E.W. Hancock. 2023. Predicting severity in COVID-19 disease using sepsis blood gene expression signatures. Sci. Reports 13:1247. 10 Kumar, A. et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med 34, 15891596 (2006). 11 Haney, E.H., and R.E.W. Hancock. 2022. Addressing antibiotic failure  beyond genetically encoded antimicrobial resistance. Frontiers Drug Discov. 2:892975. 12 Cherkasov, A., K. Hilpert, H. Jenssen, C.D. Fjell, M. Waldbrook, S.C. Mullaly, R. Volkmer and R.E.W. Hancock. 2009. Use of artificial intelligence in the design of small peptide antibiotics effective against a broad spectrum of highly antibiotic resistant Superbugs. ACS Chemical Biol. 4:65-74. 13 Hancock, R.E.W., M. Alford, and E.F. Haney. 2021. Antibiofilm activity of host defence peptides: Complexity provides opportunities. Nature Microbiol. Rev. 19:786-797. View original content to download multimedia:https://www.prnewswire.com/news-releases/asep-medical-confirms-the-use-of-ai---enables-improved-treatments-for-common-biofilm-infections-and-rapid-sepsis-diagnostics-302088727.html SOURCE ASEP Medical Holdings Inc. What did Asep Medical Holdings Inc. present at the US Biophysical Society? Asep Inc. presented ground-breaking AI technology for developing new treatments for biofilm infections and a blood-based gene expression test for sepsis at the US Biophysical Society. What is the ticker symbol for Asep Medical Holdings Inc. on the OTCQB market? The ticker symbol for Asep Medical Holdings Inc. on the OTCQB market is SEPSF. How does the SepsetER test predict sepsis onset? The SepsetER test predicts sepsis onset accurately using just 6 genes, developed using AI technology. What is the potential impact of Asep's peptides on antibiotic failure? Asep's peptides, developed using AI methods, show promising results in addressing antibiotic failure associated with biofilms and antibiotic resistance. Who announced the groundbreaking AI technology for new biofilm infection treatments? CEO Dr. Bob Hancock of Asep Medical Holdings Inc. announced the groundbreaking AI technology for new biofilm infection treatments."
"Ichor Holdings, Ltd. Announces Pricing of $125 Million Public Offering",2024-03-14T00:20:00.000Z,Low,Neutral,"Ichor Holdings, Ltd. (ICHR) announced a public offering of 3,333,334 ordinary shares at $37.50 per share, with an option for additional shares. The net proceeds will be used for debt repayment and general corporate purposes. The offering is expected to close on March 18, 2024. TD Cowen and Stifel are the joint book-running managers for the offering.","Ichor Holdings, Ltd. Announces Pricing of $125 Million Public Offering Rhea-AI Impact (Low) Rhea-AI Sentiment (Neutral) Tags offering Rhea-AI Summary Ichor Holdings, Ltd. (ICHR) announced a public offering of 3,333,334 ordinary shares at $37.50 per share, with an option for additional shares. The net proceeds will be used for debt repayment and general corporate purposes. The offering is expected to close on March 18, 2024. TD Cowen and Stifel are the joint book-running managers for the offering. Positive None. Negative None. Financial Analyst The pricing of Ichor Holdings' public offering at $37.50 per share represents a strategic move to strengthen the company's balance sheet. By repaying outstanding debt, the company is likely aiming to reduce interest expenses and improve its financial leverage ratio. This can be seen as a positive signal to investors that management is focused on maintaining a healthy capital structure. The option for underwriters to purchase additional shares could also provide a cushion for the company, potentially reducing the risk of stock price volatility post-offering. However, the dilutive effect on existing shareholders cannot be ignored, as the increase in share count will spread the company's earnings over a larger base, potentially impacting earnings per share (EPS). Market Research Analyst The semiconductor industry is known for its cyclical nature and capital-intensive operations. Ichor Holdings' decision to potentially allocate funds for capital expenditures and strategic acquisitions indicates an aggressive growth strategy. Given the industry's rapid technological advancements, staying competitive often requires continuous investment in R&D and modernizing equipment. Investors should assess the company's past capital allocation efficiency and how these investments could translate into market share gains or entry into new markets. The timing of the offering, market conditions and the company's performance relative to its peers would also be critical factors in evaluating the potential impact on the company's stock performance. Legal Expert From a legal perspective, the offering's reliance on an effective shelf registration statement on Form S-3 suggests a level of preparedness and strategic planning. Shelf registrations allow for the quick capitalization on favorable market conditions, which can be advantageous for the issuer. However, the final terms disclosed in the final prospectus supplement will be crucial for investors, as they contain detailed information about the offering's specifics and the associated risks. Investors should review these documents thoroughly to understand the legal implications and rights associated with the newly issued shares, especially in light of the SEC's regulatory framework. 03/13/2024 - 08:20 PM FREMONT, Calif.--(BUSINESS WIRE)-- Ichor Holdings, Ltd. (NASDAQ: ICHR), a leader in the design, engineering, and manufacturing of critical fluid delivery subsystems and components for semiconductor capital equipment, today announced that it has priced an underwritten public offering of 3,333,334 of its ordinary shares at $37.50 per share. In addition, the Company has granted the underwriters a 30-day option to purchase up to an additional 500,000 of its ordinary shares at the public offering price, less underwriting commissions. The Company intends to use the net proceeds it receives from the offering to repay outstanding indebtedness and for general corporate purposes, which may include, among other things, capital expenditures, potential acquisitions, growth opportunities, and strategic transactions. The offering is expected to close on March 18, 2024, subject to the satisfaction of customary closing conditions. TD Cowen and Stifel are acting as joint book-running managers and representatives of the underwriters for the offering. B. Riley Securities, Needham & Company, Craig-Hallum and D.A. Davidson & Co. are acting as co-managers for the offering. The shares are being offered by the Company pursuant to an effective shelf registration statement on Form S-3 that was filed with the Securities and Exchange Commission (""SEC"") on August 9, 2023 and became effective upon such filing. This offering is being made only by means of a prospectus supplement and accompanying base prospectus that form a part of the registration statement. A preliminary prospectus supplement relating to and describing the terms of the offering was filed with the SEC on March 12, 2024, copies of which may be obtained for free by visiting the SECs website at www.sec.gov. The prospectus supplement and accompanying base prospectus may also be obtained by sending a request to: Cowen and Company, LLC, 599 Lexington Avenue, New York, NY 10022, by telephone at (833) 2972926, or by email at Prospectus_ECM@cowen.com or Stifel, Nicolaus & Company, Incorporated, Attention: Syndicate, One Montgomery Street, Suite 3700, San Francisco, CA 94104, by telephone at (415) 3642720, or by email at syndprospectus@stifel.com. The final terms of the offering will be disclosed in a final prospectus supplement to be filed with the SEC. Investors are advised to carefully consider the investment objective, risks, charges and expenses of Ichor Holdings, Ltd. before investing. The preliminary prospectus supplement dated March 12, 2024 and the accompanying prospectus dated August 9, 2023 contain this and other information about Ichor Holdings, Ltd. and should be read carefully before investing. This press release shall not constitute an offer to sell or the solicitation of an offer to buy the Companys ordinary shares or any other securities, and there shall not be any offer, solicitation, or sale of securities mentioned in this press release in any state or jurisdiction in which such offer, solicitation, or sale would be unlawful prior to registration or qualification under the securities laws of such any state or jurisdiction. About Ichor We are a leader in the design, engineering and manufacturing of critical fluid delivery subsystems and components primarily for semiconductor capital equipment, as well as other industries such as defense/aerospace and medical. Our primary product offerings include gas and chemical delivery subsystems, collectively known as fluid delivery subsystems, which are key elements of the process tools used in the manufacturing of semiconductor devices. Our gas delivery subsystems deliver, monitor and control precise quantities of the specialized gases used in semiconductor manufacturing processes such as etch and deposition. Our chemical delivery subsystems precisely blend and dispense the reactive liquid chemistries used in semiconductor manufacturing processes such as chemical-mechanical planarization, electroplating, and cleaning. We also provide precision-machined components, weldments, e-beam and laser welded components, precision vacuum and hydrogen brazing, surface treatment technologies, and other proprietary products. We are headquartered in Fremont, CA. https://ir.ichorsystems.com. Safe Harbor Statement Certain statements in this release are ""forward-looking statements"" made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. The words anticipate, believe, contemplate, designed, estimate, expect, forecast, goal, guidance, intend, may, outlook, plan, predict, project, see, seek, target, would and similar expressions or variations or negatives of these words are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. Examples of forward-looking statements include statements regarding the completion, timing, size and use of proceeds of the offering and the satisfaction of closing conditions related to the offering, as well as any other statement that does not directly relate to any historical fact. Such forward-looking statements are based on our managements current expectations about future events as of the date hereof and involve many risks and uncertainties that could cause our actual results to differ materially from those expressed or implied in our forward-looking statements. Our actual results and outcomes could differ materially from those included in these forward-looking statements as a result of various factors, including, but not limited to: (1) geopolitical, economic and market conditions, including high inflation, changes to fiscal and monetary policy, high interest rates, currency fluctuations, challenges in the supply chain and any disruptions in the global economy as a result of the conflicts in Ukraine and the Middle East, (2) dependence on expenditures by manufacturers and cyclical downturns in the semiconductor capital equipment industry, (3) reliance on a very small number of original equipment manufacturers for a significant portion of sales, (4) negotiating leverage held by our customers, (5) competitiveness and rapid evolution of the industries in which we participate, (6) risks associated with weakness in the global economy and geopolitical instability, (7) keeping pace with developments in the industries we serve and with technological innovation generally, (8) designing, developing and introducing new products that are accepted by original equipment manufacturers in order to retain our existing customers and obtain new customers, (9) managing our manufacturing and procurement process effectively, (10) defects in our products that could damage our reputation, decrease market acceptance and result in potentially costly litigation, and (11) our dependence on a limited number of suppliers. Additional information concerning these and other factors can be found in our filings with the SEC, including other risks, relevant factors, and uncertainties identified in the ""Risk Factors"" section of our Annual Report on Form 10K for the year ended December 29, 2023 filed with the SEC on February 23, 2024 and any other periodic reports that we may file with the SEC. All forward-looking statements in this press release are based upon information available to us as of the date hereof, and qualified in their entirety by this cautionary statement. We undertake no obligation to update or revise any forward-looking statements contained herein, whether as a result of actual results, changes in our expectations, future events or developments, or otherwise, except as required by law. View source version on businesswire.com: https://www.businesswire.com/news/home/20240313163729/en/ Greg Swyt, CFO 510-897-5200 Claire McAdams, IR & Strategic Initiatives 530-265-9899 ir@ichorsystems.com Source: Ichor Holdings, Ltd. What is the ticker symbol for Ichor Holdings, Ltd.? The ticker symbol for Ichor Holdings, Ltd. is ICHR. How many ordinary shares were offered in the public offering? 3,333,334 ordinary shares were offered in the public offering. At what price were the ordinary shares priced in the offering? The ordinary shares were priced at $37.50 per share in the offering. Who are the joint book-running managers for the offering? TD Cowen and Stifel are the joint book-running managers for the offering. When is the expected closing date for the offering? The offering is expected to close on March 18, 2024. What will the net proceeds from the offering be used for? The net proceeds from the offering will be used for debt repayment and general corporate purposes."
Coinbase Announces Pricing of Upsized Offering of $1.1 Billion of 0.25% Convertible Senior Notes Due 2030,2024-03-14T00:03:00.000Z,Low,Neutral,"Coinbase Global, Inc. announced the pricing of $1.1 billion aggregate principal amount of Convertible Senior Notes due 2030 in a private offering to qualified institutional buyers. The offering size was increased from $1.0 billion, with potential net proceeds of $1.08 billion to $1.24 billion. Coinbase plans to use the funds for debt repayment, general corporate purposes, capped call transactions, and potential investments or acquisitions. The notes will bear interest at 0.25% per year and mature on April 1, 2030, with conversion rights at an initial rate of 2.9981 shares per $1,000 principal amount of notes.","Coinbase Announces Pricing of Upsized Offering of $1.1 Billion of 0.25% Convertible Senior Notes Due 2030 Rhea-AI Impact (Low) Rhea-AI Sentiment (Neutral) Tags Rhea-AI Summary Coinbase Global, Inc. announced the pricing of $1.1 billion aggregate principal amount of Convertible Senior Notes due 2030 in a private offering to qualified institutional buyers. The offering size was increased from $1.0 billion, with potential net proceeds of $1.08 billion to $1.24 billion. Coinbase plans to use the funds for debt repayment, general corporate purposes, capped call transactions, and potential investments or acquisitions. The notes will bear interest at 0.25% per year and mature on April 1, 2030, with conversion rights at an initial rate of 2.9981 shares per $1,000 principal amount of notes. Positive None. Negative None. Financial Analyst The recent announcement by Coinbase regarding the pricing of $1.1 billion in Convertible Senior Notes due 2030 marks a significant financing event for the company. The decision to increase the offering from $1.0 billion to $1.1 billion, with an additional option for initial purchasers to buy up to $165.0 million more to cover over-allotments, reflects strong demand and potentially positive market sentiment towards Coinbase's financial health and future prospects. The use of proceeds to manage existing debt obligations, such as the repayment or repurchase of outstanding notes due in 2026, 2028 and 2031, illustrates a proactive approach to capital structure management. This could be seen as a strategic move to improve the company's debt maturity profile and reduce interest expenses, as the new notes have a lower interest rate compared to some of the existing notes.Investors should consider the impact of these convertible notes on potential dilution of existing shares, although the capped call transactions are designed to mitigate this effect to some extent. The initial conversion price represents a 32.5% premium over the recent share price, which may be attractive to investors if they are bullish on the company's stock performance. Market Research Analyst Convertible notes are a hybrid financial instrument offering both debt and equity features, which can be appealing to investors seeking both fixed income and potential upside in the company's equity. The low interest rate of 0.25% per year on the notes indicates investor confidence in Coinbase's creditworthiness and future profitability. The capped call transactions, which are intended to reduce potential equity dilution and cash payment obligations upon conversion, are noteworthy as they reflect Coinbase's efforts to manage its share price volatility and protect against excessive dilution. The initial cap price of approximately $503.46 per share is double the last reported sale price of Coinbase's Class A common stock, suggesting an optimistic outlook on the company's value growth.The market's reaction to these transactions, particularly the potential share price impact from the option counterparties' hedging activities, should be monitored closely. The derivative transactions and secondary market activities by these counterparties could influence Coinbase's stock price, affecting not only the conversion attractiveness but also investor perception of the company's market stability. Legal Expert It is important to note the regulatory framework within which this offering is taking place. The notes are being offered pursuant to Rule 144A under the Securities Act of 1933, which allows for the sale of securities to qualified institutional buyers without the need for a public offering. This private offering nature limits the pool of potential investors but also simplifies the regulatory compliance requirements for Coinbase.Furthermore, the fact that the notes and any shares of Class A common stock potentially issuable upon conversion have not been registered under the Securities Act highlights the importance of adhering to exemptions from registration requirements. Investors need to be aware that the resale of these securities may be restricted, which could affect their liquidity and marketability.Lastly, the redemption features and the fundamental change repurchase rights provide Coinbase with flexibility in managing its debt while giving investors protection against significant corporate events that could adversely affect the value of their investment. 03/13/2024 - 08:03 PM Remote-First-Company/SANTA FE, N.M.--(BUSINESS WIRE)-- Coinbase Global, Inc. (Coinbase) (Nasdaq: COIN) today announced the pricing of $1.1 billion aggregate principal amount of Convertible Senior Notes due 2030 (the notes) in a private offering (the offering) to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A promulgated under the Securities Act of 1933, as amended (the Securities Act). The aggregate principal amount of the offering was increased from the previously announced offering size of $1.0 billion. Coinbase also granted the initial purchasers of the notes a 30-day option to purchase up to an additional $165.0 million principal amount of notes, solely to cover over-allotments. The sale of the notes to the initial purchasers is expected to settle on March 18, 2024, subject to customary closing conditions, and is expected to result in approximately $1.08 billion (or approximately $1.24 billion if the initial purchasers exercise their option to purchase additional notes in full) in net proceeds to Coinbase after deducting the initial purchasers discounts and commissions and estimated offering expenses payable by Coinbase. Coinbase intends to use the net proceeds from the offering to repay at maturity, or repurchase or redeem prior to maturity, from time to time and subject to market conditions, its outstanding 0.50% Convertible Senior Notes due 2026, 3.375% Senior Notes due 2028, and 3.625% Senior Notes due 2031 and for other general corporate purposes, which may include working capital and capital expenditures, and to pay the cost of the capped call transactions. If the initial purchasers exercise their option to purchase additional notes, Coinbase expects to use a portion of the net proceeds from the sale of such additional notes to enter into additional capped call transactions. Coinbase may also use a portion of the net proceeds to make investments in and acquisitions of other companies, products or technologies that Coinbase may identify from time to time. The notes will be senior, unsecured obligations of Coinbase. The notes will bear interest of 0.25% per year payable semi-annually in arrears on April 1 and October 1 of each year, beginning on October 1, 2024. The notes will mature on April 1, 2030, unless earlier repurchased, redeemed or converted. Coinbase may not redeem the notes prior to April 1, 2027. Coinbase may redeem all or any portion of the notes (subject to certain limitations), at its option, on or after April 1, 2027 and on or before the 20th scheduled trading day immediately before the maturity date, if the last reported sale price of Coinbases Class A common stock exceeds 130% of the conversion price then in effect on (1) each of at least 20 trading days (whether or not consecutive) during the 30 consecutive trading days ending on, and including, the trading day immediately before the date Coinbase sends the related redemption notice; and (2) the trading day immediately before the date Coinbase sends such notice, at a redemption price equal to 100% of the principal amount of the notes to be redeemed, plus any accrued and unpaid interest to, but excluding, the redemption date. No sinking fund is provided for the notes, which means that Coinbase is not required to redeem or retire the notes periodically. Subject to a limited exception, holders of the notes will have the right to require Coinbase to repurchase for cash all or a portion of their notes upon the occurrence of a fundamental change (as defined in the indenture governing the notes) at a purchase price of 100% of their principal amount plus any accrued and unpaid interest. The notes will be convertible at an initial conversion rate of 2.9981 shares of Coinbases Class A common stock, per $1,000 principal amount of notes (equivalent to an initial conversion price of approximately $333.54 per share of Class A common stock, which represents a conversion premium of approximately 32.5% to the last reported sale price of $251.73 per share of Coinbases Class A common stock on The Nasdaq Global Select Market on March 13, 2024). Prior to the close of business on the business day immediately preceding October 1, 2029, the notes will be convertible at the option of the noteholders only upon the satisfaction of specified conditions and during certain periods. On or after October 1, 2029 until the close of business on the second scheduled trading day preceding the maturity date, the notes will be convertible at the option of the noteholders at any time regardless of these conditions. Conversions of the notes will be settled in cash, shares of Coinbases Class A common stock, or a combination thereof, at Coinbases election. In connection with the pricing of the notes, Coinbase entered into privately negotiated capped call transactions with certain of the initial purchasers or their affiliates and/or other financial institutions (the option counterparties). The capped call transactions cover, subject to customary adjustments, the number of shares of Coinbases Class A common stock that will initially underlie the notes. The capped call transactions are expected generally to reduce the potential dilution to Coinbases Class A common stock upon any conversion of the notes and/or offset any potential cash payments Coinbase is required to make in excess of the principal amount of converted notes, as the case may be, with such reduction and/or offset subject to a cap. The cap price of the capped call transactions is initially approximately $503.46 per share, which represents a premium of 100% over the last reported sale price of Coinbases Class A common stock of $251.73 per share on March 13, 2024, and is subject to certain adjustments under the terms of the capped call transactions. Coinbase has been advised that, in connection with establishing their initial hedges of the capped call transactions, the option counterparties or their respective affiliates expect to enter into various derivative transactions with respect to Coinbases Class A common stock and/or purchase shares of Coinbases Class A common stock concurrently with or shortly after the pricing of the notes. This activity could increase (or reduce the size of any decrease in) the market price of Coinbases Class A common stock or the notes at that time. In addition, Coinbase has been advised that the option counterparties or their respective affiliates may modify their hedge positions by entering into or unwinding various derivatives with respect to Coinbases Class A common stock and/or purchasing or selling Coinbases Class A common stock or other securities of Coinbase in secondary market transactions following the pricing of the notes and from time to time prior to the maturity of the notes (and are likely to do so during the relevant valuation period under the capped call transactions or following any early conversion of the notes, any repurchase of the notes by Coinbase on any fundamental change repurchase date, any redemption date or any other date on which the notes are retired by Coinbase, in each case if Coinbase exercises its option to terminate the relevant portion of the capped call transactions). This activity could also cause or avoid an increase or a decrease in the market price of Coinbases Class A common stock or the notes, which could affect the ability of noteholders to convert the notes and, to the extent the activity occurs during any observation period related to a conversion of the notes, it could affect the number of shares of Class A common stock, if any, and value of the consideration that noteholders will receive upon conversion of the notes. The notes were only offered and sold to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A promulgated under the Securities Act by means of a private offering memorandum. Neither the notes nor the shares of Coinbases Class A common stock potentially issuable upon conversion of the notes, if any, have been, or will be, registered under the Securities Act or the securities laws of any other jurisdiction, and unless so registered, may not be offered or sold in the United States, except pursuant to an applicable exemption from such registration requirements. This announcement is neither an offer to sell nor a solicitation of an offer to buy any of the notes or any shares of Class A common stock potentially issuable upon conversion of the notes and shall not constitute an offer, solicitation, or sale in any jurisdiction in which such offer, solicitation, or sale is unlawful. About Coinbase Crypto creates economic freedom by ensuring that people can participate fairly in the economy, and Coinbase (NASDAQ: COIN) is on a mission to increase economic freedom for more than 1 billion people. Were updating the century-old financial system by providing a trusted platform that makes it easy for people and institutions to engage with crypto assets, including trading, staking, safekeeping, spending, and fast, free global transfers. We also provide critical infrastructure for onchain activity and support builders who share our vision that onchain is the new online. And together with the crypto community, we advocate for responsible rules to make the benefits of crypto available around the world. Cautionary Statement Regarding Forward-Looking Statements This press release contains forward-looking statements including, among other things, statements relating to the completion of the offering, the potential effects of entering into capped call transactions, and the expected use of proceeds from the offering. Statements containing words such as could, believe, expect, intend, will, or similar expressions constitute forward-looking statements. These forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These statements involve risks and uncertainties that could cause actual results to differ materially, including, but not limited to, whether or not Coinbase will consummate the offering, prevailing market conditions, the anticipated use of the net proceeds of the offering, which could change as a result of market conditions or for other reasons, the impact of general economic, industry or political conditions in the United States or internationally, and whether the capped call transactions will become effective. The foregoing list of risks and uncertainties is illustrative, but is not exhaustive. For information about other potential factors that could affect Coinbases business and financial results, please review the Risk Factors described in Coinbases Annual Report on Form 10-K for the year ended December 31, 2023 filed with the Securities and Exchange Commission (the SEC) and in Coinbases other filings with the SEC. Except as may be required by law, Coinbase undertakes no obligation, and does not intend, to update these forward-looking statements after the date of this release. View source version on businesswire.com: https://www.businesswire.com/news/home/20240313516156/en/ Press: press@coinbase.com Investors: investor@coinbase.com Source: Coinbase Global, Inc. What is the total principal amount of Convertible Senior Notes due 2030 offered by Coinbase in the private offering? Coinbase offered $1.1 billion aggregate principal amount of Convertible Senior Notes due 2030 in the private offering. What is the purpose of the net proceeds from the offering for Coinbase? Coinbase intends to use the net proceeds for debt repayment, general corporate purposes, capped call transactions, and potential investments or acquisitions. What is the interest rate on the Convertible Senior Notes due 2030? The notes will bear interest at 0.25% per year payable semi-annually. When will the notes mature? The notes will mature on April 1, 2030, unless earlier repurchased, redeemed, or converted. What is the initial conversion rate for the Convertible Senior Notes due 2030? The initial conversion rate is 2.9981 shares of Coinbase's Class A common stock per $1,000 principal amount of notes."
BowFlex Inc. assigned BFXXQ symbol on OTC Market,2024-03-14T00:34:00.000Z,High,Neutral,"BowFlex Inc. has been delisted from the NYSE and assigned the symbol 'BFXXQ' on the OTC market due to a Chapter 11 bankruptcy filing. Shareholders face uncertainty regarding the stock's value, trading, and market development.","BowFlex Inc. assigned BFXXQ symbol on OTC Market Rhea-AI Impact (High) Rhea-AI Sentiment (Neutral) Tags Rhea-AI Summary BowFlex Inc. has been delisted from the NYSE and assigned the symbol 'BFXXQ' on the OTC market due to a Chapter 11 bankruptcy filing. Shareholders face uncertainty regarding the stock's value, trading, and market development. Positive None. Negative The delisting from the NYSE due to a Chapter 11 bankruptcy filing poses significant risks for shareholders, including uncertainty about the stock's value and trading on the OTC market. Financial Analyst The transition of BowFlex Inc. from the NYSE to the OTC market is a significant financial event, indicating a substantial shift in the company's market standing. The assignment of a new stock symbol, 'BFXXQ', typically indicates a company in distress and in this case, it follows the initiation of Chapter 11 bankruptcy proceedings. Investors should be aware that such a move often leads to a decrease in liquidity and visibility of the stock, potentially leading to greater volatility and reduced investor confidence.Furthermore, the company's statement about the lack of obligation to maintain a market in the common stock is a clear signal of risk to stockholders. The uncertainty surrounding the ultimate effect of the bankruptcy proceedings on the stock's value is a critical consideration. In some cases, common stockholders may end up with little to no return on their investment post-bankruptcy, depending on the company's ability to restructure its debts and the priority of claims. Market Research Analyst Moving to the OTC market often results in reduced regulatory requirements and lower costs for the company but also comes with a decrease in the stock's prominence among investors. The OTC market is less regulated than major exchanges, which can lead to less stringent reporting standards and investor scrutiny. This could impact the company's ability to raise capital in the future.It's also important to note that the lack of broker quotes and an established market can deter investment, as it implies a lack of interest and support from financial institutions. This can further affect the company's stock price and trading volume. Stakeholders should closely monitor the market response to BowFlex's OTC listing to gauge the market's perception of the company's financial health and future prospects. Legal Expert Chapter 11 proceedings allow a company to reorganize and attempt to become profitable again while temporarily holding off creditors. However, the implications for common stockholders are often negative, as they are last in line during asset liquidation, behind secured creditors, bondholders and preferred stockholders. The statement from BowFlex highlights the lack of assurance regarding the trading of its common stock, which is a legal disclosure meant to temper stockholder expectations.Investors should understand that during bankruptcy, common stock can become highly speculative. The company's warning about the potential inability of stockholders to sell or transfer their stock is a legal precaution to mitigate future disputes and manage investor expectations. This serves as a reminder of the inherent risks associated with investing in stocks, especially those undergoing financial restructuring. 03/13/2024 - 08:34 PM VANCOUVER, Wash.--(BUSINESS WIRE)-- BowFlex Inc. (BowFlex or the Company) announced that its Common Stock has been assigned the symbol BFXXQ with respect to quotations on the over-the-counter (OTC) market, following its delisting from the New York Stock Exchange. BowFlex previously announced the NYSE determination that the Company is no longer suitable for listing after the Company disclosed that the Company and certain of its subsidiaries have voluntarily initiated a Chapter 11 proceeding in the United States Bankruptcy Court for the District of New Jersey. There is uncertainty as to the ultimate effect of this process on the value of the Companys common stock and stockholders may not receive any value. The Company is under no obligation to develop or maintain a market in the common stock. The Company cannot provide assurance that its common stock will trade on the OTC Market, that brokers will provide public quotes of the Company's common stock, or that a market for the Company's common stock will develop or be maintained. Holders of common stock may not be able to sell or otherwise transfer such common stock. Investors can locate current market information and real-time quotes online at www.otcmarkets.com. About BowFlex Inc. BowFlex Inc. is a global leader in digitally connected home fitness solutions. The Companys brand family includes BowFlex, Schwinn, and JRNY, its digital fitness platform. With a broad selection of exercise bikes, cardio equipment, and strength training products, we empower healthier living through individualized connected fitness experiences and in doing so, envisions building a healthier world, one person at a time. Headquartered in Vancouver, Washington, the Companys products are sold direct to consumer on brand websites and through retail partners and are available throughout the U.S. and internationally. BowFlex Inc. uses the investor relations page of its website (www.corporate.bowflex.com/investors) to make information available to its investors and the market. Forward-Looking Statements This press release includes forward-looking statements (statements which are not historical facts) within the meaning of the Private Securities Litigation Reform Act of 1995. These statements include, but are not limited to, express or implied forward-looking statements relating to the Companys statements regarding the process and potential outcomes of the Companys Chapter 11 Cases, the Companys expectations regarding the purchase agreement and related bidding procedures and the Bankruptcy Courts approval thereof, and the Companys ability to continue to operate as usual during the Chapter 11 Cases. You are cautioned that such statements are not guarantees of future performance and that our actual results may differ materially from those set forth in the forward-looking statements. All of these forward-looking statements are subject to risks and uncertainties that may change at any time. Factors that could cause the Companys actual expectations to differ materially from these forward-looking statements also include: weaker than expected demand for new or existing products; our ability to timely acquire inventory that meets our quality control standards from sole source foreign manufacturers at acceptable costs; risks associated with current and potential delays, work stoppages, or supply chain disruptions, including shipping delays due to the severe shortage of shipping containers; an inability to pass along or otherwise mitigate the impact of raw material price increases and other cost pressures, including unfavorable currency exchange rates and increased shipping costs; experiencing delays and/or greater than anticipated costs in connection with launch of new products, entry into new markets, or strategic initiatives; our ability to hire and retain key management personnel; changes in consumer fitness trends; changes in the media consumption habits of our target consumers or the effectiveness of our media advertising; a decline in consumer spending due to unfavorable economic conditions; risks related to the impact on our business of the COVID-19 pandemic or similar public health crises; softness in the retail marketplace; availability and timing of capital for financing our strategic initiatives, including being able to raise capital on favorable terms or at all; changes in the financial markets, including changes in credit markets and interest rates that affect our ability to access those markets on favorable terms and the impact of any future impairment. Additional assumptions, risks and uncertainties that could cause actual results to differ materially from those contemplated in these forward-looking statements are described in detail in our registration statements, reports and other filings with the Securities and Exchange Commission, including the Risk Factors set forth in our Annual Report on Form 10-K, as supplemented by our quarterly reports on Form 10-Q. Such filings are available on our website or at www.sec.gov. We undertake no obligation to publicly update or revise forward-looking statements to reflect subsequent developments, events, or circumstances, except as may be required under applicable securities laws. View source version on businesswire.com: https://www.businesswire.com/news/home/20240313093143/en/ Investor Relations: John Mills ICR, LLC 646-277-1254 John.Mills@icrinc.com BowFlex Inc.: Hanna Decker BowFlex Inc. hdecker@bowflex.com Source: BowFlex Inc. Why was BowFlex delisted from the NYSE? BowFlex was delisted from the NYSE due to a Chapter 11 bankruptcy filing. What is the new symbol assigned to BowFlex's Common Stock? The new symbol assigned to BowFlex's Common Stock is 'BFXXQ' on the OTC market. What is the potential impact of BowFlex's Chapter 11 proceeding on stockholders? Stockholders may face uncertainty regarding the value of the Company's common stock and may not receive any value. Where can investors find current market information and real-time quotes for BowFlex's common stock? Investors can find current market information and real-time quotes for BowFlex's common stock online at www.otcmarkets.com."
"REV Group, Inc. Announces Pricing of Secondary Offering of Common Stock",2024-03-14T00:20:00.000Z,Low,Neutral,"REV Group, Inc. (REVG) announces the pricing of a secondary public offering of 7,395,191 shares of common stock by Selling Stockholders at $18.00 per share. The Company will not receive proceeds from the sale, with the Offering expected to close on March 15, 2024. Goldman Sachs & Morgan Stanley are the joint book-running managers for the Offering.","REV Group, Inc. Announces Pricing of Secondary Offering of Common Stock Rhea-AI Impact (Low) Rhea-AI Sentiment (Neutral) Tags offering Rhea-AI Summary REV Group, Inc. (REVG) announces the pricing of a secondary public offering of 7,395,191 shares of common stock by Selling Stockholders at $18.00 per share. The Company will not receive proceeds from the sale, with the Offering expected to close on March 15, 2024. Goldman Sachs & Morgan Stanley are the joint book-running managers for the Offering. Positive None. Negative None. Financial Analyst The secondary public offering of REV Group, Inc.'s shares by American Industrial Partners represents a notable event for current and potential investors. The offering price of $18.00 per share provides a benchmark for the market's valuation of the company's stock. Investors will be closely monitoring the stock's performance relative to this price point post-offering to gauge market sentiment and the effectiveness of the underwriters' pricing strategy.It's also important to consider the implications of the company not receiving any proceeds from this offering. This detail suggests that the transaction is aimed at providing liquidity to the Selling Stockholders rather than raising capital for the company's operational needs or growth initiatives. This could be interpreted as a signal that the major shareholders are looking to diversify their investments or realize gains, rather than a reflection on the company's future prospects. Market Research Analyst From a market dynamics perspective, the large block of shares being sold can impact the stock's liquidity and may lead to increased volatility around the time of the offering's closure. The involvement of reputable financial institutions such as Goldman Sachs & Co. LLC and Morgan Stanley as joint book-running managers could potentially reassure investors about the procedural integrity of the offering.Furthermore, the use of an effective shelf registration statement expedites the process of offering securities, allowing the company to act quickly in response to market conditions. Investors might view this as a sign of strategic financial management, although it does not directly affect the company's operations or capital structure, as the proceeds do not benefit REV Group directly. Legal Expert Compliance with SEC regulations is a critical aspect of any public offering. The fact that the offering is being conducted pursuant to an effective shelf registration statement on Form S-3 indicates that REV Group has met the necessary legal requirements to make this offering available to the public. This includes the preparation of a prospectus supplement and the accompanying base prospectus, which must be filed with the SEC and made available to potential investors.The disclaimer at the end of the announcement serves as a reminder of the legal boundaries within which such offerings are conducted. It highlights that the securities cannot be sold in jurisdictions where it would be unlawful prior to registration or qualification under the securities laws of those states or jurisdictions, ensuring that the offering adheres to the legal standards set forth by regulatory authorities. 03/13/2024 - 08:20 PM MILWAUKEE--(BUSINESS WIRE)-- REV Group, Inc. (NYSE:REVG) (the Company) announced today the pricing of the previously announced underwritten secondary public offering of 7,395,191 shares of the Companys common stock (the Offering) by American Industrial Partners Capital Fund IV, LP and American Industrial Partners Capital Fund IV (Parallel), LP (the Selling Stockholders) at an offering price of $18.00 per share. The Offering consists entirely of shares of the Companys common stock to be sold by the Selling Stockholders, and the Company will not receive any proceeds from the sale of the shares being offered by the Selling Stockholders. The Offering is expected to close on March 15, 2024, subject to customary closing conditions. Goldman Sachs & Co. LLC and Morgan Stanley are acting as joint book-running managers for the Offering. The Offering is being made pursuant to an effective shelf registration statement on Form S-3 (Registration No. 333-276009), which has been filed with the Securities and Exchange Commission (SEC) and became effective on December 19, 2023. The Offering will be made only by means of a prospectus supplement and the accompanying base prospectus. You may get these documents for free, including the prospectus supplement, once available, by visiting EDGAR on the SEC website at www.sec.gov. Alternatively, copies of the prospectus supplement, once available, and the accompanying base prospectus may be obtained by contacting: Goldman Sachs & Co. LLC, 200 West Street, New York, NY 10282-2198, Attention: Prospectus Department, Telephone: 866-471-2526, Email: Prospectus-ny@ny.email.gs.com or Morgan Stanley & Co. LLC, 180 Varick Street, 2nd Floor, New York, NY 10014, Attn: Prospectus Department. This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction. About REV Group REV Group (REVG) is a leading designer, manufacturer and distributor of specialty vehicles and related aftermarket parts and services. We serve a diversified customer base, primarily in the United States, through two segments: Specialty Vehicles and Recreational Vehicles. We provide customized vehicle solutions for applications, including essential needs for public services (ambulances, fire apparatus, and transit buses), commercial infrastructure (terminal trucks and industrial sweepers) and consumer leisure (recreational vehicles). Our diverse portfolio is made up of well-established principal vehicle brands, including many of the most recognizable names within their industry. Several of our brands pioneered their specialty vehicle product categories and date back more than 50 years. REV Group trades on the NYSE under the symbol REVG. Cautionary Statement on Forward-Looking Statements This news release contains statements that the company believes to be forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. This news release includes statements that express our opinions, expectations, beliefs, plans, objectives, assumptions or projections regarding future events or future results and therefore are, or may be deemed to be, forward-looking statements. These forward-looking statements can generally be identified by the use of forward-looking terminology, including the terms believes, estimates, anticipates, expects, strives, goal, seeks, projects, intends, forecasts, outlook, guidance, plans, may, will or should or, in each case, their negative or other variations or comparable terminology. They appear in a number of places throughout this news release and include statements regarding our intentions, beliefs, goals or current expectations concerning, among other things, our results of operations, financial condition, liquidity, prospects, growth, strategies and the industries in which we operate, including REV Groups outlook for the full fiscal year 2024. Our forward-looking statements are subject to risks and uncertainties, including those highlighted under Risk Factors and Cautionary Statement on Forward-Looking Statements in the companys annual report on Form 10-K, and in the companys subsequent quarterly reports on Form 10-Q, together with the companys other filings with the SEC, which risks and uncertainties may cause actual results to differ materially from those projected or implied by the forward-looking statement. Forward-looking statements are based on current expectations and assumptions and currently available data and are neither predictions nor guarantees of future events or performance. You should not place undue reliance on forward-looking statements, which only speak as of the date hereof. The company does not undertake to update or revise any forward-looking statements after they are made, whether as a result of new information, future events, or otherwise. View source version on businesswire.com: https://www.businesswire.com/news/home/20240313762791/en/ REV Group, Inc. Drew Konop, 1-888-738-4037 (1-888-REVG-037) investors@revgroup.com Source: REV Group, Inc. What is the ticker symbol for REV Group, Inc.? The ticker symbol for REV Group, Inc. is REVG. How many shares are included in the secondary public offering announced by REV Group, Inc.? REV Group, Inc. announced a secondary public offering of 7,395,191 shares of common stock. What is the offering price per share for the secondary public offering by REV Group, Inc.? The offering price per share for the secondary public offering by REV Group, Inc. is $18.00. Who are the joint book-running managers for the Offering by REV Group, Inc.? Goldman Sachs & Morgan Stanley are acting as joint book-running managers for the Offering by REV Group, Inc. When is the expected closing date for the secondary public offering announced by REV Group, Inc.? The secondary public offering announced by REV Group, Inc. is expected to close on March 15, 2024."
Jack in the Box Celebrates St. Patricks Day With Free Oreo Cookie Mint Shakes,2024-03-14T00:05:00.000Z,No impact,Neutral,"Jack in the Box (NASDAQ: JACK) offers a free Oreo Cookie Mint Shake with a $1 minimum purchase on the Jack app or website on St. Patrick's Day. The shake, a fan favorite since 2011, features real Oreo cookie pieces mixed into a minty shake. SoCal residents can witness a rainbow over one location on March 17. The shake will be available nationwide until mid-April, starting at $5.49.","Jack in the Box Celebrates St. Patricks Day With Free Oreo Cookie Mint Shakes Rhea-AI Impact (No impact) Rhea-AI Sentiment (Neutral) Tags Rhea-AI Summary Jack in the Box (NASDAQ: JACK) offers a free Oreo Cookie Mint Shake with a $1 minimum purchase on the Jack app or website on St. Patrick's Day. The shake, a fan favorite since 2011, features real Oreo cookie pieces mixed into a minty shake. SoCal residents can witness a rainbow over one location on March 17. The shake will be available nationwide until mid-April, starting at $5.49. Positive None. Negative None. 03/13/2024 - 08:05 PM On Sunday, March 17, new and existing Jack Pack members can get a FREE OREO Cookie Mint Shake with a $1 minimum purchase on the Jack app or website SAN DIEGO--(BUSINESS WIRE)-- Jack in the Box (NASDAQ: JACK) is offering Oreo Cookie Mint Shake fans the luckiest deal on St. Patricks Day: a free Oreo Cookie Mint Shake with any $1 minimum purchase on the Jack app or website. This St. Patricks Day staple is no sham: the fan favorite features real Oreo cookie pieces mixed into the cool and minty shake, topped with whipped cream and a cherry. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240313843230/en/Jack in the Box Celebrates St. Patricks Day With Free Oreo Cookie Mint Shakes (Photo: Business Wire) Oreo Cookie Mint Shake is back for its much anticipated appearance at all Jack in the Box locations. Since its introduction in 2011, the shake has become a St. Patricks Day staple for fast food fans nationwide with a history of granting luck to all who seek it: from paying peoples rent alongside Mint Mobile last year, to steering shake-seekers away from broken ice cream machines in 2022. SoCal residents get a double dose of luck on March 17, when Jack in the Box is creating a technological miracle with a literal rainbow over one of their locations (14002 Newport Ave, Tustin, CA 92780 from 4:30pm - 5:00pm). Now, isnt a free shake at the end of the rainbow better than a broken ice cream machine at the end of some golden arches? We sure think so. After Jack in the Box celebrates St. Patricks Day in the most colorful way, fans can enjoy the Oreo Cookie Mint Shake nationwide until mid-April, starting at $5.49. About Jack in the Box Inc. Jack in the Box Inc. (NASDAQ: JACK), founded and headquartered in San Diego, California, is a restaurant company that operates and franchises Jack in the Box, one of the nation's largest hamburger chains with more than 2,180 restaurants across 21 states, and Del Taco, the second largest Mexican-American QSR chain by units in the U.S. with approximately 600 restaurants across 15 states. For more information on both brands, including franchising opportunities, visit www.jackinthebox.com and www.deltaco.com. Category: Corporate View source version on businesswire.com: https://www.businesswire.com/news/home/20240313843230/en/ Casey Middleton Public Relations, Jack in the Box media@jackinthebox.com Source: Jack in the Box Inc. How can Jack Pack members get a free Oreo Cookie Mint Shake on St. Patrick's Day? Jack Pack members can get a free Oreo Cookie Mint Shake with any $1 minimum purchase on the Jack app or website on St. Patrick's Day. What is the price of the Oreo Cookie Mint Shake after the promotional period? The Oreo Cookie Mint Shake will be available nationwide until mid-April, starting at $5.49 after the promotional period. Where can SoCal residents witness a rainbow on St. Patrick's Day? SoCal residents can witness a rainbow over the Jack in the Box location at 14002 Newport Ave, Tustin, CA 92780 from 4:30pm - 5:00pm on St. Patrick's Day."
MDU Construction Services Group Rebrands to Everus Construction Group; Spinoff Remains on Track for Late 2024,2024-03-13T20:20:00.000Z,Moderate,Neutral,"MDU Resources Group, Inc. rebrands its construction services business to Everus Construction Group, Inc. in preparation for a planned tax-free spinoff. The spinoff aims to create two independent, publicly traded companies, with the process expected to be completed late this year. Nicole A. Kivisto, CEO of MDU Resources, highlights the rebranding as a strategic move to enhance shareholder value and enable focused growth opportunities.","MDU Construction Services Group Rebrands to Everus Construction Group; Spinoff Remains on Track for Late 2024 Rhea-AI Impact (Moderate) Rhea-AI Sentiment (Neutral) Tags Rhea-AI Summary MDU Resources Group, Inc. rebrands its construction services business to Everus Construction Group, Inc. in preparation for a planned tax-free spinoff. The spinoff aims to create two independent, publicly traded companies, with the process expected to be completed late this year. Nicole A. Kivisto, CEO of MDU Resources, highlights the rebranding as a strategic move to enhance shareholder value and enable focused growth opportunities. Positive None. Negative None. Market Research Analyst The rebranding of MDU Resources Group's construction services business to Everus Construction Group marks a strategic move in anticipation of its spinoff into a separate publicly traded entity. This decision is likely to have a significant impact on the company's market positioning and investor perception. From a market research perspective, a rebranding effort can be a powerful tool to establish a new identity and differentiate the business from its parent company. It also signifies the intention to create a focused brand strategy that could potentially attract a new investor base.For existing shareholders, the spinoff promises an opportunity to benefit from the value unlocked by separating the construction services into a distinct entity. Historically, spinoffs have allowed individual businesses to pursue more targeted growth strategies, which can lead to improved operational efficiency and financial performance. However, the success of such a move depends on the market's reception to the new brand and the standalone company's ability to capitalize on growth opportunities. Financial Analyst The announcement of a tax-free spinoff by MDU Resources Group is a critical event that will likely impact the financial dynamics of the company. The separation into two independent entities can lead to a reevaluation of the stock as the market assesses the individual value propositions of MDU Resources and Everus Construction Group. Investors will be closely monitoring the financials of both companies post-spinoff to assess their performance and growth prospects.Financially, spinoffs can result in a more efficient allocation of capital and may lead to an increase in shareholder value. However, there are also risks involved, such as potential integration challenges and the costs associated with establishing Everus as a standalone entity. The market will be looking for clarity on the financial health of Everus Construction Group, including its balance sheet strength, revenue streams and profitability metrics. Legal Expert The legal process of spinning off a business unit into a separate publicly traded company involves complex regulatory compliance and due diligence to ensure a smooth transition. The tax-free nature of the spinoff suggests that it is structured to be beneficial to shareholders from a tax perspective. This is often achieved through a structure that meets specific Internal Revenue Service (IRS) guidelines to qualify as a tax-free reorganization.Legal experts will be scrutinizing the transaction to ensure that it adheres to all regulatory requirements, including securities laws and exchange listing standards. Additionally, the rebranding to Everus Construction Group must be carefully managed to avoid any trademark or intellectual property issues, which could impact the timeline of the spinoff or result in unforeseen costs. 03/13/2024 - 04:20 PM BISMARCK, N.D., March 13, 2024 /PRNewswire/ -- MDU Resources Group, Inc. (NYSE: MDU) announced today that its construction services business, MDU Construction Services Group, Inc., has rebranded to Everus Construction Group, Inc. in preparation for the planned tax-free spinoff of the business, expected to be complete late this year. MDU Resources announced on Nov. 2, 2023, that it plans to spin off the construction services business, which will result in two independent, publicly traded companies. ""Rebranding the construction services business prepares Everus to be a standalone, publicly traded company, separate from the MDU ticker symbol,"" said Nicole A. Kivisto, president and CEO of MDU Resources. ""We continue to make good progress toward completing the spinoff late this year. We believe the separation will create value for our shareholders while positioning both companies for focused growth opportunities."" Everus Construction Group provides a full spectrum of construction services through its electrical and mechanical, and transmission and distribution specialty contracting services across the United States. More information about Everus can be found at www.everus.com. ""We're very excited about this new identity for our company,"" said Jeffrey S. Thiede, president and CEO of Everus. ""While we remain one of the Top 10 largest specialty construction services businesses in the country, with the same focus on safety and our people, our new brand allows us to better distinguish our business and tell the story of the outstanding work our team performs across the country for our customers."" Forward-Looking Statements Information in this release includes certain forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934. The forward-looking statements in this release, including information about the planned spinoff of MDU Construction Services Group, statements by the president and CEO of MDU Resources and the statements by the president and CEO of Everus, are expressed in good faith and are believed by the company to have a reasonable basis. Nonetheless, actual results may differ materially from the projected results expressed in the forward-looking statements. For a discussion of important factors that could cause actual results to differ materially, refer to Item 1A  Risk Factors in MDU Resources' most recent Form 10-K and Form 10-Q and subsequent filings with the SEC. About MDU Resources MDU Resources Group, Inc., a member of the S&P MidCap 400 index, provides essential products and services through its regulated energy delivery and construction services businesses. For more information about MDU Resources, visit www.mdu.com or contact the Investor Relations Department at investor@mduresources.com. About Everus Construction Group Everus Construction Group, Inc. provides a full spectrum of construction services through its electrical and mechanical, and transmission and distribution specialty contracting services across the United States. These specialty contracting services are provided to utility, transportation, commercial, industrial, institutional, renewable and other customers. Its E&M contracting services include construction and maintenance of electrical and communication wiring and infrastructure, fire suppression systems, and mechanical piping and services. Its T&D contracting services include construction and maintenance of overhead and underground electrical, gas and communication infrastructure, as well as manufacturing and distribution of transmission line construction equipment and tools. For more information about Everus, visit www.everus.com. Investor Contact: Brent Miller, assistant treasurer, 701-530-1730 Media Contact: Laura Lueder, manager of communications and public relations, 701-530-1095 View original content to download multimedia:https://www.prnewswire.com/news-releases/mdu-construction-services-group-rebrands-to-everus-construction-group-spinoff-remains-on-track-for-late-2024-302088512.html SOURCE MDU Resources Group, Inc. What is the new name of MDU Resources Group, Inc.'s construction services business? The construction services business has been rebranded to Everus Construction Group, Inc. What is the purpose of the rebranding? The rebranding is in preparation for a planned tax-free spinoff of the business, aiming to create two independent, publicly traded companies. When is the completion of the spinoff expected? The completion of the spinoff is expected to be late this year. What growth opportunities are highlighted by the CEO? The CEO emphasizes that the separation will create value for shareholders and position both companies for focused growth opportunities."
Lexeo Therapeutics Announces Closing of Oversubscribed $95.0 Million Equity Financing,2024-03-13T20:22:00.000Z,Low,Neutral,"Lexeo Therapeutics, Inc. extends its financial runway until 2027 through a private placement led by Braidwell LP and Adage Capital Partners LP, raising approximately $95.0 million. The company sold 6,278,905 shares of its common stock at $15.13 per share. The funds will support ongoing clinical programs, working capital, and general corporate purposes, ensuring financial stability for the next few years.","Lexeo Therapeutics Announces Closing of Oversubscribed $95.0 Million Equity Financing Rhea-AI Impact (Low) Rhea-AI Sentiment (Neutral) Tags Rhea-AI Summary Lexeo Therapeutics, Inc. extends its financial runway until 2027 through a private placement led by Braidwell LP and Adage Capital Partners LP, raising approximately $95.0 million. The company sold 6,278,905 shares of its common stock at $15.13 per share. The funds will support ongoing clinical programs, working capital, and general corporate purposes, ensuring financial stability for the next few years. Positive None. Negative None. Financial Analyst The completion of a private placement by Lexeo Therapeutics, Inc. signals a robust vote of confidence from institutional investors, which is a positive indicator for the company's financial health and future prospects. The infusion of approximately $95 million into the company's coffers is substantial, particularly for a clinical-stage biotech firm. This capital injection is likely to extend Lexeo's operational runway, which is crucial for supporting ongoing clinical programs and sustaining general corporate functions without the immediate pressure of fundraising.Investors and analysts would be keen to understand how this funding aligns with Lexeo's projected cash burn rate, especially since the company has stated that the proceeds are expected to fund operations into 2027. The share price of $15.13 in this transaction could serve as a reference point for market valuation, although the private nature of the placement means that it might not fully reflect public trading dynamics. Additionally, the participation of high-profile investment firms such as RA Capital Management and Surveyor Capital suggests strong market support and could potentially lead to a reassessment of the company's risk profile. Legal Expert The legal framework surrounding this transaction involves the Securities Act of 1933, which governs the issuance and sale of securities in the United States. Lexeo's use of a private placement exempts it from the Act's registration requirements, enabling a quicker and potentially less costly capital raise. However, the inclusion of a registration rights agreement indicates that Lexeo has agreed to file a Resale Registration Statement with the SEC, which will facilitate the resale of shares by investors, thereby enhancing the liquidity of these privately placed shares.It's important to note that the private placement adheres to Nasdaq's Minimum Price rule, ensuring that the sale price is not too discounted from the market price, which protects current shareholders from excessive dilution. The legal stipulations that the common stock sold in the private placement cannot be offered or sold without registration or an exemption are standard, but they also underline the importance of regulatory compliance in such financial transactions. Medical Research Analyst From a research and development perspective, the capital raised is pivotal for Lexeo as it focuses on genetically defined cardiovascular diseases and APOE4-associated Alzheimers disease. These are areas with significant unmet medical needs and advancements could have profound implications for patient care. The funding is expected to support the advancement of ongoing clinical stage programs, which are critical milestones that can influence the company's valuation and future funding needs.Given the complexity and high costs associated with clinical trials, especially in the genetic medicine space, the financial cushion provided by this funding could be a determinant in Lexeo's ability to maintain momentum in its clinical trials without compromising on the scope or scale. The involvement of investors with a background in healthcare, such as Novo Holdings A/S, can also be indicative of a strategic interest in Lexeo's research areas, potentially offering not just capital but also expertise and networking opportunities within the biotech industry. 03/13/2024 - 04:22 PM Lexeo extends runway into 2027 with private placement co-led by Braidwell LP and Adage Capital Partners LP with participation from new and existing investors including RA Capital Management, Surveyor Capital (a Citadel company), Eventide Asset Management, Novo Holdings A/S, Invus, Laurion Capital Management, Longitude Capital, Omega Funds and Woodline Partners LPNEW YORK, March 13, 2024 (GLOBE NEWSWIRE) -- Lexeo Therapeutics, Inc. (Nasdaq: LXEO), a clinical stage genetic medicine company dedicated to pioneering treatments for genetically defined cardiovascular diseases and APOE4-associated Alzheimers disease, today announced the closing of its previously announced private placement. The financing was co-led by Braidwell LP and Adage Capital Partners LP with participation from new and existing investors including RA Capital Management, Surveyor Capital (a Citadel company), Eventide Asset Management, Novo Holdings A/S, Invus, Laurion Capital Management, Longitude Capital, Omega Funds and Woodline Partners LP for total gross proceeds of approximately $95.0 million. Lexeo sold 6,278,905 shares of its common stock (Common Stock) in a private placement exempt from the registration requirements of the Securities Act of 1933, as amended (the Securities Act), at a sale price equal to $15.13 per share. J.P. Morgan and Leerink Partners acted as co-lead placement agents for the transaction. Stifel also acted as co-placement agent. Lexeo intends to use net proceeds from the financing to fund advancement of ongoing clinical stage programs, and for working capital and general corporate purposes. The proceeds from this financing, combined with current cash, cash equivalents and marketable securities, are expected to fund operating and capital expenditures into 2027. The common stock sold in the private placement has not been registered under the Securities Act, or any state or other applicable jurisdictions securities laws and may not be offered or sold in the United States absent registration or an applicable exemption from the registration requirements of the Securities Act and applicable state or other jurisdictions securities laws. In connection with the private placement, Lexeo and the investors entered into a registration rights agreement pursuant to which Lexeo will file a registration statement (the Resale Registration Statement) with the U.S. Securities and Exchange Commission (the SEC) registering the resale of the shares sold in the private placement. Any offering of the shares sold in the private placement under the Resale Registration Statement will only be made by means of a prospectus. This press release shall not constitute an offer to sell or a solicitation of an offer to buy the Companys Common Stock, nor shall there be any offer, solicitation, or sale of the Companys Common Stock in any jurisdiction in which such offer, solicitation or sale would be unlawful. The private placement was conducted in accordance with applicable Nasdaq rules and was priced to satisfy the Minimum Price requirement (as defined in the Nasdaq rules). About Lexeo Therapeutics Lexeo Therapeutics is a New York City-based, clinical stage genetic medicine company dedicated to transforming healthcare by applying pioneering science to fundamentally change how genetically defined cardiovascular diseases and APOE4-associated Alzheimers disease are treated. Using a stepwise development approach, Lexeo is leveraging early proof-of-concept functional and biomarker data to advance a pipeline of cardiovascular and APOE4-associated Alzheimers disease programs. Cautionary Note Regarding Forward-Looking StatementsCertain statements in this press release may constitute forward-looking statements within the meaning of the federal securities laws, including, but not limited to, our expectations and plans regarding our current product candidates and programs, including statements regarding the anticipated use of proceeds from the private placement, the filing of a registration statement or final prospectus, as applicable, to register the resale of the shares of Common Stock issued and sold in the private placement, the Companys anticipated cash runway, and other information that is not historical information. Words such as may, might, will, objective, intend, should, could, can, would, expect, believe, design, estimate, predict, potential, develop, plan or the negative of these terms, and similar expressions, or statements regarding intent, belief, or current expectations, are forward-looking statements. While Lexeo believes these forward-looking statements are reasonable, undue reliance should not be placed on any such forward-looking statements. These forward-looking statements are based upon current information available to the company as well as certain estimates and assumptions and are subject to various risks and uncertainties (including, without limitation, those set forth in Lexeos filings with the SEC), many of which are beyond the companys control and subject to change. Actual results could be materially different from those indicated by such forward looking statements as a result of many factors, including but not limited to: risks and uncertainties related to global macroeconomic conditions and related volatility; expectations regarding the initiation, progress, and expected results of Lexeos preclinical studies, clinical trials and research and development programs; the unpredictable relationship between preclinical study results and clinical study results; delays in submission of regulatory filings or failure to receive regulatory approval; liquidity and capital resources, including the anticipated closing of the private placement and anticipated runway extension; and other risks and uncertainties identified in Lexeos Annual Report on Form 10-K for the annual period ended December 31, 2023, filed with the SEC on March 11, 2023, and subsequent future filings Lexeo may make with the SEC. New risks and uncertainties may emerge from time to time, and it is not possible to predict all risks and uncertainties. Lexeo claims the protection of the Safe Harbor contained in the Private Securities Litigation Reform Act of 1995 for forward-looking statements. Lexeo expressly disclaims any obligation to update or alter any statements whether as a result of new information, future events or otherwise, except as required by law. Media Response:Janine Bogris (201) 245-6838 janine.bogris@inizioevoke.com Investor Response:Laurence Watts(619) 916-7620laurence@gilmartinir.com What is the ticker symbol of Lexeo Therapeutics, Inc. mentioned in the press release? The ticker symbol is LXEO. Who co-led the private placement financing for Lexeo Therapeutics, Inc.? The private placement financing was co-led by Braidwell LP and Adage Capital Partners LP. How much was raised through the private placement financing for Lexeo Therapeutics, Inc.? Approximately $95.0 million was raised through the private placement financing. How many shares of common stock did Lexeo Therapeutics, Inc. sell in the private placement? Lexeo Therapeutics, Inc. sold 6,278,905 shares of its common stock. At what price per share did Lexeo Therapeutics, Inc. sell its common stock in the private placement? Lexeo Therapeutics, Inc. sold its common stock at a price of $15.13 per share. What will the proceeds from the financing be used for by Lexeo Therapeutics, Inc.? The proceeds will be used to fund advancement of ongoing clinical stage programs, working capital, and general corporate purposes. Until which year are Lexeo Therapeutics, Inc.'s operating and capital expenditures expected to be funded with the current cash, cash equivalents, and marketable securities? The operating and capital expenditures are expected to be funded until 2027. What agreement did Lexeo Therapeutics, Inc. enter into with the investors in connection with the private placement? Lexeo Therapeutics, Inc. entered into a registration rights agreement with the investors."
Winnebago Industries Board of Directors Approves Quarterly Cash Dividend,2024-03-13T20:30:00.000Z,Low,Neutral,"Winnebago Industries (WGO) declares a quarterly cash dividend of $0.31 per share, marking the 39th consecutive quarter of dividend payments.","Winnebago Industries Board of Directors Approves Quarterly Cash Dividend Rhea-AI Impact (Low) Rhea-AI Sentiment (Neutral) Tags management dividends Rhea-AI Summary Winnebago Industries (WGO) declares a quarterly cash dividend of $0.31 per share, marking the 39th consecutive quarter of dividend payments. Positive None. Negative None. Financial Analyst Winnebago Industries' announcement of its 39th consecutive quarterly dividend payment represents a strong signal of financial stability and shareholder commitment. This consistency suggests that the company has a reliable cash flow, which is essential for maintaining dividend payments. Investors often view a steady dividend as an indicator of a company's financial health and management's confidence in its future earnings.However, the dividend yield, calculated by annualizing the dividend and dividing it by the stock price, is a critical metric for comparing the attractiveness of Winnebago's dividends to those of other companies in the market. The current yield should be compared against sector averages and historical yields of Winnebago to assess if the dividend strategy aligns with shareholder expectations and industry norms.Long-term investors might see the consistent dividend as a reason to hold the stock, whereas potential investors could be attracted by the income-generating potential of the shares. Yet, it's important to consider the payout ratio, which indicates what portion of net income is being paid out as dividends. An excessively high payout ratio could signal that the company is not reinvesting enough into its business for growth, which might be concerning for future stock performance. Market Research Analyst The outdoor lifestyle market, in which Winnebago operates, has been subject to fluctuations due to economic cycles, consumer trends and external factors such as fuel prices and travel habits. Winnebago's ability to maintain a quarterly dividend for nearly a decade suggests that the company has navigated these challenges successfully. This could be attributed to a diversified product portfolio, effective cost management and a strong market position.However, the market will be looking at how Winnebago's dividend policy correlates with its capital expenditure plans, especially in an industry that is rapidly evolving with the introduction of electric and eco-friendly products. Investors may seek insights into whether the company is balancing its short-term shareholder returns with long-term strategic investments.Furthermore, the announcement comes at a strategic time when investors are evaluating companies based on their resilience in the face of potential economic headwinds. The consistency in dividend payments may contribute positively to investor sentiment, but it's crucial to analyze this move in the context of the company's overall financial strategy and market performance. 03/13/2024 - 04:30 PM Winnebago Industries has paid a quarterly dividend for 39 consecutive quartersEDEN PRAIRIE, Minn., March 13, 2024 (GLOBE NEWSWIRE) -- Winnebago Industries, Inc. (NYSE:WGO), a leading outdoor lifestyle product manufacturer, today announced that the companys Board of Directors approved a quarterly cash dividend of $0.31 per share payable on April 24, 2024, to common stockholders of record at the close of business on April 10, 2024. With this announcement, Winnebago Industries has paid a quarterly cash dividend to common stockholders of record for the last 39 quarters. About Winnebago IndustriesWinnebago Industries, Inc. is a leading North American manufacturer of outdoor lifestyle products under the Winnebago, Grand Design, Chris-Craft, Newmar and Barletta brands, which are used primarily in leisure travel and outdoor recreation activities. The Company builds high-quality motorhomes, travel trailers, fifth-wheel products, outboard and sterndrive powerboats, pontoons, and commercial community outreach vehicles. Committed to advancing sustainable innovation and leveraging vertical integration in key component areas, Winnebago Industries has multiple facilities in Iowa, Indiana, Minnesota and Florida. The Companys common stock is listed on the New York Stock Exchange and traded under the symbol WGO. For access to Winnebago Industries' investor relations material or to add your name to an automatic email list for Company news releases, visit http://investor.wgo.net. Contacts Investors: Ray Posadas ir@winnebagoind.com Media: Daniel Sullivan media@winnebagoind.com How much is Winnebago Industries (WGO) quarterly dividend per share? Winnebago Industries declared a quarterly cash dividend of $0.31 per share. How many consecutive quarters has Winnebago Industries (WGO) paid dividends? Winnebago Industries has paid dividends for 39 consecutive quarters. When will the quarterly dividend be payable to common stockholders of Winnebago Industries (WGO)? The quarterly dividend will be payable on April 24, 2024, to common stockholders of record as of April 10, 2024."
The Real Brokerage to Present at the 36th Annual Roth Conference,2024-03-13T20:30:00.000Z,Low,Neutral,"The Real Brokerage Inc. (NASDAQ: REAX) announces Chairman and CEO Tamir Poleg's presentation at the 36th Annual Roth Conference. The event will take place on March 19, 2024, at The Ritz Carlton, Laguna Niguel in Dana Point, CA. A live webcast and replay will be available on the company's investor relations website.","The Real Brokerage to Present at the 36th Annual Roth Conference Rhea-AI Impact (Low) Rhea-AI Sentiment (Neutral) Tags conferences Rhea-AI Summary The Real Brokerage Inc. (NASDAQ: REAX) announces Chairman and CEO Tamir Poleg's presentation at the 36th Annual Roth Conference. The event will take place on March 19, 2024, at The Ritz Carlton, Laguna Niguel in Dana Point, CA. A live webcast and replay will be available on the company's investor relations website. Positive None. Negative None. 03/13/2024 - 04:30 PM TORONTO & NEW YORK--(BUSINESS WIRE)-- The Real Brokerage Inc. (NASDAQ: REAX), the fastest growing, publicly traded real estate brokerage, today announced that its Chairman and Chief Executive Officer, Tamir Poleg, will present at the 36th Annual Roth Conference on Tuesday, March 19, 2024 at 10:30 a.m. PT, at The Ritz Carlton, Laguna Niguel in Dana Point, CA. A live webcast of the presentation will be available at the link below, and a replay will be available shortly after the conclusion of the presentation on the investor relations section of the companys website at https://investors.onereal.com/. Presentation Details: Date: Tuesday, March 19, 2024 Time: 10:30 a.m. PT (1:30 p.m. ET) Webcast link: https://wsw.com/webcast/roth48/reax/1836432 About Real Real (NASDAQ: REAX) is a real estate experience company working to make lifes most complex transaction simple. The fast-growing company combines essential real estate, mortgage and closing services with powerful technology to deliver a single seamless end-to-end consumer experience, guided by trusted agents. With a presence in all 50 states throughout the U.S. and Canada, Real supports more than 16,000 agents who use its digital brokerage platform and tight-knit professional community to power their own forward-thinking businesses. Additional information can be found on its website at www.onereal.com. View source version on businesswire.com: https://www.businesswire.com/news/home/20240313019962/en/ For additional information, please contact: Ravi Jani Vice President, Investor Relations and Financial Planning & Analysis investors@therealbrokerage.com 908.280.2515 For media inquiries, please contact: Elisabeth Warrick Senior Director, Marketing, Communications & Brand elisabeth@therealbrokerage.com 201.564.4221 Source: The Real Brokerage Inc. When will Tamir Poleg present at the 36th Annual Roth Conference? Tamir Poleg will present at the 36th Annual Roth Conference on Tuesday, March 19, 2024. Where will the presentation take place? The presentation will take place at The Ritz Carlton, Laguna Niguel in Dana Point, CA. Where can I watch the live webcast of the presentation? The live webcast of the presentation will be available at the following link: https://wsw.com/webcast/roth48/reax/1836432 Will there be a replay of the presentation available? Yes, a replay of the presentation will be available shortly after the conclusion of the event on the investor relations section of The Real Brokerage Inc.'s website at https://investors.onereal.com/"
IRADIMED CORPORATION To Participate at the 36th Annual Roth Conference,2024-03-13T20:30:00.000Z,Low,Negative,"IRADIMED CORPORATION (NASDAQ: IRMD) announced that its President and CEO, Roger Susi, will present at the 36th Annual Roth Conference in California. The event will feature meetings, fireside chats, and presentations by executives from 500 companies.","IRADIMED CORPORATION To Participate at the 36th Annual Roth Conference Rhea-AI Impact (Low) Rhea-AI Sentiment (Negative) Tags conferences Rhea-AI Summary IRADIMED CORPORATION (NASDAQ: IRMD) announced that its President and CEO, Roger Susi, will present at the 36th Annual Roth Conference in California. The event will feature meetings, fireside chats, and presentations by executives from 500 companies. Positive None. Negative None. 03/13/2024 - 04:30 PM WINTER SPRINGS, Fla., March 13, 2024 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (the Company) (NASDAQ: IRMD) today announced that Roger Susi, the Company's President and Chief Executive Officer, will present at the 36th Annual Roth Conference in Laguna Niguel, CA. Mr. Susi is scheduled for a live fireside chat on Tuesday, March 19, at 12:30 p.m. PT. A live webcast and a replay of the fireside chat will be available on Iradimeds Investor page at https://www.iradimed.com/investors/events. This years event will consist of 1-on-1 / small group meetings, analyst-selected fireside chats, thematic and industry panels, and company presentations by executive management from approximately 500 private and public companies in various growth sectors. About IRADIMED CORPORATION IRADIMED CORPORATION is a leader in developing innovative Magnetic Resonance Imaging (MRI) compatible medical devices. We design, manufacture, market, and distribute MRI-compatible medical devices, accessories, disposables, and related services. We are the only provider of a non-magnetic intravenous (IV) infusion pump system designed to be safe during MRI procedures. We were the first to develop an infusion delivery system that eliminates many dangers and problems during MRI procedures. Standard infusion pumps contain magnetic and electronic components that can create radio frequency interference and are dangerous to operate in the presence of the powerful magnet that drives an MRI system. Our patented MRidium MRI-compatible IV infusion pump system has a non-magnetic ultrasonic motor, uniquely designed non-ferrous parts, and other unique features to deliver anesthesia safely and predictably and other IV fluids during various MRI procedures. Our pump solution provides a seamless approach that enables accurate, safe, and dependable fluid delivery before, during, and after an MRI scan, which is essential to critically ill patients who cannot be removed from their vital medications and children and infants who must generally be sedated to remain immobile during an MRI scan. Our 3880 MRI-compatible patient vital signs monitoring system has been designed with non-magnetic components and other unique features to monitor a patients vital signs safely and accurately during various MRI procedures. The IRADIMED 3880 system operates dependably in magnetic fields up to 30,000 gauss, which means it can operate virtually anywhere in the MRI scanner room. The IRADIMED 3880 has a compact, lightweight design, allowing it to travel with the patient from the critical care unit to the MRI and back, resulting in increased patient safety through uninterrupted vital signs monitoring and decreasing the amount of time critically ill patients are away from critical care units. The features of the IRADIMED 3880 include wireless ECG with dynamic gradient filtering; wireless SpO2 using Masimo algorithms; non-magnetic respiratory CO2; invasive and non-invasive blood pressure; patient temperature, and optional advanced multi-gas anesthetic agent unit featuring continuous Minimum Alveolar Concentration measurements. The IRADIMED 3880 MRI-compatible patient vital signs monitoring system has an easy-to-use design and effectively communicates patient vital signs information to clinicians. For more information, please visit www.iradimed.com. When will Roger Susi present at the 36th Annual Roth Conference? Roger Susi will present on Tuesday, March 19, at 12:30 p.m. PT. Where can I watch the live fireside chat with Roger Susi? You can watch the live webcast and replay on Iradimeds Investor page at https://www.iradimed.com/investors/events. What is the purpose of the 36th Annual Roth Conference? The conference will feature 1-on-1 meetings, fireside chats, panels, and company presentations by executives from private and public companies. How many companies are expected to participate in the event? Approximately 500 private and public companies will participate in the conference. What is the ticker symbol for IRADIMED CORPORATION? The ticker symbol is IRMD."
"New York Mortgage Trust Declares First Quarter2024 Common Stock Dividend of $0.20 Per Share, and Preferred Stock Dividends",2024-03-13T20:16:00.000Z,Low,Neutral,"New York Mortgage Trust, Inc. (NYMT) declared a regular quarterly cash dividend of $0.20 per share on its common stock for the quarter ending March 31, 2024. The Board also announced cash dividends on its preferred stocks. The dividends will be payable on April 25, 2024, to common stockholders of record as of March 25, 2024.","New York Mortgage Trust Declares First Quarter 2024 Common Stock Dividend of $0.20 Per Share, and Preferred Stock Dividends Rhea-AI Impact (Low) Rhea-AI Sentiment (Neutral) Tags dividends earnings Rhea-AI Summary New York Mortgage Trust, Inc. (NYMT) declared a regular quarterly cash dividend of $0.20 per share on its common stock for the quarter ending March 31, 2024. The Board also announced cash dividends on its preferred stocks. The dividends will be payable on April 25, 2024, to common stockholders of record as of March 25, 2024. Positive None. Negative None. Financial Analyst The declaration of a regular quarterly cash dividend by New York Mortgage Trust represents a commitment to shareholder returns, signaling confidence in the company's earnings stability. The specified dividend of $0.20 per share on common stock is a critical figure for investors, as it influences the dividend yield, a key metric used to evaluate the attractiveness of a stock for income-focused portfolios.Furthermore, the declaration of dividends on the Series D, E, F and G Preferred Stocks, with varying rates, showcases the company's capital structure strategy. Preferred stock dividends are often seen as a hybrid between debt and equity, providing a fixed-income like payout while still being part of the equity capital. The different rates reflect the hierarchy of payment and risk associated with each series.Investors may also interpret these declarations as a signal of the company's financial health. Companies that consistently pay dividends are often perceived as more stable and less volatile, which can be particularly appealing during uncertain economic conditions. However, it is essential to analyze the payout ratio to ensure that the dividends are sustainable and not compromising the firm's long-term growth potential. Market Research Analyst The real estate investment trust (REIT) sector, where New York Mortgage Trust operates, is sensitive to interest rate fluctuations. Dividend announcements from REITs are scrutinized in the context of current interest rate trends and housing market dynamics. The consistency of dividend payments can be a barometer for the REIT's operational performance, especially when considering the fixed-income nature of Series D, E, F and G Preferred Stocks.Analysts and investors often use these dividends as a measure of a REIT's ability to generate cash flow from its operations, particularly from mortgage holdings and interest income. It is pertinent to assess the impact of these dividends on the company's cash reserves and borrowing costs, as REITs typically leverage to finance property acquisitions and operations.Given the competitive landscape of the mortgage investment market, the announced dividends could also reflect the company's position relative to its peers. A comparison of dividend yields and growth rates with other REITs can provide a more comprehensive understanding of the company's performance and prospects. Economist From an economic perspective, the dividend announcement by New York Mortgage Trust must be contextualized within the broader macroeconomic environment. Dividends are often seen as a distribution of profits back to shareholders and their sustainability is closely tied to economic factors such as interest rates, inflation and housing market trends.As a REIT, New York Mortgage Trust's ability to maintain and potentially increase dividends over time is influenced by the health of the housing market and the cost of borrowing. For instance, rising interest rates can increase borrowing costs for REITs, which may pressure their margins and ability to maintain dividend levels. Conversely, a stable or declining rate environment can be beneficial for mortgage REITs.Investors looking at the long-term implications of this dividend announcement should consider the Federal Reserve's monetary policy trajectory, housing market indicators and inflationary pressures, as these will play a significant role in the company's operational efficiency and profitability. 03/13/2024 - 04:16 PM NEW YORK, March 13, 2024 (GLOBE NEWSWIRE) -- New York Mortgage Trust, Inc. (Nasdaq: NYMT) (the Company) announced today that its Board of Directors (the Board) declared a regular quarterly cash dividend of $0.20 per share on shares of its common stock for the quarter ending March 31, 2024. The dividend will be payable on April 25, 2024 to common stockholders of record as of the close of business on March 25, 2024. In addition, the Board declared cash dividends on the Companys 8.000% Series D Fixed-to-Floating Rate Cumulative Redeemable Preferred Stock (Series D Preferred Stock), 7.875% Series E Fixed-to-Floating Rate Cumulative Redeemable Preferred Stock (Series E Preferred Stock), 6.875% Series F Fixed-to-Floating Rate Cumulative Redeemable Preferred Stock (Series F Preferred Stock) and 7.000% Series G Cumulative Redeemable Preferred Stock (Series G Preferred Stock) as stated below. Quarterly Preferred Stock DividendsThe Board declared cash dividends for the dividend period that began on January 15, 2024 and ends on April 14, 2024 as follows: Class of Preferred Stock Series D Series E Series F Series GRecord Date April 1, 2024 April 1, 2024 April 1, 2024 April 1, 2024Payment Date April 15, 2024 April 15, 2024 April 15, 2024 April 15, 2024Cash Dividend Per Share $0.50 $0.4921875 $0.4296875 $0.4375 About New York Mortgage TrustNew York Mortgage Trust, Inc. is a Maryland corporation that has elected to be taxed as a real estate investment trust (REIT) for federal income tax purposes. NYMT is an internally managed REIT in the business of acquiring, investing in, financing and managing primarily mortgage-related single-family and multi-family residential assets. Forward-Looking Statements When used in this press release, in future filings with the Securities and Exchange Commission (the SEC) or in other written or oral communications, statements which are not historical in nature, including those containing words such as will, believe, expect, anticipate, estimate, plan, continue, intend, could, would, should, may or similar expressions, are intended to identify forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the Exchange Act), and, as such, may involve known and unknown risks, uncertainties and assumptions. Statements regarding the following subject, among others, may be forward-looking: the payment of dividends. Forward-looking statements are based on estimates, projections, beliefs and assumptions of management of the Company at the time of such statements and are not guarantees of future performance. Forward-looking statements involve risks and uncertainties in predicting future results and conditions. Actual results and outcomes could differ materially from those projected in these forward-looking statements due to a variety of factors, including, without limitation: changes in the Companys business and investment strategy; inflation and changes in interest rates and the fair market value of the Companys assets, including negative changes resulting in margin calls relating to the financing of the Companys assets; changes in credit spreads; changes in the long-term credit ratings of the U.S., Fannie Mae, Freddie Mac, and Ginnie Mae; general volatility of the markets in which the Company invests; changes in prepayment rates on the loans the Company owns or that underlie the Companys investment securities; increased rates of default, delinquency or vacancy and/or decreased recovery rates on or at the Companys assets; the Companys ability to identify and acquire targeted assets, including assets in its investment pipeline; the Company's ability to dispose of assets from time to time on terms favorable to it, including the disposition over time of its joint venture equity investments; changes in relationships with the Companys financing counterparties and the Companys ability to borrow to finance its assets and the terms thereof; changes in the Company's relationships with and/or the performance of its operating partners; the Companys ability to predict and control costs; changes in laws, regulations or policies affecting the Companys business; the Companys ability to make distributions to its stockholders in the future; the Companys ability to maintain its qualification as a REIT for federal tax purposes; the Companys ability to maintain its exemption from registration under the Investment Company Act of 1940, as amended; impairments in the value of the collateral underlying the Company's investments; the Company's ability to manage or hedge credit risk, interest rate risk, and other financial and operational risks; the Company's exposure to liquidity risk, risks associated with the use of leverage, and market risks; and risks associated with investing in real estate assets, including changes in business conditions and the general economy, the availability of investment opportunities and the conditions in the market for Agency RMBS, non-Agency RMBS, ABS and CMBS securities, residential loans, structured multi-family investments and other mortgage-, residential housing- and credit-related assets. These and other risks, uncertainties and factors, including the risk factors and other information described in the Companys reports filed with the SEC pursuant to the Exchange Act, could cause the Companys actual results to differ materially from those projected in any forward-looking statements the Company makes. All forward-looking statements speak only as of the date on which they are made. New risks and uncertainties arise over time and it is not possible to predict those events or how they may affect the Company. Except as required by law, the Company is not obligated to, and does not intend to, update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. For Further Information AT THE COMPANYInvestor RelationsPhone: 212-792-0107Email: InvestorRelations@nymtrust.com What is the dividend amount per share declared by New York Mortgage Trust, Inc. for the quarter ending March 31, 2024? New York Mortgage Trust, Inc. declared a regular quarterly cash dividend of $0.20 per share on its common stock for the quarter ending March 31, 2024. When will the dividend be payable to common stockholders? The dividend declared by New York Mortgage Trust, Inc. will be payable on April 25, 2024, to common stockholders of record as of March 25, 2024. What are the cash dividend amounts per share for New York Mortgage Trust, Inc.'s preferred stocks? The cash dividend amounts per share for New York Mortgage Trust, Inc.'s preferred stocks are: Series D - $0.50, Series E - $0.4921875, Series F - $0.4296875, Series G - $0.4375."
Argentum Announces Appointment of Director,2024-03-13T20:20:00.000Z,Low,Neutral,Argentum Silver Corp. announces the resignation of Albert Contardi from the Board of Directors due to potential conflicts of interest and appoints Ms. Carly Burk in his place. Ms. Burk brings a strong background in securities law to the company.,"Argentum Announces Appointment of Director Rhea-AI Impact (Low) Rhea-AI Sentiment (Neutral) Tags management Rhea-AI Summary Argentum Silver Corp. announces the resignation of Albert Contardi from the Board of Directors due to potential conflicts of interest and appoints Ms. Carly Burk in his place. Ms. Burk brings a strong background in securities law to the company. Positive None. Negative None. 03/13/2024 - 04:20 PM Toronto, Ontario--(Newsfile Corp. - March 13, 2024) - Argentum Silver Corp. (TSXV: ASL) (""Argentum"" or the ""Company"") today announced the resignation of Albert Contardi from the Board of Directors, effective immediately. Mr. Contardi has tendered his resignation in order to avoid potential conflicts of interest arising from his other professional commitments. Mr. Contardi served as a member of the Board and Audit Committee Chair since 2017.""On behalf of Argentum Silver Corp., we would like to express our sincere gratitude to Mr. Contardi for his valuable contributions during his tenure on the Board of Directors,"" said Gary Nassif, CEO of Argentum Silver Corp. ""We understand and respect his decision to prioritize his other commitments, and we wish him the very best in his future endeavors.""In addition, the Company is pleased to announce that Ms. Carly Burk has been appointed to the Board of Directors, effective immediately. Ms. Burk practices securities law and works with both public and private issuers. Ms. Burk holds a Bachelor of Laws from the University of Southampton, a Certificate of Qualification from the Federation of Law Societies and a Bachelor of Arts (Honours) from Carleton University. Ms. Burk serves as an officer and/or director of several public and private entities.About Argentum Silver Corp. Argentum Silver is a junior mineral exploration company listed on the TSXV under the stock symbol ASL. Through its wholly owned subsidiary, Norsemont II Resources SAC, the company controls the Cochavara Project consisting of six silver-lead-zinc mining concessions totalling 3,479 hectares in La Libertad, Northern Peru. The mining concessions host several mineralized structures with the main mineralized zone (Margarita Mine) covering an estimated strike length of 1,500 metres. The project area is located 3.5 kilometres southwest of the historical Quiruvilca silver-lead-zinc mine deposit, a large polymetallic vein system with over 130 different mineralized structures. The Company is actively reviewing additional mineral exploration properties in North America.For further information, please visit www.argentumsilvercorp.com or contact: Gary NassifPresident & CEOPhone: 416-855-9304Email: gnassif@argentumsilvercorp.com Forward-Looking Statements This news release contains certain ""forward-looking information"" within the meaning of applicable securities law. Forward-looking information is frequently characterized by words such as ""plan"", ""expect"", ""project"", ""intend"", ""believe"", ""anticipate"", ""estimate"", ""may"", ""will"", ""would"", ""potential"", ""proposed"" and other similar words, or statements that certain events or conditions ""may"" or ""will"" occur. These statements are only predictions. Forward-looking information is based on the opinions and estimates of management at the date the information is provided and is subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those projected in the forward-looking information. For a description of the risks and uncertainties facing the Company and its business and affairs, readers should refer to the Company's Management's Discussion and Analysis. The Company undertakes no obligation to update forward-looking information if circumstances or management's estimates or opinions should change, unless required by law. The reader is cautioned not to place undue reliance on forward-looking information.Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.To view the source version of this press release, please visit https://www.newsfilecorp.com/release/201636 Why did Albert Contardi resign from the Board of Directors of Argentum Silver Corp.? Albert Contardi resigned from the Board of Directors of Argentum Silver Corp. to avoid potential conflicts of interest arising from his other professional commitments. Who has been appointed to the Board of Directors of Argentum Silver Corp.? Ms. Carly Burk has been appointed to the Board of Directors of Argentum Silver Corp. What is Ms. Carly Burk's background? Ms. Carly Burk practices securities law and works with both public and private issuers. She holds a Bachelor of Laws from the University of Southampton, a Certificate of Qualification from the Federation of Law Societies, and a Bachelor of Arts (Honours) from Carleton University."
Enzo Biochem Reports Second Quarter Fiscal 2024 Results and Provides Business Update,2024-03-13T20:26:00.000Z,Neutral,Neutral,"Enzo Biochem, Inc. (ENZ) reports a strong second quarter with revenue growth, improved gross margins, and increased net income. The Life Science division saw a 14% revenue increase, driven by a 25% growth in the United States. The company ended the quarter with $60.2 million in cash and cash equivalents.","Enzo Biochem Reports Second Quarter Fiscal 2024 Results and Provides Business Update Rhea-AI Impact (Neutral) Rhea-AI Sentiment (Neutral) Tags earnings Rhea-AI Summary Enzo Biochem, Inc. (ENZ) reports a strong second quarter with revenue growth, improved gross margins, and increased net income. The Life Science division saw a 14% revenue increase, driven by a 25% growth in the United States. The company ended the quarter with $60.2 million in cash and cash equivalents. Positive Revenue for the second quarter increased by 14% year-over-year. Life Science division's gross margin improved by 1,000 basis points to 49%. Net income for the second quarter was $1.1 million, a significant improvement from the prior year. Enzo ended the quarter with $60.2 million in cash and cash equivalents. The company's strategy focuses on sustainable revenue growth and operational efficiency. Negative None. Financial Analyst The reported financial results by Enzo Biochem, Inc. indicate a robust year-over-year revenue growth of 14% in their Life Science division, a notable achievement considering the competitive nature of the biotech industry. The 25% increase in U.S. revenue underscores a strong domestic market presence, particularly in the burgeoning drug development and cell and gene therapy segments. This growth trajectory is commendable, as it reflects the company's strategic alignment with high-growth market areas.The gross margin expansion from 39% to 49% is particularly impressive, highlighting improved operational efficiency and successful cost containment measures, such as workforce reductions. A 1,000 basis point improvement is significant and suggests a substantial enhancement in profitability. Investors should note the positive impact of such margin improvements on the company's bottom line, as evidenced by the reported net income of $1.1 million for the Life Science division, up from $0.2 million in the previous year.The reduction in net loss from continuing operations and the overall net loss, along with an improved current ratio of 3.2, paints a picture of a company that is not only growing its top line but also strengthening its financial health. However, the decrease in cash and cash equivalents by $23.1 million due to the paydown of liabilities warrants attention, as it may affect the companys liquidity in the short term. Despite this, the company's strategy of market focus and operational conservatism seems to be paying off, as evidenced by the consecutive quarters of revenue growth. Market Research Analyst Enzo Biochem's strategic focus on high-growth market segments like drug development and cell and gene therapy is well-timed, given the increasing investment and innovation in these areas. By positioning itself in these niches, Enzo is capitalizing on industry trends that are driving demand for specialized life science products. The company's emphasis on quality customer service, supported by a stable global infrastructure, is a competitive advantage that can lead to customer retention and potentially attract new business.The company's operational progress, as highlighted by the CEO, suggests a successful execution of their business strategy. The reported financials provide evidence of Enzo's ability to not only increase revenue but also to translate that into actual profit, a key determinant of a company's value to investors. As Enzo continues to execute its strategy, stakeholders should monitor the company's ability to maintain these margins and growth rates in a dynamic and competitive market. Biotech Industry Analyst The biotechnology sector is known for its high research and development costs, which often result in long periods before profitability is achieved. Enzo Biochem's improvement in gross margins by 1,000 basis points is therefore an exceptional development, indicating that the company is progressing well beyond industry norms in terms of cost management and operational efficiency.The focus on drug development and cell and gene therapy is strategic, as these are areas with significant barriers to entry due to the scientific complexity and regulatory requirements involved. Enzo's success in these segments suggests a high level of technical expertise and the ability to navigate the regulatory landscape effectively. The improved profitability in the Life Science division, despite the traditionally high costs associated with these market segments, is a testament to the company's strategic planning and execution.However, the reported decrease in cash reserves may raise questions about the sustainability of the current growth rate. It is crucial for Enzo to balance its investment in growth with the management of its cash flow to ensure long-term viability. The reduction in cash reserves could be a strategic move to optimize the balance sheet post the clinical lab asset sale, but it is essential to observe how this will affect the company's ability to fund future growth initiatives. 03/13/2024 - 04:26 PM FARMINGDALE, N.Y., March 13, 2024 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE: ENZ) (Enzo or the Company) today announced financial results for the second quarter ended January 31, 2024. Second Quarter Highlights The Company's Life Science division's second-quarter revenue of $8.5 million improved year-over-year by 14%. During the 2024 period, we experienced a 25% revenue increase in the United States, driven by increased product demand in the drug development and cell and gene therapy market segments. Revenue for the six months ended January 31, 2024 of $16.4 million improved 12% compared to the same period in the prior year.The Life Science division's second-quarter gross margin was 49%, which improved by 1,000 basis points year-over-year from 39%, and was also a sequential 500 basis point improvement from 44%. The six-month YTD margin was 47% which was also a 1,000 basis point improvement compared to the prior year. This favorable result was driven by the reported revenue increase, mix of products sold, and ongoing cost containment initiatives, including, but not limited to, a workforce reduction for continuing operations.The Life Science division reported second-quarter net income of $1.1 million, compared to net income of $0.2 million in the prior year period. The net loss in the Corporate & Other segment decreased year-over-year by $1.2 million. Enzo ended the second quarter with aggregate cash and cash equivalents of $60.2 million, a reduction of $23.1 million from July 31, 2023, primarily due to the significant paydown of accounts payable and accrued liabilities post the clinical lab asset sale. The Companys current ratio was 3.2 as of January 31, 2024.Net loss from continuing operations for Q2 FY24 was $0.9 million or ($0.02) per common share, compared to a net loss in the prior years second quarter of $2.9 million or ($0.06) per common share.Net loss, representing the results of continuing and discontinued operations for Q2 FY24, was $3.1 million, or ($0.06) per common share, compared to a net loss in the prior years second quarter of $11.3 million, or ($0.23) per common share. The weighted average basic common shares outstanding as of January 31, 2024, was 50.5 million. Enzos strategy is to deliver sustainable, profitable revenue growth through market focus, technical strength, and operational conservatism. We are pleased to report a third consecutive quarter with double-digit revenue growth in the life science division, and I am proud of the team's hard work resulting in higher gross margin and improved profitability in the second quarter within our Life Science division, said Kara Cannon, Enzos Chief Executive Officer. These achievements were driven by aligning our products in high-growth market segments made up of our drug development customers, while relying on our existing, stable global infrastructure to provide comprehensive, quality customer service. I am very encouraged by our financial and operational progress, and I am optimistic about our ability to maintain this positive momentum to deliver on longer-term goals. About Enzo Biochem Enzo Biochem, a pioneer in molecular diagnostics, contributes to advancing healthcare with its comprehensive portfolio of technical platforms and reagent sets supporting a diverse range of biomedical research and translational science needs. A leader in innovation and product development for over 45 years, scientists have trusted Enzo Biochem to manufacture and supply a comprehensive portfolio of thousands of high-quality products, including antibodies, genomic probes, assays, biochemicals, and proteins. The Companys proprietary products and technologies play central roles in all translational research and drug development areas, including cell biology, genomics, assays, immunohistochemistry, and small molecule chemistry. Enzo Biochem, Inc.s Life Science division supports the work of research centers and industry partners, shaping the future of healthcare worldwide. Enzo Biochem, Inc. has a broad and deep intellectual property portfolio, with patent coverage across many vital enabling technologies. For more information, please visit Enzo.com or follow Enzo Biochem on X and LinkedIn. Forward-Looking Statements Except for historical information, the matters discussed in this release may be considered ""forward-looking"" statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. Such statements include declarations regarding the intent, belief or current expectations of the Company and its management, including those related to cash flow, gross margins, revenues, and expenses which are dependent on a number of factors outside of the control of the Company including, inter alia, the markets for the Companys products, cost of goods sold, other expenses, government regulations, litigation, and general business conditions. See Risk Factors in the Companys Form 10-K for the fiscal year ended July 31, 2023. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve a number of risks and uncertainties that could materially affect actual results. The Company disclaims any obligations to update any forward-looking statement as a result of developments occurring after the date of this release. Enzo Biochem ContactsFor Enzo Biochem:Patricia Eckert, Chief Financial OfficerEnzo Biochem631-755-5500peckert@enzo.com Use of Non-GAAP Financial Measures by Enzo The non-GAAP financial measures contained in this press release (including, without limitation, Adjusted net income (loss), EBITDA, and Adjusted EBITDA), are not GAAP measures of the Companys financial performance or liquidity and should not be considered as alternatives to net income (loss) as a measure of financial performance or cash flows from operations as measures of liquidity, or any other performance measure derived in accordance with GAAP. A reconciliation of such non-GAAP measures is included in the presentation of the Companys financial results for the second quarter ended January 31, 2024 contained herein and is also available in the investor relations section of the Companys website (https://www.enzo.com). The Company believes the presentation of these non-GAAP measures provides useful additional information to investors because they provide information consistent with that on which management evaluates the financial performance of the Company. The Company manages its business based on its operating cash flows. It refers to EBITDA as its primary indicator of performance, and refers to Adjusted EBITDA to further exclude items of a non-recurring nature. It is reasonable to expect that one or more excluded items will occur in future periods, though the amounts recognized can vary significantly from period to period. You are encouraged to evaluate each adjustment to a non-GAAP financial measure and the reasons management considers it appropriate for supplemental analysis. Our presentation of these measures should not be construed as an inference that our future results will be unaffected by unusual or non-recurring items. We refer you to the tables attached to this press release, which includes reconciliation tables of GAAP net income (loss) to Adjusted net income (loss) and GAAP net income (loss) to EBITDA and Adjusted EBITDA. ENZO BIOCHEM, INC.(in thousands, except per share data) Three months ended Six months endedSelected operations data:January 31, January 31, (unaudited) (unaudited) 2024 2023 2024 2023 Revenues$8,553 $7,514 $16,359 $14,617 Gross profit 4,224 2,898 7,679 5,412 Gross profit % 49% 39% 47% 37% Operating loss (2,185) (4,545) (7,655) (9,173) Net loss from continuing operations (863) (2,892) (6,538) (8,245)Net loss from discontinued operations (2,198) (8,428) (3,139) (13,710)Net loss$(3,061) $(11,320) $(9,677) $(21,955) Net loss per common share- basic and diluted- Continuing Operations($0.02) ($0.06) ($0.13) ($0.17)Net loss per common share- basic and diluted- Discontinued Operations($0.04) ($0.17) ($0.06) ($0.28)Total net loss per basic and diluted common share($0.06) ($0.23) ($0.19) ($0.45) Weighted average common shares outstanding - basic and diluted 50,490 48,729 50,337 48,725 Selected balance sheet data:1/31/2024 (unaudited) 7/31/2023 (unaudited) Cash and cash equivalents (includes restricted cash of $1,000 at 7/31/23)$60,241 $83,373 Working capital 55,637 58,467 Stockholders' equity 70,775 78,462 Total assets 99,077 121,880 The following table presents a reconciliation of reported net loss and basic and diluted net loss per share to adjusted net income (loss) and basic and diluted net loss per share adjusted, for the three and six months ended January 31, 2024 and 2023: ENZO BIOCHEM, INC.Adjusted Net income (loss) Reconciliation Table(Unaudited, in thousands, except per share data) Three months ended Six months ended January 31, January 31, 2024 2023 2024 2023 Reported GAAP net loss$(3,061) $(11,320) $(9,677) $(21,955)Adjusted for: Discrete legal matters 613 174 1,476 196 Fair value adjustment 383 - 711 - Discrete separation expenses 69 982 1,742 1,808 Strategic initiative expenses - 759 - 1,648 Discontinued operations loss 2,198 8,428 3,139 13,710 Adjusted net income (loss)$202 $(977) $(2,609) $(4,593) Weighted Shares Outstanding: Basic and diluted 50,490 48,729 50,337 48,725 Basic and diluted earnings per share: Basic and diluted net income (loss) per share GAAP($0.06) ($0.23) ($0.19) ($0.45) Basic and diluted net income (loss) per share adjusted $0.00 ($0.02) ($0.05) ($0.09) The following table presents a reconciliation of reported GAAP net loss for the three and six months ended January 31, 2024 and 2023, respectively to EBITDA and Adjusted EBITDA: ENZO BIOCHEM, INC.EBITDA & Adjusted EBITDA Reconciliation Table(Unaudited, in thousands) Three months endedSix months ended January 31, January 31, 2024 2023 2024 2023 GAAP net loss$(3,061) $(11,320) $(9,677) $(21,955)Plus (minus): Depreciation and amortization 267 262 537 510 Interest income, net (893) (63) (1,870) (135)EBITDA (3,687) (11,121) (11,010) (21,580) Adjusted for: Discrete legal matters 613 174 1,476 196 Fair value adjustment 383 - 711 - Discrete separation expenses 69 982 1,742 1,808 Strategic initiative expenses - 759 - 1,648 Discontinued operations loss 2,198 8,428 3,139 13,710 Foreign exchange (gain) loss (693) (1,472) 318 (675)Adjusted EBITDA$(1,117) $(2,250) $(3,624) $(4,893) What was the revenue growth percentage for the Life Science division in the second quarter? The revenue growth for the Life Science division in the second quarter was 14%. What was the gross margin percentage for the Life Science division in the second quarter? The gross margin for the Life Science division in the second quarter was 49%. What was the net income for the second quarter? The net income for the second quarter was $1.1 million. How much cash and cash equivalents did Enzo have at the end of the second quarter? Enzo had $60.2 million in cash and cash equivalents at the end of the second quarter. What is Enzo's strategy for revenue growth? Enzo's strategy focuses on delivering sustainable, profitable revenue growth through market focus, technical strength, and operational conservatism."
Arrowroot Acquisition Corp. Announces Postponement of Special Meeting of Stockholders and New Record Date of Special Meeting of Stockholders,2024-03-13T20:15:00.000Z,Low,Neutral,"Arrowroot Acquisition Corp. postpones its Special Meeting of stockholders to March 25, 2024, accessible virtually. Stockholders can still vote and change their vote until the new deadline. The Company extends the redemption deadline for Public Shares.","Arrowroot Acquisition Corp. Announces Postponement of Special Meeting of Stockholders and New Record Date of Special Meeting of Stockholders Rhea-AI Impact (Low) Rhea-AI Sentiment (Neutral) Tags acquisition Rhea-AI Summary Arrowroot Acquisition Corp. postpones its Special Meeting of stockholders to March 25, 2024, accessible virtually. Stockholders can still vote and change their vote until the new deadline. The Company extends the redemption deadline for Public Shares. Positive None. Negative None. 03/13/2024 - 04:15 PM MARINA DEL REY, Calif., March 13, 2024 /PRNewswire/ -- Arrowroot Acquisition Corp. (""Arrowroot"" or the ""Company"") (NASDAQ: ARRWU, ARRW, ARRWW) today announced that its special meeting of stockholders (""Special Meeting"") will be postponed from its scheduled time of 9:00 a.m. Eastern Time on March 15, 2024 to 9:00 a.m. Eastern Time on March 25, 2024. The Special Meeting can still be accessed virtually by visiting www.virtualshareholdermeeting.com/ARRW2024SM. You will need the 12-digit meeting control number that is printed on your proxy card to enter the Special Meeting. The record date for the Special Meeting will be March 13, 2024. For a stockholder of record as of the close of business on January 18, 2024, the original record date, who is also a stockholder of record on the new record date of March 13, 2024, and who provided a proxy to the Company based on the original record date, such proxy shall remain in full force and effect with respect to the number of shares held by such stockholder as of the close of business on the new record date (March 13, 2024) set for the Special Meeting unless explicitly revoked, or a later dated proxy is submitted, by the applicable stockholder. Previously submitted proxies are revocable. The previous submission of proxies also will not affect your right to vote in the event that you attend the Special Meeting. Please note, however, that attendance alone at the Special Meeting without voting will not be sufficient to revoke a previously authorized proxy. Please see your proxy card for specific instructions on how to vote your shares by telephone, through the Internet or by mail. If you have not already done so, it is important that you vote your Class A Common Stock promptly. Stockholders as of the record date can vote, even if they have subsequently sold their shares. Any stockholders who wish to change their vote and need assistance should contact Okapi Partners LLC at (212) 297-0720, or info@okapipartners.com. In connection with the postponement of the Special Meeting, the Company has extended the deadline of holders of the Company's Class A common stock issued in its initial public offering (the ""Public Shares"") to submit their Public Shares for redemption until 5 p.m. Eastern Time on March 21, 2024. Stockholders who wish to withdraw their previously submitted redemption requests may do so prior to the rescheduled meeting by requesting that the transfer agent return such Public Shares prior to 9 a.m. Eastern Time on March 25, 2024. About Arrowroot Arrowroot Acquisition Corp. is a special purpose acquisition company formed for the purpose of effecting a merger, stock purchase or similar business combination with one or more businesses. The management team is led by Matthew Safaii, as Chief Executive Officer, and Thomas Olivier, as President and Chief Financial Officer, each with decades of experience identifying, evaluating, advising and investing in transformational growth companies in the technology sector. While the Company intends to evaluate opportunities in many sectors, it believes the diverse experience and extensive relationship network of its management team, board and sponsor will drive particularly attractive investment opportunities in the enterprise software sector. Participants in the Solicitation The Company and iLearningEngines (""iLearningEngines""), and their respective directors and executive officers, and other members of their management and employees, under the rules of the Securities and Exchange Commission (""SEC""), may be deemed participants in the solicitation of proxies of the Company's stockholders in respect of the proposed business combination transaction involving Arrowroot and iLearningEngines (the ""Proposed Business Combination""). Information about the directors and executive officers of the Company is set forth in the Company's filings with the SEC. Information about the directors and executive officers of iLearningEngines and more detailed information regarding the identity of all potential participants, and their direct and indirect interests by security holdings or otherwise, is set forth in the definitive proxy statement/prospectus for the Proposed Business Combination. Additional information regarding the identity of all potential participants in the solicitation of proxies to the Company's stockholders in connection with the Proposed Business Combination and other matters to be voted upon at the special meeting, and their direct and indirect interests, by security holdings or otherwise, is included in the definitive proxy statement/prospectus. Such interests may, in some cases, be different from those of iLearningEngines' or the Company's stockholders generally. No Offer or Solicitation This press release relates to a proposed transaction between iLearningEngines and Arrowroot. This press release does not constitute an offer to sell or exchange, or the solicitation of an offer to buy or exchange, any securities, nor shall there be any sale of securities in any jurisdiction in which such offer, sale or exchange would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. No offering of securities shall be made except by means of a prospectus meeting the requirements of Section 10 of the U.S. Securities Act of 1933, as amended. Additional Information This press release is being made in respect of the Proposed Business Combination. This press release may be deemed to be solicitation material in respect of the Proposed Business Combination. The Proposed Business Combination will be submitted to the Company's stockholders for their consideration. A full description of the terms of the Proposed Business Combination is provided in the Registration Statement on Form S-4 declared effective by the SEC on February 2, 2024 (the ""Registration Statement"") that includes a preliminary prospectus with respect to the combined company's securities to be issued in connection with the Proposed Business Combination and a preliminary proxy statement with respect to the shareholder meeting of the Company to vote on the Proposed Business Combination. The Company urges its investors, stockholders and other interested persons to read the Registration Statement and the definitive proxy statement/prospectus, amendments and supplements thereto as well as other documents filed with the SEC because these documents will contain important information about the Company, iLearningEngines and the Proposed Business Combination. The definitive proxy statement/prospectus was first mailed to stockholders of the Company on or about February 2, 2024. The Supplement to the definitive proxy statement/prospectus filed with the SEC on March 13, 2024 disclosing the new record date of March 13, 2024, the proxy card and the definitive proxy statement/prospectus will be distributed to all stockholders of record entitled to vote at the Special Meeting. Stockholders will also be able to obtain a copy of the Registration Statement, including the proxy statement/prospectus, and other documents filed with the SEC without charge, by directing a request to: Arrowroot Acquisition Corp., 4553 Glencoe Ave, Suite 200, Marina Del Rey, California 90292. The definitive proxy statement/prospectus can also be obtained, without charge, at the SEC's website (http://www.sec.gov). INVESTMENT IN ANY SECURITIES DESCRIBED HEREIN HAS NOT BEEN APPROVED OR DISAPPROVED BY THE SEC OR ANY OTHER REGULATORY AUTHORITY NOR HAS ANY AUTHORITY PASSED UPON OR ENDORSED THE MERITS OF THE BUSINESS COMBINATION OR THE ACCURACY OR ADEQUACY OF THE INFORMATION CONTAINED HEREIN. ANY REPRESENTATION TO THE CONTRARY IS A CRIMINAL OFFENSE. View original content:https://www.prnewswire.com/news-releases/arrowroot-acquisition-corp-announces-postponement-of-special-meeting-of-stockholders-and-new-record-date-of-special-meeting-of-stockholders-302088544.html SOURCE Arrowroot Capital Management, LLC When is Arrowroot Acquisition Corp.'s Special Meeting of stockholders postponed to? The Special Meeting is postponed to 9:00 a.m. Eastern Time on March 25, 2024. How can stockholders access the Special Meeting virtually? Stockholders can access the Special Meeting virtually by visiting www.virtualshareholdermeeting.com/ARRW2024SM and entering the 12-digit meeting control number from their proxy card. Can stockholders vote if they have sold their shares after the record date? Stockholders as of the record date can vote, even if they have subsequently sold their shares. How can stockholders change their vote? Stockholders who wish to change their vote should contact Okapi Partners LLC at (212) 297-0720, or info@okapipartners.com. What is the new deadline for submitting Public Shares for redemption? The deadline for submitting Public Shares for redemption is extended until 5 p.m. Eastern Time on March 21, 2024. How can stockholders withdraw their previously submitted redemption requests? Stockholders can withdraw their previously submitted redemption requests by requesting that the transfer agent return such Public Shares prior to 9 a.m. Eastern Time on March 25, 2024."
Two Dover Employees Receive Women MAKE Awards from the Manufacturing Institute,2024-03-13T20:15:00.000Z,Low,Very Positive,"Dover Corporation (DOV) employees Angie Bowling and Kristen Pittas have been named 2024 Women MAKE Awards Honorees by the Manufacturing Institute. Dover recognizes their exceptional contributions and commitment to diversity. Angie Bowling, a Quality Engineer at Vehicle Service Group, and Kristen Pittas, a Compliance Manager at Microwave Products Group, will be honored at the Women MAKE Awards Gala in Washington, D.C.","Two Dover Employees Receive Women MAKE Awards from the Manufacturing Institute Rhea-AI Impact (Low) Rhea-AI Sentiment (Very Positive) Tags Rhea-AI Summary Dover Corporation (DOV) employees Angie Bowling and Kristen Pittas have been named 2024 Women MAKE Awards Honorees by the Manufacturing Institute. Dover recognizes their exceptional contributions and commitment to diversity. Angie Bowling, a Quality Engineer at Vehicle Service Group, and Kristen Pittas, a Compliance Manager at Microwave Products Group, will be honored at the Women MAKE Awards Gala in Washington, D.C. Positive None. Negative None. 03/13/2024 - 04:15 PM DOWNERS GROVE, Ill., March 13, 2024 /PRNewswire/ -- Dover Corporation (NYSE: DOV) announced today that two operating company employees have been selected as 2024 Women MAKE Awards Honorees by the Manufacturing Institute. Angie Bowling, Quality Engineer at Vehicle Service Group (VSG), and Kristen Pittas, Compliance Manager at Microwave Products Group (MPG), are among 130 women nationally to receive the honor. ""We are proud to celebrate these two outstanding employees as 2024 Women MAKE Awards Honorees,"" said Kimberly Bors, Dover's Senior Vice President & Chief Human Resources Officer. ""Role models like Angie and Kristen help us drive innovation, and at the same time, inspire the next generation of female talent in our industry. We believe that cultivating an inclusive culture, where employees feel valued for their diversity and contributions, is vital for our continued success. We are committed to attracting, developing, and retaining great female talent."" As a Quality Engineer at the VSG facility in Madison, Indiana, Angie Bowling is responsible for collaborating with the production and engineering teams to develop processes, test procedures and implement systems that ensure the products and processes fulfill quality standards and meet safety regulations. Bowling is also VSG's site ISO 9001:2015 Lead Internal Auditor responsible for managing the internal audit program. Beyond work, she actively volunteers in her local community and church serving as a personal finance coach and youth group assistant teacher. Kristen Pittas is the primary site Facility Security Officer at the MPG location in Salisbury, Maryland, and her responsibilities include managing MPG's import/export compliance, global company compliance, and personnel clearances, along with education and security awareness for cleared personnel. Pittas also plays a pivotal role in MPG's defense contracting activities. As a former Girl Scout Leader, she is dedicated to mentoring women and girls, instilling empowerment values in them, including her own daughters. Bowling and Pittas will be recognized at the annual Women MAKE Awards Gala in Washington, D.C., on April 18. Since its launch in 2011, the program has honored and recognized more than 1,400 women. Presented by the Manufacturing Institute, the workforce development and education affiliate of the National Association of Manufacturers, this annual national awards program is the nation's marquee program to close the gender gap in manufacturing. The Women MAKE Awards honors women who have demonstrated excellence and leadership in their careers and represent all levels of the manufacturing industry, from the factory floor to the C-suite. About Dover: Dover is a diversified global manufacturer and solutions provider with annual revenue of over $8 billion. We deliver innovative equipment and components, consumable supplies, aftermarket parts, software and digital solutions, and support services through five operating segments: Engineered Products, Clean Energy & Fueling, Imaging & Identification, Pumps & Process Solutions and Climate & Sustainability Technologies. Dover combines global scale with operational agility to lead the markets we serve. Recognized for our entrepreneurial approach for over 65 years, our team of over 25,000 employees takes an ownership mindset, collaborating with customers to redefine what's possible. Headquartered in Downers Grove, Illinois, Dover trades on the New York Stock Exchange under ""DOV."" Additional information is available at dovercorporation.com. Investor Contact: Media Contact: Jack Dickens Adrian Sakowicz Senior Director - Investor Relations Vice President  Communications (630) 743-2566 (630) 743-5039 jdickens@dovercorp.com asakowicz@dovercorp.com View original content to download multimedia:https://www.prnewswire.com/news-releases/two-dover-employees-receive-women-make-awards-from-the-manufacturing-institute-302088323.html SOURCE Dover Who are the 2024 Women MAKE Awards Honorees announced by Dover Corporation? The 2024 Women MAKE Awards Honorees announced by Dover Corporation are Angie Bowling and Kristen Pittas. What are the roles of Angie Bowling and Kristen Pittas at their respective companies? Angie Bowling is a Quality Engineer at Vehicle Service Group, and Kristen Pittas is a Compliance Manager at Microwave Products Group. Where will Angie Bowling and Kristen Pittas be recognized for the Women MAKE Awards? Angie Bowling and Kristen Pittas will be recognized at the annual Women MAKE Awards Gala in Washington, D.C. How many women have been honored by the Women MAKE Awards program since its launch? Since its launch in 2011, the Women MAKE Awards program has honored and recognized more than 1,400 women. Who presents the Women MAKE Awards? The Women MAKE Awards are presented by the Manufacturing Institute, the workforce development and education affiliate of the National Association of Manufacturers."
Profire Energy Reports Financial Results for Fourth Quarter and Full Fiscal Year 2023,2024-03-13T20:30:00.000Z,Neutral,Positive,"Profire Energy, Inc. (PFIE) reported record full-year revenue, net income, and EBITDA for fiscal year 2023. The company's revenue increased by 27% to $58.2 million, with a gross profit of $30.5 million. Net income was $10.8 million, generating EBITDA of $13.2 million. PFIE repurchased 1.2 million shares of stock for $2 million and maintained a debt-free status. The company's solid balance sheet allowed for strategic investments and shareholder value enhancement.","Profire Energy Reports Financial Results for Fourth Quarter and Full Fiscal Year 2023 Rhea-AI Impact (Neutral) Rhea-AI Sentiment (Positive) Tags earnings Rhea-AI Summary Profire Energy, Inc. (PFIE) reported record full-year revenue, net income, and EBITDA for fiscal year 2023. The company's revenue increased by 27% to $58.2 million, with a gross profit of $30.5 million. Net income was $10.8 million, generating EBITDA of $13.2 million. PFIE repurchased 1.2 million shares of stock for $2 million and maintained a debt-free status. The company's solid balance sheet allowed for strategic investments and shareholder value enhancement. Positive None. Negative None. Financial Analyst The reported financial results of Profire Energy, Inc. show remarkable year-over-year growth in revenue, net income and EBITDA, indicating a strong financial performance for the fiscal year 2023. The company's ability to increase revenue by 27% while expanding gross margin from 47.1% to 52.5% suggests effective cost management and operational efficiency. Moreover, the repurchase of shares and the maintenance of a debt-free balance sheet are indicators of a robust financial strategy and shareholder value creation.From a valuation perspective, the increase in net income from $3.9 million to $10.8 million and the earnings per share (EPS) growth from $0.08 to $0.22, are particularly significant for investors. These metrics often serve as key determinants of a company's stock price. The one-time tax benefit and strategic tax planning have also contributed positively to the bottom line, although investors should consider the sustainability of earnings without such non-recurring adjustments.Long-term implications include the potential for continued shareholder returns through share repurchases and dividends, assuming the company maintains its profitability and cash reserves. The company's debt-free status and cash holdings provide a cushion against market volatility and strategic flexibility for future investments or acquisitions. Market Research Analyst Profire Energy's diversification strategy, which now contributes over 13% of total revenue, showcases the company's adaptability and potential for market expansion. The increase in customer demand and the successful introduction of new products beyond the traditional oil and gas markets are pivotal for future growth.The global demand for hydrocarbons and the catch-up in capital expenditures post-pandemic have likely fueled the company's revenue growth. However, it's critical to monitor the sustainability of this demand, especially in light of potential shifts towards renewable energy sources and the impact of environmental regulations on the hydrocarbon industry.Investors should also note the company's focus on enhancing the efficiency, safety and reliability of industrial combustion appliances, which aligns with industry trends towards operational excellence and safety. This focus, coupled with the company's financial results, positions Profire Energy favorably in the market. Energy Sector Analyst Profire Energy's performance within the industrial combustion appliance sector is noteworthy, given the typically cyclical nature of the energy industry. The company's record revenue and net income amidst challenging economic conditions underscore its resilience and the critical nature of its products and services.The increase in gross margin reflects not only improved pricing power but also suggests that Profire Energy may have a competitive advantage in its market niche. The company's strategy to leverage its cash flow for share repurchases demonstrates confidence in its future prospects and a commitment to delivering shareholder value.Looking ahead, Profire Energy's anticipation of attracting new users for its applications beyond the oil and gas markets could signal diversification into adjacent markets or industries, potentially mitigating risks associated with the volatility of the energy sector. 03/13/2024 - 04:30 PM Company Reports Record Full-Year Revenue, Net Income and EBITDALINDON, Utah, March 13, 2024 (GLOBE NEWSWIRE) -- Profire Energy, Inc. (NASDAQ: PFIE), a technology company (the ""Company"") that provides solutions which enhance the efficiency, safety, and reliability of industrial combustion appliances, today reported financial results for its fourth quarter and full fiscal year ending December 31, 2023. A conference call will be held on Thursday, March 14, 2024, at 8:30 a.m. ET to discuss the results. Full-year Fiscal 2023 Summary Revenue of $58.2 million, a 27% increase from prior yearGross profit of $30.5 million or 52.5% of total revenuesNet income of $10.8 million or $0.22 per diluted shareGenerated EBITDA of $13.2 millionRepurchased 1.2 million shares of stock for $2 millionCash and liquid investments of $20 million and remained debt-free Fourth Quarter Summary Revenue of $14.4 million, compared to $14 million in the prior year quarterGross profit of $7.8 million, a 19% increase compared to 4Q22Gross margin of 54.3%, a 730 basis point increase from prior yearNet income of $3.3 million, or $0.07 per diluted shareGenerated EBITDA of $3.1 million 2023 was a record year for Profire, recording our highest annual revenue, net income, and EBITDA in company history, said Ryan Oviatt, Co-Chief Executive Officer and CFO of Profire Energy. We expanded our full-year gross margin and used a portion of our operating cash flow to repurchase 1.2 million of our outstanding shares. Our solid balance sheet provides great flexibility for us to simultaneously invest in our business, repurchase shares when the market presents the opportunity and pursue other investment opportunities that will enhance our future, with the ongoing focus of delivering long-term value for our shareholders. Full Year 2023 Financial Results Total revenues for the year equaled $58.2 million, versus $45.9 million in the prior year. The increase was primarily driven by improved customer demand and progress in the Company's revenue diversification efforts. Gross profit was $30.5 million compared to $21.7 million last year. Gross margin was 52.5% of total revenues, compared to 47.1% of revenues in the prior year. The increase was driven by better fixed cost leverage as a result of the higher revenue base. Total operating expenses were $18.7 million, or 32% of revenue versus $16.5 million, or 36% of revenue in the prior year. The increase is primarily due to inflationary pressures on employee costs and increased business activity that drives variable costs, however the decrease as a percent of revenue reflects the Companys ability to manage its cost structure while still increasing business activity. Compared with last year, operating expenses for G&A increased 16%, R&D decreased 13% and depreciation decreased 8%. Net income was $10.8 million or $0.22 per diluted share, compared to $3.9 million or $0.08 per diluted share last year. This years results include a one-time $828,000, or two cent per diluted share benefit generated from a reduction adjustment to deferred tax expense based on a detailed review of our deferred tax balances. Over the past two years, Profire implemented several tax planning strategies that have had a significant benefit on the Company s financial performance and results of operations. These include filing for and receiving the employee retention credit through the CARES act, the strategic use of several years of net operating losses in Profires Canadian subsidiary and the deferred tax true-up noted above. The impact of these tax planning strategies in 2023 caused operating expenses to be lower by $760,000, reduced income tax expenses, and an increase to net income of $1.9 million or four cents per diluted share. However, even when removing these non-recuring adjustments, 2023 remains the Companys best year from an operating income, net income, and earnings per share perspective. Cash and liquid investments totaled $20.0 million on December 31, 2023 compared to $16.0 million at the end of 2022, and the Company continues to operate debt-free. Fourth Quarter 2023 Financial Results Total revenues for the period equaled $14.4 million, compared to $14.8 million in the third quarter of 2023 and $14.0 million in the prior-year quarter. Gross profit was $7.8 million, compared to $7.5 million in the third quarter of 2023 and $6.6 million in the prior-year quarter. Gross margin was 54% of revenues, compared to 50.4% of revenues in the prior quarter and 47.0% of revenues in the fourth quarter of 2022. The sequential and year-over-year increase in gross profit and gross margin is due to pricing incentives and better fixed cost coverage. Total operating expenses were $5.0 million, compared to $4.9 million in the third quarter of 2023 and $4.3 million in the year-ago quarter. The year-over-year increase is related to the inflationary pressures on our business as well as increased business activity that impacts variable costs. Compared with the same quarter last year, operating expenses for G&A increased by 18%, R&D increased 15% and depreciation decreased by 1%. Net income was $3.3 million, or $0.07 per diluted share, compared to net income of $2.0 million or $0.04 per diluted share in the third quarter of 2023 and $1.8 million or $0.04 per diluted share in the same quarter last year. This quarters results include the $828,000 or $0.02 per diluted share benefit related to the deferred tax adjustment noted earlier. Our record performance in 2023 was driven through a combination of continued demand for our legacy products and increased traction across our diversification strategy, which now represents more than 13% percent of our total revenue, compared to less than one percent in 2021, stated Cameron Tidball, Co-CEO of Profire Energy. Demand for hydrocarbons remains strong globally and we continue to benefit from operators playing catch-up on capital expenditures that had been deferred since the pandemic. We also expect to attract new users for our applications beyond the oil and gas markets during the year. Overall, we remain confident about our prospects for 2024 and beyond. Conference Call Profire Energy Executives will host the call, followed by a question-and-answer period.Date: Thursday, March 14, 2024Time: 8:30 a.m. ET (6:30 a.m. MT)Toll-free dial-in number: 1-855-327-6837International dial-in number: 1-631-891-4304The conference call will be webcast live and available for replay via this link: https://viavid.webcasts.com/starthere.jsp?ei=1653741&tp_key=d0612fee82The webcast replay will be available for one year. Please call the conference telephone number five minutes prior to the start time. An operator will register your name and organization. If you have any difficulty connecting the conference call, please contact Athena Kefalas at 1-801-701-8969. A replay of the call will be available via the dial-in numbers below after 12:30 p.m. ET on the same day through March 28, 2024. Toll-free replay number: 1-844-512-2921International replay number: 1-412-317-6671Replay Pin Number: 10022990 About Profire Energy, Inc. Profire Energy is a technology company providing solutions that enhance the efficiency, safety, and reliability of industrial combustion appliances while mitigating potential environmental impacts related to the operation of these devices. It is primarily focused in the upstream, midstream, and downstream transmission segments of the oil and gas industry. However, in recent years, we have completed many installations of our burner-management solutions in other industries that we believe will be applicable as we expand our addressable market over time. Profire specializes in the engineering and design of burner and combustion management systems and solutions used on a variety of natural and forced draft applications. Its products and services are sold primarily throughout North America. It has an experienced team of sales and service professionals that are strategically positioned across the United States and Canada. Profire has offices in Lindon, Utah; Victoria, Texas; Homer, Pennsylvania; Greeley, Colorado; Millersburg, Ohio; and Acheson, Alberta, Canada. For additional information, visit www.profireenergy.com. Cautionary Note Regarding Forward-Looking Statements. Statements made in this release that are not historical are forward-looking statements. This release contains forward-looking statements, including, but not limited to statements regarding the Companys expected growth, attracting new users beyond the oil and gas market, the Companys plans to make internal and external investments, and delivering long-term value to the Companys shareholders. Forward-looking statements are not guarantees of future results or performance and involve risks, assumptions and uncertainties that could cause actual events or results to differ materially from the events or results described in, or anticipated by, the forward-looking statements. Factors that could materially affect such forward-looking statements include certain economic, business, public market and regulatory risks and factors identified in the company's periodic reports filed with the Securities and Exchange Commission. All forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. All forward-looking statements are made only as of the date of this release and the Company assumes no obligation to update forward-looking statements to reflect subsequent events or circumstances, except as required by law. Readers should not place undue reliance on these forward-looking statements. Contact:Profire Energy, Inc.Ryan Oviatt, Co-CEO & CFO(801) 796-5127 Three Part AdvisorsSteven Hooser, Partner214-872-2710 About Non-GAAP Financial Measures To supplement our consolidated financial statements, which statements are prepared and presented in accordance with GAAP, we use the following non-GAAP financial measure of earnings before interest, taxes, depreciation and amortization (EBITDA). The presentation of this financial information is not intended to be considered in isolation or as a substitute for, or superior to, the financial information prepared and presented in accordance with GAAP. We use this non-GAAP financial measure for financial and operational decision making and as a means to evaluate period-to-period comparisons. Our management believes that this non-GAAP financial measure provides meaningful supplemental information regarding our performance. We believe that both management and investors benefit from referring to this non-GAAP financial measure in assessing our performance and when planning, forecasting, and analyzing future periods. We believe this non-GAAP financial measure is useful to investors both because it allows for greater transparency with respect to key metrics used by management in its financial and operational decision making. The Following is a tabular presentation of EBITDA, including a reconciliation to net income which the Company believes to be the most directly comparable US GAAP financial measure. PROFIRE ENERGY, INC. AND SUBSIDIARIESConsolidated Statements of Operations and Comprehensive Income For the Year Ended December 31, 2023 For the Year Ended December 31, 2022 (See note 1)REVENUES (note 10) Sales of goods, net$54,284,295 $42,318,263 Sales of services, net 3,923,765 3,618,380 Total Revenues 58,208,060 45,936,643 COST OF SALES Cost of goods sold-product 24,528,345 21,425,176 Cost of goods sold-services 3,147,697 2,860,077 Total Cost of Goods Sold 27,676,042 24,285,253 GROSS PROFIT 30,532,018 21,651,390 OPERATING EXPENSES General and administrative 17,184,917 14,776,905 Research and development 917,123 1,051,858 Depreciation and amortization 575,878 628,019 Total Operating Expenses 18,677,918 16,456,782 INCOME FROM OPERATIONS 11,854,100 5,194,608 OTHER INCOME (EXPENSE) Gain on sale of property and equipment 268,817 318,075 Other income (expense) (57,088) 14,383 Interest income 390,031 177,125 Interest expense (9,449) (18,009)Total Other Income 592,311 491,574 INCOME BEFORE INCOME TAXES 12,446,411 5,686,182 INCOME TAX EXPENSE (note 12) (1,669,697) (1,738,422) NET INCOME$10,776,714 $3,947,760 OTHER COMPREHENSIVE INCOME (LOSS) Foreign currency translation gain (loss)$275,810 $(670,167)Unrealized gains (losses) on investments 174,361 (524,239)Total Other Comprehensive Income (Loss) 450,171 (1,194,406) COMPREHENSIVE INCOME$11,226,885 $2,753,354 BASIC EARNINGS PER SHARE (note 13)$0.23 $0.08 FULLY DILUTED EARNINGS PER SHARE (note 13)$0.22 $0.08 BASIC WEIGHTED AVG NUMBER OF SHARES OUTSTANDING 47,355,978 47,161,101 FULLY DILUTED WEIGHTED AVG NUMBER OF SHARES OUTSTANDING 49,127,558 48,447,342 These financial statements should be read in conjunction with the Form 10-K and accompanying footnotes. PROFIRE ENERGY, INC. AND SUBSIDIARIESConsolidated Balance Sheets As ofASSETSDecember 31, 2023 December 31, 2022CURRENT ASSETS Cash and cash equivalents$10,767,519 $7,384,578 Short-term investments (note 2) 2,799,539 1,154,284 Accounts receivable, net 14,013,740 10,886,145 Inventories, net (note 3) 14,059,656 10,293,980 Prepaid expenses and other current assets (note 4) 2,832,262 2,314,639 Total Current Assets 44,472,716 32,033,626 LONG-TERM ASSETS Net deferred tax asset 496,785  Long-term investments (note 2) 6,425,582 7,503,419 Lease right-of-use asset (note 8) 432,907 120,239 Property and equipment, net (note 5) 10,782,372 10,423,964 Intangible assets, net (note 6) 1,104,102 1,268,907 Goodwill (note 6) 2,579,381 2,579,381 Total Long-Term Assets 21,821,129 21,895,910 TOTAL ASSETS$66,293,845 $53,929,536 LIABILITIES AND STOCKHOLDERS' EQUITY CURRENT LIABILITIES Accounts payable$2,699,556 $2,955,506 Accrued liabilities (note 7) 4,541,820 3,573,994 Current lease liability (note 8) 130,184 53,646 Income taxes payable 1,723,910 205,169 Total Current Liabilities 9,095,470 6,788,315 LONG-TERM LIABILITIES Net deferred income tax liability 52,621 488,858 Long-term lease liability (note 8) 307,528 67,883 TOTAL LIABILITIES 9,455,619 7,345,056 STOCKHOLDERS' EQUITY (note 9) Preferred stock: $0.001 par value, 10,000,000 shares authorized: no shares issued or outstanding   Common stock: $0.001 par value, 100,000,000 shares authorized: 53,047,231 issued and 46,803,868 outstanding at December 31, 2023, and 52,143,901 issued and 47,105,771 outstanding at December 31, 2022 53,048 52,144 Treasury stock, at cost (9,324,272) (7,336,323)Additional paid-in capital 32,751,749 31,737,843 Accumulated other comprehensive loss (2,844,702) (3,294,873)Retained earnings 36,202,403 25,425,689 TOTAL STOCKHOLDERS' EQUITY 56,838,226 46,584,480 TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY$66,293,845 $53,929,536 These financial statements should be read in conjunction with the Form 10-K and accompanying footnotes. PROFIRE ENERGY, INC. AND SUBSIDIARIESConsolidated Statements of Cash Flows For the Year Ended December 31, 2023 For the Year Ended December 31, 2022OPERATING ACTIVITIES Net income$10,776,714 $3,947,760 Adjustments to reconcile net income to net cash provided by operating activities: Depreciation and amortization expense 1,108,962 1,101,044 Gain on sale of property and equipment (268,817) (318,075)Bad debt expense 488,420 77,704 Stock awards issued for services 1,043,740 814,769 Changes in operating assets and liabilities: Accounts receivable (3,128,051) (4,745,871)Income taxes receivable/payable 1,515,843 765,650 Inventories (3,712,212) (3,240,049)Prepaid expenses and other current assets (480,308) (1,337,076)Deferred tax asset/liability (933,969) 512,274 Accounts payable and accrued liabilities 653,728 2,937,947 Net Cash Provided by Operating Activities 7,064,050 516,077 INVESTING ACTIVITIES Proceeds from sale of property and equipment 354,840 520,068 Sale (purchase) of investments (393,057) 91,601 Purchase of property and equipment (1,228,275) (601,012)Net Cash Provided by (Used in) Investing Activities (1,266,492) 10,657 FINANCING ACTIVITIES Value of equity awards surrendered by employees for tax liability (605,996) (145,930)Cash received in exercise of stock options 177,281 33,863 Purchase of treasury stock (1,987,949) (1,228,730)Principal paid towards lease liability (37,855) (34,214)Net Cash Used in Financing Activities (2,454,519) (1,375,011) Effect of exchange rate changes on cash 39,902 44,585 NET INCREASE (DECREASE) IN CASH 3,382,941 (803,692)CASH AT BEGINNING OF PERIOD 7,384,578 8,188,270 CASH AT END OF PERIOD$10,767,519 $7,384,578 SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION CASH PAID FOR: Interest$9,450 $17,726 Income taxes$1,155,682 $847,712 NON-CASH FINANCING AND INVESTING ACTIVITIES: Common stock issued in settlement of accrued bonuses$378,526 $212,788 These financial statements should be read in conjunction with the Form 10-K and accompanying footnotes. An image accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/ef385693-c44b-4e42-81f6-06f60c4f80d2 What was Profire Energy, Inc.'s (PFIE) revenue for fiscal year 2023? Profire Energy, Inc. reported a record revenue of $58.2 million for fiscal year 2023. What was Profire Energy, Inc.'s (PFIE) net income for fiscal year 2023? Profire Energy, Inc. achieved a net income of $10.8 million for fiscal year 2023. Did Profire Energy, Inc. (PFIE) generate EBITDA for fiscal year 2023? Yes, Profire Energy, Inc. generated EBITDA of $13.2 million for fiscal year 2023. How many shares did Profire Energy, Inc. (PFIE) repurchase in fiscal year 2023? Profire Energy, Inc. repurchased 1.2 million shares of stock for $2 million in fiscal year 2023. Was Profire Energy, Inc. (PFIE) debt-free for fiscal year 2023? Yes, Profire Energy, Inc. remained debt-free for fiscal year 2023."
Portman Ridge Finance CorporationAnnounces Fourth Quarter and Full Year 2023 Financial Results,2024-03-13T20:24:00.000Z,Low,Neutral,"Portman Ridge Finance Corporation (PTMN) reports strong year-over-year performance with total investment income of $76.3 million, an increase of 9.6%. Net investment income was $34.8 million. The company continued its share repurchase program, totaling $4.4 million in 2023. A quarterly distribution of $0.69 per share was announced for Q1 2024.","Portman Ridge Finance Corporation Announces Fourth Quarter and Full Year 2023 Financial Results Rhea-AI Impact (Low) Rhea-AI Sentiment (Neutral) Tags earnings Rhea-AI Summary Portman Ridge Finance Corporation (PTMN) reports strong year-over-year performance with total investment income of $76.3 million, an increase of 9.6%. Net investment income was $34.8 million. The company continued its share repurchase program, totaling $4.4 million in 2023. A quarterly distribution of $0.69 per share was announced for Q1 2024. Positive Total investment income increased by 9.6% year-over-year to $76.3 million. Net investment income reached $34.8 million in 2023. The company repurchased shares worth $4.4 million during the year. A quarterly distribution of $0.69 per share was declared for Q1 2024. Core investment income, excluding purchase price accounting, saw a 16.1% increase to $74.5 million in 2023. Negative None. Financial Analyst The reported increase in total investment income and net investment income (NII) for Portman Ridge Finance Corporation reflects a robust financial performance, particularly in a challenging market environment. The 9.6% year-over-year growth in investment income and a significant 16.1% increase in core investment income, excluding purchase price accounting adjustments, suggest effective asset management and a potentially favorable credit environment. The uptick in NII per share from $3.00 to $3.66 indicates enhanced profitability on a per-share basis, which is a positive signal for investors.The company's share repurchase program, with $4.4 million spent on buybacks, appears to be a strategic move to leverage the perceived undervaluation of its shares. This action is accretive to net asset value (NAV) per share, which is beneficial for remaining shareholders as it increases their stake in the company's earnings and assets. However, it is important to assess whether these repurchases are the best use of capital, especially when considering alternative investment opportunities or debt reduction.NAV is a critical metric for investment companies as it reflects the net value of their assets. A slight increase in NAV per share, despite a marginal decrease in total NAV, indicates a stable asset valuation which is reassuring. However, the year-over-year decrease in total NAV from $232.1 million to $213.5 million warrants further investigation to understand the underlying factors contributing to this decline. Market Research Analyst Portman Ridge's diversified investment portfolio, which spans 27 industries and 100 entities, demonstrates a strategy aimed at mitigating industry-specific risks. The weighted average contractual interest rate of approximately 12.5% on the Debt Securities Portfolio is a critical figure, reflecting the income-generating capability of the portfolio. Investors should consider this in the context of the current interest rate environment and credit market conditions.The company's asset coverage ratio of 165% and the decrease in net leverage from 1.49x to 1.19x are indicative of a relatively conservative capital structure, which could be appealing to risk-averse investors. This reduction in leverage may also suggest that the company is prioritizing balance sheet strength over aggressive growth, which can be a prudent approach in uncertain market conditions.The announcement of a quarterly distribution increase to $0.69 per share for the first quarter of 2024, albeit a modest one, signals confidence in the company's ability to generate and sustain cash flows. This could be interpreted as a positive sign for income-focused investors. Legal Expert The transition of Chief Financial Officer (CFO) roles, with the resignation of Jason Roos and the appointment of Brandon Satoren, is a routine corporate event that typically does not raise immediate legal concerns, especially since no disagreements were reported. However, it's important to monitor the new CFO's influence on financial strategies and reporting, as these changes can affect investor perceptions and the company's compliance with financial regulations.From a legal standpoint, the company's disclosure of non-accruals on debt investments and the fair value of investments provides transparency, which is crucial for investor trust and aligns with regulatory requirements for financial reporting. The decrease in non-accruals as a percentage of the investment portfolio at fair value from 1.6% to 1.3% suggests an improvement in the credit quality of the portfolio, which could reduce potential legal and financial risks associated with non-performing assets. 03/13/2024 - 04:24 PM Reports Strong Year-Over-Year Performance with Total Investment Income of $76.3 Million, an Increase of 9.6% and Net Investment Income of $34.8 Million Continued Share Repurchase Program for a Total of $4.4 Million During Full Year 2023 Announces Quarterly Distribution of $0.69 Per Share in the First Quarter of 2024 NEW YORK, March 13, 2024 (GLOBE NEWSWIRE) -- Portman Ridge Finance Corporation (Nasdaq: PTMN) (the Company or Portman Ridge) announced today its financial results for the fourth quarter and full year ended December 31, 2023. Full Year 2023 Milestones Total investment income was $76.3 million, an increase of 9.6% as compared to full year 2022.Net investment income (""NII"") was $34.8 million ($3.66 per share).Core investment income, excluding the impact of purchase price accounting, was $74.5 million, an increase of 16.1% as compared to full year 2022.Total shares repurchased in open market transactions under the Renewed Stock Repurchase Program during the year ended December 31, 2023, were 224,933 at an aggregate cost of approximately $4.4 million. This compares to 167,017 shares repurchased during the year ended December 31, 2022 at an aggregate cost of approximately $3.8 million.Total stockholder distributions for 2023 amount to $2.75 per share. Fourth Quarter 2023 Highlights Total investment income for the fourth quarter of 2023 was $17.8 million, a decrease of $0.8 million as compared to $18.6 million for the fourth quarter of 2022 and a decrease of $0.8 million as compared to $18.6 million for the third quarter of 2023.Core investment income1, excluding the impact of purchase price accounting, for the fourth quarter of 2023 was $17.7 million, unchanged from the fourth quarter of 2022 and a decrease of $0.6 million as compared to $18.3 million for the third quarter of 2023.Net investment income (""NII"") for the fourth quarter of 2023 was $11.2 million ($1.19 per share), an increase of $4.1 million as compared to $7.1 million ($0.74 per share) for the fourth quarter of 2022 and an increase of $4.0 million as compared to $7.2 million ($0.75 per share) for the third quarter of 2023. The increase in NII in the fourth quarter of 2023 was the result of a one-time expense reimbursement from the Companys investment adviser.Net asset value (NAV) as of December 31, 2023, was $213.5 million ($22.76 per share). This compares to NAV of $214.8 million ($22.65 per share) for the third quarter of 2023. The increase in NAV per share, despite a decrease in total NAV, was due to the accretive nature of the share repurchase program to NAV per share.Total shares repurchased in open market transactions under the Renewed Stock Repurchase Program during the quarter ended December 31, 2023, were 101,680 shares at an aggregate cost of approximately $1.8 million. Subsequent Events Declared stockholder distribution of $0.69 per share for the first quarter of 2024, payable on April 2, 2024 to stockholders of record at the close of business on March 25, 2023. This represents a $0.01 per share increase from the first quarter of 2023.On March 11, 2024, the Companys board of directors authorized a renewed stock repurchase program of up to $10 million for an approximately one-year period, effective March 11, 2024 and terminating on March 31, 2025. The renewed stock repurchase program has substantially the same terms as the prior program. Management Commentary Ted Goldthorpe, Chief Executive Officer of Portman Ridge, stated, We are pleased to announce another strong year of financial performance for Portman Ridge, as we saw a 9.6% increase in total investment income and a 16.1% increase in core investment income as compared to the previous year. These milestones are a testament to the continued positive momentum we are seeing across our platform, despite operating under difficult market conditions. Additionally, we believe that our stock remained undervalued throughout the year, thus, during 2023 we repurchased shares for an aggregate of $4.4 million, which had an accretive effect to the companys net asset value per share, reinforcing our commitment to shareholder value. On March 11, 2024, our board of directors authorized a renewed stock repurchase program of up to $10 million for an approximately one-year period. As a result of our strong financial performance during the year, the board of directors was able to approve a dividend of $0.69 per share for the first quarter of 2024, an increase of $0.01 per share as compared to the first quarter of 2023. As we step forward into 2024, we believe we have a robust pipeline, and are favorably positioned to take advantage of new investment opportunities that arise, while continuing to be highly selective in our investment and capital deployment process. We remain confident in our strategy and believe it will allow us to continue to deliver strong results and returns for our shareholders. Selected Financial Highlights for Full Year 2023 Total investment income for the year ended 2023 was $76.3 million, of which $63.5 million was attributable to interest income from the Debt Securities Portfolio. This compares to total investment income of $69.6 million for the year ended 2022, of which $55.8 million was attributable to interest income from the Debt Securities Portfolio.Core investment income for the full year 2023, excluding the impact of purchase price accounting, was $74.5 million, an increase of $10.3 million as compared to core investment income of $64.2 million for full year 2022.Net investment income (""NII"") for full year 2023 was $34.8 million ($3.66 per share) as compared to $28.9 million ($3.00 per share) for the full year 2022. The year-over-year increase was largely due to the $5.3 million expense reimbursement from the Companys investment adviser in the fourth quarter.Net asset value (NAV) as of December 31, 2023, was $213.5 million ($22.76 per share), an increase of $0.11 per share as compared to $214.8 million ($22.65 per share) for the third quarter of 2023. This compares to $232.1 million ($24.23 per share) as of December 31, 2022. The quarter-over-quarter increase in NAV per share, despite total NAV decreasing slightly, was predominantly driven by the repurchase of 101,680 shares during the fourth quarter.Non-accruals on debt investments, as of December 31, 2023, were seven debt investments representing 1.3% and 3.2% of the Companys investment portfolio at fair value and amortized cost, respectively. This compares to eight debt investments representing 1.6% and 3.6% of the Companys investment portfolio at fair value and amortized cost, respectively, as of September 30, 2023, and four debt investments representing 0.0% and 0.6% of the Companys investment portfolio at fair value and amortized cost, respectively, as of December 31, 2022.Total investments at fair value as of December 31, 2023, was $467.9 million; when excluding CLO funds, Joint Ventures, and short-term investments, these investments are spread across 27 different industries and 100 different entities with an average par balance per entity of approximately $3.1 million. This compares to $576.5 million of total investments at fair value as of December 31, 2022, comprised of investments in 31 different industries and 119 different entities, with an average par balance per entity of approximately $3.3 million.Weighted average contractual interest rate on our interest earning Debt Securities Portfolio as of December 31, 2023 was approximately 12.5%.Par value of outstanding borrowings, as of December 31, 2023, was $325.7 million with an asset coverage ratio of total assets to total borrowings of 165%. On a net basis, leverage as of December 31, 2023 was 1.19x2 compared to net leverage of 1.49x3 as of December 31, 2022. Other Updates The Company is pleased to announce that Brandon Satoren has been appointed by the Companys board of directors as the new Chief Financial Officer, Secretary and Treasurer of the Company, effective April 1, 2024. Mr. Satoren, 35, currently serves as the Chief Accounting Officer of Logan Ridge Finance Corporation as well as other registered investment companies within the broader BC Partners Credit platform and has over 14 years of experience in the asset management industry. Mr. Satoren joined BC Partners Advisors LP, an affiliate of the Companys investment adviser, in May 2021 as a member of the Credit Control team. In this role, he is responsible for directing accounting policy, execution and oversight of financial and non-financial reporting process, as well as other various finance, operations, governance and compliance responsibilities for BC Partners credit strategies. Prior to joining BC Partners Advisors LP, Mr. Satoren previously was a Vice President and Controller at PennantPark, a Vice President at AQR Capital Management, LLC and a Manager at PricewaterhouseCoopers LLP. He earned a Bachelor of Science in Accounting from the University of Central Florida in 2010. Mr. Satoren is a Certified Public Accountant licensed to practice in Colorado and is a member of the American Institute of Certified Public Accountants. On March 11, 2024, the board of directors of Portman Ridge received and accepted the resignation of Jason Roos, Chief Financial Officer, Secretary and Treasurer of the Company, effective April 1, 2024. Mr. Roos decision to resign is not related to any disagreement relating to the Companys accounting, strategy, management, operations, policies, regulatory matters, or practices (financial or otherwise). Mr. Roos will continue to support the executive team in an advisory capacity for an extended period of time. Results of Operations Operating results for the years ended December 31, 2023, and December 31, 2022, were as follows: For the Year Ended December 31, 2023 2022 Total investment income $76,315 $69,614 Net expenses(1) 41,542 40,724 Net Investment Income 34,773 28,890 Net realized gain (loss) on investments (26,766) (31,185)Net unrealized gain (loss) on investments 3,322 (17,915)Tax (provision) benefit on realized and unrealized gains (losses) on investments $414 $(786)Net realized and unrealized appreciation (depreciation) on investments, net of taxes $(23,030) $(49,886)Realized gains (losses) on extinguishments of debt $(362) $- Net Increase (Decrease) in Net Assets Resulting from Operations $11,381 $(20,996)Net Increase (Decrease) In Net Assets Resulting from Operations per Common Share: Basic and Diluted: $1.20 $(2.18)Net Investment Income Per Common Share: Basic and Diluted: $3.66 $3.00 Weighted Average Shares of Common Stock OutstandingBasic and Diluted 9,509,396 9,634,468 1During the year ended December 31, 2023, the Company received a reimbursement from its investment adviser of $5.3 million, inclusive of interest, for expenses relating to certain administrative transition services. Investment Income The composition of our investment income for the years ended December 31, 2023, and 2022 was as follows: For the Year Ended December 31,($ in thousands) 2023 2022 Interest from investments in debt excluding accretion $54,631 $44,771 Purchase discount accounting 1,774 5,425 PIK Investment Income 7,068 5,608 CLO Income 1,998 4,044 JV Income 8,948 8,591 Service Fees 1,896 1,175 Investment Income $76,315 $69,614 Less : Purchase discount accounting $(1,774) $(5,425)Core Investment Income $74,541 $64,189 Fair Value of Investments The composition of our investment portfolio as of December 31, 2023 and December 31, 2022 at cost and fair value was as follows: ($ in thousands) December 31, 2023 December 31, 2022 Security Type Cost/AmortizedCost Fair Value %(1) Cost/AmortizedCost Fair Value %(1) Senior Secured Loan $356,358 $340,159 73 $435,856 $418,722 73 Junior Secured Loan 53,888 38,875 8 65,776 56,400 10 Senior Unsecured Bond 416 43 0 416 43 0 Equity Securities 31,280 20,533 4 28,848 21,905 4 CLO Fund Securities 9,103 8,968 2 34,649 20,453 3 Asset Manager Affiliates(2) 17,791 - - 17,791 - - Joint Ventures 71,415 59,287 13 68,850 58,955 10 Derivatives 31 - - 31 - - Total $540,282 $467,865 100% $652,217 $576,478 100% 1 Represents percentage of total portfolio at fair value2 Represents the equity investment in the Asset Manager Affiliates Liquidity and Capital ResourcesAs of December 31, 2023, the Company had $325.7 million (par value) of borrowings outstanding at a current weighted average interest rate of 7.0%, of which $108.0 million par value had a fixed rate and $217.7 million par value had a floating rate. This balance was comprised of $92.0 million of outstanding borrowings under the Senior Secured Revolving Credit Facility, $125.7 million of 2018-2 Secured Notes due 2029, and $108.0 million of 4.875% Notes due 2026. As of December 31, 2023 and December 31, 2022, the fair value of investments and cash were as follows: ($ in thousands) Security Type December 31, 2023 December 31, 2022 Cash and cash equivalents $26,912 $5,148 Restricted Cash 44,652 27,983 Senior Secured Loan 340,159 418,722 Junior Secured Loan 38,875 56,400 Senior Unsecured Bond 43 43 Equity Securities 20,533 21,905 CLO Fund Securities 8,968 20,453 Asset Manager Affiliates - - Joint Ventures 59,287 58,955 Derivatives - - Total $539,429 $609,609 As of December 31, 2023, the Company had unrestricted cash of $26.9 million and restricted cash of $44.7 million. This compares to unrestricted cash of $14.9 million and restricted cash of $18.8 million as of September 30, 2023, and unrestricted cash of $5.1 million and restricted cash of $28.0 million as of December 31, 2022. As of December 31, 2023, the Company had $23 million of available borrowing capacity under the Senior Secured Revolving Credit Facility, and no remaining borrowing capacity under the 2018-2 Secured Notes. Interest Rate Risk The Companys investment income is affected by fluctuations in various interest rates, including SOFR and prime rates. As of December 31, 2023, approximately 89.7% of our Debt Securities Portfolio at par value were either floating rate with a spread to an interest rate index such as SOFR or the PRIME rate. 77.4% of these floating rate loans contain SOFR floors ranging between 0.50% and 2.50%. We generally expect that future portfolio investments will predominately be floating rate investments. In periods of rising or lowering interest rates, the cost of the portion of debt associated with the 4.875% Notes Due 2026 would remain the same, given that this debt is at a fixed rate, while the interest rate on borrowings under the Revolving Credit Facility would fluctuate with changes in interest rates. Generally, the Company would expect that an increase in the base rate index for floating rate investment assets would increase gross investment income and a decrease in the base rate index for such assets would decrease gross investment income (in either case, such increase/decrease may be limited by interest rate floors/minimums for certain investment assets). Impact on net investment income froma change in interest rates at: ($ in thousands) 1% 2% 3% Increase in interest rate $1,508 $3,017 $4,525 Decrease in interest rate $(1,508) $(3,017) $(4,525) Conference Call and Webcast We will hold a conference call on March 14, 2024, at 9:00 am Eastern Time to discuss our fourth quarter and full year 2023 financial results. To access the call, stockholders, prospective stockholders and analysts should dial (646) 307-1963 approximately 10 minutes prior to the start of the conference call and use the conference ID 4194885. A live audio webcast of the conference call can be accessed via the Internet, on a listen-only basis on the Companys website www.portmanridge.com in the Investor Relations section under Events and Presentations. The webcast can also be accessed by clicking the following link: https://edge.media-server.com/mmc/p/z9pgs7ne. The online archive of the webcast will be available on the Companys website shortly after the call. About Portman Ridge Finance Corporation Portman Ridge Finance Corporation (Nasdaq: PTMN) is a publicly traded, externally managed investment company that has elected to be regulated as a business development company under the Investment Company Act of 1940. Portman Ridges middle market investment business originates, structures, finances and manages a portfolio of term loans, mezzanine investments and selected equity securities in middle market companies. Portman Ridges investment activities are managed by its investment adviser, Sierra Crest Investment Management LLC, an affiliate of BC Partners Advisors, LP. Portman Ridges filings with the Securities and Exchange Commission (the SEC), earnings releases, press releases and other financial, operational and governance information are available on the Company's website at www.portmanridge.com. About BC Partners Advisors L.P. and BC Partners Credit BC Partners is a leading international investment firm with over 40 billion of assets under management in private equity, private credit and real estate strategies. Established in 1986, BC Partners has played an active role in developing the European buyout market for three decades. Today, BC Partners executives operate across markets as an integrated team through the firm's offices in North America and Europe. For more information, please visit https://www.bcpartners.com/. BC Partners Credit was launched in February 2017 and has pursued a strategy focused on identifying attractive credit opportunities in any market environment and across sectors, leveraging the deal sourcing and infrastructure made available from BC Partners. Cautionary Statement Regarding Forward-Looking Statements This press release contains forward-looking statements. The matters discussed in this press release, as well as in future oral and written statements by management of Portman Ridge Finance Corporation, that are forward-looking statements are based on current management expectations that involve substantial risks and uncertainties which could cause actual results to differ materially from the results expressed in, or implied by, these forward-looking statements. Forward-looking statements relate to future events or our future financial performance and include, but are not limited to, projected financial performance, expected development of the business, plans and expectations about future investments and the future liquidity of the Company. We generally identify forward-looking statements by terminology such as may, will, should, expects, plans, anticipates, could, intends, target, projects, outlook, contemplates, believes, estimates, predicts, potential or continue or the negative of these terms or other similar words. Forward-looking statements are based upon current plans, estimates and expectations that are subject to risks, uncertainties, and assumptions. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove to be incorrect, actual results may vary materially from those indicated or anticipated by such forward-looking statements. Important assumptions include our ability to originate new investments, and achieve certain margins and levels of profitability, the availability of additional capital, and the ability to maintain certain debt to asset ratios. In light of these and other uncertainties, the inclusion of a projection or forward-looking statement in this press release should not be regarded as a representation that such plans, estimates, expectations or objectives will be achieved. Important factors that could cause actual results to differ materially from such plans, estimates or expectations include, among others, (1) uncertainty of the expected financial performance of the Company; (2) expected synergies and savings associated with merger transactions effectuated by the Company; (3) the ability of the Company and/or its adviser to implement its business strategy; (4) evolving legal, regulatory and tax regimes; (5) changes in general economic and/or industry specific conditions, including but not limited to the impact of inflation; (6) the impact of increased competition; (7) business prospects and the prospects of the Companys portfolio companies; (8) contractual arrangements with third parties; (9) any future financings by the Company; (10) the ability of Sierra Crest Investment Management LLC to attract and retain highly talented professionals; (11) the Companys ability to fund any unfunded commitments; (12) any future distributions by the Company; (13) changes in regional or national economic conditions, including but not limited to the impact of the COVID-19 pandemic, and their impact on the industries in which we invest; and (14) other changes in the conditions of the industries in which we invest and other factors enumerated in our filings with the SEC. The forward-looking statements should be read in conjunction with the risks and uncertainties discussed in the Companys filings with the SEC, including the Companys most recent Form 10-K and other SEC filings. We do not undertake to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required to be reported under the rules and regulations of the SEC. Contacts:Portman Ridge Finance Corporation 650 Madison Avenue, 23rd floorNew York, NY 10022info@portmanridge.com Jason Roos Jason.Roos@bcpartners.com(212) 891-2880 The Equity Group Inc.Lena Catilcati@equityny.com(212) 836-9611 Val Ferrarovferraro@equityny.com(212) 836-9633 PORTMAN RIDGE FINANCE CORPORATIONCONSOLIDATED BALANCE SHEETS(in thousands, except share and per share amounts) December 31, 2023 December 31, 2022 ASSETS Investments at fair value: Non-controlled/non-affiliated investments (amortized cost: 2023 - $426,630; 2022 - $518,699)$398,325 $483,698 Non-controlled affiliated investments (amortized cost: 2023 - $55,611; 2022 - $75,196) 55,222 73,827 Controlled affiliated investments (cost: 2023 - $58,041; 2022 - $58,322) 14,318 18,953 Total Investments at Fair Value (cost: 2023 - $540,282; 2022 - $652,217)$467,865 $576,478 Cash and cash equivalents 26,912 5,148 Restricted cash 44,652 27,983 Interest receivable 5,162 4,828 Receivable for unsettled trades 573 1,395 Due from affiliates 1,534 930 Other assets 2,541 2,724 Total Assets$549,239 $619,486 LIABILITIES 2018-2 Secured Notes (net of discount of: 2023 - $712; 2022 - $1,226)$124,971 $176,937 4.875% Notes Due 2026 (net of discount of: 2023 - $1,225; 2022 - $1,704; net of deferred financing costs of: 2023 - $561; 2022 - $818) 106,214 105,478 Great Lakes Portman Ridge Funding LLC Revolving Credit Facility (net of deferred financing costs of: 2023 - $775; 2022 - $1,107) 91,225 90,893 Payable for unsettled trades 520 1,276 Accounts payable, accrued expenses and other liabilities 4,252 4,614 Accrued interest payable 3,928 3,722 Due to affiliates 458 900 Management and incentive fees payable 4,153 3,543 Total Liabilities$335,721 $387,363 COMMITMENTS AND CONTINGENCIES (NOTE 8) NET ASSETS Common stock, par value $0.01 per share, 20,000,000 common shares authorized; 9,943,385 issued, and 9,383,132 outstanding at December 31, 2023, and 9,916,856 issued, and 9,581,536 outstanding at December 31, 2022$94 $96 Capital in excess of par value 717,835 736,784 Total distributable (loss) earnings (504,411) (504,757)Total Net Assets$213,518 $232,123 Total Liabilities and Net Assets$549,239 $619,486 Net Asset Value Per Common Share$22.76 $24.23 PORTMAN RIDGE FINANCE CORPORATIONCONSOLIDATED STATEMENTS OF OPERATIONS(in thousands, except share and per share amounts) For the Year Ended December 31, 2023 2022 2021 INVESTMENT INCOME Interest income: Non-controlled/non-affiliated investments $55,675 $51,090 $60,236 Non-controlled affiliated investments 2,728 3,150 4,775 Total interest income $58,403 $54,240 $65,011 Payment-in-kind income: Non-controlled/non-affiliated investments (2) $6,662 $4,950 $3,355 Non-controlled affiliated investments 406 477 166 Controlled affiliated investments - 181 - Total payment-in-kind income $7,068 $5,608 $3,521 Dividend income: Non-controlled affiliated investments $6,764 $4,450 $4,006 Controlled affiliated investments 2,184 4,141 5,170 Total dividend income $8,948 $8,591 $9,176 Fees and other income: Non-controlled/non-affiliated investments $1,882 $1,135 $2,378 Non-controlled affiliated investments 14 40 - Total fees and other income $1,896 $1,175 $2,378 Total investment income $76,315 $69,614 $80,086 EXPENSES Management fees $7,452 $8,349 $7,916 Performance-based incentive fees 7,374 6,126 7,075 Interest and amortization of debt issuance costs 25,306 17,701 13,644 Professional fees 2,629 3,400 3,660 Administrative services expense 2,377 3,364 3,219 Other general and administrative expenses 1,713 1,784 2,568 Total expenses $46,851 $40,724 $38,082 Expense reimbursement $(5,309) $- $- Net expenses $41,542 $40,724 $38,082 NET INVESTMENT INCOME $34,773 $28,890 $42,004 REALIZED AND UNREALIZED GAINS (LOSSES) ON INVESTMENTS: Net realized gains (losses) from investment transactions Non-controlled/non-affiliated investments $(26,334) $(28,893) $(4,397)Non-controlled affiliated investments (399) (197) 139 Controlled affiliated investments (33) -  Derivatives - (2,095) - Net realized gain (loss) on investments $(26,766) $(31,185) $(4,258)Net change in unrealized appreciation (depreciation) on: Non-controlled/non-affiliated investments $6,696 $(8,298) $(8,047)Non-controlled affiliated investments 980 (1,428) 282 Controlled affiliated investments (4,354) (10,601) 625 Derivatives - 2,412 (1,303)Net unrealized gain (loss) on investments $3,322 $(17,915) $(8,443)Tax (provision) benefit on realized and unrealized (gains) losses on investments $414 $(786) $(1,442)Net realized and unrealized appreciation (depreciation) on investments, net of taxes $(23,030) $(49,886) $(14,143)Realized gains (losses) on extinguishments of debt $(362) $- $(1,835)NET INCREASE (DECREASE) IN NET ASSETS RESULTING FROM OPERATIONS $11,381 $(20,996) $26,026 Net Increase (Decrease) In Net Assets Resulting from Operations per Common Share (1): Basic and Diluted: $1.20 $(2.18) $3.05 Net Investment Income Per Common Share (1): Basic and Diluted: $3.66 $3.00 $4.92 Weighted Average Shares of Common Stock OutstandingBasic and Diluted (1) 9,509,396 9,634,468 8,536,079 1The Company completed a Reverse Stock Split of 10 to 1 effective August 26, 2021, the weighted average shares outstanding and per share values have been adjusted retroactively to reflect the split for all periods presented. 2During the year ended December 31, 2023, the Company received $610.2 thousand of non-recurring fee income that was paid in-kind and included in this financial statement line item. 1 Core investment income represents reported total investment income as determined in accordance with U.S. generally accepted accounting principles, or U.S. GAAP, less the impact of purchase price discount accounting in connection with the Garrison Capital Inc. (GARS) and Harvest Capital Credit Corporation (HCAP) mergers. Portman Ridge believes presenting core investment income and the related per share amount is useful and appropriate supplemental disclosure for analyzing its financial performance due to the unique circumstance giving rise to the purchase accounting adjustment. However, core investment income is a non-U.S. GAAP measure and should not be considered as a replacement for total investment income and other earnings measures presented in accordance with U.S. GAAP. Instead, core investment income should be reviewed only in connection with such U.S. GAAP measures in analyzing Portman Ridges financial performance.2 Net leverage is calculated as the ratio between (A) debt, excluding unamortized debt issuance costs, less available cash and cash equivalents, and restricted cash and (B) NAV. Portman Ridge believes presenting a net leverage ratio is useful and appropriate supplemental disclosure because it reflects the Companys financial condition net of $71.6 million and $33.1 million of cash and cash equivalents and restricted cash for the quarters ended December 31, 2023 and December 31, 2022, respectively. However, the net leverage ratio is a non-U.S. GAAP measure and should not be considered as a replacement for the regulatory asset coverage ratio and other similar information presented in accordance with U.S. GAAP. Instead, the net leverage ratio should be reviewed only in connection with such U.S. GAAP measures in analyzing Portman Ridges financial condition. What was Portman Ridge Finance Corporation's (PTMN) total investment income for the year 2023? Portman Ridge Finance Corporation reported total investment income of $76.3 million for the year 2023. How much was the net investment income for Portman Ridge Finance Corporation in 2023? Portman Ridge Finance Corporation's net investment income for 2023 was $34.8 million. What was the total cost of shares repurchased by Portman Ridge Finance Corporation during 2023? Portman Ridge Finance Corporation repurchased shares totaling approximately $4.4 million during 2023. What was the amount of quarterly distribution per share announced by Portman Ridge Finance Corporation for the first quarter of 2024? Portman Ridge Finance Corporation announced a quarterly distribution of $0.69 per share for the first quarter of 2024. What was the percentage increase in core investment income for Portman Ridge Finance Corporation in 2023? Portman Ridge Finance Corporation saw a 16.1% increase in core investment income to $74.5 million in 2023."
Watts Water Technologies Elects Kenneth Napolitano to Its Board of Directors,2024-03-13T20:30:00.000Z,Low,Neutral,"Watts Water Technologies, Inc. appoints Kenneth Napolitano to its Board of Directors, bringing extensive experience in the water and industrial process markets. Napolitano's background includes senior roles at Xylem, Inc. and ITT Corporation, making him a valuable addition to the Governance and Sustainability Committee.","Watts Water Technologies Elects Kenneth Napolitano to Its Board of Directors Rhea-AI Impact (Low) Rhea-AI Sentiment (Neutral) Tags management Rhea-AI Summary Watts Water Technologies, Inc. appoints Kenneth Napolitano to its Board of Directors, bringing extensive experience in the water and industrial process markets. Napolitano's background includes senior roles at Xylem, Inc. and ITT Corporation, making him a valuable addition to the Governance and Sustainability Committee. Positive Appointment of Kenneth Napolitano, a seasoned global executive, to the Board of Directors. Napolitano's significant experience in the water and industrial process markets. Napolitano's past senior roles at Xylem, Inc. and ITT Corporation. Napolitano's expertise in new product development, strategic planning, and operational excellence. Watts Water Technologies' position as a global manufacturer with a wide range of plumbing, heating, and water quality products. Negative None. 03/13/2024 - 04:30 PM NORTH ANDOVER, Mass.--(BUSINESS WIRE)-- Watts Water Technologies, Inc. (NYSE: WTS) today announced the election of Kenneth Napolitano as a member of the Board of Directors. Mr. Napolitano was also appointed by the Board to serve as a member of the Governance and Sustainability Committee of the Board of Directors. Mr. Napolitano served as Senior Vice President and President of the Applied Water Systems and Americas Commercial Team of Xylem, Inc. from 2017 until his retirement in 2020, and as Senior Vice President and President of Applied Water Systems at Xylem from 2011 to 2017. Xylem is a global designer, manufacturer and equipment and service provider for water and wastewater applications which spun off from ITT Corporation in 2011. Prior to the spin-off, Mr. Napolitano held several management roles at ITT from 1998 to 2011, including President of Residential and Commercial Water, President of the Industrial Products Group, Vice President of Sales and Service Operations, Americas, General Manager of PumpSmart Control Solutions and Director of Distributor Sales. Mr. Napolitano held several sales and sales management roles at Goulds Pumps, Inc. from 1984 to 1998, which was acquired by ITT in 1997. Ken is a seasoned global executive with almost four decades of experience in the water and industrial process markets, said Robert J. Pagano, Jr., Watts Chief Executive Officer, President and Chairperson of the Board. We believe Kens deep understanding of our industry, products and sales channels will be a valuable asset to our Board in the areas of new product and solution development, strategic planning, and operational excellence. Watts Water Technologies, Inc., through its family of companies, is a global manufacturer headquartered in the USA that provides one of the broadest plumbing, heating, and water quality product lines in the world. Watts Water companies and brands offer innovative plumbing, heating, and water quality solutions to control the efficiency, safety, and quality of water within commercial, residential, and industrial applications. For more information visit www.watts.com. View source version on businesswire.com: https://www.businesswire.com/news/home/20240313201036/en/ Watts Water Technologies, Inc. Diane McClintock Senior Vice President FP&A and Investor Relations Telephone: 978-689-6153 Email: investorrelations@wattswater.com Source: Watts Water Technologies, Inc Who was appointed as a member of the Board of Directors at Watts Water Technologies? Kenneth Napolitano was appointed as a member of the Board of Directors at Watts Water Technologies. What is Kenneth Napolitano's background in the industry? Kenneth Napolitano has almost four decades of experience in the water and industrial process markets. Which companies did Kenneth Napolitano work for before joining the Board of Directors at Watts Water Technologies? Kenneth Napolitano worked for Xylem, Inc. and ITT Corporation before joining the Board of Directors at Watts Water Technologies. What expertise does Kenneth Napolitano bring to the Board of Directors? Kenneth Napolitano brings expertise in new product development, strategic planning, and operational excellence to the Board of Directors. What type of products does Watts Water Technologies manufacture? Watts Water Technologies manufactures a wide range of plumbing, heating, and water quality products."
Impinj Announces Successful Settlement of Patent Litigation,2024-03-13T20:22:00.000Z,Moderate,Neutral,"Impinj, Inc. (NASDAQ: PI) settles patent disputes with NXP Semiconductors N.V., receiving an up-front payment and annual license fee. The agreement ends all legal proceedings, releases liability for past patent infringement, and licenses patents to each other. Resellers and end users are also released from infringement claims. Impinj's CEO emphasizes the importance of safeguarding their patents and promoting innovation.","Impinj Announces Successful Settlement of Patent Litigation Rhea-AI Impact (Moderate) Rhea-AI Sentiment (Neutral) Tags Rhea-AI Summary Impinj, Inc. (NASDAQ: PI) settles patent disputes with NXP Semiconductors N.V., receiving an up-front payment and annual license fee. The agreement ends all legal proceedings, releases liability for past patent infringement, and licenses patents to each other. Resellers and end users are also released from infringement claims. Impinj's CEO emphasizes the importance of safeguarding their patents and promoting innovation. Positive None. Negative None. Legal Expert From a legal standpoint, the settlement of patent disputes between Impinj, Inc. and NXP Semiconductors carries significant implications. Firstly, the termination of all pending legal proceedings reduces the immediate legal expenses and potential liabilities for both companies. Secondly, the mutual licensing agreement suggests that both parties recognize the validity and value of each other's intellectual property, which can foster a more collaborative industry environment. The release of liability for past patent infringement can also be seen as a strategic move to avoid the unpredictability of jury verdicts and the high costs associated with prolonged litigation.Moreover, the licensing deal provides a steady stream of revenue for Impinj in the form of an annual license fee. This could enhance the company's financial stability and predictability of earnings. It's important to note that such agreements can set industry standards for technology usage and patent valuations. The fact that Impinj has prevailed in multiple trials prior to this settlement might indicate a strong patent portfolio, which could deter future litigation and strengthen its market position. Financial Analyst Analyzing the financial impact, the one-time payment received by Impinj as part of the settlement likely represents a positive cash infusion that could be reflected in the company's short-term financial reporting. This inflow, along with the annual license fee, will contribute to the company's revenue stream, potentially improving its profit margins and earnings per share. Investors often view such settlements favorably, as they eliminate uncertainty and provide financial benefits.However, it's crucial to evaluate how these financial gains compare to the potential revenue that could have been generated through continued litigation victories. Additionally, the market will be watching how Impinj plans to reinvest the settlement funds into further innovation or debt reduction. The market reaction to this news will be a key indicator of how investors are valuing the settlement terms and the future prospects of the company's patent portfolio. Market Research Analyst The settlement between Impinj and NXP Semiconductors has broader implications for the RAIN RFID and Internet of Things (IoT) sectors. The resolution of this dispute may encourage other industry players to seek similar agreements, which could accelerate the consolidation of patent portfolios and standardize technology platforms. Such standardization can lead to increased adoption of RAIN RFID technology, as end users benefit from reduced risk of infringement litigation.Furthermore, the explicit mention of resellers and end users being released from infringement claims for past sales or use of UHF RFID products could improve market sentiment towards both companies' products. This aspect of the settlement may increase market penetration and customer loyalty, as it reduces the legal risk for the supply chain and end users involved with these technologies. Therefore, the settlement could have a positive impact on the overall growth trajectory of the RAIN RFID market. 03/13/2024 - 04:22 PM Company receives one-time payment and annual license fee SEATTLE--(BUSINESS WIRE)-- Impinj, Inc. (NASDAQ: PI), a leading RAIN RFID provider and Internet of Things pioneer, today announced a successful settlement of its patent disputes with NXP Semiconductors N.V. As outlined in an 8-K filed with the U.S. Securities and Exchange Commission today, the agreement terminates all pending legal proceedings, releases each party from liability for past patent infringement, and licenses each partys patents to the other. It also releases resellers and end users from infringement claims for the sale or use of the parties UHF RFID products before the date of the agreement. The agreement, which concludes a multi-year patent dispute during which Impinj prevailed in multiple trials, includes both an up-front payment and a yearly license fee to Impinj. Impinj is passionately inventive, said Chris Diorio, Impinj co-founder and CEO. Our more-than 305 issued and allowed RAIN RFID patents are the hard-earned fruits of that passion and reflect significant investment, dedication and sheer hard work. We are committed to safeguarding those patented inventions, ensuring free and fair competition and innovating solutions for our enterprise end users. I believe this settlement advances all three objectives and am pleased with the final outcome. About Impinj Impinj (NASDAQ: PI) helps businesses and people analyze, optimize, and innovate by wirelessly connecting billions of everyday things  such as apparel, automobile parts, luggage, and shipments  to the Internet. The Impinj platform uses RAIN RFID to deliver timely data about these everyday things to business and consumer applications, enabling a boundless Internet of Things. www.impinj.com View source version on businesswire.com: https://www.businesswire.com/news/home/20240313912451/en/ For more information, contact: Investor Relations Andy Cobb, CFA Vice President, Strategic Finance +1 206-315-4470 ir@impinj.com Media Relations Jill West Vice President, Strategic Communications +1 206-834-1110 jwest@impinj.com Source: Impinj, Inc. What is the ticker symbol for Impinj, Inc. mentioned in the press release? The ticker symbol for Impinj, Inc. is PI. What did Impinj receive as part of the settlement with NXP Semiconductors N.V.? Impinj received an up-front payment and an annual license fee as part of the settlement. What does the agreement between Impinj and NXP Semiconductors N.V. entail? The agreement terminates all legal proceedings, releases liability for past patent infringement, and licenses patents to each other. Why did Impinj CEO emphasize the importance of safeguarding their patents? The CEO emphasized the importance of safeguarding their patents to ensure free and fair competition and promote innovation. How many RAIN RFID patents does Impinj hold? Impinj holds more than 305 issued and allowed RAIN RFID patents."
Fitch Upgrades Kite Realty Group Trusts Rating Outlook to Positive from Stable,2024-03-13T20:30:00.000Z,Low,Neutral,"Kite Realty Group Trust (NYSE: KRG) received a positive rating outlook revision from Fitch Ratings, moving from 'Stable' to 'Positive'. Fitch affirmed the Company's ratings, including the 'BBB' Issuer Default Rating, citing improved leverage and a diversified portfolio. The revision acknowledges KRG's advantageous positioning in key markets like Texas, Florida, New York City, Washington, D.C., and Seattle, with potential for further positive rating changes in the coming months.","Fitch Upgrades Kite Realty Group Trusts Rating Outlook to Positive from Stable Rhea-AI Impact (Low) Rhea-AI Sentiment (Neutral) Tags Rhea-AI Summary Kite Realty Group Trust (NYSE: KRG) received a positive rating outlook revision from Fitch Ratings, moving from 'Stable' to 'Positive'. Fitch affirmed the Company's ratings, including the 'BBB' Issuer Default Rating, citing improved leverage and a diversified portfolio. The revision acknowledges KRG's advantageous positioning in key markets like Texas, Florida, New York City, Washington, D.C., and Seattle, with potential for further positive rating changes in the coming months. Positive None. Negative None. Financial Analyst The revision of Kite Realty Group Trust's rating outlook by Fitch Ratings from 'Stable' to 'Positive' is a significant indicator of the company's financial health and future performance. This upgrade suggests that KRG has made strides in improving its financial leverage, which refers to the degree to which a company uses borrowed money to fund its operations and growth. A lower leverage ratio can indicate a stronger balance sheet and lower risk for creditors and investors.For stakeholders, this could imply a more favorable borrowing environment and potentially lower interest costs for KRG. Additionally, the affirmation of the 'BBB' Issuer Default Rating, which is investment grade, can enhance investor confidence and could lead to a lower cost of capital. In the short term, this news may result in a positive reaction in the stock market, reflecting the anticipated improvements in KRG's financial stability. Over the long term, maintaining or improving upon the 'Positive' outlook could lead to an actual upgrade in the company's credit rating, which would further solidify its financial reputation and potentially attract more investment. Market Research Analyst The mention of KRG's diversified portfolio capitalizing on favorable demographic trends in Texas and Florida, as well as strategic markets like New York City, Washington, D.C. and Seattle, highlights the company's strategic positioning. KRG appears to be well-placed to benefit from population growth and economic development in these regions, which can lead to increased demand for real estate and higher rental income.For investors, the geographical diversification and the focus on areas with strong asset liquidity could mean a more resilient and stable revenue stream. This is particularly pertinent given the cyclical nature of real estate markets. The ability to leverage assets in strategic gateway markets also suggests KRG has high-quality assets that could be used to secure financing or be sold at a premium if necessary, providing financial flexibility. Over time, the company's strategic asset allocation could yield substantial returns, provided they continue to manage their portfolio effectively in line with market trends. Real Estate Investment Trust (REIT) Analyst Fitch's outlook revision for KRG also underscores the importance of portfolio quality and management strategy in the REIT sector. KRG's ability to leverage its portfolio in strategic markets is a testament to its asset management capabilities. Adjusted Base Rent (ABR) is an important metric in the REIT industry, reflecting the potential income generated from tenants and KRG's significant ABR contribution from growth markets in Texas and Florida (37% of ABR) indicates a robust income stream.Investors should consider the implications of this positive outlook on KRG's dividend payouts, as REITs are required to distribute at least 90% of their taxable income to shareholders. A stronger financial position could lead to increased dividends or reinvestment into the portfolio for further growth. It is also important to monitor how KRG manages its debt profile and capital expenditures to maintain or improve its credit rating, as these factors will be critical in sustaining the positive momentum identified by Fitch. 03/13/2024 - 04:30 PM INDIANAPOLIS, March 13, 2024 (GLOBE NEWSWIRE) -- Kite Realty Group Trust (NYSE: KRG) announced today that Fitch Ratings (Fitch) revised its rating outlook for KRG to Positive from Stable and affirmed the Companys ratings, including the BBB Issuer Default Rating. In its public announcement on the matter, Fitch noted the revision reflects significantly improved leverage and acknowledged KRGs diversified portfolio affords KRG the opportunity to take advantage of favorable demographic trends in Texas and Florida (37% of ABR), while also benefitting from the strong asset liquidity and leveragability of select strategic gateway markets such as New York City, Washington, D.C., and Seattle and noted if the Company is able to maintain this path, there could be positive rating momentum over the next 12 to 24 months. About Kite Realty Group Trust Kite Realty Group Trust (NYSE: KRG) is a real estate investment trust (REIT) headquartered in Indianapolis, IN that is one of the largest publicly traded owners and operators of open-air shopping centers and mixed-use assets. The Companys primarily grocery-anchored portfolio is located in high-growth Sun Belt and select strategic gateway markets. The combination of necessity-based grocery-anchored neighborhood and community centers, along with vibrant mixed-use assets makes the KRG portfolio an ideal mix for both retailers and consumers. Publicly listed since 2004, KRG has nearly 60 years of experience in developing, constructing and operating real estate. Using operational, investment, development, and redevelopment expertise, KRG continuously optimizes its portfolio to maximize value and return to shareholders. As of December 31, 2023, the Company owned interests in 180 U.S. open-air shopping centers and mixed-use assets, comprising approximately 28.1 million square feet of gross leasable space. For more information, please visit kiterealty.com. Connect with KRG: LinkedIn | Twitter | Instagram | Facebook Safe Harbor This release, together with other statements and information publicly disseminated by us, contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 (the Securities Act) and Section 21E of the Securities Exchange Act of 1934. Such statements are based on assumptions and expectations that may not be realized and are inherently subject to risks, uncertainties and other factors, many of which cannot be predicted with accuracy and some of which might not even be anticipated. Future events and actual results, performance, transactions or achievements, financial or otherwise, may differ materially from the results, performance, transactions or achievements, financial or otherwise, expressed or implied by the forward-looking statements. Risks, uncertainties and other factors that might cause such differences, some of which could be material, include but are not limited to: our ability to deliver continued outperformance and maintain a best-in-class balance sheet; national and local economic, business, banking, real estate and other market conditions, particularly in connection with low or negative growth in the U.S. economy as well as economic uncertainty (including a potential economic slowdown or recession, rising interest rates, inflation, unemployment, or limited growth in consumer income or spending); financing risks, including the availability of, and costs associated with, sources of liquidity; the Companys ability to refinance, or extend the maturity dates of, the Companys indebtedness; the level and volatility of interest rates; the financial stability of tenants; the competitive environment in which the Company operates, including potential oversupplies of and reduction in demand for rental space; acquisition, disposition, development and joint venture risks; property ownership and management risks, including the relative illiquidity of real estate investments, and expenses, vacancies or the inability to rent space on favorable terms or at all; the Companys ability to maintain the Companys status as a real estate investment trust for U.S. federal income tax purposes; potential environmental and other liabilities; impairment in the value of real estate property the Company owns; the attractiveness of our properties to tenants, the actual and perceived impact of e-commerce on the value of shopping center assets and changing demographics and customer traffic patterns; business continuity disruptions and a deterioration in our tenants ability to operate in affected areas or delays in the supply of products or services to us or our tenants from vendors that are needed to operate efficiently, causing costs to rise sharply and inventory to fall; risks related to our current geographical concentration of the Companys properties in the states of Texas, Florida, and North Carolina and the metropolitan statistical areas of New York, Atlanta, Seattle, Chicago, and Washington, D.C.; civil unrest, acts of violence, terrorism or war, acts of God, climate change, epidemics, pandemics (including COVID-19), natural disasters and severe weather conditions, including such events that may result in underinsured or uninsured losses or other increased costs and expenses; changes in laws and government regulations including governmental orders affecting the use of the Companys properties or the ability of its tenants to operate, and the costs of complying with such changed laws and government regulations; possible short-term or long-term changes in consumer behavior due to COVID-19 and the fear of future pandemics; our ability to satisfy environmental, social or governance standards set by various constituencies; insurance costs and coverage, especially in Florida and Texas coastal areas; risks associated with cybersecurity attacks and the loss of confidential information and other business disruptions; other factors affecting the real estate industry generally; and other risks identified in reports the Company files with the Securities and Exchange Commission (the SEC) or in other documents that it publicly disseminates, including, in particular, the section titled Risk Factors in the Companys Annual Report on Form 10-K for the fiscal year ended December 31, 2022, and in the Companys quarterly reports on Form 10-Q. The Company undertakes no obligation to publicly update or revise these forward-looking statements, whether as a result of new information, future events or otherwise. Contact Information: Kite Realty Group Trust Tyler HenshawSVP, Capital Markets & Investor Relations317.713.7780thenshaw@kiterealty.com What is the recent rating outlook revision for Kite Realty Group Trust? Kite Realty Group Trust (NYSE: KRG) received a 'Positive' rating outlook revision from Fitch Ratings. What is the current Issuer Default Rating for KRG according to Fitch Ratings? Fitch Ratings affirmed Kite Realty Group Trust's ratings, including the 'BBB' Issuer Default Rating. Which markets were highlighted by Fitch Ratings as advantageous for KRG? Fitch noted that KRG benefits from favorable demographic trends in Texas and Florida, as well as strong asset liquidity in markets like New York City, Washington, D.C., and Seattle. What could lead to further positive rating changes for KRG according to Fitch Ratings? Fitch mentioned that if KRG maintains its current path, there could be positive rating momentum over the next 12 to 24 months."
Absecon Bancorp Declares First-Quarter Cash Dividend of $0.75 Per Share,2024-03-13T20:17:00.000Z,Low,Neutral,"Absecon Bancorp (ASCN) declares a regular quarterly cash dividend of $0.75 per share, showcasing financial stability and commitment to shareholders.","Absecon Bancorp Declares First-Quarter Cash Dividend of $0.75 Per Share Rhea-AI Impact (Low) Rhea-AI Sentiment (Neutral) Tags dividends Rhea-AI Summary Absecon Bancorp (ASCN) declares a regular quarterly cash dividend of $0.75 per share, showcasing financial stability and commitment to shareholders. Positive None. Negative None. 03/13/2024 - 04:17 PM ABSECON, N.J., March 13, 2024 (GLOBE NEWSWIRE) -- Absecon Bancorp (the Company) (OTC, trading as ASCN), the bank holding company of First National Bank of Absecon, an Atlantic County New Jersey based community bank, announced today that its Board of Directors declared a regular quarterly cash dividend in the amount of $0.75 per share, payable on March 28, 2024 to shareholders of record as of March 14, 2024. The First National Bank of Absecon, a nationally chartered bank headquartered in Absecon, New Jersey, has a long history of serving the community since its establishment in 1916. The company is a community bank focused on providing deposit and loan products to retail customers and to small and mid-sized businesses from its primary market area in Atlantic County, New Jersey, and secondary markets consisting of portions of Burlington, Cape May, Cumberland, Gloucester, and Ocean Counties. Deposits at The First National Bank of Absecon are insured up to the legal maximum amount by the Federal Deposit Insurance Corporation (FDIC). Dividend distributions are processed by Computershare Trust Company, N.A. (Agent). Contact:C. Eric Gaupp, Vice Chairman President, and Chief Executive Officer 106 New Jersey Avenue PO Box 324 Absecon, NJ 08201 Office: 609-641-6300 email: egaupp@FNBAbsecon.com What is the ticker symbol for Absecon Bancorp? The ticker symbol for Absecon Bancorp is ASCN. When is the quarterly cash dividend payable? The regular quarterly cash dividend of $0.75 per share is payable on March 28, 2024. What is the history of First National Bank of Absecon? First National Bank of Absecon was established in 1916 and has a long history of serving the community. Where is the headquarters of First National Bank of Absecon? The headquarters of First National Bank of Absecon is in Absecon, New Jersey. How are deposits at The First National Bank of Absecon insured? Deposits at The First National Bank of Absecon are insured up to the legal maximum amount by the FDIC."
MicroStrategy Announces Proposed Private Offering of $500 Million of Convertible Senior Notes,2024-03-13T20:20:00.000Z,Low,Neutral,"MicroStrategy intends to offer $500 million aggregate principal amount of convertible senior notes due 2031 in a private offering to qualified institutional buyers. The notes will bear interest and mature on March 15, 2031. The company plans to use the proceeds to acquire additional bitcoin and for general corporate purposes.","MicroStrategy Announces Proposed Private Offering of $500 Million of Convertible Senior Notes Rhea-AI Impact (Low) Rhea-AI Sentiment (Neutral) Tags offering Rhea-AI Summary MicroStrategy intends to offer $500 million aggregate principal amount of convertible senior notes due 2031 in a private offering to qualified institutional buyers. The notes will bear interest and mature on March 15, 2031. The company plans to use the proceeds to acquire additional bitcoin and for general corporate purposes. Positive None. Negative None. Financial Analyst The announcement by MicroStrategy to offer $500 million in convertible senior notes is a significant financial move, indicative of the company's strategic efforts to raise capital. The use of convertible notes is a dual-edged strategy. On one hand, it provides the company with immediate capital infusion without diluting current shareholders' equity, assuming the notes remain unconverted. On the other hand, it could lead to future dilution if the notes are converted into equity. The potential additional offering of $75 million suggests a buffer for higher than anticipated demand, which can be interpreted as a positive signal to the market regarding investor confidence. Investors and analysts should closely monitor the interest rate and conversion rate terms upon pricing, as these will affect the attractiveness of the notes and the potential impact on the company's stock. The intended use of proceeds to acquire additional bitcoin is a reaffirmation of MicroStrategy's ongoing investment strategy in cryptocurrency, which introduces a layer of risk given bitcoin's volatility. This could have a significant impact on the company's balance sheet and future financial stability. Market Research Analyst MicroStrategy's decision to raise funds through convertible notes is also reflective of the broader market's appetite for such financial instruments. It leverages the current low interest rate environment, which makes debt financing an attractive option for corporations. However, the reliance on qualified institutional buyers indicates a targeted fundraising approach, limiting the pool of potential investors but possibly ensuring a more stable investment base. Furthermore, the stipulation that the notes are unsecured and senior obligations is crucial. It means that in the event of a default, note holders would be prioritized over other debt, but without collateral backing the notes, the risk is inherently higher. This could affect the pricing of the notes, as investors will demand a higher yield for the increased risk. The redemption features provide flexibility to MicroStrategy, allowing it to manage potential dilution and financial obligations based on its operational needs and market conditions. Cryptocurrency Expert The earmarking of proceeds for bitcoin acquisition is a continuation of MicroStrategy's aggressive cryptocurrency strategy, positioning the company as a de facto investment vehicle for bitcoin. This move will likely resonate with investors who are bullish on cryptocurrencies but prefer exposure through a publicly traded company. However, it's essential to recognize the inherent risks associated with such a strategy, as the volatility of bitcoin can significantly influence the company's asset value and investor sentiment. Given the recent fluctuations in the cryptocurrency market, MicroStrategys strategy could be seen as a high-risk maneuver that further entrenches the companys performance with the whims of the cryptocurrency market. The long-term implications of such an investment focus warrant careful consideration, as it could either greatly enhance the company's value or expose it to substantial financial risk. 03/13/2024 - 04:20 PM TYSONS CORNER, Va.--(BUSINESS WIRE)-- MicroStrategy Incorporated (Nasdaq: MSTR) (MicroStrategy) today announced that it intends to offer, subject to market conditions and other factors, $500 million aggregate principal amount of convertible senior notes due 2031 (the notes) in a private offering to persons reasonably believed to be qualified institutional buyers in reliance on Rule 144A under the Securities Act of 1933, as amended (the Securities Act). MicroStrategy also expects to grant to the initial purchasers of the notes an option to purchase, within a 13-day period beginning on, and including, the date on which the notes are first issued, up to an additional $75 million aggregate principal amount of the notes. The offering is subject to market and other conditions, and there can be no assurance as to whether, when or on what terms the offering may be completed. The notes will be unsecured, senior obligations of MicroStrategy and will bear interest payable semi-annually in arrears on March 15 and September 15 of each year, beginning on September 15, 2024. The notes will mature on March 15, 2031, unless earlier repurchased, redeemed or converted in accordance with their terms. Subject to certain conditions, on or after March 22, 2028, MicroStrategy may redeem for cash all or any portion of the notes. If MicroStrategy redeems fewer than all the outstanding notes, at least $75 million aggregate principal amount of notes must be outstanding and not subject to redemption as of the relevant redemption notice date. Holders of the notes will have the right to require MicroStrategy to repurchase for cash all or any portion of their notes on September 15, 2028. The notes will be convertible into cash, shares of MicroStrategys class A common stock, or a combination of cash and shares of MicroStrategys class A common stock, at MicroStrategys election. Prior to September 15, 2030, the notes will be convertible only upon the occurrence of certain events and during certain periods, and thereafter, at any time until the second scheduled trading day immediately preceding the maturity date. The interest rate, initial conversion rate, and other terms of the notes will be determined at the time of pricing of the offering. MicroStrategy expects that the reference price used to calculate the initial conversion price for the notes will be the U.S. composite volume weighted average price of MicroStrategys class A common stock from 9:30 AM through 4:00 PM EDT on the date of pricing. MicroStrategy intends to use the net proceeds from the sale of the notes to acquire additional bitcoin and for general corporate purposes. The notes will be offered and sold to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act. The offer and sale of the notes and the shares of MicroStrategys class A common stock issuable upon conversion of the notes, if any, have not been and will not be registered under the Securities Act or the securities laws of any other jurisdiction, and the notes and any such shares may not be offered or sold in the United States absent registration or an applicable exemption from such registration requirements. Any offer of the notes will be made only by means of a private offering memorandum. This press release shall not constitute an offer to sell, or a solicitation of an offer to buy the notes, nor shall there be any sale of, the notes in any state or jurisdiction in which such offer, solicitation or sale would be unlawful under the securities laws of any such state or jurisdiction. About MicroStrategy Incorporated MicroStrategy (Nasdaq: MSTR) considers itself the worlds first Bitcoin development company. We are a publicly-traded operating company committed to the continued development of the bitcoin network through our activities in the financial markets, advocacy and technology innovation. As an operating business, we are able to use cashflows as well as proceeds from equity and debt financings to accumulate bitcoin, which serves as our primary treasury reserve asset. We also develop and provide industry-leading AI-powered enterprise analytics software that promotes our vision of Intelligence Everywhere, and are using our software development capabilities to develop bitcoin applications. We believe that the combination of our operating structure, bitcoin strategy and focus on technology innovation provides a unique opportunity for value creation. MicroStrategy and Intelligence Everywhere are either trademarks or registered trademarks of MicroStrategy Incorporated in the United States and certain other countries. Statements in this press release about future expectations, plans, and prospects, as well as any other statements regarding matters that are not historical facts, may constitute forward-looking statements within the meaning of The Private Securities Litigation Reform Act of 1995. These statements include, but are not limited to, statements relating to the size and timing of the offering, the anticipated use of any proceeds from the offering, and the terms of the notes. The words anticipate, believe, continue, could, estimate, expect, intend, may, plan, potential, predict, project, should, target, will, would, and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. Actual results may differ materially from those indicated by such forward-looking statements as a result of various important factors, including the uncertainties related to market conditions and the completion of the offering on the anticipated terms or at all, the other factors discussed in the Risk Factors section of MicroStrategys Annual Report on Form 10-K filed with the Securities and Exchange Commission on February 15, 2024, and the risks described in other filings that MicroStrategy may make with the Securities and Exchange Commission. Any forward-looking statements contained in this press release speak only as of the date hereof, and MicroStrategy specifically disclaims any obligation to update any forward-looking statement, whether as a result of new information, future events, or otherwise. View source version on businesswire.com: https://www.businesswire.com/news/home/20240313484286/en/ MicroStrategy Incorporated Shirish Jajodia Investor Relations ir@microstrategy.com Source: MicroStrategy What is MicroStrategy's plan regarding the offering of convertible senior notes due 2031? MicroStrategy intends to offer $500 million aggregate principal amount of convertible senior notes due 2031 in a private offering to qualified institutional buyers. When will the notes mature? The notes will mature on March 15, 2031. How does MicroStrategy plan to utilize the proceeds from the sale of the notes? MicroStrategy plans to use the net proceeds to acquire additional bitcoin and for general corporate purposes. What type of buyers are the notes being offered to? The notes will be offered to qualified institutional buyers pursuant to Rule 144A under the Securities Act. Are the notes registered under the Securities Act? The notes have not been and will not be registered under the Securities Act or the securities laws of any other jurisdiction."
Neotech Metals Clarifies Technical Report Disclosure,2024-03-13T20:15:00.000Z,Low,Neutral,Neotech Metals Corp. receives a review from the British Columbia Securities Commission regarding non-compliance with NI 43-101 for its technical report on the TREO Rare Earth Element Property. The company is working on revisions to address the BCSC's comments.,"Neotech Metals Clarifies Technical Report Disclosure Rhea-AI Impact (Low) Rhea-AI Sentiment (Neutral) Tags Rhea-AI Summary Neotech Metals Corp. receives a review from the British Columbia Securities Commission regarding non-compliance with NI 43-101 for its technical report on the TREO Rare Earth Element Property. The company is working on revisions to address the BCSC's comments. Positive None. Negative None. 03/13/2024 - 04:15 PM Vancouver, British Columbia--(Newsfile Corp. - March 13, 2024) - As a result of a review by the British Columbia Securities Commission (""BCSC""), Neotech Metals Corp. (CSE: NTMC) (OTC Pink: NTMFF) (FSE: V690) (""Neotech"" or the ""Company""), is issuing the following news release to clarify that its technical report entitled, ""NI 43-101 Technical Report on the TREO Rare Earth Element Property, Cariboo Mining Division, East-Central British Columbia, Canada, NTS Reference 093J, dated effective December 10, 2023 (""Technical Report""), is not compliant with National Instrument 43-101  Standard of Disclosure for Mineral Projects (""NI 43-101""). The Company is working with the author of the Technical Report to make the revisions required to address the BCSC's comments and aims to file an amended Technical Report when completed.For more Information please contact:Reagan Glazier, Chief Executive OfficerE-mail: info@neotechmetals.comTelephone: +1 403-815-6663About Neotech Metals Corp.Neotech Metals Corp. is a mineral exploration company dedicated to discovering and developing valuable mineral resources in promising regions around the world. With a strong commitment to environmental stewardship and sustainable practices, Neotech is positioned to make a positive impact while maximizing the potential of its exploration properties.The Company is a mineral exploration company based in Vancouver, B.C., and owns 100% of its TREO Rare Earth Element Property, located 90km northeast of Prince George, British Columbia, and 100% of its Foothills Rare Earth Element Property located in Central British Columbia. The Company also holds options on the EBB nickel-cobalt property in British Columbia, Canada.Forward-Looking StatementsCertain information contained herein constitutes ""forward-looking information"" under Canadian securities legislation. Generally, forward-looking information can be identified by the use of forward-looking terminology such as ""will"", ""will be"" or variations of such words and phrases or statements that certain actions, events or results ""will"" occur. Forward-looking statements are based on the opinions and estimates of management as of the date such statements are made and they are from those expressed or implied by such forward-looking statements or forward-looking information subject to known and unknown risks, uncertainties and other factors that may cause the actual results to be materially different. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward- looking statements and forward-looking information. The Company will not update any forward-looking statements or forward-looking information that are incorporated by reference herein, except as required by applicable securities laws.The CSE has not reviewed, approved, or disapproved the contents of this press release.To view the source version of this press release, please visit https://www.newsfilecorp.com/release/201579 What is the issue Neotech Metals Corp. is facing according to the PR? Neotech Metals Corp. is facing non-compliance with NI 43-101 for its technical report on the TREO Rare Earth Element Property. Which commission reviewed Neotech Metals Corp.'s report? The British Columbia Securities Commission (BCSC) reviewed Neotech Metals Corp.'s report. What is the title of the technical report mentioned in the PR? The technical report mentioned is titled 'NI 43-101 Technical Report on the TREO Rare Earth Element Property, Cariboo Mining Division, East-Central British Columbia, Canada, NTS Reference 093J'. Who is the Chief Executive Officer of Neotech Metals Corp.? Reagan Glazier is the Chief Executive Officer of Neotech Metals Corp. How can one contact Neotech Metals Corp. for more information? For more information, one can contact Neotech Metals Corp. via email at info@neotechmetals.com or by telephone at +1 403-815-6663."
"Comtech to Report Second Quarter Fiscal 2024 Results on March 18, 2024",2024-03-13T20:30:00.000Z,Low,Neutral,"Comtech (CMTL) to Release Q2 Fiscal 2024 Results and Conduct Conference Call on March 18, 2024","Comtech to Report Second Quarter Fiscal 2024 Results on March 18, 2024 Rhea-AI Impact (Low) Rhea-AI Sentiment (Neutral) Tags conferences earnings Rhea-AI Summary Comtech (CMTL) to Release Q2 Fiscal 2024 Results and Conduct Conference Call on March 18, 2024 Positive None. Negative None. 03/13/2024 - 04:30 PM MELVILLE, N.Y.--(BUSINESS WIRE)-- March 13, 2024-- Comtech (NASDAQ: CMTL) today announced that it plans to release its second quarter fiscal 2024 results after the market closes on Monday, March 18, 2024. At 5:00 p.m. ET that day, the Company will hold a conference call to discuss its second quarter fiscal 2024 results, operations, and business trends. A webcast of the call will be available to the public at the investor relations section of the Comtech web site at www.comtech.com. Alternatively, investors can access the conference call by dialing (800) 225-9448 (domestic) or (203) 518-9708 (international) and using the conference I.D. of Comtech. A replay of the call will also be available by dialing (888) 566-0825 or (402) 220-0427 through Monday, April 1, 2024. About Comtech Comtech Telecommunications Corp. is a leading global technology company providing terrestrial and wireless network solutions, next-generation 9-1-1 emergency services, satellite and space communications technologies, and cloud native capabilities to commercial and government customers around the world. Our unique culture of innovation and employee empowerment unleashes a relentless passion for customer success. With multiple facilities located in technology corridors throughout the United States and around the world, Comtech leverages our global presence, technology leadership, and decades of experience to create the worlds most innovative communications solutions. For more information, please visit www.comtech.com. Forward-Looking Statements Certain information in this press release contains statements that are forward-looking in nature and involve certain significant risks and uncertainties. Actual results could differ materially from such forward-looking information. The Company's Securities and Exchange Commission filings identify many such risks and uncertainties. Any forward-looking information in this press release is qualified in its entirety by the risks and uncertainties described in such Securities and Exchange Commission filings. PCMTL View source version on businesswire.com: https://www.businesswire.com/news/home/20240313308920/en/ Comtech Investor Relations Maria Ceriello 631-962-7102 investors@comtech.com Source: Comtech Telecommunications Corp. When will Comtech (CMTL) release its second quarter fiscal 2024 results? Comtech (CMTL) plans to release its second quarter fiscal 2024 results after the market closes on Monday, March 18, 2024. How can investors access the conference call discussing Comtech's (CMTL) results? Investors can access the conference call by dialing (800) 225-9448 (domestic) or (203) 518-9708 (international) and using the conference I.D. of 'Comtech'. Where can the public view a webcast of Comtech's (CMTL) conference call? A webcast of the call will be available to the public at the investor relations section of the Comtech website at www.comtech.com. How long will the replay of Comtech's (CMTL) conference call be available? A replay of the call will be available through Monday, April 1, 2024, by dialing (888) 566-0825 or (402) 220-0427."
World Kinect Corporation Highlights Growth Strategy and Financial Outlook During 2024 Investor Day,2024-03-13T20:15:00.000Z,Low,Neutral,"World Kinect Corporation (WKC) aims for a 30% adjusted operating margin and $480  520 million adjusted EBITDA by 2026. Targeting $900 million to $1.2 billion Free Cash Flow over the next five years, with 40% for buybacks and dividends. The company discussed its strategy to accelerate growth and drive shareholder returns during its 2024 Investor Day.","World Kinect Corporation Highlights Growth Strategy and Financial Outlook During 2024 Investor Day Rhea-AI Impact (Low) Rhea-AI Sentiment (Neutral) Tags Rhea-AI Summary World Kinect Corporation (WKC) aims for a 30% adjusted operating margin and $480  520 million adjusted EBITDA by 2026. Targeting $900 million to $1.2 billion Free Cash Flow over the next five years, with 40% for buybacks and dividends. The company discussed its strategy to accelerate growth and drive shareholder returns during its 2024 Investor Day. Positive None. Negative None. Financial Analyst World Kinect Corporation's emphasis on achieving a 30% adjusted operating margin and projecting a significant adjusted EBITDA range for 2026 indicates a strategic focus on operational efficiency and profitability. The targeted adjusted EBITDA of $480  $520 million is ambitious, considering the company's current financials and would require a substantial increase in operational efficiency. Investors should closely monitor the company's quarterly reports for evidence of progress toward these goals, as well as any changes in market conditions that may impact the ability to achieve these targets.The announcement of targeting aggregate Free Cash Flow generation of $900 million to $1.2 billion over the next five years is a strong indicator of financial health and operational efficiency. The commitment to allocate approximately 40% to buybacks and dividends is a clear signal to the market of confidence in the company's cash-generating ability and a shareholder-friendly capital allocation policy. However, investors should consider the balance between returning capital to shareholders and reinvesting in the business for sustainable long-term growth. Market Research Analyst In the context of World Kinect's business segments, the company's strategy to expand its suite of energy-management solutions and increase the availability of renewable energy and lower-carbon fuels is timely and aligns with global trends towards sustainability and energy efficiency. The energy sector is undergoing a significant transformation and World Kinect's strategic positioning could enable it to capture new market opportunities. However, the success of this strategy hinges on the company's ability to effectively compete with established players and innovate in a rapidly evolving industry.The introduction of a new logo and the rebranding efforts reflect a broader strategic shift towards sustainability. While branding changes do not typically have a direct impact on financial performance, they can enhance the company's public image and position it more favorably in the eyes of consumers and investors who prioritize corporate responsibility and sustainability. Energy Sector Analyst The focus on driving efficiencies in the core distribution platform is crucial for World Kinect, given the competitive nature of the energy distribution market. Efficiency gains can lead to cost reductions and improved margins, which are essential for maintaining competitiveness. The energy sector's volatility, especially in the context of geopolitical tensions and environmental concerns, requires companies like World Kinect to be agile and forward-thinking in their operational strategies.World Kinect's pursuit of profitable growth in the renewable energy and lower-carbon fuels space is indicative of the sector's shift toward clean energy solutions. The company's ability to successfully integrate these offerings could be a key differentiator and drive long-term growth, but it also poses risks associated with regulatory changes, technological advancements and market acceptance of new energy solutions. 03/13/2024 - 04:15 PM Focused on achieving a 30% adjusted operating margin and full-year adjusted EBITDA of $480  520 million by 2026. Targeting aggregate Free Cash Flow generation of $900 million to $1.2 billion over the next five years, with approximately 40% allocated to buybacks and dividends. MIAMI--(BUSINESS WIRE)-- World Kinect Corporation (NYSE: WKC) (World Kinect or the Company) today hosted its 2024 Investor Day, during which the Company discussed its unique position in a large global market, its strategy to capture opportunities across its three business segments, and its financial targets to drive attractive long-term shareholder returns. As our team continues to deliver for our global customer base, we are focused on our strategy to accelerate growth by driving efficiencies in our core distribution platform, increasing the availability of renewable energy and lower-carbon fuels, and expanding our suite of energy-management solutions, said Michael J. Kasbar, Chairman and Chief Executive Officer. I am confident our clear strategy will drive greater value for our shareholders. Financial Outlook The Company remains focused on driving greater operating efficiencies with a target of achieving a 30% adjusted operating margin by 2026. Increased operating efficiencies and profitable growth are expected to contribute to annual adjusted EBITDA of $480  520 million by 2026. The Company expects to generate between $900 million and $1.2 billion of total Free Cash Flow over the next five years, with approximately 40% of such amount expected to be allocated to buybacks and dividends. With a focus on generating improved shareholder returns, today we announced an updated financial outlook for increased operating efficiencies, profitability, and free cash flow, stated Ira M. Birns, Executive Vice President and Chief Financial Officer. We believe the achievement of these efficiency improvements, coupled with profitable growth, will enhance our ability to provide sustainable returns to shareholders. New Logo The Company also debuted a new logo today, which better-reflects the Companys strategic focus on its core operating model and growing sustainability solutions. This is a continuation of rebranding efforts begun in June 2023, when the Company changed its name from World Fuel Services Corporation to World Kinect Corporation and celebrated the occasion by ringing the NYSE closing bell. Webcast and Supplemental Materials To view the Investor Day webcast and presentation materials, visit our Investor Relations website: ir.worldkinect.com. About World Kinect Corporation Headquartered in Miami, Florida, World Kinect Corporation (NYSE: WKC) is a global energy management company offering fulfillment and related services to more than 150,000 customers across the aviation, marine, and land-based transportation sectors. We also supply natural gas and power in the United States and Europe along with a growing suite of other sustainability-related products and services. For more information, visit www.world-kinect.com. Non-GAAP Financial Measures Adjusted operating margin, adjusted EBITDA and Free Cash Flow are non-GAAP metrics. Our non-GAAP financial measures exclude acquisition and divestiture related expenses, restructuring charges, impairments, gains or losses on the extinguishment of debt, gains or losses on sale of businesses, integration costs associated with our acquisitions, and non-operating legal settlements, primarily because we do not believe they are reflective of our core operating results. Adjusted Operating Margin is computed by dividing Adjusted income from operations by Adjusted gross profit. Adjusted income from operations is defined as income from operations excluding the impact of acquisition and divestiture related expenses, restructuring charges, impairments and integration costs. Adjusted gross profit is defined as gross profit excluding the impact of costs associated with our November 2023 Finnish bid error. Adjusted EBITDA is defined as net income (loss) excluding the impact of interest, income taxes, and depreciation and amortization, in addition to acquisition and divestiture related expenses, restructuring charges, impairments, gains or losses on sale of businesses, integration costs and non-operating legal settlements. Free cash flow is defined as cash provided by operating activities less total capital expenditures. Our guidance for these non-GAAP metrics depends on future levels of revenues, expenses, interest expense and other metrics which are not reasonably estimable at this time. Accordingly, we cannot provide a reconciliation between projected adjusted operating margin, adjusted EBITDA and Free Cash Flow and the most comparable GAAP metrics and related ratios without unreasonable effort. Information Relating to Forward-Looking Statements This release includes forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The forward-looking statements include, without limitation, any statement that may predict, forecast, indicate or imply future results, performance or achievements, and may contain the words ""believe,"" ""anticipate,"" ""expect,"" ""estimate,"" ""project,"" ""could,"" ""would,"" ""will,"" ""will be,"" ""will continue,"" ""plan,"" or words or phrases of similar meaning. Specifically, this release includes forward-looking statements regarding our future financial performance, including our operating margin, adjusted EBITDA and free cash flow. This release also includes statements regarding our future capital return plans, which are subject to board approval, applicable law and provisions governing the terms of our credit arrangements. All of our forward-looking statements are qualified in their entirety by cautionary statements and risk factor disclosures contained in our Securities and Exchange Commission (""SEC"") filings, including our most recent Annual Report on Form 10-K filed with the SEC. Actual results may differ materially from any forward-looking statements due to risks and uncertainties, including, but not limited to: customer and counterparty creditworthiness and our ability to collect accounts receivable and settle derivative contracts; changes in the market prices of energy or commodities or extremely high or low fuel prices that continue for an extended period of time; adverse conditions in the industries in which our customers operate; our inability to effectively mitigate certain financial risks and other risks associated with derivatives and our physical fuel products; our ability to achieve the expected level of benefit from our restructuring activities and cost reduction initiatives; relationships with our employees and potential labor disputes associated with employees covered by collective bargaining agreements; our failure to comply with restrictions and covenants governing our outstanding indebtedness; the impact of cyber and other information security related incidents; changes in the political, economic or regulatory environment generally and in the markets in which we operate, such as the current conflicts in Eastern Europe and the Middle East; greenhouse gas reduction programs and other environmental and climate change legislation adopted by governments around the world, including cap and trade regimes, carbon taxes, increased efficiency standards and mandates for renewable energy, each of which could increase our operating and compliance costs as well as adversely impact our sales of fuel products; changes in credit terms extended to us from our suppliers; non-performance of suppliers on their sale commitments and customers on their purchase commitments; non-performance of third-party service providers; our ability to effectively integrate and derive benefits from acquired businesses; our ability to meet financial forecasts associated with our operating plan; lower than expected cash flows and revenues, which could impair our ability to realize the value of recorded intangible assets and goodwill; the availability of cash and sufficient liquidity to fund our working capital and strategic investment needs; currency exchange fluctuations; inflationary pressures and their impact on our customers or the global economy, including sudden or significant increases in interest rates or a global recession; our ability to effectively leverage technology and operating systems and realize the anticipated benefits; failure to meet fuel and other product specifications agreed with our customers; environmental and other risks associated with the storage, transportation and delivery of petroleum products; reputational harm from adverse publicity arising out of spills, environmental contamination or public perception about the impacts on climate change by us or other companies in our industry; risks associated with operating in high-risk locations, including supply disruptions, border closures and other logistical difficulties that arise when working in these areas; uninsured or underinsured losses; seasonal variability that adversely affects our revenues and operating results, as well as the impact of natural disasters, such as earthquakes, hurricanes and wildfires; declines in the value and liquidity of cash equivalents and investments; our ability to retain and attract senior management and other key employees; changes in U.S. or foreign tax laws, interpretations of such laws, changes in the mix of taxable income among different tax jurisdictions, or adverse results of tax audits, assessments, or disputes; our failure to generate sufficient future taxable income in jurisdictions with material deferred tax assets and net operating loss carryforwards; changes in multilateral conventions, treaties, tariffs or other arrangements between or among sovereign nations, including the U.K.'s exit from the European Union; our ability to comply with U.S. and international laws and regulations, including those related to anti-corruption, economic sanction programs and environmental matters; the outcome of litigation, regulatory investigations and other legal matters, including the associated legal and other costs; and other risks described from time to time in our SEC filings. New risks emerge from time to time and it is not possible for management to predict all such risk factors or to assess the impact of such risks on our business. Accordingly, we undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, changes in expectations, future events, or otherwise, except as required by law. View source version on businesswire.com: https://www.businesswire.com/news/home/20240313072087/en/ Ira M. Birns, Executive Vice President & Chief Financial Officer Elsa Ballard, Vice President of Investor Relations & Communications investor@worldkinect.com Source: World Kinect Corporation What are World Kinect Corporation's (WKC) financial targets for 2026? World Kinect aims for a 30% adjusted operating margin, $480  520 million adjusted EBITDA, and $900 million to $1.2 billion Free Cash Flow by 2026. What percentage of Free Cash Flow is allocated to buybacks and dividends? Approximately 40% of the Free Cash Flow is expected to be allocated to buybacks and dividends. What did World Kinect Corporation (WKC) discuss during its 2024 Investor Day? During the 2024 Investor Day, the company discussed its unique position in the global market, strategy for growth, and financial targets to drive long-term shareholder returns. What is the significance of World Kinect Corporation's new logo? The new logo reflects the company's focus on its core operating model and sustainability solutions, aligning with its rebranding efforts started in June 2023. Where can one view World Kinect Corporation's Investor Day webcast and presentation materials? To view the Investor Day webcast and presentation materials, visit the Investor Relations website at ir.worldkinect.com."
124th Common Stock Monthly Dividend Increase Declared by Realty Income,2024-03-13T20:15:00.000Z,Low,Negative,"Realty Income Corporation (NYSE: O) announced an increase in its common stock monthly cash dividend to $0.2570 per share from $0.2565 per share. This marks the 124th dividend increase since 1994, with an annualized dividend amount of $3.084 per share. The company's commitment to providing a dependable monthly dividend that grows over time is evident in its 106th consecutive quarter of dividend increases and 645th consecutive monthly dividend.","124th Common Stock Monthly Dividend Increase Declared by Realty Income Rhea-AI Impact (Low) Rhea-AI Sentiment (Negative) Tags dividends Rhea-AI Summary Realty Income Corporation (NYSE: O) announced an increase in its common stock monthly cash dividend to $0.2570 per share from $0.2565 per share. This marks the 124th dividend increase since 1994, with an annualized dividend amount of $3.084 per share. The company's commitment to providing a dependable monthly dividend that grows over time is evident in its 106th consecutive quarter of dividend increases and 645th consecutive monthly dividend. Positive None. Negative None. Financial Analyst The marginal increase in Realty Income's monthly dividend, from $0.2565 to $0.2570 per share, reflects a conservative approach to capital distribution. While the increment is minimal, it upholds the company's reputation as a reliable dividend-paying entity. This strategy could be perceived as a signal of financial stability and a commitment to returning value to shareholders, potentially attracting income-focused investors.From a financial analysis standpoint, the annualized dividend amount's slight rise from $3.078 to $3.084 per share may not significantly affect the company's stock price in the short-term. However, the consistency in dividend growth, marking the 124th increase, underpins investor confidence and could contribute to stock resilience during market volatility. The commitment to a dependable dividend could also be a factor in the stock's risk profile, possibly lowering the perceived risk among conservative investors. Market Research Analyst Realty Income's dividend increase aligns with its long-standing branding as 'The Monthly Dividend Company', reinforcing its market position among real estate investment trusts (REITs) that prioritize regular income distributions. This incremental dividend increase strategy may not be aggressive, but it serves to differentiate Realty Income from other players in the market that may offer less frequent or less predictable dividends.Considering the broader market context, where investors may be wary of economic uncertainties or interest rate hikes, Realty Income's announcement could be seen as a move to maintain investor loyalty and attract those seeking stable, income-generating investments. The company's historical performance, with 645 consecutive monthly dividends, is likely to be highlighted in marketing efforts to strengthen its appeal to a specific investor demographic. Economist The decision to increase dividends, even marginally, can be reflective of broader economic conditions. In a low-interest-rate environment, companies like Realty Income might capitalize on cheaper borrowing costs to finance distributions. Conversely, in a rising interest rate scenario, such a move could indicate strong operational cash flows and a robust financial position that allows the company to maintain or increase dividends without overly leveraging.Long-term implications of consistent dividend increases can have a stabilizing effect on the company's stock, particularly during economic downturns when investors might seek refuge in assets that provide regular income. The company's ability to sustain its dividend policy through various economic cycles could be indicative of its resilience and strategic financial management. 03/13/2024 - 04:15 PM SAN DIEGO, March 13, 2024 /PRNewswire/ -- Realty Income Corporation (Realty Income, NYSE: O), The Monthly Dividend Company, today announced it has declared an increase in the company's common stock monthly cash dividend to $0.2570 per share from $0.2565 per share. The dividend is payable on April 15, 2024, to stockholders of record as of April 1, 2024. This is the 124th dividend increase since Realty Income's listing on the NYSE in 1994. The ex-dividend date for April's dividend is March 29, 2024. The new monthly dividend represents an annualized dividend amount of $3.084 per share as compared to the prior annualized dividend amount of $3.078 per share. ""We remain dedicated to Realty Income's mission of providing stockholders with a dependable monthly dividend that increases over time,"" said Sumit Roy, President and Chief Executive Officer of Realty Income. ""This is the 106th consecutive quarter that we have declared a dividend increase since our 1994 NYSE listing and today's declaration represents the 645th consecutive monthly dividend throughout our 55-year operating history."" About Realty Income Realty Income, The Monthly Dividend Company, is an S&P 500 company and member of the S&P 500 Dividend Aristocrats index. We invest in people and places to deliver dependable monthly dividends that increase over time. The company is structured as a REIT, and its monthly dividends are supported by the cash flow from over 15,450 real estate properties (including properties acquired in the Spirit merger in January 2024) primarily owned under long-term net lease agreements with commercial clients. To date, the company has declared 645 consecutive monthly dividends on its shares of common stock throughout its 55-year operating history and increased the dividend 124 times since Realty Income's public listing in 1994 (NYSE: O). Additional information about the company can be obtained from the corporate website at www.realtyincome.com. Forward-Looking Statements This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Exchange Act of 1934, as amended. When used in this press release, the words ""estimated,"" ""anticipated,"" ""expect,"" ""believe,"" ""intend,"" ""continue,"" ""should,"" ""may,"" ""likely,"" ""plans,"" and similar expressions are intended to identify forward-looking statements. Forward-looking statements include discussions of our business and portfolio and the intentions of management including the amount, timing and payment of dividends. Forward-looking statements are subject to risks, uncertainties, and assumptions about us, which may cause our actual future results to differ materially from expected results. Some of the factors that could cause actual results to differ materially are, among others, our continued qualification as a REIT; general domestic and foreign business, economic, or financial conditions; competition; fluctuating interest and currency rates; inflation and its impact on our clients and us; access to debt and equity capital markets and other sources of funding; continued volatility and uncertainty in the credit markets and broader financial markets; other risks inherent in the real estate business including our clients' defaults under leases, increased client bankruptcies, potential liability relating to environmental matters, illiquidity of real estate investments, and potential damages from natural disasters; impairments in the value of our real estate assets; changes in domestic and foreign income tax laws and rates; our clients' solvency; property ownership through joint ventures and partnerships which may limit control of the underlying investments; current or future epidemics or pandemics, measures taken to limit their spread, the impacts on us, our business, our clients, and the economy generally; the loss of key personnel; the outcome of any legal proceedings to which we are a party or which may occur in the future; acts of terrorism and war; the anticipated benefits from the merger with Spirit Realty Capital, Inc.; and those additional risks and factors discussed in our reports filed with the U.S. Securities and Exchange Commission. Readers are cautioned not to place undue reliance on forward-looking statements. Forward-looking statements are not guarantees of future plans and performance and speak only as of the date of this press release. Actual plans and operating results may differ materially from what is expressed or forecasted in this press release. We do not undertake any obligation to update forward-looking statements or publicly release the results of any forward-looking statements that may be made to reflect events or circumstances after the date these statements were made. View original content to download multimedia:https://www.prnewswire.com/news-releases/124th-common-stock-monthly-dividend-increase-declared-by-realty-income-302088355.html SOURCE Realty Income Corporation What is the new monthly dividend amount declared by Realty Income Corporation (NYSE: O)? Realty Income Corporation (NYSE: O) declared a new monthly dividend of $0.2570 per share. When is the dividend payable to stockholders of Realty Income Corporation (NYSE: O)? The dividend is payable on April 15, 2024, to stockholders of record as of April 1, 2024. How many consecutive quarters has Realty Income Corporation (NYSE: O) declared dividend increases? Realty Income Corporation (NYSE: O) has declared dividend increases for 106 consecutive quarters. What is the annualized dividend amount per share for Realty Income Corporation (NYSE: O) after the increase? After the increase, the annualized dividend amount per share for Realty Income Corporation (NYSE: O) is $3.084."
MileOne Autogroup joins Universal Technical Institute's Early Employment Program at Exton and Mooresville Campuses,2024-03-13T20:15:00.000Z,Neutral,Neutral,Universal Technical Institute partners with MileOne Autogroup to offer paid work experience and tuition reimbursement to automotive program students. The collaboration aims to provide students with valuable workplace knowledge and incentives for future employment opportunities.,"MileOne Autogroup joins Universal Technical Institute's Early Employment Program at Exton and Mooresville Campuses Rhea-AI Impact (Neutral) Rhea-AI Sentiment (Neutral) Tags Rhea-AI Summary Universal Technical Institute partners with MileOne Autogroup to offer paid work experience and tuition reimbursement to automotive program students. The collaboration aims to provide students with valuable workplace knowledge and incentives for future employment opportunities. Positive None. Negative None. 03/13/2024 - 04:15 PM Paid work experience available to automotive program students, tuition reimbursement to employed graduates MOORESVILLE, N.C. and EXTON, Pa., March 13, 2024 /PRNewswire/ -- Universal Technical Institute today announced the addition of MileOne Autogroup (MileOne) to its early employment program at the Exton (Pa.) and Mooresville (N.C.) campuses. Universal Technical Institute is the transportation, skilled trades and energy education division of UTI, Inc. Through this agreement, selected UTI-Exton and NASCAR Tech students enrolled in the automotive technology program can work 20-30 paid hours weekly as part of the Early Employment Program. Early Employment participants who remain at MileOne after graduation will be eligible for incentives, including up to $350 in monthly tuition reimbursement and their tool incentive program. ""We are focused on helping our students begin rewarding careers in in-demand fields. This partnership with MileOne helps equip our students with the workplace knowledge needed for today's evolving workforce,"" commented Steve McElfresh, UTI-Exton campus president. Robert Kessler, NASCAR Tech campus president, and regional vice president agreed, ""We're proud to partner with MileOne to expand our Early Employment Program and help our students begin their path toward rewarding careers in school and after they graduate."" As the largest automotive sales and service delivery network in the Mid-Atlantic area, MileOne Autogroup represents 66 franchises with 24 automotive brands along with 48 service centers in Delaware, Maryland, Pennsylvania, Virginia, and North Carolina as part of the Hall, Heritage, Herb Gordon, Annapolis, and MotorWorld divisions. ""We have several MileOne locations near the UTI-Exton and NASCAR Tech campuses. We look forward to working with the students and helping them gain real-world work experience with the potential to join the MileOne family after graduation,"" commented Courtney Zacharias, director of talent acquisition, at MileOne Autogroup. The U.S. Bureau of Labor Statistics estimates there will be 67,700 annual job openings for automotive service technicians and mechanics through 2032.1 For more information on UTI's programs, please visit https://www.uti.edu/programs. About Universal Technical Institute, Inc. UTI, Inc. (NYSE: UTI) was founded in 1965 and is a leading workforce solutions provider of transportation, skilled trades, and healthcare education programs whose mission is to serve students, partners, and communities by providing quality education and support services for in-demand careers across a number of highly skilled fields. UTI, Inc. is comprised of two divisions: Universal Technical Institute and Concorde Career Colleges. Universal Technical Institute operates 16 campuses located in 9 states and offers a wide range of transportation and skilled trades technical training programs under brands such as UTI, MIAT College of Technology, Motorcycle Mechanics Institute, Marine Mechanics Institute and NASCAR Technical Institute. Concorde operates across 17 campuses in 8 states and online, offering programs in the allied health, dental, nursing, patient care and diagnostic fields. For more information, visit www.uti.edu or www.concorde.edu, or visit us on LinkedIn at @UniversalTechnicalInstitute and @Concorde Career Colleges or on X (formerly Twitter) @news_UTI or @ConcordeCareer. About MileOne AutogroupMileOne Autogroup represents 65 franchises with 24 automotive brands along with 47 Service Centers in Maryland, Pennsylvania, Virginia, and North Carolina as part of the Hall, Heritage, Herb Gordon, Annapolis, and MotorWorld divisions. The MileOne Autogroup model provides for all of the automotive needs of its customers conveniently, on their own terms. MileOne Autogroup is the largest automotive sales and service delivery network in the Mid-Atlantic area. For more information on MileOne, visit www.mileone.com. 1 For Automotive Service Technicians and Mechanics, the U.S. Bureau of Labor Statistics projects an annual average of 67,700 job openings between 2022 and 2032. Job openings include openings due to net employment changes and net replacements. See Table 1.10 Occupational separations and openings, projected 202232, U.S. Bureau of Labor Statistics, www.bls.gov, viewed November 16, 2023. UTI and MIAT are educational institutions and cannot guarantee employment or salary. Media ContactsAlanna Vitucciavitucci@uti.edu480.710.6843 View original content to download multimedia:https://www.prnewswire.com/news-releases/mileone-autogroup-joins-universal-technical-institutes-early-employment-program-at-exton-and-mooresville-campuses-302088381.html SOURCE Universal Technical Institute, Inc. What is the partnership between Universal Technical Institute and MileOne Autogroup about? The partnership offers paid work experience to automotive program students at UTI-Exton and NASCAR Tech campuses, along with tuition reimbursement incentives for employed graduates. What benefits do Early Employment Program participants receive? Early Employment participants can work 20-30 paid hours weekly, receive up to $350 in monthly tuition reimbursement, and be eligible for the tool incentive program. How many job openings are estimated for automotive service technicians and mechanics through 2032? The U.S. Bureau of Labor Statistics estimates there will be 67,700 annual job openings for automotive service technicians and mechanics through 2032. Where can more information about UTI's programs be found? For more information on UTI's programs, please visit https://www.uti.edu/programs."
Students Learn About Financial Literacy and Energy Efficiency Through SoCalGas' Junior Achievement Storefront that Showcases Clean Energy's Future,2024-03-13T20:15:00.000Z,Low,Neutral,SoCalGas Unveils Revamped Storefront at JA Finance Park to Educate Students on Clean Energy and Financial Literacy,"Students Learn About Financial Literacy and Energy Efficiency Through SoCalGas' Junior Achievement Storefront that Showcases Clean Energy's Future Rhea-AI Impact (Low) Rhea-AI Sentiment (Neutral) Tags Rhea-AI Summary SoCalGas Unveils Revamped Storefront at JA Finance Park to Educate Students on Clean Energy and Financial Literacy Positive None. Negative None. 03/13/2024 - 04:15 PM The storefront is modeled after SoCalGas' [H2] Innovation Experience and equips the next generation of leaders with knowledge of clean energy LOS ANGELES, March 13, 2024 /PRNewswire/ -- Southern California Gas Company (SoCalGas) today unveiled its newly revamped storefront at Junior Achievement of SoCal's (JASoCal) JA Finance Park, an interactive educational space of business storefronts that provides students with lessons on financial literacy. Located just outside Griffith Park, JA Finance Park hosts more than 15,000 visitors including students and volunteers each year. Drawing inspiration from SoCalGas' H2 Innovation Experience ([H2]IE) in Downey, Calif., SoCalGas' storefront provides practical experiences in personal finance, sustainability and career exploration in STEM fields. The utility has collaborated with the organization for over 23 years and has contributed more than $300,000 to help foster leadership skills in the next generation. ""This educational space is more than just an exhibit; it's a foundation for empowering young minds with practical life skills and a deeper understanding of energy efficiency,"" said Paul Goldstein, Vice President of Gas Transmission and Storage at SoCalGas and JASoCal Board Member. ""SoCalGas employee volunteers help bring real-world financial and energy-efficient scenarios to life for students through a hands-on approach, nurturing future leaders by equipping them with vital skills. We're committed to inspiring a new generation to lead in sustainable energy through education and practical experiences."" The storefront features mock scenarios that enhance students' abilities to budget, manage expenses and make informed financial decisions. The space also emphasizes the importance of energy use in financial planning, teaching students about the benefits of energy-efficient practices and SoCalGas' customer assistance programs. By understanding how energy efficiency leads to savings, they gain practical insights into maintaining affordable living costs. Additional resources focus on advancements in energy technology with displays, like smart thermostats and energy-efficient appliances, designed to inspire interest in STEM careers. ""We're honored to continue our partnership with SoCalGas and thrilled to unveil their updated storefront at JA Finance Park,"" said Dr. Les McCabe, President & CEO of JASoCal. ""The storefronts are crucial to the immersive experience for students who are learning essential financial skills, like bill paying, but just as importantly, having a modern storefront that addresses the future of renewable energy and reflects energy-saving innovations in a home, will empower thousands of students each year to make responsible financial and environmental choices."" The storefront was remodeled to mirror the design of SoCalGas' [H2]IE, a clean hydrogen microgrid demonstration project that draws power from solar panels during the day and converts excess renewable energy into clean hydrogen to power the home at night. The [H2]IE could power up to 100 homes and highlights how microgrid technology can produce power locally and help create more sustainable communities. The project has been named a World-Changing Idea by Fast Company and was also awarded the U.S. Green Building Council of L.A.'s Sustainable Innovation Award. As part of SoCalGas' ASPIRE 2045 sustainability goals, the utility aims to invest $50 million across five years to help drive positive change in diverse and underserved communities. By providing resources for higher education and career development, SoCalGas aspires to empower the communities it serves and help prepare young leaders for success. In line with these efforts, SoCalGas has awarded more than $3.5 million in scholarships to students through its scholarship programs since 2001. To learn more about SoCalGas' Scholarship Programs, click here. For more on JA Finance Park, visit Junior Achievement of SoCal's website. Media assets can be found here. About SoCalGas Headquartered in Los Angeles, SoCalGas is the largest gas distribution utility in the United States. SoCalGas aims to deliver affordable, reliable, and increasingly renewable gas service to approximately 21 million consumers across approximately 24,000 square miles of Central and Southern California. We believe gas delivered through our pipelines plays a key role in California's clean energy transition by supporting energy system reliability and resiliency and enabling integration of renewable resources. SoCalGas' mission is to build the cleanest, safest and most innovative energy infrastructure company in America. In support of that mission, SoCalGas aspires to achieve net-zero greenhouse gas emissions in its operations and delivery of energy by 2045 and to replace 20 percent of its traditional natural gas supply to core customers with renewable natural gas (RNG) by 2030. RNG can be made from waste created by landfills and wastewater treatment plants. SoCalGas is also investing in its gas delivery infrastructure while working to keep bills affordable for customers. SoCalGas is a subsidiary of Sempra (NYSE: SRE), an energy infrastructure company based in San Diego. For more information visit socalgas.com/newsroom or connect with SoCalGas on X (formerly Twitter) (@SoCalGas), Instagram (@SoCalGas) and Facebook. This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are based on assumptions about the future, involve risks and uncertainties, and are not guarantees. Future results may differ materially from those expressed or implied in any forward-looking statement. These forward-looking statements represent our estimates and assumptions only as of the date of this press release. We assume no obligation to update or revise any forward-looking statement as a result of new information, future events or otherwise. In this press release, forward-looking statements can be identified by words such as ""believe,"" ""expect,"" ""intend,"" ""anticipate,"" ""contemplate,"" ""plan,"" ""estimate,"" ""project,"" ""forecast,"" ""envision,"" ""should,"" ""could,"" ""would,"" ""will,"" ""confident,"" ""may,"" ""can,"" ""potential,"" ""possible,"" ""proposed,"" ""in process,"" ""construct,"" ""develop,"" ""opportunity,"" ""preliminary,"" ""initiative,"" ""target,"" ""outlook,"" ""optimistic,"" ""poised,"" ""maintain,"" ""continue,"" ""progress,"" ""advance,"" ""goal,"" ""aim,"" ""commit,"" or similar expressions, or when we discuss our guidance, priorities, strategy, goals, vision, mission, opportunities, projections, intentions or expectations. Factors, among others, that could cause actual results and events to differ materially from those expressed or implied in any forward-looking statement include: decisions, investigations, inquiries, regulations, denials or revocations of permits, consents, approvals or other authorizations, renewals of franchises, and other actions, including the failure to honor contracts and commitments, by the (i) California Public Utilities Commission (CPUC), U.S. Department of Energy, U.S. Internal Revenue Service and other regulatory bodies and (ii) U.S. and states, counties, cities and other jurisdictions therein where we do business; the success of business development efforts and construction projects, including risks related to (i) completing construction projects or other transactions on schedule and budget, (ii) realizing anticipated benefits from any of these efforts if completed, (iii) obtaining third-party consents and approvals, and (iv) third parties honoring their contracts and commitments; macroeconomic trends or other factors that could change our capital expenditure plans and their potential impact on rate base or other growth; litigation, arbitrations and other proceedings, and changes to laws and regulations, including those related to tax and trade policy; cybersecurity threats, including by state and state-sponsored actors, of ransomware or other attacks on our systems or the systems of third parties with which we conduct business, including the energy grid or other energy infrastructure; the availability, uses, sufficiency, and cost of capital resources and our ability to borrow money on favorable terms and meet our obligations, including due to (i) actions by credit rating agencies to downgrade our credit ratings or place those ratings on negative outlook, (ii) instability in the capital markets, or (iii) rising interest rates and inflation; the impact on affordability of our customer rates and our cost of capital and on our ability to pass through higher costs to customers due to (i) volatility in inflation, interest rates and commodity prices and (ii) the cost of meeting the demand for lower carbon and reliable energy in California; the impact of climate and sustainability policies, laws, rules, regulations, disclosures and trends, including actions to reduce or eliminate reliance on natural gas, increased uncertainty in the political or regulatory environment for California natural gas distribution companies, the risk of nonrecovery for stranded assets, and uncertainty related to relevant emerging and early-stage technologies; weather, natural disasters, pandemics, accidents, equipment failures, explosions, terrorism, information system outages or other events, such as work stoppages, that disrupt our operations, damage our facilities or systems, cause the release of harmful materials or fires or subject us to liability for damages, fines and penalties, some of which may not be recoverable through regulatory mechanisms or insurance or may impact our ability to obtain satisfactory levels of affordable insurance; the availability of natural gas and natural gas storage capacity, including disruptions caused by failures in the pipeline system or limitations on the withdrawal of natural gas from storage facilities; and other uncertainties, some of which are difficult to predict and beyond our control. These risks and uncertainties are further discussed in the reports that the company has filed with the U.S. Securities and Exchange Commission (SEC). These reports are available through the EDGAR system free-of-charge on the SEC's website, www.sec.gov, and on Sempra's website, www.sempra.com. Investors should not rely unduly on any forward-looking statements. Sempra Infrastructure, Sempra Infrastructure Partners, Sempra Texas, Sempra Texas Utilities, Oncor Electric Delivery Company LLC (Oncor) and Infraestructura Energtica Nova, S.A.P.I. de C.V. (IEnova) are not the same companies as the California utilities, San Diego Gas & Electric Company or Southern California Gas Company, and Sempra Infrastructure, Sempra Infrastructure Partners, Sempra Texas, Sempra Texas Utilities, Oncor and IEnova are not regulated by the CPUC. View original content to download multimedia:https://www.prnewswire.com/news-releases/students-learn-about-financial-literacy-and-energy-efficiency-through-socalgas-junior-achievement-storefront-that-showcases-clean-energys-future-302088552.html SOURCE Southern California Gas Company What is the significance of SoCalGas' revamped storefront at JA Finance Park? SoCalGas unveiled its newly revamped storefront at JA Finance Park to provide students with lessons on financial literacy, sustainability, and career exploration in STEM fields. What is the inspiration behind SoCalGas' storefront design at JA Finance Park? The storefront design is inspired by SoCalGas' H2 Innovation Experience in Downey, Calif., focusing on personal finance, sustainability, and practical experiences in energy efficiency. How long has SoCalGas collaborated with JA Finance Park? SoCalGas has collaborated with JA Finance Park for over 23 years, contributing over $300,000 to foster leadership skills in the next generation. What skills do students learn at SoCalGas' storefront at JA Finance Park? Students learn budgeting, expense management, and making informed financial decisions, along with understanding the importance of energy use in financial planning. Who leads the educational efforts at SoCalGas' storefront at JA Finance Park? Paul Goldstein, Vice President of Gas Transmission and Storage at SoCalGas and JASoCal Board Member, leads the educational efforts at the storefront, empowering young minds with practical life skills."
"Super League Sets Fourth Quarter and Full Year 2023 Earnings Date, March 27, 2024",2024-03-13T20:15:00.000Z,Moderate,Neutral,"Super League (SLE) announces a 32% year-over-year increase in fourth-quarter 2023 revenue, reaching $9.4 million. The company will release its financial results on March 27, 2024, followed by a webinar to discuss the earnings.","Super League Sets Fourth Quarter and Full Year 2023 Earnings Date, March 27, 2024 Rhea-AI Impact (Moderate) Rhea-AI Sentiment (Neutral) Tags earnings Rhea-AI Summary Super League (SLE) announces a 32% year-over-year increase in fourth-quarter 2023 revenue, reaching $9.4 million. The company will release its financial results on March 27, 2024, followed by a webinar to discuss the earnings. Positive Super League (SLE) achieved a significant 32% growth in fourth-quarter 2023 revenue compared to the previous year. The company will unveil its full-year 2023 financial results on March 27, 2024, after market close. An earnings webinar is scheduled for the same day at 5:00 pm Eastern Time to provide insights and discuss the results. Super League (SLE) is a prominent creator and publisher of content experiences and media solutions across various immersive platforms. Negative None. 03/13/2024 - 04:15 PM ~ Company Previously Pre-Announced Preliminary Record Fourth Quarter 2023 Revenue of $9.4 million, an Increase of Approximately 32% Year-over-Year ~SANTA MONICA, Calif., March 13, 2024 (GLOBE NEWSWIRE) -- Super League (Nasdaq: SLE) (the Company), a leading creator and publisher of content experiences and media solutions across the worlds largest immersive platforms, announced today that the Company will post its fourth quarter and full year 2023 financial results after market close on Wednesday, March 27, 2024. A webinar will be held the same day at 5:00 pm Eastern Time to discuss the results. Super League Fourth Quarter and Full Year 2023 Earnings Webinar Date:Wednesday, March 27, 2024Time:5:00 pm Eastern TimeDial-in:1-877-407-0779International Dial-in:1-201-389-0914Webinar:Register Here About Super League Super League (Nasdaq: SLE) is a leading creator and publisher of content experiences and media solutions across the worlds largest immersive platforms. From open gaming powerhouses such as Roblox, Minecraft and Fortnite Creative, to bespoke worlds built using the most advanced 3D creation tools, Super Leagues innovative solutions provide incomparable access to massive audiences who gather in immersive digital spaces to socialize, play, explore, collaborate, shop, learn and create. As a true end-to-end activation partner for dozens of global brands, Super League is effectively a brands operating system for the 3D Web offering a complete range of development, distribution, monetization and optimization capabilities designed to engage users through dynamic, energized programs. As an originator of new experiences fueled by a network of top developers, a comprehensive set of proprietary creator tools and a future-forward team of creative professionals, Super League accelerates IP and audience success within the fastest growing sector of the media industry. For more, go to superleague.com. Investor Relations Contact:Shannon Devine/ Mark SchwalenbergMZ North AmericaMain: 203-741-8811SLE@mzgroup.us Media ContactGillian Sheldongillian.sheldon@superleague.com What was the year-over-year revenue increase announced by Super League (SLE) for the fourth quarter of 2023? Super League (SLE) reported a 32% year-over-year revenue increase, reaching $9.4 million for the fourth quarter of 2023. When will Super League (SLE) release its full-year 2023 financial results? Super League (SLE) will release its full-year 2023 financial results after market close on Wednesday, March 27, 2024. What is the scheduled time for the earnings webinar to discuss Super League (SLE) fourth-quarter and full-year 2023 results? The earnings webinar to discuss Super League (SLE) fourth-quarter and full-year 2023 results will be held at 5:00 pm Eastern Time on Wednesday, March 27, 2024."
Trinseo Announces Commencement of Sale Process for Interest in Americas Styrenics,2024-03-13T20:15:00.000Z,Low,Neutral,Trinseo initiates sale process for its 50% ownership in Americas Styrenics LLC as part of its transformation strategy. Proceeds to be used to pay down term loans. Expecting a definitive arrangement by early 2025.,"Trinseo Announces Commencement of Sale Process for Interest in Americas Styrenics Rhea-AI Impact (Low) Rhea-AI Sentiment (Neutral) Tags Rhea-AI Summary Trinseo initiates sale process for its 50% ownership in Americas Styrenics LLC as part of its transformation strategy. Proceeds to be used to pay down term loans. Expecting a definitive arrangement by early 2025. Positive None. Negative None. Financial Analyst The announcement by Trinseo to commence a sale process for its 50% ownership in Americas Styrenics LLC represents a strategic realignment of the company's portfolio. The sale is in line with Trinseo's transformation strategy to divest from its styrenics businesses and focus on specialty materials and sustainable solutions. This move can be interpreted by investors as a commitment to streamline operations and concentrate on higher-margin businesses.Financially, the proceeds from such a divestiture are earmarked for debt reduction, specifically the $1.077 billion term loans maturing in 2028. This could potentially improve the company's balance sheet and credit profile, reducing interest expenses and possibly leading to a more favorable debt-to-equity ratio. Investors would be interested in the impact this sale could have on Trinseo's financial leverage and liquidity, as well as any potential changes to future earnings and cash flows. Market Research Analyst The divestiture of Trinseo's stake in AmSty could signal a shift in the competitive landscape of the styrenics market in the Americas. AmSty, being a joint venture established with Chevron Phillips Chemical Company, holds a significant position in the production and distribution of styrenic polymers. Stakeholders, including competitors, suppliers and customers, should consider the implications of a new ownership structure on market dynamics.Market analysts would assess the potential buyers for such an asset, which could include industry peers or private equity firms. The exit of Trinseo from this joint venture might also prompt other players in the industry to reevaluate their strategic positions and could lead to further consolidation or divestitures within the sector. Legal Expert Trinseo's initiation of an ownership exit provision highlights the contractual mechanisms that are often built into joint venture agreements. Such provisions are designed to facilitate an orderly transition of ownership under predefined conditions. Legal experts would scrutinize the terms of the exit mechanism to understand any obligations, rights and potential legal implications for both Trinseo and Chevron Phillips Chemical Company.It is also critical to consider regulatory aspects, as the sale of significant assets like this may be subject to antitrust and other regulatory approvals. The timeline for a definitive arrangement, expected no later than early 2025, suggests a complex legal process that would involve due diligence, negotiation of terms and compliance with regulatory requirements. 03/13/2024 - 04:15 PM WAYNE, Pa.--(BUSINESS WIRE)-- Trinseo (Trinseo or the Company) (NYSE: TSE), a specialty material solutions provider, today announced that it has commenced a sale process for its 50% ownership in Americas Styrenics LLC (AmSty), a joint venture with Chevron Phillips Chemical Company LP. As part of its transformation strategy, the Company had previously announced its intent to divest its styrenics businesses (the Styrenics Businesses) with a focus on selectively marketing individual assets or regional businesses. AmSty was established in 2008 and is part of Trinseos regional Styrenics Businesses operating in the Americas. Trinseo has initiated an ownership exit provision of the AmSty joint venture agreement which includes a structured mechanism that is expected to ultimately lead to a sale of Trinseos ownership interest in AmSty. Any proceeds from the sale are expected to be used to pay down a portion of the recently issued $1.077 billion of term loans maturing in 2028. Frank Bozich, President and Chief Executive Officer of Trinseo, said The sale of our ownership in AmSty is a logical step in our transformation as a specialty materials and sustainable solutions provider. By executing the contractual ownership exit provision, we have a clear pathway to divest our interest in the joint venture. We expect the exit process to lead to a definitive arrangement no later than early 2025. About Trinseo Trinseo (NYSE: TSE), a specialty material solutions provider, partners with companies to bring ideas to life in an imaginative, smart, and sustainably focused manner by combining its premier expertise, forward-looking innovations, and best-in-class materials to unlock value for companies and consumers. From design to manufacturing, Trinseo taps into decades of experience in diverse material solutions to address customers unique challenges in a wide range of industries, including building and construction, consumer goods, medical and mobility. Trinseos approximately 3,100 employees bring endless creativity to reimagining the possibilities with clients all over the world from the companys locations in North America, Europe, and Asia Pacific. Trinseo reported net sales of approximately $3.7 billion in 2023. Discover more by visiting www.trinseo.com and connecting with Trinseo on LinkedIn, Twitter, Facebook and WeChat. Cautionary Note on Forward-Looking Statements This press release may contain forward-looking statements including, without limitation, statements concerning plans, objectives, goals, projections, forecasts, strategies, future events or performance, and underlying assumptions and other statements, which are not statements of historical facts or guarantees or assurances of future performance. Forward-looking statements may be identified by the use of words like ""expect,"" ""anticipate,"" believe, ""intend,"" ""forecast,"" ""outlook,"" ""will,"" ""may,"" ""might,"" ""see,"" ""tend,"" ""assume,"" ""potential,"" ""likely,"" ""target,"" ""plan,"" ""contemplate,"" ""seek,"" ""attempt,"" ""should,"" ""could,"" ""would"" or expressions of similar meaning. Forward-looking statements reflect managements evaluation of information currently available and are based on our current expectations and assumptions regarding our business, the economy, our current indebtedness, and other future conditions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict. Factors that might cause future results to differ from those expressed by the forward-looking statements include, but are not limited to, our ability to successfully implement proposed restructuring initiatives and to successfully generate cost savings through restructuring and cost reduction initiatives; our ability to successfully execute our business and transformation strategy; increased costs or disruption in the supply of raw materials; deterioration of our credit profile limiting our access to commercial credit; increased energy costs; compliance with laws and regulations impacting our business; any disruptions in production at our chemical manufacturing facilities, including those resulting from accidental spills or discharges; conditions in the global economy and capital markets; our current and future levels of indebtedness and ability to service our debt; our ability to meet the covenants under our existing indebtedness; our ability to generate cash flows from operations; and those discussed in our Annual Report on Form 10-K, under Part I, Item 1A ""Risk Factors"" and elsewhere in our other reports, filings and furnishings made with the U.S. Securities and Exchange Commission from time to time. As a result of these or other factors, our actual results, performance, or achievements may differ materially from those contemplated by the forward-looking statements. Therefore, we caution you against relying on any of these forward-looking statements. The forward-looking statements included in this press release are made only as of the date hereof. We undertake no obligation to publicly update or revise any forward-looking statement as a result of new information, future events or otherwise, except as otherwise required by law. View source version on businesswire.com: https://www.businesswire.com/news/home/20240313121654/en/ Trinseo Andy Myers Tel: +1 610-240-3221 Email: aemyers@trinseo.com Source: Trinseo What is Trinseo selling as part of its transformation strategy? Trinseo is selling its 50% ownership in Americas Styrenics LLC. What will the proceeds from the sale be used for? The proceeds from the sale are expected to be used to pay down a portion of the recently issued $1.077 billion of term loans maturing in 2028. When is Trinseo expecting a definitive arrangement from the sale process? Trinseo expects the exit process to lead to a definitive arrangement no later than early 2025."
Cadre Holdings Announces Launch of Public Primary and Secondary Offering of Common Stock,2024-03-13T20:15:00.000Z,Low,Neutral,"Cadre Holdings, Inc. (NYSE: CDRE) announces a public offering of 3,475,000 shares of common stock, with 2,200,000 shares from the company and 1,275,000 shares from a Selling Stockholder. The net proceeds will be used for general corporate purposes, with BofA Securities as the lead book-running manager for the offering.","Cadre Holdings Announces Launch of Public Primary and Secondary Offering of Common Stock Rhea-AI Impact (Low) Rhea-AI Sentiment (Neutral) Tags offering Rhea-AI Summary Cadre Holdings, Inc. (NYSE: CDRE) announces a public offering of 3,475,000 shares of common stock, with 2,200,000 shares from the company and 1,275,000 shares from a Selling Stockholder. The net proceeds will be used for general corporate purposes, with BofA Securities as the lead book-running manager for the offering. Positive None. Negative None. Financial Analyst The announcement of Cadre Holdings, Inc.'s public offering is a strategic move that has the potential to affect the company's capital structure and liquidity. The issuance of 2,200,000 shares by the company suggests a drive to raise capital for general corporate purposes, which could include expansion, debt reduction, or other investments. It is important to analyze the earnings per share (EPS) dilution that may result from the increased number of shares outstanding. Additionally, the participation of a significant shareholder, Kanders SAF, LLC, in selling 1,275,000 shares could be indicative of the shareholder's view on the company's valuation or a need for liquidity.Investors should consider the company's current financial health and future prospects when evaluating the potential impact of this offering. The underwriters' option to purchase an additional 521,250 shares could further dilute current shareholders but also provides a buffer for the company to raise additional funds if there is enough investor demand. The role of BofA Securities as the lead book-running manager is also a critical factor, as their reputation and distribution capabilities can significantly influence the offering's success. Market Research Analyst From a market perspective, the timing and size of the offering are crucial. The safety equipment industry has been experiencing growth, driven by increasing safety regulations and heightened awareness of workplace hazards. Cadre Holdings, Inc.'s position as a global leader in this sector could make the offering attractive to investors seeking exposure to this market. However, market conditions, investor sentiment and industry trends must be favorable to ensure a successful capital raise.It is also pertinent to observe the market response to the offering, as it can reflect the investment community's confidence in the company's growth strategy and governance, especially considering the involvement of the CEO in the selling shareholder entity. The market's reception to the offering will provide insights into the perceived value of Cadre Holdings, Inc. and could influence the stock's performance in the short term. Legal Expert The legal aspects of the public offering, such as the registration statement on Form S-3 and the preliminary prospectus supplement, are key documents that provide investors with detailed information about the company's financials, risks and the specifics of the offering. The fact that these documents have been declared effective by the SEC is a crucial step in the process, ensuring regulatory compliance and transparency.Investors should note that the offering is subject to securities laws and the disclaimer regarding the sale of securities not constituting an offer in states or jurisdictions where it would be unlawful is a standard legal precaution. The availability of these documents on the SEC's EDGAR website or through BofA Securities allows for due diligence, enabling investors to make informed decisions based on the disclosed risks and potential rewards associated with the offering. 03/13/2024 - 04:15 PM JACKSONVILLE, Fla.--(BUSINESS WIRE)-- Cadre Holdings, Inc. (NYSE: CDRE) (Cadre or the Company), a global leader in the manufacturing and distribution of safety equipment for professionals, today announced the commencement of a proposed public offering of 3,475,000 shares of its common stock, of which 2,200,000 shares of common stock will be offered by the Company and 1,275,000 shares of common stock will be offered by Kanders SAF, LLC (the Selling Stockholder), an entity wholly-owned by Mr. Warren B. Kanders, the Chairman of the Companys Board of Directors and Chief Executive Officer. Cadre intends to grant the underwriters a 30-day option to purchase up to an additional 521,250 shares of common stock. Cadre intends to use the net proceeds received from the offering for general corporate purposes. The Selling Stockholder will receive the net proceeds from the sale of shares of common stock sold by it in the offering. BofA Securities is acting as lead book-running manager for the offering. The Company has filed a registration statement on Form S-3 (Registration No. 333-271328) (including a base prospectus), which has been declared effective by the Securities and Exchange Commission (SEC). The Company has also filed a preliminary prospectus supplement with the SEC for the offering. The offering will be made only by means of a prospectus supplement and an accompanying prospectus. You may get these documents for free by visiting EDGAR on the SEC website at www.sec.gov. Alternatively, copies of the preliminary prospectus supplement and accompanying prospectus, as well as copies of the final prospectus supplement, once available, may be obtained by contacting: BofA Securities, 201 North Tryon Street, Charlotte, NC 28255, Mail Code NC1-022-02-25, Attention: Prospectus Department or by email at dg.prospectus_requests@bofa.com. This press release does not constitute an offer to sell or the solicitation of an offer to buy any securities, nor will there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction. About Cadre Headquartered in Jacksonville, Florida, Cadre is a global leader in the manufacturing and distribution of safety products. Cadre's equipment provides critical protection to allow users to safely and securely perform their duties and protect those around them in hazardous or life-threatening situations. The Company's core products include body armor, explosive ordnance disposal equipment, duty gear and nuclear safety products. Our highly engineered products are utilized in over 100 countries by federal, state and local law enforcement, fire and rescue professionals, explosive ordnance disposal teams, and emergency medical technicians. Our key brands include Safariland and Med-Eng, amongst others. Forward-Looking Statements Except for historical information, certain matters discussed in this press release may be forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include but are not limited to all projections and anticipated levels of future performance. Forward-looking statements involve risks, uncertainties and other factors that may cause our actual results to differ materially from those discussed herein. Any number of factors could cause actual results to differ materially from projections or forward-looking statements, including without limitation, our ability to complete the common stock offering on the proposed terms, or at all; and our expectations related to the use of proceeds from the shares of common stock offered by the Company. More information on potential factors that could affect the Companys financial results are more fully described from time to time in the Companys public reports filed with the Securities and Exchange Commission, including the Companys Annual Report on Form 10-K, Quarterly Reports on Form 10-Q, and Current Reports on Form 8-K. All forward-looking statements included in this press release are based upon information available to the Company as of the date of this press release, and speak only as of the date hereof. We assume no obligation to update any forward-looking statements to reflect events or circumstances after the date of this press release. View source version on businesswire.com: https://www.businesswire.com/news/home/20240313552270/en/ Gray Hudkins Cadre Holdings, Inc. 203 550 7148 gray.hudkins@cadre-holdings.com Investor Relations: The IGB Group Leon Berman / Matt Berkowitz 212 477 8438 / 212 227 7098 lberman@igbir.com / mberkowitz@igbir.com Media Contact: Jonathan Keehner / Andrew Siegel Joele Frank, Wilkinson Brimmer Katcher 212 355 4449 Source: Cadre Holdings, Inc. What is the ticker symbol of Cadre Holdings, Inc. mentioned in the press release? The ticker symbol is CDRE. How many shares of common stock are being offered in the public offering? 3,475,000 shares, with 2,200,000 shares from the company and 1,275,000 shares from the Selling Stockholder. Who is the Selling Stockholder mentioned in the press release? The Selling Stockholder is Kanders SAF, LLC, an entity wholly-owned by Mr. Warren B. Kanders, the Chairman of the Companys Board of Directors and Chief Executive Officer. What will Cadre Holdings, Inc. use the net proceeds received from the offering for? The net proceeds will be used for general corporate purposes. Which company is acting as the lead book-running manager for the offering? BofA Securities is acting as the lead book-running manager for the offering."
Altria Announces Intent to Sell a Portion of its Investment in Anheuser-Busch InBev,2024-03-13T20:15:00.000Z,Neutral,Neutral,"Altria Group, Inc. announced its intent to sell a portion of its investment in Anheuser-Busch InBev SA/NA through a global secondary offering. Altria plans to sell 35 million ABI ordinary shares, representing approximately 10% ownership. The proceeds will be used for additional share repurchases of Altria's common stock.","Altria Announces Intent to Sell a Portion of its Investment in Anheuser-Busch InBev Rhea-AI Impact (Neutral) Rhea-AI Sentiment (Neutral) Tags Rhea-AI Summary Altria Group, Inc. announced its intent to sell a portion of its investment in Anheuser-Busch InBev SA/NA through a global secondary offering. Altria plans to sell 35 million ABI ordinary shares, representing approximately 10% ownership. The proceeds will be used for additional share repurchases of Altria's common stock. Positive None. Negative None. Financial Analyst Altria's decision to divest a portion of its stake in Anheuser-Busch InBev represents a strategic reallocation of assets that is likely to have a material impact on both companies' liquidity and market capitalization. The sale of 35 million shares, coupled with the additional option for underwriters to purchase up to 5.25 million shares, could lead to a dilution of existing shareholders' equity in ABI. However, the concurrent $200 million share repurchase by ABI may partially offset this dilution.From a financial perspective, the transaction's timing and structure suggest Altria is capitalizing on market conditions to optimize its investment returns. The 180-day lockup period implies a short-term commitment to ABI, stabilizing the market's response to the sale. Investors should monitor Altria's share price following the announcement, as the intended use of proceeds for share repurchases may signal confidence in the company's intrinsic value and a potential increase in earnings per share. Market Research Analyst The secondary offering of ABI shares by Altria could indicate a broader strategy to focus on core operations by divesting non-core assets. This move may be well-received by investors who prefer companies with a more focused business model. Furthermore, the transaction reveals Altria's assessment of ABI's market performance and its own capital allocation strategy. The market's response to such a large offering will provide insights into investor sentiment towards both Altria and the beverage industry.It is noteworthy that Altria's CEO highlighted the historical returns of the ABI investment, emphasizing the long-term value creation from this asset. This statement, combined with the ongoing confidence in ABI's management and brand strength, suggests a nuanced divestiture rather than a complete exit, which might reassure stakeholders about the fundamental health of ABI. Corporate Strategy Expert Altria's partial divestment from ABI aligns with a strategic shift that many corporations undertake to optimize their asset portfolio. The use of proceeds for share repurchases reflects a strategic choice to invest in the company's own stock, potentially indicating a belief that Altria's shares are undervalued. This could be a strategic move to enhance shareholder value in the short term.Additionally, the lockup agreement with the lead underwriter suggests a calculated approach to ensure stability in Altria's stock post-transaction. Stakeholders should consider the long-term implications of this divestiture, as it may signal a shift in Altria's investment strategy, focusing more on its core tobacco business and less on diversification through holdings in other industries. 03/13/2024 - 04:15 PM RICHMOND, Va.--(BUSINESS WIRE)-- Altria Group, Inc. (Altria) (NYSE: MO) today announced its intent to sell a portion of its investment in Anheuser-Busch InBev SA/NA (ABI) (NYSE: BUD) (Euronext: ABI) (MEXBOL: ANB) (JSE: ANH) through a global secondary offering (offering) comprised of a public offering of ABI ordinary shares represented by American depositary shares (ADS) in the United States, a public offering of ABI ordinary shares in the United States, a concurrent private placement of ABI ordinary shares in the European Economic Area and the United Kingdom and an offering of ABI ordinary shares, including ABI ordinary shares represented by ADSs, in other countries outside the United States. In addition, ABI has agreed to repurchase $200 million of ordinary shares directly from Altria, concurrently with, and conditional on, completion of the offering. Altria currently holds approximately 197 million shares of ABI, representing approximately 10% ownership. Altria, as the selling shareholder, is offering 35 million of ABIs ordinary shares. In connection with the offering, Altria expects to grant the underwriters an option to purchase up to 5.25 million additional ABI shares owned by Altria, exercisable within 30 days following the pricing of the offering. In addition, we have agreed to a 180-day lockup with the lead underwriter for our remaining ABI shares. We expect to use the proceeds for additional share repurchases of our common stock. Future share repurchases remain subject to the discretion of our Board of Directors (Board). As good stewards of shareholder capital, we consistently review options to unlock the value of our ABI investment, and we believe this is an opportunistic transaction that realizes a portion of the substantial return on our long-term investment, said Billy Gifford, Altrias Chief Executive Officer. Over the decades of our ownership, the beer investment has provided significant income and cash returns and supported our strong balance sheet. Our continued investment reflects ongoing confidence in ABIs long-term strategies, premium global brands and experienced management team. The offering and the partial sale of our investment in ABI have been approved by our Board. ABI has filed a registration statement (including a prospectus) with the U.S. Securities and Exchange Commission (SEC) for the offering to which this release relates. Before you invest, you should read the prospectus in that registration statement and other documents ABI has filed with the SEC, including the preliminary prospectus supplement dated March 13, 2024, for more complete information about ABI and this offering. You may get these documents for free by visiting EDGAR on the SEC website at www.sec.gov. Alternatively, any underwriter or any dealer participating in the offering will arrange to send you the prospectus and the prospectus supplement, when available, if you request them by contacting: Morgan Stanley & Co. LLC, 180 Varick Street, 2nd Floor, New York, NY 10014, Attn: Prospectus Department; or J.P. Morgan Securities LLC, c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, NY 11717, by telephone at 866-803-9204 or by email at prospectus-eq_fi@jpmchase.com. This press release shall not constitute an offer to sell or the solicitation of an offer to buy the securities described herein, nor shall there be any offer or sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction. Morgan Stanley is acting as the lead underwriter for the proposed offering. J.P. Morgan is also acting as an active underwriter for the proposed offering. Forward-Looking and Cautionary Statements This release contains certain forward-looking statements with respect to the offering, which are subject to various risks and uncertainties. These forward-looking statements relate to, among other things, the anticipated completion of the offering and our intended use of proceeds. Factors that may cause actual results to differ include prevailing economic, market or business conditions or changes in such conditions. Other risk factors are detailed from time to time in our publicly filed reports, including our Annual Report on Form 10-K for the year ended December 31, 2023. These forward-looking statements speak only as of the date of this release. We assume no obligations to provide any revisions to, or update, any forward-looking statements contained in or implied by this release. View source version on businesswire.com: https://www.businesswire.com/news/home/20240313927448/en/ Altria Client Services Investor Relations 804-484-8222 Altria Client Services Media Relations 804-484-8897 Source: Altria Group, Inc. What did Altria Group, Inc. announce regarding its investment in Anheuser-Busch InBev SA/NA? Altria Group, Inc. announced its intent to sell a portion of its investment in Anheuser-Busch InBev SA/NA through a global secondary offering. How many ABI ordinary shares is Altria planning to sell? Altria plans to sell 35 million ABI ordinary shares, representing approximately 10% ownership. What is the intended use of the proceeds from the sale of ABI shares? The proceeds from the sale of ABI shares will be used for additional share repurchases of Altria's common stock."
Greystone Housing Impact Investors LP Announces Regular Quarterly Cash Distribution and Supplemental BUCs Distribution,2024-03-13T20:15:00.000Z,Low,Positive,"Greystone Housing Impact Investors LP (NYSE: GHI) declared a distribution of $0.44 per Beneficial Unit Certificate (BUC), consisting of a regular quarterly cash distribution of $0.37 per BUC and a supplemental distribution of $0.07 per BUC in the form of additional BUCs. The supplemental distribution will be paid at a ratio of 0.00417 BUCs for each issued BUC, with no fractional BUCs issued. Approximately 96,000 BUCs will be issued for the supplemental distribution, paid on April 30, 2024. The distribution reflects the Partnership's intent to distribute a portion of its 2023 gains on Vantage JV Equity Investments.","Greystone Housing Impact Investors LP Announces Regular Quarterly Cash Distribution and Supplemental BUCs Distribution Rhea-AI Impact (Low) Rhea-AI Sentiment (Positive) Tags Rhea-AI Summary Greystone Housing Impact Investors LP (NYSE: GHI) declared a distribution of $0.44 per Beneficial Unit Certificate (BUC), consisting of a regular quarterly cash distribution of $0.37 per BUC and a supplemental distribution of $0.07 per BUC in the form of additional BUCs. The supplemental distribution will be paid at a ratio of 0.00417 BUCs for each issued BUC, with no fractional BUCs issued. Approximately 96,000 BUCs will be issued for the supplemental distribution, paid on April 30, 2024. The distribution reflects the Partnership's intent to distribute a portion of its 2023 gains on Vantage JV Equity Investments. Positive None. Negative None. Financial Analyst The announcement by Greystone Housing Impact Investors LP of a distribution to its Beneficial Unit Certificate (BUC) holders is a significant event for investors and analysts monitoring the real estate investment sector. The distribution includes both a regular quarterly cash dividend and a supplemental distribution payable in additional BUCs, reflecting the company's performance and strategic financial management. Investors typically view such distributions as a positive signal of a company's profitability and financial health. The supplemental distribution, particularly, indicates that the company has realized gains from its Vantage JV Equity Investments, which suggests a successful investment strategy.The decision to pay the supplemental distribution in BUCs rather than cash is noteworthy. This approach allows the company to retain capital, which could be indicative of future investment plans or a desire to maintain a strong balance sheet. This strategy is non-dilutive to current BUC holders, meaning it does not reduce their ownership percentage. From a financial analysis perspective, this could be seen as a strategic move to balance rewarding investors and preserving capital for growth, which could be a positive sign for the company's long-term prospects.However, the market's reaction to such distributions can vary. While some investors might appreciate the additional shares and the implied confidence of the management in the company's future, others might prefer cash distributions. The trade-off between immediate liquidity and potential future growth is a key consideration for investors. The impact on the stock price will depend on how the market interprets this strategy in the context of current market conditions and the company's overall financial health. Market Research Analyst The declaration of both cash and supplemental distributions by Greystone Housing Impact Investors LP can influence market perceptions of the company's sector, specifically the real estate investment trusts (REITs) and housing investment entities. The real estate market is sensitive to interest rates, economic cycles and regulatory changes and such distributions could be interpreted as a sign of robustness within this sector. The distribution ratio, based on the closing price of the BUCs, indicates management's confidence in the value of their holdings and their commitment to delivering shareholder value.It is also essential to understand the broader market implications of such a distribution. The issuance of additional BUCs increases the number of shares outstanding, which could potentially dilute earnings per share in the future. However, the non-dilutive nature of this supplemental distribution suggests a careful calibration to avoid this outcome. This balance reflects a nuanced approach to capital management that could be reassuring to investors who are wary of dilution.Market trends in the REIT sector often mirror the overall economic environment and the payment structure of the distribution could signal management's outlook on the real estate market. If the supplemental distribution is seen as a way to invest in future growth, it could be indicative of a favorable view of the market's potential. Conversely, if the market interprets the retention of capital as caution due to potential downturns, it could affect the sector's sentiment. Legal Expert The legal implications of the distribution of additional BUCs by Greystone Housing Impact Investors LP are also worth considering. The structure of the distribution must comply with securities regulations, ensuring that the issuance of new BUCs is conducted in a manner that is fair to all shareholders and does not mislead investors about the value of their holdings. The company's disclosure about the distribution ratio and the treatment of fractional BUCs suggests transparency and adherence to regulatory requirements.Additionally, the distribution strategy must align with the company's partnership agreement and any other governing documents. The role of Greystone Manager in determining the distributions based on a disciplined evaluation of the Partnerships operating results and financial condition demonstrates a governance structure that takes into account various stakeholders' interests. This adherence to a disciplined evaluation process is crucial in maintaining investor trust and ensuring that distributions are made in the best interests of the BUC holders and the Partnership.It is important for legal compliance that the non-issuance of fractional BUCs and the decision to pay cash in lieu is handled according to the agreed-upon terms of the BUC and is communicated clearly to avoid any potential disputes. This also reflects a commitment to equitable treatment of investors, which is fundamental in maintaining corporate integrity and investor relations. 03/13/2024 - 04:15 PM OMAHA, Neb., March 13, 2024 (GLOBE NEWSWIRE) -- On March 13, 2024, Greystone Housing Impact Investors LP (NYSE: GHI) (the Partnership) announced that the Board of Managers of Greystone AF Manager LLC (Greystone Manager) declared a distribution to the Partnerships Beneficial Unit Certificate (BUC) holders of $0.44 per BUC. The distribution consists of a regular quarterly cash distribution of $0.37 per BUC plus a supplemental distribution payable in the form of additional BUCs equal in value to $0.07 per BUC. The supplemental distribution will be paid at a ratio of 0.00417 BUCs for each issued and outstanding BUC as of the record date, which represents an amount per BUC based on the closing price of the BUCs on the New York Stock Exchange on March 12, 2024 of $16.79 per BUC. No fractional BUCs will be issued in connection with the supplemental BUCs distribution, as all fractional BUCs resulting from the distribution will receive cash for such fraction based on the market value of the BUCs on the record date. The Partnership expects to issue an aggregate of approximately 96,000 BUCs for the supplemental BUCs distribution. The cash distribution and supplemental distribution will be paid on April 30, 2024 to all BUC holders of record as of the close of trading on March 28, 2024. The BUCs will trade ex-distribution as of March 27, 2024. The supplemental distribution reflects the Partnerships continuing intent to distribute a portion of the Partnerships 2023 gains on the sale of its Vantage JV Equity Investments. The payment of the supplemental distribution in the form of BUCs allows the Partnership to retain additional capital to fund future investment opportunities at a low cost and is non-dilutive to current BUC holders. We are pleased to announce the first quarter 2024 distribution of cash and additional BUCs consistent with the Boards previously stated intent, said Kenneth C. Rogozinski, Chief Executive Officer of the Partnership. We remain focused on executing our investment strategy to continue generating returns for distribution to our unitholders. Greystone Manager is the general partner of America First Capital Associates Limited Partnership Two, the Partnerships general partner. Distributions to the Partnerships BUC holders, including regular and any supplemental distributions, are determined by Greystone Manager based on a disciplined evaluation of the Partnerships current and anticipated operating results, financial condition and other factors it deems relevant. Greystone Manager continually evaluates the factors that go into BUC holder distribution decisions, consistent with the long-term best interests of the BUC holders and the Partnership. About Greystone Housing Impact Investors LP Greystone Housing Impact Investors LP was formed in 1998 under the Delaware Revised Uniform Limited Partnership Act for the primary purpose of acquiring, holding, selling and otherwise dealing with a portfolio of mortgage revenue bonds which have been issued to provide construction and/or permanent financing for affordable multifamily, seniors and student housing properties. The Partnership is pursuing a business strategy of acquiring additional mortgage revenue bonds and other investments on a leveraged basis. The Partnership expects and believes the interest earned on these mortgage revenue bonds is excludable from gross income for federal income tax purposes. The Partnership seeks to achieve its investment growth strategy by investing in additional mortgage revenue bonds and other investments as permitted by its Second Amended and Restated Limited Partnership Agreement, dated December 5, 2022, taking advantage of attractive financing structures available in the securities market, and entering into interest rate risk management instruments. Greystone Housing Impact Investors LP press releases are available at www.ghiinvestors.com. Safe Harbor Statement Certain statements in this press release are intended to be covered by the safe harbor for forward-looking statements provided by the Private Securities Litigation Reform Act of 1995. These forward-looking statements generally can be identified by use of statements that include, but are not limited to, phrases such as believe, expect, future, anticipate, intend, plan, foresee, may, should, will, estimates, potential, continue, or other similar words or phrases. Similarly, statements that describe objectives, plans, or goals also are forward-looking statements. Such forward-looking statements involve inherent risks and uncertainties, many of which are difficult to predict and are generally beyond the control of the Partnership. The Partnership cautions readers that a number of important factors could cause actual results to differ materially from those expressed in, implied, or projected by such forward-looking statements. Risks and uncertainties include, but are not limited to: defaults on the mortgage loans securing our mortgage revenue bonds and governmental issuer loans; the competitive environment in which the Partnership operates; risks associated with investing in multifamily, student, senior citizen residential properties and commercial properties; general economic, geopolitical, and financial conditions, including the current and future impact of changing interest rates, inflation, and international conflicts on business operations, employment, and financial conditions; current financial conditions within the banking industry, including the effects of recent failures of financial institutions, liquidity levels, and responses by the Federal Reserve, Department of the Treasury, and the Federal Deposit Insurance Corporation to address these issues; uncertain conditions within the domestic and international macroeconomic environment, including monetary and fiscal policy and conditions in the investment, credit, interest rate, and derivatives markets; adverse reactions in U.S. financial markets related to actions of foreign central banks or the economic performance of foreign economies, including in particular China, Japan, the European Union, and the United Kingdom; the general condition of the real estate markets in the regions in which we operate, which may be unfavorably impacted by increases in mortgage interest rates, slowing economic growth, persistent elevated inflation levels, and other factors; changes in interest rates and credit spreads, as well as the success of any hedging strategies the Partnership may undertake in relation to such changes, and the effect such changes may have on the relative spreads between the yield on investments and cost of financing; persistent inflationary trends, spurred by multiple factors including expansionary monetary and fiscal policy, higher commodity prices, a tight labor market, and low residential vacancy rates, which may result in further interest rate increases and lead to increased market volatility; the Partnerships ability to access debt and equity capital to finance its assets; current maturities of the Partnerships financing arrangements and the Partnerships ability to renew or refinance such financing arrangements; local, regional, national and international economic and credit market conditions; recapture of previously issued Low Income Housing Tax Credits in accordance with Section 42 of the Internal Revenue Code; geographic concentration of properties related to investments held by the Partnership; changes in the U.S. corporate tax code and other government regulations affecting the Partnerships business; and the other risks detailed in the Partnerships SEC filings (including but not limited to, the Partnerships Annual Report on Form 10-K, Quarterly Reports on Form 10-Q, and Current Reports on Form 8-K). Readers are urged to consider these factors carefully in evaluating the forward-looking statements. If any of these risks or uncertainties materializes or if any of the assumptions underlying such forward-looking statements proves to be incorrect, the developments and future events concerning the Partnership set forth in this press release may differ materially from those expressed or implied by these forward-looking statements. You are cautioned not to place undue reliance on these statements, which speak only as of the date of this document. We anticipate that subsequent events and developments will cause our expectations and beliefs to change. The Partnership assumes no obligation to update such forward-looking statements to reflect events or circumstances after the date of this document or to reflect the occurrence of unanticipated events, unless obligated to do so under the federal securities laws. MEDIA CONTACT:Karen MarottaGreystone212-896-9149Karen.Marotta@greyco.com INVESTOR CONTACT:Andy GrierSenior Vice President402-952-1235 What is the distribution declared by Greystone Housing Impact Investors LP (NYSE: GHI)? Greystone Housing Impact Investors LP declared a distribution of $0.44 per Beneficial Unit Certificate (BUC), comprising a regular cash distribution of $0.37 per BUC and a supplemental distribution of $0.07 per BUC in the form of additional BUCs. When will the cash distribution and supplemental distribution be paid to BUC holders of Greystone Housing Impact Investors LP (NYSE: GHI)? The cash distribution and supplemental distribution will be paid on April 30, 2024, to all BUC holders of record as of the close of trading on March 28, 2024. What does the supplemental distribution of Greystone Housing Impact Investors LP (NYSE: GHI) represent? The supplemental distribution represents the Partnership's intent to distribute a portion of its 2023 gains on the sale of its Vantage JV Equity Investments. How many BUCs will be issued for the supplemental distribution by Greystone Housing Impact Investors LP (NYSE: GHI)? Approximately 96,000 BUCs will be issued for the supplemental distribution by Greystone Housing Impact Investors LP. Who is the Chief Executive Officer of Greystone Housing Impact Investors LP (NYSE: GHI)? Kenneth C. Rogozinski is the Chief Executive Officer of Greystone Housing Impact Investors LP."
"Ocean Power Technologies, Inc.Announces Third Quarter Fiscal 2024 Results",2024-03-13T20:15:00.000Z,Neutral,Neutral,"Ocean Power Technologies, Inc. (OPTT) reported continued growth in pipeline, revenue, and gross profit for Q324, with a pipeline increase to $77 million, a significant gross margin rate improvement, and key operational highlights. The company received funding for maritime projects, won contracts for USVs, and secured funding under the NJEDA NOL program. Financially, OPTT saw revenue growth to $1.8 million for Q324, gross profit increase to $0.8 million, but also faced higher operating expenses and a net loss of $6.5 million. Cash position decreased to $9.3 million, reflecting increased operating activities.","Ocean Power Technologies, Inc. Announces Third Quarter Fiscal 2024 Results Rhea-AI Impact (Neutral) Rhea-AI Sentiment (Neutral) Tags earnings Rhea-AI Summary Ocean Power Technologies, Inc. (OPTT) reported continued growth in pipeline, revenue, and gross profit for Q324, with a pipeline increase to $77 million, a significant gross margin rate improvement, and key operational highlights. The company received funding for maritime projects, won contracts for USVs, and secured funding under the NJEDA NOL program. Financially, OPTT saw revenue growth to $1.8 million for Q324, gross profit increase to $0.8 million, but also faced higher operating expenses and a net loss of $6.5 million. Cash position decreased to $9.3 million, reflecting increased operating activities. Positive Significant pipeline growth to $77 million in Q324 from $14 million in Q323. Gross margin rate improvement to 45.4% in Q324 from 18.5% in Q323. Received $6.5 million subcontract for maritime domain awareness buoys. Transitioned focus to commercial activities, reducing R&D costs. Received funding for PowerBuoy deployment and orders for WAM-V USVs. Secured $1.2 million under NJEDA NOL program for cash flow enhancement. Revenue growth to $1.8 million in Q324, gross profit increase to $0.8 million. Operating expenses rose to $8.6 million in Q324, net loss of $6.5 million. Cash position decreased to $9.3 million, reflecting increased operating activities. Negative Higher operating expenses impacting profitability. Net loss of $6.5 million in Q324, reflecting financial challenges. Cash position decline to $9.3 million from $41.1 million in the prior year. Financial Analyst The substantial year-over-year growth in Ocean Power Technologies, Inc.'s pipeline, from approximately $14 million to $77 million, indicates a robust expansion in business prospects, particularly in the defense and security sector. This is a critical metric as it reflects future revenue potential and the company's ability to secure contracts. The reported increase in gross margin rate from 18.5% in Q323 to 45.4% in Q324 demonstrates improved profitability per unit of revenue, which is significant for investor confidence. The pivot from research and development to commercial activities can be seen as a strategic move to enhance revenue streams and achieve profitability, which is a key consideration for stakeholders assessing the company's long-term viability. Market Research Analyst The reported growth in revenues, driven by sales of WAM-V autonomous vehicles and strategic consulting services, suggests that Ocean Power Technologies is diversifying its product offerings and successfully penetrating new markets. The mention of increased activity in Latin America indicates geographical expansion, which could lead to further revenue diversification and reduced market risk. The focus on maritime domain awareness and the integration of cutting-edge technologies like Satellite communication and AT&T 5G technology in their PowerBuoy systems positions the company at the forefront of innovation in marine technology, potentially opening up new market opportunities. Legal Expert The legal expenses incurred by Ocean Power Technologies in defending against Paragon Technologies' actions are non-recurring, yet they have impacted the company's financials significantly, contributing to a net loss increase. The successful defense against these legal challenges is important for maintaining corporate governance and shareholder rights. However, investors should be aware of the potential for such disputes to distract from core business activities and incur substantial costs, impacting short-term financial performance. 03/13/2024 - 04:15 PM Continued Growth in Pipeline, Revenue, and Gross Profit ReportedMONROE TOWNSHIP, N.J., March 13, 2024 (GLOBE NEWSWIRE) -- Ocean Power Technologies, Inc. (""OPT"" or ""the Company"") (NYSE American: OPTT), today announced financial results for its fiscal third quarter ended January 31, 2024 (Q324), including year over year revenue, gross profit, and pipeline growth. Financial Highlights from the third quarter: The Companys pipeline at January 31, 2024 (Q324) was approximately $77 million, representing a 5.5x year-over-year increase over the pipeline of approximately $14 million at January 31, 2023. The Company's pipeline continues to grow, reflecting a significant increase in defense and security activity as well as an expansion of commercial opportunities.The gross margin rate was 45.4% and 18.5%, for the quarters ended Q324 and Q323, respectively. The gross margin rate was 49.7% and 21.1%, for the nine months ended January 31, 2024, and 2023, respectively.In December 2023, the Company received a letter subcontract for up to $6.5 million from a U.S. based prime contractor for multiple maritime domain awareness buoys advancing its commitment to national security and intelligence. This collaboration between OPT and the prime contractor will focus on providing multidomain marine solutions in support of U.S. government agencies. OPT believes that its PowerBuoys will play a pivotal role in enhancing surveillance capabilities above and below the waterline, contributing significantly to maritime domain awareness initiatives.In conjunction with the Company's path to profitability, in November 2023, OPT announced that it has substantially completed its research and development phase and is primarily focused on commercial activities. This pivot to commercial activities has enabled a reduction and reallocation of headcount and a material reduction in third-party expenditures. As a result, the majority of the Company's employees are now dedicated to customer delivery. Recent Operational and Other Highlights: In February 2024, the Company received funding from the Naval Postgraduate School in Monterey, California, for the deployment of a PowerBuoy in Monterey Bay, California. The PowerBuoy, integrating OPT's Maritime Domain Awareness System (MDAS) along with cutting-edge Satellite communication and AT&T 5G technology, will demonstrate its persistent surveillance and communications capacities in a maritime environment.In February 2024, the Company received multiple orders for fully integrated WAM-V Unmanned Surface Vehicles (USVs) totaling over $1.25 million. These recent commercial orders come from clients in Latin America, highlighting the wide-ranging capabilities and applications of the WAM-V USVs.In January 2024, the Company was awarded approximately $1.2 million under the New Jersey Economic Development Authority (NJEDA) 2023 Technology Business Tax Certificate Transfer Program, commonly known as the Net Operating Loss (NOL) Program. This program enables technology and life sciences businesses in New Jersey to sell a percentage of their New Jersey net operating losses and unused research and development (R&D) tax credits to unrelated profitable corporations for cash. OPT takes part in the NJEDA NOL program annually and this funding represents a significant resource as the Company continues to make progress on its previously announced path to profitability. Payment was received by the Company in March 2024. Management Commentary  Philipp Stratmann, OPT's President and Chief Executive Officer We continue to make progress on our path towards profitability as evidenced by the continued growth in our pipeline, revenues, and gross margin. Our efforts to increase our backlog and revenues in the defense and national security industry are paying off. Our recent contract wins with large government prime contractors enable us to provide autonomous vehicles and renewable energy buoys to various U.S. Government Agencies. In addition to these contract wins, we continue to deliver for our commercial customers, especially in the fields of autonomous survey operations, enabling them to lower costs and carbon emissions. Our geographic footprint continues to expand and we are seeing significant opportunities for growth in Latin America. The substantial cessation of our R&D efforts earlier in this quarter, is starting to lead to a reduction in payroll and engineering related expenditures, and the refocusing of the team towards execution is supporting our stated revenue growth. We continue to explore opportunities that will accelerate shareholder value generation as we execute our stated strategy, including cost optimization, accelerated revenue growth, partnerships, or other mechanisms. FINANCIAL HIGHLIGHTS  Q324 Income Statement: Revenues for Q324 were $1.8 million, compared to $0.7 million in Q323. Revenues for the nine months ended January 31, 2024, were $4.0 million, compared to $1.8 million for the nine months ended January 31, 2023. This growth was driven by sales of WAM-V autonomous vehicles, revenue from our previously announced contract with the Department of Energy (DOE) and strategic consulting services.Gross profit for Q324 was $0.8 million, as compared to a gross profit of $0.1 million in Q323. Gross profit for the nine months ended January 31, 2024, was $2.0 million, as compared to a gross profit of $0.4 million for the nine months ended January 31, 2023. The improvement in gross margin has been driven by the Autonomous Vehicles business, primarily through an increase in our higher margin WAM-V leasing business, and our strategic consulting services.Operating expenses were $8.6 million in Q324, materially in-line with the second quarter of fiscal 2024 from and up from $6.8 million in Q323. Operating expenses were $24.6 million for the nine months ended January 31, 2024, up from $19.5 million for the nine months ended January 31, 2023. The Company has incurred one-time, non-recurring expenses of approximately $3.2 million year to date for fiscal 2024 to defend against the actions of Paragon Technologies, Inc. (Paragon) to attain control of the Company without following applicable legal requirements. Among other things, Paragon initiated extensive litigation against the Company in Delaware, challenging the Companys position that Paragon must adhere to such requirements, and the Court ruled against Paragon. In addition, Paragon subsequently attempted to prevent the Company from achieving the necessary quorum to hold its Annual Meeting of Stockholders that resulted in further significant costs to the Company.Net loss was $6.5 million for the Q324, as compared to a net loss of $6.1 million for the Q323. Net loss was $20.8 million for the nine months ended January 31, 2024, compared to a net loss of $16.8 million for the nine months ended January 31, 2023. The year over year increases in net loss were primarily driven by the Paragon expenses noted above. Balance Sheet and Cash Flow Combined cash, restricted cash, cash equivalents and short-term investments as of January 31, 2024, was $9.3 million, compared to $41.1 million at January 31, 2023.Bank debt remained at $0 as of January 31, 2024.Net cash used in operating activities for the nine months ended Q324 was $24.7 million, compared to $16.1 million for the same period in the prior year. This reflects the net loss noted above, payment of the earnout related to our autonomous vehicles business as a result of this business exceeding our expectations, investment in inventory to satisfy growing backlog, payment of employment bonuses that were accrued during fiscal year 2023 and incurrence of Paragon related expenses as noted above. Conference Call & Webcast As announced on February 21, 2024, a conference call to discuss OPTs financial results will be held tomorrow morning, Thursday, March 14, 2024, at 9:00 a.m. Eastern Standard Time. Philipp Stratmann, CEO, Bob Powers, CFO, and Joseph DiPietro, Treasurer and Controller, will host the call. The dial-in numbers for the conference call are 877-407-8291 or 201-689-8345.Live Webcast: Webcast | Ocean Power Technologies FY2024 Q3 Earnings Conference Call (choruscall.com)Call Replay: Will be available by telephone approximately two hours after the calls completion. You may access the replay by dialing 877-660-6853 from the U.S. or 201-612-7415 for international callers and using the Conference ID 13742581. About Ocean Power TechnologiesOPT provides intelligent maritime solutions and services that enable safer, cleaner, and more productive ocean operations for the defense and security, oil and gas, science and research, and offshore wind markets. Our PowerBuoy platforms provide clean and reliable electric power and real-time data communications for remote maritime and subsea applications. We also provide WAM-V autonomous surface vessels (ASVs) and marine robotics services. The Companys headquarters is located in Monroe Township, New Jersey and has an additional office in Richmond, California. To learn more, visit www.OceanPowerTechnologies.com. Non-GAAP Measures: PipelinePipeline is not a term recognized under United States generally accepted accounting principles; however, it is a common measurement used in our industry. Our methodology for determining pipeline may not be comparable to the methodologies used by other companies. Pipeline is a representation of the journey potential customers take from the moment they become aware of our products and service to the moment they become a paying customer. The sales pipeline is divided into a series of phases, each representing a different milestone in the customer journey. It is a tool we use to track sales progress, identify potential roadblocks, and make data-driven decisions to improve our sales performance. Revenue estimates derived from our pipeline can be subject to change due to project accelerations, cancellations or delays due to various factors. These factors can also cause revenue amounts to be realized in periods and at levels different than originally projected. Forward-Looking StatementsThis release may contain forward-looking statements that are within the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are identified by certain words or phrases such as ""may"", ""will"", ""aim"", ""will likely result"", ""believe"", ""expect"", ""will continue"", ""anticipate"", ""estimate"", ""intend"", ""plan"", ""contemplate"", ""seek to"", ""future"", ""objective"", ""goal"", ""project"", ""should"", ""will pursue"" and similar expressions or variations of such expressions. These forward-looking statements reflect the Company's current expectations about its future plans and performance. These forward-looking statements rely on a number of assumptions and estimates that could be inaccurate and subject to risks and uncertainties. Actual results could vary materially from those anticipated or expressed in any forward-looking statement made by the Company. Please refer to the Company's most recent Forms 10-Q and 10-K and subsequent filings with the U.S. Securities and Exchange Commission for further discussion of these risks and uncertainties. The Company disclaims any obligation or intent to update the forward-looking statements in order to reflect events or circumstances after the date of this release. Financial Tables FollowAdditional information may be found in the Company's Quarterly Report on Form 10-Q that has been filed with the U.S. Securities and Exchange Commission. The Form 10-Q is accessible at www.sec.gov or the Investor Relations section of the Company's website (www.OceanPowerTechnologies.com/investor-relations). Ocean Power Technologies, Inc., and SubsidiariesConsolidated Balance Sheets(in thousands, except share data) January 31,2024 April 30,2023 (Unaudited) ASSETS Current assets: Cash and cash equivalents$4,720 $6,883 Short term investments 4,377 27,790 Restricted cash, short-term 154 65 Accounts receivable 625 745 Contract assets 281 152 Inventory 3,460 1,044 Other current assets 3,927 994 Total current assets 17,544 37,673 Property and equipment, net 2,217 1,280 Intangibles, net 3,656 3,978 Right-of-use assets, net 2,610 1,751 Restricted cash, long-term  155 Goodwill 8,537 8,537 Total assets$34,564 $53,374 LIABILITIES AND SHAREHOLDERS EQUITY Current liabilities: Accounts payable$1,466 $952 Earnout payable  1,500 Accrued expenses 2,991 2,346 Contingent liabilities 1,085 1,202 Right-of-use liabilities, current portion 625 529 Contract liabilities 868 1,378 Total current liabilities 7,035 7,907 Deferred tax liability 203 203 Right-of-use liabilities, less current portion 2,065 1,311 Total liabilities 9,303 9,421 Commitments and contingencies (Note 14) Shareholders Equity: Preferred stock, $0.001 par value; authorized 5,000,000 shares, none issued or outstanding; 100,000 designated as Series A   Common stock, $0.001 par value; authorized 100,000,000 shares, issued 59,551,090 shares and 56,304,642 shares, respectively; outstanding 59,463,073 shares and 56,263,728 shares, respectively 59 56 Treasury stock, at cost; 88,017 shares and 40,914 shares, respectively (368) (355)Additional paid-in capital 326,472 324,393 Accumulated deficit (300,857) (280,096)Accumulated other comprehensive loss (45) (45)Total shareholders equity 25,261 43,953 Total liabilities and shareholders equity$34,564 $53,374 Ocean Power Technologies, Inc., and SubsidiariesConsolidated Statements of Operations(in thousands, except per share data) Three months ended January 31, Nine months ended January 31, 2024 2023 2024 2023 Revenues$1,792 $734 $3,953 $1,752 Cost of revenues 979 598 1,989 1,382 Gross margin 813 136 1,964 370 Operating expenses 8,551 6,820 24,648 19,546 (Gain)/loss from change in fair value of consideration (33) 373 (117) 154 Operating loss (7,705) (7,057) (22,567) (19,330) Interest income, net 151 229 760 604 Other income, proceeds from insurance claim  458  458 Other income, employee retention credit    1,202 Loss on disposition of assets (210)  (210)  Foreign exchange gain 1 2 2 2 Loss before income taxes (7,763) (6,368) (22,015) (17,064)Income tax benefit 1,254 278 1,254 278 Net loss (6,509) (6,090) (20,761) (16,786)Basic and diluted net loss per share$(0.11) $(0.11) $(0.35) $(0.30)Weighted average shares used to compute basic and diluted net loss per common share 58,865,898 55,966,672 58,790,160 55,918,284 Ocean Power Technologies, Inc., and SubsidiariesConsolidated Statements of Cash Flows(in thousands) Nine months ended January 31, 2024 2023 Cash flows from operating activities: Net loss$(20,761) $(16,786)Adjustments to reconcile net loss to net cash used in operating activities: Depreciation of fixed assets 286 157 Foreign exchange gain 2  Amortization of intangible assets 114 119 Amortization of right of use assets 388 230 (Accretion of discount)/amortization of premium on investments (277) 198 Change in contingent consideration liability (117) 154 Stock based compensation 803 911 Loss on disposition of assets 210  Changes in operating assets and liabilities: Accounts receivable 120 (224)Contract assets (129) 293 Inventory (2,416) (995)Other assets (2,933) (1,530)Accounts payable 512 (314)Earnout payable (500)  Accrued expenses 894 747 Right-of-use liabilities (397) (254)Contract liabilities (510) 1,205 Net cash used in operating activities$(24,711) $(16,089)Cash flows from investing activities: Redemptions of short term investments 31,625 49,584 Purchases of short term investments (7,935) (30,402)Purchases of property and equipment (1,224) (302)Net cash provided by investing activities$22,466 $18,880 Cash flows from financing activities: Cash paid for tax withholding related to shares withheld (13) (14)Proceeds from issuance of common stock - Cantor At The Market offering, net of issuance costs$29 $ Net cash provided by/(used in) financing activities$16 $(14)Net (decrease) / increase in cash, cash equivalents and restricted cash$(2,229) $2,777 Cash, cash equivalents and restricted cash, beginning of period$7,103 $8,362 Cash, cash equivalents and restricted cash, end of period$4,874 $11,139 Supplemental disclosure of noncash investing and financing activities: Common stock issued related to bonus and earnout payments$1,250 $ Operating right of use asset obtained in exchange for operating lease liability$1,247 $ What was OPTT's pipeline growth in Q324? OPTT's pipeline grew to approximately $77 million in Q324, a 5.5x increase from the previous year. What was OPTT's gross margin rate in Q324? OPTT's gross margin rate was 45.4% in Q324, a significant improvement from the previous quarter. What funding did OPTT receive for maritime projects? OPTT received a $6.5 million subcontract for maritime domain awareness buoys. What program did OPTT participate in to secure funding? OPTT secured approximately $1.2 million under the NJEDA NOL program for cash flow enhancement. What were OPTT's revenue and gross profit in Q324? OPTT's revenue was $1.8 million and gross profit was $0.8 million in Q324. What were OPTT's operating expenses and net loss in Q324? OPTT's operating expenses were $8.6 million and net loss was $6.5 million in Q324. How did OPTT's cash position change in Q324 compared to the prior year? OPTT's cash position decreased to $9.3 million in Q324 from $41.1 million in the prior year."
Grid Dynamics Achieves AWS Well-Architected Partner Status,2024-03-13T20:05:00.000Z,Low,Positive,"Grid Dynamics Holdings, Inc. (NASDAQ:GDYN) achieves AWS Well-Architected Partner Status, enhancing its ability to build secure, high-performing infrastructure for AWS applications. Clients can expect cost savings, faster time to market, improved performance, and reduced security risks.","Grid Dynamics Achieves AWS Well-Architected Partner Status Rhea-AI Impact (Low) Rhea-AI Sentiment (Positive) Tags Rhea-AI Summary Grid Dynamics Holdings, Inc. (NASDAQ:GDYN) achieves AWS Well-Architected Partner Status, enhancing its ability to build secure, high-performing infrastructure for AWS applications. Clients can expect cost savings, faster time to market, improved performance, and reduced security risks. Positive None. Negative None. Cloud Technology Specialist Grid Dynamics' acquisition of the AWS Well-Architected Partner Status represents a significant endorsement of their proficiency in designing and auditing cloud infrastructure. This recognition could potentially lead to increased demand for their services, as clients often seek partners with verified expertise to ensure their cloud solutions are both cost-effective and robust. The ability to build and optimize infrastructure in accordance with AWS's well-architected practices could give Grid Dynamics a competitive edge, as these practices are designed to deliver secure, high-performing and resilient cloud environments.From a cloud technology perspective, the emphasis on security, reliability, performance, manageability and cost optimization reflects industry best practices that are critical for enterprise clients. These elements are the pillars of a strong digital infrastructure, which can lead to better application performance and reduced security risks. For businesses operating in the cloud, these factors directly correlate to operational efficiency and risk mitigation, which are key drivers of business success in the digital age. Market Research Analyst The attainment of AWS Well-Architected Partner Status by Grid Dynamics is likely to resonate positively within the investor community, as it signals Grid Dynamics' alignment with AWS's high standards and their commitment to excellence in cloud services. This could influence the perception of Grid Dynamics' stock (NASDAQ:GDYN) as a more attractive investment due to the potential for increased business opportunities and partnerships. Moreover, the ability to leverage AWS's methodology and tools may lead to operational efficiencies that could improve Grid Dynamics' profit margins over time.Furthermore, as the demand for digital transformation services continues to grow, Grid Dynamics' enhanced service offerings could capture a larger market share. The partnership status may also facilitate deeper collaborations with AWS, which could lead to joint go-to-market strategies and co-selling opportunities, amplifying Grid Dynamics' reach and visibility in the cloud services market. Financial Analyst The recognition of Grid Dynamics as an AWS Well-Architected Partner is likely to have financial implications for the company. It can be anticipated that this status will not only help in acquiring new clients but also in retaining existing ones by showcasing Grid Dynamics' commitment to maintaining high standards in cloud infrastructure. This could translate into a steady revenue stream and possibly higher margins due to the efficiency gains from utilizing AWS's well-architected framework.Investors should monitor the company's future financial disclosures to assess the impact of this status on their bottom line. It will be important to evaluate whether the costs associated with maintaining this partner status are offset by the revenue generated from the increased business it may bring. Additionally, the influence of this credential on Grid Dynamics' market position should be considered, particularly in relation to competitors who may not hold the same level of AWS partnership or recognition. 03/13/2024 - 04:05 PM Key Takeaways:Achieving the AWS Well-Architected Partner Status formally recognizes Grid Dynamics' ability to build and audit secure, high-performing, resilient, and efficient infrastructure for various applications and workloads running in an AWS environment.Clients who leverage Grid Dynamics cloud expertise, and its recently awarded AWS Well-Architected Partner Status, can benefit from significant cost savings, faster time to market, improved application performance, and reduced security risks.Earning the AWS Well-Architected Partner Status enables Grid Dynamics to leverage a well-established and proven methodology to mitigate risks and prepare our clients to modernize and future-proof application workloads and the enabling platforms.SAN RAMON, CA / ACCESSWIRE / March 13, 2024 / Grid Dynamics Holdings, Inc. (NASDAQ:GDYN) (Grid Dynamics), a leader in enterprise-level digital transformation services and an Amazon Web Services (AWS) Advanced Tier Partner, today proudly announced it has achieved the AWS Well-Architected Partner Status. Membership in this program underscores Grid Dynamics' expertise in building secure, high-performing, resilient, and efficient infrastructure for applications and workloads on AWS. The AWS Well-Architected methodology enables Grid Dynamics to strengthen its clients' digital backbones by identifying high-risk items to ensure a secure, reliable, performant, manageable, and cost-effective foundation for digital transformation. The AWS Well-Architected program provides the secure, performant, and resilient underpinning for building advanced digital commerce solutions that positively impact businesses by leveraging data, analytics, and generative AI to enrich customer experiences with higher-order cloud services. ""Clients appreciate a partner that has their best interest in mind, and this AWS credential further positions Grid Dynamics as that partner. This credential demonstrates our ability to leverage a proven methodology, with highly skilled and experienced architects, to solidify the AWS cloud as the bedrock for our clients' digital transformation"" said Chuck Tsocanos, VP of Cloud and Application Modernization at Grid Dynamics.Grid Dynamics conducts Well-Architected assessments with certified AWS architects, demonstrating the company's expertise and qualification as part of this program, to assist clients in hardening and optimizing their cloud foundations and governance models. The program enables Grid Dynamics to provide its clients with an audit of their platform architecture, ensuring they are configured correctly in accordance with well-architected practices, such as security, reliability, performance, manageability, cost optimization, and sustainability. Grid Dynamics' commitment to the AWS Well-Architected Framework goes beyond a one-time consultation; the company provides ongoing support to clients, fostering a culture of continuous improvement. This program helps organizations evolve within the ever-changing technological landscape while maintaining a foundation of excellence in their cloud architecture. With Grid Dynamics as their AWS Well-Architected Partner, companies can navigate the complexities of cloud architecture confidently, knowing that their digital platform is not only well-designed but also optimized for agility, security, and efficiency.Earning the AWS Well-Architected Partner Status grants Grid Dynamics additional exposure to potential clients, AWS field teams, and AWS Partners by being showcased across AWS webpages including the APN Partner Solutions Finder. Visit this page to learn more about the AWS/Grid Dynamics partnership, and the business-driving capabilities enabled through the AWS Well-Architected program.About Grid DynamicsGrid Dynamics (NASDAQ:GDYN) is a leading provider of technology consulting, platform and product engineering, and advanced analytics services. Fusing technical vision with business acumen, we solve the most pressing technical challenges and enable positive business outcomes for enterprise companies undergoing business transformation. A key differentiator for Grid Dynamics is our 7+ years of experience and leadership in enterprise AI, supported by profound expertise and ongoing investment in data, analytics, application modernization, cloud & DevOps, and customer experience. Founded in 2006, Grid Dynamics is headquartered in Silicon Valley with offices across the Americas, Europe, and India. Follow us on LinkedIn.Forward-Looking StatementsThis communication contains ""forward-looking statements"" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934 that are not historical facts, and involve risks and uncertainties that could cause actual results of Grid Dynamics to differ materially from those expected and projected. These forward-looking statements can be identified by the use of forward-looking terminology, including the words ""believes,"" ""estimates,"" ""anticipates,"" ""expects,"" ""intends,"" ""plans,"" ""may,"" ""will,"" ""potential,"" ""projects,"" ""predicts,"" ""continue,"" or ""should,"" or, in each case, their negative or other variations or comparable terminology. These forward-looking statements include, without limitation, quotations and statements regarding our AWS Well-Architected Partner Status, our product capabilities, and our company's future growth including with customers.These forward-looking statements involve significant risks and uncertainties that could cause the actual results to differ materially from the expected results. Most of these factors are outside Grid Dynamics' control and are difficult to predict. Factors that may cause such differences include, but are not limited to, any factors limiting our partnership with AWS, our product capabilities, the benefits of our products, and our company's growth and growth strategy.Grid Dynamics cautions that the foregoing list of factors is not exclusive. Grid Dynamics cautions readers not to place undue reliance upon any forward-looking statements, which speak only as of the date made. Grid Dynamics does not undertake or accept any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements to reflect any change in its expectations or any change in events, conditions or circumstances on which any such statement is based. Further information about factors that could materially affect Grid Dynamics, including its results of operations and financial condition, is set forth under the ""Risk Factors"" section of the Company's annual report on Form 10-K filed February 29, 2024, and in other periodic filings Grid Dynamics makes with the SEC.Media Contact:Cary Savas+1 (650) 523 5000csavas@griddynamics.comSOURCE: Grid DynamicsView the original press release on accesswire.com What is Grid Dynamics' ticker symbol? Grid Dynamics' ticker symbol is GDYN. What does achieving AWS Well-Architected Partner Status mean for Grid Dynamics? Achieving AWS Well-Architected Partner Status recognizes Grid Dynamics' expertise in building secure, high-performing infrastructure for AWS applications. What benefits can clients expect from Grid Dynamics' AWS Well-Architected Partner Status? Clients leveraging Grid Dynamics cloud expertise and AWS Well-Architected Partner Status can benefit from cost savings, faster time to market, improved performance, and reduced security risks. How does the AWS Well-Architected program help Grid Dynamics' clients? The AWS Well-Architected program enables Grid Dynamics to provide clients with a secure, reliable, performant, and cost-effective foundation for digital transformation. Who is Chuck Tsocanos and what is his role at Grid Dynamics? Chuck Tsocanos is the VP of Cloud and Application Modernization at Grid Dynamics."
CORRECTING and REPLACING GrowGeneration Reports Fourth Quarter and Full Year 2023 Financial Results; Provides First Quarter and Full Year 2024 Guidance,2024-03-13T20:05:00.000Z,No impact,Neutral,"GrowGeneration Corp. (GRWG) reports full-year net revenue of $225.9 million, beating guidance, with a net loss of $46.5 million and non-GAAP adjusted EBITDA loss of $5.6 million. The company's 2024 outlook calls for revenue from $205 million to $215 million and non-GAAP adjusted EBITDA from a loss of $2 million to a profit of $3 million. GrowGen plans to review strategic opportunities for MMI.","CORRECTING and REPLACING GrowGeneration Reports Fourth Quarter and Full Year 2023 Financial Results; Provides First Quarter and Full Year 2024 Guidance Rhea-AI Impact (No impact) Rhea-AI Sentiment (Neutral) Tags earnings Rhea-AI Summary GrowGeneration Corp. (GRWG) reports full-year net revenue of $225.9 million, beating guidance, with a net loss of $46.5 million and non-GAAP adjusted EBITDA loss of $5.6 million. The company's 2024 outlook calls for revenue from $205 million to $215 million and non-GAAP adjusted EBITDA from a loss of $2 million to a profit of $3 million. GrowGen plans to review strategic opportunities for MMI. Positive GrowGeneration exceeded its full-year revenue guidance for 2023, reporting a net revenue of $225.9 million. The company experienced a decrease in net revenues and same-store sales in the fourth quarter of 2023 compared to the prior year. GrowGen reported a net loss of $46.5 million for the full year 2023. Adjusted EBITDA for the full year 2023 was a loss of $5.6 million, compared to earnings of $16.7 million in the previous year. The company aims to enhance its brand portfolio and expand into the home gardening market in 2024. GrowGen closed and consolidated retail locations in 2023 to improve operational efficiencies. The company is exploring strategic opportunities for its storage solutions business, MMI, to further capitalize on market opportunities. Negative Net revenues and same-store sales decreased in the fourth quarter of 2023 compared to the previous year. The company reported a net loss of $46.5 million for the full year 2023. Adjusted EBITDA for the full year 2023 was a loss of $5.6 million. Revenue decreased by $52.3 million in 2023 compared to the previous year. 03/13/2024 - 04:05 PM Full Year Net Revenue of $225.9 million, Beating Guidance Full Year Net Loss of $46.5 million and Non-GAAP Adjusted EBITDA(1) Loss of $5.6 million, In Line with Guidance 2024 Outlook Calls for Revenue from $205 million to $215 million and Non-GAAP Adjusted EBITDA(1) from a Loss of $2 million to a Profit of $3 million Company to Review Strategic Opportunities for MMI DENVER--(BUSINESS WIRE)-- In the ""First Quarter and Full Year 2024 Outlook"" section of the release, the third bullet should read: First quarter 2024 net revenues in the range of $45 million to $48 million with Adjusted EBITDA(1) between a loss of $1 million and $3 million (instead of first quarter 2024 net revenues in the range of $45 million to $48 million with Adjusted EBITDA(1) between a $2 million loss and breakeven). The updated release reads: GROWGENERATION REPORTS FOURTH QUARTER AND FULL YEAR 2023 FINANCIAL RESULTS; PROVIDES FIRST QUARTER AND FULL YEAR 2024 GUIDANCE Full Year Net Revenue of $225.9 million, Beating Guidance Full Year Net Loss of $46.5 million and Non-GAAP Adjusted EBITDA(1) Loss of $5.6 million, In Line with Guidance 2024 Outlook Calls for Revenue from $205 million to $215 million and Non-GAAP Adjusted EBITDA(1) from a Loss of $2 million to a Profit of $3 million Company to Review Strategic Opportunities for MMI GrowGeneration Corp. (NASDAQ: GRWG), (GrowGen or the Company), one of the largest retailers and distributors of specialty hydroponic and organic gardening products in the United States, today announced financial results for the fourth quarter and full year ended December 31, 2023. Fourth Quarter 2023 Highlights Compared to Prior Year Net revenues decreased approximately 9% to $49.5 million, and same-store sales decreased 3.6% Gross profit increased to $11.6 million, or 23.5% of net revenues, from $9.6 million, or 17.6% of net revenues Net loss of $27.3 million, or $(0.44) per diluted share, compared to a net loss of $15.0 million, or $(0.25) per diluted share, primarily due to non-cash impairment Adjusted EBITDA(1) loss of $3.7 million, compared to a loss of $10.2 million Full Year 2023 Highlights Compared to Prior Year Net revenues decreased approximately 18.8% to $225.9 million, beating the Companys previous guidance Gross profit decreased to $61.3 million, or 27.1% of net revenues, from $70.3 million, or 25.3% of net revenues Net loss of $46.5 million, or $(0.76) per diluted share, compared to a net loss of $163.7 million, or $(2.69) per diluted share Adjusted EBITDA(1) loss of $5.6 million, compared to earnings of $16.7 million Reduced operating expense and selling, general, and administrative expense base by roughly $13.6 million through operating efficiencies and strategic cost rationalization Cash, cash equivalents, and marketable securities of $65.0 million as of December 31, 2023, along with no debt Generated $1.4 million of operating cash, primarily driven by reduction of inventory Darren Lampert, GrowGens Co-Founder and Chief Executive Officer, stated, I am pleased that our hard work and dedication to executing our strategic initiatives in 2023 allowed us to surpass our full year revenue guidance and be in line with our full year Adjusted EBITDA guidance. Our profit margins increased nearly 200 basis points as well, driven by more proprietary product sales and consumable product sales as a percent of total sales. Lastly, we ended 2023 with $65.0 million in cash, cash equivalents, and marketable securities and with no debt, positioning us well to continue to execute on our strategic initiatives in 2024. Mr. Lampert continued, 2023 was a year of strategic execution and resilience for GrowGen, and we continue into 2024 laser-focused on positioning the business for long-term, profitable growth. One key pillar for growth is continuing to enhance our brand portfolio, including launching new products and increasing sales in our higher margin proprietary brands. We are also expanding into the home gardening market with The Harvest Company, which we launched earlier this year. We believe GrowGens expertise in advanced cultivation technologies and sustainable practices developed within the cannabis industry will allow us to succeed in this new market, where consumers are seeking home gardening products to grow healthy, organic, and sustainable microgreens, fruits, and vegetables. Lastly, we remain focused on creating and sustaining operational efficiencies to position ourselves to capitalize on market opportunities as they arise, and I believe they will arise sooner than later as the legislative landscape around cannabis continues to become more favorable. Reporting Segments Update During the fourth quarter of 2023, the Company realigned its operating and reportable segments to correspond with changes to its operating model, management structure, and internal reporting, and to better align with how the Chief Executive Officer makes operating decisions, allocates resources, and assesses performance. Accordingly, the Company identified two operating segments, each its own reportable segment, based on its major lines of business: the Cultivation and Gardening segment; and the Storage Solutions segment. Fourth Quarter 2023 Consolidated Results Net revenues decreased $5.0 million, or 9%, to $49.5 million for the fourth quarter ended December 31, 2023, compared to $54.5 million for the fourth quarter ended December 31, 2022. The decline was driven primarily by a 3.6% decrease in same-store sales. Net revenues for same-store sale locations open for the same period in 2022 and 2023 were $35.6 million in the fourth quarter 2023, compared to $37.0 million in the fourth quarter 2022. Gross profit was $11.6 million for the fourth quarter 2023, an increase of $2.1 million, compared to gross profit of $9.6 million for the fourth quarter 2022. Gross profit margin was 23.5% for the fourth quarter 2023, compared to 17.6% for the fourth quarter 2022, an increase of 600 basis points, primarily due to improvements in product mix and corresponding margin performance. GAAP net loss was $27.3 million in the fourth quarter 2023, a decrease of $12.3 million, compared to a net loss of $15.0 million in the fourth quarter 2022. Net loss was $0.44 per diluted share in the fourth quarter 2023, compared to a net loss of $0.25 per diluted share in the fourth quarter 2022. The decrease in GAAP net loss was primarily due to a $15.7 million non-cash impairment recorded in the fourth quarter 2023 of goodwill and intangible assets related to prior acquisitions. Non-GAAP Adjusted EBITDA(1) was a loss of $3.7 million in the fourth quarter 2023, compared to a loss of $10.2 million in the fourth quarter 2022. The increase to Adjusted EBITDA(1) was primarily driven by improvements in gross profit and reductions in operating and corporate expenses relating to our strategic cost rationalization. Cash, cash equivalents, and marketable securities as of December 31, 2023 were $65.0 million. Full Year 2023 Consolidated Results Net revenues decreased $52.3 million, or 18.8%, to $225.9 million for the full year ended December 31, 2023, compared to $278.2 million for the full year ended December 31, 2022. The decline was driven primarily by a 19.3% decrease in same-store sales. Gross profit was $61.3 million for the full year 2023, a decrease of $9.0 million, compared to gross profit of $70.3 million for the full year 2022. Gross profit margin was 27.1% for the full year 2023, compared to 25.3% for the full year 2022, an improvement of 180 basis points. The improvement to gross margin on a percentage basis was primarily due to stronger penetration of private label as a percent of sales. GAAP net loss was $46.5 million for the full year 2023, a decrease of $117.3 million, compared to net loss of $163.7 million for the full year 2022. Net loss was $0.76 per diluted share for the full year 2023, compared to net loss of $2.69 per diluted share for the full year 2022. The improvement in net income was primarily attributable to 186 basis point improvement in gross margin percent, $13.6 million in annualized expense reductions, along with $112.2 million dollar reduction in impairment related charges. To offset, revenue decreased by $52.3 million. Non-GAAP Adjusted EBITDA(1) was a loss of $5.6 million for the full year 2023, compared to a loss of $16.7 million for the full year 2022. The improvement in Adjusted EBITDA(1) was primarily driven by improvements in the operating and corporate expense structure compared to the prior year. Geographic Footprint The Companys geographic footprint for its Cultivation and Gardening segment spans approximately 942,000 square feet of retail and warehouse space across 18 states. During 2023, the Company acquired or opened 5 new locations and expanded its physical retail presence into 2 new states. The Company also reduced redundancies in cost structure by closing and consolidating 14 retail locations in 2023, where we were generally able to serve the same customer base through a single location. To date in 2024, the Company further closed and consolidated 3 additional stores and may consider additional store consolidations in the future. First Quarter and Full Year 2024 Outlook(2) Full year 2024 net revenues in the range of $205 million to $215 million Full year 2024 Adjusted EBITDA(1) from a $2 million loss to a $3 million profit First quarter 2024 net revenues in the range of $45 million to $48 million with Adjusted EBITDA(1) between a loss of $1 million and $3 million. Exploring Strategic Opportunities for MMI The Company also announced today that it is exploring strategic opportunities for its benching, racking, and storage solutions business, MMI, which was acquired by the Company in late 2021 and currently constitutes the Companys Storage Solutions segment. Mr. Lampert commented, MMI has continued to exceed our expectations, with full year 2024 revenue of $31.4 million and $8.9 million in operating profit, reflecting the tremendous strength and potential of this business. We believe MMI is now in a place where it makes sense to consider strategic opportunities for the business, and we recently engaged Lake Street Capital Markets to advise us in this process. While we are happy having MMI within our portfolio, we also believe that the right strategic opportunity for MMI would better position GrowGen to build upon its achievements and capitalize on additional opportunities within its core Cultivation and Gardening business. Footnotes (1) Adjusted EBITDA represents earnings before interest, taxes, depreciation, and amortization as adjusted for certain items as set forth in the reconciliation table of U.S. GAAP to non-GAAP information and is a measure calculated and presented on the basis of methodologies other than in accordance with GAAP. Please refer to the Use of Non-GAAP Financial Information herein for further discussion and reconciliation of this measure to GAAP measures. (2) Sales and Adjusted EBITDA(1) guidance metrics are inclusive of acquisitions and store openings completed in 2023 and 2022, but do not include any unannounced acquisitions. Conference Call The Company will host a conference call today, March 13, 2024, at 4:30 PM Eastern Time to discuss financial results for fourth quarter and full year ended December 31, 2023. To participate in the call, please dial (888) 664-6392 (domestic) or (416) 764-8659 (international). The conference code is 80413128. The call will also be webcast and can be accessed here or in the Investor Relations section of the GrowGen website at: ir.growgeneration.com. A replay of the webcast will be available approximately two hours after the conclusion of the call and remain available for approximately 90 calendar days. About GrowGeneration Corp. GrowGen is a leading developer, marketer, retailer, and distributor of products for both indoor and outdoor hydroponic and organic gardening, as well as customized storage solutions. GrowGen carries and sells thousands of products, such as nutrients, additives, growing media, lighting, environmental control systems, and benching and racking, including proprietary brands such as Charcoir, Drip Hydro, Power Si, Ion lights, The Harvest Company, and more. Incorporated in Colorado in 2014, GrowGen is the largest chain of specialty retail hydroponic and organic garden centers in the United States. The Company also operates an online superstore for cultivators at growgeneration.com, as well as a wholesale business for resellers, HRG Distribution, and a benching, racking, and storage solutions business, Mobile Media or MMI. Forward Looking Statements This press release may include predictions, estimates, or other information considered forward-looking within the meaning of applicable securities laws. While these forward-looking statements represent current judgments, they are subject to risks and uncertainties that could cause actual results to differ materially. You are cautioned not to place undue reliance on these forward-looking statements, which reflect opinions only as of the date of this release. Please keep in mind that the Company does not have an obligation to revise or publicly release the results of any revision to these forward-looking statements in light of new information or future events. When used herein, words such as look forward, believe, continue, building, may, should, expects, anticipates, contemplates, estimates, believes, plans, projected, predicts, potential, or hopes, or the negative of these or similar terms, or variations of such words, and similar expressions are intended to identify forward-looking statements. Factors that could cause actual results to differ materially from any forward-looking statements made by us herein are often discussed in filings made with the United States Securities and Exchange Commission, available at: www.sec.gov, and on the Companys website at: www.growgeneration.com. ITEM 1. FINANCIAL STATEMENTS GROWGENERATION CORP. AND SUBSIDIARIES CONSOLIDATED BALANCE SHEETS (in thousands except shares) December 31, 2023 December 31, 2022 ASSETS Current assets: Cash and cash equivalents $ 29,757 $ 40,054 Marketable securities 35,212 31,852 Accounts receivable, net of allowance for credit losses of $1.4 million and $0.7 million at December 31, 2023 and 2022 8,895 8,336 Notes receivable, current, net of allowance for credit losses of $1.7 million and $1.3 million at December 31, 2023 and 2022 193 1,214 Inventory 64,905 77,091 Prepaid income taxes 516 5,679 Prepaid and other current assets 7,973 6,455 Total current assets 147,451 170,681 Property and equipment, net 27,052 28,669 Operating leases right-of-use assets, net 39,933 46,433 Notes receivable, long term 106  Intangible assets, net 16,180 30,878 Goodwill 7,525 15,978 Other assets 843 803 TOTAL ASSETS $ 239,090 $ 293,442 LIABILITIES & STOCKHOLDERS EQUITY Current liabilities: Accounts payable $ 11,666 $ 15,728 Accrued liabilities 2,530 1,535 Payroll and payroll tax liabilities 2,169 4,671 Customer deposits 5,359 4,338 Sales tax payable 1,185 1,341 Current maturities of lease liability 8,021 8,131 Current portion of long-term debt  50 Total current liabilities 30,930 35,794 Operating lease liability, net of current maturities 34,448 40,659 Other long-term liabilities 317 593 Total liabilities 65,695 77,046 Commitments and contingencies Stockholders Equity: Common stock; $.001 par value; 100,000,000 shares authorized; 61,483,762 and 61,010,155 shares issued and outstanding as of December 31, 2023 and 2022, respectively 61 61 Additional paid-in capital 373,433 369,938 Retained earnings (deficit) (200,099 ) (153,603 ) Total stockholders equity 173,395 216,396 TOTAL LIABILITIES AND STOCKHOLDERS EQUITY $ 239,090 $ 293,442 GROWGENERATION CORP. AND SUBSIDIARIES CONSOLIDATED STATEMENTS OF OPERATIONS (in thousands, except per share amounts) Three Months Ended December 31, Twelve Months Ended December 31, 2023 2022 2023 2022 (Unaudited) (Unaudited) Net sales $ 49,452 $ 54,456 $ 225,882 $ 278,166 Cost of sales (exclusive of depreciation and amortization shown below) 37,808 44,894 164,624 207,903 Gross profit 11,644 9,562 61,258 70,263 Operating expenses: Store operations and other operational expenses 11,794 12,796 48,082 54,680 Selling, general, and administrative 7,876 8,594 29,799 36,758 Estimated credit losses 274 (37 ) 955 1,737 Depreciation and amortization 4,130 3,968 16,607 17,132 Impairment loss 15,659  15,659 127,831 Total operating expenses 39,733 25,321 111,102 238,138 Income (loss) from operations (28,089 ) (15,759 ) (49,844 ) (167,875 ) Other income (expense): Other income (expense) (5 ) 137 781 684 Interest income 810 390 2,696 580 Interest expense (91 ) (5 ) (97 ) (21 ) Total other income (expense) 714 522 3,380 1,243 Net income (loss) before taxes (27,375 ) (15,237 ) (46,464 ) (166,632 ) Benefit (provision) for income taxes 61 248 (32 ) 2,885 Net income (loss) $ (27,314 ) (14,989 ) $ (46,496 ) $ (163,747 ) Net income (loss) per share, basic $ (0.44 ) $ (0.25 ) $ (0.76 ) $ (2.69 ) Net income (loss) per share, diluted $ (0.44 ) $ (0.25 ) $ (0.76 ) $ (2.69 ) Weighted average shares outstanding, basic 61,386 61,064 61,181 60,813 Weighted average shares outstanding, diluted 61,386 61,064 61,181 60,813 GROWGENERATION CORP. AND SUBSIDIARIES CONSOLIDATED STATEMENTS OF CASH FLOWS (in thousands) Years Ended December 31, 2023 2022 Cash flows from operating activities: Net income (loss) $ (46,496 ) $ (163,747 ) Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities: Depreciation and amortization 16,607 17,132 Estimated credit losses 955 1,737 Share-based compensation 3,171 4,967 Impairment loss related to goodwill and intangible assets 15,526 127,831 Impairment loss on operating lease right-of-use assets 133  Provision for deferred income taxes  (2,359 ) Loss on disposal of fixed assets 218 568 Change in value of marketable securities (1,438 )  Changes in operating assets and liabilities (net of the effect of acquisitions): (Increase) decrease in: Accounts and notes receivable (300 ) (3,106 ) Inventory 13,773 32,890 Prepaid expenses and other assets 3,898 10,827 Accounts payable and accrued liabilities (3,035 ) (3,359 ) Operating leases 46 508 Customer deposits 1,021 (8,590 ) Payroll and payroll tax liabilities (2,502 ) (2,769 ) Sales taxes payable (156 ) (582 ) Net cash and cash equivalents provided by (used in) operating activities 1,421 11,948 Cash flows from investing activities: Acquisitions, net of cash acquired (3,050 ) (7,230 ) Purchase of property and equipment (6,698 ) (12,896 ) Purchase of marketable securities (98,680 ) (38,692 ) Maturities of marketable securities 96,758 46,633 Proceeds from disposals of assets 265 612 Net cash and cash equivalents provided by (used in) investing activities (11,405 ) (11,573 ) Cash flows from financing activities: Principal payments on long term debt (50 ) (108 ) Common stock withheld for employee payroll taxes (263 ) (1,618 ) Proceeds from the sales of common stock and exercise of warrants and options, net of expenses  33 Net cash and cash equivalents (used in) provided by financing activities (313 ) (1,693 ) Net increase (decrease) in cash and cash equivalents (10,297 ) (1,318 ) Cash and cash equivalents at beginning of year 40,054 41,372 Cash and cash equivalents at end of year $ 29,757 $ 40,054 Supplemental Information: Cash paid for interest $ 98 $ 21 Cash paid for income taxes $ 93 $  Right to use assets acquired under new operating leases $ 4,289 $ 9,607 Indemnity holdback from business acquisition $  $ 875 Non-cash repurchase of liability awards $ 653 $  Non-cash issuance of a note receivable $ 299 $  Common stock issued for business combinations $  $ 5,710 Liability redemption associated with business acquisition $ 120 $  Common stock issued for intangible assets $  $ 173 Use of Non-GAAP Financial Information EBITDA and Adjusted EBITDA are non-GAAP financial measures commonly used in our industry and should not be construed in isolation as substitutions to net income (loss) as indicators of operating performance or as alternatives to cash flow provided by operating activities as a measure of liquidity (each as determined in accordance with GAAP). GrowGeneration defines EBITDA as net income (loss) before interest income, interest expense, income tax expense, depreciation and amortization, and Adjusted EBITDA as further adjusted to exclude certain items such as stock-based compensation, impairment losses, restructuring and corporate rationalization costs, and other non-core or non-recurring expenses and to include income from our marketable securities as these investments are part of our operational business strategy and increase the cash available to us. We believe these non-GAAP measures, when used in conjunction with net income (loss), provide meaningful supplemental information to both management and investors, facilitating the evaluation of performance across reporting periods. Management uses these non-GAAP measures for internal planning and reporting purposes. These non-GAAP measures are not in accordance with, or an alternative for, generally accepted accounting principles and may be different from non-GAAP measures used by other companies. We believe that these non-GAAP financial measures may be useful to investors in their assessment of our operating performance and valuation. In addition, these non-GAAP financial measures address questions routinely received from analysts and investors and, in order to ensure that all investors have access to the same data, we have determined that it is appropriate to make this data available to all investors. Set forth below is a reconciliation of EBITDA and Adjusted EBITDA to net income (loss) (in thousands) (unaudited): Three months ended December 31, Year ended December 31, 2023 2022 2023 2022 Net income (loss) $ (27,314 ) $ (14,989 ) $ (46,496 ) $ (163,747 ) Benefit (provision) for income taxes (61 ) (248 ) 32 (2,885 ) Interest income (810 ) (390 ) (2,696 ) (580 ) Interest expense 91 5 97 21 Depreciation and amortization 4,130 3,968 16,607 17,132 EBITDA $ (23,964 ) $ (11,654 ) $ (32,456 ) $ (150,059 ) Share-based compensation 719 987 3,171 4,967 Investment income 810  2,696  Impairment loss 15,659  15,659 127,831 Restructuring and other charges (1) 3,076 487 5,376 568 Adjusted EBITDA $ (3,700 ) $ (10,180 ) $ (5,554 ) $ (16,693 ) (1) Consists primarily of expenditures related to the activity of store and distribution consolidation and one-time severances View source version on businesswire.com: https://www.businesswire.com/news/home/20240313173939/en/ Investor Contact ICR, Inc. GrowGenIR@icrinc.com Source: GrowGeneration Corp. What was GrowGeneration's full-year net revenue for 2023? GrowGeneration reported a full-year net revenue of $225.9 million for 2023. What was the net loss for GrowGeneration in 2023? GrowGeneration reported a net loss of $46.5 million for the full year 2023. What was the adjusted EBITDA for GrowGeneration in 2023? GrowGeneration's adjusted EBITDA for the full year 2023 was a loss of $5.6 million. What strategic opportunities is GrowGeneration exploring for MMI? GrowGeneration is exploring strategic opportunities for its benching, racking, and storage solutions business, MMI. What is GrowGeneration's ticker symbol? GrowGeneration's ticker symbol is GRWG. What is GrowGeneration's cash position as of December 31, 2023? GrowGeneration had cash, cash equivalents, and marketable securities of $65.0 million as of December 31, 2023."
Turtle Beach Announces Transformational Acquisition of PDP and Intention to Launch Reverse Dutch Tender Auction,2024-03-13T20:06:00.000Z,Neutral,Positive,"Turtle Beach Corporation announces the acquisition of Performance Designed Products, enhancing its product portfolio and profitability. The company plans to repurchase up to $30 million of its common stock and appoints a new CEO. The acquisition is expected to boost revenues and EBITDA, with significant synergies and growth opportunities.","Turtle Beach Announces Transformational Acquisition of PDP and Intention to Launch Reverse Dutch Tender Auction Rhea-AI Impact (Neutral) Rhea-AI Sentiment (Positive) Tags acquisition Rhea-AI Summary Turtle Beach Corporation announces the acquisition of Performance Designed Products, enhancing its product portfolio and profitability. The company plans to repurchase up to $30 million of its common stock and appoints a new CEO. The acquisition is expected to boost revenues and EBITDA, with significant synergies and growth opportunities. Positive Acquisition of Performance Designed Products (PDP) enhances Turtle Beach's product portfolio and profitability. Expected total revenues of $390 to $410 million in the first full year post-acquisition. Anticipated cost synergies of $10 to $12 million annually and potential revenue synergies. Diversis Capital to become the largest shareholder with approximately 16% ownership. 2024 net revenues projected to be $370 to $380 million, driven by the acquisition of PDP. Pro forma combined Adjusted EBITDA estimated between $51 million and $54 million for 2024. Intention to launch a modified Dutch Auction Tender Offer to repurchase up to $30 million of common stock. Negative None. Market Research Analyst The acquisition of Performance Designed Products (PDP) by Turtle Beach is a strategic move that broadens the company's product offerings and is expected to enhance its market position in the gaming accessories sector. The gaming industry is experiencing robust growth and the demand for gaming accessories is rising in tandem. By acquiring a leading provider of gaming controllers, Turtle Beach not only diversifies its portfolio but also taps into the complementary product lines that could lead to cross-selling opportunities.Furthermore, the expected financial synergies, such as cost reductions and revenue enhancements, are significant. The anticipated $10 to $12 million in annual run-rate cost synergies could improve the combined company's margin profile. Moreover, the acquisition's accretive nature suggests that it will be beneficial to shareholders from a financial metrics standpoint, particularly in terms of earnings per share and return on investment.However, while the acquisition is projected to be immediately accretive, it is also important to monitor the integration process closely. Mergers and acquisitions can sometimes lead to unforeseen challenges, including cultural integration, systems harmonization and customer retention. The success of the acquisition will largely depend on how effectively Turtle Beach can integrate PDP's operations and realize the projected synergies. Financial Analyst The financial implications of Turtle Beach's acquisition of PDP and the subsequent modified Dutch Tender Offer are multifaceted. The enterprise value of $118 million for PDP and the transaction multiple of 4.7x post-synergy Adjusted EBITDA are particularly noteworthy. Compared to industry norms, this multiple is relatively attractive, suggesting that Turtle Beach may have negotiated favorable terms. This could be indicative of a strategic move to consolidate market share without overpaying, which is often a concern in such deals.The Tender Offer, priced at a premium to the current share price, reflects management's confidence in the company's intrinsic value and future prospects. It also represents a return of capital to shareholders, which could be seen as a positive signal regarding the company's liquidity and financial health. The financing of the Tender Offer through cash on hand and borrowing capacity indicates a balanced approach to capital allocation, preserving financial flexibility for future growth initiatives.Investors should consider the impact of these initiatives on the company's leverage, particularly the pro forma prospective net debt of 0.7x. While this level of leverage appears manageable, it is essential to evaluate the company's ability to service its debt, especially in the context of the gaming industry's cyclicality and the potential for market fluctuations. Legal Expert The legal aspects of the acquisition, such as the unanimous approval by the Boards of Directors of both Turtle Beach and PDP, indicate a clear consensus on the strategic fit and potential value creation of the transaction. The involvement of reputable legal advisors and financial institutions in structuring the deal underscores its significance and the due diligence conducted.Additionally, the immediate closure of the transaction upon execution of the definitive agreements suggests that there were no regulatory hurdles or antitrust concerns that could delay the merger. This is often an area of concern in such deals and the absence of such issues could mean a smoother integration process.It is also worth noting the governance changes, with Diversis Capital becoming the largest shareholder and adding a Senior Operating Partner to the Turtle Beach Board. This could lead to shifts in strategic direction and should be monitored for potential impacts on company policy and stakeholder interests. 03/13/2024 - 04:06 PM Highly Accretive Acquisition of Performance Designed Products Expands Product Portfolio, Strengthens Profitability and Meaningfully Enhances Size of Company Establishes a Powerhouse in Hardware Gaming Accessories with Leadership Positions in Console Headsets and Controllers, Amplified by Significant Financial Synergies Announces Intent to Launch a Modified Dutch Tender Offer to Repurchase up to $30 Million in Value of Its Common Stock Between Range of $13.75 - $15.00 Per Share Pro Forma Prospective Net Debt of 0.7X at Transaction Closing Leaves Meaningful Financial Cushion to Fund Additional Growth Initiatives and Capital Return Alternatives Announces the Appointment of Cris Keirn as Chief Executive Officer Turtle Beach Board of Directors Increases to 9 Members to Include Cris Keirn and David Muscatel, Operating Partner at Diversis Capital Provides 2024 Financial Outlook and Summary for Combined Company WHITE PLAINS, N.Y.--(BUSINESS WIRE)-- Turtle Beach Corporation (Nasdaq: HEAR) (Turtle Beach or the Company), a leading gaming accessories brand, announced today that following the Company's establishment of a Value Enhancement Committee in 2023, the Board of Directors (the Board) has approved comprehensive and value-creative changes to its business, capital allocation and senior leadership. In consultation with its financial and legal advisors over the past year, the Company considered a comprehensive range of strategic, operational and financial alternatives on behalf of shareholders, including a full sale of the Company, and following the completion of its review, announced the following updates: Strategic Acquisition of Performance Designed Products (PDP) Turtle Beach today announced the execution of definitive agreements to acquire PDP, a leading gaming accessories provider at an enterprise value for PDP of $118 million (the Transaction). PDP is a privately held third-party gaming accessories leader that designs and distributes aftermarket video game accessories, including controllers, headsets, power cases, and other accessories. The Transaction combines two leading gaming companies with industry-leading teams, significant product momentum and proven track records of delivering profitable growth. The Transaction substantially grows the size of Turtle Beach. Bringing PDPs leading gaming controller category to Turtle Beach will provide additional scale and create future development opportunities. Furthermore, the Company provided the following strategic rationale: The combined company anticipates total revenues of $390 to 410 million in the first full 12 months of ownership (Q2 2024 through Q1 2025). The post-synergy Adjusted EBITDA of PDP is projected to be $22 to $28 million in the first full 12 months of ownership (Q2 2024 through Q1 2025) implying a post-synergy transaction multiple of 4.7x at the mid-point of estimated 2024 Adjusted EBITDA. Turtle Beach expects $10 to $12 million of anticipated annual run-rate cost synergies for the transaction, with upside for incremental revenue synergies, best practice sharing and further cost synergies over time. Acquiring PDP at an attractive valuation multiple relative to the trading multiples of peers implies potential significant upside in market value for the combined company. Diversis Capital, a Los Angeles-based private equity firm and PDPs majority owner, will become the largest shareholder of Turtle Beach with approximately 16% of the pro forma basic shares outstanding prior to the expected modified Dutch Tender Offer and will add one of its Senior Operating Partners, David Muscatel, to the Turtle Beach Board. Consideration for the Transaction consists of the issuance of 3.45 million shares of Turtle Beach's common stock and approximately $79.9 million in cash. The Transaction is expected to be immediately accretive to Turtle Beach shareholders on key metrics including the Companys growth prospects, strategic positioning with retailers and customers, and financial profile. The Board of Directors of both Turtle Beach and PDP have unanimously approved the Transaction and the Transaction was closed immediately upon the execution of the definitive agreements. Jefferies LLC acted as exclusive financial advisor and Dechert LLP acted as legal counsel to Turtle Beach and OMelveny & Myers LLP acted as legal counsel to PDP in connection with the transaction. 2024 Summary Financial Outlook Turtle Beach is pleased with its share gains experienced during the holiday season, its ongoing cost improvement initiatives, and its 2024 product portfolio, all of which continue to highlight the meaningful, recent positive momentum on both the top and bottom-line for the Company. The acquisition of PDP adds significant financial benefits to Turtle Beach that, in conjunction with synergies realized, fundamentally transforms the financial profile of the Company. Accordingly, the Company expects 2024 net revenues to be in the range of $370 million to $380 million, with the growth driven primarily by the acquisition of PDP and the expected out-performance of the gaming markets in specific categories based on the Companys product plans for 2024. Additionally, in light of the Companys strong execution on its efficiency and profitability initiatives, the Company expects pro forma combined Adjusted EBITDA to be between $51 million and $54 million, which incorporates approximately 9 months of operations from PDP. In the first full four quarters of operation (Q2 2024 through Q1 2025), the combined Company expects total net sales to be in the range of $390 - $410 million and Adjusted EBITDA to be in the range of $60 - $65 million. Intends to Launch a Modified Dutch Auction Tender Offer within One (1) Month To drive further value for Turtle Beach shareholders, the Company announced today that it intends to launch a modified Dutch Auction Tender Offer (the Tender Offer) to purchase up to $30 million in value of its common stock (the Common Stock) at a price per share not less than $13.75 per share and not greater than $15.00 per share, less any applicable withholding taxes and without interest, using available cash on hand and available borrowing capacity. On March 12, 2024, the closing price of the Common Stock was $11.03 per share, setting the low-end of the Tender Offer range at a 25% premium to the most recent closing share price. The Tender Offer is anticipated to commence on or about April 10, 2024 and is expected to expire at 12 midnight, New York City time, at the end of the day on or about May 10, 2024, unless extended or terminated. A modified ""Dutch Auction"" Tender Offer allows shareholders to indicate how many shares of Common Stock and at what price within the range described above they wish to tender their shares. Based on the number of shares tendered and the prices specified by the tendering shareholders, the Company will determine the lowest per-share price that will enable it to acquire up to $30 million in value of Common Stock. The Companys Board believes the modified Dutch Auction Tender Offer structure is a mechanism that affords shareholders with an opportunity to obtain liquidity with respect to all or a portion of their shares, with less potential disruption to the share price and the usual transaction costs inherent in open market purchases and sales. Executive Management and the Board of Directors of Turtle Beach do not plan on participating in the tender offer. Announcement of Chief Executive Officer The Company announced that Turtle Beachs Board of Directors has appointed Cris Keirn as Chief Executive Officer and to the Board of Directors, effective immediately. The appointment concludes a comprehensive CEO search process, launched by the Board in the second quarter of 2023, with the mandate to appoint a highly qualified leader with extensive product innovation, operational and transformational experience, and capable of delivering strong financial and operational results to drive future growth across the business. Mr. Keirn joined Turtle Beach in 2013 and has been a key contributor in the transformation of Turtle Beachs product portfolios, including in his role as Vice-President of Business Planning and Strategy prior to his executive role in sales. Mr. Keirn has also led sales operations, customer care and market analytics teams for the Company. Prior to joining Turtle Beach, Cris held leadership positions over a 17-year span in multiple divisions at Motorola across engineering, product management, operations, quality and customer relations. Im honored to work with the amazing team at Turtle Beach, now including our new colleagues from PDP, as we continue to deliver fantastic new products for gamers and value to our shareholders, said Keirn. Working with our industry partners, and with the combined expertise of our teams, we will drive a transformational change to the companys scale and execution with innovation and expansion of our leadership positions across gaming accessory categories. After a comprehensive review of strategic actions and significant engagement by the Board of Directors, I am excited about the announcements made today that we believe will create substantial value for Turtle Beach shareholders, said Terry Jimenez, Chairman of the Board of Directors and Chairman of the Value Enhancement Committee. Acquiring PDP, announcing a modified Dutch auction tender offer, and appointing Cris Keirn as our next CEO are significant outcomes that are a result of a thorough review of our business opportunities ahead. We are pleased to welcome the PDP team to Turtle Beach, and we look forward to benefiting from our improved financial profile, gaming product portfolio and industry-leading team. In addition, we are pleased to welcome both Cris and Dave to our Board, both of whom are excellent additions. Were also excited to have Cris leading the business as CEO and believe his industry expertise and leadership skills are critical to advancing our strategy to drive growth across our gaming accessories businesses and generate substantial profit. Ultimately, each of these outcomes better position the Company for future success and value creation for shareholders. Conference Call Details Turtle Beach will host a conference call today, March 13, 2024, at 5:00 p.m. ET / 2:00 p.m. PT to review the transaction, detail its fourth quarter and full year 2023 earnings results and host a question-and-answer session. A live webcast of the call will be available on the Events & Presentations page of the Companys website at www.turtlebeachcorp.com. To access the call by phone, please go to this link (registration link) and you will be provided with dial-in details. To avoid delays, we encourage participants to dial into the conference call 15 minutes ahead of the scheduled start time. A replay of the webcast will also be available for a limited time at www.turtlebeachcorp.com. Non-GAAP Financial Measures In addition to its reported results, the Company has included in this release certain financial metrics, including adjusted EBITDA, that the Securities and Exchange Commission define as non-GAAP financial measures. Management believes that such non-GAAP financial measures, when read in conjunction with the Company's reported results, can provide useful supplemental information for investors analyzing period-to-period comparisons of the Company's results. Non-GAAP financial measures are not an alternative to the Companys GAAP financial results and may not be calculated in the same manner as similar measures presented by other companies. Adjusted EBITDA is defined by the Company as net income (loss) before interest, taxes, depreciation and amortization, stock-based compensation (non-cash), and certain non-recurring special items that we believe are not representative of core operations, as further described in Table 4 of our Full Year 2023 Earnings Release. These non-GAAP financial measures are presented because management uses non-GAAP financial measures to evaluate the Companys operating performance, to perform financial planning, and to determine incentive compensation. Therefore, the Company believes that the presentation of non-GAAP financial measures provides useful supplementary information to, and facilitates additional analysis by, investors. The non-GAAP financial measures included herein exclude items that management does not believe reflect the Companys core operating performance because such items are inherently unusual, non-operating, unpredictable, non-recurring, or non-cash. See a reconciliation of GAAP results to Adjusted EBITDA included as Table 4 in our Full Year 2023 Earnings Release for each of the three and twelve months ended December 31, 2022 and December 31, 2023. About Turtle Beach Corporation Turtle Beach Corporation (the Company) (www.turtlebeachcorp.com) is one of the worlds leading gaming accessory providers. The Companys namesake Turtle Beach brand (www.turtlebeach.com) is known for designing best-selling gaming headsets, PC gaming products, top-rated game controllers, and groundbreaking gaming simulation accessories. Innovation, first-to-market features, a broad range of products for all types of gamers, and top-rated customer support have made Turtle Beach a fan-favorite brand and the market leader in console gaming audio for over a decade. Turtle Beachs shares are traded on the Nasdaq Exchange under the symbol: HEAR. Cautionary Note on Forward-Looking Statements This press release includes forward-looking information and statements within the meaning of the federal securities laws. Except for historical information contained in this release, statements in this release may constitute forward-looking statements regarding assumptions, projections, expectations, targets, intentions or beliefs about future events. Statements containing the words may, could, would, should, believe, expect, anticipate, plan, estimate, target, goal, project, intend and similar expressions, or the negatives thereof, constitute forward-looking statements. Forward-looking statements involve known and unknown risks and uncertainties, which could cause actual results to differ materially from those contained in any forward-looking statement. The inclusion of such information should not be regarded as a representation by the Company, or any person, that the objectives of the Company will be achieved. Forward-looking statements are based on managements current beliefs and expectations, as well as assumptions made by, and information currently available to, management. While the Company believes that its expectations are based upon reasonable assumptions, there can be no assurances that its goals and strategy will be realized. Numerous factors, including risks and uncertainties, may affect actual results and may cause results to differ materially from those expressed in forward-looking statements made by the Company or on its behalf. Some of these factors include, but are not limited to, risks related to inflationary pressures, optimizing our product portfolio, reducing our cost of goods and operating expenses, reductions in logistic and supply chain challenges and costs, the substantial uncertainties inherent in the acceptance of existing and future products, the difficulty of commercializing and protecting new technology, the impact of competitive products and pricing, including promotional credits and discounts, general business and economic conditions, risks associated with the future direction or governance of the Company, risks associated with the expansion of our business, including the integration of any businesses we acquire and the integration of such businesses within our internal control over financial reporting and operations, our indebtedness, liquidity, and other factors discussed in our public filings, including the risk factors included in the Companys most recent Annual Report on Form 10-K, Quarterly Report on Form 10-Q, and the Companys other periodic reports filed with the Securities and Exchange Commission. Except as required by applicable law, including the securities laws of the United States and the rules and regulations of the Securities and Exchange Commission, the Company is under no obligation to publicly update or revise any forward-looking statement after the date of this release whether as a result of new information, future developments or otherwise. All trademarks are the property of their respective owners. View source version on businesswire.com: https://www.businesswire.com/news/home/20240313363647/en/ MacLean Marshall Sr. Director, Public Relations & Brand Communications Turtle Beach Corporation 858.914.5093 maclean.marshall@turtlebeach.com Investor Information: Alex Thompson Gateway Group 949.574.3860 hear@gateway-grp.com Source: Turtle Beach Corporation What is the enterprise value for the acquisition of Performance Designed Products (PDP)? The enterprise value for the acquisition of PDP is $118 million. What are the expected total revenues for the combined company in the first full year post-acquisition? The combined company anticipates total revenues of $390 to $410 million. Who will become the largest shareholder of Turtle Beach after the acquisition? Diversis Capital will become the largest shareholder of Turtle Beach with approximately 16% ownership. What are the projected net revenues for Turtle Beach in 2024? Turtle Beach expects 2024 net revenues to be in the range of $370 million to $380 million. What is the estimated pro forma combined Adjusted EBITDA for 2024? The estimated pro forma combined Adjusted EBITDA for 2024 is between $51 million and $54 million. How much common stock does Turtle Beach intend to repurchase through the Tender Offer? Turtle Beach intends to repurchase up to $30 million in value of its common stock through the Tender Offer."
New England Realty Associates LP Announces First-Quarter Distribution on Class A Units and Depositary Receipts and a Special One-Time Distribution,2024-03-13T20:06:00.000Z,Low,Very Positive,"New England Realty Associates Limited Partnership (NEN) announced its first-quarter distribution to Class A Limited Partners and Depositary Receipt holders. The quarterly distribution per Class A Unit is $12.00, with a special one-time distribution of $48.00. For Depositary Receipts, the quarterly distribution is $0.40, with a special one-time distribution of $1.60 per Receipt.","New England Realty Associates LP Announces First-Quarter Distribution on Class A Units and Depositary Receipts and a Special One-Time Distribution Rhea-AI Impact (Low) Rhea-AI Sentiment (Very Positive) Tags Rhea-AI Summary New England Realty Associates Limited Partnership (NEN) announced its first-quarter distribution to Class A Limited Partners and Depositary Receipt holders. The quarterly distribution per Class A Unit is $12.00, with a special one-time distribution of $48.00. For Depositary Receipts, the quarterly distribution is $0.40, with a special one-time distribution of $1.60 per Receipt. Positive None. Negative None. Financial Analyst The announcement by New England Realty Associates Limited Partnership regarding the quarterly distribution and a special one-time distribution represents a significant capital return to investors. The quarterly distribution of $12.00 per Class A Limited Partnership Unit is a direct reflection of the company's current profitability and cash flow status. Additionally, the special one-time distribution of $48.00 per Class A Unit indicates a substantial surplus of capital or a strategic decision to return capital to investors, which could be derived from asset sales, refinancing, or other one-time financial gains.It's essential to compare the distribution amounts to historical payouts to assess the growth trajectory of the company's distributions. If the distributions have increased, this may suggest improved operational efficiency or asset performance. Conversely, if the distributions have remained static or decreased, this could potentially raise concerns about the company's future growth prospects. Investors should also consider the sustainability of these distributions, as high payouts may not always be maintainable in the long term, especially if they exceed the company's free cash flow. Market Research Analyst The impact of such distributions on the stock market typically results in increased investor interest in the company's stock, as it reflects a tangible return on investment. The market's perception of the company's financial health could be positively influenced, potentially leading to a rise in the stock price. However, it is crucial to analyze the underlying reasons for the special one-time distribution. If it is a result of divesting a valuable asset, the company's future earning potential might be affected, which could offset the short-term positive impact on the stock price.Furthermore, the ratio of the distribution to the stock's price, known as the yield, is a critical metric for income-focused investors. A high yield, especially in the context of a special one-time distribution, may attract income investors but could also signal that the market is requiring a higher return due to perceived risks associated with the investment. Real Estate Investment Trust (REIT) Analyst Given that New England Realty Associates operates as a Limited Partnership, which often shares similar characteristics to Real Estate Investment Trusts (REITs), the distributions can be a significant factor in investment decisions. The company's ability to generate consistent rental income, manage operational costs effectively and navigate the real estate market's cyclical nature are all reflected in its distribution levels. The real estate market conditions, including occupancy rates, rental prices and property values, are critical determinants of the company's performance.Investors should also consider the tax implications of these distributions, as they may differ from dividends paid by corporations. In the case of REITs and similar entities, distributions are often taxed as ordinary income, which could affect the after-tax return for investors. The special one-time distribution might also carry different tax consequences, which should be analyzed carefully. 03/13/2024 - 04:06 PM ALLSTON, Mass., March 13, 2024 /PRNewswire/ -- On March 28, 2024, New England Realty Associates Limited Partnership (NYSE MKT: NEN) will make its quarterly distribution to its Class A Limited Partners and holders of Depositary Receipts of record as of March 23, 2024. The quarterly distribution per Class A Limited Partnership Unit will be $12.00 per Unit. The quarterly distribution per Depositary Receipt will be $0.40. In addition to the quarterly distribution, there will be a special one-time distribution of $48.00 per Class A Unit and $1.60 per Depositary Receipt. Each Depositary Receipt represents a beneficial ownership of one-thirtieth of a Class A Partnership Unit. Depositary Receipts are listed on The NYSE MKT under the trading symbol ""NEN"". View original content:https://www.prnewswire.com/news-releases/new-england-realty-associates-lp-announces-first-quarter-distribution-on-class-a-units-and-depositary-receipts-and-a-special-one-time-distribution-302088557.html SOURCE New England Realty Associates Limited Partnership What is the quarterly distribution per Class A Limited Partnership Unit? The quarterly distribution per Class A Unit is $12.00. What is the special one-time distribution per Class A Unit? There will be a special one-time distribution of $48.00 per Class A Unit. What is the quarterly distribution per Depositary Receipt? The quarterly distribution per Depositary Receipt is $0.40. What is the special one-time distribution per Depositary Receipt? There will be a special one-time distribution of $1.60 per Depositary Receipt. Where are Depositary Receipts listed for trading? Depositary Receipts are listed on The NYSE MKT under the trading symbol 'NEN'."
Anika Reports Fourth Quarter and Year-End 2023 Financial Results,2024-03-13T20:05:00.000Z,Neutral,Neutral,"Anika Therapeutics, Inc. (ANIK) reports strong financial results for Q4 and full year 2023, with revenue growth exceeding expectations. The company achieved record annual revenues of $102 million, up 11% in 2023. Anika anticipates generating adjusted EBITDA of $25 to $30 million in 2024, a significant increase. Despite a non-recurring impairment charge, the company is optimistic about its performance and cost reduction initiatives.","Anika Reports Fourth Quarter and Year-End 2023 Financial Results Rhea-AI Impact (Neutral) Rhea-AI Sentiment (Neutral) Tags earnings Rhea-AI Summary Anika Therapeutics, Inc. (ANIK) reports strong financial results for Q4 and full year 2023, with revenue growth exceeding expectations. The company achieved record annual revenues of $102 million, up 11% in 2023. Anika anticipates generating adjusted EBITDA of $25 to $30 million in 2024, a significant increase. Despite a non-recurring impairment charge, the company is optimistic about its performance and cost reduction initiatives. Positive Revenue growth and adjusted EBITDA exceeded expectations in Q4 and full year 2023. OA Pain Management achieved record annual revenues of $102 million, up 11% in 2023. Anika positioned to generate adjusted EBITDA of $25 to $30 million in 2024, up over 75% at the midpoint. Cost reduction initiatives to provide annualized savings of approximately $10 million. The company reported strong financial performance despite a non-recurring impairment charge. Anika's President and CEO, Cheryl R. Blanchard, expressed satisfaction with the results and highlighted key milestones achieved. Negative Recorded a non-recurring, non-cash impairment charge in Q4 2023 for intangible assets associated with acquisitions. Net loss for the year was significant due to impairment charges and other associated costs. Non-Orthopedic revenue saw a decline in Q4 and full year 2023. Cash used in operations for the year was $1.8 million. Financial Analyst Anika Therapeutics' reported revenue and adjusted EBITDA growth in the fourth quarter and full year are indicators of the company's operational efficiency and market adoption of its products. The notable 11% increase in OA Pain Management annual revenues suggests a strong market presence and effective commercial strategies. However, the non-recurring, non-cash impairment charge of $62.2 million is a significant event that reflects adjustments in the valuation of acquired assets, often indicative of changes in expected future cash flows or market conditions.The projected adjusted EBITDA of $25 to $30 million for 2024, representing a substantial increase over 75% at the midpoint and an adjusted EBITDA margin of at least 15%, is a forward-looking statement that may influence investor expectations. This projection, combined with the announced cost reduction initiatives aimed at saving $10 million annually, suggests that the company is focusing on cost efficiency and profitability. However, it is essential to consider the sustainability of these measures and their potential impact on the company's growth trajectory. Market Research Analyst The increase in OA Pain Management revenue indicates a growing demand for Anika's products in this segment, which could be due to an aging population or advances in treatment options. The upward trend in Joint Preservation and Restoration revenue, with a 9% increase, also points to a broader market acceptance. Nonetheless, the decrease in Non-Orthopedic revenue by 29% suggests challenges in that sector, which may require strategic realignment.Understanding the market dynamics and competitive landscape is crucial for forecasting the company's future performance. The emphasis on regenerative and sports medicine products, as well as joint solutions, is aligned with current industry trends towards less invasive and more regenerative treatment options. The company's ability to innovate and meet market demands will be critical for its continued success. Medical Research Analyst The reported financial outcomes are reflective of Anika Therapeutics' strategic focus on early intervention orthopedics. The record annual revenues in OA Pain Management underscore the potential of the company's hyaluronic acid (HA) franchise, which is a cornerstone in managing osteoarthritis pain. The launch of new products in regenerative and sports medicine aligns with the industry's shift towards personalized and advanced therapeutic options.It is essential to evaluate the clinical impact of these new products, as their efficacy and safety profiles will play a significant role in their market penetration and, consequently, the company's financial performance. The announced cost reduction initiatives, while beneficial from a financial standpoint, should not compromise the quality of research and development, which is vital for maintaining a competitive edge in the biotechnology and pharmaceutical sectors. 03/13/2024 - 04:05 PM Revenue growth and adjusted EBITDA1 exceeded expectations in the fourth quarter and full year OA Pain Management achieved record annual revenues of $102 million, up 11% in 2023 Announces cost reduction initiatives providing annualized savings of approximately $10 million Anika positioned to generate adjusted EBITDA1 of $25 to $30 million in 2024, up over 75% at the midpoint, representing an adjusted EBITDA1 margin of at least 15% BEDFORD, Mass., March 13, 2024 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today reported financial results for its fourth quarter and full year ended December 31, 2023. Fourth Quarter 2023 Financial Summary Revenue in the fourth quarter of 2023 was $43.0 million, up 8% compared to $39.6 million in the fourth quarter of 2022. OA Pain Management revenue of $25.1 million, up 12%, on growing global commercial adoption and some order timingJoint Preservation and Restoration revenue of $15.3 million, up 7%Non-Orthopedic revenue of $2.6 million, down 8% Gross margin was 61%, including $1.6 million of non-cash acquisition-related intangible asset amortization; Adjusted gross margin1 was 65%.Recorded a non-recurring, non-cash impairment charge in the fourth quarter of $62.2 million for the intangible assets associated with the Q1-2020 acquisitions of Arthrosurface and Parcus Medical.Including the non-cash impairment charge, net loss was ($63.0) million, or ($4.30) per share, compared to net loss of ($4.9) million, or ($0.34) per share, in the prior year period.Adjusted net income1 was $0.8 million, or $0.05 per diluted share, compared to adjusted net loss1 of ($3.0) million, or ($0.21) per share, in the fourth quarter of 2022.Adjusted EBITDA1 was $5.8 million, compared to $1.4 million in the fourth quarter of 2022.Cash from operations was $3.6 million; ending cash balance rose to $72.9 million. Full Year 2023 Financial Summary Revenue for fiscal 2023 increased 7% to $166.7 million, compared with $156.2 million in 2022. OA Pain Management revenue of $101.9 million, up 11%Joint Preservation and Restoration revenue of $54.9 million, up 9%Non-Orthopedic revenue of $9.9 million, down 29% Gross margin was 62%, including $6.2 million of non-cash acquisition-related intangible asset amortization and $0.7 million of product rationalization charges. Adjusted gross margin1, excluding these charges, was 66%.Including the fourth quarter non-cash impairment charge, net loss was ($82.7) million, or ($5.64) per share, compared to net loss of ($14.9) million, or ($1.02) per share, in 2022. Net loss also included $18.1 million, or ($1.23) per share, for charges associated with product rationalization, acquisition related amortization, discontinuation of software development, Parcus arbitration settlement and shareholder activism.Adjusted net loss1 for the year was ($4.3) million, or ($0.30) per share, compared to adjusted net loss of ($7.1) million, or ($0.49) per share in 2022.Adjusted EBITDA1 for the year was $15.5 million, compared to $12.6 million in 2022.Cash used in operations was $1.8 million. 1 See description of non-GAAP financial information contained in this release. We are pleased to report strong fourth quarter and full year results, including a record year in OA Pain Management. These results reflect the evolution of our differentiated HA franchise and the launch of exciting new products in Regenerative, Sports Medicine and Arthrosurface Joint Solutions, said Cheryl R. Blanchard, Ph.D., Anikas President and CEO. Over the course of the year, we achieved key milestones, learned a lot about the business, and are taking decisive action to further reduce spending and focus our strategy on driving the products that provide the greatest growth opportunities. Our plan to optimize performance is designed to capitalize on the significant growth potential across the business while accelerating our pivot to profitability, with adjusted EBITDA expected to grow over 75% at the midpoint in 2024. Dr. Blanchard continued, We begin 2024 with renewed energy and strong momentum across the new products in our portfolio. Our HA-based Integrity Implant System is receiving very positive feedback, and its full market release is on track for mid-2024. We also remain focused on bringing Hyalofast and Cingal to the U.S. market. As we focus the business on our core strengths and highest value opportunities, we are confident that we will enhance value for shareholders. Fiscal 2023 and Recent Business Highlights Strengthening Leadership Position in OA Pain Management Achieved record annual revenues of $102 million in OA Pain Management on global growth of its Monovisc single injection viscosupplement and continued double-digit international growth of its Cingal next generation non-opioid single injection pain product, on growing global commercial adoption and some order timing; increasing #1 U.S. market share position2.Awaiting FDA feedback on proposed non-clinical next steps regarding Cingal U.S. regulatory approval following a Type C meeting with the FDA in early 2023 and its success in meeting its latest Phase III Pivotal primary endpoint in the fall of 2022.Continuing to explore commercial partnerships for Cingal in the U.S. and select Asian markets. Advancing a Highly Differentiated Portfolio of HA-Based Regenerative Solutions Successfully completed over 100 cases with the Integrity Implant System, Anikas HA-based regenerative rotator cuff patch system, following the limited market release in late November 2023; on-track for full market release in mid-2024Fully enrolled Phase III clinical trial for Hyalofast, Anikas HA, off-the-shelf, single-stage cartilage repair product; modular PMA submission with break-through device designation commencing in 2024; final PMA module filing expected in 2025 with product launching by 2026. Launched Key Products in Sports Medicine and Arthrosurface Joint Solutions X-Twist Biocomposite Fixation System launched in Q1-2024, compliments the PEEK version launched in early 2023, together addressing the more than $600 million U.S. rotator cuff market2.RevoMotion Reverse Shoulder Arthroplasty System full market release in September 2023, expanding Anikas shoulder arthroplasty portfolio into the more than $1 billion U.S. reverse shoulder market2. 2 SmartTRAK Q3-2023 data Cost Reductions In 2023, Anika launched multiple meaningful new products and made considerable progress addressing the new MDR regulatory requirements in Europe. With the progress made in 2023, and in recognition of the slower than expected pace of growth in some of its more mature product lines, the Company has decided to further reduce its planned spending for 2024 and to reduce approximately 9% of its workforce, effective the end of the first quarter. The cost reductions, on an annualized basis, are expected to provide savings of approximately $10 million, excluding the impact of one-time costs. These actions position Anika to focus on its strengths and preserve the Companys significant opportunities with its strong, growing and differentiated product lines and pipeline, and accelerate Anikas pivot to profitability. Fiscal 2024 Guidance In 2024, Anika is prioritizing accelerated growth in profitability, with a focus on the products with the greatest growth opportunities and where the Company has the most differentiated right-to-win. As such, Anika expects revenue for fiscal year 2024 of $168 to $173 million, representing growth of 1% to 4% compared to 2023. Revenue ranges by product family are: OA Pain Management of $102 to $104 million, up 0% to 2%, on sustained above-market growth offset by some unfavorable order timingJoint Preservation and Restoration of $58 to $60.5 million, up 6% to 10%Non-Orthopedic of $8 to $8.5 million, down 14% to 19% The Company expects adjusted EBITDA for 2024 to be $25 to $30 million, up over 75% at the midpoint, representing an adjusted EBITDA margin of at least 15%, up over 6 points compared to 2023. Anikas expectations around improved profitability in 2024 reflect only partial-year cost savings as well as the early-stage ramp from Anikas new products. Strategic Business Update Beginning in mid-2023, Anika engaged Piper Sandler and conducted a company-wide strategic review, evaluating a wide range of strategic alternatives for the company to increase shareholder value, including a potential sale. Anika remains open to all value enhancing opportunities and regularly reviews what makes the most sense for the business. Conference Call and Webcast Information Anikas management will hold a conference call and webcast to discuss its financial results and business highlights today, Wednesday, March 13, 2024, at 5:00 pm ET. The conference call can be accessed by dialing 1-888-886-7786 (toll-free domestic) or 1-416-764-8658 (international) and providing the conference ID number 19479013. A live audio webcast will be available in the Investor Relations section of Anikas website, www.anika.com. A slide presentation with highlights from the conference call will be available in the Investor Relations section of the Anika website. A replay of the webcast will be available on Anikas website approximately two hours after the completion of the event. About Anika Anika Therapeutics, Inc. (NASDAQ: ANIK), is a global joint preservation company that creates and delivers meaningful advancements in early intervention orthopedic care. Leveraging our core expertise in hyaluronic acid and implant solutions, we partner with clinicians to provide minimally invasive products that restore active living for people around the world. Our focus is on high opportunity spaces within orthopedics, including Osteoarthritis Pain Management, Regenerative Solutions, Sports Medicine and Arthrosurface Joint Solutions, and our products are efficiently delivered in key sites of care, including ambulatory surgery centers. Anikas global operations are headquartered outside of Boston, Massachusetts. For more information about Anika, please visit www.anika.com. ANIKA, ANIKA THERAPEUTICS, ARTHROSURFACE, CINGAL, HYALOFAST, INTEGRITY, MONOVISC, PARCUS MEDICAL, REVOMOTION, X-TWIST, and the Anika logo are trademarks of Anika Therapeutics, Inc. or its subsidiaries or are licensed to Anika Therapeutics, Inc. for its use. Non-GAAP Financial Information Non-GAAP financial measures should be considered supplemental to, and not a substitute for, the Companys reported financial results prepared in accordance with GAAP. Furthermore, the Companys definition of non-GAAP measures may differ from similarly titled measures used by others. Because non-GAAP financial measures exclude the effect of items that will increase or decrease the Companys reported results of operations, Anika strongly encourages investors to review the Companys consolidated financial statements and publicly filed reports in their entirety. The Company presents these non-GAAP financial measures because it uses them as supplemental measures in internally assessing the Companys operating performance, and, in the case of Adjusted EBITDA, it is set as a key performance metric to determine executive compensation. The Company also recognizes that these non-GAAP measures are commonly used in determining business performance more broadly and believes that they are helpful to investors, securities analysts, and other interested parties as a measure of comparative operating performance from period to period. Adjusted Gross Margin Adjusted gross margin is defined by the Company as adjusted gross profit divided by total revenue. The Company defines adjusted gross profit as GAAP gross profit excluding amortization of certain acquired assets and non-cash product rationalization charges. Adjusted EBITDA Adjusted EBITDA is defined by the Company as GAAP net income (loss) excluding depreciation and amortization, interest and other income (expense), income taxes, stock-based compensation expense, acquisition related expenses, non-cash charges related to goodwill impairment, non-cash product rationalization charges and charges related to discontinuation of a software project. Adjusted Net Income (Loss) and Adjusted EPS Adjusted net income (loss) is defined by the Company as GAAP net income excluding acquisition related expenses, inclusive of the impact of purchase accounting, on a tax effected basis, non-cash charges related to goodwill impairment, non-cash product rationalization charges and charges related to discontinuation of a software project. Adjusted diluted EPS is defined by the Company as GAAP diluted EPS excluding acquisition related expenses and the impact of purchase accounting, each on a tax-adjusted per share basis, non-cash product rationalization charges and charges related to discontinuation of a software development project. A reconciliation of adjusted gross profit to gross profit (and the associated adjusted gross margin calculation), adjusted EBITDA to net income (loss), adjusted net income (loss) to net income (loss) and adjusted diluted EPS to diluted EPS, the most directly comparable financial measures calculated and presented in accordance with GAAP, is shown in the tables at the end of this release. Forward-Looking Statements This press release may contain forward-looking statements, within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, concerning the Company's expectations, anticipations, intentions, beliefs or strategies regarding the future which are not statements of historical fact, including statements in the sub-headings, Dr. Blanchards quote, and the section titled Cost Reductions about potential cost savings and future profitability, the statements in Dr. Blanchards quote and the section titled Fiscal 2023 and Recent Business Highlights about the timing of future product launches, and the statements made in the section titled Fiscal 2024 Guidance. These statements are based upon the current beliefs and expectations of the Company's management and are subject to significant risks, uncertainties, and other factors. The Company's actual results could differ materially from any anticipated future results, performance, or achievements described in the forward-looking statements as a result of a number of factors including, but not limited to, (i) the Company's ability to successfully commence and/or complete clinical trials of its products on a timely basis or at all; (ii) the Company's ability to obtain pre-clinical or clinical data to support domestic and international pre-market approval applications, 510(k) applications, or new drug applications, or to timely file and receive FDA or other regulatory approvals or clearances of its products; (iii) that such approvals will not be obtained in a timely manner or without the need for additional clinical trials, other testing or regulatory submissions, as applicable; (iv) the Company's research and product development efforts and their relative success, including whether we have any meaningful sales of any new products resulting from such efforts; (v) the cost effectiveness and efficiency of the Company's clinical studies, manufacturing operations, and production planning; (vi) the strength of the economies in which the Company operates or will be operating, as well as the political stability of any of those geographic areas; (vii) future determinations by the Company to allocate resources to products and in directions not presently contemplated; (viii) the Company's ability to successfully commercialize its products, in the U.S. and abroad; (ix) the Company's ability to provide an adequate and timely supply of its products to its customers; and (x) the Company's ability to achieve its growth targets. Additional factors and risks are described in the Company's periodic reports filed with the Securities and Exchange Commission, and they are available on the SEC's website at www.sec.gov. Forward-looking statements are made based on information available to the Company on the date of this press release, and the Company assumes no obligation to update the information contained in this press release. For Investor Inquiries: Anika Therapeutics, Inc. Mark Namaroff, 781-457-9287 Vice President, Investor Relations, ESG and Corporate Communications investorrelations@anika.com Anika Therapeutics, Inc. and SubsidiariesConsolidated Statements of Operations(in thousands, except per share data)(unaudited) For the Three Months Ended December 31, For the Twelve Months Ended December 31, 2023 2022 2023 2022Revenue$42,971 $39,622 $166,662 $156,236 Cost of Revenue16,642 15,491 63,574 62,660 Gross Profit26,329 24,131 103,088 93,576 Operating expenses: Research and development7,585 7,749 32,690 28,182 Selling, general and administrative20,335 23,049 95,847 84,794 Impairment of intangible assets62,190 - 62,190 - Total operating expenses90,110 30,798 190,727 112,976 Loss from operations(63,781) (6,667) (87,639) (19,400)Interest and other income (expense), net577 276 2,312 654 Loss before income taxes(63,204) (6,391) (85,327) (18,746)Benefit from income taxes(204) (1,483) (2,660) (3,887)Net loss$(63,000) $(4,908) $(82,667) $(14,859) Net loss per share: Basic$(4.30) $(0.34) $(5.64) $(1.02)Diluted$(4.30) $(0.34) $(5.64) $(1.02) Weighted average common shares outstanding: Basic14,647 14,640 14,656 14,561 Diluted14,647 14,640 14,656 14,561 Anika Therapeutics, Inc. and SubsidiariesConsolidated Balance Sheets(in thousands, except per share data)(unaudited) December 31, December 31,ASSETS2023 2022Current assets: Cash and cash equivalents$72,867 $86,327 Accounts receivable, net35,961 34,627 Inventories, net46,386 39,765 Prepaid expenses and other current assets8,095 8,828 Total current assets163,309 169,547 Property and equipment, net46,198 48,279 Right-of-use assets28,767 30,696 Other long-term assets18,672 17,219 Deferred tax assets1,489 1,449 Intangible assets, net4,626 74,599 Goodwill7,571 7,339 Total assets$270,632 $349,128 LIABILITIES AND STOCKHOLDERS EQUITY Current liabilities: Accounts payable$9,860 $9,074 Accrued expenses and other current liabilities21,199 18,840 Total current liabilities31,059 27,914 Other long-term liabilities404 398 Deferred tax liability- 6,436 Lease liabilities26,904 28,817 Stockholders equity: Common stock, $0.01 par value147 146 Additional paid-in-capital90,009 81,141 Accumulated other comprehensive loss(5,943) (6,443)Retained earnings128,052 210,719 Total stockholders equity212,265 285,563 Total liabilities and stockholders equity$270,632 $349,128 Anika Therapeutics, Inc. and Subsidiaries Reconciliation of GAAP Gross Profit to Adjusted Gross Profit (in thousands) (unaudited) For the Three Months Ended December 31, For the Twelve Months Ended December 31, 2023 2022 2023 2022Gross Profit$26,329 $24,131 $103,088 $93,576 Product rationalization related charges- 563 748 3,199 Acquisition related intangible asset amortization1,560 1,560 6,244 6,240 Adjusted Gross Profit$27,889 $26,254 $110,080 $103,015 Unadjusted Gross Margin61% 61% 62% 60%Adjusted Gross Margin65% 66% 66% 66% Anika Therapeutics, Inc. and Subsidiaries Reconciliation of GAAP Net Income to Adjusted EBITDA (in thousands) (unaudited) For the Three Months Ended December 31, For the Twelve Months Ended December 31, 2023 2022 2023 2022Net loss$(63,000) $(4,908) $(82,667) $ (14,859)Interest and other (income) expense, net(577) (276) (2,312) (654)Benefit from income taxes(204) (1,483) (2,660) (3,887)Depreciation and amortization1,787 1,880 7,069 7,340 Stock-based compensation3,815 3,813 15,243 14,315 Product rationalization- 563 748 3,199 Arbitration settlement- - 3,250 - Acquisition related intangible asset amortization1,787 1,786 7,148 7,147 Impairment of intangible assets62,190 - 62,190 - Discontinuation of software development project- - 4,473 - Costs of shareholder activism- - 3,033 - Adjusted EBITDA$ 5,798 $ 1,375 $ 15,515 $ 12,601 Anika Therapeutics, Inc. and Subsidiaries Reconciliation of GAAP Net Income to Adjusted Net Income (in thousands) (unaudited) For the Three Months Ended December 31, For the Twelve Months Ended December 31, 2023 2022 2023 2022Net loss$(63,000) $(4,908) $(82,667) $ (14,859)Product rationalization, tax effected- 456 725 2,410 Arbitration settlement, tax effected- - 3,148 - Acquisition related intangible asset amortization, tax effected1,781 1,446 6,926 5,386 Impairment of intangible assets, tax effected61,991 - 60,250 - Discontinuation of software development project, tax effected- - 4,333 - Costs of shareholder activism, tax effected- - 2,938 - Adjusted net income (loss)$ 772 $ (3,006) $ (4,347) $(7,063) Anika Therapeutics, Inc. and Subsidiaries Reconciliation of GAAP Diluted Earnings Per Share to Adjusted Diluted Earnings Per Share (in thousands, except per share data) (unaudited) For the Three Months Ended December 31, For the Twelve Months Ended December 31, 2023 2022 2023 2022Diluted net loss per share$(4.30) $(0.34) $(5.64) $(1.02)Product rationalization, tax effected- 0.03 0.05 0.17 Arbitration settlement, tax effected- - 0.21 - Acquisition related intangible asset amortization, tax effected0.12 0.10 0.47 0.36 Impairment of intangible assets, tax effected4.23 - 4.11 - Discontinuation of software development project, tax effected- - 0.30 - Costs of shareholder activism, tax effected- - 0.20 - Adjusted diluted net income (loss) per share$0.05 $(0.21) $(0.30) $(0.49) Stock-based compensation, tax effected3,803 3,088 14,767 10,783 Stock-based compensation (EPS impact)$0.26 $0.21 $1.01 $0.74 Anika Therapeutics, Inc. and SubsidiariesRevenue by Product Family(in thousands, except percentages)(unaudited) For the Three Months Ended December 31, For the Twelve Months Ended December 31, 2023 2022 $ change % change 2023 2022 $ change % changeOA Pain Management$25,072 $22,451 $2,621 12% $101,927 $91,984 $9,943 11%Joint Preservation and Restoration15,296 14,347 949 7% 54,879 50,402 4,477 9%Non-Orthopedic2,603 2,824 (221) -8% 9,856 13,850 (3,994) -29%Revenue$42,971 $39,622 $3,349 8% $166,662 $156,236 $10,426 7% What was Anika Therapeutics, Inc.'s revenue in the fourth quarter of 2023? Anika Therapeutics, Inc. reported revenue of $43.0 million in the fourth quarter of 2023, up 8% compared to the same period in 2022. What was the annual revenue for OA Pain Management in 2023? OA Pain Management achieved record annual revenues of $102 million in 2023, marking an 11% increase from the previous year. What is Anika's projected adjusted EBITDA for 2024? Anika is positioned to generate adjusted EBITDA of $25 to $30 million in 2024, representing a substantial increase over the previous year. What cost reduction initiatives did Anika announce? Anika announced cost reduction initiatives that are expected to provide annualized savings of approximately $10 million. Who is the President and CEO of Anika Therapeutics, Inc.? Cheryl R. Blanchard, Ph.D., serves as the President and CEO of Anika Therapeutics, Inc."
"Fossil Group, Inc. Reports Fourth Quarter and Fiscal Year 2023 Results",2024-03-13T20:06:00.000Z,Neutral,Negative,"Fossil Group, Inc. announces financial results for Q4 and FY 2023, reporting a decrease in net sales, operating loss, and adjusted loss per share. The company also outlines strategic plans to maximize shareholder value and provides a full-year outlook for 2024.","Fossil Group, Inc. Reports Fourth Quarter and Fiscal Year 2023 Results Rhea-AI Impact (Neutral) Rhea-AI Sentiment (Negative) Tags earnings Rhea-AI Summary Fossil Group, Inc. announces financial results for Q4 and FY 2023, reporting a decrease in net sales, operating loss, and adjusted loss per share. The company also outlines strategic plans to maximize shareholder value and provides a full-year outlook for 2024. Positive Fossil Group, Inc. reported a decrease in worldwide net sales for the fourth quarter and full year of 2023, with net sales down 16% on both a reported and constant currency basis. Operating loss for the full year was $143 million compared to an operating loss of $1 million in the previous year. Adjusted operating loss for the full year was $92 million, or 6.5% of net sales, compared to adjusted operating income of $7 million in the prior year. Full year diluted loss per share was $3.00 and adjusted loss per share was $2.24, as compared to diluted loss per share of $0.85 and adjusted loss per share of $0.71 in the previous year. Cash and cash equivalents as of December 30, 2023, were $117 million. The company announced a strategic review of its current business model and capital structure, aiming to maximize shareholder value. Fossil Group expects 2024 worldwide net sales to be approximately $1.2 billion, with an adjusted operating margin expected to be in the range of -3% to -5%. Negative Net sales declined across all regions and channels for both the fourth quarter and full year of 2023. Operating expenses as a percentage of net sales increased for the fourth quarter and full year of 2023 compared to the previous year. The company reported an operating loss for the full year of 2023, a significant decline from the previous year. Financial Analyst The recent financial results from Fossil Group, Inc. indicate a significant downturn in performance, with a 16% decline in net sales and a substantial increase in operating loss from $1 million to $143 million year-over-year. Such a decline in revenue and profitability can be attributed to multiple factors, including weakness in the wholesale channel, the strategic exit from the smartwatch category and store closures. These results are likely to influence investor sentiment and could impact stock price volatility in the short term.However, it's important to consider the company's liquidity position and cost-saving measures under the TAG Plan, which have resulted in $125 million of annualized cost savings. The anticipated additional operating income benefits of $100 million in 2024 and the expected positive free cash flow, bolstered by a significant tax refund, may provide some optimism for long-term recovery. The strategic review to optimize operations and strengthen the balance sheet, including potential asset monetization, could also reshape investor perspectives on the company's future viability. Market Research Analyst The retail landscape has been challenging for traditional watchmakers like Fossil, with the exit from the smartwatch category highlighting a strategic shift away from tech-integrated products. This decision reflects the intense competition from tech giants and a need to focus on core competencies. The reported sales declines across all regions and channels suggest a broader market trend of softening consumer demand, potentially exacerbated by the global economic climate.Moreover, the company's store rationalization initiatives are a response to the evolving retail environment where e-commerce continues to gain ground. The shift in strategy towards a more streamlined operation could potentially improve operating efficiency in the long run but may continue to impact sales negatively in the short term. It will be crucial to monitor consumer responses to these strategic shifts and the company's ability to adapt to market trends. Economist Fossil Group's financial results must be contextualized within the broader economic environment, which has been characterized by inflationary pressures and shifting consumer spending patterns. The increased interest expense is indicative of the rising cost of borrowing amid higher interest rates, which can strain companies with significant debt loads. The company's strategic review and potential restructuring suggest a proactive approach to navigating these economic headwinds.From a macroeconomic perspective, the retail sector's performance is often seen as a bellwether for consumer confidence and discretionary spending. Fossil's downturn may signal broader concerns about the health of the global economy. As such, stakeholders should be mindful of economic indicators and policy decisions that could further influence the operating context for Fossil and the retail industry at large. 03/13/2024 - 04:06 PM Worldwide Net Revenue and Adjusted Operating Margin in Line with GuidanceAnnounces Strategic Review to Maximize Shareholder ValueCompany Provides Full Year 2024 Outlook RICHARDSON, Texas, March 13, 2024 (GLOBE NEWSWIRE) -- Fossil Group, Inc. (NASDAQ: FOSL) today announced financial results for the fourth quarter and fiscal year ended December 30, 2023. Separately, the Company also announced today that Kosta N. Kartsotis has stepped down as Chief Executive Officer and Jeffrey N. Boyer, Chief Operating Officer, has been appointed Interim CEO, effective immediately. During 2023, we made solid progress under our Transform and Grow (TAG) Plan, enabling us to exit the smartwatch category, close underperforming retail stores, manage down inventories, and capture $125 million of annualized cost savings,  said Jeffrey Boyer, Interim Chief Executive Officer. We entered 2024 with a leaner cost structure, healthier inventory levels and sufficient liquidity. Importantly, we remain on track with our TAG Plan and expect to achieve our previously announced target of $300 million of annualized operating income benefits by the end of 2025. Additionally, we are taking deliberate actions to improve our financial performance, strengthen our balance sheet, and conduct a strategic review of our current business model and capital structure with the goal of maximizing shareholder value. Fourth Quarter and Full Year Summary Fourth quarter worldwide net sales decreased to $421 million, down 16% on a reported basis and 17% in constant currency, with sales declines across all regions and all channels.Full year worldwide net sales decreased to $1,412 million, down 16% on both a reported and constant currency basis, with sales declines across all regions and all channels.Full year operating loss was $143 million compared to operating loss of $1 million a year ago. Adjusted operating loss was $92 million, or 6.5% of net sales, compared to adjusted operating income of $7 million, or 0.4% of net sales, last year.Full year diluted loss per share was $3.00 and adjusted loss per share was $2.24, as compared to diluted loss per share of $0.85 and adjusted loss per share of $0.71 in the prior year.As of December 30, 2023, cash and cash equivalents of $117 million. Fourth Quarter 2023 Operating Results Amounts referred to as adjusted as well as constant currency are non-GAAP financial measures. Reconciliations of these non-GAAP financial measures to their closest reported GAAP measures are included at the end of this press release. Net sales totaled $421.3 million, a decrease of 15.6% on a reported basis and 16.9% in constant currency compared to $499.1 million in the fourth quarter of fiscal 2022. The sales decrease was largely driven by weakness in the wholesale channel, store rationalization initiatives and lower smartwatch sales, as we exit the category. Net sales, in constant currency, decreased 22% in Europe, 16% in Asia and 12% in the Americas versus the same quarter last year. Wholesale sales declined 19%, while our direct to consumer sales declined 14% on a constant currency basis. Within our direct to consumer channels, comparable retail sales declined 10%. In our major product categories, traditional watch sales declined 10% in constant currency in the fourth quarter with slight growth in the FOSSIL brand more than offset by declines in most other brands. The leathers category decreased 23% and jewelry sales declined 18% in constant currency during the fourth quarter. From a brand lens, net sales for the majority of the brands in our portfolio decreased in the fourth quarter of 2023. Gross profit totaled $200.5 million compared to $235.4 million in the fourth quarter of 2022. Gross margin increased 40 basis points to 47.6% versus 47.2% a year ago. The year-over-year increase in gross margin primarily reflects reduced freight and inventory costs. These improvements were partially offset by unfavorable product mix, driven by our exit from the smartwatch category, and minimum licensor product royalties.Operating expenses totaled $224.5 million compared to $234.1 million in the fourth quarter of 2022. As a percentage of net sales, operating expenses were 53.3% in the fourth quarter of 2023 compared to 46.9% in the prior year fourth quarter. Selling, general and administrative (SG&A) expenses, which exclude restructuring and impairment, were $207.7 million compared to $232.2 million in the fourth quarter of 2022, a reduction of 10.6%. The year-over-year decline in SG&A was largely driven by lower compensation costs related to initiatives in our TAG Plan. As a percentage of net sales, SG&A expenses were 49.3% in the fourth quarter of 2023 compared to 46.5% in the prior year fourth quarter, largely driven by deleveraging on lower sales.Operating loss was $24.0 million compared to income of $1.3 million in the fourth quarter of 2022. Operating margin was (5.7)% in the fourth quarter of 2023 compared to 0.3% in the prior year fourth quarter. Adjusted operating loss totaled $8.5 million compared to adjusted operating income of $3.2 million in the fourth quarter of 2022. Adjusted operating margin was (2.0)% in the fourth quarter of 2023 compared to 0.6% in the prior year fourth quarter.Interest expense was $5.7 million compared to $5.8 million in the fourth quarter of 2022.Other income (expense) was income of $1.9 million compared to $0.5 million in the fourth quarter of 2022.Income (loss) before income taxes was $(27.8) million compared to $(4.0) million in the fourth quarter of 2022.Adjusted EBITDA was $(1.6) million, or (0.4)% of net sales in the fourth quarter of 2023 compared to $12.1 million, or 2.4% of net sales in the prior year period.Net loss totaled $28.2 million with loss per diluted share of $0.54, which compares to a net loss of $9.4 million and loss per diluted share of $0.18 in the prior year period. Adjusted net loss for the quarter was $16.0 million with adjusted loss per diluted share of $0.30 compared to adjusted net loss of $7.0 million with adjusted loss per diluted share of $0.14 in the prior year period. During the fourth quarter of 2023, currencies favorably affected loss per diluted share by approximately $0.01.Cash flow from operating activities was $49 million in the fourth quarter of 2023 compared to $104 million in the fourth quarter of 2022. Full Year 2023 Operating Results Net sales totaled $1.4 billion, a decrease of 16.0% on a reported basis and 15.9% in constant currency compared to $1.7 billion in fiscal year 2022. The sales decrease was largely driven by weakness in the wholesale channel. Declines in smartwatch sales and our store rationalization initiatives comprised approximately 5 points of our annual sales decline. Net sales, in constant currency, decreased in all regions with Europe decreasing 21%, Americas 14% and Asia 10% versus the prior year. Global sales into wholesale channels declined 21% in constant currency, while sales into our direct to consumer channels decreased 7%. Within our direct to consumer channels, comparable retail sales decreased 2%. In our major product categories, traditional watch sales decreased 12% in constant currency with flat year over year growth in FOSSIL brand offset by declines from other major brands. Net sales in leathers and jewelry decreased 11% and 15%, respectively, in constant currency. From a brand perspective, MICHAEL KORS, FOSSIL and EMPORIO ARMANI sales declined. Gross profit totaled $679.6 million compared to $830.7 million in fiscal year 2022. Gross margin decreased 130 basis points to 48.1% versus 49.4% a year ago. The gross margin decrease primarily reflects increased promotions and licensor minimum royalty costs and unfavorable currency and product mix impact, driven by our exit from the smartwatch category. These costs were partially offset by reduced freight expense.Operating expenses totaled $822.6 million compared to $832.2 million in 2022. As a percentage of net sales, operating expenses were 58.2% compared to 49.5% in fiscal year 2022. SG&A expenses, which exclude restructuring and impairment, were $777.2 million compared to $823.7 million in fiscal year 2022, a reduction of 5.6% driven by lower operating costs, primarily from initiatives in our TAG Plan. As a percentage of net sales, SG&A expenses were 55.0% compared to 49.0% in fiscal year 2022, mainly driven by deleveraging on lower sales.Operating income (loss) was a loss of $143.0 million compared to a loss of $1.5 million in fiscal year 2022. Operating margin was (10.1)% for fiscal year 2023 compared to (0.1)% in the prior year. Adjusted operating loss totaled $(92.0) million compared to income of $7.0 million in fiscal year 2022. Adjusted operating margin was (6.5)% for fiscal year 2023 compared to 0.4% in the prior year. Interest expense increased to $21.8 million compared to $19.2 million in fiscal year 2022, primarily driven by higher interest rates. Other income (expense) was income of $8.7 million, compared to expense of $1.4 million in fiscal year 2022. Income (loss) before income taxes was a loss of $156.1 million compared to loss of $22.1 million in the prior year.Adjusted EBITDA was $(62.6) million, or (4.4)% of net sales in fiscal year 2023 and $36.1 million, or 2.1% of net sales in the prior year.Net loss totaled $157.0 million with loss per diluted share of $3.00, which compares to net loss of $44.2 million and loss per diluted share of $0.85 in the prior year period. Adjusted net loss was $116.9 million with adjusted loss per diluted share of $2.24 compared to adjusted net loss of $36.6 million with adjusted loss per diluted share of $0.71 in the prior year period. During the fiscal year 2023, currencies unfavorably affected loss per diluted share by approximately $0.10.Cash used in operations was $59 million compared to $111 million used in the prior year. Balance Sheet Summary As of December 30, 2023, the Company had total liquidity of $181 million, including $117.2 million of cash and cash equivalents and $64.0 million of availability under its revolving credit facility. Inventories at year-end totaled $252.8 million, a decrease of 32.8% versus a year ago. Total debt as of December 30, 2023 was $207.5 million. TAG Plan Update The Company remains on track with its TAG Plan, which was announced in March 2023 and is designed to reduce operating expenses, improve operating margins and advance the Companys commitment to profitable growth. The TAG Plan generated annualized operating income benefits of approximately $125 million in 2023 and is expected to generate additional annualized operating income benefits of at least $100 million in 2024. Restructuring costs associated with our TAG Plan are estimated to be $35 million in fiscal year 2024 compared to $49 million in fiscal year 2023. Strategic Business Review The Company today announced a strategic review of its current business model and capital structure. This includes efforts to optimize its business model through additional changes to its operations, as well as further structural cost reductions, which are under consideration. The Company anticipates this effort will expand on its current TAG Plan and could include additional debt and equity financing options, including monetization of various assets to strengthen its balance sheet. The Company has retained Evercore to act as its financial advisor. Outlook The Company expects 2024 worldwide net sales to be approximately $1.2 billion, reflecting approximately $100 million of negative impact related to the exit of its smartwatch business, the closure of stores and prevailing currency rates, as well as expected category, consumer and channel softness. Fiscal year adjusted operating margin is expected to be in the range of -3% to -5%. The Company expects to generate positive free cash flow, inclusive of an anticipated tax refund of approximately $56 million, which is expected to be received in the second quarter of 2024. Safe Harbor Certain statements contained herein that are not historical facts, constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and involve a number of risks and uncertainties. The actual results of the future events described in such forward-looking statements could differ materially from those stated in such forward-looking statements. Among the factors that could cause actual results to differ materially are: risks related to the success of the TAG Plan; a failure to meet the continued listing requirements of Nasdaq; the impact of activist shareholders; a downgrade in our debt ratings; our level of indebtedness; our ability to achieve consistent profitability or positive cash flow; increased political uncertainty, the effect of worldwide economic conditions; the effect of a pandemic; significant changes in consumer spending patterns or preferences; interruptions or delays in the supply of key components or products; acts of war or acts of terrorism; loss of key facilities; data breach or information systems disruptions; changes in foreign currency valuations in relation to the U.S. dollar; lower levels of consumer spending resulting from a general economic downturn or generally reduced shopping activity caused by public safety or consumer confidence concerns; the performance of our products within the prevailing retail environment; customer acceptance of both new designs and newly-introduced product lines; changes in the mix of product sales; the effects of vigorous competition in the markets in which we operate; compliance with debt covenants and other contractual provisions and meeting debt service obligation; risks related to the success of our business strategy; the termination or non-renewal of material licenses; risks related to foreign operations and manufacturing; changes in the costs of materials and labor; government regulation and tariffs; our ability to secure and protect trademarks and other intellectual property rights; levels of traffic to and management of our retail stores; loss of key personnel and the outcome of current and possible future litigation, as well as the risks and uncertainties set forth in the Companys most recent Annual Report on Form 10-K filed with the Securities and Exchange Commission (the SEC). These forward-looking statements are based on our current expectations and beliefs concerning future developments and their potential effect on us. While management believes that these forward-looking statements are reasonable as and when made, there can be no assurance that future developments affecting us will be those that we anticipate. Readers of this release should consider these factors in evaluating, and are cautioned not to place undue reliance on, the forward-looking statements contained herein. The Company assumes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise, except as required by law. About Fossil Group, Inc. Fossil Group, Inc. is a global design, marketing, distribution and innovation company specializing in lifestyle accessories. Under a diverse portfolio of owned and licensed brands, our offerings include watches, jewelry, handbags, small leather goods, belts and sunglasses. We are committed to delivering the best in design and innovation across our owned brands, Fossil, Michele, Relic, Skagen and Zodiac, and licensed brands, Armani Exchange, Diesel, DKNY, Emporio Armani, kate spade new york, Michael Kors, and Tory Burch. We bring each brand story to life through an extensive distribution network across numerous geographies, categories and channels. Certain press release and SEC filing information concerning the Company is also available at www.fossilgroup.com. Investor Relations:Christine Greany The Blueshirt Group christine@blueshirtgroup.com Additional Information and Where to Find It The Company intends to file with the SEC a proxy statement on Schedule 14A, containing a form of WHITE proxy card, with respect to its solicitation of proxies for the 2024 Annual Meeting of Stockholders (the Proxy Statement). INVESTORS AND SECURITY HOLDERS ARE URGED TO READ THE PROXY STATEMENT (INCLUDING ANY AMENDMENTS OR SUPPLEMENTS THERETO) FILED BY THE COMPANY AND ANY OTHER RELEVANT DOCUMENTS FILED WITH THE SEC WHEN THEY BECOME AVAILABLE CAREFULLY AND IN THEIR ENTIRETY BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION ABOUT ANY SOLICITATION. Investors and security holders may obtain copies of these documents and other documents filed with the SEC by the Company free of charge through the website maintained by the SEC at www.sec.gov. Copies of the documents filed by the Company are also available free of charge by accessing the Companys website at https://www.fossilgroup.com/investors/. Participants Fossil, its directors and executive officers and other members of management and employees will be participants in the solicitation of proxies with respect to a solicitation by Fossil. Information about Fossils executive officers and directors and a description of their direct and indirect interests, by security holdings or otherwise, will be included in the Proxy Statement and other relevant materials that may be filed with the SEC by Fossil. Information regarding Fossils directors and executive officers is available at Proposal 1: Election of Directors, Executive Officers and Security Ownership of Certain Beneficial Owners and Management in its definitive proxy statement for the 2023 Annual Meeting of Stockholders, which was filed with the SEC on April 12, 2023, and in its Current Reports on Form 8-K filed with the SEC on June 28, 2023 and August 9, 2023. To the extent holdings by our directors and executive officers of Fossil securities reported in the proxy statement for the 2023 Annual Meeting or in such Form 8-Ks have changed, such changes have been or will be reflected on Statements of Change in Ownership on Forms 3, 4 or 5 filed with the SEC. These documents are or will be available free of charge at the SECs website at www.sec.gov. Consolidated Income Statement DataFor the 13Weeks Ended For the 13Weeks Ended For the 52Weeks Ended For the 52Weeks Ended($ in millions, except per share data):December 30, 2023 December 31, 2022 December 30, 2023 December 31, 2022Net sales$421.3 $499.1 $1,412.4 $1,682.4 Cost of sales 220.8 263.7 732.8 851.7 Gross profit 200.5 235.4 679.6 830.7 Gross margin (% of net sales) 47.6% 47.2% 48.1% 49.4%Operating expenses: Selling, general and administrative expenses 207.7 232.2 777.2 823.7 Other long-lived asset impairments 1.3 1.2 2.1 2.4 Restructuring charges 15.5 0.7 43.3 6.1 Total operating expenses$224.5 $234.1 $822.6 $832.2 Total operating expenses (% of net sales) 53.3% 46.9% 58.2% 49.5%Operating income (loss) (24.0) 1.3 (143.0) (1.5)Operating margin (% of net sales) (5.7)% 0.3% (10.1)% (0.1)%Interest expense 5.7 5.8 21.8 19.2 Other income (expense) - net 1.9 0.5 8.7 (1.4)Income (loss) before income taxes (27.8) (4.0) (156.1) (22.1)Provision for income taxes 0.6 5.5 0.5 21.4 Less: Net income attributable to noncontrolling interest (0.2) (0.1) 0.4 0.7 Net income attributable to Fossil Group, Inc.$(28.2) $(9.4) $(157.0) $(44.2)Earnings per share: Basic$(0.54) $(0.18) $(3.00) $(0.85)Diluted$(0.54) $(0.18) $(3.00) $(0.85)Weighted average common shares outstanding: Basic 52.5 51.8 52.3 51.8 Diluted 52.5 51.8 52.3 51.8 Consolidated Balance Sheet Data ($ in millions):December 30, 2023 December 31, 2022Assets: Cash and cash equivalents$117.2 $198.7Accounts receivable - net 187.9 206.1Inventories 252.8 376.0Other current assets 152.8 164.5Total current assets 710.7 945.3Property, plant and equipment - net 57.2 79.9Operating lease right-of-use assets 151.0 156.9Intangible and other assets - net 59.1 56.0Total long-term assets 267.3 292.8Total assets$978.0 $1,238.1 Liabilities and stockholders equity: Accounts payable, accrued expenses and other current liabilities$342.0 $425.6Short-term debt 0.5 0.3Total current liabilities 342.5 425.9Long-term debt 207.0 216.1Long-term operating lease liabilities 137.6 150.2Other long-term liabilities 39.2 42.9Total long-term liabilities 383.8 409.2Stockholders equity 251.7 403.0Total liabilities and stockholders equity$978.0 $1,238.1 Constant Currency Financial Information The following tables present our business segment and product net sales on a constant currency basis, which are non-GAAP financial measures. To calculate net sales on a constant currency basis, net sales for the current fiscal year period for entities reporting in currencies other than the U.S. dollar are translated into U.S. dollars at the average rates during the comparable period of the prior fiscal year. The Company presents constant currency information to provide investors with a basis to evaluate how its underlying business performed excluding the effects of foreign currency exchange rate fluctuations. The constant currency financial information presented herein should not be considered a substitute for, or superior to, the measures of financial performance prepared in accordance with GAAP. Net Sales Net SalesFor the 13 Weeks Ended For the 52 Weeks EndedDecember 30, 2023 December 31, 2022 December 30, 2023 December 31, 2022($ in millions)As Reported Impact of Foreign Currency Exchange Rates Constant Currency As Reported As Reported Impact of Foreign Currency Exchange Rates Constant Currency As ReportedSegment: Americas$203.7 $(1.4) $202.3 $229.5 $640.8 $(2.3) $638.5 $744.0Europe 135.7 $(6.2) 129.5 165.2 437.4 (8.8) 428.6 541.3Asia 80.9 $1.1 82.0 98.0 328.2 13.2 341.4 377.6Corporate 1.0 $ 1.0 6.4 6.0  6.0 19.5Total net sales$421.3 $(6.5) $414.8 $499.1 $1,412.4 $2.1 $1,414.5 $1,682.4 Product Categories: Watches: Traditional watches$300.9 $(4.5) $296.4 $328.6 $1,015.1 $1.9 $1,017.0 $1,158.9Smartwatches$21.5 (0.5) 21.0 46.9 80.9 0.2 81.1 151.6Total Watches$322.4 $(5.0) $317.4 $375.5 $1,096.0 $2.1 $1,098.1 $1,310.5Leathers$51.8 (0.2) 51.6 67.3 158.5 0.9 159.4 178.5Jewelry$40.4 (1.2) 39.2 47.6 131.4 (1.0) 130.4 154.1Other$6.7 (0.1) 6.6 8.7 26.5 0.1 26.6 39.3Total net sales$421.3 $(6.5) $414.8 $499.1 $1,412.4 $2.1 $1,414.5 $1,682.4 ` Adjusted EBITDA, Adjusted operating income (loss), Adjusted net income (loss) and Adjusted earnings (loss) per share Adjusted EBITDA, Adjusted operating income (loss), Adjusted net income (loss) and Adjusted earnings (loss) per share are non-GAAP financial measures. We define Adjusted EBITDA as our net income (loss) before the impact of income tax expense (benefit), plus interest expense, amortization and depreciation, impairment expense, other non-cash charges, stock-based compensation expense, restructuring expense and unamortized debt issuance costs included in loss on extinguishment of debt minus interest income. We define Adjusted operating income (loss) as operating income (loss) before impairment expense and restructuring expense. We define Adjusted net income (loss) and Adjusted earnings (loss) per share as net income (loss) attributable to Fossil Group, Inc. and diluted earnings (loss) per share, respectively, before impairment expense, restructuring expense and unamortized debt issuance costs included in loss on extinguishment of debt. We have included Adjusted EBITDA, Adjusted operating income (loss), Adjusted net income (loss) and Adjusted earnings (loss) per share herein because they are widely used by investors for valuation and for comparing our financial performance with the performance of our competitors. We also use both non-GAAP financial measures to monitor and compare the financial performance of our operations. Our presentation of Adjusted EBITDA, Adjusted operating income (loss), Adjusted net income (loss) and Adjusted earnings (loss) per share may not be comparable to similarly titled measures other companies report. Adjusted EBITDA, Adjusted operating income (loss), Adjusted net income (loss) and Adjusted earnings (loss) per share are not intended to be used as alternatives to any measure of our performance in accordance with GAAP. The following tables reconcile Adjusted EBITDA to the most directly comparable GAAP financial measure, which is income (loss) before income taxes. Certain line items presented in the table below, when aggregated, may not foot due to rounding. Fiscal 2023 ($ in millions):Q1 Q2 Q3 Q4 TotalIncome (loss) before income taxes$(39.6) $(33.5) $(55.2) $(27.8) $(156.1)Plus: Interest expense 5.0 5.3 5.8 5.7 21.8 Amortization and depreciation 5.1 4.8 4.5 4.6 19.1 Impairment expense 0.1 0.2 0.6 1.3 2.2 Other non-cash charges (0.2) (0.5) (0.2) 0.1 (0.9)Stock-based compensation 1.4 1.6 1.5 1.1 5.7 Restructuring expense 7.1 4.6 16.0 15.5 43.3 Restructuring cost of sales 5.3 2.9 (1.3) (1.3) 5.5 Less: Interest Income 0.6 0.8 1.0 0.9 3.2 Adjusted EBITDA$(16.4) $(15.4) $(29.3) $(1.6) $(62.6) Fiscal 2022 ($ in millions):Q1 Q2 Q3(1) Q4 TotalIncome (loss) before income taxes$(16.7) $(16.9) $15.5 $(4.0) $(22.1)Plus: Interest expense 4.0 4.3 5.1 5.8 19.2 Amortization and depreciation 6.2 5.8 5.6 5.7 23.3 Impairment expense 0.3 0.2 0.6 1.2 2.4 Other non-cash charges (0.2) (0.2) (0.4) (0.3) (1.1)Stock-based compensation 2.2 3.8 (0.3) 2.3 8.0 Restructuring expense 2.6 2.9  0.7 6.1 Unamortized debt issuance costs included in loss on extinguishment of debt    1.1 1.1 Less: Interest Income 0.1 0.2 0.1 0.4 0.8 Adjusted EBITDA$(1.7) $(0.3) $26.0 $12.1 $36.1 (1) Prior period amounts have been adjusted to conform to the current period presentation. The following tables reconcile Adjusted operating income (loss), Adjusted net income (loss) and Adjusted earnings (loss) per share to the most directly comparable GAAP financial measures, which are operating income (loss), net income (loss) attributable to Fossil Group, Inc. and diluted earnings (loss) per share, respectively. Certain line items presented in the table below, when aggregated, may not foot due to rounding. For the 13 Weeks Ended December 30, 2023($ in millions, except per share data):As ReportedRestructuring cost of salesOther long-lived asset impairmentRestructuring expensesAs AdjustedOperating income (loss)$(24.0)$(1.3)$1.3$15.5$(8.5)Operating margin (% of net sales) (5.7)% (2.0)%Interest expense 5.7    5.7 Other income (expense) - net 1.9    1.9 Income (loss) before income taxes (27.8) (1.3) 1.3 15.5 (12.3)Provision for income taxes 0.6 (0.3) 0.3 3.3 3.9 Less: Net income attributable to noncontrolling interest 0.2    0.2 Net income (loss) attributable to Fossil Group, Inc.$(28.2)$(1.0)$1.0$12.2$(16.0)Diluted earnings (loss) per share$(0.54)$(0.02)$0.02$0.23$(0.30) For the 13 Weeks Ended December 31, 2022($ in millions, except per share data):As ReportedOther long-lived asset impairmentRestructuring expensesUnamortized debt issuance costs included in loss on extinguishment of debtAs AdjustedOperating income (loss)$1.3 $1.2$0.7$$3.2 Operating margin (% of net sales) 0.3% 0.6%Interest expense 5.8    5.8 Other income (expense) - net 0.5   1.1 1.6 Income (loss) before income taxes (4.0) 1.2 0.7 1.1 (1.0)Provision for income taxes 5.5 0.3 0.1 0.2 6.1 Less: Net income attributable to noncontrolling interest 0.1    0.1 Net income (loss) attributable to Fossil Group, Inc.$(9.4)$0.9$0.6$0.9$(7.0)Diluted earnings (loss) per share$(0.18)$0.02$0.01$0.01$(0.13) For the 52 Weeks Ended December 30, 2023($ in millions, except per share data):As ReportedRestructuring cost of salesOther long-lived asset impairmentRestructuring expensesAs AdjustedOperating income (loss)$(143.0)$5.5$2.2$43.3$(92.0)Operating margin (% of net sales) (10.1)% (6.5)%Interest expense 21.8    21.8 Other income (expense) - net 8.7    8.7 Income (loss) before income taxes (156.1) 5.5 2.2 43.3 (105.1)Provision for income taxes 0.5 1.2 0.5 9.1 11.3 Less: Net income attributable to noncontrolling interest (0.4)    (0.4)Net income (loss) attributable to Fossil Group, Inc.$(157.1)$4.3$1.7$34.2$(116.9)Diluted earnings (loss) per share$(3.00)$0.08$0.03$0.65$(2.24) For the 52 Weeks Ended December 31, 2022($ in millions, except per share data):As ReportedOther long-lived asset impairmentRestructuring expensesUnamortized debt issuance costs included in loss on extinguishment of debtAs AdjustedOperating income (loss)$(1.5)$2.4$6.1$$7.0 Operating margin (% of net sales) (0.1)% 0.4%Interest expense 19.2    19.2 Other income (expense) - net (1.4)   1.1 (0.3)Income (loss) before income taxes (22.1) 2.4 6.1 1.1 (12.5)Provision for income taxes 21.4 0.5 1.3 0.2 23.4 Less: Net income attributable to noncontrolling interest (0.6)    (0.6)Net income (loss) attributable to Fossil Group, Inc.$(44.2)$1.9$4.8$0.9$(36.6)Diluted earnings (loss) per share$(0.85)$0.04$0.09$0.01$(0.71) Store Count Information December 31, 2022 Opened Closed December 30, 2023Americas151 2 10 143Europe111 2 27 86Asia80 1 8 73Total stores342 5 45 302 What was the reported decrease in net sales for Fossil Group, Inc. in Q4 2023? In Q4 2023, Fossil Group reported a decrease of 16% in worldwide net sales on a reported basis. Who has been appointed Interim CEO of Fossil Group, Inc.? Jeffrey N. Boyer, Chief Operating Officer, has been appointed Interim CEO of Fossil Group, Inc. What was the full year adjusted loss per share for Fossil Group, Inc. in 2023? The full year adjusted loss per share for Fossil Group, Inc. in 2023 was $2.24. What is the expected range for the adjusted operating margin of Fossil Group, Inc. in 2024? The expected range for the adjusted operating margin of Fossil Group, Inc. in 2024 is -3% to -5%."
Ingredion Incorporated Declares Quarterly Dividend of $0.78 Per Share,2024-03-13T20:05:00.000Z,Low,Neutral,"Ingredion Incorporated (NYSE: INGR) declares a quarterly dividend of $0.78 per share on its common stock, payable on April 23, 2024. The dividend is for stockholders of record on April 1, 2024.","Ingredion Incorporated Declares Quarterly Dividend of $0.78 Per Share Rhea-AI Impact (Low) Rhea-AI Sentiment (Neutral) Tags dividends Rhea-AI Summary Ingredion Incorporated (NYSE: INGR) declares a quarterly dividend of $0.78 per share on its common stock, payable on April 23, 2024. The dividend is for stockholders of record on April 1, 2024. Positive None. Negative None. 03/13/2024 - 04:05 PM WESTCHESTER, Ill., March 13, 2024 (GLOBE NEWSWIRE) -- Today, the board of directors of Ingredion Incorporated (NYSE: INGR) declared a quarterly dividend of $0.78 per share on the Companys common stock. The dividend is payable on April 23, 2024, to stockholders of record at the close of business on April 1, 2024. About the CompanyIngredion Incorporated (NYSE: INGR), headquartered in the suburbs of Chicago, is a leading global ingredient solutions provider serving customers in nearly 120 countries. With 2023 annual net sales of approximately $8 billion, the Company turns grains, fruits, vegetables, and other plant-based materials into value-added ingredient solutions for the food, beverage, animal nutrition, brewing and industrial markets. With Ingredion Idea Labs innovation centers located around the world and more than 12,000 employees, the Company co-creates with customers and fulfills its purpose of bringing the potential of people, nature, and technology together to make life better. Visit ingredion.com for more information and the latest Company news. CONTACT: Investors: Noah Weiss, 773-896-5242 Media: Becca Hary, 708-551-2602 What dividend did Ingredion Incorporated (NYSE: INGR) declare? Ingredion Incorporated declared a quarterly dividend of $0.78 per share on its common stock. When is the dividend payable to stockholders? The dividend is payable on April 23, 2024. Who is eligible to receive the dividend? Stockholders of record at the close of business on April 1, 2024, are eligible to receive the dividend."
Spruce Biosciences Reports Full Year 2023 Financial Results and Provides Corporate Updates,2024-03-13T20:08:00.000Z,Neutral,Neutral,"Spruce Biosciences, Inc. (SPRB) reports financial results for 2023, highlighting positive data from CAHptain-205 study in pediatric classic CAH and challenges faced in CAHmelia-203 study for adult classic CAH. The company plans to meet regulatory authorities in 2025 for a registrational clinical program. Cost reductions extend cash runway through 2025.","Spruce Biosciences Reports Full Year 2023 Financial Results and Provides Corporate Updates Rhea-AI Impact (Neutral) Rhea-AI Sentiment (Neutral) Tags earnings Rhea-AI Summary Spruce Biosciences, Inc. (SPRB) reports financial results for 2023, highlighting positive data from CAHptain-205 study in pediatric classic CAH and challenges faced in CAHmelia-203 study for adult classic CAH. The company plans to meet regulatory authorities in 2025 for a registrational clinical program. Cost reductions extend cash runway through 2025. Positive Positive data from CAHptain-205 study in pediatric classic CAH Resource prioritization and cost reductions extend cash runway through 2025 Collaboration revenue of $10.1 million in 2023 Net loss of $47.9 million for 2023 Negative CAHmelia-203 study did not meet primary efficacy endpoint Low compliance with study medication and glucocorticoid in CAHmelia-203 study Increase in R&D expenses from $35.2 million in 2022 to $49.4 million in 2023 Financial Analyst The announcement from Spruce Biosciences regarding the CAHmelia-203 study's failure to meet its primary efficacy endpoint is a critical piece of information for investors. The study's inability to show a significant reduction in androstenedione (A4) levels could cast doubts on the future revenue potential of tildacerfont for treating adult classic Congenital Adrenal Hyperplasia (CAH). This setback may influence investor sentiment and could potentially lead to a reevaluation of the company's market valuation, especially considering the high R&D expenses reported for the year. However, the positive preliminary data from the pediatric CAHptain-205 study suggests a potential for recovery if further studies yield favorable results. The company's strategic decision to implement cost reduction measures, including a workforce reduction and termination of the CAHmelia-203 clinical trial, may improve financial stability in the short-term by extending the cash runway through the end of 2025. Medical Research Analyst The clinical implications of the CAHmelia-203 trial are significant for Spruce Biosciences. The failure to achieve the primary efficacy endpoint in a trial targeting severe hyperandrogenemia in adult patients with classic CAH is a setback for the company's drug development pipeline. However, the safety profile of tildacerfont remains a positive takeaway. The pediatric CAHptain-205 study showing a 73% efficacy endpoint achievement rate is promising and supports further investigation. The pharmacokinetic differences observed between children and adults could be pivotal in tailoring future dosing regimens. While these results do not guarantee regulatory approval, they do provide a basis for continued research and potential future trials. Market Research Analyst From a market perspective, the success of tildacerfont in pediatric patients could open a niche market segment for Spruce Biosciences, considering the unmet medical need in rare endocrine disorders like classic CAH. Pediatric indications often benefit from regulatory incentives such as extended market exclusivity, which could partially offset the impact of the adult trial's failure. The collaboration revenue from Kaken Pharmaceutical indicates a strategic move to penetrate the Japanese market, diversifying the company's revenue streams and potentially mitigating risks associated with reliance on a single product or market. The upcoming topline results from the CAHmelia-204 study and further dose-ranging data in the fourth quarter of 2024 will be pivotal in shaping the long-term commercial prospects of tildacerfont. 03/13/2024 - 04:08 PM CAHmelia-203 Study of Tildacerfont in Adult Classic Congenital Adrenal Hyperplasia (CAH) with Severe Hyperandrogenemia Did Not Meet Primary Efficacy Endpoint Positive Data from CAHptain-205 Study of Tildacerfont in Pediatric Classic CAH Supports Further Dose-Ranging Across Additional Dosing Cohorts Topline Results from CAHmelia-204 Study of Tildacerfont in Adult Classic CAH Evaluating Glucocorticoid (GC) Reduction Anticipated in Third Quarter of 2024 Resource Prioritization and Cost Reductions Extend Cash Runway Through End of 2025 Conference Call Today at 4:30 p.m. ET SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- Spruce Biosciences, Inc. (Nasdaq: SPRB), a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders with significant unmet medical need, today reported financial results for the year ended December 31, 2023 and provided corporate updates. We are grateful to all the patients, families, study team and investigators who supported the CAHmelia-203 clinical trial, said Javier Szwarcberg, M.D., M.P.H., Chief Executive Officer, Spruce Biosciences. CAHmelia-203 is the first study of its kind to address a difficult-to-treat CAH patient population with severe and more refractory hyperandrogenemia, which is often attributed to challenging real-life compliance with daily GCs. We garnered important data from this study which will inform ongoing development of tildacerfont in adult classic CAH. Dr. Szwarcberg added, Looking ahead to the third quarter of 2024, we are eager to report topline results from CAHmelia-204, which is focused on assessing GC reduction, a potentially registrational endpoint, in a different population of adult CAH patients with relatively controlled A4 levels and historically better adherence to GC therapy. Assuming positive results from CAHmelia-204 and CAHptain-205, we plan to meet with the U.S. Food and Drug Administration (FDA) and comparable foreign regulatory authorities in early 2025 to outline the design of a registrational clinical program in adult and pediatric classic CAH. Finally, we have made the difficult but necessary decision to streamline our operations and implement cost reduction measures, which has extended our cash runway through the end of 2025. I want to thank all of our employees, including those departing Spruce, for their dedication to advancing our mission of bringing forward novel therapies for CAH and other rare endocrine disorders. Recent Corporate Updates CAHmelia-203 Study of Tildacerfont in Adult Classic Congenital Adrenal Hyperplasia (CAH) with Severe Hyperandrogenemia Did Not Meet Primary Efficacy Endpoint. CAHmelia-203 enrolled 96 subjects with a mean baseline androstenedione (A4) level of 1,151 ng/dL, which is more than five times above the upper limit of normal (ULN). The clinical trial did not achieve the primary efficacy endpoint of the assessment of dose-response for the change in A4 from baseline to week 12. 200mg QD of tildacerfont demonstrated a placebo-adjusted reduction from baseline in A4 of -2.6% with a non-significant p-value at week 12. Compliance with study medication and glucocorticoid (GC) was low with only 50% of patients reporting 80% or greater compliance, resulting in lower-than-expected tildacerfont exposure. Tildacerfont was generally safe and well tolerated at all doses, with no treatment-related serious adverse events (SAEs). Most adverse events were reported as mild to moderate. Positive Data from CAHptain-205 Study of Tildacerfont in Pediatric Classic CAH Supports Further Dose-Ranging Across Additional Dosing Cohorts. CAHptain-205 enrolled 30 children between two and 17 years of age with a mean baseline GC dose of 14 mg/m2/day and mean baseline A4 level of 372 ng/dL. The study characterized the safety and pharmacokinetic profiles of tildacerfont, as well as changes in androgen levels over 12 weeks of treatment, and the ability to reduce daily GC dose upon A4 normalization. Tildacerfont was generally safe and well tolerated at all dose ranges with no treatment-related SAEs reported. Preliminary pharmacokinetic analysis suggests that tildacerfont is cleared more rapidly in children than in adult CAH patients. 73% of all patients (22 of 30 patients) met the efficacy endpoint of A4 or GC reduction from baseline at 12 weeks of treatment with tildacerfont. 70% of patients with elevated baseline A4 values (16 of 23 patients) demonstrated an A4 reduction at week 4. Anticipated Upcoming Milestones Topline results from the CAHmelia-204 clinical trial in adult classic CAH patients on supraphysiologic doses of glucocorticoids with normal or near normal levels of A4 in the third quarter of 2024 Topline results from additional dose-ranging in the Phase 2 CAHptain clinical trial in the fourth quarter of 2024 End of Phase 2 (EOP2) meeting with the U.S. FDA in the first quarter of 2025 Full Year 2023 Financial Results Cash and Cash Equivalents: Cash and cash equivalents as of December 31, 2023 were $96.3 million. The company currently has over $81 million in cash and cash equivalents. Resource prioritization and cost reductions, including termination of the CAHmelia-203 clinical trial and a reduction in force of approximately 21%, extend cash runway through the end of 2025, including beyond anticipated topline results from CAHmelia-204 and additional dose-ranging data from CAHptain-205. Collaboration Revenue: Collaboration revenue for the year ended December 31, 2023 was $10.1 million compared to nil in 2022, reflecting the partial recognition of the $15.0 million upfront payment received from Kaken Pharmaceutical (Kaken) in connection with the companys strategic collaboration with Kaken to develop and commercialize tildacerfont for the treatment of classic CAH in Japan. Research and Development (R&D) Expenses: R&D expenses for the year ended December 31, 2023 were $49.4 million compared to $35.2 million in 2022. The overall increase in R&D expenses was primarily related to progressing clinical development of tildacerfont in adult classic CAH, pediatric classic CAH and polycystic ovary syndrome (PCOS). General and Administrative (G&A) Expenses: G&A expenses for the year ended December 31, 2023 were $12.7 million compared to $12.1 million in 2022. Total Operating Expenses: Total operating expenses for the year ended December 31, 2023 were $62.1 million compared to $47.3 million in 2022. Non-cash stock-based compensation expense for the year ended December 31, 2023 was $4.6 million compared to $3.6 million in 2022. Net Loss: Net loss for the year ended December 31, 2023 was $47.9 million compared to $46.2 million in 2022. Conference Call Details Spruces management team and key study investigators will host a conference call today at 4:30 p.m. ET to discuss the topline results of the CAHmelia-203 and CAHptain-205 clinical studies. Analysts and investors can participate in the conference call by registering here or dialing (866) 777-2509. An archived copy of the call will be available on the events section of the companys investor relations website for approximately 90 days. About Spruce Biosciences Spruce Biosciences is a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders with significant unmet medical need. Spruce is initially developing its wholly-owned product candidate, tildacerfont, as the potential first non-steroidal, once-daily therapy for patients suffering from classic congenital adrenal hyperplasia (CAH) and other endocrine disorders. To learn more, visit www.sprucebio.com and follow us on X, LinkedIn, Facebook, and YouTube. Forward-Looking Statements Statements contained in this press release regarding matters that are not historical facts are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements include statements regarding, among other things, the design, results, conduct, progress and timing of Spruces clinical trials; tildacerfonts potential to be a novel treatment option that improves long-term health outcomes for patients with CAH; Spruces expectations regarding reporting results of its clinical trials in 2024; Spruces plans to meet with the FDA and comparable foreign regulatory authorities to discuss the potential registrational path forward of tildacerfont for adult and pediatric classic CAH; the impact of cost savings initiatives and the length of Spruces anticipated cash runway; and Spruces product candidate, strategy and regulatory matters. Because such statements are subject to risks and uncertainties, actual results may differ materially from those expressed or implied by such forward-looking statements. Words such as anticipate, will, potential, plan and similar expressions are intended to identify forward-looking statements. These forward-looking statements are based upon Spruces current expectations and involve assumptions that may never materialize or may prove to be incorrect. Actual results could differ materially from those anticipated in such forward-looking statements as a result of various risks and uncertainties, which include, without limitation, risks and uncertainties associated with Spruces business in general, the impact of geopolitical and macroeconomic events, and the other risks described in Spruces filings with the U.S. Securities and Exchange Commission. All forward-looking statements contained in this press release speak only as of the date on which they were made and are based on managements assumptions and estimates as of such date. Spruce undertakes no obligation to update such statements to reflect events that occur or circumstances that exist after the date on which they were made, except as required by law. SPRUCE BIOSCIENCES, INC. BALANCE SHEETS (in thousands, except share and per share amounts) December 31, 2023 2022 ASSETS Current assets: Cash and cash equivalents $ 96,339 $ 24,487 Short-term investments  54,590 Prepaid expenses 3,876 3,320 Other current assets 1,968 1,211 Total current assets 102,183 83,608 Right-of-use assets 1,181 1,400 Other assets 582 640 Total assets $ 103,946 $ 85,648 LIABILITIES AND STOCKHOLDERS EQUITY Current liabilities: Accounts payable $ 3,332 $ 1,426 Accrued expenses and other current liabilities 14,600 9,399 Term loan, current portion 1,622 1,622 Deferred revenue 4,911  Total current liabilities 24,465 12,447 Lease liabilities, net of current portion 1,019 1,261 Term loan, net of current portion 1,717 3,293 Other liabilities 236 161 Total liabilities 27,437 17,162 Commitments and contingencies Stockholders equity: Preferred stock, $0.0001 par value; 10,000,000 shares authorized and no shares issued or outstanding as of December 31, 2023 and 2022   Common stock, $0.0001 par value; 200,000,000 shares authorized as of December 31, 2023 and 2022; 41,029,832 and 23,601,004 shares issued and outstanding as of December 31, 2023 and 2022, respectively 4 3 Additional paid-in capital 273,737 218,354 Accumulated other comprehensive loss  (558 ) Accumulated deficit (197,232 ) (149,313 ) Total stockholders equity 76,509 68,486 Total liabilities and stockholders equity $ 103,946 $ 85,648 SPRUCE BIOSCIENCES, INC. STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (in thousands, except share and per share amounts) Year Ended December 31, 2023 2022 Collaboration revenue $ 10,089 $  Operating expenses: Research and development 49,432 35,198 General and administrative 12,650 12,085 Total operating expenses 62,082 47,283 Loss from operations (51,993 ) (47,283 ) Interest expense (483 ) (420 ) Interest and other income, net 4,557 1,523 Net loss (47,919 ) (46,180 ) Other comprehensive gain (loss), net of tax: Unrealized gain (loss) on available for sale securities 558 (374 ) Total comprehensive loss $ (47,361 ) $ (46,554 ) Net loss per share, basic and diluted $ (1.24 ) $ (1.96 ) Weighted-average shares of common stock outstanding, basic and diluted 38,510,220 23,527,116 View source version on businesswire.com: https://www.businesswire.com/news/home/20240313519454/en/ Media Will Zasadny Inizio Evoke Comms (619) 961-8848 will.zasadny@inizioevoke.com media@sprucebio.com Investors Samir Gharib President and CFO Spruce Biosciences, Inc. investors@sprucebio.com Source: Spruce Biosciences, Inc. What were the results of the CAHptain-205 study in pediatric classic CAH? Positive data from CAHptain-205 study showed 73% of patients met efficacy endpoint of A4 or GC reduction. What is the cash and cash equivalents as of December 31, 2023? Cash and cash equivalents were $96.3 million, with over $81 million currently available. What was the collaboration revenue for the year ended December 31, 2023? Collaboration revenue was $10.1 million, reflecting the partial recognition of upfront payment from Kaken Pharmaceutical. What was the net loss for the year ended December 31, 2023? Net loss was $47.9 million. What is the plan regarding regulatory authorities in 2025? The company plans to meet with regulatory authorities in early 2025 to outline a registrational clinical program. How did the company extend its cash runway? Resource prioritization and cost reductions, including termination of the CAHmelia-203 trial and a reduction in force, extended the cash runway through 2025."
Sphere 3D Reports Fiscal Year 2023 Financial Results and Operational Updates,2024-03-13T20:10:00.000Z,Moderate,Neutral,"Sphere 3D Corp. (ANY) reports strong financial results for fiscal year 2023, with a significant increase in Bitcoin mining operations. The company increased its operating hashrate by 409% year-over-year, mined 667 Bitcoin, and achieved a revenue increase of $15.8 million to $21.9 million. Sphere 3D streamlined operations, reduced debt, and liquidated non-strategic investments. The company aims for positive cash flows and plans for the Bitcoin halving in 2024.","Sphere 3D Reports Fiscal Year 2023 Financial Results and Operational Updates Rhea-AI Impact (Moderate) Rhea-AI Sentiment (Neutral) Tags earnings Rhea-AI Summary Sphere 3D Corp. (ANY) reports strong financial results for fiscal year 2023, with a significant increase in Bitcoin mining operations. The company increased its operating hashrate by 409% year-over-year, mined 667 Bitcoin, and achieved a revenue increase of $15.8 million to $21.9 million. Sphere 3D streamlined operations, reduced debt, and liquidated non-strategic investments. The company aims for positive cash flows and plans for the Bitcoin halving in 2024. Positive Significant increase in operating hashrate and Bitcoin mined year-over-year. Revenue increased by $15.8 million to $21.9 million in 2023. Streamlined operations by reducing SG&A, selling non-core businesses, and paying off debt. Achieved a net loss of $23.4 million in fiscal year 2023, compared to $192.8 million in 2022. Corporate developments include terminating agreements, selling assets, and entering settlement agreements. Received Core Scientific equity as part of a settlement agreement. Negative Net loss available to common shareholders in fiscal year 2023. Operating costs and expenses totaled $51.9 million in 2023. Decrease in revenues from the service and product segment. Financial Analyst The financial results of Sphere 3D Corp. reflect a significant operational improvement in the fiscal year 2023, with an increase in revenue driven by enhanced digital mining operations. The strategic divestment of non-core businesses and the repayment of all debt indicate a focus on core competencies and balance sheet strength. The increased operating hashrate is a positive indicator for future revenue potential, especially in light of the recent uptick in Bitcoin prices.However, the reported net loss and the increase in certain operational expenses, such as legal and insurance costs, suggest ongoing challenges in managing costs. The termination of the Master Services Agreement with Gryphon Digital Mining and the subsequent gain from the deconsolidation of MEOA are strategic moves that could improve gross margins and reduce complexity within the company's operational structure.The settlement with Core Scientific and the acquisition of its equity as part of Core Scientific's emergence from bankruptcy is an opportunity for Sphere 3D to potentially benefit from the recovery of the digital mining sector. However, this also introduces a new risk profile associated with the performance of Core Scientific's stock. Market Research Analyst The cryptocurrency mining industry is highly volatile and Sphere 3D's operational results must be contextualized within the broader market dynamics. The anticipated Bitcoin halving event in 2024 is expected to impact miners' profitability, as rewards for mining new blocks will decrease. Sphere 3D's proactive measures to increase operational efficiency and streamline its business model ahead of this event demonstrate strategic foresight.The company's ability to increase its hashrate significantly while also improving its gross margin is indicative of competitive advancements in its mining capabilities. This positions Sphere 3D favorably within the industry, provided that Bitcoin's price remains stable or increases, which is a significant external factor affecting the company's performance.Investors should monitor the market's reaction to these financial results, as well as the performance of Core Scientific's equity, which now constitutes a strategic asset for Sphere 3D. The company's future financial health will likely be influenced by the performance of this investment and the overall health of the cryptocurrency market. Economist The financial outcomes reported by Sphere 3D Corp. offer insights into the economic forces shaping the Bitcoin mining industry. The substantial reduction in net loss year-over-year indicates an improved cost structure, but the business continues to operate at a loss. This highlights the high fixed costs and capital-intensive nature of the cryptocurrency mining sector.The divestiture of non-core segments and the focus on digital mining operations suggest a strategic pivot towards a more concentrated business model. This could yield economic efficiencies and allow for better allocation of capital towards high-growth areas. Nevertheless, the inherent risks associated with Bitcoin's price volatility and regulatory uncertainties remain pivotal economic factors that can affect Sphere 3D's performance.From an economic standpoint, the upcoming Bitcoin halving could lead to a reduction in supply, potentially driving up the price if demand remains constant or increases. Sphere 3D's preparation for this event, coupled with its current operational scale, may position it to capitalize on potential market shifts. However, the long-term sustainability of the business model hinges on the company's ability to adapt to price fluctuations and maintain operational efficiency. 03/13/2024 - 04:10 PM Stamford, Connecticut--(Newsfile Corp. - March 13, 2024) - Sphere 3D Corp. (NASDAQ: ANY) (""Sphere 3D"" or the ""Company""), a Bitcoin mining company operating at an industrial scale, is pleased to announce financial results for its fiscal year ended December 31, 2023.COMMENTS FROM SPHERE 3D LEADERSHIP""I'm pleased to report that once again we delivered very strong results and made significant progress in our operations during 2023. I am very proud of the Sphere 3D team!"" said Patricia Trompeter, CEO of Sphere 3D. ""We increased our operating hashrate to 1.3 EH/s from just under 0.1 EH/s last year, resulting in an approximately 409% increase in Bitcoin mined year-over-year, to 667 Bitcoin. We streamlined our operations by reducing SG&A, selling non-core businesses, paying off all debt and liquidating non-strategic investments. Looking forward, with the recent rise in Bitcoin, we believe we can achieve our goal of positive cash flows on an adjusted EBITDA basis. We are focusing on not only existing operations, but on executing a plan to weather the halving anticipated in the second quarter of 2024.""2023 HIGHLIGHTSRevenue increased by $15.8 million, to $21.9 million during the year ended December 31, 2023, due to an increase in revenues from our digital mining operation;The Company mined 667 Bitcoin in 2023;The Company ended the year with 1.3 EH/s;The Company sold its service and product segment, including HVE Inc. and Unified ConneXions.BITCOIN ASSET AND VALUEAs of December 31, 2023, the Company had a self-mined Bitcoin balance of 23.8 with a carrying value of $1.0 million and an additional 21.6 Bitcoin held by Gryphon Digital Mining, Inc. on our behalf. FISCAL YEAR 2023 FINANCIAL RESULTSThe Company generated revenues of $21.9 million in fiscal year 2023 compared to $6.1 million in fiscal year 2022. The $15.8 million increase in revenue is due to the increase of $16.3 million in revenues from the Company's digital mining operation, offset by a decrease of $0.5 million in the Company service and product segment.Operating costs and expenses for fiscal year 2023 totaled $51.9 million, compared to $163.7 million for fiscal year 2022. The $111.8 million decrease in operating costs and expenses is primarily attributable to decreases in impairments of mining equipment of $75.9 million and intangible assets and provisions for losses of $17.8 million, depreciation and amortization of $22.1 million, share-based compensation of $6.1 million, professional services associated with the Company's expansion into the digital asset mining industry of $4.5 million, merger expenses of $1.9 million offset by increases in cost of revenues of $12.5 million, legal expenses of $2.8 million, SPAC-related expenses of $0.9 million, increases in insurance of $0.5 million and other of $0.2 million.The net loss available to common shareholders in fiscal year 2023 was $23.4 million, or a net loss of $1.93 per share, compared to a net loss available to common shareholders of $192.8 million, or a net loss of $20.36 per share, in fiscal year 2022. FOURTH QUARTER AND RECENT CORPORATE DEVELOPMENTS On October 6, 2023, the Company terminated the Master Services Agreement with Gryphon Digital Mining, Inc., returning 22.5% to the Company's gross margin.On December 19, 2023, the Company's 3,162,500 shares of Minority Equality Opportunities Acquisition Inc. (""MEOA"") Class B common stock were cancelled, eliminating the Company's ownership of MEOA, and the Company recognized a $6.1 million gain related to the deconsolidation of MEOA.On December 28, 2023, the Company entered into a share purchase agreement with Joseph O'Daniel (the ""Purchaser""), a related party, under which the Company sold its service and product segment, including HVE Inc. and Unified ConneXions, in consideration for $1.00 and the transfer of HVE Inc.'s and Unified ConneXions's outstanding assets and liabilities. In connection with the share purchase agreement, the Purchaser, who served as the Company's President, resigned effective December 28, 2023. The Company recognized a noncash gain of $0.7 million related to the transfer of net liabilities to the Purchaser.During fiscal year 2023, the Company sold 3,336 bitcoin miners that were included in mining equipment, for cash proceeds of $4.5 million.On January 16, 2024, the Company entered into a settlement agreement (the ""Settlement Agreement"") with Core Scientific, Inc. (""Core Scientific""), which was approved by a United States Bankruptcy Judge on January 16, 2024, as part of Core Scientific's emergence from bankruptcy, for $10.0 million of Core Scientific's equity. The Settlement Agreement includes access to potential additional funds for interest as well as an additional equity pool if the value of Core Scientific equity initially received by the Company under the Settlement Agreement decreases below its value at the date of the Settlement Agreement in the 18 months after the date of the Settlement Agreement, commensurate with the other unsecured creditors. On January 23, 2024, the Company received 2,050,982 shares of Core Scientific common stock trading under the NASDAQ symbol ""CORZ.""ABOUT SPHERE 3DSphere 3D Corp. (NASDAQ: ANY) is a cryptocurrency miner with decades of proven enterprise data-services expertise. The Company is growing its industrial-scale digital asset mining operation through the capital-efficient procurement of next-generation mining equipment and partnering with best-in-class data center operators. Sphere 3D is dedicated to increasing shareholder value while honoring its commitment to strict environmental, social, and governance standards. For more information about the Company, please visit Sphere3D.com. FORWARD-LOOKING STATEMENTSThis communication contains forward-looking statements within the meaning of Section 27A of the Securities Act, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements generally relate to future events, including the timing of the proposed transaction and other information related to the proposed transaction. In some cases, you can identify forward-looking statements because they contain words such as ""may,"" ""will,"" ""should,"" ""expects,"" ""plans,"" ""anticipates,"" ""could,"" ""intends,"" ""target,"" ""projects,"" ""contemplates,"" ""believes,"" ""estimates,"" ""predicts,"" ""potential"" or ""continue"" or the negative of these words or other similar terms or expressions. Expectations and beliefs regarding matters discussed herein may not materialize, and actual results in future periods are subject to risks and uncertainties that could cause actual results to differ materially from those projected. The forward-looking statements contained in this communication are also subject to other risks and uncertainties, including those more fully described in filings with the SEC, including Sphere 3D's reports filed on Form 10-K, Form 10-Q and Form 8-K and in other filings made by Sphere 3D with the SEC from time to time and available at www.sec.gov. These forward-looking statements are based on current expectations, which are subject to change.SPHERE 3D CONTACTSKurt Kalbfleisch, CFO, Sphere 3DInvestor.relations@sphere3d.comSPHERE 3D CORP.CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS(In thousands of U.S. dollars, except share and per share amounts) Year Ended December 31,20232022Revenues:(Unaudited) Bitcoin mining revenue$19,730$3,443Service and product revenue2,1762,634 Total revenues21,9066,077 Operating costs and expenses: Cost of Bitcoin mining revenue15,0312,044 Cost of service and product revenue9131,373 Sales and marketing9481,009 Research and development1,026605 General and administrative15,82524,134 Depreciation and amortization6,19028,263 Provision for losses on deposits due to vendor bankruptcy filings8,50916,069 Impairment of acquired intangible assets2,95213,182 Realized gain on sale of Bitcoin(1,131)(19) Loss on disposal of property and equipment960- Impairment of Bitcoin6821,148 Impairment of mining equipment-75,922 Total operating expenses51,905163,730Loss from operations(29,999)(157,653)Other income (expense): Gain on deconsolidation of SPAC6,140- Interest expense(1,183)- Interest income and other expense, net1,0622,581 Gain on disposal of service and product segment - related party663- Impairment of investments-(14,529) Forgiveness of note receivable-(13,145) Provision for losses on deposit for mining equipment-(10,000)Loss before income taxes(23,317)(192,746)Provision for income taxes13166Net loss(23,330)(192,912)Less: Non-controlling interest - income (loss)76(111)Net loss attributable to common shareholders$(23,406)$(192,801) Net loss per share: Basic and diluted$(1.93)$(20.36)Shares used in computing net loss per share: Basic and diluted12,129,3029,470,630 SPHERE 3D CORP.CONDENSED CONSOLIDATED BALANCE SHEETS(In thousands of U.S. dollars)December 31,December 31,20232022 (Unaudited) (Unaudited) ASSETS Cash and cash equivalents$586$1,337Digital assets, net9861,695Other current assets11,9387,252 Total current assets 13,510 10,284Property and equipment, net24,16634,259Intangible assets, net4,5819,477Funds held in trust account-10,297Other non-current assets3,40618,699 Total assets $ 45,663 $ 83,016 LIABILITIES, TEMPORARY EQUITY AND SHAREHOLDERS' EQUITY Current liabilities$5,346$6,200Other non-current liabilities-5,784Total temporary equity13,79436,467Total shareholders' equity26,52334,565 Total liabilities, temporary equity, and shareholders' equity $ 45,663 $83,016 To view the source version of this press release, please visit https://www.newsfilecorp.com/release/201443 What was Sphere 3D's operating hashrate increase in 2023? Sphere 3D increased its operating hashrate to 1.3 EH/s from just under 0.1 EH/s. How many Bitcoin did Sphere 3D mine in 2023? Sphere 3D mined 667 Bitcoin in 2023. What was Sphere 3D's revenue in fiscal year 2023? Sphere 3D generated revenues of $21.9 million in fiscal year 2023. What corporate developments did Sphere 3D experience in 2023? Sphere 3D terminated agreements, sold assets, and entered settlement agreements in 2023. What was the net loss available to common shareholders in fiscal year 2023? The net loss available to common shareholders was $23.4 million in fiscal year 2023."
"REV Group, Inc. Announces Launch of Secondary Offering of Common Stock",2024-03-13T20:10:00.000Z,Low,Neutral,"REV Group, Inc. (NYSE:REVG) announces a secondary public offering of 7,395,191 shares of common stock by Selling Stockholders. The Company will not receive proceeds from the sale. Goldman Sachs & Morgan Stanley are joint book-running managers. The Offering is subject to market conditions and an effective shelf registration statement.","REV Group, Inc. Announces Launch of Secondary Offering of Common Stock Rhea-AI Impact (Low) Rhea-AI Sentiment (Neutral) Tags offering Rhea-AI Summary REV Group, Inc. (NYSE:REVG) announces a secondary public offering of 7,395,191 shares of common stock by Selling Stockholders. The Company will not receive proceeds from the sale. Goldman Sachs & Morgan Stanley are joint book-running managers. The Offering is subject to market conditions and an effective shelf registration statement. Positive None. Negative None. Financial Analyst A secondary public offering, such as the one announced by REV Group, Inc., involves existing shareholders selling their shares to the public. This event can influence the company's stock price due to changes in supply and demand dynamics. The market often interprets large shareholders selling as a signal about the company's future prospects, which can lead to increased volatility in the stock price. Investors should monitor the offering price relative to the current market price, as a significant discount could suggest the sellers' urgency or a negative outlook on the stock's future performance. Market Research Analyst With American Industrial Partners Capital Fund IV, LP and its parallel fund as the selling shareholders, the market will assess the impact of their exit on REV Group's governance and strategic direction. The funds' divestiture could alter the shareholder base and potentially attract different types of investors. Market participants will also evaluate the role of Goldman Sachs & Co. LLC and Morgan Stanley, given their influence in pricing and stabilizing the offering. Their reputation and the fixed price offering strategy could affect investor confidence and the success of the transaction. Legal Expert The offering's legality hinges on compliance with the SEC regulations, as indicated by REV Group's use of an effective shelf registration statement. This legal framework allows the company to issue securities to the public with more efficiency and flexibility over a three-year period. However, the disclaimer in the press release is a standard precautionary statement to mitigate legal risk, emphasizing that the offering is contingent on market conditions and regulatory compliance, including the registration and qualification under the applicable securities laws. 03/13/2024 - 04:10 PM MILWAUKEE--(BUSINESS WIRE)-- REV Group, Inc. (NYSE:REVG) (the Company) announced today the launch of an underwritten secondary public offering of 7,395,191 shares of the Companys common stock (the Offering) by American Industrial Partners Capital Fund IV, LP and American Industrial Partners Capital Fund IV (Parallel), LP (the Selling Stockholders). The Offering consists entirely of shares of the Companys common stock to be sold by the Selling Stockholders, and the Company will not receive any proceeds from the sale of the shares being offered by the Selling Stockholders. The proposed offering is subject to market and other conditions, as well as customary closing conditions. Goldman Sachs & Co. LLC and Morgan Stanley are acting as joint book-running managers for the Offering. The underwriters intend to offer the shares of common stock to the public at a fixed price, which may be changed at any time without notice. The Offering is being made pursuant to an effective shelf registration statement on Form S-3 (Registration No. 333-276009), which has been filed with the Securities and Exchange Commission (SEC) and became effective on December 19, 2023. The Offering will be made only by means of a prospectus supplement and the accompanying base prospectus. You may get these documents for free, including the prospectus supplement, once available, by visiting EDGAR on the SEC website at www.sec.gov. Alternatively, copies of the prospectus supplement, once available, and the accompanying base prospectus may be obtained by contacting: Goldman Sachs & Co. LLC, 200 West Street, New York, NY 10282-2198, Attention: Prospectus Department, Telephone: 866-471-2526, Email: Prospectus-ny@ny.email.gs.com or Morgan Stanley & Co. LLC, 180 Varick Street, 2nd Floor, New York, NY 10014, Attn: Prospectus Department. This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction. About REV Group REV Group (REVG) is a leading designer, manufacturer and distributor of specialty vehicles and related aftermarket parts and services. We serve a diversified customer base, primarily in the United States, through two segments: Specialty Vehicles and Recreational Vehicles. We provide customized vehicle solutions for applications, including essential needs for public services (ambulances, fire apparatus, and transit buses), commercial infrastructure (terminal trucks and industrial sweepers) and consumer leisure (recreational vehicles). Our diverse portfolio is made up of well-established principal vehicle brands, including many of the most recognizable names within their industry. Several of our brands pioneered their specialty vehicle product categories and date back more than 50 years. REV Group trades on the NYSE under the symbol REVG. Cautionary Statement on Forward-Looking Statements This news release contains statements that the company believes to be forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. This news release includes statements that express our opinions, expectations, beliefs, plans, objectives, assumptions or projections regarding future events or future results and therefore are, or may be deemed to be, forward-looking statements. These forward-looking statements can generally be identified by the use of forward-looking terminology, including the terms believes, estimates, anticipates, expects, strives, goal, seeks, projects, intends, forecasts, outlook, guidance, plans, may, will or should or, in each case, their negative or other variations or comparable terminology. They appear in a number of places throughout this news release and include statements regarding our intentions, beliefs, goals or current expectations concerning, among other things, our results of operations, financial condition, liquidity, prospects, growth, strategies and the industries in which we operate, including REV Groups outlook for the full fiscal year 2024. Our forward-looking statements are subject to risks and uncertainties, including those highlighted under Risk Factors and Cautionary Statement on Forward-Looking Statements in the companys annual report on Form 10-K, and in the companys subsequent quarterly reports on Form 10-Q, together with the companys other filings with the SEC, which risks and uncertainties may cause actual results to differ materially from those projected or implied by the forward-looking statement. Forward-looking statements are based on current expectations and assumptions and currently available data and are neither predictions nor guarantees of future events or performance. You should not place undue reliance on forward-looking statements, which only speak as of the date hereof. The company does not undertake to update or revise any forward-looking statements after they are made, whether as a result of new information, future events, or otherwise. Source: REV Group, Inc. View source version on businesswire.com: https://www.businesswire.com/news/home/20240313045503/en/ REV Group, Inc. Drew Konop, 1-888-738-4037 (1-888-REVG-037) investors@revgroup.com Source: REV Group, Inc. What is the ticker symbol for REV Group, Inc.? The ticker symbol for REV Group, Inc. is REVG. How many shares are being offered in the secondary public offering? 7,395,191 shares of common stock are being offered by Selling Stockholders. Who are the joint book-running managers for the Offering? Goldman Sachs & Morgan Stanley are acting as joint book-running managers for the Offering. How can investors obtain the prospectus supplement for the Offering? Investors can obtain the prospectus supplement by visiting EDGAR on the SEC website at www.sec.gov or by contacting Goldman Sachs & Morgan Stanley. Is the Company receiving any proceeds from the sale of shares in the Offering? The Company will not receive any proceeds from the sale of shares being offered by the Selling Stockholders."
Franklin Covey to Report Second Quarter Fiscal 2024 Results,2024-03-13T20:10:00.000Z,Low,Neutral,"Franklin Covey Co. (NYSE: FC) will hold a conference call on March 27, 2024, to discuss its second-quarter fiscal 2024 financial results. The call will take place at 5:00 p.m. ET (3:00 p.m. MT), with financial results released after the market closes. Interested parties can join via webcast or telephone registration.","Franklin Covey to Report Second Quarter Fiscal 2024 Results Rhea-AI Impact (Low) Rhea-AI Sentiment (Neutral) Tags conferences earnings Rhea-AI Summary Franklin Covey Co. (NYSE: FC) will hold a conference call on March 27, 2024, to discuss its second-quarter fiscal 2024 financial results. The call will take place at 5:00 p.m. ET (3:00 p.m. MT), with financial results released after the market closes. Interested parties can join via webcast or telephone registration. Positive None. Negative None. 03/13/2024 - 04:10 PM Conference Call to be held on Wednesday, March 27, 2024 SALT LAKE CITY--(BUSINESS WIRE)-- Franklin Covey Co. (NYSE: FC), a leader in organizational performance improvement, announced today that the conference call to review the Companys second quarter fiscal 2024 financial results will take place on Wednesday, March 27, 2024, at 5:00 p.m. ET (3:00 p.m. MT). The Companys financial results are expected to be released after the close of the market on Wednesday, March 27, 2024. Interested persons may access a live webcast at https://edge.media-server.com/mmc/p/oqgb55wf or may participate via telephone by registering at https://register.vevent.com/register/BI48d1c548f55048e0b4368e6c233ffc82. Once registered, participants will have the option of 1) dialing into the call from their phone (via a personalized PIN); or 2) clicking the Call Me option to receive an automated call directly to their phone. For either option, registration will be required to access the call. A replay of the conference call webcast will be archived on the Companys website for at least 30 days. About Franklin Covey Co. FranklinCovey (NYSE: FC) is the most trusted leadership company in the world with operations in over 160 countries. We transform organizations by partnering with our clients to build leaders, teams, and cultures that get breakthrough results through collective action, which leads to a more engaging work experience for their people. Available through the FranklinCovey All Access Pass, our best-in-class content and solutions, experts, technology, and metrics seamlessly integrate together to ensure lasting behavior change at scale. This approach to leadership and organizational change has been tested and refined by working with tens of thousands of teams and organizations over the past 30 years. View source version on businesswire.com: https://www.businesswire.com/news/home/20240313945317/en/ Stephen D. Young Chief Financial Officer 801-817-1776 Source: Franklin Covey Co. When will Franklin Covey Co. (FC) hold the conference call to discuss its second-quarter fiscal 2024 financial results? Franklin Covey Co. (FC) will hold the conference call on Wednesday, March 27, 2024, at 5:00 p.m. ET (3:00 p.m. MT). How can interested individuals access the live webcast of the conference call? Interested individuals can access the live webcast of the conference call at https://edge.media-server.com/mmc/p/oqgb55wf. Is there a telephone option available for participation in the conference call? Yes, interested individuals can participate via telephone by registering at https://register.vevent.com/register/BI48d1c548f55048e0b4368e6c233ffc82. Will the conference call be archived for later viewing? Yes, a replay of the conference call webcast will be archived on the Companys website for at least 30 days."
UiPath Reports Fourth Quarter and Full Year Fiscal 2024 Financial Results,2024-03-13T20:10:00.000Z,Neutral,Neutral,"UiPath, Inc. (PATH) reports record quarterly revenue of $405 million, a 31% increase year-over-year, with ARR reaching $1.464 billion, up by 22%. The company achieves its first GAAP profitability quarter as a public entity. Cash flow from operations and non-GAAP adjusted free cash flow hit $146 million. The financial outlook for fiscal 2025 is optimistic, with revenue expected between $1.555 billion to $1.560 billion and ARR in the range of $1.725 billion to $1.730 billion.","UiPath Reports Fourth Quarter and Full Year Fiscal 2024 Financial Results Rhea-AI Impact (Neutral) Rhea-AI Sentiment (Neutral) Tags earnings Rhea-AI Summary UiPath, Inc. (PATH) reports record quarterly revenue of $405 million, a 31% increase year-over-year, with ARR reaching $1.464 billion, up by 22%. The company achieves its first GAAP profitability quarter as a public entity. Cash flow from operations and non-GAAP adjusted free cash flow hit $146 million. The financial outlook for fiscal 2025 is optimistic, with revenue expected between $1.555 billion to $1.560 billion and ARR in the range of $1.725 billion to $1.730 billion. Positive Record quarterly revenue of $405 million, up 31% year-over-year. ARR grows to $1.464 billion, showing a 22% increase year-over-year. First quarter of GAAP profitability achieved as a public company. Cash flow from operations and non-GAAP adjusted free cash flow reach $146 million. Financial outlook for fiscal 2025 is positive, with revenue expected between $1.555 billion to $1.560 billion and ARR in the range of $1.725 billion to $1.730 billion. Negative None. Financial Analyst UiPath's reported record quarterly revenue of $405 million, marking a 31% increase year-over-year and an ARR (Annual Recurring Revenue) of $1.464 billion with a 22% year-over-year growth, are strong indicators of the company's robust financial health and market demand for its automation and AI services. The first quarter of GAAP profitability for UiPath as a public company is particularly noteworthy, reflecting operational efficiency and effective cost management. The dollar-based net retention rate of 119% suggests a high level of customer satisfaction and the potential for continued revenue growth from existing customers.The non-GAAP gross margin of 89% compared to the GAAP gross margin of 87% indicates that the company has managed to maintain high profitability margins, even when excluding certain non-cash expenses like stock-based compensation. This is a positive sign for investors as it demonstrates the company's pricing power and operational leverage. Moreover, the significant cash flow from operations, reaching $146 million and the strong balance sheet with $1.9 billion in cash and marketable securities, provide the company with substantial resources to invest in growth opportunities and weather potential market downturns. Market Research Analyst UiPath's strategic investments, such as the expansion of its product offerings with Autopilot for Studio and Test Suite and the partnership with Google Cloud, position the company to capitalize on the growing demand for enterprise automation and AI solutions. The introduction of Generative AI Connectors and the expansion of UiPath Integration Service are likely to enhance the company's competitive edge by making its platform more accessible and valuable to developers.The U.S. Department of Defense agreement worth up to $95 million through UiPath partner FedResults is a significant development. It not only provides a stable revenue stream but also validates the company's solutions in high-security environments. UiPath's expanded partnership with Deloitte's Smart Finance for Growth Companies is another strategic move that could lead to deeper market penetration, particularly in the finance sector, by offering tailored automation solutions. Economist UiPath's financial outlook for fiscal year 2025, with expected revenue in the range of $1.555 billion to $1.560 billion and ARR between $1.725 billion to $1.730 billion, reflects confidence in the company's growth trajectory. However, the projected non-GAAP operating income of approximately $295 million indicates that the company plans to continue investing heavily in growth, which may affect short-term profitability but could potentially yield long-term gains in market share and technological leadership.The company's mention of typical seasonal patterns in its guidance suggests a nuanced understanding of its sales cycles, which is crucial for stakeholders when evaluating the company's future performance. The inability to provide a reconciliation of non-GAAP operating income guidance to the most directly comparable GAAP measure due to variability and complexity highlights the difficulties in predicting certain financial outcomes, which investors should consider when assessing the company's future prospects. 03/13/2024 - 04:10 PM Fourth Quarter Highlights Record quarterly revenue of $405 million increases 31 percent year-over-year ARR of $1.464 billion increases 22 percent year-over-year Achieves first quarter of GAAP profitability as a public company Cash flow from operations and non-GAAP adjusted free cash flow reach $146 million NEW YORK--(BUSINESS WIRE)-- UiPath, Inc. (NYSE: PATH), a leading enterprise automation and AI software company, today announced financial results for its fourth quarter and full year fiscal 2024 ended January 31, 2024. We delivered a strong close to the fiscal year with fourth quarter ARR growing 22 percent year-over-year to $1.464 billion, underscoring the meaningful outcomes our Business Automation Platform delivers for our customers, said Rob Enslin, UiPath Chief Executive Officer. The combination of UiPaths AI and automation is the strategic change enabler for our customers that makes any digital transformation easier and faster, while empowering customers to innovate, adapt more quickly, and grow. Fourth Quarter Fiscal 2024 Financial Highlights Revenue of $405 million increased 31 percent year-over-year. ARR of $1.464 billion increased 22 percent year-over-year. Net new ARR of $86 million. Dollar based net retention rate of 119 percent. GAAP gross margin was 87 percent. Non-GAAP gross margin was 89 percent. GAAP operating income was $15 million. Non-GAAP operating income was $111 million. Net cash flow from operations was $146 million. Non-GAAP adjusted free cash flow was $146 million. Cash, cash equivalents, and marketable securities were $1.9 billion as of January 31, 2024. Full Year Fiscal 2024 Financial Highlights Revenue of $1.308 billion increased 24 percent year-over-year. Net new ARR of $260 million. GAAP gross margin was 85 percent. Non-GAAP gross margin was 87 percent. GAAP operating loss was $(165) million. Non-GAAP operating income was $233 million. Net cash flow from operations was $299 million. Non-GAAP adjusted free cash flow was $309 million. The team executed well in the fourth quarter and I am particularly pleased with our significant year-over-year increase in operating margins, including our first quarter of GAAP profitability as a public company, and record cash flow, said Ashim Gupta, UiPath Chief Financial Officer. Looking ahead to fiscal year 2025, this afternoons guidance reflects typical seasonal patterns in the business as well as our plans to strategically invest to further expand our market leadership while continuing to drive operating leverage. Financial Outlook For the first quarter fiscal 2025, UiPath expects: Revenue in the range of $330 million to $335 million ARR in the range of $1.508 billion to $1.513 billion as of April 30, 2024 Non-GAAP operating income of approximately $55 million For the fiscal full year 2025, UiPath expects: Revenue in the range of $1.555 billion to $1.560 billion ARR in the range of $1.725 billion to $1.730 billion as of January 31, 2025 Non-GAAP operating income of approximately $295 million Reconciliation of non-GAAP operating income guidance to the most directly comparable GAAP measure is not available without unreasonable efforts on a forward-looking basis due to the high variability, complexity and low visibility with respect to the charges excluded from this non-GAAP measure; in particular, the effects of stock-based compensation expense specific to equity compensation awards that are directly impacted by unpredictable fluctuations in our stock price. We expect the variability of the above charges to have a significant, and potentially unpredictable, impact on our future GAAP financial results. Recent Business Highlights Launched UiPath Autopilot for Studio and Autopilot for Test Suite into Public Preview: Autopilot for Studio delivers enhanced productivity for developers empowering both professional and citizen automation developers to create automations, code, and expressions with natural language. Autopilot for Test Suite provides a collection of advanced AI capabilities designed to boost the productivity of testers throughout the entire testing lifecycle, including AI-powered Quality Checks, Test Design, and Test Automation. Unveiled Latest UiPath Business Automation Platform Features for Developer Community: Daniel Dines, UiPath Co-Founder and Chief Innovation Officer, and the UiPath team hosted 1,000+ professional developers, GSI partners, COE specialists, government officers, and educators in Bengaluru, India at DevCon 2024. During the conference UiPath delivered a host of new features designed to enable developers to build, test, and accelerate implementation of automations. These include an expanded collection of Generative AI Connectors that leverage industry-leading LLM providers; improved developer capabilities in UiPath Integration Service; and key investments in its Solution Accelerators, a pre-built automation framework designed to help developers implement faster and expedite time-to-value. UiPath Partner, FedResults, Awarded a U.S. Department of Defense Enterprise Software Initiative Agreement for UiPath Products and Services: The U.S. Department of Defense (DoD) has awarded an Enterprise Software Initiative (ESI) Purchase Agreement for UiPath products and services to UiPath partner FedResults for up to $95 million. The agreement has a five-year base period and will streamline the acquisition process and reduce cost of delivery of UiPath products and services to the DoD, Intelligence Community, and U.S. Coast Guard. The ESI agreement will enable these federal organizations to significantly accelerate their adoption of UiPath and put AI to work in a safe and secure manner to achieve their mission goals. Announced an Expanded Partnership with Google Cloud: The partnership between UiPath and Google Cloud will help customers facilitate their AI-powered automation journey while integrating Google Clouds Vertex AI and Google Workspace business collaboration offerings. UiPath, a Premier Level partner of Google Cloud, is now available on Google Cloud Marketplace. Introduced Turnkey Automation Offering for Growth Companies in Collaboration with Deloitte: Building on the recent announcement by Deloitte of the creation of a first-of-its-kind co-innovation market collaboration between UiPath and Deloitte, Deloittes Smart Finance for Growth Companies leverages automations built by UiPath and customized by Deloitte into value-driven packages tailored for the needs of growth companies. By leveraging this managed service offering, finance teams can quickly establish or scale their automation program to advance their capabilities and improve productivity. Announced Availability of New India Data Center: Beginning in April 2024 UiPath Automation Cloud will expand with a new data center in India to offer opportunities for public and private sector customers and partners to strategically position their infrastructure, applications, and data. The India data center meets the growing demand for cloud services, focusing on business continuity and compliance while providing high availability, low latency, improving accessibility, and service speed for customers. Named Veteran Technology Executive and AI Expert June Yang to UiPath Board: Yang is a proven strategic and transformational executive who brings extensive experience in AI, Cloud, and related technologies, as well as decades of experience in corporate management and fostering emerging technologies. Most recently, she was Vice President, Cloud AI and Industry Solutions at Google Cloud. Conference Call and Webcast UiPath will host a conference call today, Wednesday, March 13, 2024, at 5:00 p.m. Eastern Time, to discuss the Company's fourth quarter and full year fiscal 2024 financial results and its guidance for the first quarter and full year fiscal 2025. To access this call, dial 1-201-689-8057 (domestic) or 1-877-407-8309 (international). The passcode is 13744344. A live webcast of this conference call will be available on the ""Investor Relations"" page of UiPaths website (https://ir.uipath.com/), and a replay will also be archived on the website for one year. About UiPath UiPath (NYSE: PATH) is on a mission to uplevel knowledge work so more people can work more creatively, collaboratively, and strategically. The AI-powered UiPath Business Automation Platform combines the leading robotic process automation (RPA) solution with a full suite of capabilities to understand, automate, and operate end-to-end processes, offering unprecedented time-to-value. For organizations that need to evolve to survive and thrive through increasingly changing times, UiPath is The Foundation of Innovation. For more information, visit www.uipath.com. Forward Looking Statements Statements we make in this press release may include statements which are not historical facts and are considered forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, which are usually identified by the use of words such as anticipates, believes, estimates, expects, intends, may, plans, possible, projects, outlook, seeks, should, will, and variations of such words or similar expressions, including the negatives of these words or similar expressions. We intend these forward-looking statements to be covered by the safe harbor provisions for forward-looking statements contained in Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and are making this statement for purposes of complying with those safe harbor provisions. These forward-looking statements include, but are not limited to, statements regarding our guidance for the first fiscal quarter 2025 and the full fiscal year 2025, our strategic plans, objectives, and roadmap, the estimated addressable market opportunity for our platform and statements regarding the growth of the enterprise automation market, the success of our platform and new releases including the incorporation of AI, the success of our collaborations with third parties, our customers behaviors and potential automation spend, and details of UiPaths stock repurchase program. Accordingly, actual results could differ materially from those expectations expressed in the forward-looking statements or such uncertainties could cause adverse effects on our results. Forward-looking statements involve known and unknown risks, uncertainties, and other factors that may cause our actual results, performance, or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. These risks include, but are not limited to, risks and uncertainties related to: the market, political, economic, and business conditions, including turmoil and macro-economic effects caused by geopolitical tensions and conflict, increasing inflationary cost trends and foreign exchange volatility; our recent rapid growth, which may not be indicative of our future growth; our limited operating history; our ability to successfully manage our growth and achieve or maintain profitability; our ability to grow our platform and release new functionality in a timely manner; our ability and the ability of our platform and products to satisfy and adapt to customer demands, including our ability to continue to successfully develop, integrate and compete against competitors and new market entrants with artificial intelligence tools and capabilities; our dependency on our existing customers to renew their licenses and purchase additional licenses and products from us and our channel partners; our ability to attract and retain customers; the competitive markets in which we participate; our ability to maintain and expand our distribution channels; our ability to attract, retain, and motivate our management and key employees, integrate new team members, and manage management transitions, including our transition from a co-CEO structure to a single CEO; our reliance on third-party providers of cloud-based infrastructure; the potential effects that regional or global pandemics could have on our or our customers businesses, financial conditions, and future operating results; our ability or perceived inability to achieve our environmental, social and governance (ESG) goals; and the price volatility of our Class A common stock. Further information on risks that could cause actual results to differ materially from our guidance can be found in our Annual Report on Form 10-K for the annual period ended January 31, 2024 to be filed with the SEC, in our Quarterly Reports on Form 10-Q filed with the SEC, and other filings and reports that we have filed and may file from time to time with the SEC. Any forward-looking statements contained in this press release are based on assumptions that we believe to be reasonable as of this date. Except as required by law, we assume no obligation to update these forward-looking statements. Key Performance Metric Annualized Renewal Run-rate (ARR) is a key performance metric we use in managing our business because it illustrates our ability to acquire new subscription customers and to maintain and expand our relationships with existing subscription customers. We define ARR as annualized invoiced amounts per solution SKU from subscription licenses and maintenance and support obligations assuming no increases or reductions in customers subscriptions. ARR does not include the costs we may incur to obtain such subscription licenses or provide such maintenance and support, and does not reflect any actual or anticipated reductions in invoiced value due to contract non-renewals or service cancellations other than for certain reserves, for example those for credit losses or disputed amounts. ARR does not include invoiced amounts associated with perpetual licenses or professional services. ARR is not a forecast of future revenue, which can be impacted by contract start and end dates and duration. ARR should be viewed independently of revenue and deferred revenue as ARR is an operating metric and is not intended to replace these items. Dollar-based net retention rate represents the rate of net expansion of our ARR from existing customers over the preceding 12 months. We calculate dollar-based net retention rate as of a period end by starting with ARR from the cohort of all customers as of 12 months prior to such period end (Prior Period ARR). We then calculate the ARR from these same customers as of the current period end (Current Period ARR). Current Period ARR includes any expansion and is net of any contraction or attrition over the preceding 12 months but does not include ARR from new customers in the current period. We then divide total Current Period ARR by total Prior Period ARR to arrive at dollar-based net retention rate. Dollar-based net retention rate may fluctuate based on the customers that qualify to be included in the cohort used for calculation and may not reflect our actual performance. Investors should not place undue reliance on ARR or dollar-based net retention rate as an indicator of future or expected results. Our presentation of these metrics may differ from similarly titled metrics presented by other companies and therefore comparability may be limited. Non-GAAP Financial Measures Non-GAAP financial measures are financial measures that are derived from the consolidated financial statements, but that are not presented in accordance with generally accepted accounting principles in the United States (GAAP). This earnings press release includes financial measures defined as non-GAAP financial measures by the SEC, including non-GAAP cost of licenses, non-GAAP cost of subscription services, non-GAAP cost of professional services and other, non-GAAP gross profit and margin, non-GAAP sales and marketing expenses, non-GAAP research and development expenses, non-GAAP general and administrative expenses, non-GAAP operating income and margin, and non-GAAP net income and non-GAAP net income per share. These non-GAAP financial measures exclude: stock-based compensation expense; amortization of acquired intangibles; employer payroll tax expense related to employee equity transactions; restructuring costs; charitable donation of Class A common stock; and in the case of non-GAAP net income, estimated tax adjustments associated with the add-back items, as applicable. Additionally, this earnings release presents non-GAAP adjusted free cash flow, which is calculated by adjusting GAAP operating cash flows for the impact of purchases of property and equipment, cash paid for employer payroll taxes related to employee equity transactions, net payments/receipts of employee tax withholdings on stock option exercises, and cash paid for restructuring costs. UiPath uses these non-GAAP financial measures internally in analyzing its financial results and believes they are useful to investors, by excluding the effects of special items that do not reflect the ordinary earnings of our operations, and as a supplement to GAAP measures. UiPath believes that the use of these non-GAAP financial measures provides an additional tool for investors to use in evaluating ongoing operating results and trends and in comparing its financial results with other companies in UiPaths industry, many of which present similar non-GAAP financial measures to investors. Investors should consider these non-GAAP financial measures in addition to, and not as a substitute for, our financial performance measures prepared in accordance with GAAP. Further, our non-GAAP information may be different from the non-GAAP information provided by other companies. The information below provides a reconciliation of non-GAAP financial measures used in this earnings press release to the most directly comparable GAAP financial measures. We encourage investors to consider our GAAP results alongside our supplemental non-GAAP measures, and to review the reconciliation between GAAP results and non-GAAP measures that is included at the end of this earnings press release. This earnings press release and any future releases containing such non-GAAP reconciliations can also be found on the Investor Relations page of UiPaths website at https://ir.uipath.com/. UiPath, Inc. Condensed Consolidated Statements of Operations in thousands, except per share data (unaudited) Three Months Ended January 31, Twelve Months Ended January 31, 2024 2023 2024 2023 Revenue: Licenses $ 219,985 $ 158,961 $ 621,392 $ 497,836 Subscription services 176,038 138,514 649,918 508,823 Professional services and other 9,230 11,074 36,762 51,922 Total revenue 405,253 308,549 1,308,072 1,058,581 Cost of revenue: Licenses 2,133 2,506 10,469 10,421 Subscription services 33,420 23,417 111,922 87,366 Professional services and other 17,797 21,768 73,533 82,264 Total cost of revenue 53,350 47,691 195,924 180,051 Gross profit 351,903 260,858 1,112,148 878,530 Operating expenses: Sales and marketing 191,717 173,760 713,130 701,558 Research and development 85,639 81,870 332,101 285,750 General and administrative 59,452 50,375 231,637 239,505 Total operating expenses 336,808 306,005 1,276,868 1,226,813 Operating income (loss) 15,095 (45,147 ) (164,720 ) (348,283 ) Interest income 15,217 12,898 57,130 27,955 Other income, net 6,284 5,290 31,775 2,767 Income (loss) before income taxes 36,596 (26,959 ) (75,815 ) (317,561 ) Provision for income taxes 2,680 730 14,068 10,791 Net income (loss) $ 33,916 $ (27,689 ) $ (89,883 ) $ (328,352 ) Net income (loss) per share attributable to common stockholders, basic $ 0.06 $ (0.05 ) $ (0.16 ) $ (0.60 ) Net income (loss) per share attributable to common stockholders, diluted $ 0.06 $ (0.05 ) $ (0.16 ) $ (0.60 ) Weighted-average shares used in computing net income (loss) per share attributable to common stockholders, basic 567,428 553,766 563,855 548,022 Weighted-average shares used in computing net income (loss) per share attributable to common stockholders, diluted 583,191 553,766 563,855 548,022 UiPath, Inc. Condensed Consolidated Balance Sheets in thousands (unaudited) As of January 31, 2024 January 31, 2023 Assets Current assets Cash and cash equivalents $ 1,061,678 $ 1,402,119 Restricted cash 438  Marketable securities 818,145 354,774 Accounts receivable, net of allowance for credit losses of $1,119 and $2,698, respectively 436,296 374,217 Contract assets 84,197 69,260 Deferred contract acquisition costs 74,678 49,887 Prepaid expenses and other current assets 104,980 94,150 Total current assets 2,580,412 2,344,407 Marketable securities, non-current  2,942 Contract assets, non-current 6,214 6,523 Deferred contract acquisition costs, non-current 154,317 137,616 Property and equipment, net 23,982 29,045 Operating lease right-of-use assets 56,072 52,052 Intangible assets, net 14,704 23,010 Goodwill 89,026 88,010 Deferred tax assets 4,678 5,895 Other assets, non-current 25,353 45,706 Total assets $ 2,954,758 $ 2,735,206 Liabilities and stockholders' equity Current liabilities Accounts payable $ 3,447 $ 8,891 Accrued expenses and other current liabilities 83,997 76,645 Accrued compensation and employee benefits 137,442 142,582 Deferred revenue 486,805 398,334 Total current liabilities 711,691 626,452 Deferred revenue, non-current 161,027 121,697 Operating lease liabilities, non-current 58,713 56,442 Other liabilities, non-current 7,213 10,457 Total liabilities 938,644 815,048 Commitments and contingencies Stockholders' equity Class A common stock 5 5 Class B common stock 1 1 Treasury stock (102,615 )  Additional paid-in capital 4,024,079 3,736,838 Accumulated other comprehensive income 8,825 7,612 Accumulated deficit (1,914,181 ) (1,824,298 ) Total stockholders equity 2,016,114 1,920,158 Total liabilities and stockholders equity $ 2,954,758 $ 2,735,206 UiPath, Inc. Condensed Consolidated Statements of Cash Flows in thousands (unaudited) Twelve Months Ended January 31, 2024 2023 Cash flows from operating activities Net loss $ (89,883 ) $ (328,352 ) Adjustments to reconcile net loss to net cash provided by (used in) operating activities: Depreciation and amortization 22,597 18,723 Amortization of deferred contract acquisition costs 75,471 59,826 Net amortization on marketable securities (28,246 ) (1,782 ) Stock-based compensation expense 371,955 369,840 Charitable donation of Class A common stock 4,215 5,499 Non-cash operating lease expense 13,047 11,675 Abandonment and impairment charges  2,881 Provision for deferred income taxes 554 861 Other non-cash credits, net (3,700 ) (2,465 ) Changes in operating assets and liabilities: Accounts receivable (64,217 ) (123,783 ) Contract assets (14,694 ) (185 ) Deferred contract acquisition costs (118,833 ) (118,909 ) Prepaid expenses and other assets 4,222 (59,810 ) Accounts payable (5,052 ) (1,571 ) Accrued expenses and other liabilities 11,804 (14,954 ) Accrued compensation and employee benefits (4,039 ) 15,086 Operating lease liabilities, net (13,590 ) (3,307 ) Deferred revenue 137,471 160,746 Net cash provided by (used in) operating activities 299,082 (9,981 ) Cash flows from investing activities Purchases of marketable securities (1,485,965 ) (388,409 ) Maturities of marketable securities 1,050,984 151,426 Purchases of property and equipment (7,342 ) (23,815 ) Payments related to business acquisition, net of cash acquired  (29,542 ) Other investing, net 2,754 1,197 Net cash used in investing activities (439,569 ) (289,143 ) Cash flows from financing activities Repurchases of Class A common stock (102,615 )  Proceeds from exercise of stock options 6,740 8,388 Payments of tax withholdings on net settlement of equity awards (112,067 ) (73,095 ) Net payments of tax withholdings on sell-to-cover equity award transactions (645 ) (9,480 ) Proceeds from employee stock purchase plan contributions 17,555 15,011 Payment of deferred consideration related to business acquisition (5,863 )  Repurchase of unvested early exercised stock options  (1,493 ) Net cash used in financing activities (196,895 ) (60,669 ) Effect of exchange rate changes (2,621 ) (6,811 ) Net decrease in cash, cash equivalents, and restricted cash (340,003 ) (366,604 ) Cash, cash equivalents, and restricted cash - beginning of period 1,402,119 1,768,723 Cash, cash equivalents, and restricted cash - end of period $ 1,062,116 $ 1,402,119 UiPath, Inc. Reconciliation of GAAP Cost of Revenue, Gross Profit and Margin to Non-GAAP Cost of Revenue, Gross Profit and Margin in thousands, except percentages (unaudited) Three Months Ended January 31, Twelve Months Ended January 31, 2024 2023 2024 2023 GAAP cost of licenses $ 2,133 $ 2,506 $ 10,469 $ 10,421 Less: Amortization of acquired intangible assets 848 819 3,371 2,754 Non-GAAP cost of licenses $ 1,285 $ 1,687 $ 7,098 $ 7,667 GAAP cost of subscription services $ 33,420 $ 23,417 $ 111,922 $ 87,366 Less: Stock-based compensation expense 3,972 2,993 14,750 11,894 Less: Amortization of acquired intangible assets 592 581 2,359 1,811 Less: Employer payroll tax expense related to employee equity transactions 201 92 434 272 Less: Restructuring costs  45 114 182 Non-GAAP cost of subscription services $ 28,655 $ 19,706 $ 94,265 $ 73,207 GAAP cost of professional services and other $ 17,797 $ 21,768 $ 73,533 $ 82,264 Less: Stock-based compensation expense 2,412 2,896 10,958 11,855 Less: Employer payroll tax expense related to employee equity transactions 146 96 327 263 Less: Restructuring costs  390  710 Non-GAAP cost of professional services and other $ 15,239 $ 18,386 $ 62,248 $ 69,436 GAAP gross profit $ 351,903 $ 260,858 $ 1,112,148 $ 878,530 GAAP gross margin 87 % 85 % 85 % 83 % Plus: Stock-based compensation expense 6,384 5,889 25,708 23,749 Plus: Amortization of acquired intangible assets 1,440 1,400 5,730 4,565 Plus: Employer payroll tax expense related to employee equity transactions 347 188 761 535 Plus: Restructuring costs  435 114 892 Non-GAAP gross profit $ 360,074 $ 268,770 $ 1,144,461 $ 908,271 Non-GAAP gross margin 89 % 87 % 87 % 86 % UiPath, Inc. Reconciliation of GAAP Operating Expenses, Income (Loss), and Margin to Non-GAAP Operating Expenses, Income and Margin in thousands, except percentages (unaudited) Three Months Ended January 31, Twelve Months Ended January 31, 2024 2023 2024 2023 GAAP sales and marketing $ 191,717 $ 173,760 $ 713,130 $ 701,558 Less: Stock-based compensation expense 34,973 37,512 144,863 154,922 Less: Amortization of acquired intangible assets 679 667 2,706 2,153 Less: Employer payroll tax expense related to employee equity transactions 1,826 1,560 4,176 4,605 Less: Restructuring costs (5 ) 8,248 1,376 19,491 Non-GAAP sales and marketing $ 154,244 $ 125,773 $ 560,009 $ 520,387 GAAP research and development $ 85,639 $ 81,870 $ 332,101 $ 285,750 Less: Stock-based compensation expense 29,517 28,987 117,965 102,546 Less: Employer payroll tax expense related to employee equity transactions 1,455 721 3,027 1,692 Less: Restructuring costs  451 387 494 Non-GAAP research and development $ 54,667 $ 51,711 $ 210,722 $ 181,018 GAAP general and administrative $ 59,452 $ 50,375 $ 231,637 $ 239,505 Less: Stock-based compensation expense 18,056 26,655 83,419 88,623 Less: Amortization of acquired intangible assets 41 42 164 178 Less: Employer payroll tax expense related to employee equity transactions 715 444 1,924 930 Less: Restructuring costs  1,187 749 2,569 Less: Charitable donation of Class A common stock   4,215 5,499 Non-GAAP general and administrative $ 40,640 $ 22,047 $ 141,166 $ 141,706 GAAP operating income (loss) $ 15,095 $ (45,147 ) $ (164,720 ) $ (348,283 ) GAAP operating margin 4 % (15 )% (13 )% (33 )% Plus: Stock-based compensation expense 88,930 99,043 371,955 369,840 Plus: Amortization of acquired intangible assets 2,160 2,109 8,600 6,896 Plus: Employer payroll tax expense related to employee equity transactions 4,343 2,913 9,888 7,762 Plus: Restructuring costs (5 ) 10,321 2,626 23,446 Plus: Charitable donation of Class A common stock   4,215 5,499 Non-GAAP operating income $ 110,523 $ 69,239 $ 232,564 $ 65,160 Non-GAAP operating margin 27 % 22 % 18 % 6 % UiPath, Inc. Reconciliation of GAAP Net Income (Loss) and GAAP Net Income (Loss) Per Share to Non-GAAP Net Income and Non-GAAP Net Income Per Share in thousands, except per share data (unaudited) Three Months Ended January 31, Twelve Months Ended January 31, 2024 2023 2024 2023 GAAP net income (loss) attributable to common stockholders $ 33,916 $ (27,689 ) $ (89,883 ) $ (328,352 ) Plus: Stock-based compensation expense 88,930 99,043 371,955 369,840 Plus: Amortization of acquired intangible assets 2,160 2,109 8,600 6,896 Plus: Employer payroll tax expense related to employee equity transactions 4,343 2,913 9,888 7,762 Plus: Restructuring costs (5 ) 10,321 2,626 23,446 Plus: Charitable donation of Class A common stock   4,215 5,499 Tax adjustments to add-backs (830 ) (3,999 ) 2,979 (4,608 ) Non-GAAP net income $ 128,514 $ 82,698 $ 310,380 $ 80,483 GAAP net income (loss) per share, basic $ 0.06 $ (0.05 ) $ (0.16 ) $ (0.60 ) GAAP net income (loss) per share, diluted $ 0.06 $ (0.05 ) $ (0.16 ) $ (0.60 ) GAAP weighted average common shares outstanding, basic 567,428 553,766 563,855 548,022 GAAP weighted average common shares outstanding, diluted 583,191 553,766 563,855 548,022 Non-GAAP weighted average common shares outstanding, basic 567,428 553,766 563,855 548,022 Plus: Dilutive potential common shares from outstanding equity awards 15,763 9,066 12,633 12,483 Non-GAAP weighted average common shares outstanding, diluted 583,191 562,832 576,488 560,505 Non-GAAP net income per share, basic $ 0.23 $ 0.15 $ 0.55 $ 0.15 Non-GAAP net income per share, diluted $ 0.22 $ 0.15 $ 0.54 $ 0.14 UiPath, Inc. Reconciliation of GAAP Operating Cash Flow to Non-GAAP Adjusted Free Cash Flow in thousands (unaudited) Twelve Months Ended January 31, 2024 2023 GAAP net cash provided by (used in) operating activities $ 299,082 $ (9,981 ) Purchases of property and equipment (7,342 ) (23,815 ) Cash paid for employer payroll taxes related to employee equity transactions 10,483 9,112 Net payments of employee tax withholdings on stock option exercises 980 5,394 Cash paid for restructuring costs 6,180 19,339 Non-GAAP adjusted free cash flow $ 309,383 $ 49 View source version on businesswire.com: https://www.businesswire.com/news/home/20240313601802/en/ Investor Relations Contact Kelsey Turcotte Investor.relations@uipath.com UiPath Media Contact Pete Daly PR@uipath.com UiPath Source: UiPath, Inc. What was UiPath's (PATH) record quarterly revenue? UiPath reported record quarterly revenue of $405 million. By how much did the ARR increase year-over-year for UiPath (PATH)? UiPath's ARR grew by 22% year-over-year to reach $1.464 billion. Did UiPath (PATH) achieve GAAP profitability in the reported quarter? Yes, UiPath achieved its first quarter of GAAP profitability as a public company. What was the cash flow from operations and non-GAAP adjusted free cash flow for UiPath (PATH)? UiPath reported cash flow from operations and non-GAAP adjusted free cash flow of $146 million. What is the financial outlook for UiPath (PATH) in fiscal 2025? For fiscal 2025, UiPath expects revenue between $1.555 billion to $1.560 billion and ARR in the range of $1.725 billion to $1.730 billion."
SentinelOne Announces Fourth Quarter Fiscal Year 2024 Financial Results,2024-03-13T20:10:00.000Z,Neutral,Neutral,"SentinelOne, Inc. (S) announces impressive financial results for Q4 and fiscal year 2024 with a 38% revenue increase and 39% ARR growth. The company achieved a 47% revenue growth, 30 percentage point operating margin improvement, and aims for profitability by the end of 2025. Total revenue for Q4 reached $174.2 million, ARR stood at $724.4 million, and GAAP gross margin was 72%. Non-GAAP gross margin was 78%, with GAAP operating margin at (47)% and non-GAAP at (9)%. Cash, cash equivalents, and investments were $1.1 billion as of January 31, 2024. Full-year highlights include a 47% revenue increase to $621.2 million, GAAP gross margin of 71%, and non-GAAP operating margin of (19)%. The company provided guidance for Q1FY25 and FY2025, expecting revenue of $181 million in Q1 and $812-818 million for FY2025.","SentinelOne Announces Fourth Quarter Fiscal Year 2024 Financial Results Rhea-AI Impact (Neutral) Rhea-AI Sentiment (Neutral) Tags earnings Rhea-AI Summary SentinelOne, Inc. (S) announces impressive financial results for Q4 and fiscal year 2024 with a 38% revenue increase and 39% ARR growth. The company achieved a 47% revenue growth, 30 percentage point operating margin improvement, and aims for profitability by the end of 2025. Total revenue for Q4 reached $174.2 million, ARR stood at $724.4 million, and GAAP gross margin was 72%. Non-GAAP gross margin was 78%, with GAAP operating margin at (47)% and non-GAAP at (9)%. Cash, cash equivalents, and investments were $1.1 billion as of January 31, 2024. Full-year highlights include a 47% revenue increase to $621.2 million, GAAP gross margin of 71%, and non-GAAP operating margin of (19)%. The company provided guidance for Q1FY25 and FY2025, expecting revenue of $181 million in Q1 and $812-818 million for FY2025. Positive None. Negative None. Financial Analyst The reported growth in annual revenue and annualized recurring revenue (ARR) by SentinelOne is a strong indicator of the company's financial health and its ability to attract and retain customers. A 38% increase in revenue and a 39% increase in ARR year-over-year is a significant achievement, particularly in the competitive cybersecurity market. The growth in customers contributing more than $100,000 in ARR suggests that SentinelOne is successfully scaling its operations and appealing to larger enterprise clients. The dollar-based net retention rate of approximately 115% indicates that existing customers are increasing their spending, which is a positive signal for future revenue stability.Improvements in both GAAP and non-GAAP gross margins, as well as operating margins, reflect better cost management and efficiency gains. However, the company is still operating at a loss, with a GAAP operating margin of (61)% for the fiscal year. This is not uncommon for growth-stage tech companies investing heavily in expansion. The forward-looking guidance suggests an intent to narrow operating losses, which could signal a strategic shift towards profitability. Investors should monitor the company's progress towards these targets, as achieving them could have a positive impact on the stock's performance. Market Research Analyst The cybersecurity sector is experiencing rapid growth due to increasing digital threats and the adoption of cloud technologies. SentinelOne's strong revenue growth and expansion of its customer base are indicative of the company's competitive positioning in the market. The Singularity Platform's scale and breadth, as mentioned by the CFO, are likely contributing factors to the company's success in capturing market share. The emphasis on enterprise-wide visibility and autonomous cybersecurity reflects industry trends towards integrated, AI-driven security solutions.Considering the market dynamics, SentinelOne's focus on innovation and security leadership is essential for maintaining its growth trajectory. The company's financial outlook for fiscal year 2025 suggests confidence in continued growth and an improvement in profitability metrics. As enterprises increasingly prioritize cybersecurity, SentinelOne's growth prospects appear robust. However, competition remains fierce and maintaining industry-leading growth will require constant innovation and effective execution of business strategies. Economist The fiscal results of SentinelOne can be seen as a microcosm of larger economic trends, particularly in the technology and cybersecurity sectors. The substantial revenue increase and improved margins are reflective of the high demand for cybersecurity solutions in an era of digital transformation. SentinelOne's performance also suggests that the company has effectively leveraged economies of scale and potentially benefited from network effects as its platform expands.The projected guidance for future margins indicates that SentinelOne is moving towards a sustainable financial model, which is critical for long-term shareholder value. The broader economic context, including potential headwinds such as regulatory changes, shifts in technology spending and macroeconomic factors, will play a role in the company's ability to meet its guidance. Investors would do well to consider these external factors alongside the company's operational performance when evaluating its financial outlook. 03/13/2024 - 04:10 PM Revenue increased 38% year-over-year ARR up 39% year-over-year MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)-- SentinelOne, Inc. (NYSE: S) today announced financial results for the fourth quarter and fiscal year 2024 ended January 31, 2024. We closed the year on a very strong note and surpassed our fourth quarter top and bottom line expectations. In fiscal year 2024, we delivered industry-leading revenue growth of 47% and operating margin improvement of more than 30 percentage points compared to the prior year, said Tomer Weingarten, CEO of SentinelOne. Our pace of innovation and security leadership remain unmatched. Enterprises are selecting SentinelOne at a record pace across endpoint, data, cloud security, and more. We are giving control back to the enterprises through enterprise-wide visibility and autonomous cybersecurity. Once again, we delivered strong top-line growth and margin expansion, showcasing the scale and breadth of our Singularity Platform. We achieved our tenth consecutive quarter of over 25 percentage points of year-over-year operating margin improvement, said Dave Bernhardt, CFO of SentinelOne. Building on our fiscal year 2024 outperformance, we aim to maintain our industry-leading growth profile while turning the page on profitability by the end of the year. Letter to Shareholders We have also published a letter to shareholders on the Investor Relations section of our website at investors.sentinelone.com. The letter provides further discussion of our results for the fourth quarter of fiscal year 2024 as well as our first quarter and full fiscal year 2025 financial outlook. Fourth Quarter Fiscal 2024 Highlights (All metrics are compared to the fourth quarter of fiscal year 2023 unless otherwise noted) Total revenue increased 38% to $174.2 million, compared to $126.1 million. Annualized recurring revenue (ARR) increased 39% to $724.4 million as of January 31, 2024. Customers with ARR of $100,000 or more grew 30% to 1,133 as of January 31, 2024. Dollar-based net retention rate (NRR) was approximately 115%. Gross margin: GAAP gross margin was 72%, compared to 68%. Non-GAAP gross margin was 78%, compared to 75%. Operating margin: GAAP operating margin was (47)%, compared to (79)%. Non-GAAP operating margin was (9)%, compared to (35)%. Cash flow margin: Operating cash flow margin was (4)%, compared to (18)%. Free cash flow margin was (6)%, 14 percentage points higher compared to (20)%. Cash, cash equivalents, and investments were $1.1 billion as of January 31, 2024. Full Year Fiscal 2024 Highlights (All metrics are compared to fiscal year 2023 unless otherwise noted) Total revenue increased 47% to $621.2 million, compared to $422.2 million. Gross margin: GAAP gross margin was 71%, compared to 66%. Non-GAAP gross margin was 77%, compared to 72%. Operating margin: GAAP operating margin was (61)%, compared to (95)%. Non-GAAP operating margin was (19)%, compared to (49)%. Financial Outlook We are providing the following guidance for the first quarter of the fiscal year 2025 (ending April 30, 2024), and for the fiscal year 2025 (ending January 31, 2025). Q1FY25 Guidance Full FY2025 Guidance Revenue $181 million $812-818 million Non-GAAP gross margin 77.5% 77.5-78.5% Non-GAAP operating margin (14)% (6)-(2)% These statements are forward-looking and actual results may differ materially as a result of many factors. Refer to the below for information on the factors that could cause our actual results to differ materially from these forward-looking statements. Guidance for non-GAAP financial measures excludes stock-based compensation expense, employer payroll tax on employee stock transactions, amortization expense of acquired intangible assets, acquisition-related compensation costs, restructuring charges, and gains and losses on strategic investments. We have not provided the most directly comparable GAAP measures because certain items are out of our control or cannot be reasonably predicted. Accordingly, a reconciliation of non-GAAP gross margin and non-GAAP operating margin is not available without unreasonable effort. Webcast Information We will host a live audio webcast for analysts and investors to discuss our earnings results for the fourth quarter of fiscal year 2024, and outlook for the first quarter of fiscal year 2025 and full fiscal year 2025 today, March 13, 2024, at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time). The live webcast and a recording of the event will be available on the Investor Relations section of our website at investors.sentinelone.com. We have used, and intend to continue to use, the Investor Relations section of our website at investors.sentinelone.com as a means of disclosing material nonpublic information and for complying with our disclosure obligations under Regulation FD. Forward-Looking Statements This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, which statements involve risks and uncertainties, including but not limited to statements regarding our future growth, execution, competitive position, and future financial and operating performance, including our financial outlook for the first quarter of fiscal year 2025 and our full fiscal year 2025, including non-GAAP gross margin and non-GAAP operating margin; progress towards our long-term profitability targets; and general market trends. The words believe, may, will, potentially, estimate, continue, anticipate, intend, could, would, project, target, plan, expect, or the negative of these terms and similar expressions are intended to identify forward-looking statements. However, not all forward-looking statements contain these identifying words. There are a significant number of factors that could cause our actual results to differ materially from statements made in this press release, including but not limited to: our limited operating history; our history of losses; intense competition in the market we compete in; fluctuations in our operating results; actual or perceived network or security incidents against us; our ability to successfully integrate any acquisitions and strategic investments; actual or perceived defects, errors or vulnerabilities in our platform; risks associated with managing our rapid growth; general global market, political, economic, and business conditions, including those related to declining global macroeconomic conditions, interest rate volatility, supply chain disruptions and inflation, actual or perceive instability in the banking sector, potential uncertainty with respect to the federal debt ceiling and budget and potential government shutdowns related thereto, and geopolitical uncertainty, including the effects of the conflicts in the Middle East and Ukraine and the judicial reform in Israel; our ability to attract new and retain existing customers, or renew and expand our relationships with them; the ability of our platform to effectively interoperate within our customers' IT infrastructure; disruptions or other business interruptions that affect the availability of our platform including cybersecurity incidents; the failure to timely develop and achieve market acceptance of new products and subscriptions as well as existing products, subscriptions and support offerings; rapidly evolving technological developments in the market for security products and subscription and support offerings; length of sales cycles; and risks of securities class action litigation. Additional risks and uncertainties that could affect our financial results are included under the captions Risk Factors and Managements Discussion and Analysis of Financial Condition and Results of Operations set forth in our filings and reports with the Securities and Exchange Commission (SEC), including our most recently filed Annual Report on Form 10-K, subsequent Quarterly Reports on Form 10-Q and other filings and reports that we may file from time to time with the SEC, copies of which are available on our website at investors.sentinelone.com and on the SECs website at www.sec.gov. You should not rely on these forward-looking statements, as actual outcomes and results may differ materially from those contemplated by these forward-looking statements as a result of such risks and uncertainties. All forward-looking statements in this press release are based on information and estimates available to us as of the date hereof, and were based on current expectations, estimates, forecasts, and projections as well as the beliefs and assumptions of management. We do not assume any obligation to update the forward-looking statements provided to reflect events that occur or circumstances that exist after the date of this press release or to reflect new information or the occurrence of unexpected events, except as required by law. We may not actually achieve the plans, intentions, or expectations disclosed in our forward-looking statements, and you should not place undue reliance on our forward-looking statements. Non-GAAP Financial Measures In addition to our results determined in accordance with GAAP, we believe the following non-GAAP measures are useful in evaluating our operating performance. We use the following non-GAAP financial information to evaluate our ongoing operations and for internal planning and forecasting purposes. We believe that non-GAAP financial information, when taken collectively, with the financial information presented in accordance with GAAP, may be helpful to investors because it provides consistency and comparability with past financial performance. However, non-GAAP financial information is presented for supplemental informational purposes only, has limitations as an analytical tool, and should not be considered in isolation or as a substitute for financial information presented in accordance with GAAP. Other companies, including companies in our industry, may calculate similarly titled non-GAAP measures differently or may use other measures to evaluate their performance, all of which could reduce the usefulness of our non-GAAP financial measures as tools for comparison. In addition, the utility of free cash flow as a measure of our liquidity is limited as it does not represent the total increase or decrease in our cash balance for a given period. Reconciliations between non-GAAP financial measures to the most directly comparable financial measure stated in accordance with GAAP are contained below. Investors are encouraged to review the related GAAP financial measures and the reconciliation of these non-GAAP financial measures to their most directly comparable GAAP financial measures and not rely on any single financial measure to evaluate our business. As presented in the Reconciliation of GAAP to Non-GAAP Financial Information table below, each of the non-GAAP financial measures excludes one or more of the following items: Stock-based compensation expense Stock-based compensation expense is a non-cash expense that varies in amount from period to period and is dependent on market forces that are often beyond our control. As a result, management excludes this item from our internal operating forecasts and models. Management believes that non-GAAP measures adjusted for stock-based compensation expense provide investors with a basis to measure our core performance against the performance of other companies without the variability created by stock-based compensation as a result of the variety of equity awards used by other companies and the varying methodologies and assumptions used. Employer payroll tax on employee stock transactions Employer payroll tax expenses related to employee stock transactions are tied to the vesting or exercise of underlying equity awards and the price of our common stock at the time of vesting, which varies in amount from period to period and is dependent on market forces that are often beyond our control. As a result, management excludes this item from our internal operating forecasts and models. Management believes that non-GAAP measures adjusted for employer payroll taxes on employee stock transactions provide investors with a basis to measure our core performance against the performance of other companies without the variability created by employer payroll taxes on employee stock transactions as a result of the stock price at the time of employee exercise. Amortization of acquired intangible assets Amortization of acquired intangible asset expense is tied to the intangible assets that were acquired in conjunction with acquisitions, which results in noncash expenses that may not otherwise have been incurred. Management believes excluding the expense associated with intangible assets from non-GAAP measures allows for a more accurate assessment of our ongoing operations and provides investors with a better comparison of period-over-period operating results. Acquisition-related compensation costs Acquisition-related compensation costs include cash-based compensation expenses resulting from the employment retention of certain employees established in accordance with the terms of the acquisition of Attivo Networks, Inc. in May 2022 (the Attivo acquisition). Acquisition-related cash-based compensation costs have been excluded as they were specifically negotiated as part of the Attivo acquisition in order to retain such employees and relate to cash compensation that was made either in lieu of stock-based compensation or where the grant of stock-based compensation awards was not practicable. In most cases, these acquisition-related compensation costs are not factored into management's evaluation of potential acquisitions or our performance after completion of acquisitions, because they are not related to our core operating performance. In addition, the frequency and amount of such charges can vary significantly based on the size and timing of acquisitions and the maturities of the businesses being acquired. Excluding acquisition-related compensation costs from non-GAAP measures provides investors with a basis to compare our results against those of other companies without the variability caused by purchase accounting. Restructuring charges Restructuring charges primarily relate to severance payments, employee benefits, stock-based compensation, impairment charges related to excess facilities and inventory write-offs. These restructuring charges are excluded from non-GAAP financial measures because they are the result of discrete events that are not considered core-operating activities. We believe that it is appropriate to exclude restructuring charges from non-GAAP financial measures because it enables the comparison of period-over-period operating results from continuing operations. Gains and losses on strategic investments Gains and losses on strategic investments relate to the subsequent changes in the recorded value of our strategic investments. These gains and losses are excluded from non-GAAP financial measures because they are the result of discrete events that are not considered core-operating activities. We believe that it is appropriate to exclude gains and losses from strategic investments from non-GAAP financial measures because it enables the comparison of period-over-period net income (loss). Income tax benefit We believe that excluding the tax benefit associated with the partial reversal of the valuation allowance against our deferred tax assets for the second quarter of fiscal year 2023 provides our senior management as well as other users of our financial statements with a valuable perspective on the performance and health of the business. This partial reversal relates to the realization of our deferred tax assets used to offset deferred tax liabilities recorded in the Attivo acquisition. This one-time benefit is not indicative of current or future operations and expenses. Non-GAAP Cost of Revenue, Non-GAAP Gross Profit, Non-GAAP Gross Margin, Non-GAAP Loss from Operations, Non-GAAP Operating Margin, Non-GAAP Net Loss and Non-GAAP Net Loss Per Share We define these non-GAAP financial measures as their respective GAAP measures, excluding the expenses referenced above. We use these non-GAAP financial measures as part of our overall assessment of our performance, including the preparation of our annual operating budget and quarterly forecasts, to evaluate the effectiveness of our business strategies, and to communicate with our board of directors concerning our financial performance. Free Cash Flow We define free cash flow as cash used in operating activities less purchases of property and equipment and capitalized internal-use software costs. We believe free cash flow is a useful indicator of liquidity that provides our management, board of directors, and investors with information about our future ability to generate or use cash to enhance the strength of our balance sheet and further invest in our business and pursue potential strategic initiatives. Key Business Metrics We monitor the following key metrics to help us evaluate our business, identify trends affecting our business, formulate business plans, and make strategic decisions. Annualized Recurring Revenue (ARR) We believe that ARR is a key operating metric to measure our business because it is driven by our ability to acquire new subscription and consumption and usage-based customers and to maintain and expand our relationship with existing customers. ARR represents the annualized revenue run rate of our subscription and consumption and usage-based agreements at the end of a reporting period, assuming contracts are renewed on their existing terms for customers that are under contracts with us. ARR is not a forecast of future revenue, which can be impacted by contract start and end dates, usage, renewal rates, and other contractual terms. In the first quarter of fiscal year 2024, we adjusted our historical ARR. The adjustment to ARR did not impact historical total bookings or revenue. Further information relating to this adjustment can be found in Item 2. Managements Discussion and Analysis of Financial Condition and Results of Operations, Key Business Metrics in our Quarterly Report on Form 10-Q filed with the SEC on June 1, 2023. Customers with ARR of $100,000 or More We believe that our ability to increase the number of customers with ARR of $100,000 or more is an indicator of our market penetration and strategic demand for our platform. We define a customer as an entity that has an active subscription for access to our platform. We count Managed Service Providers, Managed Security Service Providers, Managed Detection & Response firms, and Original Equipment Manufacturers, who may purchase our products on behalf of multiple companies, as a single customer. We do not count our reseller or distributor channel partners as customers. Based on the adjustments to ARR described above, customers with ARR of $100,000 or more for the prior periods in fiscal year 2023 have been adjusted accordingly. Dollar-Based Net Retention Rate (NRR) We believe that our ability to retain and expand the revenue generated from our existing customers is an indicator of the long-term value of our customer relationships and our potential future business opportunities. Dollar-based net retention rate measures the percentage change in our ARR derived from our customer base at a point in time. To calculate these metrics, we first determine Prior Period ARR, which is ARR from the population of our customers as of 12 months prior to the end of a particular reporting period. We calculate Net Retention ARR as the total ARR at the end of a particular reporting period from the set of customers that is used to determine Prior Period ARR. Net Retention ARR includes any expansion, and is net of contraction and attrition associated with that set of customers. NRR is the quotient obtained by dividing Net Retention ARR by Prior Period ARR. Source: SentinelOne NYSE: S Category: Investors SENTINELONE, INC. CONDENSED CONSOLIDATED BALANCE SHEETS (in thousands) (unaudited) January 31, January 31, 2024 2023 Assets Current assets: Cash and cash equivalents $ 256,651 $ 137,941 Short-term investments 669,305 485,584 Accounts receivable, net 214,322 151,492 Deferred contract acquisition costs, current 54,158 37,904 Prepaid expenses and other current assets 102,895 101,812 Total current assets 1,297,331 914,733 Property and equipment, net 48,817 38,741 Operating lease right-of-use assets 18,474 23,564 Long-term investments 204,798 535,422 Deferred contract acquisition costs, non-current 71,640 55,536 Intangible assets, net 122,903 145,093 Goodwill 549,411 540,308 Other assets 8,033 5,516 Total assets $ 2,321,407 $ 2,258,913 Liabilities and Stockholders Equity Current liabilities: Accounts payable $ 6,759 $ 11,214 Accrued liabilities 104,671 100,015 Accrued payroll and benefits 74,345 54,955 Operating lease liabilities, current 4,689 3,895 Deferred revenue, current 399,603 303,200 Total current liabilities 590,067 473,279 Deferred revenue, non-current 114,930 103,062 Operating lease liabilities, non-current 18,239 23,079 Other liabilities 4,128 2,788 Total liabilities 727,364 602,208 Stockholders equity: Preferred stock   Class A common stock 27 21 Class B common stock 3 8 Additional paid-in capital 2,934,607 2,663,394 Accumulated other comprehensive loss (1,550 ) (6,367 ) Accumulated deficit (1,339,044 ) (1,000,351 ) Total stockholders equity 1,594,043 1,656,705 Total liabilities and stockholders equity $ 2,321,407 $ 2,258,913 SENTINELONE, INC. CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (in thousands, except share and per share data) (unaudited) Three Months Ended January 31, Twelve Months Ended January 31, 2024 2023 2024 2023 Revenue $ 174,175 $ 126,096 $ 621,154 $ 422,179 Cost of revenue(1) 48,266 39,771 179,281 144,177 Gross profit 125,909 86,325 441,873 278,002 Operating expenses: Research and development(1) 56,446 53,904 218,176 207,008 Sales and marketing(1) 101,478 87,254 397,160 310,848 General and administrative(1) 46,822 45,197 198,247 162,722 Restructuring(1) 2,377  6,706  Total operating expenses 207,123 186,355 820,289 680,578 Loss from operations (81,214 ) (100,030 ) (378,416 ) (402,576 ) Interest income 11,979 9,906 45,880 21,408 Interest expense (3 ) (605 ) (1,216 ) (1,830 ) Other income (expense), net (737 ) (648 ) 918 (1,293 ) Loss before income taxes (69,975 ) (91,377 ) (332,834 ) (384,291 ) Provision for (benefit from) income taxes 2,007 2,303 5,859 (5,613 ) Net loss $ (71,982 ) $ (93,680 ) $ (338,693 ) $ (378,678 ) Net loss per share attributable to Class A and Class B common stockholders, basic and diluted $ (0.24 ) $ (0.33 ) $ (1.15 ) $ (1.36 ) Weighted-average shares used in computing net loss per share attributable to Class A and Class B common stockholders, basic and diluted 301,356,227 283,545,048 294,923,536 277,802,861 (1) Includes stock-based compensation expense as follows: Cost of revenue $ 4,617 $ 3,011 $ 17,187 $ 10,093 Research and development 15,179 13,817 61,055 51,771 Sales and marketing 15,436 11,138 55,798 40,115 General and administrative 18,330 18,182 83,890 62,487 Restructuring   (1,060 )  Total stock-based compensation expense $ 53,562 $ 46,148 $ 216,870 $ 164,466 SENTINELONE, INC. CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (in thousands) (unaudited) Twelve Months Ended January 31, 2024 2023 CASH FLOW FROM OPERATING ACTIVITIES: Net loss $ (338,693 ) $ (378,678 ) Adjustments to reconcile net loss to net cash used in operating activities: Depreciation and amortization 38,912 29,721 Amortization of deferred contract acquisition costs 48,682 36,417 Non-cash operating lease costs 4,020 3,559 Stock-based compensation expense 216,870 164,466 Accretion of discounts, and amortization of premiums on investments, net (19,943 ) (12,217 ) Net gain on strategic investments (2,703 )  Other 4,637 (1,187 ) Changes in operating assets and liabilities, net of effects of acquisitions Accounts receivable (61,949 ) (44,442 ) Prepaid expenses and other assets (1,207 ) (14,499 ) Deferred contract acquisition costs (81,039 ) (61,289 ) Accounts payable (4,499 ) 3,670 Accrued liabilities 4,271 4,976 Accrued payroll and benefits 19,140 (7,205 ) Operating lease liabilities (4,410 ) (5,320 ) Deferred revenue 108,197 92,496 Other liabilities 1,340 (3,755 ) Net cash used in operating activities (68,374 ) (193,287 ) CASH FLOW FROM INVESTING ACTIVITIES: Purchases of property and equipment (1,304 ) (4,953 ) Purchases of intangible assets (3,505 ) (407 ) Capitalization of internal-use software (13,956 ) (13,452 ) Purchases of investments (466,253 ) (1,938,007 ) Sales and maturities of investments 639,193 925,185 Cash paid for acquisitions, net of cash and restricted cash acquired (13,585 ) (281,032 ) Net cash provided by (used in) investing activities 140,590 (1,312,666 ) CASH FLOW FROM FINANCING ACTIVITIES: Payments of deferred offering costs  (186 ) Proceeds from exercise of stock options 28,317 17,335 Proceeds from issuance of common stock under the employee stock purchase plan 19,147 19,159 Net cash provided by financing activities 47,464 36,308 EFFECT OF EXCHANGE RATE CHANGES ON CASH AND CASH EQUIVALENTS   NET CHANGE IN CASH, CASH EQUIVALENTS, AND RESTRICTED CASH 119,680 (1,469,645 ) CASH, CASH EQUIVALENTS, AND RESTRICTED CASHBeginning of period 202,406 1,672,051 CASH, CASH EQUIVALENTS, AND RESTRICTED CASHEnd of period $ 322,086 $ 202,406 SENTINELONE, INC. RECONCILIATION OF GAAP TO NON-GAAP FINANCIAL INFORMATION (in thousands, except percentages and per share data) (unaudited) Three Months Ended January 31, Twelve Months Ended January 31, 2024 2023 2024 2023 Cost of revenue reconciliation: GAAP cost of revenue $ 48,266 $ 39,771 $ 179,281 $ 144,177 Stock-based compensation expense (4,617 ) (3,011 ) (17,187 ) (10,093 ) Employer payroll tax on employee stock transactions (149 ) (35 ) (389 ) (85 ) Amortization of acquired intangible assets (5,139 ) (5,139 ) (20,389 ) (15,957 ) Acquisition-related compensation (120 ) (130 ) (499 ) (424 ) Inventory write-offs due to restructuring   (720 )  Non-GAAP cost of revenue $ 38,241 $ 31,456 $ 140,097 $ 117,618 Gross profit reconciliation: GAAP gross profit $ 125,909 $ 86,325 $ 441,873 $ 278,002 Stock-based compensation expense 4,617 3,011 17,187 10,093 Employer payroll tax on employee stock transactions 149 35 389 85 Amortization of acquired intangible assets 5,139 5,139 20,389 15,957 Acquisition-related compensation 120 130 499 424 Inventory write-offs due to restructuring   720  Non-GAAP gross profit $ 135,934 $ 94,640 $ 481,057 $ 304,561 Gross margin reconciliation: GAAP gross margin 72 % 68 % 71 % 66 % Stock-based compensation expense 3 % 2 % 3 % 2 % Employer payroll tax on employee stock transactions  %  %  %  % Amortization of acquired intangible assets 3 % 4 % 3 % 4 % Acquisition-related compensation  %  %  %  % Inventory write-offs due to restructuring  %  %  %  % Non-GAAP gross margin 78 % 75 % 77 % 72 % Research and development expense reconciliation: GAAP research and development expense $ 56,446 $ 53,904 $ 218,176 $ 207,008 Stock-based compensation expense (15,179 ) (13,817 ) (61,055 ) (51,771 ) Employer payroll tax on employee stock transactions (202 ) (86 ) (669 ) (250 ) Acquisition-related compensation (594 ) (437 ) (1,514 ) (1,165 ) Non-GAAP research and development expense $ 40,471 $ 39,564 $ 154,938 $ 153,822 Sales and marketing expense reconciliation: GAAP sales and marketing expense $ 101,478 $ 87,254 $ 397,160 $ 310,848 Stock-based compensation expense (15,436 ) (11,138 ) (55,798 ) (40,115 ) Employer payroll tax on employee stock transactions (361 ) (127 ) (1,112 ) (505 ) Amortization of acquired intangible assets (2,156 ) (2,143 ) (7,972 ) (6,613 ) Acquisition-related compensation (109 ) (706 ) (647 ) (1,780 ) Non-GAAP sales and marketing expense $ 83,416 $ 73,140 $ 331,631 $ 261,835 General and administrative expense reconciliation: GAAP general and administrative expense $ 46,822 $ 45,197 $ 198,247 $ 162,722 Stock-based compensation expense (18,330 ) (18,182 ) (83,890 ) (62,487 ) Employer payroll tax on employee stock transactions (591 ) (1,002 ) (1,259 ) (1,395 ) Amortization of acquired intangible assets  (19 ) (2 ) (75 ) Acquisition-related compensation  (320 ) (383 ) (999 ) Non-GAAP general and administrative expense $ 27,901 $ 25,674 $ 112,713 $ 97,766 Restructuring reconciliation: GAAP restructuring expense $ 2,377 $  $ 6,706 $  Stock-based compensation expense   1,060  Other restructuring charges (2,377 )  (7,766 )  Non-GAAP restructuring expense $  $  $  $  Operating loss reconciliation: GAAP operating loss $ (81,214 ) $ (100,030 ) $ (378,416 ) $ (402,576 ) Stock-based compensation expense 53,562 46,148 216,870 164,466 Employer payroll tax on employee stock transactions 1,303 1,250 3,429 2,235 Amortization of acquired intangible assets 7,295 7,301 28,363 22,645 Acquisition-related compensation 823 1,594 3,043 4,369 Inventory write-offs due to restructuring   720  Other restructuring charges 2,377  7,766  Non-GAAP operating loss $ (15,854 ) $ (43,737 ) $ (118,225 ) $ (208,861 ) Operating margin reconciliation: GAAP operating margin (47 )% (79 )% (61 )% (95 )% Stock-based compensation expense 31 % 36 % 35 % 39 % Employer payroll tax on employee stock transactions 1 % 1 % 1 % 1 % Amortization of acquired intangible assets 4 % 6 % 5 % 5 % Acquisition-related compensation  % 1 %  % 1 % Inventory write-offs due to restructuring  %  %  %  % Other restructuring charges 1 %  % 1 %  % Non-GAAP operating margin (9 )% (35 )% (19 )% (49 )% Net loss reconciliation: GAAP net loss $ (71,982 ) $ (93,680 ) $ (338,693 ) $ (378,678 ) Stock-based compensation expense 53,562 46,148 216,870 164,466 Employer payroll tax on employee stock transactions 1,303 1,250 3,429 2,235 Amortization of acquired intangible assets 7,295 7,301 28,363 22,645 Acquisition-related compensation 823 1,594 3,043 4,369 Inventory write-offs due to restructuring   720  Other restructuring charges 2,377  7,766  Gain on strategic investments   (2,703 )  Income tax benefit    (9,667 ) Non-GAAP net loss $ (6,622 ) $ (37,387 ) $ (81,205 ) $ (194,630 ) Basic and diluted EPS reconciliation: GAAP net loss per share, basic and diluted $ (0.24 ) $ (0.33 ) $ (1.15 ) $ (1.36 ) Stock-based compensation expense 0.18 0.16 0.74 0.58 Employer payroll tax on employee stock transactions   0.01 0.01 Amortization of acquired intangible assets 0.02 0.03 0.10 0.08 Acquisition-related compensation  0.01 0.01 0.02 Inventory write-offs due to restructuring     Other restructuring charges 0.01  0.03  Gain on strategic investments   (0.01 )  Income tax benefit    (0.03 ) Non-GAAP net loss per share, basic and diluted $ (0.02 ) $ (0.13 ) $ (0.28 ) $ (0.70 ) SENTINELONE, INC. SELECTED CASH FLOW INFORMATION (in thousands) (unaudited) Reconciliation of cash used in operating activities to free cash flow Three Months Ended January 31, Twelve Months Ended January 31, 2024 2023 2024 2023 GAAP net cash used in operating activities $ (6,182 ) $ (22,069 ) $ (68,374 ) $ (193,287 ) Less: Purchases of property and equipment (187 ) (126 ) (1,304 ) (4,953 ) Less: Capitalized internal-use software (4,269 ) (3,173 ) (13,956 ) (13,452 ) Free cash flow $ (10,638 ) $ (25,368 ) $ (83,634 ) $ (211,692 ) Net cash provided by (used in) investing activities $ 113,029 $ (66,674 ) $ 140,590 $ (1,312,666 ) Net cash provided by financing activities $ 23,682 $ 16,530 $ 47,464 $ 36,308 Operating cash flow margin (4 )% (18 )% (11 )% (46 )% Free cash flow margin (6 )% (20 )% (13 )% (50 )% View source version on businesswire.com: https://www.businesswire.com/news/home/20240313344515/en/ Investor relations: Doug Clark investors@sentinelone.com Press: Karen Master karen.master@sentinelone.com +1 (440) 862-0676 Source: SentinelOne What is the ticker symbol for SentinelOne? The ticker symbol for SentinelOne is S. What were the financial highlights for Q4 fiscal year 2024 for SentinelOne? In Q4 fiscal year 2024, SentinelOne saw a 38% revenue increase to $174.2 million, 39% ARR growth to $724.4 million, and GAAP gross margin of 72%. What were the full-year fiscal 2024 highlights for SentinelOne? For fiscal year 2024, SentinelOne achieved a 47% revenue increase to $621.2 million, GAAP gross margin of 71%, and non-GAAP operating margin of (19)%. What is the financial outlook provided by SentinelOne for Q1FY25 and FY2025? SentinelOne expects revenue of $181 million for Q1FY25 and $812-818 million for the full fiscal year 2025. What is the non-GAAP gross margin guidance for SentinelOne for FY2025? SentinelOne provided a non-GAAP gross margin guidance of 77.5-78.5% for the full fiscal year 2025."
"South Plains Financial, Inc. Publishes 2023 Community Impact Report",2024-03-13T20:10:00.000Z,No impact,Neutral,"South Plains Financial, Inc. (NASDAQ:SPFI) released its 2023 Community Impact Report, showcasing its commitment to environmental, social, and governance initiatives. The report highlights the company's efforts in promoting diversity, supporting small businesses, and engaging in community development.","South Plains Financial, Inc. Publishes 2023 Community Impact Report Rhea-AI Impact (No impact) Rhea-AI Sentiment (Neutral) Tags Rhea-AI Summary South Plains Financial, Inc. (NASDAQ:SPFI) released its 2023 Community Impact Report, showcasing its commitment to environmental, social, and governance initiatives. The report highlights the company's efforts in promoting diversity, supporting small businesses, and engaging in community development. Positive South Plains demonstrates a strong commitment to ESG initiatives. The company provided over $291 million in loans for small businesses, farms, and community development. Employees volunteered nearly 5,000 hours to various organizations. 68% of the Bank's customers receive e-delivery statements. Recycling efforts resulted in over 62 tons of recycled paper and technology equipment. Installation of energy-saving measures like LED lights and electronic thermostats. Partnerships with EverFi and Watermark Community Development Corporation for financial literacy programs. The full report is available at www.spfi.bank/communityimpact. Negative None. 03/13/2024 - 04:10 PM LUBBOCK, Texas, March 13, 2024 (GLOBE NEWSWIRE) -- South Plains Financial, Inc. (NASDAQ:SPFI) (South Plains or the Company), the parent company of City Bank (the Bank), today announced the release of the Companys 2023 Community Impact Report. This report demonstrates South Plains ongoing commitment to being a responsible corporate citizen in each of the unique communities in which the Company and the Bank operate. Each year, we continue to enhance and broaden our environmental, social, and governance (ESG) plans to positively impact our Company, the environment and our communities, commented Curtis Griffith, South Plains Chairman and Chief Executive Officer. Through our ESG initiatives, we are underscoring our commitment to using the power of relationships to help people succeed and live better in all of the communities that we serve. Our focus on building a financial institution that is the hometown bank in every community that we serve is enhanced by our ESG efforts. Highlights from the 2023 Community Impact Report: South Plains fosters an inclusive workplace and meets Nasdaqs board diversity requirement.Provided more than $291 million in loans for small businesses, farms and community development during the year ended December 31, 2023.Employees volunteered more than 4,979 hours to various organizations.More than 68% of the Banks customers receive their statements through e-delivery.Recycling efforts yielded more than 62 tons of recycled paper and technology equipment.Installed LED lights and electronic thermostats throughout our branch network to reduce energy usage.Partnered with EverFi and Watermark Community Development Corporation to sponsor financial literacy programs for high schools and under-resourced communities in our markets. For more information, please read the Companys 2023 Community Impact Report, available at www.spfi.bank/communityimpact. About South Plains Financial, Inc. South Plains is the bank holding company for City Bank, a Texas state-chartered bank headquartered in Lubbock, Texas. City Bank is one of the largest independent banks in West Texas and has additional banking operations in the Dallas, El Paso, Greater Houston, the Permian Basin, and College Station, Texas markets, and the Ruidoso, New Mexico market. South Plains provides a wide range of commercial and consumer financial services to small and medium-sized businesses and individuals in its market areas. Its principal business activities include commercial and retail banking, along with investment, trust and mortgage services. Please visit https://www.spfi.bank for more information. Available Information The Company routinely posts important information for investors on its web site (under www.spfi.bank and, more specifically, under the News & Events tab at www.spfi.bank/news-events/press-releases). The Company intends to use its web site as a means of disclosing material non-public information and for complying with its disclosure obligations under Regulation FD (Fair Disclosure) promulgated by the U.S. Securities and Exchange Commission (the SEC). Accordingly, investors should monitor the Companys web site, in addition to following the Companys press releases, SEC filings, public conference calls, presentations and webcasts. The information contained on, or that may be accessed through, the Companys web site is not incorporated by reference into, and is not a part of, this document. Contact:Mikella Newsom, Chief Risk Officer and Secretary investors@city.bank (866) 771-3347 Source: South Plains Financial, Inc. What is the ticker symbol for South Plains Financial, Inc.? The ticker symbol for South Plains Financial, Inc. is SPFI. What does the 2023 Community Impact Report highlight? The report showcases South Plains Financial's commitment to ESG initiatives, diversity, small business support, and community development. How much did the company provide in loans for small businesses, farms, and community development in 2023? South Plains Financial provided over $291 million in loans for small businesses, farms, and community development in 2023. What percentage of the Bank's customers receive e-delivery statements? Over 68% of the Bank's customers receive e-delivery statements. How many hours did employees volunteer to various organizations? Employees volunteered nearly 5,000 hours to various organizations. What were the results of the recycling efforts mentioned in the report? Recycling efforts yielded over 62 tons of recycled paper and technology equipment. What energy-saving measures were implemented by South Plains Financial? The company installed LED lights and electronic thermostats to reduce energy usage. Which organizations did South Plains Financial partner with for financial literacy programs? South Plains Financial partnered with EverFi and Watermark Community Development Corporation for financial literacy programs."
"HireQuest, Inc. to Hold Fourth Quarter and Year End 2023 Financial Results Conference Call on Thursday, March 21, 2024",2024-03-13T20:05:00.000Z,Neutral,Neutral,"HireQuest, Inc. (NASDAQ:HQI) schedules a conference call to discuss financial results for Q4 and year-end 2023.","HireQuest, Inc. to Hold Fourth Quarter and Year End 2023 Financial Results Conference Call on Thursday, March 21, 2024 Rhea-AI Impact (Neutral) Rhea-AI Sentiment (Neutral) Tags earnings Rhea-AI Summary HireQuest, Inc. (NASDAQ:HQI) schedules a conference call to discuss financial results for Q4 and year-end 2023. Positive None. Negative None. 03/13/2024 - 04:05 PM GOOSE CREEK, SC / ACCESSWIRE / March 13, 2024 / HireQuest, Inc. (NASDAQ:HQI), a national franchisor of direct dispatch, executive search, and commercial staffing services, today announced that it will hold a conference call on March 21, 2024, at 4:30 p.m. Eastern Time to discuss its financial results for the fourth quarter and year ended December 31, 2023.Date:Thursday, March 21, 2024Time:4:30 p.m. Eastern TimeToll-free dial-in number:888-506-0062International dial-in number:973-528-0011Entry code:576293Please call the conference telephone number 5-10 minutes prior to the start time. An operator will register your name and organization.The conference call will be broadcast live and available for replay at https://www.webcaster4.com/Webcast/Page/2359/50086 and via the investor relations section of HireQuest's website at https://hirequest.com/.A replay of the conference call will be available through Thursday, April 4, 2024.Toll-free replay number:877-481-4010International replay number:919-882-2331Replay passcode:50086About HireQuestHireQuest, Inc. is a nationwide franchisor of direct dispatch, executive search, and commercial staffing solutions for HireQuest Direct, HireQuest, Snelling, HireQuest Health, DriverQuest, TradeCorp, MRINetwork, SearchPath Global, and Northbound Executive Search franchised offices across the United States. Through its national network of over 400 franchisee-owned offices across the United States, HireQuest provides employment for approximately 81,000 individuals annually that work for thousands of customers in numerous industries including construction, light industrial, manufacturing, hospitality, clerical, medical, travel, financial services, and event services. For more information, visit www.hirequest.com.Company Contact:HireQuest, Inc.David Hartley, Vice President of Corporate Development(800) 835-6755Email: cdhartley@hirequest.comInvestor Relations Contact:IMS Investor RelationsJohn Nesbett/Jennifer Belodeau(203) 972-9200Email: hirequest@imsinvestorrelations.comSOURCE: HireQuest IncView the original press release on accesswire.com When is HireQuest, Inc. (HQI) holding a conference call to discuss its financial results for Q4 and year-end 2023? HireQuest, Inc. (HQI) will hold a conference call on March 21, 2024, at 4:30 p.m. Eastern Time. What services does HireQuest, Inc. (HQI) provide? HireQuest, Inc. (HQI) is a national franchisor of direct dispatch, executive search, and commercial staffing services. Where can I listen to the live broadcast of the conference call by HireQuest, Inc. (HQI)? The conference call will be broadcast live at https://www.webcaster4.com/Webcast/Page/2359/50086 and on HireQuest's investor relations section of their website at https://hirequest.com/. How long will the replay of the conference call be available for? The replay of the conference call will be available through Thursday, April 4, 2024. What is the international dial-in number for the conference call by HireQuest, Inc. (HQI)? The international dial-in number for the conference call is 973-528-0011."
Boxlight Reports Fourth Quarter and Full Year 2023 Financial Results,2024-03-13T20:06:00.000Z,Neutral,Neutral,"Boxlight Corporation reports financial results for Q4 and full year 2023, showing a decrease in revenue, gross profit, and net loss. New leadership and corporate restructuring aim to improve profitability and sales efficiency.","Boxlight Reports Fourth Quarter and Full Year 2023 Financial Results Rhea-AI Impact (Neutral) Rhea-AI Sentiment (Neutral) Tags earnings Rhea-AI Summary Boxlight Corporation reports financial results for Q4 and full year 2023, showing a decrease in revenue, gross profit, and net loss. New leadership and corporate restructuring aim to improve profitability and sales efficiency. Positive Revenue for Q4'23 decreased by 9.3% to $38.8 million compared to the prior year quarter. Gross profit margin in Q4'23 decreased to 31.7% due to non-recurring charges. Net loss for Q4'23 was $17.7 million, inclusive of $12.0 million impairment charges. Adjusted EBITDA decreased by $3.7 million to ($1.1) million in Q4'23. Q4'23 sales orders slightly decreased by 3% to $38.3 million. Boxlight ended Q4'23 with $17.3 million in cash, $54.1 million in working capital, and $16.8 million in stockholders' equity. FY'23 total revenues were $176.7 million, a 20.3% decrease from FY'22. Gross profit margin for FY'23 was 35.8% compared to 29.2% for FY'22. Net loss for FY'23 was $39.2 million compared to $3.7 million for FY'22. Boxlight had $17.3 million in cash and cash equivalents, $54.1 million in working capital, and $40.2 million in debt at the end of 2023. Negative Revenue decrease in Q4'23 and FY'23 due to lower sales volume. Gross profit margin decrease in Q4'23 due to one-time charges. Net loss increase in Q4'23 and FY'23, including impairment charges. Adjusted EBITDA loss in Q4'23 compared to prior year. Increase in operating expenses for Q4'23 and FY'23. Decrease in comprehensive income for Q4'23 compared to prior year. Financial Analyst The reported financial performance of Boxlight Corporation, reflected by a 9.3% decrease in quarterly revenue and a 20.3% decrease in annual revenue, indicates a contraction in the company's business operations. The gross profit margin contraction by 190 basis points in Q4'23 and the substantial net loss, including non-recurring impairment charges, suggest a challenging operational environment. The net loss per share increase from $0.25 to $1.87 year-over-year for the quarter is a significant deterioration in profitability. This performance could potentially affect investor sentiment and the company's stock price negatively in the short term. However, the liquidity position with $17.3 million in cash and a strong working capital figure provides some cushion. The forward-looking statements for Q1 2024, projecting revenue at $34 million and adjusted EBITDA at ($3.0) million, offer transparency but also indicate continued challenges ahead. The management's focus on operational efficiency and strategic realignment could be pivotal in determining the long-term recovery trajectory of the company. Market Research Analyst The interactive technology solutions sector is highly competitive and Boxlight's performance must be contextualized within broader market trends. The decline in sales orders and gross profit margin suggests that Boxlight may be facing intense competition or a shift in market demand. The company's strategic decision to open a Central European Hub Showroom in the UK could be an attempt to strengthen its market presence in Europe and mitigate regional sales volatility. Furthermore, the management's commentary on substantial changes to align with evolving market dynamics and the initial positive feedback from stakeholders may signal a potential turnaround. However, investors would likely monitor the effectiveness of these strategic initiatives closely before adjusting their valuation models. Economist Boxlight's financial results and the impact of foreign currency translation reflect macroeconomic factors, including currency volatility. The constant-currency revenue decrease of 12% and 21% for the quarter and year, respectively, indicates that the company's performance was not solely influenced by exchange rate fluctuations but also by underlying operational issues. The global economic outlook and exchange rate trends will continue to be critical in assessing Boxlight's international business segments. The company's ability to manage costs in the face of non-recurring charges and impairment losses will be crucial in maintaining financial stability. The debt level of $40.2 million also warrants attention, as it could affect the company's financial flexibility and ability to invest in growth opportunities amid changing economic conditions. 03/13/2024 - 04:06 PM New Leadership, Board Corporate Restructuring, Positions Boxlight for Improved Profitability and Sales Efficiency DULUTH, Ga.--(BUSINESS WIRE)-- Boxlight Corporation (Nasdaq: BOXL) (Boxlight or the Company), a leading provider of interactive technology solutions, today announced the Companys financial results for the fourth quarter and full year ended December 31, 2023. Financial and Operational Highlights: Revenue was $38.8 million for the quarter, a decrease of 9.3% from the prior year quarter Gross profit margin in Q4'23 decreased by 190 basis points to 31.7% due to non-recurring charges Net loss was $17.7 million, inclusive of non-recurring impairment charges of $12.0 million, compared to net loss of $2.0 million in the prior year quarter Net loss per basic and diluted common share was $1.87, compared to $0.25 net loss per basic and diluted common share in the prior year quarter Adjusted EBITDA decreased by $3.7 million to ($1.1) million from the prior year quarter Ended the quarter with $17.3 million in Cash, $54.1 million in Working Capital and $16.8 million in Stockholders Equity Expect Q1 2024 Revenue and adjusted EBITDA at $34 million and ($3.0) million, respectively Q4'23 Sales orders slightly decreased 3% to $38.3 million Announced the opening of our Central European Hub Showroom in the UK Management Commentary My first few weeks have confirmed my perception that Boxlight is comprised of high-quality assets, exceptional technology, and talented, committed employees, commented Dale Strang, Boxlight Chief Executive Officer. With that said, our customers needs, as well as the overall dynamics of our market are evolving, and strategically aligning to those changes requires that we make substantial changes to our business. My goal is to empower our team, eliminate duplicative efforts and focus our commercial messages, with the goal of quickly establishing a sustainable platform for profitable growth. Mr. Strang continued, This reset is already under way, and weve made immediate progress in the clarity in our go-to-market initiatives and a streamlined senior team focused on the evolving needs of our customers. The initial improvements, and the positive reaction from employees, customers, and other stakeholders, gives me significant optimism that we are on the right path. Financial Results for the Three Months Ended December 31, 2023 (Q4'23) vs. Three Months Ended December 31, 2022 (Q4'22) Total revenues were $38.8 million as compared to $42.8 million for Q4'22, resulting in a 9.3% decrease. The decrease in revenues was primarily due to lower sales volume across all markets. Gross profit for Q4'23 was $12.3 million as compared to $14.4 million for Q4'22, resulting in a decrease of 14.5%. Gross profit margin decreased to 31.7% for Q4'23 compared to 33.6% for Q4'22. The decrease in gross profit margin was primarily related to one-time charges and adjustments during Q4'23 that did not occur in Q4'22. Total Q4'23 operating expenses were $28.9 million, as compared to $15.2 million for Q4'22. Excluding impairment charges, total Q4'23 operating expenses were $16.9 million and represented an 11.2% increase over Q4'22. The increase in operating expenses is primarily attributable to employee-related expenses to support the Company's growth in certain markets. Net loss, inclusive of the $12.0 million impairment charges increased $15.7 million to $17.7 million for Q4'23 and was a result of the changes noted above. Net loss attributable to common shareholders was $18.0 million in Q4'23 compared to $2.3 million in Q4'22, after deducting fixed dividends paid to Series B preferred shareholders of $0.3 million in both years. Total Q4'23 comprehensive loss was $14.9 million compared to $4.8 million income for Q4'22. The change reflects the effect of foreign currency translation adjustments on consolidation, with the net effect of a $2.8 million income in Q4'23 and a $6.8 million income for Q4'22. Basic and diluted EPS for Q4'23 was ($1.87) compared to ($0.25) for Q4'22. EBITDA loss for Q4'23 was $14.6 million, as compared to EBITDA of $2.5 million for Q4'22. Adjusted EBITDA loss for Q4'23 was $1.1 million, as compared to Adjusted EBITDA of $2.6 million for Q4'22. Adjustments to EBITDA included stock-based compensation expense, impairment of goodwill, gains/losses recognized upon the settlement of certain debt instruments, gains/losses from the remeasurement of derivative liabilities, and the effects of purchase accounting adjustments in connection with prior period acquisitions. Financial Results for the Year Ended December 31, 2023 (FY'23) vs. the Year Ended December 31, 2022 (FY'22) Total revenues for FY'23 were $176.7 million as compared to $221.8 million for FY'22, resulting in a 20.3% decrease. The decrease in revenues was primarily due to lower sales volume across all markets. FY'23 gross profit was $63.3 million, or 35.8% gross profit margin, as compared to $64.9 million or 29.2% gross profit margin, for FY'22. Total operating expenses for FY'23 were $89.6 million (inclusive of the $25.2 million impairment charges) as compared to $61.8 million for FY'22. Excluding impairment charges, operating expenses for FY'23 was $64.4 million, resulting in a $2.6 million or 4.2% increase. The year-over-year increase is primarily related to personnel-related expenses to support the Company's growth in certain markets. There were no impairment charges during FY'22. Net loss for FY'23 was $39.2 million, compared to $3.7 million for FY'22. Net loss attributable to common shareholders was $40.4 million and $5.0 million for FY'23 and FY'22, respectively, after deducting fixed dividends paid to Series B preferred shareholders of $1.3 million in both years. Basic and diluted EPS for FY'23 was ($4.28) per basic and diluted share, compared to ($0.58) per basic and diluted share for FY'22. EBITDA loss for FY'23 was $17.6 million, as compared to $15.4 million EBITDA for FY'22. Adjusted EBITDA for FY'23 was $12.6 million, as compared to $18.9 million for FY'22. Balance Sheet At December 31, 2023, Boxlight had $17.3 million in cash and cash equivalents, $54.1 million in working capital, and $40.2 million in debt, net of debt issuance costs. Fourth Quarter 2023 Financial Results Conference Call The Company will hold a conference call to announce its fourth quarter and full year 2023 financial results on Wednesday, March 13, 2024, at 4:30 p.m. Eastern Time. The conference call details are as follows: Date: Wednesday, March 13, 2024 Time: 4:30 p.m. Eastern Time / 1:30 p.m. Pacific Time Dial-in: 1-888-506-0062 (Domestic) 1-973-528-0011 (International) Participant Access Code: 951719 Webcast: https://www.webcaster4.com/Webcast/Page/2213/49933 For those unable to participate during the live broadcast, a replay of the conference call will be available until 11:59 p.m. Eastern Time on Wednesday, March 27, 2024, by dialing 1-877-481-4010 (domestic) and 1-919-882-2331 (international) and referencing the replay passcode 49933. Use of Non-GAAP Financial Measures To provide investors with additional insight and allow for a more comprehensive understanding of the information used by management in its financial and decision-making surrounding pro forma operations, we supplement our consolidated financial statements presented on a basis consistent with U.S. generally accepted accounting principles, or GAAP, with EBITDA and Adjusted EBITDA, which are non-GAAP financial measures of earnings. EBITDA represents net income before income tax expense (benefit), interest expense, depreciation and amortization. Adjusted EBITDA represents EBITDA plus stock-based compensation, impairment of goodwill, the change in fair value of derivative liabilities, purchase accounting impact of inventory markup, fair value adjustments to deferred revenue, non-cash gains and losses associated with debt settlement. Our management uses EBITDA and Adjusted EBITDA as financial measures to evaluate the profitability and efficiency of our business model. We use these non-GAAP financial measures to assess the strength of the underlying operations of our business. These adjustments, and the non-GAAP financial measures that are derived from them, provide supplemental information to analyze our operations between periods and over time. We find this especially useful when reviewing pro forma results of operations, which include large non-cash amortizations of intangible assets from acquisitions and stock-based compensation. Investors should consider our non-GAAP financial measures in addition to, and not as a substitute for, financial measures prepared in accordance with GAAP. We report our operating results in accordance with U.S. GAAP. We have disclosed in the table below the results on a constant currency basis to facilitate period-to-period comparisons of our results without regard to the impact of fluctuating foreign currency exchange rates. The term foreign currency exchange rates refers to the exchange rates we use to translate our operating results into U.S. Dollars for all countries where the functional currency is not the U.S. Dollar. Because we are a global company, the foreign currency exchange rates used for translation may have a significant effect on our reported results. In general, our reported financial results are affected positively by a weaker U.S. Dollar and are affected negatively by a stronger U.S. Dollar as compared to the foreign currencies in which we conduct our business. References to our operating results on a constant-currency basis mean our operating results without the impact of foreign currency exchange rate fluctuations. We believe disclosure of constant-currency results is helpful to investors because it facilitates period-to-period comparisons of our results by increasing the transparency of our underlying performance by excluding the impact of fluctuating foreign currency exchange rates. However, constant-currency results are non-U.S. GAAP financial measures and are not meant to be considered in isolation or as a substitute for comparable measures prepared in accordance with U.S. GAAP. Constant-currency results have no standardized meaning prescribed by U.S. GAAP, are not prepared under any comprehensive set of accounting rules or principles, and should be read in conjunction with our consolidated financial statements prepared in accordance with U.S. GAAP. Constant-currency results have limitations in their usefulness to investors and may be calculated differently from, and therefore may not be directly comparable to, similarly titled measures used by other companies. Discussion of the Effect of Constant Currency on Financial Condition We calculate constant-currency amounts by translating local currency amounts in the current period at actual foreign exchange rates for the prior year period. Our constant-currency results do not eliminate the transaction currency impact of purchases and sales of products in a currency other than the functional currency. Three Months Ended December 31, 2023 Three Months Ended December 31, 2022 % Decrease (Dollars in thousands) Total revenues As reported $ 38,812 $ 42,814 (9 )% Impact of foreign currency translation (1,095 ) - Constant-currency $ 37,717 $ 42,814 (12 )% Year Ended December 31, 2023 Year Ended December 31, 2022 % Decrease (Dollars in thousands) Total revenues As reported $ 176,721 $ 221,781 (20 )% Impact of foreign currency translation (487 ) - Constant-currency $ 176,234 $ 221,781 (21 )% About Boxlight Corporation Boxlight Corporation (Nasdaq: BOXL) is a leading provider of interactive technology solutions under its award-winning brands Clevertouch, FrontRow and Mimio. Boxlight aims to improve engagement and communication in diverse business and education environments. Boxlight develops, sells, and services its integrated solution suite including interactive displays, collaboration software, audio solutions, supporting accessories, and professional services. For more information about Boxlight and the Boxlight story, visit http://www.boxlight.com, https://www.clevertouch.com and https://www.gofrontrow.com. Forward Looking Statements This press release may contain information about Boxlights view of its future expectations, plans and prospects that constitute forward-looking statements. Actual results may differ materially from historical results or those indicated by these forward-looking statements as a result of a variety of factors including, but not limited to, risks and uncertainties associated with its ability to maintain and grow its business, variability of operating results, its development and introduction of new products and services, marketing and other business development initiatives, and competition in the industry, among other things. Boxlight encourages you to review other factors that may affect its future results and performance in Boxlights filings with the Securities and Exchange Commission. Boxlight Corporation Condensed Consolidated Balance Sheets As of December 31, 2023 and December 31, 2022 (in thousands, except share and per share amounts) December 31, 2023 December 31, 2022 (as adjusted)* ASSETS Current assets: Cash and cash equivalents $ 17,253 $ 14,591 Accounts receivable  trade, net of allowances 29,523 31,009 Inventories, net of reserves 44,131 58,211 Prepaid expenses and other current assets 9,471 7,433 Total current assets 100,378 111,244 Property and equipment, net of accumulated depreciation 2,477 1,733 Operating lease right of use asset 8,846 4,350 Intangible assets, net of accumulated amortization 45,964 52,579 Goodwill  25,092 Other assets 906 397 Total assets $ 158,571 $ 195,395 LIABILITIES AND STOCKHOLDERS EQUITY Current liabilities: Accounts payable and accrued expenses $ 32,899 $ 36,566 Short-term debt 1,037 845 Operating lease liabilities, current 1,827 1,898 Deferred revenues, current 8,698 8,308 Derivative liabilities 205 472 Other short-term liabilities 1,566 386 Total current liabilities 46,232 48,475 Deferred revenues, non-current 16,347 15,603 Long-term debt 39,134 43,778 Deferred tax liabilities, net 4,316 4,680 Operating lease liabilities, non-current 7,282 2,457 Other long-term liabilities   Total liabilities 113,311 114,993 Mezzanine equity: Preferred Series B, 1,586,620 shares issued and outstanding 16,146 16,146 Preferred Series C, 1,320,850 shares issued and outstanding 12,363 12,363 Total mezzanine equity 28,509 28,509 Stockholders equity: Preferred stock, $0.0001 par value, 50,000,000 shares authorized; 167,972 and 167,972 shares issued and outstanding, respectively   Common stock, $0.0001 par value, 18,750,000 shares authorized; 9,704,496 and 9,339,587 Class A shares issued and outstanding at December 31, 2023 and 2022, respectively 1 1 Additional paid-in capital 119,724 117,849 Accumulated deficit (104,275 ) (65,043 ) Accumulated other comprehensive income (loss) 1,301 (914 ) Total stockholders equity 16,751 51,893 Total liabilities and stockholders equity $ 158,571 $ 195,395 * As adjusted for reverse stock split. Boxlight Corporation Condensed Consolidated Statements of Operations and Comprehensive Loss For the year ended December 31, 2023 and 2022 (in thousands, except per share amounts) 2023 2022 Revenues, net $ 176,721 $ 221,781 Cost of revenues 113,419 156,913 Gross profit 63,302 64,868 Operating expense: General and administrative expenses 61,252 59,337 Research and development 3,155 2,482 Impairment of goodwill 25,195  Total operating expense 89,602 61,819 (Loss) income from operations (26,300 ) 3,049 Other income (expense): Interest expense, net (10,840 ) (9,923 ) Other expense, net (417 ) (267 ) Gain on settlement of liabilities, net  856 Change in fair value of derivative liabilities 267 2,591 Total other expense (10,990 ) (6,743 ) Loss before income taxes (37,290 ) (3,694 ) Income tax expense (1,866 ) (49 ) Net loss (39,156 ) (3,743 ) Fixed dividends - Series B Preferred (1,269 ) (1,269 ) Net loss attributable to common stockholders $ (40,425 ) $ (5,012 ) Comprehensive loss: Net loss (39,156 ) (3,743 ) Other comprehensive loss: Foreign currency translation adjustment 2,215 (4,642 ) Total comprehensive loss $ (36,941 ) $ (8,385 ) Net loss per common share  basic and diluted - as adjusted* $ (4.28 ) $ (0.58 ) Weighted average number of common shares outstanding  basic and diluted - as adjusted* 9,455 8,644 * As adjusted for reverse stock split. Reconciliation of net loss for the three months and year ended December 31, 2023 and 2022 to EBITDA and Adjusted EBITDA (in thousands) Three Months Ended December 31, 2023 Three Months Ended December 31, 2022 Year Ended December 31, 2023 Year Ended December 31, 2022 Net loss $ (17,671 ) $ (2,018 ) $ (39,156 ) $ (3,743 ) Depreciation and amortization 1,966 2,311 8,859 9,129 Interest expense 2,619 2,593 10,840 9,923 Income tax (benefit) expense (1,514 ) (426 ) 1,866 49 EBITDA $ (14,600 ) $ 2,460 $ (17,591 ) $ 15,358 Stock compensation expense 1,307 648 3,131 3,313 Change in fair value of derivative liabilities (217 ) (1,054 ) (267 ) (2,591 ) Purchase accounting impact of fair valuing inventory 113 101 448 1,496 Purchase accounting impact of fair valuing deferred revenue 341 482 1,649 2,229 Net gain on settlement of debt    (856 ) Impairment of Goodwill 11,969  25,195  Adjusted EBITDA $ (1,087 ) $ 2,637 $ 12,565 $ 18,949 View source version on businesswire.com: https://www.businesswire.com/news/home/20240313168319/en/ Media Sunshine Nance +1 360-464-2119 x254 sunshine.nance@boxlight.com Investor Relations Greg Wiggins +1 360-464-4478 investor.relations@boxlight.com Source: Boxlight Corporation What was Boxlight Corporation's revenue for the fourth quarter of 2023? Boxlight Corporation reported revenue of $38.8 million for Q4'23, a 9.3% decrease from the prior year quarter. What was the net loss for Boxlight Corporation in Q4'23? Boxlight Corporation's net loss for Q4'23 was $17.7 million, inclusive of $12.0 million impairment charges. What were Boxlight Corporation's financial results for the year ended December 31, 2023? Boxlight Corporation's total revenues for FY'23 were $176.7 million, a 20.3% decrease from FY'22, with a gross profit margin of 35.8%. What were Boxlight Corporation's cash reserves at the end of 2023? At the end of 2023, Boxlight Corporation had $17.3 million in cash and cash equivalents, $54.1 million in working capital, and $40.2 million in debt."
Orexo successfully issues senior secured callable floating rate social bonds of SEK 500 m and announces results of the tender offer for its existing bonds,2024-03-13T20:08:00.000Z,Neutral,Neutral,"Orexo AB successfully issues new senior secured callable floating rate social bonds, oversubscribed, to refinance existing bonds and fund acquisitions. Company confirms long-term financing and plans early redemption of remaining bonds.","Orexo successfully issues senior secured callable floating rate social bonds of SEK 500 m and announces results of the tender offer for its existing bonds Rhea-AI Impact (Neutral) Rhea-AI Sentiment (Neutral) Tags Rhea-AI Summary Orexo AB successfully issues new senior secured callable floating rate social bonds, oversubscribed, to refinance existing bonds and fund acquisitions. Company confirms long-term financing and plans early redemption of remaining bonds. Positive None. Negative None. 03/13/2024 - 04:08 PM UPPSALA, Sweden, March 13, 2024 /PRNewswire/ -- Orexo AB (publ), (""Orexo"" or the ""Company"") (STO:ORX) (OTCQX:ORXOY) has successfully issued new senior secured callable floating rate social bonds in an amount of SEK 500 million and with a tenor of four years (the ""New Social Bonds""). The New Social Bonds carry a floating rate interest of 3m STIBOR + 650 basis points per annum and the net proceeds will be applied in accordance with the principles set out in Orexo's social financing framework, including but not limited to, refinancing of Orexo's existing senior unsecured callable floating rate bonds of SEK 500,000,000 with maturity in February 2025 (ISIN SE0015193958) (the ""Existing Bonds"") and financing or refinancing permitted acquisitions or investments under Orexo's social financing framework. Orexo intends to apply for admission to trading of the New Social Bonds on the sustainable bonds list of Nasdaq Stockholm. The issuance of the New Social Bonds was oversubscribed and received interest from both Nordic and international institutional investors. On March 8, 2024, Orexo announced, by way of a press release, an invitation to holders of the Existing Bonds to tender any or all of their Existing Bonds for purchase by the Company for cash at a price of 100.750 per cent of the nominal amount plus accrued and unpaid interest (the ""Tender Offer""). The Tender Offer expired at 16.00 CET on March 13, 2024, and Existing Bonds in an aggregate nominal amount of SEK 178,750,000 (including Existing Bonds with a nominal amount of SEK 48,750,000 held by the Company) have been tendered and accepted by Orexo. Conditional upon the Company receiving the proceeds from the issue of the New Social Bonds, Orexo intends complete the Tender Offer and repurchase the tendered and accepted Existing Bonds at the tender offer price together with accrued and unpaid interest from, but excluding, the previous interest payment date until, and including, the settlement date for the Tender Offer, which is expected to occur on or around March 28, 2024. Nikolaj Srensen, President and CEO of Orexo, said: ""Thanks to a strong interest, not least from international institutional investors, I am pleased to announce that we have successfully secured the refinancing of our outstanding corporate bond with a new social bond. The new bond confirms our long-term financing as we approach the launch of our new drug, OX124, on the US market and enables us to continue providing innovative treatment solutions for those who need them most."" Conditional upon settlement of the New Social Bonds, Orexo further intends to exercise its right to make an early redemption of the Existing Bonds not being repurchased in the Tender Offer, in accordance with the terms and conditions of the Existing Bonds. The Existing Bonds will in such early redemption be redeemed at a price of 100.750 per cent of the nominal amount plus any accrued and unpaid interest from, but excluding, the previous interest payment date until, and including, the settlement date of the early redemption, which is expected to occur on April 11, 2024 (the ""Redemption Price""), in accordance with the terms and conditions of the Existing Bonds. The Redemption Price will be paid to each person who is registered as owner of Existing Bonds in the debt register maintained by Euroclear Sweden at the end of business on April 4, 2024. A conditional notice of the early redemption is sent to directly registered owners of the Bonds in the debt register as of March 13, 2024. ABG Sundal Collier and Carnegie Investment Bank acted as joint arrangers and bookrunners in connection with the issuance of the New Social Bonds and the Tender Offer. Gernandt & Danielsson Advokatbyr KB acted as legal counsel. For further information please contact: Nikolaj Srensen, President and CEOFredrik Jrrsten, EVP and CFOLena Wange, IR & Communications DirectorTel: +46 (0)18 780 88 00E-mail: ir@orexo.com About Orexo Orexo is a Swedish pharmaceutical company with over 25 years of experience developing improved pharmaceuticals based on proprietary formulation technologies that meet large medical needs. On the US market, Orexo provides innovative treatment solutions for patients suffering from opioid use disorder and adjacent diseases. Products targeting other therapeutic areas are developed and commercialized worldwide with leading partners. Total net sales in 2023 amounted to SEK 639 million, and the number of employees to 116. Orexo is listed on Nasdaq Stockholm's main list and is available as an ADR on OTCQX (ORXOY) in the US. For more information about Orexo please visit www.orexo.com. You can also follow Orexo on X, LinkedIn, and YouTube. This information is information that Orexo AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was sent for publication, through the agency of the contact person set out above, on March 13, 2024, at 8.30 pm CET. This information was brought to you by Cision http://news.cision.com https://news.cision.com/orexo/r/orexo-successfully-issues-senior-secured-callable-floating-rate-social-bonds-of-sek-500-m-and-announ,c3945635 The following files are available for download: https://mb.cision.com/Main/694/3945635/2667969.pdf Orexo PR_Orexo successfully issues senior secured callable floating rate social bonds of SEK 500 m_March 13 2024 View original content:https://www.prnewswire.com/news-releases/orexo-successfully-issues-senior-secured-callable-floating-rate-social-bonds-of-sek-500-m-and-announces-results-of-the-tender-offer-for-its-existing-bonds-302088559.html SOURCE Orexo What type of bonds did Orexo AB issue? Orexo AB issued new senior secured callable floating rate social bonds. What is the interest rate on the New Social Bonds? The New Social Bonds carry a floating rate interest of 3m STIBOR + 650 basis points per annum. What is the purpose of the net proceeds from the New Social Bonds? The net proceeds will be applied for refinancing existing bonds and financing or refinancing permitted acquisitions or investments. Who were the joint arrangers and bookrunners for the New Social Bonds issuance? ABG Sundal Collier and Carnegie Investment Bank acted as joint arrangers and bookrunners. What is the expected settlement date for the Tender Offer? The settlement date for the Tender Offer is expected to occur on or around March 28, 2024."
"Chatham Lodging Trust Declares Quarterly Common, Preferred Dividend",2024-03-13T20:10:00.000Z,Low,Neutral,"Chatham Lodging Trust (CLDT) declares quarterly dividends for common and preferred shares, $0.07 and $0.41406 respectively, payable on April 15, 2024.","Chatham Lodging Trust Declares Quarterly Common, Preferred Dividend Rhea-AI Impact (Low) Rhea-AI Sentiment (Neutral) Tags dividends Rhea-AI Summary Chatham Lodging Trust (CLDT) declares quarterly dividends for common and preferred shares, $0.07 and $0.41406 respectively, payable on April 15, 2024. Positive None. Negative None. Financial Analyst The declaration of a quarterly common share dividend by Chatham Lodging Trust is a tangible return on investment for shareholders and reflects the company's current financial health and management's confidence in its cash flow stability. The dividend yield, calculated by dividing the annual dividend payments by the share price, is a key metric for investors. In this case, a $0.07 per common share dividend implies a potential yield that investors will compare against industry benchmarks and alternative investment opportunities.Moreover, dividends are often seen as a signal to the market. A stable or increasing dividend can attract income-focused investors and potentially support the share price. Conversely, if the dividend is lower than previous payouts or industry averages, it might raise concerns about the company's future earnings potential or financial management strategies. REIT Analyst For a lodging real estate investment trust (REIT) like Chatham Lodging Trust, the ability to pay dividends is closely tied to its funds from operations (FFO), a key REIT metric that adds depreciation and amortization to earnings. FFO provides a clearer picture of the trust's performance and its ability to generate cash flow from its operations, which is critical for maintaining and growing dividends. The dividend announcement may also reflect the trust's asset performance, including occupancy rates, average daily rates (ADR) and revenue per available room (RevPAR), all of which are vital indicators of a lodging REIT's financial health.Investors and analysts will assess the sustainability of the dividends in the context of the REIT's operational efficiency, capital expenditure requirements and the broader economic environment that influences travel and hospitality demand. Market Research Analyst The timing and consistency of dividend payments can also be indicative of the company's market positioning and competitive landscape. The lodging sector faces unique challenges and opportunities, such as seasonal demand fluctuations, changing traveler preferences and the impact of alternative lodging options like short-term rentals. A consistent dividend may suggest that Chatham Lodging Trust is effectively navigating these market forces and maintaining a competitive edge.Furthermore, the announcement's impact on the stock market will depend on how the dividend aligns with investor expectations and the current yield environment. If the declared dividend meets or exceeds market expectations, it can lead to positive investor sentiment and potentially a favorable reaction in the stock market. Conversely, if the dividend falls short of expectations, it may result in negative sentiment and stock price pressure. 03/13/2024 - 04:10 PM WEST PALM BEACH, Fla.--(BUSINESS WIRE)-- Chatham Lodging Trust (NYSE: CLDT), a lodging real estate investment trust (REIT) that invests in upscale, extended-stay hotels and premium-branded, select-service hotels and owns 38 hotels, today announced that its board of trustees declared a quarterly common share dividend of $0.07 per common share, as well as a quarterly preferred share dividend of $0.41406 per preferred share, payable on April 15, 2024, to shareholders of record as of March 28, 2024. About Chatham Lodging Trust Chatham Lodging Trust is a self-advised, publicly traded real estate investment trust (REIT) focused primarily on investing in upscale, extended-stay hotels and premium-branded, select-service hotels. The company owns 38 hotels totaling 5,735 rooms/suites in 16 states and the District of Columbia. Additional information about Chatham may be found at chathamlodgingtrust.com. Forward-Looking Statement Safe Harbor Note: This press release contains forward-looking statements within the meaning of federal securities regulations. These forward-looking statements are identified by their use of terms and phrases such as ""anticipate,"" ""believe,"" ""could,"" ""estimate,"" ""expect,"" ""intend,"" ""may,"" ""should,"" ""plan,"" ""predict,"" ""project,"" ""will,"" ""continue"" and other similar terms and phrases, including references to assumption and forecasts of future results. Forward-looking statements are not guarantees of future performance and involve known and unknown risks, uncertainties and other factors which may cause the actual results to differ materially from those anticipated at the time the forward-looking statements are made. These risks include, but are not limited to: national and local economic and business conditions, including the effect on travel of potential terrorist attacks, that will affect occupancy rates at the companys hotels and the demand for hotel products and services; operating risks associated with the hotel business; risks associated with the level of the companys indebtedness and its ability to meet covenants in its debt agreements; relationships with property managers; the companys ability to maintain its properties in a Fourth-class manner, including meeting capital expenditure requirements; the companys ability to compete effectively in areas such as access, location, quality of accommodations and room rate structures; changes in travel patterns, taxes and government regulations which influence or determine wages, prices, construction procedures and costs; the companys ability to complete acquisitions and dispositions; and the companys ability to continue to satisfy complex rules in order for the company to remain a REIT for federal income tax purposes and other risks and uncertainties associated with the companys business described in the company's filings with the SEC. Although the company believes the expectations reflected in such forward-looking statements are based upon reasonable assumptions, it can give no assurance that the expectations will be attained or that any deviation will not be material. All information in this release is as of the date hereof, and the company undertakes no obligation to update any forward-looking statement to conform the statement to actual results or changes in the companys expectations. View source version on businesswire.com: https://www.businesswire.com/news/home/20240313116748/en/ Dennis Craven (Company) Chief Operating Officer (561) 227-1386 Source: Chatham Lodging Trust What is the ticker symbol for Chatham Lodging Trust? The ticker symbol for Chatham Lodging Trust is CLDT. What type of real estate does Chatham Lodging Trust invest in? Chatham Lodging Trust invests in upscale, extended-stay hotels and premium-branded, select-service hotels. How many hotels does Chatham Lodging Trust own? Chatham Lodging Trust owns 38 hotels. When will the quarterly dividends be payable for common and preferred shares? The quarterly dividends for common and preferred shares will be payable on April 15, 2024. What is the dividend amount for common shares? The dividend amount for common shares is $0.07 per common share. What is the dividend amount for preferred shares? The dividend amount for preferred shares is $0.41406 per preferred share."
"Limbach Holdings, Inc. Reports Fourth Quarter and 2023 Results",2024-03-13T20:11:00.000Z,Neutral,Neutral,"Limbach Holdings, Inc. (Nasdaq: LMB) reported a strong financial performance for the year 2023, with a 3.9% increase in consolidated revenue, a 27.3% increase in gross profit, and a significant growth in net income and adjusted EBITDA. The Owner Direct Relationships (ODR) segment saw a revenue increase of 22.8% year-over-year for Q4 and 21.1% for the year, accounting for over half of the company's revenue and gross profit. The company's strategic shift towards the ODR business is driving higher margins and stronger performance.","Limbach Holdings, Inc. Reports Fourth Quarter and 2023 Results Rhea-AI Impact (Neutral) Rhea-AI Sentiment (Neutral) Tags earnings Rhea-AI Summary Limbach Holdings, Inc. (Nasdaq: LMB) reported a strong financial performance for the year 2023, with a 3.9% increase in consolidated revenue, a 27.3% increase in gross profit, and a significant growth in net income and adjusted EBITDA. The Owner Direct Relationships (ODR) segment saw a revenue increase of 22.8% year-over-year for Q4 and 21.1% for the year, accounting for over half of the company's revenue and gross profit. The company's strategic shift towards the ODR business is driving higher margins and stronger performance. Positive Consolidated revenue increased by 3.9% to $516.4 million in 2023. Gross profit rose by 27.3% to $119.3 million in 2023. Net income grew to $20.8 million, or $1.76 per diluted share, compared to $6.8 million in 2022. Adjusted EBITDA increased by 47.3% to $46.8 million in 2023. ODR segment revenue surged by 22.8% for Q4 and 21.1% for the year, contributing significantly to the company's financial performance. ODR segment accounted for 55.1% of revenue and 71.1% of consolidated gross profit for the quarter. Strategic focus on ODR business led to expanded margins and higher Adjusted EBITDA for the full year. Investment in rental equipment for indoor climate control to support customers' mission-critical operations. Future goal to have ODR revenue between 60% and 70% of consolidated revenue in 2024. Negative None. Financial Analyst The reported increase in Owner Direct Relationships (ODR) Segment Revenue by 22.8% in Q4 and 21.1% for the full year indicates a strategic shift in Limbach Holdings' business model towards higher-margin projects. This shift has resulted in ODR accounting for a significant portion of the company's revenue and gross profit, underscoring its importance to the overall financial health of the company. The focus on ODR has contributed to an impressive 175% growth in full-year diluted EPS and a 62.2% increase in Cash Flow from Operating Activities, signaling strong operational performance and financial discipline.However, the slight decrease in consolidated revenue by 0.6% in Q4 due to a more selective approach to project selection in the General Contractor Relationship (GCR) business could raise questions about the company's growth trajectory. Investors may scrutinize whether the benefits of higher margins will consistently outweigh the potential risks associated with reduced revenue diversity. Moreover, the commitment to a revenue goal of 60-70% from ODR for 2024 sets clear expectations for the company's strategic direction but also presents execution risks that will be closely monitored. Market Research Analyst Limbach's investment of approximately $4 million in rental equipment for indoor climate control represents an expansion into a complementary service area that could open up new revenue streams and enhance customer retention. The company's anticipation of a return on this investment in the second half of 2024 suggests confidence in the market demand for such services. This move could potentially diversify Limbach's offerings and reduce reliance on traditional project-based revenue.It is important to note that the building systems solutions market is highly competitive and Limbach's success will depend on its ability to differentiate itself and effectively market its expanded service offerings. The company's strategy to become a one-stop shop for building system solutions may resonate well with customers looking for comprehensive services, which could lead to increased market share if executed effectively. Economist The reported consolidated gross margin increase to 23.3% for the quarter and 23.1% for the year is a positive indicator of improved operational efficiency and cost management. This is particularly relevant in the context of the broader economic environment, where businesses across various sectors are facing pressure from rising costs and supply chain challenges.The company's disciplined approach to project selection, focusing on smaller contracts with shorter durations, may also be a strategic response to economic uncertainties, allowing for greater agility and potentially reducing exposure to market volatility. However, it is critical to analyze how these strategies align with macroeconomic trends and whether they can sustain profitability in the event of an economic downturn. 03/13/2024 - 04:11 PM Owner Direct Relationships (ODR) Segment Revenue up 22.8% Year-over-Year for Q4 and 21.1% for the Year ODR Segment Accounted for 55.1% of Revenue and 71.1% of Consolidated Gross Profit for the Quarter Consolidated Gross Margin Increased to 23.3% for the Quarter and 23.1% for the Year Year-end Cash and Cash Equivalents of $59.8 million WARRENDALE, Pa.--(BUSINESS WIRE)-- Limbach Holdings, Inc. (Nasdaq: LMB) (Limbach or the Company) today announced its financial results for the year ended December 31, 2023. 2023 Fourth Quarter Financial Overview Compared to 2022 Fourth Quarter Consolidated revenue of $142.7 million, a decrease of 0.6% from $143.5 million as the Company continued to take a disciplined approach to select smaller, higher margin projects. Gross profit of $33.3 million, an increase of 14.0% from $29.2 million. Net income of $5.2 million, or $0.44 per diluted share, compared to net income of $3.8 million, or $0.35 per diluted share. Adjusted EBITDA of $12.6 million, up 8.8% from $11.6 million. Net cash provided by operating activities of $13.9 million compared to $12.4 million. 2023 Overview Compared to 2022 Consolidated revenue of $516.4 million, an increase of 3.9% from $496.8 million. Gross profit of $119.3 million, an increase of 27.3% from $93.7 million. Net income of $20.8 million, or $1.76 per diluted share, compared to $6.8 million, or $0.64 per diluted share. Adjusted EBITDA of $46.8 million, up 47.3% from $31.8 million. Net cash provided by operating activities of $57.4 million compared to $35.4 million. Management Comments In 2023, we made tremendous progress executing our strategy to become a pure-play provider of buildings systems solutions. We continued to grow our ODR business as an indispensable partner helping our customers provide mission critical services to maintain uninterrupted operations in their facilities. This strategic shift in customer mix is driving higher margin opportunities and creating a stronger, more resilient Limbach, said Michael McCann, Limbachs President and Chief Executive Officer. I am pleased to report that our teams focus on accelerating the shift to the ODR business drove expanded margins and delivered Adjusted EBITDA above our guidance for the full year. We grew full-year diluted EPS 175% and Cash Flow from Operating Activities by 62.2%. Furthermore, our full-year ODR revenue increased 21.1% over the previous year. ODR revenue for the quarter was 55.1% of consolidated revenue, exceeding our annual goal of 50%. Our 2024 annual goal for ODR revenue is between 60% and 70% of consolidated revenue. While our primary focus is on ODR, we are also implementing changes in our General Contractor Relationship (GCR) business. We are taking a more selective approach to the projects we pursue by focusing on smaller contracts with shorter durations. In the fourth quarter, our consolidated revenue was by design slightly lower because of this action but going forward, this should provide greater flexibility and drive higher overall returns. We are evolving our service offerings to better support our customers as a one-stop shop for building system solutions. For example, in 2024 we have already invested approximately $4 million in rental equipment for indoor climate control. This provides our customers with an immediate solution to support their mission-critical operations during emergencies or planned downtimes. As we deploy this new rental solution into the market, we anticipate seeing a return on this investment in the second half of 2024. We are still in the early stages of our transformation to an even higher quality, more predictable business, and we are confident our strategy is working. Our team will continue our disciplined approach to projects, and we are excited about expanding our customer relationships and service offerings. We also plan to leverage our strong balance sheet to make strategic investments. We believe this strategy will continue delivering value to our customers and higher returns for our shareholders in 2024 and beyond. The following are results for the three months ended December 31, 2023, compared to the three months ended December 31, 2022: Consolidated revenue was $142.7 million, a decrease of 0.6% from $143.5 million. ODR segment revenue of $78.6 million increased by $14.6 million, or 22.8%, while GCR segment revenue of $64.1 million was down $15.4 million, or 19.4%. The increase in ODR segment revenue primarily was due to the Company's continued focus on the accelerated growth of its ODR business. The decrease in GCR segment revenue primarily was due to the Companys continued focus on improving project execution and profitability by pursuing GCR opportunities that were smaller in size and shorter in duration. Gross margin increased to 23.3%, up from 20.4%. On a dollar basis, total gross profit was $33.3 million, compared to $29.2 million. ODR gross profit increased $6.4 million, or 36.8%, due to the combination of an increase in revenue and higher margins of 30.1% versus 27.0% driven by contract mix. GCR gross profit decreased $2.3 million, or 19.1%, as a result of lower revenue. GCR gross margin was flat at 15.0%. This mix shift is a key element of the Companys strategy to increase profitability by taking a disciplined approach to select smaller, higher margin projects that mitigate the risk and volatility associated with larger, lower margin projects. SG&A expense increased approximately $3.2 million, to $25.0 million, compared to $21.8 million. The increase in SG&A primarily was due to a $2.0 million increase associated with payroll and incentive related expenses, a $0.8 million increase in stock compensation expense, a $1.2 million increase associated with costs incurred by the entities acquired in the ACME and Industrial Air transactions and $0.6 million related to an increase in professional fees, partially offset by a $1.6 million decrease related to certain legal accruals. As a percent of revenue, SG&A expense was 17.5%, up from 15.2%. Interest expense was $0.4 million compared to $0.6 million, which was the result of a lower overall outstanding debt balance period-over-period. Interest income was $0.6 million during the current quarter. This increase was due to the Company's investment strategy in overnight repurchase agreements, U.S. Treasury Bills, and money market funds during 2023. Net income was $5.2 million as compared to $3.8 million. Diluted earnings per share was $0.44 as compared to $0.35. Adjusted EBITDA was $12.6 million as compared to $11.6 million, an increase of 8.8%. Net cash provided by operating activities increased to $13.9 million as compared to $12.4 million. The following are results for the year ended December 31, 2023, compared to the year ended December 31, 2022: Consolidated revenue was $516.4 million, an increase of 3.9% from $496.8 million. ODR segment revenue of $262.0 million increased by $45.6 million, or 21.1%, while GCR segment revenue of $254.4 million decreased by $26.0 million, or 9.3%. The increase in ODR segment revenue primarily was due to the Company's continued focus on accelerating growth of its ODR business. In addition, ODR segment revenue increased by approximately $8.1 million due to the ACME and Industrial Air transactions. The decrease in GCR segment revenue primarily was due to the Companys continued focus on improving project execution and profitability by pursuing GCR opportunities that are smaller in size (based on contract value) and shorter in duration. Gross margin increased to 23.1%, up from 18.9%. On a dollar basis, total gross profit was $119.3 million, compared to $93.7 million. ODR gross profit increased $21.0 million, or 38.0%, due to the combination of an increase in revenue and higher margins driven by contract mix. GCR gross profit increased $4.6 million, or 11.9%, primarily due to higher margins despite lower revenue. SG&A expense increased approximately $9.5 million, to $87.4 million, compared to $77.9 million. The increase in SG&A primarily was due to a $6.8 million increase associated with payroll and incentive related expenses, a $2.2 million increase in stock compensation expense, a $1.5 million increase in costs incurred by the entities acquired in the ACME and Industrial Air transactions, $1.0 million related to CEO transition costs and $0.8 million related to acquisition-related costs, partially offset by a $1.2 million decrease in rent related expenses and a $1.5 million decrease related to certain legal accruals. As a percent of revenue, SG&A expense was 16.9%, up from 15.7%. Interest expense was $2.0 million compared to $2.1 million, reflecting a lower overall outstanding debt balance period-over-period, partly offset by a full-year of interest expense recognized on our financing lease liability arrangement. Interest income was $1.2 million, which was driven by the Company's investments in overnight repurchase agreements, U.S. Treasury Bills, and money market funds. Net income for the year was $20.8 million as compared to $6.8 million. Diluted earnings per share was $1.76 as compared to $0.64. Adjusted EBITDA was $46.8 million as compared to $31.8 million, an increase of 47.3%. Net cash provided by operating activities was $57.4 million as compared to $35.4 million. Balance Sheet At December 31, 2023, cash and cash equivalents was $59.8 million. Current assets were $217.0 million and current liabilities were $145.1 million at December 31, 2023, representing a current ratio of 1.50x compared to 1.42x at December 31, 2022. Working capital was $71.9 million at December 31, 2023, an increase of $4.9 million from December 31, 2022. At December 31, 2023, we had $10.0 million borrowings outstanding on our revolving credit facility and $4.1 million for standby letters of credit. For the year ended December 31, 2023, the Company made cash payments of $11.5 million on the principal portion of the A&R Wintrust Term Loan prior to its extinguishment. 2024 Guidance The Company is providing initial 2024 full year guidance, as summarized in the table below. Revenue $510 million - $530 million Adjusted EBITDA $49 million - $53 million We do not provide a reconciliation of forward-looking Adjusted EBITDA or the most directly comparable forward-looking GAAP measure of net income attributable to the Company because we cannot predict with a reasonable degree of certainty and without unreasonable efforts certain components or excluded items that are inherently uncertain and depend on various factors. For these reasons, we are unable to assess the potential significance of the unavailable information. Conference Call Details Date: Thursday, March 14, 2024 Time: 9:00 a.m. Eastern Time Participant Dial-In Numbers: Domestic callers: 877-407-6176 International callers: 201-689-8451 Access by Webcast The call will also be simultaneously webcast over the Internet via the Investor Relations section of Limbachs website at www.limbachinc.com or by clicking on the conference call link: https://event.choruscall.com/mediaframe/webcast.html?webcastid=iawWhaB5. An audio replay of the call will be archived on Limbachs website for 365 days. About Limbach Limbach is a building systems solution firm that partners with building owners and facilities managers who have mission critical mechanical (heating, ventilation and air conditioning), electrical and plumbing infrastructure. We strive to be an indispensable partner to our customers by providing services that are essential to the operation of their businesses. We work with building owners primarily in six vertical markets: healthcare, industrial and manufacturing, data centers, life science, higher education and cultural and entertainment. We have more than 1,400 team members in 19 offices across the eastern United States. Our team members uniquely combine engineering expertise with field installation skills to provide custom solutions that leverage our full life-cycle capabilities, which allows us to address both the operational and capital projects needs of our customers. Forward-Looking Statements We make forward-looking statements in this press release within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements relate to expectations or forecasts for future events, including, without limitation, our earnings, Adjusted EBITDA, revenues, expenses, backlog, capital expenditures or other future financial or business performance or strategies, results of operations or financial condition, timing of the recognition of backlog as revenue, the potential for recovery of cost overruns, the ability of Limbach to successfully remedy the issues that have led to write-downs in various business units and the Companys business being negatively affected by health crises or outbreaks of disease, such as epidemics or pandemics (and related impacts, such as supply chain disruptions). These statements may be preceded by, followed by or include the words believe, may, might, will, will likely result, should, estimate, plan, project, forecast, intend, expect, anticipate, believe, seek, continue, target or similar expressions. These forward-looking statements are based on information available to us as of the date they were made and involve a number of risks and uncertainties which may cause them to turn out to be wrong. There may be additional risks that we consider immaterial or which are unknown. Accordingly, forward-looking statements should not be relied upon as representing our views as of any subsequent date, and we do not undertake any obligation to update forward-looking statements to reflect events or circumstances after the date they were made, whether as a result of new information, future events or otherwise, except as may be required under applicable securities laws. As a result of a number of known and unknown risks and uncertainties, our actual results or performance may be materially different from those expressed or implied by these forward-looking statements. Please refer to our most recent annual report on Form 10-K, as well as our subsequent filings on Form 10-Q and Form 8-K, which are available on the SECs website (www.sec.gov), for a full discussion of the risks and other factors that may impact any forward-looking statements in this press release. LIMBACH HOLDINGS, INC. Consolidated Statements of Operations (in thousands, except share and per share data) (Unaudited) For the Quarter Ended December 31, For the Years Ended December 31, 2023 2022 2023 2022 Revenue $ 142,691 $ 143,483 $ 516,350 $ 496,782 Cost of revenue 109,385 114,256 397,060 403,041 Gross profit 33,306 29,227 119,290 93,741 Operating expenses: Selling, general and administrative 24,964 21,766 87,397 77,879 Change in fair value of contingent consideration 265 1,134 729 2,285 Amortization of intangibles 826 383 1,880 1,567 Total operating expenses 26,055 23,283 90,006 81,731 Operating income 7,251 5,944 29,284 12,010 Other (expense) income: Interest expense (431 ) (633 ) (2,046 ) (2,144 ) Interest income 593  1,217  Loss on early termination of operating lease    (849 ) Loss on debt extinguishment   (311 )  (Loss) gain on change in fair value of interest swap (277 ) 12 (124 ) 310 Gain on disposition of property and equipment 52 19 80 281 Total other expenses (63 ) (602 ) (1,184 ) (2,402 ) Income before income taxes 7,188 5,342 28,100 9,608 Income tax provision 1,939 1,534 7,346 2,809 Net income $ 5,249 $ 3,808 $ 20,754 $ 6,799 Earnings Per Share (EPS) Net income per share: Basic $ 0.48 $ 0.37 $ 1.93 $ 0.65 Diluted $ 0.44 $ 0.35 $ 1.76 $ 0.64 Weighted average number of shares outstanding: Basic 11,003,424 10,411,611 10,773,467 10,425,119 Diluted 11,865,450 10,888,777 11,812,098 10,676,534 LIMBACH HOLDINGS, INC. Consolidated Balance Sheets As of December 31, (in thousands, except share data) 2023 2022 ASSETS Current assets: Cash and cash equivalents $ 59,833 $ 36,001 Restricted cash 65 113 Accounts receivable (net of allowance for credit losses of $292 and net of allowance for doubtful accounts of $234 as of December 31, 2023 and 2022, respectively) 97,755 124,442 Contract assets 51,690 61,453 Advances to and equity in joint ventures, net 12 12 Income tax receivable  95 Other current assets 7,645 3,874 Total current assets 217,000 225,990 Property and equipment, net 20,830 18,224 Intangible assets, net 24,999 15,340 Goodwill 16,374 11,370 Operating lease right-of-use assets 19,727 18,288 Deferred tax asset 5,179 4,829 Other assets 330 515 Total assets $ 304,439 $ 294,556 LIABILITIES Current liabilities: Current portion of long-term debt $ 2,680 $ 9,564 Current operating lease liabilities 3,627 3,562 Accounts payable, including retainage 65,268 75,122 Contract liabilities 42,160 44,007 Accrued income taxes 446 1,888 Accrued expenses and other current liabilities 30,967 24,942 Total current liabilities 145,148 159,085 Long-term debt 19,631 21,528 Long-term operating lease liabilities 16,037 15,643 Other long-term liabilities 2,708 2,858 Total liabilities 183,524 199,114 Commitments and contingencies Redeemable convertible preferred stock, net, par value $0.0001, $1,000,000 shares authorized, no shares issued and outstanding ($0 redemption value)   STOCKHOLDERS EQUITY Common stock, $0.0001 par value; 100,000,000 shares authorized, issued 11,183,076 and 10,471,410, respectively; 11,003,424 and 10,291,758 outstanding, respectively 1 1 Additional paid-in capital 92,528 87,809 Treasury stock, at cost (179,652 shares at both period ends) (2,000 ) (2,000 ) Retained earnings 30,386 9,632 Total stockholders equity 120,915 95,442 Total liabilities and stockholders equity $ 304,439 $ 294,556 LIMBACH HOLDINGS, INC. Consolidated Statements of Cash Flows Year Ended December 31, (in thousands) 2023 2022 Cash flows from operating activities: Net income $ 20,754 $ 6,799 Adjustments to reconcile net income to cash provided by operating activities: Depreciation and amortization 8,244 8,158 Noncash operating lease expense 3,824 4,260 Provision for credit losses / doubtful accounts 431 292 Stock-based compensation expense 4,910 2,742 Loss on early debt extinguishment 311  Loss on early termination of operating lease  849 Amortization of debt issuance costs 79 138 Deferred income tax provision (350 ) (499 ) Gain on sale of property and equipment (80 ) (281 ) Loss (gain) on change in fair value of interest rate swap 124 (310 ) Loss on change in fair value of contingent consideration 729 2,285 Changes in operating assets and liabilities: Accounts receivable 32,607 (35,407 ) Contract assets 10,397 22,410 Other current assets (1,486 ) 1,128 Accounts payable, including retainage (10,909 ) 11,282 Contract liabilities (9,121 ) 17,296 Income tax receivable 95 19 Accrued income taxes (1,442 ) 1,387 Accrued expenses and other current liabilities 2,867 (2,934 ) Operating lease liabilities (3,795 ) (4,133 ) Payment of contingent consideration liability in excess of acquisition-date fair value (1,224 )  Other long-term liabilities 401 (108 ) Net cash provided by operating activities 57,366 35,373 Cash flows from investing activities: ACME Transaction, net of cash acquired (4,883 )  Industrial Air Transaction, net of cash acquired (10,378 )  Proceeds from sale of property and equipment 435 498 Purchase of property and equipment (2,266 ) (993 ) Net cash used in investing activities (17,092 ) (495 ) Cash flows from financing activities: Payments on Wintrust and A&R Wintrust Term Loans (21,452 ) (13,429 ) Proceeds from Wintrust Revolving Loan 10,000 15,194 Payment on Wintrust Revolving Loan  (15,194 ) Proceeds from financing transaction  5,400 Payments on financing liability  (49 ) Payment of contingent consideration liability up to acquisition-date fair value (1,776 )  Repurchase of common stock under Share Repurchase Program  (2,000 ) Payments on finance leases (2,733 ) (2,734 ) Proceeds from contributions to employee stock purchase plan 368 309 Taxes paid related to net-share settlement of equity awards (847 ) (417 ) Payments of debt issuance costs (50 ) (433 ) Net cash used in financing activities (16,490 ) (13,353 ) Increase (decrease) in cash, cash equivalents and restricted cash 23,784 21,525 Cash, cash equivalents and restricted cash, beginning of year 36,114 14,589 Cash, cash equivalents and restricted cash, end of year $ 59,898 $ 36,114 Supplemental disclosures of cash flow information Noncash investing and financing transactions: Earnout liability associated with the ACME Transaction $ 1,514 $  Earnout liability associated with the Industrial Air Transaction 3,165  Right of use assets obtained in exchange for new operating lease liabilities 3,135  Right of use assets obtained in exchange for new finance lease liabilities 5,219 2,634 Right of use assets disposed or adjusted modifying operating leases liabilities 1,112 2,455 Right of use assets disposed or adjusted modifying finance leases liabilities (93 ) (77 ) Interest paid 1,908 2,005 Cash paid for income taxes $ 9,156 $ 1,979 LIMBACH HOLDINGS, INC. Consolidated Statements of Operations (Unaudited) Three Months Ended December 31, Increase/(Decrease) (in thousands, except for percentages) 2023 2022 $ % Statement of Operations Data: Revenue: GCR $ 64,063 44.9 % $ 79,458 55.4 % $ (15,395 ) (19.4 ) % ODR 78,628 55.1 % 64,025 44.6 % 14,603 22.8 % Total revenue 142,691 100.0 % 143,483 100.0 % (792 ) (0.6 ) % Gross profit: GCR(1) 9,640 15.0 % 11,922 15.0 % (2,282 ) (19.1 ) % ODR(2) 23,666 30.1 % 17,305 27.0 % 6,361 36.8 % Total gross profit 33,306 23.3 % 29,227 20.4 % 4,079 14.0 % Total selling, general and administrative(3) 24,964 17.5 % 21,766 15.2 % 3,198 14.7 % Change in fair value of contingent consideration 265 0.2 % 1,134 0.8 % (869 ) (76.6 ) % Amortization of intangibles 826 0.6 % 383 0.3 % 443 115.7 % Total operating income $ 7,251 5.1 % $ 5,944 4.1 % $ 1,307 22.0 % (1) As a percentage of GCR revenue. (2) As a percentage of ODR revenue. (3) Included within selling, general and administrative expenses was $1.5 million and $0.8 million of stock-based compensation expense for the quarter ended December 31, 2023 and 2022, respectively. LIMBACH HOLDINGS, INC. Consolidated Statements of Operations Year Ended December 31, Increase/(Decrease) (in thousands, except for percentages) 2023 2022 $ % Statement of Operations Data: Revenue: GCR $ 254,392 49.3 % $ 280,379 56.4 % $ (25,987 ) (9.3 ) % ODR 261,958 50.7 % 216,403 43.6 % 45,555 21.1 % Total revenue 516,350 100.0 % 496,782 100.0 % 19,568 3.9 % Gross profit: GCR(1) 43,200 17.0 % 38,622 13.8 % 4,578 11.9 % ODR(2) 76,090 29.0 % 55,119 25.5 % 20,971 38.0 % Total gross profit 119,290 23.1 % 93,741 18.9 % 25,549 27.3 % Total selling, general and administrative(3) 87,397 16.9 % 77,879 15.7 % 9,518 12.2 % Change in fair value of contingent consideration 729 0.1 % 2,285 0.5 % (1,556 ) (68.1 ) % Amortization of intangibles 1,880 0.4 % 1,567 0.3 % 313 20.0 % Total operating income $ 29,284 5.7 % $ 12,010 2.4 % $ 17,274 143.8 % (1) As a percentage of GCR revenue. (2) As a percentage of ODR revenue. (3) Included within selling, general and administrative expenses was $4.9 million and $2.7 million of stock based compensation expense for the years ended December 31, 2023 and 2022, respectively. Non-GAAP Financial Measures In assessing the performance of our business, management utilizes a variety of financial and performance measures. The key measure is Adjusted EBITDA, a non-GAAP financial measure. We define Adjusted EBITDA as net income plus depreciation and amortization expense, interest expense, and taxes, as further adjusted to eliminate the impact of, when applicable, other non-cash items or expenses that are unusual or non-recurring that we believe do not reflect our core operating results. We believe that Adjusted EBITDA is meaningful to our investors to enhance their understanding of our financial performance for the current period and our ability to generate cash flows from operations that are available for taxes, capital expenditures and debt service. We understand that Adjusted EBITDA is frequently used by securities analysts, investors and other interested parties as a measure of financial performance and to compare our performance with the performance of other companies that report Adjusted EBITDA. Our calculation of Adjusted EBITDA, however, may not be comparable to similarly titled measures reported by other companies. When assessing our operating performance, investors and others should not consider this data in isolation or as a substitute for net income calculated in accordance with GAAP. Further, the results presented by Adjusted EBITDA cannot be achieved without incurring the costs that the measure excludes. A reconciliation of net income to Adjusted EBITDA, the most comparable GAAP measure, is provided below. We refer to our estimated revenue on uncompleted contracts, including the amount of revenue on contracts for which work has not begun, less the revenue we have recognized under such contracts, as backlog. Backlog includes unexercised contract options. Reconciliation of Net Income to Adjusted EBITDA (unaudited) Three Months Ended December 31, For the Years Ended December 31, (in thousands) 2023 2022 2023 2022 Net income $ 5,249 $ 3,808 $ 20,754 $ 6,799 Adjustments: Depreciation and amortization 2,493 1,985 8,244 8,158 Interest expense 431 633 2,046 2,144 Interest income (593 )  (1,217 )  Non-cash stock-based compensation expense 1,536 762 4,910 2,742 Loss on early debt extinguishment   311  Change in fair value of interest rate swap 277 (12 ) 124 (310 ) Loss on early termination of operating lease    849 CEO transition costs   958  Restructuring costs(1) 681 1,692 1,770 6,016 Change in fair value of contingent consideration 265 1,134 729 2,285 Income tax provision 1,939 1,534 7,346 2,809 Acquisition and other transaction costs 302 30 826 273 Adjusted EBITDA $ 12,580 $ 11,566 $ 46,801 $ 31,765 (1) Includes restructuring charges within our Southern California and Eastern Pennsylvania branches as well as other cost savings initiatives throughout the company. View source version on businesswire.com: https://www.businesswire.com/news/home/20240313545242/en/ Investor Relations Financial Profiles, Inc. Julie Kegley LMB@finprofiles.com Source: Limbach Holdings, Inc. What was Limbach Holdings, Inc.'s (LMB) consolidated revenue for 2023? Limbach Holdings, Inc.'s consolidated revenue for 2023 was $516.4 million, reflecting a 3.9% increase from the previous year. How much did Limbach Holdings, Inc. (LMB) report as gross profit in 2023? Limbach Holdings, Inc. reported a gross profit of $119.3 million in 2023, showing a significant increase of 27.3% compared to the previous year. What was the net income for Limbach Holdings, Inc. (LMB) in 2023? Limbach Holdings, Inc. achieved a net income of $20.8 million, or $1.76 per diluted share, in 2023, a substantial growth from $6.8 million in 2022. What was the percentage increase in Adjusted EBITDA for Limbach Holdings, Inc. (LMB) in 2023? Adjusted EBITDA for Limbach Holdings, Inc. increased by 47.3% to $46.8 million in 2023, showcasing strong financial performance. What was the revenue growth for Limbach Holdings, Inc.'s Owner Direct Relationships (ODR) segment in Q4 of 2023? Limbach Holdings, Inc.'s ODR segment saw a revenue growth of 22.8% year-over-year for Q4 of 2023, demonstrating significant progress in this business segment."
QuickLogic to Exhibit at GOMACTech 2024,2024-03-13T20:05:00.000Z,Neutral,Neutral,"QuickLogic Corporation (NASDAQ: QUIK) announces its participation in GOMACTech 2024 Conference, showcasing its innovative FPGA and eFPGA cores. The event targets government and military electronics industry, highlighting QuickLogic's 30 years of experience and track record in delivering millions of units across various applications.","QuickLogic to Exhibit at GOMACTech 2024 Rhea-AI Impact (Neutral) Rhea-AI Sentiment (Neutral) Tags Rhea-AI Summary QuickLogic Corporation (NASDAQ: QUIK) announces its participation in GOMACTech 2024 Conference, showcasing its innovative FPGA and eFPGA cores. The event targets government and military electronics industry, highlighting QuickLogic's 30 years of experience and track record in delivering millions of units across various applications. Positive None. Negative None. 03/13/2024 - 04:05 PM SAN JOSE, Calif., March 13, 2024 /PRNewswire/ -- QuickLogic Corporation (NASDAQ: QUIK), a developer of embedded FPGA (eFPGA) IP, ruggedized FPGAs and Endpoint AI/ML solutions, is pleased to announce its participation in the upcoming GOMACTech 2024 Conference. This event, a cornerstone for the government and military electronics industry, will be held on March 19th and 20th at the Embassy Suites by Hilton, Charleston Convention Center, in Charleston, SC. Exhibit Information:Dates and Times: Tuesday, March 19: 12:00 pm - 8:00 pmWednesday, March 20: 9:00 am - 4:00 pmBooth: 402 Attendees are invited to visit QuickLogic's booth to explore the company's innovative FPGA and eFPGA cores. With over 30 years of experience, QuickLogic has established a track record of delivering tens of millions of units across aerospace and defense, commercial, ruggedized, and mission-critical applications. Our Australis eFPGA IP generator transforms custom FPGA/eFPGA creation, offering rapid development from concept to tape out across any process node in mere days. We lead in FPGA tool transparency, providing the industry's first 100% open-source user tools through our Aurora FPGA User Tools, ensuring a transparent and trusted design process. About QuickLogic QuickLogic Corporation (NASDAQ: QUIK) is a fabless semiconductor company that develops innovative embedded FPGA (eFPGA) IP, discrete FPGAs, and FPGA SoCs for a variety of industrial, aerospace and defense, edge and endpoint AI, consumer, and computing applications. Our wholly owned subsidiary, SensiML Corporation, completes the end-to-end solution portfolio with AI / ML software that accelerates AI at the edge/endpoint. For more information, visit quicklogic.com. QuickLogic and logo are registered trademarks of QuickLogic. All other trademarks are the property of their respective holders and should be treated as such. View original content to download multimedia:https://www.prnewswire.com/news-releases/quicklogic-to-exhibit-at-gomactech-2024-302088522.html SOURCE QuickLogic Corporation What is QuickLogic Corporation's ticker symbol? QuickLogic Corporation's ticker symbol is NASDAQ: QUIK. Where will the GOMACTech 2024 Conference be held? The GOMACTech 2024 Conference will be held at the Embassy Suites by Hilton, Charleston Convention Center, in Charleston, SC. What will QuickLogic showcase at the conference? QuickLogic will showcase its innovative FPGA and eFPGA cores at the conference. How many years of experience does QuickLogic have? QuickLogic has over 30 years of experience in the industry. What does QuickLogic specialize in? QuickLogic specializes in embedded FPGA (eFPGA) IP, ruggedized FPGAs, and Endpoint AI/ML solutions."
NextNav Inc. Reports Fourth Quarter and Full Year 2023 Results,2024-03-13T20:05:00.000Z,Neutral,Neutral,"NextNav Inc. (NN) reported financial results for Q4 and full year 2023, with revenue at $1.2 million and $3.9 million respectively. The company acquired additional 900 MHz spectrum licenses, bringing total spectrum assets to 3.5 billion MHz-PoPs. Mariam Sorond became the new CEO, aiming to enhance PNT technology. Financially, operating loss was $19.9 million and net loss was $16.4 million in Q4 2023. The company had $81.9 million in cash as of December 31, 2023.","NextNav Inc. Reports Fourth Quarter and Full Year 2023 Results Rhea-AI Impact (Neutral) Rhea-AI Sentiment (Neutral) Tags earnings Rhea-AI Summary NextNav Inc. (NN) reported financial results for Q4 and full year 2023, with revenue at $1.2 million and $3.9 million respectively. The company acquired additional 900 MHz spectrum licenses, bringing total spectrum assets to 3.5 billion MHz-PoPs. Mariam Sorond became the new CEO, aiming to enhance PNT technology. Financially, operating loss was $19.9 million and net loss was $16.4 million in Q4 2023. The company had $81.9 million in cash as of December 31, 2023. Positive None. Negative None. Telecommunications Analyst The acquisition of additional spectrum licenses by NextNav is a strategic move that could significantly bolster its positioning in the telecommunications sector. Spectrum is a finite resource and is crucial for the delivery of wireless services. The additional 4 MHz in the lower 900 MHz band, increasing NextNav's total to 3.5 billion MHz-PoPs, enhances the company's capacity to provide robust and reliable services. This could potentially lead to new contracts and partnerships, particularly given the increasing demand for enhanced PNT and 3D geolocation services in both public and private sectors.However, the financial commitment of up to $50 million for the additional spectrum needs to be weighed against the company's current financial position. With a reported net loss of $71.7 million in the twelve months ended December 31, 2023 and an operating loss of $63.5 million, there is pressure on NextNav to monetize this investment efficiently to reassure investors and improve its financial health. Financial Analyst From a financial perspective, the reported increase in revenue is a positive indicator, although it's important to note that the revenue growth is modest when compared to the operating and net losses. The reported operating loss and net loss in the recent financial results suggest that NextNav is still in a growth phase where it is investing heavily in its technology and market expansion. This is further evidenced by the significant expenses related to stock-based compensation and payroll, which are typical for companies aiming to attract and retain talent in competitive tech sectors.Investors should consider the company's long-term strategy and the potential market for its services when evaluating the impact of these financial results. The cash position of $81.9 million provides some runway, but given the substantial losses, NextNav will need to demonstrate a clear path to profitability or continued growth in revenue to maintain investor confidence. Market Research Analyst NextNav's focus on next generation PNT technology and its optimized use of the 900 MHz spectrum could position the company as an innovator in a niche market. The telecommunications industry is rapidly evolving, with an increasing focus on applications that require precise location and timing data, such as autonomous vehicles, IoT devices and smart city infrastructure. NextNav's expanded spectrum assets could give it a competitive edge in these markets.However, the market will also be looking at how effectively NextNav can leverage its new CEO's experience and the strategic insights of its newly appointed board member to navigate the competitive landscape. The ability to convert technical capabilities into marketable solutions that address real-world problems will be key to NextNav's success and its impact on the stock market. 03/13/2024 - 04:05 PM Announced Transaction to Acquire Additional 900 MHz Spectrum Licenses Mariam Sorond Joins as NextNav CEO MCLEAN, Va., March 13, 2024 (GLOBE NEWSWIRE) -- NextNav Inc. (NASDAQ: NN) (NextNav or the Company) a leader in next generation positioning, navigation, and timing (PNT) and 3D geolocation, today reported financial results for NextNavs fourth quarter and full year ended December 31, 2023. Mariam Sorond, NextNav CEO stated, Its been an incredible first 100 days as the CEO of NextNav. I have met directly with our team and partners and see the potential to explore options to enhance our next generation PNT technology through optimized use of our valuable spectrum asset. In line with this strategy, we recently signed an exciting agreement to acquire additional spectrum licenses covering 4 MHz in the lower 900 MHz band. Following close, this significant transaction will bring NextNavs combined spectrum assets, including its existing 8MHz of contiguous 900 MHz spectrum, to a total of 3.5 billion MHz-PoPs of low band spectrum. PNT powered by low-band spectrum with optimized use is a unique and powerful opportunity to help to address many of the challenges faced by both the public and private sectors, including national security and public safety. As we move forward, we are taking a fresh look at our entire offering and considering how best to take full advantage of our valuable spectrum assets to drive growth and long-term shareholder value. Recent Operational Highlights Acquires Additional 900 MHz Spectrum Licenses: On March 11, 2024, NextNav announced it had signed an agreement to acquire spectrum licenses covering an additional 4 MHz in the lower 900 MHz band for a total purchase price of up to $50 million. Following close, NextNavs combined spectrum assets, including its existing 8MHz of contiguous 900 MHz spectrum, will total 3.5 billion MHz-PoPs of low band spectrum.Mariam Sorond Named New Chief Executive Officer: Mariam Sorond, a veteran industry leader, was appointed NextNavs new Chief Executive Officer, effective November 29, 2023. Ms. Sorond joins NextNav with over 28 years of technical and strategy experience in the telecommunications industry, including extensive spectrum expertise and proven track record of evolving telecommunication technology and strategy.Appointed John Muleta to Board of Directors: NextNav announced the appointment of John Muleta to the Board of Directors, effective January 18, 2024. Mr. Muletas brings deep expertise in the development and implementation of wireless policies, particularly in spectrum allocation and public safety in both the private and public sectors, including previously serving as the Wireless Telecommunications Bureau Chief at the Federal Communications Commission. Three and Twelve Months Ended December 31, 2023, Financial Highlights Revenue: was $1.2 million in the three months ended December 31, 2023, as compared to $803,000 in the prior year period. The increase was primarily attributable to increased recurring service revenue in the current period from technology and services contracts with commercial customers. In the twelve months ended December 31, 2023, revenue was $3.9 million, and was flat with the prior year period. There was a decrease in integration revenue which was partially offset by increased recurring service revenue from technology and service contracts with commercial customers.Operating Loss: was $19.9 million in the three months ended December 31, 2023, as compared to an operating loss of $14.5 million in the prior year period, primarily driven by increases in stock-based compensation expense and payroll-related expenses. In the twelve months ended December 31, 2023, operating loss was $63.5 million, as compared to an operating loss of $65.5 million in the prior year period, primarily driven by lower stock-based compensation expense which was partially offset by increase in payroll-related expenses.Net Loss: was $16.4 million in the three months ended December 31, 2023, including a gain on the fair value of warrants of $5.7 million, as compared to a net loss of $12.5 million in the prior year period, including a gain on the fair value of the warrants of $1.5 million. In the twelve months ended December 31, 2023, net loss was $71.7 million, including a loss on the fair value of warrants of $4.1 million as compared to a net loss of $40.1 million in the prior year period, including a gain on the fair value of the warrants of $24.7 million.Balance Sheet: as of December 31, 2023, the Company had $81.9 million in cash and cash equivalents, $4.0 million in short term investments and has $48.4 million in debt net of unamortized discount attributed to transaction costs and the issuance of warrants, with a gross value of $70.0 million. Conference Call Information NextNav will host a conference call for analysts and investors at 5:00 pm ET on Wednesday, March 13, 2024. Registration for the conference call can be completed by visiting the following website prior to, or on the day of, the conference call: https://registrations.events/direct/Q4I629368796093022208 After registering, each participant will be provided with call details and a registrant ID. Reminders will also be sent to registered participants via email. Alternatively, the conference call will be available via a live webcast. To access the live webcast or a replay, visit the Companys investor relations website at https://ir.nextnav.com/. A replay of the call can also be accessed via phone through March 20, 2024 by dialing (800) 770-2030 from the U.S., or (647) 362-9199 from outside the U.S. The conference I.D. number is 62936. About NextNav Inc. NextNav Inc. (Nasdaq: NN) is a leader in next generation positioning, navigation and timing (PNT), enabling a whole new ecosystem of applications and services that rely upon 3D geolocation and PNT technology. Powered by low-band licensed spectrum, NextNav's positioning and timing technologies deliver accurate, reliable, and resilient 3D PNT solutions for critical infrastructure, GPS resiliency and commercial use cases. For more information, please visit https://nextnav.com/ or follow NextNav on Twitter or LinkedIn. Source: NN-FIN Forward-Looking Statements This press release contains forward-looking statements within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements may be identified by the use of words such as forecast, intend, seek, target, anticipate, believe, expect, estimate, plan, outlook, and project and other similar expressions that predict or indicate future events or trends or that are not statements of historical matters. These statements, which involve risks and uncertainties, relate to analyses and other information that are based on forecasts of future results and estimates of amounts not yet determinable and may also relate to NextNavs future prospects, developments and business strategies. In particular, such forward-looking statements include the approval by the FCC of the transfer of the licenses, closing of the transactions described herein, the achievement of certain FCC-related milestones, the ability to realize the broader spectrum capacity and the advancement of NextNavs PNT services, NextNavs position to drive growth in its 3D geolocation business and expansion of its next generation PNT technologies, the business plans, objectives, expectations and intentions of NextNav, and NextNavs estimated and future business strategies, competitive position, industry environment and potential growth opportunities. These statements are based on NextNavs managements current expectations and beliefs, as well as a number of assumptions concerning future events. Such forward-looking statements are subject to known and unknown risks, uncertainties, assumptions and other important factors, many of which are outside NextNavs control that could cause actual results to differ materially from the results discussed in the forward-looking statements. These risks, uncertainties, assumptions and other important factors include, but are not limited to: (1) the risk that the requisite regulatory approvals are not obtained and the closing of the transaction does not occur; (2) the risk that the consummation of the transactions disrupts current plans and operations of NextNav; (3) the ability to recognize the anticipated benefits of the transactions, which may be affected by, among other things, competition, the ability of NextNav to grow and manage growth profitably, maintain relationships with customers and suppliers and retain its management and key employees; (4) costs related to the transactions; (5) the possibility that NextNav may be adversely affected by other economic, business and/or competitive factors; and (6) other risks and uncertainties indicated from time to time in other documents filed with the SEC by NextNav. New risks and uncertainties arise from time to time, and it is impossible for NextNav to predict these events or how they may affect the Company. You are cautioned not to place undue reliance upon any forward-looking statements, which speak only as of the date made, and NextNav undertakes no commitment to update or revise the forward-looking statements, whether as a result of new information, future events or otherwise. Contact: Erica Bartsch Sloane & Company ebartsch@sloanepr.com 212-446-1875 NEXTNAV INC.CONSOLIDATED BALANCE SHEETS(UNAUDITED) December 31, 2023 2022 (in thousands) Assets Current assets: Cash and cash equivalents $81,878 $47,230 Short Term Investment 3,954 8,216 Accounts Receivable 2,332 2,168 Other current assets 3,056 3,576 Total current assets $91,220 $61,190 Network under construction 1,676 3,574 Property and equipment, net of accumulated depreciation of $9,724 and $5,971 at December 31, 2023 and 2022, respectively 19,885 19,180 Operating lease right-of-use assets 19,267 10,143 Goodwill 17,977 17,493 Intangible assets, net 10,625 10,397 Other assets 1,508 1,811 Total assets $162,158 $123,788 Liabilities, preferred interests, and stockholders equity (deficit) Current liabilities: Accounts payable $391 $1,019 Accrued expenses and other current liabilities 6,592 5,241 Short term lease liabilities - operating 2,523 2,532 Deferred revenue 297 95 Total current liabilities $9,803 $8,887 Warrants 7,053 4,200 Long-term lease liabilities - Operating 15,145 5,290 Other long-term liabilities 1,614 1,547 Long-term debt, net of debt issuance cost and discount 48,447  Total liabilities $82,062 $19,924 Stockholders equity (deficit): Common Stock, authorized 500,000,000 shares; 111,260,257 and 106,418,442 shares issued and 111,132,222 and 106,417,265 shares outstanding at December 31, 2023 and 2022, respectively $12 $12 Additional paid-in capital 837,416 787,130 Accumulated other comprehensive income 2,198 1,371 Accumulated deficit (760,227) (688,492)Common stock in treasury, at cost, 128,035 and 1,177 shares at December 31, 2023 and December 31, 2022, respectively (665) (4)Total stockholders equity (deficit) $78,734 $100,017 Non-controlling interests 1,362 3,847 Total liabilities, preferred interests, stockholders equity (deficit) and non-controlling interests $162,158 $123,788 NEXTNAV INC.CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS(UNAUDITED) Year Ended December 31, 2023 2022 (in thousands, except per share amounts) Revenue $3,862 $3,926 Operating expenses: Cost of goods sold (exclusive of depreciation and amortization) 12,743 11,806 Research and development 19,503 17,059 Selling, general and administrative 30,324 36,926 Depreciation and amortization 4,821 3,671 Total operating expenses $ 67,391 $69,462 Operating loss (63,529) (65,536)Other income (expense): Interest income (expense) (3,664) 901 Change in fair value of warrants (4,101) 24,675 Other loss, net (220) (184)Loss before income taxes $(71,514) $(40,144)Benefit (Provision) for income taxes (221) 28 Net loss $(71,735) $(40,116)Foreign currency translation adjustment 827 1,492 Comprehensive loss $(70,908) $(38,624)Net loss $(71,735) $(40,116)Net loss attributable to common stockholders $(71,735) $(40,116)Weighted average of shares outstanding  basic and diluted 107,972 101,029 Net loss attributable to common stockholder per share  basic and diluted $(0.66) $(0.40) NEXTNAV INC.CONSOLIDATED STATEMENTS OF CASH FLOWS(UNAUDITED) Year Ended December 31, 2023 2022 (in thousands) Operating activities Net loss $(71,735) $(40,116)Adjustments to reconcile net loss to net cash used in operating activities: Depreciation and amortization 4,821 3,671 Equity-based compensation 21,838 26,501 Change in fair value of warrant liability 4,101 (24,675)Realized and unrealized gain on marketable securities (546) (72)Equity method investment loss 191 230 Asset retirement obligation accretion 66 56 Amortization of debt issuance costs and discount 3,151  Changes in operating assets and liabilities: Accounts receivables (164) (428)Other current assets 537 593 Other assets 119 161 Accounts payable (627) 486 Deferred revenue 202 (1,537)Accrued expenses and other liabilities 1,884 (2,501)Operating lease right-of-use assets and liabilities 722 536 Net cash used in operating activities $(35,440) $(37,095) Investing activities Capitalization of costs and purchases of network assets, property, and equipment (2,751) (2,964)Purchase of equity method investments  (1,125)Purchase of marketable securities (37,441) (13,644)Sale and maturity of marketable securities 42,249 5,500 Purchase of business, net of cash acquired  (2,890)Purchase of internal use software (983) (613)Net cash provided by (used in) investing activities $1,074 $(15,736) Financing activities Proceeds from debt 70,000  Payments towards debt issuance cost (1,861)  Payments towards debt (110) (17)Proceeds from exercise of stock option 73 57 Proceeds from exercise of warrants 882  Proceeds from issuance of common stock  7 Purchase of common stock (withholding taxes)  (4)Net cash provided by financing activities $68,984 $43 Effect of exchange rates on cash and cash equivalents 30 (58)Net increase (decrease) in cash and cash equivalents 34,648 (52,846)Cash and cash equivalents at beginning of period 47,230 100,076 Cash and cash equivalents at end of period $81,878 $47,230 Non-cash investing and financing activities Common stock issued in acquisition of business $ $13,888 Capital expenditure included in Accrued expenses and other current liabilities $285 $605 Reclassification of warrant liability to common stock warrants $1,248 $ Issuance of warrants $22,843 $ Interest paid in shares $1,888 $ Interest paid in cash $1,808 $ Income taxes paid, net $147 $ What were NextNav's revenue figures for Q4 and full year 2023? Revenue was $1.2 million in Q4 2023 and $3.9 million for the full year 2023. How many MHz-PoPs of low band spectrum does NextNav now have? NextNav now has a total of 3.5 billion MHz-PoPs of low band spectrum. Who is the new CEO of NextNav? Mariam Sorond is the new CEO of NextNav. What was the operating loss in Q4 2023? Operating loss was $19.9 million in Q4 2023. How much cash did NextNav have as of December 31, 2023? As of December 31, 2023, NextNav had $81.9 million in cash."
Poseida Therapeutics Announces FDA Orphan Drug Designation Granted to P-BCMA-ALLO1 for the Treatment of Multiple Myeloma,2024-03-13T20:05:00.000Z,Moderate,Positive,"Poseida Therapeutics, Inc. (PSTX) receives Orphan Drug Designation from the FDA for P-BCMA-ALLO1 therapy for multiple myeloma treatment. The company is collaborating with Roche for the treatment of relapsed/refractory multiple myeloma. Positive early safety and efficacy data were shared at the ASH Annual Meeting. The Phase 1 trial of P-BCMA-ALLO1 showed promising results in terms of safety, efficacy, and cell persistence at tumor sites.","Poseida Therapeutics Announces FDA Orphan Drug Designation Granted to P-BCMA-ALLO1 for the Treatment of Multiple Myeloma Rhea-AI Impact (Moderate) Rhea-AI Sentiment (Positive) Tags clinical trial Rhea-AI Summary Poseida Therapeutics, Inc. (PSTX) receives Orphan Drug Designation from the FDA for P-BCMA-ALLO1 therapy for multiple myeloma treatment. The company is collaborating with Roche for the treatment of relapsed/refractory multiple myeloma. Positive early safety and efficacy data were shared at the ASH Annual Meeting. The Phase 1 trial of P-BCMA-ALLO1 showed promising results in terms of safety, efficacy, and cell persistence at tumor sites. Positive Poseida Therapeutics receives Orphan Drug Designation from the FDA for P-BCMA-ALLO1 therapy for multiple myeloma treatment. Collaboration with Roche for the treatment of relapsed/refractory multiple myeloma. Positive early safety and efficacy data shared at the ASH Annual Meeting. Phase 1 trial of P-BCMA-ALLO1 demonstrates promising results in terms of safety, efficacy, and cell persistence at tumor sites. Negative None. Oncology Doctor The FDA's Orphan Drug Designation for P-BCMA-ALLO1, a BCMA-targeted allogeneic CAR-T therapy, represents a significant stride in the treatment of multiple myeloma, a hematologic cancer. This designation is typically granted to therapies that show promise for conditions with limited treatment options, thereby acknowledging the potential of P-BCMA-ALLO1 to address the unmet needs in this patient population. The therapy's TSCM-rich composition could signify a longer-lasting immune response, as TSCM cells are known for their self-renewal and multipotency, which are crucial for sustained antitumor activity. The preliminary data suggesting that P-BCMA-ALLO1 can traffic to bone marrow and differentiate into effector T cells without the need for bridging chemotherapy is particularly promising. This could reduce treatment-related morbidity and streamline the therapy process for patients. However, the long-term efficacy and safety profile will need to be closely monitored in ongoing and future clinical trials to validate these early findings. Medical Research Analyst The orphan drug status not only highlights the therapeutic potential of P-BCMA-ALLO1 but also offers Poseida Therapeutics various development and financial incentives, including tax credits and user-fee exemptions. These benefits can accelerate the development timeline and reduce costs for Poseida, which is critical for a clinical-stage company. Furthermore, the potential seven-year market exclusivity upon FDA approval could provide a substantial competitive advantage in the multiple myeloma market, assuming the therapy's clinical success.Investors should note the importance of the upcoming AACR meeting presentation, as data on patients refractory to initial BCMA targeting therapy could provide insights into the therapy's efficacy in a more resistant patient subset. Positive results may boost investor confidence and could be a catalyst for the company's stock performance. Market Research Analyst The market for multiple myeloma treatments is evolving, with increasing emphasis on personalized and targeted therapies. Allogeneic CAR-T therapies like P-BCMA-ALLO1 are particularly noteworthy as they represent a shift towards 'off-the-shelf' treatments, potentially reducing manufacturing times and costs compared to patient-specific autologous CAR-T therapies. This could lead to broader market access and increased adoption rates if clinical efficacy is proven.However, the competitive landscape includes other companies developing BCMA-targeted therapies, which means Poseida's market share will depend on the clinical differentiation of P-BCMA-ALLO1. The partnership with Roche could be instrumental in navigating commercialization challenges, leveraging Roche's established infrastructure and expertise in oncology. 03/13/2024 - 04:05 PM Data Describing Activity of P-BCMA-ALLO1 in BCMA-Experienced Patients to be Presented at Upcoming AACR Meeting SAN DIEGO, March 13, 2024 /PRNewswire/ -- Poseida Therapeutics, Inc. (Nasdaq: PSTX), a clinical-stage cell and gene therapy company advancing a new class of treatments for patients with cancer and rare diseases, today announced the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation for the treatment of multiple myeloma to P-BCMA-ALLO1, a novel BCMA-targeted allogeneic, T stem cell memory (TSCM)-rich chimeric antigen receptor (CAR)-T therapy candidate. The Company is investigating P-BCMA-ALLO1 in partnership with Roche for the treatment of relapsed/refractory multiple myeloma (RRMM). ""The Orphan Drug Designation for P-BCMA-ALLO1 underscores the high unmet medical need for a rapid and accessible off-the-shelf allogeneic CAR-T therapy for patients with multiple myeloma,"" said Kristin Yarema, Ph.D., President and Chief Executive Officer of the Company. ""This designation further validates our belief that TSCM-rich allogeneic CAR-T therapies may potentially offer the optimal combination of clinical results, on-demand availability, and high-volume production, while supporting broader access to CAR-T therapies. We look forward to continuing our work on the Phase 1 study of P-BCMA-ALLO1 and plan to share further clinical updates in 2024."" The Company is currently evaluating P-BCMA-ALLO1 in a Phase 1 clinical trial and recently shared positive early safety and preliminary efficacy data at the 65th American Society of Hematology (ASH) Annual Meeting and Exposition in December 2023. Data highlighted at the meeting showed that P-BCMA-ALLO1 was a well-tolerated off-the-shelf therapy with a favorable emerging safety profile, delivered to 100% of patients in the intent-to-treat population with no use of bridging chemotherapy or other anti-myeloma bridging therapies. Preliminary data presented at ASH also showed allogeneic TSCM-rich CAR-T cells trafficking to bone marrow, differentiating to cell-killing effector T cells and persisting at least 6 weeks after treatment, which support the hypothesis of cell persistence at tumor-relevant sites. The Company will present data on a subset of recently enrolled patients refractory to initial BCMA targeting therapy in a poster presentation at the American Association for Cancer Research (AACR) Annual Meeting in San Diego on April 8, 2024, 9:00 AM to 12:30 PM PT. Subject to coordination with Roche, the Company plans to provide an additional clinical update on the P-BCMA-ALLO1 program at a scientific meeting in the second half of 2024. The FDA's Orphan Drug Designation program provides orphan status to drugs or biologics intended for the prevention, diagnosis, or treatment of diseases that affect fewer than 200,000 people in the United States. Sponsors of medicines that are granted Orphan Drug Designation are entitled to certain incentives, including tax credits for qualified clinical trials, prescription drug user-fee exemptions, and potential seven-year marketing exclusivity upon FDA approval. About P-BCMA-ALLO1 P-BCMA-ALLO1 is an allogeneic CAR-T product candidate licensed to Roche targeting B-cell maturation antigen (BCMA) for the treatment of relapsed/refractory multiple myeloma. This allogeneic program includes a VH-based binder that targets BCMA and clinical data presented at ASH in December 2023 support the Company's belief that TSCM-rich allogeneic CAR-Ts have the potential to offer effective, safe, and reliable treatment addressing unmet needs in multiple myeloma. Additional information about the Phase 1 study is available at www.clinicaltrials.gov using identifier: NCT04960579. About Poseida Therapeutics, Inc. Poseida Therapeutics is a clinical-stage biopharmaceutical company advancing differentiated cell and gene therapies with the capacity to cure certain cancers and rare diseases. The Company's pipeline includes allogeneic CAR-T cell therapy product candidates for both solid and liquid tumors as well as in vivo gene therapy product candidates that address patient populations with high unmet medical need. The Company's approach to cell and gene therapies is based on its proprietary genetic editing platforms, including its non-viral piggyBac DNA Delivery System, Cas-CLOVER Site-Specific Gene Editing System, Booster Molecule, and nanoparticle and hybrid gene delivery technologies as well as in-house GMP cell therapy manufacturing. The Company has formed a global strategic collaboration with Roche to unlock the promise of cell therapies for patients with hematological malignancies. Learn more at www.poseida.com and connect with Poseida on X and LinkedIn. Forward-Looking Statements Statements contained in this press release regarding matters that are not historical facts are ""forward-looking statements"" within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements include statements regarding, among other things, expected plans with respect to clinical trials, including timing of regulatory submissions and approvals and clinical data updates; anticipated timelines and milestones with respect to the Company's development programs and manufacturing activities and capabilities; the potential capabilities and benefits of the Company's technology platforms and product candidates, including the efficacy and safety profile of such product candidates; the quote from Dr. Yarema; the Company's ability to exploit and consummate additional business development opportunities; the Company's ability to attract and/or retain new and existing collaborators with relevant expertise and its expectations regarding the potential benefits to be derived from any such collaborations; potential benefits from receiving Orphan Drug Designation for P-BCMA-ALLO1; and the Company's plans and strategy with respect to developing its technologies and product candidates. Because such statements are subject to risks and uncertainties, actual results may differ materially from those expressed or implied by such forward-looking statements. These forward-looking statements are based upon the Company's current expectations and involve assumptions that may never materialize or may prove to be incorrect. Actual results could differ materially from those anticipated in such forward-looking statements as a result of various risks and uncertainties, which include, without limitation, the Company's reliance on third parties for various aspects of its business; risks and uncertainties associated with development and regulatory approval of novel product candidates in the biopharmaceutical industry; the Company's ability to retain key scientific or management personnel; the fact that the Company will have limited control over the efforts and resources that Roche devotes to advancing development programs under its collaboration agreement and the Company may not receive the potential fees and payments under the collaboration agreement and the ability of Roche to early terminate the collaboration, such that the Company may not fully realize the benefits of the collaboration; and the other risks described in the Company's filings with the Securities and Exchange Commission. All forward-looking statements contained in this press release speak only as of the date on which they were made. The Company undertakes no obligation to update such statements to reflect events that occur or circumstances that exist after the date on which they were made, except as required by law. View original content to download multimedia:https://www.prnewswire.com/news-releases/poseida-therapeutics-announces-fda-orphan-drug-designation-granted-to-p-bcma-allo1-for-the-treatment-of-multiple-myeloma-302088554.html SOURCE Poseida Therapeutics, Inc. What is the significance of the FDA granting Orphan Drug Designation to P-BCMA-ALLO1? The FDA granting Orphan Drug Designation to P-BCMA-ALLO1 highlights the high unmet medical need for an off-the-shelf allogeneic CAR-T therapy for multiple myeloma patients. Who is Poseida Therapeutics collaborating with for the treatment of relapsed/refractory multiple myeloma? Poseida Therapeutics is collaborating with Roche for the treatment of relapsed/refractory multiple myeloma. What were the key findings presented at the ASH Annual Meeting regarding P-BCMA-ALLO1? Positive early safety and preliminary efficacy data were shared at the ASH Annual Meeting, demonstrating the well-tolerated nature of P-BCMA-ALLO1. What did the Phase 1 trial of P-BCMA-ALLO1 reveal? The Phase 1 trial of P-BCMA-ALLO1 showed promising results in terms of safety, efficacy, and cell persistence at tumor sites. When will the Company present data on recently enrolled patients refractory to initial BCMA targeting therapy? The Company will present data on a subset of recently enrolled patients at the AACR Annual Meeting on April 8, 2024. What incentives are sponsors entitled to with the FDA's Orphan Drug Designation program? Sponsors granted Orphan Drug Designation are entitled to incentives such as tax credits for clinical trials, prescription drug user-fee exemptions, and potential marketing exclusivity upon FDA approval."
GrowGeneration Reports Fourth Quarter and Full Year 2023 Financial Results; Provides First Quarter and Full Year 2024 Guidance,2024-03-13T20:05:00.000Z,Neutral,Neutral,"GrowGeneration Corp. (GRWG) reports full-year net revenue of $225.9 million, surpassing guidance, with a net loss of $46.5 million. The outlook for 2024 forecasts revenue from $205 million to $215 million. The company plans to review strategic options for MMI.","GrowGeneration Reports Fourth Quarter and Full Year 2023 Financial Results; Provides First Quarter and Full Year 2024 Guidance Rhea-AI Impact (Neutral) Rhea-AI Sentiment (Neutral) Tags earnings Rhea-AI Summary GrowGeneration Corp. (GRWG) reports full-year net revenue of $225.9 million, surpassing guidance, with a net loss of $46.5 million. The outlook for 2024 forecasts revenue from $205 million to $215 million. The company plans to review strategic options for MMI. Positive Exceeded full-year revenue guidance with $225.9 million in net revenue. Reported a net loss of $46.5 million for the full year 2023. 2024 outlook projects revenue between $205 million to $215 million. Reviewing strategic opportunities for MMI, focusing on benching, racking, and storage solutions. Negative Net revenues decreased by approximately 18.8% compared to the prior year. Adjusted EBITDA(1) showed a loss of $5.6 million for the full year 2023. Same-store sales decreased by 3.6% in the fourth quarter of 2023. Financial Analyst The reported full year net revenue of $225.9 million surpassing guidance and a net loss of $46.5 million present a mixed financial health for GrowGeneration Corp. The revenue beat indicates resilience in their business model despite a notable 18.8% year-over-year decline. The gross profit margin improvement by 180 basis points suggests effective cost management and a strategic shift towards higher-margin proprietary products. However, investors should consider the significant net loss, which, although improved from the previous year, still reflects challenges in achieving profitability.Furthermore, the reduction in operating expenses by $13.6 million and the lack of debt on the balance sheet are positive indicators of financial prudence. The companys cash position of $65.0 million provides a cushion for future strategic initiatives. However, the forecast for 2024 with revenues expected to decline further could be a concern, indicating either a conservative outlook or underlying market challenges. Market Research Analyst The decline in same-store sales by 19.3% is a critical metric indicating the company's organic growth challenges within existing locations. This metric, often used to gauge a retailer's health, suggests that GrowGeneration is facing competitive pressures or market saturation. The strategic decision to close and consolidate 14 retail locations aligns with efforts to optimize the operational footprint and may improve efficiency but also highlights the need to recalibrate market presence.The company's pivot towards the home gardening market with The Harvest Company could signal an attempt to diversify revenue streams and reduce reliance on the cannabis sector's legislative volatility. This diversification could potentially open new customer segments and revenue channels, but it also requires careful navigation of consumer preferences and market dynamics. Legal Expert The strategic review of MMI, the storage solutions business, suggests a focus on core competencies and potential divestiture to streamline operations. Engaging Lake Street Capital Markets indicates seriousness in exploring strategic opportunities, which could result in a sale or spin-off. The success of MMI, with $31.4 million in revenue and $8.9 million in operating profit, demonstrates its viability as a stand-alone entity or as an attractive acquisition target.However, any transaction would be subject to regulatory approvals and market conditions. The outcome of this strategic exploration could have significant implications for GrowGeneration's capital allocation and focus on its Cultivation and Gardening segment. Stakeholders should monitor this process closely as it could impact the company's strategic direction and financial position. 03/13/2024 - 04:05 PM Full Year Net Revenue of $225.9 million, Beating Guidance Full Year Net Loss of $46.5 million and Non-GAAP Adjusted EBITDA(1) Loss of $5.6 million, In Line with Guidance 2024 Outlook Calls for Revenue from $205 million to $215 million and Non-GAAP Adjusted EBITDA(1) from a Loss of $2 million to a Profit of $3 million Company to Review Strategic Opportunities for MMI DENVER--(BUSINESS WIRE)-- GrowGeneration Corp. (NASDAQ: GRWG), (GrowGen or the Company), one of the largest retailers and distributors of specialty hydroponic and organic gardening products in the United States, today announced financial results for the fourth quarter and full year ended December 31, 2023. Fourth Quarter 2023 Highlights Compared to Prior Year Net revenues decreased approximately 9% to $49.5 million, and same-store sales decreased 3.6% Gross profit increased to $11.6 million, or 23.5% of net revenues, from $9.6 million, or 17.6% of net revenues Net loss of $27.3 million, or $(0.44) per diluted share, compared to a net loss of $15.0 million, or $(0.25) per diluted share, primarily due to non-cash impairment Adjusted EBITDA(1) loss of $3.7 million, compared to a loss of $10.2 million Full Year 2023 Highlights Compared to Prior Year Net revenues decreased approximately 18.8% to $225.9 million, beating the Companys previous guidance Gross profit decreased to $61.3 million, or 27.1% of net revenues, from $70.3 million, or 25.3% of net revenues Net loss of $46.5 million, or $(0.76) per diluted share, compared to a net loss of $163.7 million, or $(2.69) per diluted share Adjusted EBITDA(1) loss of $5.6 million, compared to earnings of $16.7 million Reduced operating expense and selling, general, and administrative expense base by roughly $13.6 million through operating efficiencies and strategic cost rationalization Cash, cash equivalents, and marketable securities of $65.0 million as of December 31, 2023, along with no debt Generated $1.4 million of operating cash, primarily driven by reduction of inventory Darren Lampert, GrowGens Co-Founder and Chief Executive Officer, stated, I am pleased that our hard work and dedication to executing our strategic initiatives in 2023 allowed us to surpass our full year revenue guidance and be in line with our full year Adjusted EBITDA guidance. Our profit margins increased nearly 200 basis points as well, driven by more proprietary product sales and consumable product sales as a percent of total sales. Lastly, we ended 2023 with $65.0 million in cash, cash equivalents, and marketable securities and with no debt, positioning us well to continue to execute on our strategic initiatives in 2024. Mr. Lampert continued, 2023 was a year of strategic execution and resilience for GrowGen, and we continue into 2024 laser-focused on positioning the business for long-term, profitable growth. One key pillar for growth is continuing to enhance our brand portfolio, including launching new products and increasing sales in our higher margin proprietary brands. We are also expanding into the home gardening market with The Harvest Company, which we launched earlier this year. We believe GrowGens expertise in advanced cultivation technologies and sustainable practices developed within the cannabis industry will allow us to succeed in this new market, where consumers are seeking home gardening products to grow healthy, organic, and sustainable microgreens, fruits, and vegetables. Lastly, we remain focused on creating and sustaining operational efficiencies to position ourselves to capitalize on market opportunities as they arise, and I believe they will arise sooner than later as the legislative landscape around cannabis continues to become more favorable. Reporting Segments Update During the fourth quarter of 2023, the Company realigned its operating and reportable segments to correspond with changes to its operating model, management structure, and internal reporting, and to better align with how the Chief Executive Officer makes operating decisions, allocates resources, and assesses performance. Accordingly, the Company identified two operating segments, each its own reportable segment, based on its major lines of business: the Cultivation and Gardening segment; and the Storage Solutions segment. Fourth Quarter 2023 Consolidated Results Net revenues decreased $5.0 million, or 9%, to $49.5 million for the fourth quarter ended December 31, 2023, compared to $54.5 million for the fourth quarter ended December 31, 2022. The decline was driven primarily by a 3.6% decrease in same-store sales. Net revenues for same-store sale locations open for the same period in 2022 and 2023 were $35.6 million in the fourth quarter 2023, compared to $37.0 million in the fourth quarter 2022. Gross profit was $11.6 million for the fourth quarter 2023, an increase of $2.1 million, compared to gross profit of $9.6 million for the fourth quarter 2022. Gross profit margin was 23.5% for the fourth quarter 2023, compared to 17.6% for the fourth quarter 2022, an increase of 600 basis points, primarily due to improvements in product mix and corresponding margin performance. GAAP net loss was $27.3 million in the fourth quarter 2023, a decrease of $12.3 million, compared to a net loss of $15.0 million in the fourth quarter 2022. Net loss was $0.44 per diluted share in the fourth quarter 2023, compared to a net loss of $0.25 per diluted share in the fourth quarter 2022. The decrease in GAAP net loss was primarily due to a $15.7 million non-cash impairment recorded in the fourth quarter 2023 of goodwill and intangible assets related to prior acquisitions. Non-GAAP Adjusted EBITDA(1) was a loss of $3.7 million in the fourth quarter 2023, compared to a loss of $10.2 million in the fourth quarter 2022. The increase to Adjusted EBITDA(1) was primarily driven by improvements in gross profit and reductions in operating and corporate expenses relating to our strategic cost rationalization. Cash, cash equivalents, and marketable securities as of December 31, 2023 were $65.0 million. Full Year 2023 Consolidated Results Net revenues decreased $52.3 million, or 18.8%, to $225.9 million for the full year ended December 31, 2023, compared to $278.2 million for the full year ended December 31, 2022. The decline was driven primarily by a 19.3% decrease in same-store sales. Gross profit was $61.3 million for the full year 2023, a decrease of $9.0 million, compared to gross profit of $70.3 million for the full year 2022. Gross profit margin was 27.1% for the full year 2023, compared to 25.3% for the full year 2022, an improvement of 180 basis points. The improvement to gross margin on a percentage basis was primarily due to stronger penetration of private label as a percent of sales. GAAP net loss was $46.5 million for the full year 2023, a decrease of $117.3 million, compared to net loss of $163.7 million for the full year 2022. Net loss was $0.76 per diluted share for the full year 2023, compared to net loss of $2.69 per diluted share for the full year 2022. The improvement in net income was primarily attributable to 186 basis point improvement in gross margin percent, $13.6 million in annualized expense reductions, along with $112.2 million dollar reduction in impairment related charges. To offset, revenue decreased by $52.3 million. Non-GAAP Adjusted EBITDA(1) was a loss of $5.6 million for the full year 2023, compared to a loss of $16.7 million for the full year 2022. The improvement in Adjusted EBITDA(1) was primarily driven by improvements in the operating and corporate expense structure compared to the prior year. Geographic Footprint The Companys geographic footprint for its Cultivation and Gardening segment spans approximately 942,000 square feet of retail and warehouse space across 18 states. During 2023, the Company acquired or opened 5 new locations and expanded its physical retail presence into 2 new states. The Company also reduced redundancies in cost structure by closing and consolidating 14 retail locations in 2023, where we were generally able to serve the same customer base through a single location. To date in 2024, the Company further closed and consolidated 3 additional stores and may consider additional store consolidations in the future. First Quarter and Full Year 2024 Outlook(2) Full year 2024 net revenues in the range of $205 million to $215 million Full year 2024 Adjusted EBITDA(1) from a $2 million loss to a $3 million profit First quarter 2024 net revenues in the range of $45 million to $48 million with Adjusted EBITDA(1) between a $2 million loss and breakeven Exploring Strategic Opportunities for MMI The Company also announced today that it is exploring strategic opportunities for its benching, racking, and storage solutions business, MMI, which was acquired by the Company in late 2021 and currently constitutes the Companys Storage Solutions segment. Mr. Lampert commented, MMI has continued to exceed our expectations, with full year 2024 revenue of $31.4 million and $8.9 million in operating profit, reflecting the tremendous strength and potential of this business. We believe MMI is now in a place where it makes sense to consider strategic opportunities for the business, and we recently engaged Lake Street Capital Markets to advise us in this process. While we are happy having MMI within our portfolio, we also believe that the right strategic opportunity for MMI would better position GrowGen to build upon its achievements and capitalize on additional opportunities within its core Cultivation and Gardening business. Footnotes (1) Adjusted EBITDA represents earnings before interest, taxes, depreciation, and amortization as adjusted for certain items as set forth in the reconciliation table of U.S. GAAP to non-GAAP information and is a measure calculated and presented on the basis of methodologies other than in accordance with GAAP. Please refer to the Use of Non-GAAP Financial Information herein for further discussion and reconciliation of this measure to GAAP measures. (2) Sales and Adjusted EBITDA(1) guidance metrics are inclusive of acquisitions and store openings completed in 2023 and 2022, but do not include any unannounced acquisitions. Conference Call The Company will host a conference call today, March 13, 2024, at 4:30 PM Eastern Time to discuss financial results for fourth quarter and full year ended December 31, 2023. To participate in the call, please dial (888) 664-6392 (domestic) or (416) 764-8659 (international). The conference code is 80413128. The call will also be webcast and can be accessed here or in the Investor Relations section of the GrowGen website at: ir.growgeneration.com. A replay of the webcast will be available approximately two hours after the conclusion of the call and remain available for approximately 90 calendar days. About GrowGeneration Corp. GrowGen is a leading developer, marketer, retailer, and distributor of products for both indoor and outdoor hydroponic and organic gardening, as well as customized storage solutions. GrowGen carries and sells thousands of products, such as nutrients, additives, growing media, lighting, environmental control systems, and benching and racking, including proprietary brands such as Charcoir, Drip Hydro, Power Si, Ion lights, The Harvest Company, and more. Incorporated in Colorado in 2014, GrowGen is the largest chain of specialty retail hydroponic and organic garden centers in the United States. The Company also operates an online superstore for cultivators at growgeneration.com, as well as a wholesale business for resellers, HRG Distribution, and a benching, racking, and storage solutions business, Mobile Media or MMI. Forward Looking Statements This press release may include predictions, estimates, or other information considered forward-looking within the meaning of applicable securities laws. While these forward-looking statements represent current judgments, they are subject to risks and uncertainties that could cause actual results to differ materially. You are cautioned not to place undue reliance on these forward-looking statements, which reflect opinions only as of the date of this release. Please keep in mind that the Company does not have an obligation to revise or publicly release the results of any revision to these forward-looking statements in light of new information or future events. When used herein, words such as look forward, believe, continue, building, may, should, expects, anticipates, contemplates, estimates, believes, plans, projected, predicts, potential, or hopes, or the negative of these or similar terms, or variations of such words, and similar expressions are intended to identify forward-looking statements. Factors that could cause actual results to differ materially from any forward-looking statements made by us herein are often discussed in filings made with the United States Securities and Exchange Commission, available at: www.sec.gov, and on the Companys website at: www.growgeneration.com. ITEM 1. FINANCIAL STATEMENTS GROWGENERATION CORP. AND SUBSIDIARIES CONSOLIDATED BALANCE SHEETS (in thousands except shares) December 31, 2023 December 31, 2022 ASSETS Current assets: Cash and cash equivalents $ 29,757 $ 40,054 Marketable securities 35,212 31,852 Accounts receivable, net of allowance for credit losses of $1.4 million and $0.7 million at December 31, 2023 and 2022 8,895 8,336 Notes receivable, current, net of allowance for credit losses of $1.7 million and $1.3 million at December 31, 2023 and 2022 193 1,214 Inventory 64,905 77,091 Prepaid income taxes 516 5,679 Prepaid and other current assets 7,973 6,455 Total current assets 147,451 170,681 Property and equipment, net 27,052 28,669 Operating leases right-of-use assets, net 39,933 46,433 Notes receivable, long term 106  Intangible assets, net 16,180 30,878 Goodwill 7,525 15,978 Other assets 843 803 TOTAL ASSETS $ 239,090 $ 293,442 LIABILITIES & STOCKHOLDERS EQUITY Current liabilities: Accounts payable $ 11,666 $ 15,728 Accrued liabilities 2,530 1,535 Payroll and payroll tax liabilities 2,169 4,671 Customer deposits 5,359 4,338 Sales tax payable 1,185 1,341 Current maturities of lease liability 8,021 8,131 Current portion of long-term debt  50 Total current liabilities 30,930 35,794 Operating lease liability, net of current maturities 34,448 40,659 Other long-term liabilities 317 593 Total liabilities 65,695 77,046 Commitments and contingencies Stockholders Equity: Common stock; $.001 par value; 100,000,000 shares authorized; 61,483,762 and 61,010,155 shares issued and outstanding as of December 31, 2023 and 2022, respectively 61 61 Additional paid-in capital 373,433 369,938 Retained earnings (deficit) (200,099 ) (153,603 ) Total stockholders equity 173,395 216,396 TOTAL LIABILITIES AND STOCKHOLDERS EQUITY $ 239,090 $ 293,442 GROWGENERATION CORP. AND SUBSIDIARIES CONSOLIDATED STATEMENTS OF OPERATIONS (in thousands, except per share amounts) Three Months Ended December 31, Twelve Months Ended December 31, 2023 2022 2023 2022 (Unaudited) (Unaudited) Net sales $ 49,452 $ 54,456 $ 225,882 $ 278,166 Cost of sales (exclusive of depreciation and amortization shown below) 37,808 44,894 164,624 207,903 Gross profit 11,644 9,562 61,258 70,263 Operating expenses: Store operations and other operational expenses 11,794 12,796 48,082 54,680 Selling, general, and administrative 7,876 8,594 29,799 36,758 Estimated credit losses 274 (37 ) 955 1,737 Depreciation and amortization 4,130 3,968 16,607 17,132 Impairment loss 15,659  15,659 127,831 Total operating expenses 39,733 25,321 111,102 238,138 Income (loss) from operations (28,089 ) (15,759 ) (49,844 ) (167,875 ) Other income (expense): Other income (expense) (5 ) 137 781 684 Interest income 810 390 2,696 580 Interest expense (91 ) (5 ) (97 ) (21 ) Total other income (expense) 714 522 3,380 1,243 Net income (loss) before taxes (27,375 ) (15,237 ) (46,464 ) (166,632 ) Benefit (provision) for income taxes 61 248 (32 ) 2,885 Net income (loss) $ (27,314 ) (14,989 ) $ (46,496 ) $ (163,747 ) Net income (loss) per share, basic $ (0.44 ) $ (0.25 ) $ (0.76 ) $ (2.69 ) Net income (loss) per share, diluted $ (0.44 ) $ (0.25 ) $ (0.76 ) $ (2.69 ) Weighted average shares outstanding, basic 61,386 61,064 61,181 60,813 Weighted average shares outstanding, diluted 61,386 61,064 61,181 60,813 GROWGENERATION CORP. AND SUBSIDIARIES CONSOLIDATED STATEMENTS OF CASH FLOWS (in thousands) Years Ended December 31, 2023 2022 Cash flows from operating activities: Net income (loss) $ (46,496 ) $ (163,747 ) Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities: Depreciation and amortization 16,607 17,132 Estimated credit losses 955 1,737 Share-based compensation 3,171 4,967 Impairment loss related to goodwill and intangible assets 15,526 127,831 Impairment loss on operating lease right-of-use assets 133  Provision for deferred income taxes  (2,359 ) Loss on disposal of fixed assets 218 568 Change in value of marketable securities (1,438 )  Changes in operating assets and liabilities (net of the effect of acquisitions): (Increase) decrease in: Accounts and notes receivable (300 ) (3,106 ) Inventory 13,773 32,890 Prepaid expenses and other assets 3,898 10,827 Accounts payable and accrued liabilities (3,035 ) (3,359 ) Operating leases 46 508 Customer deposits 1,021 (8,590 ) Payroll and payroll tax liabilities (2,502 ) (2,769 ) Sales taxes payable (156 ) (582 ) Net cash and cash equivalents provided by (used in) operating activities 1,421 11,948 Cash flows from investing activities: Acquisitions, net of cash acquired (3,050 ) (7,230 ) Purchase of property and equipment (6,698 ) (12,896 ) Purchase of marketable securities (98,680 ) (38,692 ) Maturities of marketable securities 96,758 46,633 Proceeds from disposals of assets 265 612 Net cash and cash equivalents provided by (used in) investing activities (11,405 ) (11,573 ) Cash flows from financing activities: Principal payments on long term debt (50 ) (108 ) Common stock withheld for employee payroll taxes (263 ) (1,618 ) Proceeds from the sales of common stock and exercise of warrants and options, net of expenses  33 Net cash and cash equivalents (used in) provided by financing activities (313 ) (1,693 ) Net increase (decrease) in cash and cash equivalents (10,297 ) (1,318 ) Cash and cash equivalents at beginning of year 40,054 41,372 Cash and cash equivalents at end of year $ 29,757 $ 40,054 Supplemental Information: Cash paid for interest $ 98 $ 21 Cash paid for income taxes $ 93 $  Right to use assets acquired under new operating leases $ 4,289 $ 9,607 Indemnity holdback from business acquisition $  $ 875 Non-cash repurchase of liability awards $ 653 $  Non-cash issuance of a note receivable $ 299 $  Common stock issued for business combinations $  $ 5,710 Liability redemption associated with business acquisition $ 120 $  Common stock issued for intangible assets $  $ 173 Use of Non-GAAP Financial Information EBITDA and Adjusted EBITDA are non-GAAP financial measures commonly used in our industry and should not be construed in isolation as substitutions to net income (loss) as indicators of operating performance or as alternatives to cash flow provided by operating activities as a measure of liquidity (each as determined in accordance with GAAP). GrowGeneration defines EBITDA as net income (loss) before interest income, interest expense, income tax expense, depreciation and amortization, and Adjusted EBITDA as further adjusted to exclude certain items such as stock-based compensation, impairment losses, restructuring and corporate rationalization costs, and other non-core or non-recurring expenses and to include income from our marketable securities as these investments are part of our operational business strategy and increase the cash available to us. We believe these non-GAAP measures, when used in conjunction with net income (loss), provide meaningful supplemental information to both management and investors, facilitating the evaluation of performance across reporting periods. Management uses these non-GAAP measures for internal planning and reporting purposes. These non-GAAP measures are not in accordance with, or an alternative for, generally accepted accounting principles and may be different from non-GAAP measures used by other companies. We believe that these non-GAAP financial measures may be useful to investors in their assessment of our operating performance and valuation. In addition, these non-GAAP financial measures address questions routinely received from analysts and investors and, in order to ensure that all investors have access to the same data, we have determined that it is appropriate to make this data available to all investors. Set forth below is a reconciliation of EBITDA and Adjusted EBITDA to net income (loss) (in thousands) (unaudited): Three months ended December 31, Year ended December 31, 2023 2022 2023 2022 Net income (loss) $ (27,314 ) $ (14,989 ) $ (46,496 ) $ (163,747 ) Benefit (provision) for income taxes (61 ) (248 ) 32 (2,885 ) Interest income (810 ) (390 ) (2,696 ) (580 ) Interest expense 91 5 97 21 Depreciation and amortization 4,130 3,968 16,607 17,132 EBITDA $ (23,964 ) $ (11,654 ) $ (32,456 ) $ (150,059 ) Share-based compensation 719 987 3,171 4,967 Investment income 810  2,696  Impairment loss 15,659  15,659 127,831 Restructuring and other charges (1) 3,076 487 5,376 568 Adjusted EBITDA $ (3,700 ) $ (10,180 ) $ (5,554 ) $ (16,693 ) (1) Consists primarily of expenditures related to the activity of store and distribution consolidation and one-time severances View source version on businesswire.com: https://www.businesswire.com/news/home/20240313173939/en/ Investor Contact ICR, Inc. GrowGenIR@icrinc.com Source: GrowGeneration Corp. What is GrowGeneration Corp.'s (GRWG) full-year net revenue for 2023? GrowGeneration Corp. reported full-year net revenue of $225.9 million for 2023. What was the net loss for GrowGeneration Corp. (GRWG) in 2023? The net loss for GrowGeneration Corp. in 2023 was $46.5 million. What is the revenue outlook for GrowGeneration Corp. (GRWG) in 2024? The revenue outlook for GrowGeneration Corp. in 2024 ranges from $205 million to $215 million. What strategic opportunities is GrowGeneration Corp. (GRWG) exploring? GrowGeneration Corp. is exploring strategic opportunities for its benching, racking, and storage solutions business, MMI."
Rubicon Organics to Report Q4 2023 Results,2024-03-14T00:00:00.000Z,Low,Neutral,"Rubicon Organics Inc. will report its financial results for Q4 2023 on March 27, 2024. The conference call to discuss the results will be held on March 28, 2024. The company focuses on producing and selling premium organic cannabis products.","Rubicon Organics to Report Q4 2023 Results Rhea-AI Impact (Low) Rhea-AI Sentiment (Neutral) Tags conferences earnings Rhea-AI Summary Rubicon Organics Inc. will report its financial results for Q4 2023 on March 27, 2024. The conference call to discuss the results will be held on March 28, 2024. The company focuses on producing and selling premium organic cannabis products. Positive None. Negative None. 03/13/2024 - 08:00 PM VANCOUVER, British Columbia, March 13, 2024 (GLOBE NEWSWIRE) -- Rubicon Organics Inc. (TSXV: ROMJ) (OTCQX: ROMJF) (Rubicon Organics or the Company), a licensed producer focused on cultivating and selling organic certified, premium cannabis products, is pleased to announce that it will be reporting its financial results for the year ended December 31, 2023 (Q4 2023) after market close on Wednesday, March 27, 2024. The Company will be hosting a conference call to discuss Q4 2023 results on Thursday, March 28, 2024. Conference call details are as follows: Time:7:00 AM PT / 10:00 AM ETConference ID:60125Local dial-in:+1-289-514 5100Toll Free N. America:+1-800-717-1738Webcast:https://onlinexperiences.com/Launch/QReg/ShowUUID=9301B4F8-90BC-41BC-B6FD-2A7014DDDD65 ABOUT RUBICON ORGANICS INC. Rubicon Organics Inc. is the global brand leader in premium organic cannabis products. The Company is vertically integrated through its wholly owned subsidiary Rubicon Holdings Corp, a licensed producer. Rubicon Organics is focused on achieving industry leading profitability through its premium cannabis flower, product innovation and brand portfolio management, including three flagship brands: its super-premium brand Simply Bare Organic, its premium brand 1964 Supply Co, and its cannabis wellness brand Wildflower in addition to the Companys mainstream brand Homestead Cannabis Supply. The Company ensures the quality of its supply chain by cultivating, processing, branding and selling organic certified, sustainably produced, super-premium cannabis products from its state-of-the-art glass roofed facility located in Delta, BC, Canada. CONTACT INFORMATION Margaret BrodieCEOPhone: +1-437-929-1964Email: ir@rubiconorganics.com The TSX Venture Exchange or its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) does not accept responsibility for the adequacy or accuracy of this press release. Cautionary Statement Regarding Forward Looking Information This press release contains forward-looking information within the meaning of applicable securities laws. All statements that are not historical facts, including without limitation, statements regarding future estimates, plans, programs, forecasts, projections, objectives, assumptions, expectations or beliefs of future performance, statements regarding Rubicon Organics goal of achieving industry leading profitability are forward-looking statements. Forward-looking information can be identified by the use of words such as will or variations of such word or statements that certain actions, events or results will be taken, occur or be achieved. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause actual results, events or developments to be materially different from any future results, events or developments expressed or implied by such forward looking statements. The forward-looking information in this press release is based upon certain assumptions that management considers reasonable in the circumstances, the impact on revenue of new products and brands entering the market, and the timing of achieving Adjusted EBITDA profitability and cash flow positive. Risks and uncertainties associated with the forward looking information in this press release include, among others, dependence on obtaining and maintaining regulatory approvals, including acquiring and renewing federal, provincial, local or other licenses and any inability to obtain all necessary governmental approvals licenses and permits for construction at its facilities in a timely manner; regulatory or political change such as changes in applicable laws and regulations, including bureaucratic delays or inefficiencies or any other reasons; any other factors or developments which may hinder market growth; Rubicon Organics limited operating history and lack of historical profits; reliance on management; the effect of capital market conditions and other factors on capital availability; the Companys ability to attract and retain skilled staff; competition, including from more established or better financed competitors; the need to secure and maintain corporate alliances and partnerships, including with customers and suppliers. These factors should be considered carefully, and readers are cautioned not to place undue reliance on such forward-looking statements. Although Rubicon Organics has attempted to identify important risk factors that could cause actual actions, events or results to differ materially from those described in forward-looking statements, there may be other risk factors that cause actions, events or results to differ from those anticipated, estimated or intended. There can be no assurance that forward-looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in forward-looking statements. Rubicon Organics assumes no obligation to update any forward-looking statement, even if new information becomes available as a result of future events, new information or for any other reason except as required by law. When will Rubicon Organics Inc. report its financial results for Q4 2023? Rubicon Organics Inc. will report its financial results for Q4 2023 on March 27, 2024. When will the conference call to discuss the Q4 2023 results be held? The conference call to discuss the Q4 2023 results will be held on March 28, 2024. What products does Rubicon Organics Inc. focus on? Rubicon Organics Inc. focuses on producing and selling premium organic cannabis products."
"two and LatAm Logistic Properties, S.A. Announce Effectiveness of Registration Statement on Form F-4 in Connection with Business Combination",2024-03-13T23:17:00.000Z,Low,Neutral,"LatAm Logistic Properties, S.A. and TWOA plan to merge, forming a new holding company, Pubco, after SEC approval. The Business Combination is set to be approved at the Extraordinary General Meeting on March 25, 2024, with Pubco's shares expected to trade on NYSE under 'LPA'.","two and LatAm Logistic Properties, S.A. Announce Effectiveness of Registration Statement on Form F-4 in Connection with Business Combination Rhea-AI Impact (Low) Rhea-AI Sentiment (Neutral) Tags Rhea-AI Summary LatAm Logistic Properties, S.A. and TWOA plan to merge, forming a new holding company, Pubco, after SEC approval. The Business Combination is set to be approved at the Extraordinary General Meeting on March 25, 2024, with Pubco's shares expected to trade on NYSE under 'LPA'. Positive None. Negative None. Market Research Analyst An upcoming business combination between a special purpose acquisition company (SPAC) and a prominent industrial and logistics real estate firm in Latin America is noteworthy for stakeholders and investors. The involvement of TWOA and LLP in this transaction suggests a strategic expansion, potentially increasing market share and diversifying revenue streams in a region ripe for growth in industrial real estate.The anticipated listing of the new entity, Pubco, under the ticker symbol 'LPA' on the New York Stock Exchange, signifies a critical juncture that could affect investor confidence and market dynamics. The transition from private to public ownership will likely introduce new capital and governance structures, which could lead to increased scrutiny and expectations from shareholders.Furthermore, the role of BTG Pactual as a financial advisor and placement agent is a strong endorsement, given their established reputation in financial markets. This could enhance investor perception of the deal's credibility and the future company's financial stability. Financial Analyst The declaration by the SEC regarding the effectiveness of the Registration Statement is a crucial step towards the completion of the Business Combination. This regulatory milestone enables the parties to proceed with shareholder voting, which is a significant hurdle in the SPAC process. The successful merger could lead to an infusion of funds and resources, which, if managed effectively, could result in enhanced operational capabilities and long-term shareholder value.Investors should closely monitor the outcome of the Extraordinary General Meeting, as the approval of the Business Combination will pave the way for the listing of Pubco's ordinary shares. The share price post-listing will be an immediate indicator of market reception to the deal. Long-term performance will depend on Pubco's ability to leverage the combined assets and expertise to capitalize on market opportunities in the industrial and logistics sector. Legal Expert The transition from a private to a public entity involves complex legal considerations, including compliance with SEC regulations and corporate governance standards. The effectiveness of the Registration Statement indicates that Pubco has met the necessary legal criteria to move forward. Post-merger, Pubco will need to adhere to heightened transparency and reporting requirements, which can impact operational practices and investor relations.Shareholders' votes at the Extraordinary General Meeting are not only a legal formality but also reflect the trust and support of the existing investor base. The outcome of these votes will have legal implications for the completion of the Business Combination and the subsequent operations of the new public entity. 03/13/2024 - 07:17 PM LLP Sets Special Meeting DateZEPHYR COVE, Nev. and SAN JOS, Costa Rica, March 13, 2024 (GLOBE NEWSWIRE) -- two (NYSE: TWOA) (TWOA), a special purpose acquisition company, and LatAm Logistic Properties, S.A. (d/b/a LatAm Logistic Properties) (LLP), a leading developer, owner, and manager of institutional quality, Class A industrial and logistics real estate in Central and South America, today announced that the Securities and Exchange Commission (SEC) has declared effective the amended registration statement on Form F-4 (the Registration Statement) filed by Logistic Properties of the Americas (""Pubco"") in connection with LLP and TWOAs previously announced proposed business combination (the Business Combination or the Transaction). Following the close of the Business Combination, LLP and TWOA will merge with newly-formed subsidiaries of Logistic Properties of the Americas, resulting in the formation of a newly-formed holding company (Pubco), which will be the publicly traded parent company. The Registration Statement can be accessed on the SECs website at www.sec.gov. TWOA will mail the definitive proxy statement/prospectus (the Proxy Statement/Prospectus), which is a part of the Registration Statement, to its shareholders as of the close of business on March 4, 2024 (the Record Date). The Proxy Statement/Prospectus will contain a proxy card relating to the extraordinary general meeting of TWOAs shareholders (the Extraordinary General Meeting). TWOA will hold the Extraordinary General Meeting at which TWOAs shareholders will be asked to consider and vote upon proposals to approve the Business Combination and related matters. The Extraordinary General Meeting to approve the proposed Business Combination is scheduled to be held on March 25, 2024 at 10:00 am, Eastern Time, at the offices of Ellenoff Grossman & Schole LLP at 1345 Avenue of the Americas, 11th Floor, New York, New York 10105. If the proposals at the Extraordinary General Meeting are approved, the parties anticipate that the Business Combination will close and Pubcos ordinary shares are expected to be listed on the New York Stock Exchange under the new ticker symbol LPA, shortly thereafter, subject to the satisfaction or waiver, as applicable, of all other closing conditions. Every shareholders vote is important. To ensure representation at the Extraordinary General Meeting, TWOA shareholders are urged to complete, sign, date and return the proxy card accompanying the Proxy Statement/Prospectus as soon as possible. Additional details on the proposed Business Combination can be found in the original announcement from August 15, 2023, linked here. AdvisorsBTG Pactual acted as financial advisor to LLP in the business combination and sole placement agent on the PIPE. About twotwo is a special purpose acquisition company formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. For more information, visit twoaspac.com. About LatAm Logistic PropertiesLatAm Logistic Properties, S.A. is a leading developer, owner, and manager of institutional quality, class A industrial and logistics real estate in Central and South America. LLPs customers are multinational and regional e-commerce retailers, third-party logistic operators, business-to-business distributors, and retail distribution companies. LLPs strong customer relationships and insight is expected to enable future growth through the development and acquisition of high-quality, strategically located facilities in its target markets. As of September 30, 2023, LLP consisted of an operating and development portfolio of twenty-eight logistic facilities in Colombia, Peru and Costa Rica totaling more than 650,000 square meters (approximately 7.0 million square feet) of gross leasable area. Forward-Looking StatementsThis press release contains certain forward-looking information with respect to the Business Combination, which may not be included in future public filings or investor guidance. Certain statements in this press release may be considered forward-looking statements within the meaning of federal securities laws. Forward-looking statements include, without limitation, statements about future events or LLPs, TWOAs or Pubcos future financial or operating performance. For example, statements regarding the benefits of the Business Combination, and the anticipated timing of the completion of the Business Combination are forward-looking statements. In some cases, you can identify forward-looking statements by terminology such as pro forma, may, should, could, might, plan, possible, project, strive, budget, forecast, expect, intend, will, estimate, anticipate, believe, predict, potential or continue, or the negatives of these terms or variations of them or similar terminology. These forward-looking statements regarding future events and the future results of LLP, Pubco and TWOA are based on current expectations, estimates, forecasts, and projections about the industry in which LLP operates, as well as the beliefs and assumptions of LLPs management. These forward-looking statements are only predictions and are subject to known and unknown risks, uncertainties, assumptions and other factors beyond LLPs, Pubcos or TWOAs control that are difficult to predict because they relate to events and depend on circumstances that will occur in the future. They are neither statements of historical fact nor promises or guarantees of future performance. Therefore, LLPs and Pubcos actual results may differ materially and adversely from those expressed or implied in any forward-looking statements and LLP, Pubco and TWOA therefore caution against relying on any of these forward-looking statements. These forward-looking statements are based upon estimates and assumptions that, while considered reasonable by LLP and its management, TWOA and its management, and Pubco and its management, as the case may be, are inherently uncertain and are inherently subject to risks variability and contingencies, many of which are beyond LLPs, TWOAs or Pubcos control. Factors that may cause actual results to differ materially from current expectations include, but are not limited to: (i) the occurrence of any event, change or other circumstances that could give rise to the termination of any definitive agreements with respect to the Business Combination (the Business Combination Agreement); (ii) the outcome of any legal proceedings that may be instituted against LLP, TWOA, Pubco or others following the announcement of the Business Combination and any definitive agreements with respect thereto; (iii) the inability to complete the Business Combination due to the failure to obtain consents and approvals of the shareholders of TWOA, to obtain financing to complete the Business Combination or to satisfy other conditions to closing, or delays in obtaining, adverse conditions contained in, or the inability to obtain necessary regulatory approvals required to complete the transactions contemplated by the Business Combination Agreement; (iv) changes to the proposed structure of the Business Combination that may be required or appropriate as a result of applicable laws or regulations or as a condition to obtaining regulatory approval of the Business Combination; (v) LLPs and Pubcos ability to manage growth; (vi) the ability to meet stock exchange listing standards in connection with, and following, the consummation of the Business Combination; (vii) the risk that the Business Combination disrupts current plans and operations of LLP as a result of the announcement and consummation of the Business Combination; (viii) the ability to recognize the anticipated benefits of the Business Combination, which may be affected by, among other things, competition, the ability of Pubco or LLP to grow and manage growth profitably, maintain key relationships and retain its management and key employees; (ix) costs related to the Business Combination; (x) changes in applicable laws, regulations, political and economic developments; (xi) the possibility that LLP or Pubco may be adversely affected by other economic, business and/or competitive factors; (xii) LLPs estimates of expenses and profitability; and (xiii) other risks and uncertainties set forth in the filings by TWOA or Pubco with the SEC. There may be additional risks that neither LLP nor TWOA presently know or that LLP and TWOA currently believe are immaterial that could also cause actual results to differ from those contained in the forward-looking statements. Any forward-looking statements made by or on behalf of LLP, TWOA or Pubco speak only as of the date they are made. None of LLP, Pubco or TWOA undertakes any obligation to update any forward-looking statements to reflect any changes in their respective expectations with regard thereto or any changes in events, conditions or circumstances on which any such statement is based. Nothing in this press release should be regarded as a representation by any person that the forward-looking statements set forth herein will be achieved or that any of the contemplated results of such forward-looking statements will be achieved. You should not place undue reliance on forward-looking statements, which speak only as of the date they are made. LLP, TWOA and Pubco disclaim any and all liability for any loss or damage (whether foreseeable or not) suffered or incurred by any person or entity as a result of anything contained or omitted from this press release and such liability is expressly disclaimed. Additional InformationThis press release does not constitute an offer to sell or exchange, or the solicitation of an offer to buy or exchange, any securities, nor shall there be any sale of securities in any jurisdiction in which such offer, sale or exchange would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. In connection with the Business Combination, Pubco has filed with the SEC the Registration Statement, which contains the proxy statement of TWOA and a prospectus of Pubco, and was declared effective by the SEC. This press release does not contain all the information that should be considered concerning the Business Combination and is not intended to form the basis of any investment decision or any other decision in respect of the Business Combination. LLPs and TWOAs shareholders and other interested persons are advised to read the Registration Statement, including the definitive Proxy Statement/Prospectus, any amendments thereto, and any other documents filed in connection with the Business Combination, as these materials contain important information about LLP, TWOA, Pubco and the Business Combination. The Proxy Statement/Prospectus and related materials for the Business Combination will be mailed to shareholders of TWOA as of the Record Date. Shareholders may also obtain copies of the Registration Statement, including the Proxy Statement/Prospectus and other documents filed with the SEC, without charge at the SECs website at www.sec.gov, or by directing a request to: two, 195 US HWY 50, Suite 208, Zephyr Cove, NV 89448; Tel: (310) 954-9665. Participants in the SolicitationTWOA and its directors and executive officers may be deemed participants in the solicitation of proxies from TWOAs shareholders with respect to the Business Combination. A list of the names of those directors and executive officers and a description of their interests in the Business Combination is contained in TWOAs filings with the SEC and in the Registration Statement. LLP, Pubco and their respective directors and executive officers may also be deemed to be participants in the solicitation of proxies from the shareholders of TWOA in connection with the Business Combination. A list of the names of such directors and executive officers and information regarding their interests in the Business Combination is included in the Registration Statement, which was filed with the SEC and is available free of charge at the SEC's website at www.sec.gov. No Offer or SolicitationThis press release shall not constitute a solicitation of a proxy, consent or authorization with respect to any securities or in respect of the proposed Business Combination. This press release shall also not constitute an offer to sell or the solicitation of an offer to buy any securities, nor shall there be any sale of securities in any states or jurisdictions in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. No offering of securities shall be made except by means of a prospectus meeting the requirements of Section 10 of the Securities Act of 1933, as amended. INVESTMENT IN ANY SECURITIES DESCRIBED HEREIN HAS NOT BEEN APPROVED OR DISAPPROVED BY THE SEC OR ANY OTHER REGULATORY AUTHORITY NOR HAS ANY AUTHORITY PASSED UPON OR ENDORSED THE MERITS OF THE OFFERING OR THE ACCURACY OR ADEQUACY OF THE INFORMATION CONTAINED HEREIN. ANY REPRESENTATION TO THE CONTRARY IS A CRIMINAL OFFENSE. Investor Relations Contact:Gateway Group, Inc.Cody Slach(949) 574-3860TWOA@gateway-grp.com two Contact:Nick GeezaChief Financial Officerngeeza@hennessycapitalgroup.com Media Relations Contact:Zach Kouwe / Kendal Till Dukas Linden Public Relations for LatAm Logistic Properties S.A.+1 646-722-6533LLP@dlpr.com When is the Extraordinary General Meeting to approve the Business Combination scheduled? The Extraordinary General Meeting to approve the Business Combination is scheduled to be held on March 25, 2024 at 10:00 am, Eastern Time. What will be the new ticker symbol for Pubco's shares after the Business Combination? Pubco's ordinary shares are expected to be listed on the New York Stock Exchange under the new ticker symbol 'LPA'. Who acted as the financial advisor to LLP in the business combination? BTG Pactual acted as the financial advisor to LLP in the business combination."
Exro Announces Filing and Mailing of Management Information Circular in Relation to the Proposed Merger with SEA Electric,2024-03-13T23:03:00.000Z,Low,Neutral,Exro Technologies Inc. files management information circular for proposed merger with SEA Electric Inc. to strengthen its position in the electric vehicle technology sector and accelerate growth.,"Exro Announces Filing and Mailing of Management Information Circular in Relation to the Proposed Merger with SEA Electric Rhea-AI Impact (Low) Rhea-AI Sentiment (Neutral) Tags acquisition Rhea-AI Summary Exro Technologies Inc. files management information circular for proposed merger with SEA Electric Inc. to strengthen its position in the electric vehicle technology sector and accelerate growth. Positive None. Negative None. 03/13/2024 - 07:03 PM Exro Technologies Inc. files management information circular for proposed merger with SEA Electric Inc. (the ""Transaction"").The Transaction is designed to leverage complementary technologies to strengthen Exro's position in the electric vehicle technology sector, accelerate growth, and create a defined path to profitability, with multi-year commitments from leading commercial vehicle OEMs.Shareholders are encouraged to review the information circular carefully and to vote online in advance of the April 2, 2024 deadline. The special meeting of shareholders to approve the Transaction is scheduled for April 4, 2024 at 11:00 a.m. (Mountain time) (the ""Meeting"").For questions or voting assistance, please contact Carson Proxy Advisors at 1-800-530-5189 toll free in North America or 416-751-2066 local (collect outside of North America) or by email at info@carsonproxy.com.CALGARY, AB, March 13, 2024 /PRNewswire/ - Exro Technologies Inc. (TSX: EXRO), (OTCQB: EXROF) (the ""Company"" or ""Exro""), a leading clean-technology company focused on developing new generation power-control electronics that expand the capabilities of electric motors and batteries, announced today the filing of its management information circular (the ""Circular"") with respect to the Transaction with SEA Electric Inc. (""SEA Electric""). The Circular, which provides comprehensive information about the Transaction, marks another milestone in the Transaction process and precedes the Meeting. ""The Circular sets out the compelling case for shareholders to approve Exro's merger with SEA Electric,"" said Exro CEO Sue Ozdemir. ""We are at the inflection of a great step forward, combining our collective strengths to build on our OEM partnerships and combined technology to make electric vehicles (""EVs"") more practical, with a lower total cost of ownership."" The Transaction, announced on January 30, 2024, is a strategic move designed to strengthen Exro's position in the EV technology sector, while accelerating revenue growth and establishing a defined path to profitability in the first half of 2025. The Transaction will result in a fully integrated next generation electric propulsion technology company and will: Combine Exro's Coil Driver motor control technology with SEA Electric's SEA-Drive vehicle control unit (VCU) software technology to deliver superior performance, efficiency, and total cost of ownership advantages embedded in a complete package electric propulsion system for the commercial vehicle space. Following the closing of the Transaction, Exro is preparing to deliver over 1,000 propulsion systems in 2024 to blue-chip OEMs, targeting combined company annual revenues of over C$200 million.Introduce a new asset-light business model to EV technology space by leveraging the OEMs manufacturing and distribution networks (i.e. no requirement for large capital or operating expenses to build-out and operate manufacturing facilities) enabling the Company to focus on its core competency of technology innovation.In addition to the above, the Circular provides detailed information on the expected benefits of the Transaction, terms and conditions, potential risks, and voting procedures, among other relevant information. The Circular is also available under the Company's profile on SEDAR+ at www.sedarplus.ca and on the Company's website at www.exro.com and our website for the Transaction at www.exroandsea.com. The Transaction is expected to provide meaningful benefits to Exro and its shareholders, including but not limited to: Technology Synergies. The Transaction marks a significant leap forward in electrification technology. The Company following the Transaction (the ""Combined Company"") will offer comprehensive end-to-end electrification solutions that encompass full propulsion systems equipped with patented vehicle control and motor control technologies. This union enriches the Company's offering with a robust IP portfolio of over 60 patent and patent applications, supporting Exro's position at the forefront of innovation in the electrification transition.Operational Synergies. The Transaction will tap into a wealth of operational synergies. This strategic partnership blends Exro and SEA Electric's industrial expertise with a shared network of key product partnerships, catalyzing innovation in energy efficiency.Shareholder Value Creation. The Transaction is a strategic move designed to maximize shareholder value through several key avenues:anticipated increase in revenue and a decrease in cost base, thanks to operational efficiencies and combined expertise,broadened intellectual portfolio that will enable Exro to commercialize new technologies more efficiently,stronger financial performance, enhanced marketing position and a solid position for long-term growth, andaccelerated path to profitability.Shareholders are encouraged to review the Circular carefully and to vote online in advance of the April 2, 2024, 11:00 a.m. (Mountain time), vote deadline. For more information on the Transaction, shareholders are invited to: Contact Carson Proxy Advisors for questions or voting assistance at 1-800-530-5189 toll free in North America or 416-751-2066 local (collect outside of North America) or by email at info@carsonproxy.com.Visit Exro's dedicated merger website at www.exroandsea.com for detailed information about the Transaction and its strategic benefits.Watch for the next Shareholder AMA (""Ask Me Anything""). A link to submit your questions on the merger will be available via www.exro.com on March 15. Management plans to post video replies to these questions on March 21, 2024.About Exro TechnologiesExro Technologies Inc. is a leading clean technology company that has developed new generation power control electronics that change how the world optimizes energy by expanding the capabilities of electric motors and batteries. The Company's innovative technologies serve to bridge the performance-cost gap in e-mobility (Coil Driver) and stationary energy storage (Cell Driver), and act to accelerate adoption towards an electrified economy by delivering more with less  minimum energy for maximum results. For more information visit our website at www.exro.com. To view our Investor Presentation visit us at www.exro.com/investors. Visit us on social media @Exrotech. About SEA Electric Inc.SEA Electric Inc. is a leading automotive and e-mobility technology company that provides 100% electric drivetrain system technology. SEA Electric has a worldwide presence, deploying products in the USA, Canada, Australia, New Zealand, Thailand, Indonesia, India, and South Africa, collectively achieving more than three million miles of service via independent OEM-testing and real-world operation. Cautionary Statement Regarding Forward Looking Statements This news release contains forward-looking statements within the meaning of Canadian securities laws. These statements relate to future events or future performance and reflect management's expectations regarding the Company's growth, results of operations, performance and business prospects and opportunities. Such forward-looking statements reflect management's current beliefs and are based on information currently available to management. In some cases, forward-looking statements can be identified by terminology such as ""may"", ""will"", ""should"", ""expect"", ""plan"", ""anticipate"", ""believe"", ""estimate"", ""predict"", ""potential"", ""continue"", ""target"" or the negative of these terms or other comparable terminology. Forward-looking statements are necessarily based on estimates and assumptions made by management in light of management's experience and perception of historical trends, current conditions and expected future developments, as well as factors management believe are appropriate. Forward-looking statements may include but are not limited to statements respecting: the completion of the Transaction or the realization of the benefits thereof by the Combined Company; the receipt of all required regulatory and shareholder approvals of the Transaction including but not limited to the approval of the Transaction by the shareholders of Exro at the Meeting and the approval of the TSX; the timing and occurrence of the closing of the Transaction; and the Company's (and following the Transaction, the Combined Company's) ability to commercialize its technology. This news release also includes future-oriented financial information about future forecasted revenue of the Combined Company for calendar year 2024 that is not presented in the format of a historical balance sheet, income statement or cash flow statement, and which is based on assumptions about the closing of the Transaction, future economic conditions, courses of action and additional assumptions listed below (the ""FOFI""). Actual results may differ from the FOFI in the news release. The FOFI is as of the date of this news release and has been included in this news release to assist readers in understanding the potential benefit of the Transaction to the Combined Company, and readers should be cautioned that the FOFI in this news release may not be appropriate for other purposes. These statements are not guarantees of future performance and undue reliance should not be placed on them. Such FOFI necessarily involves known and unknown risks and uncertainties which may be outside of the Company's control, and which may cause actual performance and financial results in future periods to differ materially from any projections of future performance or results expressed or implied by such FOFI. These risks and uncertainties include but are not limited to risks associated with the Combined Company realizing on the perceived benefit of the completion of the Transaction, general economic conditions, adverse industry events, loss of markets, access to capital, and other factors listed below, in the Circular and in the Company's most recent annual information form and MD&A. These forward-looking statements and FOFI are based on the beliefs of the management of Exro and on assumptions which such management believes to be reasonable, based on information available at the time such statements were made. However, there can be no assurance that forward-looking statements and FOFI will prove to be accurate. Such assumptions and factors include, among other things: demand for the technology of the Company (and following the Transaction, the Combined Company); the Company's (and following the Transaction, the Combined Company's) ability to maintain existing partners and attract new partners; the impact of competition; the Company's (and following the Transaction, the Combined Company's) ability to obtain and maintain existing financing on acceptable terms; the Company's (and following the Transaction, the Combined Company's) ability to retain skilled management and staff; currency, exchange and interest rates; the availability of financing opportunities, risks associated with economic conditions, dependence on management; volatility of stock price and market conditions; technology risks and risks associated with the commercialization of the Company's (and following the Transaction, the Combined Company's) technology; the Company's reliance on key personnel; the Company's limited operating history; market uncertainties; the protection of patents and intellectual property; conflicts of interest; market competition; and operating in an environment subject to regulation. The preceding list is not exhaustive of all possible factors. Although the Company believes that the assumptions underlying these statements are reasonable, they may prove to be incorrect, and the Company cannot assure that actual results will be consistent with these forward-looking statements. Given these risks, uncertainties and assumptions, any investors or users of this document should not place undue reliance on these forward-looking statements. Whether actual results, performance or achievements will conform to the Company's expectations and predictions is subject to a number of known and unknown risks, uncertainties, assumptions and other factors. Please refer to the Circular, the Company's annual information form and other public continuous disclosure documents filed with the Canadian securities regulators under its profile on SEDAR+ at www.sedarplus.com for additional disclosure respecting the risks affecting the Company and its business. Readers should not place undue reliance on the Company's forward-looking statements, as the Company's actual results, performance or achievements may differ materially from any future results, performance or achievements expressed or implied by such forward-looking statements if known or unknown risks, uncertainties or other factors affect the Company's business, or if the Company's estimates or assumptions prove inaccurate. The Company does not undertake to update any forward-looking information, except as, and to the extent required by applicable securities laws. Neither the TSX nor the Investment Industry Regulatory Organization of Canada accepts responsibility for the adequacy or accuracy of this press release. View original content to download multimedia:https://www.prnewswire.com/news-releases/exro-announces-filing-and-mailing-of-management-information-circular-in-relation-to-the-proposed-merger-with-sea-electric-302088689.html SOURCE Exro Technologies Inc. What is Exro Technologies Inc. proposing in the management information circular? Exro Technologies Inc. is proposing a merger with SEA Electric Inc. to leverage complementary technologies and strengthen its position in the electric vehicle technology sector. When is the deadline for shareholders to vote on the proposed merger? Shareholders are encouraged to vote online in advance of the April 2, 2024 deadline. When is the special meeting of shareholders to approve the Transaction scheduled? The special meeting of shareholders to approve the Transaction is scheduled for April 4, 2024 at 11:00 a.m. (Mountain time). How can shareholders get voting assistance or ask questions? Shareholders can contact Carson Proxy Advisors at 1-800-530-5189 (toll free in North America) or 416-751-2066 (local) or email at info@carsonproxy.com."
Standard & Poors Upgrades Cemex to Investment Grade,2024-03-13T23:03:00.000Z,Low,Neutral,"Standard & Poor's upgrades Cemex's credit rating to Investment Grade (BBB-) due to strong financial performance and deleveraging strategy. Cemex's EBITDA grew 25% in 2023, with Free Cash Flow doubling.","Standard & Poors Upgrades Cemex to Investment Grade Rhea-AI Impact (Low) Rhea-AI Sentiment (Neutral) Tags Rhea-AI Summary Standard & Poor's upgrades Cemex's credit rating to Investment Grade (BBB-) due to strong financial performance and deleveraging strategy. Cemex's EBITDA grew 25% in 2023, with Free Cash Flow doubling. Positive None. Negative None. Financial Analyst The upgrade of Cemex's long-term issuer credit rating to Investment Grade (BBB-) by Standard & Poor's is a significant indicator of the company's improved financial health and market trust. This upgrade typically leads to lower borrowing costs for the company, as it is now deemed a lower credit risk by lenders. Investors may view this as a positive signal, potentially leading to a more favorable investment environment for Cemex's securities. The company's strong performance, as evidenced by a 25% growth in EBITDA and a doubling of Free Cash Flow after maintenance capital expenditures, suggests that operational efficiencies and a robust deleveraging strategy are in place. The improved national scale issue-level rating further solidifies Cemex's financial standing within the Mexican market, which could attract more domestic investment and enhance its competitive position. Market Research Analyst From a market perspective, the S&P upgrade reflects broader industry trends where construction and building materials companies are recovering and growing post-pandemic. Cemex's performance, particularly its EBITDA growth and Free Cash Flow increase, indicates a strong demand for its products and a successful adaptation to market conditions. The company's strategic decisions and capital allocation have evidently paid off, leading to this rating upgrade. This development could set a precedent for similar companies in the sector, potentially influencing investor sentiment towards the industry as a whole. It's also a sign that Cemex's medium-term strategy aligns well with market expectations and investor confidence, which could have a ripple effect on the sector's stock performance. Economist The elevation of Cemex's credit rating to Investment Grade status has macroeconomic implications. It is an indicator of economic stability and growth within the construction sector, which is a significant component of GDP in many countries. For emerging markets like Mexico, such positive developments in key companies can enhance the country's investment profile on a global scale. It also reflects well on the overall business climate, suggesting that corporations are able to successfully navigate economic challenges and implement effective financial strategies. Over time, this could lead to increased foreign direct investment, job creation and a healthier economy, benefiting a broader range of stakeholders beyond just the investors and the company itself. 03/13/2024 - 07:03 PM MONTERREY, Mexico--(BUSINESS WIRE)-- Rating agency Standard & Poors (S&P) announced today that it has upgraded Cemexs long-term global scale issuer credit rating to Investment Grade (BBB-) due to its strong financial and operating performance, deleveraging strategy, and flexible capital allocation. Achieving an investment-grade credit rating from S&P is a very important milestone for Cemex, said Fernando A. Gonzlez, CEO of Cemex. While we had record results last year, this rating is recognition of successful execution against our medium-term strategy and consistent financial performance over several years. In 2023, Cemexs EBITDA grew 25%, while Free Cash Flow after maintenance capex more than doubled. S&P also upgraded Cemexs national scale issue-level rating (Mexico) scale to mxAA+ from mxAA. About Cemex Cemex is a global construction materials company that is building a better future through sustainable products and solutions. Cemex is committed to achieving carbon neutrality through relentless innovation and industry-leading research and development. Cemex is at the forefront of the circular economy in the construction value chain and is pioneering ways to increase the use of waste and residues as alternative raw materials and fuels in its operations with the help of new technologies. Cemex offers cement, ready-mix concrete, aggregates, and urbanization solutions in growing markets around the world, powered by a multinational workforce focused on providing a superior customer experience enabled by digital technologies. For more information, please visit: www.cemex.com Except as the context otherwise may require, references in this press release to Cemex, we, us, our, refer to Cemex, S.A.B. de C.V. (NYSE: CX) and its consolidated subsidiaries. This press release contains forward-looking statements within the meaning of the U.S. federal securities laws. Cemex intends these forward-looking statements to be covered by the safe harbor provisions for forward-looking statements in the U.S. federal securities laws. These forward-looking statements reflect Cemexs current expectations and projections about future events based on Cemexs knowledge of present facts and circumstances and assumptions about future events, as well as Cemexs current plans based on such facts and circumstances, unless otherwise indicated. These statements necessarily involve risks, uncertainties, and assumptions that could cause actual results to differ materially from Cemexs expectations, including, among others, risks, uncertainties, and assumptions discussed in Cemexs most recent annual report and detailed from time to time in Cemexs other filings with the U.S. Securities and Exchange Commission and the Mexican Stock Exchange (Bolsa Mexicana de Valores), which factors are incorporated herein by reference, which if materialized could ultimately lead to Cemexs expectations and/or expected results not producing the expected benefits and/or results. Forward-looking statements should not be considered guarantees of future performance, nor the results or developments are indicative of results or developments in subsequent periods. These factors may be revised or supplemented, and the information contained in this press release is subject to change without notice, but Cemex is not under, and expressly disclaims, any obligation to update or correct this press release or revise any forward-looking statement contained herein, whether as a result of new information, future events or otherwise, or to reflect the occurrence of anticipated or unanticipated events or circumstances. Any or all of Cemexs forward-looking statements may turn out to be inaccurate. Accordingly, undue reliance on forward-looking statements should not be placed, as such forward-looking statements speak only as of the dates on which they are made. The content of this press release is for informational purposes only, and you should not construe any such information or other material as legal, tax, investment, financial, or other advice. Cemex is not responsible for, and expressly disclaims responsibility for, the content of any third-party website or webpage referenced to or accessible through this press release, nor for any quote, expectation, or projection from any third-party contained herein. Certain data used in this press release was obtained from independent industry publications and reports that Cemex believes to be reliable sources. Cemex has not independently verified this data nor sought the consent of any organizations to refer to their reports in this document. View source version on businesswire.com: https://www.businesswire.com/news/home/20240313595342/en/ Analyst and Investor Relations Fabin Orta +52 (81) 8888-4327 ir@cemex.com Media Relations Jorge Prez +52 (81) 8259-6666 jorgeluis.perez@cemex.com Source: Cemex What was Cemex's credit rating upgraded to by Standard & Poor's? Cemex's credit rating was upgraded to Investment Grade (BBB-) by Standard & Poor's. What were the reasons for Cemex's credit rating upgrade? Cemex's credit rating was upgraded due to its strong financial and operating performance, deleveraging strategy, and flexible capital allocation. By how much did Cemex's EBITDA grow in 2023? Cemex's EBITDA grew by 25% in 2023. How much did Cemex's Free Cash Flow increase after maintenance capex in 2023? Cemex's Free Cash Flow more than doubled after maintenance capex in 2023. Who is the CEO of Cemex? Fernando A. Gonzlez is the CEO of Cemex."
Lithium ION Energy Announces Debt Settlement and Grant of Stock Options,2024-03-13T22:00:00.000Z,Low,Neutral,"Lithium ION Energy Limited (IONGF) settles $143,669 in debt by issuing 606,675 common shares at $0.24 per share. The company also grants 1,250,000 stock options at $0.09 per share to consultants and insiders.","Lithium ION Energy Announces Debt Settlement and Grant of Stock Options Rhea-AI Impact (Low) Rhea-AI Sentiment (Neutral) Tags Rhea-AI Summary Lithium ION Energy Limited (IONGF) settles $143,669 in debt by issuing 606,675 common shares at $0.24 per share. The company also grants 1,250,000 stock options at $0.09 per share to consultants and insiders. Positive None. Negative None. 03/13/2024 - 06:00 PM Toronto, Ontario--(Newsfile Corp. - March 13, 2024) - Lithium ION Energy Limited (TSXV: ION) (OTCQB: IONGF) (FSE: ZA4) (""ION"" or the ""Company"") announces that it has negotiated debt settlement agreements with certain arm's length and non-arm's length creditors. Pursuant to the debt settlement agreements, and subject to acceptance by the TSX Venture Exchange (the ""TSXV""), the Company has settled an aggregate amount of $143,669 in debt, in consideration for which it will issue an aggregate of 606,675 common shares (the ""Shares"") of the Company at a deemed price of $0.24 per Share.All Shares issued in relation to these debt settlements will be subject to a hold period expiring four months and one day after the date the Shares are issued, in accordance with applicable securities laws and the policies of the TSXV.The Company also announces that it has granted to certain consultants and insiders of the Company an aggregate of 1,250,000 incentive stock options (the ""Stock Options"") to purchase common shares under the Company's incentive stock option plan (the ""Plan""). Each Stock Option is exercisable into a common share of the Company at a price of $0.09 for a period of two years from the date of grant. The Stock Options will vest immediately and be subject to the terms and conditions of the Plan and the policies of the TSX Venture Exchange.About Lithium ION Energy Ltd.Lithium ION Energy Ltd. (TSXV: ION) (OTCQB: IONGF) (FSE: ZA4) is committed to exploring and developing high quality lithium resources in strategic jurisdictions. ION's flagship, 81,000+ hectare Baavhai Uul lithium brine project represents the largest and first lithium brine exploration licence award in Mongolia. ION also holds the 29,000+ hectare Urgakh Naran highly prospective lithium brine licence in Dorngovi Province in Mongolia. With the acquisition of the Bliss Lake and Little Nahani projects in NWT, Canada, ION has enhanced its lithium asset and jurisdiction profile. ION is well-poised to be a key player in the clean energy revolution, positioned well to service the world's increased demand for lithium. Information about the Company is available on its website, www.ionenergy.ca, or under its profile on SEDAR+ at www.sedarplus.ca.For further information:COMPANY CONTACT: Ali Haji, ali@ionenergy.ca, 647-871-4571MEDIA CONTACT: Siloni Waraich, siloni@ionenergy.ca, 416-432-4920Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this news release.Cautionary Note Regarding Forward-Looking InformationInformation set forth in this news release contains forwardlooking statements. Forward-looking statements include estimates and statements that describe the Company's future plans, objectives or goals, including words to the effect that the Company or management expects a stated condition or result to occur. Forward-looking statements may be identified by such terms as ""believes"", ""anticipates"", ""expects"", ""estimates"", ""may"", ""could"", ""would"", ""will"", or ""plan"". Since forward-looking statements are based on assumptions and address future events and conditions, by their very nature they involve inherent risks and uncertainties. Although these statements are based on information currently available to the Company, the Company provides no assurance that actual results will meet management's expectations. Risks, uncertainties and other factors involved with forward-looking information could cause actual events, results, performance, prospects and opportunities to differ materially from those expressed or implied by such forward-looking information. Forward looking information in this news release includes, but is not limited to, the Company's objectives, goals or future plans, statements, anticipated regulatory approvals and completion and timing of closing of the debt settlement. Important factors that could cause actual results to differ materially from Ion's expectations include, among others, uncertainties relating to availability and costs of financing needed in the future, changes in equity markets, risks related to international operations, the actual results of current exploration activities, delays in the development of projects, conclusions of economic evaluations and changes in project parameters as plans continue to be refined as well as future prices of lithium, and ability to predict or counteract potential impact of COVID-19 coronavirus on factors relevant to the Company's business. There can be no assurance that forward-looking statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements.To view the source version of this press release, please visit https://www.newsfilecorp.com/release/201646 What debt amount did Lithium ION Energy Limited settle? Lithium ION Energy Limited settled $143,669 in debt. How many common shares did the company issue as part of the debt settlement? The company issued 606,675 common shares at a price of $0.24 per share. How many stock options were granted to consultants and insiders? 1,250,000 stock options were granted to consultants and insiders. At what price are the stock options exercisable? The stock options are exercisable at a price of $0.09 per share. What is the vesting period for the stock options? The stock options will vest immediately and be exercisable for a period of two years from the date of grant."
California American Water Receives Award for Eardley-Forest Lake Transmission Main Replacement Project,2024-03-13T21:42:00.000Z,No impact,Neutral,"California American Water's Eardley-Forest Lake Transmission Main Replacement Project wins a 2024 Award of Merit for critical emergency repairs after a major rainstorm damaged a water pipeline, costing $2.3 million and involving key partnerships.","California American Water Receives Award for Eardley-Forest Lake Transmission Main Replacement Project Rhea-AI Impact (No impact) Rhea-AI Sentiment (Neutral) Tags Rhea-AI Summary California American Water's Eardley-Forest Lake Transmission Main Replacement Project wins a 2024 Award of Merit for critical emergency repairs after a major rainstorm damaged a water pipeline, costing $2.3 million and involving key partnerships. Positive None. Negative None. 03/13/2024 - 05:42 PM PACIFIC GROVE, Calif.--(BUSINESS WIRE)-- California American Water is pleased to announce that its Eardley-Forest Lake Transmission Main Replacement Project has been awarded a 2024 Award of Merit by the American Public Works Association (APWA) Monterey Bay Chapter. The award recognizes the critical emergency repairs completed in 2023 following a major rainstorm that caused a large tree to fall and damage a 30-inch transmission main in the Monterey service area. This vital pipeline supplies water to the Monterey Peninsula, and the damage necessitated a coordinated response from the companys engineering and operations teams. To reduce the possibility of future tree incidents, California American Water designed the project so that the replacement section of pipeline would be underground and outside of a sensitive waterway. Our team responded quickly and efficiently to the critical main break, said David Pezzini, Engineering Project Manager for California American Water. We understand the importance of dependable water service for our customers, and we are committed to taking the necessary steps to help ensure safe, reliable water service for our customers and the well-being of the environment. The repair project involved the replacement and realignment of the damaged section of the transmission main and was completed in November 2023 for an investment of $2.3 million. California American Water partnered with Monterey Peninsula Engineering and Blair, Church & Flynn Consulting Engineers to successfully make repairs while maintaining water service for approximately 100,000 Monterey peninsula customers and businesses. We are honored to receive this recognition from the APWA Monterey Bay Chapter, said Pezzini. This project exemplifies our commitment to investing where it matters, whether thats during emergencies or while planning for the future. For a complete list of the 2024 APWA Monterey Bay Chapter Award winners, click here. About American Water American Water (NYSE: AWK) is the largest regulated water and wastewater utility company in the United States. With a history dating back to 1886, We Keep Life Flowing by providing safe, clean, reliable and affordable drinking water and wastewater services to more than 14 million people with regulated operations in 14 states and on 18 military installations. American Waters 6,500 talented professionals leverage their significant expertise and the companys national size and scale to achieve excellent outcomes for the benefit of customers, employees, investors and other stakeholders. For more information, visit amwater.com and join American Water on LinkedIn, Facebook, X and Instagram. About California American Water California American Water, a subsidiary of American Water, provides high-quality and reliable water and wastewater services to approximately 700,000 people. View source version on businesswire.com: https://www.businesswire.com/news/home/20240313273414/en/ Media: Josh Stratton Manager, External Affairs California American Water 831-435-6015 Josh.Stratton@amwater.com Source: California American Water What award did California American Water's Eardley-Forest Lake Transmission Main Replacement Project receive? The project received a 2024 Award of Merit by the American Public Works Association (APWA) Monterey Bay Chapter. How much was the investment for the repair project? The repair project cost $2.3 million. Who did California American Water partner with for the repair project? California American Water partnered with Monterey Peninsula Engineering and Blair, Church & Flynn Consulting Engineers for the repair project. How many customers and businesses were impacted by the repair project? Approximately 100,000 Monterey peninsula customers and businesses were impacted by the repair project. What was the main reason for the repair project? The repair project was initiated due to a major rainstorm causing damage to a 30-inch transmission main in the Monterey service area."
River Valley Community Bancorp profiled as an Exceptional Bank by The Findley Companies,2024-03-13T21:53:00.000Z,No impact,Very Positive,"River Valley Community Bancorp (RVCB) and its subsidiary, River Valley Community Bank, have been recognized as an 'Exceptional Bank' in The Findley Report's March 2024 Newsletter.","River Valley Community Bancorp profiled as an Exceptional Bank by The Findley Companies Rhea-AI Impact (No impact) Rhea-AI Sentiment (Very Positive) Tags Rhea-AI Summary River Valley Community Bancorp (RVCB) and its subsidiary, River Valley Community Bank, have been recognized as an 'Exceptional Bank' in The Findley Report's March 2024 Newsletter. Positive None. Negative None. 03/13/2024 - 05:53 PM YUBA CITY, Calif., March 13, 2024 (GLOBE NEWSWIRE) -- River Valley Community Bancorp (OTC markets: RVCB) with its wholly owned subsidiary, River Valley Community Bank (collectively referred to as the RVCB), has been featured as an Exceptional Bank in The Findley Reports March 2024 Newsletter. About the Findley CompaniesSince 1965, The Findley Companies have been committed to supporting Premier Performance for California Financial institutions. The Findley Companies publishes the highly recognized The Findley Report Newsletter, a monthly publication providing essential banking transactions and regulatory updates in an editorial format. These newsletters, and more information on the Findley Companies, can be found at www.findley-reports.com. River Valley Community Bank has been profiled as an Exceptional Bank in The Findley Reports March 2024 newsletter publication. The Findley Reports has profiled exceptional banks for several years, but only profiles four exceptional banks a year. The publication reviews RVCBs commitment to its marketplace, focus on customer satisfaction and delivering relationship-oriented service over its nearly 18 years of operation. The article also includes some key operating results and an in-depth interview with President and CEO, John M. Jelavich, about the direction and focus of RVCB, and what makes RVCB Exceptional! The entire Exceptional Bank Profile can be viewed HERE. CEO John M. Jelavich stated, We are proud to be recognized as an Exceptional Bank by The Findley Reports. This designation is a testament to the hard work and dedication of the entire RVCB team. Our reputation for hands-on, community focused, relationship-based banking continues to grow throughout our markets. We strongly believe that banks like ours play a vital role in providing full-service banking solutions for our communities and we are honored with this recognition, Jelavich concluded. The Bank remains highly rated with BauerFinancial, and Depositaccounts.com and serves its customer base through its offices located at: 1629 Colusa Avenue, Yuba City, CA580 Brunswick Rd, Grass Valley, CA905 Lincoln Way, Auburn, CA904 B Street, Marysville, CA401 Ryland Street, Ste. 205, Reno, NV (Loan Production Office)1508 Eureka Rd., Ste. 100, Roseville, CA (Loan Production Office) The Bank offers a full suite of competitive products, services, and banking technology. For more information please visit our website at www.myrvcb.com or contact John M. Jelavich at (530) 821-2469. Forward Looking Statements: This document may contain comments and information that constitute forwardlooking statements. Forwardlooking statements are subject to risks and uncertainties that could cause actual results to differ materially from those expressed in or implied by such statements. Forwardlooking statements speak only as to the date they are made. The Bank does not undertake to update forwardlooking statements to reflect circumstances or events that occur after the date the forwardlooking statements are made. What is the latest recognition received by River Valley Community Bancorp (RVCB) and its subsidiary? River Valley Community Bancorp (RVCB) and its subsidiary, River Valley Community Bank, have been recognized as an 'Exceptional Bank' in The Findley Report's March 2024 Newsletter. Which report featured River Valley Community Bancorp (RVCB) as an 'Exceptional Bank'? The Findley Report's March 2024 Newsletter featured River Valley Community Bancorp (RVCB) as an 'Exceptional Bank'. What is the ticker symbol for River Valley Community Bancorp? The ticker symbol for River Valley Community Bancorp is RVCB."
"VAALCOEnergy, Inc. Announces Fourth Quarterand Full Year 2023 Financial and Operating Results",2024-03-13T21:44:00.000Z,Neutral,Neutral,"VAALCO Energy, Inc. reports record financial results and shareholder returns for 2023, with highlights including $60.4 million net income, $280.4 million Adjusted EBITDAX, and $121 million cash at year-end. The company raised production by 83% year-over-year, increased SEC proved reserves by 3%, and invested over $70 million in capital programs in Egypt and Canada. In Q4 2023, VAALCO generated $44.0 million net income and sold 21,674 BOEPD. The company plans a 2024 capital budget of $70 to $90 million and aims to return over $25 million of Free Cash Flow to shareholders.","VAALCO Energy, Inc. Announces Fourth Quarter and Full Year 2023 Financial and Operating Results Rhea-AI Impact (Neutral) Rhea-AI Sentiment (Neutral) Tags earnings Rhea-AI Summary VAALCO Energy, Inc. reports record financial results and shareholder returns for 2023, with highlights including $60.4 million net income, $280.4 million Adjusted EBITDAX, and $121 million cash at year-end. The company raised production by 83% year-over-year, increased SEC proved reserves by 3%, and invested over $70 million in capital programs in Egypt and Canada. In Q4 2023, VAALCO generated $44.0 million net income and sold 21,674 BOEPD. The company plans a 2024 capital budget of $70 to $90 million and aims to return over $25 million of Free Cash Flow to shareholders. Positive Record net income of $60.4 million and $280.4 million Adjusted EBITDAX for FY 2023. Raised production by 83% year-over-year to 18,710 BOEPD in 2023. Increased SEC proved reserves by 3% to 28.6 million MMBOE. Generated $44.0 million net income in Q4 2023 and sold 21,674 BOEPD. Plans a 2024 capital budget of $70 to $90 million. Aims to return over $25 million of Free Cash Flow to shareholders. Negative None. Financial Analyst The financial results reported by VAALCO Energy, Inc. reflect a significant positive performance, with a net income of $60.4 million and a net cash from operating activities of $223.6 million for the full year of 2023. This indicates a robust financial health and effective operational management. The record Adjusted EBITDAX of $280.4 million and Free Cash Flow of $119.7 million are particularly noteworthy, as they represent the company's earnings before interest, taxes, depreciation, amortization and exploration expenses, which are critical indicators of a company's operating profitability. The decision to return $50.3 million to shareholders through dividends and buybacks demonstrates confidence in the company's financial stability and a commitment to shareholder value. The capital investment of over $70 million in Egypt and Canada, coupled with the company's debt-free status, suggests strategic use of capital for growth while maintaining financial prudence. Looking ahead, the all-cash acquisition of Svenska Petroleum Exploration AB is a strategic move that is expected to be accretive to shareholder value. This term 'accretive' is often used to describe a transaction expected to increase the acquiring company's earnings per share (EPS). The acquisition is poised to expand VAALCO's portfolio and enhance its ability to generate sustainable cash flow, which is a positive signal for investors. However, the commitment to return over $25 million of Free Cash Flow to shareholders in 2024 may raise questions about the balance between rewarding shareholders and reinvesting in further growth opportunities. Market Research Analyst The oil and gas sector is highly volatile, with companies like VAALCO Energy, Inc. navigating fluctuating prices and geopolitical factors. VAALCO's reported 83% year-over-year production increase and the growth of year-end SEC proved reserves by 3% indicate successful operational execution and resource management. These metrics are essential for investors as they signal the company's ability to sustain and increase production, which is a critical driver of revenue in the energy sector. The strategic acquisition of Svenska Petroleum Exploration AB represents a significant expansion into new markets, with the acquired company currently producing approximately 4,500 barrels of oil equivalent per day. This acquisition aligns with industry trends where companies seek to bolster their portfolios through strategic mergers and acquisitions, which can provide access to new reserves and diversify production risks. The impact of this acquisition on the company's production and reserves will be a key factor to watch, as it could significantly influence VAALCO's market position and stock performance. Energy Sector Analyst VAALCO Energy, Inc.'s operational success in 2023, including the substantial production increase and reserves growth, is commendable within the energy sector. The company's bank debt-free status is a rarity in an industry often characterized by high leverage due to capital-intensive operations. This positions VAALCO favorably in terms of financial flexibility and resilience against market downturns. The acquisition of Svenska Petroleum Exploration AB is a strategic move that introduces geographical diversification, which can mitigate region-specific risks such as regulatory changes or political instability. This diversification is a strategic advantage as it can lead to more stable cash flows. Investors will be interested in the integration of this acquisition and its contribution to VAALCO's overall production efficiency and cost structure. The company's focus on organic and inorganic growth opportunities, as well as the emphasis on maximizing value for shareholders, suggests a forward-looking strategy that could bolster its competitive edge in the energy sector. 03/13/2024 - 05:44 PM VAALCO Reports Record Financial Results and Shareholder Returns Following Year of ExpansionHOUSTON, March 13, 2024 (GLOBE NEWSWIRE) -- VAALCO Energy, Inc. (NYSE: EGY, LSE: EGY) (""VAALCO"" or the ""Company"") today reported operational and financial results for the fourth quarter and full year of 2023. The Company also provided 2024 operational and financial guidance for the first quarter and full year of 2024. 2023 Full Year Highlights: Reported full year (""FY"") 2023 net income of $60.4 million ($0.56 per diluted share) and net cash from operating activities of $223.6 million;Generated record Adjusted EBITDAX(1) of $280.4 million and $119.7 million of Free Cash Flow (FCF)(1) in FY 2023;Returned $50.3 million or 42% of FCF to shareholders in 2023 through dividends and buybacks;Raised production in 2023 by 83% year-over-year to 18,710 net revenue interest (NRI)(2) barrels of oil equivalent per day (BOEPD), at the higher end of the Company's increased guidance; FY 2023 working interest (WI)(3) production of 23,946 BOEPD was at the top of the increased guidance range; Increased year-end 2023 SEC proved reserves by 3% to 28.6 million barrels of oil equivalent (MMBOE);Integrated a major acquisition and invested over $70 million in a capital program focused on Egypt and Canada; and Increased cash at December 31, 2023 to $121 million, all while remaining bank debt free. Fourth Quarter 2023 Highlights: Reported Q4 2023 net income of $44.0 million ($0.41 per diluted share);Generated record Adjusted EBITDAX(1) of $95.9 million;Produced 18,065 NRI BOEPD (23,330 WI BOEPD); andSold 21,674 BOEPD in Q4 2023, at the high end of guidance. 2024 Key Items and Outlook: Announced accretive all cash acquisition with sales and purchase agreement (""SPA"") to acquire Svenska Petroleum Exploration AB (""Svenska""); Currently producing approximately 4,500 BOEPD (99% oil);Includes estimated 1P WI CPR reserves4 as of October 1, 2023, of 13.0 MMBOE (99% oil) and total 2P WI CPR4 reserves at October 1, 2023, of 21.7 million MMBOE (97% oil); Planning a 2024 capital budget of $70 to $90 million; andTarget to return over $25 million of FCF to shareholders. (1)Adjusted EBITDAX, Adjusted Net Income, Adjusted Working Capital and Free Cash Flow are Non-GAAP financial measures and are described and reconciled to the closest GAAP measure in the attached table under Non-GAAP Financial Measures.(2)All NRI production rates are VAALCO's working interest volumes less royalty volumes, where applicable(3)All WI production rates and volumes are VAALCOs working interest volumes, where applicable(4)A BOE conversion ratio of six thousand cubic feet of natural gas to one barrel of oil equivalent (6 MCF: 1Bbl) is based on an energy equivalency conversion method primarily applicable at the burner tip and does not represent a value equivalency at the wellhead. Reserves estimates were prepared in accordance with the definitions and guidelines set forth in the 2018 Petroleum Resources Management Systems approved by the Society of Petroleum Engineers. George Maxwell, VAALCOs Chief Executive Officer commented, In 2023, we delivered record financial results, successfully integrated a major acquisition and continued to return a meaningful amount of value to our shareholders through dividends and share buybacks. Sales and production volumes nearly doubled, we grew our cash position at year-end by nearly $84 million and we generated record Adjusted EBITDAX of $280 million. This allowed us to fully fund, with cash on hand, the return of over $50 million to shareholders through our dividend and buyback programs and over $70 million in a capital program focused on Egypt and Canada, all while remaining bank debt free which demonstrates the strong financial position of the Company today. Our 2023 proved reserves saw 3% growth year-over-year, despite a year of record production across our asset portfolio and significant decreases in SEC pricing. We were able to more than replace our 2023 production through strong positive revisions that more than offset production and reserve reductions due to lower SEC pricing. In early 2024, we announced our intent to utilize a portion of this strong cash position to add to our diversified portfolio of high performing assets in line with our strategic vision. With our all-cash deal to buy Svenska, which provides us with a new country entry and strong production and reserves from a proven producing asset as well as a significant organic upside opportunity, we are enhancing VAALCO's ability to generate sustainable cash flow and continue to return cash to our shareholders for many years to come. The acquisition is expected to close in Q2 2024 and is highly accretive on key metrics to our shareholder base and provides another strong asset to support future growth."" Our ability to execute on our strategic vision has led to unprecedented growth in production, reserves and cash flow, all while extending our runway for future opportunities. We are in the strongest position in VAALCOs history and are entering 2024 with more reserves, production and future potential. We are adding to that position through the Svenska acquisition, and we remain focused on prioritizing our organic and inorganic growth opportunities as we continue to build a balanced business of scale that is capable of maximizing value for our shareholders. We are excited about the future and believe that 2024 could be another record-breaking year for VAALCO. Operational Update Egypt In Egypt, VAALCO continued to use the EDC-64 rig in the Eastern Desert drilling campaign. The Company continued drilling the EA-55 development well in the fourth quarter which was the last well of the 2023 campaign. Through operational efficiencies, VAALCO drilled an average of two wells per month with the EDC-64 rig, nearly twice as fast as in 2022 and, VAALCO drilled 18 wells in 2023, while also completing the Arta-77Hz well at the beginning of 2023. The 2023 firm and contingent work program was drilled faster and cheaper compared to budget, adding to its economic returns. A summary of the Egyptian drilling campaign's impact during 2023 is presented below: VAALCO Egypt 2023 WellsWellSpud dateNet Pay (ft)Penetrated Pay ZonesCompletion ZonePerforation Interval (ft)IP-30 Rate (BOPD)EastArta-531/15/202314.8RedbedRedbedHydraulic Frac35K-812/2/202368.9Asl-D and EAsl-E13.1255K-792/21/2023190Asl-A, B, D, E and FAsl-B1 and B259150Arta-803/10/202333RedbedRedbed32440Arta-813/21/202328.5RedbedRedbed26340HE-44/2/202327.9Asl-B1 and B2Asl-B213.1440HE-5 Injector4/16/20234.9Asl-B2Asl-B29.8NAHE-35/10/20239.2Asl-B1 and B2Asl-B216.4235Arta-825/25/202342RedbedRedbed28150Arta-846/6/202334NukhulNukhulHydraulic Frac68NWG-5C16/16/2023noneNukhulTemporarily AbandonednonenoneK-806/30/2023141.4Asl-A, B, D and EAsl-E16.4144K-847/16/202398.8Asl-D, E, F and GAsl-G219.7125K-857/31/202363.3Asl-D, E, F and GAsl-E9.882M-248/14/202370.2Asl-A, B and DAsl-D9.8134Arta-919/1/202340Nukhul and RedbedRedbed20150EA-549/12/2023noneNukhul, Thebes and RedbedPlugged & AbandonednonenoneEA-5510/4/202342RedbedRedbedHydraulic FracPending Frac Canada VAALCO drilled and completed two wells in the first quarter of 2023, consisting of a 1.5-mile lateral and a 3-mile lateral, which were also required for land retention purposes. Both wells were drilled and completed safely and cost effectively without incident. The wells were tied in and equipped in April and early May with overall cycle times that were significantly less than historical cycle times. The wells began flowing in May and naturally flowed through June. In early July, the pump and rods were run on both wells. The production rates from both wells exceeded expectations, and the Company is monitoring their long-term performance while evaluating future drilling campaigns, with the intent of moving exclusively to 2.5 mile and 3-mile laterals to improve economics. This resulted in record production levels reported for Canada in 2023. A summary of the Canada drilling campaign's impact during 2023 is presented below: VAALCO Canada 2023 WellsWellSpud dateNet Pay (ft)Penetrated Pay ZonesCompletion ZonePerforation Interval (ft)IP-30 Rate (BOPD)100/12-121/28/202314,430Upper Bioturbated Cardium118 Stg x 15T Hydraulic Fracture Treatmentn/a444 BOPD ; 500 BOEPD102/16-302/22/20237,870Upper Bioturbated Cardium55 Stg x 15T Hydraulic Fracture Treatmentn/a374 BOPD ; 426 BOEPD Gabon VAALCO completed its 2021/2022 drilling campaign in the fourth quarter of 2022. The Company is currently evaluating locations and planning for its next drilling campaign. Gabon production performance in the year ended December 31, 2023 has been strong and ahead of plan driven by improved operational uptime at Etame. The cost savings from the new Floating, Storage and Offloading vessel (""FSO"") have been captured, as planned, but are being offset by increased marine costs as a consequence of inflationary (marine vessel supply rates, transportation, and contractors) and industry supply chain pressures as well as higher diesel costs due to the feed gas line being suspended due to a leak. The gas line was successfully fixed in October 2023 and the FSO is now utilizing gas rather than diesel. Year-End 2023 Reserves VAALCOs SEC proved reserves at December 31, 2023 increased by 3% to 28.6 MMBOE from 27.9 MMBOE at year-end 2022. Year-end 2023 reserves included 22.5 MMBOE in proved developed reserves and 6.2 MMBOE in proved undeveloped reserves. The Companys SEC reserves were engineered by its third-party independent reserve consultant, Netherland, Sewell & Associates, Inc., (NSAI) who has provided annual independent estimates of VAALCOs year-end SEC reserves for over 15 years and evaluates VAALCO's Gabonese and Egyptian reserves, and GLJ Ltd. (""GLJ""), who evaluates VAALCO's Canadian reserves. In 2023, the Company added 5.6 MMBOE due to positive revisions and 1.9 MMBOE of SEC proved reserves through extensions and additions, primarily in Canada with additional PUD locations. These additions were partially offset by 6.8 MMBOE of full year 2023 production. VAALCO had a reserve replacement ratio of 110% compared to the 6.8 MMBOE of production in 2023. The standardized measure of VAALCOs SEC proved reserves, utilizing SEC pricing decreased to $341.9 million at December 31, 2023 from $624.5 million at December 31, 2022. This was primarily driven by a decrease in year over year SEC prices which was utilized for the calculation and can be found in the Companys Annual Report on Form 10-K disclosure, which is expected to be filed with the SEC by March 15, 2024. MMBoe Proved SEC Reserves at December 31, 2022 27.9 2023 Production (6.8)Revisions of Previous Estimates 5.6 Extensions and Additions 1.9 Proved SEC Reserves at December 31, 2023 28.6 At year-end 2023, NSAI provided the 2P WI CPR estimates of proven and probable reserves which were prepared in accordance with the definitions and guidelines set forth in the 2018 Petroleum Resources Management Systems approved by the Society of Petroleum Engineers as of December 31, 2023 using VAALCOs management assumptions for future commodity pricing and costs shown below under Supplemental Non-GAAP Financial Measures - 2P WI CPR Reserves. The 2P WI CPR reserves attributable to VAALCOs ownership are reported on a WI basis prior to deductions for government royalties. Management's year-end 2023 2P WI CPR estimate of reserves is 77.3 MMBOE to VAALCOs WI, an increase of 1% from 76.4 MMBO at December 31, 2022. The present value discounted at 10% (""PV-10"") of VAALCOs 2P WI CPR reserves at year-end 2023, utilizing management timing assumptions and escalated pricing and cost assumptions, is $630.9 million, down 34% from $814.8 million at December 31, 2022. The PV-10 decrease is driven primarily by pricing and cost inflation. See Supplemental Non-GAAP Financial Measures below concerning 2P WI CPR reserves and 2P PV-10. Financial Update Fourth Quarter of 2023 Reported net income of $44.0 million ($0.41 per diluted share) for the fourth quarter of 2023 which was up significantly compared with net income of $6.1 million ($0.06 per diluted share) in the third quarter of 2023 and $17.8 million ($0.17 per diluted share) in the fourth quarter of 2022. The increase in earnings compared to the third quarter of 2023 is mainly due to increased sales revenue due to increased volumes and improved realized pricing due to geographic sales mix, lower credit losses due to reversal of credit loss allowances on the settlement of debts in Gabon and decreased depreciation, depletion and amortization (DD&A) expense partially offset by higher income tax expense on the increased operating profit. Similarly, the increase in earnings compared to the fourth quarter of 2022 is primarily due to higher sales revenue due to increased volumes, lower credit losses due to reversal of credit loss allowances and decreased DD&A expense partially offset by higher income tax expense. Adjusted EBITDAX totaled $95.9 million in the fourth quarter of 2023, a 34% increase from $71.4 million in the third quarter of 2023, primarily due to higher revenues driven by higher sales and improved realized commodity pricing. The increase in fourth quarter 2023 Adjusted EBITDAX to $95.9 million compared with $49.8 million generated in the same period in 2022, is primarily due to increased revenue as a result of the TransGlobe transaction and lower credit losses due to reversal of a credit loss allowance. Quarterly Summary - Sales and Net Revenue $ in thousands Three Months Ended December 31, 2023 Three Months Ended September 31, 2023 Gabon Egypt Canada Total Gabon Egypt Canada Total Oil Sales $100,398 $79,043 $5,476 $184,917 $64,100 $88,748 $7,832 $160,680 NGL Sales   $2,019 $2,019   $2,073 $2,073 Gas Sales   $818 $818   $988 $988 Gross Sales $100,398 $79,043 $8,313 $187,754 $64,100 $88,748 $10,893 $163,741 Selling Costs & carried interest $1,711 $0  $1,711 $1,378 $(497)  $881 Royalties & taxes $(13,699) $(24,393) $(1,517) $(39,609) $(8,203) $(37,944) $(2,206) $(48,353) Net Revenue $88,410 $54,650 $6,796 $149,856 $57,275 $50,307 $8,687 $116,269 Oil Sales MMB (working interest) 1,165 1,023 77 2,265 764 1,282 101 2,146 Average Oil Price Received $86.18 $77.24 $71.57 $81.65 $83.92 $69.24 $77.89 $74.87 % Change Q4 2023 vs. Q3 2023 9% Average Brent Price    $84.01    $86.65 % Change Q4 2023 vs. Q3 2023 -3% Gas Sales MMCF (working interest)   471 471   470 470 Average Gas Price Received   1.74 $1.74   $2.10 $2.10 % Change Q4 2023 vs. Q3 2023 -17% Average Aeco Price ($USD)   2 $1.86   2 $1.89 % Change Q4 2023 vs. Q3 2023 -2% NGL Sales MMB (working interest)   80 80   82 82 Average Liquids Price Received   $25.09 $25.09   $25.27 $25.27 % Change Q4 2023 vs. Q3 2023 -1% Revenue and Sales Q4 2023 Q4 2022 % Change Q4 2023 vs. Q4 2022 Q3 2023 % Change Q4 2023 vs. Q3 2023 Production (NRI BOEPD) 18,065 14,390 26% 18,844 (4)%Sales (NRI BOE) 1,994,000 1,371,000 45% 1,812,000 10%Realized commodity price ($/BOE) $73.96 $70.43 5% $63.41 17%Commodity (Per BOE including realized commodity derivatives) $73.89 $70.24 5% $63.38 17%Total commodity sales ($MM) $149.2 $96.6 54% $116.3 28% VAALCO had a net revenue increase of $32.9 million or 28% as the total NRI sales volumes of 1,994,000 BOE was higher than Q3 2023 and rose 45% compared to 1,371,000 BOE for Q4 2022. Q4 2023 sales were at the top end of VAALCO's guidance. Q4 2023 realized pricing (net of royalties) was up 17% compared to Q3 2023 and up 5% compared to Q4 2022. Costs and Expenses Q4 2023 Q4 2022 % Change Q4 2023 vs. Q4 2022 Q3 2023 % Change Q4 2023 vs. Q3 2023 Production expense, excluding offshore workovers and stock comp ($MM) $46.3 $40.8 14% $39.9 16%Production expense, excluding offshore workovers ($/BOE) $23.27 $29.80 (22)% $22.07 5%Offshore workover expense ($MM) $0.0 $4.7 (100.0)% $(0.0) %Depreciation, depletion and amortization ($MM) $20.3 $26.3 (23)% $32.5 (38)%Depreciation, depletion and amortization ($/BOE) $10.2 $19.20 (47)% $17.96 (43)%General and administrative expense, excluding stock-based compensation ($MM) $6.1 $(0.3) (2,119)% $5.2 17%General and administrative expense, excluding stock-based compensation ($/BOE) $3.0 $(0.20) (1,619)% $2.86 6%Stock-based compensation expense ($MM) $0.9 $(0.1) (1,000.0)% $1.0 (10)%Current income tax expense (benefit) ($MM) $14.3 $1.7 741% $2.1 581%Deferred income tax expense (benefit) ($MM) $(2.6) $5.3 (149)% $(2.6) -% Total production expense (excluding offshore workovers and stock compensation) of $46.3million in Q4 2023 was higher compared to Q3 2023 and the same period in 2022. The increase in Q4 2023 expense compared to Q3 2023 was driven primarily by higher costs related to higher sales volumes. The increase in Q4 2023 compared to the Q4 2022 was primarily driven by increased expense associated with higher sales and costs associated with the TransGlobe combination as well as higher costs associated with boats, diesel and other direct operating costs. VAALCO has seen inflationary and industry supply chain pressure on personnel and contractor costs. There was no offshore workover expense in Q4 2023 or Q3 2023. There was a 100% decrease in offshore workover expense in Q4 2023 compared to Q4 2022. Q4 2023 production expense per BOE, excluding offshore workover costs, remained low at $23.27 per BOE which was 5% higher than Q3 2023 and down 22% compared to Q4 2022 due to higher sales, lower costs in Etame associated with the FSO conversion and lower per BOE costs from the Egyptian and Canadian assets. DD&A expense for the Q4 2023, was $20.3 million which was lower than $32.5 million in Q3 2023 and lower than $26.3 million in Q4 2022. The decrease in Q4 2023 DD&A expense, compared to Q3 2023 and to Q4 2022 is due to year-end depletion adjustments, primarily in Egypt, that were made in Q4 upon the completion of the 2023 competent persons report. Q4 2023 included a $0.7 million expense related to an appraisal well in Egypt that was abandoned during Q4 2023 and subsequently expensed to Exploration Expense. General and administrative (G&A) expense, excluding stock-based compensation, increased to $6.1 million in Q4 2023 from $5.2 million in Q3 2023 and a negative $0.3 million in Q4 2022. The increase in general and administrative expenses is primarily due to higher professional service fees, salaries and wages, and accounting and legal fees. The Company incurred one-time reorganization costs in 2023 as it integrated the TransGlobe assets and eliminated duplicate administrative costs. Q4 2023 G&A was within the Companys guidance. The Company has made meaningful reductions to absolute G&A costs when compared with the combined TransGlobe and VAALCO combined G&A costs for 2022. Non-cash stock-based compensation expense was $0.9 million for Q4 2023 compared to Q3 2023 of $1.0 million and Q4 2022 of negative $0.1 million. Other income (expense), net, was an expense of $0.8 million for Q4 2023, compared to an income of $2.5 million during Q4 2022 and an income of $0.2 million for Q3 2023. Other income (expense), net, normally consists of foreign currency gains and losses. For Q4 2022, included in other (expense) income was a $10.8 million bargain purchase gain on the TransGlobe acquisition offset by $7.0 million of transaction costs associated with the business combination with TransGlobe. For the full year ended December 31, 2022, acquisition transaction costs were $14.6 million. Q4 2023 income tax expense was an expense of $37.6 million and is comprised of current tax expense of $41.1 million and deferred tax benefit of $3.5 million. Q3 2023 income tax expense was an expense of $25.8 million. This was comprised of $26.8 million of current tax expense and a deferred tax benefit of $0.9 million. Q4 2022 income tax expense was an expense of $7.0 million. This was comprised of $5.3 million of deferred tax expense and a current tax expense of $1.7 million. For all periods, VAALCOs overall effective tax rate was impacted by non-deductible items associated with derivative losses and corporate expenses. Foreign income taxes for Gabon are settled by the government taking their oil in-kind. Financial Update  Full Year 2023 The Company reported net income for the twelve months ended December 31, 2023 of $60.4 million, which compares to $51.9 million for the same period of 2022. The increase in net income for the twelve months ended December 31, 2023 compared to the same period in 2022 was primarily due to increased sales volumes partially offset by higher production costs, higher DD&A and lower oil prices. Both production and sales volumes for full year 2023 were up 83% to 6.8 MMBOE compared to 3.7 MMBOE production for the prior year. The increase was driven by production from the TransGlobe assets, as well as new wells from the 2021/2022 drilling campaign in Gabon. Crude oil sales are a function of the number and size of crude oil liftings in each quarter and do not always coincide with volumes produced in any given period. The average realized crude oil price for the twelve months of 2023 was $65.83 per barrel, representing a decrease of 30% from $94.77 realized in the twelve months of 2022. This decrease in crude oil price reflects the softening in commodity pricing over the past year, as well as the incorporation of the TransGlobe assets which include Canadian and Egyptian crude, natural gas, and NGLs that have lower realized pricing than Gabon. Year to Date Summary - Sales and Net Revenue $ in thousands Twelve Months Ended December 31, 2023 Twelve Months Ended December 31, 2022 Gabon Egypt Canada Total Gabon Egypt Canada Total Oil Sales 294,577 272,613 28,287 595,477 346,780 56,452 7,362 410,594 NGL Sales   8,440 8,440   2,276 2,276 Gas Sales   3,467 3,467   1,340 1,340 Gross Sales 294,577 272,613 40,194 607,384 346,780 56,452 10,978 414,210 Selling Costs & carried interest 5,301 (995)  4,306 5,843   5,843 Royalties & taxes (39,532) (110,569) (5,821) (155,922) (45,848) (18,742) (1,137) (65,727) Net Revenue 260,346 161,049 34,373 455,768 306,775 37,710 9,841 354,326 Oil Sales MMB (working interest) 3,569 4,055 394 8,018 3,355 818 93 4,266 Average Oil Price Received $82.54 $67.22 $71.88 $74.27 $103.36 $69.00 $79.59 $96.25 % Change 2023 vs. 2022 -23% Average Brent Price $82.49 $100.93 % Change 2023 vs. 2022 -18% Gas Sales MMCF (working interest)   1,798 1,798   335 335 Average Gas Price Received   $1.93 $1.93   $4.00 $4.00 % Change 2023 vs. 2022 -52% NGL Sales MMB (working interest)   317 317   63 63 Average Liquids Price Received   $26.58 $26.58   $36.13 $36.13 Capital Investments/Balance Sheet For the twelve months of 2023, net capital expenditures totaled $97.2 million on a cash basis and $72.6 million on an accrual basis. These expenditures were primarily related to costs associated with the development drilling programs in Egypt and Canada. At the end of the fourth quarter of 2023, VAALCO had an unrestricted cash balance of $121.0 million. VAALCO also has an undrawn reserve based lending (""RBL"") facility with $43.75 million of availability to further enhance the Companys liquidity position. The RBL facility is in its amortization phase. Working capital at December 31, 2023 was $100.7 million compared with $38.0 million at December 31, 2022, while Adjusted Working Capital(3) at December 31, 2023 totaled $113.8 million. VAALCO continues to work with the Egyptian General Petroleum Corporation on both collections and offsets. In addition, with the completion of drilling in Canada and Egypt, VAALCO expects to see a reduction in its outstanding Accounts Payable and Accruals. Cash Dividend Policy and Share Buyback Authorization VAALCO paid a quarterly cash dividend of $0.0625 per share of common stock for the fourth quarter of 2023 on December 21, 2023. VAALCO increased its quarterly per share dividend amount in 2023 and paid out a total $0.25 per share or approximately $27 million in dividends to its shareholders in 2023. On February 26, 2024, the Company announced its next quarterly cash dividend of $0.0625 per share of common stock for the first quarter of 2024 ($0.25 annualized), to be paid on March 28, 2024 to stockholders of record at the close of business on March 8, 2024. Future declarations of quarterly dividends and the establishment of future record and payment dates are subject to approval by the VAALCO Board of Directors. The Company's share buyback program provides for an aggregate purchase of currently outstanding common stock up to $30 million. Payment for shares repurchased under the program will be funded using the Company's cash on hand and cash flow from operations. The actual timing, number and value of shares repurchased under the share buyback program will depend on a number of factors, including constraints specified in any Rule 10b5-1 trading plans, price, general business and market conditions, and alternative investment opportunities. Under such a trading plan, the Companys third-party broker, subject to SEC regulations regarding certain price, market, volume and timing constraints, has authority to purchase the Companys common stock in accordance with the terms of the plan. The share buyback program does not obligate the Company to acquire any specific number of shares in any period, and may be expanded, extended, modified or discontinued at any time. In 2023, VAALCO repurchased $23.6 million in shares. Svenska Acquisition VAALCO expects to acquire 100% of the share capital of Svenska from Petroswede AB (Petroswede or the Seller) in the acquisition with an effective date of October 1, 2023. Gross consideration for the Acquisition is $66.5 million, subject to customary closing adjustments, with the net cash payment to be made by VAALCO on closing expected to be approximately $30 to $40 million depending on a number of factors including the timing of closing. The Acquisition is subject to a number of customary closing conditions, including regulatory and government approvals. Svenskas primary license interest is a 27.39% non-operated working interest (30.43% paying interest) in the CI-40 license, which includes the producing Baobab field, located in deepwater offshore Cote dIvoire. The field is operated by Canadian Natural Resources Limited, which holds a 57.61% working interest in the project, with the national oil company, Petroci Holding, owning the remaining 15% working interest (10% of which is carried by the other license partners). The CI-40 license has an initial term through mid-2028 with the contractual option to extend the license term by 10 years to 2038, subject to certain conditions. Current production from the Baobab field is approximately 4,500 WI BOEPD, with 1P WI CPR reserves at the Effective Date of 13.0 MMBOE (99% oil), and 2P WI CPR reserves of 21.7 MMBOE (97% oil). These reserve figures reflect currently sanctioned development activities; however, CI-40 has a significant growth runway with incremental development potential on the Baobab field, as well as the nearby Kossipo field, expected to provide a material uplift to the reserve and production volumes, supporting long-term production of the asset into the late 2030s. Cumulative gross production from the field has been approximately 150 MMBOE, a portion of the estimated over one billion barrels of oil equivalent volumes initially in place. CI-40 has a long history of production and significantly de-risked reservoirs. With almost 20 years of production to date, the FPSO is planned to come off station at the start of 2025 for planned maintenance and upgrade work to allow the FPSO to continue to produce through the end of the expected extended field license in 2038. The scope of work for the FPSO upgrade is currently being finalized. Production on Baobab is expected to re-start in 2026 following the FPSO work program. In addition, a fully appraised development drilling program is expected to start in 2026, targeting the significant incremental probable reserve base on the field. VAALCO sees reduced geological risk relating to this drilling program and the joint venture partners have already commenced the ordering of certain long-lead drilling items. Further future drilling phases have not yet been sanctioned, but there is significant incremental potential in both the Baobab field itself, as well as the nearby Kossipo development, which has also been appraised by two wells drilled in 2002 and 2019. In addition to the CI-40 license in Cote dIvoire, Svenska currently owns a 21.05% working interest in the early stage Uge discovery in the OML 145 concession in Nigeria alongside partners ExxonMobil (21.05%), Chevron (21.05%), Oando (21.05%) and NPDC (15.80%). There are minimal commitments on this license interest and no drilling or development is currently planned. Hedging The Company continued to proactively hedge a portion of its expected future production to lock in strong cash flow generation to assist in funding its capital and shareholder returns programs. The following includes hedges remaining in place at March 13,2024: Settlement PeriodType of ContractIndex Average Monthly Volumes Weighted Average Put Price Weighted Average Call Price (Bbls) (per Bbl) (per Bbl) January 2024 - March 2024CollarsDated Brent 85,000 $65.00 $97.00 April 2024 - June 2024CollarsDated Brent 65,000 $65.00 $100.00 July 2024 - September 2024CollarsDated Brent 80,000 $65.00 $92.00 2024 Guidance: The Company has provided first quarter and full year 2024 guidance. As a reminder, this guidance does not include the recently announced Svenska acquisition and will be updated once the acquisition is finalized. All of the quarterly and annual guidance is detailed in the tables below. FY 2024 Gabon Egypt CanadaProduction (BOEPD)WI20800 - 23400 8300 - 9600 9800 - 10600 2700 - 3200Production (BOEPD)NRI16100 - 18300 7200 - 8300 6700 - 7400 2200 - 2600Sales Volume (BOEPD)WI20800 - 23300 8300 - 9500 9800 - 10600 2700 - 3200Sales Volume (BOEPD)NRI16100 - 18300 7200 - 8300 6700 - 7400 2200 - 2600Production Expense (millions)WI & NRI$155.0 - $165.5 MM Production Expense per BOEWI$18.00 - $22.00 Production Expense per BOENRI$25.50 - $31.00 Offshore Workovers (millions)WI & NRI$1 - $10 MM Cash G&A (millions)WI & NRI$20.0 - $28.0 MM CAPEX (millions)WI & NRI$70 - $90 MM DD&A ($/BO)NRI$20.00 - $22.00 Q1 2024 Gabon Egypt CanadaProduction (BOEPD)WI21700 - 22400 9100 - 9300 10200 - 10600 2400 - 2500Production (BOEPD)NRI16800 - 17300 7900 - 8100 7000 - 7200 1900 - 2000Sales Volume (BOEPD)WI16800 - 21800 4200 - 8700 10200 - 10600 2400 - 2500Sales Volume (BOEPD)NRI12600 - 16800 3700 - 7600 7000 - 7200 1900 - 2000Production Expense (millions)WI & NRI$35.5 - $42.5 MM Production Expense per BOEWI$17.00 - $22.50 Production Expense per BOENRI$22.00 - $29.50 Offshore Workovers (millions)WI & NRI$0 - $0 MM Cash G&A (millions)WI & NRI$4.0 - $6.5 MM CAPEX (millions)WI & NRI$22 - $28 MM DD&A ($/BO)NRI$20.00 - $22.00 Conference Call As previously announced, the Company will hold a conference call to discuss its fourth quarter 2023 financial and operating results tomorrow, Thursday, March 14, 2024, at 10:00 a.m. Central Time (11:00 a.m. Eastern Time and 3:00 p.m. London Time). Interested parties may participate by dialing (833) 685-0907. Parties in the United Kingdom may participate toll-free by dialing 08082389064 and other international parties may dial (412) 317-5741. Participants should request to be joined to the VAALCO Energy Fourth Quarter 2023 Conference Call. This call will also be webcast on VAALCOs website at www.vaalco.com. An archived audio replay will be available on VAALCOs website. A Q4 2023 Supplemental Information investor deck will be posted to VAALCOs web site prior to its conference call on March 14, 2024 that includes additional financial and operational information. About VAALCO VAALCO, founded in 1985 and incorporated under the laws of Delaware, is a Houston, USA based, independent energy company with production, development and exploration assets in Africa and Canada. VAALCO owns a diverse portfolio of operated production, development and exploration assets across Gabon, Egypt, Equatorial Guinea and Canada. For Further Information VAALCO Energy, Inc. (General and Investor Enquiries)+00 1 713 623 0801Website:www.vaalco.com Al Petrie Advisors (US Investor Relations)+00 1 713 543 3422Al Petrie / Chris Delange Buchanan (UK Financial PR)+44 (0) 207 466 5000Ben Romney / Barry ArcherVAALCO@buchanan.uk.com Forward Looking StatementsThis press release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended (the Securities Act) and Section 21E of the Securities Exchange Act of 1934, as amended, which are intended to be covered by the safe harbors created by those laws and other applicable laws and forward-looking information within the meaning of applicable Canadian securities laws. Where a forward-looking statement expresses or implies an expectation or belief as to future events or results, such expectation or belief is expressed in good faith and believed to have a reasonable basis. All statements other than statements of historical fact may be forward-looking statements. The words anticipate, believe, estimate, expect, intend, forecast, outlook, aim, target, will, could, should, may, likely, plan and probably or similar words may identify forward-looking statements, but the absence of these words does not mean that a statement is not forward-looking. Forward-looking statements in this press release include, but are not limited to, statements relating to (i) estimates of future drilling, production, sales and costs of acquiring crude oil, natural gas and natural gas liquids; (ii) the proposed acquisition of Svenska and its terms, timing and closing, including receipt of required regulatory approvals and satisfaction of other closing conditions; (iii) the amount and timing of stock buybacks, if any, under VAALCOs stock buyback program and VAALCOs ability to enhance stockholder value through such plan; (iv) expectations regarding future exploration and the development, growth and potential of VAALCOs operations, project pipeline and investments, and schedule and anticipated benefits to be derived therefrom; (v) expectations regarding future acquisitions, investments or divestitures; (vi) expectations of future dividends, buybacks and other potential returns to stockholders; (vii) expectations of future balance sheet strength; (viii) expectations regarding VAALCOs ability to effectively integrate assets and properties it may acquire as a result of the acquisition of Svenska into its operations and the benefits of acquiring Svenska. Such forward-looking statements are subject to risks, uncertainties and other factors, which could cause actual results to differ materially from future results expressed, projected or implied by the forward-looking statements. These risks and uncertainties include, but are not limited to: the ability to obtain regulatory approvals in connection with the proposed acquisition of Svenska; the amount of any pre-closing dividends permitted by the law applicable to Svenska; the ability to complete the proposed acquisition on the anticipated terms and timetable; the possibility that various closing conditions for the acquisition of Svenska may not be satisfied or waived; risks relating to any unforeseen liabilities of the Svenska; the outcome of any cost audits undertaken by the Cote dIvoire government; timing and amounts of any decommissioning or other wind up costs relating to any acquired Nigerian assets; declines in oil or natural gas prices; the level of success in exploration, development and production activities; actions of joint-venture partners risks relating to any unforeseen liabilities of VAALCO; the ability to generate cash flows that, along with cash on hand, will be sufficient to support operations and cash requirements; the impact and costs of compliance with laws and regulations governing oil and gas operations; the risks described under the caption Risk Factors in VAALCOs filings with the Securities and Exchange Commission, including its most recent Annual Report on Form 10-K and subsequent Quarterly Reports on Form 10-Q.2022 Annual Report on Form 10-K filed with the SEC on April 6, 2023. Dividends beyond the first quarter of 2024 have not yet been approved or declared by the Board. The declaration and payment of future dividends and the terms of share buybacks remains at the discretion of the Board and will be determined based on VAALCOs financial results, balance sheet strength, cash and liquidity requirements, future prospects, crude oil and natural gas prices, and other factors deemed relevant by the Board. The Board reserves all powers related to the declaration and payment of dividends and the terms of share buybacks. Consequently, in determining the dividend to be declared and paid on VAALCO common stock or the terms of share buybacks, the Board may revise or terminate the payment level or buyback terms at any time without prior notice. Inside Information This announcement contains inside information as defined in Regulation (EU) No. 596/2014 on market abuse which is part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 (MAR) and is made in accordance with the Companys obligations under article 17 of MAR. The person responsible for arranging the release of this announcement on behalf of VAALCO is Matthew Powers, Corporate Secretary of VAALCO. VAALCO ENERGY, INC AND SUBSIDIARIESConsolidated Balance Sheets As of December 31, 2023 As of December 31, 2022 ASSETS (in thousands) Current assets: Cash and cash equivalents $121,001 $37,205 Restricted cash 114 222 Receivables: Trade, net of allowance for credit losses of $0.5 and $0.0 million, respectively 42,150 52,147 Accounts with joint venture owners, net of allowance for credit losses of $0.8 and $0.3 million, respectively 1,814 15,830 Foreign income taxes receivable  2,769 Egypt receivables and other, net of allowance for credit losses of $4.6 and $0.0 million, respectively 48,680 68,519 Crude oil inventory 1,948 3,335 Prepayments and other 12,434 20,070 Total current assets 228,141 200,097 Crude oil, natural gas and NGLs properties and equipment, net 459,786 495,272 Other noncurrent assets: Restricted cash 1,795 1,763 Value added tax and other receivables, net of allowance of $0.0 million and $8.4 million, respectively 4,214 7,150 Right of use operating lease assets 2,378 2,777 Right of use finance lease assets 89,962 90,698 Deferred tax assets 29,242 35,432 Abandonment funding 6,268 20,586 Other long-term assets 1,430 1,866 Total assets $823,216 $855,641 LIABILITIES AND SHAREHOLDERS' EQUITY Current liabilities: Accounts payable $22,152 $59,886 Accounts with joint venture owners 5,990  Accrued liabilities and other 66,924 91,392 Operating lease liabilities - current portion 2,396 2,314 Finance lease liabilities - current portion 10,079 7,811 Foreign income taxes payable 19,261  Current liabilities - discontinued operations 673 687 Total current liabilities 127,475 162,090 Asset retirement obligations 47,343 41,695 Operating lease liabilities - net of current portion 33 686 Finance lease liabilities - net of current portion 78,293 78,248 Deferred tax liabilities 73,581 81,223 Other long-term liabilities 17,709 25,594 Total liabilities 344,434 389,536 Commitments and contingencies Shareholders equity: Preferred stock, $25 par value; 500,000 shares authorized, none issued   Common stock, $0.10 par value; 160,000,000 shares authorized, 121,397,553 and 119,482,680 shares issued, 104,346,233 and 107,852,857 shares outstanding, respectively 12,140 11,948 Additional paid-in capital 357,498 353,606 Accumulated other comprehensive income 2,880 1,179 Less treasury stock, 17,051,320 and 11,629,823 shares, respectively, at cost (71,222) (47,652)Retained earnings 177,486 147,024 Total shareholders' equity 478,782 466,105 Total liabilities and shareholders' equity $823,216 $855,641 VAALCO ENERGY, INC AND SUBSIDIARIESConsolidated Statements of Operations (Unaudited) Three Months Ended Twelve Months Ended December 31, 2023 December 31, 2022 September 30, 2023 December 31, 2023 December 31, 2022 (in thousands except per share amounts) Revenues: Crude oil, natural gas and natural gas liquids sales $149,154 $96,588 $116,269 $455,066 $354,326 Operating costs and expenses: Production expense 46,397 45,514 39,956 153,157 112,661 FPSO demobilization and other costs 1,837 -  7,484 8,867 Exploration expense 706 8 1,194 1,965 258 Depreciation, depletion and amortization 20,344 26,316 32,538 115,302 48,143 General and administrative expense 7,005 (430) 6,216 23,840 10,077 Credit (recovery) losses and other (7,343) 999 822 (4,906) 3,082 Total operating costs and expenses 68,946 72,407 80,726 296,842 183,088 Other operating income (expense), net 731 43 5 433 38 Operating income 80,939 24,224 35,548 158,657 171,276 Other income (expense): Derivative instruments gain (loss), net 2,500 (290) (2,320) 232 (37,812)Interest income (expense), net (1,077) (1,679) (1,426) (6,452) (2,034)Other income (expense), net (797) 2,466 183 (2,291) (8,048)Total other income (expense), net 626 497 (3,563) (8,511) (47,894)Income from continuing operations before income taxes 81,565 24,721 31,985 150,146 123,382 Income tax expense (benefit) 37,574 6,953 25,844 89,777 71,420 Income from continuing operations 43,991 17,768 6,141 60,369 51,962 Loss from discontinued operations, net of tax  (14) - (15) (72)Net income $43,991 $17,754 $6,141 $60,354 $51,890 Other comprehensive income (loss) Currency translation adjustments 2,036  (2,216) 1,701 1,179 Comprehensive income $46,027 $17,754 $3,925 $62,055 $53,069 Basic net income (loss) per share: Income (loss) from continuing operations $0.41 $0.17 $0.06 $0.56 $0.74 Loss from discontinued operations, net of tax      Net income (loss) per share $0.41 $0.17 $0.06 $0.56 $0.74 Basic weighted average shares outstanding 104,893 101,227 106,289 106,376 69,568 Diluted net income (loss) per share: Income (loss) from continuing operations $0.41 $0.17 $0.06 $0.56 $0.73 Loss from discontinued operations, net of tax      Net income (loss) per share $0.41 $0.17 $0.06 $0.56 $0.73 Diluted weighted average shares outstanding 105,020 101,578 106,433 106,555 69,982 VAALCO ENERGY, INC AND SUBSIDIARIES Consolidated Statements of Cash Flows (Unaudited) Twelve Months Ended December 31, 2023 2022 (in thousands) CASH FLOWS FROM OPERATING ACTIVITIES: Net income $60,354 $51,890 Adjustments to reconcile net income to net cash provided by operating activities: Loss from discontinued operations, net of tax 15 72 Depreciation, depletion and amortization 115,302 48,143 Bargain purchase gain 1,412 (10,819)Exploration Expense 1,841  Deferred taxes (2,864) 44,805 Unrealized foreign exchange loss 52 (1,043)Stock-based compensation 3,323 2,200 Cash settlements paid on exercised stock appreciation rights (378) (827)Derivative instruments (gain) loss, net (232) 37,812 Cash settlements paid on matured derivative contracts, net (127) (42,935)Cash settlements paid on asset retirement obligations (6,747) (6,577)Credit loss recovery, net of expense 7,543 3,082 Other operating loss, net 55 (38)Operational expenses associated with equipment and other 3,196 2,052 Change in operating assets and liabilities: Trade receivables 9,461 18,385 Accounts with joint venture owners 19,571 (18,929)Other receivables 12,064 (9,290)Crude oil inventory 1,387 (1,742)Prepayments and other 4,743 (4,387)Value added tax and other receivables 2,427 (5,193)Other long-term assets 3,830 (2,730)Accounts payable (28,102) 23,920 Foreign income taxes receivable/(payable) 22,030 (5,897)Accrued liabilities and other (6,544) 6,964 Net cash provided by (used in) continuing operating activities 223,612 128,918 Net cash used in discontinued operating activities (15) (72)Net cash provided by (used in) operating activities 223,597 128,846 CASH FLOWS FROM INVESTING ACTIVITIES: Property and equipment expenditures (97,223) (159,897)Cash acquired from TransGlobe acquisition  36,686 Net cash provided by (used in) continuing investing activities (97,223) (123,211)Net cash used in discontinued investing activities   Net cash provided by (used in) investing activities (97,223) (123,211)CASH FLOWS FROM FINANCING ACTIVITIES: Proceeds from the issuances of common stock 673 312 Dividend distribution (26,772) (9,354)Treasury shares (23,570) (3,805)Deferred financing costs  (2,069)Payments of finance lease (7,150) (3,039)Net cash provided by (used in) in continuing financing activities (56,819) (17,955)Net cash used in discontinued financing activities   Net cash provided by (used in) in financing activities (56,819) (17,955)Effects of exchange rate changes on cash (153) (218)NET CHANGE IN CASH, CASH EQUIVALENTS AND RESTRICTED CASH 69,402 (12,538)CASH, CASH EQUIVALENTS AND RESTRICTED CASH AT BEGINNING OF PERIOD 59,776 72,314 CASH, CASH EQUIVALENTS AND RESTRICTED CASH AT END OF PERIOD $129,178 $59,776 VAALCO ENERGY, INC AND SUBSIDIARIESSelected Financial and Operating Statistics(Unaudited) Three Months Ended Twelve Months Ended December 31, 2023 December 31, 2022 September 30, 2023 December 31, 2023 December 31, 2022 NRI SALES DATA Crude oil, natural gas and natural gas liquids sales (MBOE) 1,994 1,371 1,812 6,832 3,677 WI PRODUCTION DATA Etame Crude oil (MBbl) 887 650 911 3,674 3,415 Egypt Crude oil (MBbl) 1,024 818 1,076 4,055 818 Canada Crude Oil (MBbl) 77 93 101 394 93 Canada Natural Gas (Mcf) 471 335 470 1,798 335 Canada Natural Gas Liquid (Mbbl) 81 63 82 317 63 Canada Crude oil, natural gas and natural gas liquids (MBOE) 236 211 261 1,011 211 Total Crude oil, natural gas and natural gas liquids production (MBOE) 2,146 1,680 2,248 8,740 4,445 Gabon Average daily production volumes (BOEPD) 9,641 7,065 9,901 10,066 9,356 Egypt Average daily production volumes (BOEPD) 11,126 8,893 11,691 11,111 2,241 Canada Average daily production volumes (BOEPD) 2,563 2,293 2,835 2,769 578 Average daily production volumes (BOEPD) 23,330 18,262 24,430 23,946 12,177 NRI PRODUCTION DATA Etame Crude oil (MBbl) 772 566 792 3,196 2,971 Egypt Crude oil (MBbl) 697 547 732 2,771 547 Canada Crude Oil (MBbl) 63 93 81 335.51 93 Canada Natural Gas (Mcf) 384 335 376 1,532.74 335 Canada Natural Gas Liquid (Mbbl) 66 63 66 270.69 63 Canada Crude oil, natural gas and natural gas liquids (MBOE) 193 211 210 862 211 Total Crude oil, natural gas and natural gas liquids production (MBOE) 1,662 1,324 1,734 6,829 3,729 Gabon Average daily production volumes (BOEPD) 8,391 6,152 8,609 8,756 8,140 Egypt Average daily production volumes (BOEPD) 7,576 5,946 7,957 7,593 1,499 Canada Average daily production volumes (BOEPD) 2,098 2,293 2,279 2,361 578 Average daily production volumes (BOEPD) 18,065 14,390 18,844 18,710 10,217 AVERAGE SALES PRICES: Crude oil, natural gas and natural gas liquids sales (per BOE) - WI basis $73.98 $72.01 $70.78 $69.30 $94.47 Crude oil, natural gas and natural gas liquids sales (per BOE) - NRI basis $73.96 $70.43 $63.41 $65.83 $94.77 Crude oil, natural gas and natural gas liquids sales (Per BOE including realized commodity derivatives) $73.89 $70.24 $63.38 $65.81 $83.10 COSTS AND EXPENSES (Per BOE of sales): Production expense $23.27 $33.19 $22.05 $22.42 $30.64 Production expense, excluding offshore workovers and stock compensation* 23.25 29.73 22.04 22.59 29.33 Depreciation, depletion and amortization 10.20 19.19 17.96 16.88 13.09 General and administrative expense** 3.51 (0.31) 3.43 3.49 2.74 Property and equipment expenditures, cash basis (in thousands) $42,391 $56,044 $22,533 $97,223 $159,897 *Offshore workover costs excluded from the three months ended December 31, 2023 and 2022 and September 30, 2023 are $0.0 million, $4.7 million and $0.0 million, respectively.*Stock compensation associated with production expense excluded from the three months ended December 31, 2023 and 2022 and September 30, 2023 are $0.9 million, $(0.1) million and $1.0 million, respectively.**General and administrative expenses include $0.50, $0.57 and $0.57 per barrel of oil related to stock-based compensation expense in the three months ended December 31, 2023 and 2022 and September 30, 2023, respectively. NON-GAAP FINANCIAL MEASURES Management uses Adjusted Net Income to evaluate operating and financial performance and believes the measure is useful to investors because it eliminates the impact of certain non-cash and/or other items that management does not consider to be indicative of the Companys performance from period to period. Management also believes this non-GAAP measure is useful to investors to evaluate and compare the Companys operating and financial performance across periods, as well as facilitating comparisons to others in the Companys industry. Adjusted Net Income is a non-GAAP financial measure and as used herein represents net income before discontinued operations, impairment of proved crude oil and natural gas properties, deferred income tax expense, unrealized commodity derivative loss, gain on the Sasol Acquisition and non-cash and other items. Adjusted EBITDAX is a supplemental non-GAAP financial measure used by VAALCOs management and by external users of the Companys financial statements, such as industry analysts, lenders, rating agencies, investors and others who follow the industry, as an indicator of the Companys ability to internally fund exploration and development activities and to service or incur additional debt. Adjusted EBITDAX is a non-GAAP financial measure and as used herein represents net income before discontinued operations, interest income net, income tax expense, depletion, depreciation and amortization, exploration expense, impairment of proved crude oil and natural gas properties, non-cash and other items including stock compensation expense, gain on the Sasol Acquisition and unrealized commodity derivative loss. Management uses Adjusted Working Capital as a transition tool to assess the working capital position of the Companys continuing operations excluding leasing obligations because it eliminates the impact of discontinued operations as well as the impact of lease liabilities. Under the lease accounting standards, lease liabilities related to assets used in joint operations include both the Companys share of expenditures as well as the share of lease expenditures which its non-operator joint venture owners will be obligated to pay under joint operating agreements. Adjusted Working Capital is a non-GAAP financial measure and as used herein represents working capital excluding working capital attributable to discontinued operations and current liabilities associated with lease obligations. Management uses Free Cash Flow to evaluate financial performance and to determine the total amount of cash over a specified period available to be used in connection with returning cash to shareholders, and believes the measure is useful to investors because it provides the total amount of net cash available for returning cash to shareholders by adding cash generated from operating activities, subtracting amounts used in financing and investing activities, and adding back amounts used for dividend payments and stock repurchases. Free Cash Flow is a non-GAAP financial measure and as used herein represents net change in cash, cash equivalents and restricted cash and adds the amounts paid under dividend distributions and share repurchases over a specified period. Free Cash Flow has significant limitations, including that it does not represent residual cash flows available for discretionary purposes and should not be used as a substitute for cash flow measures prepared in accordance with GAAP. Free Cash Flow should not be considered as a substitute for cashflows from operating activities before discontinued operations or any other liquidity measure presented in accordance with GAAP. Free Cash Flow may vary among other companies. Therefore, the Companys Free Cash Flow may not be comparable to similarly titled measures used by other companies. Adjusted EBITDAX and Adjusted Net Income have significant limitations, including that they do not reflect the Companys cash requirements for capital expenditures, contractual commitments, working capital or debt service. Adjusted EBITDAX, Adjusted Net Income, Adjusted Working Capital and Free Cash Flow should not be considered as substitutes for net income (loss), operating income (loss), cash flows from operating activities or any other measure of financial performance or liquidity presented in accordance with GAAP. Adjusted EBITDAX and Adjusted Net Income exclude some, but not all, items that affect net income (loss) and operating income (loss) and these measures may vary among other companies. Therefore, the Companys Adjusted EBITDAX, Adjusted Net Income, Adjusted Working Capital and Free Cash Flow may not be comparable to similarly titled measures used by other companies. PV-10 Value and Probable Reserves PV-10 is a non-GAAP financial measure and represents the period-end present value of estimated future cash inflows from VAALCOs reserves, less future development and production costs, discounted at 10% per annum to reflect timing of future cash flows. PV-10 values for 2P WI CPR reserves have been calculated using VAALCOs management assumptions for timing, escalated crude oil price and cost in the case of 2P WI CPR reserves. PV-10 generally differs from standardized measure, the most directly comparable GAAP financial measure, because it generally does not include the effects of income taxes; however, VAALCOs PV-10 does include the effect of income taxes. PV-10 is a widely used measure within the industry and is commonly used by securities analysts, banks and credit rating agencies to evaluate the estimated future net cash flows from proved reserves on a comparative basis across companies or specific properties. VAALCOs PV-10 includes the effect of income taxes. Neither PV-10 nor the standardized measure purports to represent the fair value of the Companys crude oil and natural gas reserves. VAALCO has provided summations of its PV-10 for its proved and probable reserves on a 2P WI CPR basis in this press release. The SEC strictly prohibits companies from aggregating proved, probable and possible reserves in filings with the SEC due to the different levels of certainty associated with each reserve category. GAAP does not provide a measure of estimated future net cash flows for reserves other than proved reserves and accordingly it is not practicable to reconcile the PV-10 value of 2P WI CPR reserves to a GAAP measure, such as the standardized measure. Investors should be cautioned that estimates of PV-10 of probable reserves, as well as the underlying volumetric estimates, are inherently more uncertain of being recovered and realized than comparable measures for proved reserves. Further, because estimates of probable reserve volumes have not been adjusted for risk due to this uncertainty of recovery, their summation may be of limited use. Nonetheless, VAALCO believes that PV-10 estimates for probable reserves present useful information for investors about the future net cash flows of its reserves in the absence of a comparable GAAP measure such as standardized measure. 2P WI CPR Reserves 2P WI CPR reserves represent proved plus probable estimates as reported by NSAI and GLJ and prepared in accordance with the definitions and guidelines set forth in the 2018 Petroleum Resources Management Systems approved by the Society of Petroleum Engineers as of December 31, 2021 using escalated crude oil price and cost assumptions made by VAALCOs management. The SEC definitions of proved and probable reserves are different from the definitions contained in the 2018 Petroleum Resources Management Systems approved by the Society of Petroleum Engineers as of December 31, 2021. As a result, 2P WI CPR reserves may not be comparable to United States standards. The SEC requires United States oil and gas reporting companies, in their filings with the SEC, to disclose only proved reserves after the deduction of royalties and production due to others but permits the optional disclosure of probable and possible reserves in accordance with SEC definitions. 2P WI CPR reserves and the PV-10 value for 2P WI CPR reserves, as calculated herein, may differ from the SEC definitions of proved and probable reserves because:  Pricing for SEC is the average closing price on the first trading day of each month for the prior year which is then held flat in the future, while the 2P WI CPR pricing is based on management pricing assumptions for future Brent oil pricing for 2023 of $80.00 and $70.00 in 2024, escalated 2% per year thereafter and for Equatorial Guinea, given the expectation of first oil beginning in 2026, Brent oil pricing of $74.27 was assumed for 2026, escalated 2% per year thereafter; Lease operating expenses are not escalated in the SEC case, while for the 2P WI CPR reserves case they are escalated at 2% annually beginning on January 1, 2023. For the 2P WI CPR reserves for Svenska, such reserves may differ from the SEC definitions of proved and probable reserves because: Pricing for SEC is the average closing price on the first trading day of each month for the prior year which is then held flat in the future, while the 1P and 2P WI CPR pricing is based on pricing assumptions for future Brent oil pricing for 2023 of $84.5 and up to 2030 the Brent Oil price follows the average of four available forecasts and assumes flat real thereafter. Oil price is escalated 2% per year; Lease operating expenses are typically not escalated under the SECs rules, while for the WI CPR reserves estimates, they are escalated at 2% annually beginning in 2024. Additionally, (i) the reserves estimates for Svenska were prepared by Petroleum Development Consultants Limited and prepared in accordance with the definitions and guidelines set forth in the 2018 Petroleum Resources Management Systems approved by the Society of Petroleum Engineers and (ii) are as of October 1, 2023. Management uses 2P WI CPR reserves as a measurement of operating performance because it assists management in strategic planning, budgeting and economic evaluations and in comparing the operating performance of the Company to other companies. Management believes that the presentation of 2P WI CPR reserves is useful to its international investors, particularly those that invest in companies trading on the London Stock Exchange, in order to better compare the Companys reserve information to other London Stock Exchange-traded companies that report similar measures. VAALCO also believes that this information enhances its investors and securities analysts understanding of its business. However, 2P WI CPR reserves should not be used as a substitute for proved reserves calculated in accordance with the definitions prescribed by the SEC. In evaluating VAALCOs business, investors should rely on the Companys SEC proved reserves and consider 2P WI CPR reserves only supplementally. The tables below reconcile the most directly comparable GAAP financial measures to Adjusted Net Income, Adjusted EBITDAX, Adjusted Working Capital and Free Cash Flow. VAALCO ENERGY, INC AND SUBSIDIARIESReconciliations of Non-GAAP Financial Measures(Unaudited)(in thousands) Three Months Ended Twelve Months Ended Reconciliation of Net Income to Adjusted Net Income December 31, 2023 December 31, 2022 September 30, 2023 December 31, 2023 December 31, 2022 Net income $43,991 $17,754 $6,141 $60,354 $51,890 Adjustment for discrete items: Discontinued operations, net of tax  14  15 72 Dry Hole Costs      Unrealized derivative instruments loss (gain) (2,565) 38 2,321 (359) (5,123)(Gain) /adjustment of acquisition price, net  (10,817)  1,412 (10,817)Arrangement Costs  7,006   14,630 FPSO demobilization 1,837   7,484 8,867 Deferred income tax expense (benefit) (3,538) 5,266 (985) (2,865) 44,805 Other operating (income) expense, net (731) (43) (5) (433) (38)Adjusted Net Income $38,994 $19,218 $7,472 $65,608 $104,286 Diluted Adjusted Net Income per Share $0.37 $0.19 $0.07 $0.62 $1.49 Diluted weighted average shares outstanding (1) 105,020 101,578 106,433 106,555 69,982 (1) No adjustments to weighted average shares outstanding Three Months Ended Twelve Months Ended Reconciliation of Net Income to Adjusted EBITDAX December 31, 2023 December 31, 2022 September 30, 2023 December 31, 2023 December 31, 2022 Net income $43,991 $17,754 $6,141 $60,354 $51,890 Add back: Impact of discontinued operations - 14 - 15 72 Interest expense (income), net 1,077 1,679 1,426 6,452 2,034 Income tax expense (benefit) 37,574 6,953 25,844 89,777 71,420 Depreciation, depletion and amortization 20,344 26,316 32,538 115,302 48,143 Exploration expense 706 8 1,194 1,965 258 FPSO demobilization 1,837   7,484 8,867 Non-cash or unusual items: Stock-based compensation 991 (100) 1,078 3,323 2,200 Unrealized derivative instruments loss (gain) (2,565) 38 2,321 (359) (5,123)(Gain) /adjustment of acquisition price, net  (10,817)  1,412 (10,817)Arrangement Costs  7,006   14,630 Other operating (income) expense, net (731) (43) (5) (433) (38)Credit losses and other (7,343) 999 822 (4,906) 3,082 Adjusted EBITDAX $95,881 $49,807 $71,359 $280,386 $186,618 VAALCO ENERGY, INC AND SUBSIDIARIES Reconciliations of Non-GAAP Financial Measures(Unaudited)(in thousands) Reconciliation of Working Capital to Adjusted Working Capital As of December 31, 2023 As of December 31, 2022 Change Current assets $228,141 $200,097 $28,044 Current liabilities (127,475) (162,090) 34,615 Working capital 100,666 38,007 62,659 Add: lease liabilities - current portion 12,475 10,125 2,350 Add: current liabilities - discontinued operations 673 687 (14)Adjusted Working Capital $113,814 $48,819 $64,995 Twelve Months Ended December 31, 2023Reconciliation of Free Cash Flow Net cash provided by Operating activities $223,597 Net cash used in Investing activities (97,223)Net cash used in Financing activities (56,819)Effects of exchange rate changes on cash (153)Total net cash change 69,402 Add back shareholder cash out: Dividends paid 26,772 Stock buyback 23,570 Total cash returned to shareholders 50,342 Free Cash Flow $119,744 Percent of Free Cash Flow returned to shareholders 42% What was VAALCO Energy's net income for FY 2023? VAALCO Energy reported a net income of $60.4 million for FY 2023. How much did VAALCO Energy raise production by in 2023? VAALCO Energy raised production by 83% year-over-year to 18,710 BOEPD in 2023. What was the increase in SEC proved reserves for VAALCO Energy in 2023? VAALCO Energy increased SEC proved reserves by 3% to 28.6 million MMBOE in 2023. What was VAALCO Energy's net income for Q4 2023? VAALCO Energy reported a net income of $44.0 million for Q4 2023. What is VAALCO Energy's 2024 capital budget range? VAALCO Energy plans a 2024 capital budget of $70 to $90 million. How much Free Cash Flow does VAALCO Energy aim to return to shareholders in 2024? VAALCO Energy aims to return over $25 million of Free Cash Flow to shareholders in 2024."
BEN Announces Expected Closing of Business Combination,2024-03-13T21:34:00.000Z,Low,Neutral,"Brand Engagement Network Inc. (BEN) anticipates finalizing its merger with DHC Acquisition Corp. (DHCA) on March 14, 2024. Shareholders have endorsed the deal, leading to the formation of Brand Engagement Network. The new entity is set to debut on the Nasdaq Stock Market on March 15, 2024, under the tickers 'BNAI' and 'BNAIW' for common stock and warrants, respectively.","BEN Announces Expected Closing of Business Combination Rhea-AI Impact (Low) Rhea-AI Sentiment (Neutral) Tags Rhea-AI Summary Brand Engagement Network Inc. (BEN) anticipates finalizing its merger with DHC Acquisition Corp. (DHCA) on March 14, 2024. Shareholders have endorsed the deal, leading to the formation of Brand Engagement Network. The new entity is set to debut on the Nasdaq Stock Market on March 15, 2024, under the tickers 'BNAI' and 'BNAIW' for common stock and warrants, respectively. Positive None. Negative None. Market Research Analyst The announcement of the completion of a business combination, particularly involving a special purpose acquisition company (SPAC) like DHC Acquisition Corp., is a significant event that can influence market perceptions and investor confidence. The successful shareholder approval indicates a positive reception from the investors of DHC Acquisition Corp., which can be seen as a vote of confidence in the future prospects of Brand Engagement Network Inc. (BEN).From a market research perspective, the transition to a public entity provides BEN with access to capital markets, which can be instrumental in fueling its growth initiatives and technological advancements in the AI sector. The listing under the new ticker symbols 'BNAI' for common stock and 'BNAIW' for publicly traded warrants will also enhance visibility among investors and can potentially lead to increased liquidity for the shares.It is important to monitor the post-merger performance and the integration process, as these factors will be critical in determining the long-term value creation for shareholders. The AI industry is highly competitive and BEN's ability to differentiate its personalized customer engagement solutions will be essential for its market positioning. Financial Analyst The anticipated closure of the business combination and the commencement of trading on the Nasdaq Stock Market represent pivotal financial milestones for Brand Engagement Network. The ability to trade on a major exchange often comes with a reevaluation of the company's market capitalization and provides an opportunity for institutional investors to take positions in the company.Investors will be closely watching the initial trading days to gauge market sentiment and the valuation multiples applied to BEN in comparison to its peers. The financials of the merged entity will be scrutinized for synergies realized from the business combination, cost structures and revenue projections. The performance of the stock and warrants post-listing will also serve as an indicator of investor expectations regarding future growth and profitability.Additionally, the public listing could enable BEN to leverage stock-based compensation plans to attract and retain talent, which is a critical factor for success in the technology sector. However, it is crucial to consider the potential dilution effects that could arise from the conversion of warrants and any future equity offerings. Legal Expert From a legal standpoint, the completion of a business combination with a SPAC involves a series of regulatory compliance checks, including the approval by shareholders and adherence to securities laws. The fact that the transaction was approved at an extraordinary general meeting suggests that all legal prerequisites have been met satisfactorily, paving the way for a smooth transition to a publicly traded company.It is also noteworthy that publicly traded warrants are being offered alongside common stock. Warrants provide investors with the right to purchase additional stock at a predetermined price, which can be a strategic tool for the company to raise additional capital in the future. However, the terms of these warrants, including exercise price and expiration date, will be important details for investors to consider, as they can significantly impact the potential return on investment.Going forward, as a public company, BEN will be subject to increased regulatory scrutiny, including the requirement to file periodic financial reports with the Securities and Exchange Commission (SEC), which demands transparency and could affect the company's operational flexibility. 03/13/2024 - 05:34 PM JACKSON, Wyo. & SOUTHLAKE, Texas--(BUSINESS WIRE)-- Brand Engagement Network Inc. (BEN), an emerging provider of personalized customer engagement AI, today reported that it expects to close its previously announced business combination (the Business Combination) with DHC Acquisition Corp. (Nasdaq: DHCA) tomorrow, Thursday March 14, 2024. DHC shareholders approved the transaction at DHCs extraordinary general meeting held on March 5, 2024. The combined company will be named Brand Engagement Network and expects to begin trading on the Nasdaq Stock Market on Friday, March 15, 2024, under the ticker symbol BNAI for its common stock and BNAIW for its publicly traded warrants. About BEN BEN (Brand Engagement Network) is a leading provider of conversational AI technology and human-like AI avatars headquartered in Jackson, WY. BEN delivers highly personalized, multi-modal (text, voice, and vision) AI engagement, with a focus on industries where there is a massive workforce gap and an opportunity to transform how consumers engage with networks, providers, and brands. The backbone of BENs success is a rich portfolio of conversational AI applications that drive better customer experience, increased automation and operational efficiencies. BEN seeks to partner with companies with complementary capabilities and networks to enable meaningful business outcomes. For more information about BEN, please visit: https://beninc.ai/ About DHC Acquisition Corp. DHC Acquisition Corp. (Nasdaq: DHCA) is a special purpose acquisition company (SPAC) focused on partnering with an innovative technology company. DHCs mission is to invest in companies which are charting the future of how humans and business interact at the last mile, spanning enterprise infrastructure, industrial IoT, automation, retail and E-commerce infrastructure, automotive, and aerospace. We endeavour to enable the applications of innovative technology and business models which bring goods, people, or information to its final destination. DHCs approach to business is based on teamwork, integrity and quiet professionalism, qualities we learned during our extensive training in the military. We bring our unique hybrid experience and our values into the corporate world, building high performing teams in a range of specialized industries: technology, consumer, aviation, defense, automotive, investment banking, capital markets, and asset management. Our collective experience includes: >25 years as CEOs of public companies, 8 companies founded, 13 companies acquired, and >55 years in military leadership. Forward-Looking Statements This communication contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934 that are not historical facts, and involve risks and uncertainties that could cause actual results of DHC and BEN to differ materially from those expected and projected. These forward-looking statements can be identified by the use of forward-looking terminology, including the words believes, estimates, anticipates, expects, intends, plans, may, will, potential, projects, predicts, continue, or should, or, in each case, their negative or other variations or comparable terminology. These forward-looking statements include, without limitation, statements regarding DHCs and BENs ability to complete the Business Combination on the terms and timeline set forth in the Proxy Statement or at all. These forward-looking statements involve significant risks and uncertainties that could cause the actual results to differ materially from the expected results. Most of these factors are outside DHCs control and are difficult to predict. Factors that may cause such differences include, but are not limited to: the inability of the Parties to successfully or timely consummate the Business Combination; the risk that the Business Combination may not be completed by DHCs business combination deadline and the potential failure to obtain an extension of the Business Combination deadline by DHC; failure to realize the anticipated benefits of the Business Combination; risks relating to the uncertainty of the projected financial information with respect to BEN; the occurrence of any event, change or other circumstance that could give rise to the termination of the definitive transaction agreement; BENs history of operating losses; BENs need for additional capital to support its present business plan and anticipated growth; technological changes in BENs market; the value and enforceability of BENs intellectual property protections; BENs ability to protect its intellectual property; BENs material weaknesses in financial reporting; and BENs ability to navigate complex regulatory requirements; the ability to maintain the listing of DHCs securities on a national securities exchange; the ability to implement business plans, forecasts, and other expectations after the completion of the Business Combination; the effects of competition on BENs business; the risks of operating and effectively managing growth in evolving and uncertain macroeconomic conditions, such as high inflation and recessionary environments; and continuing risks relating to the COVID 19 pandemic. The foregoing list of factors is not exhaustive. DHC and BEN caution that the foregoing list of factors is not exclusive. DHC and BEN caution readers not to place undue reliance upon any forward-looking statements, which speak only as of the date made. None of BEN nor DHC undertakes nor accepts any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements to reflect any change in its expectations or any change in events, conditions or circumstances on which any such statement is based. Further information about factors that could materially affect DHC, including its results of operations and financial condition, is set forth under Risk Factors in Part I, Item 1A of DHCs Annual Report on Form 10-K for the fiscal year ended December 31, 2022. No Offer or Solicitation This communication does not constitute an offer to sell or the solicitation of an offer to buy any securities of BEN or DHC or a solicitation of any vote or approval. No offer of securities shall be made except by means of a prospectus meeting the requirements of Section 10 of the Securities Act of 1933, as amended. View source version on businesswire.com: https://www.businesswire.com/news/home/20240313400845/en/ BEN Contacts Investors: Ryan Flanagan, ICR ryan.flanagan@icrinc.com Media: Dan Brennan, ICR dan.brennan@icrinc.com Source: Brand Engagement Network Inc. When is the expected closing date for the merger between Brand Engagement Network Inc. and DHC Acquisition Corp.? The merger is projected to be finalized on March 14, 2024. What ticker symbol will Brand Engagement Network Inc. use for its common stock post-merger? The common stock of Brand Engagement Network Inc. will trade under the ticker symbol 'BNAI' on the Nasdaq Stock Market. What was the outcome of DHC shareholders' vote regarding the merger? DHC shareholders approved the merger at the extraordinary general meeting held on March 5, 2024. When will Brand Engagement Network Inc. begin trading on the Nasdaq Stock Market? Brand Engagement Network Inc. is set to commence trading on the Nasdaq Stock Market on March 15, 2024."
American Lithium Receives NASDAQ Notice of Minimum Price Deficiency and Clarifies Previous Engagement with New Era Publishing Inc.,2024-03-13T21:30:00.000Z,Low,Neutral,"American Lithium Corp. receives a notice of non-compliance from Nasdaq due to the minimum bid price requirement. The company has 180 days to regain compliance. The engagement with New Era Publishing Inc. has concluded, and the company has no current intention to engage them further.","American Lithium Receives NASDAQ Notice of Minimum Price Deficiency and Clarifies Previous Engagement with New Era Publishing Inc. Rhea-AI Impact (Low) Rhea-AI Sentiment (Neutral) Tags Rhea-AI Summary American Lithium Corp. receives a notice of non-compliance from Nasdaq due to the minimum bid price requirement. The company has 180 days to regain compliance. The engagement with New Era Publishing Inc. has concluded, and the company has no current intention to engage them further. Positive None. Negative None. Financial Analyst The notice received by American Lithium Corp from Nasdaq regarding non-compliance with the minimum bid price requirement could have a tangible effect on investor sentiment and the company's ability to raise capital. Typically, a stock trading below the $1 threshold is seen as a 'penny stock' and may be perceived as more speculative or risky by investors. This perception can lead to increased volatility and possibly a reduced investor base, as some institutional investors have policies against investing in such stocks. The potential for delisting, if compliance is not regained, would further affect liquidity and the ability to attract new investors.However, the company's proactive stance on considering strategies to regain compliance indicates a management focus on maintaining its Nasdaq listing status. This could involve measures such as a reverse stock split or improving operational performance to bolster stock price. The company's focus on advancing its TLC and Falchani lithium projects, which are in pre-feasibility stage, suggests an underlying value that may support its efforts to meet Nasdaq's requirements. Market Research Analyst The strategic importance of lithium as a resource for the energy sector, particularly in the context of the shift towards electric vehicles and renewable energy storage, positions American Lithium Corp in a potentially high-growth industry. The company's TLC lithium project in Nevada and its development-stage projects in Peru are situated within mining-friendly jurisdictions, which is a positive factor for future project development and ease of doing business. Furthermore, the strong community support and significant expansion potential of these projects could contribute to long-term value creation.However, the market's reaction to the non-compliance notice and the company's marketing missteps with New Era Publishing could reflect on the company's governance and operational execution. The TSX Venture Exchange's rejection of the New Era engagement due to non-compliance with exchange policy could raise concerns about management oversight and adherence to regulatory requirements, potentially influencing investor confidence. Legal Expert From a legal perspective, American Lithium Corp's situation highlights the importance of adhering to stringent listing requirements set forth by stock exchanges like Nasdaq. The compliance with the minimum bid price is a regulatory mechanism to ensure that the market maintains certain standards for listed companies. Non-compliance notices serve as a warning mechanism, allowing companies time to rectify their standing and signaling to the market that regulatory oversight is in effect.The company's prior engagement with New Era Publishing and the subsequent publication of marketing materials by Raging Bull without the company's knowledge, may raise questions regarding due diligence and internal controls. It is essential for listed companies to maintain transparency and adhere to exchange policies, as failure to do so can result in reputational damage and legal scrutiny. The requirement for prior approval by the TSX Venture Exchange for future engagements is indicative of the stringent oversight necessary to maintain market integrity. 03/13/2024 - 05:30 PM VANCOUVER, British Columbia, March 13, 2024 (GLOBE NEWSWIRE) -- American Lithium Corp. (American Lithium or the Company) (TSX-V:LI | Nasdaq:AMLI | Frankfurt:5LA1) has received written notification (the Notice) from the Nasdaq Stock Market LLC (Nasdaq) on March 8, 2024, indicating that the Company is not in compliance with the minimum bid price requirement of US$1.00 per share under Nasdaq Listing Rule 5550(a)(2) based upon the closing bid price of the Companys common shares for the thirty consecutive business days from January 25, 2024 to March 7, 2024. The Notice has no immediate effect on the listing or trading of the Companys common shares on Nasdaq, and the Companys operations are not affected by the receipt of the Notice. Under Nasdaq Listing Rule 5810(c)(3)(A), the Company has been provided 180 calendar days from the date of the Notice, or until September 4, 2024, to regain compliance with the minimum bid requirement, during which time the Companys common shares will continue to trade on Nasdaq. To regain compliance the Companys common shares must have a closing bid price of at least US$1.00 for a minimum of ten consecutive business days. If the Company does not regain compliance with the minimum bid requirement by September 4, 2024, the Company may be eligible, upon satisfaction of certain Nasdaq listing requirements, for an additional period of 180 calendar days to regain compliance. The Company will closely monitor the situation and is considering various strategies to regain compliance with the minimum bid requirement under Nasdaq's listing rules. The Notice does not have any impact on the listing of the Company's common shares on the TSX Venture Exchange. New Era Publishing Inc. The Company also confirms that its previous engagement of New Era Publishing Inc. (New Era) to provide marketing services to the Company, as announced by the Company on May 8, 2023, was concluded on August 31, 2023 and no further services have been provided since that date. During the course of the engagement, New Era coordinated with Raging Bull LLC (Raging Bull) to publish certain marketing materials pertaining to the Company without the prior knowledge of the Company. The Company has no current engagement with New Era, nor does it presently have any intention to engage New Era to provide further services to the Company. The TSX Venture Exchange has not accepted the previous engagement of New Era, as it did not comply with Exchange policy, and prior approval of the TSX Venture Exchange will be required in the event of any future engagement involving New Era, Raging Bull, its principals, and any other service providers that provide activities under TSX Venture Exchange Policy 3.4. About American Lithium American Lithium is actively engaged in the development of large-scale lithium projects within mining-friendly jurisdictions throughout the Americas. The Company is currently focused on enabling the shift to the new energy paradigm through the continued development of its strategically located TLC lithium project (TLC) in the richly mineralized Esmeralda lithium district in Nevada, as well as continuing to advance its Falchani lithium (Falchani) and Macusani uranium (Macusani) development-stage projects in southeastern Peru. All three projects, TLC, Falchani and Macusani have been through robust preliminary economic assessments, exhibit strong significant expansion potential and enjoy strong community support. Pre-feasibility is advancing well TLC and Falchani. For more information, please contact the Company at info@americanlithiumcorp.com or visit our website at www.americanlithiumcorp.com. Follow us on Facebook, Twitter and LinkedIn. On behalf of the Board of Directors of American Lithium Corp. Simon Clarke CEO & Director Tel: 604 428 6128 Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this press release. Cautionary Statement Regarding Forward Looking Information This news release contains certain forward-looking information and forward-looking statements (collectively forward-looking statements) within the meaning of applicable securities legislation. All statements, other than statements of historical fact, are forward-looking statements. Forward-looking statements in this news release include, but are not limited to, statements regarding the business plans, expectations and objectives of American Lithium. Forward-looking statements are frequently identified by such words as ""may"", ""will"", ""plan"", ""expect"", ""anticipate"", ""estimate"", ""intend"", indicate, scheduled, target, goal, potential, subject, efforts, option and similar words, or the negative connotations thereof, referring to future events and results. Forward-looking statements are based on the current opinions and expectations of management and are not, and cannot be, a guarantee of future results or events. Although American Lithium believes that the current opinions and expectations reflected in such forward-looking statements are reasonable based on information available at the time, undue reliance should not be placed on forward-looking statements since American Lithium can provide no assurance that such opinions and expectations will prove to be correct. All forward-looking statements are inherently uncertain and subject to a variety of assumptions, risks and uncertainties, including risks, uncertainties and assumptions related to: American Lithiums ability to achieve its stated goals;, which could have a material adverse impact on many aspects of American Lithiums businesses including but not limited to: the ability to access mineral properties for indeterminate amounts of time, the health of the employees or consultants resulting in delays or diminished capacity, social or political instability in Peru which in turn could impact American Lithiums ability to maintain the continuity of its business operating requirements, may result in the reduced availability or failures of various local administration and critical infrastructure, reduced demand for the American Lithiums potential products, availability of materials, global travel restrictions, and the availability of insurance and the associated costs; the ongoing ability to work cooperatively with stakeholders, including but not limited to local communities and all levels of government; the potential for delays in exploration or development activities; the interpretation of drill results, the geology, grade and continuity of mineral deposits; the possibility that any future exploration, development or mining results will not be consistent with our expectations; risks that permits will not be obtained as planned or delays in obtaining permits; mining and development risks, including risks related to accidents, equipment breakdowns, labour disputes (including work stoppages, strikes and loss of personnel) or other unanticipated difficulties with or interruptions in exploration and development; risks related to commodity price and foreign exchange rate fluctuations; risks related to foreign operations; the cyclical nature of the industry in which American Lithium operates; risks related to failure to obtain adequate financing on a timely basis and on acceptable terms or delays in obtaining governmental approvals; risks related to environmental regulation and liability; political and regulatory risks associated with mining and exploration; risks related to the uncertain global economic environment and the effects upon the global market generally, any of which could continue to negatively affect global financial markets, including the trading price of American Lithiums shares and could negatively affect American Lithiums ability to raise capital and may also result in additional and unknown risks or liabilities to American Lithium. Other risks and uncertainties related to prospects, properties and business strategy of American Lithium are identified in the Risk Factors section of American Lithiums Managements Discussion and Analysis filed on January 15, 2024, and in recent securities filings available at www.sedarplus.ca. Actual events or results may differ materially from those projected in the forward-looking statements. American Lithium undertakes no obligation to update forward-looking statements except as required by applicable securities laws. Investors should not place undue reliance on forward-looking statements. Cautionary Note Regarding 32 Concessions Thirty-two of the one-hundred-seventy-four concessions comprising the Falchani and Macusani Projects are currently subject to Administrative and Judicial processes in Peru to overturn resolutions issued by INGEMMET and the Mining Council of MINEM in February 2019 and July 2019, respectively, which declared title to thirty-two concessions invalid due to late receipt of the annual validity payments. On November 2, 2021, American Lithium was awarded a favorable ruling in regard to title to the concessions, but on November 26, 2021, appeals of the judicial ruling were lodged by INGEMMET and MINEM. A three-judge tribunal of Perus Superior Court unanimously upheld the ruling in a decision reported in November 2023. American Lithium was subsequently notified that INGEMMET and MINEM have filed petitions to the Supreme Court of Peru to assume jurisdiction in the proceedings. Given the precedent of the original ruling it is hoped that the Supreme Court will not assume jurisdiction; however, there is no assurance of the outcome at this time. What notification did American Lithium Corp. receive from Nasdaq? American Lithium Corp. received a notice of non-compliance from Nasdaq regarding the minimum bid price requirement. What is the deadline for American Lithium Corp. to regain compliance with Nasdaq? American Lithium Corp. has 180 days from the date of the notice to regain compliance with the minimum bid requirement. What happened to the engagement with New Era Publishing Inc.? The engagement with New Era Publishing Inc. concluded on August 31, 2023, and there are no plans for further services from them. What projects is American Lithium Corp. focused on? American Lithium Corp. is focused on developing the TLC lithium project in Nevada, as well as the Falchani lithium and Macusani uranium projects in Peru. How can one contact American Lithium Corp. for more information? For more information, one can contact the company at info@americanlithiumcorp.com or visit their website."
Humana Completes Aggregate $2.25 Billion Debt Offering,2024-03-13T21:15:00.000Z,Low,Neutral,"Humana Inc. (NYSE: HUM) completes a $2.25 billion senior notes offering, consisting of 5.375 percent senior notes due 2031 and 5.750 percent senior notes due 2054. The net proceeds are expected to be around $2.226 billion for general corporate purposes, including debt repayment. The offering was managed by Citigroup, Goldman Sachs, Morgan Stanley, PNC Capital Markets, and Wells Fargo Securities.","Humana Completes Aggregate $2.25 Billion Debt Offering Rhea-AI Impact (Low) Rhea-AI Sentiment (Neutral) Tags Rhea-AI Summary Humana Inc. (NYSE: HUM) completes a $2.25 billion senior notes offering, consisting of 5.375 percent senior notes due 2031 and 5.750 percent senior notes due 2054. The net proceeds are expected to be around $2.226 billion for general corporate purposes, including debt repayment. The offering was managed by Citigroup, Goldman Sachs, Morgan Stanley, PNC Capital Markets, and Wells Fargo Securities. Positive None. Negative None. Financial Analyst The completion of Humana Inc.'s public offering of $2.25 billion in senior notes is a significant financial event that warrants a detailed analysis from a financial perspective. The issuance of these notes, with a substantial aggregate principal amount and varying maturities, indicates the company's strategic approach to capital management. The interest rates of 5.375 percent and 5.750 percent for the 2031 and 2054 maturities, respectively, reflect the current cost of borrowing for corporations and are likely influenced by prevailing market conditions as well as the company's creditworthiness.Investors and stakeholders should note the intended use of proceeds for general corporate purposes, which may include the repayment of existing debt. This could potentially lead to an improved debt profile and credit ratings over time. However, the impact on the company's leverage and interest coverage ratios needs to be monitored. The involvement of high-profile financial institutions as joint book-running managers suggests a strong market interest and confidence in the offering. Overall, the capital raised could provide Humana with the financial flexibility to pursue strategic initiatives and manage liquidity needs. Debt Market Analyst From a debt market perspective, the issuance of senior notes by Humana Inc. is indicative of the company's leverage strategy and investor appetite for corporate bonds. The pricing of the notes at just below par suggests a balanced demand relative to the offered interest rates, which are competitive given the current interest rate environment. The long-term nature of the notes, with maturities extending to 2054, provides insight into investor confidence in the company's long-term stability and growth prospects.It is also important to consider the yield spread between these notes and comparable government securities, as this will affect the attractiveness of the notes to fixed-income investors. The spread reflects the market's perception of the risk associated with Humana's debt. Additionally, the use of proceeds to potentially repay existing indebtedness can be a prudent move to manage the company's cost of capital, especially if it targets high-cost debt. However, investors should be aware of the refinancing risk associated with such a large issuance, particularly in an environment where interest rates may rise. Corporate Strategist Examining the broader strategic implications of Humana Inc.'s senior notes offering, it is evident that the company is proactively managing its capital structure. The decision to issue long-term debt provides Humana with the opportunity to lock in current interest rates, which could be advantageous if rates increase in the future. The flexibility gained from this capital infusion could support acquisitions, investments in technology and expansion into new markets, which are critical for maintaining competitive advantage in the healthcare industry.Moreover, the allocation of funds for general corporate purposes, including the potential repayment of short-term borrowings, suggests a strategic move to optimize the company's balance sheet. Such financial prudence can enhance investor confidence and potentially lead to a more favorable perception of the company's stock. The strategic use of these funds will be closely watched by investors as it could have significant implications for Humana's growth trajectory and market positioning. 03/13/2024 - 05:15 PM LOUISVILLE, Ky.--(BUSINESS WIRE)-- Humana Inc. (the company) (NYSE: HUM) announced today the completion of its public offering of $2.25 billion in aggregate principal amount of senior notes. These senior notes are comprised of $1.25 billion of the companys 5.375 percent senior notes, due 2031, at 99.940 percent of the principal amount, and $1.00 billion of the companys 5.750 percent senior notes, due 2054, at 99.949 percent of the principal amount (collectively, the Senior Notes Offerings). The company expects net proceeds from the Senior Notes Offerings will be approximately $2.226 billion after deducting underwriters discounts and estimated offering expenses. The company intends to use the net proceeds from the Senior Notes Offerings for general corporate purposes, which may include the repayment of existing indebtedness, including borrowings under its commercial paper program. Citigroup Global Markets Inc., Goldman Sachs & Co. LLC, Morgan Stanley & Co. LLC, PNC Capital Markets LLC and Wells Fargo Securities, LLC acted as active joint book-running managers for the Senior Notes Offerings. The Senior Notes Offerings were made pursuant to an effective shelf registration statement (including a base prospectus) filed with the Securities and Exchange Commission (the SEC). The Senior Notes Offerings were made by means of a prospectus and related prospectus supplement, copies of which may be obtained by calling Citigroup Global Markets Inc. toll-free at (800) 831-9146, Goldman Sachs & Co. LLC toll-free at (866) 471-2526, Morgan Stanley & Co. LLC toll-free at (866) 718-1649, PNC Capital Markets LLC toll-free at (855) 881-0697 or Wells Fargo Securities, LLC toll-free at (800) 645-3751. An electronic copy of the registration statement and prospectus supplement, together with the base prospectus, is available on the SECs website at www.sec.gov. This news release does not constitute an offer to sell or a solicitation of an offer to buy the securities described herein, nor shall there be any sale of these securities in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. Cautionary Statement This news release includes forward-looking statements regarding Humana within the meaning of the Private Securities Litigation Reform Act of 1995. When used in investor presentations, press releases, SEC filings, and in oral statements made by or with the approval of one of Humanas executive officers, the words or phrases like expects, believes, anticipates, intends, likely will result, estimates, projects or variations of such words and similar expressions are intended to identify such forward-looking statements. These forward-looking statements are not guarantees of future performance and are subject to risks, uncertainties, and assumptions, including, among other things, information set forth in the Risk Factors section of the companys SEC filings, a summary of which includes but is not limited to the following: If Humana does not design and price its products properly and competitively, if the premiums Humana receives are insufficient to cover the cost of healthcare services delivered to its members, if the company is unable to implement clinical initiatives to provide a better healthcare experience for its members, lower costs and appropriately document the risk profile of its members, or if its estimates of benefits expense are inadequate, Humanas profitability could be materially adversely affected. Humana estimates the costs of its benefit expense payments, and designs and prices its products accordingly, using actuarial methods and assumptions based upon, among other relevant factors, claim payment patterns, medical cost inflation, and historical developments such as claim inventory levels and claim receipt patterns. The company continually reviews estimates of future payments relating to benefit expenses for services incurred in the current and prior periods and makes necessary adjustments to its reserves, including premium deficiency reserves, where appropriate. These estimates involve extensive judgment, and have considerable inherent variability because they are extremely sensitive to changes in claim payment patterns and medical cost trends. Accordingly, Humanas reserves may be insufficient. If Humana fails to effectively implement its operational and strategic initiatives, including its Medicare initiatives, which are of particular importance given the concentration of the company's revenues in these products, state-based contract strategy, the growth of its CenterWell business, and its integrated care delivery model, the companys business may be materially adversely affected. In addition, there can be no assurances that the company will be successful in maintaining or improving its Star ratings in future years. If Humana, or the third-party service providers on which it relies, fails to properly maintain the integrity of its data, to strategically maintain existing or implement new information systems, to protect Humanas proprietary rights to its systems, or to defend against cybersecurity attacks, contain such attacks when they occur, or prevent other privacy or data security incidents that result in security breaches that disrupt the companys operations or in the unintentional dissemination of sensitive personal information or proprietary or confidential information, the companys business may be materially adversely affected. Humana is involved in various legal actions, or disputes that could lead to legal actions (such as, among other things, provider contract disputes and qui tam litigation brought by individuals on behalf of the government), governmental and internal investigations, and routine internal review of business processes any of which, if resolved unfavorably to the company, could result in substantial monetary damages or changes in its business practices. Increased litigation and negative publicity could also increase the companys cost of doing business. As a government contractor, Humana is exposed to risks that may materially adversely affect its business or its willingness or ability to participate in government healthcare programs including, among other things, loss of material government contracts; governmental audits and investigations; potential inadequacy of government determined payment rates; potential restrictions on profitability, including by comparison of profitability of the companys Medicare Advantage business to non-Medicare Advantage business; or other changes in the governmental programs in which Humana participates. Changes to the risk adjustment model utilized by the Centers for Medicare and Medicaid Services (CMS) to adjust premiums paid to Medicare Advantage plans or retrospective recovery by CMS of previously paid premiums as a result of the final rule related to the risk adjustment data validation audit methodology published by CMS on January 30, 2023 (Final RADV Rule), which Humana believes fails to address adequately the statutory requirement of actuarial equivalence and violates the Administrative Procedure Act due to its failure to include a Fee for Service Adjuster, could have a material adverse effect on the companys operating results, financial position and cash flows. Humanas business activities are subject to substantial government regulation. New laws or regulations, or legislative, judicial, or regulatory changes in existing laws or regulations or their manner of application could increase the company's cost of doing business and have a material adverse effect on Humanas results of operations (including restricting revenue, enrollment and premium growth in certain products and market segments, restricting the companys ability to expand into new markets, increasing the companys medical and operating costs by, among other things, requiring a minimum benefit ratio on insured products, lowering the companys Medicare payment rates and increasing the companys expenses associated with a non-deductible health insurance industry fee and other assessments); the companys financial position (including the companys ability to maintain the value of its goodwill); and the companys cash flows. Humanas failure to manage acquisitions, divestitures and other significant transactions successfully may have a material adverse effect on the companys results of operations, financial position, and cash flows. If Humana fails to develop and maintain satisfactory relationships with the providers of care to its members, the companys business may be adversely affected. Humana faces significant competition in attracting and retaining talented employees. Further, managing succession for, and retention of, key executives is critical to the companys success, and its failure to do so could adversely affect the companys businesses, operating results and/or future performance. Humanas pharmacy business is highly competitive and subjects it to regulations and supply chain risks in addition to those the company faces with its core health benefits businesses. Changes in the prescription drug industry pricing benchmarks may adversely affect Humanas financial performance. Humanas ability to obtain funds from certain of its licensed subsidiaries is restricted by state insurance regulations. Downgrades in Humanas debt ratings, should they occur, may adversely affect its business, results of operations, and financial condition. Volatility in the securities and credit markets, including changes in interest rates, may significantly and adversely affect the value of Humanas investment portfolio and the investment income that Humana derives from this portfolio. In making forward-looking statements, Humana is not undertaking to address or update them in future filings or communications regarding its business or results. In light of these risks, uncertainties, and assumptions, the forward-looking events discussed herein may or may not occur. There also may be other risks that the company is unable to predict at this time. Any of these risks and uncertainties may cause actual results to differ materially from the results discussed in the forward-looking statements. Humana advises investors to read the Form 10-K for the year ended December 31, 2023 as filed by the company with the SEC for further discussion both of the risks it faces and its historical performance. About Humana Humana Inc. (NYSE: HUM) is committed to putting health first - for our teammates, our customers, and our company. Through our Humana insurance services, and our CenterWell health care services, we make it easier for the millions of people we serve to achieve their best health - delivering the care and service they need, when they need it. These efforts are leading to a better quality of life for people with Medicare, Medicaid, families, individuals, military service personnel, and communities at large. View source version on businesswire.com: https://www.businesswire.com/news/home/20240313796958/en/ Lisa Stoner Investor Relations Humana Inc. 502-580-2652 e-mail: lstamper@humana.com Mark Taylor Corporate Communications Humana Inc. 317-753-0345 e-mail: mtaylor108@humana.com Source: Humana Inc. What is the total amount of the senior notes offering by Humana Inc. (NYSE: HUM)? Humana Inc. (NYSE: HUM) completed a $2.25 billion senior notes offering. What are the interest rates and maturity dates for the senior notes offered by Humana Inc. (NYSE: HUM)? The senior notes include $1.25 billion of 5.375 percent senior notes due 2031 and $1.00 billion of 5.750 percent senior notes due 2054. How much are the net proceeds expected to be from the senior notes offering by Humana Inc. (NYSE: HUM)? Humana Inc. (NYSE: HUM) anticipates net proceeds of approximately $2.226 billion after deducting underwriters discounts and estimated offering expenses. What are the intended uses of the net proceeds from the senior notes offering by Humana Inc. (NYSE: HUM)? The net proceeds from the senior notes offering by Humana Inc. (NYSE: HUM) will be used for general corporate purposes, potentially including the repayment of existing indebtedness. Who were the active joint book-running managers for the senior notes offerings by Humana Inc. (NYSE: HUM)? Citigroup Global Markets Inc., Goldman Sachs & Co. LLC, Morgan Stanley & Co. LLC, PNC Capital Markets LLC, and Wells Fargo Securities, LLC acted as active joint book-running managers for the senior notes offerings."
C.H. Robinson Announces Michael McGarry and Paige Robbins as Nominees for Board of Directors,2024-03-13T21:21:00.000Z,Low,Very Positive,"C.H. Robinson Worldwide, Inc. nominates Michael McGarry and Paige Robbins as new directors, while Scott Anderson and James Stake retire. McGarry brings leadership experience from PPG Industries, Inc., and Robbins brings operational expertise from Grainger. The Board aims for accelerated profitable growth and increased shareholder value.","C.H. Robinson Announces Michael McGarry and Paige Robbins as Nominees for Board of Directors Rhea-AI Impact (Low) Rhea-AI Sentiment (Very Positive) Tags management Rhea-AI Summary C.H. Robinson Worldwide, Inc. nominates Michael McGarry and Paige Robbins as new directors, while Scott Anderson and James Stake retire. McGarry brings leadership experience from PPG Industries, Inc., and Robbins brings operational expertise from Grainger. The Board aims for accelerated profitable growth and increased shareholder value. Positive None. Negative None. 03/13/2024 - 05:21 PM EDEN PRAIRIE, Minn.--(BUSINESS WIRE)-- C.H. Robinson Worldwide, Inc. (C.H. Robinson) (Nasdaq: CHRW), a leading global logistics provider, today announced that the Board of Directors, upon recommendation of the Governance Committee, has nominated new directors, Michael McGarry and Paige Robbins, to stand for election to the Board at the companys 2024 annual meeting of stockholders. The company also announced that Scott Anderson and James Stake have each decided not to stand for re-election to the Board of Directors at the 2024 annual meeting and will retire from the Board. A top priority for the Board is ensuring that we have the right composition of Board members to oversee execution of the Companys strategy and guide C.H. Robinson to win through accelerated profitable growth, said Jodee Kozlak, Chair of the Board of Directors of C.H. Robinson. Michael McGarry brings extensive leadership experience having recently retired as Executive Chairman of PPG Industries, Inc., where he led the company through a multi-year transformation and expansion of PPGs portfolio in key growth markets. Paige Robbins brings a strategic mindset and broad operational experience, as an executive leader at Grainger where she has delivered strong operational results. She currently oversees all commercial functions for the Grainger brand in North America. The Board looks forward to their contributions and remains committed to driving positive change and increasing shareholder value. On behalf of the Board, I want to extend our gratitude to retiring directors Scott Anderson and Jim Stake for their exemplary service over the past decade and more. Scotts leadership was invaluable during his tenure as interim CEO, and as former Chair, and the Board remains deeply appreciative of Jims service as Audit Chair and his counsel and influence, continued Kozlak. Michael McGarry, 66, retired in 2023 as Executive Chairman of PPG Industries, Inc. (PPG), the worlds leading paint and coatings company, after more than four decades of service. He played a pivotal role in transforming PPG from a diversified glass, chemicals and coatings company into a highly focused coatings enterprise, with revenues of over $18 billion and operations in more than 70 countries. He held various leadership positions in PPG, including President, Chief Executive Officer, Chief Operating Officer and board member. Currently he serves as a board director at United States Steel, where he is on the Audit Committee and Compensation and Organization Committee, and Shin-Etsu Chemical, a public Japanese chemicals company. Paige Robbins, 55, is a senior executive at W.W. Grainger, Inc. (Grainger) with extensive experience in logistics and supply chain, strategy, technology, and business transformation. As Senior Vice President and President, Grainger Business Unit, she is responsible for the integrated commercial functions of Graingers High-Touch Solutions segment in North America which had revenues of $13.3 billion in 2023. In this role, she oversees sales, customer solutions, marketing, pricing, merchandising, procurement, sourcing, and supplier management. Paige has a broad set of experiences in which she has displayed discerning judgment, strategic thinking, a customer focus, values-driven people leadership, logistics expertise, and experience leveraging technology, data and analytics to drive measurable value. Since joining Grainger in 2010, she has held various senior executive roles including Chief Technology, Merchandising, Marketing and Strategy Officer, Chief Digital Officer and positions of increasing responsibility in Supply Chain. C.H. Robinson's President and Chief Executive Officer, Dave Bozeman, said, ""These two business leaders have deep experience running and expanding global, integrated businesses, providing a great customer experience and delivering shareholder value."" He added, ""We are excited to learn from their perspectives as we continue to chart our path forward."" Michael McGarry said, ""I am pleased to be nominated to join the Board of Directors of C.H. Robinson. I respect the company's culture, its deep industry expertise, and its focus on customer service, and I hope to contribute my insights and expertise from leading a global company. I look forward to working with the other directors and the management team to help C.H. Robinson achieve its goals and create value for its stakeholders."" ""I am honored to be nominated to join the Board of Directors of C.H. Robinson, a company that I admire for its innovation, customer-centricity, and global reach. I look forward to collaborating with the other directors and the management team to help support and advance the company's strategic vision and goals,"" said Paige Robbins. The company will provide additional information about the nominees in its proxy statement, which will be filed with the Securities and Exchange Commission and made available to shareholders in advance of the annual meeting. About C.H. Robinson C.H. Robinson solves logistics problems for companies across the globe and across industries, from the simple to the most complex. With $22 billion in freight under management and 19 million shipments annually, we are one of the worlds largest logistics platforms. Our global suite of services accelerates trade to seamlessly deliver the products and goods that drive the worlds economy. With the combination of our multimodal transportation management system and expertise, we use our information advantage to deliver smarter solutions for more than 90,000 customers and 450,000 contract carriers on our platform. Our technology is built by and for supply chain experts to bring faster, more meaningful improvements to our customers businesses. As a responsible global citizen, we are also proud to contribute millions of dollars to support causes that matter to our company, our Foundation and our employees. For more information, visit us at www.chrobinson.com (Nasdaq: CHRW). CHRW-IR View source version on businesswire.com: https://www.businesswire.com/news/home/20240313907156/en/ FOR INVESTOR INQUIRIES, CONTACT: Chuck Ives, Director of Investor Relations Email: chuck.ives@chrobinson.com FOR MEDIA INQUIRIES, CONTACT: Duncan Burns, Chief Communications Officer Email: PublicRelations@chrobinson.com Source: C.H. Robinson Who are the new directors nominated by C.H. Robinson? The new directors nominated by C.H. Robinson are Michael McGarry and Paige Robbins. What is Michael McGarry's background and experience? Michael McGarry recently retired as Executive Chairman of PPG Industries, Inc., with over four decades of service. He led PPG through a transformation and expansion phase, focusing on coatings enterprise. What is Paige Robbins' role at Grainger? Paige Robbins is a senior executive at Grainger, overseeing the integrated commercial functions of Grainger's High-Touch Solutions segment in North America. What is the goal of C.H. Robinson's Board of Directors? The Board aims for accelerated profitable growth and increased shareholder value at C.H. Robinson. What is the reaction of C.H. Robinson's CEO, Dave Bozeman, to the new directors? Dave Bozeman is excited to learn from the perspectives of the new directors as C.H. Robinson continues to chart its path forward."
Build-A-Bear Workshop Initiates Quarterly Dividend Program,2024-03-13T21:15:00.000Z,Low,Positive,"Build-A-Bear Workshop, Inc. (NYSE: BBW) introduces a new quarterly dividend program with an initial cash dividend of $0.20 per share. The dividend will be paid on April 11, 2024, to stockholders of record as of March 28, 2024. The company plans to pay dividends quarterly, reflecting confidence in future prospects.","Build-A-Bear Workshop Initiates Quarterly Dividend Program Rhea-AI Impact (Low) Rhea-AI Sentiment (Positive) Tags dividends Rhea-AI Summary Build-A-Bear Workshop, Inc. (NYSE: BBW) introduces a new quarterly dividend program with an initial cash dividend of $0.20 per share. The dividend will be paid on April 11, 2024, to stockholders of record as of March 28, 2024. The company plans to pay dividends quarterly, reflecting confidence in future prospects. Positive None. Negative None. Financial Analyst The initiation of a quarterly dividend by Build-A-Bear Workshop, Inc. signifies a pivotal shift in the company's capital allocation strategy. Such a move is often interpreted by the market as a signal of matured and stable cash flows, indicating that the company has reached a point where it can predictably generate excess capital. This decision to return capital to shareholders in the form of dividends is a testament to the company's financial health and management's confidence in its ongoing operations and future prospects.From a valuation standpoint, the announcement of a $0.20 per share dividend can have implications for the company's stock price. Dividend Discount Models, which are used to estimate the value of a company based on its future dividends, will now incorporate this new information, potentially affecting the intrinsic value calculations made by investors. Additionally, the dividend yield, calculated as the annual dividends per share divided by the stock price, will become a new factor for income-focused investors when evaluating the attractiveness of Build-A-Bear Workshop's stock. Market Research Analyst Introducing a dividend can have a broader impact on the company's shareholder base. Typically, a dividend-paying company attracts a different investor profile compared to growth-oriented companies that do not pay dividends. Income-seeking investors, such as retirees or conservative investment funds, may now find Build-A-Bear Workshop's shares more appealing. This could lead to a change in the stock's trading dynamics and potentially increase its stability during market volatility. It is essential to monitor how this change affects the company's stock liquidity and volatility in the upcoming quarters.Moreover, the market's reaction to such announcements can serve as a barometer for investor sentiment towards the company's governance and strategic direction. If the dividend is well received, it might suggest that the market approves of the company's capital distribution policy and its ability to sustain such payouts. Conversely, if the market reacts negatively, it could indicate concerns over the sustainability of the dividend or the opportunity cost of not reinvesting the capital back into the business for growth. Corporate Governance Expert The declaration of a quarterly dividend by Build-A-Bear Workshop also sheds light on the company's governance practices. Dividend policy is a direct reflection of the board's strategic priorities and their commitment to shareholder returns. It suggests a balanced approach to capital management, where the company is not solely focused on reinvesting all its earnings back into the business or on aggressive expansion but is also considering shareholder wealth maximization.It is important to assess how this dividend policy aligns with the company's long-term strategic plan. If the dividend payments are well-covered by free cash flow and do not impede the company's ability to invest in future growth opportunities, it can be seen as a positive governance practice. However, if future investments are compromised or debt levels increase to sustain the dividend, it could raise red flags about the sustainability of such a policy. The market will closely observe these factors to gauge the prudence of the board's decision in the context of the company's long-term strategy. 03/13/2024 - 05:15 PM ST. LOUIS--(BUSINESS WIRE)-- Build-A-Bear Workshop, Inc. (NYSE: BBW) announced today that its Board of Directors approved a new quarterly dividend program to evolve its strategic use of capital. The Board of Directors declared an initial quarterly cash dividend of $0.20 per share. The dividend will be paid on April 11, 2024, to all stockholders of record as of March 28, 2024. The Company intends to pay dividends quarterly in the future, subject to market conditions and approval by the Board of Directors. We are pleased to be able to provide a direct return to our stockholders with the initiation of a quarterly regular dividend that together with our previously authorized stock repurchase plan shows the continued confidence that the Board has in the companys future and our commitment to regularly return capital to stockholders. Our strong cash flow and capital structure provide the flexibility for us to return capital to our stockholders through share repurchases and regular dividend payments while maintaining the ability to invest for profitable growth and execute our strategic plan, said Craig Leavitt, Non-Executive Chairman of the Board. About Build-A-Bear Build-A-Bear is a multi-generational global brand focused on its mission to add a little more heart to life appealing to a wide array of consumer groups who enjoy the personal expression in making their own furry friends to celebrate and commemorate life moments. More than 500 interactive brick-and-mortar experience locations operated through a variety of formats provide guests of all ages a hands-on entertaining experience, which often fosters a lasting and emotional brand connection. The Company also offers engaging e-commerce/digital purchasing experiences on www.buildabear.com including its online Bear-Builder as well as HeartBox and its age-gated adult-focused Bear Cave. In addition, extending its brand power beyond retail, Build-A-Bear Entertainment, a subsidiary of Build-A-Bear Workshop, Inc., is dedicated to creating engaging content for kids and adults that fulfills the Companys mission, while the Company also offers products at wholesale and in non-plush consumer categories via licensing agreements with leading manufacturers. Build-A-Bear Workshop, Inc. (NYSE: BBW) posted total revenues of $467.9 million for fiscal 2022. For more information, visit the Investor Relations section of buildabear.com. Forward-Looking Statements: This press release contains certain statements that are, or may be considered to be, forward-looking statements for the purpose of federal securities laws, including, but not limited to, statements that reflect our current views with respect to future events and financial performance. We generally identify these statements by words or phrases such as may, might, should, expect, plan, anticipate, believe, estimate, intend, predict, future, potential or continue, the negative or any derivative of these terms and other comparable terminology. All of the information concerning our future liquidity, future revenues, margins and other future financial performance and results, achievement of operating of financial plans or forecasts for future periods, sources and availability of credit and liquidity, future cash flows and cash needs, success and results of strategic initiatives and other future financial performance or financial position, as well as our assumptions underlying such information, constitute forward-looking information. These statements are based only on our current expectations and projections about future events. Because these forward-looking statements involve risks and uncertainties, there are important factors that could cause our actual results, level of activity, performance or achievements to differ materially from the results, level of activity, performance or achievements expressed or implied by these forward-looking statements, including those factors discussed under the caption entitled Risks Related to Our Business and Forward-Looking Statements in our Annual Report on Form 10-K filed with the Securities and Exchange Commission (SEC) on April 13, 2023 and other periodic reports filed with the SEC which are incorporated herein. All of our forward-looking statements are as of the date of this Press Release only. In each case, actual results may differ materially from such forward-looking information. We can give no assurance that such expectations or forward-looking statements will prove to be correct. An occurrence of or any material adverse change in one or more of the risk factors or other risks and uncertainties referred to in this Press Release or included in our other public disclosures or our other periodic reports or other documents or filings filed with or furnished to the SEC could materially and adversely affect our continuing operations and our future financial results, cash flows, available credit, prospects and liquidity. Except as required by law, the Company does not undertake to publicly update or revise its forward-looking statements, whether as a result of new information, future events or otherwise. View source version on businesswire.com: https://www.businesswire.com/news/home/20240313216723/en/ Investor Relations Contact Gary Schnierow, Vice President, Investor Relations & Corporate Finance garys@buildabear.com Media Relations Contact pr@buildabear.com Source: Build-A-Bear Workshop, Inc. What is the ticker symbol for Build-A-Bear Workshop, Inc.? The ticker symbol for Build-A-Bear Workshop, Inc. is BBW. What is the amount of the initial quarterly cash dividend declared by Build-A-Bear Workshop, Inc.? Build-A-Bear Workshop, Inc. declared an initial quarterly cash dividend of $0.20 per share. When will the dividend be paid to stockholders of Build-A-Bear Workshop, Inc.? The dividend will be paid on April 11, 2024, to stockholders of record as of March 28, 2024. How often does Build-A-Bear Workshop, Inc. plan to pay dividends in the future? Build-A-Bear Workshop, Inc. intends to pay dividends quarterly in the future, subject to market conditions and approval by the Board of Directors. Who is the Non-Executive Chairman of the Board of Build-A-Bear Workshop, Inc.? Craig Leavitt is the Non-Executive Chairman of the Board of Build-A-Bear Workshop, Inc."
Tecogen Announces Fourth Quarter 2023 Results,2024-03-13T21:09:00.000Z,Neutral,Negative,"Tecogen Inc. reported Q4 2023 revenue of $5.9 million, a 30.2% increase QoQ, with a net loss of $1.8 million. Adjusted EBITDA loss narrowed to $527 thousand. Revenues for the year were $25.1 million. The company aims to increase recurring cash flow from Energy and Services to cover fixed costs and secure profitable large projects.","Tecogen Announces Fourth Quarter 2023 Results Rhea-AI Impact (Neutral) Rhea-AI Sentiment (Negative) Tags earnings Rhea-AI Summary Tecogen Inc. reported Q4 2023 revenue of $5.9 million, a 30.2% increase QoQ, with a net loss of $1.8 million. Adjusted EBITDA loss narrowed to $527 thousand. Revenues for the year were $25.1 million. The company aims to increase recurring cash flow from Energy and Services to cover fixed costs and secure profitable large projects. Positive Revenue increased by 30.2% in Q4 2023 compared to the same period in 2022. Adjusted EBITDA loss decreased to $527 thousand in Q4 2023. Revenues for the year ended December 31, 2023, were $25.1 million. Focus on increasing recurring cash flow from Energy and Services to achieve profitability. Received orders for multiple unit chiller and cogeneration projects nationwide. Expect sustained profitability and growth from securing additional multiple unit product orders. Proprietary software and utility demand response capabilities provide a competitive advantage. Net loss in Q4 2023 driven by increased bad debt expense and obsolete inventory reserves. Gross profit margins affected by costs for engine replacements and site improvements. Credit line and cash position to support factory move later in the quarter. Negative Net loss increased to $1.8 million in Q4 2023. Decrease in Products revenue for the year ended December 31, 2023. Gross profit and margin decreased in Q4 2023 due to various factors. Operating expenses increased in Q4 2013 and for the year ended December 31, 2023. Adjusted EBITDA was negative for Q4 2013 and the year ended December 31, 2023. 03/13/2024 - 05:09 PM Q4 2023 Revenue of $5.9 Million, an Increase of 30.2% QoQ WALTHAM, MA, March 13, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire Tecogen Inc. (OTCQX:TGEN), a leading manufacturer of clean energy products, reported revenues of $5.9 million and a net loss of $1.8 million for the quarter ended December 31, 2023 compared to revenues of $4.5 million, and a net loss of $1.4 million in 2022. The increase in net loss was primarily driven by an increase in bad debt reserves for installation projects from 2017 an increase in reserves for obsolete inventory. Our Adjusted EBITDA loss narrowed to $527 thousand for the quarter ended December 31, 2023 compared to $1.1 million in 2022. For the year ended December 31, 2023 revenues were $25.1 million and the net loss was $4.5 million compared to revenues of $25.0 million, and net loss of $2.4 million for the same period in 2022. For the year the Adjusted EBITDA loss was $2.6 million in 2023 and $1.7 million in 2022. ""During the 4th quarter we had positive cash flow from operations and a recovery in gross margin for our Services segment. We continue to execute on our strategy of increasing recurring cash flow from Energy and Services to cover our fixed costs. This will allow us to be cash flow positive while we secure profitable large dollar value projects. Unlike in the past where our sales were predominantly small cogeneration projects for residential buildings in New York City, we are now seeing the market shift to multiple unit chiller and cogeneration projects nationwide. We recently received a 6 unit (3 hybrid chillers and 3 Inverde cogeneration units) as well as a 12 unit cogeneration order. We are now focused on securing additional multiple unit product orders that we expect will result in sustained profitability and growth. In fact, we are specified on large chiller projects for some iconic facilities that are on track to close later this year. We are also receiving significant interest from customers who are limited in electrical capacity or facing sharp increases in peak electricity charges. We expect customer pain point to increase as electrification efforts place higher pressure on the ability of utilities to supply sufficient power. As a result, our proprietary software and utility demand response capabilities will give us a competitive advantage in securing new product orders and increased Services revenue. Although we showed a significant net loss in Q4, this was driven by a $1 million increase in bad debt expense associated with old installation project receivables and obsolete inventory. We also performed much needed work on replacing engines in the Services fleet and site improvement work within our energy fleet. These costs and the obsolete inventory reserve drove down gross profit margins but are an essential investment to improve unit runtime going forward. We have $1 million remaining on our credit line which will help us execute our factory move later this quarter, and our present cash position of $1.1 million,"" commented Abinand Rangesh, Tecogen's Chief Executive Officer. Key Takeaways Revenues Revenues for Q4 2023 were $5.9 million compared to $4.5 million for the same period in 2022, a 30.2% increase. Products revenue was $1.8 million in Q4 2023 compared to $1.0 million in the same period in 2022, an increase of 76.6%, primarily due to increased chiller sales and cogeneration sales, which was offset partially by decreased sales of engineered accessories.Services revenue was $3.6 million in Q4 2023 compared to $3.0 million in the same period in 2022, an increase of 19.1%, primarily due to revenue from acquired maintenance contracts.Energy Production revenue increased 4.7%, to $542 thousand in Q4 2023 compared to $517 thousand in the same period in 2022. Revenues for the year ended December 31, 2023 were $25.1 million compared to $25.0 million for the same period in 2022, a 0.5% increase. Products revenue was $8.9 million in the year ended December 31, 2023 compared to $11.2 million in the same period in 2022, a decrease of 20.6%, primarily due to decreased cogeneration sales, partially offset by increased chiller sales into our key market segments including controlled environment agriculture.Services revenue was $14.5 million in the year ended December 31, 2023 compared to $12.1 million in the same period in 2022, an increase of 20.4%, primarily due to revenue from acquired maintenance contracts and a 4.8% increase in revenue from existing service contracts.Energy Production revenue decreased 1.6%, to $1.76 million in the year ended December 31, 2023 compared to $1.79 million in the same period in 2022. Net Loss and Earnings Per Share Net loss in Q4 2023 was $1.8 million compared to net loss of $1.4 million in Q4 2022, an increase of $0.4 million, primarily due to increased operating expenses. EPS was a net loss of $0.07/share and a net loss of $0.06 in Q4 2023 and Q4 2022, respectively.Net loss for the year ended December 31, 2023 was $4.6 million compared to net loss of $2.4 million in the comparable 2022 period, an increase of $2.2 million, due primarily to lower Products segment revenue and gross profit and an increase in operating expenses. EPS was a net loss of $0.19/share for the year ended December 31, 2023 compared to $0.10/share in 2022. Loss from Operations Loss from operations for Q4 2023 increased to $1.8 million compared to a loss of $1.4 million for the same period in 2022 due to higher operating expenses.Loss from operations for the year ended December 31, 2023 was $4.4 million compared to a loss of $2.3 million for the same period in 2022, an increase of $2.1 million. The loss from operations increased due to lower revenue and gross profit margins in our Products segment and increased operating expenses. Gross Profit and Gross Margin Gross profit for Q4 2023 was $2.3 million compared to $2.4 million in the fourth quarter of 2022. Gross margin was 39.8% in Q4 2023 quarter compared to 52.5% for the same period in 2022. Products margin decreased to 19.4% from 32.1% due to an increase in the provision for obsolete inventory, higher material costs, and increased product warranty costs. Services margin decreased to 51.3% from 60.1%, due to increased labor and material costs and an increase in the provision for obsolete inventory. In particular, as supply chain constraints for engines eased, we performed significant engine related replacements and upgrades which negatively impacted Service margins. Energy Production margin decreased to 30.3% in Q4 2023 from 47.7% in the comparable period in 2022 due to increased costs incurred to repair certain of our energy sites.Gross profit for the year ended December 31, 2023 decreased to $10.2 million compared to $11.1 million in the same period in 2022, a decrease of $0.9 million. Gross margin decreased to 40.6% in the year ended December 31, 2023 compared to 44.3% for the same period in 2022. Products margin decreased to 33.1% from 33.5%, due primarily to increased provisions for obsolete inventory. Services margin decreased to 45.5% from 54.2%, due to increased labor and material costs and an increase in the provision for obsolete inventory. In particular, as supply chain constraints for engines eased, we performed a significant number of engine replacements in the year ended December 31, 2023 which negatively impacted Services margins. Energy Production margin deceased to 37.1% from 44.2% due to increased costs incurred to repair certain of our energy sites. Operating Expenses Operating expenses increased 10.2% to $4.2 million in Q4 2023 compared to $3.8 million in the same period in 2022 due primarily to an increase in bad debt expense, due to certain install receivables which were deemed uncollectible, increases in depreciation and amortization, travel, and business insurance, which are attributable in part to the Aegis acquisition. Operating expenses increased by $1.2 million, or 8.9% to $14.6 million for the year ended December 31, 2023 compared to $13.4 million in the same period in 2022 due primarily to an increase in bad debt expense due to certain install receivables which were deemed uncollectible, increases in depreciation and amortization, travel, and business insurance, which are attributable in part to the Aegis acquisition. Adjusted EBITDA(1) was negative $527 thousand for the fourth quarter of 2023 compared to negative $1.1 million for the fourth quarter of 2022. Adjusted EBITDA(1) was negative $2.6 million for the year ended December 31, 2023 compared to negative $1.7 million for the comparable period in 2022. (Adjusted EBITDA is defined as net income or loss attributable to Tecogen, adjusted for interest, income taxes, depreciation and amortization, stock-based compensation expense, unrealized gain or loss on equity securities, goodwill impairment charges, inventory writedowns, bad debt provision and other non-cash non-recurring charges or gains including abandonment of intangible assets and the extinguishment of debt. See the table following the Condensed Consolidated Statements of Operations for a reconciliation from net income (loss) to Adjusted EBITDA, as well as important disclosures about the company's use of Adjusted EBITDA). Conference Call Scheduled for March 14, 2024, at 9:30 am ET Tecogen will host a conference call on March 14, 2024 to discuss the fourth quarter results beginning at 9:30 AM eastern time. To listen to the call please dial (877) 407-7186 within the U.S. and Canada, or (201) 689-8052 from other international locations. Participants should ask to be joined to the Tecogen Fourth Quarter 2023 earnings call. Please begin dialing 10 minutes before the scheduled starting time. The earnings press release will be available on the Company website at www.Tecogen.com in the ""News and Events"" section under ""About Us."" The earnings conference call will be webcast live. To view the associated slides, register for and listen to the webcast, go to https://ir.tecogen.com/ir-calendar. Following the call, the recording will be archived for 14 days. The earnings conference call will be recorded and available for playback one hour after the end of the call. To listen to the playback, dial (877) 660-6853 within the U.S. and Canada, or (201) 612-7415 from other international locations and use Conference Call ID#: 13672659. About Tecogen Tecogen Inc. designs, manufactures, sells, installs, and maintains high efficiency, ultra-clean, cogeneration products including engine-driven combined heat and power, air conditioning systems, and high-efficiency water heaters for residential, commercial, recreational and industrial use. The company provides cost effective, environmentally friendly and reliable products for energy production that nearly eliminate criteria pollutants and significantly reduce a customers carbon footprint. In business for over 35 years, Tecogen has shipped more than 3,200 units, supported by an established network of engineering, sales, and service personnel across the United States. For more information, please visit www.tecogen.com or contact us for a free Site Assessment. Tecogen, InVerde e+, Tecochill, Tecopower, Tecofrost, Tecopack, and Ultera are registered trademarks of Tecogen Inc. Forward Looking Statements This press release and any accompanying documents, contain forward-looking statements which may describe strategies, goals, outlooks or other non-historical matters, or projected revenues, income, returns or other financial measures, that may include words such as ""believe,"" ""expect,"" ""anticipate,"" ""intend,"" ""plan,"" ""estimate,"" ""project,"" ""target,"" ""potential,"" ""will,"" ""should,"" ""could,"" ""likely,"" or ""may"" and similar expressions intended to identify forward-looking statements. These statements are only predictions and involve known and unknown risks, uncertainties, and other factors that may cause our actual results to differ materially from those expressed or implied by such forward-looking statements. Given these uncertainties, you should not place undue reliance on these forward-looking statements. Forward-looking statements speak only as of the date on which they are made, and we undertake no obligation to update or revise any forward-looking statements. In addition to those factors described in our Annual Report on Form 10-K, our Quarterly Reports on Form 10-Q and on our Form 8-K, under Risk Factors, among the factors that could cause actual results to differ materially from past and projected future results are the following: fluctuations in demand for our products and services, competing technological developments, issues relating to research and development, the availability of incentives, rebates, and tax benefits relating to our products and services, changes in the regulatory environment relating to our products and services, integration of acquired business operations, and the ability to obtain financing on favorable terms to fund existing operations and anticipated growth. In addition to GAAP financial measures, this press release includes certain non-GAAP financial measures, including adjusted EBITDA which excludes certain expenses as described in the presentation. We use Adjusted EBITDA as an internal measure of business operating performance and believe that the presentation of non-GAAP financial measures provides a meaningful perspective of the underlying operating performance of our current business and enables investors to better understand and evaluate our historical and prospective operating performance by eliminating items that vary from period to period without correlation to our core operating performance and highlights trends in our business that may not otherwise be apparent when relying solely on GAAP financial measures. Tecogen Media & Investor Relations Contact Information: Abinand RangeshP: 781-466-6487E: Abinand.Rangesh@tecogen.com TECOGEN INCCONDENSED CONSOLIDATED BALANCE SHEETS(unaudited) December 31, 2023 December 31, 2022ASSETS Current assets: Cash and cash equivalents$ 1,351,270 $ 1,913,969 Accounts receivable, net 6,735,337 6,714,122 Employee retention credit receivable 46,147 713,269 Unbilled revenue 1,258,532 1,805,330 Inventory, net 10,553,419 10,482,729 Prepaid and other current assets 360,639 401,189 Total current assets 20,305,344 22,030,608 Property, plant and equipment, net 1,162,577 1,407,720 Right of use assets 943,283 1,245,549 Intangible assets, net 2,436,230 997,594 Goodwill 2,743,424 2,406,156 Other assets 201,771 165,230 TOTAL ASSETS$ 27,792,629 $ 28,252,857 LIABILITIES AND STOCKHOLDERS EQUITY Current liabilities: Related party loan$ 505,505 $  Accounts payable 4,514,415 3,261,952 Accrued expenses 2,504,629 2,384,447 Deferred revenue, current 1,647,206 1,115,627 Lease obligations, current 289,473 687,589 Acquisition liabilities, current 845,363  Unfavorable contract liabilities, current 176,207 236,705 Total current liabilities 10,482,798 7,686,320 Long-term liabilities: Deferred revenue, net of current portion 369,611 371,823 Lease obligations, net of current portion 683,307 623,452 Acquisition liabilities, net of current portion 1,181,779  Unfavorable contract liability, net of current portion 422,839 583,512 Total liabilities 13,140,334 9,265,107 Stockholders equity: Tecogen Inc. shareholders equity: Common stock, $0.001 par value; 100,000,000 shares authorized; 24,850,261 and 24,850,261 issued and outstanding at December 31, 2023 and 2022, respectively 24,850 24,850 Additional paid-in capital 57,601,402 57,351,008 Accumulated deficit (42,879,656) (38,281,548) Total Tecogen Inc. stockholders equity 14,746,596 19,094,310 Noncontrolling interest (94,301) (106,560) Total stockholders equity 14,652,295 18,987,750 TOTAL LIABILITIES AND STOCKHOLDERS EQUITY$27,792,629 $ 28,252,857 TECOGEN INC. CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS(unaudited) Three Months Ended December 31, 2023 December 31, 2022Revenues Products$ 1,765,390 $ 999,771 Services 3,591,310 3,014,586 Energy production 541,613 517,230 5,898,313 4,531,587 Cost of sales Products 1,422,325 678,855 Services 1,749,347 1,202,800 Energy production 377,379 270,693 Gross Profit 3,549,051 2,152,348 Operating expenses 2,349,262 2,379,239 General and administrative 3,461,807 3,267,067 Selling 504,716 238,863 Research and Development 214,320 195,747 Gain on sale of assets (16,257)  Long-lived asset impairment  76,049 Total operating expenses 4,164,586 3,777,726 Loss from operations (1,815,324) (1,398,487)Other income (expense) Interest and other income (expense) (24,442) (12,157)Interest expense (7,421) (415)Unrealized loss on investment securities 18,749 (18,749)Total other expense, net (13,114) (31,321)Loss before income taxes (1,828,438) (1,429,808)Income tax provision 239  Consolidated net loss (1,828,677) (1,429,808)Income attributable to the noncontrolling interest (17,720) 5,402 Net loss attributable to Tecogen Inc (1,846,397) (1,424,406)Net loss per share - basic$ (0.07) $ (0.06)Weighted average shares outstanding - basic 24,850,261 24,850,261 Net loss per share - diluted$ (0.07) $ (0.06)Weighted average shares outstanding - diluted 24,850,261 24,850,261 Three Months Ended December 31, 2023 December 31, 2022Non-GAAP financial disclosure (1) Net loss attributable to Tecogen Inc$ (1,846,397) $ (1,424,406) Interest expense, net 7,421 415 Provision for income taxes 239  Depreciation and amortization, net 107,933 103,381 EBITDA (1,730,804) (1,320,610) Stock-based compensation 75,683 79,431 Unrealized loss on securities (18,749) 18,749 Inventory write down 402,883  Long-lived asset impairment  76,049 Bad debt provision 744,248  Adjusted EBITDA$ (526,739) $(1,146,381) TECOGEN INC. CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS(unaudited) Years Ended December 31, 2023 December 31, 2022Revenues Products$ 8,859,946 $ 11,156,099 Services 14,523,054 12,060,661 Energy production 1,756,419 1,785,854 25,139,419 25,002,614 Cost of sales Products 5,923,096 7,413,320 Services 7,909,202 5,525,493 Energy production 1,105,503 996,990 14,937,801 13,935,803 Gross profit 10,201,618 11,066,811 Operating expenses: General and administrative 11,880,389 10,909,251 Selling 1,931,037 1,811,085 Research and development 840,011 732,873 Gain on sale of assets (36,207) (41,931) Long-lived asset impairment  4,674 Total operating expenses 14,615,230 13,415,952 Loss from operations (4,413,612) (2,349,141) Other income (expense) Interest and other income (expense) (61,003) (34,713) Interest expense (16,050) (16,255) Unrealized gain on marketable securities  18,749 Total other expense, net (77,053) (32,219) Loss before income taxes (4,490,665) (2,381,360) State income tax provision 32,491 16,352 Consolidated net loss (4,523,156) (2,397,712) Income attributable to the noncontrolling interest (74,952) (50,215) Net loss attributable to Tecogen Inc.$ (4,598,108) $ (2,447,927) Net loss per share - basic$ (0.19) $(0.10) Weighted average shares outstanding - basic 24,850,261 24,850,261 Net loss per share - diluted$ (0.19) $ (0.10) Weighted average shares outstanding -diluted 24,850,261 24,850,261 Years Ended Non-GAAP financial disclosure (1)December 31, 2023 December 31, 2022Net loss attributable to Tecogen Inc$ (4,598,108) $ (2,447,927) Interest expense, net 16,050 16,255 Provision for income taxes 32,491 16,352 Depreciation and amortization, net 567,712 428,348 EBITDA (3,981,855) (1,986,972) Stock-based compensation 250,394 334,149 Unrealized loss on investment securities  (18,749) Inventory writedown 402,883  Long-lived asset impairment  4,674 Bad debt provision 744,248  Adjusted EBITDA$ (2,584,329) $ (1,666,898) (1) Non-GAAP Financial MeasuresIn addition to reporting net income, a U.S. generally accepted accounting principle (GAAP) measure, this news release contains information about Adjusted EBITDA (net income (loss) attributable to Tecogen Inc adjusted for interest, income taxes, depreciation and amortization, stock-based compensation expense, unrealized gain or loss on investment securities, goodwill impairment charges and other non-cash non-recurring charges including abandonment of certain intangible assets, extinguishment of debt, inventory writedown and bad debt provision), which is a non-GAAP measure. The Company believes Adjusted EBITDA allows investors to view its performance in a manner similar to the methods used by management and provides additional insight into its operating results. Adjusted EBITDA is not calculated through the application of GAAP. Accordingly, it should not be considered as a substitute for the GAAP measure of net income and, therefore, should not be used in isolation of, but in conjunction with, the GAAP measure. The use of any non-GAAP measure may produce results that vary from the GAAP measure and may not be comparable to a similarly defined non-GAAP measure used by other companies. TECOGEN INC.CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS(unaudited) Years Ended December 31, 2023 December 31, 2022Consolidated loss$ (4,523,156) $ (2,397,712) Adjustments to reconcile net loss to net cash used in operating activities: Depreciation, accretion and amortization, net 567,712 428,348 Long-lived asset impairment  4,674 Gain on sale of assets (36,207) (41,931) Provision for doubtful accounts receivable 902,432 (70,987) Provision for litigation  150,000 Provision for inventory reserve 402,883 107,000 Unrealized gain on investment securities  (18,749) Stock-based compensation 250,394 334,149 Changes in operating assets and liabilities: (Increase) decrease in: Accounts receivable (81,195) 2,401,904 Inventory, net (82,525) (2,824,740) Unbilled revenue 56,994 1,452,860 Prepaid expenses and other current assets 40,550 177,612 Other non-current assets 265,725 625,320 Increase (decrease) in: Accounts payable 1,161,416 (246,401) Accrued expenses 128,869 (109,282) Deferred revenue 543,842 (678,758) Other current liabilities (421,049) (645,236) Net cash used in operating activities (823,315) (1,351,929) CASH FLOWS FROM INVESTING ACTIVITIES: Purchases of property and equipment (46,851) (314,879) Proceeds on sale of property and equipment 34,655 72,655 Purchases of intangible assets  (29,505) Payment for business acquisition (170,000)  Distributions to noncontrolling interest (62,693) (76,836) Net used in investing activities (244,889) (348,565) CASH FLOWS FROM FINANCING ACTIVITIES: Proceeds from related party note 505,505  Net cash provided by financing activities 505,505  Change in cash and cash equivalents (562,699) (1,700,494) Cash and cash equivalents, beginning of the year 1,913,969 3,614,463 Cash and cash equivalents, end of the year$ 1,351,270 $ 1,913,969 Supplemental disclosure of cash flow information: Cash paid for interest$ 10,926 $ 14,597 Cash paid for taxes$ 32,491 $ 16,352 What was Tecogen Inc.'s revenue in Q4 2023? Tecogen Inc. reported Q4 2023 revenue of $5.9 million, a 30.2% increase QoQ. What was the net loss for Tecogen Inc. in Q4 2023? Tecogen Inc. reported a net loss of $1.8 million in Q4 2023. How did the Adjusted EBITDA loss change in Q4 2023 compared to 2022? The Adjusted EBITDA loss narrowed to $527 thousand in Q4 2023. What were the revenues for Tecogen Inc. for the year ended December 31, 2023? Revenues for the year ended December 31, 2023, were $25.1 million. What is Tecogen Inc.'s strategy to achieve profitability? Tecogen Inc. aims to increase recurring cash flow from Energy and Services to cover fixed costs and secure profitable large projects. What types of projects did Tecogen Inc. receive orders for? Tecogen Inc. received orders for multiple unit chiller and cogeneration projects nationwide. How does Tecogen Inc. plan to secure sustained profitability and growth? Tecogen Inc. plans to secure additional multiple unit product orders to achieve sustained profitability and growth. What gives Tecogen Inc. a competitive advantage in securing new product orders? Tecogen Inc.'s proprietary software and utility demand response capabilities provide a competitive advantage. What factors drove the net loss in Q4 2023 for Tecogen Inc.? The net loss in Q4 2023 was driven by increased bad debt expense and obsolete inventory reserves. How were Tecogen Inc.'s gross profit margins affected in Q4 2023? Gross profit margins were affected by costs for engine replacements and site improvements. What support does Tecogen Inc. have for its factory move later in the quarter? Tecogen Inc. has $1 million remaining on its credit line and a present cash position of $1.1 million to support the factory move later in the quarter."
AM Best Affirms Credit Ratings of Most of CVS Health Corporations Aetna Inc. Subsidiaries; Withdraws Credit Ratings of Members of Texas Health Aetna,2024-03-13T21:03:00.000Z,Low,Very Positive,"AM Best affirms Aetna Life Insurance Company's Financial Strength Rating of A (Excellent) and positive outlook on Long-Term Issuer Credit Ratings. The ratings reflect strong balance sheet strength, operating performance, and risk-adjusted capitalization.","AM Best Affirms Credit Ratings of Most of CVS Health Corporations Aetna Inc. Subsidiaries; Withdraws Credit Ratings of Members of Texas Health Aetna Rhea-AI Impact (Low) Rhea-AI Sentiment (Very Positive) Tags Rhea-AI Summary AM Best affirms Aetna Life Insurance Company's Financial Strength Rating of A (Excellent) and positive outlook on Long-Term Issuer Credit Ratings. The ratings reflect strong balance sheet strength, operating performance, and risk-adjusted capitalization. Positive AM Best affirms Aetna Life Insurance Company's Financial Strength Rating of A (Excellent) and positive outlook on Long-Term Issuer Credit Ratings. The ratings reflect strong balance sheet strength, operating performance, and risk-adjusted capitalization. Aetna Health & Life Group has reported underwriting and net income exceeding $2 billion in each of the past five years. The group's return on revenues exceeds 5% and return on equity exceeds 20%. Aetna's Medicare Advantage and Medicaid managed care markets have experienced significant membership growth. Aetna remains competitive and continues to gain enrollment in other segments. AM Best recognizes the inherent execution risk within the acquisitions of Signify Health Inc. and Oak Street Health Inc. There may be pressure from additional business expansion related to acquisitions in the near term. Negative The financial leverage at CVS Health has increased modestly at year-end 2023. Goodwill-to-shareholders equity exceeded 110% at year-end 2023. There is negative impact from CVS Health's elevated financial leverage and goodwill on Aetna Health & Life Group. The resumption of redeterminations following the end of the public health emergency may lead to declines in Medicaid membership in 2023 and the first half of 2024. Insurance Industry Analyst The affirmation of the Financial Strength Rating (FSR) and Long-Term Issuer Credit Ratings (Long-Term ICRs) for Aetna Life Insurance Company (ALIC) and its related entities by AM Best indicates a stable and positive outlook for these companies within the insurance market. The stable outlook suggests that the companies are expected to maintain their financial strength and creditworthiness in the medium term, while the positive outlook on the Long-Term ICRs points to a potential upgrade if the companies continue to demonstrate financial resilience and strong performance.The balance sheet strength, characterized by a 'very strong' assessment, is underpinned by steady capital growth and a conservative investment approach, with a reduction in holdings in riskier asset classes. This prudent financial management is particularly relevant to stakeholders, as it suggests a lower risk of volatility in the companies' financial standing. The strong operating performance, with underwriting and net income exceeding $2 billion in the past five years, reflects efficient business operations and effective cost management, which are essential for long-term profitability and competitiveness.The moderate reinsurance leverage and the unique reinsurance arrangements differentiate Aetna from its peers and may provide a strategic advantage in managing underwriting risk. The lack of debt held by Aetna Life & Health Group is a positive indicator of financial stability and reduces financial risk for the company. Healthcare Market Analyst The growth in membership across commercial, Medicare Advantage and Medicaid managed care product lines has been a key driver of premium growth for Aetna Health & Life Group. The expected continuation of growth in commercial and Medicare Advantage segments aligns with the broader trend in the healthcare industry towards managed care and value-based arrangements, which have been gaining traction due to their potential to improve care quality and cost-efficiency.However, the projected decline in Medicaid membership due to the resumption of redeterminations post-public health emergency could impact premium revenues. This anticipated change underscores the importance of market adaptability and the need for healthcare insurers to navigate regulatory environments effectively. Furthermore, the acquisitions of Signify Health Inc. and Oak Street Health Inc. by CVS Health, Aetna's parent company, reflect a strategic expansion into home health care and value-based primary care, which are growing segments in the healthcare market. These acquisitions, while offering potential growth opportunities, also carry execution risks that must be managed to ensure they contribute positively to the company's overall performance. Financial Risk Analyst The elevated financial leverage and goodwill of CVS Health, Aetna's ultimate parent, present potential risks that could impact the financial stability of the group. While the financial leverage has decreased since the acquisition of Aetna, the recent modest increase due to further acquisitions is a point of attention for stakeholders. The high goodwill-to-shareholders equity ratio, exceeding 110% at year-end 2023, indicates a significant amount of intangible assets, which can be a concern if not managed properly. Goodwill impairment could lead to volatility in earnings and affect investor confidence.The positive outlook on Aetna's Long-Term ICRs, however, suggests that AM Best anticipates the group's risk-adjusted capitalization will remain at the strongest level, which may mitigate some of the concerns related to financial leverage and goodwill. Stakeholders should monitor the integration of the new acquisitions and the management's ability to realize synergies and maintain strong capitalization levels. 03/13/2024 - 05:03 PM OLDWICK, N.J.--(BUSINESS WIRE)-- AM Best has affirmed the Financial Strength Rating (FSR) of A (Excellent) and the Long-Term Issuer Credit Ratings (Long-Term ICRs) of a (Excellent) of Aetna Life Insurance Company (ALIC) (Hartford, CT) and the other members of Aetna Health & Life Group, which are operating entities of Aetna Inc. (Aetna) and wholly owned subsidiaries of CVS Health Corporation (CVS Health) [NYSE: CVS]. The outlook of the FSR is stable, while the outlook of the Long-Term ICR is positive. (Please see below for a detailed listing of the companies.) Concurrently, AM Best has affirmed the FSR of A (Excellent) and the Long-Term ICR of a (Excellent) of Allina Health and Aetna Insurance Company (Allina Health) (St. Louis Park, MN). Allina Health is a joint venture with subsidiaries of Aetna Inc. The outlook of these Credit Ratings (ratings) is stable. In addition, AM Best has affirmed the FSR of A (Excellent) and the Long-Term ICRs of a (Excellent) of Texas Health + Aetna Health Insurance Company, as well as Texas Health + Aetna Health Plan Inc. Both companies are domiciled in Arlington, TX, and collectively are referred to as Texas Health Aetna. The outlook of these ratings is stable. At the same time, AM Best has withdrawn the ratings of Texas Health Aetna as the companies have requested to no longer participate in AM Bests interactive rating process. The ratings of Aetna Health & Life Group reflect its balance sheet strength, which AM Best assesses as very strong, as well as its strong operating performance, favorable business profile and appropriate enterprise risk management (ERM). The positive outlook on the Long-Term ICR for Aetna Health & Life Group reflects the groups risk-adjusted capitalization, which remains at the strongest level, as measured by its Best Capital Adequacy Ratio (BCAR). Capital and surplus has grown steadily despite large annual dividend payments in each of the past five years. The growth in absolute capital is reflected in the group's five-year compound annual growth rate of 7.6%. The risk profile of the investment portfolio has improved over time, as there has been a reduction in the holdings in several asset classes over the past few years, including commercial mortgages and equities, as well as the allocation to Class 2 and below investment grade bonds. Additionally, the balance sheet strength is supported by adequate liquidity measures, which are strengthened by access to the Federal Home Loan Bank of Boston at the lead entity, ALIC. Aetna Life & Health Group has moderate reinsurance leverage and its reinsurance arrangements differentiates Aetna from its health insurance peers. In addition to traditional reinsurance with highly rated carriers, Aetna Health & Life Group maintains a quota share reinsurance agreement with Health Re Inc. and subsequent excess of loss protection by Vitality Re entities. Furthermore, the group exhibits good quality of capital and currently does not hold any debt. Over the past few years, favorable development in net premium has been driven by membership growth in the commercial, Medicare Advantage and Medicaid managed care product lines. While premium growth is expected to continue for commercial and Medicare Advantage over the near term, it will be offset partially by declines in Medicaid membership in 2023 and the first half of 2024 due to the resumption of redeterminations following the end of the public health emergency. Premium growth has impacted operating earnings trends positively over the past few years. Aetna Health & Life Group has reported underwriting and net income exceeding $2 billion in each of the past five years with return on revenues at or exceeding 5% and return on equity exceeding 20%. The group reported an increase in underwriting income through year-end 2022; however, it noted an increase in claims driven by increased utilization in its Medicare Advantage segment, a trend that began in 2023, and is expected to continue into 2024. Moreover, investment income has been steady over the past five years and is expected to improve in 2023 and 2024 due to the interest rate environment. Investment income has meaningfully contributed to net earnings. Aetna is one of the leading players in the managed care markets offering products throughout the United States. While Aetnas Medicare Advantage and Medicaid managed care markets have experienced significant membership growth over the past few years, Aetna remains competitive and continues to gain enrollment in other segments. The ratings of Aetna Health & Life Group reflect the negative impact from its ultimate parent, CVS Health, which has elevated financial leverage and goodwill that is not expected to change materially in the near to medium term. While the financial leverage at CVS Health has declined substantially since the acquisition of Aetna, financial leverage increased modestly at year-end 2023, driven by the acquisitions of Signify Health Inc. and Oak Street Health Inc. Signify Health adds in-home health care to the CVS Health organization, while Oak Street Health is a leading multi-payer, value-based primary care company. Goodwill-to-shareholders equity increased over the prior year and exceeded 110% at year-end 2023. While the acquisitions of Oak Street and Signify Health are part of the organizations health care services strategy, AM Best recognizes the inherent execution risk within these transactions. Over the near term, there may be pressure from additional business expansion related to acquisitions. The ratings of Allina Health reflect its balance sheet strength, which AM Best assesses as adequate, as well as its marginal operating performance, limited business profile and appropriate ERM. In 2022, Allina Health marked its first year of underwriting gains since inception. However, the company continues to report net losses as underwriting gains were not sufficient to offset the amortization of intangible assets. In recent years, premium growth has trended favorably in Medicare Advantage products, while commercial products have increased modestly. The ratings of Texas Health Aetna reflect its balance sheet strength, which AM Best assesses as strong, as well as its adequate operating performance, limited business profile and appropriate ERM. Texas Health Aetna was supported by the strongest level of risk-adjusted capitalization, as measured by BCAR. Underwriting results have been favorable in four of the past five years and net income turned positive in 2022 as the amortization of intangibles concluded. The FSR of A (Excellent) and the Long-Term ICRs of a (Excellent) have been affirmed, with a stable outlook for the FSR and a positive outlook for the Long-Term ICRs, for the following members of Aetna Health & Life Group: Aetna Life Insurance Company Aetna Health and Life Insurance Company Aetna Life & Casualty (Bermuda) Ltd. Aetna Health Inc. (a Connecticut corporation) Aetna Health Inc. (a Florida corporation) Aetna Health Inc. (a Georgia corporation) Aetna Health Inc. (a Louisiana corporation) Aetna Health Inc. (a New Jersey corporation) Aetna Health Inc. (a New York corporation) Aetna Health Inc. (a Maine Corporation) Aetna Health Inc. (a Pennsylvania corporation) Aetna Health Inc. (a Texas corporation) Aetna Health Insurance Company Aetna Health Insurance Company of New York Aetna Better Health of Florida, Inc. Aetna Health of California Inc. Aetna Health of Iowa, Inc. Aetna Health of Utah, Inc. Aetna Dental of California Inc. Aetna Dental Inc. (a New Jersey corporation) Aetna Dental Inc. (a Texas corporation) American Continental Insurance Company Accendo Insurance Company Continental Life Insurance Company of Brentwood, Tennessee Coventry Health and Life Insurance Company Aetna Better Health of Michigan, Inc. Aetna Better Health of Missouri, LLC Coventry Health Care of Illinois, Inc. Coventry Health Care of Kansas, Inc. Coventry Health Care of Missouri, Inc. Coventry Health Care of Nebraska, Inc. Coventry Health Care of Virginia, Inc. Coventry Health Care of West Virginia, Inc. First Health Life & Health Insurance Company SilverScript Insurance Company This press release relates to Credit Ratings that have been published on AM Bests website. For all rating information relating to the release and pertinent disclosures, including details of the office responsible for issuing each of the individual ratings referenced in this release, please see AM Bests Recent Rating Activity web page. For additional information regarding the use and limitations of Credit Rating opinions, please view Guide to Best's Credit Ratings. For information on the proper use of Bests Credit Ratings, Bests Performance Assessments, Bests Preliminary Credit Assessments and AM Best press releases, please view Guide to Proper Use of Bests Ratings & Assessments. AM Best is a global credit rating agency, news publisher and data analytics provider specializing in the insurance industry. Headquartered in the United States, the company does business in over 100 countries with regional offices in London, Amsterdam, Dubai, Hong Kong, Singapore and Mexico City. For more information, visit www.ambest.com. Copyright  2024 by A.M. Best Rating Services, Inc. and/or its affiliates. ALL RIGHTS RESERVED. View source version on businesswire.com: https://www.businesswire.com/news/home/20240313364627/en/ Jon Housel Financial Analyst +1 908 882 1898 jon.housel@ambest.com Christopher Sharkey Associate Director, Public Relations +1 908 882 2310 christopher.sharkey@ambest.com Sally Rosen Senior Director +1 908 882 2284 sally.rosen@ambest.com Al Slavin Senior Public Relations Specialist +1 908 882 2318 al.slavin@ambest.com Source: AM Best What is Aetna Life Insurance Company's Financial Strength Rating? AM Best has affirmed Aetna Life Insurance Company's Financial Strength Rating of A (Excellent). What is the outlook for the Long-Term Issuer Credit Ratings of Aetna Life Insurance Company? The outlook for the Long-Term Issuer Credit Ratings is positive. What factors contribute to the positive outlook on the Long-Term Issuer Credit Ratings of Aetna Life Insurance Company? The positive outlook is due to the group's risk-adjusted capitalization, which remains at the strongest level, and steady growth in capital and surplus. How has Aetna Health & Life Group's underwriting income trended over the past five years? Aetna Health & Life Group has reported underwriting and net income exceeding $2 billion in each of the past five years. What is the impact of the acquisitions of Signify Health Inc. and Oak Street Health Inc. on Aetna Health & Life Group? AM Best recognizes the inherent execution risk within these transactions and anticipates pressure from additional business expansion related to acquisitions in the near term."
"LogicMark, Inc. to Announce Fourth Quarter and Full Year 2023 Financial Results on March 27, 2024",2024-03-13T21:01:00.000Z,Neutral,Neutral,"LogicMark, Inc. (Nasdaq: LGMK) announced the release of financial results for Q4 and full year 2023 on March 27, 2024. The live investor call will be hosted by CEO Ms. Chia-Lin Simmons and CFO Mr. Mark Archer. LogicMark offers personal emergency response systems and health communication devices, aiming to enhance the care economy.","LogicMark, Inc. to Announce Fourth Quarter and Full Year 2023 Financial Results on March 27, 2024 Rhea-AI Impact (Neutral) Rhea-AI Sentiment (Neutral) Tags earnings Rhea-AI Summary LogicMark, Inc. (Nasdaq: LGMK) announced the release of financial results for Q4 and full year 2023 on March 27, 2024. The live investor call will be hosted by CEO Ms. Chia-Lin Simmons and CFO Mr. Mark Archer. LogicMark offers personal emergency response systems and health communication devices, aiming to enhance the care economy. Positive None. Negative None. 03/13/2024 - 05:01 PM LOUISVILLE, Ky., March 13, 2024 (GLOBE NEWSWIRE) -- LogicMark, Inc. (Nasdaq: LGMK), a provider of personal emergency response systems, health communications devices, and technology for the growing care economy, today announced that on March 27, 2024, after market close, the Company will release financial results for the fourth quarter and full year ended December 31, 2023. Ms. Chia-Lin Simmons, CEO, and Mr. Mark Archer, CFO, will host a live investor call and webcast to review the results the same day at 1:30 PM (PDT) / 4:30 PM (EDT). Investors and analysts wishing to participate in the conference call must register to obtain their dial-in and pin number here https://register.vevent.com/register/BI3e8bde93af4144ae98420eb4f2c24f1c. To listen to the live webcast, please visit the LogicMark Investor Relations website here, or use the following link: https://edge.media-server.com/mmc/p/z449z9mq. The associated press release, SEC filings, and webcast replay will also be accessible on the investor relations website. For more information, please also visit www.logicmark.com. About UsLogicMark, Inc. (Nasdaq: LGMK) provides personal emergency response systems (PERS), health communications devices and technologies to create a Connected Care Platform. The Companys devices give people the ability to receive care at home and the confidence to age in place. LogicMark revolutionized the PERS industry by incorporating two-way voice communication technology directly into its medical alert pendant and providing this life-saving technology at a price point everyday consumers can afford. The Companys PERS technologies are sold through the United States Veterans Health Administration, dealers, distributors, and direct-to-consumers. LogicMark has been awarded a contract by the U.S. General Services Administration that enables the Company to distribute its products to federal, state, and local governments. Cautionary Statement Regarding Forward-Looking StatementsThis press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements reflect managements current expectations, as of the date of this press release, and involve certain risks and uncertainties. Forward-looking statements include statements herein with respect to the successful execution of the Companys business strategy. The Companys actual results could differ materially from those anticipated in these forward-looking statements because of various factors. Such risks and uncertainties include, among other things, our ability to establish and maintain the proprietary nature of our technology through the patent process, as well as our ability to possibly license from others patents and patent applications necessary to develop products; the availability of financing; the Companys ability to implement its long-range business plan for various applications of its technology; the Companys ability to enter into agreements with any necessary marketing and/or distribution partners; the impact of competition, the obtaining and maintenance of any necessary regulatory clearances applicable to applications of the Companys technology; the Companys ability to maintain its Nasdaq listing for its common stock; and management of growth and other risks and uncertainties that may be detailed from time to time in the Companys reports filed with the SEC. Investor Relations Contact:investors@logicmark.com When will LogicMark release its financial results for Q4 and full year 2023? LogicMark will release its financial results for Q4 and full year 2023 on March 27, 2024. Who will host the live investor call to review the financial results? The live investor call to review the financial results will be hosted by CEO Ms. Chia-Lin Simmons and CFO Mr. Mark Archer. What products and services does LogicMark offer? LogicMark offers personal emergency response systems (PERS), health communications devices, and technologies to create a Connected Care Platform. How does LogicMark aim to revolutionize the PERS industry? LogicMark revolutionized the PERS industry by incorporating two-way voice communication technology directly into its medical alert pendant, making this life-saving technology affordable for everyday consumers. Who are LogicMark's target customers for its PERS technologies? LogicMark's PERS technologies are sold through the United States Veterans Health Administration, dealers, distributors, and direct-to-consumers."
"North American Construction Group Ltd. Announces Results for the Fourth Quarter and Year Ended December 31, 2023",2024-03-13T21:05:00.000Z,Neutral,Neutral,"North American Construction Group Ltd. (NACG) announced its fourth-quarter and year-end results for 2023, highlighting the successful closure of the MacKellar Group acquisition, strong revenue growth, and record-setting figures. The company reported a combined revenue of $403.4 million, a company quarterly record, driven by the transformative acquisition of MacKellar. Adjusted EBITDA reached $101.1 million, also a company record, with a margin of 25.1%. Despite positive results, the company faced challenges with project losses impacting margins and increased debt levels. NACG's President and CEO, Joseph Lambert, expressed optimism for 2024, emphasizing geographic diversification and operational excellence.","North American Construction Group Ltd. Announces Results for the Fourth Quarter and Year Ended December 31, 2023 Rhea-AI Impact (Neutral) Rhea-AI Sentiment (Neutral) Tags earnings Rhea-AI Summary North American Construction Group Ltd. (NACG) announced its fourth-quarter and year-end results for 2023, highlighting the successful closure of the MacKellar Group acquisition, strong revenue growth, and record-setting figures. The company reported a combined revenue of $403.4 million, a company quarterly record, driven by the transformative acquisition of MacKellar. Adjusted EBITDA reached $101.1 million, also a company record, with a margin of 25.1%. Despite positive results, the company faced challenges with project losses impacting margins and increased debt levels. NACG's President and CEO, Joseph Lambert, expressed optimism for 2024, emphasizing geographic diversification and operational excellence. Positive Successful closure of the MacKellar Group acquisition. Record combined revenue of $403.4 million for the fourth quarter. Adjusted EBITDA of $101.1 million, a company record, with a margin of 25.1%. Challenges with project losses impacting margins and increased debt levels. Positive outlook for 2024 focusing on geographic diversification and operational excellence. Negative Margins impacted by project losses from the Nuna Group of Companies. Net debt increased to $720.9 million at December 31, 2023, from debt-funded acquisitions and spending. General and administrative expenses increased due to one-time costs related to the MacKellar acquisition. Financial Analyst The acquisition of the MacKellar Group by North American Construction Group Ltd. (NACG) represents a significant strategic move, indicating a strong push towards geographical diversification and increased market presence in Australia. The acquisition, valued at $369.7 million net of cash acquired, coupled with growth capital spending of $35.9 million, is noteworthy as it was fully funded through senior and vendor-provided debt. This financing approach may raise concerns regarding the company's leverage and its ability to service this debt, especially given the increase in net debt to $720.9 million at year-end 2023.The reported record revenues of $403.4 million for the quarter, which include three months of operations from MacKellar, suggest that the acquisition is already contributing significantly to the top line. However, investors should be cautious about the impact of integration costs and the sustainability of MacKellar's gross profit margin of 23.7% in the quarter. The reported increase in general and administrative expenses, including one-time acquisition costs and the uptick in interest expense due to higher debt levels are factors that could affect net income in the short term.It is also important to consider the company's liquidity position, which appears robust with total available capital liquidity of $292.6 million. This liquidity, together with the strong free cash flow of $110.6 million for the quarter, may provide some reassurance to investors regarding the company's financial health and its ability to manage its increased debt load. The forward-looking statements projecting key measures for 2024, including a significant rise in adjusted EBITDA to $430 - $470 million, suggest management's confidence in the company's growth trajectory. Market Research Analyst From a market perspective, NACG's aggressive expansion into the Australian market through the MacKellar acquisition could be seen as a strategic move to capitalize on the region's construction and mining sectors. This diversification could protect the company against regional downturns in North America and provide access to new revenue streams. However, the success of this expansion will depend on NACG's ability to integrate MacKellar's operations seamlessly and realize the anticipated synergies.Investors should also note the company's focus on operational excellence and the restructuring initiative within the Nuna Group of Companies, which is expected to enhance project execution and potentially improve margins. The emphasis on safety, execution and operational excellence are positive indicators of the company's commitment to sustainable growth. Moreover, the strategic focus on diversification and sustainability aligns with broader industry trends, which could enhance the company's competitive position and appeal to socially conscious investors.Given the cyclical nature of the construction and mining industries, the company's performance will be influenced by commodity prices, economic conditions and competition. As such, while the current outlook appears positive, investors should monitor these external factors closely as they can significantly impact the company's financial performance. Legal Expert It is crucial to examine the implications of NACG's financial strategy from a legal and regulatory standpoint. The financing of the MacKellar acquisition through debt raises questions about compliance with debt covenants and the company's long-term financial stability. Investors should be aware of the terms of the credit facility agreement and any potential risks associated with the company's increased leverage. The change in presentation of finance lease obligations within the consolidated balance sheets, now included in long-term debt, should also be scrutinized to ensure transparency and adherence to US GAAP principles.Furthermore, with the upcoming adoption of new FASB standards, such as ASU 2023-05 and ASU 2023-07, NACG will need to assess and potentially adjust its accounting practices. This could lead to changes in how joint venture formations and segment reporting are handled in the future, impacting the presentation of financial statements and the disclosures provided to investors. 03/13/2024 - 05:05 PM ACHESON, Alberta, March 13, 2024 (GLOBE NEWSWIRE) -- North American Construction Group Ltd. (""NACG"") (TSX:NOA/NYSE:NOA) today announced results for the fourth quarter and year ended December 31, 2023. Unless otherwise indicated, figures are expressed in Canadian dollars with comparisons to prior periods ended December 31, 2022. Fourth Quarter 2023 Highlights: Closure of the MacKellar Group (""MacKellar"") acquisition on October 1, 2023, a seamless change in control, and three months of strong equipment utilization provided a full quarter of operating results in Australia, and a step change in geographic diversification.The allocated purchase price of MacKellar was $369.7 million, net of cash acquired, along with growth capital spending of $35.9 million incurred in the quarter was fully funded with senior and vendor-provided debt and establishes a strong platform for opportunities in Australia.Combined revenue of $403.4 million is a company quarterly record based on the transformative acquisition of MacKellar. Revenue of $326.3 million, compared to $233.4 million in the same period last year, includes this step-change increase along with steady and consistent operations in the Fort McMurray region.Our net share of revenue from equity consolidated joint ventures was $77.1 million, compared to $86.7 million in the same period last year. Quarter-over-quarter increases at the Fargo-Moorhead project were offset by the successful 2023 Q3 completion of the construction project at the gold mine in Northern Ontario.Adjusted EBITDA of $101.1 million, also a company record, and EBITDA margin of 25.1% compared to the prior period metrics of $85.9 million and 26.8%, respectively. Margins were impacted by project losses posted by the Nuna Group of Companies; restructuring efforts are well underway to resolve temporary challenges.Cash flows generated from operating activities of $160.9 million in the quarter, compared to $78.1 million in the prior year quarter, resulting from higher earnings and changes in working capital balances when comparing to the same period in the prior year.Free cash flow (""FCF"") of $110.6 million in the quarter was the result of strong revenues, steady and consistent margins, modest capital spending, and positive changes in working capital balances.Net debt was $720.9 million at December 31, 2023, an increase of $325.6 million from September 30, 2023, resulting from the debt-funded purchase price and growth spending in Australia offset by free cash flow directed to debt reduction during the quarter. NACG President and CEO, Joseph Lambert, commented: ""The acquisition of the MacKellar Group is a milestone moment for our company and I'd like to thank all the employees for the hard work that has been put in to make these first few months in Australia such a success. In both Queensland and Western Australia, we are excited by the many prospects we have in front of us and look forward to sharing best practices and in-house maintenance expertise, as well as equipment where appropriate, to facilitate these growth opportunities. As we've geographically diversified, I continue to closely monitor our various regions. In North Dakota and based on a recent trip there, construction at Fargo-Moorhead is progressing well into this most important period for the project. In northern Canada, we are undergoing a restructuring initiative within the Nuna Group of Companies which will return it to its legacy of operational excellence. In Fort McMurray, our fleet continues to operate day-in day-out as we work with our customers in their goal to achieve low-cost operations in the oil sands region. 2024 will be a busy year for us and we are looking forward to executing and delivering another record year."" Consolidated Financial Highlights Three months ended Year ended December 31, December 31,(dollars in thousands, except per share amounts) 2023 2022 2023 2022 Revenue $326,298 $233,417 $957,220 $769,539 Cost of sales 218,853 154,967 671,684 548,723 Depreciation 41,990 35,860 131,319 119,268 Gross profit $65,455 $42,590 $154,217 $101,548 Gross profit margin 20.1% 18.2% 16.1% 13.2%General and administrative expenses (excluding stock-based compensation)(i) 18,702 6,648 41,016 25,075 Stock-based compensation expense (496) 4,910 15,828 4,780 Operating income 45,779 31,565 95,714 71,157 Interest expense, net 14,007 7,774 36,948 24,543 Net income 17,646 26,081 63,141 67,372 Adjusted EBITDA(i) 101,136 85,875 296,963 245,352 Adjusted EBITDA margin(i)(ii) 25.1% 26.8% 23.3% 23.3% Per share information Basic net income per share $0.66 $0.99 $2.38 $2.46 Diluted net income per share $0.58 $0.84 $2.09 $2.15 Adjusted EPS(i) $0.87 $1.10 $2.83 $2.41 (i) See ""Non-GAAP Financial Measures"". (ii)Adjusted EBITDA margin is calculated using adjusted EBITDA over total combined revenue. Three months ended Year ended December 31, December 31,(dollars in thousands) 2023 2022 2023 2022 Consolidated Statements of Cash Flows Cash provided by operating activities $160,870 $78,099 $270,391 $169,201 Cash used in investing activities (137,756) (17,524) (244,879) (97,469)Effect of exchange rate on changes in cash 3,167 (94) 1,705 304 Add back of growth and non-cash items included in the above figures: Acquisition of MacKellar(i) 51,671  51,671  Acquisition costs 5,934  7,095  Growth capital additions(ii) 35,941  40,416  Acquisition of ML Northern(iii)  7,207  7,207 Non-cash changes in fair value of contingent consideration (8,268)  (8,268)  Capital additions financed by leases(ii) (931) (236) (28,159) (8,931)Free cash flow(i) $110,628 $67,452 $89,972 $70,312 (i)See ""Non-GAAP Financial Measures"". Results for the Three Months Ended December 31, 2023 Combined revenue of $403.4 million, compared to $320.1 million in the same period last year, and revenue from wholly-owned entities was $326.3 million, up from $233.4 million in the same period last year. The majority of the quarter-over-quarter increase in revenue was driven by the October 2023 acquisition of MacKellar. MacKellar generated a full quarter of revenue totaling $122.5 million. Aside from MacKellar, revenue was down over the same period in 2022 as a result of changes in timing of reclamation projects beginning later than the previous year and certain construction scopes concluding earlier in 2023, relative to the same period in 2022. Combined gross profit margin of 18.4% was up from 17.8% in the prior year. The improvement in combined gross profit in the current period was driven by the acquisition of MacKellar. MacKellar generated gross profit of 23.7% in the quarter. General and administrative expenses (excluding stock-based compensation expense) were $18.7 million, or 5.7% of revenue for the three months ended December 31, 2023, up from $6.6 million, or 2.8% of revenue in the same period last year. General and administrative expenses in the quarter include one-time costs of $5.9 million related to the acquisition of MacKellar. MacKellar's administrative cost profile is similar to the Canadian and U.S. operations. Cash related interest expense of $13.2 million represents an average cost of debt of 8.8% (compared to $7.5 million and 7.1%, respectively, for the three months ended December 31, 2022). The increase in interest expense is primarily attributed to the higher balance on the Credit Facility and increases in the variable rate. Net income of $17.6 million in Q4 2023 compared to $26.1 million in the same period last year as higher gross profit was more than offset by increased interest expense, increased general and administrative expenses from the one-time acquisition costs, and lower equity earnings from our joint ventures. Free cash flow in the quarter was $110.6 million driven primarily by adjusted EBITDA of $101.1 million less sustaining capital spending of $40.8 million and cash interest paid of $13.2 million. Liquidity Including equipment financing availability and factoring in the amended Credit Facility agreement, total available capital liquidity of $292.6 million includes total liquidity of $217.9 million, $60.1 million of unused finance lease borrowing availability, and $14.6 million of unused other borrowing availability as at December 31, 2023. Liquidity is primarily provided by the terms of our $478.0 million credit facility which allows for funds availability based on a trailing twelve-month EBITDA as defined in the agreement, and is now scheduled to expire in October 2026. Business Updates Strategic Focus Areas for 2024 Safety - now on a global basis, maintain our uncompromising commitment to health and safety while elevating the standard of excellence in the field;Execution - enhance equipment availability in Canada and Australia through in-house fleet maintenance, reliability programs, technical improvements, and management systems;Operational excellence - with a specific focus on Nuna Group of Companies, put into action practical and experienced-based protocols to ensure predictable high-quality project execution;Integration - implement ERP and best practices at MacKellar, including identification of opportunities to better utilize our capital and equipment in Australia;Diversification - pursue diversification of customers and resources through strategic partnerships, industry expertise and investment in Indigenous joint ventures; andSustainability - further develop and deliver into our environmental, social, and governance targets as disclosed and committed to in our annual reporting. Outlook for 2024 The following table provides projected key measures for 2024 and actual results of 2023 and 2022. The measures for 2024 are predicated on contracts currently in place, including expected renewals and the heavy equipment fleet that we own and operate. Key measures 2022 Actual 2023 Actual 2024 OutlookCombined revenue $1.1B $1.3B $1.5 - $1.7BAdjusted EBITDA(i) $245M $297M $430 - $470MSustaining capital(i) $113M $169M $170 - $190MAdjusted EPS(i) $2.41 $2.83 $4.25 - $4.75Free cash flow(i) $70M $90M $160 - $185M Capital allocation Growth spending $13M $40M $55 - $70MNet debt leverage(i) 1.5x 1.7x Targeting 1.5x (i)See ""Non-GAAP Financial Measures"".(ii)Shareholder activity includes common shares purchased under a NCIB, dividends paid and the purchase of treasury shares. Conference Call and Webcast Management will hold a conference call and webcast to discuss our financial results for the three months and year ended December 31, 2023, tomorrow, Thursday, March 14, 2024, at 9:00 am Eastern Time (7:00 am Mountain Time). The call can be accessed by dialing: Toll free: 1-888-886-7786Conference ID: 29416987 A replay will be available through April 12, 2024, by dialing: Toll Free: 1-877-674-7070Conference ID: 29416987Playback Passcode: 416987 A slide deck for the webcast will be available for download the evening prior to the call and will be found on the companys website at www.nacg.ca/presentations/ The live presentation and webcast can be accessed at: https://onlinexperiences.com/scripts/Server.nxp?LASCmd=AI:4;F:QS!10100&ShowUUID=E7B12076-0168-45B4-8211-E024A0E31C5D A replay will be available until April 12, 2024, using the link provided. Basis of Presentation We have prepared our consolidated financial statements in conformity with accounting principles generally accepted in the United States (""US GAAP""). Unless otherwise specified, all dollar amounts discussed are in Canadian dollars. Please see the Managements Discussion and Analysis (""MD&A"") for the three months and year ended December 31, 2023, for further detail on the matters discussed in this release. In addition to the MD&A, please reference the dedicated Q4 2023 Results Presentation for more information on our results and projections which can be found on our website under Investors - Presentations. Change in significant accounting policy - Basis of presentation During the first quarter of 2023, the Company updated the presentation of finance lease obligations within the Consolidated Balance Sheets to be included in long-term debt. Within the long-term debt note, finance lease obligations, financing obligations, and promissory notes have been combined as equipment financing. Finance lease obligations are the finance lease liabilities recognized in accordance with the Company's lease policy which is disclosed in our Annual Report. Financing obligations arise when the Company finances its owned equipment. There has been no change in the Companys accounting policy for finance lease obligations or change in the recognition or measurement of the related balances now recognized within long-term debt. The change in presentation had no effect on the reported results of operations. The comparative period has been updated to reflect this presentation change. Recent accounting pronouncements not yet adopted Joint venture formations In August 2023, the FASB issued ASU 2023-05, Business Combinations - Joint Venture Formations. This accounting standard update was issued to create new requirements for valuing contributions made to a joint venture upon formation. This standard is effective January 1, 2025, with early adoption permitted. We are assessing the impact the adoption of this standard may have on its consolidated financial statements. Segment reporting In November 2023, the FASB issued ASU 2023-07, Segment Reporting: Improvements to Reportable Segment Disclosures. This accounting standard update was issued to improve reportable segment disclosure requirements, primarily through enhanced disclosures about significant segment expenses. This standard is effective for the fiscal year beginning January 1, 2024. We are assessing the impact the adoption of this standard may have on its consolidated financial statements. Income taxes In December 2023, the FASB issued ASU 2023-09, Income Taxes: Improvements to Income Tax Disclosures. This accounting standard update was issued to increase transparency by improving income tax disclosures primarily related to the rate reconciliation and income taxes paid information. This standard is effective for the fiscal year beginning January 1, 2025, with early adoption permitted. We are assessing the impact the adoption of this standard may have on its consolidated financial statements. Forward-Looking Information The information provided in this release contains forward-looking statements. Forward-looking statements include statements preceded by, followed by or that include the words ""anticipate"", ""believe"", ""expect"", ""should"" or similar expressions and include guidance with respect to financial metrics provided in our outlook for 2024. The material factors or assumptions used to develop the above forward-looking statements include, and the risks and uncertainties to which such forward-looking statements are subject, are highlighted in the MD&A for the three months and year ended December 31, 2023. Actual results could differ materially from those contemplated by such forward-looking statements because of any number of factors and uncertainties, many of which are beyond NACGs control. Undue reliance should not be placed upon forward-looking statements and NACG undertakes no obligation, other than those required by applicable law, to update or revise those statements. For more complete information about NACG, please read our disclosure documents filed with the SEC and the CSA. These free documents can be obtained by visiting EDGAR on the SEC website at www.sec.gov or on the CSA website at www.sedarplus.ca and on our company website at www.nacg.ca. Non-GAAP Financial Measures This press release presents certain non-GAAP financial measures, non-GAAP ratios, and supplementary financial measures that may be useful to investors in analyzing our business performance, leverage, and liquidity. A non-GAAP financial measure is defined by relevant regulatory authorities as a numerical measure of an issuer's historical or future financial performance, financial position or cash flow that is not specified, defined or determined under the issuers GAAP and that is not presented in an issuers financial statements. A ""non-GAAP ratio"" is a ratio, fraction, percentage or similar expression that has a non-GAAP financial measure as one or more of its components. Non-GAAP financial measures and ratios do not have standardized meanings under GAAP and therefore may not be comparable to similar measures presented by other issuers. They should not be considered in isolation or as a substitute for measures of performance prepared in accordance with GAAP. A ""supplementary financial measure"" is a financial measure disclosed, or intended to be disclosed, on a periodic basis to depict historical or future financial performance, financial position or cash flows that does not fall within the definition of a non-GAAP financial measure or non-GAAP ratio. The non-GAAP financial measures and ratios we present include, ""adjusted EBIT"", ""adjusted EBITDA"", ""adjusted EBITDA margin"" ""adjusted EPS"", ""adjusted net earnings"", ""backlog"", ""capital additions"", ""capital expenditures, net"", ""capital inventory"", ""capital work in progress"", ""cash provided by operating activities prior to change in working capital"", ""combined gross profit"", ""combined gross profit margin"", ""equity investment depreciation and amortization"", ""equity investment EBIT"", ""free cash flow"", ""general and administrative expenses (excluding stock-based compensation)"", ""gross profit"", ""growth capital"", ""invested capital"", ""net debt"", ""sustaining capital"", ""total capital liquidity"", ""total combined revenue"", and ""total debt"". We also use supplementary financial measures such as ""gross profit margin"" and ""total net working capital (excluding cash and current portion of long-term debt)"" in our MD&A. Each non-GAAP financial measure used in this press release is defined under ""Financial Measures"" in our Management's Discussion and Analysis filed on EDGAR on the SEC website at www.sec.gov or on the CSA website at www.sedarplus.ca and on our company website at www.nacg.ca. Reconciliation of total reported revenue to total combined revenue Three months ended Year ended December 31, December 31,(dollars in thousands) 2023 2022 2023 2022 Revenue from wholly-owned entities per financial statements $326,298 $233,417 $957,220 $769,539 Share of revenue from investments in affiliates and joint ventures 169,662 183,006 686,299 596,033 Elimination of joint venture subcontract revenue (92,522) (96,315) (369,891) (311,307)Total combined revenue(i) $403,438 $320,108 $1,273,628 $1,054,265 (i) See ""Non-GAAP Financial Measures"". Reconciliation of reported gross profit to combined gross profit Three months ended Year ended December 31, December 31,(dollars in thousands) 2023 2022 2023 2022Gross profit from wholly-owned entities per financial statements $65,455 $42,590 $154,217 $101,548Share of gross profit from investments in affiliates and joint ventures 8,670 14,541 49,638 49,581Combined gross profit(i) $74,125 $57,131 $203,855 $151,129 (i) See ""Non-GAAP Financial Measures"". Reconciliation of net income to adjusted net earnings, adjusted EBIT and adjusted EBITDA Three months ended Year ended December 31, December 31,(dollars in thousands) 2023 2022 2023 2022 Net income $17,646 $26,081 $63,141 $67,372 Adjustments: Loss (gain) on disposal of property, plant and equipment 1,470 (533) 1,659 536 Stock-based compensation (benefit) expense (496) 4,910 15,828 4,780 Acquisition costs 5,934  7,095  Loss on equity investment customer bankruptcy claim settlement   759  Loss (gain) on derivative financial instruments 916 (778) (6,063) (778)Equity investment (gain) loss on derivative financial instruments (713) 364 (1,362) (4,776)Tax effect of the above items (1,589) (1,006) (5,829) (1,222)Adjusted net earnings(i) $23,168 $29,038 $75,228 $65,912 Adjustments: Tax effect of the above items 1,589 1,006 5,829 1,222 Change in fair value of contingent consideration 4,681  4,681  Interest expense, net 14,007 7,774 36,948 24,543 Income tax expense 10,930 6,889 22,822 17,073 Equity earnings in affiliates and joint ventures(i) (2,401) (8,401) (25,815) (37,053)Equity investment EBIT(i) 1,787 9,363 25,545 42,148 Adjusted EBIT(i) $53,761 $45,669 $145,238 $113,845 Adjustments: Depreciation and amortization 42,277 36,094 132,516 120,124 Equity investment depreciation and amortization(i) 5,098 4,112 19,209 11,383 Adjusted EBITDA(i) $101,136 $85,875 $296,963 $245,352 Adjusted EBITDA margin(i)(ii) 25.1% 26.8% 23.3% 23.3% (i) See ""Non-GAAP Financial Measures"".(ii)Adjusted EBITDA margin is calculated using adjusted EBITDA over total combined revenue. Reconciliation of equity earnings in affiliates and joint ventures to equity investment EBIT Three months ended Year ended December 31, December 31,(dollars in thousands) 2023 2022 2023 2022Equity (earnings) loss in affiliates and joint ventures $2,401 $8,401 $25,815 $37,053Adjustments: Interest expense, net (268) 688 (1,183) 2,589Income tax expense (324) 275 970 2,442(Gain) loss on disposal of property, plant and equipment (22) (1) (57) 64Equity investment EBIT(i) $1,787 $9,363 $25,545 $42,148Depreciation 4,983 3,936 18,555 10,679Amortization of intangible assets 115 176 654 704Equity investment depreciation and amortization(i) $5,098 $4,112 $19,209 $11,383 (i) See ""Non-GAAP Financial Measures"" About the Company North American Construction Group Ltd. is a premier provider of heavy civil construction and mining services in Canada, the U.S. and Australia. For 70 years, NACG has provided services to the mining, resource and infrastructure construction markets. For further information contact: Jason Veenstra, CPA, CAChief Financial OfficerNorth American Construction Group Ltd.(780) 960.7171ir@nacg.cawww.nacg.ca Consolidated Balance Sheets As at December 31 (Expressed in thousands of Canadian Dollars) 2023 2022 Assets Current assets Cash $88,614 $69,144 Accounts receivable 97,855 83,811 Contract assets 35,027 15,802 Inventories 64,962 49,898 Prepaid expenses and deposits 7,402 10,587 Assets held for sale 1,340 1,117 295,200 230,359 Property, plant and equipment 1,142,946 645,810 Operating lease right-of-use assets 12,782 14,739 Intangible assets 6,971 6,773 Investments in affiliates and joint ventures 81,435 75,637 Other assets 7,144 5,808 Deferred tax assets  387 Total assets $1,546,478 $979,513 Liabilities and shareholders' equity Current liabilities Accounts payable $146,190 $102,549 Accrued liabilities 94,726 43,784 Contract liabilities 59 1,411 Current portion of long-term debt 81,306 42,089 Current portion of operating lease liabilities 1,742 2,470 324,023 192,303 Long-term debt 611,313 378,452 Operating lease liabilities 11,307 12,376 Other long-term obligations 134,357 18,576 Deferred tax liabilities 108,824 71,887 1,189,824 673,594 Shareholders' equity Common shares (authorized  unlimited number of voting common shares; issued and outstanding  December 31, 2023 - 27,827,282 (December 31, 2022  27,827,282)) 229,455 229,455 Treasury shares (December 31, 2023 - 1,090,187 (December 31, 2022 - 1,406,461)) (16,165) (16,438)Additional paid-in capital 20,739 22,095 Retained earnings 123,032 70,501 Accumulated other comprehensive (loss) income (407) 306 Shareholders' equity 356,654 305,919 Total liabilities and shareholders' equity $1,546,478 $979,513 Consolidated Statements of Operations and Comprehensive Income For the years ended December 31(Expressed in thousands of Canadian Dollars, except per share amounts) 2023 2022 Revenue $957,220 $769,539 Cost of sales 671,684 548,723 Depreciation 131,319 119,268 Gross profit 154,217 101,548 General and administrative expenses 56,844 29,855 Loss on disposal of property, plant and equipment 1,659 536 Operating income 95,714 71,157 Equity earnings in affiliates and joint ventures (25,815) (37,053)Interest expense, net 36,948 24,543 Change in fair value of contingent consideration 4,681  Gain on derivative financial instruments (6,063) (778)Income before income taxes 85,963 84,445 Current income tax expense 6,841 1,627 Deferred income tax expense 15,981 15,446 Net income 63,141 67,372 Other comprehensive income Unrealized foreign currency translation loss (gain) 713 (304)Comprehensive income $62,428 $67,676 Per share information Basic net income per share $2.38 $2.46 Diluted net income per share $2.09 $2.15 What was the allocated purchase price for the MacKellar Group acquisition? The allocated purchase price for the MacKellar Group acquisition was $369.7 million. What was the revenue for the fourth quarter of 2023 compared to the same period in 2022? The revenue for the fourth quarter of 2023 was $326.3 million, compared to $233.4 million in the same period in 2022. What was the adjusted EBITDA margin for the fourth quarter of 2023? The adjusted EBITDA margin for the fourth quarter of 2023 was 25.1%. What were the challenges faced by NACG in the fourth quarter of 2023? NACG faced challenges with project losses impacting margins and increased debt levels in the fourth quarter of 2023. What is the outlook for NACG in 2024? The outlook for NACG in 2024 focuses on geographic diversification and operational excellence."
Rafael Holdings Reports Second Quarter Fiscal 2024 Financial Results,2024-03-13T21:04:00.000Z,Neutral,Neutral,"Rafael Holdings, Inc. (NYSE: RFL) reports financial results for Q2 fiscal 2024, showing a net income of $5.9 million and increased ownership in Day Three Labs to 79%. The company aims to enhance shareholder value through strategic investments and portfolio advancement, welcoming Dr. John Goldberg as Chief Medical Officer. Notable progress in Cyclo Therapeutics' Phase 3 trial for Niemann-Pick Disease Type C and Day Three Labs' innovative cannabis products development.","Rafael Holdings Reports Second Quarter Fiscal 2024 Financial Results Rhea-AI Impact (Neutral) Rhea-AI Sentiment (Neutral) Tags earnings Rhea-AI Summary Rafael Holdings, Inc. (NYSE: RFL) reports financial results for Q2 fiscal 2024, showing a net income of $5.9 million and increased ownership in Day Three Labs to 79%. The company aims to enhance shareholder value through strategic investments and portfolio advancement, welcoming Dr. John Goldberg as Chief Medical Officer. Notable progress in Cyclo Therapeutics' Phase 3 trial for Niemann-Pick Disease Type C and Day Three Labs' innovative cannabis products development. Positive None. Negative None. Financial Analyst The reported financial results by Rafael Holdings, Inc. for the second quarter of fiscal 2024 indicate a significant turnaround in performance, with net income from continuing operations of $5.9 million, compared to a net loss in the previous year. This shift is primarily attributed to an unrealized gain of $9.7 million from investments in Cyclo Therapeutics. The strategic decision to increase ownership in Day Three Labs to a majority interest aligns with the company's commitment to expand its portfolio and leverage its financial position.However, it is noteworthy that the company recorded a loss of $1.6 million on its initial investment in Day Three Labs. This highlights the inherent risks associated with strategic investments, especially in industries such as cannabis, which are subject to regulatory and market volatility. The reduction in research and development expenses suggests a strategic pivot or streamlining of operations, possibly indicating a focus on fewer, more promising projects or a reallocation of resources towards the newly consolidated Day Three Labs. Market Research Analyst The pharmaceutical and biotech sectors are highly competitive and subject to rapid change. Rafael Holdings' investment in Cyclo Therapeutics, particularly during its Phase 3 clinical trial for Niemann-Pick Disease Type C, suggests confidence in the potential market success of the therapy. The disease, being rare, may benefit from orphan drug status, potentially offering market exclusivity and pricing advantages. The company's increased stake in Day Three Labs, which focuses on enhancing cannabis products with pharmaceutical-grade technology, indicates an attempt to diversify and tap into the burgeoning cannabis market.Investors should consider the long-term growth potential of these strategic moves, while also acknowledging the challenges of integrating new acquisitions and the time required for clinical trials to potentially translate into marketable products. The increased general and administrative expenses, primarily due to non-cash stock-based compensation and professional fees, reflect the costs associated with these strategic endeavors and the company's expansion. Biotech Investment Analyst The financial performance of Rafael Holdings is closely tied to the success of its strategic investments, particularly in the biotech sector. The unrealized gains from Cyclo Therapeutics underscore the volatility and potential for high returns in biotech investments. The pivot towards a majority ownership in Day Three Labs represents a diversification strategy, potentially spreading risk across different segments of the healthcare and biotechnology market.While the reduction in R&D expenses might raise questions about the company's long-term innovation pipeline, it could also signal a strategic focus on bringing current assets to market. The consolidation of Day Three Labs' financial results may impact the company's balance sheet and income statement in the future, depending on the subsidiary's performance. As the cannabis market is still in a nascent and evolving regulatory environment, this investment might carry a higher risk profile, which stakeholders should monitor closely. 03/13/2024 - 05:04 PM Company remains focused on generating shareholder value by advancing portfolio and identifying attractive opportunities for strategic investments Increased ownership in Day Three Labs to a majority interest of 79% NEWARK, N.J., March 13, 2024 (GLOBE NEWSWIRE) -- Rafael Holdings, Inc. (NYSE: RFL), today reported its financial results for the second quarter of fiscal 2024  and the six months ended January 31, 2024. During fiscal 2024, we will continue to focus on advancing our existing portfolio and intend to leverage our strong balance sheet with selective strategic investments in companies with the potential to generate value for our stockholders. We are extremely pleased to welcome Dr. John Goldberg to the Rafael team as our Chief Medical Officer. John is a highly respected senior executive with nearly two decades of experience in drug development. John will be an integral member of our team, as we advance our existing assets and evaluate additional opportunities for investment, said Bill Conkling, CEO of Rafael Holdings. Bill added, We are encouraged by the positive developments for Cyclo Therapeutics (Nasdaq: CYTH) Phase 3 registrational clinical trial for patients with Niemann-Pick Disease Type C and in the increasing momentum behind Day Three Labs, which reimagines existing cannabis offerings with pharmaceutical-grade technology to bring to market better, cleaner, more precise and predictable products. Rafael Holdings, Inc. Second Quarter Fiscal Year 2024 Financial Results As of January 31, 2024, we had cash, cash equivalents and marketable securities of $71.7 million. For the three months ended January 31, 2024, we recorded net income from continuing operations of $5.9 million, or $0.25 per fully diluted share versus a net loss from continuing operations of $3.3 million, or $0.13 per share in the year ago period. The net income reported during the second quarter was driven by an unrealized gain of $9.7 million on our investments in Cyclo Therapeutics, offset by a loss of $1.6 million on our initial investment in Day Three Labs. During the second quarter of 2024, we increased our investment in Day Three Labs and now hold a majority interest in the company with 79% of the shares outstanding and began consolidating its financial results in the second quarter of 2024. For the three months ended January 31, 2024, research and development expenses were $0.6 million compared to $2.2 million in the year ago period. The year over year reduction is due to the, previously disclosed, winding down of early-stage programs, including at Barer Institute. For the three months ended January 31, 2024, general and administrative expenses from continuing operations were $2.6 million. For the same period in the prior year, general and administrative expenses were $2.1 million. The increase was primarily related to increases in non-cash stock-based compensation expenses and professional fees. Rafael Holdings, Inc. First Half Fiscal Year 2024 Financial Results For the six months ended January 31, 2024, we recorded net income from continuing operations of $2.1 million, or $0.10 per fully diluted share versus a net loss from continuing operations of $8.5 million, or $0.36 per share in the year ago period. The net income recorded during the first half of fiscal 2024 was driven by an unrealized gain of $7.6 million on our investments in Cyclo Therapeutics, offset by a loss of $1.6 million on our initial investment in Day Three Labs. During the second quarter of 2024, we increased our investment in Day Three Labs and now hold a majority interest in the company with 79% of the shares outstanding and we began reporting consolidated its financial results in January 2024. For the six months ended January 31, 2024, research and development expenses were $1.1 million compared to $4.3 million in the year ago period. The year over year reduction is due to the winding down of early-stage programs, including at Barer Institute. For the six months ended January 31, 2024, general and administrative expenses from continuing operations were $4.6 million. For the same period in the prior year, general and administrative expenses were $5.2 million. The decrease was primarily related to a decrease in non-cash stock-based compensation and payroll expenses. About Rafael Holdings, Inc. Rafael Holdings is a holding company with interests in clinical and early-stage pharmaceutical companies, including a majority investment in Cornerstone Pharmaceuticals, Inc., formerly known as Rafael Pharmaceuticals Inc., a cancer metabolism-based therapeutics company, a majority equity interest in LipoMedix Pharmaceuticals Ltd., a clinical stage pharmaceutical company, the Barer Institute Inc., a wholly-owned preclinical cancer metabolism research operation, an investment in Cyclo Therapeutics Inc. (Nasdaq: CYTH), a clinical-stage biotechnology company dedicated to developing life-changing medicines for patients and families living with challenging diseases through its lead therapeutic asset, Trappsol Cyclo, a majority investment in Day Three Labs, Inc., a company which reimagines existing cannabis offerings with pharmaceutical-grade technology and innovation like Unlokt to bring to market better, cleaner, more precise and predictable products in the cannabis industry, and a majority interest in Rafael Medical Devices, LLC, an orthopedic-focused medical device company developing instruments to advance minimally invasive surgeries. The Companys primary focus is to expand our investment portfolio through opportunistic and strategic investments including therapeutics which address high unmet medical needs. Forward Looking Statements This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements contained in this press release that do not relate to matters of historical fact should be considered forward-looking statements, including without limitation statements regarding our expectations surrounding the potential, safety, efficacy, and regulatory and clinical progress of our product candidates; plans regarding the further evaluation of clinical data; and the potential of our pipeline, including our internal cancer metabolism research programs. These statements are neither promises nor guarantees, but involve known and unknown risks, uncertainties and other important factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements, including, but not limited to, those disclosed under the caption Risk Factors in our Annual Report on Form 10-K for the year ended July 31, 2023, and our other filings with the SEC. These factors could cause actual results to differ materially from those indicated by the forward-looking statements made in this press release. Any such forward-looking statements represent managements estimates as of the date of this press release. While we may elect to update such forward-looking statements at some point in the future, we disclaim any obligation to do so, even if subsequent events cause our views to change. Contact:Barbara RyanBarbara.ryan@rafaelholdings.com(203) 274-2825 RAFAEL HOLDINGS, INC. CONSOLIDATED BALANCE SHEETS (in thousands, except share and per share data) January 31, 2024 July 31, 2023 ASSETS (unaudited) CURRENT ASSETS Cash and cash equivalents $7,136 $21,498 Available-for-sale securities 64,587 57,714 Interest receivable 560 387 Convertible note receivable, related party 1,924 1,921 Accounts receivable, net of allowance for doubtful accounts of $245 at January 31, 2024 and July 31, 2023 379 213 Prepaid expenses and other current assets 487 914 Investment in equity securities  294 Total current assets 75,073 82,941 Property and equipment, net 2,064 1,695 Investments  Other Pharmaceuticals  65 Investments  Hedge Funds 2,369 4,984 Investment  Day Three  2,797 Investments  Cyclo Therapeutics Inc. 19,567 4,763 Goodwill 3,571  Intangible assets 1,888  In-process research and development 1,575 1,575 Other assets 42 9 TOTAL ASSETS $106,149 $98,829 LIABILITIES AND EQUITY CURRENT LIABILITIES Accounts payable $509 $333 Accrued expenses 845 763 Other current liabilities 140 1,023 Due to related parties 69 26 Installment note payable 1,700  Total current liabilities 3,263 2,145 Deferred income tax liabilities, net 545  Other liabilities 87 55 TOTAL LIABILITIES $3,895 $2,200 COMMITMENTS AND CONTINGENCIES EQUITY Class A common stock, $0.01 par value; 35,000,000 shares authorized, 787,163 shares issued and outstanding as of January 31, 2024 and July 31, 2023 8 8 Class B common stock, $0.01 par value; 200,000,000 shares authorized, 23,882,117 issued and 23,695,332 outstanding (excluding treasury shares of 101,487) as of January 31, 2024, and 23,708,365 shares issued and 23,490,527 shares outstanding as of July 31, 2023 238 236 Additional paid-in capital 266,159 264,010 Accumulated deficit (164,924) (167,333) Treasury stock, at cost; 101,487 and 0 Class B shares as of January 31, 2024 and July 31, 2023, respectively (168)  Accumulated other comprehensive loss related to unrealized loss on available-for-sale securities (88) (353) Accumulated other comprehensive income related to foreign currency translation adjustment 3,714 3,725 Total equity 104,939 100,293 Noncontrolling interests (2,685) (3,664) TOTAL EQUITY ATTRIBUTABLE TO RAFAEL HOLDINGS, INC. 102,254 96,629 TOTAL LIABILITIES AND EQUITY $106,149 $98,829 RAFAEL HOLDINGS, INC. CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS) (in thousands, except share and per share data) (unaudited) (unaudited) Three Months Ended January 31, Six Months Ended January 31, 2024 2023 2024 2023 Revenues$68 $70 $136 $140 G&A Expenses 2,561 2,085 4,601 5,194 R&D Expenses 612 2,225 1,101 4,306 Depreciation and amortization 38 19 55 41 Operating Loss (3,143) (4,259) (5,621) (9,401) Unrealized gain (loss) on investments - Hedge Funds 51 378 (115) 251 Impairment of investments - Other Pharmaceuticals - (67) - (223) Loss on initial investment in Day Three upon acquisition (1,633) - (1,633) - Unrealized gain on investments - Cyclo Therapeutics Inc 9,718 - 7,594 Other, net 1,117 701 2,347 924 Income (loss) before incomes taxes from continuing operations 6,110 (3,247) 2,572 (8,449) Benefit from (provision for) taxes - (5) (6) (10) Equity in loss of Day Three (206) - (422) - Consolidated net income (loss) from continuing operations 5,904 (3,252) 2,144 (8,459) Discontinued Operations Loss from discontinued operations related to 520 Property - (157) - (241) Gain on disposal of 520 Property - - - 6,784 (Loss) income from discontinued operations - (157) - 6,543 Consolidated net income (loss) 5,904 (3,409) 2,144 (1,916) Net loss attributable to noncontrolling interests (143) (159) (265) (258) Net income (loss) attributable to Rafael Holdings, Inc.$6,047 $(3,250) $2,409 $(1,658) Continuing operations earnings (loss) per share Net income (loss) from continuing operations$5,904 $(3,252) $2,144 $(8,459) Net loss attributable to noncontrolling interests (143) (159) (265) (258) Numerator for income (loss) per share from continuing operations$6,047 $(3,093) $2,409 $(8,201) Discontinued operations earnings (loss) per share Net income (loss) from discontinued operations$- $(157) $- $6,543 Earnings (loss) per share - Basic Continuing operations$0.26 $(0.13) $0.10 $(0.36) Discontinued operations - (0.01) - 0.28 Total basic earnings (loss) per common share$0.26 $(0.14) $0.10 $(0.07) Earnings (loss) per share - Diluted Continuing operations$0.25 $(0.13) $0.10 $(0.36) Discontinued operations - (0.01) - 0.28 Total diluted earnings (loss) per common share$0.25 $(0.14) $0.10 $(0.07) Weighted average number of shares used in calculation of earnings (loss) per share - basic 23,642,421 23,155,018 23,643,660 23,085,612 Weighted average number of shares used in calculation of earnings (loss) per share - diluted 24,402,069 23,155,018 24,403,308 23,085,612 What are Rafael Holdings, Inc.'s financial results for the second quarter of fiscal 2024? Rafael Holdings reported a net income of $5.9 million for Q2 fiscal 2024, with cash, cash equivalents, and marketable securities totaling $71.7 million as of January 31, 2024. What is Rafael Holdings, Inc.'s ownership percentage in Day Three Labs? Rafael Holdings increased its ownership in Day Three Labs to a majority interest of 79% in the second quarter of 2024. Who is the new Chief Medical Officer at Rafael Holdings, Inc.? Dr. John Goldberg joined Rafael Holdings as the Chief Medical Officer, bringing nearly two decades of experience in drug development. What positive developments were mentioned for Cyclo Therapeutics in the press release? Cyclo Therapeutics showed positive progress in its Phase 3 registrational clinical trial for patients with Niemann-Pick Disease Type C. What innovative approach is Day Three Labs taking in the cannabis market? Day Three Labs is reimagining cannabis offerings with pharmaceutical-grade technology to develop better, cleaner, more precise, and predictable products."
Everspin Technologies Expands Board of Directors with Appointment of Douglas Mitchell,2024-03-13T21:00:00.000Z,Low,Neutral,"Everspin Technologies appoints Douglas Mitchell, a semiconductor industry veteran, to its Board of Directors. Mitchell brings over 40 years of experience in memory products and technology, with a focus on high-performance non-volatile memory ICs. His strategic guidance is expected to drive Everspin's growth and market opportunities.","Everspin Technologies Expands Board of Directors with Appointment of Douglas Mitchell Rhea-AI Impact (Low) Rhea-AI Sentiment (Neutral) Tags management Rhea-AI Summary Everspin Technologies appoints Douglas Mitchell, a semiconductor industry veteran, to its Board of Directors. Mitchell brings over 40 years of experience in memory products and technology, with a focus on high-performance non-volatile memory ICs. His strategic guidance is expected to drive Everspin's growth and market opportunities. Positive None. Negative None. 03/13/2024 - 05:00 PM Mitchell will Draw on Previous Everspin Experience and 40 Years of Semiconductor Expertise to Guide Strategic Growth. CHANDLER, Ariz.--(BUSINESS WIRE)-- Everspin Technologies, Inc. (NASDAQ: MRAM), the worlds leading developer and manufacturer of Magnetoresistive Random Access Memory (MRAM) persistent memory solutions, announced the appointment of Douglas Mitchell to its Board of Directors, effective February 26, 2024. Mr. Mitchell has held various executive management positions focusing on corporate leadership, technology, marketing and business development of micro-controllers, digital signal processors and memories. His principal focus has been market requirements, providing rapid growth opportunities for high-performance, non-volatile memory ICs. During his tenure at Infineon Technologies, he served as Vice President of RAM products, overseeing P&L responsibilities for a broad range of volatile and non-volatile memory technologies. Prior to Infineon, Mr. Mitchell worked with Microelectronics Research Development Corporation and the US Air Force Research Labs, developing memory products for space applications. At Everspin, Mr. Mitchell served as Vice President of Sales & Marketing, leading business development efforts for the company's MRAM products shortly after their spin-off from Freescale. Earlier, he was President & CEO of Simtek Corporation, a publicly traded provider of non-volatile RAM ICs. He was responsible for establishing a cooperative development contract with Cypress Semiconductor that led to Cypress acquisition of Simtek. ""We look forward to Doug's return to Everspin, but this time as a distinguished member of our Board,"" said President and Chief Executive Officer Sanjeev Aggarwal. ""Doug's deep understanding of competitive memory products and technologies, coupled with extensive experience in application use cases and go-to-market strategies, makes him a valued asset. His 40+ years of valuable expertise in the semiconductor industry, proven leadership and strategic acumen will significantly contribute to Everspin's strategic direction and growth trajectory."" About Everspin Technologies Everspin Technologies, Inc. is the worlds leading provider of Magnetoresistive RAM (MRAM). Everspin MRAM delivers the industrys most robust, highest performance non-volatile memory for Industrial IoT, Data Center, and other mission-critical applications where data persistence is paramount. Headquartered in Chandler, Arizona, Everspin provides commercially available MRAM solutions to a large and diverse customer base. For more information, visit www.everspin.com. NASDAQ: MRAM. Forward-Looking Statements in this press release relating to future events or results are forward-looking statements that involve risks and uncertainties that could cause actual results or events to differ materially from the expectations disclosed in the forward-looking statements. Specifically, there can be no assurances that Everspin will be awarded any funds in connection with its Chips Act application. Actual results could differ materially from these forward-looking statements as a result of certain risks and uncertainties, including, without limitation, the risks set forth under the caption Risk Factors in Everspins Annual Report on Form 10-K for the year ended December 31, 2023, filed with the SEC on February 29, 2024, as well as in Everspins subsequent filings with the SEC. Any forward-looking statements made by Everspin in this press release speak only as of the date on which they are made, and subsequent events may cause these expectations to change. Everspin disclaims any obligation to update or alter these forward-looking statements in the future, whether as a result of new information, future events or otherwise, except as required by law. View source version on businesswire.com: https://www.businesswire.com/news/home/20240313708997/en/ Investor Relations: Monica Gould The Blueshirt Group T: 212-871-3927 ir@everspin.com Source: Everspin Technologies, Inc. Who was appointed to Everspin Technologies' Board of Directors? Douglas Mitchell was appointed to Everspin Technologies' Board of Directors. What is the ticker symbol for Everspin Technologies? The ticker symbol for Everspin Technologies is MRAM. What is Douglas Mitchell's background in the semiconductor industry? Douglas Mitchell has over 40 years of experience in the semiconductor industry, focusing on memory products and technology. What role did Douglas Mitchell play at Infineon Technologies? At Infineon Technologies, Douglas Mitchell served as Vice President of RAM products, overseeing a broad range of volatile and non-volatile memory technologies. What is Douglas Mitchell's contribution expected to be at Everspin Technologies? Douglas Mitchell's strategic guidance and extensive experience in memory products and technology are expected to drive Everspin's growth and market opportunities."
Dole plc Announces Completion of Sale of Progressive Produce to Arable Capital,2024-03-13T20:53:00.000Z,Low,Neutral,Dole plc (NYSE: DOLE) completes the sale of its 65% stake in Progressive Produce LLC to PTF Holdings for $120.25 million.,"Dole plc Announces Completion of Sale of Progressive Produce to Arable Capital Rhea-AI Impact (Low) Rhea-AI Sentiment (Neutral) Tags Rhea-AI Summary Dole plc (NYSE: DOLE) completes the sale of its 65% stake in Progressive Produce LLC to PTF Holdings for $120.25 million. Positive None. Negative None. Financial Analyst The divestiture of Dole's 65% equity stake in Progressive Produce LLC for a gross cash proceed of $120.25 million represents a strategic reallocation of resources and a potential shift in the company's business focus. This transaction likely aims to streamline operations, optimize the portfolio, or raise capital for reinvestment in core areas. From a financial perspective, the influx of cash could improve Dole's liquidity position and potentially strengthen its balance sheet, which may be favorably viewed by investors and credit rating agencies.However, the impact on Dole's revenue streams and profitability must be considered, as the sale of a substantial asset could lead to a reduction in diversification and future earnings potential. It is important to assess the valuation of the deal, comparing it to industry multiples and recent transactions within the sector to determine whether the sale price reflects fair market value. This analysis can provide insight into the company's strategic decision-making and its implications for shareholder value. Market Research Analyst The sale of a majority stake in a subsidiary can have implications for Dole's market positioning. Progressive Produce LLC operates within the produce sector and its divestment might signal Dole's intent to concentrate on other segments or to exit what it perceives as non-core or less profitable markets. For competitors and the broader market, this could mean a reshuffling of market shares, with Pacific Trellis Fruit, LLC potentially gaining a stronger foothold.Understanding the competitive dynamics and the strategic fit of Progressive Produce LLC within PTF Holdings' portfolio is crucial. If the acquisition allows PTF Holdings to achieve synergies or enhance its product offerings, this could alter competitive pressures within the industry. For stakeholders, including suppliers and customers, the realignment may affect sourcing strategies, pricing and availability of produce. Mergers & Acquisitions (M&A) Expert In the context of mergers and acquisitions, the sale of Dole's stake in Progressive Produce LLC to PTF Holdings reflects a consolidation trend within the agricultural and produce industry. The role of private equity, as seen with Arable Capital Partners' involvement, is significant in reshaping the landscape through strategic acquisitions and investments. This transaction could be part of a broader M&A wave, driven by the search for efficiency, scale and market reach.An analysis of the deal structure, the strategic rationale provided by both Dole and Arable and the anticipated integration plan for Progressive Produce LLC into PTF Holdings' operations would provide a deeper understanding of the potential synergies and the expected impact on industry dynamics. Additionally, assessing the post-transaction performance of similar M&A activities in the past can offer predictive insights into the success and challenges that may arise from this deal. 03/13/2024 - 04:53 PM DUBLIN--(BUSINESS WIRE)-- Dole plc (NYSE: DOLE) (Dole) has today announced that it has completed the previously announced sale of its 65% equity stake in Progressive Produce LLC to PTF Holdings, LLC (PTF Holdings), the parent company of Pacific Trellis Fruit, LLC. PTF Holdings is a portfolio company of Arable Capital Partners, LLC (Arable). Dole has received gross cash proceeds of $120.25 million from this sale. Additional details of the transaction can be found in a press release issued on February 27, 2024. About Dole plc: A global leader in fresh produce, Dole plc grows, markets, and distributes an extensive variety of fresh produce sourced locally and from around the world. Dedicated and passionate in exceeding our customers requirements in over 75 countries, our goal is to make the world a healthier and a more sustainable place. For more information visit our website at www.doleplc.com. About Arable Capital Partners: Arable Capital Partners is a leader in sustainable food and agribusiness investing and partners with businesses and owners across the food value chain. Arable currently has five platform investments, including Pacific Trellis Fruit, organicgirl, Royal Ridge Fruits, Blazer Wilkinson Gee and Laurel Ag & Water. For more information about Arable visit its website at www.arablecp.com. View source version on businesswire.com: https://www.businesswire.com/news/home/20240313209228/en/ Investor Contact Dole plc: James ORegan, Head of Investor Relations investors@doleplc.com +353 1 887 2794 Media Contact Dole plc: Brian Bell, Ogilvy brian.bell@ogilvy.com +353 87 2436 130 Source: Dole plc What stake did Dole plc sell in Progressive Produce LLC? Dole plc sold its 65% equity stake in Progressive Produce LLC. Who acquired Dole's stake in Progressive Produce LLC? PTF Holdings, the parent company of Pacific Trellis Fruit, LLC, acquired Dole's stake. How much did Dole plc receive from the sale? Dole plc received gross cash proceeds of $120.25 million from the sale. When was the sale completed? The sale was completed recently, as per the press release issued on February 27, 2024."
Artesian Resources Corporation Reports 2023 Year-End Earnings and Fourth Quarter Results,2024-03-13T20:45:00.000Z,Low,Neutral,"Artesian Resources Corporation (ARTNA) reported a decrease in net income for the year 2023 compared to 2022. Revenues remained stable at $98.9 million. Operating expenses increased slightly, with utility expenses rising due to employee benefits and payroll costs. The company invested $62.2 million in water and wastewater infrastructure projects in 2023 to improve service quality and meet growth demands.","Artesian Resources Corporation Reports 2023 Year-End Earnings and Fourth Quarter Results Rhea-AI Impact (Low) Rhea-AI Sentiment (Neutral) Tags earnings Rhea-AI Summary Artesian Resources Corporation (ARTNA) reported a decrease in net income for the year 2023 compared to 2022. Revenues remained stable at $98.9 million. Operating expenses increased slightly, with utility expenses rising due to employee benefits and payroll costs. The company invested $62.2 million in water and wastewater infrastructure projects in 2023 to improve service quality and meet growth demands. Positive Stable revenues of $98.9 million for both 2022 and 2023. Increase in water sales revenue by $1.7 million due to rate increase and water consumption. Operating expenses increased slightly, with utility expenses rising by 5.6%. Investment of $62.2 million in water and wastewater infrastructure projects in 2023. Negative Net income decreased by $1.3 million, or 7.2%, for the year 2023 compared to 2022. Non-utility operating revenue decreased by $2.4 million, or 26.9%. Short-term debt interest increased by $0.1 million. Financial Analyst An examination of Artesian Resources Corporation's financial results reveals a mixed performance. The year-end net income decline by 7.2% alongside a decrease in diluted net income per share from $1.90 to $1.67 indicates a contraction in profitability. However, this must be contextualized within industry performance and broader economic conditions. The steady revenue, maintained at $98.9 million, suggests operational stability, but the unchanged revenue juxtaposed with rising operating expenses could signal margin compression. The increase in water sales revenue and customer base growth are positive indicators, reflecting the company's ability to expand its market share and benefit from rate increases. However, the decrease in non-utility operating revenue and the rise in operating expenses highlight challenges in cost management and the potential impact of project completion on revenue streams.Investors should note the increase in property and other taxes, which may affect future net income. The rise in depreciation and amortization expense is a natural consequence of the company's substantial capital investments in infrastructure. These investments are critical for long-term growth but can pressure short-term earnings. The increase in federal and state income tax expense, despite lower pre-tax income, warrants attention as it affects net income. Furthermore, the increase in long-term and short-term debt interest expenses reflects the company's financing strategy amidst a potentially rising interest rate environment, which could impact future interest payments and financial flexibility. Market Research Analyst Artesian Resources Corporation's strategic focus on capital improvements, as evidenced by the $62.2 million investment in water and wastewater infrastructure, positions the company in a favorable light in terms of service quality and reliability. This proactive approach, particularly the investment in PFAS treatment ahead of anticipated EPA regulations, demonstrates foresight and may provide a competitive advantage. The ability to anticipate regulatory changes and prepare accordingly is a strong indicator of management's strategic planning capabilities.The temporary rate increase and the pending rate case with the DEPSC are critical factors for future revenue projections. The outcome of the rate case will significantly influence the company's revenue stream and investment recovery. Stakeholders should monitor the DEPSC's decision closely as it will have implications for the company's financial health and stock performance. Additionally, the company's ability to grow its customer base in its franchise area suggests potential for market expansion, which could drive future revenue growth. Economist The performance of Artesian Resources Corporation must be analyzed against the backdrop of macroeconomic conditions. The company's increased expenses in payroll and benefits, as well as supply and treatment costs, reflect broader inflationary pressures that many industries are facing. The ability to pass on these costs to consumers through rate increases is a positive sign of pricing power, which is crucial in inflationary times. However, the reliance on regulatory approval for rate increases introduces an element of uncertainty into the company's revenue forecasts.Furthermore, the company's investment in infrastructure, while necessary for long-term sustainability and compliance with anticipated regulations, must be balanced against the cost of capital. The increased interest expenses due to higher debt levels could become more burdensome if interest rates continue to rise. This scenario would have implications for the company's capital structure and cost of financing future projects. The current economic environment, characterized by uncertainty around interest rates and regulatory changes, poses both challenges and opportunities for Artesian Resources Corporation. 03/13/2024 - 04:45 PM NEWARK, Del., March 13, 2024 (GLOBE NEWSWIRE) -- Artesian Resources Corporation (Nasdaq: ARTNA), a leading provider of water and wastewater services, and related services, on the Delmarva Peninsula, today announced earnings results for the fourth quarter and year ended December 31, 2023. Year End Results Net income was $16.7 million, a $1.3 million, or 7.2%, decrease compared to net income recorded during the twelve months ended December 31, 2022. Diluted net income per share decreased to $1.67, compared to $1.90 for the same period in 2022. Revenues totaled $98.9 million for both the year ended December 31, 2023 and December 31, 2022, respectively: Water sales revenue increased $1.7 million, or 2.2%, primarily related to a temporary net rate increase of 7.50% of gross water sales placed into effect on November 28, 2023, as permitted under Delaware law, until permanent rates are determined by the Delaware Public Service Commission, or DEPSC, and an increase in overall water consumption. In addition, fixed fee revenue increased as a result of additional customers. Other utility operating revenue increased approximately $0.7 million, or 6.0%. This increase is primarily due to an increase in wastewater revenue associated with customer growth and an increase in fee revenue related to inspection, service and finance charges. Non-utility operating revenue decreased approximately $2.4 million, or 26.9%. This decrease is primarily due to a decrease in contract service revenue related to a contract for the design and construction of wastewater infrastructure now nearing completion, partially offset by an increase in Service Line Protection Plan, or SLP Plan, revenue. Operating expenses, excluding depreciation and amortization and income taxes, increased $0.2 million, or 0.4%. Utility operating expenses increased $2.4 million, or 5.6%, primarily the result of increases in employee benefits and payroll costs, computer system maintenance costs, and supply and treatment costs for our water and wastewater systems. These increases are partially offset by a decrease in purchased water under a new contract, effective January 2022, in which the minimum amount of water required to be purchased was reduced. Non-utility operating expenses decreased $2.4 million, or 35.4%, primarily due to a decrease in costs associated with a wastewater infrastructure design and construction contract. Property and other taxes increased $0.2 million, or 3.9%, primarily due to an increase in utility plant subject to taxation and an increase in payroll taxes, related to increased payroll related expenses. Property taxes are assessed on land, buildings and certain utility plant, which include the footage and size of pipe, hydrants and wells. Depreciation and amortization expense increased $0.7 million, or 5.7%, primarily due to continued investment in utility plant providing supply, treatment, storage and distribution of water to customers and service to our wastewater customers. Federal and state income tax expense increased $0.5 million, or 8.0%, primarily due to adjustments related to the application of state net operating loss valuation allowances and stock options exercised in 2022, partially offset by lower pre-tax income in 2023 compared to 2022. Other income increased $0.8 million, primarily due to a $0.7 million increase in allowance for funds used during construction, or AFUDC, as a result of higher long-term construction activity subject to AFUDC. Miscellaneous income increased $0.1 million primarily related to an increase in the annual patronage refund from CoBank, ACB. The primary refund calculation for both 2023 and 2022 was based on the average loan balance outstanding. Long-term debt interest increased $0.5 million, primarily related to an increase in long-term debt interest associated with the Series W First Mortgage Bond issued on April 29, 2022. Short-term debt interest increased $0.1 million, primarily related to higher interest rates. In April 2023 we filed a request for an increase in water rates in our Delaware operations. We requested a $16.7 million increase in annual revenue, which is necessary to recover increased operating costs and significant investments made to ensure water quality and resiliency, including upgrades of our treatment equipment and facilities, new elevated water storage, replacement of aging water mains, and investments in information technology. We began charging temporary rates on November 28, 2023, as permitted by the Delaware Public Service Commission, while the full request is under examination. We are now beginning to see recovery of some of these investments and increased expenses, said Dian C. Taylor, CEO. Fourth Quarter Results Net income was $3.5 million for the three months ended December 31, 2023, a $1.2 million, or 49.7%, increase compared to net income recorded during the three months ended December 31, 2022. Diluted net income per share increased to $0.34 compared to $0.24 for the same period in 2022. Revenues totaled $24.5 million, a decrease of $0.6 million, or 2.3%, compared to revenues recorded for the same period in 2022. Water sales revenue increased $1.0 million, or 5.3%, primarily related to a temporary net rate increase of 7.50% of gross water sales placed into effect on November 28, 2023, as permitted under Delaware law, until permanent rates are determined by the DEPSC, and an increase in overall water consumption. In addition, fixed fee revenue increased as a result of additional customers. Other utility operating revenue decreased approximately $0.1 million, or 3.5%, primarily due to decreased operating subsidies from developers and the timing of industrial wastewater revenue, partially offset by an increase in wastewater revenue associated with additional customers served. Non-utility operating revenue decreased approximately $1.5 million, or 46.1%, primarily due to a decrease in contract service revenue related to a contract for the design and construction of wastewater infrastructure now nearing completion, partially offset by an increase in SLP Plan revenue. Operating expenses, excluding depreciation and amortization and income taxes, decreased $2.3 million, or 13.9%. Utility operating expenses decreased $1.1 million, or 8.3%, primarily the result of an overall decrease in payroll and employee benefits costs and water treatment costs. Non-utility operating expenses decreased $1.3 million, or 54.8%, primarily due to a decrease in costs associated with a wastewater infrastructure design and construction contract. Property and other taxes increased $0.1 million, or 4.6%, primarily due to an increase in utility plant subject to taxation and an increase in payroll taxes, related to increased payroll related expenses. Property taxes are assessed on land, buildings and certain utility plant, which include the footage and size of pipe, hydrants and wells. Depreciation and amortization expense increased $0.2 million, or 5.6%, primarily due to continued investment in utility plant providing supply, treatment, storage and distribution of water customers and service to our wastewater customers. Federal and state income tax expense increased $0.3 million, or 32.4%, primarily due to higher pre-tax income in 2023 compared to 2022. Other income decreased $0.2 million, primarily due to a $0.1 million decrease in AFUDC, as a result of lower long-term construction activity subject to AFUDC. Capital Expenditures As part of Artesians ongoing effort to ensure high-quality reliable service to customers, $62.2 million was invested in water and wastewater infrastructure projects during 2023 compared to $48.5 million for the same period in 2022. We invested in our rehabilitation program for transmission and distribution facilities by replacing aging or deteriorating mains, installation of new mains, enhancing or improving existing treatment facilities, construction of new water storage tanks, and replacing aging wells and pumping equipment to better serve our customers. We also continue to invest in wastewater treatment and distribution facilities. In 2023 we invested over $62 million in capital improvements. These investments in utility plant not only ensure that we provide high quality and reliable water and wastewater services to our customers, but allow us to meet growth demands in our expanding franchise area. Additionally, we continue to make investments proactively to treat for PFAS in drinking water in anticipation of the EPAs release of a more stringent regulation, staying ahead of the upcoming equipment supply needs of other utilities, said Nicki Taylor, President of Artesian Water Company. About Artesian ResourcesArtesian Resources Corporation operates as a holding company of wholly-owned subsidiaries offering water and wastewater services, and a number of other related core business services, on the Delmarva Peninsula. Artesian Water Company, the principal subsidiary, is the oldest and largest regulated water utility on the Delmarva Peninsula and has been providing water service since 1905. Artesian Water Company supplies 8.7 billion gallons of water per year through 1,470 miles of main to over a third of Delawareans. Forward Looking StatementsThis release contains forward looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 regarding, among other things, recovery of investments in water utility plant and increased operating costs in rates charged to customers as presented in our current filing before the Delaware Public Service Commission, expectations regarding the cost, timing and recovery in customer rates of infrastructure investments and increased operational costs, our expectations in 2024, our ability to continue to provide high-quality and reliable water and wastewater service to customers and meet increased demands, and our growth strategy and continued growth in our business and the number of customers served. These statements involve risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such forward-looking statements including: changes in weather, changes in our contractual obligations, changes in government policies, the timing and results of our rate requests, failure to receive regulatory approval, changes in economic and market conditions generally and other matters discussed in our filings with the Securities and Exchange Commission. While the Company may elect to update forward-looking statements, we specifically disclaim any obligation to do so and you should not rely on any forward-looking statement as representation of the Companys views as of any date subsequent to the date of this release. Contact:Nicki TaylorInvestor Relations(302) 453-6900ntaylor@artesianwater.com Artesian Resources Corporation Condensed Consolidated Statement of Operations (In thousands, except per share amounts) (Unaudited) Three months ended Twelve months ended December 31, December 31, 2023 2022 2023 2022 Operating Revenues Water sales$19,739 $18,751 $80,033 $78,318 Other utility operating revenue 3,112 3,226 12,195 11,506 Non-utility operating revenue 1,694 3,140 6,633 9,073 24,545 25,117 98,861 98,897 Operating Expenses Utility operating expenses 11,717 12,778 46,205 43,772 Non-utility operating expenses 1,099 2,432 4,428 6,850 Depreciation and amortization 3,453 3,270 13,335 12,620 State and federal income taxes 1,192 900 6,348 5,878 Property and other taxes 1,570 1,499 6,099 5,871 19,031 20,879 76,415 74,991 Operating Income 5,514 4,238 22,446 23,906 Allowance for funds used during construction 309 431 2,002 1,329 Miscellaneous (148) (47) 1,407 1,265 Income Before Interest Charges 5,675 4,622 25,855 26,500 Interest Charges 2,195 2,297 9,156 8,502 Net Income$3,480 $2,325 $16,699 $17,998 Weighted Average Common Shares Outstanding - Basic 10,281 9,497 10,018 9,462 Net Income per Common Share - Basic$0.34 $0.24 $1.67 $1.90 Weighted Average Common Shares Outstanding - Diluted 10,284 9,505 10,022 9,481 Net Income per Common Share - Diluted$0.34 $0.24 $1.67 $1.90 Artesian Resources Corporation Condensed Consolidated Balance Sheets (In thousands) (Unaudited) December 31, December 31, 2023 2022 Assets Utility Plant, at original cost less accumulated depreciation$714,284 $668,031 Current Assets 30,617 27,804 Regulatory and Other Assets 21,931 23,956 $766,832 $719,791 Capitalization and Liabilities Stockholders' Equity$230,397 $187,930 Long Term Debt, Net of Current Portion 178,307 175,619 Current Liabilities 22,414 44,070 Net Advances for Construction 2,797 3,686 Contributions in Aid of Construction 247,934 224,308 Other Liabilities 84,983 84,178 $766,832 $719,791 What was Artesian Resources Corporation's net income for the year 2023? Artesian Resources Corporation reported a net income of $16.7 million for the year 2023, which was a decrease of $1.3 million compared to the previous year. How much did the water sales revenue increase by in 2023? Water sales revenue increased by $1.7 million in 2023 primarily due to a temporary rate increase of 7.50% and an increase in overall water consumption. How much did Artesian invest in water and wastewater infrastructure projects in 2023? Artesian invested $62.2 million in water and wastewater infrastructure projects in 2023 to improve service quality and meet growth demands. What caused the increase in utility operating expenses in 2023? Utility operating expenses increased by 5.6% in 2023 due to rises in employee benefits, payroll costs, and water treatment expenses. What was the total revenue for Artesian Resources Corporation in the fourth quarter of 2023? The total revenue for Artesian Resources Corporation in the fourth quarter of 2023 was $24.5 million, a decrease of $0.6 million compared to the same period in 2022."
10x Genomics Begins Commercial Shipments of Chromium GEM-X Products,2024-03-13T20:05:00.000Z,Neutral,Positive,"10x Genomics, Inc. introduces GEM-X technology architecture, enhancing single cell analysis with improved sensitivity, scalability, cost-efficiency, and data quality. The new products, Chromium Single Cell Gene Expression 3' v4 and Chromium Single Cell Immune Profiling 5' v3, offer superior performance and workflow advantages.","10x Genomics Begins Commercial Shipments of Chromium GEM-X Products Rhea-AI Impact (Neutral) Rhea-AI Sentiment (Positive) Tags Rhea-AI Summary 10x Genomics, Inc. introduces GEM-X technology architecture, enhancing single cell analysis with improved sensitivity, scalability, cost-efficiency, and data quality. The new products, Chromium Single Cell Gene Expression 3' v4 and Chromium Single Cell Immune Profiling 5' v3, offer superior performance and workflow advantages. Positive None. Negative None. Biotechnology Analyst The introduction of 10x Genomics' GEM-X technology represents a significant advancement in the field of single cell analysis. The enhanced sensitivity of detecting up to two times more genes allows for a more detailed understanding of cellular heterogeneity, which is crucial for identifying nuanced biological differences between cells. This could lead to breakthroughs in fields such as oncology, immunology and neurobiology, where understanding individual cell behavior is paramount.Moreover, the ability to capture a higher number of cells per channel and the reduction in cost per cell are pivotal developments. They not only make the technology more accessible to a broader range of research institutions but also enable large-scale studies that were previously cost-prohibitive. The financial implications for 10x Genomics are potentially substantial as these improvements could drive increased adoption of their technology and provide a competitive edge in the market.However, challenges remain in the scalability of such technologies and the interpretation of the vast amounts of data generated. The biotechnology industry continues to grapple with the need for advanced computational tools and expertise to handle this data, which could be a limiting factor in the widespread application of GEM-X. Market Research Analyst The release of GEM-X technology by 10x Genomics is poised to disrupt the single cell analysis market. The doubling of gene detection and the increased cell capture capacity are likely to be received positively by the research community, which has been seeking more efficient and cost-effective solutions in single cell sequencing.From a market perspective, this innovation could lead to an expansion of the single cell analysis market size, as it lowers the barriers to entry for researchers with limited budgets. The cost reduction and improved data quality are critical factors that can influence purchasing decisions and potentially increase the market share for 10x Genomics. This development could also put pressure on competitors to accelerate their own technological advancements, leading to an innovation race within the sector.It is important to monitor how this technology is adopted in the market and the subsequent impact on 10x Genomics' financial performance, particularly in terms of revenue growth and market penetration. The company's ability to capitalize on this innovation and convert it into a sustainable competitive advantage will be key to its long-term success. Healthcare Industry Analyst The GEM-X technology's enhanced assay robustness and increased sample recovery are particularly relevant for the healthcare industry, where the quality and efficiency of sample analysis can directly impact clinical research outcomes. The improved recovery rate of up to 80% for cells is especially beneficial for precious or limited samples, such as those obtained from tissue biopsies, which are common in clinical settings.With the potential for more accurate and comprehensive data, researchers could make more informed decisions in areas such as precision medicine and patient stratification. This could eventually lead to more targeted therapies and personalized treatment plans. The long-term implications for healthcare could be profound, as these technologies enable a deeper understanding of disease mechanisms at the cellular level.However, it is crucial to consider the regulatory landscape and the speed at which such technological advancements can be translated into clinical practice. The adoption of GEM-X in clinical research will depend on regulatory approvals and the demonstration of clear clinical benefits over existing technologies. 03/13/2024 - 04:05 PM The next generation of the company's leading single cell technology architecture, GEM-X, enables higher performance at larger scale and lower cost PLEASANTON, Calif., March 13, 2024 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today that it has started shipping the first two products powered by the GEM-X technology architecture, Chromium Single Cell Gene Expression 3' v4 and Chromium Single Cell Immune Profiling 5' v3. GEM-X is the next generation of the company's leading single cell technology architecture and is built on a new and improved microfluidic chip design, featuring the latest technological advancements and optimized reagents for superior performance and high reliability. ""It's been incredible to see the enthusiasm from customers since we first announced the GEM-X architecture last month, and we can't wait to get these new products in researchers' hands,"" said Michael Schnall-Levin, Founding Scientist and Chief Technology Officer of 10x Genomics. ""GEM-X sets a new standard for single cell analysis and gives customers important performance advantages that will immediately benefit their research. This is one of multiple steps we have planned to make single cell more accessible for all."" GEM-X is exclusively available for use on Chromium X Series instruments and delivers important performance and workflow advantages, including: Substantially increased sensitivity: Detect up to two times more genes compared to on-market Chromium assays to gain a more comprehensive view of cellular heterogeneityBuilt to scale: Two-fold increase in cells captured per channelMore cost effective: More than two-fold reduction in cost per cellEnhanced data quality: Two-fold reduction in multiplet rate enabling high quality data at scaleMaximum sample recovery: Recovery of up to 80% of cells, improving capture efficiency and making it ideal for samples typically yielding few cells, such as tissue biopsies or previously flow sorted cellsImproved assay robustness: Redesigned microfluidics and optimized reagents for faster and more efficient cell partitioning""Selecting the optimal assay for single-cell experiments is challenging. However, it's evident that identifying more genes per cell enriches our understanding of cellular functions and the intricacies of biology,"" said Luciano Martelotto, Associate Professor at the University of Adelaide. ""GEM-X, with its exceptional transcript capture, can enhance our capacity to differentiate cell types, spot rare cells and decode regulatory pathways. Improved accuracy in transcriptome data further facilitates the seamless integration of single-cell findings from diverse research projects and platforms."" About 10x Genomics10x Genomics is a life science technology company building products to accelerate the mastery of biology and advance human health. Our integrated solutions include instruments, consumables and software for single cell and spatial biology, which help academic and translational researchers and biopharmaceutical companies understand biological systems at a resolution and scale that matches the complexity of biology. Our products are behind breakthroughs in oncology, immunology, neuroscience and more, fueling powerful discoveries that are transforming the world's understanding of health and disease. To learn more, visit 10xgenomics.com or connect with us on LinkedIn or X (Twitter). Forward Looking StatementsThis press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 as contained in Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, which fall under the ""safe harbor"" provisions of those sections. All statements, other than statements of historical facts, may be forward-looking statements. Forward-looking statements generally can be identified by the use of forward-looking terminology such as ""may,"" ""might,"" ""will,"" ""should,"" ""expect,"" ""plan,"" ""anticipate,"" ""could,"" ""intend,"" ""target,"" ""project,"" ""contemplate,"" ""believe,"" ""estimate,"" ""predict,"" ""potential"" or ""continue"" or variations of them or similar terminology, but the absence of these words does not mean that a statement is not forward-looking. These forward-looking statements include statements regarding 10x Genomics, Inc.'s (""10x Genomics"") product launches, performance, configuration, costs, capabilities, adoption and pipeline. These statements are based on management's current expectations, forecasts, beliefs, assumptions and information currently available to management, and actual outcomes and results could differ materially from these statements due to a number of factors. Other risks and uncertainties that could affect 10x Genomics' financial and operating results and cause actual results to differ materially from those indicated by the forward-looking statements made in this press release include those discussed under the captions ""Risk Factors"" and ""Management's Discussion and Analysis of Financial Condition and Results of Operations"" and elsewhere in the documents 10x Genomics files with the Securities and Exchange Commission (the ""SEC"") from time to time. Although 10x Genomics believes that the expectations reflected in the forward-looking statements are reasonable, it cannot provide any assurance that these expectations will prove to be correct nor can it guarantee that the future results, levels of activity, performance and events and circumstances reflected in the forward-looking statements will be achieved or occur. The forward-looking statements in this press release are based on information available to 10x Genomics as of the date hereof, and 10x Genomics disclaims any obligation to update any forward-looking statements provided to reflect any change in its expectations or any change in events, conditions or circumstances on which any such statement is based, except as required by law. These forward-looking statements should not be relied upon as representing 10x Genomics' views as of any date subsequent to the date of this press release. Disclosure Information10x Genomics uses filings with the Securities and Exchange Commission, our website (www.10xgenomics.com), press releases, public conference calls, public webcasts and our social media accounts as means of disclosing material non-public information and for complying with our disclosure obligations under Regulation FD. ContactsInvestors: investors@10xgenomics.comMedia: media@10xgenomics.com View original content to download multimedia:https://www.prnewswire.com/news-releases/10x-genomics-begins-commercial-shipments-of-chromium-gem-x-products-302088504.html SOURCE 10x Genomics, Inc What is the new technology architecture introduced by 10x Genomics, Inc.? 10x Genomics, Inc. introduced the GEM-X technology architecture, the next generation of its leading single cell technology. What are the first two products powered by the GEM-X technology architecture? The first two products powered by the GEM-X technology architecture are Chromium Single Cell Gene Expression 3' v4 and Chromium Single Cell Immune Profiling 5' v3. What are the key advantages of GEM-X technology? The key advantages of GEM-X technology include substantially increased sensitivity, scalability, cost-effectiveness, enhanced data quality, maximum sample recovery, and improved assay robustness. Who is Michael Schnall-Levin? Michael Schnall-Levin is the Founding Scientist and Chief Technology Officer of 10x Genomics. What benefits does GEM-X technology offer for single-cell experiments? GEM-X technology enriches understanding of cellular functions, differentiates cell types, spots rare cells, decodes regulatory pathways, and facilitates seamless integration of single-cell findings."
"KORU Medical Systems, Inc. Announces 2023 Fourth Quarter, Full Year Financial Results, and 2024 Guidance",2024-03-13T20:05:00.000Z,Neutral,Neutral,"KORU Medical Systems, Inc. (NASDAQ: KRMD) reported financial results for Q4 and full year 2023, with 2% decrease in Q4 net revenues and 2% increase in full year net revenues. The company achieved 6.7% core business growth, improved gross margins, and positive cash flow. They entered collaborations for Novel Therapies and issued guidance for 2024 with expected revenue growth of 10-13%.","KORU Medical Systems, Inc. Announces 2023 Fourth Quarter, Full Year Financial Results, and 2024 Guidance Rhea-AI Impact (Neutral) Rhea-AI Sentiment (Neutral) Tags earnings Rhea-AI Summary KORU Medical Systems, Inc. (NASDAQ: KRMD) reported financial results for Q4 and full year 2023, with 2% decrease in Q4 net revenues and 2% increase in full year net revenues. The company achieved 6.7% core business growth, improved gross margins, and positive cash flow. They entered collaborations for Novel Therapies and issued guidance for 2024 with expected revenue growth of 10-13%. Positive 6.7% core business growth in 2023 driven by SCIg market growth and share gains. Gross margin improvement with 60.3% in Q4 and 58.6% for full year 2023. Positive cash flow of $0.7 million in Q4 2023 and cash balance of $11.5 million. Entered collaborations for Novel Therapies and issued guidance for 2024 with revenue growth of 10-13%. Adjusted EBITDA was ($6.0) million for 2023. Signed a $10 million credit facility with HSBC USA for strategic growth capital. Net loss for 2023 was ($13.7) million, including a tax valuation allowance of $6.0 million. Entered into a new debt facility with HSBC Bank USA. Received an assessment report from BSI in the EU regarding certification. Guidance for 2024 includes revenue growth, new collaborations, and gross margin expectations. Negative None. Financial Analyst The financial results and guidance issued by KORU Medical Systems, Inc. indicate a mixed performance with a slight decrease in net revenues for Q4 2023 but an overall annual increase. The reported 2% annual revenue growth, while modest, aligns with cautious optimism in the healthcare sector, often characterized by steady but slow growth. The gross margin improvements are significant, suggesting enhanced operational efficiency, which is a positive indicator for investors concerned with cost management and profitability.From a financial perspective, the company's ability to generate positive cash flow in the fourth quarter and end the year with a healthy cash balance of $11.5 million demonstrates fiscal prudence and improved liquidity. The net loss, including a non-cash valuation allowance, is concerning; however, the adjusted EBITDA being relatively stable year-over-year indicates underlying operational consistency. The new $10 million credit facility could provide strategic capital for growth, but it also increases the company's leverage, which requires careful monitoring. Market Research Analyst Within the context of the healthcare market, KORU Medical's focus on large volume subcutaneous infusion solutions (SCIg) is particularly relevant. The SCIg market is experiencing growth due to the shift towards home-based treatments and patient-centric solutions. KORU's expansion into new geographies and the FDA clearance of a new product platform suggest potential for market share gains, especially in the U.S. However, the decline in Novel Therapies net revenues by 62% year-over-year could be a point of concern for the company's diversification strategy.The guidance for 2024, which forecasts 10-13% revenue growth, appears optimistic and may reflect confidence in their Core business and the expected contribution from new collaborations. Nonetheless, the appeal against the EU's certification body's recommendation presents a risk that could potentially impact international revenue streams. Medical Device Industry Analyst From an industry standpoint, KORU Medical's focus on patient-centric infusion solutions is strategically aligned with current trends towards personalized medicine and home-based care. The improvement in gross margins suggests successful operational enhancements, such as manufacturing efficiency, which is crucial in an industry with high regulatory compliance costs. The launch of the 50mL prefill pump platform could be a significant differentiator in the competitive landscape of medical devices for infusion therapy.The collaborations in Novel Therapies are indicative of the company's commitment to innovation and could lead to future revenue streams, though the recent decline in this segment's revenues warrants close observation. Furthermore, the management's reference to Vision 2026 strategy suggests a long-term plan for sustainable growth, which is critical in a sector where product development cycles can be lengthy. 03/13/2024 - 04:05 PM MAHWAH, N.J.--(BUSINESS WIRE)-- KORU Medical Systems, Inc. (NASDAQ: KRMD) (""KORU Medical"" or the ""Company""), a leading medical technology company focused on development, manufacturing, and commercialization of innovative and patient-centric large volume subcutaneous infusion solutions, today reported financial results for the fourth quarter and full year ended December 31, 2023. The Company also issued guidance for the full year 2024. Recent Highlights Fourth quarter 2023 net revenues of $7.2 million, a 2% decrease from the prior year; Full year 2023 net revenues of $28.5 million, a 2% increase over the prior year Full year 6.7% Core business growth (U.S. and International) driven by overall SCIg market growth, share gains and expansion in new geographies Fourth quarter gross margin of 60.3%, reflecting year-over-year improvement of 470 basis points; Full year gross margin of 58.6%, reflecting year-over-year improvement of 350 basis points Positive cash flow of $0.7 million in the fourth quarter of 2023, ending the year with a cash balance of $11.5 million Entered 3 Novel Therapies collaborations during 2023 and announced 2 new collaborations in the first quarter of 2024 Recorded a non-cash valuation allowance against deferred tax assets of $6.0 million. Net loss for the year, which included this allowance, was ($13.7) million, or ($0.30) per share. Adjusted EBITDA was ($6.0) million, or ($0.13) per share vs. ($6.1) million or ($0.14) in the prior year. Signed a $10 million credit facility with HSBC USA to replace an expired $3.5 million revolver agreement; the credit facility will be reserved for strategic growth capital Issued full year 2024 net revenues guidance of $31.2-$32.2 million, representing 10-13% growth I am proud of the KORU team for delivering a solid end to 2023, led by performance in our Core business. Entry into multiple geographic markets drove international sales, and in the US, we hit a key milestone with the FDA clearance and launch of the 50mL prefill pump platform, which we anticipate will be a significant growth driver in 2024. Additionally, we saw double-digit growth in our end-user specialty pharmacy sales, reflective of share gains and a growing Ig market, said Linda Tharby, KORU Medical's President and CEO. Within our Novel Therapies business, we recently announced collaborations for two late-stage therapies. On the operational side, we increased gross margins, were cash flow positive in the fourth quarter and finished the year with a significantly lower cash burn than the prior year. We are excited by the momentum we are carrying into 2024; we remain focused on the execution of our Vision 2026 strategy, and positioning KORU for growth, profitability and value creation for our customers and shareholders. 2023 Fourth Quarter Financial Results Three Months Ended December 31, Change from Prior Year % of Total 2023 2022 $ % 2023 2022 Net Revenues Domestic Core $ 5,565,349 $ 5,314,836 $ 250,513 4.7 % 77.4 % 72.4 % International Core 1,315,036 1,221,540 93,496 7.7 % 18.3 % 16.6 % Novel Therapies 305,547 808,305 (502,758 ) (62.2 %) 4.3 % 11.0 % Total $ 7,185,932 $ 7,344,681 $ (158,749 ) (2.2 %) Total net revenues decreased $0.2 million, or 2.2%, for the three months ended December 31, 2023, as compared with the same period last year. Domestic Core net revenues increased by 4.7% year-over-year, driven by growth in pumps and consumables, due to competitive share gain in new accounts. International Core net revenues increased by 7.7%, driven by strong SCIg volume and growth in several OUS geographies as we continue to expand into new markets. Novel Therapies net revenues declined by 62% year-over-year, primarily driven by the completion of a large milestone for a pharmaceutical NRE agreement in 2022. Gross profit increased $0.3 million or 6.2% for the three months ended December 31, 2023, as compared with the same period last year. Gross profit stated as a percentage of net revenues increased to 60.3% for the fourth quarter of 2023 compared to 55.5% in the fourth quarter of 2022. The increase was primarily driven by production efficiencies from the completion of an outsourced manufacturing initiative and consolidation of our manufacturing sites. Allowing for a one-time inventory adjustment for a product discontinuation, adjusted gross margin for the fourth quarter of 2023 was 63.1%. A reconciliation of adjusted gross margin to the most directly comparable GAAP measure is provided at the end of this press release. Total operating expenses for the fourth quarter of 2023 were $6.7 million, an increase of $0.1 million or 1.6%, compared to $6.6 million in the prior year period. The increase was driven primarily by the hiring of our new Chief Commercial Officer to lead our Core business growth strategy, partially offset by efficiencies in insourcing R&D. Net loss for the fourth quarter of 2023 was $7.5 million, or $(0.16) per diluted share, compared to a net loss of $2.0 million, or ($0.04) per diluted share for the same period of 2022. Net loss included a tax valuation allowance of $6.0 million for the fourth quarter of 2023. Adjusted EBITDA for the quarter was ($1.0 million), or ($0.02) per diluted share versus ($1.6 million), or ($0.04) in the prior year. A reconciliation of adjusted EBITDA and adjusted diluted EPS to the most directly comparable GAAP measures is provided at the end of this press release. 2023 Full Year Financial Results Years Ended December 31, Change from Prior Year % of Total 2023 2022 $ % 2023 2022 Net Revenues Domestic Core $ 22,446,519 $ 21,205,204 $ 1,241,315 5.9 % 78.7 % 76.0 % International Core 4,596,097 4,164,714 431,383 10.4 % 16.1 % 14.9 % Novel Therapies 1,475,050 2,526,119 (1,051,069 ) (41.6 %) 5.2 % 9.1 % Total $ 28,517,666 $ 27,896,037 $ 621,629 2.2 % Total net revenues increased $0.6 million, or 2.2%, for the year ended December 31, 2023, as compared with the same period last year. Domestic Core growth of 5.9% was driven by volume growth in pumps and consumables attributed to share gains. International Core growth of 10.4% was driven by increased volume across several EU markets and the entry into multiple new geographic markets. The growth in Core offset a 41.6% year-over-year decline in Novel Therapies net revenues, primarily driven by the completion of a large milestone for a pharmaceutical NRE agreement in 2022. Gross profit increased $1.3 million or 8.7% for the year ended December 31, 2023, compared to the same period in 2022. Gross profit as a percentage of net revenues increased to 58.6% compared to 55.1% from the prior year. The increase was driven by improvements in manufacturing productivity and product mix. Allowing for a one-time inventory adjustment for a product discontinuation, adjusted gross margin for the year ended 2023 was 59.6%. A reconciliation of adjusted gross margin to the most directly comparable GAAP measure is provided at the end of this press release. Selling, general and administrative expenses decreased $0.2 million, or 1.2%, during the year ended December 31, 2023, compared to the same period last year, primarily driven by lower executive restructuring costs partially offset by an increase of new hires in commercial business development and medical affairs. Research and development expenses increased $0.8 million, or 15.9%, during the year ended December 31, 2023, compared with the same period last year, primarily due to compensation and expenses to support new hires focused on new product development. Net loss for the full year 2023 was $13.7 million, or $(0.30) per diluted share, compared to a net loss of $8.7 million, or $(0.19) per diluted share for the same period of 2022. Net loss included a tax valuation allowance of $6.0 million for the full year 2023. Adjusted EBITDA for the full year was ($6.0) million, or ($0.13) per diluted share versus ($6.1) million or ($0.14) in the prior year. A reconciliation of adjusted EBITDA and adjusted diluted EPS to the most directly comparable GAAP measures is provided at the end of this press release. Cash and cash equivalents were $11.5 million as of December 31, 2023, reflecting positive cash flow of $0.7 million in the fourth quarter and a reduction of cash burn to $5.9 million in 2023 from $8 million in 2022. Subsequent Events The Company has entered into a $5M revolving credit facility and a $5M term loan facility with HSBC Bank USA, which replaced a $3.5M revolving credit facility with a regional bank that expired in August of 2023. This new debt facility provides KORU Medical with additional capital flexibility to support a reserve for growth and strategic opportunities. The Company has received an assessment report from its notified body in the EU, BSI, stating that, following BSIs review of technical documentation submitted by the Company in connection with a prior audit nonconformance, a recommendation for continued certification cannot be made. The Company has filed an appeal to this determination. Management believes that the Companys appeal will be successful in limiting the scope of the suspension to have minimal impact on the Companys revenues, if any. Assumptions and Guidance for Full Year 2024 KORU Medical's guidance for the full year 2024 reflects numerous assumptions that could affect its business, based on the information management has as of this date. Management will discuss its outlook and several of its assumptions on its fourth quarter 2023 earnings call. KORU Medical expects: Full year 2024 net revenue between $31.2 and $32.2 million, representing growth in the range of 10% to 13% SCIg market growth of mid-to-high single digits Three new Novel Therapies collaborations Prefilled syringe market penetration of approximately 20%-25% Gross margin between 59% and 61% for the full year 2024 Geographic expansion into lower ASP markets Supply chain inflationary pricing pressure Production line start-up in Q4 for new product introduction 2024 year-end cash balance greater than $8.0 million Operating expenses of approximately $23.5- $24.0 million, exclusive of stock compensation expense Cash flow breakeven in the fourth quarter of 2024 and cash flow positive for full year 2025 Ending cash balance is exclusive of the new $10 million credit facility, which will be reserved for strategic growth capital opportunities Conference Call and Webcast Details The Company will host a live conference call and webcast to discuss these results and provide a corporate update on Wednesday, March 13, 2024, at 4:30 PM ET. To participate in the call, please dial (844) 826-3035 (domestic) or (412) 317-5195 (international) and provide conference ID: 6447448. The live webcast will be available on the IR Calendar on the News/Events page of the Investors section of KORU Medical's website. Non-GAAP Measures This press release includes the non-GAAP financial measures ""adjusted gross margin, ""adjusted diluted EPS"" and adjusted EBITDA that are not in accordance with, nor an alternate to, generally accepted accounting principles and may be different from non-GAAP measures used by other companies. These non-GAAP measures are not based on any comprehensive set of accounting rules or principles. Non-GAAP financial measures should not be considered a substitute for, or superior to, measures of financial performance prepared in accordance with GAAP. They are limited in value because they exclude charges that have a material effect on KORU Medical's reported results and, therefore, should not be relied upon as the sole financial measures to evaluate the Company's financial results. Non-GAAP financial measures are meant to supplement, and to be viewed in conjunction with, GAAP financial results. Reconciliations of the Company's non-GAAP measures are included at the end of this press release. About KORU Medical Systems KORU Medical develops, manufactures, and commercializes innovative and patient-centric large volume subcutaneous infusion solutions that improve quality of life for patients around the world. The FREEDOM Syringe Infusion System (the FREEDOM System) currently includes the FREEDOM60 and FreedomEdge Syringe Infusion Drivers, Precision Flow Rate Tubing and HIgH-Flo Subcutaneous Safety Needle Sets. These devices are used for infusions administered in the home and alternate care settings. For more information, please visit www.korumedical.com. Forward-looking Statements This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 that involve risks and uncertainties. All statements that are not historical fact are forward-looking statements, including, but not limited to, financial guidance and expected operating performance for fiscal 2024. Forward-looking statements discuss the Company's current expectations and projections relating to its financial position, results of operations, plans, objectives, future performance, and business. Forward-looking statements can be identified by words such as ""guidance"", ""expect"", ""plan"", ""believe"" and ""will"". Actual results may differ materially from the results predicted and reported results should not be considered as an indication of future performance. The potential risks and uncertainties that could cause actual results to differ from the results predicted include, among others, uncertainties associated with SCIg market growth, prefilled syringe penetration, plasma supply, clinical trial activity and success, the Companys EU certification, the shift to increased healthcare delivery in the home, new patient diagnoses, customer ordering patterns, global health crises, innovation and competition, labor and supply price increases, inflationary impacts, labor supply, and those risks and uncertainties included under the captions ""Risk Factors"" in our Annual Report on Form 10-K for the year ended December 31, 2023 which is on file with the SEC and available on our website at www.korumedical.com/investors and on the SEC website at www.sec.gov. All information provided in this release and in the attachments is as of March 13, 2024. Undue reliance should not be placed on the forward-looking statements in this press release, which are based on information available to us on the date hereof. We undertake no duty to update this information unless required by law. KORU MEDICAL SYSTEMS, INC. BALANCE SHEETS December 31, December 31, 2023 2022 ASSETS CURRENT ASSETS Cash and cash equivalents $ 11,482,240 $ 17,408,257 Accounts receivable less allowance for doubtful accounts of $24,777 and $21,459 for December 31, 2023, and December 31, 2022, respectively 4,045,211 3,558,884 Inventory 3,481,301 6,404,867 Other receivables 28,889 972,396 Prepaid expenses and other 1,218,288 1,457,232 TOTAL CURRENT ASSETS 20,255,929 29,801,636 Property and equipment, net 3,837,657 3,886,975 Intangible assets, net of accumulated amortization of $390,341 and $325,872 at December 31, 2023 and December 31, 2022, respectively 754,361 787,182 Operating lease right-of-use assets 3,514,055 3,786,545 Deferred income tax assets, net allowance for non-realization of deferred tax assets of $6,002,777 and zero for December 31, 2023 and December 31, 2022, respectively  3,967,480 Other assets 98,970 102,625 TOTAL ASSETS $ 28,460,972 $ 42,332,443 LIABILITIES AND STOCKHOLDERS EQUITY CURRENT LIABILITIES Accounts payable $ 975,193 $ 2,391,799 Accrued expenses 1,711,427 2,889,941 Note Payable 314,344 433,295 Other liabilities 512,520 257,337 Accrued payroll and related taxes 462,941 542,399 Finance lease liability  current 109,540 98,335 Operating lease liability  current 368,313 345,834 TOTAL CURRENT LIABILITIES 4,454,278 6,958,940 Finance lease liability, net current portion 316,623 394,283 Operating lease liability, net of current portion 3,336,300 3,653,257 TOTAL LIABILITIES 8,107,201 11,006,480 Commitments and contingencies (Refer to Note 8) STOCKHOLDERS EQUITY Common stock, $0.01 par value, 75,000,000 shares authorized, 49,089,864 and 48,861,891 shares issued; 45,669,362 and 45,441,389 shares outstanding at December 31, 2023, and December 31, 2022, respectively 490,899 488,619 Additional paid-in capital 47,018,707 44,252,117 Treasury stock, 3,420,502 shares at December 31, 2023 and December 31, 2022, at cost (3,843,562 ) (3,843,562 ) Retained Deficit (23,312,273 ) (9,571,211 ) TOTAL STOCKHOLDERS EQUITY 20,353,771 31,325,963 TOTAL LIABILITIES AND STOCKHOLDERS EQUITY $ 28,460,972 $ 42,332,443 See accompanying Notes to Financial Statements. KORU MEDICAL SYSTEMS, INC. STATEMENTS OF OPERATIONS Three Months Ended Twelve Months Ended December 31, December 31, 2023 2022 2023 2022 NET REVENUES $ 7,185,932 $ 7,344,681 $ 28,517,666 $ 27,896,037 Cost of goods sold 2,854,987 3,266,535 11,809,384 12,527,051 Gross Profit 4,330,946 4,078,146 16,708,282 15,368,986 OPERATING EXPENSES Selling, general and administrative 5,012,646 4,761,173 20,365,617 20,606,507 Research and development 1,287,515 1,640,732 5,742,254 4,956,215 Depreciation and amortization 228,340 187,658 870,390 587,137 Total Operating Expenses 6,528,501 6,589,563 26,978,261 26,149,859 Net Operating Loss (2,197,555 ) (2,511,417 ) (10,269,979 ) (10,780,873 ) Non-Operating (Expense)/Income (Loss)/Gain on currency exchange 7,418 (977 ) (5,124 ) (39,874 ) Loss on disposal of fixed assets, net   (59,807 )  Interest (expense)/income, net 169,230 101,008 561,328 145,587 TOTAL OTHER (EXPENSE)/INCOME 176,648 100,031 496,397 105,713 LOSS BEFORE INCOME TAXES (2,020,907 ) (2,411,386 ) (9,773,582 ) (10,675,160 ) Income Tax Benefit/(Expense) (5,445,123 ) 434,659 (3,967,480 ) 2,014,018 NET LOSS $ (7,466,029 ) $ (1,976,727 ) $ (13,741,062 ) $ (8,661,142 ) NET LOSS PER SHARE Basic $ (0.16 ) $ (0.04 ) $ (0.30 ) $ (0.19 ) Diluted $ (0.16 ) $ (0.04 ) $ (0.30 ) $ (0.19 ) WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING Basic 45,669,691 45,372,132 45,601,346 45,002,074 Diluted 45,669,691 45,372,132 45,601,346 45,002,074 KORU MEDICAL SYSTEMS, INC. STATEMENTS OF CASH FLOWS For the Years Ended December 31, 2023 2022 CASH FLOWS FROM OPERATING ACTIVITIES Net Loss $ (13,741,062 ) $ (8,661,142 ) Adjustments to reconcile net loss to net cash used in operating activities: Stock-based compensation expense 2,768,870 3,079,427 Depreciation and amortization 870,390 587,137 Loss on disposal of fixed assets 59,807  Deferred income taxes (2,035,297 ) (2,026,226 ) Allowance for non-realization of deferred tax asset 6,002,777  ROU landlord credit (21,988 ) 212,546 Changes in operating assets and liabilities: (Increase)/Decrease in accounts receivable (486,327 ) 34,002 Decrease/(Increase) in inventory 2,923,566 (298,529 ) Decrease/(Increase) in other receivables 943,507 (254,176 ) Decrease in prepaid expenses and other assets 242,599 28,776 (Decrease)/Increase in accounts payable (1,416,606 ) 1,164,266 (Decrease)/Increase in accrued payroll and related taxes (79,458 ) 381,796 Increase in other liabilities 255,183 167,337 (Decrease)/Increase in accrued expenses (1,178,514 ) 180,237 NET CASH USED IN OPERATING ACTIVITIES (4,892,553 ) (5,404,549 ) CASH FLOWS FROM INVESTING ACTIVITIES Purchases of property and equipment (782,949 ) (2,761,056 ) Purchases of intangible assets (31,648 ) (40,512 ) NET CASH USED IN INVESTING ACTIVITIES (814,597 ) (2,801,568 ) CASH FLOWS FROM FINANCING ACTIVITIES Proceeds from issuance of equity  406,623 Borrowings from indebtedness 565,172 783,799 Payments on indebtedness (684,123 ) (859,087 ) Finance lease ROU asset (33,461 )  Payments on finance lease liability (66,455 ) (51,850 ) NET CASH (USED IN) PROVIDED BY FINANCING ACTIVITIES (218,867 ) 279,485 NET DECREASE IN CASH AND CASH EQUIVALENTS (5,926,017 ) (7,926,632 ) CASH AND CASH EQUIVALENTS, BEGINNING OF YEAR 17,408,257 25,334,889 CASH AND CASH EQUIVALENTS, END OF YEAR $ 11,482,240 $ 17,408,257 Supplemental Information Cash paid during the years for: Interest $ 50,832 $ 28,490 Income taxes $ 3,160 $  Schedule of Non-Cash Operating, Investing and Financing Activities: Issuance of common stock as compensation $ 446,349 $ 513,082 See accompanying Notes to Financial Statements. KORU MEDICAL SYSTEMS, INC. SUPPLEMENTAL INFORMATION (UNAUDITED) A reconciliation of our non-GAAP measures is below: Three Months Ended Twelve Months Ended Reconciliation of GAAP Net Loss December 31, December 31, to Non-GAAP Adjusted EBITDA: 2023 2022 2023 2022 GAAP Net Loss $ (7,466,029 ) (1,976,727 ) $ (13,741,062 ) $ (8,661,142 ) Tax (Benefit)/Expense (557,654 ) (434,659 ) (2,035,297 ) (2,014,018 ) Valuation Allowance for DTA 6,002,777  6,002,777  Depreciation and Amortization 228,340 187,658 870,390 587,137 Interest (Income), Net (169,230 ) (101,009 ) (561,328 ) (145,587 ) Reorganization Charges 329,869  329,869 765,433 Manufacturing Initiative Expenses  184,343 55,361 293,229 Product Discontinuance 280,000  280,000  Stock-based Compensation Expense 389,256 588,654 2,768,869 3,079,426 Adjusted EBITDA $ (962,671 ) $ (1,551,740 ) $ (6,030,421 ) $ (6,095,522 ) Three Months Ended Twelve Months Ended Reconciliation of Reported Diluted EPS December 31, December 31, to Non-GAAP Adjusted Diluted EPS: 2023 2022 2023 2022 Reported Diluted Earnings Per Share $ (0.16 ) $ (0.04 ) $ (0.30 ) $ (0.19 ) Tax (Benefit)/Expense (0.01 ) (0.01 ) (0.04 ) (0.05 ) Valuation Allowance for DTA 0.13  0.13  Depreciation and Amortization   0.02 0.01 Interest (Income)/Expense, Net   (0.01 )  Reorganization Charges 0.01  0.01 0.02 Manufacturing Initiative Expenses     Product Discontinuance     Stock-based Compensation Expense 0.01 0.01 0.06 0.07 Adjusted Diluted Earnings Per Share $ (0.02 ) $ (0.04 ) $ (0.13 ) $ (0.14 ) Three Months Ended Twelve Months Ended Reconciliation of GAAP Gross Profit to December 31, December 31, Adjusted Gross Margin 2023 2022 2023 2022 Reported Gross Profit stated as a percentage of Net Revenues (Gross Margin) 60.3 % 55.6 % 58.6 % 55.1 % Product Discontinuance 2.8 % 0.0 % 1.0 % 0.0 % Adjusted Gross Profit stated as a percentage of Net Revenues (Adjusted Gross Margin) 63.1 % 55.6 % 59.6 % 55.1 % *Numbers presented are rounded to the nearest whole cent and percentage Reorganization Charges. We have excluded the effect of reorganization charges in calculating our non-GAAP measures. In 2022 and 2023 we incurred severance expenses related to the reorganization of the leadership team, which we would not have otherwise incurred in periods presented as part of continuing operations. Manufacturing Initiative Expenses. We have excluded the effect of expenses related to creating manufacturing efficiencies in calculating our non-GAAP measures. We incurred expenses in connection with these initiatives which we would not have otherwise incurred in periods presented as part of our continuing operations. Stock-based Compensation Expense. We have excluded the effect of stock-based compensation expense in calculating our non-GAAP measures. We record non-cash compensation expenses related to grants of options and restricted shares for executives, employees and consultants, and grants of shares to our board of directors. Depending upon the size, timing and the terms of the grants, the non-cash compensation expense may vary significantly but will recur in future periods. Allowance for nonrealization of deferred tax assets (DTA). We have excluded the effect of recording a full valuation allowance on our deferred tax assets in the fourth quarter ended 2023 in the amount of $6.0 million to illustrate the impact on net loss and earnings per share. Product Discontinuation. We have excluded the effect of disposing of a non-launched inventoried product that has no value in our core business product portfolio. View source version on businesswire.com: https://www.businesswire.com/news/home/20240313563140/en/ Investor Contact: Louisa Smith investor@korumedical.com Source: KORU Medical Systems, Inc. What were KORU Medical's Q4 2023 net revenues? KORU Medical reported Q4 2023 net revenues of $7.2 million, a 2% decrease from the prior year. What was the full year 2023 net revenues growth rate? The full year 2023 net revenues increased by 2% over the prior year. What was the gross margin in Q4 2023? The gross margin in Q4 2023 was 60.3%, reflecting a year-over-year improvement of 470 basis points. What was the net loss for the year 2023? The net loss for the year 2023 was ($13.7) million, including a tax valuation allowance of $6.0 million. What credit facility did KORU Medical sign? KORU Medical signed a $10 million credit facility with HSBC USA for strategic growth capital. What guidance did KORU Medical issue for full year 2024? KORU Medical issued guidance for full year 2024 with expected net revenues between $31.2-$32.2 million, representing 10-13% growth."
Pixie Dust Technologies Announces CFO Transition,2024-03-13T20:05:00.000Z,Low,Neutral,"Pixie Dust Technologies, Inc. appoints Nobuhiro Takagi and Nobufusa Tarumi as co-Chief Financial Officers, enhancing their finance and equity market expertise to drive growth initiatives.","Pixie Dust Technologies Announces CFO Transition Rhea-AI Impact (Low) Rhea-AI Sentiment (Neutral) Tags Rhea-AI Summary Pixie Dust Technologies, Inc. appoints Nobuhiro Takagi and Nobufusa Tarumi as co-Chief Financial Officers, enhancing their finance and equity market expertise to drive growth initiatives. Positive None. Negative None. 03/13/2024 - 04:05 PM NEW YORK and TOKYO, March 13, 2024 /PRNewswire/ - Pixie Dust Technologies, Inc. (Nasdaq: PXDT) (the ""Company""), a Japanese technology company focused on commercializing innovative products and materials utilizing proprietary wave control technology, announced the appointment of Nobuhiro Takagi and Nobufusa Tarumi as co-Chief Financial Officer (""co-CFO""), effective March 13, 2024. Messrs. Takagi and Tarumi succeed Mr. Mamoru Miwa, whose resignation was not the result of any disagreement or conflict with the Company, its operations, policies, or practices. The role of the Company's Chief Accounting Officer (""CAO""), previously held by Nobuhiro Takagi, will be assumed by the co-CFOs. Mr. Takagi has served as the CAO of the Company since November 2023, and previously served as an audit manager at KPMG AZSA LLC, Tokyo from July 2017 to September 2020. Mr. Takagi graduated from Keio University in Tokyo, Japan in March 2003. Mr. Tarumi has served as the Treasury Manager for the Company since September 2023. Mr. Tarumi Mr. Tarumi has roughly two decades of experience in the equity capital markets, working within the Equity Capital Market Department at SBI SECURITIES Co., Ltd. and Mizuho Securities Co., Ltd. since 2004. Mr. Tarumi graduated from the University of Tokyo in Tokyo, Japan in March 2002. ""On behalf of Pixie Dust Technologies, I am pleased to announce Mr. Takagi and Mr. Tarumi as our new co-CFOs,"" said CEO Yoichi Ochiai. ""Their extensive experience in finance and equity markets will be instrumental in driving Pixie Dust Technologies' growth initiatives moving forward. With both Mr. Takagi and Mr. Tarumi already being current members of our team, we anticipate and aim to further strengthen our financial well-being, enabling us to pursue new opportunities to expand our enterprise technology."" Forward-Looking StatementsCertain statements contained in this press release are ""forward-looking statements"" made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements reflect the Company's current expectations or beliefs concerning future events and actual events may differ materially from current expectations. Words such as ""expect,"" ""anticipate,"" ""should,"" ""believe,"" ""hope,"" ""target,"" ""project,"" ""aim,"" ""objective,"" ""goal,"" ""estimate,"" ""potential,"" ""predict,"" ""may,"" ""will,"" ""might,"" ""could,"" ""intend,"" variations of these terms or the negative of these terms and similar expressions are intended to identify these forward-looking statements. Any such forward-looking statements are subject to various risks and uncertainties, many of which involve factors or circumstances that are beyond the Company's control, including but not limited to the strength of the economy, changes to the market for securities, the effects of inflation and its associated impact on prevailing interest rates, political or financial instability, and other factors which are set forth in the Company's prospectus that forms a part of the Registration Statement on Form F-1 (File No. 333-272476), as amended, and in all filings with the SEC made by the Company subsequent to the filing thereof. The forward-looking statements included in this press release represent the Company's views as of the date of this press release. The Company anticipates that subsequent events and developments will cause its views to change. These forward-looking statements should not be relied upon as representing the Company's views as of any date subsequent to the date of this press release. The Company does not undertake to publicly update or revise its forward-looking statements, whether as a result of new information, future events or otherwise. About Pixie Dust Technologies, Inc.Pixie Dust Technologies, Inc. is a Japanese technology company focused on commercializing innovative products and materials utilizing proprietary wave technology. The Company is currently focusing on two areas of product development: (1) ""Personal Care & Diversity"", where wave control technology is applied to mechanobiology and intervention/assistance in vision, hearing, and touch, and (2) ""Workspace & Digital Transformation,"" where metamaterials (technology that creates properties through structure rather than material) and solutions to commercial design problems, such as in offices or construction sites, are applied. View original content to download multimedia:https://www.prnewswire.com/news-releases/pixie-dust-technologies-announces-cfo-transition-302087791.html SOURCE Pixie Dust Technologies Who are the new co-Chief Financial Officers of Pixie Dust Technologies, Inc.? The new co-Chief Financial Officers of Pixie Dust Technologies, Inc. are Nobuhiro Takagi and Nobufusa Tarumi. When were Nobuhiro Takagi and Nobufusa Tarumi appointed as co-CFOs of Pixie Dust Technologies, Inc.? Nobuhiro Takagi and Nobufusa Tarumi were appointed as co-Chief Financial Officers of Pixie Dust Technologies, Inc. on March 13, 2024. What is the background of Nobuhiro Takagi? Nobuhiro Takagi has served as the Chief Accounting Officer of Pixie Dust Technologies, Inc. since November 2023 and previously worked as an audit manager at KPMG AZSA LLC, Tokyo. What is the experience of Nobufusa Tarumi in equity capital markets? Nobufusa Tarumi has approximately two decades of experience in equity capital markets, working at SBI SECURITIES Co., Ltd. and Mizuho Securities Co., Ltd. since 2004. Who announced the appointment of Nobuhiro Takagi and Nobufusa Tarumi as co-CFOs? CEO Yoichi Ochiai announced the appointment of Nobuhiro Takagi and Nobufusa Tarumi as co-Chief Financial Officers of Pixie Dust Technologies, Inc. What is the significance of the appointment of new co-CFOs for Pixie Dust Technologies, Inc.? The appointment of new co-Chief Financial Officers is expected to strengthen the financial well-being of Pixie Dust Technologies, Inc. and drive growth initiatives."
"Adams Resources & Energy, Inc. Announces Fourth Quarter And Full Year 2023 Results",2024-03-13T20:05:00.000Z,Low,Neutral,"Adams Resources & Energy, Inc. (AE) reported a year-over-year increase in cash flow from operations and total liquidity. Total revenue for the fourth quarter of 2023 was $709.8 million, with a net loss of ($0.9) million. Adjusted net earnings were $0.1 million. Cash and cash equivalents stood at $33.3 million, and liquidity was $80.3 million at December 31, 2023. For the full year 2023, net income was $0.2 million on revenues of $2.75 billion, with adjusted net loss of ($3.7) million. Net cash provided by operating activities was $30.3 million. The company highlighted operational improvements and financial strength amidst industry challenges.","Adams Resources & Energy, Inc. Announces Fourth Quarter And Full Year 2023 Results Rhea-AI Impact (Low) Rhea-AI Sentiment (Neutral) Tags earnings Rhea-AI Summary Adams Resources & Energy, Inc. (AE) reported a year-over-year increase in cash flow from operations and total liquidity. Total revenue for the fourth quarter of 2023 was $709.8 million, with a net loss of ($0.9) million. Adjusted net earnings were $0.1 million. Cash and cash equivalents stood at $33.3 million, and liquidity was $80.3 million at December 31, 2023. For the full year 2023, net income was $0.2 million on revenues of $2.75 billion, with adjusted net loss of ($3.7) million. Net cash provided by operating activities was $30.3 million. The company highlighted operational improvements and financial strength amidst industry challenges. Positive Year-over-year increase in cash flow from operations and total liquidity Fourth quarter total revenue of $709.8 million with a net loss of ($0.9) million Adjusted net earnings of $0.1 million Cash and cash equivalents of $33.3 million at December 31, 2023 Liquidity of $80.3 million at December 31, 2023 Full year 2023 net income of $0.2 million on revenues of $2.75 billion Adjusted net loss of ($3.7) million for full year 2023 Net cash provided by operating activities of $30.3 million Operational improvements and financial strength highlighted by the company Negative None. Financial Analyst The reported increase in cash flow from operations and total liquidity by Adams Resources & Energy, Inc. presents a positive signal to stakeholders regarding the company's operational efficiency and financial health. The improvement in net loss and the transition to a net cash provided by operating activities indicate a turnaround in the company's ability to generate cash through its core business activities, which is a critical factor for sustaining operations and funding future growth. The increase in liquidity, from $55.9 million to $80.3 million, strengthens the company's financial flexibility, potentially allowing it to navigate macroeconomic challenges more effectively.Moreover, the payment of dividends, despite the net loss, suggests confidence by the management in the company's long-term profitability and commitment to shareholder returns. However, the decrease in total revenue year-over-year may raise concerns about the company's market position and ability to grow sales in a competitive environment. Investors should closely monitor the company's future performance, particularly in its crude oil marketing segment, which has seen a reduction in marketed barrels per day, likely impacting revenue streams. Market Research Analyst Adams Resources & Energy's operational highlights, such as the exit from Red River operations and the sale of liquidated equipment, suggest strategic adjustments to optimize its asset portfolio. The gains from these sales have likely contributed positively to the company's cash flow. The reported decrease in marketed barrels of crude oil and transportation miles could be indicative of broader industry trends or specific operational challenges, which may have implications for the company's market share and competitive positioning.Additionally, the strategic acquisitions in the logistics and repurposing segment signal an expansion of services that could diversify revenue streams and reduce dependency on core segments. The modernization of the fleet, with a reduced average life of tractors, could lead to increased operational efficiency and potentially lower maintenance costs over time. These factors, combined with the company's solid positioning with crude oil inventory, may provide a buffer against market volatility and position Adams for recovery as anticipated in the latter half of 2024. Energy Sector Analyst The sector-specific implications of Adams Resources & Energy's financial results are noteworthy. The reduction in throughput for the Victoria Express Pipeline System and terminalling volumes year-over-year could reflect industry-wide challenges, such as fluctuating demand or price volatility in the energy sector. The company's ability to maintain a solid inventory of crude oil despite these challenges suggests a deliberate inventory management strategy that could mitigate risks associated with price swings.Furthermore, the company's anticipation of a gradual recovery in its GulfMark and Service Transport segments aligns with broader economic forecasts indicating potential stabilization or improvement in the energy market. The strategic exit from underperforming operations and the focus on maintaining liquidity are prudent steps in such an unpredictable sector. These moves could help Adams navigate short-term headwinds while positioning for long-term growth as market conditions improve. 03/13/2024 - 04:05 PM Reports Year-over-Year Increase in Cash Flow from Operations and Total Liquidity HOUSTON, March 13, 2024 /PRNewswire/ -- Adams Resources & Energy, Inc. (NYSE AMERICAN: AE) (""Adams"" or the ""Company""), a company engaged in marketing, transportation, logistics and repurposing of crude oil, refined products and dry bulk materials, today announced operational and financial results for the quarter and year ended December 31, 2023. Fourth Quarter 2023 Financial Summary Total revenue of $709.8 million, versus $747.7 million for the fourth quarter of 2022.Net loss for the quarter improved $6.4 million year-over-year to ($0.9) million, or ($0.34) per common share.Adjusted net earnings of $0.1 million, or $0.03 per diluted common share, compared to adjusted net loss of ($2.7) million, or ($0.85) per common share, for the prior-year quarter.Net cash provided by operating activities of $22.4 million, versus net cash used in operating activities of $2.1 million for the fourth quarter of 2022.Cash and cash equivalents of $33.3 million at December 31, 2023 versus $20.5 million at December 31, 2022 and $16.3 million at September 30, 2023.Liquidity of $80.3 million at December 31, 2023, versus $55.9 million at September 30, 2023 and $72.1 million at December 31, 2022.Paid dividends of $0.24 per common share.Full Year 2023 Financial Summary Net income of $0.2 million, or $0.08 per diluted common share, on revenues of $2.75 billion, compared to $3.5 million, or $0.85 per diluted common share, on revenues of $3.37 billion for the prior year.Adjusted net loss of ($3.7) million, or ($1.45) per common share, compared to adjusted net earnings of $4.2 million, or $1.02 per diluted common share in the prior year.Net cash provided by operating activities of $30.3 million, compared to $13.8 million for the full year 2022.Adjusted net (losses) earnings and adjusted net (losses) earnings per common share are non-generally accepted accounting principle (""non-GAAP"") financial measures that are defined and reconciled, along with the non-GAAP financial measure adjusted cash flow in the financial tables later in this release. ""Our performance in the fourth quarter showcased several encouraging highlights in a very challenging environment. Our crude oil marketing segment demonstrated a sequential increase in operating income despite a number of headwinds,"" said Kevin J. Roycraft, Chief Executive Officer of Adams. ""Moreover, we increased our cash balance and liquidity and nearly tripled our net income on a sequential basis."" ""We believe the challenges facing our GulfMark and Service Transport segments are expected to remain in place for the next few months, and we anticipate a gradual recovery to begin late in the first half of 2024,"" Mr. Roycraft continued. ""Our Company remains in a very strong financial position to navigate the continued macroeconomic challenges affecting our industries. We are well-prepared to deliver meaningful performance when our key markets begin to improve. In addition, our continued commitment to our dividend should deliver long-term value to our shareholders,"" Mr. Roycraft concluded. Additional Operational Highlights In the fourth quarter, Adams' crude oil marketing subsidiary, GulfMark Energy, Inc. (""GulfMark""), successfully exited its Red River operations in Oklahoma and North Texas, recognizing nearly $1 million in one-time expenses associated with the closure, as well as $2.6 million in gains on sales of liquidated equipment. GulfMark marketed 73,381 barrels per day (""bpd"") of crude oil during the fourth quarter of 2023, compared to 99,441 bpd during the fourth quarter of 2022 and 92,556 bpd for the third quarter of 2023. The primary driver for the barrel reduction was the Red River closure. For the full year 2023, GulfMark marketed 87,985 bpd of crude oil versus 94,873 bpd for the full year 2022.The collective fleet of Service Transport Company (""Service Transport""), Adams' liquid chemicals, pressurized gases, asphalt and dry bulk transportation subsidiary, traveled 6.13 million miles during the fourth quarter of 2023, versus 6.07 million miles during the fourth quarter of 2022 and 6.51 million miles during the third quarter of 2023. For the full year 2023, Service Transport traveled 25.5 million miles versus 26.5 million miles for the full year 2022.Adams' crude oil pipeline and storage segment, which includes the Victoria Express Pipeline System, throughput was 9,377 bpd for the fourth quarter of 2023, compared to 10,615 bpd for the fourth quarter of 2022 and 8,548 bpd for the third quarter of 2023. Terminalling volumes were 9,589 bpd for the fourth quarter of 2023, versus 10,833 bpd for the fourth quarter of 2022 and 9,350 bpd for the third quarter of 2023. For the full year 2023, pipeline throughput was 9,140 bpd versus 11,084 bpd for the full year 2022, while terminalling volumes were 10,026 bpd for 2023 versus 11,296 bpd for 2022.The logistics and repurposing segment, which includes the Firebird Bulk Carriers, Inc. and Phoenix Oil, Inc. businesses acquired in August 2022, had another quarter of positive impact on quarterly and full year 2023 cash flow.Adams' remained solidly positioned with 267,731 barrels of crude oil inventory at December 31, 2023 compared to 328,562 barrels at December 31, 2022.Ended 2023 with a combined owned or leased fleet across the organization of 605 tractors and 1,131 trailers compared to 668 tractors and 1,219 trailers at the end of 2022. Through its continued targeted efforts to maintain a modernized fleet, Adams' average life of its tractor fleet was 3.5 years at December 31, 2023 compared to 3.6 years at December 31, 2022.Capital Investments and Dividends During the fourth quarter of 2023, the Company had capital expenditures of $3.0 million for the purchase of eight tractors, thirteen trailers and other field equipment. In addition, Adams paid dividends of $0.6 million, or $0.24 per common share. For the full year 2023, Adams had capital expenditures of $11.9 million relating to the purchase of 26 tractors and 24 trailers, the purchase of land for our Dayton expansion project, and other various equipment. As previously announced on February 20, 2024, the Company's Board of Directors declared a quarterly cash dividend for the fourth quarter of 2023 in the amount of $0.24 per common share, payable on March 22, 2024 to shareholders of record as of March 8, 2024. Use of Non-GAAP Financial Measures This press release and accompanying schedules includes the non-GAAP financial measures of adjusted cash flow, adjusted net earnings (losses) and adjusted earnings (losses) per common share. The accompanying schedules provide reconciliations of these non-GAAP financial measures to their most directly comparable financial measures calculated and presented in accordance with GAAP. Company management believes these measures are useful indicators of the financial performance of our business and uses these measurements as aids in monitoring the Company's ongoing financial performance from quarter to quarter and year to year on a regular basis and for benchmarking against peer companies. Our non-GAAP financial measures should not be considered as alternatives to GAAP measures such as net income, operating income, net cash flow provided by operating activities, earnings per share or any other measure of financial performance calculated and presented in accordance with GAAP. Adams' non-GAAP financial measures may not be comparable to similarly titled measures of other companies because they may not calculate such measures in the same manner as Adams does. Conference Call The Company will host a conference call to discuss its fourth quarter results on Thursday, March 14, 2024 at 9:00 a.m. ET (8:00 a.m. CT). To participate in the live conference call, dial 1-844-413-3976 (Toll-Free) within the U.S., or 1-412-317-1802 (Toll-Required) outside the U.S., or log into the webcast, available on Adams' investor relations website at adamsresources.com/investor-relations. A replay will also be available on the Company's website or by dialing 1-877-344-7529 (Toll-Free) within the U.S., or 1-412-317-0088 (Toll-Required) outside the U.S. and entering code 9826581. About Adams Resources & Energy, Inc. Adams Resources & Energy, Inc. is engaged in crude oil marketing, transportation, terminalling and storage, tank truck transportation of liquid chemicals and dry bulk, interstate bulk transportation logistics of crude oil, condensate, fuels, oils and other petroleum products and recycling and repurposing of off-specification fuels, lubricants, crude oil and other chemicals through its subsidiaries, GulfMark Energy, Inc., Service Transport Company, Victoria Express Pipeline, LLC, GulfMark Terminals, LLC, Firebird Bulk Carriers, Inc. and Phoenix Oil, Inc. For more information, visit www.adamsresources.com. Cautionary Statement Regarding Forward-Looking Statements This news release contains forward-looking statements. Forward-looking statements relate to future events and anticipated results of operations, business strategies, capital deployment plans and other aspects of our operations or operating results as well as future industry developments and economic conditions. In many cases you can identify forward-looking statements by terminology such as ""anticipate,"" ""intend,"" ""plan,"" ""project,"" ""estimate,"" ""continue,"" ""potential,"" ""should,"" ""could,"" ""may,"" ""will,"" ""objective,"" ""guidance,"" ""outlook,"" ""effort,"" ""expect,"" ""believe,"" ""predict,"" ""budget,"" ""projection,"" ""goal,"" ""forecast,"" ""target"" or similar words. Statements may be forward looking even in the absence of these particular words. Where, in any forward-looking statement, the Company expresses an expectation or belief as to future results or conditions, such expectation or belief is expressed in good faith and believed to have a reasonable basis. Forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially from those expressed or implied in the forward-looking statements, and any other risk factors included in Adams' reports filed with the Securities and Exchange Commission. However, there can be no assurance that such expectation or belief will result or be achieved. Unless legally required, Adams undertakes no obligation to update publicly any forward-looking statements, whether as a result of new information, future events or otherwise. Company Contact Tracy E. OhmartEVP, Chief Financial Officertohmart@adamsresources.com(713) 881-3609 Investor Relations Contact John Beisler or Steven HooserThree Part Advisors(817) 310-8776 ADAMS RESOURCES & ENERGY, INC. AND SUBSIDIARIES UNAUDITED CONSOLIDATED STATEMENTS OF OPERATIONS (In thousands, except per share data) Three Months Ended Year Ended December 31, December 31, 2023 2022 2023 2022 Revenues: Marketing $ 671,682 $ 707,728 $ 2,585,355 $ 3,232,193 Transportation 23,256 26,322 98,359 112,376 Pipeline and storage 15  323  Logistics and repurposing 14,798 13,671 61,256 22,348 Total revenues 709,751 747,721 2,745,293 3,366,917 Costs and expenses: Marketing 665,868 710,121 2,560,284 3,208,595 Transportation 18,676 21,702 80,991 89,973 Pipeline and storage 757 703 3,107 2,502 Logistics and repurposing 14,269 12,069 55,717 19,651 General and administrative 4,283 4,858 14,932 17,718 Depreciation and amortization 6,574 6,598 27,863 22,707 Total costs and expenses 710,427 756,051 2,742,894 3,361,146 Operating (losses) earnings (676) (8,330) 2,399 5,771 Other income (expense): Interest income 578 256 1,471 921 Interest expense (859) (918) (3,384) (1,287) Total other (expense) income, net (281) (662) (1,913) (366) (Losses) earnings before income taxes (957) (8,992) 486 5,405 Income tax benefit (provision) 83 1,723 (274) (1,918) Net (losses) earnings $ (874) $ (7,269) $ 212 $ 3,487 (Losses) earnings per share: Basic net (losses) earnings per common share $ (0.34) $ (2.34) $ 0.08 $ 0.86 Diluted net (losses) earnings per common share $ (0.34) $ (2.34) $ 0.08 $ 0.85 Dividends per common share $ 0.24 $ 0.24 $ 0.96 $ 0.96 ADAMS RESOURCES & ENERGY, INC. AND SUBSIDIARIES UNAUDITED CONSOLIDATED BALANCE SHEETS (In thousands) December 31, 2023 2022 ASSETS Current assets: Cash and cash equivalents $ 33,256 $ 20,532 Restricted cash 11,990 10,535 Accounts receivable, net of allowance for doubtful accounts 164,295 189,039 Inventory 19,827 26,919 Prepayments and other current assets 3,103 3,118 Total current assets 232,471 250,143 Property and equipment, net 105,065 106,425 Operating lease right-of-use assets, net 5,832 7,720 Intangible assets, net 7,985 9,745 Goodwill 6,673 6,428 Other assets 3,308 3,698 Total assets $ 361,334 $ 384,159 LIABILITIES AND SHAREHOLDERS' EQUITY Current liabilities: Accounts payable $ 183,102 $ 204,391 Accounts payable  related party  31 Derivative liabilities  330 Current portion of finance lease obligations 6,206 4,382 Current portion of operating lease liabilities 2,829 2,712 Current portion of long-term debt 2,500  Other current liabilities 16,150 19,214 Total current liabilities 210,787 231,060 Other long-term liabilities: Long-term debt 19,375 24,375 Asset retirement obligations 2,514 2,459 Finance lease obligations 19,685 12,085 Operating lease liabilities 3,006 5,007 Deferred taxes and other liabilities 13,251 15,996 Total liabilities 268,618 290,982 Commitments and contingencies Shareholders' equity 92,716 93,177 Total liabilities and shareholders' equity $ 361,334 $ 384,159 ADAMS RESOURCES & ENERGY, INC. AND SUBSIDIARIES UNAUDITED CONSOLIDATED STATEMENTS OF CASH FLOWS (In thousands) Three Months Ended Year Ended December 31, December 31, 2023 2022 2023 2022 Operating activities: Net (losses) earnings $ (874) $ (7,269) $ 212 $ 3,487 Adjustments to reconcile net (losses) earnings to net cash provided by (used in) operating activities: Depreciation and amortization 6,574 6,598 27,863 22,707 Gains on sales of property (2,607) (803) (4,036) (2,512) Provision for doubtful accounts   29 (20) Stock-based compensation expense 149 310 1,193 1,022 Change in contingent consideration liability   (2,566)  Deferred income taxes (2,419) (375) (2,416) (2,136) Net change in fair value contracts 5 2,237 (330) 353 Changes in assets and liabilities: Accounts receivable 54,968 9,483 24,715 (46,577) Accounts receivable/payable, affiliates  16 (31) 33 Inventories 7,823 2,925 7,092 (7,334) Income tax receivable 510   6,424 Prepayments and other current assets (633) (1,060) 15 (592) Accounts payable (43,509) (12,163) (21,270) 34,762 Accrued liabilities 2,294 (2,162) (415) 4,327 Other 156 208 220 (167) Net cash provided by (used in) operating activities 22,437 (2,055) 30,275 13,777 Investing activities: Property and equipment additions (2,980) (694) (11,897) (7,491) Acquisition of Firebird and Phoenix, net of cash acquired  443  (33,147) Proceeds from property sales 5,707 893 8,785 3,102 Insurance and state collateral refunds  1,202  1,533 Net cash provided by (used in) investing activities 2,727 1,844 (3,112) (36,003) Financing activities: Borrowings under Credit Agreement  72,000 76,000 117,000 Repayments under Credit Agreement (625) (62,625) (78,500) (92,625) Principal repayments of finance lease obligations (3,572) (1,250) (8,516) (4,741) Cash paid for debt issuance costs  (1,679)  (1,679) Repurchase of common shares from KSA  (69,928)  (69,928) Net proceeds from sale of equity  1,441 549 1,724 Dividends paid on common stock (609) (595) (2,517) (3,775) Net cash used in financing activities (4,806) (62,636) (12,984) (54,024) Increase (Decrease) in cash and cash equivalents, including restricted cash 20,358 (62,847) 14,179 (76,250) Cash and cash equivalents, including restricted cash, at beginning of period 24,888 93,914 31,067 107,317 Cash and cash equivalents, including restricted cash, at end of period $ 45,246 $ 31,067 $ 45,246 $ 31,067 ADAMS RESOURCES & ENERGY, INC. AND SUBSIDIARIES NON-GAAP RECONCILIATIONS (In thousands, except per share data) Three Months Ended Year Ended December 31, December 31, 2023 2022 2023 2022 Reconciliation of Adjusted Cash Flow to Net (Losses) Earnings: Net (losses) earnings $ (874) $ (7,269) $ 212 $ 3,487 Add (subtract): Income tax (benefit) provision (83) (1,723) 274 1,918 Depreciation and amortization 6,574 6,598 27,863 22,707 Gains on sales of property (2,607) (803) (4,036) (2,512) Stock-based compensation expense 149 310 1,193 1,022 Change in contingent consideration liability   (2,566)  Inventory valuation losses 3,673 4,070 751 2,008 Net change in fair value contracts 5 2,237 (330) 353 Adjusted cash flow $ 6,837 $ 3,420 $ 23,361 $ 28,983 Reconciliation of Net (Losses) Earnings to Adjusted Net (Losses) Earnings and Adjusted (Losses) Earnings per Common Share: Net (losses) earnings $ (874) $ (7,269) $ 212 $ 3,487 Add (subtract): Gains on sales of property (2,607) (803) (4,036) (2,512) Stock-based compensation expense 149 310 1,193 1,022 Change in contingent consideration liability   (2,566)  Net change in fair value contracts 5 2,237 (330) 353 Inventory valuation losses 3,673 4,070 751 2,008 Tax effect of adjustments to (losses) earnings (256) (1,221) 1,048 (183) Adjusted net earnings (losses) $ 90 $ (2,676) $ (3,728) $ 4,175 Adjusted earnings (losses) per common share $ 0.03 $ (0.85) $ (1.45) $ 1.02 Reconciliation of Adjusted Cash Flow to Net Cash Provided by (Used in) Operating Activities: Net cash provided by (used in) operating activities $ 22,437 $ (2,055) $ 30,275 $ 13,777 Add (subtract): Income tax (benefit) provision (83) (1,723) 274 1,918 Deferred income taxes 2,419 375 2,416 2,136 Provision for doubtful accounts   (29) 20 Inventory valuation losses 3,673 4,070 751 2,008 Changes in assets and liabilities (21,609) 2,753 (10,326) 9,124 Adjusted cash flow $ 6,837 $ 3,420 $ 23,361 $ 28,983 View original content to download multimedia:https://www.prnewswire.com/news-releases/adams-resources--energy-inc-announces-fourth-quarter-and-full-year-2023-results-302088457.html SOURCE Adams Resources & Energy, Inc. What was Adams Resources & Energy, Inc.'s total revenue for the fourth quarter of 2023? Adams Resources & Energy, Inc.'s total revenue for the fourth quarter of 2023 was $709.8 million. What was the net loss for the fourth quarter of 2023? The net loss for the fourth quarter of 2023 was ($0.9) million. What were the adjusted net earnings for the fourth quarter of 2023? The adjusted net earnings for the fourth quarter of 2023 were $0.1 million. How much were the cash and cash equivalents at December 31, 2023? The cash and cash equivalents at December 31, 2023 were $33.3 million. What was the liquidity at December 31, 2023? The liquidity at December 31, 2023 was $80.3 million. What was the net income for the full year 2023? The net income for the full year 2023 was $0.2 million on revenues of $2.75 billion. What was the adjusted net loss for full year 2023? The adjusted net loss for full year 2023 was ($3.7) million. How much net cash was provided by operating activities for the full year 2023? Net cash provided by operating activities for the full year 2023 was $30.3 million. What were the operational highlights mentioned in the press release? Operational highlights included improvements in the crude oil marketing segment and financial strength amidst industry challenges."
Purple Innovation to Present at the 36th Annual ROTH Conference,2024-03-13T20:05:00.000Z,Low,Neutral,"Purple Innovation, Inc. (NASDAQ: PRPL) announces participation in the 36th Annual ROTH Conference with a fireside chat presentation scheduled for March 18, 2024. The event will be broadcast online, offering investors insights into Purple's future strategies and innovations.","Purple Innovation to Present at the 36th Annual ROTH Conference Rhea-AI Impact (Low) Rhea-AI Sentiment (Neutral) Tags conferences Rhea-AI Summary Purple Innovation, Inc. (NASDAQ: PRPL) announces participation in the 36th Annual ROTH Conference with a fireside chat presentation scheduled for March 18, 2024. The event will be broadcast online, offering investors insights into Purple's future strategies and innovations. Positive None. Negative None. 03/13/2024 - 04:05 PM LEHI, Utah, March 13, 2024 /PRNewswire/ -- Purple Innovation, Inc. (NASDAQ: PRPL) (""Purple""), a comfort innovation company known for creating the ""World's First No Pressure Mattress,"" today announced that the management team is participating in the 36th Annual ROTH Conference. A fireside chat presentation is scheduled for Monday, March 18, 2024 at 2:00 p.m. Pacific Time. The presentation will be simultaneously broadcast on the internet and available at https://investors.purple.com/. About Purple Purple, the leading premium mattress company with the #1 Gel Grid technology in the world, the GelFlex Grid, thoughtfully engineers products that make restorative sleep effortless for every kind of sleeper. The result of over 30 years of innovation and in comfort technologies, Purple's GelFlex Grid is the most significant advancement in mattresses in decades and is proven to reduce aches and pains. It instantly adapts as you move, balances temperature, relieves pressure and offers support in all the right places. Purple products, including mattresses, pillows, cushions, frames, sheets, and more, can be found online at Purple.com, in 60 Purple stores and over 3,000 retailers nationwide. Sleep Better. Live Purple. Investor Contact:Brendon Frey, ICRbrendon.frey@icrinc.com203-682-8200 View original content to download multimedia:https://www.prnewswire.com/news-releases/purple-innovation-to-present-at-the-36th-annual-roth-conference-302088390.html SOURCE Purple Innovation, Inc. When is Purple Innovation, Inc. (PRPL) participating in the 36th Annual ROTH Conference? Purple Innovation, Inc. (PRPL) is participating in the 36th Annual ROTH Conference with a fireside chat presentation scheduled for March 18, 2024. Where can investors watch the presentation by Purple Innovation, Inc. (PRPL) at the 36th Annual ROTH Conference? Investors can watch the presentation by Purple Innovation, Inc. (PRPL) at the 36th Annual ROTH Conference online at https://investors.purple.com/. What is Purple Innovation, Inc. (PRPL) known for creating? Purple Innovation, Inc. (PRPL) is known for creating the 'World's First No Pressure Mattress.' What time is the fireside chat presentation by Purple Innovation, Inc. (PRPL) scheduled for at the 36th Annual ROTH Conference? The fireside chat presentation by Purple Innovation, Inc. (PRPL) is scheduled for Monday, March 18, 2024, at 2:00 p.m. Pacific Time."
Vroom Announces Fourth Quarter and Full Year 2023 Results,2024-03-13T20:05:00.000Z,Neutral,Neutral,"Vroom, Inc. (VRM) reported financial results for Q4 and FY 2023, with $135.6 million cash, 4,780 Ecommerce units sold, and $4,742 Ecommerce GPPU. The company incurred net losses of $(141.3) million for Q4 and $(365.5) million for FY 2023. Vroom is winding down its ecommerce operations as part of a Value Maximization Plan to focus on United Auto Credit and CarStory.","Vroom Announces Fourth Quarter and Full Year 2023 Results Rhea-AI Impact (Neutral) Rhea-AI Sentiment (Neutral) Tags earnings Rhea-AI Summary Vroom, Inc. (VRM) reported financial results for Q4 and FY 2023, with $135.6 million cash, 4,780 Ecommerce units sold, and $4,742 Ecommerce GPPU. The company incurred net losses of $(141.3) million for Q4 and $(365.5) million for FY 2023. Vroom is winding down its ecommerce operations as part of a Value Maximization Plan to focus on United Auto Credit and CarStory. Positive Positive: Strong cash position of $135.6 million as of December 31, 2023. Positive: Ecommerce unit growth with 4,780 units sold in Q4 2023. Negative: Significant net losses of $(141.3) million for Q4 and $(365.5) million for FY 2023. Negative: Discontinuation of ecommerce operations leading to a reduction-in-force and wind down. Negative: Reduced financial outlook with an estimated cash range of $35.0 to $65.0 million by year-end 2024. Negative None. Financial Analyst The reported financial results for Vroom, Inc. highlight a mix of growth in certain areas and significant challenges in others. The increase in Ecommerce units sold quarter-over-quarter indicates a successful expansion in this segment. However, the substantial net losses and negative Adjusted EBITDA figures for both the fourth quarter and the full year are concerning, suggesting operational inefficiencies or market challenges that are impacting profitability.The company's liquidation of aged inventory and write-downs due to the discontinuance of ecommerce operations reflect a strategic pivot that could be aimed at reducing losses and focusing on more profitable segments. The convertible note repurchases at a discount could be a strategic move to manage debt and potentially improve the balance sheet. However, investors should closely monitor the company's cash burn rate and liquidity position, especially given the anticipated cash and cash equivalents for year-end 2024, which signals a significant decrease from the current level. Market Research Analyst The automotive ecommerce industry is highly competitive, with several major players vying for market share. Vroom's decision to wind down its ecommerce operations may be a response to this intense competition and a strategy to optimize its business model. The growth in Ecommerce unit sales and Ecommerce gross profit per unit (GPPU) suggests that while the company was able to sell more units and increase profitability per unit, the overall strategy was not sustainable in the long term.By focusing on the remaining businesses, United Auto Credit and CarStory, Vroom is likely aiming to leverage niche markets within the used vehicle sector. This pivot could be an attempt to differentiate from competitors and focus on areas with higher margins or less direct competition. Economist The automotive sector is sensitive to economic cycles and Vroom's performance must be contextualized within the broader economic environment. The substantial net losses reported may partly reflect macroeconomic headwinds such as fluctuating consumer demand, supply chain disruptions and increased competition, which can compress margins and elevate operational costs.The reduction-in-force and other cost-cutting measures indicate a response to these economic pressures. The strategic focus on value maximization could be a prudent approach to navigating the current economic climate, especially if it leads to a leaner, more focused operation that can adapt to changing market conditions. 03/13/2024 - 04:05 PM Substantial Progress on Value Maximization Plan NEW YORK--(BUSINESS WIRE)-- Vroom, Inc. (Nasdaq:VRM) today announced financial results for the fourth quarter and fiscal year ended December 31, 2023. HIGHLIGHTS OF FOURTH QUARTER AND FULL YEAR 2023 $135.6 million cash and cash equivalents as of December 31, 2023 4,780 and 17,401 Ecommerce units sold for the fourth quarter and full year, respectively, representing third consecutive quarter of Ecommerce unit growth $4,742 and $3,403 Ecommerce gross profit per unit (GPPU) for the fourth quarter and full year, respectively $(141.3) million and $(365.5) million net loss for the fourth quarter and full year, respectively $(91.6) million and $(277.2) million Adjusted EBITDA for the fourth quarter and full year, respectively, including ~$27 million impact of aged inventory liquidations and inventory write-downs due to the discontinuance of ecommerce operations(1) $41.4 million and $74.2 million convertible note repurchases during the fourth quarter and full year, respectively, for $23.3 million and $36.5 million, respectively CURRENT PROGRESS ON VALUE MAXIMIZATION PLAN Expected to be substantially complete with the ecommerce wind down by the end of the first quarter 2024 ~$94.0 million cash and cash equivalents as of February 29, 2024 Sold substantially all of our used vehicle inventory Repaid outstanding balance on Ally Floorplan Facility Reducing our outstanding commitments and executing a reduction-in-force commensurate with our reduced operations Tom Shortt, the Companys Chief Executive Officer, said As we previously announced, in January 2024 Vrooms Board of Directors approved a Value Maximization Plan pursuant to which the Company has discontinued its ecommerce operations and is winding down its used vehicle dealership business. I am incredibly proud of the commitment and professionalism demonstrated by our team as they execute an orderly wind down of our ecommerce operations with a focus on timeliness and cost effectiveness. We anticipate that the wind-down will be substantially complete by the end of the month and look forward to working to maximize stakeholder value through our remaining businesses, United Auto Credit and CarStory. (1) While the Value Maximization Plan was approved in January 2024, we determined a triggering event existed as of December 31, 2023 related to our long lived assets, which led to additional write-downs of inventory in the fourth quarter of 2023. FOURTH QUARTER 2023 FINANCIAL DISCUSSION All financial comparisons are on a year-over-year basis unless otherwise noted. Ecommerce Results Three Months Ended December 31, Year Ended December 31, 2023 2022 Change % Change 2023 2022 Change % Change (in thousands, except unit data and average days to sale) (in thousands, except unit data and average days to sale) Ecommerce units sold 4,780 4,144 636 15.3 % 17,401 39,278 (21,877 ) (55.7 )% Ecommerce revenue: Vehicle revenue $ 136,360 $ 131,069 $ 5,291 4.0 % $ 523,945 $ 1,304,797 $ (780,852 ) (59.8 )% Product revenue 16,101 10,689 5,412 50.6 % 52,225 59,398 (7,173 ) (12.1 )% Total ecommerce revenue $ 152,461 $ 141,758 $ 10,703 7.6 % $ 576,170 $ 1,364,195 $ (788,025 ) (57.8 )% Ecommerce gross profit: Vehicle gross profit $ 7,387 $ (5,579 ) $ 12,966 232.4 % $ 10,343 $ 40,575 $ (30,232 ) (74.5 )% Product gross profit 15,281 10,689 4,592 43.0 % 48,888 59,398 (10,510 ) (17.7 )% Total ecommerce gross profit $ 22,668 $ 5,110 $ 17,558 343.6 % $ 59,231 $ 99,973 $ (40,742 ) (40.8 )% Average vehicle selling price per ecommerce unit $ 28,527 $ 31,629 $ (3,102 ) (9.8 )% $ 30,110 $ 33,220 $ (3,110 ) (9.4 )% Product revenue per ecommerce unit 3,368 2,579 789 30.6 % 3,001 1,512 1,489 98.5 % Gross profit per ecommerce unit: Vehicle gross profit per ecommerce unit $ 1,545 $ (1,346 ) $ 2,891 214.8 % $ 594 $ 1,033 $ (439 ) (42.5 )% Product gross profit per ecommerce unit 3,197 2,579 618 24.0 % 2,809 1,512 1,297 85.8 % Total gross profit per ecommerce unit $ 4,742 $ 1,233 $ 3,509 284.6 % $ 3,403 $ 2,545 $ 858 33.7 % Ecommerce average days to sale 135 244 (109 ) (44.7 )% 217 131 86 65.6 % Results by Segment Three Months Ended December 31, Year Ended December 31, 2023 2022 Change % Change 2023 2022 Change % Change (in thousands, except unit data) (in thousands, except unit data) Units: Ecommerce 4,780 4,144 636 15.3 % 17,401 39,278 (21,877 ) (55.7 )% Wholesale 1,821 1,768 53 3.0 % 7,094 20,876 (13,782 ) (66.0 )% All Other (1) 337 350 (13 ) (3.7 )% 1,359 3,758 (2,399 ) (63.8 )% Total units 6,938 6,262 676 10.8 % 25,854 63,912 (38,058 ) (59.5 )% Revenue: Ecommerce $ 152,461 $ 141,758 $ 10,703 7.6 % $ 576,170 $ 1,364,195 $ (788,025 ) (57.8 )% Wholesale 28,526 23,039 5,487 23.8 % 104,119 293,528 (189,409 ) (64.5 )% Retail Financing (2) 41,999 32,537 9,462 29.1 % 156,938 152,542 4,396 2.9 % All Other (3) 12,938 12,015 923 7.7 % 55,976 138,636 (82,660 ) (59.6 )% Total revenue $ 235,924 $ 209,349 $ 26,575 12.7 % $ 893,203 $ 1,948,901 $ (1,055,698 ) (54.2 )% Gross profit (loss): Ecommerce $ 22,668 $ 5,110 $ 17,558 343.6 % $ 59,231 $ 99,973 $ (40,742 ) (40.8 )% Wholesale (28,927 ) (4,359 ) (24,568 ) 563.6 % (34,353 ) (10,620 ) (23,733 ) 223.5 % Retail Financing (2) 33,427 28,744 4,683 16.3 % 125,610 138,381 (12,771 ) (9.2 )% All Other (3) 1,879 (36 ) 1,915 5,319.4 % 11,459 17,053 (5,594 ) (32.8 )% Total gross profit $ 29,047 $ 29,459 $ (412 ) (1.4 )% $ 161,947 $ 244,787 $ (82,840 ) (33.8 )% Gross profit (loss) per unit (4): Ecommerce $ 4,742 $ 1,233 $ 3,509 284.6 % $ 3,403 $ 2,545 $ 858 33.7 % Wholesale $ (15,885 ) $ (2,465 ) $ (13,420 ) 544.4 % $ (4,843 ) $ (509 ) $ (4,334 ) 851.5 % (1) All Other units consist of retail sales of used vehicles from TDA. (2) The Retail Financing segment represents UACCs operations with its network of third-party dealership customers as of the closing of the UACC acquisition in February 2022. (3) All Other revenues and gross profit consist of retail sales of used vehicles from TDA and fees earned on sales of value-added products associated with those vehicles sales and the CarStory business. (4) Gross profit per unit metrics exclude the Retail Financing gross profit and All Other gross profit. SG&A Three Months Ended December 31, Year Ended December 31, 2023 2022 Change % Change 2023 2022 Change % Change (in thousands) (in thousands) Compensation & benefits $ 35,738 $ 52,043 $ (16,305 ) (31.3 )% $ 166,056 $ 251,153 $ (85,097 ) (33.9 )% Marketing expense 8,570 9,852 (1,282 ) (13.0 )% 48,440 79,670 (31,230 ) (39.2 )% Outbound logistics 2,215 (902 ) 3,117 345.6 % 8,466 39,023 (30,557 ) (78.3 )% Occupancy and related costs 4,410 5,955 (1,545 ) (25.9 )% 18,010 23,363 (5,353 ) (22.9 )% Professional fees 4,625 6,870 (2,245 ) (32.7 )% 20,129 33,455 (13,326 ) (39.8 )% Software and IT costs 8,912 11,164 (2,252 ) (20.2 )% 36,466 44,570 (8,104 ) (18.2 )% Other 13,109 5,778 7,331 126.9 % 43,090 95,153 (52,063 ) (54.7 )% Total selling, general & administrative expenses $ 77,579 $ 90,760 $ (13,181 ) (14.5 )% $ 340,657 $ 566,387 $ (225,730 ) (39.9 )% Non-GAAP Financial Measures In addition to our results determined in accordance with U.S. GAAP, we believe the following non-GAAP financial measures are useful in evaluating our operating performance: EBITDA; Adjusted EBITDA; Adjusted EBITDA excluding non-recurring costs to address operational and customer experience issues; Adjusted EBITDA excluding securitization gain; and Adjusted EBITDA excluding securitization gain and non-recurring costs to address operational and customer experience issues. These non-GAAP financial measures have limitations as analytical tools in that they do not reflect all of the amounts associated with our results of operations as determined in accordance with U.S. GAAP. Because of these limitations, these non-GAAP financial measures should be considered along with other operating and financial performance measures presented in accordance with U.S. GAAP. The presentation of these non-GAAP financial measures is not intended to be considered in isolation or as a substitute for, or superior to, financial information prepared and presented in accordance with U.S. GAAP. We have reconciled all non-GAAP financial measures with the most directly comparable U.S. GAAP financial measures. EBITDA, Adjusted EBITDA, Adjusted EBITDA excluding non-recurring costs to address operational and customer experience issues, Adjusted EBITDA excluding securitization gain, and Adjusted EBITDA excluding securitization gain and non-recurring costs to address operational and customer experience issues are supplemental performance measures that our management uses to assess our operating performance and the operating leverage in our business. Because each of these non-GAAP financial measures facilitate internal comparisons of our historical operating performance on a more consistent basis, we use these measures for business planning purposes. EBITDA We calculate EBITDA as net loss before interest expense, interest income, income tax expense and depreciation and amortization expense. Adjusted EBITDA We calculate Adjusted EBITDA as EBITDA adjusted to exclude severance costs, gain on debt extinguishment, severe weather-related costs, long-lived asset impairment charges, goodwill impairment charge, realignment costs, acquisition related costs, and the acceleration of non-cash stock-based compensation. Changes in fair value of financial instruments can fluctuate significantly from period to period and previously related primarily to historical finance receivables and debt which have been securitized, and acquired on February 1, 2022 from UACC. As a result of current market conditions, the financial instruments related to the 2022-2 and 2023-1 securitization transactions are recognized on balance-sheet and accounted for under the fair value option. See Note 17  Financial Instruments and Fair Value Measurements to our consolidated financial statements included in our Annual Report on Form 10-K for the year ended December 31, 2023. As a result, the majority of our finance receivables are now carried at fair value and a significant portion of the risk of loss associated with these finance receivables have been retained by UACC. We therefore have determined we will no longer make any adjustments for such fluctuations in fair value to our Adjusted EBITDA results. We have recast the prior period presented to conform to current period presentation. We may account for future securitizations as on balance sheet transactions depending on the market conditions. Adjusted EBITDA excluding non-recurring costs to address operational and customer experience issues We calculate Adjusted EBITDA excluding non-recurring costs to address operational and customer experience issues as Adjusted EBITDA adjusted to exclude the non-recurring costs incurred to address operational and customer experience issues, including rental cars for our customers and legal settlements with customers and state DMVs. Adjusted EBITDA excluding securitization gain We calculate Adjusted EBITDA excluding securitization gain as Adjusted EBITDA adjusted to exclude the securitization gain from the sale of UACC's finance receivables, and believe that it provides a useful perspective on the underlying operating results and trends and a means to compare our period-over-period results. Adjusted EBITDA excluding securitization gain and non-recurring costs to address operational and customer experience issues We calculate Adjusted EBITDA excluding securitization gain and non-recurring costs to address operational and customer experience issues as Adjusted EBITDA adjusted to exclude the securitization gain from the sale of UACCs finance receivables and the non-recurring costs incurred to address operational and customer experience issues. The following table presents a reconciliation of the foregoing non-GAAP financial measures to net loss, which is the most directly comparable U.S. GAAP measure: Three Months Ended December 31, Year Ended December 31, 2023 2022 2023 2022 (in thousands) (in thousands) Net loss $ (141,321 ) $ 24,765 $ (365,540 ) $ (451,910 ) Adjusted to exclude the following: Interest expense 14,530 12,076 45,445 40,693 Interest income (4,789 ) (6,372 ) (21,158 ) (19,363 ) Provision (benefit) for income taxes (303 ) 2,405 615 (19,680 ) Depreciation and amortization 11,055 10,702 43,476 38,707 EBITDA $ (120,828 ) $ 43,576 $ (297,162 ) $ (411,553 ) Severance costs $ 48 $  $ 6,703 $  Gain on debt extinguishment (18,238 ) (126,767 ) (37,878 ) (164,684 ) Hail storm costs   2,353  Long-lived asset impairment charges 47,396 3,679 48,748 5,806 Goodwill impairment charge    201,703 Realignment costs  2,253  15,025 Acquisition related costs    5,653 Acceleration of non-cash stock-based compensation  2,439  2,439 Adjusted EBITDA $ (91,622 ) $ (74,820 ) $ (277,236 ) $ (345,611 ) Non-recurring costs to address operational and customer experience issues 3,247 374 4,065 25,433 Adjusted EBITDA excluding non-recurring costs to address operational and customer experience issues $ (88,375 ) $ (74,446 ) $ (273,171 ) $ (320,178 ) Securitization gain    (45,589 ) Adjusted EBITDA excluding securitization gain $ (91,622 ) $ (74,820 ) $ (277,236 ) $ (391,200 ) Adjusted EBITDA excluding securitization gain and non-recurring costs to address operational and customer experience issues $ (88,375 ) $ (74,446 ) $ (273,171 ) $ (365,767 ) FOURTH QUARTER 2023 AS COMPARED TO THIRD QUARTER 2023 Three Months Ended December 31, Three Months Ended September 30, 2023 2023 Change % Change (in thousands, except unit data) Total revenues $ 235,924 $ 235,634 $ 290 0.1 % Total gross profit $ 29,047 $ 48,094 $ (19,047 ) (39.6 )% Ecommerce units sold 4,780 4,561 219 4.8 % Ecommerce revenue $ 152,461 $ 149,851 $ 2,610 1.7 % Ecommerce gross profit $ 22,668 $ 14,339 $ 8,329 58.1 % Vehicle gross profit (loss) per ecommerce unit $ 1,545 $ 516 $ 1,029 199.4 % Product gross profit per ecommerce unit 3,197 2,628 569 21.7 % Total gross profit per ecommerce unit $ 4,742 $ 3,144 $ 1,598 50.8 % Wholesale units sold 1,821 2,270 (449 ) (19.8 )% Wholesale revenue $ 28,526 $ 30,898 $ (2,372 ) (7.7 )% Wholesale gross (loss) profit $ (28,927 ) $ (1,495 ) $ (27,432 ) 1,834.9 % Wholesale gross (loss) profit per unit $ (15,885 ) $ (659 ) $ (15,226 ) 2,310.5 % Retail Financing revenue $ 41,999 $ 40,823 $ 1,176 2.9 % Retail Financing gross profit $ 33,427 $ 32,341 $ 1,086 3.4 % Total selling, general, and administrative expenses $ 77,579 $ 79,586 $ (2,007 ) (2.5 )% Three Months Ended December 31, Three Months Ended September 30, 2023 2023 Change % Change (in thousands) Net loss $ (141,321 ) $ (82,857 ) $ (58,464 ) 70.6 % Adjusted to exclude the following: Interest expense 14,530 12,058 2,472 20.5 % Interest income (4,789 ) (5,506 ) 717 13.0 % Provision for income taxes (303 ) 260 (563 ) (216.5 )% Depreciation and amortization 11,055 11,248 (193 ) (1.7 )% EBITDA $ (120,828 ) $ (64,797 ) $ (56,031 ) 86.5 % Severance costs $ 48 $ 274 $ (226 ) (82.4 )% Gain on debt extinguishment (18,238 )  (18,238 ) (100.0 )% Long-lived asset impairment charges 47,396  47,396 100.0 % Adjusted EBITDA $ (91,622 ) $ (64,523 ) $ (27,099 ) 42.0 % Non-recurring costs to address operational and customer experience issues 3,247 32 3,215 10,047.2 % Adjusted EBITDA excluding non-recurring costs to address operational and customer experience issues $ (88,375 ) $ (64,491 ) $ (23,884 ) (37.0 )% Securitization gain    0.0 % Adjusted EBITDA excluding securitization gain $ (91,622 ) $ (64,523 ) $ (27,099 ) 42.0 % Adjusted EBITDA excluding securitization gain and non-recurring costs to address operational and customer experience issues $ (88,375 ) $ (64,491 ) $ (23,884 ) 37.0 % Liquidity Outlook We expect year-end 2024 cash and cash equivalents in the range of $35.0 to $65.0 million. The foregoing estimate is a forward-looking statement that reflects the Companys expectation as of March 13, 2024 and is subject to substantial uncertainty. See Forward-Looking Statements below. About Vroom (Nasdaq: VRM) Vroom owns and operates United Auto Credit Corporation (UACC), a leading indirect automotive lender serving the independent and franchise dealer market nationwide, and CarStory, a leader in AI-powered analytics and digital services for automotive retail. During fiscal 2023, Vroom also operated an end-to-end ecommerce platform to buy and sell used vehicles. Pursuant to its previously announced Value Maximization Plan, Vroom discontinued its ecommerce operations and is winding down its used vehicle dealership business. Forward-Looking Statements This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements contained in this press release that do not relate to matters of historical fact should be considered forward-looking statements, including without limitation statements regarding the potential impacts of the execution of and the expected benefits and cost-savings, if any, from our Value Maximization Plan, any anticipated costs and charges related to the Value Maximization Plan and the anticipated timeline of such costs, charges, implementation or completion of the Value Maximization Plan, our expectations regarding United Auto Credit Corporation and CarStory; our ability to successfully wind down and halt our ecommerce operations, and future results of operations and financial position, including our liquidity outlook for 2024. These statements are based on managements current assumptions and are neither promises nor guarantees, but involve known and unknown risks, uncertainties and other important factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. For factors that could cause actual results to differ materially from the forward-looking statements in this press release, please see the risks and uncertainties identified under the heading ""Risk Factors"" in our Annual Report on Form 10-K for the year ended December 31, 2023, which is available on our Investor Relations website at ir.vroom.com and on the SEC website at www.sec.gov. All forward-looking statements reflect our beliefs and assumptions only as of the date of this press release. We undertake no obligation to update forward-looking statements to reflect future events or circumstances. VROOM, INC. CONSOLIDATED BALANCE SHEETS (in thousands, except share and per share amounts) (unaudited) As of December 31, 2023 2022 ASSETS Current Assets: Cash and cash equivalents $ 135,585 $ 398,915 Restricted cash (including restricted cash of consolidated VIEs of $49.1 million and $24.7 million, respectively) 73,234 73,095 Accounts receivable, net of allowance of $11.2 million and $21.5 million, respectively 9,139 13,967 Finance receivables at fair value (including finance receivables of consolidated VIEs of $11.8 million and $11.5 million, respectively) 12,501 12,939 Finance receivables held for sale, net (including finance receivables of consolidated VIEs of $457.2 million and $305.9 million, respectively) 503,546 321,626 Inventory 163,250 320,648 Beneficial interests in securitizations 4,485 20,592 Prepaid expenses and other current assets (including other current assets of consolidated VIEs of $25.2 million and $11.7 million, respectively) 50,899 58,327 Total current assets 952,639 1,220,109 Finance receivables at fair value (including finance receivables of consolidated VIEs of $329.6 million and $119.6 million, respectively) 336,169 140,235 Property and equipment, net 24,132 50,201 Intangible assets, net 131,892 158,910 Operating lease right-of-use assets 7,063 23,568 Other assets (including other assets of consolidated VIEs of $1.8 million and $0 million, respectively) 23,527 26,004 Total assets $ 1,475,422 $ 1,619,027 LIABILITIES AND STOCKHOLDERS EQUITY Current Liabilities: Accounts payable $ 26,762 $ 34,702 Accrued expenses (including accrued expenses of consolidated VIEs of $4.0 million and $1.5 million, respectively) 52,452 76,795 Vehicle floorplan 151,178 276,988 Warehouse credit facilities of consolidated VIEs 421,268 229,518 Current portion of long-term debt (including current portion of securitization debt of consolidated VIEs at fair value of $163.5 million and $47.2 million, respectively) 172,410 47,239 Deferred revenue 14,025 10,655 Operating lease liabilities, current 8,737 9,730 Other current liabilities 9,974 17,693 Total current liabilities 856,806 703,320 Long-term debt, net of current portion (including securitization debt of consolidated VIEs of $150.6 million and $32.6 million at fair value, respectively) 454,173 402,154 Operating lease liabilities, excluding current portion 25,183 20,129 Other long-term liabilities (including other long-term liabilities of consolidated VIEs of $10.4 million and $7.4 million, respectively) 17,109 18,183 Total liabilities 1,353,271 1,143,786 Commitments and contingencies (Note 14) Stockholders equity: Common stock, $0.001 par value; 500,000,000 shares authorized as of December 31, 2023 and 2022; 1,791,286 and 1,727,525 shares issued and outstanding as of December 31, 2023 and 2022, respectively 2 2 Additional paid-in-capital 2,088,381 2,075,931 Accumulated deficit (1,966,232 ) (1,600,692 ) Total stockholders equity 122,151 475,241 Total liabilities and stockholders equity $ 1,475,422 $ 1,619,027 VROOM, INC. CONSOLIDATED STATEMENTS OF OPERATIONS (in thousands, except share and per share amounts) (unaudited) Three Months Ended December 31, Year Ended December 31, 2023 2022 2023 2022 Revenue: Retail vehicle, net $ 146,424 $ 142,579 $ 565,972 $ 1,425,842 Wholesale vehicle 28,526 23,039 104,119 293,528 Product, net 15,754 10,793 52,253 62,747 Finance 41,999 32,537 156,938 152,542 Other 3,221 401 13,921 14,242 Total revenue 235,924 209,349 893,203 1,948,901 Cost of sales: Retail vehicle 138,648 147,867 553,565 1,382,005 Wholesale vehicle 57,453 27,399 138,472 304,148 Product 819  3,337  Finance 8,573 3,793 31,328 14,161 Other 1,384 831 4,554 3,800 Total cost of sales 206,877 179,890 731,256 1,704,114 Total gross profit 29,047 29,459 161,947 244,787 Selling, general and administrative expenses 77,579 90,760 340,657 566,387 Depreciation and amortization 10,924 10,562 42,769 38,290 Impairment charges 47,395 5,746 48,748 211,873 Loss from operations (106,851 ) (77,609 ) (270,227 ) (571,763 ) Gain on debt extinguishment (18,238 ) (126,767 ) (37,878 ) (164,684 ) Interest expense 14,530 12,076 45,445 40,693 Interest income (4,789 ) (6,372 ) (21,158 ) (19,363 ) Other loss, net 43,270 16,284 108,289 43,181 (Loss) income before provision for income taxes (141,624 ) 27,170 (364,925 ) (471,590 ) (Benefit) provision for income taxes (303 ) 2,405 615 (19,680 ) Net (loss) income $ (141,321 ) $ 24,765 $ (365,540 ) $ (451,910 ) Net (loss) income per share attributable to common stockholders, basic $ (80.51 ) $ 14.34 $ (209.70 ) $ (262.15 ) Weighted-average number of shares outstanding used to compute net (loss) income per share attributable to common stockholders, basic 1,755,387 1,727,203 1,743,128 1,723,843 Net (loss) income per share attributable to common stockholders, diluted $ (80.51 ) $ 13.52 $ (209.70 ) $ (262.15 ) Weighted-average number of shares outstanding used to compute net (loss) income per share attributable to common stockholders, diluted 1,755,387 1,832,223 1,743,128 1,723,843 VROOM, INC. CONSOLIDATED STATEMENTS OF CASH FLOWS (in thousands) (unaudited) Year Ended December 31, 2023 2022 Operating activities Net loss $ (365,540 ) $ (451,910 ) Adjustments to reconcile net loss to net cash used in operating activities: Impairment charges 48,748 211,873 Gain on debt extinguishment (37,878 ) (164,684 ) Depreciation and amortization 43,476 38,707 Amortization of debt issuance costs 4,598 4,809 Realized gains on securitization transactions  (45,589 ) Deferred taxes  (23,855 ) Losses on finance receivables and securitization debt, net 114,702 66,839 Stock-based compensation expense 10,051 11,957 Provision to record inventory at lower of cost or net realizable value (2,360 ) 1,812 Provision for bad debt 4,074 13,406 Provision to record finance receivables held for sale at lower of cost or fair value 20,566 6,541 Amortization of unearned discounts on finance receivables at fair value (25,954 ) (14,593 ) Other, net (17,393 ) (7,512 ) Changes in operating assets and liabilities: Finance receivables, held for sale Originations of finance receivables held for sale (582,170 ) (625,575 ) Principal payments received on finance receivables held for sale 105,858 64,521 Proceeds from sale of finance receivables held for sale, net  509,612 Other (1,606 ) (7,701 ) Accounts receivable 754 78,060 Inventory 159,758 403,924 Prepaid expenses and other current assets 22,711 4,146 Other assets 3,266 (2,546 ) Accounts payable (7,940 ) (24,281 ) Accrued expenses (24,766 ) (53,553 ) Deferred revenue 3,370 (65,148 ) Other liabilities (10,009 ) (38,325 ) Net cash used in operating activities (533,684 ) (109,065 ) Investing activities Finance receivables at fair value Purchases of finance receivables at fair value (3,392 ) (56,484 ) Principal payments received on finance receivables at fair value 174,748 132,391 Proceeds from sale of finance receivables at fair value, net  43,262 Consolidation of VIEs 11,409  Principal payments received on beneficial interests 5,193 8,341 Purchase of property and equipment (14,805 ) (24,234 ) Acquisition of business, net of cash acquired of $47.9 million  (267,488 ) Net cash provided by (used in) investing activities 173,153 (164,212 ) Financing activities Proceeds from the issuance of common stock in at-the-market offering, net of offering costs 2,399  Proceeds from borrowings under secured financing agreements 261,991  Principal repayment under secured financing agreements (208,476 ) (192,839 ) Proceeds from financing of beneficial interests in securitizations 24,506  Principal repayments of financing of beneficial interests in securitizations (8,698 )  Proceeds from vehicle floorplan 559,331 1,403,042 Repayments of vehicle floorplan (685,141 ) (1,638,855 ) Proceeds from warehouse credit facilities 480,100 520,800 Repayments of warehouse credit facilities (290,483 ) (467,216 ) Repurchases of convertible senior notes (36,536 ) (90,208 ) Other financing activities (1,653 ) (4,212 ) Net cash provided by (used in) financing activities 97,340 (469,488 ) Net (decrease) increase in cash, cash equivalents and restricted cash (263,191 ) (742,765 ) Cash, cash equivalents and restricted cash at the beginning of period 472,010 1,214,775 Cash, cash equivalents and restricted cash at the end of period $ 208,819 $ 472,010 VROOM, INC. CONSOLIDATED STATEMENTS OF CASH FLOWS (continued) (in thousands) (unaudited) Supplemental disclosure of cash flow information: Cash paid for interest $ 59,351 $ 34,907 Cash paid for income taxes $ 5,363 $ 2,409 Supplemental disclosure of non-cash investing and financing activities: Finance receivables from consolidation of 2022-2 securitization transaction $ 180,706 $  Elimination of beneficial interest from the consolidation of 2022-2 securitization transaction $ 9,811 $  Securitization debt from consolidation of 2022-2 securitization transaction $ 186,386 $  Reclassification of finance receivables held for sale to finance receivables at fair value, net $ 248,081 $  Fair value of beneficial interests received in securitization transactions $  $ 30,082 View source version on businesswire.com: https://www.businesswire.com/news/home/20240313922393/en/ Investor Relations: Vroom Jon Sandison investors@vroom.com Source: Vroom, Inc. What was Vroom's cash position as of December 31, 2023? Vroom reported $135.6 million in cash and cash equivalents as of December 31, 2023. How many Ecommerce units were sold in Q4 2023? Vroom sold 4,780 Ecommerce units in the fourth quarter of 2023. What were Vroom's net losses for Q4 and FY 2023? Vroom incurred net losses of $(141.3) million for the fourth quarter and $(365.5) million for the full year of 2023. What is Vroom's Value Maximization Plan? Vroom's Value Maximization Plan involves discontinuing ecommerce operations and winding down the used vehicle dealership business to focus on United Auto Credit and CarStory. What is Vroom's financial outlook for year-end 2024? Vroom expects cash and cash equivalents in the range of $35.0 to $65.0 million by year-end 2024."
Zomedica Provides NYSE American Listing Update,2024-03-13T20:45:00.000Z,Neutral,Neutral,Zomedica Corp. is in dialogue with NYSE American to regain compliance with listing standards after receiving a notice in 2023. The company held a Special Meeting of Shareholders but failed to effect a share consolidation action. CEO Larry Heaton is optimistic about the future despite the risk of delisting.,"Zomedica Provides NYSE American Listing Update Rhea-AI Impact (Neutral) Rhea-AI Sentiment (Neutral) Tags Rhea-AI Summary Zomedica Corp. is in dialogue with NYSE American to regain compliance with listing standards after receiving a notice in 2023. The company held a Special Meeting of Shareholders but failed to effect a share consolidation action. CEO Larry Heaton is optimistic about the future despite the risk of delisting. Positive None. Negative Zomedica failed to effect an 80:1 share consolidation action at a Special Meeting of Shareholders, risking delisting if share price deteriorates further. Market Research Analyst The situation with Zomedica Corp. reflects a critical juncture for the company's relationship with the stock exchange and its investors. The inability to execute an 80:1 reverse stock split due to the lack of shareholder approval indicates a significant disconnect between the company's management and its shareholders. This failed corporate action suggests a lack of confidence in the management's strategy or a misalignment regarding the company's valuation and future prospects.From a market perspective, the ongoing dialogue with NYSE American is a positive sign, showing that the company is actively seeking solutions to maintain its listing status. However, the mention of potential delisting due to additional deterioration in share price is a red flag that may concern investors. It highlights the urgency for Zomedica to not only communicate its progress and opportunities but also to deliver tangible results that can be reflected in its financial performance and, subsequently, its stock price.Investors and potential investors should closely monitor Zomedica's future announcements and performance metrics, as these will be critical in determining the company's ability to sustain its stock price and comply with listing standards. The implications of a delisting could be severe, including reduced liquidity and access to capital markets, which would impact the company's ability to fund operations and growth initiatives. Financial Analyst The notice of non-compliance received by Zomedica from the NYSE American is a significant financial event that directly affects the company's stock market presence and investor perception. The reference to Section 1003(f)(v) indicates that the company's share price has fallen below a level acceptable to the exchange, which typically requires a minimum average share price to maintain listing.Financially, the failure to execute the reverse stock split could be interpreted as a missed opportunity to adjust the share structure and potentially stabilize the stock price. This decision, or lack thereof, may have implications for the company's market capitalization and could influence investor confidence in the company's governance and long-term viability. Moreover, the CEO's statement about highlighting the company's progress suggests a need to improve investor relations and market sentiment.Given the current situation, stakeholders should evaluate the company's operational performance, market position in the veterinary health sector and the execution of its strategic plans. These factors will play a crucial role in Zomedica's ability to regain compliance and avoid the consequences of a delisting, which could include diminished investor interest and a challenging fundraising environment. Veterinary Industry Expert Zomedica's core business in the veterinary health sector, focusing on point-of-care diagnostics and therapeutic products for animals, is a niche yet growing market. The company's performance in this sector is critical to understanding its potential for price improvement and compliance with NYSE American's listing standards.The demand for veterinary care and advanced diagnostics is on the rise, driven by increased pet ownership and a greater focus on animal health and welfare. Zomedica's ability to capitalize on these trends and effectively communicate its value proposition to the market is essential. The CEO's reference to the company's progress over the years and future opportunities indicates that Zomedica may have a solid product portfolio or pipeline that could drive growth. However, the failure to implement the reverse stock split raises questions about the company's strategic decision-making and ability to adapt to market conditions.Stakeholders, including veterinary professionals and investors interested in the animal health industry, should consider the company's technological advancements, competitive positioning and the potential impact of regulatory changes on its business model. These aspects are vital for Zomedica to maintain investor interest and achieve a stock price that reflects its intrinsic value. 03/13/2024 - 04:45 PM ANN ARBOR, MI / ACCESSWIRE / March 13, 2024 / Zomedica Corp. (NYSE American:ZOM) (""Zomedica"" or the ""Company""), a veterinary health company offering point-of-care diagnostics and therapeutic products for equine and companion animals, today announced that it is continuing dialogue with senior regulatory staff at the NYSE American regarding next steps to regaining compliance with its listing standards. Zomedica shares will remain listed on the NYSE American at this time.As announced on September 13, 2023, Zomedica received formal notice from the NYSE American that it was not in compliance with continued listing standards as set forth in Section 1003(f)(v) of the NYSE American Company Guide. According to the notice, the Company had a reasonable period of time, which was determined to be March 12, 2024, to effect a reverse stock split or otherwise demonstrate sustained price improvement.While the notice did not result in an immediate delisting of Zomedica's common shares, it did prompt the Company to announce that it would undertake certain cure measures to regain compliance.A Special Meeting of Shareholders was held on February 28, 2024, with the company unable to effect an 80:1 share consolidation corporate action by a required majority of 67.7% votes as set forth by the Company's bylaws.Larry Heaton, Chief Executive Officer of Zomedica Corp. stated, ""Following the rejection of our proposed reverse stock split, we have been in contact with the NYSE American to understand the implications for Zomedica's continued listing. The exchange has indicated that they will continue to monitor our share price and other developments and noted that additional deterioration of the share price could result in delisting. This gives us time to continue to highlight the progress the Company has made over the last several years, and the tremendous opportunities ahead, to positively impact our share price.""About ZomedicaBased in Ann Arbor, Michigan, Zomedica (NYSE American:ZOM) is a veterinary health company creating products for horses, dogs, and cats by focusing on the unmet needs of clinical veterinarians. Zomedica's product portfolio includes innovative diagnostics and medical devices that emphasize patient health and practice health. Zomedica's mission is to provide veterinarians the opportunity to increase productivity and grow revenue while better serving the animals in their care. For more information, visit www.zomedica.com.About ZomedicaBased in Ann Arbor, Michigan, Zomedica (NYSE American: ZOM) is a veterinary health company creating products for horses, dogs, and cats by focusing on the unmet needs of clinical veterinarians. Zomedica's product portfolio includes innovative diagnostics and medical devices that emphasize patient health and practice health. Zomedica's mission is to provide veterinarians the opportunity to increase productivity and grow revenue while better serving the animals in their care. For more information, visit www.zomedica.com.Follow ZomedicaEmail Alerts: http://investors.zomedica.comLinkedIn: https://www.linkedin.com/company/zomedicaFacebook: https://m.facebook.com/zomedicaX (formerly Twitter): https://twitter.com/zomedicaInstagram: https://www.instagram.com/zomedica_incCautionary Note Regarding Forward-Looking StatementsExcept for statements of historical fact, this news release contains certain ""forward-looking information"" or ""forward-looking statements"" (collectively, ""forward-looking information"") within the meaning of applicable securities law. Forward-looking information is frequently characterized by words such as ""plan"", ""expect"", ""project"", ""intend"", ""believe"", ""anticipate"", ""estimate"" and other similar words, or statements that certain events or conditions ""may"" or ""will"" occur and include statements relating to our expectations regarding future results. Although we believe that the expectations reflected in the forward-looking information are reasonable, there can be no assurance that such expectations will prove to be correct. We cannot guarantee future results, performance, or achievements. Consequently, there is no representation that the actual results achieved will be the same, in whole or in part, as those set out in the forward-looking information.Forward-looking information is based on the opinions and estimates of management at the date the statements are made, including assumptions with respect to economic growth, demand for the Company's products, the Company's ability to produce and sell its products, sufficiency of our budgeted capital and operating expenditures, the satisfaction by our strategic partners of their obligations under our commercial agreements, our ability to realize upon our business plans and cost control efforts and the impact of COVID-19 on our business, results and financial condition.Our forward-looking information is subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those anticipated in the forward-looking information. Some of the risks and other factors that could cause the results to differ materially from those expressed in the forward-looking information include, but are not limited to: the outcome of clinical studies, the application of generally accepted accounting principles, which are highly complex and involve many subjective assumptions, estimates, and judgments, uncertainty as to whether our strategies and business plans will yield the expected benefits; uncertainty as to the timing and results of development work and verification and validation studies; uncertainty as to the timing and results of commercialization efforts, as well as the cost of commercialization efforts, including the cost to develop an internal sales force and manage our growth; uncertainty as to our ability to successfully integrate acquisitions; uncertainty as to our ability to supply products in response to customer demand; uncertainty as to the likelihood and timing of any required regulatory approvals, and the availability and cost of capital; the ability to identify and develop and achieve commercial success for new products and technologies; veterinary acceptance of our products; competition from related products; the level of expenditures necessary to maintain and improve the quality of products and services; changes in technology and changes in laws and regulations; our ability to secure and maintain strategic relationships; performance by our strategic partners of their obligations under our commercial agreements, including product manufacturing obligations; risks pertaining to permits and licensing, intellectual property infringement risks, risks relating to any required clinical trials and regulatory approvals, risks relating to the safety and efficacy of our products, the use of our products, intellectual property protection, risks related to the COVID-19 pandemic and its impact upon our business operations generally, including our ability to develop and commercialize our products, and the other risk factors disclosed in our filings with the SEC and under our profile on SEDAR+ at www.sedarplus.com. Readers are cautioned that this list of risk factors should not be construed as exhaustive.The forward-looking information contained in this news release is expressly qualified by this cautionary statement. We undertake no duty to update any of the forward-looking information to conform such information to actual results or to changes in our expectations except as otherwise required by applicable securities legislation. Readers are cautioned not to place undue reliance on forward-looking information.Investor Relations Contact:Zomedica Investor Relationsinvestors@zomedica.com1-734-369-2555SOURCE: Zomedica Corp.View the original press release on accesswire.com What is Zomedica Corp. (ZOM) currently doing to regain compliance with NYSE American listing standards? Zomedica Corp. is in dialogue with senior regulatory staff at NYSE American to determine next steps for regaining compliance. When did Zomedica receive a notice of non-compliance with NYSE American listing standards? Zomedica received a notice of non-compliance on September 13, 2023. What action did Zomedica fail to effect at a Special Meeting of Shareholders? Zomedica failed to effect an 80:1 share consolidation corporate action at a Special Meeting of Shareholders. Who is the Chief Executive Officer of Zomedica Corp.? Larry Heaton is the Chief Executive Officer of Zomedica Corp. What could happen if Zomedica's share price deteriorates further? Further deterioration of Zomedica's share price could result in delisting from NYSE American."
"AM Best Comments on Credit Ratings of James River Group Holdings, Ltd. and Its Subsidiaries Following Filed Complaint With NY State Supreme Court",2024-03-13T20:44:00.000Z,Low,Neutral,"AM Best comments on James River Group Holdings, Ltd.'s credit ratings remaining unchanged after filing a complaint against Fleming Intermediate Holdings LLC for failing to complete an acquisition agreement.","AM Best Comments on Credit Ratings of James River Group Holdings, Ltd. and Its Subsidiaries Following Filed Complaint With NY State Supreme Court Rhea-AI Impact (Low) Rhea-AI Sentiment (Neutral) Tags Rhea-AI Summary AM Best comments on James River Group Holdings, Ltd.'s credit ratings remaining unchanged after filing a complaint against Fleming Intermediate Holdings LLC for failing to complete an acquisition agreement. Positive None. Negative None. Legal Expert The initiation of legal proceedings by James River Group Holdings against Fleming Intermediate Holdings LLC for alleged non-completion of a negotiated acquisition is a significant event that could have material implications for both parties involved. From a legal perspective, the crux of the matter lies in the interpretation and enforcement of the Stock Purchase Agreement. The specific performance sought by JRG Holdings indicates a strong conviction in their legal position and the terms agreed upon.Such legal disputes can often result in protracted litigation, which may impact the operational and financial stability of the entities involved. The uncertainty surrounding the outcome could potentially affect investor sentiment, as prolonged legal battles often entail substantial legal expenses and can distract from the companies' core business operations. Stakeholders should monitor the progression of this case closely, as any ruling could set precedents for similar transactions within the industry. Financial Analyst The announcement by AM Best that the credit ratings of James River Group Holdings and its subsidiaries remain unchanged post the legal filing provides a short-term reassurance to investors and stakeholders. However, the long-term financial implications hinge on the outcome of the legal proceedings. If JRG Holdings is successful in its legal action, it could lead to a swift closure of the transaction, potentially improving the company's financial position and strategic outlook.Conversely, if the acquisition does not proceed as planned, it could result in financial strain or strategic setbacks, thereby affecting future credit ratings. Investors should consider the potential for volatility in JRG Holdings' stock price as the market reacts to updates on the legal situation and its implications for the company's financial health and growth trajectory. Market Research Analyst The dispute between JRG Holdings and Fleming is indicative of broader trends in M&A activity within the insurance industry. The resolution of this case could influence market dynamics, particularly regarding the perceived risks of deal-making with private equity-backed entities. It is essential for market participants to understand the implications of such legal actions on the stability and attractiveness of M&A deals.Furthermore, the insurance industry is closely regulated and highly sensitive to reputational risks. Any negative publicity stemming from this legal action could potentially impact the market perception of the involved parties, thereby influencing their competitive position and market share. The industry will be watching this case for insights into how legal challenges can affect not only the parties involved but also the broader M&A landscape in the insurance sector. 03/13/2024 - 04:44 PM OLDWICK, N.J.--(BUSINESS WIRE)-- AM Best has commented that the Credit Rating (ratings) of James River Group Holdings, Ltd. (JRG Holdings) [NASDAQ: JRVR] (Bermuda) and its subsidiaries remain unchanged at this time following the announcement that JRG Holdings has filed a complaint in the Supreme Court, New York County, Commercial Division against Fleming Intermediate Holdings LLC (Fleming), a portfolio company of private equity sponsor, Altamont Capital Partners. The action seeks specific performance of Flemings obligation to complete the acquisition of JRG Reinsurance Company Ltd. (JRG Re) in accordance with the Stock Purchase Agreement executed between the parties as of Nov. 8, 2023. JRG Holdings will seek expedited relief from the Court to require Fleming to close the transaction. This legal action, as stated in JRG Holdings lawsuit, is a result of the refusal of Fleming to complete the fully negotiated transaction as executed in November. JRG Holdings has confirmed that as long as it owns JRG Re, JRG Holdings will continue to operate and support JRG Re and its cedents as it has throughout its ownership. AM Best will closely monitor the progress of the legal action and its potential impact on ratings of JRG Holdings and its subsidiaries. This press release relates to Credit Ratings that have been published on AM Bests website. For all rating information relating to the release and pertinent disclosures, including details of the office responsible for issuing each of the individual ratings referenced in this release, please see AM Bests Recent Rating Activity web page. For additional information regarding the use and limitations of Credit Rating opinions, please view Guide to Best's Credit Ratings. For information on the proper use of Bests Credit Ratings, Bests Performance Assessments, Bests Preliminary Credit Assessments and AM Best press releases, please view Guide to Proper Use of Bests Ratings & Assessments. AM Best is a global credit rating agency, news publisher and data analytics provider specializing in the insurance industry. Headquartered in the United States, the company does business in over 100 countries with regional offices in London, Amsterdam, Dubai, Hong Kong, Singapore and Mexico City. For more information, visit www.ambest.com. Copyright  2024 by A.M. Best Rating Services, Inc. and/or its affiliates. ALL RIGHTS RESERVED. View source version on businesswire.com: https://www.businesswire.com/news/home/20240313003597/en/ Gordon McLean Senior Financial Analyst +1 908 882 2109 gordon.mclean@ambest.com Edin Imsirovic Director +1 908 882 1903 edin.imsirovic@ambest.com Christopher Sharkey Associate Director, Public Relations +1 908 882 2310 christopher.sharkey@ambest.com Al Slavin Senior Public Relations Specialist +1 908 882 2318 al.slavin@ambest.com Source: AM Best What is the current status of James River Group Holdings, Ltd.'s credit ratings? AM Best has commented that the credit ratings of James River Group Holdings, Ltd. remain unchanged at this time. Who did James River Group Holdings, Ltd. file a complaint against? James River Group Holdings, Ltd. filed a complaint against Fleming Intermediate Holdings LLC. What legal action is James River Group Holdings, Ltd. seeking? James River Group Holdings, Ltd. is seeking specific performance of Fleming's obligation to complete the acquisition of JRG Reinsurance Company Ltd. What was the reason for the legal action mentioned in the press release? The legal action was a result of the refusal of Fleming to complete the fully negotiated transaction as executed in November. How will James River Group Holdings, Ltd. proceed while owning JRG Re? James River Group Holdings, Ltd. will continue to operate and support JRG Re and its cedents as it has throughout its ownership."
Tri Counties Bank Celebrates 50th Anniversary by Helping Community College Students Achieve Their Dreams,2024-03-13T20:35:00.000Z,No impact,Positive,"Tri Counties Bank marks its 50th Anniversary with a fundraising campaign supporting California Community Colleges Student Ambassador Program. The bank's $50,000 contribution aims to address food and housing insecurity among college students, with plans for various fundraising events and volunteer activities throughout the year.","Tri Counties Bank Celebrates 50th Anniversary by Helping Community College Students Achieve Their Dreams Rhea-AI Impact (No impact) Rhea-AI Sentiment (Positive) Tags Rhea-AI Summary Tri Counties Bank marks its 50th Anniversary with a fundraising campaign supporting California Community Colleges Student Ambassador Program. The bank's $50,000 contribution aims to address food and housing insecurity among college students, with plans for various fundraising events and volunteer activities throughout the year. Positive None. Negative None. 03/13/2024 - 04:35 PM SACRAMENTO, Calif.--(BUSINESS WIRE)-- Tri Counties Bank, a leading community bank in California, kicked off its 50th Anniversary Celebration today with the launch of a year-long fundraising campaign to support the California Community Colleges Student Ambassador Program. In a press event at Sacramento City College, the bank launched the campaign with a $50,000 contribution and announced it will hold a variety of fundraising events and volunteer activities in partnership with the Foundation for California Community Colleges (FoundationCCC), which oversees the program. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240313397944/en/ The Student Ambassador Program trains and empowers students as on-campus leaders in peer-to-peer outreach. Ambassadors connect fellow students to food, housing, and other basic needs resources that ease barriers to education (such as CalFresh and Crisis Text Line), provide hands-on benefit application assistance, and reduce the stigma around getting help. Through the partnership, Tri Counties Bank employees in California will be connected directly with local student ambassadors across the California Community College system. We chose FoundationCCC as a partner for our 50th Anniversary campaign because of the positive impact the California Community Colleges and the Student Ambassador Program have on the communities we serve throughout the state, said Rick Smith, President and CEO of Tri Counties Bank. Tri Counties Bank believes in people, first and foremost, and we plan to continue that mission over the next fifty years. The partnership comes at a critical time. A 2023 survey found that two-thirds of California community college students struggle with food or housing insecurity. Nearly half of California community college students are unsure of where their next meal will come from, and roughly one in four face homelessness. Each ambassador can reach approximately 1,000 students, providing crucial support to address these challenges and ease their pathway towards college and career success. As a single parent who had to balance education with childcare responsibilities, Ive seen first-hand how access to food and housing resources can transform lives, said Yuriko Curiel, Student Ambassador Program Coordinator for the FoundationCCC. Once a part of the program herself, Curiel now trains future student ambassadors. Tri Counties Banks year-long 50th Anniversary initiative will involve multiple fundraising efforts, including encouraging donations through the Banks Mobile and Online Banking, and a new checking account that will benefit the FoundationCCC. Additionally, as part of the Banks mission to improve the financial success of its communities, Tri Counties Bank has committed to providing financial education training to student ambassadors and community college students, and will be hosting a needs drive in all bank branches, to be launched this summer to help community college students throughout the academic year. Tri Counties Banks 50th Anniversary Campaign will celebrate its past, present, and future with a focus on its customers, shareholders, communities and employees. As part of the campaign, the Bank encourages current and former customers to submit their favorite Tri Counties Bank moments and find a customer appreciation event taking place near them at TriCountiesBank.com/50. To learn more about Tri Counties Banks 50th Anniversary and its groundbreaking partnership with FoundationCCC, visit TriCountiesBank.com/50. About Tri Counties Bank Established in 1975, Tri Counties Bank is a wholly-owned subsidiary of TriCo Bancshares (NASDAQ: TCBK) headquartered in Chico, California, with assets of almost $10 billion and nearly 50 years of financial stability. Tri Counties Bank provides a unique brand of Service With Solutions for communities throughout California with a breadth of personal, small business and commercial banking services, plus an extensive branch network, access to approximately 40,000 surcharge-free ATMs nationwide, and advanced mobile and online banking. Tri Counties Bank participates in the Cities for Financial Empowerment (CFE) Funds BankOn program that seeks to ensure that everyone has access to safe and affordable financial products and services. Visit TriCountiesBank.com to learn more. Member FDIC. Equal Housing Lender. NMLS #458732 About the Foundation for California Community Colleges The Foundation for California Community Colleges works to benefit students, colleges, and communities by accelerating paths to economic and social mobility, strengthening communities, and reducing barriers to opportunities for all Californians. FoundationCCC is a 501(c)(3) tax-exempt non-profit organization founded in 1998. It serves as the official statewide nonprofit organization supporting the California Community Colleges, the largest system of higher education in the nation. For more information, visit foundationccc.org. View source version on businesswire.com: https://www.businesswire.com/news/home/20240313397944/en/ Megan Sheehan, AVP, Public Relations Manager Tri Counties Bank megansheehan@tcbk.com (530) 332-2330 Sarah London Senior Director of Executive Communications Foundation for California Community Colleges slondon@foundationccc.org (916) 995-7903 Source: Tri Counties Bank What is Tri Counties Bank celebrating with a fundraising campaign? Tri Counties Bank is celebrating its 50th Anniversary with a fundraising campaign. What program is Tri Counties Bank supporting through its fundraising campaign? Tri Counties Bank is supporting the California Community Colleges Student Ambassador Program. How much did Tri Counties Bank contribute to kick off the campaign? Tri Counties Bank contributed $50,000 to kick off its fundraising campaign. What issues does the Student Ambassador Program aim to address? The Student Ambassador Program aims to address food and housing insecurity among college students. What initiatives will Tri Counties Bank undertake as part of the campaign? Tri Counties Bank will hold fundraising events, volunteer activities, and financial education training for student ambassadors and community college students."
Lennar Reports First Quarter 2024 Results,2024-03-13T20:30:00.000Z,Neutral,Neutral,"Lennar Corporation reports strong first-quarter results in 2024 with significant increases in net earnings, new orders, deliveries, and total revenues. The company's focus on production and sales pace, along with strategic pricing and incentives, has led to positive growth despite challenges in the housing market. Lennar has also made substantial investments in stock repurchases, dividend increases, and balance sheet fortification.","Lennar Reports First Quarter 2024 Results Rhea-AI Impact (Neutral) Rhea-AI Sentiment (Neutral) Tags earnings Rhea-AI Summary Lennar Corporation reports strong first-quarter results in 2024 with significant increases in net earnings, new orders, deliveries, and total revenues. The company's focus on production and sales pace, along with strategic pricing and incentives, has led to positive growth despite challenges in the housing market. Lennar has also made substantial investments in stock repurchases, dividend increases, and balance sheet fortification. Positive Net earnings per diluted share increased by 25% to $2.57 compared to the prior year quarter. New orders surged by 28% to 18,176 homes, with a dollar value increase of 21% to $7.7 billion. Deliveries saw a 23% increase to 16,798 homes, contributing to a 13% rise in total revenues to $7.3 billion. Homebuilding operating earnings reached $1.0 billion, with a gross margin on home sales of 21.8%. The company repurchased 3.4 million shares of common stock for $506 million and increased its stock repurchase program by $5.0 billion. Lennar raised its annual dividend from $1.50 per share to $2.00 per share, showcasing confidence in future performance. Negative None. Market Research Analyst The reported increase in net earnings per diluted share by 25% and overall net earnings by 21% for Lennar Corporation is a strong indicator of the company's profitability and operational efficiency. The growth in new orders by 28% and the subsequent increase in the dollar value of these orders by 21% suggest a robust demand for the company's homes. Additionally, the 23% increase in deliveries reflects the company's ability to meet this demand effectively. The reported backlog, with a dollar value of $7.4 billion, provides a clear visibility into future revenues, which is a positive sign for investors.From a financial standpoint, the company's strategic repurchase of shares, increase in dividend payouts and the reported strong balance sheet with $5.0 billion in cash and cash equivalents, coupled with no outstanding borrowings, demonstrate a solid financial position and a commitment to returning value to shareholders. The homebuilding debt to total capital ratio of 9.6% is particularly low for the industry, which typically sees higher leverage ratios, indicating a conservative approach to debt management that may appeal to risk-averse investors. Financial Analyst The detailed financial metrics provided, such as the gross margin on home sales of 21.8% and the net margin of 13.6%, are essential for evaluating the company's cost management and profitability. An increase in gross margin suggests that Lennar has been successful in managing construction costs and pricing strategies. The S,G&A expenses as a percentage of revenues from home sales at 8.2% reflect operational efficiency and cost control.The company's capital allocation strategy, including the repurchase of $506 million of common stock and the authorization of an additional $5.0 billion stock repurchase program, indicates a bullish stance by management regarding the company's valuation. Increasing the annual dividend from $1.50 to $2.00 per share is a significant return to shareholders and may attract income-focused investors. The financial services operating earnings of $131 million provide diversification to the company's revenue streams, while the multifamily and Lennar Other operating losses are areas that require attention to improve overall profitability. Real Estate Industry Analyst Lennar's report highlights several key factors influencing the real estate market, including interest rate fluctuations, strong employment and a persistent shortage of housing supply. The company's strategic focus on matching production pace with sales pace, despite the 8% decrease in the average sales price per home delivered, implies an operational shift towards volume over price maximization. This strategy may be in response to affordability challenges in the housing market, which is a significant factor for potential homebuyers.The emphasis on a 'land light' strategy, with a reduction in years supply of owned homesites and an increase in the percentage of controlled homesites, suggests a move towards greater flexibility and reduced inventory risk. This approach can lead to improved capital efficiency and potentially higher returns on investment. The improvement in the company's return on inventory to 30.5% is a testament to the effectiveness of these operational strategies and could signal a competitive advantage in the industry. 03/13/2024 - 04:30 PM First Quarter 2024 Highlights - comparisons to the prior year quarter Net earnings per diluted share increased 25% to $2.57Net earnings increased 21% to $719 millionNew orders increased 28% to 18,176 homes; new orders dollar value increased 21% to $7.7 billionBacklog of 16,270 homes with a dollar value of $7.4 billionDeliveries increased 23% to 16,798 homesTotal revenues increased 13% to $7.3 billionHomebuilding operating earnings of $1.0 billionGross margin on home sales of 21.8%S,G&A expenses as a % of revenues from home sales of 8.2%Net margin on home sales of 13.6%Financial Services operating earnings of $131 millionMultifamily operating loss of $16 millionLennar Other operating loss of $40 millionHomebuilding cash and cash equivalents of $5.0 billionYears supply of owned homesites of 1.3 years and controlled homesites of 77%No outstanding borrowings under the Company's $2.6 billion revolving credit facilityHomebuilding debt to total capital of 9.6%Repurchased 3.4 million shares of Lennar common stock for $506 millionIncreased stock repurchase program up to an additional $5.0 billionIncreased annual dividend from $1.50 per share to $2.00 per shareMIAMI, March 13, 2024 /PRNewswire/ -- Lennar Corporation (NYSE: LEN and LEN.B), one of the nation's leading homebuilders, today reported results for its first quarter ended February 29, 2024. First quarter net earnings attributable to Lennar in 2024 were $719 million, or $2.57 per diluted share, compared to first quarter net earnings attributable to Lennar in 2023 of $597 million, or $2.06 per diluted share. Stuart Miller, Executive Chairman and Co-Chief Executive Officer of Lennar, said, ""We are pleased to report another strong quarter as we remained focused on consistent production pace driving sales pace, while using pricing, incentives, marketing spend, and margin informed by dynamic pricing to enable consistent sales volume in a fluctuating interest rate environment. Although affordability continued to be tested by interest rate movements, purchasers remained responsive to increased sales incentives, resulting in a 28% increase in our new orders and a 23% increase in our deliveries year over year."" ""The macroeconomic environment remained relatively consistent throughout our first quarter, with interest rates fluctuating within a manageable range, employment remaining strong, housing supply remaining chronically short due to production deficits over a decade, and demand strength driven by strong household formation. Housing market fundamentals remained strong as demand continued to outweigh supply. These conditions remained constructive for our overall operating strategy of focusing on production and sales pace over price while growing market share."" ""Earnings were $719 million, or $2.57 per diluted share, compared to $597 million, or $2.06 per diluted share last year. We delivered 16,798 homes in our first quarter and our new orders were 18,176, up 28%, year over year. Our average sales price, net of incentives, per home delivered was $413,000 in the first quarter, down 8% from last year, and our homebuilding gross margin in the first quarter was 21.8%, up 60 basis points from last year, as a result of our careful management of incentives combined with our intense focus on reducing construction costs, while homebuilding S,G&A expenses were 8.2%, resulting in a 13.6% net margin."" ""Driven by this quarter's strong operating performance, we constructively allocated capital while we continued to strengthen and fortify our balance sheet. During the quarter, we repurchased $506 million of our common stock, ending the quarter with homebuilding debt to total capital of 9.6%, no borrowings on our $2.6 billion revolver and cash of $5.0 billion. With cash on hand exceeding our debt, and with overall liquidity of $7.6 billion, our balance sheet remains extremely strong. Against that backdrop, we remain focused on our ""land strategies"" initiatives in order to intensify our land light focus and assure consistency of execution now and in the future as we embrace an ever-more focused manufacturing model for Lennar."" Jon Jaffe, Co-Chief Executive Officer and President of Lennar, said, ""Operationally, both our starts pace and sales pace were 4.9 homes per community in the first quarter, as we continue to move closer to an even flow operating model. Our cycle time was down to 154 days, or 30% year over year, as our production first focus has positively impacted our production times, while our inventory turn improved to 1.5 times reflecting broader efficiencies. Concurrently, the Lennar Machine continued to carefully match our sales pace to our production pace using our digital marketing and dynamic pricing models."" ""During the quarter, we continued the execution of our land light strategy. This was evidenced by our years supply of owned homesites improving to 1.3 years from 1.9 years last year and our controlled homesite percentage increasing to 77% from 68% year over year. These results drove our return on inventory to 30.5%, a sequential improvement of 110 basis points."" Mr. Miller concluded, ""We continue to remain enthusiastic about our current execution and our future. We have remained focused on our operating strategies, while at the same time being observant of current economic and market trends. This has positioned us particularly well as the economic environment continues to define itself throughout the complicated election year in 2024. As we look ahead to our second quarter, we expect to deliver between 19,000 and 19,500 homes with a gross margin of approximately 22.5%. We remain focused on delivering 80,000 homes for the full year, with a margin that remains consistent with last year's margin. We will continue to fortify our balance sheet with significant liquidity and operate from a position of strength, thus enabling us to continue to execute on our core strategies to drive strong cash flow and higher returns."" RESULTS OF OPERATIONSTHREE MONTHS ENDED FEBRUARY 29, 2024 COMPARED TOTHREE MONTHS ENDED FEBRUARY 28, 2023 Homebuilding Revenues from home sales increased 13% in the first quarter of 2024 to $6.9 billion from $6.1 billion in the first quarter of 2023. Revenues were higher primarily due to a 23% increase in the number of home deliveries, partially offset by an 8% decrease in the average sales price of homes delivered. New home deliveries increased to 16,798 homes in the first quarter of 2024 from 13,659 homes in the first quarter of 2023. The average sales price of homes delivered was $413,000 in the first quarter of 2024, compared to $448,000 in the first quarter of 2023. The decrease in average sales price of homes delivered in the first quarter of 2024 compared to the same period last year was primarily due to pricing to market through an increased use of incentives and product mix. Gross margins on home sales were $1.5 billion, or 21.8%, in the first quarter of 2024, compared to $1.3 billion, or 21.2%, in the first quarter of 2023. During the first quarter of 2024, gross margins increased because of a decrease in costs per square foot as the Company continued to focus on construction cost savings, which was partially offset by a decrease in average sales price and an increase in land costs. Selling, general and administrative expenses were $568 million in the first quarter of 2024, compared to $450 million in the first quarter of 2023. As a percentage of revenues from home sales, selling, general and administrative expenses increased to 8.2% in the first quarter of 2024, from 7.4% in the first quarter of 2023, primarily due to an increase in the use of brokers due to current market conditions and an increase in digital marketing and advertising costs to generate more direct sales. Financial Services Operating earnings for the Financial Services segment were $131 million in the first quarter of 2024, compared to $78 million in the first quarter of 2023. The increase in operating earnings was primarily due to a higher profit per locked loan in the Company's mortgage business as a result of higher margins, and higher lock volume because of increased capture rate and Lennar deliveries. There was also an increase in profitability from the Company's title business due to higher volume and productivity as a result of continued implementation of technology initiatives. Other Ancillary Businesses Operating loss for the Multifamily segment was $16 million in the first quarter of 2024, compared to operating loss of $22 million in the first quarter of 2023. Operating loss for the Lennar Other segment was $40 million in the first quarter of 2024, compared to an operating loss of $41 million in the first quarter of 2023. Tax Rate In the first quarter of 2024 and 2023, the Company had tax provisions of $211 million and $185 million, respectively, which resulted in an overall effective income tax rate of 22.7% and 23.7%, respectively. In the first quarter of 2024, the Company's overall effective income tax rate was lower than last year, primarily due to tax benefits from share-based compensation. Share Repurchases In the first quarter of 2024, the Company repurchased 3.4 million shares of its common stock for $506 million at an average share price of $148.95. Liquidity At February 29, 2024, the Company had $5.0 billion of Homebuilding cash and cash equivalents and no outstanding borrowings under its $2.6 billion revolving credit facility, thereby providing approximately $7.6 billion of available capacity. Guidance The following are the Company's expected results of its homebuilding and financial services activities for the second quarter of 2024: Second Quarter 2024 New Orders 20,900 - 21,300 Deliveries 19,000 - 19,500 Average Sales Price $420,000 - $425,000 Gross Margin % on Home Sales About 22.5% S,G&A as a % of Home Sales About 7.2% Financial Services Operating Earnings $110 million - $115 million About Lennar Lennar Corporation, founded in 1954, is one of the nation's leading builders of quality homes for all generations. Lennar builds affordable, move-up and active adult homes primarily under the Lennar brand name. Lennar's Financial Services segment provides mortgage financing, title and closing services primarily for buyers of Lennar's homes and, through LMF Commercial, originates mortgage loans secured primarily by commercial real estate properties throughout the United States. Lennar's Multifamily segment is a nationwide developer of high-quality multifamily rental properties. LENX drives Lennar's technology, innovation and strategic investments. For more information about Lennar, please visit www.lennar.com. Note Regarding Forward-Looking Statements: Some of the statements in this press release are ""forward-looking statements,"" as that term is defined in the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements relating to the homebuilding market and other markets in which we participate. You can identify forward-looking statements by the fact that these statements do not relate strictly to historical or current matters. Rather, forward-looking statements relate to anticipated or expected events, activities, trends or results. Accordingly, these forward-looking statements should be evaluated with consideration given to the many risks and uncertainties inherent in our business that could cause actual results and events to differ materially from those anticipated by the forward-looking statements. We wish to caution readers not to place undue reliance on any forward-looking statements, which are expressly qualified in their entirety by this cautionary statement and speak only as of the date made. Important factors that could cause differences between anticipated and actual results include slowdowns in real estate markets in regions where we have significant Homebuilding or Multifamily development activities or own a substantial number of single-family homes for rent; decreased demand for our homes, either for sale or for rent, or Multifamily rental apartments; the potential impact of inflation; the impact of increased cost of mortgage financing for homebuyers, increased interest rates or increased competition in the mortgage industry; supply shortages and increased costs related to construction materials, including lumber, and labor; cost increases related to real estate taxes and insurance; the effect of increased interest rates with regard to our funds' borrowings on the willingness of the funds to invest in new projects; reductions in the market value of our investments in public companies; natural disasters or catastrophic events for which our insurance may not provide adequate coverage; our inability to successfully execute our strategies, including our land light strategy, and our planned spin-off of certain businesses; a decline in the value of the land and home inventories we maintain and resulting possible future writedowns of the carrying value of our real estate assets; the forfeiture of deposits related to land purchase options we decide not to exercise; the effects of public health issues such as a major epidemic or pandemic that could have a negative impact on the economy and on our businesses; possible unfavorable results in legal proceedings; conditions in the capital, credit and financial markets; changes in laws, regulations or the regulatory environment affecting our business, and the other risks and uncertainties described in our filings from time to time with the Securities and Exchange Commission, including those included under the captions ""Risk Factors"" and ""Management's Discussion and Analysis of Financial Condition and Results of Operations"" in our most recent Annual Report on Form 10-K and Quarterly Reports on Form 10-Q. We undertake no obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise. A conference call to discuss the Company's first quarter earnings will be held at 11:00 a.m. Eastern Time on Thursday, March 14, 2024. The call will be broadcast live on the Internet and can be accessed through the Company's website at investors.lennar.com. If you are unable to participate in the conference call, the call will be archived at investors.lennar.com for 90 days. A replay of the conference call will also be available later that day by calling 203-369-3032 and entering 5723593 as the confirmation number. LENNAR CORPORATION AND SUBSIDIARIES Selected Revenues and Operating Information (In thousands, except per share amounts) (unaudited) Three Months Ended February 29, 2024 February 28, 2023 Revenues: Homebuilding $ 6,930,991 6,156,305 Financial Services 249,720 182,981 Multifamily 129,677 143,523 Lennar Other 2,542 7,620 Total revenues $ 7,312,930 6,490,429 Homebuilding operating earnings $ 1,028,796 906,839 Financial Services operating earnings 131,296 78,737 Multifamily operating loss (15,639) (21,601) Lennar Other operating loss (39,548) (39,757) Corporate general and administrative expenses (157,321) (126,106) Charitable foundation contribution (16,798) (13,659) Earnings before income taxes 930,786 784,453 Provision for income taxes (210,865) (185,145) Net earnings (including net earnings attributable to noncontrolling interests) 719,921 599,308 Less: Net earnings attributable to noncontrolling interests 587 2,774 Net earnings attributable to Lennar $ 719,334 596,534 Average shares outstanding: Basic 276,946 286,074 Diluted 276,946 286,074 Earnings per share: Basic $ 2.57 2.06 Diluted $ 2.57 2.06 Supplemental information: Interest incurred (1) $ 36,511 49,577 EBIT (2): Net earnings attributable to Lennar $ 719,334 596,534 Provision for income taxes 210,865 185,145 Interest expense included in: Costs of homes sold 39,214 49,452 Homebuilding other income (expense), net 4,915 3,593 Total interest expense 44,129 53,045 EBIT $ 974,328 834,724 (1) Amount represents interest incurred related to homebuilding debt. (2) EBIT is a non-GAAP financial measure defined as earnings before interest and taxes. This financial measure has been presented because the Company finds it important and useful in evaluating its performance and believes that it helps readers of the Company's financial statements compare its operations with those of its competitors. Although management finds EBIT to be an important measure in conducting and evaluating the Company's operations, this measure has limitations as an analytical tool as it is not reflective of the actual profitability generated by the Company during the period. Management compensates for the limitations of using EBIT by using this non-GAAP measure only to supplement the Company's GAAP results. Due to the limitations discussed, EBIT should not be viewed in isolation, as it is not a substitute for GAAP measures. LENNAR CORPORATION AND SUBSIDIARIES Segment Information (In thousands) (unaudited) Three Months Ended February 29, 2024 February 28, 2023 Homebuilding revenues: Sales of homes $ 6,901,781 6,093,827 Sales of land 20,752 9,718 Other homebuilding 8,458 52,760 Total homebuilding revenues 6,930,991 6,156,305 Homebuilding costs and expenses: Costs of homes sold 5,395,532 4,802,843 Costs of land sold 14,017 22,077 Selling, general and administrative 567,987 449,794 Total homebuilding costs and expenses 5,977,536 5,274,714 Homebuilding net margins 953,455 881,591 Homebuilding equity in earnings from unconsolidated entities 13,302 3,186 Homebuilding other income, net 62,039 22,062 Homebuilding operating earnings $ 1,028,796 906,839 Financial Services revenues $ 249,720 182,981 Financial Services costs and expenses 118,424 104,244 Financial Services operating earnings $ 131,296 78,737 Multifamily revenues $ 129,677 143,523 Multifamily costs and expenses 132,667 148,956 Multifamily equity in loss from unconsolidated entities and other income (expense), net (12,649) (16,168) Multifamily operating loss $ (15,639) (21,601) Lennar Other revenues $ 2,542 7,620 Lennar Other costs and expenses 9,088 6,476 Lennar Other equity in loss from unconsolidated entities, other income (expense), net, and other gain (27,865) (16,947) Lennar Other unrealized losses from technology investments (1) (5,137) (23,954) Lennar Other operating loss $ (39,548) (39,757) (1) The following is a detail of Lennar Other unrealized losses from mark-to-market adjustments on technology investments: Three Months Ended February 29, 2024 February 28, 2023 Blend Labs (BLND) $ 2,936 586 Hippo (HIPO) 16,449 6,632 Opendoor (OPEN) 1,315 (7,691) SmartRent (SMRT) (1,963) 1,305 Sonder (SOND) 51 (320) Sunnova (NOVA) (23,925) (24,466) $ (5,137) (23,954) LENNAR CORPORATION AND SUBSIDIARIESSummary of Deliveries, New Orders and Backlog(Dollars in thousands, except average sales price)(unaudited) Lennar's reportable homebuilding segments and all other homebuilding operations not required to be reported separately have divisions located in: East: Alabama, Florida, New Jersey and PennsylvaniaCentral: Georgia, Illinois, Indiana, Maryland, Minnesota, North Carolina, South Carolina, Tennessee and VirginiaTexas: TexasWest: Arizona, California, Colorado, Idaho, Nevada, Oregon, Utah and WashingtonOther: Urban divisions First Quarter 2024 2023 2024 2023 2024 2023 Deliveries: Homes Dollar Value Average Sales Price East 4,724 3,855 $ 1,950,631 1,711,945 $ 413,000 444,000 Central 3,560 2,740 1,395,644 1,201,395 392,000 438,000 Texas 4,263 3,421 1,070,159 1,016,973 251,000 297,000 West 4,238 3,642 2,521,491 2,194,022 595,000 602,000 Other 13 1 6,817 1,165 524,000 1,165,000 Total 16,798 13,659 $ 6,944,742 6,125,500 $ 413,000 448,000 Of the total homes delivered listed above, 77 homes with a dollar value of $43 million and an average sales price of $558,000 represent home deliveries from unconsolidated entities for the three months ended February 29, 2024, compared to 63 home deliveries with a dollar value of $32 million and an average sales price of $503,000 for the three months ended February 28, 2023. First Quarter 2024 2023 2024 2023 2024 2023 2024 2023 New Orders: Active Communities Homes Dollar Value Average Sales Price East 304 317 4,526 3,841 $ 1,898,078 1,674,177 $ 419,000 436,000 Central 320 322 4,274 2,741 1,718,536 1,147,817 402,000 419,000 Texas 233 219 4,431 3,142 1,119,999 879,456 253,000 280,000 West 368 356 4,927 4,465 2,996,239 2,708,326 608,000 607,000 Other 2 3 18 5 9,530 3,686 529,000 737,000 Total 1,227 1,217 18,176 14,194 $ 7,742,382 6,413,462 $ 426,000 452,000 Of the total homes listed above, 46 homes with a dollar value of $25 million and an average sales price of $548,000 represent homes in six active communities from unconsolidated entities for the three months ended February 29, 2024, compared to 97 homes with a dollar value of $38 million and an average sales price of $394,000 in seven active communities for the three months ended February 28, 2023. First Quarter 2024 2023 2024 2023 2024 2023 Backlog: Homes Dollar Value Average Sales Price East 6,382 8,147 $ 2,656,497 3,544,939 $ 416,000 435,000 Central 3,877 4,570 1,698,509 2,039,469 438,000 446,000 Texas 2,063 2,418 525,781 699,567 255,000 289,000 West 3,940 4,263 2,547,090 2,740,782 646,000 643,000 Other 8 5 4,241 3,685 530,000 737,000 Total 16,270 19,403 $ 7,432,118 9,028,442 $ 457,000 465,000 Of the total homes in backlog listed above, 116 homes with a backlog dollar value of $57 million and an average sales price of $495,000 represent the backlog from unconsolidated entities at February 29, 2024, compared to 200 homes with a backlog dollar value of $84 million and an average sales price of $422,000 at February 28, 2023. LENNAR CORPORATION AND SUBSIDIARIES Condensed Consolidated Balance Sheets (In thousands, except per share amounts) (unaudited) February 29, 2024 November 30, 2023 ASSETS Homebuilding: Cash and cash equivalents $ 4,950,128 6,273,724 Restricted cash 12,635 13,481 Receivables, net 897,371 887,992 Inventories: Finished homes and construction in progress 11,092,033 10,455,666 Land and land under development 4,734,116 4,904,541 Inventory owned 15,826,149 15,360,207 Consolidated inventory not owned 3,547,921 2,992,528 Inventory owned and consolidated inventory not owned 19,374,070 18,352,735 Deposits and pre-acquisition costs on real estate 2,408,877 2,002,154 Investments in unconsolidated entities 1,206,564 1,143,909 Goodwill 3,442,359 3,442,359 Other assets 1,473,563 1,512,038 33,765,567 33,628,392 Financial Services 3,056,442 3,566,546 Multifamily 1,379,279 1,381,513 Lennar Other 749,911 657,852 Total assets $ 38,951,199 39,234,303 LIABILITIES AND EQUITY Homebuilding: Accounts payable $ 1,565,464 1,631,401 Liabilities related to consolidated inventory not owned 3,043,888 2,540,894 Senior notes and other debts payable, net 2,830,332 2,816,482 Other liabilities 2,689,263 2,739,217 10,128,947 9,727,994 Financial Services 1,721,333 2,447,039 Multifamily 249,625 278,177 Lennar Other 73,364 79,127 Total liabilities 12,173,269 12,532,337 Stockholders' equity: Preferred stock   Class A common stock of $0.10 par value 25,983 25,848 Class B common stock of $0.10 par value 3,660 3,660 Additional paid-in capital 5,651,836 5,570,009 Retained earnings 22,949,315 22,369,368 Treasury stock (1,988,200) (1,393,100) Accumulated other comprehensive income 5,241 4,879 Total stockholders' equity 26,647,835 26,580,664 Noncontrolling interests 130,095 121,302 Total equity 26,777,930 26,701,966 Total liabilities and equity $ 38,951,199 39,234,303 LENNAR CORPORATION AND SUBSIDIARIES Supplemental Data (Dollars in thousands) (unaudited) February 29, 2024 November 30, 2023 February 28, 2023 Homebuilding debt $ 2,830,332 2,816,482 4,033,335 Stockholders' equity 26,647,835 26,580,664 24,418,255 Total capital $ 29,478,167 29,397,146 28,451,590 Homebuilding debt to total capital 9.6 % 9.6 % 14.2 % Homebuilding debt $ 2,830,332 2,816,482 4,033,335 Less: Homebuilding cash and cash equivalents 4,950,128 6,273,724 4,057,956 Net homebuilding debt $ (2,119,796) (3,457,242) (24,621) Net homebuilding debt to total capital (1) (8.6) % (15.0) % (0.1) % (1) Net homebuilding debt to total capital is a non-GAAP financial measure defined as net homebuilding debt (homebuilding debt less homebuilding cash and cash equivalents) divided by total capital (net homebuilding debt plus stockholders' equity). The Company believes the ratio of net homebuilding debt to total capital is a relevant and a useful financial measure to investors in understanding the leverage employed in homebuilding operations. However, because net homebuilding debt to total capital is not calculated in accordance with GAAP, this financial measure should not be considered in isolation or as an alternative to financial measures prescribed by GAAP. Rather, this non-GAAP financial measure should be used to supplement the Company's GAAP results. Contact:Ian FrazerInvestor RelationsLennar Corporation(305) 485-4129 View original content:https://www.prnewswire.com/news-releases/lennar-reports-first-quarter-2024-results-302088530.html SOURCE Lennar Corporation What was Lennar's net earnings per diluted share in the first quarter of 2024? Lennar's net earnings per diluted share in the first quarter of 2024 increased by 25% to $2.57 compared to the prior year quarter. How much did new orders increase by in the first quarter of 2024? New orders in the first quarter of 2024 surged by 28% to 18,176 homes, with a dollar value increase of 21% to $7.7 billion. What was the percentage increase in deliveries in the first quarter of 2024? Deliveries in the first quarter of 2024 saw a 23% increase to 16,798 homes. What was the homebuilding operating earnings in the first quarter of 2024? Homebuilding operating earnings reached $1.0 billion in the first quarter of 2024. How much did Lennar repurchase in common stock during the first quarter of 2024? Lennar repurchased 3.4 million shares of common stock for $506 million during the first quarter of 2024."
MSC INDUSTRIAL SUPPLY CO. TO WEBCAST REVIEW OF FISCAL 2024 SECOND QUARTER RESULTS,2024-03-13T20:30:00.000Z,Low,Neutral,"MSC Industrial Supply Co. (MSM) will host a live conference call to discuss its fiscal year 2024 second quarter results and operations on March 28, 2024. The call will be accessible via webcast or phone. An online archive will be available after the call.","MSC INDUSTRIAL SUPPLY CO. TO WEBCAST REVIEW OF FISCAL 2024 SECOND QUARTER RESULTS Rhea-AI Impact (Low) Rhea-AI Sentiment (Neutral) Tags conferences earnings Rhea-AI Summary MSC Industrial Supply Co. (MSM) will host a live conference call to discuss its fiscal year 2024 second quarter results and operations on March 28, 2024. The call will be accessible via webcast or phone. An online archive will be available after the call. Positive None. Negative None. 03/13/2024 - 04:30 PM MELVILLE, N.Y. and DAVIDSON, N.C., March 13, 2024 /PRNewswire/ -- MSC INDUSTRIAL SUPPLY CO. (NYSE: MSM), a premier distributor of Metalworking and Maintenance, Repair and Operations (MRO) products and services to industrial customers throughout North America, today announced that the Company's conference call to review its fiscal year 2024 second quarter results, as well as its current operations, will be broadcast live over the Internet Thursday, March 28, 2024 at 8:30 a.m. Eastern Time. To access the earnings release, webcast, presentation slides and operational statistics, please visit the Company's website at: http://investor.mscdirect.com. Alternatively, the conference call can be accessed by dialing 1-877-443-5575 (U.S.), 1-855-669-9657 (Canada) or 1-412-902-6618 (international). An online archive of the broadcast will be available within one hour of the conclusion of the call and remain available until Thursday, April 11, 2024. About MSC Industrial Supply Co. MSC Industrial Supply Co. (NYSE:MSM) is a leading North American distributor of metalworking and maintenance, repair and operations (MRO) products and services. We help our customers drive greater productivity, profitability and growth with approximately 2.4 million products, inventory management and other supply chain solutions, and deep expertise from more than 80 years of working with customers across industries. Our experienced team of more than 7,000 associates is dedicated to working side by side with our customers to help drive results for their businesses - from keeping operations running efficiently today to continuously rethinking, retooling, and optimizing for a more productive tomorrow. For more information on MSC, please visit mscdirect.com. View original content to download multimedia:https://www.prnewswire.com/news-releases/msc-industrial-supply-co-to-webcast-review-of-fiscal-2024-second-quarter-results-302088478.html SOURCE MSC Industrial Supply Co. When will MSC Industrial Supply Co. host the conference call to review its fiscal year 2024 second quarter results? MSC Industrial Supply Co. will host the conference call on March 28, 2024. How can investors access the conference call? Investors can access the conference call via webcast on the Company's website or by phone. What is the ticker symbol for MSC Industrial Supply Co.? The ticker symbol for MSC Industrial Supply Co. is MSM. When will the online archive of the conference call be available? The online archive will be available within one hour of the call's conclusion and will remain accessible until April 11, 2024."
"Bit Digital, Inc. Announces Date for Fiscal Year 2023 Financial Results and Conference Call",2024-03-13T20:30:00.000Z,Neutral,Very Negative,"Bit Digital, Inc. (BTBT) will release its fiscal year 2023 results on March 18, 2024, with a live webcast and conference call the following day. The press release will be available on the company's website.","Bit Digital, Inc. Announces Date for Fiscal Year 2023 Financial Results and Conference Call Rhea-AI Impact (Neutral) Rhea-AI Sentiment (Very Negative) Tags earnings Rhea-AI Summary Bit Digital, Inc. (BTBT) will release its fiscal year 2023 results on March 18, 2024, with a live webcast and conference call the following day. The press release will be available on the company's website. Positive None. Negative None. 03/13/2024 - 04:30 PM NEW YORK, March 13, 2024 /PRNewswire/ -- Bit Digital, Inc. (Nasdaq: BTBT) (""Bit Digital"" or the ""Company""), a sustainable platform for digital assets and artificial intelligence (""AI"") infrastructure headquartered in New York, announced today that it will release its fiscal year 2023 results on Monday, March 18, 2024, after the stock market closes. Senior management will host a live webcast and conference call to review the results on Tuesday, March 19, 2024, at 10 a.m. ET. To register for the earnings call, please click here. The Company will issue a press release regarding the fiscal year 2023 earnings prior to the conference call. The press release will be posted on the Bit Digital website at www.bit-digital.com. About Bit Digital Bit Digital, Inc. is a sustainable platform for digital assets and artificial intelligence (""AI"") infrastructure headquartered in New York City. Our bitcoin mining operations are located in the US, Canada, and Iceland. The Company has also established a business line, Bit Digital AI, that offers specialized cloud-infrastructure services for artificial intelligence applications. For additional information, please contact ir@bit-digital.com or visit our website at www.bit-digital.com. Investor Notice Investing in our securities involves a high degree of risk. Before making an investment decision, you should carefully consider the risks, uncertainties and forward-looking statements described under ""Risk Factors"" in Item 3.D of our most recent Annual Report on Form 20-F for the fiscal year ended December 31, 2022. If any material risk was to occur, our business, financial condition or results of operations would likely suffer. In that event, the value of our securities could decline and you could lose part or all of your investment. The risks and uncertainties we describe are not the only ones facing us. Additional risks not presently known to us or that we currently deem immaterial may also impair our business operations. In addition, our past financial performance may not be a reliable indicator of future performance, and historical trends should not be used to anticipate results in the future. Future changes in the network-wide mining difficulty rate or bitcoin hash rate may also materially affect the future performance of Bit Digital's production of bitcoin. Actual operating results will vary depending on many factors including network difficulty rate, total hash rate of the network, the operations of our facilities, the status of our miners, and other factors. Safe Harbor Statement This press release may contain certain ""forward-looking statements"" relating to the business of Bit Digital, Inc., and its subsidiary companies. All statements, other than statements of historical fact included herein are ""forward-looking statements."" These forward-looking statements are often identified by the use of forward-looking terminology such as ""believes,"" ""expects,"" or similar expressions, involving known and unknown risks and uncertainties. Although the Company believes that the expectations reflected in these forward-looking statements are reasonable, they do involve assumptions, risks and uncertainties, and these expectations may prove to be incorrect. Investors should not place undue reliance on these forward-looking statements, which speak only as of the date of this press release. The Company's actual results could differ materially from those anticipated in these forward-looking statements as a result of a variety of factors, including those discussed in the Company's periodic reports that are filed with the Securities and Exchange Commission and available on its website at http://www.sec.gov. All forward-looking statements attributable to the Company or persons acting on its behalf are expressly qualified in their entirety by these factors. Other than as required under the securities laws, the Company does not assume a duty to update these forward-looking statements. View original content to download multimedia:https://www.prnewswire.com/news-releases/bit-digital-inc-announces-date-for-fiscal-year-2023-financial-results-and-conference-call-302088465.html SOURCE Bit Digital, Inc. When will Bit Digital release its fiscal year 2023 results? Bit Digital will release its fiscal year 2023 results on March 18, 2024. What time will the live webcast and conference call to review the results take place? The live webcast and conference call to review the results will take place on March 19, 2024, at 10 a.m. ET. Where can I find the press release regarding the fiscal year 2023 earnings? The press release regarding the fiscal year 2023 earnings will be posted on the Bit Digital website at www.bit-digital.com."
"Paysign, Inc. Reinforces Payment Processing Acumen With New Executive Hire",2024-03-13T20:30:00.000Z,Neutral,Very Positive,"Paysign, Inc. (PAYS) announces Sandy Ortins as the new VP of EFT Services, bringing extensive experience in payment processing. Sandy's background in banking and ACH operations will enhance Paysign's efficiency and growth in transaction volume.","Paysign, Inc. Reinforces Payment Processing Acumen With New Executive Hire Rhea-AI Impact (Neutral) Rhea-AI Sentiment (Very Positive) Tags Rhea-AI Summary Paysign, Inc. (PAYS) announces Sandy Ortins as the new VP of EFT Services, bringing extensive experience in payment processing. Sandy's background in banking and ACH operations will enhance Paysign's efficiency and growth in transaction volume. Positive None. Negative None. 03/13/2024 - 04:30 PM Sandy Ortins Joins as VP, EFT Services HENDERSON, Nev.--(BUSINESS WIRE)-- Paysign, Inc. (NASDAQ: PAYS), a leading provider of prepaid card programs, comprehensive patient affordability offerings, digital banking services and integrated payment processing, today announced a key executive recruitment that supports their foundation as an end-to-end payment processor. Sandy Ortins, AAP, APRP, NCP, was brought on as the companys vice president of electronic funds transfer (EFT) services, an essential addition to the team. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240313051763/en/Sandy Ortins Joins Paysign as VP, EFT Services (Photo: Business Wire) Prior to joining Paysign, Sandy served as senior Vice President of Operations at the New England Automated Clearing House (ACH) Association, a NACHA member association that focuses on regulatory compliance, risk management and sound operational practices for the ACH industry. She holds three professional credentials that highlight her commitment to payment processing: Accredited ACH Professional (AAP), Accredited Payments Risk Professional (APRP) and National Check Professional (NCP). Sandys wealth of experience in guiding organizations to peak efficiency perfectly complements our payments strategy as we scale our processing operations to accommodate our transaction volume growth, said Mark Newcomer, Paysign CEO. We welcome her aboard as a valuable member of our executive team. One of the deciding factors in accepting this position at Paysign is the ability to apply the skills Ive attained throughout my career in banking and ACH to establish precise and efficient processes for the companys rapidly growing EFT services, stated Ortins. As Paysigns VP, EFT Services, Sandy will focus on day-to-day processing operations, including audit, compliance, risk management, and future processing connections. About Paysign Paysign, Inc. is a leading provider of prepaid card programs, comprehensive patient affordability offerings, digital banking services and integrated payment processing designed for businesses, consumers and government institutions. Founded in 2001 and headquartered in southern Nevada, the company creates customized, innovative payment solutions for clients across all industries, including pharmaceutical, healthcare, hospitality and retail. Built on the foundation of a reliable payments platform, Paysigns end-to-end technologies securely enable digital payout solutions and facilitate the distribution of funds for donor compensation, copay assistance, customer incentives, employee rewards, travel expenses and per diem, reimbursements, gift cards, rebates, and countless other exchanges of value. Paysigns solutions lower costs, streamline operations and improve customer, employee and partner loyalty. To learn more, visit paysign.com. View source version on businesswire.com: https://www.businesswire.com/news/home/20240313051763/en/ Investor Relations ir@paysign.com 888.522.4853 paysign.com/investors Media Relations Alicia Ches 702.749.7257 pr@paysign.com Source: Paysign, Inc. Who is the new VP of EFT Services at Paysign? Sandy Ortins, with a background in banking and ACH operations, has been appointed as the new VP of EFT Services at Paysign. What are Sandy Ortins' professional credentials? Sandy Ortins holds three professional credentials: Accredited ACH Professional (AAP), Accredited Payments Risk Professional (APRP), and National Check Professional (NCP). What was Sandy Ortins' previous role before joining Paysign? Sandy Ortins was the Senior Vice President of Operations at the New England Automated Clearing House (ACH) Association before joining Paysign. What will Sandy Ortins focus on as the VP of EFT Services at Paysign? Sandy Ortins will focus on day-to-day processing operations, including audit, compliance, risk management, and future processing connections as the VP of EFT Services at Paysign."
TBIL Hits Three Bil: The US Treasury 3 Month Bill ETF (TBIL) Surpasses $3 Billion in Assets,2024-03-13T20:53:00.000Z,Low,Neutral,"F/m Investments' US Benchmark Series raises $4.25 billion since August 2022, with The US Treasury 3 Month Bill ETF (TBIL) crossing $3 billion in assets. The Series offers 10 ETFs providing access to US Treasuries at specific points along the yield curve, attracting investors seeking safety and yield. F/m's President highlights the demand for easy access to short-term investments amidst market volatility. The launch of the US Credit Series further demonstrates F/m's commitment to providing efficient investment tools. F/m's novel exemptive application to the SEC aims to expand accessibility to the US Benchmark Series through mutual fund share classes.","TBIL Hits Three Bil: The US Treasury 3 Month Bill ETF (TBIL) Surpasses $3 Billion in Assets Rhea-AI Impact (Low) Rhea-AI Sentiment (Neutral) Tags Rhea-AI Summary F/m Investments' US Benchmark Series raises $4.25 billion since August 2022, with The US Treasury 3 Month Bill ETF (TBIL) crossing $3 billion in assets. The Series offers 10 ETFs providing access to US Treasuries at specific points along the yield curve, attracting investors seeking safety and yield. F/m's President highlights the demand for easy access to short-term investments amidst market volatility. The launch of the US Credit Series further demonstrates F/m's commitment to providing efficient investment tools. F/m's novel exemptive application to the SEC aims to expand accessibility to the US Benchmark Series through mutual fund share classes. Positive The US Treasury 3 Month Bill ETF (TBIL) has surpassed $3 billion in assets, contributing to the total $4.25 billion raised by F/m Investments' US Benchmark Series since August 2022. Investors are drawn to the US Benchmark Series for its 10 ETFs offering exposure to US Treasuries at various points on the yield curve, providing a balance of safety and yield. F/m's President emphasizes the growing demand for accessible short-term investments amidst the influx of new asset classes and cryptocurrencies in the market. The introduction of the US Credit Series aligns with F/m's goal of simplifying investment processes by tracking the industry's first investable index in investment grade credit. F/m's innovative exemptive application to the SEC seeks approval for mutual fund share classes within the US Benchmark Series, potentially broadening access to a wider range of investors. Negative None. Market Research Analyst The recent announcement by F/m Investments regarding the success of their US Benchmark Series, particularly the US Treasury 3 Month Bill ETF (TBIL), which has surpassed $3 billion in assets, is a strong indicator of investor sentiment and behavior. Amidst market volatility and the influx of novel asset classes, there is a clear trend towards the safety and predictability of US Treasury securities. The diversification of the US Benchmark Series across different maturities of the yield curve caters to a wide range of investment strategies, from short-term liquidity management to long-term fixed income allocation.Moreover, the introduction of the US Credit Series ETFs, tracking the first investable index in investment grade credit, signifies an expansion of F/m's product offerings, aiming to provide investors with broader tools for portfolio construction. This could potentially disrupt the traditional mutual fund market, as it offers a level of precision and liquidity that is typically associated with ETFs.The potential SEC approval for a mutual fund share class for the ETFs in the US Benchmark Series could democratize access to these investment vehicles, aligning with the ongoing trend of convergence between mutual funds and ETFs. This could open up opportunities for a segment of investors who are restricted to mutual fund investments due to regulatory or policy constraints. Financial Analyst The accumulation of over $4.25 billion in assets for the US Benchmark Series within 18 months of its inception reflects a strong market demand for these products. This is an important financial metric, as it demonstrates significant capital inflow into the series, which can be seen as a vote of confidence from the investment community. The growth of TBIL, in particular, suggests that investors are seeking haven in short-term securities amidst uncertain economic conditions, which may be indicative of a risk-averse stance in the current market environment.From an investment perspective, the exemptive application filed with the SEC for offering a mutual fund share class is a strategic move that could potentially increase the liquidity and flexibility of the US Benchmark Series. If approved, this could lead to a reshaping of investor portfolios, as they could combine the benefits of mutual funds, such as familiarity and ease of use, with the advantages of ETFs, including intraday trading and typically lower fees. Legal Expert The exemptive application filed by F/m Investments with the SEC is a noteworthy legal development within the ETF industry. If granted, this would set a precedent for ETFs to offer a mutual fund share class, potentially bridging the gap between two distinct types of investment products. The legal implications of such a decision by the SEC could lead to a significant shift in the regulatory landscape, influencing how investment products are structured and offered to different investor classes.Understanding the legal nuances of this application is critical for stakeholders, as it could potentially alter the competitive dynamics within the investment fund industry. The ability to offer a mutual fund share class could provide ETFs with a competitive edge over traditional mutual funds, particularly in attracting a segment of the investor base that has been historically limited to mutual fund investments due to various constraints, including 401(k) plans and other retirement accounts. 03/13/2024 - 04:53 PM F/m Investments US Benchmark Series raises $4.25 billion since August 2022 WASHINGTON--(BUSINESS WIRE)-- F/m Investments LLC (F/m) announces The US Treasury 3 Month Bill ETF (Ticker: TBIL) has crossed the $3 billion threshold in assets, highlighting investors' demand for innovative ways to access the short end of the yield curve. TBIL and the nine additional ETFs that comprise the US Benchmark Series give investors access to US Treasuries at 10 specific points across the US Treasury yield curve. Each ETF in the US Benchmark Series holds the most current (on the run[1]) US Treasury security that corresponds to its tenor. The 10 ETFs in the Series are: The US Treasury 3 Month Bill ETF (TBIL) The US Treasury 6 Month Bill ETF (XBIL) The US Treasury 12 Month Bill ETF (OBIL) The US Treasury 2 Year Note ETF (UTWO) The US Treasury 3 Year Note ETF (UTRE) The US Treasury 5 Year Note ETF (UFIV) The US Treasury 7 Year Note ETF (USVN) The US Treasury 10 Year Note ETF (UTEN) The US Treasury 20 Year Bond ETF (UTWY) The US Treasury 30 Year Bond ETF (UTHY) The Series has raised more than $4.25 billion in total in the 18 months since launch, confirming investor demand for a better way to invest in US Treasury securities. TBILs continued growth highlights investors appetite for easy access to safety and yield at the short end of the curve, said Alexander Morris, F/ms President, and CIO. In a market inundated recently by novel asset classes and even cryptocurrencies, the US Benchmark Series ETFs  both short and longer durations  are attracting assets from investors seeking duration exposure with the clarity and precision that these ETFs enable. While TBIL remains the most recognized of F/ms products, its not their most recent innovation. Consistent with F/ms mission to provide a set of tools that investors can use to build portfolios with precision and efficiency, F/m in January launched the US Credit Series, a suite of ETFs that track the industrys first investable index in investment grade credit. We launched TBIL and the US Benchmark Series to bring efficiency and simplicity to US Treasury investing, but our goal was always larger, said Pete Baden, senior portfolio manager and co-creator of the US Benchmark Series. Its our mission to build institutional quality, precise, diversified portfolios with the ease and efficiency of ETFs. As part of F/ms mission to expand access for investors, they recently filed a novel exemptive application with the U.S. Securities and Exchange Commission (the SEC) seeking an order that would permit each of the ETFs in the US Benchmark Series to offer a mutual fund share class. The exemptive relief requested by the application is the first of its kind in the ETF industry and, if granted by the SEC, has the potential to make the US Benchmark Series accessible to investor segments that today can only access mutual funds. [1] This periodic transition to the most-recently auctioned Treasury bill, note, or bond of a stated maturity, which is referred to as the on-the-run or OTR security of that maturity, occurs on one day. An OTR security is the most recently issued of a periodically issued security (as opposed to an off-the-run security, which is a security that has been issued before the most recent issue and is still outstanding). __________________________ About US Treasury 3 Month Bill ETF The investment objective of the US Treasury 3 Month Bill ETF is to seek investment results that correspond (before fees and expenses) generally to the price and yield performance of the ICE BofA US 3-Month Treasury Bill Index (G0O1) About The US Benchmark Series The US Benchmark Series allows investors of all sizes to own each of the Benchmark US Treasuries in a single-security ETF. Each ETF holds the most current (on the run) US Treasury security that corresponds to its stated tenor. For more information, please visit www.ustreasuryetf.com. About F/m Investments F/m Investments is a $6 billion multi-boutique investment firm providing diversified investment strategies to advisors and institutional investors across asset classes, markets, and styles. For more information, please visit www.fminvest.com. Investors should consider the investment objectives, risks, charges and expenses carefully before investing. For a prospectus or summary prospectus with this and other information about the Fund, please call (888)123-4589 or visit our website at www.fminvest.com. Read the prospectus or summary prospectus carefully before investing. Disclosures: Investors should consider the investment objectives, risks, charges and expenses carefully before investing. For a prospectus or summary prospectus with this and other information about the Fund, please call 1-800-617-0004 or visit our website at www.ustreasuryetf.com. Read the prospectus or summary prospectus carefully before investing. As with all ETFs, Shares may be bought and sold in the secondary market at market prices. Interest rate risk is the risk of losses attributable to changes in interest rates. In general, if prevailing interest rates rise, the values of debt instruments tend to fall, and if interest rates fall, the values of debt instruments tend to rise. Fund Risks: The UST 3 Month Bill Fund may be susceptible to an increased risk of loss, including losses due to adverse events that affect the UST 3 Month Bill Funds investments more than the market as a whole, to the extent that the UST 3 Month Bill Funds investments are concentrated in a particular issue, issuer or issuers, country, market segment, or asset class. While U.S. Treasury obligations are backed by the full faith and credit of the U.S. Government, such securities are nonetheless subject to credit risk (i.e., the risk that the U.S. Government may be, or be perceived to be, unable or unwilling to honor its financial obligations, such as making payments). ICE BofA US 3-Month Treasury Bill Index is comprised of a single issue purchased at the beginning of the month and held for a full month. At the end of the month that issue is sold and rolled into a newly selected issue. The issue selected at each month-end rebalancing is the outstanding Treasury Bill that matures closest to, but not beyond, three months from the rebalancing date. To qualify for selection, an issue must have settled on or before the month-end rebalancing date. Investments involve risk. Principal loss is possible. Distributed by Quasar Distributors, LLC View source version on businesswire.com: https://www.businesswire.com/news/home/20240313942109/en/ Tucker Slosburg Lyceus Group 206.635.4196 fmpr@lyceusgroup.com Source: F/m Investments LLC How much has F/m Investments' US Benchmark Series raised since August 2022? F/m Investments' US Benchmark Series has raised over $4.25 billion since August 2022. What is the asset threshold crossed by The US Treasury 3 Month Bill ETF (TBIL)? The US Treasury 3 Month Bill ETF (TBIL) has crossed the $3 billion threshold in assets. How many ETFs are included in the US Benchmark Series? The US Benchmark Series comprises 10 ETFs, including The US Treasury 3 Month Bill ETF (TBIL) and others focusing on different points along the US Treasury yield curve. What was F/m's recent innovation besides TBIL? F/m's recent innovation, following TBIL, was the launch of the US Credit Series, a suite of ETFs tracking the industry's first investable index in investment grade credit. What is F/m's mission regarding portfolio building? F/m's mission is to provide tools for investors to build precise and efficient portfolios, demonstrated through the creation of the US Benchmark Series and other innovative products. What unique application did F/m file with the SEC recently? F/m filed a novel exemptive application with the SEC to allow each ETF in the US Benchmark Series to offer a mutual fund share class, potentially expanding accessibility to a broader range of investors."
"T. ROWE PRICE OHA SELECT PRIVATE CREDIT FUND ANNOUNCES DECEMBER 31, 2023 FINANCIAL RESULTS AND CLOSES PRIVATE PLACEMENT OF $300M 5-YEAR SENIOR UNSECURED NOTES",2024-03-13T21:35:00.000Z,Low,Neutral,"T. Rowe Price OHA Select Private Credit Fund (TROW) announces strong financial results with a $300M Private Placement of 5-Year Senior Unsecured Notes. The Company's net investment income per share was $1.03, with a weighted average yield on debt and income producing investments at 12.7%. Earnings per share stood at $1.42 with an annualized return of 15.96%. The net asset value per share increased to $28.00, up 1.9% from the previous quarter. The Company had successful investment fundings and debt management strategies, showcasing robust performance.","T. ROWE PRICE OHA SELECT PRIVATE CREDIT FUND ANNOUNCES DECEMBER 31, 2023 FINANCIAL RESULTS AND CLOSES PRIVATE PLACEMENT OF $300M 5-YEAR SENIOR UNSECURED NOTES Rhea-AI Impact (Low) Rhea-AI Sentiment (Neutral) Tags earnings Rhea-AI Summary T. Rowe Price OHA Select Private Credit Fund (TROW) announces strong financial results with a $300M Private Placement of 5-Year Senior Unsecured Notes. The Company's net investment income per share was $1.03, with a weighted average yield on debt and income producing investments at 12.7%. Earnings per share stood at $1.42 with an annualized return of 15.96%. The net asset value per share increased to $28.00, up 1.9% from the previous quarter. The Company had successful investment fundings and debt management strategies, showcasing robust performance. Positive None. Negative None. Financial Analyst The financial results and private placement announcement by T. Rowe Price OHA Select Private Credit Fund (OCREDIT) are indicative of a significant capital management strategy and growth trajectory. The company's successful ramp from $50 million in initial equity commitments to a portfolio exceeding $1 billion demonstrates robust fund performance and investor confidence. The issuance of $300 million in 5-Year Senior Unsecured Notes at a fixed interest rate of 7.77% is particularly noteworthy as it aligns with the current credit market conditions where investors are seeking higher yields amidst a fluctuating interest rate environment.OCREDIT's net investment income (NII) per share increase and earnings per share (EPS) growth reflect a strong earnings quality and operational efficiency. The net unrealized appreciation signifies potential for future gains, while the increase in net asset value (NAV) per share suggests a positive trend in asset valuation. It is important to note that the ending debt-to-equity ratio of 0.79x, compared to the prior quarter's 0.78x, remains within a manageable range, indicating a balanced approach to leverage. However, investors should monitor this metric closely as excessive leverage can pose risks to financial stability.The company's investment portfolio, predominantly composed of first lien senior secured loans, highlights a conservative risk profile with a focus on capital preservation. The floating rate nature of the debt investments is a strategic advantage in a rising interest rate environment, as it allows for interest income to potentially increase in tandem with rate hikes, thereby protecting margins. Market Research Analyst The private credit market, where OCREDIT operates, has been expanding as traditional banks have become more regulated, creating opportunities for alternative lenders. OCREDIT's focus on senior private lending is strategic, tapping into a growing demand for private credit solutions among mid-sized companies. The fund's diverse investment across 22 industries suggests a well-diversified portfolio, which can mitigate industry-specific risks and provide stability in returns.The significant increase in total fair value of investments and total assets for OCREDIT highlights the fund's aggressive investment activity and asset growth. This, coupled with consistent distributions, including a special distribution, showcases the fund's ability to return capital to shareholders while still expanding its asset base. The annualized distribution yield of 9.9% is attractive, especially when considering the current low-interest-rate environment, which often leaves income-focused investors searching for higher-yielding opportunities.Investors should consider the implications of OCREDIT's growth strategy on the broader private credit and business development company (BDC) sectors. As funds like OCREDIT continue to scale, they may exert competitive pressure on yields and drive innovation in deal structuring within the private lending space. Legal Expert The Master Note Purchase Agreement for the issuance of $300 million in Series 2024A Senior Notes is a critical legal document that outlines the terms and conditions of the notes offering. The fixed interest rate of 7.77% per annum until 2029 provides investors with clarity regarding their expected income from these notes. It is essential for investors to understand the covenants and restrictions associated with these notes, as they can affect the company's operational flexibility and financial obligations.Furthermore, the classification of the notes as 'Senior Unsecured' means they are given a high priority in case of liquidation, although they are not backed by specific collateral. This positioning in the capital structure is crucial for investors to assess the risk-return profile of the notes.It is also worth noting that the private placement nature of the notes offering implies a more selective process of investor solicitation, often targeting institutional investors. This can have implications for the liquidity and marketability of the notes, as they may not be as readily tradable as publicly issued securities. 03/13/2024 - 05:35 PM NEW YORK, March 13, 2024 /PRNewswire/ -- T. Rowe Price OHA Select Private Credit Fund (the ""Company"" or ""OCREDIT"") today announced financial results for the fourth quarter and year ended December 31, 2023, and the closing of a $300M Private Placement of 5-Year Senior Unsecured Notes. ""We are pleased with OCREDIT's performance and ramp to-date, having grown from $50 million in initial equity commitments to a billion-dollar-plus portfolio of high-quality investments,"" Eric Muller, OCREDIT's Chief Executive Officer said. ""The Company's inaugural notes offering pursuant to a private placement marks a milestone in its capital management, and we look forward to continue to scale OCREDIT alongside the growing opportunity in senior private lending for the benefit of our shareholders."" QUARTERLY HIGHLIGHTS Net investment income (NII) per share was $1.03 with weighted average yield on debt and income producing investments, at amortized cost of 12.7%1;Earnings per share was $1.42 with inception-to-date2 annualized return of 15.96%3;Net unrealized appreciation on investments was $9.2 million;Net asset value per share as of December 31, 2023 was $28.00, up 1.9% from $27.49 as of September 30, 2023;Gross and net investment fundings were $228.9 million and $208.3 million, respectively;Ending debt-to-equity was 0.79x, as compared to 0.78x as of September 30, 2023;The Company had debt outstanding of $558.6 million with a weighted average cost of debt of 8.0%. During the fourth quarter, the Company had net borrowings of $175 million across their credit facilities;On March 7, 2024, the Company entered into a Master Note Purchase Agreement governing the issuance of $300.0 million in aggregate principal amount of Series 2024A Senior Notes, due March 7, 2029, with a fixed interest rate of 7.77% per year;During the fourth quarter, the Company issued 7,179,054 of Class I common shares for proceeds of $200.6 million. From January 1, 2024 through March 13, 2024, the Company received total proceeds of $125.1 million from common shareholders in connection with its public offering4.DIVIDENDS During the fourth quarter, the Company declared total distributions of $0.89 per share, of which $0.23 per share was a special distribution declared on December 27, 2023. As of December 31, 2023, the Company's annualized distribution yield (excluding special distributions) was 9.9%.5 From January 1, 2024 through March 13, 2024, the Company declared the following distributions: ($ per share) January 29, 2024 February 27, 2024 Base Distribution $0.20 $0.20 Variable Distribution $0.03 $0.03 Total Distribution $0.23 $0.23 SELECTED FINANCIAL HIGHLIGHTS ($ in millions, unless otherwise noted) Q4 2023 Q3 2023 Net investment income per share $1.03 $1.02 Net investment income $21,038 $12,292 Earnings per share $1.42 $1.67 ($ in millions, unless otherwise noted) As of December 31, 2023 As of September 30, 2023 Total fair value of investments $1,148.4 $929.6 Total assets $1,286.1 $1,096.2 Total net assets $704.4 $494.2 Net asset value per share $28.00 $27.49 INVESTMENT ACTIVITY For three months ended December 31, 2023, net investment fundings were $208.3 million. The Company invested $228.9 million during the quarter, including $147.6 million in 7 new companies and $81.3 million in existing companies. The Company had $20.6 million of principal repayments and sales during the quarter. ($ in millions, unless otherwise noted) Q4 2023 Q3 2023 Investment Fundings $228.9 $334.2 Sales and Repayments $20.6 $12.8 Net Investment Activity $208.3 $322.5 As of December 31, 2023, the Company's investment portfolio had a fair value of $1,148.4 million, comprised of investments in 90 portfolio companies operating across 22 different industries. The investment portfolio at fair value was comprised of 90.8% first lien senior secured loans and 9.2% second lien senior secured loans. In addition, as of December 31, 2023, 100% of the Company's debt investments based on fair value were at floating rates, and there were no investments on non-accrual status. ABOUT T. ROWE PRICE OHA SELECT PRIVATE CREDIT FUND T. Rowe Price OHA Select Private Credit Fund (the ""Company"" or ""OCREDIT"") is a non-diversified, closed-end management investment company that has elected to be regulated as a business development company (""BDC"") under the Investment Company Act of 1940, as amended (the ""1940 Act""). The Company has also elected to be treated as a regulated investment company (""RIC"") under the Internal Revenue Code of 1986, as amended (the ""Code""). OHA Private Credit Advisors LLC (the ""Adviser"") is the investment adviser of the Company. The Adviser is registered as an investment adviser with the U.S. Securities and Exchange Commission (the ""SEC"") under the Investment Advisers Act of 1940. OCREDIT's registration statement became effective on September 29, 2023. From inception through December 31, 2023, the Company has invested approximately $1,172.3 million in aggregate cost of debt investments prior to any subsequent exits or repayments. The Company's investment objective is to generate attractive risk-adjusted returns, predominately in the form of current income, with select investments capturing long-term capital appreciation, while maintaining a strong focus on downside protection. OCREDIT invests primarily in directly originated and customized private financing solutions, including loans and other debt securities with a strong focus on senior secured lending to larger companies. Please visit www.ocreditfund.com for additional information. FORWARD-LOOKING STATEMENTS Certain information contained in this communication constitutes ""forward-looking statements"" within the meaning of the federal securities laws and the Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by the use of forward-looking terminology, such as ""outlook,"" ""indicator,"" ""believes,"" ""expects,"" ""potential,"" ""continues,"" ""may,"" ""can,"" ""will,"" ""should,"" ""seeks,"" ""approximately,"" ""predicts,"" ""intends,"" ""plans,"" ""estimates,"" ""anticipates"", ""confident,"" ""conviction,"" ""identified"" or the negative versions of these words or other comparable words thereof. These may include financial projections and estimates and their underlying assumptions, statements about plans, objectives, and expectations with respect to future operations, statements regarding future performance, statements regarding economic and market trends and statements regarding identified but not yet closed investments. Such forward-looking statements are inherently uncertain and there are or may be important factors that could cause actual outcomes or results to differ materially from those indicated in such statements. OCREDIT believes these factors also include but are not limited to those described under the section entitled ""Risk Factors"" in its prospectus, and any such updated factors included in its periodic filings with the Securities and Exchange Commission (the ""SEC""), which are accessible on the SEC's website at www.sec.gov. These factors should not be construed as exhaustive and should be read in conjunction with the other cautionary statements that are included in this document (or OCREDIT's prospectus and other filings). Except as otherwise required by federal securities laws, OCREDIT undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future developments or otherwise. ABOUT OAK HILL ADVISORS Oak Hill Advisors (OHA) is a leading global credit-focused alternative asset manager with over 30 years of investment experience. OHA works with institutions and individuals and seeks to deliver a consistent track record of risk-adjusted returns with downside focus. The firm manages approximately $63 billion of capital across credit strategies, including private credit, high yield bonds, leveraged loans, stressed and distressed debt and collateralized loan obligations as of December 31, 2023. OHA's emphasis on long-term partnerships with companies, sponsors and other partners provides access to a proprietary opportunity set allowing for customized credit solutions with strength across market cycles. With over 420 experienced professionals across six global offices, OHA brings a collaborative approach to offering investors a single platform to meet their diverse credit needs. OHA is the private markets platform of T. Rowe Price Group, Inc. (NASDAQ  GS: TROW). For more information, please visit oakhilladvisors.com. ABOUT T. ROWE PRICE Founded in 1937, T. Rowe Price (NASDAQ  GS: TROW) helps individuals and institutions around the world achieve their long-term investment goals. As a large global asset management company known for investment excellence, retirement leadership, and independent proprietary research, the firm is built on a culture of integrity that puts client interests first. Clients rely on the award-winning firm for its retirement expertise and active management of equity, fixed income, alternatives, and multi-asset investment capabilities. T. Rowe Price has $1.51 trillion in assets under management as of February 29, 2024, and serves millions of clients globally. News and other updates can be found on Facebook, Instagram, LinkedIn, X, YouTube, and troweprice.com/newsroom. T. Rowe Price OHA Select Private Credit Fund Consolidated Statements of Assets and Liabilities (in thousands, except per share amounts) As of December 31, 2023 December 31, 2022 Assets Investments at fair value: Non-controlled/non-affiliated investments (cost of $1,131,726 and $72,246 at December 31, 2023 and December 31, 2022, respectively) $ 1,148,412 $ 71,758 Cash, cash equivalents and restricted cash 105,456 19,486 Interest receivable for non-controlled/non-affiliated investments 15,498 356 Deferred financing costs 6,021 335 Deferred offering costs 1,705 - Receivable for investments sold 9,044 65 Total assets $ 1,286,136 $ 92,000 LIABILITIES Debt (Note 6) $ 558,630 $ 31,000 Payable for investments purchased 151 10,894 Interest and debt fee payable 4,846 103 Distribution payable 11,573 - Board of Trustees fee payable - 92 Unrealized depreciation on foreign currency forward contracts 1,048 - Accrued expenses and other liabilities 5,457 216 Total liabilities $ 581,705 $ 42,305 Commitments and contingencies (Note 8) NET ASSETS Class I shares, $0.01 par value (25,158,870 and 2,000,000 shares issued and outstanding at December 31, 2023 and December 31, 2022, respectively) 252 20 Additional paid in capital 687,139 49,980 Distributable earnings (loss) 17,040 (305) Total net assets $ 704,431 $ 49,695 Total liabilities and net assets $ 1,286,136 $ 92,000 Net asset value per share $ 28.00 $ 24.85 See accompanying notes to consolidated financial statements.EDGAR Entity Landing Page (sec.gov) T. Rowe Price OHA Select Private Credit Fund Consolidated Statements of Operations (in thousands, except per share amounts) For the YearEnded December 31,2023 For the Period from November 14, 2022 (commencement of operations) to December 31,2022 Investment income from non-controlled / non-affiliatedinvestments: Interest income $ 56,379 $ 487 Other income 3,465 130 Total investment income 59,844 617 Expenses: Interest and debt fee expense 19,516 129 Management fees 2,522 - Income incentive fees 4,178 - Professional fees 1,299 208 Board of Trustees fees 389 92 Administrative service expenses 550 13 Organizational costs 94 - Other general & administrative expenses 1,463 - Amortization of deferred offering costs 1,102 - Total expenses before fee waivers and expense support 31,113 442 Expense support (402) - Management fees waiver (2,522) - Income incentive fee waiver (4,178) - Total expenses net of fee waivers and expense support 24,011 442 Net investment income before taxes 35,833 175 Excise tax expense 275 - Net investment income 35,558 175 Realized and unrealized gain (loss): Realized gain (loss): Non-controlled/non-affiliated investments 51 8 Foreign currency transactions 114 - Foreign currency forward contracts 194 - Net realized gain (loss) 359 8 Net change in unrealized appreciation (depreciation): Non-controlled/non-affiliated investments 17,174 (488) Foreign currency forward contracts (1,048) - Net change in unrealized appreciation (depreciation) 16,126 (488) Net realized and unrealized gain (loss) 16,485 (480) Net increase (decrease) in net assets resulting from operations $ 52,043 $ (305) Net investment income per common share $ 3.85 $ (0.09) Increase in net assets resulting from operations per common share $ 5.64 $ (0.15) Weighted average common shares outstanding 9,227,235 2,000,000 See accompanying notes to consolidated financial statements.EDGAR Entity Landing Page (sec.gov) For a more detailed description of OCREDIT's investment guidelines and risk factors, please refer to the prospectus. Consider the investment objectives, risks, and charges and expenses carefully before investing or sending money. For a free prospectus containing this and other information, call 1-855-405-6488 or visit www.troweprice.com. Read it carefully. OCREDIT is a non-exchange traded business development company (""BDC"") that expects to invest at least 80% of its total assets (net assets plus borrowings for investment purposes) in private credit investments. An investment in OCREDIT involves a high degree of risk. An investor should purchase securities of OCREDIT only if they can afford the complete loss of the investment. Neither the Securities and Exchange Commission nor any state securities regulator has approved or disapproved of these securities or determined if this prospectus is truthful or complete. Securities regulators have also not passed upon whether this offering can be sold in compliance with existing or future suitability or Regulation Best Interest standard to any or all purchasers. As of October 4, 2023, OCREDIT is available in 51 states and territories, excluding Arkansas, Massachusetts, and Washington. No offers or sales of OCREDIT securities may be made to residents of Arkansas, Massachusetts, and Washington. As of October 4, 2023, OCREDIT is not registered for offer or sale outside of the United States. BDCs may charge management fees, incentive fees, as well as other fees associated with servicing loans. These fees will detract from the total return. OCREDIT may in certain circumstances invest in companies experiencing distress increasing the risk of default or failure. OCREDIT is not listed on an exchange which heightens liquidity risk for an investor. OCREDIT has limited prior operating history and there is no assurance that it will achieve its investment objectives. The Company's public offering is a ""blind pool"" offering and thus investors will not have the opportunity to evaluate the Company's investments before they are made. Investors should not expect to be able to sell shares regardless of performance and should consider that they may not have access to the money invested for an extended period of time and may be unable to reduce their exposure in a market downturn. OCREDIT employs leverage, which increases the volatility of OCREDIT's investments and will magnify the potential for loss. Fixed-income securities are subject to credit risk, call risk, and interest rate risk. As interest rates rise, bond prices fall. Investments in high-yield bonds involve greater risk. International investments can be riskier than U.S. investments and subject to foreign exchange risk. OCREDIT is ""non-diversified,"" meaning it may invest a greater portion of its assets in a single company. OCREDIT's share price can be expected to fluctuate more than that of a comparable diversified fund. OCREDIT may invest in derivatives, which may be riskier or more volatile than other types of investments because they are generally more sensitive to changes in market or economic conditions. Account opening and closing fees may apply depending on the amount invested and the timing of the account closure. There may be costs associated with the investments in the account such as periodic management fees, incentive fees, loads, other expenses or brokerage commissions. Fees for optional services may also apply. Opinions and estimates offered herein constitute the judgment of Oak Hill Advisors, L.P. as of the date this document is provided to an investor and are subject to change as are statements about market trends. All opinions and estimates are based on assumptions, all of which are difficult to predict and many of which are beyond the control of Oak Hill Advisors, L.P. In preparing this document, Oak Hill Advisors, L.P. has relied upon and assumed, without independent verification, the accuracy and completeness of all information. Oak Hill Advisors, L.P. believes that the information provided herein is reliable; however, it does not warrant its accuracy or completeness. Certain information contained in the press release discusses general market activity, industry, or sector trends, or other broad-based economic, market or political conditions and should not be construed as research or investment advice. Diversification cannot assure a profit or protect against loss in a declining market. Potential investors are urged to consult a tax professional regarding the possible economic, tax, legal, or other consequences of investing in OCREDIT in light of their particular circumstances. In the United States, the Company's securities are offered through T. Rowe Price Investment Services Inc., a broker-dealer registered with the U.S. Securities and Exchange Commission and a member of FINRA. OHA is a T. Rowe Price company.  2024 Oak Hill Advisors. All Rights Reserved. OHA is a trademark of Oak Hill Advisors, L.P. T. ROWE PRICE is a trademark of T. Rowe Price Group, Inc. All other trademarks shown are the property of their respective owners. Use does not imply endorsement, sponsorship, or affiliation of Oak Hill Advisors with any of the trademark owners. 202403-3435059 1 Computed as (a) the annual stated interest rate or yield plus the annual accretion of discounts or less the annual amortization of premiums, as applicable, on income producing securities, divided by (b) the total relevant investments at amortized cost or fair value, as applicable. 2 Inception is November 14, 2022. 3 Annualized return based on net asset value calculated as the change in net asset value per share during the respective period, assuming distributions that have been declared are reinvested on the effects of the performance of the Company during the period. Past performance is no guarantee of future results. 4 Does not include common shares sold through the Company's distribution reinvestment plan. 5 Future distribution payments are not guaranteed. View original content:https://www.prnewswire.com/news-releases/t-rowe-price-oha-select-private-credit-fund-announces-december-31-2023-financial-results-and-closes-private-placement-of-300m-5-year-senior-unsecured-notes-302088634.html SOURCE Oak Hill Advisors; T. Rowe Price Associates, Inc. What is the ticker symbol for T. Rowe Price OHA Select Private Credit Fund? The ticker symbol is TROW. What were the quarterly highlights of T. Rowe Price OHA Select Private Credit Fund's financial results? The Company reported a net investment income per share of $1.03, earnings per share of $1.42, and a net asset value per share of $28.00 as of December 31, 2023. What was the total fair value of investments for T. Rowe Price OHA Select Private Credit Fund as of December 31, 2023? The total fair value of investments was $1,148.4 million. What was the Company's debt outstanding and weighted average cost of debt during the fourth quarter? The Company had debt outstanding of $558.6 million with a weighted average cost of debt of 8.0%. What were the total distributions declared by T. Rowe Price OHA Select Private Credit Fund during the fourth quarter? The Company declared total distributions of $0.89 per share, with a special distribution of $0.23 per share declared on December 27, 2023."
RTX's Collins Aerospace delivers first aircraft seats from Philippines facility,2024-03-14T00:00:00.000Z,Low,Neutral,"Collins Aerospace, an RTX business, delivers Meridian main cabin seats to Airbus from its Philippines facility, enhancing passenger comfort and storage. The seating assembly capacity is set to triple in 2024, benefiting multiple customers across various linefit programs.","RTX's Collins Aerospace delivers first aircraft seats from Philippines facility Rhea-AI Impact (Low) Rhea-AI Sentiment (Neutral) Tags Rhea-AI Summary Collins Aerospace, an RTX business, delivers Meridian main cabin seats to Airbus from its Philippines facility, enhancing passenger comfort and storage. The seating assembly capacity is set to triple in 2024, benefiting multiple customers across various linefit programs. Positive None. Negative None. Market Research Analyst The announcement of Collins Aerospace's first delivery of Meridian main cabin seats from its Philippines facility to Airbus signifies a strategic expansion in the company's production capabilities. This expansion is poised to enhance the company's competitive edge in the Asia Pacific market, which is one of the fastest-growing aviation markets globally. The increase in seating assembly capacity, with the expectation to triple throughout 2024, indicates a significant investment in the operational efficiency and scalability of Collins Aerospace.The strategic location in the Philippines allows the company to leverage lower labor costs and provides a strategic logistical advantage for serving customers in the Asia Pacific region. This could result in improved lead times and customer satisfaction, thereby potentially increasing market share and strengthening client relationships.The diversification of production to include main cabin seating, in addition to other cabin interior products, showcases Collins Aerospace's commitment to offering a comprehensive product portfolio. This diversification is key to mitigating risks associated with demand fluctuations in different product lines and could lead to more stable revenue streams. Financial Analyst The delivery of the Meridian main cabin seats to Airbus represents a tangible step towards fulfilling existing contracts and possibly securing future ones, given the expected tripling of the site's seating assembly capacity. For investors, this operational milestone may suggest a forward momentum in revenue growth for Collins Aerospace and by extension, its parent company RTX. The focus on ergonomic comfort and increased living space in the seats could cater to the evolving consumer preferences, potentially enhancing the product's marketability and driving sales.It is also important to consider the capital expenditure involved in expanding the facility and whether this aligns with RTX's broader capital allocation strategy. Investors should monitor the impact of these developments on RTX's financials, particularly looking for improvements in profit margins due to economies of scale and operational efficiencies gained from the new facility.Furthermore, the creation of additional jobs and the development of new business in the local area can foster goodwill and potentially result in incentives from the local government, which may have favorable financial implications for the company. Supply Chain Expert The expansion of Collins Aerospace's seating production in the Philippines is a strategic move that addresses supply chain optimization. By situating production closer to the burgeoning Asia Pacific market, Collins Aerospace can potentially reduce shipping times and costs, contributing to a leaner supply chain. The ability to support multiple original equipment manufacturer linefits and retrofit locations enhances the company's agility and responsiveness to market demands.With the expected increase in assembly capacity, it is crucial for Collins Aerospace to maintain a robust supply chain to manage the influx of raw materials and ensure timely delivery of finished products. This requires a well-coordinated logistics strategy and may involve developing stronger partnerships with local suppliers to reduce the risk of supply disruptions.As the facility also produces a range of other cabin interior products, there are opportunities for streamlining operations and achieving cost synergies. The integration of different production lines can facilitate cross-utilization of resources and expertise, which is critical in maintaining a competitive advantage in the market. 03/13/2024 - 08:00 PM Meridian main cabin seats will fly on an Airbus narrow body platform TANAUAN CITY, Philippines, March 13, 2024 /PRNewswire/ -- Collins Aerospace, an RTX (NYSE: RTX) business, recently delivered the first seating shipment from its Tanauan City, Philippines facility to Airbus. The delivery of the Meridian main cabin seat supports an airline customer's narrow body linefit program, providing passengers with ergonomic comfort, increased living space and ample in-seat storage. ""Adding main cabin seating production to our Philippines facility is a critical milestone in the future of Collins' seating business,"" said Christophe Blanc, vice president and general manager of Aircraft Seating for Collins Aerospace. ""The continued growth of our seating operations in the Philippines not only represents new business and additional jobs in the local area but provides crucial proximate seating support for our customers in the Asia Pacific region."" The site's seating assembly capacity is expected to triple throughout 2024, with deliveries to 14 separate customers across multiple original equipment manufacturer linefits and several retrofit locations. First opened in 2012, Collins' Philippines facility also manufactures a range of other cabin interior products, including galleys, galley inserts, oxygen equipment and lavatories. About Collins AerospaceCollins Aerospace, an RTX business, is a leader in integrated and intelligent solutions for the global aerospace and defense industry. Our 80,000 employees are dedicated to delivering future-focused technologies to advance sustainable and connected aviation, passenger safety and comfort, mission success, space exploration, and more. About RTXRTX is the world's largest aerospace and defense company. With more than 185,000 global employees, we push the limits of technology and science to redefine how we connect and protect our world. Through industry-leading businesses  Collins Aerospace, Pratt & Whitney, and Raytheon  we are advancing aviation, engineering integrated defense systems for operational success, and developing next-generation technology solutions and manufacturing to help global customers address their most critical challenges. The company, with 2023 sales of $68.9 billion, is headquartered in Arlington, Virginia. For questions or to schedule an interview, please contact corporatepr@rtx.com View original content to download multimedia:https://www.prnewswire.com/news-releases/rtxs-collins-aerospace-delivers-first-aircraft-seats-from-philippines-facility-302084229.html SOURCE RTX What type of seats did Collins Aerospace deliver to Airbus from its Philippines facility? Collins Aerospace delivered Meridian main cabin seats to Airbus. What benefits do the Meridian main cabin seats provide to passengers? The Meridian main cabin seats provide ergonomic comfort, increased living space, and ample in-seat storage. What is the expected increase in seating assembly capacity at Collins Aerospace's Philippines facility in 2024? The seating assembly capacity is expected to triple throughout 2024. How many customers are set to receive deliveries from Collins Aerospace's Philippines facility? Collins Aerospace's Philippines facility will deliver to 14 separate customers. What other cabin interior products does Collins' Philippines facility manufacture? Collins' Philippines facility also manufactures galleys, galley inserts, oxygen equipment, and lavatories."
Canaans RISC-V based edge AIoT SoC adopted VeriSilicons ISP and GPU IPs,2024-03-14T00:00:00.000Z,Neutral,Very Positive,"VeriSilicon integrates pixel processing IP portfolio into Canaan's K230 chip, enhancing edge AIoT solutions. ISP8000 supports real-time video processing, DW200 corrects distortions, and GCNanoV delivers high-quality graphics processing. Collaboration with Canaan boosts performance and image quality of edge AIoT SoCs.","Canaans RISC-V based edge AIoT SoC adopted VeriSilicons ISP and GPU IPs Rhea-AI Impact (Neutral) Rhea-AI Sentiment (Very Positive) Tags Rhea-AI Summary VeriSilicon integrates pixel processing IP portfolio into Canaan's K230 chip, enhancing edge AIoT solutions. ISP8000 supports real-time video processing, DW200 corrects distortions, and GCNanoV delivers high-quality graphics processing. Collaboration with Canaan boosts performance and image quality of edge AIoT SoCs. Positive None. Negative None. Semiconductor Industry Analyst The integration of VeriSilicon's advanced pixel processing IPs into Canaan's K230 chip represents a strategic enhancement in edge AIoT technology. The incorporation of the ISP8000, DW200 and GCNanoV IPs is poised to bolster the K230 chip's capabilities in handling high-definition video streams and complex image processing tasks. This development is likely to strengthen Canaan's competitive position in the fast-growing edge AIoT market, which is characterized by a high demand for low-latency and high-precision processing.Given the K230's support for the RISC-V Vector 1.0 standard, this move underscores the growing industry trend towards open-source architectures, which can potentially reduce licensing costs and increase flexibility for developers. The improved image quality and processing power, combined with low power consumption, are critical factors that can influence the adoption rate among edge device vendors. This, in turn, could lead to increased market share and revenue growth for Canaan and potentially impact its stock performance positively. AI and IoT Technology Expert The collaboration between VeriSilicon and Canaan highlights the significance of integrated solutions in the realm of intelligent products. The ability of the ISP8000 IP to manage multiple high-definition video streams in real-time is particularly relevant for applications requiring advanced visual capabilities, such as interactive robots and smart manufacturing systems. The DeWarp Processor IP's ability to correct lens distortions and support multi-channel output can enhance the functionality of AI applications that require diverse spatial outputs.Furthermore, the 2.5D GPU IP's high-quality vector graphics processing capabilities are indicative of the growing need for superior visual outputs in edge AIoT devices. The Multi-Context Management feature of ISP8000, which supports multiple sensors, is a noteworthy advancement that could lead to new use cases and a broader application spectrum for the K230 chip. The strategic importance of these technological enhancements cannot be overstated, as they contribute to the overall efficiency and effectiveness of edge AIoT solutions, potentially influencing the adoption curve and market penetration rate of Canaan's products. Market Research Analyst The edge AIoT sector is witnessing significant growth, driven by the increasing need for intelligent edge computing solutions across various industries. The integration of VeriSilicon's IPs into Canaans K230 chip is a development that could resonate well with industry needs for high-performance, energy-efficient and cost-effective components. The ability to support large-model and multimodal input edge terminals, as well as applications in smart manufacturing and AI education, opens up new market opportunities for Canaan.It is important to monitor how this technological advancement translates into market adoption and whether it can create a competitive edge in terms of pricing, performance, or energy efficiency. The impact on Canaan's business could be substantial if the K230 chip gains traction among edge device vendors, potentially leading to increased sales volumes and an enhanced reputation for innovation in the semiconductor industry. Long-term, the success of such integrations could also attract partnerships and collaborations, further solidifying Canaan's position in the market. 03/13/2024 - 08:00 PM Integrating VeriSilicons pixel processing IP portfolio into the high-precision, low-latency K230 chip SHANGHAI--(BUSINESS WIRE)-- VeriSilicon (688521.SH) today announced the integration of its Image Signal Processor (ISP) IP ISP8000, DeWarp Processor IP DW200, and 2.5D Graphics Processor Unit (GPU) IP GCNanoV into Canaans K230 chip, the worlds first commercial mass production edge AIoT chip supporting the RISC-V Vector 1.0 standard. This collaboration marks a significant advancement in the high-precision, low-latency edge AIoT solutions for a wide range of intelligent products, such as large-model and multimodal input edge terminals, 3D-structured light perception modules, interactive robots, open-source hardwares, as well as hardwares for smart manufacturing, smart home solutions and AI education. VeriSilicons ISP8000 IP is capable of real-time processing of three or more streams of high-definition video. Its 20-bit depth pipeline architecture supports advanced image processing algorithms such as triple-exposure High Dynamic Range (HDR) and 3D Noise Reduction (3DNR). ISP8000s optimized software collaborates seamlessly with the RISC-V processors to efficiently manage and schedule system resources. On the K230 chip, leveraging the RT-Thread real-time operating system and the performance and power advantages of the RISC-V processors, ISP8000 can perform real-time scheduling and efficiently run software under a dual-core processor architecture. It is perfectly compatible with the K230 Software Development Kit (SDK), supporting RTOS and Linux dual operating systems, achieving an optimal balance between real-time and non-real-time operations. VeriSilicons DW200 IP not only precisely corrects distortions in wide-angle or fisheye lens, but also supports multi-channel downscaling output through low-bandwidth direct link mode, enriching user application scenarios, and is particularly suited for AI applications with diverse spatial output requirements. For MCU/MPU devices, VeriSilicons low-power 2.5D GPU IP delivers high-performance and high-quality vector graphics processing capabilities along with superior image output. Hong-Gang Wang, VP of research and development at Canaan said, Leveraging VeriSilicons advanced pixel processing IP portfolio, our RISC-V based K230 achieved leading performance and image quality compared with other edge AIoT SoCs in its class. This enables more edge device vendors to develop innovative products with broader market applications. VeriSilicons ISP is one of the key factors driving innovation in our edge AIoT SoCs. RISC-V is increasingly important in embedded products. We have partnered with all leading RISC-V CPU IP vendors to ensure our comprehensive Glass-to-Glass (from camera-in to display-out) intelligent pixel processing IP portfolio collaborates seamlessly and efficiently with RISC-V architectures, said Wei-Jin Dai, Executive VP and GM of IP Division at VeriSilicon. Through our close collaboration with Canaan, the edge AIoT SoC K230 has achieved high image quality while maintaining low power consumption and latency. Moreover, K230 can support multiple sensors leveraging the advanced Multi-Context Management (MCM) feature of ISP8000, further enhancing its market competitiveness. About Canaan Inc. Canaan Inc. (Nasdaq: CAN) is a leading provider of high-performance ASIC chips. With a diversified strategy centered on blockchain + AI, Canaan is dedicated to the research and development of high-performance ASIC computing chips, AI chips, and devices. As a Nasdaq-listed company, Canaan holds the distinction of being the worlds first blockchain stock company and the initial Chinese firm with independent intellectual property in AI chips to be listed in the US. Canaan is committed to harnessing ASIC technology to achieve its mission of Super Computing Is What We Do, Social Enrichment is Why We Do, positioning itself as a leader in high-performance computing for blockchain and AI. For more information, please visit: canaan.io About VeriSilicon VeriSilicon is committed to providing customers with platform-based, all-around, one-stop custom silicon services and semiconductor IP licensing services leveraging its in-house semiconductor IP. For more information, please visit: www.verisilicon.com View source version on businesswire.com: https://www.businesswire.com/news/home/20240313405660/en/ Canaan Inc. Media Contact: pr@canaan-creative.com VeriSilicon Media Contact: press@verisilicon.com Source: VeriSilicon What IP portfolio did VeriSilicon integrate into Canaan's K230 chip? VeriSilicon integrated its ISP8000, DW200, and GCNanoV IP into Canaan's K230 chip. What capabilities does VeriSilicon's ISP8000 IP offer? VeriSilicon's ISP8000 IP supports real-time processing of three or more streams of high-definition video and advanced image processing algorithms like HDR and 3DNR. How does VeriSilicon's DW200 IP benefit AI applications? VeriSilicon's DW200 IP corrects distortions in wide-angle or fisheye lens and supports multi-channel downscaling output, suitable for AI applications with diverse spatial output requirements. Who mentioned the importance of RISC-V in embedded products? Wei-Jin Dai, Executive VP and GM of IP Division at VeriSilicon, highlighted the increasing importance of RISC-V in embedded products. What did Hong-Gang Wang, VP of research and development at Canaan, say about VeriSilicon's pixel processing IP portfolio? Hong-Gang Wang praised VeriSilicon's advanced pixel processing IP portfolio for enabling leading performance and image quality in Canaan's K230 chip."
"BGSF, Inc. Reports Full Year and Fourth Quarter 2023 Financial Results",2024-03-13T23:29:00.000Z,Neutral,Neutral,"BGSF, Inc. reported full-year revenues of $313.2 million, up 4.9% from the previous year. Operating cash flow reached $20.4 million. The company closed a new credit facility on March 12, 2024. Fiscal year 2023 saw positive growth in revenues, gross profit, and operating income. Adjusted EBITDA and EPS also showed improvements. The company's CEO highlighted successful strategic plans, acquisitions, and revenue growth despite challenges.","BGSF, Inc. Reports Full Year and Fourth Quarter 2023 Financial Results Rhea-AI Impact (Neutral) Rhea-AI Sentiment (Neutral) Tags earnings Rhea-AI Summary BGSF, Inc. reported full-year revenues of $313.2 million, up 4.9% from the previous year. Operating cash flow reached $20.4 million. The company closed a new credit facility on March 12, 2024. Fiscal year 2023 saw positive growth in revenues, gross profit, and operating income. Adjusted EBITDA and EPS also showed improvements. The company's CEO highlighted successful strategic plans, acquisitions, and revenue growth despite challenges. Positive Full-year revenues increased by 4.9% to $313.2 million Operating cash flow reached $20.4 million New credit facility closed on March 12, 2024 Gross profit rose by 8.0% to $111.8 million Adjusted EBITDA increased to $25.1 million, up 15.9% from the previous year CEO emphasized successful execution of long-term strategic plans and revenue growth Negative None. Financial Analyst The reported full-year revenues of $313.2 million, representing a 4.9% increase, are indicative of BGSF, Inc.'s capacity to grow its top line. This growth, particularly in the Property Management and Professional segments, suggests resilience in the face of economic challenges. The organic growth in Property Management revenues, at 3.3%, is slightly below the Professional segment's growth, which includes contributions from the Arroyo Consulting acquisition. The acquisition strategy appears to be paying off, adding $14.8 million in new revenues, although there is a noted decline in the existing Professional business. This could signal potential issues in core operations that may need addressing.The significant non-cash impairment charge of $22.5 million related to rebranding efforts is a one-time event that has heavily impacted net income figures. However, stakeholders should consider the long-term benefits of such a rebranding, which may enhance brand recognition and market positioning. The increase in gross profit margins by 100 basis points to 35.7% is a positive sign of improved operational efficiency or pricing power. Adjusted EBITDA's increase of 15.9% year over year is a robust indicator of the company's earnings before interest, taxes, depreciation and amortization, adjusted for one-off events, which provides a clearer picture of operational performance. Market Research Analyst The growth in revenues and adjusted EBITDA, despite the reported net loss, suggests that BGSF's market strategy and service offerings are aligning well with client needs. The company's focus on building stronger relationships with world-class ERP technologies could be a strategic move to cement its position in a niche market, which is a positive signal for investors looking for specialized service providers. However, the decline in the existing Professional business segment raises questions about the competitiveness and potential saturation in the market that BGSF operates in. The market for consulting, managed services and professional workforce solutions is highly competitive and the company's ability to differentiate itself through its service offerings and client relationships will be crucial for its continued growth. Economist Despite the macroeconomic headwinds impacting corporations throughout North America, BGSF's ability to grow its revenue and generate $20.4 million of operating cash flow is commendable. This demonstrates the company's operational resilience and financial discipline. The new credit facility closed on March 12, 2024, with a maturity date of March 12, 2028, provides BGSF with financial flexibility. The facility's structure, which includes revolving credit and term loans, suggests a strategic approach to debt management that may support future growth initiatives or provide a buffer against economic downturns. The consistent quarterly cash dividends indicate confidence in the company's cash flow generation capabilities and a commitment to shareholder returns, which can be appealing to investors seeking income-generating investments. 03/13/2024 - 07:29 PM Record Full Year Revenues of $313.2 million, up 4.9% Generated $20.4 Million of Operating Cash Flow New Credit Facility Closed March 12, 2024 PLANO, Texas--(BUSINESS WIRE)-- BGSF, Inc. (NYSE: BGSF), a growing provider of consulting, managed services, and professional workforce solutions, today reported financial results for its fiscal year and fourth fiscal quarter ended December 31, 2023. Note: Fiscal 2023 financial results are on a 52-week year ended December 31, 2023, compared to Fiscal 2022 financial results on a 53-week year ended January 1, 2023. Full Year 2023 Highlights from Continuing Operations2,3: Revenues were $313.2 million, up 4.9% from 2022. Property Management revenues grew organically by 3.3% versus the prior year. Professional revenues grew by 6.1% from prior year, with Arroyo Consulting acquisition contributing $14.8 million in new revenues, partially offset by a decline in the existing Professional business. Gross profit was $111.8 million, up 8.0% from 2022. Gross profit margins increased 100 basis points to 35.7%. Operating loss in 2023 includes a non-cash impairment of $22.5 million related to trade name intangible assets from the rebranding to BGSF for all entities. The after-tax impact was $17.5 million or $1.63 per diluted share, using the year-to-date effective tax rate. Net loss from continuing operations was $10.2 million, or $0.95 per diluted share, vs. net income from continuing operations of $11.3 million, or $1.07 per diluted share in 2022, primarily due to the trade name impairment and increased acquisition amortization and interest expense. Adjusted EBITDA1 from continuing operations was $25.1 million (8.0% of revenues), up from $21.7 million (7.3% of revenues) in 2022, an increase of 15.9% year over year. Adjusted EPS1 from continuing operations was $1.19 in 2023, vs. $1.26 in 2022. Fiscal 2023 Same Day Revenue(1), Same Day Gross Profit(1) and Same Day EBITDA(1) increased 7.1%, 10.2%, and 18.1% from 2022, respectively. Note: Fourth quarter 2023 financial results are on a 13-week period ended December 31, 2023, compared to fourth quarter 2022 financial results on a 14-week period ended January 1, 2023. Q4 2023 Highlights from Continuing Operations2,3: Revenues were $73.6 million, vs. $77.3 million in 2022. Gross profit was $25.4 million, compared to $27.1 million in 2022. Operating income was $3.2 million in 2023, up from $2.8 million in 2022. Net income from continuing operations was $1.0 million, or $0.11 per diluted share, vs. net income from continuing operations of $1.4 million, or $0.14 per diluted share in 2022, primarily due to increased acquisition amortization and interest expense. Adjusted EBITDA1 from continuing operations was $5.5 million (7.5% of revenues), vs. $4.3 million (5.6% of revenues) in 2022, an increase of 27.6% over prior year. Adjusted EPS1 from continuing operations was $0.21 for 2023 up from $0.19 in 2022. Fourth quarter 2023 Same Day Revenue(1), Same Day Gross Profit(1) and Same Day EBITDA(1) increased 3.1%, 1.8%, and 38.2% from 2022, respectively. 1Non-GAAP financial measure. See reconciliation below for details. 22022 includes three weeks of operating results from the Horn Solutions acquisition. 3 2023 includes 39 weeks of Arroyo Consulting and a full year of Horn Solutions. On March 12, 2024, our credit agreement was amended with BMO Bank, N.A., as administrative agent, and swing line lender, and BMO Capital Markets Corp., as sole lead arranger and sole book runner, with a maturity date of March 12, 2028. The revolving credit facility with an outstanding balance of approximately $22 million provides for the borrowing of funds from time to time in an aggregate amount up to $40 million. Term loans with an outstanding principal balance of $34 million were outstanding under the Credit Agreement and remain outstanding under the amended agreement. Beth A. Garvey, Chair, President and CEO, said, Fiscal 2023 was a significant year for BGSF. We successfully executed our long-term strategic plans through an accretive acquisition, rebranding all our businesses, and building stronger relationships with world-class ERP technologies. For the year, we grew revenues to $313 million, up almost 5%, and generated over $20 million of cash from operations. I am proud of our teams ability to achieve key objectives in 2023 despite project delays and persistent macroeconomic headwinds impacting corporations throughout North America. Our confidence in BGSFs business and strategy was demonstrated through our return to shareholders by consistent quarterly cash dividends. Conference Call BGSF will discuss its fourth fiscal quarter and full year 2023 financial results during a conference call and webcast at 9:00 a.m. ET on March 14, 2024. Interested participants may dial 1-877-317-6789 (Toll Free) or 1-412-317-6789 (International). A replay of the call will be available until March 21, 2024. To access the replay, please dial 1-877-344-7529 (Toll Free), or 1-412-317-0088 (International) and enter access code 6349244. The live webcast and archived replay are accessible from the investor relations section of the Companys website at https://investor.bgsf.com/events-and-presentations/default.aspx About BGSF BGSF provides consulting, managed services and professional workforce solutions to a variety of industries through its various divisions in IT, Finance & Accounting, Managed Solutions, and Property Management (formally known as Real Estate which includes apartment communities and commercial buildings). BGSF has integrated several regional and national brands achieving scalable growth. The Company was ranked by Staffing Industry Analysts as the 121st largest U.S. staffing company and the 52nd largest IT staffing firm in 2023. The Companys disciplined acquisition philosophy, which builds value through both financial growth and the retention of unique and dedicated talent within BGSFs family of companies, has resulted in a seasoned management team with strong tenure and the ability to offer exceptional service to our field talent and client partners while building value for investors. For more information on the Company and its services, please visit its website at www.bgsf.com. Forward-Looking Statements The forward-looking statements in this press release are made under the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements may include, but are not limited to, statements regarding our future financial performance and the expectations and objectives of our board or management. The Companys actual results could differ materially from those indicated by the forward-looking statements because of various other risks and uncertainties, including those listed in Item 1A of the Companys Annual Report on Form 10-K and in the Companys other filings and reports with the Securities and Exchange Commission. All of the risks and uncertainties are beyond the ability of the Company to control, and in many cases, the Company cannot predict the risks and uncertainties that could cause its actual results to differ materially from those indicated by the forward-looking statements. When used in this press release, the words allows, believes, plans, expects, estimates, should, would, may, might, forward, will, intends, continue, outlook, temporarily, progressing, ""prospects,"" and anticipates and similar expressions as they relate to the Company or its management are intended to identify forward-looking statements. Except as required by law, the Company is not obligated to publicly release any revisions to these forward-looking statements to reflect the events or circumstances after the date of this press release or to reflect the occurrence of unanticipated events. GAAP FINANCIAL MEASURES Portions of the following tables have been derived from our unaudited consolidated financial statements and summarize key components of our statements of operations for the periods indicated, as well as a reconciliation of revenue and operating income (loss) from continuing operations by reportable segment to consolidated results for the periods indicated. CONSOLIDATED BALANCE SHEETS (in thousands, except share amounts) December 31, 2023 January 1, 2023 ASSETS Current assets Accounts receivable (net of allowance for credit losses of $554 and $558, respectively) $ 56,776 $ 66,285 Prepaid expenses 2,963 2,418 Other current assets 7,172 7,459 Total current assets 66,911 76,162 Property and equipment, net 1,217 2,081 Other assets Deposits 2,699 2,616 Other, net 5,026 4,411 Deferred income taxes, net 7,271 2,196 Right-of-use asset - operating leases 5,435 4,462 Intangible assets, net 30,370 47,552 Goodwill 59,588 55,193 Total other assets 110,389 116,430 Total assets $ 178,517 $ 194,673 LIABILITIES AND STOCKHOLDERS' EQUITY Current liabilities Accounts payable $ 95 $ 587 Accrued payroll and expenses 14,902 19,171 Line of credit (net of debt issuance costs of $128) 24,746  Long-term debt, current portion 34,000 4,000 Accrued interest 438 273 Income taxes payable 282 253 Contingent consideration, current portion 4,208 1,081 Convertible Note 4,368  Other current liabilities  1,000 Lease liabilities, current portion 2,016 1,842 Total current liabilities 85,055 28,207 Line of credit (net of debt issuance costs of $259)  22,303 Long-term debt, less current portion  36,000 Contingent consideration, less current portion 4,112  Convertible note  4,368 Lease liabilities, less current portion 3,814 3,049 Other long-term liabilities  10 Total liabilities 92,981 93,937 Commitments and contingencies Preferred stock, $0.01 par value per share, 500,000 shares authorized, -0- shares issued and outstanding   Common stock, $0.01 par value per share; 19,500,000 shares authorized, 10,887,509 and 10,772,515 shares issued and outstanding, respectively, net of treasury stock, at cost, of 3,930 and 1,845 shares, respectively 52 70 Additional paid in capital 68,551 67,003 Retained earnings 16,933 33,663 Total stockholders equity 85,536 100,736 Total liabilities and stockholders equity $ 178,517 $ 194,673 CONSOLIDATED STATEMENTS OF OPERATIONS (in thousands, except share amounts) Fiscal Quarter Ended Fiscal Year Ended December 31, 2023 January 1, 2023 December 31, 2023 January 1, 2023 (unaudited) Revenues $ 73,567 $ 77,283 $ 313,167 $ 298,422 Cost of services 48,120 50,225 201,383 194,874 Gross profit 25,447 27,058 111,784 103,548 Selling, general and administrative expenses 20,175 23,210 88,650 83,211 Impairment losses   22,545  Depreciation and amortization 2,045 1,087 7,774 4,054 Operating income (loss) 3,227 2,761 (7,185 ) 16,283 Interest expense, net (1,601 ) (644 ) (5,976 ) (1,363 ) Income (loss) from continuing operations before income taxes 1,626 2,117 (13,161 ) 14,920 Income tax benefit (expense) from continuing operations (627 ) (699 ) 2,938 (3,659 ) Income (loss) from continuing operations 999 1,418 (10,223 ) 11,261 Income from discontinued operations: Income    1,235 Gain on sale  409  17,675 Income tax expense  95  4,810 Net income (loss) $ 999 $ 1,732 $ (10,223 ) $ 25,361 Net income (loss) per share - diluted Net (loss) income from continuing operations $ 0.11 $ 0.14 $ (0.95 ) $ 1.07 Net income from discontinued operations: Income    0.12 Gain on sale  0.03  1.69 Income tax expense  (0.01 )  (0.46 ) Net income (loss) per share - diluted $ 0.11 $ 0.16 $ (0.95 ) $ 2.42 BUSINESS SEGMENTS (dollars in thousands) Fiscal Quarter Ended Fiscal Year Ended December 31, 2023 January 1, 2023 December 31, 2023 January 1, 2023 (unaudited) Revenue: Property Management $ 29,624 40 % $ 31,956 41 % $ 125,077 40 % $ 121,093 41 % Professional 43,943 60 % 45,327 59 % 188,090 60 % 177,329 59 % Total $ 73,567 100 % $ 77,283 100 % $ 313,167 100 % $ 298,422 100 % Gross profit: Property Management $ 11,589 46 % $ 12,602 47 % $ 49,785 45 % $ 47,695 46 % Professional 13,858 54 % 14,456 53 % 61,999 55 % 55,853 54 % Total $ 25,447 100 % $ 27,058 100 % $ 111,784 100 % $ 103,548 100 % Operating income (loss): Property Management $ 5,479 $ 4,803 $ 23,155 $ 19,803 Professional -without impairment losses 2,626 3,146 12,292 15,604 Professional - impairment losses   (22,545 )  Home office (4,878 ) (5,188 ) (20,087 ) (19,124 ) Total $ 3,227 $ 2,761 $ (7,185 ) $ 16,283 CONSOLIDATED STATEMENTS OF CASH FLOWS (in thousands) Years ended December 31, 2023, January 1, 2023 and December 26, 2021 2023 2022 2021 Cash flows from operating activities Net (loss) income $ (10,223 ) $ 25,361 $ 14,109 (Income) from discontinued operations  (1,235 ) (4,570 ) Adjustments to reconcile net (loss) income to net cash provided by (used in) operating activities: Depreciation 446 597 685 Amortization 7,328 3,457 3,013 Gain on sale of discontinued operations  (17,675 )  Impairment losses 22,545   CARES Act credit   (2,368 ) Loss on disposal of property and equipment 17 6 8 Contingent consideration adjustment   (2,403 ) Amortization of debt issuance costs 199 172 75 Interest expense on contingent consideration payable 740 128 252 Provision for credit losses 798 315 221 Share-based compensation 1,029 1,085 1,058 Deferred income taxes, net of acquired deferred tax liability (5,075 ) 2,353 1,279 Net changes in operating assets and liabilities, net of effects of acquisitions: Accounts receivable 12,163 (14,793 ) (15,178 ) Prepaid expenses and other current assets (2,159 ) (866 ) (200 ) Deposits (83 ) 1,503 (126 ) Other assets 720 660 319 Accounts payable (492 ) (228 ) 156 Accrued payroll and expenses (7,426 ) 1,633 5,730 Accrued interest 165 171 24 Income taxes receivable and payable 729 (1,202 ) (560 ) Other current liabilities (1,000 ) (4,551 ) 19 Operating leases (35 ) (127 ) (107 ) Other long-term liabilities  (64 ) (78 ) Net cash provided by (used in) continuing operating activities 20,386 (3,300 ) 1,358 Net cash (used in) provided by discontinued operating activities  (3,822 ) 5,305 Net cash provided by (used in) operating activities 20,386 (7,122 ) 6,663 Cash flows from investing activities Businesses acquired, net of cash acquired (6,917 ) (33,940 ) (3,791 ) Businesses sold  30,722  Capital expenditures (2,597 ) (5,680 ) (3,204 ) Proceeds from sale of property and equipment   5 Net cash used in continuing investing activities (9,514 ) (8,898 ) (6,990 ) Net cash used in discontinued investing activities  (26 ) (34 ) Net cash used in investing activities (9,514 ) (8,924 ) (7,024 ) CONSOLIDATED STATEMENTS OF CASH FLOWS (CONTINUED) (in thousands) Years ended December 31, 2023, January 1, 2023 and December 26, 2021 2023 2022 2021 Cash flows from financing activities Net borrowings under line of credit 2,312 9,781 6,804 Proceeds from issuance of long-term debt  40,000  Principal payments on long-term debt (6,000 ) (26,863 ) (2,063 ) Payments of dividends (6,507 ) (6,290 ) (4,567 ) Issuance of ESPP shares 512 653 340 Issuance of shares under the 2013 Long-Term Incentive Plan and Form S-3 registration statement costs, net of exercises (10 ) (1 ) (41 ) Contingent consideration paid (1,110 ) (1,110 )  Debt issuance costs (69 ) (236 )  Net cash (used in) provided by continuing financing activities (10,872 ) 15,934 473 Net change in cash and cash equivalents  (112 ) 112 Cash and cash equivalents, beginning of year  112  Cash and cash equivalents, end of year $  $  $ 112 Supplemental cash flow information: Cash paid for interest, net $ 4,668 $ 641 $ 879 Cash paid for taxes, net of refunds $ 1,378 $ 7,562 $ 3,676 NON-GAAP FINANCIAL MEASURES The financial results of BGSF, Inc. are prepared in conformity with accounting principles generally accepted in the United States of America (GAAP) and the rules of the U.S. Securities and Exchange Commission. To help the readers understand the Company's financial performance, the Company supplements its GAAP financial results with Adjusted EBITDA, Same Day EBITDA, Adjusted EPS, Same Day Adjusted EPS, Same Day Revenue, and Same Day Gross Profit. A non-GAAP financial measure is a numerical measure of a company's financial performance that excludes or includes amounts so as to be different than the most directly comparable measure calculated and presented in accordance with GAAP in the statement of operations, balance sheet or statement of cash flows of a company. Adjusted EBITDA, Same Day EBITDA, Adjusted EPS, Same Day Adjusted EPS, Same Day Revenue, and Same Day Gross Profit are not measurements of financial performance under GAAP and should not be considered as alternatives to net income, net income per diluted share, operating income, revenue, gross profit, or any other performance measure derived in accordance with GAAP, or as alternatives to cash flow from operating activities or measures of our liquidity. We believe that Adjusted EBITDA, Same Day EBITDA, Adjusted EPS, Same Day Adjusted EPS, Same Day Revenue, and Same Day Gross Profit are useful performance measures and are used by us to facilitate comparisons of our operating performance on a consistent basis from period-to-period and to provide for a more complete understanding of factors and trends affecting our business than measures under GAAP can provide alone. In addition, the financial covenants in our credit agreement are based on EBITDA as defined in the credit agreement. We define Adjusted EBITDA"" as earnings before interest expense, income taxes, depreciation and amortization expense, transaction fees and certain non-cash expenses such as share-based compensation expense, as well as certain specific events that management does not consider in assessing our on-going operating performance. We define Same Day EBITDA as Adjusted EBITDA on a fifty-two week fiscal year. We define Same Day Revenue and Same Day Gross Profit as revenue and gross profit on a fifty-two week fiscal year. We define Adjusted EPS as diluted earnings per share eliminating amortization expense of intangible assets from acquisitions, transaction fees, and certain non-cash expenses such as impairment losses, as well as certain specific events that management does not consider in assessing our on-going operating performance, net of the respective income tax effect. RECONCILIATION OF INCOME FROM CONTINUING OPERATIONS TO ADJUSTED AND SAME DAY EBITDA (dollars in thousands) Fiscal Quarter Ended Fiscal Year Ended December 31, 2023 January 1, 2023 December 31, 2023 January 1, 2023 Income (loss) from continuing operations $ 999 $ 1,417 $ (10,223 ) $ 11,261 Income tax expense (benefit) from continuing operations 626 699 (2,938 ) 3,659 Interest expense, net 1,601 644 5,976 1,363 Operating income (loss) 3,226 2,760 (7,185 ) 16,283 Depreciation and amortization 2,045 1,087 7,774 4,054 Impairment losses   22,545  Share-based compensation 184 220 1,029 1,085 Transaction fees 73 265 974 271 Adjusted EBITDA from continuing operations 5,528 4,332 25,137 21,693 Adjusted EBITDA Margin (% of revenue) 7.5 % 5.6 % 8.0 % 7.3 % Adjusted EBITDA from continuing operations $ 5,528 $ 4,332 $ 25,137 $ 21,693 Same day adjustment  (332 )  (410 ) Same Day EBITDA from continuing operations $ 5,528 $ 4,000 $ 25,137 $ 21,283 RECONCILIATION OF ADJUSTED EPS AND SAME DAY ADJUSTED EPS Fiscal Quarter Ended Fiscal Year Ended December 31, 2023 January 1, 2023 December 31, 2023 January 1, 2023 Net income (loss) from continuing operations per diluted share $ 0.11 $ 0.14 $ (0.95 ) $ 1.07 Acquisition amortization 0.15 0.05 0.57 0.22 Impairment losses   2.09  Transaction fees 0.01 0.03 0.09 0.03 Income tax expense adjustment (0.06 ) (0.03 ) (0.61 ) (0.06 ) Adjusted EPS from continuing operations $ 0.21 $ 0.19 $ 1.19 $ 1.26 Same day adjustment  (0.02 )  (0.03 ) Same Day Adjusted EPS from continuing operations $ 0.21 $ 0.17 $ 1.19 $ 1.23 RECONCILIATION OF SAME DAY REVENUES AND SAME DAY GROSS PROFIT (dollars in thousands) January 1, 2023 Revenues Gross Profit Fourteen Weeks (65 revenue days) - GAAP $ 77,283 $ 27,058 Five Days (5,916 ) (2,068 ) Thirteen Weeks (60 revenue days) - Same Day $ 71,367 $ 24,990 Fifty-three Weeks (254 revenue days) - GAAP $ 298,422 $ 103,548 Five Days (5,916 ) (2,068 ) Fifty-two Weeks (249 revenue days) - Same Day $ 292,506 $ 101,480 View source version on businesswire.com: https://www.businesswire.com/news/home/20240313226666/en/ Steven Hooser or Sandy Martin Three Part Advisors ir@bgstaffing.com 214.872.2710 or 214.616.2207 Source: BGSF, Inc. What were BGSF's full-year revenues for 2023? BGSF reported full-year revenues of $313.2 million for 2023, showing a 4.9% increase from the previous year. What was the operating cash flow for BGSF in 2023? BGSF's operating cash flow in 2023 reached $20.4 million. When was the new credit facility closed by BGSF? BGSF closed a new credit facility on March 12, 2024. What was the gross profit for BGSF in 2023? BGSF's gross profit in 2023 was $111.8 million, up 8.0% from the previous year. How much did BGSF's Adjusted EBITDA increase by in 2023? BGSF's Adjusted EBITDA increased to $25.1 million in 2023, marking a 15.9% growth from the previous year. What did the CEO of BGSF highlight in the PR? The CEO emphasized successful execution of long-term strategic plans, acquisitions, and revenue growth despite challenges in the PR."
Hallador Energy Company Reports Record Net Income and Adjusted EBITDA for 2023; Signs MOU to attract data centers to Merom Power Plant,2024-03-13T21:05:00.000Z,High,Neutral,"Hallador Energy Company (NASDAQ: HNRG) reports strong financial performance for full year 2023 with net income of $44.8 million, basic earnings per share of $1.35, operating cash flow of $59.4 million, and adjusted EBITDA of $107 million. The company secured nearly $500 million in new long-term contracts and restructured its coal division to enhance margins. Additionally, Hallador signed a significant MOU with Hoosier Energy and WIN REMC to explore non-traditional energy sales at the Merom site, aiming to drive increased margins and support the power grid's transition to new energy sources.","Hallador Energy Company Reports Record Net Income and Adjusted EBITDA for 2023; Signs MOU to attract data centers to Merom Power Plant Rhea-AI Impact (High) Rhea-AI Sentiment (Neutral) Tags Rhea-AI Summary Hallador Energy Company (NASDAQ: HNRG) reports strong financial performance for full year 2023 with net income of $44.8 million, basic earnings per share of $1.35, operating cash flow of $59.4 million, and adjusted EBITDA of $107 million. The company secured nearly $500 million in new long-term contracts and restructured its coal division to enhance margins. Additionally, Hallador signed a significant MOU with Hoosier Energy and WIN REMC to explore non-traditional energy sales at the Merom site, aiming to drive increased margins and support the power grid's transition to new energy sources. Positive Hallador Energy Company achieved notable financial results for full year 2023, including a net income of $44.8 million. The company's basic earnings per share stood at $1.35, showcasing strong profitability. Operating cash flow for 2023 reached $59.4 million, reflecting sound financial management. Hallador reported an adjusted EBITDA of $107 million, indicating robust operational performance. The company secured approximately $500 million in new long-term capacity and energy contracts through 2028. Hallador restructured its coal division to enhance margins and adapt to current market conditions, reducing capital expenditure and maintaining high-margin coal production. Through ATM and unsecured notes, the company raised approximately $19 million to support liquidity and strategic initiatives. The MOU signed with Hoosier Energy and WIN REMC aims to explore new energy sales opportunities at the Merom site, targeting high-density power users for increased margins and operational efficiency. Negative None. Financial Analyst The reported increase in net income and adjusted EBITDA for Hallador Energy Company represents a significant improvement in the company's profitability and operational efficiency. The restructuring of their coal division, aimed at increasing margins and adjusting to current market conditions, suggests a strategic move to optimize operations amidst volatile market conditions. The reduction in capital expenditure and employee headcount, along with the idling of high-cost surface mines, indicates a focus on cost management and operational agility.From a financial perspective, the raising of approximately $19 million through ATM and unsecured notes is a noteworthy development. It reflects an active approach to managing liquidity and signals confidence from the board members who provided the unsecured notes. However, it's essential to monitor the terms of these notes and the potential dilution effect of the ATM on existing shareholders.The secured long-term capacity and energy contracts worth nearly $500 million through 2028 provide revenue visibility and a degree of stability in cash flows. The average contracted prices for coal and power, along with the percentage of energy and capacity sold, are critical metrics for investors to assess the company's future revenue streams and pricing power in the market. Market Research Analyst The MOU with Hoosier Energy and WIN REMC could open up new revenue streams for Hallador Energy by tapping into the demand from non-traditional energy consumers like data centers and AI providers. This diversification strategy could mitigate risks associated with fluctuations in traditional energy markets. The focus on supplying reliable electricity to high-density power users aligns with broader industry trends, where energy companies are seeking partnerships with growing sectors to bolster demand for their output.Additionally, the forward-looking statements regarding the potential for increased margins and operational efficiency at the Merom site should be evaluated in light of the broader transition to renewable energy sources. While the company is positioning itself to support the power grid through this transition, investors should consider the long-term sustainability of coal as an energy source against the backdrop of increasing regulatory pressures and shifts in public sentiment towards greener alternatives. Energy Sector Analyst The energy sector is undergoing significant changes with the transition to new energy sources. Hallador Energy's strategic initiatives, including the diversification into power sales and capacity agreements, are timely as they align with the sector's evolution. The company's ability to secure substantial long-term contracts insulates it from some of the risks associated with this transition, but it's important to consider the long-term implications of a potential decline in coal demand.The detailed breakdown of contracted coal revenues and power energy contracts provides transparency into the company's future revenue projections. However, the energy sector's shift towards renewables could impact the valuation of these contracts. An understanding of the MISO accreditation and its implications for capacity revenue is essential, as it reflects the reliability and performance of the company's assets in meeting energy demands. 03/13/2024 - 05:05 PM TERRE HAUTE, Ind., March 13, 2024 (GLOBE NEWSWIRE) -- Hallador Energy Company (NASDAQ  HNRG) reports full year 2023 net income of $44.8 million, $1.35 basic earnings per share, operating cash flow of $59.4 million, and adjusted EBITDA of $107 million, all respectively. Brent Bilsland, President and Chief Executive Officer, stated, Hallador had a solid year as a company. Our coal division had near record margins for the full year, the continued integration of Hallador Power shows tremendous promise for future sales of energy and capacity and our recent MOU with Hoosier Energy and WIN REMC will allow us to market our Merom site to data centers, AI providers and other high-density power users to more efficiently operate the plant and drive increased margins to what we are seeing today. While the fourth quarter presented challenges in all sectors, we believe that our recent restructuring in our coal division, agreements like the MOU and the momentum that we are seeing in forward power sales will all continue to improve the long-term outlook for the company. Below are highlights for the full year results of 2023: We increased Net Income, Operating Cash Flow and Adjusted EBITDA for the Year Net income increased by approximately $27 million to $45 million for 2023. Operating Cash Flow increased by approximately $5 million to $59.4 million for 2023. Adjusted EBITDA* improved to $107 million for the year, an increase of approximately $51 million. Since January 1, 2023, We Secured Nearly $500 Million in New Long-Term Capacity and Energy Contracts We have secured approximately $225 million in new capacity deals through 2028. We have secured approximately $275 million in new energy deals through 2028. We Restructured our Coal Division to Increase Margins and Adjust to Current Market Conditions The restructuring will reduce capital expenditure at the Oaktown Mining Complex by $10 million. Maintains 4.5 million tons of annual production of our highest margin coal. Reduced employee headcount by 110. Idled highest cost surface mines. We Raised Approximately $19 Million Through ATM and Unsecured Notes to Support Liquidity ATM raised $7.3 million in December and $6.6 million in January. Raised $5 million in unsecured one-year notes from members of the Board of Directors in March 2024. Capital used to support liquidity and accelerate strategic initiatives. We Signed Memorandum of Understanding (MOU) with Hoosier Energy and WIN REMC to Provide Opportunities for Non-Traditional Energy Sales at the Merom Site Allows us to potentially capture additional margins above our traditional wholesale energy markets. Allows us to market industrial users of power, such as data centers, AI providers and power dense manufacturers, to the Merom property. We believe utilizing our plant to help supply these large users of energy with reliable, resilient electricity should allow us to operate more efficiently in a volatile power environment, generate increased margins and support the fragile power grid as it navigates the challenges of transition to new sources of energy in the coming decades. 2024 2025 2026 2027 2028 TotalCoal Priced tons - 3rd party (in millions) 3.4 1.8 0.5 0.5 - 6.2Average price per ton - 3rd party$51.82 $50.57 $56.09 $56.09 $- Priced tons (in millions) - Merom 1.5 2.3 2.3 2.3 2.3 10.7Average price per ton - Merom$51.00 $51.00 $51.00 $51.00 $51.00 Contracted coal revenue (in millions)$252.69 $208.33 $145.35 $145.35 $117.30 $869.02% Priced 109% 91% 62% 62% 51% Committed & unpriced tons (in millions) - 3rd party - 1.0 1.0 1.0 - 3.0Committed & unpriced tons (in millions) - Merom - - - - - -Total contracted tons (in millions) 4.9 5.1 3.8 3.8 2.3 19.9 % Coal Sold* 109% 113% 84% 84% 51% Average cost per ton of coal sold was $33.67 for the year ended December 31, 2023 ($26.98 after eliminating for intercompany sales to Merom) 2024 Coal Capex Budget (in millions)$25.00 Power Energy Contracted MWh (in millions) 1.87 1.90 1.83 1.78 1.09 8.47Average contracted price per MWh$35.23 $36.06 $55.37 $54.65 $52.98 Contracted revenue (in millions)$65.88 $68.51 $101.33 $97.28 $57.75 $390.75% Energy Sold* 31% 32% 31% 30% 18% Capacity Average daily contracted capacity 810 748 743 623 454 % Capacity Contracted** 94% 87% 86% 72% 53% Average contracted capacity price per MWd$200 $210 $230 $226 $224 Contracted capacity revenue (in millions)$59.13 $57.33 $62.37 $51.39 $37.12 $267.34 Total Energy & Capacity Revenue Contracted Power Revenue (in millions)$125.01 $125.84 $163.70 $148.67 $94.87 $658.09Contracted Power Revenue per MWh*$45.69 $47.05 $67.40 $66.47 $64.70 2023 average cost per MWh sold was $33.67 for the year ended December 31, 2023 ($26.98 assuming intercompany sales of coal were sold at cost) 2024 Power Capex Budget (in millions)$18.00 TOTAL CONTRACTED REVENUE (IN MILLIONS)$377.70 $334.17 $309.05 $294.02 $212.17 $1,527.11 *Based on coal production of 4.5 million tons and 6.0 million MWh annually.**Based on a MISO accreditation of 860MW per day. Accreditations are adjusted annually based on 3-year rolling performance metrics. The table below represents some of our critical metrics (in thousands, except for per ton data): December 31, 2023 2022 Net income$44,793 $18,105 Total revenues$634,480 $361,991 Tons sold (consolidated basis, after eliminations) 5,595 6,341 Average price per ton (consolidated basis, after eliminations)$60.97 $45.64 Tons sold (before elimination) 6,922 6,341 Average price per ton (segment basis, before eliminations)$62.54 $45.64 Bank debt$91,500 $85,213 Operating cash flow$59,414 $54,169 Adjusted EBITDA*$107,376 $56,233 -------------------------------- *Non-GAAP financial measure, defined as operating cash flows less effects of certain subsidiary and equity method investment activity, plus bank interest, less effects of working capital period changes, plus other amortization Adjusted EBITDA should not be considered an alternative to net income, income from operations, cash flows from operating activities or any other measure of financial performance presented in accordance with GAAP. Our method of computing Adjusted EBITDA may not be the same method used to compute similar measures reported by other companies. Management believes the non-GAAP financial measure, Adjusted EBITDA, is an important measure in analyzing our liquidity and is a key component of certain material covenants contained within our Credit Agreement, specifically a maximum leverage ratio and a debt service coverage ratio. Noncompliance with the leverage ratio or debt service coverage ratio covenants could result in our lenders requiring the Company to immediately repay all amounts borrowed. If we cannot satisfy these financial covenants, we would be prohibited under our Credit Agreement from engaging in certain activities, such as incurring additional indebtedness, making certain payments, and acquiring and disposing of assets. Consequently, Adjusted EBITDA is critical to the assessment of our liquidity. The required amount of Adjusted EBITDA is a variable based on our debt outstanding and/or required debt payments at the time of the quarterly calculation based on a rolling prior 12-month period. Reconciliation of the non-GAAP financial measure, Adjusted EBITDA, to cash provided by operating activities, the most comparable GAAP measure, is as follows (in thousands) for the years ended December 31, 2023 and 2022, respectively. Reconciliation of GAAP ""Cash provided by operating activities"" to non-GAAP ""Adjusted EBITDA"" (in thousands) Twelve Months Ended December 31, 2023 2022 Cash provided by operating activities$59,414 $54,169 Current income tax benefit (164) - W/O of deferred financing costs 1,541 - Loss from Hourglass Sands & Sunrise Indemnity 10 8 Distribution from Sunrise Energy (625) - Bank and other interest expense 10,478 8,278 Working capital period changes 21,998 (5,861)Other long-term asset and liability changes - - Cash paid on asset retirement obligation reclamation 3,384 3,162 Market adjustments - Merom acquisition - (9,009)ASC 606 Capacity Adjustment 3,703 - Other amortization 7,637 5,486 Adjusted EBITDA$107,376 $56,233 Cash used in investing activities$(75,290) $(53,365) Cash used in financing activities$16,573 $(207) Forward-Looking Statements This release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended (the Securities Act), and Section 21E of the Securities Exchange Act of 1934, as amended (the Exchange Act). Statements that are not strictly historical statements constitute forward-looking statements and may often, but not always, be identified by the use of such words such as expects, believes, intends, anticipates, plans, estimates, guidance, target, potential, possible, or probable or statements that certain actions, events or results may, will, should, or could be taken, occur or be achieved. Forward-looking statements are based on current expectations and assumptions and analyses made by Hallador and its management in light of experience and perception of historical trends, current conditions and expected future developments, as well as other factors appropriate under the circumstances that involve various risks and uncertainties that could cause actual results to differ materially from those reflected in the statements. These risks include, but are not limited to, those set forth in Hallador's annual report on Form 10-K for the year ended December 31, 2022 and other Securities and Exchange Commission filings. Hallador undertakes no obligation to revise or update publicly any forward-looking statements except as required by law. Conference Call As previously announced, the Company will host a live conference call on Thursday, March 14, 2024 at 2:00 p.m. Eastern Time. For US callers dial (833)-470-1428 and use access code 135892. A replay of the conference call will be available for seven days. For US callers to listen to the replay, dial (866) 813-9403 and use access code 573916. The conference call will also be available via a live listen-only webcast on the Companys website at www.halladorenergy.com. Hallador is headquartered in Terre Haute, Indiana and through its wholly-owned subsidiaries, Sunrise Coal, LLC and Hallador Power, LLC, produces coal and electricity in the Illinois Basin for the electric power generation industry. To learn more about Hallador, visit our website at www.halladorenergy.com. Contact:Investor RelationsPhone:(303) 839-5504 Hallador Energy CompanyConsolidated Balance SheetsAs of December 31,(in thousands)(Unaudited) 2023 2022 ASSETS Current assets: Cash and cash equivalents$2,842 $3,009 Restricted cash 4,281 3,417 Accounts receivable 19,937 29,889 Inventory 23,075 49,796 Parts and supplies 38,877 28,295 Contract asset - coal purchase agreement  19,567 Prepaid expenses 2,262 4,546 Total current assets 91,274 138,519 Property, plant and equipment: Land and mineral rights 115,486 115,595 Buildings and equipment 537,131 534,129 Mine development 158,642 140,108 Finance lease right-of-use assets 12,346  Total property, plant and equipment 823,605 789,832 Less - accumulated depreciation, depletion and amortization (334,971) (309,370)Total property, plant and equipment, net 488,634 480,462 Investment in Sunrise Energy 2,811 3,988 Other assets 7,061 7,585 Total assets$589,780 $630,554 LIABILITIES AND STOCKHOLDERS' EQUITY Current liabilities: Current portion of bank debt, net 24,438 $33,031 Accounts payable and accrued liabilities 62,908 82,972 Current portion of lease financing 3,933  Deferred revenue 23,062 35,485 Contract liability - power purchase agreement and capacity payment reduction 43,254 88,114 Total current liabilities 157,595 239,602 Long-term liabilities: Bank debt, net 63,453 49,713 Convertible notes payable 10,000 10,000 Convertible notes payable - related party 9,000 9,000 Long-term Lease Financing 8,157  Deferred income taxes 9,235 4,606 Asset retirement obligations 14,538 17,254 Contract liability - power purchase agreement 47,425 84,096 Other 1,789 1,259 Total long-term liabilities 163,597 175,928 Total liabilities 321,192 415,530 Commitments and contingencies Stockholders' equity: Preferred stock, $.10 par value, 10,000 shares authorized; none issued   Common stock, $.01 par value, 100,000 shares authorized; 34,052 and 32,983 issued and outstanding, respectively 341 330 Additional paid-in capital 127,548 118,788 Retained earnings 140,699 95,906 Total stockholders equity 268,588 215,024 Total liabilities and stockholders equity$589,780 $630,554 Hallador Energy CompanyConsolidated Statements of OperationsFor the years ended December 31,(in thousands, except per share data)(Unaudited) 2023 2022 SALES AND OPERATING REVENUES: Coal sales$361,926 $289,376 Electric sales 267,927 66,252 Other revenues 4,627 6,363 Total sales and operating revenues 634,480 361,991 OPERATING EXPENSES: Operating expenses 473,390 266,608 Depreciation, depletion and amortization 67,211 46,875 Asset retirement obligations accretion 1,804 1,010 Exploration costs 904 651 General and administrative 26,159 16,417 Total operating expenses 569,468 331,561 INCOME FROM OPERATIONS 65,012 30,430 Interest expense (1) (13,711) (11,012)Loss on extinguishment of debt (1,491)  Equity method investment (loss) income (552) 443 INCOME BEFORE INCOME TAXES 49,258 19,861 INCOME TAX EXPENSE (BENEFIT): Current (164)  Deferred 4,629 1,756 Total income tax expense 4,465 1,756 NET INCOME$44,793 $18,105 NET INCOME PER SHARE: Basic$1.35 $0.57 Diluted$1.25 $0.55 WEIGHTED AVERAGE SHARES OUTSTANDING: Basic 33,133 32,043 Diluted 36,827 33,649 ____________ (1) Interest Expense: Interest on bank debt$8,636 $7,563 Other interest 1,842 715 Amortization and swap related interest: Payments on interest rate swap, net of changes in value  (867)Amortization of debt issuance costs 3,233 3,601 Total amortization and swap related interest 3,233 2,734 Total interest expense$13,711 $11,012 Hallador Energy CompanyConsolidated Statements of Cash FlowsFor the years ended December 31,(in thousands)(Unaudited) 2023 2022 CASH FLOWS FROM OPERATING ACTIVITIES: Net income$44,793 $18,105 Adjustments to reconcile net income to net cash provided by operating activities: Deferred income taxes 4,629 1,756 Equity income (loss)  Sunrise Energy 552 (443)Cash distribution - Sunrise Energy 625  Depreciation, depletion and amortization 67,211 46,875 Loss on extinguishment of debt 1,491  Loss (gain) on sale of assets 398 (264)Payments on interest rate swap, net of changes in value  (867)Amortization of debt issuance costs 3,233 3,601 Asset retirement obligations accretion 1,804 1,010 Cash paid on asset retirement obligation reclamation (3,384) (3,162)Stock-based compensation 3,554 1,269 Provision for loss on customer contracts  159 Amortization of contract asset and contract liabilities (39,791) (19,731)Change in current assets and liabilities: Accounts receivable 9,952 (16,305)Inventory 15,548 (25,863)Parts and supplies (10,582) (6,271)Prepaid expenses 1,186 (5,941)Accounts payable and accrued liabilities (18,992) 24,037 Deferred revenue (23,423) 35,485 Other 610 719 Net cash provided by operating activities$59,414 $54,169 Hallador Energy CompanyConsolidated Statements of Cash FlowsFor the years ended December 31,(in thousands)(Unaudited)(continued) 2023 2022 CASH FLOWS FROM INVESTING ACTIVITIES: Capital expenditures$(75,352) $(54,020)Proceeds from sale of equipment 62 655 Net cash used in investing activities (75,290) (53,365) CASH FLOWS FROM FINANCING ACTIVITIES: Payments on bank debt (59,713) (78,225)Borrowings of bank debt 66,000 51,700 Proceeds from sale and leaseback arrangement 11,082  Issuance of convertible notes payable  11,000 Issuance of related party convertible notes payable  18,000 Debt issuance costs (6,013) (2,097)Distributions to redeemable noncontrolling interests  (585)ATM Offering 7,318  Taxes paid on vesting of RSUs (2,101)  Net cash provided by (used in) financing activities 16,573 (207)Increase in cash, cash equivalents, and restricted cash 697 597 Cash, cash equivalents, and restricted cash, beginning of year 6,426 5,829 Cash, cash equivalents, and restricted cash, end of year$7,123 $6,426 CASH, CASH EQUIVALENTS, AND RESTRICTED CASH: Cash and cash equivalents$2,842 $3,009 Restricted cash 4,281 3,417 $7,123 $6,426 SUPPLEMENTAL CASH FLOW INFORMATION: Cash paid for interest$9,966 $8,123 SUPPLEMENTAL NON-CASH FLOW INFORMATION: Change in capital expenditures included in accounts payable and finance lease$1,882 $3,440 Hallador Energy CompanyConsolidated Statement of Stockholders' Equity(in thousands)(Unaudited) Additional Total Common Stock Issued Paid-in Retained Stockholders' Shares Amount Capital Earnings Equity BALANCE, DECEMBER 31, 2021 30,785 $308 $104,126 $77,801 182,235 Stock-based compensation   1,269  1,269 Cancellation of redeemable noncontrolling interests   3,415  3,415 Stock issued on redemption of convertible note 232 2 998  1,000 Stock issued on redemption of related party convertible notes 1,966 20 8,980  9,000 Net income    18,105 18,105 BALANCE, DECEMBER 31, 2022 32,983 330 118,788 95,906 215,024 Stock-based compensation   3,554  3,554 Stock issued on vesting of RSUs 473 5 (5)   Taxes paid on vesting of RSUs (198) (2) (2,099)  (2,101)Stock issued in ATM offering 794 8 7,310  7,318 Net income    44,793 44,793 BALANCE, DECEMBER 31, 2023 34,052 341 127,548 140,699 268,588 What was Hallador Energy Company's net income for full year 2023? Hallador Energy Company reported a net income of $44.8 million for full year 2023. What is the basic earnings per share for Hallador Energy Company in 2023? Hallador Energy Company's basic earnings per share for 2023 stood at $1.35. What is the operating cash flow reported by Hallador Energy Company for 2023? Hallador Energy Company reported an operating cash flow of $59.4 million for 2023. What is the adjusted EBITDA figure disclosed by Hallador Energy Company for 2023? Hallador Energy Company reported an adjusted EBITDA of $107 million for 2023. How much did Hallador Energy Company secure in new long-term capacity and energy contracts through 2028? Hallador Energy Company secured approximately $500 million in new capacity and energy contracts through 2028. What strategic initiative did Hallador Energy Company undertake to enhance margins in its coal division? Hallador Energy Company restructured its coal division to increase margins and adapt to market conditions. How much capital did Hallador Energy Company raise through ATM and unsecured notes for liquidity support? Hallador Energy Company raised approximately $19 million through ATM and unsecured notes to support liquidity. With whom did Hallador Energy Company sign a Memorandum of Understanding (MOU) for non-traditional energy sales at the Merom site? Hallador Energy Company signed an MOU with Hoosier Energy and WIN REMC for non-traditional energy sales at the Merom site."
Mesoblast Successfully Completes Placement and Accelerated Entitlement Offer,2024-03-13T23:30:00.000Z,Neutral,Neutral,"Mesoblast Limited raises A$97 million through entitlement offer and institutional placement, with Dr. Eric Rose subscribing for additional shares.","Mesoblast Successfully Completes Placement and Accelerated Entitlement Offer Rhea-AI Impact (Neutral) Rhea-AI Sentiment (Neutral) Tags Rhea-AI Summary Mesoblast Limited raises A$97 million through entitlement offer and institutional placement, with Dr. Eric Rose subscribing for additional shares. Positive None. Negative None. Financial Analyst The capital raise by Mesoblast Limited through its entitlement offer and institutional placement, amounting to A$97 million, is a significant financial move for the company. This influx of capital is likely to bolster the company's balance sheet, providing the necessary funds to continue its research and development into allogeneic cellular medicines. The participation of major shareholders, including a substantial investment by Dr. Eric Rose, signals confidence in the company's trajectory. However, investors should assess the potential dilutive effect of the new shares on their holdings and consider the company's valuation post-capital raise.Furthermore, the commitment of funds by a high-profile medical professional such as Dr. Rose may also serve as a qualitative indicator of the company's potential, given his background and expertise. Yet, it is crucial for investors to evaluate whether the capital raised aligns with the company's strategic growth plans and the competitive landscape of the biotech sector. The long-term success of this capital injection will depend on Mesoblast's ability to effectively utilize the funds to achieve clinical and commercial milestones. Medical Research Analyst Mesoblast's focus on allogeneic cellular medicines for inflammatory diseases positions it within a cutting-edge segment of the biotechnology industry. The successful capital raise provides the company with an opportunity to further its clinical trials and potentially bring new therapies to market. The involvement of Dr. Eric Rose not only adds credibility to the company's endeavors but also underscores the potential impact of its research on the treatment of heart-related conditions, especially considering Dr. Rose's history with the LVAD.Investors should monitor the company's pipeline progress and regulatory interactions, particularly with entities like the FDA, as these will be critical in determining the company's ability to capitalize on its research investments. The long-term implications for Mesoblast's stock will largely hinge on the successful development and commercialization of its cellular therapies, which address a significant unmet medical need in the treatment of inflammatory diseases. Market Research Analyst The biotech sector is known for its high volatility and the substantial capital required to fund R&D and navigate regulatory pathways. Mesoblast's successful capital raise indicates a robust fundraising environment and investor willingness to support biotech firms with promising pipelines. The A$97 million raised could enable Mesoblast to maintain its competitive edge in the allogeneic cellular medicine space, which is anticipated to grow due to increasing demand for innovative treatments.Analyzing the investment patterns and the confidence shown by existing shareholders, including Dr. Rose's personal investment, can offer insights into the perceived market potential of Mesoblast's technology. However, the impact on the stock will also depend on broader market trends, investor sentiment towards biotech innovation and the outcomes of Mesoblast's ongoing and future clinical trials. It is essential for stakeholders to consider these factors alongside the company's financial health and R&D progress when evaluating the potential impact of this news on the company's market position. 03/13/2024 - 07:30 PM NEW YORK, March 13, 2024 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today announced it has received firm commitments to complete its pro-rata accelerated non-renounceable entitlement offer that was launched on 4 December, 2023 (Entitlement Offer). Together the entitlement offer and institutional placement raised gross proceeds of A$97 million, including A$36.7 million committed today on the same terms as the Entitlement Offer, primarily from Mesoblasts existing major shareholders. Dr. Eric Rose, the Companys Chief Medical Officer and a director of Mesoblast, subscribed for additional shares of A$1.5 million, subject to shareholder approval. Dr. Rose is a world-renowned heart surgeon who performed the worlds first successful heart transplant in children and was for many years Chairman of Columbia Universitys Department of Surgery. Dr. Rose was the Principal Investigator of the pivotal trial resulting in FDA approval of the first implantable left ventricular assist device (LVAD) for long term support of patients with heart failure, spawning an entire new industry. About Mesoblast Mesoblast (the Company) is a world leader in developing allogeneic (off-the-shelf) cellular medicines for the treatment of severe and life-threatening inflammatory conditions. The Company has leveraged its proprietary mesenchymal lineage cell therapy technology platform to establish a broad portfolio of late-stage product candidates which respond to severe inflammation by releasing anti-inflammatory factors that counter and modulate multiple effector arms of the immune system, resulting in significant reduction of the damaging inflammatory process. Mesoblast has a strong and extensive global intellectual property portfolio with protection extending through to at least 2041 in all major markets. The Companys proprietary manufacturing processes yield industrial-scale, cryopreserved, off-the-shelf, cellular medicines. These cell therapies, with defined pharmaceutical release criteria, are planned to be readily available to patients worldwide. Mesoblast is developing product candidates for distinct indications based on its remestemcel-L and rexlemestrocel-L allogeneic stromal cell technology platforms. Remestemcel-L is being developed for inflammatory diseases in children and adults including steroid refractory acute graft versus host disease, biologic-resistant inflammatory bowel disease, and acute respiratory distress syndrome. Rexlemestrocel-L is in development for advanced chronic heart failure and chronic low back pain. Two products have been commercialized in Japan and Europe by Mesoblasts licensees, and the Company has established commercial partnerships in Europe and China for certain Phase 3 assets. Mesoblast has locations in Australia, the United States and Singapore and is listed on the Australian Securities Exchange (MSB) and on the Nasdaq (MESO). For more information, please see www.mesoblast.com, LinkedIn: Mesoblast Limited and Twitter: @Mesoblast Forward-Looking StatementsThis press release includes forward-looking statements that relate to future events or our future financial performance and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance or achievements to differ materially from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. We make such forward-looking statements pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 and other federal securities laws. Forward-looking statements should not be read as a guarantee of future performance or results, and actual results may differ from the results anticipated in these forward-looking statements, and the differences may be material and adverse. Forward-looking statements include, but are not limited to, statements about: the initiation, timing, progress and results of Mesoblasts preclinical and clinical studies, and Mesoblasts research and development programs; Mesoblasts ability to advance product candidates into, enroll and successfully complete, clinical studies, including multi-national clinical trials; Mesoblasts ability to advance its manufacturing capabilities; the timing or likelihood of regulatory filings and approvals (including any future decision that the FDA may make on the BLA for remestemcel-L for pediatric patients with SR-aGVHD), manufacturing activities and product marketing activities, if any; the commercialization of Mesoblasts product candidates, if approved; regulatory or public perceptions and market acceptance surrounding the use of stem-cell based therapies; the potential for Mesoblasts product candidates, if any are approved, to be withdrawn from the market due to patient adverse events or deaths; the potential benefits of strategic collaboration agreements and Mesoblasts ability to enter into and maintain established strategic collaborations; Mesoblasts ability to establish and maintain intellectual property on its product candidates and Mesoblasts ability to successfully defend these in cases of alleged infringement; the scope of protection Mesoblast is able to establish and maintain for intellectual property rights covering its product candidates and technology; estimates of Mesoblasts expenses, future revenues, capital requirements and its needs for additional financing; Mesoblasts financial performance; developments relating to Mesoblasts competitors and industry; and the pricing and reimbursement of Mesoblasts product candidates, if approved. You should read this press release together with our risk factors, in our most recently filed reports with the SEC or on our website. Uncertainties and risks that may cause Mesoblasts actual results, performance or achievements to be materially different from those which may be expressed or implied by such statements, and accordingly, you should not place undue reliance on these forward-looking statements. We do not undertake any obligations to publicly update or revise any forward-looking statements, whether as a result of new information, future developments or otherwise. Release authorized by the Chief Executive. For more information, please contact: Corporate Communications / InvestorsMediaPaul HughesBlueDot MediaT: +61 3 9639 6036Steve DabkowskiE: investors@mesoblast.comT: +61 419 880 486 E: steve@bluedot.net.au What is Mesoblast Limited's ticker symbol? Mesoblast Limited's ticker symbol is MESO. How much did Mesoblast Limited raise through the entitlement offer and institutional placement? Mesoblast Limited raised gross proceeds of A$97 million through the entitlement offer and institutional placement. Who subscribed for additional shares in Mesoblast Limited? Dr. Eric Rose, the Companys Chief Medical Officer and a director of Mesoblast, subscribed for additional shares of A$1.5 million, subject to shareholder approval."
"Pangaea Logistics Solutions Ltd. Reports Financial Results for the Three Months and Year Ended December 31, 2023",2024-03-13T21:12:00.000Z,Neutral,Neutral,"Pangaea Logistics Solutions Ltd. announces strong financial results for the fourth quarter and full year 2023, with net income of $1.1 million and $26.3 million respectively. The company reported adjusted EBITDA of $19.7 million for Q4 and $79.7 million for the full year, showing a decline in TCE rates but exceeding industry benchmarks. Pangaea's strategic focus on premium-rate, cargo-centric operations and fleet expansion is driving growth and shareholder value.","Pangaea Logistics Solutions Ltd. Reports Financial Results for the Three Months and Year Ended December 31, 2023 Rhea-AI Impact (Neutral) Rhea-AI Sentiment (Neutral) Tags earnings Rhea-AI Summary Pangaea Logistics Solutions Ltd. announces strong financial results for the fourth quarter and full year 2023, with net income of $1.1 million and $26.3 million respectively. The company reported adjusted EBITDA of $19.7 million for Q4 and $79.7 million for the full year, showing a decline in TCE rates but exceeding industry benchmarks. Pangaea's strategic focus on premium-rate, cargo-centric operations and fleet expansion is driving growth and shareholder value. Positive Strong financial performance with net income of $1.1 million for Q4 and $26.3 million for full year 2023. Adjusted EBITDA of $19.7 million for Q4 and $79.7 million for the full year, despite declining TCE rates. Strategic focus on premium-rate, cargo-centric operations driving growth and shareholder value. Completion of the sale of Supramax Bulk Trident for $9.8 million in November 2023. Expansion of logistics capabilities through acquisitions and fleet renewal strategy in 2023. Focus on driving superior returns on capital deployed and returning capital to shareholders. Management commentary highlighting the company's outperformance in TCE rates and industry leadership. Plans for fleet and logistics capabilities growth in 2024 to enhance shareholder value. Negative Decline in TCE rates for Q4 and full year 2023. Decrease in Adjusted EBITDA margin from 21.0% to 14.9% for Q4 compared to the prior year period. Increase in net debt to trailing twelve-month adjusted EBITDA ratio from 1.25x to 2.12x. Total Adjusted EBITDA margin declined from 20.1% in 2022 to 16.0% in 2023 for the full year. Full year TCE rates declined by 35% on a year-over-year basis in 2023. Financial Analyst The reported net income and adjusted net income for Pangaea Logistics Solutions Ltd. reflect a mixed financial performance. A net income of $1.1 million for Q4 2023 and $26.3 million for the full year, alongside adjusted figures of $7.4 million and $31.4 million respectively, indicate a company that is managing to remain profitable despite challenging market conditions. The Time Charter Equivalent (TCE) rates, a key metric in the shipping industry representing the average daily revenue performance of a vessel, have declined year-over-year but still outperform the industry average indices by a significant margin. This outperformance can be attributed to the company's specialized fleet and long-term contracts, which provide a buffer against market volatility.The Adjusted EBITDA figures are crucial for understanding the company's operational efficiency and ability to generate profit from its core business operations. The year-over-year decrease in Adjusted EBITDA and margin reflects the impact of lower market rates and increased shipping days, which, while increasing revenue potential, also add to operational costs. The reported ratio of net debt to trailing twelve-month Adjusted EBITDA has increased, indicating a higher debt load relative to earnings, which could be a concern for long-term financial stability.Investors may find the strategic updates encouraging, as the company's focus on fleet utilization, strategic expansions and capital returns hint at a management team that is proactive in navigating a dynamic market. The sale of non-core assets and investment in fleet renewal are positive signs of strategic asset management that can lead to improved TCE rates and operational efficiency in the long run. Market Research Analyst The maritime logistics sector is sensitive to global trade dynamics and Pangaea's performance offers insights into broader market trends. The company's increased shipping days and successful outperformance against benchmark indices suggest a robust demand for specialized shipping services, despite the overall decline in TCE rates. The company's ability to secure premium rates through its cargo-centric strategy and specialized fleet, such as ice-class vessels, is a competitive advantage that helps mitigate the risk of fluctuating market rates.However, the decline in Adjusted EBITDA margin and the impact of elevated Panama Canal transit fees due to drought conditions are indicative of external factors that can affect operational costs. The strategic focus on expanding port terminal operations and joint operations partnerships in the U.S. Gulf Coast could lead to diversification of revenue streams and potentially higher margins due to integrated shipping and logistics services.The global supply chain disruptions and the constrained supply of newer, compliant fleet tonnage present both challenges and opportunities. Pangaea's approach to capitalizing on market inefficiencies and the limited order book for new dry bulk vessels suggests a favorable outlook for the company's specialized services, particularly if the demand for dry bulk shipping remains robust as anticipated. Economist The financial results of Pangaea Logistics Solutions Ltd. offer a microcosmic view of the economic forces at play in the maritime logistics industry. The company's performance, particularly the ratio of net debt to Adjusted EBITDA, serves as an indicator of leverage and financial health in a capital-intensive industry. The increase in this ratio could signal a cautious note for investors about the company's growing leverage amidst uncertain economic conditions.Furthermore, the company's strategic investments and divestments are a response to broader economic trends, such as the need for fleet modernization to comply with environmental regulations and the strategic positioning in niche markets like Arctic trade routes. These moves are reflective of a company adapting to the evolving economic landscape, where efficiency, compliance and specialization are becoming increasingly important.The company's focus on delivering shareholder value through dividends and capital returns, despite the pressures of a challenging market, reflects a balanced approach to growth and profitability. This is particularly relevant in the context of the ongoing geopolitical trade disruptions, which have the potential to create both obstacles and opportunities for companies like Pangaea that are agile enough to navigate these changes. 03/13/2024 - 05:12 PM NEWPORT, R.I., March 13, 2024 /PRNewswire/ -- Pangaea Logistics Solutions Ltd. (""Pangaea"" or the ""Company"") (NASDAQ: PANL), a global provider of comprehensive maritime logistics solutions, announced today its results for the three months and year ended December 31, 2023. FOURTH QUARTER 2023 RESULTS Net income of $1.1 million, or $0.03 per diluted shareAdjusted net income attributable to Pangaea Logistics Solutions Ltd. of $7.4 million, or $0.16 per diluted shareOperating cash flow of $23.9 millionAdjusted EBITDA of $19.7 millionTime Charter Equivalent (""TCE"") rates earned by Pangaea of $17,685 per dayPangaea's TCE rates exceeded the average Baltic Panamax and Supramax indices by 27%Ratio of net debt to trailing twelve-month Adjusted EBITDA of 2.12xIn November 2023, completed the sale of the Supramax Bulk Trident for $9.8 millionFULL YEAR 2023 RESULTS Net income attributable to Pangaea Logistics Solutions Ltd. of $26.3 million, or $0.58 per diluted shareAdjusted Net Income attributable to Pangaea Logistics Solutions Ltd. of $31.4 million, or $0.69 per diluted shareOperating cash flow of $53.8 millionAdjusted EBITDA of $79.7 millionTime Charter Equivalent (""TCE"") rates earned by Pangaea of $15,849 per dayPangaea's TCE rates exceeded the average Baltic Panamax and Supramax indices by 39%For the fourth quarter ended December 31, 2023, Pangaea reported non-GAAP adjusted net income of $7.4 million, or $0.16 per diluted share, on total revenue of $131.9 million. Fourth quarter TCE rates declined 11.7% on a year-over-year basis, while total shipping days, which include both voyage and time charter days, increased 11% to 4,087 days, when compared to the year-ago period. The TCE earned was $17,685 per day for the three months ended December 31, 2023, compared to an average of $20,023 per day for the same period in 2022. During the fourth quarter 2023, the Company's average TCE rate exceeded the benchmark average Baltic Panamax and Supramax indices by approximately 27%, supported by Pangaea's long-term contracts of affreightment (""COAs""), specialized fleet, and cargo-focused strategy. Total Adjusted EBITDA decreased by 27% to $19.7 million in the fourth quarter due to fewer total shipping days and lower market rates, partially offset by the benefit of more owned ship days from a larger owned fleet and a decline in charter-hire expenses. Total Adjusted EBITDA margin was 14.9% during the fourth quarter of 2023, compared to 21.0% during the prior year period. The decrease in Adjusted EBITDA margin reflects the 11% year-over-year increase in shipping days, coupled with the 12% year-over-year decrease in TCE rate, partially offset by a 4% year-over-year decline in vessel operating expenses per day, net of technical management fees. Fourth quarter 2024 expenses also reflect approximately $1.0 million impact from elevated Panama Canal transit fees caused by drought conditions in portions of Central and South America. For the full year ended December 31, 2023, Pangaea reported non-GAAP adjusted net income of $31.4 million or $0.69 per diluted share, on total revenue of $499.3 million. Total Adjusted EBITDA was $79.7 million for the full year 2023 and total Adjusted EBITDA margin was 16.0%, compared to 20.1% for the full year 2022. Full year TCE rates declined 35% on a year-over-year basis in 2023 , while total shipping days decreased 5.7% to 16,711 when compared to 2022. The Company's average TCE rate during 2023 exceeded the benchmark average Baltic Panamax and Supramax indices by approximately 39%, supported by Pangaea's specialized fleet of ice-class vessels, long-term COAs, and cargo-focused strategies. As of December 31, 2023, the Company had $99.0 million in cash and equivalents. Total debt, including lease finance obligations was $264 million at year-end 2023. At the end of the fourth quarter 2023, the ratio of net debt to trailing twelve-month adjusted EBITDA was 2.12x, versus 1.25x in the prior-year period. During the three months ended December 31, 2023, the Company repaid $3.3 million of long-term debt, $8.0 million of finance leases, and paid $4.5 million of cash dividends. As previously announced on Feb 15, 2024, the Company's Board of Directors declared a quarterly cash dividend of $0.10 per common share, to be paid on March 15, 2024, to all shareholders of record as of March 1, 2024. MANAGEMENT COMMENTARY ""We continued to execute on our premium-rate, cargo-centric strategy throughout the year, culminating in a strong fourth quarter operating performance,"" stated Mark Filanowski, Chief Executive Officer of Pangaea Logistics Solutions. ""While the fourth quarter is generally a slower period for Pangaea as we complete the peak Arctic trade season, ongoing geopolitical trade disruptions have led to increased demand for our solutions outside of our traditional trade routes, contributing to increased shipping days in the period compared to the prior year."" ""During the fourth quarter and full-year 2023, our TCE rate exceeded the benchmark BSI Index by nearly 27% and 39%, respectively,"" continued Filanowski. ""This performance is demonstrates our ability to drive relative out performance versus the broader industry even in periods of pronounced rate volatility. We believe we are the industry leader in this regard. During 2023, we also celebrated our 27th year of service to our loyal customer base and we rebranded our operating companies, Phoenix Bulk and Nordic Bulk, with proud Pangaea Logistics names."" ""Entering 2024, trade disruptions are causing persistent market inefficiencies driving a higher seasonal freight rate environment,"" continued Filanowski. ""Through today, we have performed 3,513 shipping days generating a TCE of $17,430/day, representing a strong seasonal start to the new year."" ""While dry bulk demand conditions remain robust, the global supply of newer, compliant fleet tonnage remains constrained, with the order book for new dry bulk vessels continuing to sit well below historical levels,"" continued Filanowski. ""With a limited volume of newbuild vessels scheduled to enter service over the next several years, the existing fleet of vessels in operation are expected to stay in high demand, a dynamic supportive of a strengthening rate environment."" ""In a strengthening dry-bulk market, Pangaea will continue to focus on driving superior returns on capital deployed,"" continued Filanowski. ""In 2023, we invested in the strategic expansion of our logistics capabilities through the acquisition of new port and terminal operations, deployed more than $34 million in our fleet renewal strategy, reduced our long-term debt by $36 million, and returned more than $18 million of capital to shareholders through our quarterly cash dividend. In 2024, we intend to prioritize growth in our fleet and logistics capabilities, while we continue to maintain a stable return of capital program, consistent with our long-term focus on shareholder value creation."" STRATEGIC UPDATE Pangaea remains committed to developing a leading dry bulk logistics and transportation services company of scale, providing its customers with specialized shipping and supply chain and logistics offerings in commodity and niche markets, which drive premium returns measured in time charter equivalent per day. Leverage integrated shipping and logistics model. In addition to operating one of the largest high ice class dry bulk fleet of Panamax and post-Panamax vessels globally, Pangaea also performs stevedoring services, together with port and terminal operations capabilities. Following the acquisition of marine port terminal operations in Port Everglades/Ft. Lauderdale, Port of Palm Beach, Florida, and Port of Baltimore, Maryland in June 2023, the company has been actively working to expand its onshore relationships with new and existing customers. During 2024, the Company intends to opportunistically expand its marine port terminal operations footprint across the U.S Gulf Coast through strategic joint operations partnerships. Continue to drive strong fleet utilization. In the fourth quarter, Pangaea's 24 owned vessels were fully utilized and supplemented with an average of 20 chartered-in vessels to support cargo and COA commitments. While the Company benefited from continued artic trade activity demand early in the quarter, global trade disruptions bolstered demand, resulting in an 11% increase in shipping days. Going forward, the Company will continue to opportunistically evaluate the composition of its fleet in order to meet the growing needs of new and existing customers. Continue to upgrade fleet, while divesting older, non-core assets. In November 2023, the Company completed the sale of the 2006-built Supramax Bulk Trident for $9.8 million. Looking ahead, the Company intends to opportunistically manage its fleet with the purpose of maximizing TCE rates, while continuing to support client requirements on an on-demand basis. FOURTH QUARTER 2023 CONFERENCE CALL The Company's management team will host a conference call to discuss the Company's financial results on Thursday, March 14, 2024 at 8:00 a.m., Eastern Time (ET). Accompanying presentation materials will be available in the Investor Relations section of the Company's website at https://www.pangaeals.com/investors/. To participate in the live teleconference: Domestic Live: 1-800-245-3047International Live: 1-203-518-9765Conference ID: PANLQ423 To listen to a replay of the teleconference, which will be available through March 21, 2024: Domestic Replay: 1-800-839-5630International Replay: 1-402-220-2557 Pangaea Logistics Solutions Ltd. Consolidated Statements of Operations Three months ended December 31, Twelve months ended December 31, 2023 2022 2023 2022 (unaudited) (unaudited) Revenues: Voyage revenue $ 122,280,728 $ 117,339,854 $ 468,580,914 $ 640,033,668 Charter revenue 7,078,975 10,583,556 23,715,895 59,673,238 Terminal & stevedore revenue 2,517,214  6,971,025  Total revenue 131,876,917 127,923,410 499,267,834 699,706,906 Expenses: Voyage expense 57,085,198 54,214,070 227,434,670 262,088,555 Charter hire expense 33,850,149 28,156,765 111,033,537 222,332,197 Vessel operating expenses 14,713,363 15,380,167 55,783,562 56,859,340 Terminal & stevedore expenses 1,916,707  5,809,025  General and administrative 5,665,924 3,907,905 22,780,937 20,103,346 Depreciation and amortization 7,524,045 7,529,397 30,070,395 29,489,810 Loss on impairment of vessels    3,007,809 Loss on sale of vessels 566,315  1,738,511 318,032 Total expenses 121,321,701 109,188,304 454,650,637 594,199,089 Income from operations 10,555,216 18,735,106 44,617,197 105,507,817 Other (expense) income: Interest expense (4,300,627) (4,264,918) (17,025,547) (15,704,233) Interest income 704,220 614,978 3,572,134 932,069 Loss (income) attributable to Non-controlling interest recorded as long-term liability interest expense 565,648 (755,563) (462,150) (6,717,414) Unrealized (loss) gain on derivative instruments (5,685,406) 1,192,416 (2,925,347) 682,323 Other income 338,849 290,025 761,485 807,142 Total other expense, net (8,377,316) (2,923,062) (16,079,425) (20,000,113) Net income 2,177,900 15,812,044 28,537,772 85,507,704 Income attributable to noncontrolling interests (1,041,698) (309,443) (2,214,472) (6,016,291) Net income attributable to Pangaea Logistics Solutions Ltd. $ 1,136,202 $ 15,502,601 $ 26,323,300 $ 79,491,413 Earnings per common share: Basic $ 0.03 $ 0.35 $ 0.59 $ 1.79 Diluted $ 0.03 $ 0.34 $ 0.58 $ 1.76 Weighted average shares used to compute earnings per common share Basic 44,815,282 44,435,664 44,773,899 44,398,987 Diluted 45,392,225 44,985,969 45,475,453 45,059,587 Pangaea Logistics Solutions Ltd. Consolidated Balance Sheets December 31, 2023 December 31, 2022 Assets Current Assets Cash and cash equivalents $ 99,037,866 $ 128,384,606 Accounts receivable (net of allowance of $5,657,837 and $4,367,848 atDecember 31, 2023 and 2022, respectively) 47,891,501 36,755,149 Bunker inventory 16,556,266 29,104,436 Advance hire, prepaid expenses and other current assets 28,340,246 28,266,831 Total current assets 191,825,879 222,511,022 Fixed assets, at cost, net of accumulated depreciation of $127,015,253and $108,844,668, at December 31, 2023 and 2022, respectively 474,265,171 476,524,752 Finance lease right of use assets, at cost, net of accumulated depreciation of$10,393,823 and $12,139,654 at December 31, 2023 and 2022, respectively 30,393,823 43,921,569 Goodwill 3,104,800  Other Non-current Assets 5,590,295 5,284,127 Total assets $ 705,179,968 $ 748,241,470 Liabilities and stockholders' equity Current liabilities Accounts payable, accrued expenses and other current liabilities $ 35,836,262 $ 38,554,131 Deferred revenue 15,629,886 20,883,958 Current portion of long-term debt 30,751,726 15,782,530 Current portion of finance lease liabilities 21,970,124 16,365,075 Dividends payable 1,146,321 626,178 Total current liabilities 105,334,319 92,211,872 Secured long-term debt, net 68,446,309 98,819,739 Finance lease liabilities 143,266,867 168,513,939 Long-term liabilities - other 17,936,540 19,974,390 Stockholders' equity: Preferred stock, $0.0001 par value, 1,000,000 shares authorized and no shares issued or outstanding   Common stock, $0.0001 par value, 100,000,000 shares authorized, 46,466,622 and 45,898,395 sharesissued and outstanding at December 31, 2023 and 2022, respectively 4,648 4,590 Additional paid-in capital 164,854,546 162,894,080 Retained Earnings 159,026,799 151,327,392 Total Pangaea Logistics Solutions Ltd. equity 323,885,993 314,226,062 Non-controlling interests 46,309,940 54,495,468 Total stockholders' equity 370,195,933 368,721,530 Total liabilities and stockholders' equity $ 705,179,968 $ 748,241,470 Pangaea Logistics Solutions Ltd. Consolidated Statements of Cash Flows Years ended December 31, 2023 2022 Operating activities Net income $ 28,537,772 $ 85,507,704 Adjustments to reconcile net income to net cash provided by operations: Depreciation and amortization expense 30,070,395 29,489,810 Amortization of deferred financing costs 946,593 1,005,487 Amortization of prepaid rent 121,532 122,343 Unrealized loss (gain) on derivative instruments 2,925,347 (682,323) Income from equity method investee (684,470) (807,142) Earnings attributable to non-controlling interest recorded as interest expense 462,150 6,717,414 Provision for doubtful accounts 2,938,879 2,377,389 Loss on impairment of vessels  3,007,809 Loss on sales of vessels 1,738,511  Drydocking costs (4,154,283) (6,019,126) Share-based compensation 2,087,807 1,767,726 Change in operating assets and liabilities: Accounts receivable (14,075,231) 15,126,727 Bunker inventory 12,548,170 (1,956,676) Advance hire, prepaid expenses and other current assets (342,776) 19,086,893 Accounts payable, accrued expenses and other current liabilities (4,079,047) (8,939,313) Deferred revenue (5,254,072) (11,321,354) Net cash provided by operating activities 53,787,277 134,801,400 Investing activities Purchase of vessels and vessel improvements (27,264,044) (35,740,482) Proceeds from sale of vessels 17,271,489 8,400,000 Acquisitions, net of cash acquired (7,200,000)  Purchase of equipment and internal use software  (653,452) Contributions to non-consolidated subsidiaries (427,270) (515,162) Dividends received from equity method investments 1,637,500  Net cash used in investing activities (15,982,325) (28,509,096) Financing activities Proceeds from long-term debt  8,500,000 Payments of financing and issuance costs  (466,544) Payments of long-term debt (15,782,528) (15,443,115) Proceeds from finance leases  15,000,000 Payments on finance lease obligation (20,238,131) (15,834,059) Payments on other long-term liability  (5,000,000) Dividends paid to non-controlling interests (10,400,000) (5,000,000) Common stock accrued dividends paid (18,103,750) (13,414,984) Cash paid for incentive compensation shares relinquished (127,283) (407,898) Payments to non-controlling interest recorded as long-term liability (2,500,000) (2,050,000) Net cash used in financing activities (67,151,692) (34,116,600) Net (decrease) increase in cash and cash equivalents (29,346,740) 72,175,704 Cash and cash equivalents at beginning of period 128,384,606 56,208,902 Cash and cash equivalents at end of period $ 99,037,866 $ 128,384,606 Supplemental cash flow items: Cash paid for interest $ 18,850,078 $ 14,906,972 Pangaea Logistics Solutions Ltd. Reconciliation of Non-GAAP Measures (unaudited) For the three months ended For the twelve months ended December 31, 2023 December 31, 2022 December 31, 2023 December 31, 2022 Net Transportation and Service Revenue Gross Profit $ 19,040,854 $ 22,700,870 $ 69,868,128 $ 129,050,037 Add: Vessel Depreciation and amortization 7,187,353 7,471,538 29,338,912 29,376,777 Net transportation and service revenue $ 26,228,207 $ 30,172,408 $ 99,207,040 $ 158,426,814 Adjusted EBITDA Net Income $ 2,177,900 $ 15,812,044 $ 28,537,772 $ 85,507,704 Interest expense, net 3,596,407 3,649,940 13,453,413 14,772,164 (Loss) income attributable to Non-controlling interest recordedas long-term liability interest expense (565,648) 755,563 462,150 6,717,414 Depreciation and amortization 7,524,045 7,529,397 30,070,395 29,489,810 EBITDA 12,732,704 27,746,944 72,523,730 136,487,092 Non-GAAP Adjustments: Loss on impairment of vessels    3,007,809 Loss on sale of vessels 566,315  1,738,511 318,032 Share-based compensation 694,293 309,754 2,087,807 1,767,726 Unrealized loss (gain) on derivative instruments, net 5,685,406 (1,192,416) 2,925,347 (682,323) Other non-recurring items $ 3,195 $  $ 448,373 $  Adjusted EBITDA $ 19,681,913 $ 26,864,282 $ 79,723,768 $ 140,898,336 Earnings Per Common Share Net income attributable to Pangaea Logistics Solutions Ltd. $ 1,136,202 $ 15,502,601 $ 26,323,300 $ 79,491,413 Weighted average number of common shares - basic 44,815,282 44,435,664 44,773,899 44,398,987 Weighted average number of common shares - diluted 45,392,225 44,985,969 45,475,453 45,059,587 Earnings per common share - basic $ 0.03 $ 0.35 $ 0.59 $ 1.79 Earnings per common share - diluted $ 0.03 $ 0.34 $ 0.58 $ 1.76 Adjusted EPS Net income attributable to Pangaea Logistics Solutions Ltd. $ 1,136,202 $ 15,502,601 $ 26,323,300 $ 79,491,413 Non-GAAP Add: Loss on impairment of vessels    3,007,809 Loss on sale of vessels 566,315  1,738,511 318,032 Unrealized loss (gain) on derivative instruments, net 5,685,406 (1,192,416) 2,925,347 (682,323) Other non-recurring items 3,195  448,373  Non-GAAP adjusted net income attributable to Pangaea Logistics Solutions Ltd. $ 7,391,118 $ 14,310,185 $ 31,435,531 $ 82,134,931 Weighted average number of common shares - basic 44,815,282 44,435,664 44,773,899 44,398,987 Weighted average number of common shares - diluted 45,392,225 44,985,969 45,475,453 45,059,587 Adjusted EPS - basic $ 0.16 $ 0.32 $ 0.70 $ 1.85 Adjusted EPS - diluted $ 0.16 $ 0.32 $ 0.69 $ 1.82 INFORMATION ABOUT NON-GAAP FINANCIAL MEASURES. As used herein, ""GAAP"" refers to accounting principles generally accepted in the United States of America. To supplement our consolidated financial statements prepared and presented in accordance with GAAP, this earnings release discusses non-GAAP financial measures, including non-GAAP net revenue, non-GAAP adjusted EBITDA and non-GAAP Adjusted EPS. These are considered non-GAAP financial measures as defined in Rule 101 of Regulation G promulgated by the Securities and Exchange Commission. Generally, a non-GAAP financial measure is a numerical measure of a company's historical or future performance, financial position, or cash flows that either excludes or includes amounts that are not normally excluded or included in the most directly comparable measure calculated and presented in accordance with GAAP. The presentation of this non-GAAP financial information is not intended to be considered in isolation or as a substitute for, or superior to, the financial information prepared and presented in accordance with GAAP. We use non-GAAP financial measures for internal financial and operational decision making purposes and as a means to evaluate period-to-period comparisons of the performance and results of operations of our core business. Our management believes that non-GAAP financial measures provide meaningful supplemental information regarding the performance of our core business by excluding charges that are not incurred in the normal course of business. Non-GAAP financial measures also facilitate management's internal planning and comparisons to our historical performance and liquidity. We believe certain non-GAAP financial measures are useful to investors as they allow for greater transparency with respect to key metrics used by management in its financial and operational decision making and are used by our institutional investors and the analyst community to help them analyze the performance and operational results of our core business. Gross Profit. Gross profit represents total revenue less net transportation and service revenue and less vessel depreciation and amortization. Net transportation and service revenue. Net transportation and service revenue represents total revenue less the total direct costs of transportation and services, which includes charter hire, voyage and vessel operating expenses. Net transportation and service revenue is included because it is used by management and certain investors to measure performance by comparison to other logistic service providers. Net transportation and service revenue is not an item recognized by the generally accepted accounting principles in the United States of America, or U.S. GAAP, and should not be considered as an alternative to net income, operating income, or any other indicator of a company's operating performance required by U.S. GAAP. Pangaea's definition of net transportation and service revenue used here may not be comparable to an operating measure used by other companies. Adjusted EBITDA and adjusted EPS. Adjusted EBITDA represents net income (or loss), determined in accordance with U.S. GAAP, excluding interest expense, income taxes, depreciation and amortization, loss on sale and leaseback of vessels, share-based compensation and other non-operating income and/or expense, if any. Earnings per share represents net income divided by the weighted average number of common shares outstanding. Adjusted earnings per share represents net income attributable to Pangaea Logistics Solutions Ltd. plus, when applicable, loss on sale of vessel, loss on sale and leaseback of vessel, loss on impairment of vessel, unrealized gains and losses on derivative instruments, and certain non-recurring charges, divided by the weighted average number of shares of common stock. There are limitations related to the use of net revenue versus income from operations, adjusted EBITDA versus income from operations, and adjusted EPS versus EPS calculated in accordance with GAAP. In particular, Pangaea's definition of adjusted EBITDA used here are not comparable to EBITDA. The table set forth above provides a reconciliation of the non-GAAP financial measures presented to the most directly comparable financial measures prepared in accordance with GAAP. About Pangaea Logistics Solutions Ltd. Pangaea Logistics Solutions Ltd. (NASDAQ: PANL) and its subsidiaries (collectively, ""Pangaea"" or the ""Company"") provides seaborne drybulk logistics and transportation services as well as terminal and stevedoring services. Pangaea utilizes its logistics expertise to service a broad base of industrial customers who require the transportation of a wide variety of drybulk cargoes, including grains, coal, iron ore, pig iron, hot briquetted iron, bauxite, alumina, cement clinker, dolomite and limestone. The Company addresses the logistics needs of its customers by undertaking a comprehensive set of services and activities, including cargo loading, cargo discharge, port and terminal operations, vessel chartering, voyage planning, and vessel technical management. Learn more at www.pangaeals.com. Investor Relations Contacts Gianni Del Signore Noel Ryan or Stefan Neely Chief Financial Officer 401-846-7790 Investors@pangaeals.com PANL@val-adv.com Forward-Looking Statements Certain statements in this press release are ""forward-looking statements"" within the meaning of the Private Securities Litigation Act of 1995. These forward-looking statements are based on our current expectations and beliefs and are subject to a number of risk factors and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. The Company disclaims any obligation to publicly update or revise these statements whether as a result of new information, future events or otherwise, except as required by law. Such risks and uncertainties include, without limitation, the strength of world economies and currencies, general market conditions, including fluctuations in charter rates and vessel values, changes in demand for dry bulk shipping capacity, changes in our operating expenses, including bunker prices, dry-docking and insurance costs, the market for our vessels, availability of financing and refinancing, charter counterparty performance, ability to obtain financing and comply with covenants in such financing arrangements, changes in governmental rules and regulations or actions taken by regulatory authorities, potential liability from pending or future litigation, general domestic and international political conditions, potential disruption of shipping routes due to accidents or political events, vessels breakdowns and instances of off-hires and other factors, as well as other risks that have been included in filings with the Securities and Exchange Commission, all of which are available at www.sec.gov. View original content to download multimedia:https://www.prnewswire.com/news-releases/pangaea-logistics-solutions-ltd-reports-financial-results-for-the-three-months-and-year-ended-december-31-2023-302088621.html SOURCE Pangaea Logistics Solutions LTD What was Pangaea Logistics Solutions Ltd.'s net income for the full year 2023? Pangaea Logistics Solutions Ltd. reported a net income of $26.3 million for the full year 2023. What was the Adjusted EBITDA for Pangaea Logistics Solutions Ltd. in the fourth quarter of 2023? Pangaea Logistics Solutions Ltd. reported an Adjusted EBITDA of $19.7 million for the fourth quarter of 2023. What strategic focus is driving growth for Pangaea Logistics Solutions Ltd.? Pangaea Logistics Solutions Ltd. is focusing on premium-rate, cargo-centric operations and fleet expansion to drive growth and shareholder value. What major event occurred in November 2023 for Pangaea Logistics Solutions Ltd.? In November 2023, Pangaea Logistics Solutions Ltd. completed the sale of the Supramax Bulk Trident for $9.8 million. How does Pangaea Logistics Solutions Ltd. plan to enhance shareholder value in 2024? Pangaea Logistics Solutions Ltd. plans to prioritize growth in fleet and logistics capabilities in 2024 while maintaining a stable return of capital program."
"Zai Lab to Present Data Highlighting ZL-1310, a Novel Antibody-Drug Conjugate (ADC) for Treatment of Solid Tumors",2024-03-13T23:05:00.000Z,Low,Neutral,"Zai Lab Limited announces the presentation of preclinical data on ZL-1310, an innovative ADC targeting DLL3 for small cell lung cancer and other solid tumors at the European Lung Cancer Congress 2024. ZL-1310 shows high affinity for DLL3 and promising therapeutic potential, leading to a Phase 1 clinical trial initiation in January 2024.","Zai Lab to Present Data Highlighting ZL-1310, a Novel Antibody-Drug Conjugate (ADC) for Treatment of Solid Tumors Rhea-AI Impact (Low) Rhea-AI Sentiment (Neutral) Tags conferences Rhea-AI Summary Zai Lab Limited announces the presentation of preclinical data on ZL-1310, an innovative ADC targeting DLL3 for small cell lung cancer and other solid tumors at the European Lung Cancer Congress 2024. ZL-1310 shows high affinity for DLL3 and promising therapeutic potential, leading to a Phase 1 clinical trial initiation in January 2024. Positive Zai Lab Limited presents preclinical findings on ZL-1310 at ELCC 2024. ZL-1310 is an ADC targeting DLL3, a therapeutic target in small cell lung cancer. The preclinical data highlights ZL-1310's high affinity for DLL3 and therapeutic potential. Zai Lab initiated a Phase 1 clinical trial for ZL-1310 in January 2024. Negative None. Oncology Doctor From a clinical perspective, the development of ZL-1310 as an antibody-drug conjugate (ADC) targeting DLL3 is significant. DLL3 expression in small cell lung cancer (SCLC) has been established as a therapeutic target, given its role in tumor cell proliferation and survival. The mechanism involving high-affinity binding and payload delivery resulting in cell cycle arrest and apoptosis is a sophisticated approach to cancer treatment. The preclinical efficacy demonstrated in both CDX and PDX models suggests a promising therapeutic index, especially for patients with relapsed and refractory SCLC post-platinum-based therapy, a group with limited treatment options. Medical Research Analyst Analyzing the preclinical data of ZL-1310, it's clear that the collaboration with MediLink Therapeutics and the utilization of their TMALIN platform could represent a significant advancement in ADC technology. The initiation of a Phase 1 clinical trial indicates confidence in the preclinical findings and a commitment to advancing oncology therapeutics. The ability of ZL-1310 to induce a bystander effect, where the payload can affect neighboring tumor cells not expressing DLL3, could enhance its therapeutic potential. This multifaceted mechanism of action, if validated in clinical trials, could set a new precedent for ADCs in solid tumors. Biotech Market Analyst The strategic partnership between Zai Lab and MediLink Therapeutics, leading to the development of ZL-1310, underscores the importance of collaborative innovation in the biotech industry. The licensing agreement provides Zai Lab with a potentially valuable asset in the competitive oncology market, particularly for SCLC where treatment advancements are urgently needed. The market will be closely monitoring the Phase 1 trial's progress, as positive outcomes could enhance Zai Lab's valuation and market position. The upcoming presentation at ELCC 2024 will likely attract investor attention, as it provides a platform for Zai Lab to showcase their R&D capabilities and the potential of ZL-1310 to address a high unmet medical need. 03/13/2024 - 07:05 PM ZL-1310 is an innovative ADC targeting DLL3, a promising therapeutic target in small cell lung cancer and other DLL3+ solid tumors Data will be shared in a poster presentation at the European Lung Cancer Congress 2024 (ELCC 2024) SHANGHAI & CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced that it will present findings from preclinical studies highlighting the therapeutic potential of ZL-1310, the companys global next-generation antibody-drug conjugate (ADC) program. The preclinical profile of ZL-1310 will be the focus of a poster presentation at the European Lung Cancer Congress 2024 (ELCC 2024), scheduled for March 20-23, 2024 in Prague, Czech Republic. ZL-1310 is a novel and promising ADC within the Zai Lab global oncology R&D pipeline, targeting the Delta-like ligand 3 (DLL3), a validated therapeutic target in the treatment of small cell lung cancer (SCLC). DLL3, which is expressed on the cell surface of most SCLC, plays a pivotal role in promoting SCLC cell proliferation, migration and invasion. ZL-1310 has high affinity for the target, DLL3, and releases its payload both intracellularly and in the tumor microenvironment, also allowing for bystander effect of its camptothecin-derived payload, said Rafael G. Amado, M.D., president, head of Global Oncology Research and Development, Zai Lab. The encouraging preclinical data we will present at ELCC 2024 formed the basis for the ZL-1310 Phase 1 clinical trial that we initiated in January of this year. Data from the preclinical IND-enabling studies which will be shared at ELCC 2024 indicate that ZL-1310 exhibits a strong and specific binding to DLL3 on the cell surface, leading to internalization, cell cycle arrest and the induction of apoptosis in tumor cells. In-vivo, ZL-1310 effectively suppressed the growth of established human tumors in a dose-dependent manner in both cancer cell-derived (CDX) and SCLC patient sample-derived (PDX) xenograft models. ZL-1310 was discovered with MediLink Therapeutics proprietary TMALIN platform, a next-generation ADC platform designed to leverage the tumor microenvironment to overcome the challenges with current ADC drugs. Zai Lab entered a partnership and exclusive worldwide license agreement with MediLink in April 2023. Subsequently, in January 2024, Zai Lab initiated a global Phase 1 study of ZL-1310 in patients with relapsed and refractory SCLC who have progressed after platinum-based treatment. Details regarding the poster presentation at ELCC 2024 are as follows: Title: Development and characterization of a novel DLL3-targeting antibody drug conjugate (ADC) for the treatment of solid tumors Presenter: Linda N Liu, Senior Vice President, Biologics Discovery, Zai Lab Date/Time: Friday, March 22, 2024, 12:00 PM - 12:45 PM CET Location: Prague Congress Centre, Congress Hall Foyer About Small Cell Lung Cancer (SCLC) and Neuroendocrine Tumors SCLC and neuroendocrine tumors are diseases with significant unmet medical needs globally. There are over 300,000 SCLC annual incidences globally.1 More than 88% of SCLC patients overexpress DLL3 and could benefit from targeted therapeutic agents.2 In addition, DLL3 is a promising target highly expressed in several tumors with neuroendocrine features. There are approximately 171,000 people living with neuroendocrine tumors in the United States, and the numbers are continuing to increase, but the treatment options remain limited.3 About Zai Lab Zai Lab (NASDAQ: ZLAB; HKEX: 9688) is an innovative, research-based, commercial-stage biopharmaceutical company based in China and the United States. We are focused on discovering, developing, and commercializing innovative products that address medical conditions with significant unmet needs in the areas of oncology, autoimmune disorders, infectious diseases, and neuroscience. Our goal is to leverage our competencies and resources to positively impact human health in China and worldwide. For additional information about Zai Lab, please visit www.zailaboratory.com or follow us at www.twitter.com/ZaiLab_Global. Zai Lab Forward-Looking Statements This press release contains forward-looking statements relating to our future expectations, plans, and prospects, for Zai Lab, including, without limitation, statements relating to our prospects and plans for developing and commercializing next generation ADCs, including ZL-1310, the potential benefits of ZL-1310, and the potential treatment of SCLC and neuroendocrine tumors. These forward-looking statements may contain words such as aim, anticipate, believe, could, estimate, expect, forecast, goal, intend, may, plan, possible, potential, will, would, and other similar expressions. Such statements constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are not statements of historical fact or guarantees or assurances of future performance. Forward-looking statements are based on our expectations and assumptions as of the date of this press release and are subject to inherent uncertainties, risks, and changes in circumstances that may differ materially from those contemplated by the forward-looking statements. Actual results may differ materially from those indicated by such forward-looking statements as a result of various important factors, including but not limited to (1) our ability to successfully commercialize and generate revenue from our approved products, (2) our ability to obtain funding for our operations and business initiatives, (3) the results of our clinical and pre-clinical development of our product candidates, (4) the content and timing of decisions made by the relevant regulatory authorities regarding regulatory approvals of our product candidates, (5) risks related to doing business in China, and (6) other factors identified in our most recent annual and quarterly reports and in other reports we have filed with the U.S. Securities and Exchange Commission (SEC). We anticipate that subsequent events and developments will cause our expectations and assumptions to change, and we undertake no obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise, except as may be required by law. These forward-looking statements should not be relied upon as representing our views as of any date subsequent to the date of this press release. Our SEC filings can be found on our website at www.zailaboratory.com and on the SECs website at www.sec.gov. Reference: 1. Globocan 2020 2. Orgilmma Regzedmma etc. 2019, Oncotarget and Therapy 3. Statistics of Neuroendocrine Tumor in Cancer.Net [ASCO Knowledge Conquers Cancer] View source version on businesswire.com: https://www.businesswire.com/news/home/20240313685689/en/ For more information, please contact: Investor Relations: Christine Chiou / Lina Zhang +1 (917) 886-6929 / +86 136 8257 6943 christine.chiou1@zailaboratory.com / lina.zhang@zailaboratory.com Media: Jennifer Chang / Xiaoyu Chen +1 (857) 270-8985 / +86 185 0015 5011 jennifer.chang@zailaboratory.com / xiaoyu.chen@zailaboratory.com Source: Zai Lab Limited What is Zai Lab Limited presenting at ELCC 2024? Zai Lab Limited is presenting preclinical findings on ZL-1310, an ADC targeting DLL3 for small cell lung cancer and other solid tumors at ELCC 2024. What is the therapeutic target of ZL-1310? The therapeutic target of ZL-1310 is DLL3, validated in the treatment of small cell lung cancer. When was the Phase 1 clinical trial for ZL-1310 initiated? The Phase 1 clinical trial for ZL-1310 was initiated in January 2024. Who is the presenter of the poster presentation at ELCC 2024? Linda N Liu, Senior Vice President, Biologics Discovery at Zai Lab, is the presenter of the poster presentation at ELCC 2024. What platform was ZL-1310 discovered with? ZL-1310 was discovered with MediLink Therapeutics' proprietary TMALIN platform."
Solaris Provides Disclosure Clarifications,2024-03-13T23:00:00.000Z,Neutral,Neutral,"Solaris Resources Inc. announces the retraction of a mineral resource estimate for an indicative starter pit at the Warintza project, confirming the unchanged mineral resource estimate for the greater Warintza project. The Company discloses Indicated mineral resources of 579Mt at 0.59% CuEq and Inferred mineral resources of 887Mt at 0.47% CuEq above a 0.3% CuEq cut-off grade. The Company will file an amended technical report to reflect these changes.","Solaris Provides Disclosure Clarifications Rhea-AI Impact (Neutral) Rhea-AI Sentiment (Neutral) Tags Rhea-AI Summary Solaris Resources Inc. announces the retraction of a mineral resource estimate for an indicative starter pit at the Warintza project, confirming the unchanged mineral resource estimate for the greater Warintza project. The Company discloses Indicated mineral resources of 579Mt at 0.59% CuEq and Inferred mineral resources of 887Mt at 0.47% CuEq above a 0.3% CuEq cut-off grade. The Company will file an amended technical report to reflect these changes. Positive Solaris Resources Inc. retracts disclosure of a mineral resource estimate for an indicative starter pit at the Warintza project. The Company confirms the mineral resource estimate for the greater Warintza project with Indicated mineral resources of 579Mt at 0.59% CuEq and Inferred mineral resources of 887Mt at 0.47% CuEq above a 0.3% CuEq cut-off grade. Copper equivalent assumes recoveries of 90% Cu, 85% Mo, and 70% Au based on preliminary metallurgical testwork, and metal prices of US$3.50/lb Cu, US$15.00/lb Mo, and US$1,500/oz Au. The Company will amend its technical report to reflect the retraction of the mineral resource estimate for the indicative starter pit. The Company has disclosed historical district estimates, historical estimates at adjacent properties, and potential future results for the property in its corporate presentation. Qualified Person Mario E. Rossi approved the scientific and technical information related to the mineral resource estimate. Indicated mineral resources were defined with a nominal drill hole spacing of 120m, while Inferred mineral resources were defined by blocks estimated within search ellipses to a maximum distance of 350m. Sample assay results have been monitored through a quality control/quality assurance program, including the insertion of blind certified reference materials, blanks, and field duplicate samples. Negative The Company retracts disclosure of potential economic results for the property and consensus analyst estimates for the mineral resource estimate. Readers should not infer that the Company will achieve similar results at its own property based on information regarding adjacent and regional properties disclosed in the corporate presentation. 03/13/2024 - 07:00 PM VANCOUVER, British Columbia, March 13, 2024 (GLOBE NEWSWIRE) -- Solaris Resources Inc. (TSX: SLS; OTCQB: SLSSF) (Solaris or the Company) is issuing the following news release as a result of a continuous disclosure review by the British Columbia Securities Commission. The Company has disclosed in its technical report with an effective date of April 1, 2022, certain Company press releases, and in its corporate presentation both a mineral resource estimate for the greater Warintza project and a mineral resource estimate for an indicative starter pit at the Warintza project. CIM Best Practices state that there can only be one mineral resource on a project. The Company is therefore required to select one of these mineral resource estimates as its mineral resource estimate for the Warintza project. On this basis, the Company is retracting its disclosure of a mineral resource estimate for its indicative starter pit and confirms its mineral resource estimate at the Warintza Project is the unchanged mineral resource estimate for the greater Warintza project, with Indicated mineral resources of 579 million tonnes (Mt) at 0.59% copper equivalent (CuEq) and Inferred mineral resources of 887 Mt at 0.47% CuEq above a 0.3% CuEq cut-off grade at an effective date of April 1, 2022 (the MRE). Copper equivalent assumes recoveries of 90% Cu, 85% Mo, and 70% Au based on preliminary metallurgical testwork, and metal prices of US$3.50/lb Cu, US$15.00/lb Mo, and US$1,500/oz Au. The CuEq formula used is: CuEq (%) = Cu (%) + 4.0476  Mo (%) + 0.487  Au (g/t). The Company will file an amended technical report as soon as practicable with disclosure relating to the indicative starter pit removed from such disclosure. The Company has disclosed in its corporate presentation historical district estimates, historical estimates at adjacent properties and potential future results for the property. This disclosure is restricted as it is not categorized as an inferred mineral resource, an indicated mineral resource, a measured mineral resource, a probable mineral reserve, or a proven mineral reserve. The Company has also made certain disclosure in its corporate presentation regarding potential economic results for the property and consensus analyst estimates for the MRE. Disclosure of gross values of a mineral resource estimate is restricted. The Company is retracting the foregoing disclosure noted in this paragraph and confirms it has not completed an economic assessment at the project. The Company has disclosed in its corporate presentation information regarding adjacent and regional properties. This could be misleading if readers infer that the Company will achieve similar results at its own property. The Company would like to clarify that readers should not infer that the Company will obtain similar results at its own property. Qualified Person The MRE was prepared and the scientific and technical information in this news release related to the MRE was approved by Independent Qualified Person, Mario E. Rossi, FAusIMM, SME, IAMG, Principal Geostatistician of Geosystems International Inc (GSI). Mr. Rossi is a qualified person pursuant to NI 43-101 and is independent of Solaris under Section 1.5 of NI 43-101. Mr. Rossi has over 30 years of experience in mining and geostatistics, mineral resource and reserves estimation, audits and reviews in over 100 mining projects at various stages of development and operation. GSI is an independent, international mining consulting practice offering services specializing in porphyry deposits from exploration through feasibility, mine planning, and production. Resource Estimation Methodology and Parameters Indicated mineral resources were defined where the nominal drill hole spacing is 120m. The classification reflects not only the drill spacing, but the confidence level in the continuity of the grade and the geometry of the deposit. Inferred mineral resources were defined by blocks which were estimated with less stringent requirements within search ellipses defined for each domain to a maximum distance of 350m. Resources include grade capping and internal dilution. Grade was interpolated by ordinary kriging populating a block model with block dimensions of 25m x 25m x 15m. The Indicated and Inferred mineral resources are classified in a manner that is consistent with the May 10, 2014 CIM Definition Standards for Mineral Resources and Mineral Reserves. Mineral resources that are not mineral reserves do not have demonstrated economic viability. In Mr. Rossis opinion, there are currently no relevant factors or legal, political, environmental, or other risks that could materially affect the potential development of the mineral resources. Quality Control & Quality Assurance Sample assay results have been independently monitored through a quality control/quality assurance (QA/QC) program that includes the insertion of blind certified reference materials (standards), blanks and field duplicate samples. Logging and sampling are completed at a secured Company facility located in Quito, Ecuador. Drill core is cut in half on site and samples are securely transported to ALS Labs in Quito. Sample pulps are sent to ALS Labs in Lima, Peru and Vancouver, Canada for analysis. Total copper and molybdenum contents are determined by four-acid digestion with AAS finish. Gold is determined by fire assay of a 30-gram charge. In addition, selected pulp check samples are sent to Bureau Veritas lab in Lima, Peru. Both ALS Labs and Bureau Veritas lab are independent of Solaris. Solaris is not aware of any drilling, sampling, recovery or other factors that could materially affect the accuracy or reliability of the data referred to herein. Mr. Rossi verified the data disclosed, including sampling, analytical, and test data underlying the information included in this news release for which such qualified person is responsible, by personally inspecting the drill core used in the disclosure and performing a number of checks to confirm the accuracy of such data. In addition, Mr. Rossi reviewed the QA/QC reports from the Companys drill programs and noted that there were no issues that arose which would affect confidence with the assay data. Mr. Rossi considers the sampling method appropriate for the deposit type, adequate security and QA/QC measures were maintained, and samples are representative of the existing mineralization. On behalf of the Board of Solaris Resources Inc. Daniel EarlePresident & CEO, Director For Further Information Jacqueline Wagenaar, VP Investor RelationsDirect: 416-366-5678 Ext. 203Email: jwagenaar@solarisresources.com About Solaris Resources Solaris is advancing a portfolio of copper and gold assets in the Americas, which includes a world class copper resource with expansion and discovery potential at its Warintza Project in Ecuador; a series of grass roots exploration projects with discovery potential in Peru and Chile; and significant leverage to increasing copper prices through its 60% interest in the La Verde joint-venture project with a subsidiary of Teck Resources in Mexico. Cautionary Notes and Forward-looking Statements This news release contains certain forward-looking information and forward-looking statements within the meaning of applicable securities legislation (collectively forward-looking statements). The use of the words will and expected and similar expressions are intended to identify forward-looking statements. These statements include statements regarding filing of an amended technical report. Although Solaris believes that the expectations reflected in such forward-looking statements and/or information are reasonable, readers are cautioned that actual results may vary from the forward-looking statements. These statements are based on a variety of assumptions including assumptions made about potential quantity and that further exploration will define a mineral resource at this target. These statements also involve known and unknown risks, uncertainties and other factors that may cause actual results or events to differ materially from those anticipated in such forward-looking statements, including the risks, uncertainties and other factors identified in the Solaris Managements Discussion and Analysis, for the year ended December 31, 2022 available at www.sedarplus.ca. Furthermore, the forward-looking statements contained in this news release are made as at the date of this news release and Solaris does not undertake any obligation to publicly update or revise any of these forward-looking statements except as may be required by applicable securities laws. What mineral resource estimate is Solaris Resources Inc. retracting? Solaris Resources Inc. is retracting its disclosure of a mineral resource estimate for an indicative starter pit at the Warintza project. What are the Indicated mineral resources disclosed by Solaris Resources Inc.? Solaris Resources Inc. discloses Indicated mineral resources of 579Mt at 0.59% CuEq for the greater Warintza project. Who approved the scientific and technical information related to the mineral resource estimate? Mario E. Rossi, an Independent Qualified Person, approved the scientific and technical information. What methodology was used for the resource estimation? Indicated mineral resources were defined with a nominal drill hole spacing of 120m, while Inferred mineral resources were defined by blocks estimated within search ellipses to a maximum distance of 350m. How are sample assay results monitored by Solaris Resources Inc.? Sample assay results are independently monitored through a quality control/quality assurance program that includes the insertion of blind certified reference materials, blanks, and field duplicate samples."
Mannatech Announces Retirement of Alfredo Bala and Promotion of Landen Fredrick to President and CEO,2024-03-13T23:30:00.000Z,Low,Neutral,"Mannatech, Incorporated (NASDAQ: MTEX) announced the retirement of CEO Al Bala and the appointment of Landen Fredrick as the new President and CEO. Al Bala will continue as an advisor focusing on customer acquisition and sales growth. Landen Fredrick, with extensive experience in sales and business development, is set to lead Mannatech into its next phase of growth.","Mannatech Announces Retirement of Alfredo Bala and Promotion of Landen Fredrick to President and CEO Rhea-AI Impact (Low) Rhea-AI Sentiment (Neutral) Tags Rhea-AI Summary Mannatech, Incorporated (NASDAQ: MTEX) announced the retirement of CEO Al Bala and the appointment of Landen Fredrick as the new President and CEO. Al Bala will continue as an advisor focusing on customer acquisition and sales growth. Landen Fredrick, with extensive experience in sales and business development, is set to lead Mannatech into its next phase of growth. Positive None. Negative None. 03/13/2024 - 07:30 PM FLOWER MOUND, Texas--(BUSINESS WIRE)-- Mannatech, Incorporated (NASDAQ: MTEX) reported that Alfredo (Al) Bala, announced his retirement as the companys CEO effective April 1, 2024. J. Stanley Fredrick, Chairman of the Board of Mannatech, Incorporated stated, Al will continue to serve the company as an advisor focused on customer acquisition and sales growth. This transition enables Al to work more closely with our associates in the field which has always been his first love. In this new role, Al will also focus on field and leadership development, leveraging his 43 years of experience in direct sales at both the field and corporate level helping to create and develop programs dedicated to growing people and sales. Mr. Fredrick further stated, Coinciding with Als retirement, I am pleased to announce the promotion of Landen Fredrick to the position of President and CEO. Landens succession to the CEO position was made possible by Als mentorship over the past few years where Landen served as President and Chief Operating Officer. As CEO, Landen will oversee the senior executive team and the team of general managers over our international markets, driving operational excellence, and executing the companys strategic initiatives. Tyler Rameson, a member of Mannatechs Board of Directors, and chairman of the companys nominating committee said, Our committee of independent directors engaged in an extensive succession planning process, and together with Als recommendation, unanimously approved appointing Landen to CEO. With his extensive experience in sales, marketing, operations, and business development, Landen is well-positioned to lead Mannatech into its next phase of growth. Commenting on Landens promotion, Al Bala stated, Landens exceptional leadership skills, dedication, and visionary approach will be a fresh start for Mannatech and will be instrumental in driving Mannatechs success. I am excited to see Landen in this expanded role, and I look forward to supporting him as he makes a positive impact on the companys future. About Mannatech: Mannatech is a leading global health and wellness company committed to empowering everyone to live their best life through cutting-edge, science-backed nutritional products, patented technology, and a rewarding business opportunity. With operations in 25 markets, Mannatech helps people to live healthier, more fulfilling lives while making a positive social impact in the world. To learn more, visit www.mannatech.com. Mannatech operates in China under a cross-border e-commerce platform that is separate from its network marketing model. Please Note: This release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995. These forward-looking statements generally can be identified by use of phrases or terminology such as may, will, should, ""hope,"" could, would, expects, plans, intends, anticipates, believes, estimates, approximates, predicts, projects, potential, and continues or other similar words or the negative of such terminology. Similarly, descriptions of Mannatechs objectives, strategies, plans, goals or targets contained herein are also considered forward-looking statements. Mannatech believes this release should be read in conjunction with all of its filings with the United States Securities and Exchange Commission and cautions its readers that these forward-looking statements are subject to certain events, risks, uncertainties, and other factors. Some of these factors include, among others, the impact of COVID-19 on Mannatech's business, Mannatechs inability to attract and retain associates and members, increases in competition, litigation, regulatory changes, and its planned growth into new international markets. Although Mannatech believes that the expectations, statements, and assumptions reflected in these forward-looking statements are reasonable, it cautions readers to always consider all of the risk factors and any other cautionary statements carefully in evaluating each forward-looking statement in this release, as well as those set forth in its latest Annual Report on Form 10-K, and other filings filed with the United States Securities and Exchange Commission, including its current reports on Form 8-K. All of the forward-looking statements contained herein speak only as of the date of this release. View source version on businesswire.com: https://www.businesswire.com/news/home/20240313782516/en/ Donna Giordano Manager, Executive Office Administration 972-471-6512 ir@mannatech.com www.mannatech.com Source: Mannatech, Incorporated Who is retiring as the CEO of Mannatech, Incorporated? Alfredo (Al) Bala is retiring as the CEO of Mannatech, Incorporated. When is Al Bala's retirement effective? Al Bala's retirement as the CEO is effective on April 1, 2024. Who is the new President and CEO of Mannatech, Incorporated? Landen Fredrick has been appointed as the new President and CEO of Mannatech, Incorporated. What role will Al Bala have after his retirement? After his retirement, Al Bala will serve as an advisor focused on customer acquisition and sales growth. What is Landen Fredrick's background? Landen Fredrick has extensive experience in sales, marketing, operations, and business development."
"ARMOUR Residential REIT, Inc. Announces Chief Financial Officer Transition",2024-03-13T22:55:00.000Z,Low,Neutral,"ARMOUR Residential REIT, Inc. appoints Gordon Harper as Chief Financial Officer and Secretary, replacing James Mountain. Harper brings extensive finance experience from Deloitte and has been with ARMOUR since 2015. The Company aims to file its Form 10-K by March 15, 2024.","ARMOUR Residential REIT, Inc. Announces Chief Financial Officer Transition Rhea-AI Impact (Low) Rhea-AI Sentiment (Neutral) Tags Rhea-AI Summary ARMOUR Residential REIT, Inc. appoints Gordon Harper as Chief Financial Officer and Secretary, replacing James Mountain. Harper brings extensive finance experience from Deloitte and has been with ARMOUR since 2015. The Company aims to file its Form 10-K by March 15, 2024. Positive None. Negative None. 03/13/2024 - 06:55 PM VERO BEACH, Florida, March 13, 2024 (GLOBE NEWSWIRE) -- ARMOUR Residential REIT, Inc. (NYSE: ARR and ARR PRC) (ARMOUR or the Company) today announced the appointment of Vice President of Finance and Controller Gordon Harper as Chief Financial Officer and Secretary, effective March 11, 2024. He will remain Controller of the Company. Mr. Harper succeeds James Mountain, who was removed as Chief Financial Officer and Secretary. Mr. Harper has served as the Vice President of Finance and Controller for the Company as well as its external manager, ARMOUR Capital Management LP, since 2015. He became a named executive officer of the Company in February 2017. Prior to ARMOUR, Mr. Harper spent 25 years at Deloitte as an audit client service partner, serving banking and insurance clients in the United States, Canada and the Caribbean. Mr. Harper is a Chartered Professional Accountant Ontario, and a Certified Public Accountant, Illinois. The Company is continuing to work toward filing its Form 10-K for the fiscal year ended December 31, 2023, on or before March 15, 2024. About ARMOUR Residential REIT, Inc.ARMOUR invests primarily in fixed rate residential, adjustable rate and hybrid adjustable rate residential mortgage-backed securities issued or guaranteed by U.S. Government-sponsored enterprises or guaranteed by the Government National Mortgage Association. ARMOUR is externally managed and advised by ARMOUR Capital Management LP, an investment advisor registered with the Securities and Exchange Commission (SEC). Safe Harbor This press release includes forward-looking statements within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Actual results may differ from expectations, estimates and projections and, consequently, you should not rely on these forward-looking statements as predictions of future events. Words such as expect, estimate, project, budget, forecast, anticipate, intend, plan, may, will, could, should, believes, predicts, potential, continue, and similar expressions are intended to identify such forward-looking statements. These forward-looking statements involve significant risks and uncertainties that could cause the actual results to differ materially from the expected results. The Company disclaims any obligation to release publicly any updates or revisions to any forward-looking statement to reflect any change in its expectations or any change in events, conditions or circumstances on which any such statement is based, except as required by law. Additional Information and Where to Find ItInvestors, security holders and other interested persons may find additional information regarding the Company at the SECs internet site at www.sec.gov, or the Company website at www.armourreit.com or by directing requests to: ARMOUR Residential REIT, Inc., 3001 Ocean Drive, Suite 201, Vero Beach, Florida 32963, Attention: Investor Relations. Contact: Investors:investor@armourreit.comJeffrey J. Zimmer / Scott J. Ulm ARMOUR Residential REIT, Inc.(772) 617-4340 Media:Meaghan Repko / Mahmoud Siddig / Tim RagonesJoele Frank, Wilkinson Brimmer Katcher(212) 355-4449 Who is the new Chief Financial Officer and Secretary of ARMOUR Residential REIT, Inc.? Gordon Harper has been appointed as the new Chief Financial Officer and Secretary, replacing James Mountain. What is Gordon Harper's background and experience? Gordon Harper has 25 years of experience at Deloitte, serving banking and insurance clients in the US, Canada, and the Caribbean. He is a Chartered Professional Accountant Ontario and a Certified Public Accountant, Illinois. When did Gordon Harper become a named executive officer of the Company? Gordon Harper became a named executive officer of the Company in February 2017. What is the Company's timeline for filing its Form 10-K for the fiscal year ended December 31, 2023? The Company aims to file its Form 10-K on or before March 15, 2024. Who was Gordon Harper's predecessor at ARMOUR Residential REIT, Inc.? James Mountain was the predecessor of Gordon Harper as Chief Financial Officer and Secretary. What is ARMOUR Residential REIT, Inc.'s ticker symbol? The ticker symbol for ARMOUR Residential REIT, Inc. is ARR."
Crown Castle Deserves Better: An Open Letter to Shareholders from Crown Castle Co-Founder Ted B. Miller,2024-03-13T22:13:00.000Z,Moderate,Neutral,"Crown Castle Inc. faces a critical moment as co-founder Ted B. Miller and Boots Capital Management issue an open letter urging immediate action to restore leadership and prevent further erosion of shareholder value. The company's detailed operating plan aims to bolster leadership, maximize the value of its fiber business, and position Crown Castle as a premier tower company. With potential to reach $150 in the next 18 months, the plan emphasizes the need for experienced tower professionals to drive operational excellence and create lasting value.","Crown Castle Deserves Better: An Open Letter to Shareholders from Crown Castle Co-Founder Ted B. Miller Rhea-AI Impact (Moderate) Rhea-AI Sentiment (Neutral) Tags Rhea-AI Summary Crown Castle Inc. faces a critical moment as co-founder Ted B. Miller and Boots Capital Management issue an open letter urging immediate action to restore leadership and prevent further erosion of shareholder value. The company's detailed operating plan aims to bolster leadership, maximize the value of its fiber business, and position Crown Castle as a premier tower company. With potential to reach $150 in the next 18 months, the plan emphasizes the need for experienced tower professionals to drive operational excellence and create lasting value. Positive Detailed operating plan to restore operational excellence and bolster leadership. Recommendation of four directors with world-class experience to make a valuable difference. Urgent need for comprehensive leadership change highlighted by Elliott Investment Management L.P. Study of the fate of the fiber business and completion of a detailed plan for a fiber sale by Boots Capital. Call for a top-to-bottom reboot with trusted, long-term leadership and a concrete plan for the fiber sale. Devoted seven months to a vetted and detailed plan focused on operational excellence. Nominees provide unrivaled tower-industry experience and expertise to complement the current Board. Focus on building shareholder value rather than legal maneuvers highlighted, including scrutiny of the Cooperation Agreement with Elliott. Court's order emphasizes the need to stop being adversaries and work together to improve the Company and shareholder prospects. Emphasis on the personal investment and commitment of the co-founder in the future of Crown Castle. Negative Limited number of questions raised by the Board during the presentation of the detailed plan. Scrutiny of the Cooperation Agreement with Elliott and legal maneuvers affecting shareholder value. Expensive and distracting litigation surrounding the Company's actions and decisions. Need for a more diverse Board with depth of tower operating and public-company CEO experience. Financial Analyst The open letter from Ted B. Miller and Boots Capital Management to the Crown Castle Board of Directors indicates a significant push towards strategic changes within the company, specifically targeting the sale of the fiber business and a restructuring of leadership to enhance operational excellence. This initiative, if executed, could potentially lead to a rerating of Crown Castle's stock and impact its market valuation. The advocacy for new board members with extensive tower industry experience suggests a strategic pivot that could streamline the company's focus on its core tower operations.From a financial perspective, the sale of the fiber business could unlock capital to be reinvested in core competencies or returned to shareholders. However, the success of this divestiture will depend on the valuation of the fiber assets and market conditions at the time of sale. Shareholders might experience short-term volatility as the market reacts to these proposed changes and the ongoing litigation with Elliott. Long-term implications include the potential for improved operational efficiency and shareholder value, but this hinges on the effectiveness of the new leadership and their strategic decisions. Market Research Analyst The telecom infrastructure industry, particularly tower operations, is highly competitive and requires specialized expertise. Miller's push for a board with deep industry knowledge aligns with the need for strategic decision-making in a rapidly evolving market. The emphasis on operational excellence could resonate with investors who are looking for companies with strong and focused management teams. Furthermore, the outcome of the litigation with Elliott and the subsequent actions taken by the board could signal to the market the company's commitment to governance and shareholder interests.It is also important to consider the broader industry trend of consolidation and specialization within telecom infrastructure providers. If Crown Castle successfully repositions itself as a 'premier pure-play tower company,' it could benefit from increased investor interest in a sector that is critical for the deployment of 5G technology and beyond. However, this transition must be managed carefully to avoid disruption to current operations and preserve customer relationships. Legal Expert The Delaware Vice Chancellor's comments and the ongoing litigation underscore the legal complexities involved in shareholder activism and corporate governance disputes. The court's scrutiny of the Cooperation Agreement and the requirement for advance notice to Miller in the event of significant corporate actions, such as hiring a new CEO or selling the fiber unit, highlight the importance of transparency and due process in corporate decision-making.For stakeholders, the legal proceedings could serve as a catalyst for change or a deterrent, depending on the outcome. While the court's involvement might expedite a resolution, it also adds an element of uncertainty that can affect investor sentiment. The litigation's resolution will be critical in setting a precedent for how Crown Castle addresses shareholder concerns and navigates complex governance issues in the future. 03/13/2024 - 06:13 PM Provides Detailed Operating Plan to Restore Operational Excellence, Bolster Leadership with Experienced Tower Professionals, Maximize Value of the Company's Fiber Business to Position Crown Castle as Premier Pure-Play Tower Company Believes Crown Castle Can be Worth at Least $150 in the Next 18 Months if Board Takes Immediate Action to Restore Leadership and Prevent Further Erosion of Shareholder Value HOUSTON, March 13, 2024 /PRNewswire/ -- Ted B. Miller, co-founder of Crown Castle Inc., (NYSE: CCI) (""Crown Castle"" or the ""Company"") and his investment vehicle Boots Capital Management, LLC (""Boots Capital"") today issued the following open letter to the Crown Castle Board of Directors (the ""Board""), the Company's employees, and its shareholders: This is a crucial moment for Crown Castle, its shareholders and employees. It's why we have recommended a slate of four directors who we believe will make a valuable difference with their world class experience, skills and leadership. While the Board has undergone significant change in recent years, this turnover has still left it lacking directors who have the depth of tower operating and public-company CEO experience essential to drive the Company forward. A need for comprehensive leadership change was also put forth by Elliott Investment Management L.P. (""Elliott"") in its November 27, 2023 letter to the Board. At long last, Crown Castle is, after prodding from Elliott, studying the fate of its fiber business. Bankers and lawyers have been hired to do their typical work. That work together with a detailed plan for a fiber sale and a rerating of Crown Castle stock has been completed by Boots and offered to the Company without response. But in our view the work does not stop there. Crown Castle is in dire need of a top-to-bottom reboot with trusted, long-term leadership. The Company needs a concrete plan for the fiber sale, and then an operational revival informed by people who live and breathe towers. We have devoted seven months to a vetted and detailed plan that we believe will create lasting value through a commitment to operational excellence. We shared this detailed plan with the Board during a 90-minute meeting in January. Not surprisingly  since only one member of the Board has any experience as an executive of a tower business  there were a very limited number of questions raised, even then primarily asked by advisors. Meanwhile, many shareholders have responded to our approach and nominees with the response: ""Why wouldn't Crown Castle do this?"" Our nominees provide unrivaled tower-industry experience and expertise and offer a critical operational complement to the academic, legal, telecom-services and asset-management background of the current Board. As a large shareholder, we expect the Board to have a laser focus on building shareholder value, rather than be involved in ""clever"" legal maneuvers such as the Cooperation Agreement with Elliott, which was hastily rewritten after we challenged it in court. That agreement is even under more scrutiny, after the Delaware Vice Chancellor hearing our case rejected a Company effort to delay the hearing of the case, saying last week that ""there are colorable claims"" to the way the Cooperation Agreement was struck. The court also said that the Company should give me advance notice to object should it hire a new CEO or sell the fiber unit. The court's order should be a sign to all involved in this expensive and distracting litigation: That enough is enough. It's time to stop being adversaries and work together to improve the Company and all shareholder prospects, as we've intended all along. To be clear: this is not ""a trade"" for me. I co-founded Crown Castle. I care deeply about the long-term success of the Company. And I am here for the long-term. With our plan, it's time to restore Crown Castle to its prominence as a pure-play tower company, and reestablish it as one of the most strategically important American companies. Outlined below are details about what our four highly qualified nominees intend to do and why our multi-pronged operating plan to improve Crown Castle is value enhancing. 1) Creating Value From the Fiber Sale Based on our analysis, since the decision was made to invest in fiber, we believe the unit has required $22 billion of capital and continues to consume over a billion in capital expenditures each year  2024 management guidance is $1.4 billion alone. The Board has announced that it is studying the possible sale of the fiber segment, and we also believe that the Board is weighing whether to sell the enterprise fiber business while retaining the small cells. We have spent seven months modeling every possible structure for a sale of fiber from an operational, financial and tax perspective. While the particulars of any transaction must be evaluated on their own merit, our work has given us a very clear point-of-view: there is much more value to be created by selling an estimated 75% interest in the entire fiber/small-cell portfolio, as it resets Crown Castle as a more capital-efficient tower operator. There is a role for small cells in our industry, but our modeling revealed Crown Castle would earn an underwhelming return on its capital on the current fiber/small cells business through at least 2050. A sale of the fiber business is essential for our intended value-creating path as a pure play tower company, with, in our view, a multiple of at least 25 times EBITDA compared to 18 times today. Moreover, if the Company can conclude a fiber sale in 2024, we believe more than $1 billion can be saved in tax efficiencies. The Board nonetheless has ignored our hundreds of pages of thorough analysis, which could be leveraged by its advisors instead of recreating the wheel, and elected not to work with us to evaluate the details of the $1 billion in potential value that could be saved in tax efficiencies. When it comes to executing the fiber sale, time is literally money. And this Board is burning both. We believe our carefully vetted approach creates the most value and best preserves a healthy, sustainable dividend. 2) Maintaining a Healthy, Sustainable Dividend The financials show that Crown Castle cannot support its current dividend trajectory while maintaining the small-cell buildout pace. In the last three years, Crown Castle has funded the dividend by incurring debt  an approach that we do not believe is sustainable. We have a long-term plan  not a short-term trading strategy  to generate sustainable performance for all shareholders. Our approach will drive meaningful operational improvements to enhance margins, as outlined in our unredacted board presentation, which we released yesterday. Our plan protects the underlying health of the dividend and the absolute dividend amount itself. Specifically, our plan offers the Company optionality to pay a $4.62 dividend solely out of cash flow (as outlined in our presentation) or incur an estimated $1.3b of debt in total between now and 2029 and sustain the dividend at its current $6.26 level. This creates soundness and flexibility around the dividend, about which we will continue to take soundings from the shareholder base. Either way, we believe our plan would materially improve Crown Castle's cash flow dynamics. Our approach creates the most value and best preserves a healthy, sustainable dividend. With the fiber sale, we estimate this extra value to be an additional $40+ per share for Crown Castle shareholders. 3) Restoring Operational Excellence We have heard the question asked: Why do the shareholders need our slate if the Board has been recently reconstituted? Start with a simple number. Crown Castle has a 12-person Board, yet only one of its members includes a tower business in their resume. The Board's sum of towers-operating experience from one board member is just seven years. And only one current director has been a public company CEO  of a bank. This is a $75 billion enterprise with virtually no senior leadership experience running either public or tower companies. Our director candidates have over 50 combined years of direct and unrivaled leadership in the towers space and have created billions of dollars of value for investors. Three of us were at the founding of the industry itself, and have remained involved for the 30 years since. That sounds like exactly what Elliott had in mind in its December letter to the Board: ""How much more value destruction will this Board permit before finally taking action and changing the leadership of Crown Castle?"" Yet, over the past several years, much of Crown Castle's executive management team has stepped down, including its former CEO, CFO, and EVP/COO of towers. This Company must urgently attract and retain leaders with the experience, vision and confidence to execute the operational changes and tower-focused innovation necessary for a better future. This need is all the more acute because of a brain drain that has persisted at towers since the fiber investments began. We believe this pattern of departures, coupled with the fact that the Board had no succession plan  a primary obligation of any board  and is still in the process of conducting its CEO search, reflects a lack of leadership and operational capability at the management level as well as the failure of the Board's overall strategic initiatives. Not all of Crown Castle's needed changes will be easy. Transformation must start from the top  from Board leadership. And that Board requires leaders with credibility, operational expertise, and a strong vision for the future at a difficult moment like this. Crown Castle employees want to feel like they're understood, and customers want to know they're being listened to. As founder and a substantial shareholder, I have a special perch from which to drive a cultural and operational reawakening, yet the Board continues to refuse to meaningfully engage with us or our value enhancing proposal. We will keep fighting for our shareholders, employees, suppliers, customers and lenders, and for the future Crown Castle deserves. INVESTOR AND MEDIA CONTACTS Investors:Morrow Sodali LLCPaul Schulman/William Dooley/Jonathan EylBy Phone: 1-800-662-5200 or 208-658-9400By Email: Boots@info.morrowsodali.com Media:Jonathan Gasthalter/Nathaniel Garnick/Grace CartwrightGasthalter & Co.By Phone: 212-257-4170By Email: bootscapital@gasthalter.com CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS The information herein contains ""forward-looking statements."" Specific forward-looking statements can be identified by the fact that they do not relate strictly to historical or current facts and include, without limitation, words such as ""may,"" ""will,"" ""expects,"" ""believes,"" ""anticipates,"" ""plans,"" ""estimates,"" ""projects,"" ""potential,"" ""targets,"" ""forecasts,"" ""seeks,"" ""could,"" ""should"" or the negative of such terms or other variations on such terms or comparable terminology. Similarly, statements that describe the Participants' (as defined below) objectives, plans or goals are forward-looking. Forward-looking statements are subject to various risks and uncertainties and assumptions. There can be no assurance that any idea or assumption herein is, or will be proven, correct. If one or more of the risks or uncertainties materialize, or if the underlying assumptions of Boots Capital (as defined below) or any of the other Participants in the proxy solicitation described herein prove to be incorrect, the actual results may vary materially from outcomes indicated by these statements. Accordingly, forward-looking statements should not be regarded as a representation by Boots Capital or the other Participants that the future plans, estimates or expectations contemplated will ever be achieved. You should not rely upon forward-looking statements as a prediction of actual results and actual results may vary materially from what is expressed in or indicated by the forward-looking statements. Except to the extent required by applicable law, neither Boots Capital nor any Participant will undertake and specifically declines any obligation to disclose the results of any revisions that may be made to any projected results or forward-looking statements herein to reflect events or circumstances after the date of such projected results or statements or to reflect the occurrence of anticipated or unanticipated events. Certain statements and information included herein have been sourced from third parties. Boots Capital and the other Participants do not make any representations regarding the accuracy, completeness or timeliness of such third party statements or information. Except as may be expressly set forth herein, permission to cite such statements or information has neither been sought nor obtained from such third parties. Any such statements or information should not be viewed as an indication of support from such third parties for the views expressed herein. CERTAIN INFORMATION CONCERNING THE PARTICIPANTS Boots Capital and the other Participants (as defined below) intend to file a preliminary proxy statement and accompanying GOLD universal proxy card (the ""Proxy Statement"") with the Securities and Exchange Commission (the ""SEC"") to be used to solicit proxies for, among other matters, the election of its slate of director nominees at the 2024 annual meeting of shareholders (the ""2024 Annual Meeting"") of Crown Castle Inc., a Delaware corporation (""Crown Castle"" or the ""Corporation""). The participants in the proxy solicitation are currently anticipated to be Boots Parallel 1, LP, Boots, LP (and together with Boots Parallel 1, LP, the ""Boots Funds""), Boots Capital Management, LLC (""Boots Capital""), Boots GP, LLC (""Boots GP""), 4M Management Partners, LLC (""4M Management Partners""), 4M Investments, LLC (""4M Investments""), WRCB, L.P. (""WRCB""), Theodore B. Miller, Jr. and Tripp H. Rice (collectively, the ""Boots Parties""); and Charles Campbell Green III and David P. Wheeler (together with Mr. Miller and Mr. Rice, the ""Boots Nominees,"" and together with the Boots Parties, the ""Participants""). Boots GP, as the general partner of each of the Boots Funds, and 4M Management Partners, as the investment advisor of each of the Boots Funds, may each be deemed to beneficially own interests in an aggregate of 784,009 shares of the Corporation's common stock, $0.01 par value (the ""Common Stock"") held in the Boots Funds (including interests in 182,997 shares of Common Stock underlying over-the-counter forward purchase contracts and interests in 601,012 shares of Common Stock underlying over-the-counter share option contracts). WRCB beneficially owns interests in 135 shares of Common Stock underlying a call option. Mr. Miller has direct ownership of 200 shares of Common Stock, which includes 100 shares of Common Stock held of record and 100 shares of Common Stock held of record as tenant in common with his wife. In addition, Mr. Miller may be deemed to beneficially own interests in an aggregate of 784,716.958 shares of Common Stock (which includes interests in 784,009 shares of Common Stock held by the Boots Funds, which Mr. Miller may be deemed to beneficially own as the President and managing member of 4M Management Partners and a Manager and the President of Boots GP, interests in 400 shares of Common Stock underlying call options owned beneficially and as a tenant in common with his wife, interests in 135 shares of Common Stock underlying a call option owned beneficially by WRCB, which Mr. Miller may be deemed to beneficially own as sole member of one of the general partners of WRCB, and 172.958 shares of Common Stock held through the Corporation's 401(k) Plan in the Crown Castle Stock Fund. Mr. Rice is the record holder of 100 shares of Common Stock and, as the Vice President of 4M Management Partners and a Manager and the Vice President of Boots GP, Mr. Rice may be deemed to beneficially own interests in 784,009 shares of Common Stock held by the Boots Funds. Mr. Green beneficially owns 1,736 shares of Common Stock in joint tenancy with his wife. All of the foregoing information is as of the date hereof unless otherwise disclosed. IMPORTANT INFORMATION AND WHERE TO FIND IT BOOTS CAPITAL STRONGLY ADVISES ALL SHAREHOLDERS OF CROWN CASTLE TO READ THE PRELIMINARY PROXY STATEMENT, ANY AMENDMENTS OR SUPPLEMENTS TO SUCH PROXY STATEMENT, THE DEFINITIVE PROXY STATEMENT, AS WELL AS PROXY MATERIALS FILED BY CROWN CASTLE AS THEY BECOME AVAILABLE BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION. SUCH PROXY MATERIALS WILL BE AVAILABLE AT NO CHARGE ON THE SEC'S WEBSITE AT WWW.SEC.GOV. IN ADDITION, THE PARTICIPANTS IN THIS PROXY SOLICITATION WILL PROVIDE COPIES OF THE PROXY STATEMENT WITHOUT CHARGE, WHEN AVAILABLE, UPON REQUEST. REQUESTS FOR COPIES SHOULD BE DIRECTED TO THE PARTICIPANTS' PROXY SOLICITOR. View original content:https://www.prnewswire.com/news-releases/crown-castle-deserves-better-an-open-letter-to-shareholders-from-crown-castle-co-founder-ted-b-miller-302088656.html SOURCE Boots Capital Management, LLC What is the purpose of the detailed operating plan issued by Ted B. Miller and Boots Capital Management? The plan aims to restore operational excellence, bolster leadership, and maximize the value of Crown Castle's fiber business. Why is there a call for comprehensive leadership change at Crown Castle? The need for comprehensive leadership change is highlighted due to the lack of directors with essential tower operating and public-company CEO experience. What is the significance of the court's order regarding the Cooperation Agreement with Elliott? The court's order emphasizes the need to stop being adversaries, work together to improve the Company, and give advance notice in case of significant decisions like hiring a new CEO or selling the fiber unit. How long has Boots Capital dedicated to developing the detailed plan for Crown Castle? Boots Capital has devoted seven months to a vetted and detailed plan focused on operational excellence. What is the expected value of Crown Castle in the next 18 months according to the plan? The plan suggests that Crown Castle can be worth at least $150 in the next 18 months if immediate action is taken to restore leadership and prevent further erosion of shareholder value."
"Gold Resource Corporation Reports Results of Operations for the Year Ended December 31, 2023",2024-03-13T20:59:00.000Z,Low,Neutral,"Gold Resource Corporation (GORO) releases full-year operational results for 2023, highlighting 18,534 ounces of gold, 1,036,229 ounces of silver, and more. The company faces challenges with lower financial results due to external factors like a strengthened Mexican Peso and lower metal prices. Despite this, the company maintains a cash balance of $6.3 million with no debt and working capital of $15.2 million. The completion of the Back Forty Optimization Study shows promising economic returns, while ongoing exploration efforts aim to enhance future mine plans and resources. The company's focus remains on maximizing shareholder value through strategic alternatives, including a potential sale or merger.","Gold Resource Corporation Reports Results of Operations for the Year Ended December 31, 2023 Rhea-AI Impact (Low) Rhea-AI Sentiment (Neutral) Tags Rhea-AI Summary Gold Resource Corporation (GORO) releases full-year operational results for 2023, highlighting 18,534 ounces of gold, 1,036,229 ounces of silver, and more. The company faces challenges with lower financial results due to external factors like a strengthened Mexican Peso and lower metal prices. Despite this, the company maintains a cash balance of $6.3 million with no debt and working capital of $15.2 million. The completion of the Back Forty Optimization Study shows promising economic returns, while ongoing exploration efforts aim to enhance future mine plans and resources. The company's focus remains on maximizing shareholder value through strategic alternatives, including a potential sale or merger. Positive None. Negative Lower financial results than planned due to external factors like a strengthened Mexican Peso and lower metal prices. Cash balance decreased by $17.4 million from the previous year, primarily driven by cash outflows for capital investments and operating activities. Working capital decreased by 29% from the previous year, mainly due to the decline in cash balance. Total cash costs and all-in sustaining costs per gold equivalent ounce were $1,250 and $1,630, respectively. The company suspended future quarterly dividends to focus on exploration and resource development. Formal review process initiated to evaluate strategic alternatives for maximizing shareholder value, including a potential sale or merger of the company. Financial Analyst Gold Resource Corporation's announcement of its full-year operational results and corporate update presents several key financial metrics that are crucial for evaluating the company's performance and future prospects. The reported cash balance of $6.3 million at the end of 2023, alongside a working capital of $15.2 million, are indicators of the company's liquidity and short-term financial health. A significant decrease from the previous year's figures could indicate cash flow challenges or large capital expenditures. The total cash cost after co-product credits of $1,250 per gold equivalent ounce is a vital measure of production efficiency, directly impacting profitability. The net loss of $16.0 million and operating cash outflow of $5.2 million are concerning, as they suggest the company is not currently generating profit from its operations.The suspension of future quarterly dividends reflects a strategic shift to preserve capital and focus on exploration and development, which could be seen as a move to strengthen long-term value at the expense of short-term shareholder returns. The initiation of a formal review process to evaluate strategic alternatives, including a potential sale or merger, is a signal that the company is actively seeking ways to enhance shareholder value, which could lead to significant stock market movement depending on the outcome of this review. Market Research Analyst From a market perspective, the operational results and strategic decisions of Gold Resource Corporation are likely to influence investor sentiment. The production and sale of 18,534 ounces of gold and 1,036,229 ounces of silver, along with other metals like zinc, copper and lead, show the company's diverse commodity exposure, which can affect its resilience to metal price volatility. The lower metal prices for co-product metals and external factors such as the strengthened Mexican Peso and increased local power costs have negatively impacted the financial results, which is critical information for investors considering the company's exposure to commodity prices and exchange rate risks.The Back Forty Optimization Study results, indicating an After-Tax NPV6% of $214 million with a 25.7% IRR and a 2.5-year payback, are promising for the project's future profitability and could be a catalyst for future investment. However, the environmental considerations and the success of the permitting process will be crucial for the project's advancement and are factors that environmentally-conscious investors will monitor closely. Mining Industry Analyst Analyzing the operational specifics, the Don David Gold Mine has achieved a lost time injury frequency rate of 0.96 per million hours, substantially below the industry benchmark, indicating a strong safety culture that could lead to fewer operational disruptions. The discovery of the Gloria vein system and the successful testing of northern extensions of existing veins signal potential for resource expansion, which is critical for the mine's long-term sustainability and could positively impact the stock valuation if these explorations translate into increased reserves.The decrease in royalty fee from 5% to 3% for certain mining claims is a positive development that will reduce operational costs. However, the company's 2024 guidance with projected production costs and capital investments suggests an anticipation of increased spending, which could pressure the company's financials if not offset by higher metal prices or production efficiencies. 03/13/2024 - 04:59 PM DENVER--(BUSINESS WIRE)-- Gold Resource Corporation (NYSE American: GORO) (the Company) is pleased to announce its full-year operational results from its Don David Gold Mine (DDGM) near Oaxaca, Mexico, and a corporate update on its other activities. 2023 Highlights include: Produced and sold 18,534 ounces of gold and 1,036,229 ounces of silver Produced and sold 10,954 tonnes of zinc, 904 tonnes of copper, and 3,681 tonnes of lead Total cash cost after co-product credits for the full year was $1,250 per gold equivalent ounce Cash balance of $6.3 million with no debt and working capital of $15.2 million at December 31, 2023 Completed Back Forty Optimization Study that indicates an After-Tax of $214 million NPV6% with a 25.7% IRR and a 2.5 year payback Our operational results for the final quarter of 2023 were in line with our mine plan and guidance even though our financial results were lower than planned, stated Allen Palmiere, President and CEO for the Company. Factors that are out of our control affected our bottom line, including a strengthened Mexican Peso to the US dollar, increased local power costs, and lower metal prices for our co-product metals of copper, lead, and zinc. We continue to be committed to the identification and implementation of opportunities that will reduce costs and increase efficiencies to offset these factors as we move forward. Our exploration drilling program at DDGM yielded encouraging drill results from our underground exploration program and will continue with the goal of increasing the average grade of our 2024 mine plan and life of mine resources. We also completed the optimization work for the Back Forty project and filed an inaugural S-K 1300 that resulted in an improved project valuation and increased economic returns, while reducing environment impacts. Corporate and Financial: The Company closed the year with a $6.3 million cash balance as at December 31, 2023. The decrease of $17.4 million from December 31, 2022 is attributable to a cash outflow of $12.5 million for capital investments and a cash outflow of $5.2 million from operating activities for 2023, which included $7.8 million of income tax payments for the tax years 2022 and 2023, exploration investment of $4.2 million at the DDGM, and $1.6 million in spending on the Back Forty Project optimization work, offset by a $0.2 million increase in the value of cash due to the strengthening of the peso. Working capital at December 31, 2023, was $15.2 million, a 29% decrease from the December 31, 2022, working capital of $21.4 million. The decrease is primarily driven by the decline in cash balance discussed above. DDGM total cash costs (after co-product credits) and total all-in sustaining cost per gold equivalent (AuEq)1 ounce sold were $1,250 and $1,630, respectively. See Item 7. Managements Discussion and Analysis of Financial Condition and Results of OperationsNon-GAAP Measures below for a reconciliation of non-GAAP measures to applicable GAAP measures. The Companys At-The-Market Offering Agreement with H.C. Wainwright & Co., LLC (the Agent), which was entered into in November 2019 (the ATM Agreement), pursuant to which the Agent agreed to act as the Companys sales agent with respect to the offer and sale from time to time of the Companys common stock having an aggregate gross sales price of up to $75.0 million, was renewed in June 2023. On February 13, 2023, the Company announced the suspension of future quarterly dividends to protect the balance sheet and to focus capital resources on exploration and resource and reserve development. In November 2023, the Companys Board of Directors decided to initiate a formal review process, with the assistance of outside financial and legal advisors, to evaluate strategic alternatives for the Company. The comprehensive process, which is ongoing, is evaluating a broad range of options to maximize shareholder value, including a potential sale or merger of the Company. Don David Gold Mine: The Don David Gold Mine (DDGM) safety program aims to bolster the overall health and safety culture of our employees. In 2023, two incidents resulting in lost time were recorded. Despite their low potential for harm, comprehensive investigations were conducted, and requisite measures were implemented accordingly. The full year lost time injury frequency rate per million hours was 0.96, which is substantially below the 3.95 Camimex (Mexican Chamber of Mines) benchmark.2 DDGM received the Mexican Empresa Socialmente Responsable (ESR) award in 2023 for the ninth consecutive year. The Don David Gold Mine produced and sold a total of 31,085 gold equivalent ounces, comprising of 18,534 gold ounces and 1,036,229 silver ounces, sold at an average price per ounce of $1,955 and $23.68, respectively. During the year, our exploration program was executed as planned, maintaining a dual focus on both infill and expansion drilling, with encouraging results from targets in the Switchback, Arista, and Three Sisters vein systems. The 2023 expansion (step-out) drilling program proved highly successful, culminating in the discovery of the Gloria vein system, located immediately north of the Three Sisters system, as well as successfully testing the projected northern extensions of the Splay 31 and Marena North veins of the Arista system. The Company purchased over two thousand tonnes of tailings material for $0.3 million from a third-party artisanal mining operation as a collaborative initiative with the local community at the end of 2022. Some of this material was processed in early 2023 to ensure the proper environmental treatment and storage of the material. During the fourth quarter of 2023, negotiations were successfully undertaken to decrease the royalty fee from 5% to 3% for the mining claims at La Tehuana, El Aguila, and Mina El Aire. Back Forty Project: Optimization work related to the metallurgy and the economic model for the Back Forty Project in Michigan, USA was completed, and the Company filed the Back Forty Project Technical Report Summary, which was prepared in accordance with subpart 1300 of Regulation S-K (S-K 1300), as Exhibit 96.1 to the Form 8-K filed on October 26, 2023 (the Back Forty Project Technical Report Summary). Results of the work indicate a more robust economic project with no planned impacts to wetlands that is more protective of the environment, which should facilitate a successful mine permitting process. Full Year 2023 Financial Results Financial Measures (Unaudited) ($s in millions) Cash balance at December 31, 2023 $6.3 For the Year Ended December 31, 2023 Cash used in operating activities $(5.2) Net loss $(16.0) Net sales $97.7 Production costs $76.1 Depreciation, amortization, & reclamation $26.1 Mining gross loss $(5.3) EBITDA $4.4 2023 Capital and Exploration Investment Summary For the nine months ended September 30, 2023 2023 full year guidance (in thousands) Sustaining Investments: Underground Development Capital $ 4,386 Infill Drilling Capitalized Exploration 4,096 Other Sustaining Capital Capital 1,420 Surface and Underground Exploration Development & Other Capitalized Exploration 1,139 Subtotal of Sustaining Investments: 11,041 $ 9 - 11 million Growth Investments: DDGM growth: Surface Exploration / Other Exploration 2,240 Underground Exploration Drilling Exploration 1,927 Underground Exploration Development Capitalized Exploration 357 Back Forty growth: Back Forty Project Optimization & Permitting Exploration 1,642 Subtotal of Growth Investments: 6,166 $ 6 - 7 million Total Capital and Exploration: $ 17,207 $ 15 - 18 million Trending Highlights 2022 2023 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Operating Data Total tonnes milled 136,844 129,099 110,682 116,616 117,781 113,510 116,626 111,254 Average Grade - Gold (g/t) 3.00 2.63 1.98 2.51 2.33 1.59 1.52 1.44 Silver (g/t) 81 64 80 109 94 86 73 85 Copper (%) 0.41 0.32 0.37 0.45 0.37 0.37 0.32 0.39 Lead (%) 1.97 1.99 1.59 1.58 1.73 1.64 1.29 1.39 Zinc (%) 4.89 4.00 4.21 4.27 3.88 3.72 3.24 2.95 Metal production (before payable metal deductions) Gold (ozs.) 11,187 9,317 5,851 7,767 7,171 4,637 4,443 4,077 Silver (ozs.) 332,292 249,088 261,256 370,768 322,676 289,816 247,159 282,487 Copper (tonnes) 431 303 296 406 336 334 276 341 Lead (tonnes) 2,073 2,020 1,249 1,323 1,559 1,389 1,048 1,072 Zinc (tonnes) 5,562 4,282 3,901 4,198 3,837 3,569 3,223 2,884 Metal produced and sold Gold (ozs.) 8,381 8,746 5,478 7,514 6,508 4,287 3,982 3,757 Silver (ozs.) 265,407 231,622 225,012 335,168 294,815 274,257 208,905 258,252 Copper (tonnes) 408 286 282 372 332 327 245 327 Lead (tonnes) 1,639 1,755 1,056 941 1,417 1,317 947 820 Zinc (tonnes) 4,359 3,590 2,943 3,265 3,060 3,141 2,571 2,182 Average metal prices realized Gold ($ per oz.) $ 1,898 $ 1,874 $ 1,627 $ 1,734 $ 1,915 $ 2,010 $ 1,934 $1,985 Silver ($ per oz.) $ 23.94 $ 22.05 $ 18.54 $ 21.25 $ 23.04 $ 24.93 $ 23.61 $23.14 Copper ($ per tonne) $ 10,144 $ 9,275 $ 7,115 $ 8,221 $ 9,172 $ 8,397 $ 8,185 $8,205 Lead ($ per tonne) $ 2,347 $ 2,168 $ 1,882 $ 1,954 $ 2,158 $ 2,153 $ 2,196 $2,122 Zinc ($ per tonne) $ 3,842 $ 4,338 $ 3,186 $ 2,577 $ 3,195 $ 2,485 $ 2,195 $2,516 Gold equivalent ounces sold Gold Ounces 8,381 8,746 5,478 7,514 6,508 4,287 3,982 3,757 Gold Equivalent Ounces from Silver 3,348 2,729 2,564 4,107 3,547 3,402 2,550 3,011 Total AuEq oz 11,729 11,475 8,042 11,621 10,055 7,689 6,532 6,768 Financial Data Total sales, net (in thousands) $ 45,417 $ 37,064 $ 23,869 $ 32,374 $ 31,228 $ 24,807 $ 20,552 $21,141 Production Costs (in thousands) $ 20,074 $ 21,722 $ 19,380 $ 19,773 $ 19,850 $ 20,302 $ 18,957 $17,034 Production Costs/Tonnes Milled $ 147 $ 168 $ 175 $ 170 $ 169 $ 179 $ 163 $153 Operating Cash Flows (in thousands) $ 4,230 $ 7,976 ($ 4,292) $ 6,243 $ 1,024 ($ 551) ($ 7,475) $1,783 Net income (loss) (in thousands) $ 4,019 $ 2,673 ($ 9,730) ($ 3,283) ($ 1,035) ($ 4,584) ($ 7,341) $(3,057) Earnings (loss) per share - basic $ 0.05 $0.03 ($ 0.11) ($ 0.04) ($ 0.01) ($ 0.05) ($ 0.08) $(0.03) Trending Highlights of Non-GAAP Measures 2022 2023 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 (in thousands, except per oz) Gold equivalent ounces sold (oz) 11,729 11,475 8,042 11,621 10,055 7,689 6,532 6,768 Total production costs $ 20,074 $ 21,722 $ 19,380 $ 19,773 $ 19,850 $ 20,302 $ 18,957 $ 17,034 Treatment and refining charges 2,748 3,137 2,860 3,327 3,184 3,328 2,788 2,330 Co-product credits (1) (24,732) (22,027) (13,369) (13,314) (15,881) (13,384) (9,733) (9,908) Total cash cost after co-product credits ($ 1,910) $ 2,832 $ 8,871 $ 9,786 $ 7,153 $ 10,246 $ 12,012 $ 9,456 Total cash cost after co-product credits per AuEq oz sold ($ 163) $ 247 $ 1,103 $ 842 $ 711 $ 1,333 $ 1,839 $ 1,397 Sustaining - capitalized expenditure $ 4,596 $ 4,028 $ 3,605 $ 4,110 $ 2,588 $ 2,187 $ 3,489 $ 1,638 Sustaining - Exploration Expenditure - - - - 548 531 52 8 Reclamation and remediation (2) 62 61 58 620 195 200 216 163 Subtotal of DDGM sustaining costs $ 4,658 $ 4,089 $ 3,663 $ 4,730 $ 3,331 $ 2,918 $ 3,757 $ 1,809 DDGM all-in sustaining cost after co-product credits per AuEq oz sold $ 234 $ 603 $ 1,559 $ 1,249 $ 1,043 $ 1,712 $ 2,414 $ 1,664 Sustaining - general and administrative, including stock-based compensation expenses $ 2,673 $ 2,313 $ 2,249 $ 2,768 $ 1,790 $ 2,137 $ 1,662 $ 1,675 Consolidated all-in sustaining cost after co-product credits $ 5,421 $ 9,234 $ 14,783 $ 17,284 $ 12,274 $ 15,301 $ 17,431 $ 12,940 Total consolidated all-in sustaining cost after co-product credits per AuEq oz sold $ 462 $ 805 $ 1,838 $ 1,487 $ 1,221 $ 1,990 $ 2,669 $ 1,912 Non-sustaining cost- capital expenditure $ 1,353 $ 541 $ - $ - $ - $ 147 $ 209 $ 1 Non-sustaining cost- exploration expenditure 2,305 2,837 4,973 2,934 1,839 1,440 1,960 570 Subtotal of non-sustaining costs $ 3,658 $ 3,378 $ 4,973 $ 2,934 $ 1,839 $ 1,587 $ 2,169 $ 571 Total all-in cost after co-product credits $ 9,079 $ 12,612 $ 19,756 $ 20,218 $ 14,113 $ 16,888 $ 19,600 $ 13,511 Total all-in cost after co-product credits per AuEq oz sold $ 774 $ 1,099 $ 2,457 $ 1,740 $ 1,404 $ 2,196 $ 3,001 $ 1,996 (1) Refer to Realized/Unrealized Derivatives for copper, zinc, and lead in the Annual and Quarterly Reports, Item 8 Financial Statements and Supplementary Data: Fair Value Measurement and Item 1Condensed Consolidated Interim Financial Statements and Notes (unaudited): Fair Value Measurement. Note that Co-product credits for the prior year (2022) comparable numbers were adjusted to include realized embedded derivatives only for co-products (which better represents the cash cost after co-product credits because it now excludes unrealized gains or losses) and align with the current year presentation. (2) Refer to Reclamation and remediation in the Annual and Quarterly Reports, Item 8 Financial Statements and Supplementary Data: Reclamation and Remediation and Item 1Condensed Consolidated Interim Financial Statements and Notes (unaudited): Reclamation and Remediation. Note that the prior years (2022) comparable numbers were adjusted to include Reclamation and remediation (which better represents the all-in sustaining cost after co-product credits because Reclamation and remediation are part of normal operating activities) and to align with the current years presentation. 2024 Guidance The Companys focus continues to be on unlocking the value of the Don David Gold Mine, existing infrastructure, and large property position in Oaxaca, Mexico and therefore we plan to make significant investments for infrastructure and exploration in 2024. Measure 2024 Guidance Metals Produced & Sold 13,000 to 15,000 Gold Ounces 1,250,000 to 1,400,000 Silver Ounces 29,500 to 31,500 Gold Equivalent Ounces Cash Cost after Co-product Credits per AuEq ounces (1) (2) $1,100 to $1,300 All-in-Sustaining Cost after Co-Product Credits per AuEq ounce (1) $1,450 to $1,650 (DDGM) $1,600 to $1,800 (Consolidated) Capital Investment (DDGM) $6.8 to $8.0 million (Sustaining Capital) $2.0 to $3.0 million (Sustaining Capitalized Exploration) $0.5 to $0.8 million (Non-Sustaining Capitalized Exploration) Exploration Investment (DDGM) $2.0 to $3.5 million (Non-Sustaining Exploration Expense) Back Forty Investment $0.7 to $0.9 million General & Administrative Expense $5.0 to $6.0 million, excluding Stock-based-Compensation (1) Calculations of cost after co-product credits per gold equivalent ounce and all-in sustaining cost after co-product credits per AuEq ounce are non-GAAP financial measures. Please see Item 7. Managements Discussion and Analysis of Financial Condition and Results of OperationsNon-GAAP Measures in the Annual Report for a complete reconciliation of the non-GAAP measures to U.S. GAAP. (2) Co-product credits directly impact the Cash Costs and All-in Sustaining Costs per AuEq ounce calculation. Guidance is based on 3,630 tonnes of lead sold at a $0.95 per pound metal price, 1,007 tonnes of copper sold at a $3.80 per pound metal prices and 10,174 tonnes of zinc sold at a $1.15 per pound metal price. About GRC Gold Resource Corporation is a gold and silver producer, developer, and explorer with its operations centered on the Don David Gold Mine in Oaxaca, Mexico. Under the direction of an experienced board and senior leadership team, the Companys focus is to unlock the significant upside potential of its existing infrastructure and large land position surrounding the mine in Oaxaca, Mexico, and to develop the Back Forty Project in Michigan, USA. For more information, please visit GRCs website, located at www.goldresourcecorp.com, and read the Companys Form 10-K for an understanding of the risk factors associated with its business. Q4 2023 Conference Call The Company will host a conference call on Thursday, March 14, 2024, at 10:00 p.m. Eastern Time. Our 2023 Form 10-K will be filed at a future date, no later than April 1,2024, once our External Audit Firm, BDO USA, P.C., completes their audit procedures. The conference call will be recorded and posted to the Companys website later in the day following the conclusion of the call. Following prepared remarks, Allen Palmiere, President and Chief Executive Officer, Alberto Reyes, Chief Operating Officer, and Chet Holyoak, Chief Financial Officer, will host a live question and answer (Q&A) session. There are two ways to join the conference call. To join the conference via webcast, please click on the following link: https://onlinexperiences.com/Launch/QReg/ShowUUID=F24608AC-00ED-4198-B37C-E83FCE95DDEB To join the call via telephone, please use the following dial-in details: Participant Toll Free: +1 (888) 886-7786 International: +1 (416) 764-8658 Conference ID: 34193701 Please connect to the conference call at least 10 minutes prior to the start time using one of the connection options listed above. Forward-Looking Statements: This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. In some cases, you can identify forward-looking statements by the following words: ""may,"" ""might,"" ""will,"" ""could,"" ""would,"" ""should,"" ""expect,"" ""plan,"" ""anticipate,"" ""intend,"" ""seek,"" ""believe,"" ""estimate,"" ""predict,"" ""potential,"" ""continue,"" ""contemplate,"" ""possible,"" or the negative of these terms or other comparable terminology, although not all forward-looking statements contain these words. They are not historical facts, nor are they guarantees of future performance. Any express or implied statements contained in this announcement that are not statements of historical fact may be deemed to be forward-looking statements, including, without limitation, statements regarding the timing and scope of a process to explore strategic alternatives for the Company, including a potential sale of the Company. It is possible that the Companys actual results, financial condition, and developments may differ, possibly materially, from the anticipated results, developments, and financial condition indicated in these forward-looking statements. Management believes that these forward-looking statements are reasonable as of the time made. However, caution should be taken not to place undue reliance on any such forward-looking statements because such statements speak only as of the date when made. Our Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise, except as required by law. These forward-looking statements are neither promises nor guarantees, but involve known and unknown risks and uncertainties that could cause actual results to differ materially from those projected, including, without limitation: whether the objectives of the strategic alternative review process will be achieved; the terms, structure, benefits and costs of any strategic transaction; the timing of any transaction and whether any transaction will be consummated at all; the risk that the strategic alternatives review and its announcement could have an adverse effect on the ability of the Company to retain and hire key personnel and maintain relationships with suppliers, employees, shareholders, and other business relationships, and on its operating results and business generally; the risk the strategic alternatives review could divert the attention and time of the Companys management; the risk of any unexpected costs or expenses resulting from the review; the risk of any litigation relating to the review; and the risks and uncertainties described in Item 1A. Risk Factors in our Annual report on Form 10-K for the year ended December 31, 2022, and those described from time to time in our future reports filed with the Securities and Exchange Commission. ___________________________ 1 Gold equivalent is determined by taking gold ounces produced and sold, plus silver ounces produced and sold, converted to gold equivalent ounces using the gold to silver average realized price ratio for the period. 2 Further information regarding the Mexican Chamber of Mines benchmark can be found at https://camimex.org.mx/sostenibilidad2023/indicadores.html. Information contained therein is not a part of this report and is not incorporated by reference herein. View source version on businesswire.com: https://www.businesswire.com/news/home/20240313689211/en/ Chet Holyoak Chief Financial Officer Chet.holyoak@grc-usa.com www.GoldResourceCorp.com Source: Gold Resource Corporation What were the highlights of Gold Resource Corporation's operational results for 2023? Gold Resource Corporation produced and sold 18,534 ounces of gold, 1,036,229 ounces of silver, 10,954 tonnes of zinc, 904 tonnes of copper, and 3,681 tonnes of lead. What were the challenges faced by Gold Resource Corporation in 2023? Gold Resource Corporation faced challenges with lower financial results due to external factors like a strengthened Mexican Peso, increased local power costs, and lower metal prices for copper, lead, and zinc. What was the cash balance of Gold Resource Corporation at the end of 2023? Gold Resource Corporation closed the year with a cash balance of $6.3 million. What was the working capital of Gold Resource Corporation at the end of 2023? Gold Resource Corporation had a working capital of $15.2 million at the end of 2023, a 29% decrease from the previous year. What were the total cash costs and all-in sustaining costs per gold equivalent ounce for Gold Resource Corporation in 2023? The total cash cost after co-product credits was $1,250 per gold equivalent ounce, and the total all-in sustaining cost per gold equivalent ounce was $1,630. Why did Gold Resource Corporation suspend future quarterly dividends? Gold Resource Corporation suspended future quarterly dividends to protect the balance sheet and focus capital resources on exploration and resource development. What strategic alternatives is Gold Resource Corporation evaluating to maximize shareholder value? Gold Resource Corporation is evaluating strategic alternatives, including a potential sale or merger of the company, to maximize shareholder value."
Bakkt Notified by NYSE of Non-Compliance with NYSE Trading Share Price Listing Rule,2024-03-13T21:40:00.000Z,Low,Neutral,"Bakkt Holdings, Inc. (BKKT) received a notice from the NYSE regarding non-compliance with the stock price requirement. The company aims to rectify the deficiency within a six-month period to maintain its listing on the NYSE.","Bakkt Notified by NYSE of Non-Compliance with NYSE Trading Share Price Listing Rule Rhea-AI Impact (Low) Rhea-AI Sentiment (Neutral) Tags Rhea-AI Summary Bakkt Holdings, Inc. (BKKT) received a notice from the NYSE regarding non-compliance with the stock price requirement. The company aims to rectify the deficiency within a six-month period to maintain its listing on the NYSE. Positive None. Negative None. Financial Analyst The notification received by Bakkt Holdings, Inc. from the NYSE regarding non-compliance with the minimum share price requirement is a critical financial development. This scenario, often referred to as a 'share price deficiency', can be indicative of market sentiments and underlying financial health. It's important to note that a sub-$1 share price can sometimes lead to reduced investor confidence and potential delisting if not addressed. The six-month cure period provided by the NYSE is a grace period for the company to rectify this issue, with options like a reverse stock split, which consolidates the number of existing shares into fewer, proportionally more valuable shares to boost the stock price.For stakeholders, the short-term focus will be on the company's strategy to regain compliance. A successful increase in share price could stabilize investor confidence, while failure to do so could lead to volatility and further scrutiny of the company's financial stability. Long-term implications hinge on the effectiveness of the chosen remedy and the company's overall performance post-compliance. Market Research Analyst The market's reaction to Bakkt Holdings' share price deficiency and the subsequent steps the company takes to remedy the situation will be telling of the broader market perception of the company's value and prospects. A reverse stock split, while mechanically increasing the share price, does not inherently change the company's market capitalization or address the fundamental issues that may have led to the stock's decline. Investors and analysts will closely monitor the company's operational performance and growth strategies to determine whether the price correction aligns with genuine value creation or is merely a cosmetic change.Moreover, the company's ability to maintain other NYSE listing standards throughout this period is crucial. Any additional non-compliance issues could compound investor concerns and further impact the stock's performance. The situation presents a learning opportunity regarding the delicate balance between stock market regulations, investor relations and corporate governance. 03/13/2024 - 05:40 PM Intends to cure the deficiency and return to compliance with NYSE standard ALPHARETTA, Ga.--(BUSINESS WIRE)-- Bakkt Holdings, Inc. (NYSE: BKKT) announced today that the New York Stock Exchange (the NYSE) notified the Company (the Notice) that the Company is not in compliance with Section 802.01C of the NYSE Listed Company Manual because, as of March 12, 2024, the average closing price of the Companys Class A Common Stock (the Common Stock) was less than $1.00 per share over a consecutive 30-day trading period. The notice does not result in the immediate delisting of the Common Stock from the NYSE. On March 13, 2024, the Company notified the NYSE that it intends to cure the stock price deficiency and to return to compliance with the NYSE continued listing standard. The Company can regain compliance at any time within the six-month period following receipt of the NYSE notice if the Company has a share price of at least $1.00 on the last trading day of any calendar month within the six-month cure period and an average share price of at least $1.00 over the 30 trading-day period ending on the last trading day of that month. Under the NYSEs rules, if the Company determines that it will cure such average stock price deficiency by taking an action that will require stockholder approval, it must so inform the NYSE, and the noncompliance with the price condition will be deemed cured if the price promptly exceeds $1.00 per share and the price remains above that level for at least the following 30 trading days. The Company intends to consider all available alternatives to resolve this issue, including but not limited to a reverse stock split, subject to shareholder approval. The Common Stock will continue to be listed and trade on the NYSE during this period, subject to the Companys compliance with other NYSE continued listing standards. Forward-Looking Statements This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Such statements include, but are not limited to, statements regarding the Companys intention to cure the stock price deficiency, to return to compliance with the NYSE continued listing standard and to consider alternatives, including effecting a reverse stock split, to cure the NYSE continued listing requirement deficiency, among others. Forward-looking statements can be identified by words such as will, likely, expect, continue, anticipate, estimate, believe, intend, plan, projection, outlook, grow, progress, potential or words of similar meaning. Such forward-looking statements are based upon the current beliefs and expectations of Bakkts management and are inherently subject to significant business, economic and competitive uncertainties and contingencies, many of which are difficult to predict and beyond Bakkts control. Actual results and the timing of events may differ materially from the results anticipated in such forward-looking statements as a result of the following factors, among others: Bakkts ability to continue as a going concern; Bakkts ability to grow and manage growth profitably; changes in Bakkts business strategy; Bakkts ability to integrate its acquisitions and achieve desired synergies; Bakkts future capital requirements and sources and uses of cash, including funds to satisfy its liquidity needs; changes in the market in which Bakkt competes, including with respect to its competitive landscape, technology evolution or changes in applicable laws or regulations; changes in the markets that Bakkt targets; disruptions in the crypto market that subject Bakkt to additional risks, including the risk that banks may not provide banking services to Bakkt; the possibility that Bakkt may be adversely affected by other economic, business, and/or competitive factors; the inability to launch new services and products or to profitably expand into new markets and services; the inability to execute Bakkts growth strategies, including identifying and executing acquisitions and Bakkts initiatives to add new clients; Bakkts failure to comply with extensive government regulation, oversight, licensure and appraisals; uncertain regulatory regime governing blockchain technologies and crypto; the inability to develop and maintain effective internal controls and procedures; the exposure to any liability, protracted and costly litigation or reputational damage relating to Bakkts data security; the impact of any goodwill or other intangible assets impairments on Bakkts operating results; Bakkts inability to maintain the listing of its securities on the NYSE; and other risks and uncertainties indicated in Bakkts filings with the Securities and Exchange Commission. You are cautioned not to place undue reliance on such forward-looking statements. Such forward-looking statements relate only to events as of the date on which such statements are made and are based on information available to us as of the date of this press release. Unless otherwise required by law, we undertake no obligation to update any forward-looking statements made in this press release to reflect events or circumstances after the date of this press release or to reflect new information or the occurrence of unanticipated events. About Bakkt Founded in 2018, Bakkt builds solutions that enable our clients to grow with the crypto economy. Through institutional-grade custody, trading, and onramp capabilities, our clients leverage technology thats built for sustainable, long-term involvement in crypto. Bakkt is headquartered in Alpharetta, GA. For more information, visit: https://www.bakkt.com/ | X (Formerly Twitter) @Bakkt | LinkedIn https://www.linkedin.com/company/bakkt/. Bakkt-C View source version on businesswire.com: https://www.businesswire.com/news/home/20240313401585/en/ Investor Relations Ann DeVries, Head of Investor Relations Ann.DeVries@bakkt.com Media press@bakkt.com Source: Bakkt Holdings, Inc. What notification did Bakkt Holdings, Inc. receive from the NYSE? Bakkt Holdings, Inc. received a notice from the NYSE stating that the company is not in compliance with Section 802.01C of the NYSE Listed Company Manual. What was the average closing price of Bakkt Holdings' Common Stock as of March 12, 2024? As of March 12, 2024, the average closing price of Bakkt Holdings' Common Stock was less than $1.00 per share over a consecutive 30-day trading period. How can Bakkt Holdings regain compliance with NYSE listing standards? Bakkt Holdings can regain compliance by having a share price of at least $1.00 on the last trading day of any calendar month within the six-month cure period and an average share price of at least $1.00 over the 30 trading-day period ending on the last trading day of that month. What action might Bakkt Holdings take to resolve the stock price deficiency? Bakkt Holdings may consider a reverse stock split, subject to shareholder approval, as one of the alternatives to resolve the stock price deficiency."
Noventiq and Corner Growth Acquisition Corp. File Form F-4/A; Reports Strong H1 FY24 Results Ahead of Proposed Nasdaq Listing,2024-03-13T21:33:00.000Z,Neutral,Neutral,Noventiq Holdings PLC and Corner Growth Acquisition Corp. file Registration Statement with the SEC for proposed Business Combination. Noventiq reports strong financial results with revenue growth of 36.4% year-over-year in FY24. CEO Herv Tessler highlights continued business momentum and transformational agenda.,"Noventiq and Corner Growth Acquisition Corp. File Form F-4/A; Reports Strong H1 FY24 Results Ahead of Proposed Nasdaq Listing Rhea-AI Impact (Neutral) Rhea-AI Sentiment (Neutral) Tags acquisition Rhea-AI Summary Noventiq Holdings PLC and Corner Growth Acquisition Corp. file Registration Statement with the SEC for proposed Business Combination. Noventiq reports strong financial results with revenue growth of 36.4% year-over-year in FY24. CEO Herv Tessler highlights continued business momentum and transformational agenda. Positive Noventiq reports a significant increase in revenue for the first six months of FY24, with a 36.4% year-over-year growth. Gross profit also shows a positive trend, increasing by 25.3% on a reported currency basis. Adjusted EBITDA (excluding share-based compensation) experiences a substantial growth of 178.4% on a reported currency basis. Noventiq completes an audit in compliance with PCAOB requirements for financial statements of FY22 and FY23, along with a review of the first six months of H1 FY24. CEO Herv Tessler expresses satisfaction with the company's growth and momentum, emphasizing the focus on business transformation and global expansion. Noventiq aims for a Nasdaq listing, showcasing confidence in its operational performance and strategic investments in technology and capabilities. Negative None. Market Research Analyst The recent filing by Noventiq Holdings PLC and Corner Growth Acquisition Corp. regarding a Registration Statement on Form F-4/A in connection with their proposed Business Combination is a significant event that warrants the attention of market research analysts. The substantial year-over-year revenue growth reported by Noventiq, particularly the 36.4% increase on a reported currency basis and even more pronounced 41.4% in constant currency, indicates a robust expansion in their business operations. This performance is further underscored by a notable 178.4% surge in adjusted EBITDA, which is a key indicator of a company's financial health and operating profitability.These results suggest that Noventiq is successfully navigating the digital transformation and cybersecurity landscape, sectors that are experiencing high demand. The company's focus on investing in technology and capabilities, as well as its compliance with PCAOB requirements, positions it favorably for a Nasdaq listing. Investors and stakeholders could view this as a positive signal of the company's commitment to transparency and adherence to high standards of financial reporting. Financial Analyst From a financial analysis perspective, the impressive growth in gross profit by 25.3% on a reported currency basis and 32.6% in constant currency for Noventiq is indicative of efficient cost management and a potentially scalable business model. The adjusted EBITDA margin of 6.4% is also a critical metric, reflecting the company's ability to convert revenue into profit while excluding non-cash expenses like share-based compensation.Investors should consider the implications of Noventiq's operational performance on its valuation, especially in light of the proposed business combination with Corner Growth Acquisition Corp. The strategic move towards a Nasdaq listing could enhance liquidity and provide access to a broader investor base, potentially leading to a re-rating of the company's stock. However, it is important to analyze these financials in the context of industry benchmarks and the competitive landscape to fully assess the investment potential. Legal Expert From a legal standpoint, the filing of the Registration Statement on Form F-4/A is a crucial step in the process of a business combination, especially for a special purpose acquisition company (SPAC) like Corner Growth Acquisition Corp. This document provides detailed information about the proposed transaction, the companies involved and the financial implications, all of which are essential for regulatory approval by the SEC.The compliance with PCAOB requirements for financial statement audits is also significant, as it demonstrates Noventiq's adherence to stringent U.S. auditing standards. This level of compliance is important for investor confidence, particularly for a company seeking to list on a U.S. exchange like Nasdaq, where regulatory scrutiny is high. The legal ramifications of this compliance cannot be overstated, as it minimizes the risk of future litigation or regulatory action that could adversely affect shareholders. 03/13/2024 - 05:33 PM LONDON & PALO ALTO, Calif.--(BUSINESS WIRE)-- Noventiq Holdings PLC (Noventiq), a global digital transformation and cybersecurity solutions and services provider, and Corner Growth Acquisition Corp. (Nasdaq: COOL) (Corner Growth), a special purpose acquisition company led by veteran technology investors (Sponsors), today filed with the U.S. Securities and Exchange Commission (the SEC) a Registration Statement on Form F-4/A (the F-4/A) in connection with the previously announced proposed Business Combination (as defined below). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240313935971/en/ Recent Key Business Developments Noventiq delivered strong results with revenue for the first six months FY24 of $219.8 million, an increase of 36.4% year-over-year on a reported currency basis and 41.4% in constant currency. Gross profit was $93.8 million, an increase of 25.3% on a reported currency basis, and 32.6% in constant currency. Adjusted EBITDA (excluding share based compensation) was $14.0 million, an increase of 178.4% on a reported currency basis. Adjusted EBITDA (excluding share based compensation) margin on revenue was 6.4%. Noventiq recently completed an audit in compliance with Public Company Accounting Oversight Board (PCAOB) requirements on its financial statements for FY22 and FY23, and a review by its auditors on the first six months of H1 FY24. Noventiq has also published its updated investor presentation which includes highlights of its strategy, positioning and financial results, which can be found at [Noventiq IR] Herv Tessler, CEO of Noventiq, said: I am very pleased with the strong growth and continued momentum in our business as we position Noventiq for a Nasdaq listing. In addition to the strength of our operational performance, we continue to drive our transformational agenda across our global client base as we invest at scale in our business and our people, and in new and enhanced technologies and capabilities. I am excited about the opportunities ahead as we make significant progress towards delivering more value for all our stakeholders. Marvin Tien, Co-Chairman & CEO of Corner Growth, said: Noventiq continues to drive significant top line and EBITDA growth through its strong and special partnerships with Microsoft and Amazon and secular tailwinds for growing IT spend in India and other core emerging markets. With deep expertise in digital transformation, cybersecurity and artificial intelligence solutions, and a track record of successfully scaling in high-growth emerging markets, we believe Noventiq is truly a transformative company with a substantial opportunity ahead. We are very excited for the future, and pleased to be a key partner and supporter of Noventiq as they pursue this transaction. Continued Momentum for the six months to 30 September 2023 (H1, FY24) Revenue for the six months FY24 of $219.8 million, an increase of 36.4% year-over-year on a reported currency basis and 41.4% in constant currency. Noventiq reported broad based strength with double-digit growth across all three business segments. Services revenue of $95.7 million grew 37.3% year-over-year, Hardware revenue of $60.4 million grew 54.7% year-over-year, and Software & Cloud revenue of $63.6 million grew 21.6% year-over-year. From a geographic perspective, APAC and EMEA were particularly strong with revenue growth of 96.2%, and 44.6%, respectively. Recurring revenue was $43.1 million representing an increase of 23.1% year-over-year. Gross profit was $93.8 million, an increase of 25.3% year-over-year on a reported currency basis, and 32.6% in constant currency. Gross profit in Services was $41.8 million with growth of 30.9% year-over-year. Gross profit in Software & Cloud was $42.2 million with growth of 22.1% year-over-year. Gross profit in Hardware was $9.8 million with growth of 16.8% year-over-year. Adjusted EBITDA (excluding share based compensation) was $14.0 million, an increase of 178.4% year-over-year on a reported currency basis. Adjusted EBITDA (excluding share based compensation) margin on revenue was 6.4%. Refer to exhibits to this press release for reconciliations of Non-IFRS financial measures to IFRS financial measures. Business Outlook While the company expects continued strong demand from its customers for digital transformation, it remains mindful of the continued broader economic and geopolitical uncertainty. For FY24 (fiscal year ended March 31, 2024), Noventiq is now targeting revenue of at least $495 million, representing at least 23% growth on a reported currency basis. Noventiq aims to deliver Adjusted EBITDA (excluding share based compensation) of approximately $38 million, representing growth of approximately 25%. For FY25 (fiscal year ended March 31, 2025), Noventiq is targeting revenue of at least $550 million, and approximately $46 million of Adjusted EBITDA (excluding share based compensation), representing approximately 21% growth over FY24. Investor Presentation The investor presentation can be found here: [Noventiq IR] Non-IFRS measures This communication includes certain non-IFRS financial measures, such as Adjusted EBITDA excluding share based compensation, recurring revenue, and growth in constant currency which are defined in the F-4/A. These non-IFRS financial measures may not be comparable to similarly titled measures presented by other companies, nor should they be construed as an alternative to other financial measures determined in accordance with IFRS. We believe these additional metrics are meaningful indicators of financial and operational performance. No Offer or Solicitation This communication relates to the proposed Business Combination between Noventiq and Corner Growth. This document does not constitute an offer to sell or exchange, or the solicitation of an offer to buy or exchange, any securities, nor shall there be any sale of securities in any jurisdiction in which such offer, sale or exchange would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. No offer of securities shall be made except by means of a prospectus meeting the requirements of Section 10 of the Securities Act. Additional Information and Where to Find It In connection with the Business Combination, Noventiq Holding Company has filed with the SEC a Registration Statement on Form F-4 (as may be amended from time to time, the ""Registration Statement""), which includes a preliminary prospectus and preliminary proxy statement. Corner Growth will mail a definitive proxy statement, definitive prospectus and other relevant documents to its shareholders when the Registration Statement is declared effective. This communication is not a substitute for the Registration Statement, the definitive proxy statement, the definitive prospectus or any other document that Corner Growth will send to its shareholders in connection with the Business Combination. Investors and security holders of Corner Growth are advised to read, when available, the proxy statement in connection with Corner Growth's solicitation of proxies for its special meeting of shareholders to be held to approve the Business Combination (and related matters) because the proxy statement will contain important information about the Business Combination and the parties to the Business Combination. The definitive proxy statement will be mailed to shareholders of Corner Growth as of a record date to be established for voting on the Business Combination. Shareholders will also be able to obtain copies of the proxy statement, without charge, once available, at the SEC's website www.sec.gov or by directing a request to: ryan.flanagan@icrinc.com. Participants in the Solicitation Corner Growth, Noventiq and their respective directors, executive officers, other members of management, and employees, under SEC rules, may be deemed to be participants in the solicitation of proxies of Corner Growth's shareholders in connection with the Business Combination. Investors and security holders may obtain more detailed information regarding the names and interests in the Business Combination of Corner Growth's directors and officers in Corner Growth's filings with the SEC including the Registration Statement which will include the proxy statement of Corner Growth for the Business Combination, and such information and names of Noventiq's directors and executive officers will also be in the Registration Statement which will include the proxy statement of Corner Growth for the Business Combination. About Noventiq Noventiq (Noventiq Holdings PLC) is a leading global solutions and services provider in digital transformation and cybersecurity, headquartered in London. The company enables, facilitates, and accelerates digital transformation for its customers businesses, connecting organizations across a comprehensive range of industries with best-in-class IT vendors, alongside its own services and proprietary solutions. The companys rapid growth is underpinned by its three-dimensional strategy to expand its market penetration, product portfolio, and sales channels. This is supported by an active approach to M&A, positioning Noventiq to capitalize on the industrys ongoing consolidation. With around 6,400 employees globally, Noventiq operates in approximately 60 countries with significant growth potential in multiple regions including Latin America, EMEA, and APAC  with a notable presence in India. About Corner Growth Acquisition Corp. Corner Growth Acquisition Corp. (Nasdaq: COOL) is a special purpose acquisition company (SPAC) focused on partnering with a high growth technology company. Corner Growths mission is to deliver value to its investors by providing a compelling alternative to a traditional public offering. Corner Growth is uniquely positioned to deliver on its value-add approach given its management teams history, experience, relationships, leadership and track record in identifying and investing in disruptive technology companies across all technology verticals. Corner Growth also brings a group of highly respected investment professionals, with strong track records and deep individual experience in SPAC and de-SPAC processes, a rolodex of premier public market investors, and a team of advisors who offer experience and access to networks across a broad functional and physical geography. Forward Looking Statements Certain statements made herein that are not historical facts are forward-looking statements for purposes of the safe harbor provisions under The Private Securities Litigation Reform Act of 1995. Forward-looking statements generally are accompanied by words such as believe, may, will, estimate, continue, anticipate, intend, expect, target, aim, should, would, plan, predict, potential, seem, seek, future, outlook and similar expressions that predict or indicate future events or trends or that are not statements of historical matters. These forward-looking statements include, but are not limited to, statements regarding future events, the Business Combination between Corner Growth and Noventiq, the estimated or anticipated future results and benefits of the Combined Company following the Business Combination, including the likelihood and ability of the parties to successfully consummate the Business Combination, future opportunities for the Combined Company, statements regarding Noventiq's future financial position, and other statements that are not historical facts. These statements are based on the current expectations of Corner Growths management and/or Noventiqs management, as applicable, and are not predictions of actual performance. These forward-looking statements are provided for illustrative purposes only and are not intended to serve as, and must not be relied on, by any investor as a guarantee, an assurance, a prediction or a definitive statement of fact or probability. Actual events and circumstances are difficult or impossible to predict and will differ from assumptions. Many actual events and circumstances are beyond the control of Corner Growth and Noventiq. These statements are subject to a number of risks and uncertainties regarding Noventiqs business, Corner Growths businesses and the Business Combination, and actual results may differ materially. These risks and uncertainties include, but are not limited to, general economic, political and business conditions; the inability of the parties to consummate the Business Combination or the occurrence of any event, change or other circumstances that could give rise to the termination of the Business Combination Agreement; the outcome of any legal proceedings that may be instituted against the parties following the announcement of the Business Combination; the receipt of an unsolicited offer from another party for an alternative business transaction that could interfere with the Business Combination; the risk that the approval of the shareholders of Corner Growth or Noventiq for the potential transaction is not obtained; failure to realize the anticipated benefits of the Business Combination, including as a result of a delay in consummating the potential transaction or difficulty in integrating the businesses of Corner Growth or Noventiq; the risk that the Business Combination disrupts current plans and operations as a result of the announcement and consummation of the Business Combination; the ability of the Combined Company to grow and manage growth profitably and retain its key employees; the amount of redemption requests made by Corner Growths shareholders; the inability to obtain or maintain the listing of the post-acquisition companys securities on Nasdaq following the Business Combination; costs related to the Business Combination; the impact of competitive products and pricing on Noventiq; Noventiqs ability to offer the products and services of its key vendors, particularly Microsoft, for sale to customers and to earn incentives on such sales; demand for Noventiqs services and solutions; the ability of Noventiq to achieve operating synergies from acquired businesses; the successful integration of acquired businesses; breaches in cybersecurity or disruption to IT systems; Noventiqs ability to attract, hire, train and retain experienced personnel; fluctuations in currency exchange rates; the ability to comply with the laws and regulations across the markets in which Noventiq operates and the effectiveness of its internal controls, procedures, compliance systems and risk management systems; other risks and uncertainties detailed in the F-4; and those factors discussed in Corner Growths Annual Report on Form 10-K for the fiscal year ended December 31, 2020, filed with the SEC on March 31, 2021, in Corner Growths Annual Report on Form 10-K for the fiscal year ended December 31, 2022, filed with the SEC on March 31, 2023, and other filings with the SEC. If any of these risks materialize or if assumptions prove incorrect, actual results could differ materially from the results implied by these forward-looking statements. There may be additional risks that Corner Growth and/or Noventiq presently do not know or that Corner Growth and/or Noventiq currently believe are immaterial that could also cause actual results to differ from those contained in the forward-looking statements. In addition, forward-looking statements provide the expectations, plans or forecasts of future events and views of Corner Growth and/or Noventiq as of the date of this communication. Corner Growth and Noventiq anticipate that subsequent events and developments will cause their assessments to change. However, while Corner Growth and/or Noventiq may elect to update these forward-looking statements at some point in the future, Corner Growth and Noventiq specifically disclaim any obligation to do so. These forward-looking statements should not be relied upon as representing Corner Growths and/or Noventiqs assessments as of any date subsequent to the date of this communication. Accordingly, undue reliance should not be placed upon the forward-looking statements. Disclaimer The financial information included in this communication comprises financial information for the years ended March 31, 2023 and 2022 derived from the audited financial statements of Noventiq, and the unaudited financial statements for the six months ended September 30, 2023. This communication includes certain non-IFRS financial measures, such as Adjusted EBITDA excluding share based compensation, recurring revenue, and growth in constant currency which are defined in the F-4/A. These non-IFRS financial measures may not be comparable to similarly titled measures presented by other companies, nor should they be construed as an alternative to other financial measures determined in accordance with IFRS. Certain figures contained in this communication, including financial information, have been subject to rounding adjustments (and, in certain circumstances, may not conform exactly to the total figure given). Exhibit 1 - Reconciliation of Non-IFRS financial measures to IFRS financial measures. (in thousands of U.S. dollars, unless otherwise indicated) Six months ended September 30, 2023 2022 Revenue 219,757 161,105 Add/(Less): Indian rupee impact -1,412 1,582 Egyptian pound impact 1,608 534 Euro impact -722 2,217 Argentine peso impact 1,804 641 Turkish lira impact 988 1,728 Belarusian ruble impact 5,260 931 Kazakh tenge impact -220 807 Other 664 1,204 Revenue, CCY 227,727 170,749 Revenue growth, CCY 41.4%  (in thousands of U.S. dollars, unless otherwise indicated) Six months ended September 30, 2023 2022 Gross profit 93,810 74,887 Add/(Less): Egyptian pound impact 1,405 455 Indian rupee impact -558 927 Argentine peso impact 1,511 432 Euro impact -339 861 Turkish lira impact 604 790 Belarusian ruble impact 2,340 442 Other 535 1,046 Gross profit, CCY 99,308 79,840 Gross profit growth, CCY 32.6%  Six months ended September 30, 2023 2022 (in millions of U.S. dollars) Loss for the year from continuing operations -28.2 -22.9 Added back: Income tax expense 3.8 0.5 Depreciation and amortization 10.9 6.9 Foreign exchange (gain) / loss 5.9 6.0 Net financial income and expenses 8.9 6.3 Property and equipment write-off 0.0 0.1 Employee termination payments 0.3 0.1 Impairment losses 6.0 6.3 One-off items (penalties and acquisition related expenses) 6.4 1.7 Adjusted EBITDA (excluding share based compensation) 14.0 5.0 Six months ended September 30, 2023 2022 (in thousands of U.S. dollars) Software subscription 9,742 7,706 Third-party cloud resale products 31,112 24,776 Own cloud solutions 2,225 2,502 Recurring revenue 43,079 34,984 Software and licenses 22,799 19,852 Services 93,472 67,214 Hardware 60,407 39,055 Non-recurring revenue 176,678 126,121 Total revenue 219,757 161,105 View source version on businesswire.com: https://www.businesswire.com/news/home/20240313935971/en/ Noventiq Contacts Investors: Steven Salter VP Corporate Affairs IR@noventiq.com Media: Rocio Herraiz Global Head of Communications pr@noventiq.com Corner Growth Contacts Investors: Ryan Flanagan, ICR ryan.flanagan@icrinc.com Media: Brian Ruby, ICR Brian.ruby@icrinc.com Source: Corner Growth Acquisition Corp. & Noventiq Holdings PLC What is the revenue growth percentage for Noventiq in the first six months of FY24? Noventiq reports a revenue growth of 36.4% year-over-year in the first six months of FY24. What is the increase in gross profit for Noventiq on a reported currency basis? Noventiq's gross profit increased by 25.3% on a reported currency basis. What is the growth percentage of Adjusted EBITDA (excluding share-based compensation) for Noventiq? Adjusted EBITDA (excluding share-based compensation) shows a growth of 178.4% on a reported currency basis for Noventiq. What compliance requirements did Noventiq recently fulfill regarding its financial statements? Noventiq completed an audit in compliance with PCAOB requirements for its financial statements of FY22 and FY23, along with a review of the first six months of H1 FY24. What is the CEO of Noventiq, Herv Tessler, pleased with regarding the company's performance? CEO Herv Tessler expresses satisfaction with the strong growth and continued momentum in Noventiq's business, highlighting the focus on transformation and global expansion. What listing is Noventiq aiming for as mentioned in the press release? Noventiq aims for a Nasdaq listing, showcasing confidence in its operational performance and strategic investments in technology and capabilities."
CARMICHAEL LYNCH EXPANDS FULL-SERVICE OFFERING TO PHILADELPHIA,2024-03-13T21:20:00.000Z,Low,Very Positive,"Carmichael Lynch, a renowned marketing communications firm, announced the integration of Tierney, a leading Mid-Atlantic firm, into its operations effective May 1, 2024. Tierney's CEO, Mary Stengel Austen, will step down, and Tracey Santilli will continue as President. The move aims to enhance creative services and expand operations across Philadelphia, New York, and Minneapolis.","CARMICHAEL LYNCH EXPANDS FULL-SERVICE OFFERING TO PHILADELPHIA Rhea-AI Impact (Low) Rhea-AI Sentiment (Very Positive) Tags Rhea-AI Summary Carmichael Lynch, a renowned marketing communications firm, announced the integration of Tierney, a leading Mid-Atlantic firm, into its operations effective May 1, 2024. Tierney's CEO, Mary Stengel Austen, will step down, and Tracey Santilli will continue as President. The move aims to enhance creative services and expand operations across Philadelphia, New York, and Minneapolis. Positive None. Negative None. 03/13/2024 - 05:20 PM MINNEAPOLIS, March 13, 2024 /PRNewswire/ -- Today, Carmichael Lynch announced that Tierney, a leading marketing communications firm in the Mid-Atlantic, will become part of Carmichael Lynch effective May 1, 2024. With the addition of this office, the expanded full-service agency will maintain its headquarters in Minneapolis, along with offices in New York and now Philadelphia. Both agencies are owned by Interpublic Group (NYSE: IPG). In conjunction with this news, Mary Stengel Austen, co-founder and CEO of Tierney, announced that she is stepping down from her role leading Tierney on March 31st, and Tracey Santilli, who Austen appointed President of Tierney in 2022, will continue in that role, reporting to Carmichael Lynch CEO Marcus Fischer. Carmichael Lynch is an internationally recognized leader in creativity, executing stand apart ideas across all channels with award-winning creative and marketing services including Carmichael Lynch Media and Carmichael Lynch Relate public relations. The 62-year-old agency's client list includes top brands such as Subaru, Sherwin-Williams, Hostess Brands, Bush's Beans, Post Consumer Brands, and Saputo. ""We'd like to thank Mary for her 36 years of building Tierney to where it is today,"" said Fischer. ""And, a big welcome to our new co-workers including Tracey Santilli and the rest of the team. We look forward to expanding our 'Come Together. Stand Apart.' motto. We find the best people from every discipline to make the very best brand-building, business-altering work with our partners. With Tracey and the Philadelphia team joining us, we are expanding our creatively driven integrated work to ensure that all of our clients benefit from this new opportunity."" Headquartered in Philadelphia with offices in Harrisburg, Pennsylvania and New York City, Tierney Communications has approximately 100 employees and has been a lead agency for clients including Independence Blue Cross, Cencora, Comcast, McDonald's, Choice Hotels, and TD Bank. Under Austen's leadership, the agency's work has been recognized with multiple regional and national awards. ""I consider co-founding and building Tierney a privilege and an honor. As I look back on my journey, I am most proud of the talented people I have worked with and learned from, the breakthrough work we have produced, and the clients who have trusted us to guide and partner with them through the years. We have also developed and launched many marketing and communications leaders and spawned multiple businesses and industries in this market and beyond,"" said Austen. Austen co-founded the agency in 1989. She would rise through the ranks to become CEO after her original partner, Brian Tierney, left the agency in the early 2000s. Austen will stay on through the end of March as Santilli transitions into the top role. ""Tracey is the perfect person to evolve the business and architect what is next,"" continued Austen. ""We are grateful for Mary's years of service to the agency and community, and I am looking forward to this next phase of expansion and collaborating with my new co-workers at Carmichael Lynch. The combination of our creative work and agency cultures ensures more innovation and an environment where this collaboration will thrive for our clients,"" said Santilli. About Carmichael LynchAs a fully integrated creative agency, Carmichael Lynch offers a collaborative, holistic approach to marketing, leveraging paid, earned and owned media, and creative strategies. The agency's work has been heralded by international award shows and its company culture and diversity and inclusion initiatives have won a multitude of honors. Carmichael Lynch Inc. is owned by the Interpublic Group of Companies Inc. (NYSE: IPG), New York. For more information, visit www.carmichaellynch.com. Media ContactsTim Spreitzer tspreitzer@tierneyagency.com215.514.0170 Suzanne McGee Suzanne.mcgee@clynch.com 781.354.2434 View original content to download multimedia:https://www.prnewswire.com/news-releases/carmichael-lynch-expands-full-service-offering-to-philadelphia-302088625.html SOURCE Tierney Communications, Inc When will Tierney become part of Carmichael Lynch? Tierney will become part of Carmichael Lynch effective May 1, 2024. Who is stepping down as CEO of Tierney? Mary Stengel Austen, co-founder and CEO of Tierney, is stepping down from her role. Who will continue as President of Tierney? Tracey Santilli, appointed President of Tierney in 2022, will continue in that role. Who is the CEO of Carmichael Lynch? Marcus Fischer is the CEO of Carmichael Lynch. Which brands are associated with Carmichael Lynch? Carmichael Lynch works with brands like Subaru, Sherwin-Williams, Hostess Brands, Bush's Beans, Post Consumer Brands, and Saputo."
Mirum Pharmaceuticals LIVMARLI Receives FDA Approval for Treatment of Cholestatic Pruritus in Patients with Progressive Familial Intrahepatic Cholestasis,2024-03-13T22:00:00.000Z,Moderate,Neutral,"Mirum Pharmaceuticals, Inc. (MIRM) receives FDA approval for LIVMARLI, an oral solution for cholestatic pruritus in PFIC patients. The approval is based on the Phase 3 MARCH study, showing significant reduction in pruritus severity. LIVMARLI also approved for Alagille syndrome. Immediate availability in the U.S. and plans for label expansion for younger patients.","Mirum Pharmaceuticals LIVMARLI Receives FDA Approval for Treatment of Cholestatic Pruritus in Patients with Progressive Familial Intrahepatic Cholestasis Rhea-AI Impact (Moderate) Rhea-AI Sentiment (Neutral) Tags fda approval Rhea-AI Summary Mirum Pharmaceuticals, Inc. (MIRM) receives FDA approval for LIVMARLI, an oral solution for cholestatic pruritus in PFIC patients. The approval is based on the Phase 3 MARCH study, showing significant reduction in pruritus severity. LIVMARLI also approved for Alagille syndrome. Immediate availability in the U.S. and plans for label expansion for younger patients. Positive None. Negative None. Medical Research Analyst The FDA's approval of LIVMARLI for cholestatic pruritus in PFIC patients represents a significant milestone in the treatment of this rare liver disease. The efficacy of LIVMARLI, as evidenced by the MARCH Phase 3 study, indicates a high level of statistical significance (p<0.0001), suggesting that the drug has a strong effect on reducing pruritus severity compared to placebo. This outcome is especially relevant for pediatric patients, as PFIC primarily affects children, leading to severe symptoms and impacting their quality of life.From a medical research perspective, the broad label coverage for various PFIC subtypes implies that LIVMARLI can cater to a wider patient population. This inclusivity is noteworthy since rare diseases often struggle with limited treatment options. The additional sNDA for a higher concentration formulation to include younger patients further demonstrates Mirum's commitment to addressing unmet needs within this patient community.For stakeholders, the immediate availability of LIVMARLI in the U.S. could lead to an uptick in the company's revenue stream. However, the long-term impact will depend on the adoption rate among healthcare providers, patient accessibility and potential competition from other treatments. The cost of treatment and insurance coverage will also play a crucial role in its market penetration. Market Research Analyst The approval of LIVMARLI by the FDA not only signifies a breakthrough in the therapeutic landscape for PFIC but also has the potential to disrupt the market for cholestatic pruritus treatments. Given the rarity of PFIC, with an estimated prevalence of 1 in every 50,000 to 100,000 live births, the market size is relatively small. However, the lack of alternative treatments provides Mirum Pharmaceuticals with a significant competitive advantage.Investors should note the potential for market expansion with Mirum's strategic move to submit an sNDA for a higher concentration formulation, which could increase the addressable market by including younger patients. The company's proactive approach to label expansion could be indicative of its long-term growth strategy and commitment to consolidating its presence in the rare disease market.It is important to monitor how Mirum Pharmaceuticals capitalizes on its first-mover advantage and how it navigates pricing and reimbursement challenges. The company's performance in the coming quarters will provide insights into the drug's market uptake and its impact on Mirum's financial health. Healthcare Economist The economic implications of introducing a new treatment like LIVMARLI are multifaceted. On one hand, the drug provides a non-surgical alternative to liver transplantation, which could lead to significant cost savings for the healthcare system. On the other hand, the pricing strategy for orphan drugs, typically high due to research and development costs, could impose a financial burden on patients and payers.An analysis of the cost-effectiveness of LIVMARLI should consider the potential reduction in healthcare resource utilization, such as fewer hospitalizations and medical interventions due to improved disease management. Additionally, the impact on patients' quality of life and the indirect costs associated with PFIC, such as lost productivity for caregivers, must be factored into the overall economic assessment.While LIVMARLI's approval is a positive development for patients, it is crucial to examine the sustainability of its pricing and reimbursement models, especially as healthcare systems globally are increasingly pressured to balance patient access with affordability. 03/13/2024 - 06:00 PM - FDA approval based on MARCH Phase 3 study with highly statistically significant (p<0.0001) reduction in pruritus severity between LIVMARLI vs. placebo - Label covers broad range of PFIC subtypes - Immediate launch and availability for eligible patients in the U.S. FOSTER CITY, Calif.--(BUSINESS WIRE)-- Mirum Pharmaceuticals, Inc. (NASDAQ: MIRM) today announced that the U.S. Food and Drug Administration (FDA) has approved LIVMARLI (maralixibat) oral solution for the treatment of cholestatic pruritus in patients five years of age and older with progressive familial intrahepatic cholestasis (PFIC). Mirum has also submitted an additional supplemental new drug application (sNDA) to introduce a higher concentration formulation of LIVMARLI, used during the MARCH study, to enable label expansion for younger patients with PFIC, later this year. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240313135184/en/LIVMARLI (maralixibat) oral solution is now available for prescribing in the US for cholestatic pruritus in patients with PFIC. (Photo: Business Wire) LIVMARLI is also approved for the treatment of cholestatic pruritus in patients with Alagille syndrome (ALGS) in the U.S. (three months and older), Europe (two months and older), in Canada and other regions globally. LIVMARLI has the potential to have a transformational impact for patients with cholestatic pruritus associated with PFIC, and importantly, offers an option for those patients with the rarest of subtypes, said Chris Peetz, chief executive officer at Mirum. Thank you to the patients, families, and clinicians whose study participation made this approval possible. The approval is based on data from the Phase 3 MARCH study, the largest randomized trial conducted in PFIC, with 93 patients across a range of genetic PFIC types, including PFIC1, PFIC2, PFIC3, PFIC4, PFIC6, and unidentified mutational status. LIVMARLIs approval in cholestatic pruritus for patients with PFIC is a result of years of investigation and a collection of a strong body of clinical evidence showing meaningful improvements across a number of important parameters, including pruritus, affecting children with PFIC, said Richard Thompson, professor of molecular hepatology at Kings College London and an investigator in the MARCH study. I am pleased that we will have a well-studied and efficacious option to offer patients whose life has been disrupted by itch. PFIC is a difficult disease for both the patient and family and significantly impedes the quality of life for all, said Emily Ventura, executive director of the PFIC Network and mom to a daughter with PFIC. These young and fragile patients endure an itch so severe that they experience deficits in their sleep, nutrition, growth, and, in the past, some have turned to transplant to resolve their itch. We are hopeful that LIVMARLI will have a measurable impact for patients, potentially offering a new normal and relief from the sleepless nights and disruption to their lives caused by cholestatic pruritus. About PFIC Progressive familial intrahepatic cholestasis (PFIC) is a rare genetic disorder that causes progressive liver disease typically leading to liver failure. In people with PFIC, liver cells are less able to secrete bile. The resulting buildup of bile causes liver disease in affected individuals. Signs and symptoms of PFIC typically begin in infancy. Patients experience severe itching, jaundice, failure to grow at the expected rate (failure to thrive), and an increasing inability of the liver to function (liver failure). The disease is estimated to affect one in every 50,000 to 100,000 births in the United States and Europe. More than six types of PFIC have been genetically identified, all of which are similarly characterized by impaired bile flow and progressive liver disease. About LIVMARLI (maralixibat) oral solution LIVMARLI (maralixibat) oral solution is an orally administered, once-daily, ileal bile acid transporter (IBAT) inhibitor and the only approved medication by the U.S. Food and Drug Administration for the treatment of cholestatic pruritus in patients with Alagille syndrome (ALGS) three months of age and older and progressive familial intrahepatic cholestasis (PFIC) five years of age and older. LIVMARLI is also the only approved IBAT inhibitor approved by the European Commission for the treatment of cholestatic pruritus in patients with ALGS two months and older, and by Health Canada for the treatment of cholestatic pruritus in ALGS. For more information for U.S. residents, please visit LIVMARLI.com. Mirum has also submitted LIVMARLI for approval in Europe in PFIC for patients two months of age and older. LIVMARLI has received Breakthrough Therapy designation for ALGS and PFIC type 2 and orphan designation for ALGS and PFIC. To learn more about ongoing clinical trials with LIVMARLI, please visit Mirums clinical trials section on the companys website. IMPORTANT SAFETY INFORMATION Limitation of Use: LIVMARLI is not for use in PFIC type 2 patients who have a severe defect in the bile salt export pump (BSEP) protein. LIVMARLI can cause side effects, including: Liver injury. Changes in certain liver tests are common in patients with Alagille syndrome and PFIC but can worsen during treatment. These changes may be a sign of liver injury. In PFIC, this can be serious or may lead to liver transplant or death. Your healthcare provider should do blood tests and physical exams before starting and during treatment to check your liver function. Tell your healthcare provider right away if you get any signs or symptoms of liver problems, including nausea or vomiting, skin or the white part of the eye turns yellow, dark or brown urine, pain on the right side of the stomach (abdomen), bloating in your stomach area, loss of appetite or bleeding or bruising more easily than normal. Stomach and intestinal (gastrointestinal) problems. LIVMARLI can cause stomach and intestinal problems, including diarrhea and stomach pain. Your healthcare provider may advise you to monitor for new or worsening stomach problems including stomach pain, diarrhea, blood in your stool or vomiting. Tell your healthcare provider right away if you have any of these symptoms more often or more severely than normal for you. A condition called Fat Soluble Vitamin (FSV) Deficiency caused by low levels of certain vitamins (vitamin A, D, E, and K) stored in body fat is common in patients with Alagille syndrome and PFIC but may worsen during treatment. Your healthcare provider should do blood tests before starting and during treatment and may monitor for bone fractures and bleeding which have been reported as common side effects. US Prescribing Information EU SmPC Canadian Product Monograph About Mirum Pharmaceuticals, Inc. Mirum Pharmaceuticals, Inc. is a biopharmaceutical company dedicated to transforming the treatment of rare diseases affecting children and adults. Mirum has three approved medications: LIVMARLI (maralixibat) oral solution, CHOLBAM (cholic acid) capsules, and CHENODAL (chenodiol) tablets. LIVMARLI, an IBAT inhibitor, is approved for the treatment of two rare liver diseases affecting children and adults. It is approved for the treatment of cholestatic pruritus in patients with Alagille syndrome in the U.S. (three months and older), in Europe (two months and older), and in other regions globally. It is also approved in the U.S. in cholestatic pruritus in PFIC patients five years of age and older. Mirum has submitted for approval in Europe for the treatment of PFIC in patients two months of age and older. CHOLBAM is FDA-approved for the treatment of bile acid synthesis disorders due to single enzyme deficiencies and adjunctive treatment of peroxisomal disorders in patients who show signs or symptoms or liver disease. CHENODAL has received medical necessity recognition by the FDA to treat patients with cerebrotendinous xanthomatosis (CTX). Mirums late-stage pipeline includes two investigational treatments for debilitating liver diseases. Volixibat, an IBAT inhibitor, is being evaluated in two potentially registrational studies including the Phase 2b VISTAS study for primary sclerosing cholangitis and Phase 2b VANTAGE study for primary biliary cholangitis. Lastly, CHENODAL, has been evaluated in a Phase 3 clinical study, RESTORE, to treat patients with CTX, with positive topline results reported in 2023. To learn more about Mirum, visit mirumpharma.com and follow Mirum on Facebook, LinkedIn, Instagram and Twitter. Forward-Looking Statements Statements contained in this press release regarding matters that are not historical facts are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements include statements regarding, among other things, the potential impacts of LIVMARLI in PFIC and for any future label expansion, the additional improvements in disease beyond pruritus, and the ability of LIVMARLI to modify PFIC patient disease experience and the continued commercial success of LIVMARLI across ALGS and PFIC. Because such statements are subject to risks and uncertainties, actual results may differ materially from those expressed or implied by such forward-looking statements. Words such as will, intended, potential and similar expressions are intended to identify forward-looking statements. These forward-looking statements are based upon Mirums current expectations and involve assumptions that may never materialize or may prove to be incorrect. Actual results could differ materially from those anticipated in such forward-looking statements as a result of various risks and uncertainties, which include, without limitation, risks and uncertainties associated with Mirums business in general, the impact of geopolitical and macroeconomic events , and the other risks described in Mirums filings with the Securities and Exchange Commission, including its most recent Annual Report on Form 10-K, as updated by any subsequent Quarter Reports on Form 10-Q. All forward-looking statements contained in this press release speak only as of the date on which they were made and are based on managements assumptions and estimates as of such date. Mirum undertakes no obligation to update such statements to reflect events that occur or circumstances that exist after the date on which they were made, except as required by law. View source version on businesswire.com: https://www.businesswire.com/news/home/20240313135184/en/ Media: Erin Murphy 510-508-6521 media@mirumpharma.com Investors: Andrew McKibben ir@mirumpharma.com Sam Martin Argot Partners ir@mirumpharma.com Source: Mirum Pharmaceuticals, Inc. What is the FDA approval for MIRM (Mirum Pharmaceuticals, Inc.)? The FDA has approved LIVMARLI, an oral solution for cholestatic pruritus in patients with progressive familial intrahepatic cholestasis (PFIC) aged five and above. What study led to the FDA approval for LIVMARLI? The FDA approval is based on the Phase 3 MARCH study, showing a highly statistically significant reduction in pruritus severity. For which conditions is LIVMARLI approved? LIVMARLI is approved for cholestatic pruritus in patients with PFIC and Alagille syndrome (ALGS). What is the potential impact of LIVMARLI according to Mirum Pharmaceuticals? Mirum Pharmaceuticals states that LIVMARLI has the potential to be transformational for patients with cholestatic pruritus associated with PFIC. Who is the chief executive officer at Mirum Pharmaceuticals? Chris Peetz is the chief executive officer at Mirum Pharmaceuticals."
"Guess?, Inc. to Webcast Conference Call on Fourth Quarter and Fiscal Year 2024 Financial Results",2024-03-13T20:45:00.000Z,Low,Neutral,"Guess?, Inc. (GES) will report its Q4 and fiscal year 2024 financial results on March 20, 2024. The company designs, markets, and distributes lifestyle products globally through retail stores and partners.","Guess?, Inc. to Webcast Conference Call on Fourth Quarter and Fiscal Year 2024 Financial Results Rhea-AI Impact (Low) Rhea-AI Sentiment (Neutral) Tags conferences earnings Rhea-AI Summary Guess?, Inc. (GES) will report its Q4 and fiscal year 2024 financial results on March 20, 2024. The company designs, markets, and distributes lifestyle products globally through retail stores and partners. Positive None. Negative None. 03/13/2024 - 04:45 PM LOS ANGELES--(BUSINESS WIRE)-- Guess?, Inc. (NYSE: GES) will release its financial results for the fourth quarter and fiscal year 2024, which ended February 3, 2024, on Wednesday, March 20, 2024. The Company will webcast a conference call at 4:45 p.m. (ET) that day to discuss the results. A live webcast will be accessible at www.guess.com via the Investor Relations link. A replay of the conference will be archived on the website for 30 days. Guess?, Inc. designs, markets, distributes and licenses a lifestyle collection of contemporary apparel, denim, handbags, watches, eyewear, footwear and other related consumer products. Guess? products are distributed through branded Guess? stores as well as better department and specialty stores around the world. At October 28, 2023, the Company directly operated 1,015 retail stores in Europe, the Americas and Asia. The Companys partners and distributors operated 544 additional retail stores worldwide. At October 28, 2023, the Company and its partners and distributors operated in approximately 100 countries worldwide. For more information about the Company, please visit www.guess.com. View source version on businesswire.com: https://www.businesswire.com/news/home/20240312961277/en/ Guess?, Inc. Fabrice Benarouche Senior Vice President Finance, Investor Relations and Chief Accounting Officer (213) 765-5578 Source: Guess?, Inc. When will Guess?, Inc. release its financial results for Q4 and fiscal year 2024? Guess?, Inc. (GES) will release its financial results for the fourth quarter and fiscal year 2024 on March 20, 2024. What products does Guess?, Inc. design and distribute? Guess?, Inc. designs, markets, distributes, and licenses a lifestyle collection of contemporary apparel, denim, handbags, watches, eyewear, footwear, and other consumer products. How many retail stores did Guess?, Inc. operate as of October 28, 2023? As of October 28, 2023, Guess?, Inc. directly operated 1,015 retail stores in Europe, the Americas, and Asia, with partners and distributors operating an additional 544 stores worldwide. Where can investors access the live webcast of Guess?, Inc.'s conference call? Investors can access the live webcast of Guess?, Inc.'s conference call at www.guess.com via the 'Investor Relations' link."
GENAI SUBSIDIARY ENTERS FRAMEWORK SERVICES AGREEMENT,2024-03-13T21:00:00.000Z,Moderate,Neutral,"Generative AI Solutions Corp. announces a framework services agreement with a Cloud, GPU, and AI Infrastructure services provider through its subsidiary, MAI Cloud Solutions Inc. The Provider will deploy GPU infrastructure as a service to MAI Cloud for five years, with potential revenue from reselling compute time on the GPUs.","GENAI SUBSIDIARY ENTERS FRAMEWORK SERVICES AGREEMENT Rhea-AI Impact (Moderate) Rhea-AI Sentiment (Neutral) Tags Rhea-AI Summary Generative AI Solutions Corp. announces a framework services agreement with a Cloud, GPU, and AI Infrastructure services provider through its subsidiary, MAI Cloud Solutions Inc. The Provider will deploy GPU infrastructure as a service to MAI Cloud for five years, with potential revenue from reselling compute time on the GPUs. Positive None. Negative None. 03/13/2024 - 05:00 PM VANCOUVER, BC, March 13, 2024 /PRNewswire/ - Generative AI Solutions Corp. (""GenAI"" or the ""Company"") (CSE: AICO) (OTCQB: AICOF) is pleased to announce that its wholly-owned subsidiary, MAI Cloud Solutions Inc. (""MAI Cloud""), has entered into a framework services agreement dated March 7, 2024 (the ""Services Agreement"") with a Cloud, GPU (""Graphics Processing Unit"") and AI Infrastructure services provider (the ""Provider""), pursuant to which, the Provider has agreed to, among other things, provide the deployment of GPU infrastructure as a service (the ""Service"") to MAI Cloud for a period of five years (the ""Initial Term""), subject to the terms and conditions of the Services Agreement. Pursuant to the Services Agreement, the Provider is expected to complete the deployment of the full GPU infrastructure in several stages, over a period of 36 months from the date of the Services Agreement (the ""Effective Date"") and will deliver AI Infrastructure as service to MAI Cloud for a period of 60 months from each stage services activation date. MAI Cloud retains the right to extend the Initial Term for successive two year periods (""Extension Periods"") and to unilaterally terminate the Services Agreement during the Initial Term or any Extension Periods upon 120 days' written notice to the Provider. The Service Agreement may also be terminated by the Provider or MAI Cloud upon 30 days' written notice, in event of default or breach of contractual obligations in the Services Agreement by either party. Entering into the Services Agreement is a step forward in GenAI's engagement in diversified AI operations, and GenAI anticipates reselling a significant portion of the compute time on the GPUs provided under the Services Agreement to third parties at market rates, creating a diversified revenue stream for GenAI to complement its existing business lines. The actual revenue to be realized by GenAI in respect of the Services Agreement is subject to the value, manner and type of resale arrangement in respect of the Services to be provided by GenAI to third parties. On Behalf of the Board of Directors,Ryan Selby CEO, Director, and Chairman of the Board of Directors Generative AI Solutions Corp.Toll-free North America: +1-833-879-7632Outside North America: +1-406-879-7632info@genai-solutions.com www.genai-solutions.com ABOUT GENERATIVE AI SOLUTIONS CORP.GenAI is a pioneering artificial intelligence company focused on developing a vertically integrated AI solutions business through its proprietary MAI Cloud platform, with the development and commercialization of AI-powered tools and solutions for businesses and consumers across multiple industries. At GenAI, our mission is to harness the power of AI to create transformative products and services that benefit business and consumers across various sectors. Our team of talented AI professionals and engineers are dedicated to developing state-of-the-art AI-based solutions that have broad applicability and can be seamlessly integrated into diverse workflows. By leveraging our MAI Cloud platform and our expertise in machine learning, natural language processing, and data analytics, we build versatile high-performance tools that redefine efficiency, productivity, and user experience. For more information on GenAI, please visit www.genai-solutions.com. Trading in the securities of the Company should be considered highly speculative. Forward-Looking StatementsThis news release contains ""forward-looking statements"" within the meaning of applicable securities laws. All statements contained herein that are not clearly historical in nature may constitute forward-looking statements. Forward-looking information in this news release are based on certain assumptions and expected future events. These statements involve known and unknown risks, uncertainties and other factors, which may cause actual results, performance or achievements to differ materially from those expressed or implied by such statements. Readers are further cautioned not to place undue reliance on forward-looking statements, as there can be no assurance that the plans, intentions or expectations upon which they are placed will occur. Such information, although considered reasonable by management at the time of preparation, may prove to be incorrect and actual results may differ materially from those anticipated. Forward-looking statements contained in this news release are expressly qualified by this cautionary statement and reflect the Company's expectations as of the date hereof and are subject to change thereafter. The Company undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, estimates or opinions, future events or results or otherwise or to explain any material difference between subsequent actual events and such forward-looking information, except as required by applicable law. For the reasons set forth above, undue reliance should not be placed on forward-looking statements. Neither the CSE nor its Regulation Services Provider accepts responsibility for the adequacy or accuracy of this release. View original content to download multimedia:https://www.prnewswire.com/news-releases/genai-subsidiary-enters-framework-services-agreement-302088540.html SOURCE GENERATIVE AI SOLUTIONS CORP. What agreement did Generative AI Solutions Corp. enter into? Generative AI Solutions Corp. entered into a framework services agreement with a Cloud, GPU, and AI Infrastructure services provider through its subsidiary, MAI Cloud Solutions Inc. What services will the Provider offer to MAI Cloud? The Provider will provide the deployment of GPU infrastructure as a service to MAI Cloud for a period of five years. How long is the Initial Term of the Services Agreement? The Initial Term of the Services Agreement is for a period of five years. Can MAI Cloud extend the Initial Term of the Services Agreement? MAI Cloud retains the right to extend the Initial Term for successive two-year periods. What potential revenue stream does GenAI anticipate from the Services Agreement? GenAI anticipates reselling a significant portion of the compute time on the GPUs provided under the Services Agreement to third parties at market rates, creating a diversified revenue stream."
Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4),2024-03-13T21:00:00.000Z,Low,Very Positive,"Travere Therapeutics, Inc. (NASDAQ: TVTX) granted 51,600 inducement equity grants to four new employees on March 10, 2024. The grants include 25,000 stock options and 26,600 restricted stock units outside the 2018 Equity Incentive Plan. The stock options have an exercise price of $7.99 per share, a 10-year term, and vest over four years. The RSUs also vest over four years, with 25% of shares vesting on each anniversary of the grant date.","Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Rhea-AI Impact (Low) Rhea-AI Sentiment (Very Positive) Tags Rhea-AI Summary Travere Therapeutics, Inc. (NASDAQ: TVTX) granted 51,600 inducement equity grants to four new employees on March 10, 2024. The grants include 25,000 stock options and 26,600 restricted stock units outside the 2018 Equity Incentive Plan. The stock options have an exercise price of $7.99 per share, a 10-year term, and vest over four years. The RSUs also vest over four years, with 25% of shares vesting on each anniversary of the grant date. Positive None. Negative None. 03/13/2024 - 05:00 PM SAN DIEGO, March 13, 2024 (GLOBE NEWSWIRE) -- Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced that on March 10, 2024, the Compensation Committee of its Board of Directors granted inducement equity grants covering an aggregate of 51,600 shares of its common stock to four new employees, consisting of inducement stock options to purchase an aggregate of 25,000 shares of common stock and inducement restricted stock units, or RSUs, covering an aggregate of 26,600 shares of its common stock. These inducement stock options and inducement RSUs are subject to the terms of Traveres 2018 Equity Incentive Plan (2018 Plan), but were granted outside of the 2018 Plan and were granted as inducements material to the new employees entering into employment with Travere in accordance with Nasdaq Listing Rule 5635(c)(4). The stock options have an exercise price of $7.99 per share, the closing price of Traveres common stock on the next trading day following the date of grant, are non-qualified stock options, have a 10-year term and vest over four years, with 25% of the shares vesting on the one-year anniversary of the grant date and the remaining 75% of the shares vesting in equal monthly installments over the following 36 months, subject to the new employees continued service relationship with Travere through the applicable vesting dates. The RSUs vest over four years, with 25% of the shares vesting on each anniversary of the grant date, subject to the new employees continued service relationship with Travere through the applicable vesting dates. About Travere Therapeutics At Travere Therapeutics, we are in rare for life. We are a biopharmaceutical company that comes together every day to help patients, families, and caregivers of all backgrounds as they navigate life with a rare disease. On this path, we know the need for treatment options is urgent  that is why our global team works with the rare disease community to identify, develop, and deliver life-changing therapies. In pursuit of this mission, we continuously seek to understand the diverse perspectives of rare patients and to courageously forge new paths to make a difference in their lives and provide hope  today and tomorrow. For more information, visit travere.com. Contact Info Media:Investors:888-969-7879 888-969-7879mediarelations@travere.comIR@travere.com How many shares were granted to new employees by Travere Therapeutics, Inc.? Travere Therapeutics, Inc. granted a total of 51,600 shares of its common stock to four new employees. What is the exercise price of the stock options granted by Travere Therapeutics, Inc.? The stock options granted by Travere Therapeutics, Inc. have an exercise price of $7.99 per share. How do the stock options vest for the new employees at Travere Therapeutics, Inc.? The stock options granted to new employees at Travere Therapeutics, Inc. vest over four years, with 25% of the shares vesting on the one-year anniversary of the grant date and the remaining 75% vesting monthly over the following 36 months. What is the term of the stock options granted by Travere Therapeutics, Inc.? The stock options granted by Travere Therapeutics, Inc. have a 10-year term. What is the nature of the stock options granted by Travere Therapeutics, Inc.? The stock options granted by Travere Therapeutics, Inc. are non-qualified stock options. How do the restricted stock units (RSUs) vest for the new employees at Travere Therapeutics, Inc.? The RSUs granted to new employees at Travere Therapeutics, Inc. vest over four years, with 25% of the shares vesting on each anniversary of the grant date."
American Outdoor Brands to Participate in ROTH Investor Conference,2024-03-13T21:00:00.000Z,Low,Neutral,"American Outdoor Brands, Inc. (AOUT) will participate in the 36th Annual ROTH Conference on March 18, 2024, providing an opportunity for institutional investors to engage with the company.","American Outdoor Brands to Participate in ROTH Investor Conference Rhea-AI Impact (Low) Rhea-AI Sentiment (Neutral) Tags conferences Rhea-AI Summary American Outdoor Brands, Inc. (AOUT) will participate in the 36th Annual ROTH Conference on March 18, 2024, providing an opportunity for institutional investors to engage with the company. Positive None. Negative None. 03/13/2024 - 05:00 PM COLUMBIA, Mo., March 13, 2024 /PRNewswire/ -- American Outdoor Brands, Inc. (NASDAQ Global Select: AOUT), an industry leading provider of products and accessories for rugged outdoor enthusiasts, announced that it will participate in the 36th Annual ROTH Conference on March 18, 2024. To participate in the American Outdoor Brands meetings at the conference, institutional investors should reach out to their ROTH representative for more information. About American Outdoor Brands, Inc.American Outdoor Brands, Inc. (NASDAQ Global Select: AOUT) is an industry leading provider of outdoor products and accessories, including hunting, fishing, camping, shooting, outdoor cooking, and personal security and defense products, for rugged outdoor enthusiasts. The Company produces innovative, top quality products under its brands BOG; BUBBA; Caldwell; Crimson Trace; Frankford Arsenal; Grilla Grills; Hooyman; Imperial; LaserLyte; Lockdown; MEAT!; Old Timer; Schrade; Tipton; Uncle Henry; ust; and Wheeler. For more information about all the brands and products from American Outdoor Brands, Inc., visit www.aob.com. Contact: Liz Sharp, VP, Investor Relationslsharp@aob.com(573) 303-4620 View original content to download multimedia:https://www.prnewswire.com/news-releases/american-outdoor-brands-to-participate-in-roth-investor-conference-302088579.html SOURCE American Outdoor Brands, Inc. When will American Outdoor Brands participate in the 36th Annual ROTH Conference? American Outdoor Brands (AOUT) will participate in the 36th Annual ROTH Conference on March 18, 2024. What is the ticker symbol for American Outdoor Brands? The ticker symbol for American Outdoor Brands is AOUT. How can institutional investors engage with American Outdoor Brands at the conference? Institutional investors interested in engaging with American Outdoor Brands at the conference should reach out to their ROTH representative for more information."
SDG&E'S SUPPLY CHAIN BOOSTS ECONOMY BY $2.6 BILLION IN 2023,2024-03-13T21:00:00.000Z,Low,Positive,"SDG&E's procurement program generated $2.59 billion in direct economic impact in 2023, with 43% of total expenditures going to diverse suppliers. The company exceeded CPUC's supplier diversity goal for the 19th consecutive year, showcasing a commitment to economic prosperity and inclusion.","SDG&E'S SUPPLY CHAIN BOOSTS ECONOMY BY $2.6 BILLION IN 2023 Rhea-AI Impact (Low) Rhea-AI Sentiment (Positive) Tags Rhea-AI Summary SDG&E's procurement program generated $2.59 billion in direct economic impact in 2023, with 43% of total expenditures going to diverse suppliers. The company exceeded CPUC's supplier diversity goal for the 19th consecutive year, showcasing a commitment to economic prosperity and inclusion. Positive None. Negative None. Economist The economic impact of San Diego Gas & Electric's (SDG&E) procurement program, generating $2.59 billion and contracting with over 2,000 businesses, is significant. The program's focus on diversity, with 43% of total expenditures going to diverse suppliers, aligns with broader economic trends emphasizing inclusive growth. The direct local impact, with $450.6 million spent in San Diego County and $950.7 million in California, suggests a substantial multiplier effect on the regional economy. This effect can stimulate job creation, increase local revenue and foster a more resilient economic environment.SDG&E's long-term commitment to surpassing the California Public Utilities Commission's (CPUC) supplier diversity goal for 19 years consecutively demonstrates a sustainable approach to corporate social responsibility. This is likely to enhance the company's reputation and could lead to a more favorable regulatory environment, potentially benefiting shareholders. Moreover, by investing in small and diverse businesses, SDG&E may be contributing to innovation and competitiveness, which can indirectly support the company's operational efficiency and growth prospects. Market Research Analyst The success of SDG&E's procurement program can be attributed to its strategic engagement with small and diverse businesses, which reflects a growing consumer and investor interest in companies with strong Environmental, Social and Governance (ESG) practices. The involvement with local suppliers, like Rancho Tree Service, indicates a potential competitive advantage for SDG&E in terms of community relations and local brand perception.Furthermore, the emphasis on diverse suppliers could appeal to a broader customer base and may lead to increased customer loyalty. This procurement strategy, which includes mentoring relationships between primes and subcontractors, could also create a more robust supply chain for SDG&E, reducing risks associated with supplier concentration and enhancing the company's agility in the face of market changes or disruptions. Sustainability Expert SDG&E's procurement program is not only a driver of economic growth but also a reflection of the company's commitment to sustainability and social responsibility. By integrating vegetation management services into their Wildfire Mitigation Plan, SDG&E is addressing critical environmental concerns. This initiative, particularly in a state prone to wildfires, underscores the importance of sustainable practices in utility operations.The engagement of a Minority Business Enterprise as a prime contractor for such services highlights the dual focus on environmental sustainability and social equity. This approach can enhance SDG&E's sustainability profile and potentially attract investors who prioritize responsible environmental stewardship and community engagement in their investment decisions. 03/13/2024 - 05:00 PM Program Expanded Opportunities for Hundreds of Small and Diverse Businesses, Helping to Promote Economic Prosperity SAN DIEGO, March 13, 2024 /PRNewswire/ -- San Diego Gas & Electric's (SDG&E) procurement program generated $2.59 billion in direct economic impact in 2023, contracting with more than 2,000 businesses for goods and services to deliver on the company's mission to serve the 3.7 million people in its service area with increasingly clean, safe and reliable energy infrastructure. More than 43% of SDG&E's total expenditures were with diverse suppliers  enterprises owned by minorities, women, LGBT individuals, service-disabled veterans and persons with disabilities, according to the company's annual supplier diversity report submitted recently to the California Public Utilities Commission (CPUC). Nearly 600, or a third of the suppliers who did business with SDG&E in 2023, were diverse businesses. In 2023, SDG&E's spending with diverse businesses reached $450.6 million in San Diego County and $950.7 million in California. For the 19th consecutive year, SDG&E has not only met but surpassed the CPUC's supplier diversity goal. ""We are laser-focused on maximizing every dollar for our customers, while also growing economic opportunities for small and diverse businesses in our region,"" said SDG&E CEO Caroline Winn. ""Championing people by creating opportunities through diversity, equity and inclusion is one of our core values."" SDG&E contracts with suppliers for a wide range of goods and services, everything from vegetation management, undergrounding, civil engineering and electric construction to IT, fire prevention, project management and material procurement and transport. Since launching its supplier diversity program in the 1980s, SDG&E has helped many small businesses grow into primes. Some of the company's diverse primes are paying it forward by serving as mentors to diverse subcontractors. Last year, for the first time, SDG&E engaged Rancho Tree Service, a Minority Business Enterprise, as a prime contractor to provide vegetation management services  an important component of the company's Wildfire Mitigation Plan. ""We are a family-owned business, and we are proud of our local operation and the jobs we have created through our vegetation management work with SDG&E,"" said Jose De La Cruz, owner of Rancho Tree Service. ""Our crews help keep local communities safe from wildfires by trimming and clearing trees, bushes and other plants to prevent them from coming into contact with our electric infrastructure, such as power lines."" ""Large employers like SDG&E play a significant role in sustaining and growing our region's economy because of the large volume of goods and services they purchase,"" said Mark Cafferty, president and chief executive officer of the San Diego Regional Economic Development Corporation. ""Our research has shown that if major companies make small shifts in procurement to direct more spending locally, it can help create thousands of jobs and add tens of millions of dollars to the local economy."" SDG&E continues to grow its diverse supplier pool through collaboration with community-based organizations and business associations. Learn more about how to do business with SDG&E at sdge.com/SupplierDiversity. About SDG&E:SDG&E is an innovative energy delivery company that provides clean, safe and reliable energy to better the lives of the people it serves in San Diego and southern Orange counties. The company is committed to creating a sustainable future by increasing energy delivered from low or zero-carbon sources; accelerating the adoption of electric vehicles; and investing in innovative technologies to ensure the reliable operation of the region's infrastructure for generations to come. SDG&E is a subsidiary of Sempra (NYSE: SRE). For more information, visit SDGEnews.com or connect with SDG&E on X (formerly Twitter) (@SDGE), Instagram (@SDGE) and Facebook. View original content to download multimedia:https://www.prnewswire.com/news-releases/sdges-supply-chain-boosts-economy-by-2-6-billion-in-2023--302088473.html SOURCE SDG&E How much economic impact did SDG&E's procurement program generate in 2023? SDG&E's procurement program generated $2.59 billion in direct economic impact in 2023. What percentage of SDG&E's total expenditures were with diverse suppliers? 43% of SDG&E's total expenditures were with diverse suppliers. How much did SDG&E spend with diverse businesses in San Diego County in 2023? SDG&E spent $450.6 million with diverse businesses in San Diego County in 2023. How many diverse suppliers did business with SDG&E in 2023? Nearly 600 diverse suppliers did business with SDG&E in 2023. What is the name of the Minority Business Enterprise engaged by SDG&E for vegetation management services? Rancho Tree Service, a Minority Business Enterprise, was engaged by SDG&E for vegetation management services."
The New England Journal of Medicine Publishes Cologuard Plus Test Results from Pivotal BLUE-C Study,2024-03-13T21:03:00.000Z,Neutral,Positive,"Exact Sciences Corp. announces the online publication of the BLUE-C study results in The New England Journal of Medicine, showcasing the performance of their next-generation multitarget stool DNA test, Cologuard Plus, for colorectal cancer screening. The study demonstrated 94% sensitivity for CRC at 91% specificity, outperforming the fecal immunochemical test. Cologuard Plus aims to reduce unnecessary follow-up colonoscopies and is set to be available in 2025 pending FDA approval.","The New England Journal of Medicine Publishes Cologuard Plus Test Results from Pivotal BLUE-C Study Rhea-AI Impact (Neutral) Rhea-AI Sentiment (Positive) Tags Rhea-AI Summary Exact Sciences Corp. announces the online publication of the BLUE-C study results in The New England Journal of Medicine, showcasing the performance of their next-generation multitarget stool DNA test, Cologuard Plus, for colorectal cancer screening. The study demonstrated 94% sensitivity for CRC at 91% specificity, outperforming the fecal immunochemical test. Cologuard Plus aims to reduce unnecessary follow-up colonoscopies and is set to be available in 2025 pending FDA approval. Positive None. Negative None. Medical Research Analyst The findings from the BLUE-C study regarding Exact Sciences' Cologuard Plus are significant for the medical community and patients alike. The reported 94% sensitivity for colorectal cancer (CRC) is a substantial improvement over the 67% sensitivity of the traditional fecal immunochemical test (FIT). This high sensitivity is crucial for early detection, which is directly linked to better treatment outcomes and survival rates for CRC patients. Moreover, the high specificity rates, particularly the 96% in the 45-54 age group, suggest a reduction in false-positive results, which can alleviate the burden on healthcare systems by minimizing unnecessary colonoscopies.It is also noteworthy that the study included a diverse population, which enhances the generalizability of the results across different racial and ethnic groups in the U.S. The inclusion of participants with a family history of CRC serves to broaden the potential application of the test to higher-risk groups. The potential market expansion for Cologuard Plus could be substantial, given the emphasis on early detection and personalized medicine in oncology. Healthcare Economist From an economic perspective, the introduction of Cologuard Plus could have a considerable impact on the healthcare industry. The tests ability to reduce false positives and its high sensitivity may lead to a decrease in unnecessary procedures, which in turn could result in cost savings for both patients and insurers. This is particularly relevant in the context of the U.S. healthcare system, where the cost of medical procedures is a significant concern.Furthermore, early and accurate detection of CRC through Cologuard Plus could lead to lower treatment costs associated with late-stage cancer care. This preventative approach aligns with value-based care initiatives that prioritize patient outcomes and cost-effectiveness. The potential approval and market release of Cologuard Plus in 2025 could disrupt the current CRC screening market, potentially affecting the stock valuations of companies involved in CRC screening and diagnostics. Market Research Analyst For investors and stakeholders in Exact Sciences, the publication of the BLUE-C study in a prestigious journal like The New England Journal of Medicine adds credibility and visibility to Cologuard Plus. The reported performance metrics position the product as a leader in the noninvasive CRC screening space. Given the size of the CRC screening market and the emphasis on noninvasive tests, the introduction of Cologuard Plus could capture significant market share.However, the timeline for FDA approval and market availability in 2025 suggests a lag before revenue impact is realized. Investors will need to weigh the potential long-term gains against the current investment in research and development, as well as regulatory approval processes. The impact on Exact Sciences stock will likely be influenced by investor confidence in the companys ability to navigate these processes successfully and the anticipation of market adoption rates post-approval. 03/13/2024 - 05:03 PM Cologuard Plus is only noninvasive test to be evaluated head-to-head against an independent fecal immunochemical test, which it significantly outperformed 20,000-participant BLUE-C study included 98 colorectal cancers and reflects racial and ethnic diversity of U.S. Company will host conference call and webcast at 8:00 a.m. ET on March 14 to discuss study results MADISON, Wis.--(BUSINESS WIRE)-- Exact Sciences Corp. (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic tests, today announced online publication of the BLUE-C study results in The New England Journal of Medicine. The peer-reviewed study, ""Next-Generation Multitarget Stool DNA Test for Colorectal Cancer Screening"", will also appear in the journal's March 14, 2024 print issue. The 20,000-participant BLUE-C study was designed to determine the performance characteristics of Exact Sciences next-generation multitarget stool DNA test, Cologuard Plus, for colorectal cancer (CRC) and to compare that performance to the fecal immunochemical test (FIT), a commonly used noninvasive CRC screening test. Exact Sciences submitted to the U.S. Food and Drug Administration (FDA) its pre-market approval (PMA) application for Cologuard Plus in December 2023, including complete results from BLUE-C, and plans to make the test available in 2025, pending approval. Cologuard Plus met all BLUE-C study endpoints, demonstrating 94% sensitivity for CRC at 91% specificity including non-advanced findings, and 93% specificity including no findings. Specificity was even better in younger age groups, at 96% in 45-54 year olds. Cologuard Plus will minimize unnecessary follow-up colonoscopies by reducing the likelihood of a false-positive screening test. Results from BLUE-C also show Cologuard Plus significantly outperformed an independent FIT* for overall CRC sensitivity, treatable-stage CRC (stages I-III) sensitivity, high-grade dysplasia sensitivity, and advanced precancerous lesion sensitivity. Cologuard Plus1 Independent FIT1 Cancer sensitivity 94 67 Specificity including non-advanced findings 91 95 Specificity including no findings 93 96 Stages I-III cancer sensitivity 93 65 High-grade dysplasia sensitivity 75 47 Advanced precancer sensitivity 43 23 Note: specificity including non-advanced findings includes colonoscopy results that were negative for cancer or advanced precancer upon histopathological review; specificity including no findings includes no findings on colonoscopy and no histopathological review; high-grade dysplasia is a subtype of advanced precancer that includes carcinoma in situ or stage 0 cancer To potentially expand the eligible screening population beyond average-risk patients, the BLUE-C study enrolled a small subset of participants with a first-degree relative with a history of CRC. Sensitivities for CRC and advanced precancerous lesions were similar among participants with a first-degree relative with a history of CRC and those without such a relative. Among the subset of nearly 19,000 participants who were average-risk, without a first-degree relative with a history of CRC, Cologuard Plus exhibited 95% sensitivity for CRC and 43% sensitivity for advanced precancerous lesions at a 91% specificity including non-advanced findings, or 94% specificity including no findings. Cologuard Plus is highly sensitive for detecting colorectal cancer, said Thomas F. Imperiale, MD, professor of medicine at the Indiana University School of Medicine, research scientist at the Regenstrief Institute, and principal investigator for the BLUE-C study. This noninvasive test also detected a good proportion of the most advanced precancerous lesions, and did so with a low number of false-positive test results. The prospective, multi-center BLUE-C study utilized colonoscopy as a reference method, directly comparing Cologuard Plus and an independent FIT. BLUE-C investigators also collected blood samples for evaluation of a blood-based CRC screening test developed by Exact Sciences. BLUE-Cs publication in The New England Journal of Medicine reflects a decade of deep scientific and medical research in collaboration with Mayo Clinic, said Kevin Conroy, chairman and CEO of Exact Sciences. Were eager to bring an improved, noninvasive colorectal cancer screening test to patients in Cologuard Plus, as colorectal cancer remains the most preventable, yet least prevented cancer. The BLUE-C study cohort was diverse and reflective of the U.S. population. About 40% of all participants identified as Hispanic or Latino, Black, Asian, American Indian or Alaska Native, or Pacific Islander. This enrollment diversity helps ensure that the BLUE-C findings and Cologuard Plus are relevant for all screen-eligible individuals, regardless of race or ethnicity. Many of the 53,000 Americans killed by colorectal cancer each year come from communities of color, a disparity we must work together to eliminate, said Gary A. Puckrein, Ph.D., president and chief executive officer of National Minority Quality Forum. Access to innovations in colorectal cancer screening like the Cologuard Plus test and navigation that helps people get screened will play an important role in helping reduce the disproportionate and deadly impact colorectal cancer has on communities of color. Conference call and webcast details Exact Sciences management will host a conference call and webcast on March 14 at 8:00 a.m. ET to discuss results of the pivotal BLUE-C study. The webcast will be available at www.exactsciences.com. Domestic callers should dial (800) 715-9871 and international callers should dial +1 646-307-1963. The access code for both domestic and international callers is 5347907. An archive of the webcast will be available at www.exactsciences.com. The webcast, conference call, and replay are open to all interested parties. About the BLUE-C Study BLUE-C was a multi-center, prospective study (NCT04144738) of more than 20,000 adults 40 years of age and older.1 The trial was designed to evaluate the performance of Cologuard Plus (next generation multitarget stool DNA or mt-sDNA). Using colonoscopy as a reference method, the robust study design directly compared Cologuard Plus and an independent FIT. Blood samples were also collected for evaluation of a blood-based screening test developed by Exact Sciences. BLUE-C is one of the largest, noninvasive CRC screening trials ever conducted, and the study population reflects the racial and ethnic makeup of the United States according to the 2020 census.1,2 About Cologuard Plus Developed in collaboration with Mayo Clinic, Cologuard Plus features novel biomarkers and improved laboratory processes. It also incorporates enhanced sample stability components to provide patients more time to return their sample to Exact Sciences' lab and increase the valid result rate. Exact Sciences is preparing for FDA approval and the commercialization of Cologuard Plus. About Exact Sciences Corp. A leading provider of cancer screening and diagnostic tests, Exact Sciences gives patients and health care professionals the clarity needed to take life-changing action earlier. Building on the success of the Cologuard and Oncotype tests, Exact Sciences is investing in its pipeline to develop innovative solutions for use before, during, and after a cancer diagnosis. For more information, visit ExactSciences.com, follow Exact Sciences on X (formerly known as Twitter) @ExactSciences, or find Exact Sciences on LinkedIn and Facebook. NOTE: Exact Sciences and Cologuard Plus are trademarks or registered trademarks of Exact Sciences Corporation. Oncotype is a registered trademark of Genomic Health, Inc., a wholly-owned subsidiary of Exact Sciences Corporation. All other trademarks and service marks are the property of their respective owners. Forward-Looking Statements This news release contains forward-looking statements concerning our expectations, anticipations, intentions, beliefs, or strategies regarding the future. These forward-looking statements are based on assumptions that we have made as of the date hereof and are subject to known and unknown risks and uncertainties that could cause actual results, conditions and events to differ materially from those anticipated. Therefore, you should not place undue reliance on forward-looking statements. Examples of forward-looking statements include, among others, statements we make regarding the development and commercialization of the Cologuard Plus test; the performance characteristics and healthcare benefits of Cologuard Plus in a commercial setting; and the timing and anticipated results of FDA submission. Risks and uncertainties that may affect our forward-looking statements are described in the Risk Factors sections of our most recent Annual Report on Form 10-K and any subsequent Quarterly Reports on Form 10-Q, and in our other reports filed with the Securities and Exchange Commission. We undertake no obligation to publicly update any forward-looking statement, whether written or oral, that may be made from time to time, whether as a result of new information, future developments or otherwise. *The commercially-available Polymedco OC-Auto Micro 80 iFOB Test References Imperiale T, et al. N Engl J Med (2024) United States Census Bureau. Annual Estimates of the Resident Population by Single Year of Age and Sex for the United States: April 1, 2020 to July 1, 2022 (NC-EST2022-AGESEX-RES). Accessed 16 October 2023. https://www.census.gov/data/tables/time-series/demo/popest/2020s-national-detail.html View source version on businesswire.com: https://www.businesswire.com/news/home/20240313292947/en/ Media (U.S.): Lindsey Dickinson +1 608-690-0383 lidickinson@exactsciences.com Investor: Nathan Harrill +1 608 535-8659 investorrelations@exactsciences.com Source: Exact Sciences Corp. What is the publication mentioned in the PR regarding Exact Sciences Corp.? The publication is the BLUE-C study results in The New England Journal of Medicine. What is the sensitivity of Cologuard Plus for CRC according to the BLUE-C study? Cologuard Plus demonstrated 94% sensitivity for CRC at 91% specificity. When is Cologuard Plus expected to be available for use? Cologuard Plus is set to be available in 2025 pending FDA approval. Who is the principal investigator for the BLUE-C study? Thomas F. Imperiale, MD, professor of medicine at the Indiana University School of Medicine. What did the BLUE-C study aim to compare Cologuard Plus against? The study aimed to compare Cologuard Plus against the fecal immunochemical test (FIT)."
AM Best Assigns Issue Credit Ratings to Humana Inc.s New Senior Unsecured Notes and New Shelf Registrations,2024-03-13T20:47:00.000Z,Low,Positive,AM Best assigns 'bbb' Long-Term Issue Credit Ratings to Humana Inc.'s recently announced senior unsecured notes. The outlook is stable. Humana plans to use the proceeds for general corporate purposes and debt repayment.,"AM Best Assigns Issue Credit Ratings to Humana Inc.s New Senior Unsecured Notes and New Shelf Registrations Rhea-AI Impact (Low) Rhea-AI Sentiment (Positive) Tags Rhea-AI Summary AM Best assigns 'bbb' Long-Term Issue Credit Ratings to Humana Inc.'s recently announced senior unsecured notes. The outlook is stable. Humana plans to use the proceeds for general corporate purposes and debt repayment. Positive None. Negative None. Financial Analyst The assignment of Long-Term Issue Credit Ratings to Humana Inc.'s senior unsecured notes by AM Best reflects a significant financial event for the company and its investors. The ratings of 'bbb' for both the $1.25 billion and $1 billion notes due in 2031 and 2054, respectively, indicate a good ability to meet ongoing financial obligations, which can be seen as a positive signal for current and potential investors. The stable outlook suggests a low likelihood of a near-term rating change, implying a stable financial environment for the company.However, it is important to note that Humana's financial leverage slightly exceeds its target debt-to-capital ratio of 40%, standing at 42% at year-end 2023. This could indicate a slightly higher risk profile in terms of debt management. Investors might be concerned that excessive leverage could affect the company's financial flexibility. Nonetheless, the planned use of proceeds for repayment of existing debt and outstanding commercial paper could mitigate such concerns by improving the company's debt maturity profile and potentially reducing interest costs. Market Research Analyst From a market perspective, the issuance of senior unsecured notes by Humana could be interpreted as a strategic move to optimize its capital structure amidst fluctuating interest rates. The interest rates of 5.375% and 5.75% on the newly issued notes are indicative of the current cost of borrowing for corporations and should be compared with industry benchmarks for a comprehensive analysis. Investors and analysts will likely monitor the impact of these notes on Humana's EBIT interest coverage, which remains solid. A strong interest coverage ratio suggests that Humana is well-positioned to cover its interest expenses, a reassuring factor for debt holders.Additionally, the withdrawal of ratings on the expired shelf registration is a routine administrative process and is unlikely to have a material impact on the company's financial health or market perception. The key takeaway for the market is the company's proactive approach to managing its debt portfolio, which can be a positive indicator of its financial prudence and strategic planning. Economist The broader economic implications of Humana's recent financial activities must be considered, especially in the context of the healthcare industry's capital requirements. The decision to issue long-term debt in a potentially rising interest rate environment can be a double-edged sword. On one hand, it locks in capital for long-term projects at fixed rates, which can be advantageous if interest rates rise further. On the other hand, it could increase the cost of future borrowing if rates stabilize or fall.Given the stable outlook, it appears that the economic environment and industry-specific factors are favorable for Humana, which may have contributed to the decision to proceed with the issuance. The company's ability to maintain a solid EBIT interest coverage ratio in this context suggests a robust operational performance capable of sustaining higher levels of debt without jeopardizing financial stability. This strategic financial maneuvering is indicative of a responsive management team attuned to both market conditions and the company's long-term financial strategy. 03/13/2024 - 04:47 PM OLDWICK, N.J.--(BUSINESS WIRE)-- AM Best has assigned Long-Term Issue Credit Ratings (Long-Term IRs) of bbb (Good) to Humana Inc.s (Humana) (headquartered in Louisville, KY) [NYSE: HUM] recently announced $1.25 billion 5.375% senior unsecured notes, due 2031, and $1 billion 5.75% senior unsecured notes, due 2054. In addition, AM Best has assigned indicative Long-Term IRs of bbb (Good) to senior unsecured issues, bbb- (Good) to subordinated issues and bb+ (Fair) to preferred stock and of the recently filed shelf registration of Humana. The outlook assigned to these Credit Ratings (ratings) is stable. Concurrently, AM Best has withdrawn the ratings on the previous shelf registration, which expired. Humana is anticipated to use the proceeds from the senior unsecured notes issuance for general corporate purposes, including the repayment of existing debt and outstanding commercial paper. As such, AM Best expects the issuance to be mostly neutral to financial leverage. Financial leverage, as measured by AM Best, was approximately 42% as of year-end 2023, slightly exceeding the organization's long-term target debt-to-capital ratio of 40%. Humanas earnings before interest and taxes (EBIT) interest coverage remains solid at about 8 times; however, it did decrease at year-end 2023 due to a moderate decline in operating results driven by increased utilization in its Medicare Advantage segment in the fourth quarter of 2023, as well as higher interest expense. Humana has sound liquidity measures as the organization maintains consolidated cash holdings of $4.7 billion and generates consistently strong operating cash flows, which totaled $4 billion in 2023. Liquidity is also supported by subsidiary dividends, its $4 billion commercial paper program, and access to short-term borrowings from the Federal Home Loan Bank of Cincinnati through its subsidiary, Humana Insurance Company. The organizations consistent profitability has driven equity growth over the past five years. Humana generated strong premium growth in 2023, driven by a membership increase in its core Medicare Advantage segment. However, service revenue derived from its CenterWell segment declined because of the divestiture of its 60% ownership in Gentiva Hospice operations. While profitability remained solid in 2023, net income was impacted by increased utilization in Medicare Advantage and supplementary benefits in the fourth quarter of 2023. AM Best expects the companys earnings to remain positive albeit with margin compression. This press release relates to Credit Ratings that have been published on AM Bests website. For all rating information relating to the release and pertinent disclosures, including details of the office responsible for issuing each of the individual ratings referenced in this release, please see AM Bests Recent Rating Activity web page. For additional information regarding the use and limitations of Credit Rating opinions, please view Guide to Best's Credit Ratings. For information on the proper use of Bests Credit Ratings, Bests Performance Assessments, Bests Preliminary Credit Assessments and AM Best press releases, please view Guide to Proper Use of Bests Ratings & Assessments. AM Best is a global credit rating agency, news publisher and data analytics provider specializing in the insurance industry. Headquartered in the United States, the company does business in over 100 countries with regional offices in London, Amsterdam, Dubai, Hong Kong, Singapore and Mexico City. For more information, visit www.ambest.com. Copyright  2024 by A.M. Best Rating Services, Inc. and/or its affiliates. ALL RIGHTS RESERVED. View source version on businesswire.com: https://www.businesswire.com/news/home/20240313694339/en/ Timothy Willey Financial Analyst +1 908 882 2433 timothy.willey@ambest.com Christopher Sharkey Associate Director, Public Relations +1 908 882 2310 christopher.sharkey@ambest.com Joseph Zazzera Director +1 908 882 2442 joseph.zazzera@ambest.com Al Slavin Senior Public Relations Specialist +1 908 882 2318 al.slavin@ambest.com Source: AM Best What are the Long-Term Issue Credit Ratings assigned to Humana Inc.'s senior unsecured notes? AM Best has assigned Long-Term Issue Credit Ratings of 'bbb' (Good) to Humana Inc.'s recently announced $1.25 billion 5.375% senior unsecured notes, due 2031, and $1 billion 5.75% senior unsecured notes, due 2054. What is the intended use of the proceeds from the senior unsecured notes issuance? Humana Inc. plans to use the proceeds from the senior unsecured notes issuance for general corporate purposes, including the repayment of existing debt and outstanding commercial paper. What is the outlook assigned to the Credit Ratings for Humana Inc.'s senior unsecured notes? The outlook assigned to these Credit Ratings is stable, indicating a positive outlook for the company's financial standing. What is Humana Inc.'s current financial leverage ratio? Humana Inc.'s financial leverage, as measured by AM Best, was approximately 42% as of year-end 2023, slightly exceeding the organization's long-term target debt-to-capital ratio of 40%."
TE Connectivity shareholders elect Carol 'John' Davidson as new board chairman,2024-03-13T20:45:00.000Z,Low,Neutral,TE Connectivity Ltd. shareholders elect Carol Davidson as new chairman and approve $2.60 per share quarterly dividend at annual meeting.,"TE Connectivity shareholders elect Carol 'John' Davidson as new board chairman Rhea-AI Impact (Low) Rhea-AI Sentiment (Neutral) Tags Rhea-AI Summary TE Connectivity Ltd. shareholders elect Carol Davidson as new chairman and approve $2.60 per share quarterly dividend at annual meeting. Positive None. Negative None. Market Research Analyst The election of Carol 'John' Davidson as the new chairman of the board for TE Connectivity Ltd. signifies a strategic shift in leadership which could influence the company's governance and decision-making processes. With Davidson's extensive experience and previous role as lead independent director, his appointment may be viewed positively by investors seeking stability and seasoned oversight. Furthermore, the approval of a consistent dividend payout may reinforce investor confidence, as it suggests a stable financial position and a commitment to returning value to shareholders.From a market research perspective, leadership transitions can have a profound impact on investor perception and stock performance. Davidson's election could potentially lead to shifts in company strategy, especially considering his cross-industry leadership background. Investors will likely monitor the company's performance closely in the subsequent quarters to gauge the effectiveness of the new chairman's influence on the company's growth trajectory. Financial Analyst The announcement of a $2.60 per share annual dividend, distributed in quarterly increments, is a critical piece of financial information for current and potential investors. This dividend yield, based on the current stock price, can be compared to industry averages to assess TE Connectivity's attractiveness as an investment. The commitment to a quarterly dividend also suggests that the company has a reliable cash flow and is managing its capital efficiently enough to reward shareholders. This could be indicative of fiscal prudence and a strong balance sheet.Long-term investors might be particularly interested in the sustainability of these dividends. It is essential to analyze the companys payout ratio and compare it to earnings to evaluate whether the dividends are supported by profits or if they could potentially strain the company's finances in the future. A financial analysis of TE Connectivity's past dividend history and financial health could provide valuable insights into the company's long-term strategic financial planning. 03/13/2024 - 04:45 PM Shareholders also approve quarterly dividend at annual general meeting SCHAFFHAUSEN, Switzerland, March 13, 2024 /PRNewswire/ -- Shareholders of TE Connectivity Ltd. (NYSE: TEL), a world leader in connectors and sensors, elected Carol ""John"" Davidson as the new chairman of the board at the company's March 13 annual general meeting of shareholders. Davidson assumes the chairman's role from Tom Lynch, who retired from the board after serving as the chairman since 2013. Davidson has served as a member of the board since 2016 and has been the lead independent director of TE since 2022. He has more than 30 years of leadership experience across multiple industries and is an experienced board leader. Dividend approved Shareholders also approved a dividend of $2.60 per share. The dividend will be distributed to shareholders in four equal quarterly installments of $0.65, as follows: TEL Quarter, Fiscal Year Payment Date Record Date 3rd Quarter, Fiscal Year 2024 June 7, 2024 May 24, 2024 4th Quarter, Fiscal Year 2024 Sept. 6, 2024 Aug. 23, 2024 1st Quarter, Fiscal Year 2025 Dec. 6, 2024 Nov. 22, 2024 2nd Quarter, Fiscal Year 2025 March 7, 2025 Feb. 21, 2025 About TE Connectivity TE Connectivity Ltd. (NYSE: TEL) is a global industrial technology leader creating a safer, sustainable, productive, and connected future. Our broad range of connectivity and sensor solutions enable the distribution of power, signal and data to advance next-generation transportation, renewable energy, automated factories, data centers, medical technology and more. With more than 85,000 employees, including 8,000 engineers, working alongside customers in approximately 140 countries, TE ensures that EVERY CONNECTION COUNTS. Learn more at www.te.com and on LinkedIn, Facebook, WeChat, Instagram and X (formerly Twitter). View original content to download multimedia:https://www.prnewswire.com/news-releases/te-connectivity-shareholders-elect-carol-john-davidson-as-new-board-chairman-302087820.html SOURCE TE Connectivity, LTD Who was elected as the new chairman of TE Connectivity Ltd.? Carol Davidson was elected as the new chairman of TE Connectivity Ltd. What is the approved dividend per share for TE Connectivity Ltd.? The approved dividend per share for TE Connectivity Ltd. is $2.60. How will the dividend be distributed to shareholders? The dividend will be distributed in four equal quarterly installments of $0.65 each. When is the payment date for the 3rd quarter dividend in fiscal year 2024? The payment date for the 3rd quarter dividend in fiscal year 2024 is June 7, 2024. Who was the previous chairman of TE Connectivity Ltd.? The previous chairman of TE Connectivity Ltd. was Tom Lynch. How many years of leadership experience does Carol Davidson have? Carol Davidson has more than 30 years of leadership experience. When did Tom Lynch retire from the board of TE Connectivity Ltd.? Tom Lynch retired from the board after serving as the chairman since 2013. Who has been the lead independent director of TE Connectivity Ltd. since 2022? Carol Davidson has been the lead independent director of TE Connectivity Ltd. since 2022."
Kinetik Announces Secondary Offering of Common Stock,2024-03-13T20:45:00.000Z,Low,Neutral,"Kinetik Holdings Inc. (NYSE: KNTK) announced a secondary offering of 11,373,801 shares of its Class A common stock by Apache Midstream LLC, a subsidiary of Apache Corporation. The Company will not receive proceeds from the sale. The Offering includes a 30-day option for additional shares. The Chief Executive Officer expressed interest in purchasing shares. Goldman Sachs, BofA Securities, J.P. Morgan, and Mizuho are acting as joint lead managers for the Offering.","Kinetik Announces Secondary Offering of Common Stock Rhea-AI Impact (Low) Rhea-AI Sentiment (Neutral) Tags offering Rhea-AI Summary Kinetik Holdings Inc. (NYSE: KNTK) announced a secondary offering of 11,373,801 shares of its Class A common stock by Apache Midstream LLC, a subsidiary of Apache Corporation. The Company will not receive proceeds from the sale. The Offering includes a 30-day option for additional shares. The Chief Executive Officer expressed interest in purchasing shares. Goldman Sachs, BofA Securities, J.P. Morgan, and Mizuho are acting as joint lead managers for the Offering. Positive None. Negative None. Financial Analyst The secondary offering of Kinetik Holdings Inc. shares by Apache Midstream LLC represents a liquidity event for the selling shareholder rather than a capital raise for the company itself. This transaction will not directly infuse new capital into Kinetik, as the proceeds do not go to the company. However, the market's response to this offering could indirectly impact Kinetik's stock price due to potential changes in the stock's perceived value and supply and demand dynamics.Investors should note that the CEO's indication of interest in purchasing shares could be interpreted as a positive signal of confidence in the company's value and prospects. The involvement of prominent financial institutions as book-running managers may also lend credibility to the offering and facilitate the process. Nonetheless, it is important to monitor the offering's pricing, as it may affect the market's valuation of Kinetik's shares. Market Research Analyst Understanding the context of Kinetik's secondary offering requires analyzing the broader energy sector and midstream market conditions. If the industry is facing headwinds, such as volatile commodity prices or regulatory challenges, the offering might be met with cautious investor sentiment. Conversely, a robust sector outlook could lead to a more favorable reception.Additionally, the size of the offering and the option for underwriters to purchase additional shares could indicate the selling shareholder's outlook on Kinetik's future stock performance. A successful offering could potentially enhance Kinetik's trading liquidity and shareholder base diversity, which are factors that can contribute to a more stable stock performance in the long run. Legal Expert From a legal standpoint, the offering's conduction under a previously filed registration statement that became automatically effective signals adherence to SEC regulations. The preliminary prospectus supplement will provide crucial information and prospective investors should review these documents thoroughly. It is essential to consider the legal implications and the accuracy of the disclosures made in these filings, as they can significantly impact investor decisions and the success of the offering.Moreover, the 30-day option granted to the underwriters is a standard practice known as a 'greenshoe' option, which can help stabilize the stock price after the offering. This mechanism allows underwriters to manage potential excess demand and reduce price volatility, which could benefit both the selling shareholder and existing investors. 03/13/2024 - 04:45 PM HOUSTON & MIDLAND, Texas--(BUSINESS WIRE)-- Kinetik Holdings Inc. (NYSE: KNTK) (Kinetik or the Company) announced today the commencement of an underwritten secondary offering of 11,373,801 shares of its Class A common stock (the Offering) by Apache Midstream LLC (the Selling Stockholder), a subsidiary of Apache Corporation. Kinetik is not selling any shares of Class A common stock in the Offering and will not receive the proceeds from any sale of shares by the Selling Stockholder. In connection with the Offering, the Selling Stockholder intends to grant to the underwriters a 30-day option to purchase up to an additional 1,706,070 shares of Kinetiks Class A common stock. The Offering is subject to market and other conditions, and there can be no assurance as to whether or when the Offering may be completed. In connection with the Offering, the Companys Chief Executive Officer has provided an indication of interest in purchasing shares of Class A common stock from the underwriters at the public offering price. Goldman Sachs & Co. LLC, BofA Securities, J.P. Morgan and Mizuho are acting as joint lead book-running managers for the Offering. The Offering is being made only by means of a prospectus supplement. When available, a copy of the prospectus supplement and the accompanying base prospectus may be obtained from Goldman Sachs & Co. LLC, Prospectus Department, 200 West Street, New York, NY 10282, by telephone at (866) 471-2526, by facsimile at (212) 902-9316 or by emailing Prospectus-ny@ny.email.gs.com; J.P. Morgan, c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, NY 11717, by telephone at (866) 803-9204; BofA Securities, Inc., NC1-022-02-25, 201 North Tryon Street, Charlotte, NC 28255-0001, Attn: Prospectus Department, Email: dg.prospectus_requests@bofa.com; Mizuho Securities USA LLC, 1271 Avenue of the Americas, 3rd Floor, New York, New York 10020, Attn: Equity Capital Market, telephone at +1 (212) 205-7600. The offering is being conducted pursuant to a registration statement, filed with the SEC on March 13, 2024, that became automatically effective upon filing, and the base prospectus included therein. A preliminary prospectus supplement thereto will be filed with the SEC. Before investing, prospective investors should read the prospectus supplement, accompanying base prospectus and the documents incorporated by reference therein for more complete information about the Company and the Offering. An electronic copy of the prospectus supplement and accompanying base prospectus is available from the U.S. Securities and Exchange Commissions website at www.sec.gov. This news release does not constitute an offer to sell or a solicitation of an offer to buy any securities, nor shall there be any sale of any securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction. About Kinetik Holdings Inc. Kinetik is a fully integrated, pure-play, Permian-to-Gulf Coast midstream C-corporation operating in the Delaware Basin. Kinetik is headquartered in Midland, Texas and has a significant presence in Houston, Texas. Kinetik provides comprehensive gathering, transportation, compression, processing and treating services for companies that produce natural gas, natural gas liquids, crude oil and water. Forward-looking statements This news release includes certain statements that may constitute forward-looking statements for purposes of the federal securities laws. Forward-looking statements include, but are not limited to, statements that refer to projections, forecasts or other characterizations of future events or circumstances, including any underlying assumptions. The words anticipate, believe, continue, could, estimate, expect, intends, may, might, plan, seeks, possible, potential, predict, project, prospects, guidance, outlook, should, would, will, and similar expressions may identify forward-looking statements, but the absence of these words does not mean that a statement is not forward-looking. These statements include, but are not limited to, statements regarding the Offering. While forward-looking statements are based on assumptions and analyses made by us that we believe to be reasonable under the circumstances, whether actual results and developments will meet our expectations and predictions depend on a number of risks and uncertainties which could cause our actual results, performance, and financial condition to differ materially from our expectations. See Part I, Item 1A. Risk Factors in our Annual Report on Form 10-K for the year ended December 31, 2023. Any forward-looking statement made by us in this news release speaks only as of the date on which it is made. Factors or events that could cause our actual results to differ may emerge from time to time, and it is not possible for us to predict all of them. We undertake no obligation to publicly update any forward-looking statement, whether as a result of new information, future development, or otherwise, except as may be required by law. View source version on businesswire.com: https://www.businesswire.com/news/home/20240313243714/en/ Kinetik Investors: (713) 487-4832 Maddie Wagner (713) 574-4743 Alex Durkee Source: Kinetik Holdings Inc. What is the ticker symbol for Kinetik Holdings Inc.? The ticker symbol for Kinetik Holdings Inc. is KNTK. How many shares are included in the secondary offering by Apache Midstream LLC? Apache Midstream LLC is offering 11,373,801 shares of Kinetik's Class A common stock. Who will not receive proceeds from the sale of shares in the Offering? Kinetik Holdings Inc. will not receive proceeds from the sale of shares in the Offering. Which companies are acting as joint lead book-running managers for the Offering? Goldman Sachs, BofA Securities, J.P. Morgan, and Mizuho are acting as joint lead book-running managers for the Offering. Is the Chief Executive Officer of Kinetik Holdings Inc. involved in the Offering? Yes, the Chief Executive Officer of Kinetik Holdings Inc. has expressed interest in purchasing shares of Class A common stock from the underwriters at the public offering price."
Guardant Health ECLIPSE Study Data Demonstrating Efficacy of Shield Blood-based Test for Colorectal Cancer Screening to be Published in The New England Journal of Medicine,2024-03-13T21:00:00.000Z,Neutral,Neutral,"Guardant Health, Inc. announces successful results from the ECLIPSE study showing the effectiveness of its Shield blood test in detecting colorectal cancer. The study reveals 83% sensitivity in detecting individuals with CRC and 88% sensitivity in detecting Stages I-III. Shield's potential FDA approval could revolutionize CRC screening, offering a convenient and accurate alternative to traditional methods.","Guardant Health ECLIPSE Study Data Demonstrating Efficacy of Shield Blood-based Test for Colorectal Cancer Screening to be Published in The New England Journal of Medicine Rhea-AI Impact (Neutral) Rhea-AI Sentiment (Neutral) Tags Rhea-AI Summary Guardant Health, Inc. announces successful results from the ECLIPSE study showing the effectiveness of its Shield blood test in detecting colorectal cancer. The study reveals 83% sensitivity in detecting individuals with CRC and 88% sensitivity in detecting Stages I-III. Shield's potential FDA approval could revolutionize CRC screening, offering a convenient and accurate alternative to traditional methods. Positive None. Negative None. Oncology Doctor The recent findings from the ECLIPSE study represent a significant advancement in the field of oncology, particularly in the early detection of colorectal cancer (CRC). The study's reported 83% sensitivity in detecting CRC and 90% specificity are notable because early-stage detection is crucial for improving patient outcomes. The high sensitivity rates for Stages II and III, both at 100%, are particularly encouraging, as these stages are often when CRC is most treatable. However, the lower sensitivity for Stage I, at 65% for pathology-confirmed and 55% for clinical Stage I, suggests there is still room for improvement in detecting the earliest stages of CRC.From a clinical perspective, the potential FDA approval and subsequent Medicare coverage of the Shield blood test could lead to increased screening adherence, given the non-invasiveness and convenience compared to traditional methods like colonoscopy. This shift could ultimately result in earlier diagnoses and better survival rates, as the 5-year relative survival rate for early-stage colon cancer is significantly higher than that of advanced stages. The test's ability to detect circulating tumor DNA (ctDNA) is a testament to the advancements in precision medicine and the move towards more patient-friendly screening modalities. Market Research Analyst Guardant Health's Shield test has the potential to disrupt the CRC screening market by offering a more accessible and less invasive alternative to current methods. The test's high adherence rate in real-world settings and the ability to triple screening rates among previously non-compliant adults are particularly promising for the company's market penetration and growth. The market impact could be substantial, not only for Guardant Health but also for competitors, as it may set a new standard for CRC screening practices.Investors should monitor the FDA's decision on Shield's premarket approval application closely, as approval could lead to significant revenue growth for Guardant Health. Additionally, the test's alignment with the increasing preference for non-invasive medical procedures could position the company favorably within the precision oncology sector. It's important to note, however, that market adoption rates and the impact on Guardant Health's financials will depend on factors such as insurance coverage, pricing strategy and the ability to maintain high sensitivity and specificity in a broader population. Health Economist The introduction of the Shield blood test could have profound implications for healthcare economics, particularly in the realm of preventative care for colorectal cancer. The potential for Medicare coverage is a critical factor in ensuring widespread access and could lead to cost savings by reducing the number of advanced-stage CRC cases that are more expensive to treat. Moreover, the test's convenience could lead to increased compliance with screening guidelines, which is cost-effective in the long run by catching cancers earlier when they are less costly to manage.However, it is essential to consider the cost-effectiveness of the Shield test compared to existing screening methods. While non-invasive, if the cost per test is significantly higher, it could offset the savings from increased early detection. Furthermore, the economic impact will also depend on the test's adoption by healthcare providers and whether it can truly replace or complement current screening protocols. Long-term studies on health outcomes and cost implications will be crucial to assess the full economic impact of incorporating Shield into standard CRC screening practices. 03/13/2024 - 05:00 PM Study shows blood-based cancer screening test detects 83% of people with colorectal cancer with specificity of 90% Results pave the way for first potential FDA-approved blood test for colorectal cancer screening to meet requirements for Medicare coverage PALO ALTO, Calif.--(BUSINESS WIRE)-- Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced that results from the ECLIPSE study showing the effectiveness of its ShieldTM blood test for detecting colorectal cancer (CRC) in average-risk adults will be published in the March 14 issue of The New England Journal of Medicine. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240313547689/en/Shield (TM) from Guardant Health is a blood test for colorectal cancer screening for adults age 45-84 who are at average risk. (Photo: Business Wire) Over 50 million eligible Americans do not get recommended screenings for colorectal cancer, partly because current screening methods are inconvenient or unpleasant, said AmirAli Talasaz, Guardant Health co-CEO. We believe the publication of the ECLIPSE study in The New England Journal of Medicine, one of the worlds leading medical journals, is an endorsement of the quality of our clinical data and the potential value of the Shield test. We are confident that offering an accurate blood test has the potential to significantly reduce preventable colorectal cancer deaths. One of the largest studies of its kind, ECLIPSE (Evaluation of ctDNA LUNAR Assay In an Average Patient Screening Episode) is a 20,000+-patient registrational study to evaluate the performance of Shield compared to a screening colonoscopy. The Shield test detects colorectal cancer signals in the bloodstream from DNA that is shed by tumors, called circulating tumor DNA (ctDNA). Highlights of the study results to be published in The New England Journal of Medicine* show that Shield demonstrated: 83% sensitivity in detecting individuals with CRC 88% sensitivity in detecting pathology-confirmed Stages I-III Sensitivity by stage of: 65% for pathology-confirmed Stage I; 55% for clinical Stage I 100% for Stage II 100% for Stage III 100% for Stage IV These results are on par with the performance of other guideline-recommended non-invasive screening modalities, where overall sensitivity in detecting colorectal cancer ranges from 74% to 92%.1 More than 3 out of 4 Americans who die from colorectal cancer are not up to date with their recommended screening,2 highlighting the need for a more convenient and less invasive screening method that can overcome barriers associated with traditional options, said Daniel Chung, MD, gastroenterologist at Massachusetts General Hospital and Professor of Medicine at Harvard Medical School. The ECLIPSE study results published today support the use of a blood test as a screening option that could help overcome these barriers and improve CRC screening rates."" Publication of ECLIPSE follows Guardant Healths submission of its premarket approval (PMA) application to the U. S. Food and Drug Administration (FDA) for Shield, which included key data points from the study. Since the launch of the lab-developed version of the Shield test in May 2022, it has been used by more than 20,000 people and more than 90% of patients who were prescribed the test in the real-world clinical setting completed it. One recent study showed that CRC screening rates tripled among adults who had declined prior CRC screening when they were offered Shield. The tests sensitivity in detecting CRC, combined with this real-world adherence, suggests that Shield has the potential to detect more CRCs at a curable stage than traditional screening methods.3,4,5,6 Colorectal cancer is highly treatable if caught in the early stages, yet more than 50 million people in the U.S. are still not completing their recommended screening with the methods available today, said Chris Evans, president of the Colon Cancer Coalition. This publication gets us one step closer to having an additional option to offer patients  one that is both convenient and accessibleand will help us close the screening gap. Colorectal cancer is the second-leading cause of cancer deaths in the U.S. The American Cancer Society estimates that more than 150,000 people will be diagnosed with CRC in 20247 and it is expected to become the leading cause of cancer-related deaths by 2030 in adults aged 20-49.8 More than 75% of people who die from CRC are not up to date with recommended screening,9 often due to the perception that current methods such as colonoscopy or stool-based tests are invasive, time-consuming and inconvenient. Early detection, however, is crucial. When colon cancer is found at an early stage before it has spread, the 5-year relative survival rate is 91%. If the cancer has spread to distant parts of the body, the 5-year survival rate is 13%. The results of the study are a promising step toward developing more convenient tools to detect colorectal cancer early while it is more easily treated, said corresponding author William M. Grady, MD, a gastroenterologist at Fred Hutchinson Cancer Center. The test, which has an accuracy rate for colon cancer detection similar to stool tests used for early detection of cancer, could offer an alternative for patients who may otherwise decline current screening options."" * Representatives of the media who are not able to access the article content can contact press@guardanthealth.com. About the ECLIPSE study ECLIPSE is a prospective registrational study to evaluate the performance of Guardant Healths blood test in detecting signs of CRC compared to a screening colonoscopy in average-risk adults between the ages of 45 and 84 from across the U.S. The ECLIPSE study included more than 200 clinical trial sites in rural and urban communities across 34 states. Study data includes 12% Black, 13% Hispanic and 7% Asian American populations. Enrollment among Black Americans was above average for a clinical trial, which is important given the disproportionate impact of CRC on the Black community.10 About Shield The Shield test for colorectal cancer screening is commercially available for eligible individuals by prescription only through healthcare professionals. This LDT (Laboratory Developed Test) is intended to be complementary to, and not a replacement for, current recommended CRC screening methods. A negative result does not rule out the presence of cancer. Patients with an abnormal blood-based screening result should be referred for a diagnostic colonoscopic evaluation. More information about the Shield test is available at bloodbasedscreening.com. About Guardant Health Guardant Health is a leading precision medicine company focused on guarding wellness and giving every person more time free from cancer. Founded in 2012, Guardant is transforming patient care by providing critical insights into what drives disease through its advanced blood and tissue tests, real-world data and AI analytics. Guardant tests help improve outcomes across all stages of care, including screening to find cancer early, monitoring for recurrence in early-stage cancer, and helping doctors select the best treatment for patients with advanced cancer. For more information, visit guardanthealth.com and follow the company on LinkedIn, X (Twitter) and Facebook. Forward-Looking Statements This press release contains forward-looking statements within the meaning of federal securities laws, including statements regarding the potential utilities, values, benefits and advantages of Guardant Healths liquid biopsy tests or assays, which involve risks and uncertainties that could cause the actual results to differ materially from the anticipated results and expectations expressed in these forward-looking statements. These statements are based on current expectations, forecasts and assumptions, and actual outcomes and results could differ materially from these statements due to a number of factors. These and additional risks and uncertainties that could affect Guardant Healths financial and operating results and cause actual results to differ materially from those indicated by the forward-looking statements made in this press release include those discussed under the captions Risk Factors and Managements Discussion and Analysis of Financial Condition and Results of Operation and elsewhere in its Annual Report on Form 10-K for the year ended December 31, 2023, and any current and periodic reports filed with or furnished to the Securities and Exchange Commission thereafter. The forward-looking statements in this press release are based on information available to Guardant Health as of the date hereof, and Guardant Health disclaims any obligation to update any forward-looking statements provided to reflect any change in its expectations or any change in events, conditions, or circumstances on which any such statement is based, except as required by law. These forward-looking statements should not be relied upon as representing Guardant Healths views as of any date subsequent to the date of this press release. Disclosures Dr. Chung and Dr. Grady are paid members of Guardant Healths ECLIPSE Steering Committee. Both advised on the design and procedure of the clinical study and data analysis. References Chung, D., et al. Clinical Validation of a Cell-Free DNA Blood-Based Test for Colorectal Cancer in an Average Risk Population. Abstract #3910067. Digestive Disease Week 2023; May 6-9, 2023; Chicago, IL. Gastroenterology. 2019 Jan; 156(1): 6374.e6. www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&retmode=ref&cmd=prlinks&id=30268788. Accessed March 6, 2024. Bretthauer M, Lberg M, Wieszczy P, et al.; NordICC Study Group. Effect of colonoscopy screening on risks of colorectal cancer and related death. N Engl J Med. 2022;387:1547-1556. Knudsen AB, Rutter CM, Peterse EFP, et al. Colorectal cancer screening: An updated decision analysis for the U.S. Preventive Services Task Force. Rockville (MD): Agency for Healthcare Research and Quality; 2021a. Report No.: 202s. Imperiale TF, Ransohoff DF, Itzkowitz SH, et al. Multitarget stool DNA testing for colorectal-cancer screening. N Eng J Med. 2014. Coronado GD, Jenkins CL, Shuster E, et al. Blood-based colorectal cancer screening in an integrated health system: a randomised trial of patient adherence. Gut. Epub ahead of print:23 January 2024. doi:10.1136/gutjnl-2023-330980. American Cancer Society: Colorectal Cancer Key Statistics. www.cancer.org/cancer/colon-rectal-cancer/about/key-statistics.html Accessed online Feb 5, 2021. Colorectal Cancer Alliance. https://colorectalcancer.org/resources-support/community-support/young-onset-support/young-onset-crc-facts. Accessed March 13, 2024. Doubeni CA, Fedewa SA, Levin TR, et al. Modifiable Failures in the Colorectal Cancer Screening Process and Their Association With Risk of Death. Gastroenterology 2019;156:6374. U.S. Food & Drug Administration. 2022 Drug Trials Snapshots Summary Report. https://www.fda.gov/drugs/drug-approvals-and-databases/drug-trials-snapshots. Accessed December 18, 2023. View source version on businesswire.com: https://www.businesswire.com/news/home/20240313547689/en/ Investor Contact: investors@guardanthealth.com Media Contact: Michael Weist press@guardanthealth.com +1 650-647-3643 Source: Guardant Health, Inc. What is the name of the company mentioned in the press release? The company mentioned in the press release is Guardant Health, Inc. with the ticker symbol GH. What is the sensitivity rate of Shield in detecting individuals with colorectal cancer? Shield demonstrated an 83% sensitivity rate in detecting individuals with colorectal cancer. What is the sensitivity rate of Shield in detecting Stages I-III colorectal cancer? Shield showed an 88% sensitivity rate in detecting pathology-confirmed Stages I-III colorectal cancer. What is the potential significance of the Shield blood test for colorectal cancer screening? The Shield blood test has the potential to significantly reduce preventable colorectal cancer deaths by offering a convenient and accurate screening method. What is the expected impact of Shield on CRC screening rates? Shield has the potential to help overcome barriers associated with traditional screening methods and improve CRC screening rates."
Pagaya Announces Public Offering of Class A Ordinary Shares,2024-03-13T20:40:00.000Z,Low,Neutral,"Pagaya Technologies Ltd. (NASDAQ: PGY) has announced a public offering of 6,500,000 Class A ordinary shares to support future growth and general corporate purposes. The Company aims to use the net proceeds for working capital expenses and investments.","Pagaya Announces Public Offering of Class A Ordinary Shares Rhea-AI Impact (Low) Rhea-AI Sentiment (Neutral) Tags offering Rhea-AI Summary Pagaya Technologies Ltd. (NASDAQ: PGY) has announced a public offering of 6,500,000 Class A ordinary shares to support future growth and general corporate purposes. The Company aims to use the net proceeds for working capital expenses and investments. Positive None. Negative None. Financial Analyst When a company announces a public offering of shares, it is typically a strategic move to raise capital. In this case, Pagaya Technologies Ltd.'s decision to offer 6,500,000 Class A ordinary shares can be an indicator of the company's need for liquidity or desire to fund growth initiatives. The additional option for underwriters to purchase up to 975,000 shares suggests confidence in the offering's success, potentially indicating a positive market sentiment towards Pagaya.Investors will be interested in the utilization of the net proceeds, which are earmarked for 'general corporate purposes and to support future growth.' This broad description warrants scrutiny, as the specifics of these investments can significantly affect the company's financial trajectory. The involvement of reputable financial institutions as active joint book-running managers and co-managers, such as Citigroup and Jefferies, can be seen as a vote of confidence in the offering's management.However, it's crucial to consider the dilutive effect on existing shareholders. The increase in outstanding shares can lead to earnings per share dilution if the capital raised does not result in a proportional increase in net income. Market reaction to such offerings can be mixed, depending on the perceived value of the investment for which the capital is raised. Market Research Analyst From a market perspective, Pagaya Technologies Ltd.'s public offering can reflect broader trends in the financial technology sector. AI infrastructure is a rapidly growing field and companies like Pagaya are at the forefront of innovation. The success of this offering could signal to the market that investors are eager to support companies that are leveraging AI to disrupt traditional financial ecosystems.It is also important to monitor the market conditions at the time of the offering. If market conditions are favorable, Pagaya might secure better terms and pricing for their shares, which can be beneficial for both the company and the investors. Conversely, in a bear market, the offering might be priced lower, potentially leading to less capital raised than anticipated. Legal Expert The legal framework surrounding a public offering is complex and requires compliance with regulatory requirements. Pagaya's use of a shelf registration statement allows them to prepare the offering documents in advance and go to market quickly when conditions are favorable. This is a common strategy for companies looking to have the flexibility to time their offerings to market conditions.Investors should be aware that the prospectus and prospectus supplement will contain critical information, including risk factors and detailed use of proceeds. These documents are key to understanding the legal and financial implications of the offering. The SEC's role in reviewing these documents is to ensure transparency and protect investor interests. 03/13/2024 - 04:40 PM NEW YORK--(BUSINESS WIRE)-- Pagaya Technologies Ltd. (NASDAQ: PGY) (Pagaya, the Company or we), a global technology company delivering artificial intelligence infrastructure for the financial ecosystem, today announced that it has commenced an underwritten public offering (the Offering) of 6,500,000 Class A ordinary shares, no par value (Class A Ordinary Shares). The Company intends to grant the underwriters a 30-day option to purchase up to 975,000 additional Class A Ordinary Shares. The Company intends to use the net proceeds from the Offering for general corporate purposes and to support future growth, which may include working capital expenses and associated investments. The Offering is subject to market and other conditions. Citigroup and Jefferies are active joint book-running managers of the Offering. Keefe, Bruyette & Woods, A Stifel Company is a book-runner of the Offering. B. Riley Securities is acting as a co-manager of the Offering. The Offering is being made pursuant to an effective shelf registration statement on Form F-3, filed with the Securities and Exchange Commission (SEC) on October 4, 2023, with an effective date of October 16, 2023. The Offering will be made only by means of a prospectus supplement and the accompanying prospectus. Before investing, prospective investors should read the prospectus, the prospectus supplement and the documents incorporated by reference therein for more complete information about the Company and the Offering. These documents may be obtained for free by visiting the SECs website at www.sec.gov. Alternatively, copies of the prospectus supplement and accompanying prospectus, when available, may be obtained from: Citigroup Global Markets Inc., c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, NY 11717 or by telephone at 1-800-831-9146; or from Jefferies LLC, Attn: Equity Syndicate Prospectus Department, 520 Madison Avenue, New York, New York 10022, or by telephone at (877) 821-7388 or by email at Prospectus_Department@Jefferies.com. This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction. About Pagaya Technologies Pagaya (NASDAQ: PGY) is a global technology company making life-changing financial products and services available to more people nationwide. By using machine learning, a vast data network and a sophisticated AI-driven approach, Pagaya provides comprehensive consumer credit and residential real estate solutions for its partners, their customers, and investors. Its proprietary API and capital solutions integrate into its network of partners to deliver seamless user experiences and greater access to the mainstream economy. Pagaya has offices in New York and Tel Aviv. Cautionary Note About Forward-Looking Statements This document contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, that involve risks and uncertainties. These forward-looking statements generally are identified by the words anticipate, believe, continue, can, could, estimate, expect, intend, may, opportunity, future, strategy, might, outlook, plan, possible, potential, predict, project, should, strive, will, would, will be, will continue, will likely result, and similar expressions. These statements are based on the Companys current beliefs and expectations. Such forward-looking statements include, but are not limited to, statements relating to the offering, including the timing and size of the offering and the anticipated use of proceeds therefrom and the grant of the underwriters 30-day option to purchase additional shares. Actual results may differ from those set forth in this press release due to the risks and uncertainties associated with market conditions and the satisfaction of customary closing conditions related to the proposed public offering and the other risks and uncertainties described in the Companys filings with the SEC, included under the heading Risk Factors in the Companys Annual Report on Form 20-F and any subsequent filings with the SEC. These forward-looking statements involve known and unknown risks, uncertainties and other important factors that may cause the Companys actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. These forward-looking statements reflect the Companys views with respect to future events as of the date hereof and are based on assumptions and subject to risks and uncertainties. Given these uncertainties, investors should not place undue reliance on these forward-looking statements. The forward-looking statements made as of the date hereof reflect the Companys current beliefs and are based on information currently available as of the date they are made, and the Company assumes no obligation and does not intend to update these forward-looking statements. All forward-looking statements are qualified in their entirety by this cautionary statement, which is made under the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. View source version on businesswire.com: https://www.businesswire.com/news/home/20240313182521/en/ Investors & Analysts ir@pagaya.com Media & Press press@pagaya.com Source: Pagaya Technologies Ltd. What is the ticker symbol for Pagaya Technologies Ltd.? The ticker symbol for Pagaya Technologies Ltd. is PGY. How many Class A ordinary shares are being offered in the public offering? The Company is offering 6,500,000 Class A ordinary shares in the public offering. What is the purpose of the net proceeds from the Offering? The Company intends to use the net proceeds for general corporate purposes and to support future growth, including working capital expenses and investments. Who are the active joint book-running managers of the Offering? Citigroup and Jefferies are the active joint book-running managers of the Offering. When was the effective date of the shelf registration statement for the Offering? The shelf registration statement for the Offering was filed with the SEC on October 4, 2023, with an effective date of October 16, 2023."
Planet 13 Announces Q4 2023 Financial Results,2024-03-13T20:30:00.000Z,Neutral,Neutral,"Planet 13 Holdings Inc. reported Q4 2023 revenue of $23.0 million with a net loss of $14.3 million, including a non-cash impairment loss of $7.2 million. Adjusted EBITDA stood at $1.3 million. Despite economic uncertainties and cannabis price pressure, the company maintained a strong quarter with 9% of Nevada's retail market share and top brands in each category. The acquisition of VidaCann positions them for growth in Florida's potential adult-use market.","Planet 13 Announces Q4 2023 Financial Results Rhea-AI Impact (Neutral) Rhea-AI Sentiment (Neutral) Tags earnings Rhea-AI Summary Planet 13 Holdings Inc. reported Q4 2023 revenue of $23.0 million with a net loss of $14.3 million, including a non-cash impairment loss of $7.2 million. Adjusted EBITDA stood at $1.3 million. Despite economic uncertainties and cannabis price pressure, the company maintained a strong quarter with 9% of Nevada's retail market share and top brands in each category. The acquisition of VidaCann positions them for growth in Florida's potential adult-use market. Positive None. Negative None. 03/13/2024 - 04:30 PM Q4 2023 Revenue of $23.0 millionQ4 2023 Net loss of $14.3 million, which included a non-cash impairment loss of $7.2 millionQ4 2023 Adjusted EBITDA of $1.3 millionAll results are reported in United States dollars ($) unless otherwise indicated.LAS VEGAS, NV / ACCESSWIRE / March 13, 2024 / Planet 13 Holdings Inc. (CSE:PLTH)(OTCQX:PLNH) (""Planet 13"" or the ""Company""), a leading vertically-integrated cannabis company, today announced its financial results for the three-month and twelve-month periods ended December 31, 2023. Planet 13's financial statements are prepared in accordance with U.S. Generally Accepted Accounting Principles (""GAAP"").""Amidst recent challenges, economic uncertainties, and ongoing pressure on cannabis prices, I am pleased to announce a strong quarter. Our performance was highlighted by solid revenue and positive Adjusted EBITDA, fueled by the expansion of gross margins and effective cost management. We were responsible for approximately 9% of Nevada's retail market share and boasted a top brands in each category, underscoring the resilience of our operations and brand appeal in Nevada,"" stated Larry Scheffler, Co-CEO of Planet 13.""We recently took decisive actions to fortify our balance sheet and set the Company up for growth through our acquisition of VidaCann. With the potential for adult-use in Florida, we are now well positioned to capture the full benefit of this tremendous opportunity,"" commented Bob Groesbeck, Co-CEO of Planet 13.Financial Highlights - Q4 - 2023Operating ResultsAll comparisons below are to the quarter ended December 31, 2022, unless otherwise notedRevenues were $23.0 million as compared to $24.8 million, a decrease of 7.5%. The decline in revenue was driven by lower sales at the SuperStore and a decline in wholesale revenue in Nevada.Gross profit was $11.0 million or 47.8% as compared to $10.7 million or 43.0%. The improvement in gross margin was driven by a decrease in product discounting at retail.Operating expenses were $18.1 million as compared to $45.9 million, a decrease of 60.5%Net loss of $14.3 million as compared to a net loss of $49.2 millionAdjusted EBITDA of $1.3 million as compared to Adjusted EBITDA loss of $0.6 million. Adjusted EBITDA margin was higher due to better gross margin performance and strong cost control.Financial Highlights - Full Year 2023Operating ResultsAll comparisons below are to the full year ended December 31, 2022, unless otherwise notedRevenues were $98.5 million as compared to $104.6 million, a decrease of 5.8%. The decline in revenue was driven by lower sales at the SuperStore and a decline in wholesale revenue in Nevada.Gross profit was $44.8 million or 45.5% as compared to $48.0 million or 45.9%. Gross margin was essentially flat due to an increase in vertical integration and strong cost control offsetting price compression.Total expenses were $105.9 million as compared to $96.7 million, an increase of 9.5%. This included a one-time, non-cash $46.8 million impairment. Excluding impairment, total expenses were $59.1 million.Net loss of $73.6 million as compared to a net loss of $59.6 million. The increase in net loss was driven by the one-time $46.8 million impairment charge.Adjusted EBITDA of $1.4 million as compared to Adjusted EBITDA loss of $7.5 million.Balance SheetAll comparisons below are to December 31, 2022, unless otherwise notedCash of $17.3 million as compared to $38.8 millionTotal assets of $151.7 million as compared to $220.1 millionTotal liabilities of $44.1 million as compared to $42.7 millionQ4 Highlights and Recent DevelopmentsFor a more comprehensive overview of these highlights and recent developments, please refer to Planet 13's Management's Discussion and Analysis of the Financial Condition and Results of Operations for the Three and Twelve Months Ended December 31, 2023 (the ""MD&A"").On November 1, 2023, Planet 13 announced plans for the Dazed! Consumption Lounge.On November 14, 2023, Planet 13 entered into a settlement agreement.On November 17, 2023, Planet 13 provided an update regarding certain cash accounts.On December 4, 2023, Planet 13 opened its dispensary in Waukegan, Illinois.On December 11, 2023, Planet 13 announced Koolsville Tattoo, a new attraction at the SuperStore.On January 22, 2024, Planet 13 entered into a definitive agreement to sell its redundant Medical Marijuana Treatment Center License in Florida.On February 8, 2024, Planet 13 announced an expansion of the leadership team and board.On March 4, 2024, Planet 13 announced the commencement of an underwritten public offering of units.On March 7, 2024, Planet 13 closed the previously announced public offering of units.Results of Operations (Summary)The following table sets forth consolidated statements of financial information for the three-month and full-year periods ended December 31, 2023 and December 31, 2022.(Figures in millions For the Three Months Ended For the Full Year Ended and % change based December 31, December 31, December 31, December 31, on these figures) 2023 2022 change 2023 2022 change Total Revenue $23.0 $24.8 -7.5%$98.5 $104.6 -5.8%Gross Profit $11.0 $10.7 2.8%$44.8 $48.0 -6.6%Gross Profit % 47.8% 43.0% 11.2% 46% 46% -0.8%Operating Expenses $18.1 $45.9 -60.5%$95.2 $80.9 17.7%Operating Expenses % 79% 185% 97% 77% 24.9%Net Loss Before Provision for Income Taxes $(10.3)$(48.3) -78.7%$(62.1)$(50.8) 22.2%Net Loss $(14.3)$(49.2) -71.0%$(73.6)$(59.5) 23.6%Adjusted EBITDA $1.3 $(0.6) -329.6%$1.4 $(7.5) -119.2%Adjusted EBITDA Margin % 5.6% -2.3% 1.5% (7.2)% The Company's Annual Report on Form 10-K for the year ended December 31, 2023, is available on the SEC's website at www.sec.gov or at https://www.planet13.com/investors-information/. The Company's Management Discussion and Analysis for the year and the accompanying financial statements and notes are available under the Company's profile on SEDAR+ and on its website at https://www.planet13.com/investors-information/.This news release is not in any way a substitute for reading those financial statements, including the notes to the financial statements.Conference CallPlanet 13 will host a conference call on March 13, 2024 at 6:00 p.m. ET to discuss its fourth quarter and full year financial results and provide investors with key business highlights, strategy and outlook. The call will be chaired by Bob Groesbeck, Co-CEO, Larry Scheffler, Co-CEO, and Dennis Logan, CFO.CONFERENCE CALL DETAILSDate: March 13, 2024 | Time: 6:00 p.m. ESTParticipant Dial-in: Toll Free 888-506-0062 or International 973-528-0011. Access Code: 815562Replay Dial-in: Toll Free 877-481-4010 or International 919-882-2331. Replay Passcode: 50013Listen to webcast: https://www.webcaster4.com/Webcast/Page/2477/50013Non-GAAP Financial MeasuresThere are financial measures included in this press release that are not in accordance with GAAP and therefore may not be comparable to similarly titled measures and metrics presented by other publicly traded companies. These non-GAAP financial measures should be considered as supplemental to, and not a substitute for, our reported financial results prepared in accordance with GAAP. The Company includes EBITDA and Adjusted EBITDA because it believes certain investors use these measures and metrics as a means of assessing financial performance. EBITDA is calculated as net income (loss) before interest, taxes, depreciation and amortization, and Adjusted EBITDA is calculated as EBITDA before share-based compensation, the change in fair value of warrants and one-time non-recurring expenses.The following table presents a reconciliation of net income (loss) to Adjusted EBITDA for each of the periods presented:Reconciliation of Non-GAAP Adjusted EBITDA (Figures in millions For the Three Months Ended For the Full Year Ended and % change based December 31, December 31, December 31, December 31, on these figures) 2023 2022 change 2023 2022 change Net Loss $(14.3)$(38.6) -63.1%$(73.6)$(59.5) 23.6%Add impact of: Interest expense $(0.1)$(0.0) 639.2%$(0.2)$(0.2) 3.3%Provision for income taxes $4.0 $0.9 341.4%$11.5 $8.8 31.8%Depreciation and amortization $2.0 $2.4 -17.0%$8.2 $8.3 -1.9%Depreciation included in cost of goods sold $1.0 $1.1 -11.9%$3.3 $1.9 71.3%EBITDA $(7.5)$(34.2) -78.2%$(50.8)$(40.7) 24.7%Impairment of goodwill and other intangibles $7.2 $32.8 $46.8 $32.8 Gain on sale-leaseback $- $(0.5) $- $(0.5) Change in fair value of warrants $- $(0.2) -100.0%$(0.0)$(7.2) -99.7%Professional fees expensed related to M&A activities $0.2 $0.2 -7.6%$2.6 $0.7 296.8%Professional fees expensed related to SEC Domestic Issuer Form 10 filing and U.S Domestication from British Columbia to Nevada $- $- 0.0%$0.3 $- 0.0%Share-based compensation and related premiums $1.3 $1.3 1.7%$2.5 $7.5 -66.2%Adjusted EBITDA $1.3 $(0.6) -329.6%$1.4 $(7.5) -119.2%About Planet 13Planet 13 (https://planet13.com/investors/) is a vertically integrated cannabis company, with award-winning cultivation, production and dispensary operations across its locations in California, Nevada, Illinois, and upcoming sites in Florida. Home to the nation's largest dispensary located just off The Strip in Las Vegas, Planet 13 recently opened its first Illinois dispensary in Waukegan, bringing unparalleled cannabis experiences to the Chicago metro area. Planet 13 holds a medical marijuana treatment center license in Florida allowing for state-wide expansion throughout the Sunshine State. Planet 13's mission is to build a recognizable global brand known for world-class dispensary operations and innovative cannabis products. Licensed cannabis activity is legal in the states Planet 13 operates in but remains illegal under U.S. federal law. Planet 13's shares trade on the Canadian Securities Exchange (CSE) under the symbol PLTH and are quoted on the OTCQX under the symbol PLNH.Cautionary Note Regarding Forward-Looking InformationThis news release contains forward-looking information and forward-looking statements within the meaning of applicable securities laws. All statements, other than statements of historical fact, are forward-looking statements and are often, but not always, identified by phrases such ""plans"", ""expects"", ""proposed"", ""may"", ""could"", ""would"", ""intends"", ""anticipates"", or ""believes"", or variations of such words and phrases. In this news release, forward-looking statements relate to the Company's fourth quarter 2023 financial performance and expectations for future financial performance. Such forward-looking statements reflect what management of the Company believes, or believed at the time, to be reasonable assumptions and accordingly readers are cautioned not to place undue reliance upon such forward-looking statements and that actual results may vary from such forward-looking statements. These assumptions, risks and uncertainties which may cause actual results to differ include, among others, those assumptions, risks and uncertainties discussed under the heading ""Risk Factors"" in the Company's Annual Report on Form 10-K/A for the year ended December 31, 2022 and any of the Company's subsequent periodic reports filed with the U.S. Securities and Exchange Commission at www.sec.gov and on SEDAR+ at www.sedarplus.ca. Forward-looking statements contained herein are made only as to the date of this press release and we assume no obligation to update or revise any forward-looking statements should they change, except as required by law. No stock exchange, securities commission or other regulatory authority has approved or disapproved the information contained herein.For further inquiries, please contact:LodeRock Advisors Inc., Planet 13 Investor Relationsmark.kuindersma@loderockadvisors.comBob Groesbeck and Larry SchefflerCo-Chief Executive Officersir@planet13lasvegas.comPLANET 13 HOLDINGS INC.Interim Condensed Consolidated Balance Sheets(In United States Dollars) December 31, December 31, 2023 2022 ASSETS Current Assets: Cash $11,831,008 $38,789,604 Restricted Cash 5,450,584 - Accounts Receivable 1,195,927 1,326,795 Inventory 15,760,648 13,004,839 Asset held for sale 9,000,000 - Prepaid Expenses and Other Current Assets 4,072,820 3,810,394 Total Current Assets 47,310,987 56,931,632 Property and Equipment 67,551,697 71,466,051 Intangible Assets and Goodwill 15,253,797 69,288,007 Right of Use Assets - Operating 20,054,369 21,168,171 Long-term Deposits and Other Assets 869,853 862,545 Deferred Tax Asset 706,038 346,257 TOTAL ASSETS $151,746,741 $220,062,663 LIABILITIES AND SHAREHOLDERS' EQUITY LIABILITIES Current: Accounts Payable $2,850,922 $3,112,820 Accrued Expenses 6,097,641 8,072,224 Income Taxes Payable 4,782,538 2,826,501 Notes Payable - Current Portion 884,000 884,000 Operating Lease Liabilities 674,594 479,161 Total Current Liabilities 15,289,695 15,374,706 Long-Term Liabilities: Operating Lease Liabilities 25,271,706 25,833,071 Warrant Liability - 18,127 Other Long-term Liabilities 33,000 28,000 Deferred Tax Liability 3,511,559 1,487,204 Total Liabilities 44,105,960 42,741,108 Shareholders' Equity Common Stock, no par value, 1,500,000,000 shares authorized, 223,317,270 issued and outstanding at December 31, 2023 and 220,470,061 at December 31, 2022 - - Preferred Stock, no par value, 50,000,000 shares authorized, 0 issued and outstanding at December 31, 2023 and 0 at December 31, 2022 - - Additional Paid-In Capital 315,951,343 312,023,359 Deficit (208,310,562) (134,701,804)Total Shareholders' Equity 107,640,781 177,321,555 TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY $151,746,741 $220,062,663 PLANET 13 HOLDINGS INC.Interim Condensed Consolidated Statements of Operations and Comprehensive Loss (In United States Dollars, except share amounts) December 31, 2023 2022 Revenues, net of discounts $98,505,170 $104,574,377 Cost of Goods Sold (53,682,026) (56,599,623)Gross Profit 44,823,144 47,974,754 Expenses: General and Administrative 42,421,172 49,395,500 Sales and Marketing 5,368,473 3,504,309 Lease Expense 3,105,996 2,744,532 Impairment loss 46,846,866 32,750,466 Depreciation and Amortization 8,180,465 8,337,476 Total Expenses 105,922,972 96,732,283 Loss From Operations (61,099,828) (48,757,529) Other Income (Expense): Interest income (expense), net 195,722 189,473 Foreign exchange gain (loss) 3,653 (25,528)Change in fair value of warrant liability 18,127 7,177,805 Gain on Sale-Leaseback - 509,392 Provision for stolen funds (2,000,000) (10,300,000)Other Income, net 807,023 413,029 Total Other Income (Expense) (975,475) (2,035,829) Loss Before Provision for Income Taxes (62,075,303) (50,793,358) Provision For Income Taxes Current Tax Expense (9,868,881) (10,672,538)Deferred Tax Recovery (1,664,574) 1,920,177 (11,533,455) (8,752,361) Net Loss and Comprehensive Loss $(73,608,758) $(59,545,719) Loss per Share Basic and diluted loss per share $(0.33) $(0.27) Weighted Average Number of Shares of Common Stock Basic and diluted 221,964,287 216,586,621 PLANET 13 HOLDINGS INC.Interim Condensed Consolidated Statements of Cash Flows (In United States Dollars) December 31, 2023 December 31, 2022 CASH PROVIDED BY (USED IN) OPERATING ACTIVITIES Net loss $(73,608,758) $(59,545,719)Adjustments for items not involving cash: Share based compensation 2,520,407 7,459,267 Non-cash lease expense 4,974,644 4,737,162 Depreciation 12,147,052 11,258,697 Amortization of intangibles - 372,222 Change in fair value of warrant liability (18,127) (7,177,805)Gain on translation of warrant liability - (10,117)Deferred tax recovery 2,024,355 (1,736,724)Proceeds from lease incentive - 1,100,000 Lease incentive amortization (109,902) (239,133)Impairment of goodwill - 25,802,688 Impairment of intangible assets 46,846,866 6,947,778 Gain on sale leaseback - (509,392)Shares issued for SDC settlement 728,700 - Loss on disposal of property and equipment 180,177 70,601 (4,314,586) (11,470,475) Net Changes in Non-cash Working Capital Items (3,589,711) 8,273,643 Repayment of lease liabilities (4,141,221) (3,566,817)Total Operating (12,045,518) (6,763,649) FINANCING ACTIVITIES Proceeds from exercise of warrants and options - 1,142,238 Taxes paid in lieu of share issuance - RSUs (267,529) Total Financing (267,529) 1,142,238 INVESTING ACTIVITIES Purchase of property, plant and equipment (8,393,593) (16,674,704)Proceeds from sale of fixed assets 64,878 - Net cash acquired through NGW acquisition - 1,479,134 Purchase of licenses (866,250) - Proceeds from sale/lease back - 1,049,633 Purchase of domain name - (30,000)Total Investing (9,194,965) (14,175,937) NET CHANGE IN CASH DURING THE YEAR (21,508,012) (19,797,348) CASH AND RESTRICTED CASH Beginning of Year 38,789,604 58,586,952 End of Year $17,281,592 $38,789,604 SOURCE: Planet 13 HoldingsView the original press release on accesswire.com What was Planet 13 Holdings Inc.'s Q4 2023 revenue? Planet 13 Holdings Inc. reported Q4 2023 revenue of $23.0 million. What was the net loss for Planet 13 Holdings Inc. in Q4 2023? Planet 13 Holdings Inc. recorded a net loss of $14.3 million in Q4 2023, which included a non-cash impairment loss of $7.2 million. What was the Adjusted EBITDA for Planet 13 Holdings Inc. in Q4 2023? Planet 13 Holdings Inc. achieved an Adjusted EBITDA of $1.3 million in Q4 2023. What percentage of Nevada's retail market share did Planet 13 Holdings Inc. hold? Planet 13 Holdings Inc. held approximately 9% of Nevada's retail market share. What acquisition did Planet 13 Holdings Inc. make to position itself for growth? Planet 13 Holdings Inc. acquired VidaCann to position itself for growth in Florida's potential adult-use market."
UNDER ARMOUR ANNOUNCES LEADERSHIP TRANSITION,2024-03-13T20:30:00.000Z,Low,Neutral,"Under Armour, Inc. announces Kevin Plank as the new President & CEO, succeeding Stephanie Linnartz. Mohamed A. El-Erian named Chair of the Board. Plank to take over on April 1, 2024, with Linnartz stepping down. El-Erian to become non-executive Chair of the Board. Linnartz to advise until April 30, 2024.","UNDER ARMOUR ANNOUNCES LEADERSHIP TRANSITION Rhea-AI Impact (Low) Rhea-AI Sentiment (Neutral) Tags management Rhea-AI Summary Under Armour, Inc. announces Kevin Plank as the new President & CEO, succeeding Stephanie Linnartz. Mohamed A. El-Erian named Chair of the Board. Plank to take over on April 1, 2024, with Linnartz stepping down. El-Erian to become non-executive Chair of the Board. Linnartz to advise until April 30, 2024. Positive None. Negative None. 03/13/2024 - 04:30 PM Kevin Plank to Become Chief Executive Officer; Mohamed A. El-Erian, Under Armour's Lead Director, Named Chair of the Board BALTIMORE, March 13, 2024 /PRNewswire/ -- Under Armour, Inc. (NYSE: UA, UAA) today announced that Kevin Plank will become President & Chief Executive Officer, effective April 1, 2024. Plank will succeed Stephanie Linnartz, who will be stepping down as President & Chief Executive Officer and member of the Board. In connection with Plank's appointment, Dr. Mohamed A. El-Erian, an independent director since 2018 and Lead Director since 2020, will become the non-executive Chair of the Board. Plank, who will transition from Executive Chair of the Board, will remain a director. Linnartz will remain an advisor to the company through April 30, 2024. ""On behalf of the full team, I want to thank Stephanie for her contributions to Under Armour. We deeply appreciate her hard work and dedication,"" said Plank. ""During her tenure, she strengthened the leadership team with executive hires in critical areas, including product, design, supply chain, consumer connectivity, and regional management. Her prior experience leading major brands was instrumental in focusing our consumer strategy, including the launch of the U.S. loyalty program, UA Rewards. Her efforts have helped set us on the right path, and we wish her success in her future endeavors."" ""I feel honored to have served as Under Armour's President & CEO and worked with many incredible teammates who care deeply about the company's purpose and mission,"" said Linnartz. ""I am proud of our progress against our strategic plan, including strengthening our team, evolving our products and marketing, and increasing our focus on profitability. We have a strong foundation in place for future growth and the company's potential is limitless. I will continue to root for Under Armour's success."" Reflecting on his appointment, Plank said, ""For nearly 30 years, Under Armour has focused on inspiring athletes with industry-leading, performance solutions they never knew they needed and once they've tried them, can't imagine living without. As the company continues to navigate several post-pandemic consumer, industry, and brand-specific factors, we are working hard to reconstitute our strengths and make thoughtful, balanced business decisions to drive enduring success for athletes, customers, and shareholders. I am energized about the team we have put into place and look forward to seizing the opportunities ahead."" ""On behalf of the Board, I want to thank Stephanie for her many valuable contributions to Under Armour,"" said incoming Board Chair Dr. El-Erian. ""With Kevin's vision and drive serving as critical components, Board members and I look forward to working closely with him and the Under Armour leadership team to unleash shareholder value and drive the company forward."" Plank founded Under Armour in 1996, and since then, he has been the driving force behind its innovative products and brand. From 1996 to 2019, he served as Under Armour's Chief Executive Officer and Chair of the Board of Directors. In January 2020, Plank was appointed Executive Chair and Brand Chief. Dr. Mohamed A. El-Erian is the President of Queens' College, University of Cambridge. Since 2014, he has served as Chief Economic Advisor at Allianz, the corporate parent of PIMCO, where he was chief executive and co-chief investment officer (2007-2014). He is Chair of Gramercy Fund Management, a columnist for Bloomberg Opinion, and a contributing editor at the Financial Times. He is a professor of practice at the Wharton School of the University of Pennsylvania and a Senior Global Fellow at the Lauder Institute there. Before PIMCO, Dr. El-Erian was a managing director at Solomon Smith Barney/Citigroup in London, and before that, he spent 15 years at the International Monetary Fund in Washington, D.C., where he served as Deputy Director before moving to the private sector. Dr. El-Erian holds bachelor's and master's degrees from Cambridge University and a master's and doctorate from Oxford University. About Under Armour, Inc. Under Armour, Inc., headquartered in Baltimore, Maryland, is a leading inventor, marketer, and distributor of branded athletic performance apparel, footwear, and accessories. Designed to empower human performance, Under Armour's innovative products and experiences are engineered to make athletes better. For further information, please visit http://about.underarmour.com. Forward-Looking Statements Some of the statements contained in this press release constitute forward-looking statements. Forward-looking statements relate to expectations, beliefs, projections, plans and strategies, anticipated events or trends, and similar expressions concerning matters that are not historical facts, such as statements regarding our future financial condition or results of operations, our prospects and strategies for future growth, expectations regarding promotional activities, freight, product cost pressures, and foreign currency impacts, the impact of global economic conditions and inflation on our results of operations, our liquidity and use of capital resources, the development and introduction of new products, the implementation of our marketing and branding strategies, the future benefits and opportunities from significant investments, and the impact of litigation or other proceedings. In many cases, you can identify forward-looking statements by terms such as ""may,"" ""will,"" ""should,"" ""could,"" ""expects,"" ""plans,"" ""anticipates,"" ""believes,"" ""estimates,"" ""predicts,"" ""outlook,"" ""potential"" or the negative of these terms or other comparable terminology. The forward-looking statements in this press release reflect our current views about future events. They are subject to risks, uncertainties, assumptions, and circumstances that may cause events or our actual activities or results to differ significantly from those expressed in any forward-looking statement. Although we believe the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future events, results, actions, activity levels, performance, or achievements. Readers are cautioned not to place undue reliance on these forward-looking statements. A number of important factors could cause actual results to differ materially from those indicated by these forward-looking statements, including, but not limited to: changes in general economic or market conditions, including inflation, that could affect overall consumer spending in our industry; the impact of the COVID-19 pandemic on our industry and our business, financial condition and results of operations, including impacts on the global supply chain; failure of our suppliers, manufacturers or logistics providers to produce or deliver our products in a timely or cost-effective manner; labor or other disruptions at ports or our suppliers or manufacturers; increased competition causing us to lose market share or reduce the prices of our products or to increase our marketing efforts significantly; fluctuations in the costs of raw materials and commodities we use in our products and costs related to our supply chain (including labor); changes to the financial health of our customers; our ability to successfully execute our long-term strategies; our ability to effectively develop and launch new, innovative and updated products; our ability to accurately forecast consumer shopping and engagement preferences and consumer demand for our products and manage our inventory in response to changing demands; loss of key customers, suppliers or manufacturers; our ability to effectively market and maintain a positive brand image; our ability to further expand our business globally and to drive brand awareness and consumer acceptance of our products in other countries; our ability to manage the increasingly complex operations of our global business; the impact of global events beyond our control, including military conflicts; our ability to successfully manage or realize expected results from significant transactions and investments; our ability to effectively meet the expectations of our stakeholders with respect to environmental, social and governance practices; the availability, integration and effective operation of information systems and other technology, as well as any potential interruption of such systems or technology; any disruptions, delays or deficiencies in the design, implementation or application of our global operating and financial reporting information technology system; our ability to attract key talent and retain the services of our senior management and other key employees; our ability to effectively drive operational efficiency in our business; our ability to access capital and financing required to manage our business on terms acceptable to us; our ability to accurately anticipate and respond to seasonal or quarterly fluctuations in our operating results; risks related to foreign currency exchange rate fluctuations; our ability to comply with existing trade and other regulations, and the potential impact of new trade, tariff and tax regulations on our profitability; risks related to data security or privacy breaches; and our potential exposure to and the financial impact of litigation and other proceedings. The forward-looking statements here reflect our views and assumptions only as of the date of this press release. We undertake no obligation to update any forward-looking statement to reflect events or circumstances after the statement's date or to reflect unanticipated events. View original content to download multimedia:https://www.prnewswire.com/news-releases/under-armour-announces-leadership-transition-302088163.html SOURCE Under Armour, Inc. Who will become the new President & CEO of Under Armour? Kevin Plank will become the new President & CEO of Under Armour, effective April 1, 2024. Who is named as the Chair of the Board at Under Armour? Mohamed A. El-Erian, Under Armour's Lead Director, will become the non-executive Chair of the Board. When will Kevin Plank take over as President & CEO of Under Armour? Kevin Plank will take over as President & CEO of Under Armour on April 1, 2024. Until when will Stephanie Linnartz advise the company? Stephanie Linnartz will advise the company until April 30, 2024."
Starwood Property Trust Announces Upsizing and Pricing of Private Offering of Sustainability Bonds,2024-03-13T22:08:00.000Z,No impact,Neutral,"Starwood Property Trust, Inc. announced the pricing of $600 million in unsecured senior notes due 2029, upsized from $400 million. The proceeds will finance green and/or social projects and repay existing debts.","Starwood Property Trust Announces Upsizing and Pricing of Private Offering of Sustainability Bonds Rhea-AI Impact (No impact) Rhea-AI Sentiment (Neutral) Tags offering Rhea-AI Summary Starwood Property Trust, Inc. announced the pricing of $600 million in unsecured senior notes due 2029, upsized from $400 million. The proceeds will finance green and/or social projects and repay existing debts. Positive None. Negative None. 03/13/2024 - 06:08 PM GREENWICH, Conn., March 13, 2024 /PRNewswire/ -- Starwood Property Trust, Inc. (NYSE: STWD) (the ""Company"") today announced that it has priced its private offering of $600 million aggregate principal amount of its 7.250% unsecured senior notes due 2029 (the ""Notes""), which was upsized from the previously announced $400 million aggregate principal amount. The Notes priced at 100.0% of the principal amount and the settlement of the offering is expected to occur on March 27, 2024, subject to customary closing conditions. The Company intends to allocate an amount equal to the net proceeds from the offering to finance or refinance, in whole or in part, recently completed or future eligible green and/or social projects. Net proceeds allocated to previously incurred costs associated with eligible green and/or social projects will be available for the repayment of indebtedness previously incurred. Pending full allocation of an amount equal to the net proceeds to eligible green and/or social projects, the Company intends to use the net proceeds for general corporate purposes, including the repayment of outstanding indebtedness under the Company's repurchase facilities. The Notes were offered only to persons reasonably believed to be qualified institutional buyers in reliance on Rule 144A under the Securities Act of 1933, as amended (the ""Securities Act""), and non-U.S. persons outside the United States pursuant to Regulation S under the Securities Act. The Notes will not initially be registered under the Securities Act or any state securities laws and may not be offered or sold in the United States absent an effective registration statement or an applicable exemption from the registration requirements of the Securities Act or any state securities laws. This press release shall not constitute an offer to sell, or the solicitation of an offer to buy, these securities, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction. About Starwood Property Trust, Inc. Starwood Property Trust, Inc. (NYSE: STWD), an affiliate of global private investment firm Starwood Capital Group, is a leading diversified finance company with a core focus on the real estate and infrastructure sectors. As of December 31, 2023, the Company has successfully deployed over $97 billion of capital since inception and manages a portfolio of over $27 billion across debt and equity investments. Starwood Property Trust's investment objective is to generate attractive and stable returns for shareholders, primarily through dividends, by leveraging a premiere global organization to identify and execute on the best risk adjusted returning investments across its target assets. Forward-Looking Statements Statements in this press release which are not historical fact may be deemed forward-looking statements within the meaning of Section 27A of the Securities Act and Section 21E of the Securities Exchange Act of 1934, as amended, including statements with respect to the anticipated settlement of the offering and the use of proceeds. Although the Company believes the expectations reflected in any forward-looking statements are based on reasonable assumptions, it can give no assurance that its expectations will be attained. Factors that could cause actual results to differ materially from the Company's expectations include: (i) factors described in the Company's Annual Report on Form 10-K for the year ended December 31, 2023, including those set forth under the captions ""Risk Factors"", ""Business"", and ""Management's Discussion and Analysis of Financial Condition and Results of Operations""; (ii) defaults by borrowers in paying debt service on outstanding indebtedness; (iii) impairment in the value of real estate property securing the Company's loans or in which the Company invests; (iv) availability of mortgage origination and acquisition opportunities acceptable to the Company; (v) potential mismatches in the timing of asset repayments and the maturity of the associated financing agreements; (vi) the Company's ability to achieve the benefits that it anticipates from the prior acquisition of the project finance origination, underwriting and capital markets business of GE Capital Global Holdings, LLC; (vii) national and local economic and business conditions, including as a result of the impact of public health emergencies; (viii) the occurrence of certain geo-political events (such as wars, terrorist attacks and tensions between states) that affect the normal and peaceful course of international relations; (ix) general and local commercial and residential real estate property conditions; (x) changes in federal government policies; (xi) changes in federal, state and local governmental laws and regulations; (xii) increased competition from entities engaged in mortgage lending and securities investing activities; (xiii) changes in interest rates; and (xiv) the availability of, and costs associated with, sources of liquidity. Contact: Zachary TanenbaumStarwood Property TrustPhone: 203-422-7788Email: ztanenbaum@starwood.com View original content:https://www.prnewswire.com/news-releases/starwood-property-trust-announces-upsizing-and-pricing-of-private-offering-of-sustainability-bonds-302088652.html SOURCE Starwood Property Trust, Inc. What is the principal amount of the unsecured senior notes offered by Starwood Property Trust, Inc.? Starwood Property Trust, Inc. offered $600 million in aggregate principal amount of its 7.250% unsecured senior notes due 2029. When is the settlement of the offering expected to occur for the notes? The settlement of the offering for the notes is expected to occur on March 27, 2024, subject to customary closing conditions. How will the net proceeds from the offering be allocated by the Company? The net proceeds from the offering will be allocated to finance or refinance recently completed or future eligible green and/or social projects. They will also be used for the repayment of previously incurred indebtedness associated with such projects. Who were the Notes offered to? The Notes were offered to qualified institutional buyers under Rule 144A and non-U.S. persons outside the United States under Regulation S. Will the Notes be initially registered under the Securities Act or any state securities laws? The Notes will not initially be registered under the Securities Act or any state securities laws."
Navigator Gas Fourth Quarter and Full Year 2023 Results,2024-03-13T20:32:00.000Z,Neutral,Neutral,"Navigator Holdings Ltd. declared a cash dividend of $0.05 per share for Q4 2023, with total operating revenue of $141.6 million. Net income was $17.8 million, and EBITDA was $66.3 million. The Company plans to repurchase $0.8 million of common stock. Operational TCE increased to $28,428, while utilization decreased to 91.3%. The Ethylene Export Terminal throughput was 208,495 metric tons. Navigator invested $1.4 million in Azane for ammonia fuel handling. The Company's Return of Capital policy includes quarterly dividends and share repurchases. A Zoom conference call will discuss Q4 2023 financial results.","Navigator Gas Fourth Quarter and Full Year 2023 Results Rhea-AI Impact (Neutral) Rhea-AI Sentiment (Neutral) Tags earnings Rhea-AI Summary Navigator Holdings Ltd. declared a cash dividend of $0.05 per share for Q4 2023, with total operating revenue of $141.6 million. Net income was $17.8 million, and EBITDA was $66.3 million. The Company plans to repurchase $0.8 million of common stock. Operational TCE increased to $28,428, while utilization decreased to 91.3%. The Ethylene Export Terminal throughput was 208,495 metric tons. Navigator invested $1.4 million in Azane for ammonia fuel handling. The Company's Return of Capital policy includes quarterly dividends and share repurchases. A Zoom conference call will discuss Q4 2023 financial results. Positive Declaration of a cash dividend of $0.05 per share for Q4 2023. Total operating revenue of $141.6 million and net income of $17.8 million. EBITDA of $66.3 million and adjusted EBITDA of $71.7 million for Q4 2023. Plan to repurchase approximately $0.8 million of common stock. Increase in operational TCE to $28,428 and decrease in fleet utilization to 91.3%. Ethylene Export Terminal throughput of 208,495 metric tons in Q4 2023. Investment of $1.4 million in Azane for ammonia fuel handling. Implementation of Return of Capital policy with quarterly dividends and share repurchases. Upcoming Zoom conference call to discuss Q4 2023 financial results. Negative None. Financial Analyst The recent declaration of a cash dividend by Navigator Holdings Ltd. indicates a positive return to shareholders, reflecting the company's financial stability and commitment to shareholder value. The dividend payout, coupled with the share repurchase program, suggests a strategic approach to capital allocation that aligns with the company's Return of Capital policy. This policy, which aims to distribute 25% of net income, could be appealing to income-focused investors and may influence the stock's attractiveness in the market.Furthermore, the reported increase in net income and earnings per share (EPS) year-over-year signifies an improved financial performance, likely driven by operational efficiencies and favorable market conditions. The repayment of long-term debt also demonstrates prudent financial management, potentially enhancing the company's credit profile and reducing interest expenses in future periods. Market Research Analyst The reported increase in average daily time charter equivalent (TCE) rates suggests a robust demand for Navigator Gas's services, which could be attributed to market dynamics such as the longer ton-miles due to the constrained Panama transit. However, the slight decrease in fleet utilization may warrant monitoring, as it could indicate market saturation or operational challenges. The handysize market assessments provide a bullish outlook for the sector, particularly for ethylene transport, which is likely benefiting from the increased demand for shipping due to longer transit routes.The investment in the Ethylene Export Terminal Expansion Project is a forward-looking move that could position Navigator Gas advantageously in the growing market for gas exports. This expansion aligns with global energy trends and could result in increased throughput capacity and revenue streams. The capital expenditure involved in this expansion and its financing strategy, will be critical areas for stakeholder evaluation, as they may impact the company's leverage and liquidity profiles. Energy Sector Analyst The strategic investment in Azane aligns with the broader industry shift towards green fuels, positioning Navigator Gas at the forefront of the transition to low-carbon shipping solutions. The focus on ammonia as a marine fuel is particularly noteworthy, given the maritime industry's search for viable alternatives to traditional fossil fuels. This joint venture could provide Navigator Gas with a competitive edge in a nascent market, potentially opening up new revenue streams and partnerships.However, it is important to consider the risks associated with emerging technologies and markets, such as regulatory uncertainty and the pace of adoption. The projected delivery timeline for the green ammonia bunkering units also suggests a long-term horizon for any substantial impact on the company's financials. Stakeholders should weigh the potential for future value creation against the inherent risks of investing in unproven technologies and markets. 03/13/2024 - 04:32 PM LONDON, March 13, 2024 (GLOBE NEWSWIRE) -- Financial Highlights On March 12, 2024, the Board of Navigator Holdings Ltd. (the ""Company"", Navigator Gas,""we"", ""our"" and ""us"") (NYSE: NVGS) declared a cash dividend of $0.05 per share, for the quarter ended December 31, 2023, (the Dividend) under the Company's Return of Capital policy. The Dividend will be payable on April 25, 2024, to all shareholders of record as of the close of business New York time on April 4, 2024.Also as part of the Company's Return of Capital policy for the quarter ended December 31, 2023, the Company expects to repurchase approximately $0.8 million common stock (the Share Repurchases) between March 13, 2024, and March 31, 2024, subject to operating needs, market conditions and other circumstances, such that the Dividend and Share Repurchases together equal 25% of net income for the quarter ended December 31, 2023.The Company reported total operating revenue of $141.6 million for the three months ended December 31, 2023, compared to $123.3 million for the three months ended December 31, 2022.Net Income attributable to stockholders' of the Company was $17.8 million for the three months ended December 31, 2023, compared to $10.0 million for the three months ended December 31, 2022.Earnings per share was $0.24 for the three months ended December 31, 2023, compared to $0.13 per share for the three months ended December 31, 2022. Adjusted earnings per share which excludes realized and unrealized gains or losses on non-designated derivative instruments and profit and loss from sale of vessel, was $0.32 for the three months ended December 31, 2023.EBITDA(1) was $66.3 million for the three months ended December 31, 2023, compared to $58.5 million for the three months ended December 31, 2022. Adjusted EBITDA(1) was $71.7 million for the three months ended December 31, 2023, compared to $55.0 million for the three months ended December 31, 2022. The Company repaid $23.8 million of the $111.8 million Term Loan and Revolving Credit Facility held with Credit Agricole on December 28, 2023 which resulted in an equal reduction in long-term debt outstanding and cash and cash equivalents. The amount repaid of $23.8 million remains available to be redrawn by the Company in accordance with the terms of the Term Loan and Revolving Credit Facility which matures in September 2028. (1) EBITDA and Adjusted EBITDA are not measurements prepared in accordance with U.S. GAAP. EBITDA represents net income before net interest expense, income taxes, depreciation and amortization. We define Adjusted EBITDA as EBITDA before profit/loss on sale of vessel, unrealized gain/loss on non-designated derivative instruments and foreign currency exchange gain or loss on senior secured bonds. Management believes that EBITDA and Adjusted EBITDA are useful to investors in evaluating the operating performance of the Company. EBITDA and Adjusted EBITDA do not represent and should not be considered alternatives to consolidated net income, cash generated from operations or any measure. Other Highlights and Developments Operational Update Average daily time charter equivalent (""TCE"") across the fleet increased to $28,428 for the three months ended December 31, 2023, compared to $23,622 for the three months ended December 31, 2022. Utilization across the fleet decreased from 93.4% in the third quarter of 2023 to 91.3% in the fourth quarter of 2023. Utilization during fourth quarter of 2022 was 94.1%. During the fourth quarter of 2023, the handysize 12-month market assessment for semi-refrigerated and fully refrigerated vessels increased by $60,000 and $115,000 per calendar month (pcm), to $885,000 pcm and $910,000 pcm, respectively. The handysize ethylene market assessment increased by $400,000 pcm to $1,400,000 pcm. During the fourth quarter of 2023 we experienced downward pressure on ethylene arbitrage to Asia, however this was compensated by additional activity on the ethane spot and time charter (""TC"") market. Low rainfall in Panama, and a subsequent reduction in available daily transits meant that ethane transport between US Gulf and China had to sail a longer distance via Cape of Good Hope. This resulted in longer ton-miles and more demand for shipping, which supported the handysize ethylene market assessment. In the fourth quarter of 2023 we had approximately 30 vessels engaged under time charters, 17 vessels on spot voyage charters and contracts of affreightment (""CoA"") and nine vessels were operated in the independently managed Unigas Pool. From January 1, 2024, and 12 months out, we have 48% of our ship days covered under time charter. Our midsize and fully refrigerated vessels are largely employed on time charters, our semi-refrigerated vessels are employed under time charters and spot voyage charters, and most of our ethylene capable vessels are employed on the spot voyage market. Ethylene Export Terminal The Ethylene Export Terminal throughput during the fourth quarter of 2023 was 208,495 metric tons, compared to 262,835 metric tons during the fourth quarter of 2022. We, together with Enterprise Products Partners L.P, our joint venture partner, have agreed to invest in the Terminal Expansion Project, which is expected to increase the export capacity from approximately one million tons per year to at least 1.55 million tons. Long lead items have been ordered, groundwork is progressing and construction is expected to occur throughout 2024 with completion in the fourth quarter of 2024. The total capital contributions required from us to the Export Terminal Joint Venture for the Terminal Expansion Project are expected to be approximately $130 million which the Company expects to finance using existing cash resources, distributions from the Export Terminal Joint Venture during the course of the expansion and additional debt. Of the expected total of $130 million, $35.0 million has been contributed as of December 31, 2023, $17.0 million of which was contributed during the fourth quarter of 2023. Azane Fuel Solutions AS (""Azane"") Azane, a joint venture between ECONNECT Energy AS and Amon Maritime AS, both of Norway, was founded in Norway in 2020 to develop proprietary technology and services for ammonia fuel handling and to facilitate the transition to green fuels for shipping. The Company acquired a 14.5% interest in Azane on October 25, 2023, for $1.4 million. Azane intends to build the worlds first ammonia bunkering network, with Yara Clean Ammonia already pre-ordering 15 units from Azane. The first green ammonia bunkering units are scheduled to be delivered in 2025 enabling low carbon fuel offering to shipowners. The investment made by Yara and Navigator is expected to enable Azane to begin construction of its first bunkering unit for ammonia supply in Norway, aiming to kickstart the transition to zero-carbon fuels for maritime transportation. Future value creation for Azane is expected to come through international expansion with its bunkering solutions and broadening of its offerings in ammonia fuel handling technology. Return of Capital Policy The Companys current Return of Capital policy, which is subject to operating needs and other circumstances, is based on paying out quarterly cash dividends of $0.05 per share of common stock and returning additional capital in the form of additional cash dividends and/or share repurchases, such that the two elements combined equal at least 25% of net income for the applicable quarter. As part of the Return of Capital policy, we expect to repurchase the Companys common stock (the Share Repurchases) and any such Share Repurchases will be made via open market transactions, privately negotiated transactions or any other method permitted under U.S. securities laws and the rules of the U.S. Securities and Exchange Commission. Declarations of any dividends in the future, and the amount of any such dividend, are subject to the discretion of the Companys Board. The Return of Capital policy does not oblige the Company to pay any dividends or repurchase any of its shares in the future and it may be suspended, discontinued or modified by the Company at any time, for any reason. Further, the timing of any share repurchases under the Return of Capital policy will be determined by the Companys management and will depend on market conditions, legal requirements, stock price, and other factors. Navigator Gas Fourth Quarter 2023 Earnings Zoom Conference Call On Thursday, March 14, 2024 at 10:00 A.M. E.D.T., the Companys management team will host a Zoom conference call and slide presentation to discuss the financial results for the fourth quarter of 2023. Those wishing to participate should register for the Zoom conference call using the following details: https://us06web.zoom.us/webinar/register/WN_-8fJUJyZTzCtK7zntKuqHg#/registration Webcast ID: 848 0163 7361Passcode: 699933 Participants can also join by phone by dialing: United States:+1 929 205 6099United Kingdom:+44 330 088 5830 A full list of US and international numbers is available via the following link: International Dial-in numbers The Zoom conference call and slide presentation will be available for replay on Navigator Gas website (www.navigatorgas.com) under Financials and Quarterly Results in the Investors Centre section. About Navigator Gas We are the owner and operator of 56 liquefied gas carriers, which includes the worlds largest fleet of handysize gas carriers. We also own a 50% share in an ethylene export marine terminal at Morgans Point, Texas on the Houston Ship Channel (the Ethylene Export Terminal) through a joint venture (the Export Terminal Joint Venture). Our liquefied gas carrier fleet currently consists of 42 handysize liquefied gas carriers, which we define as those with capabilities between 15,000 and 24,999 cubic meters, or cbm. In addition, we have five larger 37,300  38,000 cbm midsize liquefied gas carriers; five 12,000 cbm ethylene carriers and four smaller 3,770  9,000 cbm semi-refrigerated liquefied gas carriers. Of our total fleet of 56 liquefied gas carriers, 25 are ethylene or ethane capable gas carriers. Our handysize liquefied gas carriers typically transport LPG on short or medium distance routes that may be uneconomical for smaller vessels and can call at ports that are unable to support larger vessels due to limited onshore capacity, absence of fully-refrigerated loading or discharge infrastructure and/or vessel size restrictions. These handysize liquefied gas carriers are amongst the largest semi-refrigerated vessels in the world, which also makes them the ideal choice for transporting petrochemicals on long routes, typically intercontinental. We play a vital role in the liquefied gas supply chain for energy companies, industrial consumers and commodity traders, with our sophisticated vessels providing an efficient and reliable floating pipeline. We carry LPG typically for major international energy companies, state-owned utilities and reputable commodities traders. LPG, which consists of propane and butane, is a relatively clean alternative energy source with more than 1,000 applications, including as a heating, cooking and transportation fuel and as a petrochemical and refinery feedstock. LPG is a by-product of oil refining and natural gas extraction, and shale gas, principally from the U.S. We also carry petrochemical gases for numerous industrial users. Petrochemical gases, including ethylene, propylene, butadiene and vinyl chloride monomer, are derived from the cracking of petroleum feedstocks such as ethane, LPG and naphtha and are primarily used as raw materials in various industrial processes, like the manufacture of plastics, vinyl and rubber, with a wide application of end uses. Our vessels also carry ammonia mainly for the producers of fertilizers in the agricultural industry, and for ammonia traders. Our 50% share in the Ethylene Export Terminal at Morgans Point comprises an ethylene refrigeration unit and an ethylene cryogenic storage tank with a capacity of 30,000 tons. The terminal has the capacity to export approximately one million tons of ethylene per year and is capable of loading ethylene-capable gas carriers at rates of 1,000 tons per hour. Navigator Gas common stock trades on the New York Stock Exchange under the symbol NVGS. Contact us investorrelations@navigatorgas.com and randy.giveans@navigatorgas.com Houston:333 Clay Street, Suite 2480, Houston, Texas, U.S.A. 77002Tel:+1 713 373 6197 London:10 Bressenden Place, London, SW1E 5DH. United Kingdom.Tel:+44 20 7340 4850 Unaudited Results of Operations for the three months ended December 31, 2023 compared to the three months ended December 31, 2022 Three months ended December 31, 2022Three months ended December 31, 2023Percentagechange (in thousands, except Percentage change)Operating revenues$105,115 $129,068 22.8%Operating revenues  Unigas Pool 11,837 12,564 6.1%Operating revenues  Luna Pool collaborative arrangements 6,333  (100.0)%Total operating revenue 123,285 141,632 14.9%Expenses: Brokerage commission 1,494 1,706 14.2%Voyage expenses 16,865 18,115 7.4%Voyage expenses  Luna Pool collaborative arrangements 5,533  (100.0)%Vessel operating expenses 43,924 46,715 6.4%Depreciation and amortization 30,559 32,828 7.4%General and administrative costs 8,389 8,878 5.8%Loss/(profit) from sale of vessel (4,363) 144  Other income (105) 36 133.8%Total operating expenses 102,296 108,422 6.0%Operating Income 20,989 33,210 58.2%Other income/(expense) Foreign currency exchange loss on senior secured bond (5,969)  (100.0)%Realized gain on non-designated derivative instruments 6,888  (100.0)%Unrealized loss on non-designated derivative instruments (471) (5,254)1015.4%Loss on repayment of senior bonds (1,102)  (100.0)%Write off of deferred financing costs (212)  (100.0)%Interest expense (13,983) (16,355)17.0%Interest income 713 2,060 188.9%Income before taxes and share of result of equity method investments 6,853 13,661 99.3%Income taxes (4,459) (56)(98.7)%Share of result of equity method investments 7,861 5,540 (29.5)%Net Income 10,255 19,145 86.7%Net income attributable to non-controlling interest (287) (1,394)385.6%Net Income attributable to stockholders ofNavigator Holdings Ltd.$9,968 $17,751 78.1% Operating Revenues. Operating revenues, net of address commissions, was $129.1 million for the three months ended December 31, 2023, an increase of $24.0 million or 22.8% compared to $105.1 million for the three months ended December 31, 2022. This increase was primarily due to: an increase in operating revenues of approximately $19.3 million attributable to an increase in average monthly time charter equivalent rates, which increased to an average of approximately $28,428 per vessel per day ($864,670 per vessel per calendar month) for the three months ended December 31, 2023, compared to an average of approximately $23,622 per vessel per day ($718,539 per vessel per calendar month) for the three months ended December 31, 2022;an decrease in operating revenues of approximately $3.4 million attributable to a decrease in fleet utilization, which declined to 91.3% for the three months ended December 31, 2023, compared to 94.1% for the three months ended December 31, 2022;an increase in operating revenues of approximately $6.8 million or 7.7%, attributable to a 305 day increase in vessel available days for the three months ended December 31, 2023, compared to the three months ended December 31, 2022. This increase was in part as a result of five handysize vessels acquired by the Navigator Greater Bay Joint Venture being fully operational during the three months ended December 31, 2023, compared to the three months ended December 31, 2022, in which only one vessel had been acquired and was operational for only 12 days.a increase in operating revenues of approximately $1.2 million primarily attributable to an increase in pass through voyage costs for the three months ended December 31, 2023, compared to the three months ended December 31, 2022. The following table presents selected operating data for the three months ended December 31, 2023, and 2022, which we believe are useful in understanding the basis of movements in our operating revenues. Three months ended December 31, 2022Three months ended December 31, 2023* Fleet Data: Weighted average number of vessels 44.0 47.0 Ownership days 4,048 4,324 Available days 3,968 4,273 Earning days 3,736 3,903 Fleet utilization 94.1% 91.3%** Average daily Time Charter Equivalent$23,622 $28,428 * Fleet Data - Our nine owned smaller vessels in the independently managed Unigas Pool and the vessels owned by Pacific Gas in our Luna Pool prior to their acquisition by the Navigator Greater Bay Joint Venture are not included in this data. ** Non-GAAP Financial MeasureTime charter equivalent: Time charter equivalent (TCE) is a measure of the average daily revenue performance of a vessel. TCE is not calculated in accordance with U.S. GAAP. For all charters, we calculate TCE by dividing total operating revenues (excluding collaborative arrangements and revenues from the Unigas Pool), less any voyage expenses (excluding collaborative arrangements), by the number of earning days for the relevant period. TCE excludes the effects of the collaborative arrangements, as earning days and fleet utilization, on which TCE is based, is calculated for our owned vessels, and not the average of all pool vessels. Under a time charter, the charterer pays substantially all of the vessel's voyage related expenses, whereas for voyage charters, also known as spot market charters, we pay all voyage expenses. TCE is a shipping industry performance measure used primarily to compare period-to-period changes in a companys performance despite changes in the mix of charter types (i.e., voyage charters, time charters and contracts of affreightment) under which the vessels may be employed. We include average daily TCE, as we believe it provides additional meaningful information in conjunction with net operating revenues. Our calculation of TCE may not be comparable to that reported by other companies. Reconciliation of Operating Revenues to TCE The following table represents a reconciliation of operating revenues to TCE. Operating revenues are the most directly comparable financial measure calculated in accordance with U.S. GAAP for the periods presented. Three months ended December 31, 2022Three months ended December 31, 2023 (in thousands, except earning days and average daily time charter equivalent rate)Fleet Data: *** Operating revenue$105,115$129,068*** Voyage expenses 16,865 18,115Operating revenue less voyage expenses 88,250 110,953Earning days 3,736 3,903Average daily time charter equivalent rate$23,622$28,428 ***Operating revenues and voyage expenses excluding collaborative arrangements and Unigas Pool. Operating Revenues  Unigas Pool. Operating revenues  Unigas Pool was $12.6 million an increase of 6.1% for the three months ended December 31, 2023, compared to $11.8 million for the three months ended December 31, 2022, and represents our share of the revenues earned from our nine vessels operating within the Unigas Pool, based on agreed pool points. Operating Revenues  Luna Pool Collaborative Arrangements. Luna Pool earnings are aggregated and then allocated (after deducting pool overheads and manager's fees) to the pool participants in accordance with the Pooling Agreement. Operating revenues - Luna Pool collaborative arrangements was $nil for the three months ended December 31, 2023, compared to $6.3 million for the three months ended December 31, 2022 and represents our share of pool net revenues generated by the other participants vessels in the pool, prior to the acquisition of the vessels by Navigator Greater Bay Joint Venture. This decrease was primarily a result of the arrangement ending following the acquisition of the final vessel, Navigator Vega, on April 13, 2023. Brokerage Commissions. Brokerage commissions, which typically vary between 1.25% and 2.5% of operating revenues, increased by $0.2 million or 14.2% to $1.7 million for the three months ended December 31, 2023, from $1.5 million for the three months ended December 31, 2022, primarily due to an increase in operating revenues on which brokerage commissions are based. Voyage Expenses. Voyage expenses increased by $1.2 million or 7.4% to $18.1 million for the three months ended December 31, 2023, from $16.9 million for the three months ended December 31, 2022. These voyage expenses are pass through costs, corresponding to an increase in operating revenues of the same amount. Voyage Expenses  Luna Pool Collaborative Arrangements. Voyage expenses  Luna Pool collaborative arrangements was $nil for the three months ended December 31, 2023, compared to $5.5 million for the three months ended December 31, 2022. These voyage expenses  Luna Pool collaborative arrangements represent the other participants share of pool net revenues generated by our vessels in the pool, prior to the acquisition of the vessels by Navigator Greater Bay Joint Venture. This decrease was primarily a result of the arrangement ending following the acquisition of the final vessel Navigator Vega on, April 13, 2023. Vessel Operating Expenses. Vessel operating expenses increased by $2.8 million or 6.4% to $46.7 million for the three months ended December 31, 2023, from $43.9 million for the three months ended December 31, 2022. Average daily vessel operating expenses increased by $7 per vessel per day, or 0.1%, to $9,067 vessel per day for the three months ended December 31, 2023, compared to $9,060 per vessel per day for the three months ended December 31, 2022. Depreciation and Amortization. Depreciation and amortization increased by $2.3 million to $32.8 million for the three months ended December 31, 2023 compared to $30.6 million for the three months ended December 31, 2022. The increase is driven by the acquisition of the five vessels by the Navigator Greater Bay Joint Venture. Depreciation and amortization included amortization of capitalized drydocking costs of $5.0 million and $4.7 million for the three months ended December 31, 2023 and 2022, respectively. General and Administrative Costs. General and administrative costs increased by $0.5 million or 5.8% to $8.9 million for the three months ended December 31, 2023, from $8.4 million for the three months ended December 31, 2022. Non-Operating Results Foreign Currency Exchange Gain on Senior Secured Bonds. In December 2022, we redeemed all of the 600 million Norwegian Kroner then outstanding principal amount of our senior secured bonds (the 2018 Bonds). No exchange gains and losses were recorded for the three months ended December 31, 2023. A foreign currency exchange gain of $6.0 million was recorded for the three months ended December 31, 2022, as a result of the Norwegian Kroner weakening against the U.S. Dollar. Realized Gain on Cross Currency Interest Rate Swap. The realized gain of $6.9 million on cross currency interest rate swap related to the movement in the fair value of our cross-currency interest rate swap between September 30, 2022 and the actual value of the swap on December 23, 2022, when our 2018 Bonds, on which the swap was based, were redeemed. Unrealized Gains / (Losses) on Non-Designated Derivative Instruments. The unrealized loss of $5.3 million on non-designated derivative instruments for the three months ended December 31, 2023, relates to fair value losses on interest rate swaps associated with a number of our secured term loan and revolving credit facilities, as a result of a decrease in forward Secured Overnight Financing Rate (SOFR) interest rates, compared to an unrealized loss of $0.5 million for the three months ended December 31, 2022. Interest Expense. Interest expense increased by $2.4 million, or 17.0%, to $16.4 million for the three months ended December 31, 2023, from $14.0 million for the three months ended December 31, 2022. This is primarily as a result of increases in US dollar SOFR rates and the draw down of facilities that provided financing for the acquisition of five ethylene carriers by the Navigator Greater Bay Joint Venture. Income Taxes. Income taxes relate to taxes on our subsidiaries and businesses incorporated around the world including those incorporated in the United States of America. Income taxes is $0.1 million for the three months ended December 31, 2023, compared to $4.5 million for the three months ended December 31, 2022, primarily as a result of current tax of $1.3 million and a deferred tax gain of $1.4 million in relation to our investment in the Ethylene Export Terminal. Share of Result of Equity Method Investments. The share of the result of the Companys 50% ownership in the Export Terminal Joint Venture was an income of $5.5 million for the three months ended December 31, 2023, compared to an income of $7.9 million for the three months ended December 31, 2022. This decrease is a result of higher gas prices resulting in reduced throughput rates and by decreased volumes exported through the Ethylene Export Terminal, of 208,495 tons for the three months ended December 31, 2023, compared to 262,835 tons for the three months ended December 31, 2022. Non-Controlling Interest. The Company entered into a sale and leaseback arrangement in November 2019 with a wholly-owned special purpose vehicle of a financial institution (Lessor SPV). Although we do not hold any equity investments in this Lessor SPV, we have determined that we are the primary beneficiary of this entity and accordingly we are required to consolidate this Variable Interest Entity (""VIE"") into our financial results. The net income attributable to the Lessor SPV was $0.3 million and this is presented as a non-controlling interest for each period for both the three months ended December 31, 2023, and three months ended December 31, 2022. In September 2022, the Company entered into the Navigator Greater Bay Joint Venture to acquire five ethylene vessels, Navigator Luna, Navigator Solar, Navigator Castor, Navigator Equator and Navigator Vega. The joint venture is owned 60% by the Company and 40% by Greater Bay Gas. The Navigator Greater Bay Joint Venture is accounted for as a consolidated subsidiary in our consolidated financial statements, with the 40% owned by Greater Bay Gas accounted for as a non-controlling interest. A gain attributable to Greater Bay Gas of $1.1 million is presented as part of the non-controlling interest in our financial results for the three months ended December 31, 2023, compared to effectively $nil for the three months ended December 31, 2022 . Reconciliation of Non-GAAP Financial Measures The following table shows a reconciliation of net income to EBITDA and Adjusted EBITDA for the three months and year ended December 31, 2023 and 2022: Three months endedYear ended December 31, 2022December 31, 2023December 31, 2022December 31, 2023 (in thousands)(in thousands)Net income$10,255 $19,145$54,878 $86,872 Net interest expense 13,270 14,296 49,758 59,192 Income taxes 4,459 56 5,949 4,325 Depreciation and amortization 30,559 32,828 126,220 129,202 EBITDA(1)$58,543 $66,325$236,805 $279,591 Unrealized loss/(gain) on non-designated derivative instruments 471 5,254 (25,124) 7,282 Realized (gain)/loss on non-designated derivatives instruments (6,888)  6,270  Loss on repayment of senior bonds 1,102  1,102  Write off of deferred financing costs 212  212 171 Foreign currency exchange loss/(gain) on senior secured bond 5,969  (6,589)  (Profit)/Loss from sale of vessel (4,363) 144 (4,721) (4,797)Adjusted EBITDA(1)$55,046 $71,723$207,955 $282,247 (1) EBITDA and Adjusted EBITDA are not measurements prepared in accordance with U.S. GAAP. EBITDA represents net income before net interest expense, income taxes, depreciation and amortization. We define Adjusted EBITDA as EBITDA before profit/loss on sale of vessel, unrealized gain/loss on non-designated derivative instruments and foreign currency exchange gain or loss on senior secured bonds. Management believes that EBITDA and Adjusted EBITDA are useful to investors in evaluating the operating performance of the Company. EBITDA and Adjusted EBITDA do not represent and should not be considered alternatives to consolidated net income, cash generated from operations or any measure. Liquidity and Capital Resources Liquidity and Cash Needs Our primary sources of funds are cash and cash equivalents, cash from operations, undrawn bank borrowings and proceeds from bond issuances. As of December 31, 2023, we had cash, cash equivalents and restricted cash of $158.2 million . The Company repaid $23.8 million of the $111.8 million Term Loan and Revolving Credit Facility held with Credit Agricole on December 28, 2023 which resulted in an equal reduction in long-term debt outstanding and cash and cash equivalents. The amount repaid of $23.8 million remains available to be redrawn by the Company in accordance with the terms of the Term Loan and Revolving Credit Facility which matures in September 2028. Our secured term loan facilities and revolving credit facilities require that the borrowers have liquidity of no less than (i) $35.0 million or $50.0 million, as applicable to the relevant loan facility, or (ii) 5% of total debt (which was $45.1 million as of December 31, 2023), whichever is greater. Our primary uses of funds are drydocking and other vessel maintenance expenditures, voyage expenses, vessel operating expenses, general and administrative costs, insurance costs, expenditures incurred in connection with ensuring that our vessels comply with international and regulatory standards, financing expenses, quarterly repayment of bank loans and the Terminal Expansion Project. We also expect to use funds in connection with our Return of Capital policy. In addition our medium-term and long-term liquidity needs relate to debt repayments, repayment of bonds, potential future vessel newbuildings, related investments, vessel acquisitions, and or related port or terminal projects. As of December 31, 2023, we had $906.1 million in outstanding obligations, which includes principal repayments on long-term debt, including our bonds, commitments in respect of the Navigator Aurora Facility and office lease commitments. Of the total outstanding obligations, $123.8 million matures during the twelve months ending December 31, 2024, and $782.4 million matures after December 31, 2024. We believe, given our current cash balances, that our financial resources, including the cash expected to be generated within the year, will be sufficient to meet our liquidity and working capital needs for at least the next twelve months, taking into account our existing capital commitments and debt service requirements. Capital Expenditures Liquefied gas transportation by sea is a capital-intensive business, requiring significant investment to maintain an efficient fleet and to stay in regulatory compliance. We currently have no newbuildings on order. However, we may place newbuilding orders or acquire additional vessels as part of our growth strategy. We may invest further in terminal infrastructure, such as the expansion of our existing Ethylene Export Terminal. The total capital contributions required from us related to the Terminal Expansion Project are expected to be approximately $130 million, of which $35.0 million has been contributed as of December 31, 2023. $17.0 million was contributed during the fourth quarter of 2023. Cash Flows The following table summarizes our cash, cash equivalents and restricted cash provided by / (used in) operating, investing and financing activities for the twelve months ended December 31, 2023 and 2022: Year ended December 31, 2022Year endedDecember 31, 2023 (in thousands)Net cash provided by operating activities$130,308 $174,703 Net cash provided by/(used in) investing activities1 29,725 (176,481)Net cash (used in)/provided by financing activities1 (128,225) 6,809 Effect of exchange rate changes on cash, cash equivalents and restricted cash (2,837) 17 Net increase in cash, cash equivalents and restricted cash$28,971 $5,048 Operating Cash Flows. Net cash provided by operating activities for the twelve months ended December 31, 2023, increased to $174.7 million, from $130.3 million for the twelve months ended December 31, 2022, an increase of $44.4 million . This increase was primarily due to an increase in net income of $4.6 million (after adding back the unrealized gains and loss on derivative instruments and our share of the result from equity method investments); a decrease in drydocking payments of $3.5 million and changes in working capital of $12.5 million during the twelve months ended December 31, 2023, compared to the twelve months ended December 31, 2022. Net cash flow from operating activities principally depends upon charter rates attainable, fleet utilization, fluctuations in working capital balances, repairs and maintenance activity, amount and duration of drydocks and changes in foreign currency rates. We are required to drydock each vessel once every five years until it reaches 15 years of age, after which we drydock vessels approximately every two and a half years. Drydocking each vessel, including travelling to and from the drydock, can take approximately 30 days in total being approximately 5-10 days of voyage time to and from the shipyard and approximately 15-20 days of actual drydocking time. Ten of our vessels completed their respective drydockings during the twelve months ended December 31, 2023, We estimate the current cost of a five-year drydocking for one of our vessels is approximately $1.0 million, a ten-year drydocking cost is approximately $1.3 million, and the 15 year and 17 year drydocking costs is approximately $1.5 million each (including the cost of classification society surveys). As our vessels age and our fleet expands, our drydocking expenses will increase. Ongoing costs for compliance with environmental regulations are primarily included as part of drydocking, such as the requirement to install ballast water treatment plants, and classification society survey costs, with a balance included as a component of our operating expenses. Investing Cash Flows1. Net cash used in investing activities was $176.5 million for the twelve months ended December 31, 2023, primarily as a result of $191.7 million used by the Navigator Greater Bay Joint Venture for the acquisition of four vessels and contributions to our investment in the ethylene export terminal via the Terminal Expansion Project of $35.0 million, offset by distributions received from our investment in the Export Terminal Joint Venture of $30.8 million and proceeds from the sale of Navigator Orion of $20.7 million. Net cash provided by investing activities of $29.7 million million for the year ended December 31, 2022, primarily represents net proceeds from the sale of vessels of $38.8 million, distributions from our equity method investments of $27.5 million, insurance recoveries during the year of $9.3 million and capital contributions from non-controlling interests of $5.9 million; offset by expenditure on vessels and their equipment of $45.7 million. Financing Cash Flows. Net cash provided by financing activities was $6.8 million for the twelve months ended December 31, 2023 primarily as a result of the drawdown of $200.0 million from our March 2023 Secured Term Loan facility and $123.6 million from our Navigator Greater Bay Joint Venture Secured Term Loan facility to partially finance the acquisition of four vessels; as well as $27.3 million received as a capital contribution from the non-controlling interest for those vessels; offset by our regular quarterly debt repayments and the refinancing of our two maturing secured term loan facilities totaling $268.3 million, $48.7 million for our share repurchase program and $7.3 million for our quarterly dividends. Net cash used in financing activities of $128.2 million for the year ended December 31, 2022, principally relates to repayments of our secured term loan facilities of $186.4 million, the repayment of the NOK Bond and the settlement of the related cross currency swap of $72.9 million, the repurchase of the Companys shares pursuant to the share repurchase program in the amount of $5.5 million, as well as an extemporaneous repayment of $6.7 million on the Navigator Aurora Facility held within our consolidated lessor VIE, offset by drawdowns on the new term loan facilities of $139.3 million. Condensed Consolidated Statements of Operations (Unaudited) Three months ended December 31,Year ended December 31, 2022 2023 2022 2023 (in thousands except share and per share data)Revenues Operating revenues$ 105,115 $ 129,068 $ 405,346 $ 493,339 Operating revenues  Unigas Pool 11,837 12,564 46,345 50,043 Operating revenues  Luna Pool collaborative arrangements 6,333  22,101 7,355 Total operating revenue 123,285 141,632 473,792 550,737 Expenses Brokerage commission 1,494 1,706 5,900 6,923 Voyage expenses 16,865 18,115 78,674 74,509 Voyage expenses  Luna Pool collaborative arrangements 5,533  20,716 5,561 Vessel operating expenses 43,924 46,715 159,266 170,952 Depreciation and amortization 30,559 32,828 126,220 129,202 General and administrative costs 8,389 8,878 27,439 31,213 Loss/(profit) from sale of vessel (4,363) 144 (4,721) (4,797)Other income (105) 36 (364) (60)Total operating expenses 102,296 108,422 413,130 413,503 Operating Income 20,989 33,210 60,662 137,234 Other income/(expense) Foreign currency exchange (loss)/gain on senior secured bonds (5,969)  6,589  Realized gain/(loss) on cross currency interest rate swap 6,888  (6,270)  Unrealized (loss)/gain on non-designated derivative instruments (471) (5,254) 25,124 (7,282)Loss on repayment of senior bonds (1,102)  (1,102)  Write off of deferred financing costs (212)  (212) (171)Interest expense (13,983) (16,355) (50,840) (64,898)Interest income 713 2,060 1,082 5,707 Income before taxes and share of result of equity method investments 6,853 13,661 35,033 70,590 Income taxes (4,459) (56) (5,949) (4,325)Share of result of equity method investments 7,861 5,540 25,794 20,607 Net Income 10,255 19,145 54,878 86,872 Net income attributable to non-controlling interest (287) (1,394) (1,405) (4,617)Net Income attributable to stockholders of Navigator Holdings Ltd.$ 9,968 $ 17,751 $ 53,473 $ 82,255 Earnings per share attributable to stockholders of Navigator Holdings Ltd.: Basic:$ 0.13 $ 0.24 $ 0.69 $ 1.11 Diluted:$ 0.13 $ 0.24 $ 0.69 $ 1.10 Dividend Paid$  $ 0.05 $  $ 0.10 Weighted average number of shares outstanding in the period: Basic: 77,264,139 73,265,815 77,234,830 74,096,284 Diluted: 77,574,995 73,813,208 77,558,494 74,607,449 Number of shares outstanding at the end of the period: 76,804,474 73,208,586 76,804,474 73,208,586 Condensed Consolidated Statements of Comprehensive Income(Unaudited) Three months endedDecember 31, 2022Three months endedDecember 31, 2023Year endedDecember 31, 2022Year endedDecember 31, 2023 (in thousands)Net income$10,255 $19,145 $54,878 $86,872Other comprehensive income: Foreign currency translation (loss)/income (141) (49) (215) 311Total comprehensive income 10,114 19,096 54,663 87,183Total comprehensive income attributable to: Stockholders of Navigator Holdings Ltd. 9,827 17,702 53,263 82,566Non-controlling interest 287 1,394 1,400 4,617Total comprehensive income$10,114 $19,096 $54,663 $87,183 Condensed Consolidated Balance Sheets(Unaudited) As at December 31, 2022As at December 31, 2023 (in thousands, except share data)Assets Current Assets Cash, cash equivalents and restricted cash$ 153,194 $ 158,242 Accounts receivable, net of allowance for credit losses 18,245 34,653 Accrued income 9,367 2,437 Prepaid expenses and other current assets 21,152 17,068 Bunkers and lubricant oils 8,548 9,044 Insurance receivable 1,452 526 Amounts due from related parties 16,363 33,402 Total current assets 228,321 255,372 Non-current Assets Vessels, net 1,692,494 1,754,382 Property, plant and equipment, net 198 142 Intangible assets, net of accumulated amortization 239 332 Equity method investments 148,534 174,910 Derivative assets 21,955 14,674 Right-of-use asset for operating leases 3,625 2,873 Prepaid expenses and other non-current assets 1,372  Total non-current assets 1,868,417 1,947,313 Total Assets$ 2,096,738 $ 2,202,685 Liabilities and Stockholders Equity Current Liabilities Current portion of secured term loan facilities, net of deferred financing costs$ 99,009 $ 120,327 Current portion of operating lease liabilities 219 914 Accounts payable 7,773 11,643 Accrued expenses and other liabilities 24,708 20,847 Accrued interest 4,211 5,488 Deferred income 23,108 25,617 Amounts due to related parties 595 606 Total current liabilities 159,623 185,442 Non-current Liabilities Secured term loan facilities and revolving credit facilities, net of current portion and deferred financing costs 608,338 641,975 Senior unsecured bond, net of deferred financing costs 98,943 90,336 Operating lease liabilities, net of current portion 4,032 3,500 Deferred tax liabilities 4,250 7,016 Amounts due to related parties 48,140 41,342 Total non-current liabilities 763,703 784,169 Total Liabilities 923,326 969,611 Commitments and Contingencies - Note 11 Stockholders Equity Common stock$0.01 par value per share; 400,000,000 shares authorized; 73,208,586 shares issued and outstanding, (December 31, 2022: 76,804,474) 769 733 Additional paid-in capital 798,188 799,472 Accumulated other comprehensive loss (463) (152)Retained earnings 364,000 390,221 Total Navigator Holdings Ltd. Stockholders Equity 1,162,494 1,190,274 Non-controlling interest 10,918 42,800 Total equity 1,173,412 1,233,074 Total Liabilities and Stockholders Equity$ 2,096,738 $ 2,202,685 Condensed Consolidated Statements of Cash Flows(Unaudited) Year Ended December 31, 2022Year Ended December 31, 2023 (in thousands)Cash flows from operating activities Net income$54,878 $86,872 Adjustments to reconcile net income/(loss) to net cash provided by operating activities Foreign exchange gain on senior secured bonds (6,589)  Unrealized (gain)/loss on non-designated derivative instruments (25,124) 7,282 Realized loss on cross currency interest rate swap 6,270  Depreciation and amortization 126,220 129,202 Payment of drydocking costs (18,338) (12,424)Profit from sale of vessel (4,721) (4,797)Share-based compensation expense 869 1,284 Amortization of deferred financing costs 3,863 3,716 Share of results of equity method investments (25,794) (20,607)Deferred taxes  2,363 Other unrealized foreign exchange loss/(gain) 2,872 (159)Changes in operating assets and liabilities Accounts receivable 13,661 (16,408)Insurance claim receivable (3,858) 400 Bunkers and lubricant oils 3,958 (496)Accrued income, prepaid expenses and other current assets (9,541) 11,013 Accounts payable, accrued interest, accrued expenses and other liabilities 10,478 4,501 Amounts due from related parties 1,204 (17,039)Net cash provided by operating activities 130,308 174,703 Cash flows from investing activities Additions to vessels and equipment (45,719) (191,727)Contributions to equity method investments  (36,558)Distributions from equity method investments 27,469 30,790 Purchase of other property, plant and equipment and intangibles (50) (233)Net proceeds from sale of vessel 38,762 20,720 Insurance recoveries 9,263 527 Net cash provided by/(used in) investing activities 29,725 (176,481)Cash flows from financing activities Proceeds from secured term loan facilities and revolving credit facilities 139,273 323,561 Direct financing cost of secured term loan and revolving credit facilities (1,874) (3,548)Repayment of senior bonds (61,564)  Repurchase of share capital (5,485) (48,736)Settlement of derivatives (11,322)  Repayments under operating lease obligations  (289)Purchase of senior unsecured bonds  (9,000)Repayment of secured term loan facilities and revolving credit facilities (186,430) (268,311)Repayment of refinancing of vessel to related parties (6,738) (6,798)Cash received from non-controlling interest 5,915 27,264 Dividend paid  (7,334)Net cash (used in)/provided by financing activities (128,225) 6,809 Effect of exchange rate changes on cash, cash equivalents and restricted cash (2,837) 17 Net increase in cash, cash equivalents and restricted cash 28,971 5,048 Cash, cash equivalents and restricted cash at beginning of year 124,223 153,194 Cash, cash equivalents and restricted cash at end of year$153,194 $158,242 Supplemental Information Total interest paid during the year, net of amounts capitalized$48,600 $62,109 Total tax paid during the year$2,438 $1,800 Our Fleet The following table provides details of our vessels as of March 13, 2024: Operating VesselYearBuiltVessel Size(cbm)EmploymentStatusCurrent CargoTime CharterExpiration DateEthylene/ethane capable semi-refrigerated midsize Navigator Aurora201637,300Time CharterEthaneDecember 2026Navigator Eclipse201637,300Time CharterEthaneMarch 2026Navigator Nova201737,300Time CharterEthaneSeptember 2026Navigator Prominence201737,300Time CharterEthaneMarch 2025 Ethylene/ethane capable semi-refrigerated handysize Navigator Pluto*200022,085Time CharterEthaneMarch 2024Navigator Saturn*200022,085Time CharterEthaneJune 2024Navigator Venus*200022,085Spot MarketEthaneNavigator Atlas*201421,000Spot MarketEthaneMay 2024Navigator Europa*201421,000Time CharterEthaneDecember 2024Navigator Oberon*201421,000Spot MarketEthaneNavigator Triton*201521,000Spot MarketEthaneNavigator Umbrio*201521,000Time CharterEthaneJanuary 2025Navigator Luna*201817,000Spot MarketEthyleneNavigator Solar*201817,000Spot MarketEthyleneNavigator Castor*201922,000Spot MarketEthyleneNavigator Equator*201922,000Time CharterEthaneJune 2024Navigator Vega*201922,000Time CharterEthyleneApril 2024 Ethylene/ethane capable semi-refrigerated smaller size Happy Condor**20089,000Unigas PoolHappy Pelican**20126,800Unigas PoolHappy Penguin**20136,800Unigas PoolHappy Kestrel**201312,000Unigas PoolHappy Osprey**201312,000Unigas PoolHappy Peregrine**201412,000Unigas PoolHappy Albatross**201512,000Unigas PoolHappy Avocet**201712,000Unigas Pool Semi-refrigerated handysize Navigator Aries200820,750Time CharterLPGJuly 2024Navigator Capricorn200820,750Time CharterLPGOctober 2024Navigator Gemini200920,750Navigator Pegasus200922,200Time CharterPropyleneMarch 2024Navigator Phoenix200922,200Time CharterAmmoniaSeptember 2024Navigator Scorpio200920,750Time CharterLPGJanuary 2026Navigator Taurus200920,750Time CharterAmmoniaJune 2024Navigator Virgo200920,750Time CharterLPGApril 2024Navigator Leo201120,600Time CharterLPGDecember 2024Navigator Libra201220,600Time CharterLPGMarch 2025Atlantic Gas201422,000Time CharterLPGDecember 2024Adriatic Gas201522,000Time CharterLPGMay 2024Balearic Gas201522,000Celtic Gas201522,000Spot MarketLPGApril 2024Navigator Centauri201521,000Time CharterLPGMay 2025Navigator Ceres201521,000Time CharterLPGJune 2025Navigator Ceto201621,000Time CharterLPGMay 2025Navigator Copernico201621,000Time CharterLPGMay 2025Bering Gas201622,000Spot MarketLPGNavigator Luga201722,000Time CharterLPGJuly 2024Navigator Yauza201722,000Time CharterLPGJuly 2024Arctic Gas201722,000Pacific Gas201722,000Time CharterLPGMay 2024 Semi-refrigerated smaller size Happy Falcon**20023,770Unigas Pool Fully-refrigerated Navigator Glory201022,500Time CharterAmmoniaJune 2025Navigator Grace201022,500Time CharterAmmoniaJanuary 2025Navigator Galaxy201122,500Time CharterAmmoniaDecember 2024Navigator Genesis201122,500Time CharterAmmoniaJanuary 2025Navigator Global201122,500Time CharterAmmoniaDecember 2024Navigator Gusto201122,500Time CharterAmmoniaMarch 2025Navigator Jorf201738,000Time CharterAmmoniaAugust 2027 * denotes our owned vessels that operate within the Luna Pool** denotes our owned vessels that operate within the independently managed Unigas Pool Category: Financial 1 In connection with the preparation of the Companys consolidated financial statements for the three months ended March 31, 2023, a reclassification was made in relation to cash received from the non-controlling interest in the Navigator Greater Bay Joint Venture in our statement of cash flows presented in our consolidated financial statements for the year ended December 31, 2022. A receipt of $5.9 million reported in the consolidated statement of cash flows within Cash flows from investing activities was moved to Cash flows from financing activities. resulting in a decrease in cash flows from investing activities of $5.9 million and an increase in cash flows from financing activities of $5.9 million for the year ended December 31, 2022. This reclassification had no impact on the consolidated balance sheet or statements of operations, comprehensive income and stockholders equity. What was the cash dividend declared by Navigator Holdings Ltd. for Q4 2023? Navigator Holdings Ltd. declared a cash dividend of $0.05 per share for the quarter ended December 31, 2023. What was the total operating revenue reported by Navigator Holdings Ltd. for Q4 2023? Navigator Holdings Ltd. reported total operating revenue of $141.6 million for the three months ended December 31, 2023. What was the net income attributable to stockholders' of Navigator Holdings Ltd. for Q4 2023? The net income attributable to stockholders' of Navigator Holdings Ltd. was $17.8 million for the three months ended December 31, 2023. What was the EBITDA reported by Navigator Holdings Ltd. for Q4 2023? Navigator Holdings Ltd. reported an EBITDA of $66.3 million for the three months ended December 31, 2023. What was the adjusted EBITDA reported by Navigator Holdings Ltd. for Q4 2023? Navigator Holdings Ltd. reported an adjusted EBITDA of $71.7 million for the three months ended December 31, 2023. What was the Ethylene Export Terminal throughput for Q4 2023? The Ethylene Export Terminal throughput during the fourth quarter of 2023 was 208,495 metric tons. What was the investment made by Navigator Holdings Ltd. in Azane for ammonia fuel handling? Navigator Holdings Ltd. acquired a 14.5% interest in Azane on October 25, 2023, for $1.4 million. What does the Return of Capital policy of Navigator Holdings Ltd. include? The Return of Capital policy includes paying out quarterly cash dividends of $0.05 per share of common stock and returning additional capital in the form of additional cash dividends and/or share repurchases. When will the Zoom conference call to discuss Q4 2023 financial results be held? The Zoom conference call will be held on Thursday, March 14, 2024, at 10:00 A.M. E.D.T."
Intel Appoints Stacy Smith to Board of Directors,2024-03-13T20:30:00.000Z,Low,Very Positive,"Intel Corporation appoints Stacy Smith, executive chairman of Kioxia Corporation, to its board of directors. Smith brings extensive semiconductor industry experience and financial expertise to guide Intel's transformation journey.","Intel Appoints Stacy Smith to Board of Directors Rhea-AI Impact (Low) Rhea-AI Sentiment (Very Positive) Tags management Rhea-AI Summary Intel Corporation appoints Stacy Smith, executive chairman of Kioxia Corporation, to its board of directors. Smith brings extensive semiconductor industry experience and financial expertise to guide Intel's transformation journey. Positive None. Negative None. 03/13/2024 - 04:30 PM SANTA CLARA, Calif.--(BUSINESS WIRE)-- Intel Corporation today announced that Stacy Smith, executive chairman of Kioxia Corporation, formerly Toshiba Memory Corporation, and chair of Autodesk Inc., was appointed to Intels board of directors, effective immediately. Smith will serve as an independent director and join the boards Audit & Finance Committee. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240313236334/en/Stacy J. Smith joined Intel Corporations board of directors in March 2024. (Credit: Intel Corporation) Stacys deep understanding of the semiconductor industry, along with Intels history and strategy, will be a significant asset to the board as it guides the companys transformation journey, said Frank D. Yeary, chairman of the Intel board. In particular, Stacys expertise in finance and leading capital allocation strategies in the capital-intensive semiconductor industry will be additive to Intels board as the company continues its efforts to create a globally resilient semiconductor supply chain. Smith, 61, spent nearly 30 years at Intel, serving in a variety of leadership roles. Prior to his retirement in 2018, he served as the group president of manufacturing, operations and sales, leading the companys global Technology and Manufacturing Group and its worldwide sales organization. Prior to this, he spent more than a decade in finance leadership roles, including as chief financial officer. In addition, Smith held the role of chief information officer and, before that, was general manager of Intel Europe, Middle East and Africa (EMEA), where he was responsible for Intel sales and marketing for the EMEA region. I am excited to be joining the Intel board at this pivotal moment as the company accelerates its IDM 2.0 strategy to win in its core markets, grow in emerging compute markets and become one of the worlds leading foundries, said Smith. Intel is executing one of the most significant transformations in the semiconductor industry, and it is an honor to have the opportunity to contribute to the companys evolution as it regains its iconic position in the global technology ecosystem. In addition to Smiths extensive breadth of semiconductor industry, operations and manufacturing, and sales, marketing and branding expertise, he brings extensive public company board experience to Intel. He has served as executive chairman of Kioxia since 2018 and as chairman of the board of Autodesk since 2011. Additionally, he has served on the board of Wolfspeed since 2023. Previously, he served on the board of directors for Virgin America from 2014 to 2016 and Gevo Inc. from 2010 to 2014. Smith holds an MBA in finance from the University of Texas. About Intel Intel (Nasdaq: INTC) is an industry leader, creating world-changing technology that enables global progress and enriches lives. Inspired by Moores Law, we continuously work to advance the design and manufacturing of semiconductors to help address our customers greatest challenges. By embedding intelligence in the cloud, network, edge and every kind of computing device, we unleash the potential of data to transform business and society for the better. To learn more about Intels innovations, go to newsroom.intel.com and intel.com.  Intel Corporation. Intel, the Intel logo and other Intel marks are trademarks of Intel Corporation or its subsidiaries. Other names and brands may be claimed as the property of others. View source version on businesswire.com: https://www.businesswire.com/news/home/20240313236334/en/ Penny Bruce Intel Media Relations 1-408-893-0601 penelope.bruce@intel.com Kylie Altman Intel Investor Relations 1-916-356-0320 investor.relations@intel.com Source: Intel Corporation Who was appointed to Intel's board of directors? Stacy Smith, executive chairman of Kioxia Corporation. What committee will Stacy Smith join on Intel's board? Audit & Finance Committee. What is Stacy Smith's background in Intel? Smith spent nearly 30 years at Intel, serving in various leadership roles including group president of manufacturing, operations, and sales, CFO, and chief information officer. What is Stacy Smith's expertise in finance? Smith has expertise in finance and leading capital allocation strategies in the semiconductor industry. What is Intel's strategy that Stacy Smith will contribute to? Intel's IDM 2.0 strategy to win in core markets, grow in emerging compute markets, and become a leading foundry."
Granite Earns its Fourth Consecutive Early Talent Award from Handshake,2024-03-13T20:30:00.000Z,Low,Very Positive,"Granite (GVA) wins Handshake's Early Talent Award for the fourth year, highlighting its excellence in talent engagement. The company stands out among 900,000+ employers for brand resonance, effective engagement, event participation, and strong student relationships. Granite's commitment to nurturing early talent is evident through its award-winning college recruitment efforts, fostering a diverse and talented workforce.","Granite Earns its Fourth Consecutive Early Talent Award from Handshake Rhea-AI Impact (Low) Rhea-AI Sentiment (Very Positive) Tags Rhea-AI Summary Granite (GVA) wins Handshake's Early Talent Award for the fourth year, highlighting its excellence in talent engagement. The company stands out among 900,000+ employers for brand resonance, effective engagement, event participation, and strong student relationships. Granite's commitment to nurturing early talent is evident through its award-winning college recruitment efforts, fostering a diverse and talented workforce. Positive None. Negative None. 03/13/2024 - 04:30 PM WATSONVILLE, Calif.--(BUSINESS WIRE)-- Granite (NYSE:GVA) continues to shine in talent engagement. For the fourth consecutive year, the company has secured Handshakes Early Talent Award (ETA). This annual award celebrates the best employers for people starting their careers, and Granite is one of a select group in its industry to be recognized (out of 900,000+ employers using Handshake). The ETAs are awarded to employers that demonstrate brand resonance, engage effectively (measured by unique clicks per distinct message recipient), actively participate in events (such as career fairs and event registrations), and maintain strong relationships with students through reciprocal messaging. These criteria underscore the evolving landscape of talent acquisition, emphasizing the importance of companies fully engaging with early talent to secure future industry leaders. Jessica Somers, Granites Director of Talent Acquisition, expressed the companys commitment to early talent. She stated, Were excited to celebrate this award and to continue nurturing a program that early talent finds engaging and best-in-class. This award symbolizes our commitment to those launching their careers. Its truly exciting to receive Handshakes recognition for the fourth consecutive year, added Tim Gruber, Granite SVP of Human Resources. Our teams exceptional efforts in college recruitment have created a best-in-class program, fostering a more diverse, inclusive, and talented workforce. Granites dedication to identifying and developing talent remains unwavering, and this award reaffirms its commitment to shaping the future of the construction industry. Visit Handshake for more information about the ETAs and the 2024 winners: https://joinhandshake.com/early-talent-awards/ About Handshake Handshakes mission is to democratize access to opportunity, and Handshake is the best place to start or accelerate a careerno connections, experience, or luck required. Our community includes 15M+ students and young alumni from 1,500+ educational institutions, including four-year colleges, community colleges, boot camps, and 300+ minority-serving institutions. We connect emerging talent with 900K+ employersfrom Fortune 500 companies to thousands of public-school districts, healthcare systems, nonprofits, and more. About Granite Granite is Americas Infrastructure Company. Incorporated since 1922, Granite (NYSE:GVA) is one of the largest diversified construction and construction materials companies in the United States as well as a full-suite civil construction provider. Granites Code of Conduct and strong Core Values guide the Company and its employees to uphold the highest ethical standards. Granite is an industry leader in safety and an award-winning firm in quality and sustainability. For more information, visit the Granite website, graniteconstruction.com, and connect with Granite on LinkedIn, X, Facebook, and Instagram. View source version on businesswire.com: https://www.businesswire.com/news/home/20240313456550/en/ Media Erin Kuhlman 831-768-4111 Investors Wenjun Xu - 831-761-7861 Source: Granite How many employers were recognized in the Handshake's Early Talent Award (ETA)? Granite (GVA) is one of a select group of employers recognized out of 900,000+ using Handshake. What criteria are considered for the ETAs? Criteria include brand resonance, effective engagement, event participation, and strong relationships with students. Who expressed Granite's commitment to early talent in the PR? Jessica Somers, Granite's Director of Talent Acquisition, expressed the company's commitment to early talent. What did Tim Gruber, Granite's SVP of Human Resources, mention in the PR? Tim Gruber highlighted the exceptional efforts in college recruitment that have created a best-in-class program. What does the award symbolize for Granite according to the PR? The award symbolizes Granite's commitment to those launching their careers and shaping the future of the construction industry."
United Rentals Introduces Tower Crane Battery Energy Systems to North American Fleet,2024-03-13T21:30:00.000Z,Low,Neutral,"United Rentals, Inc. introduces battery energy systems for tower cranes in collaboration with Termaco, providing clean, sustainable power to reduce fuel consumption and emissions. Award Construction successfully implements the system, reducing generator run time by 91% and achieving an 80% fuel and emissions reduction.","United Rentals Introduces Tower Crane Battery Energy Systems to North American Fleet Rhea-AI Impact (Low) Rhea-AI Sentiment (Neutral) Tags Rhea-AI Summary United Rentals, Inc. introduces battery energy systems for tower cranes in collaboration with Termaco, providing clean, sustainable power to reduce fuel consumption and emissions. Award Construction successfully implements the system, reducing generator run time by 91% and achieving an 80% fuel and emissions reduction. Positive None. Negative None. Environmental Sustainability Expert The integration of battery energy systems in construction equipment, particularly tower cranes, represents a significant advancement in environmental sustainability within the construction industry. This technology reduces the reliance on diesel generators, which are traditionally used to power such equipment. By minimizing generator run time and leveraging the potential for solar panel integration, the system substantially cuts down on fuel consumption and carbon emissions. This not only aligns with global efforts to reduce greenhouse gases but also meets the increasing demand for green construction practices from both regulators and the public.The long-term implications for stakeholders include potential cost savings on fuel and maintenance, as well as compliance with stricter environmental regulations. Construction firms adopting such technologies may also gain a competitive edge by aligning with the values of environmentally conscious clients and partners. However, the initial investment in battery energy systems and the scalability of such solutions for larger projects could pose challenges that need to be addressed. Financial Analyst From a financial perspective, the adoption of battery energy systems by United Rentals could lead to operational efficiencies and cost savings for their clients, as evidenced by the case study of Award Construction. A reduction in generator run time by 91% and a corresponding decrease in fuel consumption by approximately 80% could translate into significant cost reductions over the lifespan of construction projects. For United Rentals, this move may enhance their value proposition and potentially drive demand for their rental equipment, which could positively impact their financial performance.Investors and stakeholders should monitor the adoption rate of this technology and its impact on United Rentals' revenue streams. While the upfront costs of these systems may be higher, the long-term operational savings and potential for increased market share in an environmentally conscious market could provide a return on investment. However, it's important to consider the competitive landscape and the speed at which competitors might introduce similar sustainable solutions. Market Research Analyst The construction industry is increasingly moving towards sustainability and the market for eco-friendly construction solutions is expanding. The introduction of battery energy systems for tower cranes by United Rentals taps into this growing trend. As a market research analyst, observing the market's response to such innovations is crucial. Early adopters like Award Construction showcase the practical benefits and could serve as a case study for other firms considering similar investments.Market acceptance will be determined by factors such as the reliability of the technology, cost-effectiveness compared to traditional methods and the regulatory environment promoting sustainable practices. It's also essential to understand how this fits into the broader trend of electrification and renewable energy adoption in construction. The ability of United Rentals to capitalize on this trend will depend on their marketing strategy, the effectiveness of their technology and their capacity to scale up operations in response to demand. 03/13/2024 - 05:30 PM Helping Award Construction Achieve More Sustainable Jobsite at St. Albert Project STAMFORD, Conn.--(BUSINESS WIRE)-- United Rentals, Inc. (NYSE: URI), the world's largest equipment rental company, today announced it has added battery energy systems for tower cranes to its North American rental fleet. Developed by Termaco in collaboration with United Rentals, this innovative system provides clean, sustainable power that enables contractors to reduce fuel consumption and equipment-related downtime while achieving quieter, lower-emission jobsites. Configurable up to 500kW, the system operates alongside a generator to deliver reliable power to support tower crane operations. It minimizes generator run time by storing energy in batteries and running on battery power whenever possible. For smaller applications, the battery unit can be powered by solar panels to create a completely emission-free solution. This allows a contractor to significantly downsize the generator and dramatically reduce generator run time and emissions, while still meeting peak power demands. Battery energy systems for tower cranes provide a great application of practical sustainability on the jobsite by helping contractors address their economic and environmental goals, said Larry Worthington, Region Vice President, Power and HVAC, United Rentals. This solution demonstrates United Rentals commitment to bringing innovative products to market that deliver outstanding value to our customers. Proven in the Field General contracting firm Award Construction, based in Alberta, Canada, pioneered the use of the United Rentals battery energy system to fully power an 8-ton, 70-meter-tall tower crane at Riverbank Landing, a 20-acre planned mixed-use community being built in Edmonton. At the project, Award went from running a 300kVA T4 generator 24 hours a day to power its tower crane, to charging the battery energy system with a 100kW generator for just two and a half hours a day and operating the crane solely on battery power. Generator run time was reduced by 91%, which resulted in a fuel and emissions reduction of approximately 80%. Sustainable building aligns with our companys core values. We are proud our Riverbank Landing construction site is making history as one of the first in Canada to fully power its site tower crane entirely by battery, said Brian Hennessey, Construction Manager, Award Construction. This innovative tower crane battery energy system is part of a range of low and zero-emission solutions. Learn more on the Sustainability at United Rentals webpage. About United Rentals United Rentals, Inc. is the largest equipment rental company in the world. The company has an integrated network of 1,504 rental locations in North America, 38 in Europe, 23 in Australia and 19 in New Zealand. In North America, the company operates in 49 states and every Canadian province. The companys approximately 26,300 employees serve construction and industrial customers, utilities, municipalities, homeowners and others. The company offers approximately 4,800 classes of equipment for rent with a total original cost of $20.66 billion. United Rentals is a member of the Standard & Poors 500 Index, the Barrons 400 Index and the Russell 3000 Index and is headquartered in Stamford, Conn. Additional information about United Rentals is available at unitedrentals.com. View source version on businesswire.com: https://www.businesswire.com/news/home/20240313492057/en/ Elizabeth Grenfell Vice President, Investor Relations O: (203) 618-7125 investors@ur.com Source: United Rentals, Inc. What new system has United Rentals added to its North American rental fleet? United Rentals has added battery energy systems for tower cranes to its North American rental fleet. Who developed the battery energy system for tower cranes in collaboration with United Rentals? The system was developed by Termaco in collaboration with United Rentals. How much can the battery energy system for tower cranes be configured up to? The system can be configured up to 500kW. What does the battery energy system do to minimize generator run time? The system minimizes generator run time by storing energy in batteries and running on battery power whenever possible. What reduction in fuel and emissions did Award Construction achieve by using the battery energy system? Award Construction achieved a 91% reduction in generator run time and an approximately 80% reduction in fuel and emissions."
Travel + Leisure Co. Increases Cash Dividend 11%,2024-03-13T20:30:00.000Z,Low,Neutral,"Travel + Leisure Co. (TNL) announces an 11% increase in its quarterly dividend rate to $0.50 per share from $0.45 per share. The dividend is payable on March 29, 2024, to shareholders of record as of March 21, 2024. The company's decision reflects confidence in growth prospects and cash generation.","Travel + Leisure Co. Increases Cash Dividend 11% Rhea-AI Impact (Low) Rhea-AI Sentiment (Neutral) Tags dividends Rhea-AI Summary Travel + Leisure Co. (TNL) announces an 11% increase in its quarterly dividend rate to $0.50 per share from $0.45 per share. The dividend is payable on March 29, 2024, to shareholders of record as of March 21, 2024. The company's decision reflects confidence in growth prospects and cash generation. Positive Travel + Leisure Co. (TNL) increases its quarterly dividend rate by 11% to $0.50 per share. The dividend is payable on March 29, 2024, to shareholders of record as of March 21, 2024. The board's decision showcases confidence in growth prospects and cash generation capabilities. The company's CFO emphasizes the commitment to returning cash to shareholders and effective capital allocation strategies. Negative None. Financial Analyst The declaration of an increased dividend by Travel + Leisure Co. signals a robust financial posture and a commitment to shareholder returns. The 11% hike in the quarterly dividend to $0.50 per share from the previous $0.45 is a substantial increment, which suggests that the company has a positive outlook on its cash flow and profitability. This move might attract income-focused investors, potentially leading to an increased demand for the stock.It's important to consider the dividend yield, which is a financial ratio that shows how much a company pays out in dividends each year relative to its stock price. An increase in dividends can affect this yield and make the stock more attractive if the price remains stable or grows at a slower pace than the dividend increase. Moreover, the company's capital allocation strategy, including share repurchases, organic growth investments and potential M&A activities, indicates a comprehensive approach to utilizing its capital for driving shareholder value. Market Research Analyst The travel and leisure industry has been recovering post-pandemic and Travel + Leisure Co.'s decision to increase dividends likely reflects the company's confidence in the industry's continued growth. This confidence is also supported by the CFO's statement regarding the company's prospects for growth. An increased dividend can be seen as a signal to the market about the company's future performance expectations.However, it is essential to monitor the company's ability to sustain this increased dividend through its future earnings and cash flow. Investors should be aware that a high dividend payout, if not supported by solid financial health, can become unsustainable in the long term. Therefore, analyzing the company's earnings, payout ratio and free cash flow is crucial in assessing the sustainability of the dividend increase. Economist In the broader economic context, dividend policy changes can be influenced by macroeconomic factors like interest rates and economic growth. In a low-interest-rate environment, higher dividends might be particularly attractive as they offer better returns than many fixed-income alternatives. However, as interest rates rise, the relative attractiveness of dividend stocks may diminish unless they can maintain a yield advantage.Furthermore, the travel and leisure sector's performance is closely tied to consumer discretionary spending, which is affected by economic cycles. In periods of economic expansion, consumers are more likely to increase spending on travel and leisure, benefiting companies like Travel + Leisure Co. Conversely, during economic downturns, such companies might face challenges in maintaining their financial performance and, by extension, their dividend payouts. 03/13/2024 - 04:30 PM ORLANDO, Fla.--(BUSINESS WIRE)-- The board of directors of Travel + Leisure Co. (NYSE:TNL) declared a regular cash dividend on the companys common stock, increasing the quarterly dividend rate by 11% to $0.50 per share from $0.45 per share. The dividend is payable March 29, 2024 to shareholders of record as of March 21, 2024. The boards decision to increase the dividend reflects our continued confidence in our strong prospects for growth and our ongoing ability to generate significant amounts of cash after funding the capital needs of the business. The dividend demonstrates our commitment to return cash to shareholders, a priority in our balanced and effective capital allocation strategy, which also includes share repurchases, investing in organic growth, enhancing our balance sheet and pursuing opportunistic M&A when appropriate, said Mike Hug, Chief Financial Officer of Travel + Leisure Co. About Travel + Leisure Co. As the worlds leading membership and leisure travel company, Travel + Leisure Co. (NYSE:TNL) transformed the way families vacation with the introduction of the most dynamic points-based vacation ownership program at Club Wyndham, and the first vacation exchange network, RCI. The company delivers more than six million vacations each year at 245+ timeshare resorts worldwide, through tailored travel and membership products, and via Travel + Leisure GO - the signature subscription travel club inspired by the pages of Travel + Leisure magazine. With hospitality and responsible tourism at the heart of all we do, our 19,000+ dedicated associates bring out the best in people and places around the globe. We put the world on vacation. Learn more at travelandleisureco.com. Forward-Looking Statements This press release includes forward-looking statements as that term is defined by the Securities and Exchange Commission (SEC). Forward-looking statements are any statements other than statements of historical fact, including statements regarding our expectations, beliefs, hopes, intentions or strategies regarding the future. In some cases, forward-looking statements can be identified by the use of words such as will, intends, or expects, or other words of similar meaning. Forward-looking statements are subject to risks and uncertainties that could cause actual results of Travel + Leisure Co. and its subsidiaries (Travel + Leisure Co. or we) to differ materially from those discussed in, or implied by, the forward-looking statements. Factors that might cause such a difference include, but are not limited to, risks associated with: the future prospects and plans for Travel + Leisure Co., including our ability to compete in the highly competitive timeshare and leisure travel industries; the health of the travel industry and declines or disruptions caused by adverse economic conditions (including inflation, higher interest rates, and recessionary pressures), terrorism or acts of gun violence, political strife, war (including hostilities in Ukraine and the Middle East), pandemics, and severe weather events and other natural disasters; adverse changes in consumer travel and vacation patterns, consumer preferences and demand for our products; increased or unanticipated operating costs and other inherent business risks; our ability to comply with financial and restrictive covenants under our indebtedness; our ability to access capital and insurance markets on reasonable terms, at a reasonable cost or at all; maintaining the integrity of internal or customer data and protecting our systems from cyber-attacks; and those other factors disclosed as risks under Risk Factors in documents we have filed with the SEC, including in Part I, Item 1A of our Annual Report on Form 10-K for the fiscal year ended December 31, 2023, filed with the SEC on February 21, 2024. We caution readers that any such statements are based on currently available operational, financial and competitive information, and they should not place undue reliance on these forward-looking statements, which reflect managements opinion only as of the date on which they were made. Except as required by law, we undertake no obligation to review or update these forward-looking statements to reflect events or circumstances as they occur. View source version on businesswire.com: https://www.businesswire.com/news/home/20240313027297/en/ Investor Contact: Kendrick Calilao Investor Relations (407) 626-4487 Kendrick.Calilao@travelandleisure.com Media Contact: Steven Goldsmith Public Relations (407) 626-5882 Steven.Goldsmith@travelandleisure.com Source: Travel + Leisure Co. What is the new quarterly dividend rate announced by Travel + Leisure Co. (TNL)? Travel + Leisure Co. (TNL) has announced an increase in its quarterly dividend rate by 11% to $0.50 per share from $0.45 per share. When will the dividend be payable to shareholders of Travel + Leisure Co. (TNL)? The dividend declared by Travel + Leisure Co. (TNL) will be payable on March 29, 2024, to shareholders of record as of March 21, 2024. Why did the board of directors decide to increase the dividend for Travel + Leisure Co. (TNL)? The board's decision to increase the dividend reflects confidence in the company's growth prospects and its ability to generate significant cash after funding capital needs. What does the CFO of Travel + Leisure Co. (TNL) emphasize regarding the dividend increase? The CFO highlights the commitment to returning cash to shareholders, which is a priority in the company's balanced and effective capital allocation strategy."
"Orchid Island Capital Announces March 2024 Monthly Dividend and February 29, 2024 RMBS Portfolio Characteristics",2024-03-13T20:52:00.000Z,Low,Neutral,"Orchid Island Capital, Inc. (ORC) declares a monthly dividend of $0.12 per share for March 2024, with plans for regular distributions. The company's REIT status requires significant dividend payouts. RMBS portfolio details are also provided, showcasing asset valuation and risk measures.","Orchid Island Capital Announces March 2024 Monthly Dividend and February 29, 2024 RMBS Portfolio Characteristics Rhea-AI Impact (Low) Rhea-AI Sentiment (Neutral) Tags dividends Rhea-AI Summary Orchid Island Capital, Inc. (ORC) declares a monthly dividend of $0.12 per share for March 2024, with plans for regular distributions. The company's REIT status requires significant dividend payouts. RMBS portfolio details are also provided, showcasing asset valuation and risk measures. Positive None. Negative None. Financial Analyst The announcement of a monthly dividend payment by Orchid Island Capital, Inc. is a tangible indicator of the company's current financial health and its commitment to returning value to shareholders. The declared dividend of $0.12 per share is particularly noteworthy for income-focused investors and could affect the stock's attractiveness in the dividend-paying sector of the market. The consistency of dividend payments suggests a stable cash flow position, which can be reassuring to investors during volatile market conditions.However, it is crucial to assess the sustainability of these dividends. The REIT structure requires the distribution of at least 90% of taxable income, which could limit the company's ability to reinvest earnings into growth opportunities. Furthermore, the lack of a minimum distribution payment level indicates that future dividends are not guaranteed and could be influenced by changes in taxable income or available cash. This uncertainty may introduce a level of risk that should be considered in portfolio management decisions. Tax Specialist From a taxation perspective, the REIT status of Orchid Island Capital has important implications. The obligation to distribute at least 90% of its REIT taxable income helps the company avoid paying corporate income tax on distributed amounts, but it also exposes the company to potential income and excise taxes on undistributed taxable income. This tax structure necessitates careful financial planning to optimize distributions while minimizing tax liabilities.The company's potential exposure to excise tax for not distributing a certain percentage of its taxable income by specified dates adds another layer of complexity to its financial strategy. Investors should be aware of these tax considerations as they can significantly impact the net income of the company and ultimately affect the sustainability of dividend payments. Market Research Analyst Looking at the broader market, REITs like Orchid Island Capital are often evaluated based on their yield, stability and the quality of their underlying assets. The details provided on the RMBS portfolio characteristics such as valuation, assets by agency and risk measures will be closely scrutinized by investors. These portfolio characteristics can signal the company's risk management strategy and the expected performance of its RMBS assets.Given that the RMBS market can be sensitive to interest rate changes and economic conditions, the portfolio's composition and the company's exposure to repurchase agreements are critical factors. Investors should monitor these aspects to gauge the company's ability to maintain dividend payments and navigate market fluctuations. This information, although preliminary, gives a snapshot of the company's investment focus and risk profile, which are essential for making informed investment decisions in the fixed-income space. 03/13/2024 - 04:52 PM March 2024 Monthly Dividend of $0.12 Per Share of Common Stock RMBS Portfolio Characteristics as of February 29, 2024 Next Dividend Announcement Expected April 10, 2024 VERO BEACH, Fla.--(BUSINESS WIRE)-- Orchid Island Capital, Inc. (the Company) (NYSE: ORC) announced today that the Board of Directors of the Company declared a monthly cash dividend for the month of March 2024. The dividend of $0.12 per share will be paid April 26, 2024 to holders of record of the Companys common stock on March 28, 2024, with an ex-dividend date of March 27, 2024. The Company plans on announcing its next common stock dividend on April 10, 2024. The Company intends to make regular monthly cash distributions to its holders of common stock. In order to qualify as a real estate investment trust (REIT), the Company must distribute annually to its stockholders an amount at least equal to 90% of its REIT taxable income, determined without regard to the deduction for dividends paid and excluding any net capital gain. The Company will be subject to income tax on taxable income that is not distributed and to an excise tax to the extent that a certain percentage of its taxable income is not distributed by specified dates. The Company has not established a minimum distribution payment level and is not assured of its ability to make distributions to stockholders in the future. As of March 13, 2024, the Company had 51,358,301 shares of common stock outstanding. As of February 29, 2024, the Company had 51,303,301 shares of common stock outstanding. As of December 31, 2023, the Company had 51,636,074 shares of common stock outstanding. RMBS Portfolio Characteristics Details of the RMBS portfolio as of February 29, 2024 are presented below. These figures are preliminary and subject to change. The information contained herein is an intra-quarter update created by the Company based upon information that the Company believes is accurate: RMBS Valuation Characteristics RMBS Assets by Agency Investment Company Act of 1940 (Whole Pool) Test Results Repurchase Agreement Exposure by Counterparty RMBS Risk Measures About Orchid Island Capital, Inc. Orchid Island Capital, Inc. is a specialty finance company that invests on a leveraged basis in Agency RMBS. Our investment strategy focuses on, and our portfolio consists of, two categories of Agency RMBS: (i) traditional pass-through Agency RMBS, such as mortgage pass-through certificates and collateralized mortgage obligations issued by Fannie Mae, Freddie Mac or Ginnie Mae, and (ii) structured Agency RMBS. The Company is managed by Bimini Advisors, LLC, a registered investment adviser with the Securities and Exchange Commission. Forward-Looking Statements This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and other federal securities laws. These forward-looking statements include, but are not limited to, statements about the Companys distributions. These forward-looking statements are based upon Orchid Island Capital, Inc.s present expectations, but these statements are not guaranteed to occur. Investors should not place undue reliance upon forward-looking statements. For further discussion of the factors that could affect outcomes, please refer to the Risk Factors section of the Companys Annual Report on Form 10-K for the fiscal year ended December 31, 2023. RMBS Valuation Characteristics ($ in thousands) Realized Realized Dec-23 - Feb-24 Feb-24 Net Weighted CPR CPR Weighted Average (1-Month) (3-Month) Modeled Interest Current Fair % of Current Average Maturity (Reported (Reported Rate Sensitivity (1) Type Face Value Portfolio Price Coupon GWAC Age (Months) in Mar) in Mar) (-50 BPS) (+50 BPS) Fixed Rate RMBS 15yr 5.0 TBA $ 50,000 $ 49,695 1.25 % 99.39 5.00 % 5.80 % 9 166 n/a n/a $ 648 $ (749 ) 15yr 5.5 TBA 50,000 50,137 1.26 % 100.27 5.50 % 6.26 % 8 167 n/a n/a 534 (646 ) 15yr Total 100,000 99,832 2.51 % 99.83 5.25 % 6.03 % 9 167 n/a n/a 1,182 (1,395 ) 30yr 3.0 1,379,958 1,195,575 30.07 % 86.64 3.00 % 3.46 % 35 319 6.3 % 5.1 % 37,519 (37,915 ) 30yr 3.5 191,733 173,898 4.37 % 90.70 3.50 % 4.04 % 48 301 6.0 % 5.8 % 4,909 (4,962 ) 30yr 4.0 558,154 515,043 12.96 % 92.28 4.00 % 4.78 % 25 332 2.7 % 2.3 % 13,385 (14,249 ) 30yr 4.5 336,108 319,163 8.03 % 94.96 4.50 % 5.45 % 20 338 7.4 % 6.2 % 6,670 (7,308 ) 30yr 5.0 547,247 531,880 13.38 % 97.19 5.00 % 5.93 % 18 339 3.4 % 3.8 % 10,510 (11,802 ) 30yr 5.5 269,605 268,567 6.76 % 99.61 5.50 % 6.43 % 11 347 5.1 % 3.5 % 4,609 (5,389 ) 30yr 6.0 438,333 441,729 11.11 % 100.77 6.00 % 7.00 % 9 348 5.4 % 8.6 % 5,722 (6,991 ) 30yr 6.5 328,935 335,782 8.45 % 102.08 6.50 % 7.39 % 7 350 10.9 % 8.7 % 3,200 (4,137 ) 30yr 7.0 74,392 76,799 1.93 % 103.23 7.00 % 7.94 % 5 351 2.4 % 4.5 % 564 (750 ) 30yr Total 4,124,465 3,858,436 97.05 % 93.55 4.38 % 5.12 % 24 332 5.6 % 5.1 % 87,088 (93,503 ) Total Pass Through RMBS 4,224,465 3,958,268 99.57 % 93.70 4.40 % 5.14 % 23 328 5.6 % 5.1 % 88,270 (94,898 ) Structured RMBS IO 20yr 4.0 8,456 866 0.02 % 10.24 4.00 % 4.57 % 146 87 10.0 % 10.2 % 5 (4 ) IO 30yr 3.0 2,876 345 0.01 % 11.99 3.00 % 3.63 % 109 241 24.3 % 9.4 % - (1 ) IO 30yr 4.0 79,341 14,790 0.37 % 18.64 4.00 % 4.60 % 114 237 6.2 % 8.4 % (205 ) 155 IO 30yr 4.5 3,412 636 0.02 % 18.65 4.50 % 4.99 % 164 182 4.4 % 5.5 % (2 ) - IO 30yr 5.0 1,859 372 0.01 % 20.01 5.00 % 5.36 % 164 184 3.7 % 5.0 % (4 ) 2 IO Total 95,944 17,009 0.43 % 17.73 4.01 % 4.60 % 119 221 7.0 % 8.5 % (206 ) 152 IIO 30yr 4.0 25,989 279 0.01 % 1.08 0.00 % 4.40 % 77 271 7.6 % 7.0 % 89 (73 ) Total Structured RMBS 121,933 17,288 0.43 % 14.18 3.15 % 4.55 % 110 231 7.1 % 8.1 % (117 ) 79 Total Mortgage Assets $ 4,346,398 $ 3,975,556 100.00 % 4.37 % 5.12 % 26 326 5.7 % 5.2 % $ 88,153 $ (94,819 ) Average Hedge Modeled Interest Notional Period Rate Sensitivity (1) Hedge Balance End (-50 BPS) (+50 BPS) 3-Month SOFR Futures $ (100,000 ) Mar-26 $ (875 ) $ 875 5-Year Treasury Future(2) (491,500 ) Jun-24 (10,050 ) 9,743 10-Year Treasury Future(3) (320,000 ) Jun-24 (10,365 ) 10,016 Swaps (2,531,800 ) Dec-29 (62,894 ) 60,682 TBA (370,700 ) Mar-24 (8,955 ) 9,587 Swaptions (800,000 ) May-24 (130 ) 936 Hedge Total $ (4,614,000 ) $ (93,269 ) $ 91,839 Rate Shock Grand Total $ (5,116 ) $ (2,980 ) (1) Modeled results from Citigroup Global Markets Inc. Yield Book. Interest rate shocks assume instantaneous parallel shifts and horizon prices are calculated assuming constant SOFR option-adjusted spreads. These results are for illustrative purposes only and actual results may differ materially. (2) Five-year Treasury futures contracts were valued at prices of $106.91 at March 13, 2024. The market value of the short position was $525.5 million. (3) Ten-year Treasury futures contracts were valued at prices of $110.44 at March 13, 2024. The market value of the short position was $353.4 million. RMBS Assets by Agency ($ in thousands) Percentage Fair of Asset Category Value Portfolio As of February 29, 2024 Fannie Mae $ 2,815,792 70.8 % Freddie Mac 1,159,764 29.2 % Total Mortgage Assets $ 3,975,556 100.0 % Investment Company Act of 1940 Whole Pool Test ($ in thousands) Percentage Fair of Asset Category Value Portfolio As of February 29, 2024 Non-Whole Pool Assets $ 138,580 3.5 % Whole Pool Assets 3,836,976 96.5 % Total Mortgage Assets $ 3,975,556 100.0 % Borrowings By Counterparty ($ in thousands) Weighted Weighted % of Average Average Total Total Repo Maturity Longest As of February 29, 2024 Borrowings Debt Rate in Days Maturity RBC Capital Markets, LLC $ 290,394 7.8 % 5.47 % 13 3/13/2024 ASL Capital Markets Inc. 266,916 7.1 % 5.45 % 44 7/15/2024 J.P. Morgan Securities LLC 257,401 6.9 % 5.46 % 20 3/20/2024 Mitsubishi UFJ Securities (USA), Inc 254,957 6.8 % 5.48 % 23 4/1/2024 Cantor Fitzgerald & Co 250,237 6.7 % 5.46 % 13 3/13/2024 Citigroup Global Markets Inc 242,522 6.5 % 5.45 % 26 3/26/2024 ABN AMRO Bank N.V. 227,266 6.1 % 5.47 % 26 4/15/2024 Wells Fargo Bank, N.A. 206,994 5.5 % 5.47 % 25 3/25/2024 Mirae Asset Securities (USA) Inc. 193,807 5.2 % 5.46 % 46 4/22/2024 Merrill Lynch, Pierce, Fenner & Smith 190,974 5.1 % 5.48 % 15 3/27/2024 Daiwa Securities America Inc. 175,179 4.7 % 5.47 % 55 4/24/2024 Bank of Montreal 166,942 4.5 % 5.49 % 13 3/13/2024 StoneX Financial Inc. 163,248 4.4 % 5.46 % 47 4/16/2024 Marex Capital Markets Inc. 158,597 4.2 % 5.48 % 33 4/26/2024 Goldman, Sachs & Co 154,577 4.1 % 5.45 % 19 3/28/2024 Banco Santander SA 152,076 4.1 % 5.51 % 29 4/15/2024 ING Financial Markets LLC 130,630 3.5 % 5.48 % 21 3/21/2024 DV Securities, LLC Repo 112,001 3.0 % 5.46 % 71 5/14/2024 South Street Securities, LLC 103,491 2.8 % 5.46 % 39 5/13/2024 Clear Street LLC 19,000 0.5 % 5.45 % 60 4/29/2024 Lucid Cash Fund USG LLC 17,745 0.5 % 5.46 % 14 3/14/2024 Total Borrowings $ 3,734,954 100.0 % 5.47 % 29 7/15/2024 View source version on businesswire.com: https://www.businesswire.com/news/home/20240313204503/en/ Orchid Island Capital, Inc. Robert E. Cauley Telephone: (772) 231-1400 Source: Orchid Island Capital, Inc. What is the dividend amount declared by Orchid Island Capital, Inc. (ORC) for March 2024? Orchid Island Capital, Inc. (ORC) declared a monthly cash dividend of $0.12 per share for March 2024. When will the dividend for March 2024 be paid to shareholders of Orchid Island Capital, Inc. (ORC)? The dividend for March 2024 will be paid on April 26, 2024, to holders of record as of March 28, 2024, with an ex-dividend date of March 27, 2024. What is the purpose of Orchid Island Capital, Inc. (ORC) announcing monthly dividends? Orchid Island Capital, Inc. (ORC) intends to make regular monthly cash distributions to its holders of common stock to maintain its REIT status. How does Orchid Island Capital, Inc. (ORC) ensure compliance with REIT regulations regarding dividend distributions? Orchid Island Capital, Inc. (ORC) aims to distribute at least 90% of its REIT taxable income annually to stockholders to meet REIT requirements. What are the implications for Orchid Island Capital, Inc. (ORC) if it fails to distribute the required taxable income to stockholders? Failure to distribute the required taxable income may subject Orchid Island Capital, Inc. (ORC) to income tax and excise tax penalties. How many shares of common stock did Orchid Island Capital, Inc. (ORC) have outstanding as of March 13, 2024? As of March 13, 2024, Orchid Island Capital, Inc. (ORC) had 51,358,301 shares of common stock outstanding. What are some characteristics of Orchid Island Capital, Inc. (ORC)'s RMBS portfolio as of February 29, 2024? Orchid Island Capital, Inc. (ORC) provided details on RMBS valuation, assets by agency, investment company act compliance, repurchase agreement exposure, and risk measures in their portfolio as of February 29, 2024."
OPAL Fuels Reports Fourth Quarter and Full Year 2023 Results,2024-03-13T21:00:00.000Z,Neutral,Neutral,"OPAL Fuels Inc. announces strong financial and operational results for the fourth quarter and full year 2023, with revenue reaching $256.1 million, up 9% year-over-year. The company's net income stood at $127.0 million for the year. Adjusted EBITDA was $52.0 million for the year. OPAL Fuels continues to expand its RNG production and fueling station network, with strategic initiatives in place for future growth.","OPAL Fuels Reports Fourth Quarter and Full Year 2023 Results Rhea-AI Impact (Neutral) Rhea-AI Sentiment (Neutral) Tags earnings Rhea-AI Summary OPAL Fuels Inc. announces strong financial and operational results for the fourth quarter and full year 2023, with revenue reaching $256.1 million, up 9% year-over-year. The company's net income stood at $127.0 million for the year. Adjusted EBITDA was $52.0 million for the year. OPAL Fuels continues to expand its RNG production and fueling station network, with strategic initiatives in place for future growth. Positive Revenue for OPAL Fuels in 2023 reached $256.1 million, a 9% increase from the previous year. Net income for the company in 2023 was $127.0 million. Adjusted EBITDA for 2023 stood at $52.0 million. OPAL Fuels doubled its RNG production over the last two years and expanded its fueling station network. The company anticipates ending 2024 with 8.8 million MMBtu of RNG capacity online. OPAL Fuels expects Adjusted EBITDA for 2024 to range between $90 million and $100 million. The company's liquidity as of December 31, 2023, was $347.8 million, with sufficient funding to meet existing needs. Negative None. Financial Analyst OPAL Fuels Inc. has reported a substantial year-over-year revenue increase of 30% for the quarter and 9% for the full year, indicating a positive trend in the company's financial performance. The net income shows a significant increase for the annual figure, rising from $32.6 million to $127.0 million, which could be attributed to the company's operational efficiency and strategic initiatives, including the closing of a $500 million credit facility. However, there is a notable decrease in quarterly net income from $32.0 million to $20.1 million, which warrants further analysis to understand the underlying factors.The company's Adjusted EBITDA also presents a mixed picture, increasing for the quarter but showing a slight decline on an annual basis. This metric is crucial for investors as it provides insight into the company's operating profitability by excluding non-operating expenses and revenue. The RNG Pending Monetization amount of $18.5 million suggests that the company has a significant volume of RNG that is produced but not yet sold, which could impact future revenue streams.Considering the capital expenditure of approximately $230 million planned for 2024, it is essential to evaluate the company's liquidity position. With $347.8 million in liquidity, OPAL Fuels appears well-positioned to fund its upcoming projects. The anticipated growth in the Fuel Station Services segment by 75%-90% could be a key driver for future revenue, provided the company successfully navigates the challenges in the RNG market. Market Research Analyst The renewable energy sector, particularly the RNG market, is experiencing strong tailwinds due to increased policy support and demand. OPAL Fuels' strategic focus on expanding its RNG production capacity and fueling station network is well-aligned with industry trends. The company's projection of ending the year with 8.8 million MMBtu of RNG capacity online indicates an aggressive growth strategy that could capture a larger market share.Moreover, the company's vertical integration allows for better control over the supply chain, potentially leading to cost efficiencies and competitive advantages. The growth in the volume of RNG sold as transportation fuel by 44% and 49% for the three and twelve months, respectively, reflects the increasing demand for cleaner fuel alternatives in the heavy-duty fleet sector.Investors should note the company's guidance for 2024, which forecasts an Adjusted EBITDA range between $90 million and $100 million. This guidance, along with the expected growth in RNG production, provides a promising outlook. However, external factors such as the price volatility of environmental attributes like D3 RINs and LCFS credits and natural gas prices will play a crucial role in the company's performance. Energy Sector Analyst The report highlights OPAL Fuels' commitment to increasing its design capacity for RNG production, which is essential for meeting the rising demand for low carbon intensity energy products. The company's operational highlights, including the anticipated commencement of commercial operations for multiple projects, suggest a strategic expansion in line with the global shift towards renewable energy sources.The dispute with the Engineering, Procurement and Construction contractor over change order requests for two dairy projects in California may pose risks to project timelines and cost overruns. It is crucial for stakeholders to monitor such developments closely, as they could impact future earnings and operational efficiency.It's also important to consider the company's focus on renewable power projects. The Fall River project, with 2.4 MW of renewable power nameplate capacity, diversifies the company's product offerings and may provide additional revenue streams. The industry-specific terms such as GGEs, MMBtu and utilization rates are critical for understanding the company's operational capacity and efficiency. For instance, the utilization rates of inlet gas reflect the efficiency of converting feedstock biogas into RNG, which is a key performance indicator in the RNG sector. 03/13/2024 - 05:00 PM WHITE PLAINS, N.Y.--(BUSINESS WIRE)-- OPAL Fuels Inc. (OPAL Fuels or the Company) (Nasdaq: OPAL), a vertically integrated leader in the capture and conversion of biogas into low carbon intensity renewable natural gas (RNG) and renewable electricity, today announced financial and operating results for the three and twelve months ended December 31, 2023. OPAL Fuels continues to progress on its strategic and operational goals, said Co-CEO Jonathan Maurer. Over the last two years, we have more than doubled RNG production and significantly expanded our fueling station network while continuing to organically grow our project pipeline with industry leading partners. We are pleased with our results as we leverage the benefits of our vertically integrated platform. Fourth quarter and full year 2023 financial and operational results were in-line with our most recent guidance, said Maurer. These results, coupled with achieving strategic initiatives such as closing on our $500 million credit facility and advancing industry partnerships, put us in a position to capitalize on favorable industry fundamentals in 2024. We now have 5.2 million MMBtu of annual design capacity online at eight RNG facilities. We anticipate ending the year with 8.8 million MMBtu of RNG capacity online, adding 3.6 million MMBtu in 2024 as Prince William, Sapphire and Polk County (Florida) projects begin operations. We also anticipate bringing online 2.4 MW of renewable power nameplate capacity (0.2 million MMBtu of biomethane equivalent per year) as our Fall River project commences operations in the fourth quarter. Further, we expect several additional RNG projects to enter construction this year and see increasing momentum in Fuel Station Services, supporting growth beyond 2024. The tailwinds from the capture and conversion of biogas into low carbon intensity energy products that replace fossil fuels continue to be strong. Constructive domestic and international policy support continues to broaden, and demand for RNG is increasing as positive feedback continues from heavy duty fleets testing RNG, said Co-CEO Adam Comora. Our business model is designed to position us to take advantage of these tailwinds and drive growth. Financial Highlights Revenue for the three and twelve months ended December 31, 2023, was $87.0 million and $256.1 million, respectively, up 30% and 9%, compared to same periods last year. Net income for the three and twelve months ended December 31, 2023, was $20.1 million and $127.0 million, respectively, compared to $32.0 million and $32.6 million, in the comparable periods last year. Basic net earnings per share attributable to Class A common shareholders for the three and twelve months ended December 31, 2023, was $0.11 and $0.70, respectively compared to $0.18 and $0.13 in the comparable periods last year. Adjusted EBITDA1 for the three and twelve months ended December 31, 2023, was $32.0 million and $52.0 million, respectively, compared to $20.4 million and $53.4 million in comparable periods last year. At December 31, 2023, RNG Pending Monetization totaled $18.5 million. Operational Highlights We exited 2023 with an aggregate annual design capacity of our operating RNG projects of 5.2 million MMBtu.2,3 RNG produced was 0.8 million and 2.7 million MMBtu, for the three and twelve months ended December 31, 2023, an increase of 33% and 23% compared to the prior-year periods. RNG sold as transportation fuel was 13.5 million and 43.8 million GGEs, respectively, for the three and twelve months ended December 31, 2023, an increase of 44% and 49% compared to the prior-year periods. The Fuel Station Services segment sold, dispensed, and serviced an aggregate of 35.3 million and 133.2 million GGEs of transportation fuel for the three and twelve months ended December 31, 2023, an increase of 8% and 15% compared to the prior-year periods. ____________________________ 1 This is a non-GAAP measure. A reconciliation of non-GAAP financial measure to comparable GAAP measure has been provided in the financial tables included in this press release. An explanation of this measure and how it is calculated is also included below under the heading Non-GAAP Financial Measures."" 2 Design capacity is the annual design output for each facility and may not reflect actual production from the projects, which depends on many variables including, but not limited to, quantity and quality of the biogas, operational up-time of the facility, and actual productivity of the facility. 3 Represents OPAL Fuels' proportional share with respect to RNG projects owned with joint venture partners. Construction Update The Prince William RNG project is mechanically complete and in commissioning. The project will commence commercial operations in the coming weeks. This project, owned 100% by OPAL Fuels, represents approximately 1.7 million MMBtu of annual design capacity. We anticipate commencing commercial operations at our Sapphire RNG project in the third quarter of 2024. This project represents approximately 0.8 million MMBtu for OPAL Fuels 50% ownership share of annual design capacity. We expect the Polk County (Florida) RNG project to commence commercial operations in the fourth quarter of 2024. This project, owned 100% by OPAL Fuels, represents approximately 1.1 million MMBtu of annual design capacity. Completion of construction at two dairy projects in California (Hilltop and Vander Schaaf) has been delayed due to a dispute with the Engineering, Procurement and Construction contractor over a series of change order requests.4 The Atlantic RNG project is expected to commence commercial operations in mid-2025. This project represents approximately 0.3 million MMBtu for OPAL Fuels 50% ownership share of annual design capacity. The Fall River project is a renewable power project that is expected to commence operations at the end of 2024. This project represents 2.4 MW of renewable power nameplate capacity (0.2 million MMBtus of biomethane equivalent per year) and is 100% owned by OPAL Fuels. ____________________________________________ 4 For more information, please see the Companys Annual Report on Form 10-K for the twelve months ended December 31, 2023. 2024 Guidance The Company currently estimates that Adjusted EBITDA for the full year 2024 will range between $90 million and $100 million. Adjusted EBITDA does not include: Approximately $40 million of potential ITC cash proceeds from Emerald and the three landfill RNG projects coming online this year, which would be included in net income in 2024; An increase of approximately $15 million from RNG pending monetization in 2024, which represents the time lag between the recognition of RNG production costs compared with the associated revenues; and An adjustment for development and project start up expenses5 of approximately $12 million in 2024, which is predominantly the Prince William virtual pipeline expense. We anticipate Adjusted EBITDA from our Fuel Station Services segment to grow by 75%-90% compared to 2023. We expect 2024 RNG production to range from 4.4 to 4.8 million MMBtu. We expect full year 2024 capital expenditures at wholly-owned and joint venture projects to total approximately $230 million. This total includes approximately $28 million for Fuel Station Services and $41 million relating to equity method investments in RNG projects. We anticipate putting into construction at least 2.0 million annual MMBtu of RNG design capacity in 2024 which is included in our 2024 capital expenditure guidance. 2024 guidance assumes a weighted average annual price for D3 RINs of approximately $3.0/gallon, natural gas price of $2.00/MMBtu, and an LCFS credit price of $65.0/metric ton. ___________________ 5Project development and start up expenses will be presented as a separate line item on the Income Statement in 2024. Results of Operations ($ thousands of dollars) Three Months Ended December 31, Twelve Months Ended December 31, (Unaudited) (Unaudited) 2023 2022 2023 2022 Revenue RNG Fuel $ 28,824 $ 24,343 $ 66,292 $ 73,158 Fuel Station Services 46,923 30,039 135,012 117,415 Renewable Power 11,261 12,335 54,804 44,958 Total Revenue $ 87,008 $ 66,717 $ 256,108 $ 235,531 Net income $ 20,093 $ 32,019 $ 127,024 $ 32,579 Adjusted EBITDA (1) RNG Fuel 23,280 14,791 48,703 43,374 Fuel Station Services 12,034 7,235 22,847 21,603 Renewable Power 3,865 8,155 26,132 22,221 Corporate (7,160 ) (9,803 ) (45,732 ) (33,797 ) Consolidated Adjusted EBITDA (1) $ 32,019 $ 20,378 $ 51,950 $ 53,401 RNG Fuel volume produced (Million MMBtus) 0.8 0.6 2.7 2.2 RNG Fuel volume sold (Million GGEs) 13.5 9.4 43.8 29.4 Total volume delivered (Million GGEs) 35.3 32.8 133.2 115.9 (1) This is a non-GAAP measure. A reconciliation of non-GAAP financial measure to comparable GAAP measure has been provided in the financial tables included in this press release. An explanation of this measure and how it is calculated is also included below under the heading Non-GAAP Financial Measures."" Landfill RNG Facility Capacity and Utilization Summary Three Months Ended December 31, Twelve Months Ended December 31, 2023 2022 2023 2022 Landfill RNG Facility Capacity and Utilization(1)(2)(3)(4) Design Capacity (Million MMBtus) 1.3 0.9 4.1 3.2 Volume of Inlet Gas (Million MMBtus) 1.0 0.7 3.2 2.4 Inlet Design Capacity Utilization % 80 % 75 % 78 % 75 % RNG Fuel volume produced (Million MMBtus) 0.7 0.6 2.6 2.0 Utilization of Inlet Gas % 79 % 84 % 83 % 86 % (1) Design Capacity for RNG facilities is measured as the volume of feedstock biogas that the facility is capable of accepting at the inlet and processing during the associated period. Design Capacity is presented as OPALs ownership share (i.e., net of joint venture partners ownership) of the facility and is calculated based on the number of days in the period. New facilities that come online during a quarter are pro-rated for the number of days in commercial operation. (2) Inlet Design Capacity Utilization is measured as the Volume of Inlet Gas for a period, divided by the total Design Capacity for such period. The Volume of Inlet Gas varies over time depending on, among other factors, (i) the quantity and quality of waste deposited at the landfill, (ii) waste management practices by the landfill, and (iii) the construction, operations and maintenance of the landfill gas collection system used to recover the landfill gas. The Design Capacity for each facility will typically be correlated to the amount of landfill gas expected to be generated by the landfill during the term of the related gas rights agreement. The Company expects Inlet Design Capacity Utilization to be in the range of 75-85% on an aggregate basis over the next several years. Typically, newer facilities perform at the lower end of this range and demonstrate increasing utilization as they mature and the biogas resource increases at open landfills. (3) Utilization of Inlet Gas is measured as RNG Fuel Volume Produced divided by the Volume of Inlet Gas. Utilization of Inlet Gas varies over time depending on availability and efficiency of the facility and the quality of landfill gas (i.e., concentrations of methane, oxygen, nitrogen, and other gases). The Company generally expects Utilization of Inlet Gas to be in the range of 80% to 90%. (4) Data not available for the Company's dairy projects, i.e., Sunoma and Biotown. Total RNG fuel design capacity for the three and twelve months ended December 31, 2023 is 1.3 million MMBtu and 4.3 million MMBtu, respectively. Including Sunoma and Biotown, RNG fuel volume produced is 0.8 and 2.7 million MMBtu for the three and twelve months ended December 31, 2023, respectively. RNG Pending Monetization Summary Three Months Ended (In 000's) December 31, 2023 RNG Fuel Fuel Station Services Total Stored Gas Metrics (1) Beginning balance Stored RNG as of September 30, 2023 264 54 318 Add: RNG production (MMBtus) 776 57 833 Less: Current period RNG volumes dispensed (804 ) (53 ) (857 ) Ending Balance Stored RNG (MMBtus) as of December 31, 2023 236 58 294 Value of ending balance Stored RNG using quarter end price (1) (2) $ 12,127 $ 6,101 $ 18,228 RIN Metrics Beginning balance as of September 30, 2023 3,854 1,132 4,986 Add: Generated in current period 8,343 2,134 10,477 Less: Sales (12,197 ) (3,244 ) (15,441 ) Ending RIN credit balance (Available for sale) as of December 31, 2023  22 22 D3 price per RIN at quarter end $ 3.18 $ 3.18 $ 3.18 Value of RINs using quarter end price (2) $  $ 70 $ 70 LCFS Metrics Beginning balance (net share) as of September 30, 2023  73 73 Add: Generated in current period 5 30 35 Less: Sales (5 ) (102 ) (107 ) Ending LCFS credit balance (Available for sale) as of December 31, 2023  1 1 LCFS credit price at quarter end $  $ 103.40 $ 103.40 Value of LCFSs using quarter end price (2) $  $ 103 $ 103 Value of RECs using quarter end price   $ 57 Other Metrics Average realized sales price - RIN   $ 2.83 Average realized sales price - LCFS   $ 72.30 Total Value of RNG Pending Monetization at quarter end $ 12,127 $ 6,274 $ 18,458 (1) Reflects OPALs ownership share of Stored RNG (i.e., net of joint venture partners ownership) including equity method investments (2) Reflects OPALs ownership share of RIN and LCFS credits (i.e., net of joint venture partners ownership) including equity method investments and presented net of discounts and any direct transaction costs such as dispensing fees, third-party royalties and transaction costs as applicable. Liquidity As of December 31, 2023, we have drawn approximately $186.6 million, and utilized $13.8 million of our revolver availability to issue letters of credit, under the $500 million senior secured credit facility we entered into in September 2023. As of December 31, 2023, our liquidity was $347.8 million, consisting of $299.6 million of availability under the above referenced credit facility, and $48.2 million of cash, cash equivalents, and short-term investments. We believe our liquidity and anticipated cash flows from operations are sufficient to meet our existing funding needs. Capital Expenditures During the twelve months ended December 31, 2023, OPAL Fuels invested $113.8 million across RNG projects in construction and OPAL Fuels proprietary fueling stations in construction as compared to $131.4 million in the prior year. In addition, for the twelve months ended December 31, 2023, the Company's portion of capital expenditures in unconsolidated entities was $20.6 million. This represents our share of capital expenditures incurred by Paragon for the Emerald and Sapphire projects post deconsolidation. Earnings Call A webcast to review OPAL Fuels Fourth Quarter and Full Year 2023 results is being held tomorrow, March 14, 2024 at 11:00AM EDT. Materials to be discussed in the webcast will be available before the call on the Company's website. Participants may access the call at https://edge.media-server.com/mmc/p/igoxez25. Investors can also listen to a webcast of the presentation on the companys Investor Relations website at https://investors.opalfuels.com/news-events/events-presentations. _____________________ Glossary of terms Environmental Attributes refer to federal, state, and local government incentives in the United States, provided in the form of Renewable Identification Numbers, Renewable Energy Credits, Low Carbon Fuel Standard credits, rebates, tax credits and other incentives to end users, distributors, system integrators and manufacturers of renewable energy projects that promote the use of renewable energy. GGE refers to Gasoline gallon equivalent. The conversion ratio is 1MMBtu of natural gas equal to 7.74 GGE. LFG refers to landfill gas. MMBtu refers to British thermal units. Renewable Power refers to electricity generated from renewable sources. RNG refers to renewable natural gas. D3 refers to cellulosic biofuel with a 60% GHG reduction requirement. RIN refers to Renewal Identification Numbers. EPA refers to Environmental Protection Agency. About OPAL Fuels Inc. OPAL Fuels Inc. (Nasdaq: OPAL) is a leader in the capture and conversion of biogas into low carbon intensity renewable electricity and renewable natural gas (RNG). OPAL Fuels is also a leader in the marketing and distribution of RNG to heavy duty trucking and other hard to de-carbonize industrial sectors. RNG is chemically identical to the natural gas Americans use to cook with, heat homes, and fuel natural gas engines, with one significant difference: RNG is produced by recycling harmful methane emissions created by decaying organic waste as opposed to fossil natural gas which is pumped from the ground. For additional information please visit www.opalfuels.com. Forward-Looking Statements Certain statements in this communication may be considered forward-looking statements within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Forward-looking statements are statements that are not historical facts and generally relate to future events or OPAL Fuels (the Company) future financial or other performance metrics. In some cases, you can identify forward-looking statements by terminology such as believe, may, will, potentially, estimate, continue, anticipate, intend, could, would, project, target, plan, expect, or the negatives of these terms or variations of them or similar terminology. Such forward-looking statements are subject to risks and uncertainties, which could cause actual results to differ materially from those expressed or implied by such forward-looking statements. New risks and uncertainties may emerge from time to time, and it is not possible to predict all risks and uncertainties. These forward-looking statements are based upon estimates and assumptions that, while considered reasonable by the Company and its management, as the case may be, are inherently uncertain and subject to material change. Factors that may cause actual results to differ materially from current expectations include various factors beyond managements control, including but not limited to general economic conditions and other risks, uncertainties and factors set forth in the sections entitled Risk Factors and Cautionary Statement Regarding Forward-Looking Statements in the Company's annual report on Form 10K filed on March 29, 2023, and other filings the Company makes with the Securities and Exchange Commission. Nothing in this communication should be regarded as a representation by any person that the forward-looking statements set forth herein will be achieved or that any of the contemplated results of such forward-looking statements will be achieved. You should not place undue reliance on forward-looking statements in this communication, which speak only as of the date they are made and are qualified in their entirety by reference to the cautionary statements herein. The Company expressly disclaims any obligations or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in the Companys expectations with respect thereto or any change in events, conditions, or circumstances on which any statement is based. Disclaimer This communication is for informational purposes only and is neither an offer to purchase, nor a solicitation of an offer to sell, subscribe for or buy, any securities, nor shall there be any sale, issuance or transfer or securities in any jurisdiction in contravention of applicable law. No offer of securities shall be made except by means of a prospectus meeting the requirements of Section 10 of the Securities Act of 1933, as amended. OPAL FUELS INC. CONSOLIDATED BALANCE SHEETS (In thousands of U.S. dollars, except per share data) December 31, 2023 December 31, 2022 Assets Current assets: Cash and cash equivalents (includes $166 and $12,506 at December 31, 2023 and December 31, 2022, respectively, related to consolidated VIEs) $ 38,348 $ 40,394 Accounts receivable, net (includes $33 and $966 at December 31, 2023 and December 31, 2022, respectively, related to consolidated VIEs) 27,623 31,083 Accounts receivable, related party 18,696 12,421 Restricted cash - current (includes $4,395 and $6,971 at December 31, 2023 and December 31, 2022, respectively, related to consolidated VIEs) 4,395 32,402 Short term investments 9,875 64,976 Fuel tax credits receivable 5,345 4,144 Contract assets 6,790 9,771 Parts inventory (includes $29 and $ at December 31, 2023 and December 31, 2022, respectively, related to consolidated VIEs) 10,191 7,311 Environmental credits held for sale 172 1,674 Prepaid expense and other current assets (includes $107 and $415 at December 31, 2023 and December 31, 2022, respectively, related to consolidated VIEs) 6,005 7,625 Derivative financial assets, current portion 633 182 Total current assets 128,073 211,983 Capital spares 3,468 3,443 Property, plant, and equipment, net (includes $26,626 and $73,140 at December 31, 2023 and December 31, 2022, respectively, related to consolidated VIEs) 339,493 297,323 Operating right-of use assets 12,301 11,744 Investment in other entities 207,099 51,765 Note receivable - variable fee component 2,302 1,942 Derivative financial assets, non-current portion  954 Deferred financing costs  3,013 Other long-term assets 1,162 1,489 Intangible assets, net 1,604 2,167 Restricted cash - non-current (includes $1,850 and $2,923 at December 31, 2023 and December 31, 2022, respectively, related to consolidated VIEs) 4,499 4,425 Goodwill 54,608 54,608 Total assets $ 754,609 $ 644,856 Liabilities and Equity Current liabilities: Accounts payable (includes $744 and $4,896 at December 31, 2023 and December 31, 2022, respectively, related to consolidated VIEs) 13,401 17,649 Accounts payable, related party (includes $1,046 and $433 at December 31, 2023 and December 31, 2022, respectively, related to consolidated VIEs) 7,024 6,376 Fuel tax credits payable 4,558 3,320 Accrued payroll 9,023 8,979 Accrued capital expenses (includes $0 and $7,821 at December 31, 2023 and December 31, 2022, respectively, related to consolidated VIEs) 15,128 11,922 Accrued expenses and other current liabilities (includes $647 and $646 at December 31, 2023 and December 31, 2022, respectively, related to consolidated VIEs) 14,745 9,573 Contract liabilities 6,314 8,013 Senior Secured Credit Facility - term loan, current portion, net of debt issuance costs  15,250 Senior Secured Credit Facility - working capital facility, current portion  7,500 OPAL Term Loan, current portion  27,732 Sunoma loan, current portion (includes $1,608 and $380 at December 31, 2023 and December 31, 2022, respectively, related to consolidated VIEs) 1,608 380 Convertible Note Payable  28,528 Municipality Loan  76 Derivative financial liability, current portion  4,596 Operating lease liabilities - current portion 638 630 Other current liabilities (includes $92 and $ at December 31, 2023 and December 31, 2022, respectively, related to consolidated VIEs) 92 1,085 Asset retirement obligation, current portion 3,860 1,296 Total current liabilities 76,391 152,905 Asset retirement obligation, non-current portion 2,868 4,960 OPAL Term Loan, net of debt issuance costs 176,532 66,600 Sunoma loan, net of debt issuance costs (includes $20,010 and $21,712 at December 31, 2023 and December 31, 2022, respectively, related to consolidated VIEs) 20,010 21,712 Operating lease liabilities - non-current portion 11,824 11,245 Earn out liabilities 1,900 8,790 Other long-term liabilities (includes $211 and $ at December 31, 2023 and December 31, 2022, respectively, related to consolidated VIEs) 7,599 825 Total liabilities 297,124 267,037 Commitments and contingencies Redeemable preferred non-controlling interests 132,617 138,142 Redeemable non-controlling interests 802,720 1,013,833 Stockholders' (deficit) equity Class A common stock, $0.0001 par value, 340,000,000 shares authorized as of December 31, 2023; 29,701,146 and 29,477,766 shares, issued and outstanding at December 31, 2023 and December 31, 2022, respectively 3 3 Class B common stock, $0.0001 par value, 160,000,000 shares authorized as of December 31, 2023; None issued and outstanding as of December 31, 2023 and December 31, 2022   Class C common stock, $0.0001 par value, 160,000,000 shares authorized as of December 31, 2023; None issued and outstanding as of December 31, 2023 and December 31, 2022   Class D common stock, $0.0001 par value, 160,000,000 shares authorized as of December 31, 2023; 144,399,037 issued and outstanding at December 31, 2023 and December 31, 2022 14 14 Additional paid-in capital   Accumulated deficit (467,195 ) (800,813 ) Accumulated other comprehensive (loss) income (15 ) 195 Class A common stock in treasury, at cost; 1,635,783 and  shares at December 31, 2023 and December 31, 2022, respectively (11,614 )  Total Stockholders' (deficit) equity attributable to the Company (478,807 ) (800,601 ) Non-redeemable non-controlling interests 955 26,445 Total Stockholders' (deficit) equity (477,852 ) (774,156 ) Total liabilities, Redeemable preferred, Redeemable non-controlling interests and Stockholders' (deficit) equity $ 754,609 $ 644,856 OPAL FUELS INC. CONSOLIDATED STATEMENTS OF OPERATIONS (In thousands of U.S. dollars, except per unit data) Twelve Months Ended December 31, 2023 2022 Revenues: RNG fuel (includes revenues from related party of $56,069 and $58,185 for the years ended December 31, 2023 and 2022, respectively) $ 66,292 $ 73,158 Fuel station services (includes revenues from related party of $28,468 and $18,735 for the years ended December 31, 2023 and 2022, respectively) 135,012 117,415 Renewable Power (includes revenues from related party of $6,614 and $5,495 for the years ended December 31, 2023 and 2022, respectively) 54,804 44,958 Total revenues 256,108 235,531 Operating expenses: Cost of sales - RNG fuel 32,028 32,367 Cost of sales - Fuel station services 115,322 98,845 Cost of sales - Renewable Power 36,550 31,580 Project development and start up costs 4,866 6,438 Selling, general, and administrative 51,262 51,386 Depreciation, amortization, and accretion 14,565 13,136 Income from equity method investments (5,525 ) (5,784 ) Total expenses 249,068 227,968 Operating income 7,040 7,563 Interest and financing expense, net (9,306 ) (6,640 ) Change in fair value of derivative instruments, net 7,346 33,081 Other income 124,472 1,943 Loss on debt extinguishment (2,190 )  Loss on warrant exchange (338 ) (3,368 ) Income before provision for income taxes 127,024 32,579 Provision for income taxes   Net income 127,024 32,579 Net income attributable to redeemable non-controlling interests 97,426 22,409 Net loss attributable to non-redeemable non-controlling interests (349 ) (1,153 ) Dividends on Redeemable preferred non-controlling interests (1) 11,011 7,932 Net income attributable to Class A common stockholders $ 18,936 $ 3,391 Weighted average shares outstanding of Class A common stock : Basic 27,148,538 25,774,312 Diluted 27,494,016 26,062,398 Per share amounts: Basic $ 0.70 $ 0.13 Diluted $ 0.69 $ 0.12 OPAL FUELS INC. CONSOLIDATED STATEMENTS OF CASH FLOWS In thousands of U.S. dollars) Twelve Months Ended December 31, 2023 2022 Cash flows from operating activities: Net income $ 127,024 $ 32,579 Adjustments to reconcile net income to net cash provided by (used in) operating activities: Income from equity method investments (5,525 ) (5,784 ) Distributions from equity method investments 12,242  Loss on exchange of Warrants 338 3,368 Depreciation and amortization 14,043 13,015 Amortization of deferred financing costs 1,720 1,943 Amortization of operating lease right-of-use assets 643 770 Loss on debt extinguishment 2,190  Accretion expense related to asset retirement obligation 521 121 Stock-based compensation 5,904 1,469 Provision for bad debts 518 499 Paid-in-kind interest income (360 ) (286 ) Change in fair value of Convertible Note Payable 1,579 413 Change in fair value of the earnout liabilities (6,890 ) (37,111 ) Unrealized gain on derivative financial instruments (270 ) 3,867 Gain on repayment of Note receivable  (1,943 ) Gain on deconsolidation of VIEs (122,873 )  Changes in operating assets and liabilities: Accounts receivable 2,942 (6,191 ) Accounts receivable, related party (6,275 ) (12,421 ) Proceeds received on previously recorded paid-in-kind interest income  288 Fuel tax credits receivable (1,201 ) (1,751 ) Capital spares (25 ) (418 ) Parts inventory (2,880 ) (2,168 ) Environmental credits held for sale 1,502 (1,288 ) Prepaid expense and other current assets 2,200 (3,108 ) Contract assets 2,981 (1,287 ) Accounts payable 6,184 10,143 Accounts payable, related party 1,228 1,180 Fuel tax credits payable 1,238 1,342 Accrued payroll 66 127 Accrued expenses 3,775 3,237 Operating lease liabilities - current and non-current (613 ) (640 ) Asset retirement obligations (49 )  Other current and non-current liabilities (1,910 ) 452 Contract liabilities (1,699 ) (1,772 ) Net cash provided by (used in) operating activities 38,268 (1,355 ) Cash flows from investing activities: Purchase of property, plant, and equipment (113,826 ) (131,410 ) Deconsolidation of VIEs, net of cash (11,947 )  Proceeds (purchase) of short term investments 55,101 (64,976 ) Cash paid for investment in other entities (8,314 ) (597 ) Proceeds received from repayment of Note receivable  10,855 Distributions received from equity method investment 4,840 2,100 Net cash used in investing activities (74,146 ) (184,028 ) Cash flows from financing activities: Proceeds from Sunoma loan  4,593 Proceeds from OPAL Term Loan 196,617 40,000 Proceeds received from Business Combination  138,850 Financing costs paid to other third parties (10,264 ) (8,321 ) Repayment of Senior Secured Credit Facility (22,750 ) (58,603 ) Repayment of Convertible Note Payable (30,107 )  Repayment of OPAL Term Loan (106,090 ) (18,910 ) Repayment of Sunoma Loan (546 )  Repayment of Municipality loan (76 ) (202 ) Repayment of finance lease liabilities (993 )  Proceeds from equipment loan 303  Proceeds from sale of non-redeemable non-controlling interest, related party 12,753 23,143 Reimbursement of financing costs by joint venture partner 842  Payment of paid-in-kind preferred dividends (16,536 )  Cash paid for taxes related to net share settlement of equity awards (896 )  Cash paid for purchase of shares upon exercise of put option (16,391 )  Distribution to non-redeemable non-controlling interest (333 )  Proceeds from issuance of shares of Class A common stock under the ATM program, net 366  Proceeds from issuance of redeemable preferred non-controlling interests, related party  100,000 Contributions from members   Net cash provided by financing activities 5,899 220,550 Net (decrease) increase in cash, restricted cash, and cash equivalents (29,979 ) 35,167 Cash, restricted cash, and cash equivalents, beginning of period 77,221 42,054 Cash, restricted cash, and cash equivalents, end of period $ 47,242 $ 77,221 Supplemental disclosure of cash flow information Interest paid, net of $5,475 and $3,678 capitalized, respectively $ 6,929 $ 7,013 Noncash investing and financing activities: Fair value of Class A common stock issued for redemption of Convertible Note Payable $  $ 30,595 Fair value of Class A common stock issued for redemption of Public and Private warrants $ 338 $ 25,919 Fair value of Derivative warrant liabilities assumed related to Business Combination $  $ 13,524 Fair value of Earnout liabilities related to Business Combination $  $ 45,900 Fair value of put option on a forward purchase agreement related to Business Combination $  $ 4,600 Paid-in-kind dividend on redeemable preferred non-controlling interests $ 2,617 $ 7,932 Right-of-use assets for finance leases included in Property, Plant and equipment, net $ 9,048 $ 801 Lease liabilities for finance leases included in Accrued expenses and other current liabilities $ 1,398 $ 316 Lease liabilities for finance leases included in Other long-term liabilities $ 7,388 $ 485 Accrual for purchase of Property, plant and equipment included in Accounts payable and Accrued capital expenses $ 15,570 $ 11,922 Non-GAAP Financial Measures (Unaudited) This release includes various financial measures that are non-GAAP financial measures as defined under the rules of the Securities and Exchange Commission. We believe these measures provide important supplemental information to investors to use in evaluating ongoing operating results. We use these measures, together with accounting principles generally accepted in the United States (""GAAP"" or ""U.S. GAAP""), for internal managerial purposes and as a means to evaluate period-to-period comparisons. However, we do not, and you should not, rely on non-GAAP financial measures alone as measures of our performance. We believe that non-GAAP financial measures reflect an additional way of viewing aspects of our operations, that when taken together with GAAP results and the reconciliations to corresponding GAAP financial measures that we also provide give a more complete understanding of factors and trends affecting our business. We strongly encourage you to review all of our financial statements and publicly filed reports in their entirety and to not solely rely on any single non-GAAP financial measure. Non-GAAP financial measures are limited as an analytical tool and should not be considered in isolation from, or as a substitute for, the Company's GAAP results. The Company expects to continue reporting non-GAAP financial measures, adjusting for the items described below (and/or other items that may arise in the future as the Company's management deems appropriate), and the Company expects to continue to incur expenses, charges or gains like the non-GAAP adjustments described below. Accordingly, unless expressly stated otherwise, the exclusion of these and other similar items in the presentation of non-GAAP financial measures should not be construed as an inference that these costs are unusual, infrequent, or non-recurring. These Non-GAAP financial measures are not recognized terms under GAAP and do not purport to be alternatives to GAAP net income or any other GAAP measure as indicators of operating performance. Moreover, because not all companies use identical measures and calculations, the Company's presentation of Non-GAAP financial measures may not be comparable to other similarly titled measures used by other companies. We strongly encourage you to review all of our financial statements and publicly filed reports in their entirety and to not solely rely on any single non-GAAP financial measure. Adjusted EBITDA To supplement the Company's unaudited condensed consolidated financial statements presented in accordance with GAAP, the Company uses a non-GAAP financial measure that it calls adjusted EBITDA (""Adjusted EBITDA""). This non-GAAP measure adjusts net income for interest and financing expense, net, loss on debt extinguishment, net (income) loss attributable to non-controlling interests, depreciation, amortization and accretion expense, adjustments to reflect Adjusted EBITDA from equity method investments, loss on warrant exchange, unrealized (gain) loss on derivative instruments, non-cash charges, one-time non-recurring expenses, major maintenance on renewable power and gain on deconsolidation of VIEs. Management believes this non-GAAP measure provides meaningful supplemental information about the Company's performance, for the following reasons: (1) it allows for greater transparency with respect to key metrics used by management to assess the Company's operating performance and make financial and operational decisions; (2) the measure excludes the effect of items that management believes are not directly attributable to the Company's core operating performance and may obscure trends in the business; (3) the measure better aligns revenues with expenses; and (4) the measure is used by institutional investors and the analyst community to help analyze the Company's business. In future quarters, the Company may adjust for other expenditures, charges or gains to present non-GAAP financial measures that the Company's management believes are indicative of the Company's core operating performance. Non-GAAP financial measures are limited as an analytical tool and should not be considered in isolation from, or as a substitute for, the Company's GAAP results. The Company expects to continue reporting non-GAAP financial measures, adjusting for the items described below (and/or other items that may arise in the future as the Company's management deems appropriate), and the Company expects to continue to incur expenses, charges or gains like the non-GAAP adjustments described below. Accordingly, unless expressly stated otherwise, the exclusion of these and other similar items in the presentation of non-GAAP financial measures should not be construed as an inference that these costs are unusual, infrequent, or non-recurring. Adjusted EBITDA is not a recognized term under GAAP and does not purport to be an alternative to GAAP net income or any other GAAP measure as an indicator of operating performance. Moreover, because not all companies use identical measures and calculations, the Company's presentation of Adjusted EBITDA may not be comparable to other similarly titled measures used by other companies. The following table presents the reconciliation of our Net income to Adjusted EBITDA: Reconciliation of GAAP Net income to Adjusted EBITDA For the Three and Twelve Months Ended December 31, 2023 and 2022 (In thousands of dollars) Three Months Ended December 31, 2023 Twelve Months Ended December 31, 2023 RNG Fuel Fuel Station Services Renewable Power Corporate Total RNG Fuel Fuel Station Services Renewable Power Corporate Total Net income (loss) (1) $ 12,726 $ 10,479 $ 1,888 $ (5,000 ) $ 20,093 $ 22,203 $ 17,908 $ 12,472 $ 74,441 $ 127,024 Adjustments to reconcile net income (loss) to Adjusted EBITDA Interest and financing expense, net 4,352 (14 ) 20 466 4,824 8,968 (134 ) 280 192 9,306 Loss on debt extinguishment (2)    (658 ) (658 )    2,190 2,190 Net (income) loss attributable to non-redeemable non-controlling interests (182 )    (182 ) 349    349 Depreciation, amortization and accretion 1,314 1,175 1,178 (36 ) 3,631 5,268 3,730 5,567  14,565 Adjustments to reflect Adjusted EBITDA from equity method investments (3) 2,658    2,658 5,912    5,912 Loss on warrant exchange         338 338 Unrealized (gain) loss on derivative instruments (4)   (30 ) (3134 ) (3,164 )   (763 ) (7140 ) (7,903 ) Non-cash charges (5)  174  1,123 1,297  174  6,003 6,177 One-time non-recurring charges (6) 2,412 220 45 79 2,756 6,003 1,169 1,336 1,117 9,625 Major maintenance for Renewable Power   764  764   7,240  7,240 Gain on deconsolidation of VIEs         (122,873 ) (122,873 ) Adjusted EBITDA $ 23,280 $ 12,034 $ 3,865 $ (7,160 ) $ 32,019 $ 48,703 $ 22,847 $ 26,132 $ (45,732 ) $ 51,950 Three Months Ended December 31, 2022 Twelve Months Ended December 31, 2022 RNG Fuel Fuel Station Services Renewable Power Corporate Total RNG Fuel Fuel Station Services Renewable Power Corporate Total Net income (loss) (1) $ 7,831 $ 4,521 $ 3,367 $ 16,300 $ 32,019 $ 32,114 $ 18,245 $ 4,681 $ (22,461 ) $ 32,579 Adjustments to reconcile net income (loss) to Adjusted EBITDA Interest and financing expense, net (240 ) 871 1,702 (2,905 ) (572 )  899 5,261 480 6,640 Net loss attributable to non-redeemable non-controlling interests 329    329 1,153    1,153 Depreciation, amortization and accretion 1,362 230 1,413 30 3,035 6,469 846 5,696 125 13,136 Adjustments to reflect Adjusted EBITDA from equity method investments (3) 1,095    1,095 2,073    2,073 Loss on warrant exchange    3,368 3,368    3368 3,368 Unrealized (gain) loss on derivative instruments (4)   260 (30,822 ) (30,562 )   512 (28,719 ) (28,207 ) Non-cash charges (5) 844 207  515 1,566 844 207  2,109 3,160 One-time non-recurring charges (6) 3,570 1,406 1,370 3,711 10,057 6,481 1,406 1,370 11,301 20,558 Major maintenance for Renewable Power   43  43   4,701  4,701 Gain on repayment of Note Receivable and reversal of liability to non-redeemable non-controlling interest      (5,760 )    (5,760 ) Adjusted EBITDA $ 14,791 $ 7,235 $ 8,155 $ (9,803 ) $ 20,378 $ 43,374 $ 21,603 $ 22,221 $ (33,797 ) $ 53,401 (1) Net income (loss) by segment is included in our quarterly report on Form 10 K. Net loss for RNG Fuel includes our portion of net income on our equity method investments. (2) Loss on debt extinguishment relates to assignment of our senior secured credit facility to Paragon and debt restructuring related to OPAL Term Loan. (3) Includes interest, depreciation, amortization and accretion on equity method investments. (4) Unrealized (gain) loss on derivative instruments includes change in fair value of interest rate swaps, commodity swaps, earnout liabilities and put option on a forward purchase agreement. (5) Non-cash charges include stock-based compensation expense, certain expenses included in selling, general and administrative expenses relating to employee benefit accruals, inventory write down charges included in cost of sales - RNG fuel and loss on disposal of assets. (6) One-time non-recurring charges include (i) certain expenses related to development expenses on our RNG facilities such as lease expenses and virtual pipeline costs, incurred during construction phase that could not be capitalized per GAAP for the year ended December 31, 2023, and (ii) transaction costs relating to the Business Combination for the year ended December 31, 2022. View source version on businesswire.com: https://www.businesswire.com/news/home/20240313288921/en/ Investors Todd Firestone Vice President Investor Relations & Corporate Development 914-705-4001 investors@opalfuels.com ICR, Inc. OPALFuelsPR@icrinc.com Source: OPAL Fuels Inc. What was OPAL Fuels' revenue for the twelve months ended December 31, 2023? OPAL Fuels reported revenue of $256.1 million for the twelve months ended December 31, 2023. What was the net income for OPAL Fuels in 2023? OPAL Fuels' net income for 2023 was $127.0 million. What was the Adjusted EBITDA for OPAL Fuels in 2023? OPAL Fuels' Adjusted EBITDA for 2023 was $52.0 million. How much RNG capacity does OPAL Fuels anticipate having online by the end of 2024? OPAL Fuels anticipates ending 2024 with 8.8 million MMBtu of RNG capacity online. What is the expected range for OPAL Fuels' Adjusted EBITDA in 2024? OPAL Fuels expects Adjusted EBITDA for 2024 to range between $90 million and $100 million. What was OPAL Fuels' liquidity as of December 31, 2023? As of December 31, 2023, OPAL Fuels' liquidity was $347.8 million."
Intellipharmaceutics International Inc. Announces Transfer of Listing to NEX and New Stock Option Plan,2024-03-13T21:15:00.000Z,Low,Neutral,"Intellipharmaceutics International Inc. announces its listing on NEX, a separate board of the TSX Venture Exchange, due to a Cease Trade Order. The company will be delisted from TSX and listed on NEX with a new trading symbol. Additionally, a new stock option plan has been approved.","Intellipharmaceutics International Inc. Announces Transfer of Listing to NEX and New Stock Option Plan Rhea-AI Impact (Low) Rhea-AI Sentiment (Neutral) Tags Rhea-AI Summary Intellipharmaceutics International Inc. announces its listing on NEX, a separate board of the TSX Venture Exchange, due to a Cease Trade Order. The company will be delisted from TSX and listed on NEX with a new trading symbol. Additionally, a new stock option plan has been approved. Positive None. Negative The company is currently subject to a Cease Trade Order for failure to satisfy financial reporting requirements, leading to the transfer to NEX. Shareholder approval is not required for the transfer to NEX, as an alternative market will exist for the listed securities. 03/13/2024 - 05:15 PM TORONTO, ON / ACCESSWIRE / March 13, 2024 / Intellipharmaceutics International Inc. (OTCQB:IPCIF)(TSX:IPCI) - (""Intellipharmaceutics"" or the ""Company""), a pharmaceutical company specializing in the research, development and manufacture of novel and generic controlled-release and targeted-release oral solid dosage drugs, today announces its listing on NEX, a separate board of the TSX Venture Exchange (the ""TSXV""). The Company has applied to transfer its listing from the TSX to TSXV as previously disclosed. However, as the Company is currently subject to a Cease Trade Order issued by the Ontario Securities Commission for failure to satisfy financial reporting requirements (as previously disclosed on March 6, 2024), the Company will be transferred to NEX. If the Company comes back into good standing with the securities commissions and its continuous disclosure obligations, it can apply for a reactivation of its listing on TSXV.The Company will be voluntarily delisted from the TSX at the close of March 25, 2024 and will be listed on the NEX at the open of March 26, 2024. According to Section 720 of the TSX Company Manual, shareholder approval is not required as an acceptable alternative market will exist for the listed securities.Upon the transfer of its listing to NEX, the trading symbol of the Company's common shares will change from ""IPCI"" to ""IPCI.H"". The .H symbol extension differentiates NEX symbols from other symbols on the main stock list of the TSXV. There is no change in the Company's name or CUSIP number, and no consolidation of capital. The Company's common shares will also continue to be listed on the OTCQB Marketplace in the United States under the symbol ""IPCIF"".The Company also announces that the TSXV has approved a new stock option plan of the Company (the ""SOP"") that will be subject to shareholder approval at the next annual meeting of shareholders of the Company.The new SOP is a rolling plan (with 10% of shares reserved for issuance), which will replace all existing security based compensation plans of the Company.Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.About IntellipharmaceuticsIntellipharmaceutics International Inc. is a pharmaceutical company specializing in the research, development and manufacture of novel and generic controlled-release and targeted-release oral solid dosage drugs. The Company's patented Hypermatrix  technology is a multidimensional controlled-release drug delivery platform that can be applied to a wide range of existing and new pharmaceuticals.Intellipharmaceutics has developed several drug delivery systems based on this technology platform, with a pipeline of products (some of which have received FDA approval) in various stages of development. The Company has ANDA and NDA 505(b)(2) drug product candidates in its development pipeline. These include the Company's abuse-deterrent oxycodone hydrochloride extended-release formulation (""Oxycodone ER"") based on its proprietary nPODDDS; novel Point Of Divergence Drug Delivery System (for which an NDA has been filed with the FDA), and Regabatin; XR (pregabalin extended-release capsules).Cautionary Statement Regarding Forward-Looking InformationCertain statements in this news release constitute ""forward-looking statements"" within the meaning of the United States Private Securities Litigation Reform Act of 1995 and/or ""forward-looking information"" under the Securities Act (Ontario) (collectively, ""forward-looking statements""). These statements include, without limitation, statements expressed or implied regarding the potential future listing of the Shares on the TSXV, which remains subject to approval by the TSXV, the Company's expectation that it will regain compliance with its continuous disclosure obligations, including with respect to results and timing of the processes related to any of the foregoing. In some cases, you can identify forward-looking statements by terminology such as ""appear"", ""unlikely"", ""target"", ""may"", ""will"", ""should"", ""expects"", ""plans"", ""plans to"", ""anticipates"", ""believes"", ""estimates"", ""predicts"", ""confident"", ""prospects"", ""potential"", ""continue"", ""intends"", ""look forward"", ""could"", ""would"", ""projected"", ""set to"", ""seeking"" or the negative of such terms or other comparable terminology. We made a number of assumptions in the preparation of our forward-looking statements. You should not place undue reliance on our forward-looking statements, which are subject to a multitude of known and unknown risks and uncertainties that could cause actual results, future circumstances or events to differ materially from those stated in or implied by the forward-looking statements. Risks and uncertainties relating to us and our business include the Company's inability to list its Shares on the TSXV or to regain compliance with continuous disclosure requirements and lifting any applicable cease trade order, and other risk factors described under the ""Risk Factors"" section of our latest annual information form, our latest Form 20-F, and our latest Form F-1 and Form F-3 registration statements (including any documents forming a part thereof or incorporated by reference therein), as amended, as well as in our reports, public disclosure documents and other filings with the securities commissions and other regulatory bodies in Canada and the U.S., which are available on www.sedarplus.ca and www.sec.gov. The forward-looking statements herein reflect our current views with respect to future events and are based on what we believe are reasonable assumptions as of the date of this document and we disclaim any intention and have no obligation or responsibility, except as required by law, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.Trademarks used herein are the property of their respective holders.Unless the context otherwise requires, all references to ""we,"" ""us,"" ""our,"" Intellipharmaceutics,"" and the ""Company"" refer to Intellipharmaceutics International Inc. and its subsidiaries.CONTACT INFORMATIONCompany Contact:Intellipharmaceutics International Inc.Isa OdidiChief Executive Officer416.854.9090investors@intellipharmaceutics.comSOURCE: Intellipharmaceutics International Inc.View the original press release on accesswire.com Why is Intellipharmaceutics International Inc. being transferred to NEX? The company is being transferred to NEX due to a Cease Trade Order issued by the Ontario Securities Commission for failure to satisfy financial reporting requirements. What will happen to the trading symbol of the company after the transfer? The trading symbol of the company's common shares will change from 'IPCI' to 'IPCI.H' upon the transfer to NEX. Is shareholder approval required for the transfer to NEX? No, shareholder approval is not required as an acceptable alternative market will exist for the listed securities. What is the new stock option plan approved by TSXV? The new stock option plan (SOP) of the company, subject to shareholder approval, is a rolling plan with 10% of shares reserved for issuance, replacing all existing security-based compensation plans."
Onco360 Selected as the Preferred National Specialty Pharmacy Partner for XPOVIO (selinexor),2024-03-13T20:35:00.000Z,Neutral,Neutral,"Onco360, the largest independent Oncology Pharmacy, partners with Karyopharm to distribute XPOVIO, a first-in-class XPO-1 inhibitor for multiple oncology indications. XPOVIO is approved for multiple myeloma and diffuse large B-cell lymphoma, addressing unmet medical needs. The partnership aims to improve access to XPOVIO for patients in need.","Onco360 Selected as the Preferred National Specialty Pharmacy Partner for XPOVIO (selinexor) Rhea-AI Impact (Neutral) Rhea-AI Sentiment (Neutral) Tags Rhea-AI Summary Onco360, the largest independent Oncology Pharmacy, partners with Karyopharm to distribute XPOVIO, a first-in-class XPO-1 inhibitor for multiple oncology indications. XPOVIO is approved for multiple myeloma and diffuse large B-cell lymphoma, addressing unmet medical needs. The partnership aims to improve access to XPOVIO for patients in need. Positive None. Negative None. Oncology Pharmacist The partnership between Onco360 and Karyopharm for the distribution of XPOVIO is a significant development in the field of oncology pharmaceuticals. XPOVIO, being a first-in-class XPO-1 inhibitor, represents a novel approach in treating multiple myeloma and diffuse large B-cell lymphoma (DLBCL). As an oncology pharmacist, it's crucial to understand the implications of this partnership for patient access to treatment. The availability of XPOVIO through Onco360 may improve the distribution efficiency and accessibility for patients, which is particularly important given the high relapse rate in multiple myeloma and the aggressive nature of DLBCL.From a pharmaceutical standpoint, XPOVIO's mechanism of action, inhibiting the nuclear export protein XPO-1, offers a unique therapeutic option for patients who have exhausted other treatments. This could potentially lead to improved outcomes in a patient population with limited options. However, managing the complex treatment regimens and potential side effects will require specialized knowledge and patient education, which Onco360 is well-positioned to provide as a specialty pharmacy. Market Research Analyst The strategic partnership between Onco360 and Karyopharm could have a substantial impact on the market dynamics of oncology treatments. As a market research analyst, assessing the potential market penetration and growth prospects is essential. XPOVIO's approval for multiple indications broadens its target patient population, potentially increasing its market share in the oncology segment. Onco360's role as a national specialty pharmacy network partner may enhance Karyopharm's distribution capabilities and market reach, possibly leading to increased sales and revenue.It is important to monitor how this partnership affects Karyopharm's market position relative to competitors, especially those with established treatments for multiple myeloma and DLBCL. The partnership's success will also depend on the efficacy and safety profile of XPOVIO, as well as the ability of Onco360 to effectively manage and support the treatment's distribution and patient adherence. Financial Analyst From a financial perspective, the partnership between Onco360 and Karyopharm is likely to influence Karyopharm's financial performance. As a financial analyst, it's important to evaluate how this partnership might affect Karyopharm's revenue streams, given that XPOVIO is approved for multiple oncology indications. The drug's positioning as a treatment option for patients with limited alternatives could command a premium pricing strategy, potentially leading to higher profit margins.Investors should consider the costs associated with the partnership, such as marketing and distribution expenses, against the anticipated increase in sales volume. Additionally, the long-term financial impact will hinge on the drug's clinical success and adoption by healthcare providers. It's also vital to assess the potential risks, including competition from emerging therapies and the possibility of adverse clinical findings affecting drug utilization. 03/13/2024 - 04:35 PM LOUISVILLE, Ky.--(BUSINESS WIRE)-- Onco360, the nations largest independent Oncology Pharmacy, is now the national specialty pharmacy network partner for Karyopharms product XPOVIO (selinexor), a first-in-class, XPO-1 inhibitor. XPOVIO is approved in multiple oncology indications, including: (i) in combination with Velcade (bortezomib) and dexamethasone (XVd) in patients with multiple myeloma after at least one prior therapy; (ii) in combination with dexamethasone in patients with heavily pre-treated multiple myeloma; and (iii) in patients with diffuse large B-cell lymphoma (DLBCL), including DLBCL arising from follicular lymphoma, after at least two lines of systemic therapy. Onco360 is excited to expand our partnership with the team at Karyopharm and become the preferred national specialty pharmacy partner for XPOVIO, said Benito Fernandez, Chief Commercial Officer. Multiple myeloma is an incurable hematological malignancy involving plasma cells. Only 50 percent of patients diagnosed with multiple myeloma survive past five years following initial diagnosis. The National Cancer Institute estimates that in 2018, approximately 30,770 new patients were diagnosed with multiple myeloma in the U.S.1 Unfortunately, most multiple myeloma patients will relapse following the first complete remission and often require continuous treatment to prevent disease progression. Previously, there were no U.S. Food and Drug Administration (FDA)-approved products or regimens for patients with relapsed or refractory multiple myeloma who failed treatment with lenalidomide, pomalidomide, bortezomib, carfilzomib, and/or daratumumab. XPOVIO is manufactured by Karyopharm Therapeutics, and has received multiple approvals from the U.S. FDA since 2019.2 XPOVIO functions by selectively binding to and inhibiting the nuclear export protein XPO-1. Please see the full Prescribing Information for XPOVIO About Onco360 Oncology Pharmacy: Onco360 is the nations largest independent Oncology Pharmacy and clinical support services company. Onco360 was founded in 2003 to bring together the stakeholders involved in the cancer treatment process and serve the specialized needs of oncologists, patients, hospitals, cancer centers of excellence, manufacturers, health plans, and payers. It dispenses nationally through its network of URAC-, and ACHC-accredited Oncology Pharmacies. Onco360 is headquartered in Louisville, Kentucky, and is a flagship specialty pharmacy brand of PharMerica Corporation, a leading institutional pharmacy, specialty infusion, and hospital services company servicing healthcare facilities in the United States. For more information about Onco360, please visit Onco360.com. About Karyopharm Therapeutics Karyopharm Therapeutics Inc. (Nasdaq: KPTI) is a commercial-stage pharmaceutical company pioneering novel cancer therapies. Since its founding, Karyopharm has been an industry leader in oral Selective Inhibitor of Nuclear Export (SINE) compound technology, which was developed to address a fundamental mechanism of oncogenesis: nuclear export dysregulation. Karyopharm's XPOVIO (selinexor), is approved in the U.S. and marketed by the Company in three oncology indications and has received regulatory approvals in a growing number of ex-U.S. territories and countries, including Europe, the United Kingdom, China, South Korea, Israel, Singapore, Hong Kong, Mainland China, Australia, Canada, Taiwan and Macau, and is marketed in those areas by Karyopharms global partners. Karyopharm has a focused pipeline targeting multiple high unmet need cancer indications, including in multiple myeloma, endometrial cancer and myelofibrosis. For more information about our people, science and pipeline, please visit www.karyopharm.com, and follow us on Twitter at @Karyopharm and LinkedIn. References: National Cancer Institute, seer.cancer.gov. Key Statistics for Multiple Myeloma (2019). https://www.clinicaltrials.gov/study/NCT02336815 View source version on businesswire.com: https://www.businesswire.com/news/home/20240313022739/en/ Benito Fernandez, Chief Commercial Officer Benito.Fernandez@Onco360.com 516-640-1332 Source: Onco360 Oncology Pharmacy What is the partnership between Onco360 and Karyopharm regarding XPOVIO? Onco360 is now the national specialty pharmacy network partner for Karyopharm's product XPOVIO, aimed at improving access to the medication for patients with multiple myeloma and diffuse large B-cell lymphoma. What are the approved indications for XPOVIO? XPOVIO is approved for multiple oncology indications, including in combination with Velcade and dexamethasone for multiple myeloma patients after prior therapy, heavily pre-treated multiple myeloma patients, and patients with diffuse large B-cell lymphoma. How does XPOVIO function? XPOVIO functions by selectively binding to and inhibiting the nuclear export protein XPO-1, providing a unique mechanism of action for treating multiple myeloma and diffuse large B-cell lymphoma. What is the significance of the partnership between Onco360 and Karyopharm for patients? The partnership aims to improve access to XPOVIO, a crucial medication for patients with multiple myeloma and diffuse large B-cell lymphoma, addressing unmet medical needs in these patient populations."
Nevada Exploration Announces Upsizing of Financing,2024-03-13T20:38:00.000Z,Low,Neutral,"Nevada Exploration Inc. (NVDEF) increases its private placement due to excess demand, raising it from C$550,000 to up to C$605,000. The Company plans to offer 5,500,000 units at C$0.11 per unit, with each unit consisting of a common share and a warrant. The proceeds will be used for general working capital purposes, subject to regulatory approvals and hold periods.","Nevada Exploration Announces Upsizing of Financing Rhea-AI Impact (Low) Rhea-AI Sentiment (Neutral) Tags Rhea-AI Summary Nevada Exploration Inc. (NVDEF) increases its private placement due to excess demand, raising it from C$550,000 to up to C$605,000. The Company plans to offer 5,500,000 units at C$0.11 per unit, with each unit consisting of a common share and a warrant. The proceeds will be used for general working capital purposes, subject to regulatory approvals and hold periods. Positive None. Negative None. 03/13/2024 - 04:38 PM VANCOUVER, British Columbia, March 13, 2024 (GLOBE NEWSWIRE) -- Nevada Exploration Inc. (NGE or the Company) (TSX-V:NGE; OTCQB:NVDEF) announces that further to its news release dated February 20, 2024, that due to excess demand the private placement has been increased from C$550,000 to up to C$605,000. Subject to TSX Venture Exchange approval, the Company now intends to complete a non-brokered private placement offering of up to 5,500,000 units (the Units) at a price of C$0.11 per Unit (the Offering), for total gross proceeds of up to C$605,000. Each Unit will consist of one common share in the capital of the Company (a Common Share) and one Common Share purchase warrant (a Warrant), with each Warrant entitling the holder thereof to acquire an additional Common Share at an exercise price of C$0.20 per Common Share for 36 months after the date of issuance (the Closing Date). If after four months plus one day from the Closing Date the closing price (or closing bid price on days when there are no trades) of NGEs common shares is greater than C$0.40 per share for 10 consecutive trading days, NGE may accelerate the expiry date of the Warrants to the 30th day after the date on which NGE gives notice to the Warrant holders of such acceleration, with such notice being the issuance of a news release by the Company announcing the acceleration of the expiry date. Proceeds from the Offering will be used for general working capital purposes. The Offering is subject to receipt of all necessary regulatory and TSX Venture Exchange approvals. The securities issued at closing of the Offering will be subject to a four month plus one day hold period from the date of issue, as well as to any other re-sale restrictions imposed by applicable securities regulatory authorities. Subject to approval by the TSX Venture Exchange and applicable securities legislation, NGE may pay finders fees with respect to certain subscriptions from arms length subscribers in accordance with the TSX Venture Exchange Policies. About Nevada Exploration Inc. NGE has for the past several years been applying modern technology to systematically explore for the undiscovered second half of Nevadas gold endowment waiting to be uncovered within Nevadas valley basins. The Company is examining other opportunities in its quest to create shareholder value. For further information, please contact: Nevada Exploration Inc.Email: info@nevadaexploration.comTelephone: +1 (604) 601 2006Website: www.nevadaexploration.com Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. What is the new total amount for Nevada Exploration Inc.'s private placement? The private placement has been increased from C$550,000 to up to C$605,000. How many units will Nevada Exploration Inc. offer in the private placement? Nevada Exploration Inc. plans to offer up to 5,500,000 units. What is the price per unit in the private placement? The price per unit in the private placement is C$0.11. What does each unit in the private placement consist of? Each unit consists of one common share and one common share purchase warrant. What will the proceeds from the private placement be used for? The proceeds will be used for general working capital purposes."
Hall of Fame Resort & Entertainment Company Announces Release Date for Fourth Quarter 2023 Results,2024-03-13T20:30:00.000Z,Neutral,Neutral,"Hall of Fame Resort & Entertainment Company (HOFV) to release Q4 fiscal 2023 results on March 20, 2024, followed by a conference call on March 21, 2024.","Hall of Fame Resort & Entertainment Company Announces Release Date for Fourth Quarter 2023 Results Rhea-AI Impact (Neutral) Rhea-AI Sentiment (Neutral) Tags earnings Rhea-AI Summary Hall of Fame Resort & Entertainment Company (HOFV) to release Q4 fiscal 2023 results on March 20, 2024, followed by a conference call on March 21, 2024. Positive None. Negative None. 03/13/2024 - 04:30 PM CANTON, Ohio, March 13, 2024 /PRNewswire/ -- Hall of Fame Resort & Entertainment Company (NASDAQ: HOFV, HOFVW), the only resort, entertainment, and media company centered around the power of professional football, will release its fourth quarter fiscal 2023 results for the period ended December 31, 2023, on Wednesday, March 20, 2024, after the close of trading on Nasdaq. The Company will host a conference call on Thursday, March 21, 2024, at 8:30 a.m. ET, to provide commentary on the business. Investors and all other interested parties can access the live webcast and replay at the Company's website: ir.hofreco.com. About Hall of Fame Resort & Entertainment CompanyHall of Fame Resort & Entertainment Company (NASDAQ: HOFV, HOFVW) is a resort and entertainment company leveraging the power and popularity of professional football and its legendary players in partnership with the Pro Football Hall of Fame. Headquartered in Canton, Ohio, the Hall of Fame Resort & Entertainment Company is the owner of the Hall of Fame Village a multi-use sports, entertainment and media destination centered around the Pro Football Hall of Fame's campus. Additional information on the Company can be found at www.HOFREco.com. View original content to download multimedia:https://www.prnewswire.com/news-releases/hall-of-fame-resort--entertainment-company-announces-release-date-for-fourth-quarter-2023-results-302088116.html SOURCE Hall of Fame Resort & Entertainment Company When will Hall of Fame Resort & Entertainment Company release its Q4 fiscal 2023 results? Hall of Fame Resort & Entertainment Company will release its Q4 fiscal 2023 results on March 20, 2024. When is the conference call scheduled for discussing the business? The conference call for discussing the business is scheduled for March 21, 2024, at 8:30 a.m. ET. Where can investors and interested parties access the live webcast and replay? Investors and interested parties can access the live webcast and replay at the Company's website: ir.hofreco.com."
"Robinhood Markets, Inc. Reports February 2024 Operating Data",2024-03-13T20:05:00.000Z,Low,Neutral,"Robinhood Markets, Inc. reported strong growth in February 2024 with 23.6 million funded customers, $118.7 billion in Assets Under Custody, and $3.6 billion in Net Deposits. Trading volumes increased across all asset classes, with notable growth in Equity, Options, and Crypto trading. Margin Balances and Cash Sweep Balances also saw positive growth.","Robinhood Markets, Inc. Reports February 2024 Operating Data Rhea-AI Impact (Low) Rhea-AI Sentiment (Neutral) Tags Rhea-AI Summary Robinhood Markets, Inc. reported strong growth in February 2024 with 23.6 million funded customers, $118.7 billion in Assets Under Custody, and $3.6 billion in Net Deposits. Trading volumes increased across all asset classes, with notable growth in Equity, Options, and Crypto trading. Margin Balances and Cash Sweep Balances also saw positive growth. Positive None. Negative None. Financial Analyst The reported growth in Funded Customers and Assets Under Custody (AUC) for Robinhood indicates a positive trend in customer acquisition and retention, which is crucial for the company's revenue generation. A 16% month-over-month increase in AUC and a 29% annual growth rate in Net Deposits are significant indicators of customer trust and an expanding user base. These metrics are essential for evaluating the company's financial health and growth trajectory, especially when considering the competitive landscape of online brokerage platforms. Moreover, the substantial increase in Trading Volumes across all asset classes suggests heightened trading activity, which could lead to increased transaction-based revenues. The rise in Margin Balances and Total Cash Sweep Balances also points to an increase in revenue-generating activities for Robinhood, such as interest on margin lending and cash management services. However, it is important to note the potential risks associated with margin lending, such as credit risk and market volatility that could affect the company's financial stability. The Total Securities Lending Revenue, despite being up 8% month-over-month, shows a year-over-year decline of 24%. This discrepancy could be due to a variety of factors, including changes in market demand for securities lending or alterations in Robinhood's revenue strategies. Investors should monitor these figures closely, as they could have implications for future revenue and profitability. Market Research Analyst Robinhood's performance metrics provide valuable insights into user engagement and platform utilization. The growth in Equity Notional Trading Volumes and Options Contracts Traded is indicative of an increased appetite for investment risk, which may be driven by market conditions or enhanced user confidence in Robinhood's platform. The uptick in Crypto Notional Trading Volumes reflects the ongoing interest in cryptocurrency trading, despite the volatile nature of this asset class. It is also noteworthy that the Total Cash Sweep Balances have seen a substantial year-over-year increase. This could suggest that users are opting to keep more idle cash in their Robinhood accounts, potentially due to the platform's cash management features or as a strategic response to the current interest rate environment. This trend can be seen as a positive sign of user engagement and trust in the platform's ability to manage funds. These metrics provide a snapshot of Robinhood's operational performance and can be used to benchmark against competitors. The data suggests that Robinhood is successfully capitalizing on market opportunities and user trends, which could have favorable implications for its market position and future growth prospects. Economist The data from Robinhood reflects broader economic trends, such as retail investor participation in the financial markets and the impact of economic conditions on investment behavior. The increase in Net Deposits and Assets Under Custody implies that despite potential economic headwinds, retail investors remain active, which could be a sign of consumer confidence or a search for yield in a low-interest-rate environment. This behavior has implications for the overall market liquidity and volatility. Furthermore, the rise in Margin Balances suggests that investors may be leveraging their investments to capitalize on market opportunities, which could amplify market movements. The growth in Trading Volumes indicates that retail investors continue to play a significant role in market dynamics. This can have both stabilizing effects, through increased liquidity and destabilizing effects, if driven by speculative trading. Lastly, the increase in Cash Sweep Balances could be interpreted as a sign that investors are keeping cash reserves in a volatile market, which may reflect a cautious outlook on future market conditions. This behavior could potentially influence monetary policy considerations, such as interest rate decisions, which affect the broader economy. 03/13/2024 - 04:05 PM MENLO PARK, Calif., March 13, 2024 (GLOBE NEWSWIRE) -- Robinhood Markets, Inc. (Robinhood) (NASDAQ: HOOD) today reported selected monthly operating data for February 2024: Funded Customers at the end of February were 23.6 million, up approximately 130 thousand from January 2024.Assets Under Custody (AUC) at the end of February were $118.7 billion, up 16% from January 2024. Net Deposits were $3.6 billion in February, translating to a 42% annualized growth rate relative to January 2024 AUC. Over the last twelve months, Net Deposits were $21.6 billion, translating to an annual growth rate of 29% relative to February 2023 AUC.Trading Volumes in February were higher across all asset classes relative to January 2024. Equity Notional Trading Volumes were $80.9 billion (up 36%). Options Contracts Traded were 119.1 million (up 12%). Crypto Notional Trading Volumes were $6.5 billion (up 10%).Margin Balances at the end of February were $3.8 billion, up 6% from the end of January 2024.Total Cash Sweep Balances at the end of February were $18.1 billion, up $1.3 billion or 8% from the end of January 2024.Total Securities Lending Revenue in February was $13 million, up 8% from January 2024. February2024January2024M/MChangeFebruary2023Y/YChange(M - in millions, B - in billions) Funded Customer Growth (M) Funded Customers23.623.5-23.12% Assets Under Custody (AUC) ($B) Total AUC$118.7$102.416%$74.759%Net Deposits$3.6$3.8NM$1.5NM Trading Trading Days (Equities and Options)2021(5%)195%Total Trading Volumes Equity ($B)$80.9$59.336%$57.341%Options Contracts (M)119.1106.212%89.433%Crypto ($B)$6.5$5.910%$3.586% Daily Average Revenue Trades (DARTs) (M) Equity1.91.712%1.619%Options0.80.714%0.714%Crypto0.30.3-0.250% Customer Margin and Cash Sweep Balances ($B) Margin Book$3.8$3.66%$3.315%Total Cash Sweep$18.1$16.88%$8.0126%Gold Cash Sweep$17.4$16.18%$7.0149%Non-Gold Cash Sweep$0.7$0.7-$1.0(30%) Total Securities Lending Revenue ($M)$13$128%$17(24%) For definitions and additional information regarding these metrics, please refer to Robinhoods full monthly metrics release, which is available on investors.robinhood.com. The information in this release is unaudited and the information for the months in the most recent fiscal quarter is preliminary, based on Robinhoods estimates, and subject to completion of financial closing procedures. Final results for the most recent fiscal quarter, as reported in Robinhoods quarterly and annual filings with the U.S. Securities and Exchange Commission (SEC), might vary from the information in this release. About Robinhood Robinhood Markets, Inc. is on a mission to democratize finance for all. In the U.S., people can invest with no account minimums through Robinhood Financial LLC, a registered broker dealer (member SIPC), buy and sell crypto through Robinhood Crypto, LLC, spend and earn rewards through debit cards with Robinhood Money, LLC and credit cards with Robinhood Credit, Inc., trade U.S. stocks without commission or FX fees in the UK through Robinhood U.K. Ltd., trade crypto in select jurisdictions in the European Union through Robinhood Europe, UAB, and access easy-to-understand educational content through Robinhood Learn. Robinhood uses the Overview tab of its Investor Relations website (accessible at investors.robinhood.com/overview) and its Newsroom (accessible at newsroom.aboutrobinhood.com) as means of disclosing information to the public for purposes of the SECs Regulation Fair Disclosure (Reg. FD). Investors should routinely monitor those web pages, in addition to Robinhoods press releases, SEC filings, and public conference calls and webcasts, as information posted on them could be deemed to be material information. ""Robinhood"" and the Robinhood feather logo are registered trademarks of Robinhood Markets, Inc. Contacts Investor Relations ir@robinhood.com Media press@robinhood.com How many funded customers did Robinhood have at the end of February 2024? Robinhood had 23.6 million funded customers at the end of February 2024. What was the Assets Under Custody (AUC) at the end of February 2024? The Assets Under Custody (AUC) at the end of February 2024 were $118.7 billion. What were the Net Deposits in February 2024? The Net Deposits in February 2024 were $3.6 billion. How did the Trading Volumes in February 2024 compare to January 2024? Trading Volumes in February 2024 were higher across all asset classes compared to January 2024. What was the percentage increase in Margin Balances at the end of February 2024 compared to January 2024? Margin Balances at the end of February 2024 were up 6% from January 2024. What was the Total Securities Lending Revenue in February 2024? The Total Securities Lending Revenue in February 2024 was $13 million."
Jushi Holdings Inc. Reports Fourth Quarter and Full Year 2023 Financial Results,2024-03-13T20:05:00.000Z,Neutral,Neutral,"Jushi Holdings Inc. reported strong financial results for Q4 2023 and FY 2023, with total revenue of $67.8 million and $269.4 million respectively. The company achieved a gross profit margin of 40.2% in Q4 2023 and 43.1% for FY 2023. Net loss decreased to $18.0 million in Q4 2023 from $139.9 million in Q4 2022. Adjusted EBITDA improved to $11.3 million in Q4 2023 and $40.8 million for FY 2023. Jushi-branded product sales accounted for approximately 53.4% of total retail revenue in Q4 2023, and the company introduced 175 new unique SKUs. The company also filed an Amended and Restated Material Change Report.","Jushi Holdings Inc. Reports Fourth Quarter and Full Year 2023 Financial Results Rhea-AI Impact (Neutral) Rhea-AI Sentiment (Neutral) Tags earnings Rhea-AI Summary Jushi Holdings Inc. reported strong financial results for Q4 2023 and FY 2023, with total revenue of $67.8 million and $269.4 million respectively. The company achieved a gross profit margin of 40.2% in Q4 2023 and 43.1% for FY 2023. Net loss decreased to $18.0 million in Q4 2023 from $139.9 million in Q4 2022. Adjusted EBITDA improved to $11.3 million in Q4 2023 and $40.8 million for FY 2023. Jushi-branded product sales accounted for approximately 53.4% of total retail revenue in Q4 2023, and the company introduced 175 new unique SKUs. The company also filed an Amended and Restated Material Change Report. Positive Strong financial performance with total revenue of $67.8 million in Q4 2023 and $269.4 million for FY 2023. Gross profit margin of 40.2% in Q4 2023 and 43.1% for FY 2023. Net loss decreased to $18.0 million in Q4 2023 from $139.9 million in Q4 2022. Improved Adjusted EBITDA of $11.3 million in Q4 2023 and $40.8 million for FY 2023. Jushi-branded product sales represented 53.4% of total retail revenue in Q4 2023. Introduction of 175 new unique SKUs in Q4 2023. Filed an Amended and Restated Material Change Report. Negative None. 03/13/2024 - 04:05 PM Maintained Strong Gross Profit Margin of 40.2% in Q4 2023 and 43.1% for FY 2023 Net Loss of $18.0 Million in Q4 2023 Compared to $139.9 Million in Q4 2022 Improved Adjusted EBITDA and Adjusted EBITDA Margin to $11.3 Million and 16.7% Respectively in Q4 2023 and $40.8 Million and 15.1% Respectively for FY 2023 Bolstered Margins and Achieved Jushi-branded Product Sales of Approximately 53.4% of Total Retail Revenue Across the Company's Five Vertical Markets in Q4 2023 Enhanced Product and Brand Offerings with the Debut of 175 New Unique SKUs in Q4 2023 Filed an Amended and Restated Material Change Report BOCA RATON, Fla., March 13, 2024 (GLOBE NEWSWIRE) -- Jushi Holdings Inc. (Jushi or the Company) (CSE: JUSH) (OTCQX: JUSHF), a vertically integrated, multi-state cannabis operator, is pleased to announce its financial results for the fourth quarter (Q4 2023) and full year ended December 31, 2023 (FY 2023). All financial information is provided in U.S. dollars unless otherwise indicated and is prepared under U.S. Generally Accepted Accounting Principles (GAAP). Financial Highlights Q4 2023 Total revenue of $67.8 millionGross profit of $27.2 million, an increase of 24.0% year-over-yearNet loss of $18.0 millionAdjusted EBITDA1 of $11.3 million, an improvement of $5.3 million year-over-yearAdjusted EBITDA1 margin of 16.7%Cash, cash equivalents and restricted cash were $31.3 millionNet cash flows provided by operations of $4.5 million FY 2023 Total revenue of $269.4 millionGross profit of $116.2 million, an increase of 21.7% year-over-yearNet loss of $65.1 millionAdjusted EBITDA1 of $40.8 million, an improvement of $33.7 million year-over-yearAdjusted EBITDA1 margin of 15.1% 1 See Use of Non-GAAP Financial Information and Unaudited Reconciliation of Net Income (Loss) to Adjusted EBITDA and Calculation of Adjusted EBITDA Margin below. Fourth Quarter 2023 Company Highlights Achieved Jushi-branded product sales of approximately 53.4% of total retail revenue in Q4 2023 across the Company's five vertical markets.Increased wholesale revenue in Q4 2023, a 30% improvement over Q3 2023.Launched 175 new unique SKUs throughout the Companys footprint, including the debut of a differentiated line of troches in Pennsylvania which are vegan and utilize natural ingredients responsibly sourced from France.Received $2.0 million in cash proceeds from the sales of non-core assets in Q4 2023. Post Quarter-End Developments Opened relocated dispensary in Mount Pocono, Pennsylvania, marking the 17th operational Beyond Hello storefront in Pennsylvania.Refinanced approximately $9.9 million of unsecured debt with $4.8 million principal amount of Second Lien Notes, fully detached warrants to purchase an aggregate of 1,800,000 of the Companys Subordinate Voting Shares (""SVS""), with each warrant having an exercise price of $1.00 per SVS, and $2.8 million in cash.Further reduced debt with scheduled payment of approximately $2.4 million on the Companys first lien financing with SunStream Bancorp Inc. Management Commentary Our fourth quarter was a strong finish to an incredible year for Jushi as we successfully increased our margins through our commitments to reducing operating expenses and driving operational efficiencies across the business, said Jim Cacioppo, Chief Executive Officer, Chairman, and Founder of Jushi. Looking ahead we expect to continue to strengthen our profitability through further optimization of our grower processor facilities, including reducing green waste, increasing our yields and potency, and introducing higher margin products in our vertical markets. In addition to our improved profitability, we continue to focus on de-levering our balance sheet. Mr. Cacioppo continued, During the year, we launched new SKUs into the market that were developed using the proprietary retail data and consumer insights we have gathered across our footprint. Focusing on proprietary retail data and consumer insights during the development process has helped us develop products that are in demand and fit into the marketplace enabling us to add more Jushi-branded products on shelves. These new products, including Sch Kind Grind and Fine Grind, have been performing exceptionally well and have helped grow our Jushi-branded sales to approximately 53% of our total retail revenue across our vertical footprint in Q4 2023. Mr. Cacioppo concluded, ""I am incredibly proud of what our team has accomplished this past year, and we believe we are extremely well-positioned and ready for potential new adult-use markets to come online in key states such as Virginia and Pennsylvania. Financial Results for the Fourth Quarter Ended December 31, 2023($ in millions) Quarter EndedDecember 31,2023 Quarter EndedDecember 31,2022 % ChangeRevenue$67.8 $76.8 (11.8)%Gross profit$27.2 $22.0 24.0 %Selling, general and administrative expenses$25.2 $39.1 (35.6)%Asset impairments$8.6 $122.0 (93.0)%Net loss$(18.0) $(139.9) 87.1 %Adjusted EBITDA1$11.3 $6.0 88.3 % Revenue in Q4 2023 decreased 11.8% to $67.8 million as compared to $76.8 million in the fourth quarter of 2022 (Q4 2022). The year-over-year decrease in revenue can be attributed to a reduction in Nevada and Pennsylvania sales due to increased competition and pricing pressures, a reduction in Illinois sales due to the impact of the state of Missouri beginning adult-use (i.e. recreational) cannabis sales, and the closure of four underperforming stores in California and Pennsylvania. The decrease was partially offset by increased sales in Ohio, Massachusetts, and Virginia. In our five vertical markets, Jushi-branded product sales grew as a percentage of total retail sales from 47% in Q4 2022, to 52% in Q3 2023, to approximately 53% in Q4 2023. Gross profit in Q4 2023 was $27.2 million, or 40.2% of revenue, compared to $22.0 million, or 28.6% of revenue in Q4 2022. Year-over-year improvements in gross profit and gross profit margin were driven by increased operating efficiencies at the Company's grower-processor facilities, as well as increased sell-through of our branded products which have higher margins. This increase was partially offset by market price compression and increased competition in Nevada and Pennsylvania, as well as in Illinois due to the impact of the state of Missouri beginning adult-use. Selling, general and administrative expenses for Q4 2023 were $25.2 million compared to $39.1 million in Q4 2022. The decrease was primarily driven by lower salaries, wages, and employee-related expenses due to a decrease in the number of employees as the Company worked to right size the organization, as well as due to changes to the Company's staffing model at retail stores. Additionally, lower share-based compensation expense reflects lower value of share-based compensation granted as well as forfeitures of unvested equity awards. Asset impairments for Q4 2023 were $8.6 million compared to $122.0 million in Q4 2022. The asset impairment charges primarily related to indefinite-lived assets. The net loss for Q4 2023 was $18.0 million, compared to a net loss of $139.9 million in Q4 2022. The decrease in the net loss was driven primarily by asset impairment charges in Q4 2022 as discussed above, lower fair value gain on derivatives, and loss on redemption of the 10% senior notes in 2022, partially offset by increased gross profit. Adjusted EBITDA1 in Q4 2023 was $11.3 million compared to $6.0 million in Q4 2022. The improvement in Adjusted EBITDA1 is primarily due to increased gross profit due to realizing the benefits of operational efficiencies and a reduction in selling, general and administrative expenses as discussed above. 1See Use of Non-GAAP Financial Information and Unaudited Reconciliation of Net Income (Loss) to Adjusted EBITDA and Calculation of Adjusted EBITDA Margin below. Financial Results for the Year Ended December 31, 2023($ in millions) Year Ended December 31, 2023 Year Ended December 31, 2022 % ChangeRevenue$269.4 $284.3 (5.2)%Gross profit$116.2 $95.5 21.7 %Selling, general and administrative expenses$110.5 $156.2 (29.3)%Asset impairments$8.6 $159.6 (94.6)%Net loss$(65.1) $(202.3) 67.8 %Adjusted EBITDA1$40.8 $7.1 474.6 % Revenue decreased 5.2% to $269.4 million, compared to $284.3 million in 2022. The year-over-year decrease can be attributed to a reduction in Pennsylvania sales due to increased competition, a reduction in Illinois sales due to the impact of the state of Missouri beginning adult-use (i.e., recreational) cannabis sales, and the closure of four underperforming stores in California and Pennsylvania. The decrease in retail revenue was partially offset by new Beyond Hello dispensary openings in Virginia and Ohio, and increased wholesale revenue from continued advancements at our cultivation and processing facilities that have enabled us to diversify our product offerings and increase our competitiveness with respect to quality, cost, and distribution. The Company ended 2023 with thirty-four operating dispensaries in seven states, as compared to thirty-five in six states at the end of 2022. Gross profit was $116.2 million, or 43.1% of revenue, in 2023 compared to $95.5 million, or 33.6% of revenue, in 2022. The improvement in gross profit was driven by operating efficiencies at our grower-processor facilities and cost optimization initiatives such as changes to our packaging and changes to our retail labor model. The benefit of these improvements was partially offset by declines in retail revenue in Illinois and Pennsylvania driven by competition both inside of such states and, with respect to Illinois, in neighboring Missouri. Selling, general and administrative expenses were $110.5 million in 2023 compared to $156.2 million in 2022. Salaries, wages, and employee-related expenses decreased due to a decrease in the number of employees as the Company works to right size the organization, as well as due to changes to the Company's staffing model at the retail stores. Lower share-based compensation expense reflects lower value of share-based compensation granted as well as forfeitures of unvested equity awards. Additionally, 2022 included general and administrative expenses related to the Company's transition to GAAP reporting and costs associated with the Company's registration with the Securities and Exchange Commission (the ""SEC""). Asset impairments for 2023 were $8.6 million compared to $159.6 million in 2022. The asset impairment charges primarily related to indefinite-lived assets. The net loss in 2023 was $65.1 million, primarily due to a loss from operations of $2.8 million, net interest expense of $37.0 million, income tax expense of $31.8 million, and other expense of $3.1 million, which was partially offset by fair value gain on derivatives of $9.6 million. This compared to a net loss of $202.3 million in 2022 primarily due to a loss from operations of $220.3 million that included non-cash asset impairment charges as previously discussed, net interest expense of $45.6 million, income tax expense of $8.4 million, and other expense of $19.8 million primarily relating to loss on redemption of the 10% senior notes in 2022, which was partially offset by a gain on the fair value of derivatives of $91.9 million. Adjusted EBITDA1 in 2023 was $40.8 million compared to $7.1 million in 2022 representing an improvement of $33.7 million. The improvement in Adjusted EBITDA1 is primarily due to increased gross profit and realizing the benefits of operational efficiencies. 1See Use of Non-GAAP Financial Information and Unaudited Reconciliation of Net Income (Loss) to Adjusted EBITDA and Calculation of Adjusted EBITDA Margin below. Balance Sheet and Liquidity As of December 31, 2023, the Company had approximately $31.3 million of cash, cash equivalents and restricted cash. For FY 2023, the Company paid $10.7 million in capital expenditures. In 2024, the Company expects maintenance capital expenditures to be approximately $3.0 - $5.0 million. Capital expenditures for new projects will be dependent on expansion in certain markets that may transition to recreational use. As of December 31, 2023, the Company had $225.6 million in principal amount of total debt, excluding leases and property, plant, and equipment financing obligations. Excluding the notes payable to Sammartino and the Jushi Europe debt as the repayments of these two debts are contingent on the resolution of the Sammartino matter and the completion of the liquidation of Jushi Europe, respectively, the Company had $200.8 million in principal amount of debt that is subject to scheduled repayments. As of March 8, 2024, the Companys issued and outstanding shares were 196,634,931 and its fully diluted shares outstanding were 312,786,702. Use of Non-GAAP Financial Information We believe that the presentation of non-GAAP financial information provides important supplemental information to management and investors regarding financial and business trends relating to our financial condition and results of operations. For further information regarding these non-GAAP measures, including the reconciliation of these non-GAAP financial measures to their most directly comparable GAAP financial measures, please refer to the Unaudited Reconciliation of Net Income (Loss) to Adjusted EBITDA and Calculation of Adjusted EBITDA Margin section of this press release. Conference Call and Webcast InformationThe Company will host a conference call to discuss its financial results for the fourth quarter and full year ended December 31, 2023 at 5:00 p.m. ET today, Wednesday, March 13, 2024. Event:Fourth Quarter and Full Year 2023 Financial Results Conference CallDate:Wednesday, March 13, 2024Time:5:00 p.m. Eastern TimeLive Call:1-877-407-0792 (U.S. & Canada Toll-Free)Conference ID:13744312#Webcast:Register For interested individuals unable to join the conference call, a webcast of the call will be available for one month following the conference call and can be accessed via webcast on Jushis Investor Relations website. Amended and Restated Material Change Report The Company also announced that further to the review by the Ontario Securities Commission (OSC) of the Companys continuous disclosure, and a subsequent request from OSC staff in connection therewith, it has filed an amended and restated material change report (the Amended MCR) in respect of the Companys private offering (the Offering) of approximately US$73.5 million aggregate principal amount of its 12% second lien notes and detached warrants to purchase up to approximately 17.5 million of the Companys SVS. The Amended MCR replaces and supersedes the material change report of the Company dated December 16, 2022 (the Original MCR) originally filed in connection with the Offering and contains additional disclosure required under Multilateral Instrument 61-101  Protection of Minority Security Holders in Special Transactions that was not included in the Original MCR. A copy of the Amended MCR can be found under the Companys profile on SEDAR+ at www.sedarplus.com. About Jushi Holdings Inc.We are a vertically integrated cannabis company led by an industry-leading management team. Jushi is focused on building a multi-state portfolio of branded cannabis assets through opportunistic acquisitions, distressed workouts, and competitive applications. Jushi strives to maximize shareholder value while delivering high-quality products across all levels of the cannabis ecosystem. For more information, visit jushico.com or our social media channels, Instagram, Facebook, X and LinkedIn. Forward-Looking Information and Statements This press release may contain forward-looking statements and forwardlooking information within the meaning of applicable securities laws, including Canadian securities legislation and United States (U.S.) securities legislation (collectively, forward-looking information) which are based upon the Companys current internal expectations, estimates, projections, assumptions and beliefs. All information, other than statements of historical facts, included in this report that address activities, events or developments that Jushi expects or anticipates will or may occur in the future constitutes forwardlooking information. Forwardlooking information is often identified by the words, may, would, could, should, will, intend, plan, anticipate, believe, estimate, expect or similar expressions and includes, among others, information regarding: future business strategy, competitive strengths, goals, expansion and growth of Jushis business, operations and plans, including new revenue streams, roll out of new operations, the implementation by Jushi of certain product lines, implementation of certain research and development, the application for additional licenses and the grant of licenses that will be or have been applied for, the expansion or construction of certain facilities, the reduction in the number of our employees, the expansion into additional U.S. markets, any potential future legalization of adult use and/or medical marijuana under U.S. federal law; the expectation of repayment of debt to de-lever our balance sheet; expectations of market size and growth in the U.S. and the states in which Jushi operates; expectations for other economic, business, regulatory and/or competitive factors related to Jushi or the cannabis industry generally; and other events or conditions that may occur in the future. Readers are cautioned that forwardlooking information is not based on historical facts but instead is based on reasonable assumptions and estimates of the management of Jushi at the time they were provided or made and such information involves known and unknown risks, uncertainties, including our ability to continue as a going concern, and other factors that may cause the actual results, level of activity, performance or achievements of Jushi, as applicable, to be materially different from any future results, performance or achievements expressed or implied by such forwardlooking information. Such factors include, among others: risks relating to U.S. regulatory landscape and enforcement related to cannabis, including political risks; risks relating to antimoney laundering laws and regulation; other governmental and environmental regulation; public opinion and perception of the cannabis industry; risks related to the economy generally; risks related to inflation, the rising cost of capital, and stock market instability; risks relating to pandemics and forces of nature; risks related to contracts with third party service providers; risks related to the enforceability of contracts; the limited operating history of Jushi; Jushi's history of operating losses and negative operating cash flows; reliance on the expertise and judgment of senior management of Jushi; risks inherent in an agricultural business; risks related to coinvestment with parties with different interests to Jushi; risks related to proprietary intellectual property and potential infringement by third parties; risks relating to the management of growth; costs associated with Jushi being a publicly-traded company and a U.S. and Canadian filer; increasing competition in the industry; risks associated with cannabis products manufactured for human consumption including potential product recalls; reliance on key inputs, suppliers and skilled labor; reliance on manufacturers and contractors; risks of supply shortages or supply chain disruptions; cybersecurity risks; constraints on marketing products; fraudulent activity by employees, contractors and consultants; tax and insurance related risks; risk of litigation; conflicts of interest; risks relating to certain remedies being limited and the difficulty of enforcing judgments and effecting service outside of Canada; risks related to completed, pending or future acquisitions or dispositions, including potential future impairment of goodwill or intangibles acquired and/or post-closing disputes; sales of a significant amount of shares by existing shareholders; the limited market for securities of the Company; risks related to the continued performance of existing operations in California, Illinois, Massachusetts, Nevada, Ohio, Pennsylvania, and Virginia; risks related to the anticipated openings of additional dispensaries or relocation of existing dispensaries; risks relating to the expansion and optimization of the grower-processor in Pennsylvania, the vertically integrated facilities in Virginia and Massachusetts and the facility in Nevada; risks related to opening new facilities, which is subject to licensing approval; limited research and data relating to cannabis; risks related to challenges from governmental authorities of positions the Company has taken with respect to tax credits; and risks related to the Companys critical accounting policies and estimates; and these and other risks identified under the Risk Factors, Managements Discussion and Analysis of Financial Condition and Results of Operations and Business sections of our most recent Annual Report on Form 10-K and otherwise identified from time to time in our reports and other filings with the U.S. Securities and Exchange Commission and Canadian securities regulators. Although Jushi has attempted to identify important factors that could cause actual results to differ materially, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such forwardlooking information will prove to be accurate as actual results and future events could differ materially from those anticipated in such information. Accordingly, readers should not place undue reliance on the forwardlooking information contained in this press release or other forward-looking statements made by Jushi. Forwardlooking information is provided and made as of the date of this press release and Jushi does not undertake any obligation to revise or update any forwardlooking information or statements other than as required by applicable law. Unless the context requires otherwise, references in this press release to Jushi, Company, we, us and our refer to Jushi Holdings Inc. and our subsidiaries. For further information, please contact: Lisa FormanDirector of Investor Relations617-767-4419investors@jushico.com JUSHI HOLDINGS INC.CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (in thousands of U.S. dollars, except share and per share amounts)(Unaudited) Three Months Ended December 31, Year Ended December 31, 2023 2022 2023 2022 REVENUE, NET$67,770 $76,822 $269,445 $284,284 COST OF GOODS SOLD (40,551) (54,866) (153,217) (188,806)GROSS PROFIT 27,219 21,956 116,228 95,478 OPERATING EXPENSES Selling, general and administrative 25,178 39,118 110,472 156,166 Asset impairments 8,574 122,045 8,574 159,645 Total operating expenses 33,752 161,163 119,046 315,811 LOSS FROM OPERATIONS (6,533) (139,207) (2,818) (220,333) OTHER INCOME (EXPENSE): Interest expense, net (9,311) (11,417) (36,966) (45,591)Fair value gains on derivatives 7,929 28,654 9,589 91,887 Other, net (4,988) (19,478) (3,101) (19,839)Total other income (expense), net (6,370) (2,241) (30,478) 26,457 LOSS BEFORE INCOME TAX (12,903) (141,448) (33,296) (193,876)Income tax benefit (expense) (5,101) 1,511 (31,806) (8,448)NET LOSS AND COMPREHENSIVE LOSS (18,004) (139,937) (65,102) (202,324)Net loss attributable to non-controlling interests     NET LOSS AND COMPREHENSIVE LOSS ATTRIBUTABLE TO JUSHI SHAREHOLDERS$(18,004) $(139,937) $(65,102) $(202,324)LOSS PER SHARE - BASIC$(0.09) $(0.71) $(0.33) $(1.06)Weighted average shares outstanding - basic 195,129,737 196,220,220 194,770,212 190,021,550 LOSS PER SHARE - DILUTED$(0.09) $(0.83) $(0.33) $(1.44)Weighted average shares outstanding - diluted 195,129,737 203,346,826 194,770,212 204,235,432 JUSHI HOLDINGS INC.CONDENSED CONSOLIDATED BALANCE SHEETS(in thousands of U.S. dollars, except share amounts)(Unaudited) December 31, 2023 December 31, 2022ASSETS CURRENT ASSETS: Cash and cash equivalents$26,027 $26,196 Restricted cash - current 3,128  Accounts receivable, net 3,380 4,809 Inventories, net 33,586 35,089 Prepaid expenses and other current assets 15,514 3,957 Total current assets 81,635 70,051 NON-CURRENT ASSETS: Property, plant and equipment, net 159,268 177,755 Right-of-use assets - finance leases 63,107 114,021 Other intangible assets, net 95,967 100,082 Goodwill 30,910 38,239 Other non-current assets 30,358 28,243 Restricted cash - non-current 2,150 950 Total non-current assets 381,760 459,290 Total assets$463,395 $529,341 LIABILITIES AND EQUITY CURRENT LIABILITIES: Accounts payable$15,383 $21,313 Accrued expenses and other current liabilities 44,070 46,329 Income tax payable 5,190 19,921 Debt, net - current portion (including related party principal amounts of $3,298 and $3,189 as of December 31, 2023, and 2022, respectively) 86,514 8,704 Finance lease obligations - current 8,885 11,361 Derivative liabilities - current 2,418  Total current liabilities 162,460 107,628 NON-CURRENT LIABILITIES: Debt, net - non-current (including related party principal amounts of $19,788 and $17,491 as of December 31, 2023, and 2022, respectively) 126,041 180,558 Finance lease obligations - non-current 52,839 102,375 Derivative liabilities - non-current 220 14,134 Unrecognized tax benefits 100,343 57,200 Other liabilities - non-current 29,111 21,555 Total non-current liabilities 308,554 375,822 Total liabilities 471,014 483,450 COMMITMENTS AND CONTINGENCIES EQUITY: Common stock, no par value; authorized shares - unlimited; issued and outstanding shares - 196,631,598 and 196,686,372 Subordinate Voting Shares as of December 31, 2023, and 2022, respectively   Paid-in capital 503,612 492,020 Accumulated deficit (509,844) (444,742)Total Jushi shareholders' (deficit) equity (6,232) 47,278 Non-controlling interests (1,387) (1,387)Total (deficit) equity (7,619) 45,891 Total liabilities and equity$463,395 $529,341 JUSHI HOLDINGS INC.CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS(in thousands of U.S. dollars)(Unaudited) Year Ended December 31, 2023 2022 Net cash flows used in operating activities$(3,318) $(21,416)Net cash flows used in investing activities (6,392) (80,859)Net cash flows provided by financing activities 13,869 33,983 Effect of currency translation on cash and cash equivalents  (49)NET CHANGE IN CASH AND CASH EQUIVALENTS AND RESTRICTED CASH 4,159 (68,341)CASH AND CASH EQUIVALENTS AND RESTRICTED CASH, BEGINNING OF YEAR 27,146 95,487 CASH AND CASH EQUIVALENTS AND RESTRICTED CASH, END OF YEAR$31,305 $27,146 JUSHI HOLDINGS INC.UNAUDITED RECONCILIATION OF NET INCOME (LOSS) TO ADJUSTED EBITDA and CALCULATION OF ADJUSTED EBITDA MARGIN(in thousands of U.S. dollars) EBITDA, Adjusted EBITDA, and Adjusted EBITDA Margin In addition to providing financial measurements based on GAAP, we provide additional financial metrics that are not prepared in accordance with GAAP. We use non-GAAP financial measures, in addition to GAAP financial measures, to understand and compare operating results across accounting periods, for financial and operational decision making, for planning and forecasting purposes and to evaluate our financial performance. These non-GAAP financial measures are EBITDA, Adjusted EBITDA, and Adjusted EBITDA Margin (each as defined below). We believe that these non-GAAP financial measures reflect our ongoing business by excluding the effects of expenses that are not reflective of our operating business performance and allow for meaningful comparisons and analysis of trends in our business. These non-GAAP financial measures also facilitate comparing financial results across accounting periods and to those of peer companies. As there are no standardized methods of calculating these non-GAAP measures, our methods may differ from those used by others, and accordingly, the use of these measures may not be directly comparable to similar measures used by others, thus limiting their usefulness. Accordingly, these non-GAAP measures are intended to provide additional information and should not be considered in isolation or as a substitute for measures of performance prepared in accordance with GAAP. EBITDA, Adjusted EBITDA, and Adjusted EBITDA Margin are financial measures that are not defined under GAAP. We define EBITDA as net income (loss), or earnings, before interest, income taxes, depreciation and amortization. We define Adjusted EBITDA as EBITDA before: (i) non-cash share-based compensation expense; (ii) inventory-related adjustments; (iii) fair value changes in derivatives; (iv) other income/expense items (v) transaction costs; (vi) asset impairment; (vii) loss on debt extinguishment; and (viii) start-up costs. Adjusted EBITDA Margin is calculated by dividing Adjusted EBITDA by total revenue. These financial measures are metrics that have been adjusted from the GAAP net income (loss) measure in an effort to provide readers with a normalized metric in making comparisons more meaningful across the cannabis industry, as well as to remove non-recurring, irregular and one-time items that may otherwise distort the GAAP net income measure. Other companies in our industry may calculate this measure differently, limiting their usefulness as comparative measures. Unaudited Reconciliation of Net Income (Loss) to Adjusted EBITDA(In thousands of U.S. Dollars, unless otherwise stated) Three Months Ended December 31, Year Ended December 31, 2023 2022 2023 2022 NET LOSS(1)$(18,004) $(139,937) $(65,102) $(202,324)Income tax expense (benefit) 5,101 (1,511) 31,806 8,448 Interest expense, net 9,311  11,417 36,966 45,591 Depreciation and amortization(2) 6,808 10,829 26,588 26,492 EBITDA (Non-GAAP) 3,216 (119,202) 30,258 (121,793)Non-cash share-based compensation 2,362 5,959 8,092 23,073 Inventory charge adjustments(3) 34 5,510 285 7,792 Indefinite-lived intangible asset impairment 845 73,915 845 111,515 Goodwill impairment 7,329 39,643 7,329 39,643 Tangible long-lived asset impairment 400 8,487 400 8,487 Fair value changes in derivatives (7,929) (28,654) (9,589) (91,887)Losses on debt redemptions/extinguishments/modifications  18,858  18,858 Other, net(4)(7) 5,081 851 3,129 2,021 Start-up costs(5)  319  4,143 Transaction costs(6)  344 19 5,221 Adjusted EBITDA (Non-GAAP)(7)$11,338 $6,030 $40,768 $7,073 (1) Net income (loss) includes amounts attributable to non-controlling interests. (2) Includes amounts that are included in cost of goods sold and in operating expenses. (3) Includes: (i) inventory step-up on business combinations; (ii) inventory recall reserves; and (iii) reserves for discontinued products. The inventory step-up on business combinations relates to the fair value write-up on inventory acquired on the business acquisition date and then sold subsequent to the acquisition date. The inventory recall reserves relate to the estimated impact of the Pennsylvania Department of Health recall and ban of vape products containing certain cannabis concentrates. The ban was lifted in June 2022. (4) Includes: (i) remeasurement of contingent consideration related to acquisitions; (ii) losses (gains) on investments and financial assets; (iii) losses (gains) on legal settlements; (iv) severance costs; (v) foreign exchange losses (gains); and (vi) indemnification asset adjustments related to acquisitions. (5) Expansion and start-up costs incurred in order to prepare a location for its intended use. Start-up costs are expensed as incurred and are not indicative of ongoing operations of each new location. (6) Transaction costs include: (i) registration statement costs such as professional fees and other costs relating to our SEC registration; and (ii) acquisition and deal costs. (7) The sum of the four quarters in 2023 will not add to the year to date amounts due to an overstatement of $503 add back relating to net foreign exchange losses. Calculation of Adjusted EBITDA Margin(In thousands of U.S. Dollars, unless otherwise stated) Three Months Ended December 31, Year Ended December 31, 2023 2022 2023 2022 Total revenue, net$67,770 $76,822 $269,445 $284,284 Adjusted EBITDA (Non-GAAP)$11,338 $6,030 $40,768 $7,073 Adjusted EBITDA Margin (Non-GAAP) 16.7% 7.8% 15.1% 2.5% What was Jushi Holdings Inc.'s total revenue for Q4 2023? Jushi Holdings Inc. reported total revenue of $67.8 million for Q4 2023. What was the net loss for Jushi Holdings Inc. in Q4 2023? Jushi Holdings Inc. reported a net loss of $18.0 million in Q4 2023. What was the gross profit margin for Jushi Holdings Inc. in Q4 2023? Jushi Holdings Inc. achieved a gross profit margin of 40.2% in Q4 2023. How much did Jushi Holdings Inc. improve its Adjusted EBITDA by in Q4 2023? Jushi Holdings Inc. improved its Adjusted EBITDA to $11.3 million in Q4 2023. What percentage of total retail revenue did Jushi-branded product sales represent in Q4 2023? Jushi-branded product sales accounted for approximately 53.4% of total retail revenue in Q4 2023. How many new unique SKUs did Jushi Holdings Inc. introduce in Q4 2023? Jushi Holdings Inc. introduced 175 new unique SKUs in Q4 2023. What report did Jushi Holdings Inc. file post-quarter end? Jushi Holdings Inc. filed an Amended and Restated Material Change Report post-quarter end."
Cyclacel Pharmaceuticals to Release Fourth Quarter and Full Year 2023 Financial Results,2024-03-13T20:05:00.000Z,Neutral,Neutral,"Cyclacel Pharmaceuticals, Inc. will announce its fourth quarter and full year 2023 financial results on March 19, 2024. The company focuses on developing innovative cancer medicines. A conference call will be held the same day at 4:30pm ET, with webcast and replay options available.","Cyclacel Pharmaceuticals to Release Fourth Quarter and Full Year 2023 Financial Results Rhea-AI Impact (Neutral) Rhea-AI Sentiment (Neutral) Tags earnings Rhea-AI Summary Cyclacel Pharmaceuticals, Inc. will announce its fourth quarter and full year 2023 financial results on March 19, 2024. The company focuses on developing innovative cancer medicines. A conference call will be held the same day at 4:30pm ET, with webcast and replay options available. Positive None. Negative None. 03/13/2024 - 04:05 PM BERKELEY HEIGHTS, N.J., March 13, 2024 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; ""Cyclacel"" or the ""Company""), a biopharmaceutical company developing innovative medicines based on cancer cell biology, will announce fourth quarter and full year 2023 financial results on Tuesday, March 19, 2024. The Company will host a conference call at 4:30pm ET on the same day. Conference call information: Participant Toll-Free Number: 800-579-2543 Primary Participant Direct/International Number: 785-424-1789 Alternate Code for live and archived conference call is CYCCQ423. Webcast Link For the live and archived webcast, please visit the Corporate Presentations page on the Cyclacel website at www.cyclacel.com. The webcast will be archived for 90 days and the audio replay for 7 days. About Cyclacel Pharmaceuticals, Inc. Cyclacel is a clinical-stage, biopharmaceutical company developing innovative cancer medicines based on cell cycle, transcriptional regulation and mitosis biology. The transcriptional regulation program is evaluating fadraciclib, a CDK2/9 inhibitor, and the anti-mitotic program CYC140, a PLK1 inhibitor, in patients with both solid tumors and hematological malignancies. Cyclacel's strategy is to build a diversified biopharmaceutical business based on a pipeline of novel drug candidates addressing oncology and hematology indications. For additional information, please visit www.cyclacel.com. Forward-looking StatementsThis news release contains certain forward-looking statements that involve risks and uncertainties that could cause actual results to be materially different from historical results or from any future results expressed or implied by such forward-looking statements. Such forward-looking statements include statements regarding, among other things, the efficacy, safety and intended utilization of Cyclacels product candidates, the conduct and results of future clinical trials, plans regarding regulatory filings, future research and clinical trials and plans regarding partnering activities. Factors that may cause actual results to differ materially include the risk that product candidates that appeared promising in early research and clinical trials do not demonstrate safety and/or efficacy in larger-scale or later clinical trials, trials may have difficulty enrolling, Cyclacel may not obtain approval to market its product candidates, the risks associated with reliance on outside financing to meet capital requirements, the potential effects of the COVID-19 pandemic, and the risks associated with reliance on collaborative partners for further clinical trials, development and commercialization of product candidates. You are urged to consider statements that include the words ""may,"" ""will,"" ""would,"" ""could,"" ""should,"" ""believes,"" ""estimates,"" ""projects,"" ""potential,"" ""expects,"" ""plans,"" ""anticipates,"" ""intends,"" ""continues,"" ""forecast,"" ""designed,"" ""goal,"" or the negative of those words or other comparable words to be uncertain and forward-looking. For a further list and description of the risks and uncertainties the Company faces, please refer to our most recent Annual Report on Form 10-K and other periodic and other filings we file with the Securities and Exchange Commission and are available at www.sec.gov. Such forward-looking statements are current only as of the date they are made, and we assume no obligation to update any forward-looking statements, whether as a result of new information, future events or otherwise. Contacts Company:Paul McBarron, (908) 517-7330, pmcbarron@cyclacel.comInvestor Relations:Grace Kim, IR@cyclacel.com  Copyright 2024 Cyclacel Pharmaceuticals, Inc. All Rights Reserved. The Cyclacel logo and Cyclacel are trademarks of Cyclacel Pharmaceuticals, Inc. When will Cyclacel Pharmaceuticals announce its fourth quarter and full year 2023 financial results? Cyclacel Pharmaceuticals will announce its fourth quarter and full year 2023 financial results on March 19, 2024. What is the focus of Cyclacel Pharmaceuticals? Cyclacel Pharmaceuticals focuses on developing innovative medicines based on cancer cell biology. When is the conference call scheduled after the financial results announcement? The conference call will be held at 4:30pm ET on the same day as the financial results announcement. Where can I find the webcast link for the live and archived conference call? The webcast link can be found on the Corporate Presentations page on the Cyclacel website at www.cyclacel.com. How long will the webcast be archived? The webcast will be archived for 90 days. How long will the audio replay be available? The audio replay will be available for 7 days."
PepGen to Participate in Upcoming Investor Conferences,2024-03-13T20:05:00.000Z,Low,Neutral,PepGen Inc. (PEPG) to participate in investor conferences to discuss advancements in oligonucleotide therapies for neuromuscular and neurological diseases.,"PepGen to Participate in Upcoming Investor Conferences Rhea-AI Impact (Low) Rhea-AI Sentiment (Neutral) Tags conferences Rhea-AI Summary PepGen Inc. (PEPG) to participate in investor conferences to discuss advancements in oligonucleotide therapies for neuromuscular and neurological diseases. Positive None. Negative None. 03/13/2024 - 04:05 PM BOSTON, March 13, 2024 (GLOBE NEWSWIRE) -- PepGen Inc. (Nasdaq: PEPG), a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapies with the goal of transforming the treatment of severe neuromuscular and neurological diseases, today announced that management will participate in the following upcoming investor conferences: Stifel 2024 CNS Days (Virtual) Tuesday, March 19, 2024, at 1:00 p.m. ET, Fireside Chat Needham Annual Healthcare Conference (Virtual) Monday, April 8, 2024, at 3:45 p.m. ET, Company presentation A webcast of each conference presentation will be available on the Events & Presentations page within the Investors section of the PepGen website at https://investors.pepgen.com/. Replays of the webcasts will be available on the PepGen website for 90 days following the presentation dates. About PepGen PepGen Inc. is a clinical-stage biotechnology company advancing the next-generation of oligonucleotide therapies with the goal of transforming the treatment of severe neuromuscular and neurological diseases. PepGens Enhanced Delivery Oligonucleotide, or EDO, platform is founded on over a decade of research and development and leverages cell-penetrating peptides to improve the uptake and activity of conjugated oligonucleotide therapeutics. Using these EDO peptides, we are generating a pipeline of oligonucleotide therapeutic candidates that are designed to target the root cause of serious diseases. Investor Contact Laurence Watts Gilmartin Group Laurence@gilmartinir.com Media Contact Sarah Sutton Argot Partners pepgen@argotpartners.com When is PepGen Inc. participating in the Stifel 2024 CNS Days conference? PepGen Inc. is participating in the Stifel 2024 CNS Days conference on Tuesday, March 19, 2024, at 1:00 p.m. ET. What is the goal of PepGen Inc. in advancing oligonucleotide therapies? PepGen Inc. aims to transform the treatment of severe neuromuscular and neurological diseases through the next generation of oligonucleotide therapies. Where can investors access the webcast of PepGen Inc.'s conference presentations? Investors can access the webcast of PepGen Inc.'s conference presentations on the 'Events & Presentations' page within the Investors section of the PepGen website at https://investors.pepgen.com/."
"Fossil Group, Inc. Announces Leadership Changes",2024-03-13T20:05:00.000Z,Low,Neutral,"Fossil Group, Inc. announces Jeffrey N. Boyer as Interim CEO, Kosta N. Kartsotis steps down. Kevin Mansell becomes Chairman of the Board. Boyer to lead during transition period with a strategic review ongoing.","Fossil Group, Inc. Announces Leadership Changes Rhea-AI Impact (Low) Rhea-AI Sentiment (Neutral) Tags management Rhea-AI Summary Fossil Group, Inc. announces Jeffrey N. Boyer as Interim CEO, Kosta N. Kartsotis steps down. Kevin Mansell becomes Chairman of the Board. Boyer to lead during transition period with a strategic review ongoing. Positive None. Negative None. 03/13/2024 - 04:05 PM Jeffrey N. Boyer Named Interim CEO and Director Kevin Mansell Becomes Chairman of the Board of Directors RICHARDSON, Texas, March 13, 2024 (GLOBE NEWSWIRE) -- Fossil Group, Inc. (Fossil or the Company, NASDAQ: FOSL) today announced that Kosta N. Kartsotis is stepping down from his position as Chief Executive Officer and a member of the Board of Directors (the Board), effective immediately. To ensure a seamless transition, Kartsotis will remain with the Company in a transitional role until September 2024 and, thereafter, will provide consulting services to the Company until September 2025. Jeffrey N. Boyer, the Companys Executive Vice President and Chief Operating Officer since April 2021, has been appointed as Interim CEO and as a member of the Board of Directors, effective immediately. The Board has retained an executive search firm to identify a permanent CEO and will consider both internal and external candidates. Kevin Mansell, Lead Independent Director of the Board, has been appointed as Chairman of the Board, effective immediately. Mansell was elected to the Board in May 2019, and is currently the Lead Independent Director and Chairman of the Companys Compensation and Talent Management Committee. Mansell has over 40 years of retail industry experience, most recently serving as Chairman, CEO and President of Kohls Corporation (NYSE: KSS), one of the largest department store retail chains in the U.S., until his retirement in May 2018. Mr. Mansell stated, On behalf of the entire Board, I thank Kosta for his unwavering commitment and leadership to Fossil. We have great confidence in Jeff to guide the Company through this period of transition as we undergo a strategic review, continue to advance our Transform and Grow Plan and pursue our search for the Companys next CEO in our effort to create long-term value for our stockholders. Boyer has over 30 years of experience in retail and has been instrumental in leading key initiatives under the Companys TAG Plan. He has been a member of the executive leadership team at Fossil Group since 2017 and has served as Chief Operating Officer since April 2021. He previously served as the Companys Chief Financial Officer and Treasurer for four years and was a member of the Board of Directors for 10 years prior to joining the management team. Prior to Fossil Group, he held executive leadership positions across the retail and consumer landscape, including Pier 1 Imports, Inc., Tuesday Morning Corporation, 24 Hour Fitness Worldwide Holdings, Inc., and Michaels Stores, Inc. Prior to his work in retail, he served in leadership roles in several consumer product firms including The Pillsbury Company and Kraft General Foods. Boyer is currently a member of the Board of Directors of Sally Beauty Holdings, Inc. (NYSE: SBH), where he serves on the Audit Committee and the Compensation and Talent Committee. About Fossil Group, Inc. Fossil Group, Inc. is a global design, marketing, distribution and innovation company specializing in lifestyle accessories. Under a diverse portfolio of owned and licensed brands, our offerings include watches, jewelry, handbags, small leather goods, belts and sunglasses. We are committed to delivering the best in design and innovation across our owned brands, Fossil, Michele, Relic, Skagen and Zodiac, and licensed brands, Armani Exchange, Diesel, DKNY, Emporio Armani, kate spade new york, Michael Kors and Tory Burch. We bring each brand story to life through an extensive distribution network across numerous geographies, categories, and channels. Certain press release and SEC filing information concerning the Company is also available at www.fossilgroup.com. Safe Harbor Safe Harbor Certain statements contained herein that are not historical facts, constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and involve a number of risks and uncertainties. The actual results of the future events described in such forward-looking statements could differ materially from those stated in such forward-looking statements. Among the factors that could cause actual results to differ materially are: risks related to the success of the Transform and Grow plan; a failure to meet the continued listing requirements of Nasdaq; the impact of activist shareholders; a downgrade in our debt ratings; our level of indebtedness; our ability to achieve consistent profitability or positive cash flow; increased political uncertainty, the effect of worldwide economic conditions; the effect of a pandemic; significant changes in consumer spending patterns or preferences; interruptions or delays in the supply of key components or products; acts of war or acts of terrorism; loss of key facilities; data breach or information systems disruptions; changes in foreign currency valuations in relation to the U.S. dollar; lower levels of consumer spending resulting from a general economic downturn or generally reduced shopping activity caused by public safety or consumer confidence concerns; the performance of our products within the prevailing retail environment; customer acceptance of both new designs and newly-introduced product lines; changes in the mix of product sales; the effects of vigorous competition in the markets in which we operate; compliance with debt covenants and other contractual provisions and meeting debt service obligation; risks related to the success of our business strategy; the termination or non-renewal of material licenses; risks related to foreign operations and manufacturing; changes in the costs of materials and labor; government regulation and tariffs; our ability to secure and protect trademarks and other intellectual property rights; levels of traffic to and management of our retail stores; loss of key personnel and the outcome of current and possible future litigation, as well as the risks and uncertainties set forth in the Companys most recent Annual Report on Form 10-K filed with the Securities and Exchange Commission (the SEC). These forward-looking statements are based on our current expectations and beliefs concerning future developments and their potential effect on us. While management believes that these forward-looking statements are reasonable as and when made, there can be no assurance that future developments affecting us will be those that we anticipate. Readers of this release should consider these factors in evaluating, and are cautioned not to place undue reliance on, the forward-looking statements contained herein. The Company assumes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise, except as required by law. Investor Relations Contact: Christine Greany The Blueshirt Group (858) 722-7815 christine@blueshirtgroup.com Additional Information and Where to Find It The Company intends to file with the SEC a proxy statement on Schedule 14A, containing a form of WHITE proxy card, with respect to its solicitation of proxies for the 2024 Annual Meeting of Stockholders (the Proxy Statement). INVESTORS AND SECURITY HOLDERS ARE URGED TO READ THE PROXY STATEMENT (INCLUDING ANY AMENDMENTS OR SUPPLEMENTS THERETO) FILED BY THE COMPANY AND ANY OTHER RELEVANT DOCUMENTS FILED WITH THE SEC WHEN THEY BECOME AVAILABLE CAREFULLY AND IN THEIR ENTIRETY BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION ABOUT ANY SOLICITATION. Investors and security holders may obtain copies of these documents and other documents filed with the SEC by the Company free of charge through the website maintained by the SEC at www.sec.gov. Copies of the documents filed by the Company are also available free of charge by accessing the Companys website at https://www.fossilgroup.com/investors/. Participants Fossil, its directors and executive officers and other members of management and employees will be participants in the solicitation of proxies with respect to a solicitation by Fossil. Information about Fossils executive officers and directors and a description of their direct and indirect interests, by security holdings or otherwise, will be included in the Proxy Statement and other relevant materials that may be filed with the SEC by Fossil. Information regarding Fossils directors and executive officers is available at Proposal 1: Election of Directors, Executive Officers and Security Ownership of Certain Beneficial Owners and Management in its definitive proxy statement for the 2023 Annual Meeting of Stockholders, which was filed with the SEC on April 12, 2023, and in its Current Reports on Form 8-K filed with the SEC on June 28, 2023 and August 9, 2023. To the extent holdings by our directors and executive officers of Fossil securities reported in the proxy statement for the 2023 Annual Meeting or in such Form 8-Ks have changed, such changes have been or will be reflected on Statements of Change in Ownership on Forms 3, 4 or 5 filed with the SEC. These documents are or will be available free of charge at the SECs website at www.sec.gov. Who is the new Interim CEO of Fossil Group? Jeffrey N. Boyer has been appointed as the new Interim CEO of Fossil Group. Who is stepping down from the CEO position at Fossil Group? Kosta N. Kartsotis is stepping down from his position as Chief Executive Officer of Fossil Group. Who is the new Chairman of the Board at Fossil Group? Kevin Mansell has been appointed as the new Chairman of the Board at Fossil Group. What is the ticker symbol for Fossil Group? The ticker symbol for Fossil Group is NASDAQ: FOSL. What is the background of Jeffrey N. Boyer, the new Interim CEO of Fossil Group? Jeffrey N. Boyer has over 30 years of experience in retail and has been with Fossil Group since 2017, leading key initiatives under the Company's TAG Plan."
Superior Group of Companies Reports Fourth Quarter Results,2024-03-13T20:05:00.000Z,Low,Neutral,"Superior Group of Companies, Inc. (SGC) announced its Q4 2023 results with total net sales of $147.2 million, a slight decrease from the prior year. Net income rose to $3.6 million, and EBITDA improved to $9.9 million. The company provided a positive full-year outlook for 2024, expecting sales of $558-568 million and earnings per share of $0.61-0.68.","Superior Group of Companies Reports Fourth Quarter Results Rhea-AI Impact (Low) Rhea-AI Sentiment (Neutral) Tags earnings Rhea-AI Summary Superior Group of Companies, Inc. (SGC) announced its Q4 2023 results with total net sales of $147.2 million, a slight decrease from the prior year. Net income rose to $3.6 million, and EBITDA improved to $9.9 million. The company provided a positive full-year outlook for 2024, expecting sales of $558-568 million and earnings per share of $0.61-0.68. Positive Total net sales of $147.2 million in Q4 2023. Net income increased to $3.6 million compared to the prior year. EBITDA improved to $9.9 million from $3.5 million in the previous year. Full-year 2024 outlook includes sales forecasted at $558-568 million and earnings per share of $0.61-0.68. Negative None. Financial Analyst Superior Group of Companies' financial results indicate a marginal decrease in net sales by 0.9%, which may seem negligible but can be a signal of a plateau in revenue growth or increased competition. However, the increase in net income from $2.2 million to $3.6 million suggests improved operational efficiency or cost management. The substantial rise in EBITDA from an adjusted $3.5 million to $9.9 million is particularly noteworthy, representing a significant improvement in earnings before interest, taxes, depreciation and amortization, which could imply better cash flow management and profitability.The provided outlook for 2024, with sales forecasted to grow to $558 million to $568 million, indicates optimism about the company's revenue growth. The forecasted earnings per share (EPS) of $0.61 to $0.68, up from $0.54 diluted adjusted EPS, suggests an expectation of continued profitability improvements. This guidance will be closely monitored by investors as it provides a proxy for the company's financial health and future performance. Market Research Analyst Superior Group of Companies' reference to strong retention and new client wins may reflect the company's competitive positioning and customer satisfaction levels. The mention of growth in all three attractive end markets signifies potential for expansion and increased market share. However, investors should consider the highly fragmented nature of these markets, which could present both opportunities and challenges in terms of competition and market penetration.The company's statement about a stronger financial position enabling market share capture and shareholder value enhancement could be indicative of strategic investments or acquisitions planned for 2024. This strategic direction, if executed effectively, could positively impact the company's long-term market standing and stock performance. Economist The company's performance and optimistic outlook must be contextualized within the broader economic environment. Factors such as inflation, interest rates and economic growth rates can significantly influence the company's operating costs, consumer demand and overall financial health. Given the current economic indicators and market trends, the company's ability to improve profitability despite a slight sales decline could be viewed as a robust operational outcome.Moreover, the company's improved balance sheet, as indicated by the CEO, is a positive sign for financial stability. A strong balance sheet can provide a buffer against economic downturns and enable the company to invest in growth opportunities, which is essential for long-term shareholder value creation. 03/13/2024 - 04:05 PM  Total net sales of $147.2 million versus $148.6 million in prior year fourth quarter  Net income of $3.6 million versus net income of $2.2 million in prior year fourth quarter  EBITDA of $9.9 million versus adjusted $3.5 million in prior year fourth quarter  Provides full-year outlook  ST. PETERSBURG, Fla., March 13, 2024 (GLOBE NEWSWIRE) -- Superior Group of Companies, Inc. (NASDAQ: SGC) (the Company), today announced its fourth quarter 2023 results. We capped off 2023 with our best quarter of the year, delivering sequential improvement, stronger profitability and continued positive cash flow along with a substantially improved balance sheet, said Michael Benstock, Chief Executive Officer. Underlying fundamentals are moving in the right direction, consistent with what we saw through much of 2023. With our strong retention and new client wins, we are optimistic that we will continue to drive improved performance and consistently solid results. All three of our attractive end markets are growing and highly fragmented, and we believe our stronger financial position will enable us to take additional market share and enhance shareholder value in 2024 and beyond. Fourth Quarter Results For the fourth quarter ended December 31, 2023, net sales decreased 0.9% to $147.2 million compared to fourth quarter 2022 net sales of $148.6 million. Pretax income was $4.2 million compared to $1.2 million in the fourth quarter of 2022. Net income was $3.6 million or $0.22 per diluted share compared to $2.2 million or $0.14 per diluted share for the fourth quarter of 2022. In the prior year fourth quarter, the Company realized a pre-tax, non-operating gain of $3.4 million. On an adjusted basis, which excludes the prior years pre-tax, non-operating gain, this quarters net income of $3.6 million or $0.22 per diluted share compares to a net loss of $0.9 million or $0.06 per diluted share for the prior year. At the conclusion of this press release is a reconciliation of reported to adjusted results, including a description of significant items. 2024 Full-Year Outlook The Company is forecasting full year 2024 sales to be $558 million to $568 million versus 2023 sales of $543 million, and forecasting earnings per share to be $0.61 to $0.68, compared to $0.54 diluted adjusted earnings per share in 2023. Webcast and Conference Call The Company will host a webcast and conference call at 5:00 pm Eastern Time today. The live webcast and archived replay can be accessed in the investor relations section of the Company's website at https://ir.superiorgroupofcompanies.com/Presentations. Interested individuals may also join the teleconference by dialing 1-844-861-5505 for U.S. dialers and 1-412-317-6586 for International dialers. The Canadian Toll-Free number is 1-866-605-3852. Please ask to be joined to the Superior Group of Companies call. A telephone replay of the teleconference will be available through March 27, 2024. To access the replay, dial 1-877-344-7529 in the United States or 1-412-317-0088 from international locations. Canadian dialers can access the replay at 855-669-9658. Please reference conference number 2106897 for replay access. Disclosure Regarding Forward Looking Statements Certain matters discussed in this press release are forward-looking statements intended to qualify for the safe harbors from liability established by the Private Securities Litigation Reform Act of 1995. These forward-looking statements can generally be identified by use of the words may, will, should, could, expect, anticipate, estimate, believe, intend, project, potential, or plan or the negative of these words or other variations on these words or comparable terminology. Forward-looking statements in this press release may include, without limitation: (1) projections of revenue, income, and other items relating to our financial position and results of operations, including short-term and long-term plans for cash, (2) statements of our plans, objectives, strategies, goals and intentions, (3) statements regarding the capabilities, capacities, market position and expected development of our business operations, and (4) statements of expected industry and general economic trends. Such forward-looking statements are subject to certain risks and uncertainties that may materially adversely affect the anticipated results. Such risks and uncertainties include, but are not limited to, the following: the impact of competition; uncertainties related to supply disruptions, inflationary environment (including with respect to the cost of finished goods and raw materials and shipping costs), employment levels (including labor shortages), and general economic and political conditions in the areas of the world in which the Company operates or from which it sources its supplies or the areas of the United States of America (U.S. or United States) in which the Companys customers are located; changes in the healthcare, retail chain, food service, transportation and other industries where uniforms and service apparel are worn; our ability to identify suitable acquisition targets, discover liabilities associated with such businesses during the diligence process, successfully integrate any acquired businesses, or successfully manage our expanding operations; the price and availability of raw materials; attracting and retaining senior management and key personnel; the effect of the Companys material weakness in internal control over financial reporting; the Companys ability to successfully remediate its material weakness in internal control over financial reporting and to maintain effective internal control over financial reporting; and other factors described in the Companys filings with the Securities and Exchange Commission, including those described in the Risk Factors section of our Annual Report on Form 10-K for the fiscal year ended December 31, 2023. Shareholders, potential investors and other readers are urged to consider these factors carefully in evaluating the forward-looking statements made herein and are cautioned not to place undue reliance on such forward-looking statements. The forward-looking statements made herein are only made as of the date of this press release and we disclaim any obligation to publicly update such forward-looking statements to reflect subsequent events or circumstances, except as may be required by law. About Superior Group of Companies, Inc. (SGC): Established in 1920, Superior Group of Companies is comprised of three attractive business segments each serving large, fragmented and growing addressable markets. Across Healthcare Apparel, Branded Products and Contact Centers, each segment enables businesses to create extraordinary brand engagement experiences for their customers and employees. SGCs commitment to service, quality, advanced technology, and omnichannel commerce provides unparalleled competitive advantages. We are committed to enhancing shareholder value by continuing to pursue a combination of organic growth and strategic acquisitions. For more information, visit www.superiorgroupofcompanies.com. Investor Relations Contact: Investors@Superiorgroupofcompanies.com Comparative figures are as follows: SUPERIOR GROUP OF COMPANIES, INC. AND SUBSIDIARIESCONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS(Unaudited)(In thousands, except shares and per share data) Three Months Ended December 31, Years Ended December 31, 2023 2022 2023 2022 Net sales $147,241 $148,613 $543,302 $578,831 Costs and expenses: Cost of goods sold 91,596 103,805 339,755 385,472 Selling and administrative expenses 49,198 44,322 183,205 176,320 Goodwill impairment charge - - - 45,918 Intangible assets impairment charge - - - 5,581 Other periodic pension costs 213 532 855 2,116 Interest expense 2,060 2,218 9,718 4,894 143,067 150,877 533,533 620,301 Gain on sale of property, plant and equipment - 3,435 - 3,435 Income (loss) before income tax expense 4,174 1,171 9,769 (38,035)Income tax expense (benefit) 617 (1,023) 997 (6,065)Net income (loss) $3,557 $2,194 $8,772 $(31,970) Net income (loss) per share: Basic $0.22 $0.14 $0.55 $(2.03)Diluted $0.22 $0.14 $0.54 $(2.03) Weighted average shares outstanding during the period: Basic 16,010,006 15,841,296 15,968,199 15,764,859 Diluted 16,238,736 16,075,494 16,159,308 15,764,859 Cash dividends per common share $0.14 $0.14 $0.56 $0.54 SUPERIOR GROUP OF COMPANIES, INC. AND SUBSIDIARIESCONDENSED CONSOLIDATED BALANCE SHEETS(Unaudited)(In thousands, except share and par value data) December 31, 2023 2022 ASSETS Current assets: Cash and cash equivalents $19,896 $17,722 Accounts receivable, less allowance for doubtful accounts of $4,237 and $7,622, respectively 103,494 104,813 Accounts receivable - other 307 3,326 Inventories 98,067 124,976 Contract assets 48,715 52,980 Prepaid expenses and other current assets 8,881 14,166 Total current assets 279,360 317,983 Property, plant and equipment, net 46,890 51,392 Operating lease right-of-use assets 17,909 9,113 Deferred tax asset 12,356 10,718 Intangible assets, net 51,160 55,753 Other assets 14,775 11,982 Total assets $422,450 $456,941 LIABILITIES AND SHAREHOLDERS EQUITY Current liabilities: Accounts payable $50,520 $42,060 Other current liabilities 43,978 38,646 Current portion of long-term debt 4,688 3,750 Current portion of acquisition-related contingent liabilities 1,403 736 Total current liabilities 100,589 85,192 Long-term debt 88,789 151,567 Long-term pension liability 13,284 12,864 Long-term acquisition-related contingent liabilities 557 2,245 Long-term operating lease liabilities 12,809 3,936 Other long-term liabilities 8,784 8,538 Total liabilities 224,812 264,342 Commitments and contingencies Shareholders equity: Preferred stock, $.001 par value - authorized 300,000 shares (none issued) - - Common stock, $.001 par value - authorized 50,000,000 shares, issued and outstanding - 16,564,712 and 16,376,683 shares, respectively 16 16 Additional paid-in capital 77,443 72,615 Retained earnings 122,464 122,979 Accumulated other comprehensive income (loss), net of tax: Pensions (1,122) (1,113)Foreign currency translation adjustment (1,163) (1,898)Total shareholders equity 197,638 192,599 Total liabilities and shareholders equity $422,450 $456,941 SUPERIOR GROUP OF COMPANIES, INC. AND SUBSIDIARIESCONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS(Unaudited)(In thousands) Years Ended December 31, 2023 2022 CASH FLOWS FROM OPERATING ACTIVITIES Net income (loss) $8,772 $(31,970)Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities: Depreciation and amortization 13,995 13,004 Goodwill impairment charge - 45,918 Intangible assets impairment charge - 5,581 Inventory write-downs 2,346 13,569 Provision for bad debts - accounts receivable 539 2,891 Share-based compensation expense 3,787 4,289 Deferred income tax benefit (1,635) (12,352)Gain on sale of property, plant and equipment - (3,435)Change in fair value of acquisition-related contingent liabilities (189) (450)Change in fair value of written put options 489 (1,565)Changes in assets and liabilities, net of acquisition of businesses: Accounts receivable 1,051 680 Accounts receivable - other 3,019 1,347 Contract assets 4,310 (15,092)Inventories 24,672 (15,898)Prepaid expenses and other current assets 5,496 5,225 Other assets (2,012) 1,858 Accounts payable and other current liabilities 13,310 (14,614)Payment of acquisition-related contingent liabilities (279) (3,346)Long-term pension liability 407 2,190 Other long-term liabilities 851 (434)Net cash provided by (used in) operating activities 78,929 (2,604) CASH FLOWS FROM INVESTING ACTIVITIES Additions to property, plant and equipment (4,963) (11,018)Proceeds from disposals of property, plant and equipment - 4,795 Acquisition of businesses - (11,202)Other investments (545) - Net cash used in investing activities (5,508) (17,425) CASH FLOWS FROM FINANCING ACTIVITIES Proceeds from borrowings of debt 6,000 332,143 Repayment of debt (67,750) (292,773)Debt issuance costs (300) (869)Payment of cash dividends (9,188) (8,653)Payment of acquisition-related contingent liabilities (553) (1,416)Proceeds received on exercise of stock options 175 728 Tax withholdings on vesting of restricted shares and performance based shares and on exercise of stock rights - (314)Net cash provided by (used in) financing activities (71,616) 28,846 Effect of currency exchange rates on cash 369 (30)Net increase in cash and cash equivalents 2,174 8,787 Cash and cash equivalents balance, beginning of year 17,722 8,935 Cash and cash equivalents balance, end of year $19,896 $17,722 SUPERIOR GROUP OF COMPANIES, INC. AND SUBSIDIARIESNON-GAAP FINANCIAL MEASURES(Unaudited)(In thousands, except shares and per share data) Three Months Ended December 31, Years Ended December 31, 2023 2022 2023 2022 Net income (loss) $3,557 $2,194 $8,772 $(31,970)Interest expense 2,060 2,218 9,718 4,894 Income tax expense (benefit) 617 (1,023) 997 (6,065)Depreciation and amortization 3,664 3,500 13,995 13,004 Goodwill impairment charge - - - 45,918 Intangible assets impairment charge - - - 5,581 Gain on sale of property, plant and equipment - (3,435) - (3,435)Adjusted EBITDA(1) $9,898 $3,454 $33,482 $27,927 Net income (loss) $3,557 $2,194 $8,772 $(31,970)Adjustment for items: Goodwill impairment charge - - - 45,918 Intangible assets impairment charge - - - 5,581 Gain on sale of property, plant and equipment - (3,435) - (3,435)Tax impact of adjustments(2) - 324 - (6,061)Adjusted net income (loss)(3) $3,557 $(917) $8,772 $10,033 Diluted net income (loss) per share $0.22 $0.14 $0.54 $(2.03)Adjustment for items, after-tax, per diluted share - (0.20) - 2.65 Diluted adjusted net income (loss) per share(3) $0.22 $(0.06) $0.54 $0.62 Weighted average shares outstanding during the period: Diluted, as reported 16,238,736 16,075,494 16,159,308 15,764,859 Diluted, as adjusted(4) 16,238,736 15,841,296 16,159,308 16,165,240 (1) Adjusted EBITDA, which is a non-GAAP financial measure, is defined as net income (loss) excluding interest expense, income tax expense, depreciation and amortization expense, impairment charges and the other items described in the following sentence. The Company believes Adjusted EBITDA is an important measure of operating performance because it allows management, investors and others to evaluate and compare the Companys core operating results from period to period by removing (i) the impact of the Companys capital structure (interest expense from outstanding debt), (ii) tax consequences, (iii) asset base (depreciation and amortization), (iv) the non-cash charges from asset impairments and (v) gains or losses on the sale of property, plant and equipment. The Company uses Adjusted EBITDA internally to monitor operating results and to evaluate the performance of its business. In addition, the compensation committee has used Adjusted EBITDA in evaluating certain components of executive compensation, including performance-based annual incentive programs. Adjusted EBITDA is not a measure of financial performance under GAAP and should not be considered in isolation or as an alternative to net income (loss), cash flows from operating activities or any other measure determined in accordance with GAAP. The items excluded to calculate Adjusted EBITDA are significant components in understanding and assessing the Companys results of operations. The presentation of the Companys Adjusted EBITDA may change from time to time, including as a result of changed business conditions, new accounting pronouncements or otherwise. If the presentation changes, the Company undertakes to disclose any change between periods and the reasons underlying that change. The Companys Adjusted EBITDA may not be comparable to a similarly titled measure of another company because other entities may not calculate Adjusted EBITDA in the same manner. (2) The tax impact of adjustments includes the tax effect of each separate adjustment based on the statutory tax rate for the jurisdiction(s) in which the adjustment was taxable or deductible, and the tax effect of items that relate to tax specific financial transactions. (3) Adjusted net income (loss) and diluted adjusted net income (loss) per share, which are non-GAAP measures, are defined as net income (loss) and net income (loss) per share, excluding the impacts of impairment charges and gains or losses on the sale of property, plant and equipment. Management believes adjusted net income (loss) and diluted adjusted net income (loss) per share provides useful information to investors because it allows management, investors and others to evaluate and compare our operating results from period to period by removing the impact of impairment charges and gains or losses on the sale of property, plant and equipment that are not reflective of our core business. (4) Diluted weighted average shares outstanding used to calculate diluted adjusted net loss per share excludes shares of common stock of 234,198 for the three months ended December 31, 2022, as the Company recognized an adjusted net loss and their inclusion would have been antidilutive. Diluted weighted average shares outstanding used to calculate diluted adjusted net income per share includes shares of common stock of 400,381 for the year ended December 31, 2022. These shares were excluded from diluted weighted average shares outstanding used to calculate diluted net income (loss) per share, as the Company recognized a net loss and their inclusion would have been antidilutive. SUPERIOR GROUP OF COMPANIES, INC. AND SUBSIDIARIESSUPPLEMENTAL INFORMATION - REPORTABLE SEGMENTS(Unaudited)(In thousands) Branded Products Healthcare Apparel Contact Centers Intersegment Eliminations Other Total For the Year Ended December 31, 2023: Net sales $342,680 $113,878 $91,500 $(4,756) $- $543,302 Cost of goods sold 228,053 71,597 42,352 (2,247) - 339,755 Gross margin 114,627 42,281 49,148 (2,509) - 203,547 Selling and administrative expenses 88,225 38,209 39,682 (2,509) 19,598 183,205 Other periodic pension cost - - - - 855 855 Add: Depreciation and amortization 6,744 3,925 2,942 - 384 13,995 Segment Adjusted EBITDA(1) $33,146 $7,997 $12,408 $- $(20,069) $33,482 Branded Products Healthcare Apparel Contact Centers Intersegment Eliminations Other Total For the Year Ended December 31, 2022: Net sales $387,931 $113,321 $84,218 $(6,639) $- $578,831 Cost of goods sold 273,134 80,719 34,439 (2,820) - 385,472 Gross margin 114,797 32,602 49,779 (3,819) - 193,359 Selling and administrative expenses 90,118 39,295 33,631 (3,819) 17,095 176,320 Other periodic pension cost - - - - 2,116 2,116 Add: Depreciation and amortization 6,465 3,946 2,373 - 220 13,004 Segment Adjusted EBITDA(1) $31,144 $(2,747) $18,521 $- $(18,991) $27,927 Branded Products Healthcare Apparel Contact Centers Intersegment Eliminations Other Total For the Three Months Ended December 31, 2023: Net sales $97,725 $28,003 $22,565 $(1,052) $- $147,241 Cost of goods sold 63,561 17,725 10,807 (497) - 91,596 Gross margin 34,164 10,278 11,758 (555) - 55,645 Selling and administrative expenses 24,392 9,748 10,180 (555) 5,433 49,198 Other periodic pension cost - - - - 213 213 Add: Depreciation and amortization 1,918 911 732 - 103 3,664 Segment Adjusted EBITDA(1) $11,690 $1,441 $2,310 $- $(5,543) $9,898 Branded Products Healthcare Apparel Contact Centers Intersegment Eliminations Other Total For the Three Months Ended December 31, 2022: Net sales $102,040 $26,426 $21,415 $(1,268) $- $148,613 Cost of goods sold 70,712 24,653 9,001 (561) - 103,805 Gross margin 31,328 1,773 12,414 (707) - 44,808 Selling and administrative expenses 22,300 9,246 9,337 (707) 4,146 44,322 Other periodic pension cost - - - - 532 532 Add: Depreciation and amortization 1,769 1,004 676 - 51 3,500 Segment Adjusted EBITDA(1) $10,797 $(6,469) $3,753 $- $(4,627) $3,454 (1) Segment Adjusted EBITDA is our primary measure of segment profitability under U.S. GAAP ASC 280 Segment Reporting. Amounts included in income (loss) before income tax expense and excluded from Segment Adjusted EBITDA include: interest expense, depreciation and amortization expense, impairment charges and the other items not tied to the operational performance of the segment. Total Segment Adjusted EBITDA is a non-GAAP financial measure. Please see reconciliation of Adjusted EBITDA included in the Non-GAAP Financial Measures table above. What were Superior Group of Companies, Inc.'s (SGC) total net sales in Q4 2023? Superior Group of Companies, Inc. (SGC) reported total net sales of $147.2 million in Q4 2023. How did the net income compare in Q4 2023 to the prior year for Superior Group of Companies, Inc. (SGC)? The net income for Superior Group of Companies, Inc. (SGC) rose to $3.6 million in Q4 2023 compared to the prior year. What was the EBITDA for Superior Group of Companies, Inc. (SGC) in Q4 2023? Superior Group of Companies, Inc. (SGC) reported an EBITDA of $9.9 million in Q4 2023, an improvement from $3.5 million in the previous year. What is the full-year 2024 sales forecast for Superior Group of Companies, Inc. (SGC)? Superior Group of Companies, Inc. (SGC) expects full-year 2024 sales to be between $558-568 million. What is the earnings per share outlook for Superior Group of Companies, Inc. (SGC) in 2024? Superior Group of Companies, Inc. (SGC) forecasts earnings per share to be in the range of $0.61-0.68 for 2024."
"Mineralys Therapeutics to Announce Fourth Quarter and Full Year 2023 Financial Results and Host Conference Call on Thursday, March 21, 2024",2024-03-13T20:05:00.000Z,Neutral,Neutral,"Mineralys Therapeutics, Inc. (MLYS) to report financial results for Q4 and full year 2023 on March 21, 2024. The company focuses on developing medicines for hypertension and chronic kidney disease.","Mineralys Therapeutics to Announce Fourth Quarter and Full Year 2023 Financial Results and Host Conference Call on Thursday, March 21, 2024 Rhea-AI Impact (Neutral) Rhea-AI Sentiment (Neutral) Tags earnings Rhea-AI Summary Mineralys Therapeutics, Inc. (MLYS) to report financial results for Q4 and full year 2023 on March 21, 2024. The company focuses on developing medicines for hypertension and chronic kidney disease. Positive None. Negative None. 03/13/2024 - 04:05 PM RADNOR, Pa., March 13, 2024 (GLOBE NEWSWIRE) -- Mineralys Therapeutics, Inc. (NASDAQ: MLYS), a clinical-stage biopharmaceutical company focused on developing medicines to target hypertension, chronic kidney disease (CKD) and other diseases driven by abnormally elevated aldosterone, today announced it will report its financial results from the fourth quarter and full year ended December 31, 2023, before the financial markets open on Thursday, March 21, 2024. Thursday, March 21st @ 8:30 a.m. ET Domestic:1-888-886-7786International:1-416-764-8658Conference ID:27947513Webcast:Link Participants can use the dial-in information above or choose the Call me option (click here) for instant telephone access to the event which will be made active 15 minutes prior to the scheduled start time. A live webcast or replay of the conference call may be found here or on the News & Events page in the Investor Relations section of the Mineralys Therapeutics website. About Mineralys TherapeuticsMineralys Therapeutics is a clinical-stage biopharmaceutical company focused on developing medicines to target hypertension, chronic kidney disease and other diseases driven by abnormally elevated aldosterone. Its initial product candidate, lorundrostat, is a proprietary, orally administered, highly selective aldosterone synthase inhibitor that Mineralys Therapeutics is developing for cardiorenal conditions affected by abnormally elevated aldosterone, including hypertension and CKD. Mineralys is based in Radnor, Pennsylvania, and was founded by Catalys Pacific. For more information, please visit https://mineralystx.com. Contact:Investor Relationsinvestorrelations@mineralystx.com Media RelationsTom WeibleElixir Health Public RelationsPhone: (1) 515-707-9678Email: tweible@elixirhealthpr.com When will Mineralys Therapeutics, Inc. report its financial results for Q4 and full year 2023? Mineralys Therapeutics, Inc. will report its financial results for Q4 and full year 2023 on Thursday, March 21, 2024. What diseases does Mineralys Therapeutics, Inc. focus on developing medicines for? Mineralys Therapeutics, Inc. focuses on developing medicines for hypertension, chronic kidney disease (CKD), and other diseases driven by abnormally elevated aldosterone. What is the ticker symbol for Mineralys Therapeutics, Inc.? The ticker symbol for Mineralys Therapeutics, Inc. is MLYS."
Quoin Pharmaceuticals Provides Corporate Update and Announces Fourth Quarter and 2023 Financial Results,2024-03-13T20:05:00.000Z,Neutral,Neutral,"Quoin Pharmaceuticals Ltd. (QNRX) reports positive initial clinical data for QRX003 in Netherton Syndrome study, lowers enrollment age, and extends cash runway into 2025. Financially, the company had $10.7 million in cash by December 31, 2023, with a net loss of $2.0 million for the quarter.","Quoin Pharmaceuticals Provides Corporate Update and Announces Fourth Quarter and 2023 Financial Results Rhea-AI Impact (Neutral) Rhea-AI Sentiment (Neutral) Tags earnings Rhea-AI Summary Quoin Pharmaceuticals Ltd. (QNRX) reports positive initial clinical data for QRX003 in Netherton Syndrome study, lowers enrollment age, and extends cash runway into 2025. Financially, the company had $10.7 million in cash by December 31, 2023, with a net loss of $2.0 million for the quarter. Positive Positive initial clinical data for QRX003 in Netherton Syndrome study Lowered eligibility age for enrollment to fourteen years and older No safety concerns observed in ongoing clinical studies Cash runway extended into the second half of 2025 with $6.5 million offering on March 5th Additional extension of cash runway by $8 million Equity Line of Credit arrangement FDA clearance for teen subject recruitment in Netherton Syndrome studies Filed patent applications for novel Netherton Syndrome combination product Positive clinical data from open-label trial with significant improvement in pruritus Improvement in skin scoring system and favorable impression of QRX003 by subjects Financially, $10.7 million in cash, with net loss of $2.0 million for the quarter ended December 31, 2023 Negative None. Medical Research Analyst Quoin Pharmaceuticals Ltd.'s announcement regarding the positive initial clinical data for QRX003 in treating Netherton Syndrome is a significant milestone in the field of rare and orphan diseases. The observed clinical benefits in the first six subjects, coupled with no reported safety concerns, suggest a favorable risk-benefit profile for the drug. This data may expedite the drug's development pathway, potentially leading to an accelerated approval process. The expansion of the trial to include adolescents broadens the potential patient base and underscores the unmet need within this demographic.From a research perspective, the efficacy metrics, such as reduction in pruritus and improvement in skin scoring, are critical. They not only demonstrate QRX003's potential impact on patients' quality of life but also strengthen the drug's value proposition. It is important to monitor the long-term outcomes and any emerging safety data as the trial progresses to ensure these initial results translate into sustained therapeutic benefits. Financial Analyst The financial stability of Quoin Pharmaceuticals, as indicated by its cash runway extension into the second half of 2025, provides the firm with a solid financial footing to continue its clinical trials without the immediate need for further capital raising. This is reassuring for investors, as it suggests that the company can focus on its core operations and drug development without the overhang of short-term financing concerns.Additionally, the $6.5 million capital raise and the $8 million equity line of credit arrangement, pending shareholder approval, are strategic moves that could potentially dilute current shareholders but also provide the necessary funds to reach critical milestones. The net loss figures show a marginal improvement year-over-year, which, while not indicative of profitability, may signal a controlled burn rate and efficient use of capital in the company's operations. Market Research Analyst The market potential for QRX003 targeting Netherton Syndrome, a rare and underserved condition, could be substantial given the lack of approved treatments. The company's strategic patent filings for a novel combination product further indicate an attempt to solidify its market position and create barriers to entry for competitors.Investors and stakeholders should consider the implications of Quoin's recent FDA clearances and clinical optimizations, as these developments may enhance the company's reputation and credibility within the biopharmaceutical sector. The market reaction to these milestones will likely be contingent upon continued positive data and the successful navigation of the regulatory pathway. 03/13/2024 - 04:05 PM Company reported positive initial clinical data for QRX003 from first six evaluable subjects in ongoing open-label Netherton Syndrome study with positive benefits observed across a number of clinical endpoints Eligibility age for enrollment into both studies has been lowered to fourteen years and older No safety concerns have been observed to date in either ongoing clinical study Quoin expects its cash runway will extend into the second half of 2025 following $6.5 million offering on March 5th Cash Runway to be further extended by $8 million Equity Line of Credit arrangement signed January 25, 2024 ASHBURN, Va., March 13, 2024 (GLOBE NEWSWIRE) -- Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (the Company or Quoin), a clinical stage, specialty pharmaceutical company focused on rare and orphan diseases, today provides a business update and announces financial results for the quarter and year ended December 31, 2023. Quoin CEO, Dr. Michael Myers, said, 2023 marked another year of significant progress for Quoin and for the development of QRX003 for the treatment of Netherton Syndrome. Notably, we released initial positive data from our open label clinical study, representing a first for the very underserved Netherton community. That progress has continued, and based on the strength of the initial positive clinical data, we implemented a number of important protocol changes that we believe could lead to a more streamlined development program overall. We have also strengthened our balance sheet through the recently completed $6.5 million capital raise and we have the capacity to further solidify our cash position via the $8.0 million equity line of credit transaction we entered into earlier this year, once shareholder approval is received. We continue to believe that Quoin is in position to deliver the first approved treatment for this terrible disease. Recent Corporate Highlights  On March 4th, Quoin announced FDA Clearance to recruit teen subjects into both ongoing Netherton Syndrome clinical studies.On February 8th, 2024, Quoin filed U.S. and International patent applications for a novel Netherton Syndrome combination product.On December 13th, Quoin announced FDA clearance of the Clinical Optimization Plan for QRX003 for Netherton SyndromeOn October 24th, Quoin announced positive clinical data from the first six evaluable patients in the companys open-label clinical trial in Netherton Syndrome patients. Five of the six subjects reported that their pruritus, or itch, was either negligible or absent following treatment with QRX003, a significant improvement from prior to the study.All six subjects exhibited improvement in the Investigator assessed skin scoring system with three subjects showing improvement at the completion of the study and the other three at various points during the study.All six subjects expressed a favorable impression of QRX003 across multiple assessed metrics.No safety concerns have been reported to date for any subject in either of Quoins studies. Financial Highlights Quoin had approximately $10.7 million in cash, cash equivalents and marketable securities as of December 31, 2023. This does not include the proceeds from the $6.5 million public offering of common shares that the company announced on March 5, 2024, nor the anticipated proceeds from the $8 million equity line of credit transaction which was entered into in January of this year. Implementation of this remains subject to shareholder approval.Net loss for the quarter ended December 31, 2023 was approximately $2.0 million compared to approximately $2.0 million for the quarter ended December 31, 2022. Net loss for the twelve months ended December 31, 2023 was $8.7 million compared to $9.4 million for the twelve months ended December 31, 2022.Investors are encouraged to read the Companys Annual Report on Form 10-K when it is filed with the Securities and Exchange Commission (the SEC), which will contain additional details about Quoins financial results as of and for the period ended December 31, 2023. Quoin will host a conference call and webcast at 8:30am ET on Thursday, March 14, 2024. The call will include a discussion of fourth quarter and full year 2023 financial results and a corporate update. The live call can be accessed by dialing 1-800-603-0527 (domestic) or 1-412-317-0688 (international). The live and archived webcast of the call will also be available on the Quoin Pharmaceuticals website under the Investors section or by following this link: https://event.choruscall.com/mediaframe/webcast.html?webcastid=ZmehVyN5 About Quoin Pharmaceuticals Ltd. Quoin Pharmaceuticals Ltd. is a clinical stage specialty pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases. We are committed to addressing unmet medical needs for patients, their families, communities and care teams. Quoins innovative pipeline comprises four products in development that collectively have the potential to target a broad number of rare and orphan indications, including Netherton Syndrome, Peeling Skin Syndrome, Palmoplantar Keratoderma, Scleroderma, Epidermolysis Bullosa and others. For more information, visit: www.quoinpharma.com or LinkedIn for updates. Cautionary Note Regarding Forward Looking Statements The Company cautions that statements in this press release that are not a description of historical facts are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements may be identified by the use of words referencing future events or circumstances such as expect, intend, plan, anticipate, believe, and will, among others. All statements that reflect the Companys expectations, assumptions, projections, beliefs, or opinions about the future, other than statements of historical fact, are forward-looking statements, including, without limitation, statements relating to the Companys expected cash runway, the belief that certain protocol changes could lead to a more streamlined development program and the belief that the Company is in a position to deliver the first approved treatment for Netherton Syndrome. Because such statements are subject to risks and uncertainties, actual results may differ materially from those expressed or implied by such forward-looking statements. These forward-looking statements are based upon the Companys current expectations and involve assumptions that may never materialize or may prove to be incorrect. Actual results and the timing of events could differ materially from those anticipated in such forward-looking statements as a result of various risks and uncertainties. More detailed information about the risks and uncertainties affecting the Company is contained under the heading Risk Factors included in the Companys Annual Report on Form 10-K for the year ended December 31, 2023 that the Company filed with the SEC. One should not place undue reliance on these forward-looking statements, which speak only as of the date on which they were made. The Company undertakes no obligation to update such statements to reflect events that occur or circumstances that exist after the date on which they were made, except as may be required by law. For further information: PCG Advisory Stephanie Prince sprince@pcgadvisory.com (646) 863-6341 -Tables Follow- QUOIN PHARMACEUTICALS LTD. Consolidated Balance Sheets December 31, December 31, 2023 2022 ASSETS Current assets: Cash and cash equivalents $2,401,198 $2,860,628 Investments 8,293,663 9,992,900 Prepaid expenses and other current assets 591,034 516,584 Total current assets 11,285,895 13,370,112 Prepaid expenses - long term 300,000 383,390 Intangible assets, net 583,334 704,561 Total assets $12,169,229 $14,458,063 LIABILITIES AND SHAREHOLDERS' EQUITY Current liabilities: Accounts payable $526,523 $605,600 Accrued expenses 1,308,706 1,175,705 Accrued interest and financing expense 1,146,251 1,146,251 Due to officers - short term 600,000 600,000 Total current liabilities 3,581,480 3,527,556 Due to officers - long term 2,923,733 3,523,733 Total liabilities $6,505,213 $7,051,289 Commitments and contingencies Shareholders' equity: Ordinary shares, no par value per share, 100,000,000 and 8,333,334 ordinary shares authorized at December 31, 2023 and 2022, respectively - 987,220 (987,220 ADS's) $- $- ordinary shares issued and outstanding at December 31, 2023 and 403,887 (403,887 ADS's) at December 31, 2022 Treasury stock, - (2,932,000)-0- ordinary shares issued at December 31, 2023 and 45 ordinary shares issued at December 31, 2022 Additional paid in capital 51,867,336 47,855,521 Accumulated deficit (46,203,320) (37,516,747)Total shareholders' equity 5,664,016 7,406,774 Total liabilities and shareholders' equity $12,169,229 $14,458,063 QUOIN PHARMACEUTICALS LTD. Consolidated Statements of Operations Years Ended December 31, Three months ended December 31, 2023 2022 2023 2022 (Audited) (Audited) (Unaudited) (Unaudited)Operating expenses General and administrative$6,070,517 $6,584,868 $1,385,276 $1,472,866 Research and development 3,307,987 2,672,836 832,391 613,067 Total operating expenses 9,378,504 9,257,704 2,217,667 2,085,933 Other (income) and expenses Forgiveness of accounts payable - (416,000) - - Warrant liability (income) expense - (77,237) - - Unrealized loss (gain) 2,683 (1,307) (9,243) (4,360)Realized and accrued interest income (694,614) (95,745) (158,546) (80,613)Interest and financing expense - 714,081 - - Total other (income) expense (691,931) 123,792 (167,789) (84,973)Net loss$(8,686,573) $(9,381,496) $(2,049,878) $(2,000,960)Deemed dividend on warrant modification - (65,266) - - Net loss attributable to shareholders$(8,686,573) $(9,446,762) $(2,049,878) $(2,000,960) Loss per ADS Basic$(9.64) $(46.81) $(2.08) $(4.95)Fully-diluted$(9.64) $(46.81) $(2.08) $(4.95) Weighted average number of ADS's outstanding Basic 900,919 201,826 987,220 403,884 Fully-diluted 900,919 201,826 987,220 403,884 What is the ticker symbol for Quoin Pharmaceuticals Ltd.? The ticker symbol for Quoin Pharmaceuticals Ltd. is QNRX. What positive clinical data was reported for QRX003 in the Netherton Syndrome study? Positive initial clinical data was reported for QRX003 in the Netherton Syndrome study, showing benefits across various clinical endpoints. What changes were made to the eligibility age for enrollment into the studies? The eligibility age for enrollment into both studies has been lowered to fourteen years and older. How has Quoin extended its cash runway? Quoin extended its cash runway into the second half of 2025 with a $6.5 million offering on March 5th and further extended it by $8 million through an Equity Line of Credit arrangement. What recent FDA clearance did Quoin announce? Quoin announced FDA Clearance to recruit teen subjects into both ongoing Netherton Syndrome clinical studies. What were the financial highlights for Quoin Pharmaceuticals Ltd. by December 31, 2023? Quoin had approximately $10.7 million in cash, cash equivalents, and marketable securities by December 31, 2023, with a net loss of $2.0 million for the quarter."
PagerDuty Appoints Teresa Carlson to Board of Directors,2024-03-13T20:05:00.000Z,Low,Very Positive,"PagerDuty, Inc. appoints Teresa Carlson, a former AWS, Splunk, and Microsoft executive, to its Board of Directors. Carlson brings over 25 years of industry experience in digital operations management, SaaS, data management, and cloud businesses. Her expertise will aid PagerDuty in scaling global organizations and growing enterprise and public sector businesses.","PagerDuty Appoints Teresa Carlson to Board of Directors Rhea-AI Impact (Low) Rhea-AI Sentiment (Very Positive) Tags management Rhea-AI Summary PagerDuty, Inc. appoints Teresa Carlson, a former AWS, Splunk, and Microsoft executive, to its Board of Directors. Carlson brings over 25 years of industry experience in digital operations management, SaaS, data management, and cloud businesses. Her expertise will aid PagerDuty in scaling global organizations and growing enterprise and public sector businesses. Positive None. Negative None. 03/13/2024 - 04:05 PM Former AWS, Splunk and Microsoft Executive Brings Go-to-Market, Public Sector and Operations Expertise SAN FRANCISCO--(BUSINESS WIRE)-- PagerDuty, Inc. (NYSE:PD), a global leader in digital operations management, announced today the appointment of Teresa Carlson to the companys Board of Directors. Carlson brings more than 25 years of industry experience and expertise in leading complex business transformations for premier SaaS, data management and cloud businesses, including Amazon Web Services (AWS), Splunk, Microsoft and General Catalyst. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240313201924/en/Teresa Carlson, a member of PagerDuty's Board of Directors (Photo: Business Wire) Teresa is an accomplished go-to-market leader in both private and public sectors, with a proven track record scaling global organizations, said Jennifer Tejada, PagerDuty Chairperson and CEO. As PagerDuty continues to build momentum and deliver on the promises of the PagerDuty Operations Cloud, Teresas industry accomplishments and cloud expertise will be valuable as we continue to grow our enterprise and public sector businesses. Carlson spent more than a decade at AWS where she started the Worldwide Public Sector business unit, which included federal, central, and state and local governments, Education, Education Technology (EdTech), Government Technology (GovTech), nonprofits and non-governmental organizations (NGOs). She also started an aerospace and satellite business unit and added responsibilities for other regulated industries. Previously, she was President and Chief Growth Officer at Splunk where Carlson was responsible for aligning sales, customer success and marketing leaders to drive business transformation across go-to-market business segments. During her time on Splunks executive leadership team, she successfully advanced cloud-first initiatives, created new market opportunities and accelerated growth. Additionally, Carlson served as Vice President of Microsoft Federal Government, where she oversaw the companys US Federal Government business. Carlson holds a bachelor of science and a master of science degree from Western Kentucky University. PagerDuty has long been a company that Ive admired for its visionary leadership, industry-leading technology and tens of thousands of passionate customers, stated Carlson. Right now CIOs, CTOs and CEOs of all organizations are focused on leveraging technology to gain a competitive advantage. I look forward to bringing my go-to-market expertise to PagerDuty, supporting Jennifer, and working with my fellow board members. About PagerDuty Inc. PagerDuty, Inc. (NYSE:PD) is a global leader in digital operations management. The PagerDuty Operations Cloud revolutionizes how critical work gets done, and powers the agility that drives digital transformation. Customers rely on the PagerDuty Operations Cloud to compress costs, accelerate productivity, win revenue, sustain seamless digital experiences, and earn customer trust. More than half of the Fortune 500 and more than two-thirds of the Fortune 100 trust PagerDuty, including Cisco, Cox Automotive, DoorDash, Electronic Arts, Genentech, Shopify, Zoom and more. To learn more and try PagerDuty for free, visit www.pagerduty.com. Follow our blog and connect with us on LinkedIn, X, YouTube and Facebook. Were also hiring, visit https://www.careers.pagerduty.com/ to learn more. The PagerDuty Operations Cloud The PagerDuty Operations Cloud is the platform for mission-critical, time-critical operations work in the modern enterprise. Through the power of AI and automation, it detects and diagnoses disruptive events, mobilizes the right team members to respond, and streamlines infrastructure and workflows across your digital operations. The Operations Cloud is essential infrastructure for revolutionizing digital operations to compete and win as a modern digital business. View source version on businesswire.com: https://www.businesswire.com/news/home/20240313201924/en/ Media Contact: Debbie OBrien media@pagerduty.com Investor Relations Contact: Tony Righetti investor@pagerduty.com SOURCE PagerDuty Source: PagerDuty, Inc. Who was appointed to PagerDuty's Board of Directors? Teresa Carlson, a former AWS, Splunk, and Microsoft executive. What is Teresa Carlson's expertise? She has over 25 years of experience in digital operations management, SaaS, data management, and cloud businesses. What impact will Teresa Carlson's appointment have on PagerDuty? Her expertise will help PagerDuty scale global organizations and grow its enterprise and public sector businesses. What are Teresa Carlson's key accomplishments? She started the Worldwide Public Sector business unit at AWS, led sales alignment at Splunk, and oversaw Microsoft Federal Government business. What degrees does Teresa Carlson hold? She holds a bachelor's and a master's degree from Western Kentucky University."
Culture Kings Returns as an Official Partner of Rolling Loud California,2024-03-13T20:05:00.000Z,Low,Very Positive,"Culture Kings partners with Rolling Loud California for the second consecutive year, presenting an exclusive merchandise capsule and branded stage at the hip-hop festival. Attendees can shop the limited-edition collection online or at the festival's pop-up shop.","Culture Kings Returns as an Official Partner of Rolling Loud California Rhea-AI Impact (Low) Rhea-AI Sentiment (Very Positive) Tags Rhea-AI Summary Culture Kings partners with Rolling Loud California for the second consecutive year, presenting an exclusive merchandise capsule and branded stage at the hip-hop festival. Attendees can shop the limited-edition collection online or at the festival's pop-up shop. Positive None. Negative None. 03/13/2024 - 04:05 PM Culture Kings x Rolling Loud Capsule Available Now! LAS VEGAS--(BUSINESS WIRE)-- Culture Kings, a premier international streetwear brand and retail destination, proudly announces its return as an official partner of Rolling Loud California, taking place in Inglewood, CA from March 14th to March 17th, 2024. This marks the second consecutive year of the global partnership between Culture Kings and Rolling Loud, the Worlds Largest Hip-Hop Festival, further solidifying the brands commitment to music, fashion, and culture. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240313503909/en/Culture Kings proudly returns as an official partner of Rolling Loud California. (Photo: Business Wire) As part of this exciting collaboration, Culture Kings will once again serve as the official streetwear retailer at the renowned hip-hop festival, presenting an exclusive Rolling Loud merchandise capsule commemorating the partnership. Attendees can shop the limited-edition collection online or at the branded pop-up shop on-site at the festival. Additionally, Culture Kings will present a branded stage at Rolling Loud California, showcasing some of music's most vital emerging artists. This stage will be a hub of energy and excitement, featuring electrifying performances that embody the spirit attendees have grown to love since the inception of the iconic festival. Culture Kings will also elevate the experience by constructing a branded basketball court on-site, providing festival-goers with a unique and interactive space to engage with the brand. Culture Kings and Rolling Loud share a passion for pushing culture forward with music and fashion, and we are excited to continue our partnership through Rolling Loud California 2024, said Rolling Loud Co-Founders/Co-CEOs Matt Zingler and Tariq Cherif. The Culture Kings Stage will showcase some of the most exciting rising rappers in the game today, including local heroes from L.A. and the West Coast, and we know fans will love what we cooked up for our 2024 merch collab. Were excited to team up with Rolling Loud yet again and bring Culture Kings disruptive retailtainment ethos to life on our branded stage, through our exclusive capsule collection with our merch customization station, and our Culture Kings Court basketball activation. As huge fans of the Rolling Loud festivals, were confident that our brand activations will create a memorable experience for festival-goers and make this Rolling Loud x Culture Kings experience one for the books, said Jonathan Yuska, Culture Kings U.S. President. Culture Kings exclusive merchandise for Rolling Loud California will be available for purchase at the festival and online for a limited time. For more information, please visit the Rolling Loud page on Culture Kings website HERE. About Culture Kings: Culture Kings is a premier international streetwear brand and retail destination, standing at the intersection of fashion, art, sports, and music, and a leader in the worldwide streetwear phenomenon. With roots in Australias Gold Coast, the Culture Kings brand has become internationally recognized for its immersive shopping experiences, both online and in-stores, with 9 incredible retail stores across in the United States, Australia and New Zealand that offer customers top brands and exclusive products, live DJs, Holy Grail arcades, basketball courts, and music performances. About Rolling Loud: Founded by 7-time Billboard Hip-Hop Power Players Matt Zingler & Tariq Cherif as a one-day Miami show, Rolling Loud has grown into a global festival phenomenon, putting on shows on both coasts and in multiple countries across four continents. Rolling Loud is the Worlds Largest Hip-Hop Festival, known for its expert curation of wide-ranging lineups that reflect the state of the genre. In 2023, Rolling Loud expanded its empire even further, hosting a series of star-studded festivals in all corners of the globe, including debuts in Thailand and Germany, plus its flagship affair, Rolling Loud Miami, which offered its most diverse and wide-ranging lineup to date. Throughout 2024, Rolling Loud commemorates ""10 Years Of Rolling Loud,"" celebrating the festival's rise from humble origins to world dominance. Since the first Miami festival, Rolling Loud has evolved into a major force in hip-hop, providing a massive stage for rap's biggest names, giving early exposure to future superstars, including Travis Scott, Juice WRLD, and Ice Spice, and inspiring some of the most memorable moments in the genre's recent history. Now, Rolling Loud is hip-hops biggest stage, with star-studded festivals on four continents and more milestones to come. Stay tuned for announcements about Rolling Loud's 2024 World Tour, including upcoming festivals in Los Angeles, Europe, and more. View source version on businesswire.com: https://www.businesswire.com/news/home/20240313503909/en/ Media Contact media@aka-brands.com Source: a.k.a. Brands What is the partnership between Culture Kings and Rolling Loud California about? Culture Kings partners with Rolling Loud California, presenting an exclusive merchandise capsule and branded stage at the hip-hop festival. Where can attendees shop the limited-edition collection? Attendees can shop the limited-edition collection online or at the festival's pop-up shop. What will Culture Kings present at Rolling Loud California in addition to the merchandise capsule? Culture Kings will present a branded stage at Rolling Loud California, showcasing emerging artists and constructing a branded basketball court on-site. Who are the Co-Founders/Co-CEOs of Rolling Loud? The Co-Founders/Co-CEOs of Rolling Loud are Matt Zingler and Tariq Cherif."
electroCore Announces Fourth Quarter and Full Year 2023Financial Results,2024-03-13T20:05:00.000Z,Neutral,Negative,"electroCore, Inc. (ECOR) reported a significant increase in net sales for the full year 2023, reaching $16.0 million, an 87% growth over 2022. The company highlighted revenue growth across major channels, including prescription gammaCore devices and nonprescription products. Despite a rise in gross profit and a decrease in research and development expenses, the company faced increased operating expenses, resulting in a GAAP net loss of $18.8 million for 2023. Adjusted EBITDA net loss improved in Q4 2023 compared to Q4 2022. The company's cash position decreased from $18.0 million in 2022 to $10.6 million in 2023, despite raising $7.5 million through a direct offering in July 2023.","electroCore Announces Fourth Quarter and Full Year 2023 Financial Results Rhea-AI Impact (Neutral) Rhea-AI Sentiment (Negative) Tags earnings Rhea-AI Summary electroCore, Inc. (ECOR) reported a significant increase in net sales for the full year 2023, reaching $16.0 million, an 87% growth over 2022. The company highlighted revenue growth across major channels, including prescription gammaCore devices and nonprescription products. Despite a rise in gross profit and a decrease in research and development expenses, the company faced increased operating expenses, resulting in a GAAP net loss of $18.8 million for 2023. Adjusted EBITDA net loss improved in Q4 2023 compared to Q4 2022. The company's cash position decreased from $18.0 million in 2022 to $10.6 million in 2023, despite raising $7.5 million through a direct offering in July 2023. Positive Significant increase in net sales for electroCore, Inc. (ECOR) in 2023, reaching $16.0 million, an 87% growth over 2022. Revenue growth seen across major channels, including prescription gammaCore devices and nonprescription products. Gross profit for 2023 was $13.2 million with a gross margin of 83%, up from $7.0 million and 81% in 2022. Operating expenses increased to approximately $32.5 million in 2023 compared to $29.9 million in 2022. Research and development expenses decreased to $5.3 million in 2023 due to cost-cutting measures. GAAP net loss for 2023 was $18.8 million, an improvement from the $22.2 million net loss in 2022. Adjusted EBITDA net loss improved in Q4 2023 to $2.9 million from $4.7 million in Q4 2022. Net cash used in operating activities decreased to $14.7 million in 2023 from $16.6 million in 2022. Cash position decreased from $18.0 million in 2022 to $10.6 million in 2023, despite raising $7.5 million through a direct offering in July 2023. Negative Decrease in cash position from $18.0 million in 2022 to $10.6 million in 2023 despite raising $7.5 million through a direct offering in July 2023. Financial Analyst An 87% increase in net sales for electroCore is a significant leap, indicative of a robust demand for the company's bioelectronic medicine and wellness products. The gross margin improvement from 81% to 83% suggests that the company is effectively managing its cost of goods sold (COGS), a key indicator of operational efficiency and profitability. However, the reported GAAP net loss of $18.8 million, despite being an improvement over the previous year's $22.2 million, raises concerns about the company's current profitability and cash burn rate.Investors should note the company's cash position which decreased from $18.0 million to $10.6 million year-over-year, signaling a substantial cash burn despite the capital raised in July. This trend, if sustained, could lead to future liquidity challenges or the need for additional funding, which might dilute current shareholders or impose additional debt burdens.Adjusted EBITDA net loss figures are often scrutinized as they exclude certain expenses that are nonetheless real costs to the business. The improvement in adjusted EBITDA net loss from $19.0 million to $15.4 million indicates some level of cost control, but stakeholders should be wary of overreliance on these figures for a true health assessment of the company. Market Research Analyst The substantial revenue growth in the prescription gammaCore segment, particularly from the VA/DoD channel, suggests that electroCore is gaining traction within the governmental healthcare sector, which is a promising sign for future contracts and stability. The expansion in international sales and the successful introduction of nonprescription products like Truvaga and TAC-STIM also highlight the company's diversification strategy and potential for market expansion.However, the slight decrease in U.S. commercial sales of Rx gammaCore raises questions about market saturation or competitive pressures in the domestic market. It is important to analyze the company's marketing strategies and customer acquisition costs to ensure that the increased spending in these areas is yielding proportional benefits.Investors should consider the company's product pipeline and any upcoming regulatory milestones that could significantly impact future sales. The R&D investments mentioned by the company in smart phone-integrated therapies could represent a strategic move to capitalize on the growing digital health market. Medical Research Analyst The performance of electroCore's medical devices, such as gammaCore, is a testament to the increasing acceptance and integration of bioelectronic medicine into treatment paradigms. The technology's non-invasive nature and application in various conditions, including migraine and cluster headache, may be driving its adoption. The company's ability to maintain a high gross margin suggests that its products have a competitive edge in terms of cost-effectiveness and value proposition to healthcare providers.Future R&D focus on smart phone-connected therapies could tap into the trend of personalized and accessible healthcare solutions. The efficacy and user-friendliness of such technologies will be critical for their success. It will be important to monitor clinical trial outcomes and peer-reviewed publications to assess the potential impact of these therapies on patient outcomes and healthcare costs. 03/13/2024 - 04:05 PM Record full year 2023 net sales of $16.0 million increased 87% over $8.6 million for the full year 2022 Company to host conference call and webcast today, March 13, 2024 at 4:30pm EST ROCKAWAY, N.J., March 13, 2024 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR) (the Company), a commercial-stage bioelectronic medicine and wellness company, today announced fourth quarter and full year 2023 financial results. Fourth Quarter 2023 and Recent Highlights Reported record full year of 2023 revenue of $16.0 million, an increase of approximately 87% over full year of 2022Record revenue in the fourth quarter of 2023 of $5.2 million, an increase of approximately 103% over the fourth quarter of 2022 Fourth Quarter and Full Year 2023 Financial Results For the year ended December 31, 2023, electroCore reported net sales of $16.0 million, compared to $8.6 million during the same period of 2022, which represents an approximately 87% increase over the prior year. The increase of $7.4 million is due to an increase in net sales across major channels including our prescription gammaCore medical devices sold in the U.S. and abroad; and revenue from the sales of our nonprescription general well-being and human performance Truvaga and TAC-STIM products. Three months ended Year ended(in thousands)December 31, December 31, Channel2023 2022 % Change 2023 2022 % ChangeRx gammaCore  VA/DoD$3,113 $1,539 102% $9,636 $5,099 89% Rx gammaCore  U.S. Commercial 483 489 (1%) 1,797 1,735 4% Outside the United States 523 429 22% 1,821 1,618 13% Truvaga 323 15 * 1,027 15 * TAC-STIM 749 88 * 1,749 125 * $5,191 $2,560 103% $16,030 $8,592 87% * not applicable Gross profit for the full year of 2023 was $13.2 million as compared to $7.0 million for the full year of 2022. Gross margin was 83% and 81% for the years ended December 31, 2023 and 2022, respectively. Total operating expenses for the full year of 2023 were approximately $32.5 million, as compared to $29.9 million for the full year of 2022. Research and development expense for the full year of 2023 was $5.3 million as compared to $5.5 million for the full year of 2022. This decrease in research and development expense was due to a decrease in compensation associated with cost cutting measures effected April 1, 2023, offset by targeted investments to support the future iterations of our therapy delivery platform, including the use of our intellectual property around the delivery of smart phone-integrated and smart phone-connected non-invasive therapies. Selling, general and administrative expense for the full year of 2023 was $27.2 million as compared to $24.3 million for the full year of 2022. This increase was due to greater variable selling and marketing costs consistent with our increase in sales and severance charges, offset by decreases in insurance and stock-based compensation expenses. GAAP net loss for the full year of 2023 was $18.8 million, as compared to the $22.2 million net loss for the full year of 2022. Adjusted EBITDA net loss in the fourth quarter of 2023 was a loss of $2.9 million as compared to a loss of $4.7 million in the fourth quarter of 2022. Adjusted EBITDA net loss for the full year of 2023 was a loss of $15.4 million, as compared to an adjusted EBITDA net loss of $19.0 million for the full year of 2022. The Company defines adjusted EBITDA net loss as GAAP net loss, adjusting to exclude non-operating gains/losses, depreciation and amortization, stock-compensation expense, write-off of right of use operating lease, inventory reserve charges, legal fees associated with stockholders litigation, and provision/benefit from income taxes. A reconciliation of GAAP net loss to Non-GAAP adjusted EBITDA net loss has been provided in the financial statement tables included in this press release. Net cash used in operating activities for the full year ended December 31, 2023 was $14.7 million, as compared to $16.6 million for the full year of 2022. Cash, cash equivalents and restricted cash at December 31, 2023, totaled approximately $10.6 million, as compared to approximately $18.0 million as of December 31, 2022. In July 2023, the Company raised net proceeds of approximately $7.5 million through a registered direct offering and concurrent private placements priced at the market under NASDAQ rules. Webcast and Conference Call Information electroCores management team will host a conference call today, March 13, 2024, beginning at 4:30 pm EST. Investors interested in listening to the conference call or webcast may do so by dialing 877-407-8835 for domestic callers or 201-689-8779 for international callers, using conference ID: 13744117, or connecting to the Web at: https://event.choruscall.com/mediaframe/webcast.html?webcastid=ISZCGFO3. An archived webcast of the event will be available on the Investors section of the Companys website at: www.electrocore.com. About electroCore, Inc. electroCore, Inc. is a commercial stage bioelectronic medicine and wellness company dedicated to improving health through its non-invasive vagus nerve stimulation (nVNS) technology platform. Our focus is the commercialization of medical devices for the management and treatment of certain medical conditions and consumer product offerings utilizing nVNS to promote general wellbeing and human performance in the United States and select overseas markets. For more information, visit www.electrocore.com. Forward-Looking StatementsThis press release and other written and oral statements made by representatives of electroCore may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements include, but are not limited to, statements about, electroCores business prospects and clinical and product development plans; its pipeline or potential markets for its technologies; the timing, outcome and impact of regulatory, clinical and commercial developments; business prospects around its general wellness Truvaga and TAC-STIM products and other new products and markets, and other statements that are not historical in nature, particularly those that utilize terminology such as anticipates, will, expects, believes, intends, and other words of similar meaning, derivations of such words and the use of future dates. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the ability to raise the additional funding needed to continue to pursue electroCores business and product development plans, the inherent uncertainties associated with developing new products or technologies, the ability to commercialize gammaCore, TAC-STIM, and Truvaga, electroCores results of operations and financial performance, inflation and currency fluctuations, and any expectations electroCore may have with respect thereto, competition in the industry in which electroCore operates and overall economic and market conditions. Any forward-looking statements are made as of the date of this press release, and electroCore assumes no obligation to update the forward-looking statements or to update the reasons why actual results could differ from those projected in the forward-looking statements, except as required by law. Investors should consult all of the information set forth herein and should also refer to the risk factor disclosure set forth in the reports and other documents electroCore files with the SEC available at www.sec.gov. Contact:ECOR Investor Relations(973) 302-9253investors@electrocore.com electroCore, Inc.Consolidated Statements of Operations(in thousands, except per share data) Three months ended Year ended December 31, December 31, 2023 2022 2023 2022Net sales$5,191 $2,560 $16,030 $8,592 Cost of goods sold 1,100 640 2,804 1,616 Gross profit 4,091 1,920 13,226 6,976 Operating expenses Research and development 1,108 1,628 5,321 5,520 Selling, general and administrative 6,941 6,209 27,174 24,330 Total operating expenses 8,049 7,837 32,495 29,850 Loss from operations (3,958) (5,917) (19,269) (22,874)Other (income) expense Interest and other income (135) (142) (433) (287)Other expense 184 1 184 6 Total other income 49 (141) (249) (281)Loss before income taxes (4,007) (5,776) (19,020) (22,593)(Provision) Benefit from income taxes (25) (14) 186 431 Net loss$(4,032) $(5,790) $(18,834) $(22,162)Net loss per share of common stock - Basic and Diluted$(0.61) $(1.22) $(3.42) $(4.69)Weighted average number of common shares outstanding - Basic and Diluted 6,616 4,744 5,515 4,729 All common stock share and per share data reflects the reverse stock split effective February 15, 2023. electroCore, Inc. Consolidated Balance Sheet Information(in thousands) December 31, 2023 December 31, 2022Cash and cash equivalents$10,331 $17,712 Restricted cash$250 $250 Total assets$16,102 $24,756 Current liabilities$8,123 $7,045 Total liabilities$8,660 $7,670 Total equity$7,442 $17,086 (Unaudited) Use of Non-GAAP Financial Measure The Company is presenting adjusted EBITDA net loss because it believes this measure is a useful indicator of its operating performance. Management uses this non-GAAP measure principally as a measure of the Companys core operating performance and believes that this measure is useful to investors because it is frequently used by the financial community, investors, and other interested parties to evaluate companies in the Companys industry. The Company also believes that this measure is useful to its management and investors as a measure of comparative operating performance from period to period. Additionally, the Company believes its use of non-GAAP adjusted EBITDA net loss from operations facilitates managements internal comparisons to historical operating results by factoring out potential differences caused by gains and charges not related to its regular, ongoing business, including, without limitation, non-cash charges and certain large and unpredictable charges such as restructuring expenses. The Company defines adjusted EBITDA net loss as GAAP net loss, adjusting to exclude non-operating gains/losses, depreciation and amortization, stock-compensation expense, write-off of right of use operating lease, inventory reserve charges, legal fees associated with stockholders litigation, and provision/benefit from income taxes. A reconciliation of GAAP net loss to Non-GAAP adjusted EBITDA net loss is provided in the financial statement table below. Three months ended Year ended December 31, December 31, (in thousands)2023 2022 2023 2022GAAP net loss$(4,032) $(5,790) $(18,834) $(22,162)Depreciation and amortization 227 148 962 548 Stock-based compensation 400 587 1,698 2,682 Inventory reserve charge 424 217 682 217 Severance and other related charges 19 - 464 - Legal fees associated with stockholders litigation 8 251 50 400 Interest and other income / expense 49 (141) (249) (281)Provision (benefit) from income taxes 25 14 (186) (431)Adjusted EBITDA net loss$(2,880) $(4,714) $(15,413) $(19,027) The Companys use of a non-GAAP measure has limitations as an analytical tool, and you should not consider it in isolation or as a substitute for analysis of its results as reported under GAAP. Some of these limitations are: (i) the non-GAAP measure does not reflect interest or tax payments that may represent a reduction in cash available; (ii) although depreciation and amortization are non-cash charges, the assets being depreciated and amortized may have to be replaced in the future, and the non-GAAP measure does not reflect cash capital expenditure requirements for such replacements or for new capital expenditure requirements; (iii) the non-GAAP measure does not reflect the potentially dilutive impact of equity-based compensation; and (iv) the non-GAAP measure does not reflect changes in, or cash requirements for working capital needs; other companies, including companies in electroCores industry, may calculate adjusted EBITDA net loss differently, effectively reducing its usefulness as a comparative measure. Because of these and other limitations, you should consider the non-GAAP measure together with other GAAP-based financial performance measures, including various cash flow metrics, net loss, and other GAAP results. A reconciliation of GAAP net loss to non-GAAP adjusted EBITDA net loss has been provided in the preceding financial statements table of this press release. What were electroCore, Inc.'s (ECOR) net sales for the full year 2023? electroCore reported net sales of $16.0 million for the full year 2023, representing an 87% increase over 2022. What contributed to the increase in net sales for electroCore in 2023? The increase in net sales was attributed to growth across major channels, including prescription gammaCore devices and revenue from nonprescription products. What was electroCore's gross profit for 2023? electroCore's gross profit for 2023 was $13.2 million with a gross margin of 83%. How did electroCore's operating expenses change in 2023 compared to 2022? Operating expenses increased to approximately $32.5 million in 2023 from $29.9 million in 2022. What was electroCore's GAAP net loss for 2023? electroCore reported a GAAP net loss of $18.8 million for 2023, an improvement from the $22.2 million net loss in 2022."
SuRo Capital Corp. Reports Fourth Quarter and Fiscal Year 2023 Financial Results,2024-03-13T20:05:00.000Z,Neutral,Neutral,"SuRo Capital Corp. announces a Net Asset Value of $7.99 per share as of December 31, 2023, along with a Modified Dutch Auction Tender Offer to repurchase up to 2 million shares. The company's financial results for Q4 and fiscal year 2023 show net assets of approximately $203.4 million, with notable investments in various portfolio companies. SuRo Capital aims to enhance shareholder value through strategic initiatives and believes the market undervalues its portfolio.","SuRo Capital Corp. Reports Fourth Quarter and Fiscal Year 2023 Financial Results Rhea-AI Impact (Neutral) Rhea-AI Sentiment (Neutral) Tags earnings Rhea-AI Summary SuRo Capital Corp. announces a Net Asset Value of $7.99 per share as of December 31, 2023, along with a Modified Dutch Auction Tender Offer to repurchase up to 2 million shares. The company's financial results for Q4 and fiscal year 2023 show net assets of approximately $203.4 million, with notable investments in various portfolio companies. SuRo Capital aims to enhance shareholder value through strategic initiatives and believes the market undervalues its portfolio. Positive None. Negative None. Financial Analyst The reported Net Asset Value (NAV) of $7.99 per share by SuRo Capital as of December 31, 2023, indicates a moderate increase from the previous year's $7.39 per share but a decrease from $8.41 per share in the preceding quarter. This fluctuation in NAV reflects the company's asset valuation adjustments and investment performance over time. The modified Dutch Auction tender offer to repurchase up to 2 million shares is a strategic move to manage the company's capital structure and potentially enhance shareholder value, particularly as the share price trades at a discount to NAV. This repurchase program could signal management's confidence in the intrinsic value of their portfolio and may be accretive to NAV per share if executed below the current NAV.Investors should note the company's investment activity, including new investments in privately held companies and follow-on investments, which suggest an active portfolio management approach. The top five investments, representing 56% of the total portfolio, indicate a concentrated exposure which can lead to higher volatility in NAV based on the performance of these key holdings. The investment in Liquid Death, a consumer packaged goods brand, reflects a strategic move into a high-growth potential market, which could diversify the portfolio's risk profile. Market Research Analyst The broader market context mentioned by SuRo Capital's CEO, with megacap stocks driving public indices and a decline in private market valuations, sets the stage for potential opportunities in undervalued assets. SuRo Capital's strategy to capitalize on these conditions by investing in new and existing portfolio companies could position the firm well if the market corrects these valuations upward. The focus on sectors like logistics, technology and consumer goods, through investments in companies like FourKites, Xpoint and Liquid Death, aligns with current trends of digital transformation and consumer health consciousness, potentially offering robust growth prospects.However, the concentration of the portfolio in a few significant investments can pose risks if any single investment underperforms. Diversification across more holdings or sectors could mitigate this risk. Stakeholders should also consider the impact of lock-up provisions on publicly held companies within the portfolio, which may restrict liquidity and affect the timing of potential returns. Legal Expert The modified Dutch Auction tender offer is a notable corporate action that requires careful legal structuring to comply with securities regulations. It offers shareholders the option to tender their shares at a chosen price within a specified range, which can be beneficial for both the company and shareholders. The company can repurchase shares below NAV, which may be accretive to the remaining shareholders, while shareholders have the opportunity to liquidate their holdings at a potentially favorable price.Additionally, the legal implications of holding both private and public equity, particularly with lock-up provisions, necessitate robust compliance frameworks to manage insider trading risks and reporting obligations. Investors should be aware that such provisions can affect the liquidity and valuation of these assets, potentially impacting the timing and magnitude of realized returns. 03/13/2024 - 04:05 PM Net Asset Value of $7.99 Per Share as of December 31, 2023 Modified Dutch Auction Tender Offer to Repurchase Up To 2 Million Shares Commenced on February 20 NEW YORK, March 13, 2024 (GLOBE NEWSWIRE) -- SuRo Capital Corp. (SuRo Capital, the Company, we, us, and our) (Nasdaq: SSSS) today announced its financial results for the fourth quarter and fiscal year ended December 31, 2023. Net assets totaled approximately $203.4 million, or $7.99 per share, at December 31, 2023, as compared to $8.41 per share at September 30, 2023 and $7.39 per share at December 31, 2022. In 2023, public market indices were driven higher by a handful of megacap stocks, while the private markets saw decreased valuations and fundraising volume. We have stated for several quarters that we believe valuations are becoming more attractive and that we are continuing to see more investable opportunities. We are now executing on these opportunities. During the fourth quarter, we added one new portfolio company through a $1.6 million investment in Colombier Sponsor II LLC and completed a $2.7 million follow-on investment in FourKites, Inc. and a $0.3 million follow-on investment in XGroup Holdings Limited (d/b/a Xpoint) through SuRo Capital Sports, LLC. Subsequent to year-end, we added one new portfolio company through a $10.0 million primary investment in Supplying Demand, Inc. (d/b/a Liquid Death), a CPG brand focused on still water, sparkling water, and teas, said Mark Klein, Chairman and Chief Executive Officer of SuRo Capital. As we have consistently demonstrated, SuRo Capital is committed to initiatives that enhance shareholder value, and we believe the market is currently undervaluing our portfolio. Accordingly, as previously announced on February 14, 2024, our Board of Directors authorized a modified Dutch Auction tender offer to purchase up to 2.0 million shares of our common stock at a price per share between $4.00 and $5.00. Given that our stock is trading at a significant discount to net asset value per share, we believe the modified Dutch Auction tender offer to be an efficient and accretive deployment of capital, Mr. Klein concluded. Investment Portfolio as of December 31, 2023 At December 31, 2023, SuRo Capital held positions in 38 portfolio companies  34 privately held and 4 publicly held, some of which may be subject to certain lock-up provisions  with an aggregate fair value of approximately $184.1 million, excluding short-term US treasuries. The Companys top five portfolio company investments accounted for approximately 56% of the total portfolio at fair value as of December 31, 2023. Top Five Investments as of December 31, 2023 Portfolio Company ($ in millions)Cost BasisFair Value% of Total PortfolioLearneo, Inc.$15.0 $56.030.4%Stormwind, LLC 6.4 12.56.8 ServiceTitan, Inc. 10.0 12.06.5 Blink Health Inc. 15.0 11.76.4 Locus Robotics Corp. 10.0 10.75.8 Total (may not sum due to rounding)$56.4 $102.855.9% Fourth Quarter 2023 Investment Portfolio Activity During the three months ended December 31, 2023, SuRo Capital made the following investments, excluding short-term US treasuries: Portfolio CompanyInvestmentTransaction DateAmountColombier Sponsor II LLCClass B Units & Class W Units11/20/2023$1.6 millionFourKites, Inc.(1)Common Shares12/21/2023$2.7 millionXgroup Holdings Limited (d/b/a Xpoint)(2)Convertible Note10/26/2023$0.3 million __________________(1) Represents a follow-on investment.(2) Represents a follow-on investment made through SuRo Capital Sports, LLC. During the three months ended December 31, 2023, SuRo Capital exited or received proceeds from the following investments, excluding short-term US treasuries: Portfolio CompanyTransaction DateQuantityAverage Net Share Price(1)NetProceeds Realized Gain/(Loss)Churchill Sponsor VI LLC12/4/2023N/AN/A$-$(0.2 million)Forge Global, Inc.(2)Various1,465,994$3.56$5.2 million$3.9 millionNewLake Capital Partners, Inc.(3)Various105,820$14.02$1.5 million$(0.7 million)Nextdoor Holdings, Inc.(4)Various150,000$1.98$0.3 million$(0.5 million)PSQ Holdings, Inc. (d/b/a PublicSquare)  Public Warrants(5)Various303,963$1.05$0.3 million$0.2 millionResidential Homes For Rent, LLC (d/b/a Second Avenue)(6)VariousN/AN/A$0.3 million$-True Global Ventures 4 Plus Pte Ltd12/18/2023N/AN/A$0.1 million$- __________________(1) The average net share price is the net share price realized after deducting all commissions and fees on the sale(s), if applicable.(2) As of December 31, 2023, SuRo Capital held 1,145,875 remaining Forge Global, Inc. public common shares.(3) As of December 15, 2023, SuRo Capital had sold its remaining NewLake Capital Partners, Inc. public common shares.(4) As of December 31, 2023, SuRo Capital held 112,420 remaining Nextdoor Holdings, Inc. public common shares.(5) As of December 31, 2023, SuRo Capital held 2,396,037 remaining PSQ Holdings, Inc. (d/b/a PublicSquare) public warrants.(6) On December 26, 2023, a final payment was received from Residential Homes For Rent, LLC (d/b/a Second Avenue) related to the 15% term loan due December 23, 2023. During the three months ended December 31, 2023, approximately $0.3 million was received, of which approximately $0.3 million repaid the outstanding principal and the remaining was attributed to interest. Subsequent to year-end through March 13, 2024, SuRo Capital made the following investment, excluding short-term US treasuries: Portfolio CompanyInvestmentTransaction DateAmountSupplying Demand, Inc. (d/b/a Liquid Death)Series F-1 Preferred Shares1/18/2024$10.0 million Subsequent to year-end through March 13, 2024, SuRo Capital exited or received proceeds from the following investments, excluding short-term US treasuries: Portfolio CompanyTransaction DateQuantityAverage Net Share Price(1)Net Proceeds Realized Gain/(Loss)Nextdoor Holdings, Inc.(2)Various112,420$1.92$0.2 million$(0.4 million)PSQ Holdings, Inc. (d/b/a PublicSquare)  Public Warrants(3)Various100,000$1.03$0.1 million$0.1 million ________________________________(1) The average net share price is the net share price realized after deducting all commissions and fees on the sale(s), if applicable.(2) As of February 23, 2024, SuRo Capital had sold its remaining Nextdoor Holdings, Inc. public common shares.(3) As of March 13, 2024, SuRo Capital held 2,296,037 remaining PSQ Holdings, Inc. (d/b/a PublicSquare) public warrants. Fourth Quarter 2023 Financial Results Quarter EndedDecember 31, 2023Quarter EndedDecember 31, 2022$ in millionsper share(1)$ in millionsper share(1) Net investment loss$(2.7)$(0.11)$(2.9)$(0.10) Net realized gain/(loss) on investments2.60.10(1.9)(0.07) Net change in unrealized depreciation of investments(9.0)(0.36)(7.6)(0.27) Net decrease in net assets resulting from operations  basic(2)(9.1)(0.37)(12.4)(0.44) Stock-based compensation0.5(0.06)0.60.00 Decrease in net asset value(2)$(8.7)$(0.43)$(11.8)$(0.44) ________________________________(1) Based on weighted-average number of shares outstanding for the relevant period.(2) Total may not sum due to rounding. Fiscal Year 2023 Financial Results Fiscal Year EndedDecember 31, 2023Fiscal Year EndedDecember 31, 2022$ in millionsper share(1)$ in millionsper share(1) Net investment loss$(13.4)$(0.51)$(14.7)$(0.49) Net realized loss on investments(11.9)(0.46)(5.9)(0.20) Net change in unrealized appreciation/(depreciation) of investments30.51.16(111.6)(3.72) Net increase/(decrease) in net assets resulting from operations  basic(3)5.10.19(132.2)(4.41) Dividends declared--(3.4)(0.11) Issuance of common stock from public offering--0.20.01 Stock-based compensation2.40.092.00.07 Repurchase of common stock(2)(14.2)0.32(21.5)0.11 Increase/(decrease) in net asset value(3)$(6.7)$0.60$(154.8)$(4.33) ________________________________(1) Based on weighted-average number of shares outstanding for the relevant period.(2) During the year ended December 31, 2023, under the Companys Share Repurchase Program, the Company repurchased 186,493 shares of its common stock for approximately $0.7 million in cash. Additionally, pursuant to the modified Dutch Auction tender offer, the Company repurchased 3,000,000 shares of its common stock on or about April 17, 2023 at a price of $4.50 per share. The use of cash in connection with the repurchases decreased net asset value as of year-end; however, the reduction in shares outstanding as of year-end resulted in an increase to net asset value per share.(3) Total may not sum due to rounding. Weighted-average common basic shares outstanding were approximately 26.2 million and 30.0 million for the years ended December 31, 2023 and 2022, respectively. As of December 31, 2023, there were 25,445,805 shares of the Companys common stock outstanding. SuRo Capitals liquid assets were approximately $99.0 million as of December 31, 2023, consisting of cash, short-term US Treasuries, and securities of publicly traded portfolio companies not subject to lock-up restrictions at year-end. Modified Dutch Auction Tender Offer On February 14, 2024, the Companys Board of Directors authorized a modified Dutch Auction tender offer (the Tender Offer) to purchase up to 2,000,000 shares of its common stock at a price per share not less than $4.00 and not greater than $5.00 in $0.10 increments, using available cash. The Tender Offer commenced on February 20, 2024 and will expire at 5:00 P.M. Eastern Time on April 1, 2024, unless extended. If the Tender Offer is fully subscribed, the Company will purchase 2,000,000 shares, or approximately 7.9%, of the Companys outstanding shares of its common stock. Any shares tendered may be withdrawn prior to expiration of the Tender Offer. Stockholders that do not wish to participate in the Tender Offer do not need to take any action. Based on the number of shares tendered and the prices specified by the tendering stockholders, the Company will determine the lowest per-share price that will enable it to acquire up to 2,000,000 shares of its common stock. All shares accepted in the Tender Offer will be purchased at the same price even if tendered at a lower price. The Tender Offer is not contingent upon any minimum number of shares being tendered. The Tender Offer is, however, subject to other conditions, which are disclosed in the Tender Offer documents filed with the U.S. Securities and Exchange Commission on February 20, 2024. In the future, the Board of Directors may consider additional tender offer(s) or other measures to enhance shareholder value based upon a variety of factors, including the market price of the Companys common stock and its net asset value. The Companys Board of Directors is not making any recommendation to stockholders as to whether to tender or refrain from tendering their shares into the Tender Offer. Stockholders must decide how many shares they will tender, if any, and the price within the stated range at which they will offer their shares for purchase. The information agent for the Tender Offer is D.F. King & Co. Inc., and the depositary is Equiniti Trust Company, LLC. The offer to purchase (the Offer to Purchase), a letter of transmittal and related documents have been mailed to registered holders and certain of our beneficial holders. Beneficial holders may alternatively receive the Offer to Purchase and a communication to consult with their bank, broker or custodian if they wish to tender shares. For questions and information, please contact the information agent at suro@dfking.com. Banks and brokers may call the information agent at (212) 269-5550, and all others may call the information agent toll-free at (877) 361-7972. Share Repurchase Program Under the Share Repurchase Program, the Company may repurchase its outstanding common stock in the open market, provided it complies with the prohibitions under its insider trading policies and procedures and the applicable provisions of the Investment Company Act of 1940, as amended, and the Securities Exchange Act of 1934, as amended. Since inception of the Share Repurchase Program in August 2017, SuRo Capital has repurchased over 6.0 million shares of its common stock for an aggregate purchase price of approximately $39.3 million. This does not include repurchases under various tender offers during this time period. During the year ended December 31, 2023, SuRo Capital repurchased approximately 0.2 million shares of common stock for approximately $0.7 million through the Share Repurchase Program. The dollar value of shares that may yet be purchased by SuRo Capital under the Share Repurchase Program is approximately $20.7 million. The Share Repurchase Program is authorized through October 31, 2024. Conference Call and Webcast Management will hold a conference call and webcast for investors at 2:00 p.m. PT (5:00 p.m. ET) on March 13, 2024. The conference call access number for U.S. participants is 866-580-3963, and the conference call access number for participants outside the U.S. is +1 786-697-3501. The conference ID number for both access numbers is 4463363. Additionally, interested parties can listen to a live webcast of the call from the ""Investor Relations"" section of SuRo Capitals website at www.surocap.com. An archived replay of the webcast will also be available for 12 months following the live presentation. A replay of the conference call may be accessed until 8:00 p.m. ET (5:00 p.m. PT) on March 20, 2024 by dialing 866-583-1035 (U.S.) or +44 (0) 20 3451 9993 (International) and using conference ID number 4463363. Forward-Looking Statements Statements included herein, including statements regarding SuRo Capital's beliefs, expectations, intentions, or strategies for the future, may constitute ""forward-looking statements"". SuRo Capital cautions you that forward-looking statements are not guarantees of future performance and that actual results or developments may differ materially from those projected or implied in these statements. All forward-looking statements involve a number of risks and uncertainties, including the impact of any market volatility that may be detrimental to our business, our portfolio companies, our industry, and the global economy, that could cause actual results to differ materially from the plans, intentions, and expectations reflected in or suggested by the forward-looking statements. Risk factors, cautionary statements, and other conditions which could cause SuRo Capital's actual results to differ from management's current expectations are contained in SuRo Capital's filings with the Securities and Exchange Commission. SuRo Capital undertakes no obligation to update any forward-looking statement to reflect events or circumstances that may arise after the date of this press release. About SuRo Capital Corp. SuRo Capital Corp. (Nasdaq: SSSS) is a publicly traded investment fund that seeks to invest in high-growth, venture-backed private companies. The fund seeks to create a portfolio of high-growth emerging private companies via a repeatable and disciplined investment approach, as well as to provide investors with access to such companies through its publicly traded common stock. SuRo Capital is headquartered in New York, NY and has offices in San Francisco, CA. Connect with the company on X, LinkedIn, and at www.surocap.com. ContactSuRo Capital Corp.(212) 931-6331IR@surocap.com SURO CAPITAL CORP. AND SUBSIDIARIESCONSOLIDATED STATEMENTS OF ASSETS AND LIABILITIES December 31, 2023 December 31, 2022ASSETS Investments at fair value: Non-controlled/non-affiliate investments (cost of $160,994,161 and $155,103,810, respectively)$147,167,535 $130,901,546 Non-controlled/affiliate investments (cost of $32,775,940 and $41,140,804, respectively) 24,931,333 12,591,162 Controlled investments (cost of $18,771,097 and $19,883,894, respectively) 11,982,381 13,695,870 Total Portfolio Investments 184,081,249 157,188,578 Investments in U.S. Treasury bills (cost of $63,792,704 and $84,999,598, respectively) 63,810,855 85,056,817 Total Investments (cost of $276,333,902 and $301,128,106, respectively) 247,892,104 242,245,395 Cash 28,178,352 40,117,598 Escrow proceeds receivable 309,293 628,332 Interest and dividends receivable 132,607 138,766 Deferred financing costs 594,726 555,761 Prepaid expenses and other assets(1) 494,602 727,006 Total Assets 277,601,684 284,412,858 LIABILITIES Accounts payable and accrued expenses(1) 346,308 708,827 Dividends payable 152,523 296,170 6.00% Notes due December 30, 2026(2) 73,745,207 73,387,159 Total Liabilities 74,244,038 74,392,156 Net Assets$203,357,646 $210,020,702 NET ASSETS Common stock, par value $0.01 per share (100,000,000 authorized; 25,445,805 and 28,429,499 issued and outstanding, respectively)$254,458 $284,295 Paid-in capital in excess of par 248,454,107 330,899,254 Accumulated net investment loss (4,304,111) (64,832,605)Accumulated net realized gain/(loss) on investments, net of distributions (12,348,772) 2,552,465 Accumulated net unrealized appreciation/(depreciation) of investments (28,698,036) (58,882,707)Net Assets$203,357,646 $210,020,702 Net Asset Value Per Share$7.99 $7.39 ________________________________(1) This balance includes a right of use asset and corresponding operating lease liability, respectively.(2) As of December 31, 2023, the 6.00% Notes due December 30, 2026 (effective interest rate of 6.53%) had a face value $75,000,000. As of December 31, 2022, the 6.00% Notes due December 30, 2026 (effective interest rate of 6.13%) had a face value $75,000,000. SURO CAPITAL CORP. AND SUBSIDIARIESCONSOLIDATED STATEMENTS OF OPERATIONS Year Ended December 31, 2023 2022 2021 INVESTMENT INCOME Non-controlled/non-affiliate investments: Interest income(1) $795,847 $403,029 $507,772 Dividend income 211,310 541,239 470,438 Non-controlled/affiliate investments: Dividend income   102,632 Controlled investments: Interest income 1,331,258 1,685,000 390,000 Dividend income 500,000   Interest income from U.S. Treasury bills 3,758,365 826,925  Total Investment Income 6,596,780 3,456,193 1,470,842 OPERATING EXPENSES Compensation expense 9,482,867 7,566,452 6,162,716 Directors fees 645,548 675,716 752,442 Professional fees 2,602,894 3,395,260 2,665,689 Interest expense 4,858,049 4,845,549 693,526 Income tax expense 624,049 82,238 9,347 Other expenses 1,822,982 1,598,986 1,117,941 Total Operating Expenses 20,036,389 18,164,201 11,401,661 Net Investment Loss (13,439,609) (14,708,008) (9,930,819)Realized Gain/(Loss) on Investments: Non-controlled/non-affiliated investments (1,185,273) (5,835,074) 216,870,940 Non-controlled/affiliate investments (10,762,231) (70,379) 1,864,564 Net Realized Gain/(Loss) on Investments (11,947,504) (5,905,453) 218,735,504 Change in Unrealized Appreciation/(Depreciation) of Investments: Non-controlled/non-affiliated investments 10,349,592 (109,553,034) (59,057,641)Non-controlled/affiliate investments 20,705,035 (1,947,553) (2,902,517)Controlled investments (600,692) (63,005) 227,194 Net Change in Unrealized Appreciation/(Depreciation) of Investments 30,453,935 (111,563,592) (61,732,964)Net Change in Net Assets Resulting from Operations $5,066,822 $ (132,177,053) $147,071,721 Net Change in Net Assets Resulting from Operations per Common Share: Basic $0.19 $(4.40) $5.69 Diluted(2) $0.19 $(4.40) $5.52 Weighted-Average Common Shares Outstanding Basic 26,222,667 30,023,202 25,861,642 Diluted(2) 26,222,667 30,023,202 26,758,367 ________________________________(1) Includes interest income earned on idle cash.(2) As of December 31, 2023, 2022, and 2021, there were no potentially dilutive securities outstanding. SURO CAPITAL CORP. AND SUBSIDIARIESNOTES TO CONSOLIDATED FINANCIAL STATEMENTSDecember 31, 2023  Year Ended December 31, 2023 2022 2021 2020 2019 Per Basic Share Data Net asset value at beginning of the year $7.39 $11.72 $15.14 $11.38 $9.89 Net investment loss(1) (0.51) (0.49) (0.38) (0.81) (0.49)Net realized gain/(loss) on investments(1) (0.46) (0.20) 8.46 0.92 0.99 Net change in unrealized appreciation/(depreciation) of investments(1) 1.16 (3.72) (2.39) 3.78 0.69 Benefit from taxes on unrealized depreciation of investments(1)     0.05 Dividends declared  (0.11) (8.00) (0.87) (0.32)Issuance of common stock from stock dividend   0.74   Issuance of common stock from public offering(1)  0.01 0.01 0.30  Issuance of common stock from conversion of 4.75% Convertible Notes due 2023(1)   (1.91) (0.11)  Repurchase of common stock(1) 0.32 0.11  0.43 0.52 Stock-based compensation(1) 0.09 0.07 0.05 0.12 0.05 Net asset value at end of year $7.99 $7.39 $11.72 $15.14 $11.38 Per share market value at end of year $3.94 $3.80 $12.95 $13.09 $6.55 Total return based on market value(2) 3.68% (69.45)% 60.05% 99.85% 31.61%Total return based on net asset value(2) 8.12% (36.01)% 30.25% 33.04% 15.08%Shares outstanding at end of year 25,445,805 28,429,499 31,118,556 19,914,023 17,564,244 Ratios/Supplemental Data:     Net assets at end of year $203,357,646 $210,020,702 $364,846,624 $301,583,073 $199,917,289 Average net assets $207,608,591 $310,086,061 $396,209,139 $205,430,809 $209,261,190 Ratio of gross operating expenses to average net assets(3) 9.70% 5.87% 2.88% 7.95% 6.08%Ratio of income tax provision to average net assets % % % % (0.42)%Ratio of net operating expenses to average net assets(3) 9.70% 5.87% 2.88% 7.95% 5.66%Ratio of net investment loss to average net assets(3) (6.51)% (4.76)% (2.51)% (7.07)% (4.52)%Portfolio Turnover Ratio 9.34% 4.31% 28.34% 14.87% 12.95% ________________________________(1) Based on weighted-average number of shares outstanding for the relevant period.(2) Total return based on market value is based upon the change in market price per share between the opening and ending market values per share in the period, adjusted for dividends and equity issuances. Total return based on net asset value is based upon the change in net asset value per share between the opening and ending net asset values per share in the period, adjusted for dividends and equity issuances. (3) For the year ended December 31, 2021, the Company excluded $100,274 of non-recurring expenses. For the year ended December 31, 2020, the Company excluded $1,962,431 of non-recurring expenses. For the year ended December 31, 2019, the Company excluded $1,769,820 of non-recurring expenses. Because the ratios are calculated for the Companys common stock taken as a whole, an individual investors ratios may vary from these ratios. What is SuRo Capital Corp.'s Net Asset Value per share as of December 31, 2023? SuRo Capital Corp.'s Net Asset Value per share was $7.99 as of December 31, 2023. What type of tender offer did SuRo Capital Corp. announce? SuRo Capital Corp. announced a Modified Dutch Auction Tender Offer to repurchase up to 2 million shares of its common stock. What were some of SuRo Capital Corp.'s notable investments during Q4 2023? SuRo Capital Corp. made investments in Colombier Sponsor II LLC, FourKites, Inc., and XGroup Holdings Limited (d/b/a Xpoint) during Q4 2023. What was the total fair value of SuRo Capital Corp.'s investment portfolio as of December 31, 2023? The total fair value of SuRo Capital Corp.'s investment portfolio was approximately $184.1 million as of December 31, 2023. How many portfolio companies did SuRo Capital Corp. hold positions in as of December 31, 2023? SuRo Capital Corp. held positions in 38 portfolio companies as of December 31, 2023."
Acadia Pharmaceuticals to Participate in the UBS Virtual CNS Day,2024-03-13T20:05:00.000Z,Low,Neutral,"Acadia Pharmaceuticals Inc. (ACAD) will take part in the UBS Virtual CNS Day on March 18, 2024. The live webcast of the presentation will be on Acadia's website, with an archived recording available for a month.","Acadia Pharmaceuticals to Participate in the UBS Virtual CNS Day Rhea-AI Impact (Low) Rhea-AI Sentiment (Neutral) Tags conferences Rhea-AI Summary Acadia Pharmaceuticals Inc. (ACAD) will take part in the UBS Virtual CNS Day on March 18, 2024. The live webcast of the presentation will be on Acadia's website, with an archived recording available for a month. Positive None. Negative None. 03/13/2024 - 04:05 PM SAN DIEGO--(BUSINESS WIRE)-- Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that it will participate in the UBS Virtual CNS Day on Monday, March 18, 2024 at 2:00 p.m. Eastern Time. The conference will be held virtually. A live webcast of Acadias presentation will be accessible on the companys website, Acadia.com, under the investors section and an archived recording will be available on the website for approximately one month following the presentation. About Acadia Pharmaceuticals Acadia is advancing breakthroughs in neuroscience to elevate life. For 30 years we have been working at the forefront of healthcare to bring vital solutions to people who need them most. We developed and commercialized the first and only FDA-approved drug to treat hallucinations and delusions associated with Parkinsons disease psychosis and the first and only FDA-approved drug for the treatment of Rett syndrome. Our clinical-stage development efforts are focused on treating Prader-Willi syndrome, Alzheimers disease psychosis and multiple other programs targeting neuropsychiatric symptoms in central nervous system disorders. For more information, visit us at Acadia.com and follow us on LinkedIn and Twitter. View source version on businesswire.com: https://www.businesswire.com/news/home/20240313546332/en/ Investor Contact: Acadia Pharmaceuticals Inc. Al Kildani (858) 261-2872 ir@acadia-pharm.com Acadia Pharmaceuticals Inc. Jessica Tieszen (858) 261-2950 ir@acadia-pharm.com Source: Acadia Pharmaceuticals Inc. When will Acadia Pharmaceuticals Inc. participate in the UBS Virtual CNS Day? Acadia Pharmaceuticals Inc. (ACAD) will participate in the UBS Virtual CNS Day on March 18, 2024. Where can I watch the live webcast of Acadia's presentation? The live webcast of Acadia's presentation will be accessible on the company's website, Acadia.com, under the investors section. How long will the archived recording of the presentation be available? The archived recording of the presentation will be available on the website for approximately one month following the event."
"H.B. Fuller to Report First Quarter 2024 Results on March 27, 2024",2024-03-13T20:05:00.000Z,Low,Neutral,"H.B. Fuller Company (FUL) is set to release its financial results for the three-month fiscal period ending March 2, 2024. An investor conference call is scheduled for March 28, 2024, to discuss the results. The webcast can be accessed on the company's website, with a replay available afterward.","H.B. Fuller to Report First Quarter 2024 Results on March 27, 2024 Rhea-AI Impact (Low) Rhea-AI Sentiment (Neutral) Tags conferences earnings Rhea-AI Summary H.B. Fuller Company (FUL) is set to release its financial results for the three-month fiscal period ending March 2, 2024. An investor conference call is scheduled for March 28, 2024, to discuss the results. The webcast can be accessed on the company's website, with a replay available afterward. Positive None. Negative None. 03/13/2024 - 04:05 PM ST. PAUL, Minn.--(BUSINESS WIRE)-- H.B. Fuller Company (NYSE: FUL) announced plans to report its financial results for the three-month fiscal period ended March 2, 2024, in a press release issued after the market close on March 27, 2024. The Company will hold an investor conference call on March 28, 2024, at 9:30 a.m. CT (10:30 a.m. ET) to discuss its financial results. Interested parties may listen to the conference call on a live webcast. The webcast, along with a supplemental presentation, may be accessed from the companys website at https://investors.hbfuller.com. Participants must register prior to accessing the webcast using this link and should do so at least 10 minutes prior to the start of the call to install and test any necessary software and audio connections. Participants can pre-register for the webcast at any time using the link above. The webcast will be archived on the companys website. A telephone replay of the conference call will be available from 12:30 p.m. CT on March 28, 2024 to 10:59 p.m. CT on April 4, 2024. To access the telephone replay dial 1-800-770-2030 (toll free) or 1-647-362-9199 and enter the Conference ID: 6370505. About H.B. Fuller Company: As the largest pureplay adhesives company in the world, H.B. Fullers (NYSE: FUL) innovative, functional coatings, adhesives and sealants enhance the quality, safety and performance of products people use every day. Founded in 1887, with 2023 revenue of $3.5 billion, our mission to Connect What Matters is brought to life by more than 7,000 global team members who collaborate with customers across more than 30 market segments in over 140 countries to develop highly specified solutions that enable customers to bring world-changing innovations to their end markets. Learn more at www.hbfuller.com. View source version on businesswire.com: https://www.businesswire.com/news/home/20240313030961/en/ Steven Brazones Investor Relations Contact 651-236-5060 Source: H.B. Fuller Company When will H.B. Fuller Company (FUL) report its financial results for the three-month fiscal period ended March 2, 2024? H.B. Fuller Company (FUL) will report its financial results on March 27, 2024, after the market close. When is the investor conference call scheduled to discuss H.B. Fuller Company's financial results? The investor conference call is set for March 28, 2024, at 9:30 a.m. CT (10:30 a.m. ET). How can interested parties access the conference call webcast? Interested parties can access the webcast on the company's website at https://investors.hbfuller.com. Is pre-registration required to access the webcast? Participants must register prior to accessing the webcast using the provided link and should do so at least 10 minutes before the call starts. Will there be a replay of the conference call available? Yes, a telephone replay of the conference call will be available from March 28, 2024, to April 4, 2024. Dial 1-800-770-2030 (toll free) or 1-647-362-9199 and enter the Conference ID: 6370505."
"RCM Technologies, Inc. Announces Fourth Quarter and Fiscal Year 2023 Results",2024-03-13T20:05:00.000Z,Neutral,Positive,"RCM Technologies, Inc. (RCMT) announced financial results for the thirteen and fifty-two weeks ended December 30, 2023. Revenue for the current quarter was $71.0 million, a 1.1% increase from the prior year. Gross profit and GAAP operating income also saw growth. However, for the current year, revenue decreased by 7.5% to $263.2 million. GAAP net income for the year was $16.8 million, down from $20.9 million in the prior year. Adjusted EBITDA and net income per diluted share improved in the current quarter. The company aims for $20 million in cash flow from operations in fiscal 2024.","RCM Technologies, Inc. Announces Fourth Quarter and Fiscal Year 2023 Results Rhea-AI Impact (Neutral) Rhea-AI Sentiment (Positive) Tags earnings Rhea-AI Summary RCM Technologies, Inc. (RCMT) announced financial results for the thirteen and fifty-two weeks ended December 30, 2023. Revenue for the current quarter was $71.0 million, a 1.1% increase from the prior year. Gross profit and GAAP operating income also saw growth. However, for the current year, revenue decreased by 7.5% to $263.2 million. GAAP net income for the year was $16.8 million, down from $20.9 million in the prior year. Adjusted EBITDA and net income per diluted share improved in the current quarter. The company aims for $20 million in cash flow from operations in fiscal 2024. Positive Revenue for the current quarter increased by 1.1% to $71.0 million compared to the prior year. Gross profit and GAAP operating income showed growth for the current quarter. Adjusted EBITDA for the current quarter improved to $8.9 million. GAAP net income per diluted share increased to $0.65 for the current quarter. For the current year, revenue decreased by 7.5% to $263.2 million. GAAP net income for the year was $16.8 million, down from $20.9 million in the prior year. Adjusted EBITDA and net income per diluted share improved for the current quarter. The company aims for $20 million in cash flow from operations in fiscal 2024. Negative None. Financial Analyst The financial results of RCM Technologies for both the thirteen and fifty-two weeks ending December 30, 2023, demonstrate a nuanced performance with varied implications for stakeholders. While the company reported a slight increase in quarterly revenue and a notable improvement in gross profit, the annual figures show a decline in both revenue and gross profit. This mixed performance could suggest that while the company may be implementing effective cost control or pricing strategies in the short term, there might be underlying challenges in sustaining long-term growth.It is particularly noteworthy that the company's adjusted EBITDA and adjusted net income per diluted share have increased on a quarterly basis, signaling improved operational efficiency and profitability. However, the decline in annual operating income and net income warrants attention, as it could be indicative of competitive pressures or market saturation affecting the company's core business segments.Investors may find the CFO's comment on improved cash collections and the confidence in achieving a $20 million cash flow from operations in fiscal 2024 to be a positive forward-looking statement. This could potentially signal to the market that management is focused on liquidity and cash management, which is critical for the company's ability to invest in growth opportunities and service any existing debt. Market Research Analyst RCM Technologies' performance must be contextualized within the broader industry trends of business and technology solutions. The modest revenue growth in the quarterly comparison, juxtaposed with the annual revenue decline, might reflect shifting demand for the company's services or increased competition. The technology sector is rapidly evolving and companies like RCM Technologies must continuously innovate to maintain market share.From a market perspective, the positive quarterly results, including the growth in adjusted EBITDA, could be a sign that RCM Technologies is adapting well to market demands and operational challenges. It is also encouraging to see that all three business segments are contributing to growth, as diversification can be a key strength in the face of sector volatility.However, the annual decline in key financial metrics could raise concerns about the company's strategic direction and market position. Investors and analysts will likely scrutinize the company's upcoming conference call for insights into management's plans to address these challenges and capitalize on market opportunities. Economist The financial results of RCM Technologies reflect broader economic conditions that may be impacting the business and technology solutions sector. While the quarterly increase in revenue and gross profit suggests resilience in the face of economic headwinds, the annual figures indicate a contraction that could be associated with broader macroeconomic factors such as reduced business spending due to economic uncertainty or supply chain disruptions.Additionally, the company's focus on cash flow generation as a goal for fiscal 2024 suggests a strategic emphasis on financial stability in an uncertain economic climate. The ability to generate strong cash flow is essential for weathering economic downturns and investing in strategic initiatives that can drive future growth.Stakeholders should consider how macroeconomic trends, such as interest rate changes, inflation and shifts in consumer and business spending, could influence the company's performance moving forward. The management's commentary during the upcoming conference call could provide valuable insights into how RCM Technologies plans to navigate these economic challenges and leverage any potential opportunities that may arise. 03/13/2024 - 04:05 PM PENNSAUKEN, N.J., March 13, 2024 (GLOBE NEWSWIRE) -- RCM Technologies, Inc. (NasdaqGM: RCMT), a premier provider of business and technology solutions designed to enhance and maximize the operational performance of its customers through the adaptation and deployment of advanced engineering, specialty health care, and information technology services, today announced financial results for the thirteen and fifty-two weeks ended December 30, 2023. RCM Technologies reported revenue of $71.0 million for the thirteen weeks ended December 30, 2023 (the current quarter), an increase of 1.1% compared to $70.2 million for the thirteen weeks ended December 31, 2022 (the comparable prior quarter). Gross profit was $21.6 million for the current quarter, a 5.7% increase compared to $20.5 million for the comparable prior quarter. The Company experienced GAAP operating income of $7.9 million for the current quarter compared to $6.8 million for the comparable prior quarter. The Company experienced GAAP net income of $5.3 million, or $0.65 per diluted share, for the current quarter compared to $4.8 million, or $0.48 per diluted share, for the comparable prior quarter. The Company experienced adjusted EBITDA (non-GAAP) of $8.9 million for the current quarter compared to $7.5 million for the comparable prior quarter. The Company experienced $0.71 of adjusted net income per diluted share (non-GAAP) for the current quarter as compared to $0.52 for the comparable prior quarter. RCM Technologies reported revenue of $263.2 million for the fifty-two weeks ended December 30, 2023 (the current year), a decrease of 7.5% compared to $284.7 million for the fifty-two weeks ended December 31, 2022 (the comparable prior year). Gross profit was $76.7 million for the current year, a 7.5% decrease compared to $82.9 million for the comparable prior year. The Company experienced GAAP operating income of $23.7 million for the current year compared to $28.8 million for the comparable prior year. The Company experienced GAAP net income of $16.8 million, or $1.96 per diluted share, for the current year compared to $20.9 million, or $2.00 per diluted share, for the comparable prior year. The Company experienced adjusted EBITDA (non-GAAP) of $26.6 million for the current year compared to $31.1 million for the comparable prior year. The Company experienced $2.11 of adjusted net income per diluted share (non-GAAP) for the current year as compared to $2.08 for the comparable prior year. Bradley Vizi, Executive Chairman of RCM Technologies, commented, We finished 2023 strong with $8.9 million of adjusted EBITDA in the fourth quarter, a growth rate of 18.5%. All three business segments provided healthy contributions to growth. Kevin Miller, Chief Financial Officer of RCM Technologies, commented, Improved cash collections in the first quarter have helped bolster our confidence in achieving our goal of $20 million in cash flow from operations in fiscal 2024. Conference Call On Thursday, March 14, 2024, RCM Technologies will host a conference call to discuss these results. The call will begin at 11:00 a.m. Eastern Time. The dial-in number is (800) 285-6670. About RCM RCM Technologies (NasdaqGM: RCMT) is a business and technology solutions provider with world-class talent in key market segments. We help design, build, and enable the Industries of Tomorrow, Today. Operating at the intersection of resources, critical infrastructure and modernization of industries through advanced technologies, RCM is a provider of services in Health Care, Engineering, Aerospace & Defense, Process & Industrial, Life Sciences and Data & Solutions. www.rcmt.com. The statements contained in this release that are not purely historical are forward-looking statements within the Private Securities Litigation Reform Act of 1995. They are subject to various risks, uncertainties, and other factors that could cause the Companys actual results, performance, or achievements to differ materially from those expressed or implied by such forward-looking statements. These statements often include words such as may, will, expect, anticipate, continue, estimate, project, intend, believe, plan, seek, could, can, should, are confident or similar expressions. In addition, statements that are not historical should also be considered forward-looking statements. These statements are based on assumptions that we have made in light of our experience in the industry, and our perceptions of historical trends, current conditions, expected future developments, and other factors we believe are appropriate in these circumstances. Forward-looking statements include, but are not limited to, those relating to demand for the Companys services, expectations regarding our future revenues and other financial results, our pipeline, and potential project wins, and our expectations for investment and growth in our business. Such statements are based on current expectations that involve several known and unknown risks, uncertainties, and other factors, which may cause actual events to be materially different from those expressed or implied by such forward-looking statements. Risk, uncertainties, and other factors may emerge from time to time that could cause the Companys actual results to differ from those indicated by the forward-looking statements. Investors are directed to consider such risks, uncertainties, and other factors described in documents filed by the Company with the Securities and Exchange Commission, including our most recent Annual Report on Form 10-K and subsequent Quarterly Reports on Form 10-Q. The Company assumes no obligation (and expressly disclaims any such obligation) to update any forward-looking statements contained in this release as a result of new information or future events or developments, except as may be required by law. Tables to Follow RCM Technologies, Inc. Condensed Consolidated Statements of Operations (Unaudited) (In Thousands, Except Per Share Amounts) Thirteen Weeks Ended December 30,2023 December 31,2022 Revenue$71,028 $70,221 Cost of services 49,397 49,755 Gross profit 21,631 20,466 Selling, general and administrative 13,403 13,433 Depreciation and amortization of property and equipment 276 266 Amortization of acquired intangible assets 46 46 Remeasurement of acquisition related contingent consideration - (88)Operating income 7,906 6,809 Other expense, net 532 349 Income before income taxes 7,374 6,460 Income tax expense 2,119 1,623 Net income$5,255 $4,837 Diluted net earnings per share data$0.65 $0.48 Diluted weighted average shares outstanding 8,142,184 10,076,898 Fifty-Two Weeks Ended December 30,2023 December 31,2022 Revenue$263,237 $284,680 Cost of services 186,541 201,753 Gross profit 76,696 82,927 Selling, general and administrative 52,185 53,395 Depreciation and amortization of property and equipment 1,032 995 Amortization of acquired intangible assets 182 46 Gain on sale of assets (395) (219)Remeasurement of acquisition related contingent consideration - (88)Operating income 23,692 28,798 Other expense, net 1,497 318 Income before income taxes 22,195 28,480 Income tax expense 5,364 7,591 Net income$16,831 $20,889 Diluted net earnings per share data$1.96 $2.00 Diluted weighted average shares outstanding 8,592,572 10,442,176 RCM Technologies, Inc. Supplemental Operating Results on a Non-GAAP Basis (Unaudited) (In Thousands) The following non-GAAP measures, which adjust for the categories of expenses described below, are non-GAAP financial measures. Our management believes that these non-GAAP financial measures (Adjusted operating income, EBITDA and Adjusted EBITDA) are useful information for investors, shareholders, and other stakeholders of our Company in gauging our results of operations on an ongoing basis and to enhance investors overall understanding of our current financial performance and period-to-period comparisons. Adjusted operating income, EBITDA and Adjusted EBITDA should not be considered alternatives to net income as an indicator of performance. In addition, Adjusted operating income, EBITDA and Adjusted EBITDA do not take into account changes in certain assets and liabilities and interest and income taxes that can affect cash flows. We do not intend the presentation of these non-GAAP measures to be considered in isolation or as a substitute for results prepared in accordance with GAAP. These non-GAAP measures should be read-only in conjunction with our consolidated financial statements prepared in accordance with GAAP. The following unaudited table presents the Companys GAAP net income and the corresponding adjustments used to calculate Adjusted operating income, EBITDA and Adjusted EBITDA for the thirteen and fifty-two weeks ended December 30, 2023 and December 31, 2022. Thirteen Weeks Ended Fifty-Two Weeks Ended December 30, 2023 December 31, 2022 December 30, 2023 December 31, 2022 GAAP operating income$7,906 $6,809 $23,692 $28,798 Adjustments Gain on sale of assets - - (395) (219)Remeasurement of acquisition related contingent consideration - (88) - (88)Equity compensation 641 452 2,092 1,582 Adjusted operating income (non-GAAP)$8,547 $7,173 $25,389 $30,073 GAAP net income$5,255 $4,837 $16,831 $20,889 Income tax expense 2,119 1,623 5,364 7,591 Interest expense, net 429 169 1,399 370 Depreciation of property and equipment 276 266 1,032 995 Amortization of acquired intangible assets 46 46 182 46 EBITDA (non-GAAP)$8,125 $6,941 $24,808 $29,891 Adjustments Gain on sale of assets - - (395) (219)Remeasurement of acquisition related contingent consideration - (88) - (88)Loss (gain) on foreign currency transactions 103 180 98 (52)Equity compensation 641 452 2,092 1,582 Adjusted EBITDA (non-GAAP)$8,869 $7,485 $26,603 $31,114 RCM Technologies, Inc. Supplemental Operating Results on a Non-GAAP Basis (Continued) (Unaudited) (In Thousands) Thirteen Weeks Ended Fifty-Two Weeks Ended December 30, 2023 December 31, 2022 December 30, 2023 December 31, 2022 GAAP net income$5,255 $4,837 $16,831 $20,889 Adjustments Gain on sale of assets - - (395) (219)Remeasurement of acquisition related contingent consideration - (88) - (88)Loss (gain) on foreign currency transactions 103 180 98 (52)Equity compensation 641 452 2,092 1,582 Tax impact from normalized rate (186) (147) (467) (356)Adjusted net income (non-GAAP)$5,813 $5,234 $18,159 $21,756 GAAP diluted net earnings per share$0.65 $0.48 $1.96 $2.00 Adjustments Gain on sale of assets - - ($0.05)($0.02)Remeasurement of acquisition related contingent consideration - (0.01) - ($0.01)Loss (gain) on foreign currency transactions 0.01 0.02 $0.01 ($0.01)Equity compensation 0.07 0.05 $0.24 $0.15 Tax impact from normalized rate (0.02) (0.02)($0.05)($0.03)Adjusted diluted net earnings per share (non-GAAP)$0.71 $0.52 $2.11 $2.08 RCM Technologies, Inc. Summary of Selected Income Statement Data (Unaudited) (In Thousands) Thirteen Weeks Ended December 30, 2023 Specialty Health Care Engineering Life Sciences and IT Consolidated Revenue$36,688 $22,719 $11,621 $71,028 Cost of services 25,686 16,589 7,122 49,397 Gross profit 11,002 6,130 4,499 21,631 Gross profit margin 30.0% 27.0% 38.7% 30.5% Thirteen Weeks Ended December 31, 2022 Specialty Health Care Engineering Life Sciences and IT Consolidated Revenue$35,810 $24,211 $10,200 $70,221 Cost of services 24,771 18,565 6,419 49,755 Gross profit$11,039 $5,646 $3,781 $20,466 Gross profit margin 30.8% 23.3% 37.1% 29.15% Fifty-Two Weeks Ended December 30, 2023 Specialty Health Care Engineering Life Sciences and IT Consolidated Revenue$136,241 $84,675 $42,321 $263,237 Cost of services 96,309 64,071 26,161 186,541 Gross profit 39,932 20,604 16,160 76,696 Gross profit margin 29.3% 24.3% 38.2% 29.1% Fifty-Two Weeks Ended December 31, 2022 Specialty Health Care Engineering Life Sciences and IT Consolidated Revenue$159,448 $85,937 $39,295 $284,680 Cost of services 111,543 64,218 25,992 201,753 Gross profit$47,905 $21,719 $13,303 $82,927 Gross profit margin 30.0% 25.3% 33.9% 29.1% RCM Technologies, Inc. Condensed Consolidated Balance Sheets (Unaudited) (In Thousands, Except Share Amounts) December 30, December 31, 2023 2022 Current assets: Cash and cash equivalents$6,284 $339 Accounts receivable, net 70,690 50,762 Contract assets 8,891 3,280 Prepaid expenses and other current assets 4,637 4,636 Total current assets 90,502 59,017 Property and equipment, net 4,005 2,098 Other assets: Deposits 313 173 Deferred tax assets, net, domestic - - Deferred tax assets, foreign 55 - Goodwill 22,147 22,147 Operating right of use asset 2,779 3,665 Intangible assets, net 683 864 Total other assets 25,977 26,849 Total assets$120,484 $87,964 Current liabilities: Accounts payable and accrued expenses$12,454 $14,147 Contract liabilities 31,102 9,767 Accrued payroll and related costs 11,203 13,023 Finance lease payable 233 462 Income taxes payable 330 85 Operating right of use liability 693 1,349 Contingent consideration from acquisitions 300 472 Deferred revenue 1,881 1,119 Total current liabilities 58,196 40,424 Deferred income taxes, net, foreign 187 166 Deferred income taxes, net, domestic 1,568 1,495 Finance lease payable - 232 Contingent consideration from acquisitions, net of current portion 1,671 1,970 Operating right of use liability, net of current portion 2,268 2,932 Borrowings under line of credit 30,804 8,783 Total liabilities 94,694 56,002 Contingencies (note 16) and Commitments (note 18) Stockholders equity: Preferred stock, $1.00 par value; 5,000,000 shares authorized; no shares issued or outstanding - - Common stock, $0.05 par value; 40,000,000 shares authorized; 17,673,427 shares issued and 7,844,821 shares outstanding at December 30, 2023, 17,287,967 shares issued and 9,285,318 shares outstanding at December 31, 2022 and 16,903,157 shares issued and 10,290,935 shares outstanding at January 1, 2022 882 863 Additional paid-in capital 116,579 113,878 Accumulated other comprehensive loss (2,813) (2,863) Accumulated deficit (19,265) (36,096) Treasury stock, 9,828,606 shares at December 30, 2023, 8,002,649 shares at December 31, 2022 and 6,612,222 shares at January 1, 2022 (69,593) (43,820) Stockholders equity 25,790 31,962 Total liabilities and stockholders equity$120,484 $87,964 RCM Technologies, Inc. Condensed Consolidated Statements of Cash Flows (Unaudited) (In Thousands) Thirteen Weeks Ended December 30, 2023 December 31, 2022 Net income$5,255 $4,837 Adjustments to reconcile net income to cash used in operating activities 1,526 2,989 Changes in operating assets and liabilities: Accounts receivable (13,880) 81 Prepaid expenses and other current assets 678 (2,953) Net of transit accounts receivable and payable (6,660) 6,431 Accounts payable and accrued expenses 292 3,440 Accrued payroll and related costs (3,421) (4,211) Right of use liabilities (337) (336) Income taxes payable 80 (2,298) Deferred revenue 1,546 (441) Deposits (145) 3 Total adjustments (20,321) 2,705 Net cash (used in) provided by operating activities($15,066)$7,542 Net cash used in investing activities (2,056) (4,367)Net cash provided by (used in) financing activities 22,706 (3,659)Effect of exchange rate changes on cash and cash equivalents 46 62 Increase in cash and cash equivalents$5,630 ($422) Common stock repurchase (1,324) (11,166) Fifty-Two Weeks Ended December 30, 2023 December 31, 2022 Net income$16,831 $20,889 Adjustments to reconcile net income to cash used in operating activities 4,321 4,539 Changes in operating assets and liabilities: Accounts receivable (20,576) (1,509) Prepaid expenses and other current assets 3 (2,350) Net of transit accounts receivable and payable 15,724 5,433 Accounts payable and accrued expenses (1,506) 4,919 Accrued payroll and related costs (1,825) 24 Right of use liabilities (1,353) (1,642) Income taxes payable 242 276 Deferred revenue 762 (2,299) Deposits (141) 3 Total adjustments (4,349) 7,394 Net cash provided by operating activities 12,482 28,283 Net cash used in investing activities (2,536) (4,820)Net cash used in financing activities (3,852) (23,127)Effect of exchange rate changes on cash and cash equivalents (149) (232)Increase in cash and cash equivalents 5,945 $104 Common stock repurchase (25,773) (17,560) RCM Technologies, Inc.Tel: 856.356.4500Corporate Contacts:2500 McClellan Avenueinfo@rcmt.comBradley S. ViziPennsauken, NJ 08109www.rcmt.comExecutive Chairman Kevin D. Miller Chief Financial Officer What was RCM Technologies' (RCMT) revenue for the current quarter? RCM Technologies reported revenue of $71.0 million for the current quarter. How did RCM Technologies' (RCMT) revenue for the current quarter compare to the prior year? Revenue for the current quarter increased by 1.1% to $71.0 million compared to the prior year. What was RCM Technologies' (RCMT) GAAP net income per diluted share for the current quarter? RCM Technologies experienced GAAP net income of $5.3 million, or $0.65 per diluted share, for the current quarter. What was RCM Technologies' (RCMT) revenue for the current year? For the current year, revenue decreased by 7.5% to $263.2 million. What was RCM Technologies' (RCMT) GAAP net income for the current year? GAAP net income for the year was $16.8 million, down from $20.9 million in the prior year. What is RCM Technologies' (RCMT) goal for cash flow from operations in fiscal 2024? The company aims for $20 million in cash flow from operations in fiscal 2024."
Turtle Beach Announces Fourth Quarter and Full Year 2023 Earnings Results,2024-03-13T20:05:00.000Z,Low,Neutral,"Turtle Beach Corporation (HEAR) reported its financial results for Q4 and full year 2023, showing a slight decrease in net revenue for the quarter but a significant increase for the full year. The company also improved its net income and Adjusted EBITDA compared to the previous year. Management is optimistic about the future, highlighting share gains and strategic initiatives driving margin improvements.","Turtle Beach Announces Fourth Quarter and Full Year 2023 Earnings Results Rhea-AI Impact (Low) Rhea-AI Sentiment (Neutral) Tags earnings Rhea-AI Summary Turtle Beach Corporation (HEAR) reported its financial results for Q4 and full year 2023, showing a slight decrease in net revenue for the quarter but a significant increase for the full year. The company also improved its net income and Adjusted EBITDA compared to the previous year. Management is optimistic about the future, highlighting share gains and strategic initiatives driving margin improvements. Positive None. Negative None. Financial Analyst The reported financial results from Turtle Beach Corporation indicate a mixed performance with a slight decrease in net revenue for the fourth quarter but an overall increase for the full year. The transition from a net loss to net income in the fourth quarter and a significant improvement in adjusted EBITDA both quarterly and annually are positive indicators of the company's operational efficiency and cost management effectiveness. These figures suggest a turnaround in profitability, which is crucial for investor confidence and can influence the company's stock performance positively.Despite the net revenue decline in the fourth quarter, the year-over-year growth in annual revenue reflects resilience in the core business of console gaming headsets. The strategic focus on portfolio optimization and SKU rationalization mentioned by the CEO could streamline operations and potentially enhance margins. Investors will be interested in the 2024 projections, which promise groundbreaking product launches and further cost management initiatives. The anticipation of these developments could generate investor interest and influence stock market activity in anticipation of future growth. Market Research Analyst The gaming accessories market is highly competitive, with continuous innovation and product launches being key drivers for success. Turtle Beach's focus on new product development and expansion across multiple categories and geographies indicates a strategic approach to capturing market share. The mention of significant share gains is an important aspect that investors should note, as market share gains can lead to increased revenue and profitability in the long term.The post-pandemic transitional effects mentioned by Turtle Beach's CEO reflect a broader industry trend where gaming companies are adjusting to changes in consumer behavior as the world moves beyond the pandemic. The company's optimistic outlook for 2024, with the expected launch of groundbreaking products, suggests potential for growth and market leadership. However, investors should also consider the risks associated with product launches, including market reception and the competitive response. Economist The gaming industry has experienced significant growth over the past few years, partly fueled by the pandemic-induced demand. Turtle Beach's financial results indicate that the company is navigating the post-pandemic market effectively, with an increase in annual net revenue and a substantial improvement in adjusted EBITDA. These improvements are indicative of a robust business strategy that could withstand economic fluctuations.Furthermore, the company's focus on cost management initiatives is a prudent approach in an uncertain economic environment, where inflationary pressures and supply chain challenges are prevalent. Effective cost management can safeguard profit margins and provide stability to the company in the face of economic headwinds. The projected improvements for 2024, if realized, could position Turtle Beach favorably in an economy that may still be recovering from the effects of the pandemic and facing potential new challenges. 03/13/2024 - 04:05 PM WHITE PLAINS, N.Y.--(BUSINESS WIRE)-- Turtle Beach Corporation (Nasdaq: HEAR) (Turtle Beach or the Company), a leading gaming accessories brand, today reported financial results for the fourth quarter and full year ended December 31, 2023. Fourth Quarter Summary vs. Year-Ago Quarter: Net revenue was $99.5 million, a decrease of 1.3% compared to $100.9 million a year ago; Net income was $8.6 million, or $0.47 per diluted share, compared to net loss of $23.2 million, or $1.40 per diluted share, a year ago; Adjusted EBITDA improved to $14.0 million compared to $1.0 million a year ago. 2023 Full-Year Summary vs. 2022: Net revenue was $258.1 million, an increase of 7.5% compared to $240.2 million a year ago; Net loss was $17.7 million, or $1.03 per diluted share, compared to $59.5 million, or $3.62 per diluted share, a year ago; Adjusted EBITDA improved to $6.5 million compared to an Adjusted EBITDA loss of $29.9 million a year ago. Management Commentary Turtle Beachs resilience and adaptability have elevated our leadership position across gaming accessories, said Cris Keirn, Chief Executive Officer, Turtle Beach Corporation. Our 2023 full year net revenue increased by 7.5% year-over-year as a result of significant share gains across multiple categories and geographies, including our core business of console gaming headsets. With post-pandemic transitional effects to gaming markets and our business now behind us, we are looking forward to a strong era of exciting new products and growth. We continued to execute against our strategic pillars and ongoing cost management initiatives, which drove margin improvements ahead of our expectations. These initiatives, including portfolio optimization, SKU rationalization, and platformed product development, come into full effect in 2024. We look forward to realizing these benefits with dramatically improved business performance and a 2024 portfolio that will showcase groundbreaking product launches across key categories. We anticipate that these new products, along with our continued focus on multiple cost management initiatives, will result in significant improvements in Turtle Beachs performance in 2024. We are incredibly optimistic about our 2024 prospects given our progress against optimizing the business for the future, our growth prospects in all our gaming categories driven by fantastic new product launches, and our focus on significantly increasing profitability. In addition, today we separately announced the highly accretive acquisition of PDP to significantly diversify our leadership position in gaming accessories, strengthen profitability and meaningfully enhance scale. We view this as a transformational change for the company and our growth prospects have never been stronger. Additionally, as part of our 2024 strategy, we will be consolidating all PC products, including mice, keyboards and headsets, under our best-selling Turtle Beach Brand. Over the last few years, weve demonstrated the power of our brand through our successful entries into other accessories categories, and we expect our customers and portfolio of PC products to benefit from this consolidation. We will continue to drive growth and build on our innovative expansion of gaming categories and products while maintaining our leadership in gaming headsets. With our highly accretive acquisition of PDP and continued category expansion for Turtle Beach products, we expect revenue contribution outside of console gaming headsets to exceed 40% of total revenues in 2024. We believe Turtle Beach is poised for significant value creation in 2024 and beyond. Fourth Quarter 2023 Financial Results Net revenue in the fourth quarter of 2023 was $99.5 million, a decrease of 1% compared to $100.9 million a year ago, driven primarily by a softer than expected console gaming headset market, but returned to growth in late December. Additionally, the slight decline was driven by higher promotional spend than anticipated due to the softer than expected console gaming headset market. Gross margin in the fourth quarter of 2023 increased to 32.0%, the highest level in the past seven quarters, compared to 19.8% a year ago. This increase was driven primarily by lower freight costs and promotional spend. In the fourth quarter of 2022, the Company recorded a $4.5 million incremental inventory provision related to the pandemic driven supply chain challenges. Excluding this provision, the fourth quarter of 2022 adjusted gross margin was 24.3% resulting in an expansion of 770 basis points after this normalization. Operating expenses in the fourth quarter of 2023 were $23.4 million compared to $28.1 million a year ago. Fourth quarter recurring operating expenses declined approximately 12.6% year over year, primarily driven by continued proactive expense management. Net income in the fourth quarter of 2023 was $8.6 million, or $0.47 per diluted share, compared to net loss of $23.2 million, or $1.40 per diluted share, in the year-ago quarter. The weighted average diluted share count for the fourth quarter of 2023 was 18.4 million compared to 16.6 million in the year-ago quarter. Adjusted EBITDA (as defined below in Non-GAAP Financial Measures) in the fourth quarter of 2023 improved to $14.0 million, compared to $1.0 million in the year-ago period. The adjusted EBITDA improvement of $12.9 million for the quarter was due to gross margin expansion and operating expense reductions. 2023 Financial Results Net revenue in 2023 was $258.1 million, an increase of 7.5% compared to $240.2 million a year ago, driven by market share gains and new product launches. Gross margin in 2023 increased to 29.3%, compared to 20.5% a year ago. This increase was driven primarily by lower freight and logistics costs as the elevated freight rates driven by the pandemic normalized. In 2022, the Company recorded a $9.8 million incremental inventory provision related to the pandemic driven supply chain challenges. Excluding this provision, 2022 adjusted gross margin was 24.6%. Operating expenses in 2023 were $91.9 million compared to $100.7 million a year ago. Full year 2023 recurring operating expenses declined approximately 10.6% year over year, primarily driven by continued proactive expense management. Net loss in 2023 was $17.7 million, or $1.03 per diluted share, compared to $59.5 million, or $3.62 per diluted share, in the year-ago quarter. The weighted average diluted share count for 2023 was 17.1 million compared to 16.5 million in the year-ago quarter. Adjusted EBITDA (as defined below in Non-GAAP Financial Measures) in 2023 improved to $6.5 million, compared to adjusted EBITDA loss of $29.9 million in the year-ago period. Balance Sheet and Cash Flow Summary At December 31, 2023, the Company had $18.7 million of cash and no outstanding borrowings on its revolver. This compares to $11.4 million of cash and $19.1 million outstanding on its revolver at December 31, 2022. This is a $26.4 million improvement in the Companys net cash position versus a year ago. Inventories at December 31, 2023 were $44.0 million compared to $71.3 million at December 31, 2022. Cash flow from operations for the twelve months ended December 31, 2023 was $27.0 million, a $68.9 million improvement year over year. Outlook Turtle Beach separately announced today, among other strategic items, the acquisition of PDP, adding significant financial benefits to Turtle Beach that, in conjunction with synergies realized, fundamentally transforms the financial profile of the Company. Accordingly, the Company expects 2024 net revenues to be in the range of $370 million to $380 million, with the growth driven primarily by the acquisition of PDP and the expected out-performance of the gaming markets in specific categories based on the Companys product plans for 2024. Additionally, in light of the Companys strong execution on its efficiency and profitability initiatives, the Company expects pro forma combined Adjusted EBITDA to be between $51 million and $54 million, which incorporates approximately 9 months of operations from PDP. The Company further reiterates its long-term goals of a 10%+ revenue CAGR, a mid-30s gross margin percentage, and is now focused on low to mid-teens percentage for Adjusted EBITDA margins. Value Enhancement Committee Review The Company today issued a separate press release announcing the outcome of the Boards Value Enhancement Committee review, which can be found at https://corp.turtlebeach.com/press-releases/. With respect to the Company's adjusted EBITDA outlook, a reconciliation to its net income (loss) outlook for the same periods has not been provided because of the variability, complexity, and lack of visibility with respect to certain reconciling items between adjusted EBITDA and net income (loss), including other income (expense), provision for income taxes and stock-based compensation. These items cannot be reasonably and accurately predicted without the investment of undue time, cost and other resources and, accordingly, a reconciliation of the Companys adjusted EBITDA outlook to its net income (loss) outlook for such periods is not provided. These reconciling items could be material to the Companys actual results for such periods. Conference Call Details In conjunction with this announcement, Turtle Beach will host a conference call at 5:00 p.m. ET / 2:00 p.m. PT with the Companys Chief Executive Officer, Cris Keirn, and CFO, John Hanson. A live webcast of the call will be available on the Events & Presentations page of the Companys website at www.corp.turtlebeach.com. To access the call by phone, please go to this link (registration link) and you will be provided with dial in details. To avoid delays, we encourage participants to dial into the conference call 15-minutes ahead of the scheduled start time. A replay of the webcast will also be available for a limited time at www.corp.turtlebeach.com. Non-GAAP Financial Measures In addition to its reported results, the Company has included in this earnings release certain financial metrics, including adjusted EBITDA, that the Securities and Exchange Commission define as non-GAAP financial measures. Management believes that such non-GAAP financial measures, when read in conjunction with the Company's reported results, can provide useful supplemental information for investors analyzing period-to-period comparisons of the Company's results. Non-GAAP financial measures are not an alternative to the Companys GAAP financial results and may not be calculated in the same manner as similar measures presented by other companies. Adjusted EBITDA is defined by the Company as net income (loss) before interest, taxes, depreciation and amortization, stock-based compensation (non-cash), and certain non-recurring special items that we believe are not representative of core operations, as further described in Table 4. These non-GAAP financial measures are presented because management uses non-GAAP financial measures to evaluate the Companys operating performance, to perform financial planning, and to determine incentive compensation. Therefore, the Company believes that the presentation of non-GAAP financial measures provides useful supplementary information to, and facilitates additional analysis by, investors. The non-GAAP financial measures included herein exclude items that management does not believe reflect the Companys core operating performance because such items are inherently unusual, non-operating, unpredictable, non-recurring, or non-cash. See a reconciliation of GAAP results to Adjusted EBITDA included as Table 4 below for each of the three and twelve months ended December 31, 2022 and December 31, 2023. About Turtle Beach Corporation Turtle Beach Corporation (the Company) (www.turtlebeachcorp.com) is one of the worlds leading gaming accessory providers. The Companys namesake Turtle Beach brand (www.turtlebeach.com) is known for designing best-selling gaming headsets, PC gaming products, top-rated game controllers, and groundbreaking gaming simulation accessories. Innovation, first-to-market features, a broad range of products for all types of gamers, and top-rated customer support have made Turtle Beach a fan-favorite brand and the market leader in console gaming audio for over a decade. Turtle Beachs shares are traded on the Nasdaq Exchange under the symbol: HEAR. Cautionary Note on Forward-Looking Statements This press release includes forward-looking information and statements within the meaning of the federal securities laws. Except for historical information contained in this release, statements in this release may constitute forward-looking statements regarding assumptions, projections, expectations, targets, intentions or beliefs about future events. Statements containing the words may, could, would, should, believe, expect, anticipate, plan, estimate, target, goal, project, intend and similar expressions, or the negatives thereof, constitute forward-looking statements. Forward-looking statements are only predictions and are not guarantees of performance. Forward-looking statements involve known and unknown risks and uncertainties, which could cause actual results to differ materially from those contained in any forward-looking statement. The inclusion of such information should not be regarded as a representation by the Company, or any person, that the objectives of the Company will be achieved. Forward-looking statements are based on managements current beliefs and expectations, as well as assumptions made by, and information currently available to, management. While the Company believes that its expectations are based upon reasonable assumptions, there can be no assurances that its goals and strategy will be realized. Numerous factors, including risks and uncertainties, may affect actual results and may cause results to differ materially from those expressed in forward-looking statements made by the Company or on its behalf. Some of these factors include, but are not limited to, risks related to general business and economic conditions, inflationary pressures, the impact of competitive products and pricing, including promotional credits and discounts, optimizing our product portfolio, the substantial uncertainties inherent in the acceptance of existing and future products, our dependence on third parties to manufacture and transport our products, reductions in logistic and supply chain challenges and costs, reducing our cost of goods and operating expenses, the difficulty of commercializing and protecting new technology, risks associated with the future direction or governance of the Company, risks associated with the expansion of our business, including the integration of PDP and any other businesses we acquire and the integration of such businesses within our internal control over financial reporting and operations, our indebtedness, liquidity, and other factors discussed in our public filings, including the risk factors included in the Companys most recent Annual Report on Form 10-K, Quarterly Report on Form 10-Q, and the Companys other periodic reports filed with the Securities and Exchange Commission. Except as required by applicable law, including the securities laws of the United States and the rules and regulations of the Securities and Exchange Commission, the Company is under no obligation to publicly update or revise any forward-looking statement after the date of this release whether as a result of new information, future developments or otherwise. All trademarks are the property of their respective owners. Turtle Beach Corporation Condensed Consolidated Statements of Operations (in thousands, except per-share data) (unaudited) Table 1. Three Months Ended Twelve Months Ended December 31, December 31, December 31, December 31, 2023 2022 2023 2022 Net revenue $ 99,538 $ 100,900 $ 258,122 $ 240,166 Cost of revenue 67,734 80,882 182,618 190,979 Gross profit 31,804 20,018 75,504 49,187 Operating expenses: Selling and marketing 13,032 14,124 43,489 47,090 Research and development 4,467 4,335 17,137 19,123 General and administrative 5,946 7,785 31,321 32,558 Goodwill and other intangible asset impairment - 1,896 - 1,896 Total operating expenses 23,445 28,140 91,947 100,667 Operating income (loss) 8,359 (8,122 ) (16,443 ) (51,480 ) Interest expense 251 577 504 1,220 Other non-operating expense (income), net (405 ) (2,330 ) 394 1,753 Income (loss) before income tax 8,513 (6,369 ) (17,341 ) (54,453 ) Income tax expense benefit (39 ) 16,864 338 5,093 Net income (loss) $ 8,552 $ (23,233 ) $ (17,679 ) $ (59,546 ) Net income (loss) per share Basic $ 0.49 $ (1.40 ) $ (1.03 ) $ (3.62 ) Diluted $ 0.47 $ (1.40 ) $ (1.03 ) $ (3.62 ) Weighted average number of shares: Basic 17,449 16,562 17,135 16,450 Diluted 18,383 16,562 17,135 16,450 Turtle Beach Corporation Condensed Consolidated Balance Sheets (in thousands, except par value and share amounts) Table 2. December 31, December 31, 2023 2022 (unaudited) ASSETS (in thousands, except par value and share amounts) Current Assets: Cash $ 18,726 $ 11,396 Accounts receivable, net 54,390 43,336 Inventories 44,019 71,252 Prepaid expenses and other current assets 7,720 9,196 Total Current Assets 124,855 135,180 Property and equipment, net 4,824 6,362 Goodwill 10,686 10,686 Intangible assets, net 1,734 2,612 Other assets 7,868 8,547 Total Assets $ 149,967 $ 163,387 LIABILITIES AND STOCKHOLDERS EQUITY Current Liabilities: Revolving credit facility $  $ 19,053 Accounts payable 26,908 19,846 Other current liabilities 29,424 25,433 Total Current Liabilities 56,332 64,332 Income tax payable 1,546 2,076 Other liabilities 7,012 8,038 Total Liabilities 64,890 74,446 Commitments and Contingencies Stockholders Equity Common stock, $0.001 par value - 25,000,000 shares authorized; 17,531,702 and 16,569,173 shares issued and outstanding as of December 31, 2023 and 2022, respectively 18 17 Additional paid-in capital 220,185 206,916 Accumulated deficit (134,277 ) (116,598 ) Accumulated other comprehensive loss (849 ) (1,394 ) Total Stockholders Equity 85,077 88,941 Total Liabilities and Stockholders Equity $ 149,967 $ 163,387 Turtle Beach Corporation Condensed Consolidated Statements of Cash Flows (in thousands) (unaudited) Table 3. Year Ended December 31, 2023 December 31, 2022 CASH FLOWS FROM OPERATING ACTIVITIES $ 27,044 $ (41,846 ) CASH FLOWS FROM INVESTING ACTIVITIES (2,159 ) (3,549 ) CASH FLOWS FROM FINANCING ACTIVITIES Borrowings on revolving credit facilities 210,210 91,945 Repayment of revolving credit facilities (229,263 ) (72,892 ) Proceeds from exercise of stock options and warrants 2,261 653 Repurchase of common stock (974 ) - Debt financing costs (80 ) - Net cash provided by (used for) financing activities (17,846 ) 19,706 Effect of exchange rate changes on cash 291 (635 ) Net decrease in cash 7,330 (26,324 ) Cash - beginning of period 11,396 37,720 Cash - end of period $ 18,726 $ 11,396 Turtle Beach Corporation GAAP to Adjusted EBITDA Reconciliation (in thousands) Table 4. Three Months Ended Year Ended December 31, December 31, 2023 2022 2023 2022 (in thousands) Net income (loss) $ 8,552 $ (23,233 ) $ (17,679 ) $ (59,546 ) Interest expense 251 577 504 1,220 Depreciation and amortization 1,166 1,352 4,839 5,816 Stock-based compensation (1) 3,429 2,209 11,983 7,984 Income tax expense (39 ) 16,864 338 5,093 Impairment charge (2)  1,896  1,896 Restructuring expense (3) (43 )  1,061 556 CEO transition related costs (4)   2,874  Business transaction expense (5) 653  653  Proxy contest and other (6) (15 ) 1,372 1,921 7,092 Adjusted EBITDA $ 13,954 $ 1,037 $ 6,494 $ (29,889 ) (1) Increase in stock-based compensation in the year ended December 31, 2023 over the comparable prior year period primarily driven by $4.0 million dollar charge related to accelerated vesting of equities associated with the separation of our former CEO. (2) Impairment charge includes costs related to impairment of intangible assets. (3) Restructuring charges are expenses that are paid in connection with reorganization of our operations. These costs primarily include severance and related benefits. (4) CEO transition related expense includes one-time costs associated with the separation of its former CEO. Such costs included severance, bonus, medical benefits and the tax impact of accelerated vesting of stock-based compensation. (5) Business transaction expense includes one-time costs we incurred in connection with acquisitions including professional fees such as legal and accounting along with other certain integration related costs of the acquisitions. (6) Proxy contest and other primarily includes (one-time legal, other professional fees, as well as employee retention costs associated with proxy challenges presented by certain shareholder activists. View source version on businesswire.com: https://www.businesswire.com/news/home/20240313431086/en/ MacLean Marshall Sr. Director, Public Relations & Brand Communications Turtle Beach Corporation 858.914.5093 maclean.marshall@turtlebeach.com Investor Information: Alex Thompson Gateway Group 949.574.3860 hear@gateway-grp.com Source: Turtle Beach Corporation What were Turtle Beach Corporation's (HEAR) net revenue and net income for the fourth quarter of 2023? Turtle Beach reported a net revenue of $99.5 million and net income of $8.6 million for the fourth quarter of 2023. How did Turtle Beach Corporation (HEAR) perform in terms of net revenue for the full year 2023 compared to 2022? Turtle Beach's net revenue for the full year 2023 was $258.1 million, a 7.5% increase compared to $240.2 million in 2022. What was Turtle Beach Corporation's (HEAR) net loss for the full year 2023? Turtle Beach reported a net loss of $17.7 million for the full year 2023. How did Turtle Beach Corporation (HEAR) improve its Adjusted EBITDA in 2023 compared to the previous year? Turtle Beach's Adjusted EBITDA improved to $6.5 million in 2023 compared to an Adjusted EBITDA loss of $29.9 million in the previous year. What strategic initiatives did Turtle Beach Corporation (HEAR) mention for driving margin improvements? Turtle Beach highlighted portfolio optimization, SKU rationalization, and platformed product development as strategic initiatives driving margin improvements."
"ESS Tech, Inc. Announces Fourth Quarter and Full Year 2023 Financial Results",2024-03-13T20:05:00.000Z,Neutral,Neutral,"ESS Tech, Inc. (GWH) reported a 50% decrease in Q4 Adjusted EBITDA loss YoY, exiting 2023 with over $100 million in cash. The company achieved record revenue of $7.5M in FY 2023, successfully delivering Energy Warehouses to key partners like Honeywell. ESS plans to further reduce EW unit costs by 40% in 2024 to achieve non-GAAP gross margin profitability.","ESS Tech, Inc. Announces Fourth Quarter and Full Year 2023 Financial Results Rhea-AI Impact (Neutral) Rhea-AI Sentiment (Neutral) Tags earnings Rhea-AI Summary ESS Tech, Inc. (GWH) reported a 50% decrease in Q4 Adjusted EBITDA loss YoY, exiting 2023 with over $100 million in cash. The company achieved record revenue of $7.5M in FY 2023, successfully delivering Energy Warehouses to key partners like Honeywell. ESS plans to further reduce EW unit costs by 40% in 2024 to achieve non-GAAP gross margin profitability. Positive 50% decrease in Q4 Adjusted EBITDA loss YoY Record revenue of $7.5M in FY 2023 Exited 2023 with over $100 million in cash Successful delivery of Energy Warehouses to key partners like Honeywell Plans to reduce EW unit costs by 40% in 2024 Negative None. Financial Analyst The announcement by ESS Tech, Inc. of a significant reduction in their Q4 adjusted EBITDA loss and the maintenance of a robust cash and short-term investments balance above $100 million is a strong indication of the company's improving financial health. The ability to lower Energy Warehouse manufacturing costs by 60% in 2023 and set a target for a further 40% reduction in 2024 is a testament to the company's operational efficiencies and cost management. These improvements are crucial as they directly contribute to the company's path towards non-GAAP gross margin profitability.From a financial perspective, the cost reductions and cash conservation strategies suggest a proactive approach to managing the company's burn rate and extending its operational runway. This is particularly significant given the capital-intensive nature of the energy storage industry. The strategic focus on shipping to customers with the greatest long-term opportunity, rather than volume, indicates a prioritization of quality partnerships over short-term revenue maximization. This could bode well for sustainable growth, although it may affect short-term revenue projections.Investors should note that the company's record revenue of $7.5M for FY 2023, while a positive development, needs to be evaluated in the context of the company's overall financial position, including its net loss figures and cash flow statements. Additionally, the expected revenue of approximately $2 million in Q1 2024, which was delayed from Q4 2023, highlights the importance of understanding the timing and certainty of revenue recognition in evaluating the company's performance. Energy Market Analyst The deployment of the first Energy Warehouses under a partnership with Honeywell and the expected commissioning of the Energy Center for Portland General Electric later this year represent strategic milestones for ESS Tech, Inc. in the long-duration energy storage (LDES) market. The LDES market is gaining traction as utilities and other stakeholders seek to integrate more renewable energy sources into the grid, which requires storage solutions capable of balancing supply and demand over longer periods.The Energy Center's ability to provide up to eight hours of energy storage is particularly noteworthy, as it addresses a gap in the market for storage solutions beyond the short-duration capabilities of lithium-ion batteries. The scalability of ESS's technology could position the company favorably in a market that is increasingly looking for flexible and long-term storage solutions.Furthermore, the company's engagement in projects like the Burbank Water and Power EcoCampus and the Turlock Irrigation District's Project Nexus demonstrates the versatility of its storage solutions in different applications, from pairing with renewables to tactical microgrids for military use. These projects not only serve as proof of concept for the technology but also help in establishing a track record of successful deployments that can attract additional customers.It is crucial to understand that the LDES market, while growing, is still at a relatively early stage of development. The pace of regulatory changes, technological advancements and cost declines will significantly influence the adoption rate of LDES solutions and, consequently, the performance of companies like ESS Tech, Inc. Sustainability Expert ESS Tech, Inc.'s focus on long-duration energy storage systems is a critical component of the transition to a more sustainable energy grid. The company's efforts to reduce the cost of its Energy Warehouse systems by 60% in 2023, with a further 40% reduction targeted for 2024, are significant for the affordability and scalability of renewable energy solutions. The cost reductions in energy storage are essential for making renewable energy sources like solar and wind more viable and reliable, as they enable the storage of excess energy for use when production is low.The company's projects, such as the pairing of an Energy Warehouse system with solar panels over irrigation canals, showcase innovative approaches to integrating energy storage with renewable energy generation. These initiatives not only generate clean energy but also contribute to water conservation by reducing evaporation, demonstrating the multifaceted benefits of such sustainable practices.Additionally, the deployment of ESS's iron flow battery technology within a tactical microgrid at a US Army Corps of Engineers facility underscores the broader implications of LDES for energy security and resilience. The ability to reduce fuel consumption at Contingency Bases through the use of LDES is an example of how sustainability measures can also align with strategic and economic objectives.Stakeholders should consider the environmental and social governance (ESG) implications of ESS Tech, Inc.'s advancements, as these factors are increasingly relevant to investors and may influence the company's valuation and access to capital in the long term. 03/13/2024 - 04:05 PM Lowered Q4 Adjusted EBITDA loss by More Than 50% year over year Exited 2023 with Cash and Short-Term Investments over $100 million; Expected to Carry ESS Well Into H125 Delivered First Energy Warehouses to Honeywell Energy Warehouse manufacturing cost lowered by 60% in 2023 Target 40% 2024 EW Cost Reduction to Achieve non-GAAP Gross Margin Profitability WILSONVILLE, Ore.--(BUSINESS WIRE)-- ESS Tech, Inc. (ESS, ESS, Inc. or the Company) (NYSE:GWH), a leading manufacturer of long-duration energy storage systems (LDES) for commercial and utility-scale applications, today announced financial results for its fourth quarter and full year ended December 31, 2023. During 2023 our team made significant progress towards our most important objectives, including securing transformative partnerships with LEAG and Honeywell, optimizing our internal operations, and pursuing design initiatives to lower production costs by improving manufacturability and scale. While we faced customer-related delays that impacted our financial results, the teams work during the year laid a solid foundation for us to scale the business, launch the Energy Center and move toward unit profitability in 2024. In fact, our strategic decision to make fewer Energy Warehouses (EWs) and ship them to customers with the greatest long-term opportunity allowed us to conserve cash and exit the year with a cash and short-term investments balance over $100 million. Importantly, we brought down costs to build an EW by almost 60% during 2023 and successfully cut our Q4 adjusted EBITDA loss in half year over year, said Eric Dresselhuys, CEO of ESS. ESS continues to make tremendous progress on our strategy to build a world class, scalable company that is well-positioned to serve the immense long-duration energy storage market. The actions weve already taken have resonated with customers and we continue to see robust customer engagement. In 2024 we plan to further reduce EW unit costs by up to 40% as we move toward unit profitability while ramping our scale and maintaining a healthy cash balance. Recent Business Highlights Achieved record revenue of $7.5M for FY 2023. Delivered first Energy Warehouses under the partnership with Honeywell in Q4 2023 and recently cleared previously announced customer delays in Australia, which we expect will result in revenue of approximately $2 million in Q1 2024 which was originally anticipated in Q4 2023. At the end of 2023, ESS successfully lifted its first Energy Center (EC), a key milestone in the manufacturing process. The EC is a utility-scale, front-of-the-meter long-duration energy storage product which provides up to eight hours of energy storage with a flexible, scalable platform to meet the LDES needs of utilities worldwide. We expect this inaugural EC system will be commissioned and delivered to Portland General Electric later this year. Delivered an Energy Warehouse system to the Burbank Water and Power (BWP) EcoCampus, BWPs first utility-scale battery storage project. This EW will be paired with an on-site solar array where ESS technology will demonstrate the critical role of LDES in a fully renewable grid. Delivered two Energy Warehouses to Turlock Irrigation District (TID) in Central California to support TIDs Project Nexus. At TID, the EW will be paired with a proof of concept of solar panels over irrigation canals. which aims to conserve water resources by reducing evaporation while generating clean energy, reducing diesel generation and reducing energy costs. Completed commissioning of an Energy Warehouse system at the Contingency Base Integration Training Evaluation Center (CBITEC) operated by the US Army Corps of Engineers Engineer Research and Development Center in Fort Leonard Wood, Missouri. This EW has been incorporated into a tactical microgrid at CBITEC and will demonstrate the key role that LDES, specifically iron flow battery technology, can play to reduce fuel consumption at Contingency Bases such as Forward Operating Bases or other temporary use locations providing humanitarian assistance or disaster relief. Conference Call Details ESS will hold a conference call on Wednesday, March 13, 2024 at 5:00 p.m. EDT to discuss financial results for its fourth quarter and full year ended December 31, 2023. Interested parties may join the conference call beginning at 5:00 p.m. EDT on Wednesday, March 13, 2024 via telephone by calling (833) 927-1758 in the U.S., or for international callers, by calling +1 (929) 526-1599 and entering conference ID 261003. A telephone replay will be available until March 20, 2024, by dialing (866) 813-9403 in the U.S., or for international callers, +44 (204) 525-0658 with conference ID 769695. A live webcast of the conference call will be available on ESS Investor Relations website at http://investors.essinc.com/. A replay of the call will be available via the web at http://investors.essinc.com/. About ESS, Inc. At ESS (NYSE: GWH), our mission is to accelerate global decarbonization by providing safe, sustainable, long-duration energy storage that powers people, communities and businesses with clean, renewable energy anytime and anywhere its needed. As more renewable energy is added to the grid, long-duration energy storage is essential to providing the reliability and resiliency we need when the sun is not shining, and the wind is not blowing. Our technology uses earth-abundant iron, salt and water to deliver environmentally safe solutions capable of providing up to 12 hours of flexible energy capacity for commercial and utility-scale energy storage applications. Established in 2011, ESS, Inc. enables project developers, independent power producers, utilities and other large energy users to deploy reliable, sustainable long-duration energy storage solutions. For more information visit www.essinc.com. Use of Non-GAAP Financial Measures In this press release and the accompanying earnings call, the Company includes Non-GAAP Operating Expenses and Adjusted EBITDA, which are non-GAAP performance measures that the Company uses to supplement its results presented in accordance with U.S. GAAP. As required by the rules of the Securities and Exchange Commission (SEC), the Company has provided herein a reconciliation of the non-GAAP financial measures contained in this press release and the accompanying earnings call to the most directly comparable measures under GAAP. The Companys management believes Non-GAAP Operating Expenses and Adjusted EBITDA are useful in evaluating its operating performance and are similar measures reported by publicly-listed U.S. companies, and regularly used by securities analysts, institutional investors, and other interested parties in analyzing operating performance and prospects. By providing these non-GAAP measures, the Companys management intends to provide investors with a meaningful, consistent comparison of the Companys profitability for the periods presented. Adjusted EBITDA is not intended to be a substitute for net income/loss or any U.S. GAAP financial measure and, as calculated, may not be comparable to other similarly titled measures of performance of other companies in other industries or within the same industry. Further, Non-GAAP Operating Expenses are not intended to be a substitute for GAAP Operating Expenses or any U.S. GAAP financial measure and, as calculated, may not be comparable to other similarly titled measures of performance of other companies in other industries or within the same industry. The Company defines and calculates Non-GAAP Operating Expenses as GAAP Operating Expenses adjusted for stock-based compensation and other special items determined by management as they are not indicative of business operations. The Company defines and calculates Adjusted EBITDA as net loss before interest, other non-operating expense or income, (benefit) provision for income taxes, and depreciation, and further adjusted for stock-based compensation and other special items determined by management, including, but not limited to, fair value adjustments for certain financial liabilities associated with debt and equity transactions as they are not indicative of business operations. Forward-Looking Statements This communication contains certain forward-looking statements, including statements regarding ESS and its management teams expectations, hopes, beliefs, intentions or strategies regarding the future. The words anticipate, believe, continue, could, estimate, expect, intends, may, might, plan, possible, potential, predict, project, should, will would and similar expressions may identify forward-looking statements, but the absence of these words does not mean that a statement is not forward-looking. Examples of forward-looking statements include, among others, statements regarding the Companys manufacturing plans, the Companys order and sales pipeline, the Companys ability to execute on orders, the Companys ability to effectively manage costs and the Companys partnerships with third parties such as Amsterdam Airport Schiphol, BWP, CMS, ESIAP, the Sacramento Municipal Utility District and the Turlock Irrigation District. These forward-looking statements are based on ESS current expectations and beliefs concerning future developments and their potential effects on ESS. Many factors could cause actual future events to differ materially from the forward-looking statements in this communication. There can be no assurance that the future developments affecting ESS will be those that we have anticipated. These forward-looking statements involve a number of risks, uncertainties (some of which are beyond ESS control) or other assumptions that may cause actual results or performance to be materially different from those expressed or implied by these forward-looking statements, which include, but are not limited to, continuing supply chain issues; delays, disruptions, or quality control problems in the Companys manufacturing operations; the Companys ability to hire, train and retain an adequate number of manufacturing employees; issues related to the shipment and installation of the Companys products; issues related to customer acceptance of the Companys products; issues related to the Companys partnerships with third parties; inflationary pressures; risk of loss of government funding for customer projects; and the Companys need to achieve significant business growth to achieve sustained, long-term profitability. Except as required by law, ESS is not undertaking any obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise. ESS Tech, Inc. Statements of Operations and Comprehensive Loss (Unaudited, in thousands, except share and per share data) Three Months Ended December 31, 2023 2022 Revenue: Revenue $ 2,796 $ 15 Revenue - related parties  1 Total revenue 2,796 16 Cost of revenue 10,312  Gross profit (loss) (7,516 ) 16 Operating expenses: Research and development 3,842 22,789 Sales and marketing 2,096 1,721 General and administrative 5,611 6,902 Total operating expenses 11,549 31,412 Loss from operations (19,065 ) (31,396 ) Other income (expenses), net: Interest income, net 1,525 1,188 Gain on revaluation of common stock warrant liabilities 1,375 5,273 Other income (expense), net 35 (140 ) Total other income, net 2,935 6,321 Net loss and comprehensive loss to common stockholders $ (16,130 ) $ (25,075 ) Net loss per share - basic and diluted $ (0.09 ) $ (0.16 ) Weighted average shares used in per share calculation - basic and diluted 173,552,254 153,414,471 ESS Tech, Inc. Statements of Operations and Comprehensive Loss (in thousands, except share and per share data) Years Ended December 31, 2023 2022 Revenue: Revenue $ 7,537 $ 610 Revenue - related parties 3 284 Total revenue 7,540 894 Cost of revenue 20,495  Gross profit (loss) (12,955 ) 894 Operating expenses: Research and development 42,632 71,979 Sales and marketing 7,744 6,938 General and administrative 22,574 27,469 Total operating expenses 72,950 106,386 Loss from operations (85,905 ) (105,492 ) Other income (expenses), net: Interest income, net 5,262 2,187 Gain on revaluation of common stock warrant liabilities 2,292 25,788 Other income (expense), net 773 (452 ) Total other income, net 8,327 27,523 Net loss and comprehensive loss to common stockholders $ (77,578 ) $ (77,969 ) Net loss per share - basic and diluted $ (0.48 ) $ (0.51 ) Weighted average shares used in per share calculation - basic and diluted 159,958,645 152,676,155 ESS Tech, Inc. Balance Sheets (in thousands, except share data) December 31, 2023 December 31, 2022 Assets Current assets: Cash and cash equivalents $ 20,165 $ 34,767 Restricted cash, current 1,373 1,213 Accounts receivable, net 1,990 4,952 Short-term investments 87,899 105,047 Inventory 3,366  Prepaid expenses and other current assets 3,305 5,657 Total current assets 118,098 151,636 Property and equipment, net 16,266 17,570 Intangible assets, net 4,923  Operating lease right-of-use assets 2,167 3,401 Restricted cash, non-current 945 675 Other non-current assets 833 271 Total assets $ 143,232 $ 173,553 Liabilities and Stockholders Equity Current liabilities: Accounts payable $ 2,755 $ 3,036 Accrued and other current liabilities 10,755 14,125 Accrued product warranties 2,129 1,643 Operating lease liabilities, current 1,581 1,421 Deferred revenue, current 2,546 6,168 Notes payable, current  1,600 Total current liabilities 19,766 27,993 Notes payable, non-current  315 Operating lease liabilities, non-current 957 2,535 Deferred revenue, non-current 3,835 2,442 Deferred revenue, non-current - related parties 14,400  Common stock warrant liabilities 917 3,209 Other non-current liabilities  85 Total liabilities 39,875 36,579 Stockholders equity: Preferred stock ($0.0001 par value, 200,000,000 shares authorized, none issued and outstanding as of December 31, 2023 and 2022)   Common stock ($0.0001 par value; 2,000,000,000 shares authorized, 174,211,911 and 153,821,339 shares issued and outstanding as of December 31, 2023 and 2022, respectively) 18 16 Additional paid-in capital 799,496 755,537 Accumulated deficit (696,157 ) (618,579 ) Total stockholders equity 103,357 136,974 Total liabilities and stockholders equity $ 143,232 $ 173,553 ESS Tech, Inc. Consolidated Statements of Cash Flows (in thousands) Years Ended December 31, 2023 2022 Cash flows from operating activities: Net loss $ (77,578 ) $ (77,969 ) Adjustments to reconcile net loss to net cash used in operating activities: Depreciation and amortization 6,513 1,523 Non-cash interest income (3,635 ) (1,349 ) Non-cash lease expense 1,234 1,134 Stock-based compensation expense 10,635 11,889 Inventory write-down and losses on noncancellable purchase commitments 11,932  Change in fair value of common stock warrant liabilities (2,292 ) (25,788 ) Other non-cash income and expenses, net (60 ) 483 Changes in operating assets and liabilities: Accounts receivable, net 3,633 (1,886 ) Inventory (14,661 )  Prepaid expenses and other current assets 2,422 (311 ) Accounts payable (229 ) 1,464 Accrued and other current liabilities (3,378 ) 6,789 Accrued product warranties 486 1,643 Deferred revenue 11,500 1,881 Operating lease liabilities (1,418 ) (1,123 ) Net cash used in operating activities (54,896 ) (81,620 ) Cash flows from investing activities: Purchases of property and equipment (5,790 ) (14,180 ) Maturities and purchases of short-term investments, net 20,861 (103,704 ) Net cash provided by (used in) investing activities 15,071 (117,884 ) Cash flows from financing activities: Proceeds from issuance of common stock and common stock warrants, net of issuance costs 27,132  Payments on notes payable (1,733 ) (1,900 ) Proceeds from stock options exercised 237  Repurchase of shares from employees for income tax withholding purposes (310 ) (2,808 ) Proceeds from contributions to Employee Stock Purchase Plan 541 492 Proceeds from warrants exercised  165 Other, net (214 ) (22 ) Net cash provided by (used in) financing activities 25,653 (4,073 ) Net change in cash, cash equivalents and restricted cash (14,172 ) (203,577 ) Cash, cash equivalents and restricted cash, beginning of period 36,655 240,232 Cash, cash equivalents and restricted cash, end of period $ 22,483 $ 36,655 ESS Tech, Inc. Consolidated Statements of Cash Flows (continued) (in thousands) Years Ended December 31, 2023 2022 Supplemental disclosures of cash flow information: Cash paid for operating leases included in cash used in operating activities $ 1,670 $ 1,625 Cash paid for interest  154 Non-cash investing and financing transactions: Common stock warrants issued for the acquisition of intangible assets 4,990  Purchase of property and equipment included in accounts payable and accrued and other current liabilities 704 1,358 Right-of-use operating lease assets obtained in exchange for lease obligations  4,534 Right-of-use finance lease assets obtained in exchange for lease obligations  123 Warrant vested under contracts with customers  46 Cash and cash equivalents $ 20,165 $ 34,767 Restricted cash, current 1,373 1,213 Restricted cash, non-current 945 675 Total cash, cash equivalents and restricted cash shown in the statements of cash flows $ 22,483 $ 36,655 ESS Tech, Inc. Reconciliation of GAAP to Non-GAAP Operating Expenses (Unaudited, in thousands) Three Months Ended December 31, Twelve Months Ended December 31, 2023 2023 Research and development $ 3,842 $ 42,632 Less: stock-based compensation(1) (295 ) (2,696 ) Non-GAAP research and development $ 3,547 $ 39,936 Sales and marketing $ 2,096 $ 7,744 Less: stock-based compensation(1) (290 ) (816 ) Non-GAAP sales and marketing $ 1,806 $ 6,928 General and administrative $ 5,611 $ 22,574 Less: stock-based compensation(1) (1,502 ) (5,370 ) Non-GAAP general and administrative $ 4,109 $ 17,204 Total operating expenses $ 11,549 $ 72,950 Less: stock-based compensation (2,087 ) (8,882 ) Non-GAAP total operating expenses $ 9,462 $ 64,068 (1) For purposes of calculating Non-GAAP total operating expenses, stock-based compensation is allocated on a departmental basis based on the classification of the award holder. ESS Tech, Inc. Reconciliation of GAAP Net Loss to Adjusted EBITDA (Unaudited, in thousands) Three Months Ended December 31, Twelve Months Ended December 31, 2023 2023 Net loss $ (16,130 ) $ (77,578 ) Interest income, net (1,525 ) (5,262 ) Stock-based compensation 2,962 10,635 Depreciation and amortization 3,326 6,513 Gain on revaluation of warrant liabilities (1,375 ) (2,292 ) Other expense, net (35 ) (773 ) Adjusted EBITDA $ (12,777 ) $ (68,757 ) Source: ESS Tech, Inc. View source version on businesswire.com: https://www.businesswire.com/news/home/20240313875100/en/ Investors: Erik Bylin investors@essinc.com Media: Morgan Pitts 503.568.0755 Morgan.Pitts@essinc.com Source: ESS, Inc. What was the percentage decrease in Q4 Adjusted EBITDA loss YoY for ESS Tech, Inc. (GWH)? ESS Tech, Inc. (GWH) reported a 50% decrease in Q4 Adjusted EBITDA loss YoY. What was the record revenue for ESS Tech, Inc. (GWH) in FY 2023? ESS Tech, Inc. (GWH) achieved record revenue of $7.5M in FY 2023. How much cash did ESS Tech, Inc. (GWH) exit 2023 with? ESS Tech, Inc. (GWH) exited 2023 with over $100 million in cash. Which key partner did ESS Tech, Inc. (GWH) successfully deliver Energy Warehouses to? ESS Tech, Inc. (GWH) successfully delivered Energy Warehouses to key partners like Honeywell. What are ESS Tech, Inc.'s (GWH) plans regarding reducing EW unit costs in 2024? ESS Tech, Inc. (GWH) plans to further reduce EW unit costs by 40% in 2024 to achieve non-GAAP gross margin profitability."
"Trevi Therapeutics to Report Q4 and Year End 2023 Financial Results and Provide a Corporate Update on March 20, 2024",2024-03-13T20:05:00.000Z,Low,Neutral,"Trevi Therapeutics, Inc. (Nasdaq: TRVI) will host a conference call and webcast to discuss the investigational therapy Haduvio for chronic cough in IPF and RCC. The event will cover financial results for Q4 2023 and the full year.","Trevi Therapeutics to Report Q4 and Year End 2023 Financial Results and Provide a Corporate Update on March 20, 2024 Rhea-AI Impact (Low) Rhea-AI Sentiment (Neutral) Tags conferences earnings Rhea-AI Summary Trevi Therapeutics, Inc. (Nasdaq: TRVI) will host a conference call and webcast to discuss the investigational therapy Haduvio for chronic cough in IPF and RCC. The event will cover financial results for Q4 2023 and the full year. Positive None. Negative None. 03/13/2024 - 04:05 PM Conference call and webcast to be held at 4:30 p.m. ET NEW HAVEN, Conn., March 13, 2024 /PRNewswire/ -- Trevi Therapeutics, Inc. (Nasdaq: TRVI), a clinical-stage biopharmaceutical company developing the investigational therapy Haduvio (oral nalbuphine ER) for patients with chronic cough in idiopathic pulmonary fibrosis (IPF) and refractory chronic cough (RCC), today announced that senior management will host a conference call and live audio webcast on Wednesday, March 20, 2024, at 4:30 p.m. ET, to provide a corporate update and review the Company's financial results for the quarter and year ended December 31, 2023. To participate in the live conference call by phone, please dial (888) 317 6003 (domestic) or (412) 317 6061 (international) and provide access code 4401006. A live audio webcast will be accessible from the 'Investors & News' section on the Company's website at www.TreviTherapeutics.com. An archived replay of the webcast will also be available for 30 days on the Company's website following the event. About Trevi Therapeutics, Inc.Trevi Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing the investigational therapy Haduvio (oral nalbuphine ER) for patients with chronic cough in idiopathic pulmonary fibrosis (IPF) and refractory chronic cough (RCC). Trevi also is evaluating Haduvio for prurigo nodularis. Haduvio is a dual -opioid receptor agonist and -opioid receptor antagonist that works both centrally in the brain as well as peripherally in the lungs and has the potential for a synergistic antitussive effect to treat chronic cough. The impact of chronic cough is significant and often leads to a decline in patients' social, physical, and psychological quality of life. In IPF, chronic cough may lead to worsening disease and may be associated with a higher risk of progression, death, or need for lung transplant. There are no approved therapies for the treatment of chronic cough in IPF and current treatment options provide minimal relief to patients. RCC affects up to 10% of the adult population, and Haduvio's expansion into RCC has the potential to reach patients suffering from moderate to severe chronic cough. There are also no approved therapies for RCC in the US. Parenteral nalbuphine is not scheduled by the U.S. Drug Enforcement Agency. Trevi intends to propose Haduvio as the trade name for oral nalbuphine ER. Its safety and efficacy have not been evaluated by any regulatory authority. For more information, visit www.TreviTherapeutics.com and follow Trevi on X (formerly Twitter) and LinkedIn. Investor Contact Katie McManus Trevi Therapeutics, Inc. 203-304-2499 k.mcmanus@trevitherapeutics.com Media Contact Rosalia Scampoli 914-815-1465 rscampoli@marketcompr.com View original content to download multimedia:https://www.prnewswire.com/news-releases/trevi-therapeutics-to-report-q4-and-year-end-2023-financial-results-and-provide-a-corporate-update-on-march-20-2024-302086846.html SOURCE Trevi Therapeutics, Inc. When will Trevi Therapeutics host the conference call and webcast? Trevi Therapeutics will host the conference call and webcast on Wednesday, March 20, 2024, at 4:30 p.m. ET. What is the ticker symbol for Trevi Therapeutics? The ticker symbol for Trevi Therapeutics is TRVI. What therapy is Trevi Therapeutics developing for chronic cough? Trevi Therapeutics is developing the investigational therapy Haduvio for chronic cough in idiopathic pulmonary fibrosis (IPF) and refractory chronic cough (RCC). Where can one access the live audio webcast of the conference call? The live audio webcast of the conference call will be accessible from the 'Investors & News' section on Trevi Therapeutics' website at www.TreviTherapeutics.com. How long will the archived replay of the webcast be available? The archived replay of the webcast will be available for 30 days on Trevi Therapeutics' website following the event."
California State Lottery Awards ICF New $58 Million Contract,2024-03-13T20:05:00.000Z,Low,Neutral,"ICF (NASDAQ:ICFI) secures a $58 million contract with the California State Lottery to enhance website development and cloud infrastructure support services, aiming to improve user experience and compliance with the Americans with Disabilities Act.","California State Lottery Awards ICF New $58 Million Contract Rhea-AI Impact (Low) Rhea-AI Sentiment (Neutral) Tags Rhea-AI Summary ICF (NASDAQ:ICFI) secures a $58 million contract with the California State Lottery to enhance website development and cloud infrastructure support services, aiming to improve user experience and compliance with the Americans with Disabilities Act. Positive None. Negative None. Market Research Analyst The new $58 million contract between ICF and the California State Lottery indicates a significant investment in digital infrastructure, which is a growing trend across various sectors. This collaboration underscores the importance of digital transformation as a means to enhance user experience and operational efficiency.From a market perspective, the contract suggests a stable revenue stream for ICF over the next five years, with the potential for extension. This stability can be appealing to investors, as it provides predictable cash flows and may contribute to the company's financial health. Furthermore, the emphasis on cloud solutions and data analytics aligns with the broader industry's shift towards cloud computing and big data, which are key drivers of innovation and growth.For the California State Lottery, the improved website and cloud infrastructure could result in increased sales and customer engagement, which is essential for the organization's goal of raising supplemental funding for public schools. This is indicative of how digital platforms can be leveraged by state-run entities to improve public services and funding mechanisms. Financial Analyst ICF's contract with the California State Lottery represents a substantial long-term investment that could positively impact ICF's earnings and stock performance. The contract's duration and extensions provide a long-term outlook for revenue, which can be factored into financial models and forecasts for the company.Investors often look for companies with strong, diversified contract portfolios that demonstrate the ability to secure and maintain large-scale projects. ICF's ability to renew and expand its collaboration with the Lottery is a testament to its competitive position within the technology services industry.It's also worth noting that contracts with government entities, like state lotteries, are often seen as more secure compared to private sector contracts, which can be subject to more volatility. This could be perceived as a lower-risk revenue source, potentially making ICF more attractive to risk-averse investors. Legal Expert The compliance aspect of the contract with the Americans with Disabilities Act (ADA) is crucial, as it demonstrates ICF's commitment to inclusivity and legal compliance. Ensuring that digital platforms are accessible to all users is not only a legal requirement but also expands the potential customer base for the California State Lottery.ADA compliance can also mitigate the risk of potential legal challenges, which could result in costly settlements and damage to reputation. By focusing on these legal standards, ICF not only protects its client but also positions itself as a responsible and ethical service provider, which can be a differentiating factor in the industry. 03/13/2024 - 04:05 PM Company Will Expand Website Development and Cloud Infrastructure Support Services RESTON, Va., March 13, 2024 /PRNewswire/ -- California State Lottery has recently expanded its collaboration with global consulting and technology services provider ICF (NASDAQ:ICFI) through a new $58 million contract award to continue supporting the Lottery's website. The base contract term is five years, with three optional extensions (two two-year extensions and one one-year extension). The contract was awarded in the fourth quarter of 2023. ICF will support the design and enhancement of the Lottery's cloud-hosted website, as well as provide around-the-clock maintenance and operations support. The company will also provide ongoing development of new site features and functionality to create a better user experience, including ensuring the site continues to be compliant with the Americans with Disabilities Act. ""ICF has collaborated with the California State Lottery since 2015 to build a solid digital foundation and cloud-based infrastructure,"" said James Morgan, ICF chief operating officer. ""With this new contract, we will continue to bring our expertise in cloud solutions, data analytics, human-centered design and digital communications to improve website performance, which we believe will help the Lottery meet their goal of increasing sales and amplifying customer engagement."" The California State Lottery plays a vital role in raising supplemental funding for California's public schools and raised $2.07 billion for education in the 20212022 fiscal year. This website will help the Lottery meet their goal of generating additional supplemental funding for the state's public schools. ICF combines deep domain expertise with leading-edge technologies, advanced analytics and human-centered practices to help clients design technology solutions that reduce time-to-value. The company brings marketing, communications and technology together with strategy and design to make a measurable impact for clients and bring organizations closer to the people they serve. ICF's over 2,000 technologists work hand-in-hand with thousands of industry experts and an expansive ecosystem of over 30 platform partners to rapidly deliver scalable technology solutions that accelerate mission readiness, improve mission outcomes and achieve a step change in productivity. Read more about ICF's technology services and partnerships. About ICFICF is a global consulting and technology services company with approximately 9,000 employees, but we are not your typical consultants. At ICF, business analysts and policy specialists work together with digital strategists, data scientists and creatives. We combine unmatched industry expertise with cutting-edge engagement capabilities to help organizations solve their most complex challenges. Since 1969, public and private sector clients have worked with ICF to navigate change and shape the future. Learn more at icf.com. Caution Concerning Forward-looking StatementsStatements that are not historical facts and involve known and unknown risks and uncertainties are ""forward-looking statements"" as defined in the Private Securities Litigation Reform Act of 1995. Such statements may concern our current expectations about our future results, plans, operations and prospects and involve certain risks, including those related to the government contracting industry generally; our particular business, including our dependence on contracts with U.S. federal government agencies; our ability to acquire and successfully integrate businesses; and the effects of the novel coronavirus disease (COVID-19), or any other future pandemic, and related national, state and local government actions and reactions, on the health of our staff and that of our clients, the continuity of our and our clients' operations, our results of operations and our outlook. These and other factors that could cause our actual results to differ from those indicated in forward-looking statements that are included in the ""Risk Factors"" section of our securities filings with the Securities and Exchange Commission. The forward-looking statements included herein are only made as of the date hereof, and we specifically disclaim any obligation to update these statements in the future. Contact: Lauren Dyke, lauren.dyke@ICF.com, +1.571.373.5577 View original content to download multimedia:https://www.prnewswire.com/news-releases/california-state-lottery-awards-icf-new-58-million-contract-302088243.html SOURCE ICF What is the contract amount of the collaboration between ICF and the California State Lottery? ICF secured a $58 million contract with the California State Lottery. What services will ICF provide to the California State Lottery under the new contract? ICF will support the design and enhancement of the Lottery's cloud-hosted website, provide around-the-clock maintenance and operations support, and develop new site features and functionality to improve user experience. What is the base contract term for the collaboration between ICF and the California State Lottery? The base contract term is five years, with three optional extensions. How does ICF plan to help the California State Lottery meet their goal of increasing sales and customer engagement? ICF will bring expertise in cloud solutions, data analytics, human-centered design, and digital communications to improve website performance, aiming to help the Lottery increase sales and customer engagement. What is the role of the California State Lottery in raising supplemental funding for public schools? The California State Lottery plays a vital role in raising supplemental funding for California's public schools and raised $2.07 billion for education in the 20212022 fiscal year."
Vivid Seats to Participate in Canaccord Genuity's eCommerce Sustainable Advantage Forum,2024-03-13T20:05:00.000Z,Low,Neutral,Vivid Seats Inc. (NASDAQ: SEAT) CFO to present at Canaccord Genuity's eCommerce Sustainable Advantage Forum. Webcast available on Investor Relations website.,"Vivid Seats to Participate in Canaccord Genuity's eCommerce Sustainable Advantage Forum Rhea-AI Impact (Low) Rhea-AI Sentiment (Neutral) Tags conferences Rhea-AI Summary Vivid Seats Inc. (NASDAQ: SEAT) CFO to present at Canaccord Genuity's eCommerce Sustainable Advantage Forum. Webcast available on Investor Relations website. Positive None. Negative None. 03/13/2024 - 04:05 PM CHICAGO, March 13, 2024 (GLOBE NEWSWIRE) -- Vivid Seats Inc. (NASDAQ: SEAT) (Vivid Seats), a leading marketplace that utilizes its technology platform to connect millions of buyers with thousands of ticket sellers across hundreds of thousands of events each year, today announced that Lawrence Fey, Chief Financial Officer, will be presenting at Canaccord Genuity's eCommerce Sustainable Advantage Forum on Thursday, March 14, 2024 at 11:00 a.m. ET. A live webcast of the presentation will be accessible on the Vivid Seats Investor Relations website at https://investors.vividseats.com/ under News & Events. About Vivid SeatsFounded in 2001, Vivid Seats is a leading online ticket marketplace committed to becoming the ultimate partner for connecting fans to the live events, artists, and teams they love. Based on the belief that everyone should Experience It Live, the Chicago-based company provides exceptional value by providing one of the widest selections of events and tickets in North America and an industry leading Vivid Seats Rewards program where all fans earn on every purchase. Vivid Seats has been chosen as the official ticketing partner by some of the biggest brands in the entertainment industry including ESPN, Rolling Stone, and the Los Angeles Clippers. Vivid Seats also owns Vivid Picks, a daily fantasy sports app. Through its proprietary software and unique technology, Vivid Seats drives the consumer and business ecosystem for live event ticketing and enables the power of shared experiences to unite people. Vivid Seats has been recognized by Newsweek as one of Americas Best Companies for Customer Service in ticketing. Fans who want to have the best live experiences can start by downloading the Vivid Seats mobile app, going to vividseats.com, or calling 866-848-8499. Contacts: InvestorsKate Africk Kate.Africk@vividseats.com MediaJulia YoungJulia.Young@vividseats.com When will Lawrence Fey, CFO of Vivid Seats Inc. present at Canaccord Genuity's eCommerce Sustainable Advantage Forum? Lawrence Fey, CFO of Vivid Seats Inc. will present at the forum on Thursday, March 14, 2024 at 11:00 a.m. ET. Where can I access the live webcast of the presentation by Vivid Seats Inc. CFO? The live webcast of the presentation will be available on the Vivid Seats Investor Relations website at https://investors.vividseats.com/ under 'News & Events'."
Acri Capital Acquisition Corporation Announces Extension of the Deadline for an Initial Business Combination,2024-03-13T20:05:00.000Z,No impact,Neutral,"Acri Capital Acquisition Corporation (ACAC) extends business combination deadline by a month by depositing $75,000 into the Trust Account, allowing more time for potential mergers or acquisitions.","Acri Capital Acquisition Corporation Announces Extension of the Deadline for an Initial Business Combination Rhea-AI Impact (No impact) Rhea-AI Sentiment (Neutral) Tags acquisition Rhea-AI Summary Acri Capital Acquisition Corporation (ACAC) extends business combination deadline by a month by depositing $75,000 into the Trust Account, allowing more time for potential mergers or acquisitions. Positive None. Negative None. 03/13/2024 - 04:05 PM Austin, Texas, March 13, 2024 (GLOBE NEWSWIRE) -- Acri Capital Acquisition Corporation (the Company) (Nasdaq: ACAC), a special purpose acquisition company, today announced that, in order to extend the date by which the Company must complete its initial business combination from March 14, 2024 to April 14, 2024, Acri Capital Sponsor LLC, the sponsor of the Company, has deposited into its trust account (the Trust Account) an aggregate of $75,000 (the New Monthly Extension Payment). Pursuant to the Companys Amended and Restated Certificate of Incorporate currently in effect, the Company may extend on monthly basis from July 14, 2023 until April 14, 2024 or such an earlier date as may be determined by its board to complete a business combination by depositing the New Monthly Extension Payment for each month into the Trust Account. About Acri Capital Acquisition Corporation Acri Capital Acquisition Corporation is a blank check company, also commonly referred to as a special purpose acquisition company, or SPAC, formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses with one or more businesses or entities. Cautionary Statement Regarding Forward-Looking Statements This Press Release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements include, but are not limited to, statements about future financial and operating results, our plans, objectives, expectations and intentions with respect to future operations, products and services; and other statements identified by words such as will likely result, are expected to, will continue, is anticipated, estimated, believe, intend, plan, projection, outlook or words of similar meaning. Such forward-looking statements are based upon the current beliefs and expectations of our management and are inherently subject to significant business, economic and competitive uncertainties and contingencies, many of which are difficult to predict and generally beyond our control. Actual results and the timing of events may differ materially from the results anticipated in these forward-looking statements. Contact Information Company Contact: Acri Capital Acquisition CorporationMs. Joy Yi Hua, ChairwomanEmail: acri.capital@gmail.com Investor Relations Contact: International Elite CapitalAnnabelle ZhangTelephone: +1(646) 866-7989Email: acri@iecapitalusa.com What is the ticker symbol for Acri Capital Acquisition Corporation? The ticker symbol for Acri Capital Acquisition Corporation is ACAC. Why did Acri Capital Acquisition Corporation extend its business combination deadline? Acri Capital Acquisition Corporation extended its business combination deadline to April 14, 2024, by depositing $75,000 into the Trust Account to allow more time for completing potential mergers or acquisitions. How much money did Acri Capital Sponsor LLC deposit into the Trust Account for the extension? Acri Capital Sponsor LLC deposited an aggregate of $75,000 into the Trust Account as the New Monthly Extension Payment to extend the business combination deadline."
MorphoSys AG Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update,2024-03-13T20:02:00.000Z,Low,Neutral,"MorphoSys AG reports positive results for the fourth quarter and full year 2023, showcasing successful Phase 3 MANIFEST-2 study outcomes and significant financial figures. The company entered a Business Combination Agreement with Novartis, aiming to be acquired for  68.00 per share in cash. Novartis plans to develop and commercialize pelabresib and tulmimetostat globally, with the transaction expected to close in the first half of 2024.","MorphoSys AG Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update Rhea-AI Impact (Low) Rhea-AI Sentiment (Neutral) Tags earnings Rhea-AI Summary MorphoSys AG reports positive results for the fourth quarter and full year 2023, showcasing successful Phase 3 MANIFEST-2 study outcomes and significant financial figures. The company entered a Business Combination Agreement with Novartis, aiming to be acquired for  68.00 per share in cash. Novartis plans to develop and commercialize pelabresib and tulmimetostat globally, with the transaction expected to close in the first half of 2024. Positive Positive Phase 3 MANIFEST-2 study results demonstrate the potential of pelabresib in myelofibrosis treatment. Novartis' acquisition agreement with MorphoSys at  68.00 per share in cash indicates a premium of 94% and 142% on the volume-weighted average price. Financially, MorphoSys reported Monjuvi U.S. net product sales of US$ 24.1 million for Q4 2023 and US$ 92.0 million for the full year 2023. The company had  680.5 million in cash and other financial assets as of December 31, 2023, ensuring operational sustainability until early 2026. MorphoSys plans to submit a New Drug Application for pelabresib in myelofibrosis treatment to the FDA and EMA in mid-2024. The sale of tafasitamab rights to Incyte for US$ 25 million and the completion of a share capital increase generated additional funds for the company. Negative Total revenues decreased by 28% in Q4 2023 compared to the same period in 2022. Operating loss increased to  81.4 million in Q4 2023, indicating financial challenges. Consolidated net loss for Q4 2023 was  48.3 million, showcasing a negative financial outcome. The revocation of the 2024 financial guidance due to the sale of tafasitamab to Incyte raises uncertainties about future financial performance. R&D expenses for the full year 2023 were  283.6 million, reflecting significant investments in development activities. Financial Analyst The acquisition of MorphoSys by Novartis at a substantial premium indicates a strategic move by Novartis to bolster its pipeline with MorphoSys' advanced clinical assets, particularly pelabresib. This acquisition price suggests a strong confidence in the future revenue streams and market potential of these assets. The significant premium also reflects the competition and scarcity of advanced biotech assets in the market. Investors should note the liquidity position of MorphoSys, which is robust with 680.5 million in cash and financial assets, providing operational runway until early 2026. However, the reported operating loss and net loss for both the quarter and the full year are areas of concern, indicating a need for further efficiency in operations or a strategic pivot to return to profitability. Medical Research Analyst The Phase 3 MANIFEST-2 study results for pelabresib are pivotal, as they show potential for a new standard of care in myelofibrosis treatment. The combination therapy with ruxolitinib, a JAK inhibitor, has shown significant improvements in disease hallmarks, which could lead to a strong market position if approved. The safety profile aligning with previous trials adds to the compound's credibility. The planned submission of a New Drug Application to the FDA and a Marketing Authorization Application to the EMA in mid-2024 is a critical next step for MorphoSys and will be a key driver of the company's value proposition post-acquisition. Market Research Analyst The decrease in Monjuvi's U.S. net product sales year-over-year, despite the overall stability in annual revenues, may raise questions about the drug's market penetration and competitive landscape. The royalty revenue growth is a positive sign, reflecting the underlying value of MorphoSys' licensing agreements. The sale of tafasitamab rights to Incyte for a modest sum suggests a strategic repositioning, possibly to streamline the company's focus on pelabresib and tulmimetostat. Investors should monitor the market response to pelabresib's potential approval and commercial launch, as it will significantly influence MorphoSys' future financial performance within the Novartis portfolio. 03/13/2024 - 04:02 PM  Entered into Business Combination Agreement to be acquired by Novartis for  68.00 per share in cash or  2.7 billion equity value  Sold all tafasitamab rights worldwide to Incyte  Presented comprehensive Phase 3 MANIFEST-2 study results at ASH 2023 Annual Meeting, demonstrating pelabresib improves all four disease hallmarks of myelofibrosis  Monjuvi U.S. net product sales of US$ 24.1 million ( 22.4 million) for the fourth quarter of 2023 and US$ 92.0 million ( 85.0 million) for the full year of 2023   680.5 million in cash and other financial assets as of December 31, 2023  MorphoSys to host conference call and webcast on Thursday, March 14, 2024, at 1:00 pm CET (12:00 pm GMT; 8:00 am EDT) PLANEGG/MUNICH, Germany--(BUSINESS WIRE)-- MorphoSys AG (FSE: MOR; NASDAQ: MOR) reports results for the fourth quarter and the full year 2023. In 2023, we demonstrated the potential for pelabresib to shift the myelofibrosis treatment paradigm, as results from our Phase 3 MANIFEST-2 study showed that all four disease hallmarks were improved with the pelabresib and ruxolitinib combination therapy over standard of care, said Jean-Paul Kress, M.D., Chief Executive Officer of MorphoSys. Now, in 2024, we are pleased that Novartis is committing to the future of our promising pipeline. With its ample resources, additional scientific expertise and global footprint, Novartis can help accelerate pelabresib's potential worldwide. The acquisition process is progressing steadily, and we expect to close the proposed transaction in the first half of the year. Novartis Public Takeover Offer: On February 5, 2024, MorphoSys announced the company entered into a Business Combination Agreement with Novartis BidCo AG (formerly known as Novartis data42 AG) and Novartis AG (hereinafter collectively referred to as Novartis) based on Novartis intention to submit a voluntary public takeover offer for all outstanding MorphoSys no-par value bearer shares at an offer price of  68.00 per share in cash. The offer price corresponds to a premium of 94% and 142% on the volume-weighted average price during the last month and three months, as of the unaffected January 25, 2024, close, respectively. As part of the Business Combination Agreement with Novartis, Novartis seeks to obtain exclusive, worldwide rights to develop and commercialize pelabresib, an investigational BET inhibitor, and tulmimetostat, an investigational next-generation dual inhibitor of EZH2 and EZH1, across all indications. The offer will contain customary closing conditions, in particular a minimum acceptance threshold of 65% of MorphoSys share capital and antitrust clearances. MorphoSys and Novartis have received antitrust clearance in Germany and Austria. The companies have also made antitrust filings in the U.S. under the HSR Act and continue to expect the closing to take place in the first half of 2024. Pelabresib Highlights: On December 10, 2023, comprehensive results from the Phase 3 MANIFEST-2 study at 24 weeks were presented during an oral presentation at the 65th American Society of Hematology (ASH) Annual Meeting and Exposition. In MANIFEST-2, the combination of pelabresib and the JAK inhibitor ruxolitinib improved all four disease hallmarks of myelofibrosis, including a significant reduction in spleen size with a response rate nearly double that of placebo plus ruxolitinib. The combination therapy showed a strong positive trend in reducing symptom burden and improvements in measures of anemia and bone marrow fibrosis, and demonstrated safety results in line with assessments from prior clinical trials. Monjuvi/Minjuvi Highlights: Monjuvi (tafasitamab-cxix) U.S. net product sales of US$ 24.1 million ( 22.4 million) for the fourth quarter 2023 (Q4 2022: US$ 25.3 million ( 24.7 million)) and US$ 92.0 million ( 85.0 million) for the full year of 2023 (2022: US$ 89.4 million ( 84.9 million)). Minjuvi royalty revenue of  1.3 million for sales outside of the U.S. in the fourth quarter 2023 (Q4 2022:  0.7 million) and  5.4 million for the full year of 2023 (2022:  3.0 million). On February 5, 2024, MorphoSys also announced it entered into a Purchase Agreement to sell and transfer all rights worldwide related to tafasitamab to Incyte Corporation (Incyte). Under the terms of MorphoSys Purchase Agreement with Incyte, Incyte will obtain exclusive rights worldwide, assume full responsibility and cover all costs going forward for the development and commercialization of tafasitamab for a purchase price of US$ 25 million. Corporate Developments: On December 14, 2023, MorphoSys announced the completion of a share capital increase from  34,231,943 by  3,423,194 to  37,655,137 through a full utilization of its authorized capital 2023-II, resulting in gross proceeds of  102.7 million. Financial Results for the Fourth Quarter of 2023 (IFRS): Total revenues for the fourth quarter 2023 were  59.0 million compared to  81.6 million for the same period in 2022. The decrease resulted first and foremost from prior year revenues stemming from the execution of an out-licensing agreement with Novartis. in  million* Q4 2023 Q3 2023 Q4 2022 Q-Q  Y-Y  Total revenues 59.0 63.8 81.6 (8)% (28)% Monjuvi product sales 22.4 21.5 24.7 4% (9)% Royalties 34.0 34.0 29.1 0% 17% Licenses, milestones and other 2.6 8.3 27.9 (69)% (91)% * Differences due to rounding. Cost of Sales: In the fourth quarter of 2023, cost of sales was  14.6 million compared to  15.4 million for the comparable period in 2022. Research and Development (R&D) Expenses: In the fourth quarter 2023, R&D expenses were  80.3 million compared to  94.0 million for the same period in 2022. The decrease mainly resulted from lower expenses for external services. Selling, General and Administrative (SG&A) Expenses: Selling expenses in the fourth quarter 2023 were  22.6 million compared to  23.0 million for the same period in 2022. General and administrative (G&A) expenses amounted to  22.9 million compared to  17.5 million for the same period in 2022. Operating Loss: Operating loss amounted to  81.4 million in the fourth quarter 2023 compared to  68.4 million for the same period in 2022. Consolidated Net Loss: For the fourth quarter 2023, consolidated net loss was  48.3 million compared to  329.4 million for the same period in 2022. Financial Results for the Full Year 2023 (IFRS): Total Revenues for the full year 2023 were  238.3 million compared to  278.3 million in 2022. The decrease resulted first and foremost from prior year revenues stemming from the execution of out-licensing agreements with HI-Bio and Novartis. Royalties in 2023 include  5.4 million from the sale of Minjuvi outside of the U.S. by our partner Incyte and  111.0 million from Tremfya sales which is fully passed on to Royalty Pharma. in  million* 2023 2022 Y-Y  Total revenues 238.3 278.3 (14)% Monjuvi product sales 85.0 84.9 0% Royalties 116.4 99.9 17% Licenses, milestones and other 36.9 93.5 (61)% * Differences due to rounding. Cost of Sales: For the full year 2023, cost of sales were  58.4 million compared to  48.6 million in 2022. The increase compared to the previous year is mainly due to one-off effects from write-downs on inventories in the amount of  11.9 million recognized in 2023. R&D Expenses: For the full year 2023, R&D expenses were  283.6 million compared to  297.8 million in 2022. The decrease of R&D expenses reflects our current clinical study progress as well as prioritization activities relating to our R&D portfolio. SG&A Expenses: Selling expenses for the full year 2023 were  81.4 million compared to  92.4 million in 2022. The decrease is mainly due to the ongoing measures to streamline and focus sales efforts. G&A expenses amounted to  65.8 million for 2023 compared to  60.1 million in 2022. The increase was mainly driven by the increase in share-based payment expenses. Operating Loss: Operating loss amounted to  252.5 million for the full year 2023 compared to a loss of  220.7 million in 2022. Consolidated Net Loss: For the full year 2023, consolidated net loss was  189.7 million compared to a net loss of  151.1 million in 2022. Cash and Other Financial Assets: As of December 31, 2023, the Company had cash and other financial assets of  680.5 million compared to  907.2 million on December 31, 2022. The liquid funds are predominantly required to advance the development of the proprietary portfolio to key clinical and regulatory milestones. The Management Board believes that the cash and other financial assets, which also incorporates the additional cash impacts from the sale of tafasitamab to Incyte as announced on February 5, 2024, will be sufficient to fund the operating activities and other cash requirements until early 2026 including the repayment of the convertible bonds. Any potential cashflows resulting from the Novartis Business Combination Agreement as announced on February 5, 2024, were not considered in the recent corporate planning. Under the Business Combination Agreement, Novartis agreed to use all such efforts which are from the perspective of a prudent business person reasonable and appropriate to provide MorphoSys with the financial resources required following completion of the Novartis Takeover Offer to enable MorphoSys to pay any obligations of MorphoSys arising from the implementation of the Novartis Takeover Offer as and when due, for example, but not limited to the obligation from the convertible bonds and the obligations arising from the long-term incentive plans, each to the extent triggered by the completion of the Novartis Takeover Offer. For the unlikely case that the proposed transaction with Novartis is not consummated, and MorphoSys consequently would remain a stand-alone company, management would need to assess different financing options to ensure the going-concern assumption beyond the said timeframe according to regulatory requirements. Management would then consider both anti-dilutive financing options, such as out-licensing of (pre-) clinical assets or the sale of potential future royalties, but also consider accessing the capital markets by way of issuance of new shares or share instruments (ADSs) and/ or issuance or refinancing of convertible debt. Number of Shares: The number of shares issued totaled 37,655,137 on December 31, 2023. Financial Guidance 2024: As a consequence of the sale and transfer of tafasitamab to Incyte on February 5, 2024, MorphoSys' 2024 financial guidance published on January 30, 2024, cannot be maintained and therefore was revoked. For the time being, MorphoSys will no longer make a forecast for revenues from product sales, as no such revenues will be realized. For 2024, the Group expects R&D expenses of  170 million to  185 million. R&D expenses mainly represent our investments in the development of pelabresib and tulmimetostat. Selling, administrative and general expenses are expected to be between  90 million and  105 million. Any effects from the implementation of the Novartis takeover offer are not included in this forecast. The overall forecast is subject to a number of uncertainties, including inflation and foreign currency effects. Operational Outlook: The following activity is planned for 2024: Submit a New Drug Application for pelabresib in combination with ruxolitinib in myelofibrosis to the U.S. Food and Drug Administration (FDA) and a Marketing Authorization Application to the European Medicines Agency in the middle of 2024. MorphoSys Group Key Figures (IFRS, end of financial year: December 31, 2023) in  million Q4 2023 Q4 2022  2023 2022  Revenues 59.0 81.6 (28)% 238.3 278.3 (14)% Product Sales 22.4 24.7 (9)% 85.0 84.9 0% Royalties 34.0 29.1 17% 116.4 99.9 17% Licenses, Milestones and Other 2.6 27.9 (91)% 36.9 93.5 (61)% Cost of Sales (14.6) (15.4) (5)% (58.4) (48.6) 20% Gross Profit 44.4 66.2 (33)% 179.9 229.6 (22)% Total Operating Expenses (125.8) (134.6) (7)% (432.4) (450.4) (4)% Research and Development (80.3) (94.0) (15)% (283.6) (297.8) (5)% Selling (22.6) (23.0) (2)% (81.4) (92.4) (12)% General and Administrative (22.9) (17.5) 31% (65.8) (60.1) 9% Impairment of Goodwill (1.6)  n/a (1.6)  n/a Operating Profit / (Loss) (81.4) (68.4) 19% (252.5) (220.7) 14% Other Income 0.1 (7.8) >(100)% 5.0 12.0 (58)% Other Expenses (3.9) 7.4 >(100)% (7.1) (15.6) (54)% Finance Income 174.3 325.0 (46)% 213.4 412.1 (48)% Finance Expenses (40.8) 249.5 >(100)% (142.0) (165.9) (14)% Income from Reversals of Impairment Losses / (Impairment Losses) on Financial Assets (0.1) 0.4 >(100)% 0.5  n/a Share of Loss of Associates accounted for using the Equity Method (1.6) (4.0) (60)% (8.2) (4.3) 91% Income Tax Benefit / (Expenses) 1.6 (172.7) >(100)% 1.2 (168.6) >(100)% Consolidated Net Profit / (Loss) 48.3 329.4 (85)% (189.7) (151.1) 26% Earnings per Share, Basic and Diluted (in )   n/a (5.53) (4.42) 25% Earnings per Share, Basic (in ) 1.28 9.64 (87)%   n/a Earnings per Share, Diluted (in ) 1.22 8.93 (86)%   n/a Cash and other financial assets (end of period) 680.5 907.2 (25)% 680.5 907.2 (25)% MorphoSys will hold its conference call and webcast tomorrow, March 14, 2024, at 1:00 pm CET (12:00 pm GMT/8:00 am EDT) to present the results for the fourth quarter and the full year 2023. Participants for the call may pre-register and will receive dedicated dial-in details to easily and quickly access the call: https://services.choruscall.it/DiamondPassRegistration/register?confirmationNumber=3038013&linkSecurityString=637b0c07e Please dial in 10 minutes before the beginning of the conference. The live webcast (audio and presentation) can be directly accessed via https://www.webcast-eqs.com/morphosys-2023-ye or via the Investors section under ""Events & Conferences"" on the MorphoSys website, www.morphosys.com; after the call, a slide-synchronized audio replay of the conference call will be available at the same location. Consolidated Financial Statements 2023 (IFRS) are available for download at: https://www.morphosys.com/en/investors/financial-information About MorphoSys At MorphoSys, we are driven by our mission: More life for people with cancer. As a global commercial-stage biopharmaceutical company, we develop and deliver innovative medicines, aspiring to redefine how cancer is treated. MorphoSys is headquartered in Planegg, Germany, and has its U.S. operations anchored in Boston, Massachusetts. To learn more, visit us at www.morphosys.com and follow us on Twitter at X and LinkedIn. About Pelabresib Pelabresib (CPI-0610) is an investigational selective small molecule designed to promote anti-tumor activity by inhibiting the function of bromodomain and extra-terminal domain (BET) proteins to decrease the expression of abnormally expressed genes in cancer. Pelabresib is being investigated as a treatment for myelofibrosis and has not yet been approved by any regulatory authorities. Its safety and efficacy have also not been established in a pivotal trial. The development of pelabresib was funded in part by The Leukemia and Lymphoma Society. About MANIFEST-2 MANIFEST-2 (NCT04603495) is a global, double-blind, Phase 3 clinical trial that randomized 430 JAK inhibitor-nave adult patients with myelofibrosis 1:1 to receive pelabresib in combination with ruxolitinib or placebo plus ruxolitinib. The primary endpoint of the study is a 35% or greater reduction in spleen volume (SVR35) from baseline at 24 weeks. The key secondary endpoints of the study are the absolute change in total symptom score (TSS) from baseline at 24 weeks and the proportion of patients achieving a 50% or greater improvement in total symptom score (TSS50) from baseline at 24 weeks. TSS is measured using the myelofibrosis self-assessment form (MFSAF) v4.0, which asks patients to report the severity of seven common symptoms, rating each of them on a scale from 0 (absent) to 10 (worst imaginable). The new key secondary endpoint, absolute change in TSS, was added to directly measure change in the average TSS from baseline to week 24 of treatment and is listed as the first key secondary endpoint in the MANIFEST-2 hierarchical testing scheme. The decision to update the MANIFEST-2 clinical trial protocol was made following a Type C meeting with the U.S. Food and Drug Administration (FDA) in September 2023. Additional secondary endpoints include progression-free survival, overall survival, duration of the splenic and total symptom score response, hemoglobin response rate and improvement in bone marrow fibrosis, among others. Constellation Pharmaceuticals, Inc., a MorphoSys company, is the MANIFEST-2 trial sponsor. About Tafasitamab Tafasitamab is a humanized Fc-modified CD19 targeting immunotherapy. In 2010, MorphoSys licensed exclusive worldwide rights to develop and commercialize tafasitamab from Xencor, Inc. Tafasitamab incorporates an XmAb engineered Fc domain, which mediates B-cell lysis through apoptosis and immune effector mechanism including Antibody-Dependent Cell-Mediated Cytotoxicity (ADCC) and Antibody-Dependent Cellular Phagocytosis (ADCP). In the United States, Monjuvi (tafasitamab-cxix) is approved by the U.S. Food and Drug Administration in combination with lenalidomide for the treatment of adult patients with relapsed or refractory DLBCL not otherwise specified, including DLBCL arising from low grade lymphoma, and who are not eligible for autologous stem cell transplant (ASCT). This indication is approved under accelerated approval based on overall response rate. Continued approval for this indication may be contingent upon verification and description of clinical benefit in a confirmatory trial(s). Please see the U.S. full Prescribing Information for Monjuvi for important safety information. In Europe, Minjuvi (tafasitamab) received conditional marketing authorization in combination with lenalidomide, followed by Minjuvi monotherapy, for the treatment of adult patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL) who are not eligible for autologous stem cell transplant (ASCT). Tafasitamab is being clinically investigated as a therapeutic option in B-cell malignancies in several ongoing combination trials. Its safety and efficacy for these investigational uses have not been established in pivotal trials. Monjuvi and Minjuvi are registered trademarks of Incyte. Tafasitamab is marketed under the brand name Monjuvi in the U.S., and Minjuvi in Europe and Canada. XmAb is a registered trademark of Xencor, Inc. Additional Information and Where to Find it The takeover offer described in this communication (the Takeover Offer) has not yet commenced. This communication is neither an offer to purchase nor a solicitation of an offer to sell shares of MorphoSys AG (the Company). The final terms and further provisions regarding the Takeover Offer will be in the offer document once the publication of the offer document by Novartis BidCo AG (formerly known as Novartis data42 AG) (the Bidder) has been approved by the German Federal Financial Supervisory Authority (the BaFin), after which the offer document will be filed with the U.S. Securities and Exchange Commission (the SEC). A solicitation and an offer to buy shares of the Company will be made only pursuant the offer document. In connection with the Takeover Offer, the Bidder and Novartis AG will file a Tender Offer Statement on Schedule TO with the SEC (together with the offer document, an Offer to Purchase including the means to tender and other related documents, the Takeover Offer Documents), the Companys management board and supervisory board will issue a joint reasoned statement in accordance with sec. 27 of the German Securities Acquisition and Takeover Act and the Company will file a Solicitation/Recommendation Statement on Schedule 14D-9 with the SEC (together with the joint reasoned statement, the Recommendation Statements). THE COMPANYS STOCKHOLDERS AND OTHER INVESTORS ARE URGED TO READ THE TAKEOVER OFFER DOCUMENTS AND THE RECOMMENDATION STATEMENTS BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION WHICH SHOULD BE READ CAREFULLY BEFORE ANY DECISION IS MADE WITH RESPECT TO THE TAKEOVER OFFER. The Takeover Offer Documents and the Recommendation Statements will be distributed to all stockholders of the Company in accordance with German and U.S. securities laws. The Tender Offer Statement on Schedule TO and the Solicitation/Recommendation Statement on Schedule 14D-9 will be made available for free at the SECs website at www.sec.gov. Additional copies may be obtained for free by contacting the Bidder or the Company. Free copies of these materials and certain other offering documents will be made available on the Companys website in English at morphosys.com/en/investors/Novartis-TakeoverOffer and in German at morphosys.com/de/investoren/Novartis-TakeoverOffer, by mail to MorphoSys AG, Semmelweisstrasse 7, 82152 Planegg, Germany or by phone at +49 89 8992 7179. In addition to the Offer to Purchase, including the means to tender and certain other Takeover Offer Documents, as well as the Solicitation/Recommendation Statement, the Company files other information with the SEC. The Companys filings with the SEC are also available for free to the public from commercial document-retrieval services and at the website maintained by the SEC at www.sec.gov and are also available free of charge under the SEC Filings section of the Companys website at www.morphosys.com/en/investors. In order to reconcile certain areas where German law and U.S. law conflict, Novartis AG and the Bidder expect to request no-action and exemptive relief from the SEC to conduct the Takeover Offer in the manner described in the offer document. Acceptance of the Takeover Offer by stockholders residing outside Germany and the United States of America may be subject to further legal requirements. With respect to the acceptance of the Takeover Offer outside Germany and the United States, no responsibility is assumed for the compliance with such legal requirements applicable in the respective jurisdiction. Forward Looking Statements This communication contains certain forward-looking statements concerning the Company, the Bidder and the Takeover Offer that involve substantial risks and uncertainties. Forward-looking statements include any statements containing the words anticipate, believe, estimate, expect, intend, goal, may, might, plan, predict, project, seek, target, potential, will, would, could, should, continue and similar expressions. In this communication, the Companys forward-looking statements include statements about the parties ability to satisfy the conditions to the consummation of the Takeover Offer; statements about the expected timetable for the consummation of the Takeover Offer; the Companys plans, objectives, expectations and intentions; and the financial condition, results of operations and business of the Company and Novartis AG. The forward-looking statements contained in this communication represent the judgment of the Company as of the date of this communication and involve known and unknown risks and uncertainties, which might cause the actual results, financial condition and liquidity, performance or achievements of the Company, or industry results, to be materially different from any historic or future results, financial conditions and liquidity, performance or achievements expressed or implied by such forward-looking statements. In addition, even if the Company's results, performance, financial condition and liquidity, and the development of the industry in which it operates are consistent with such forward-looking statements, they may not be predictive of results or developments in future periods. Those risks and uncertainties that could cause the actual results to differ from expectations contemplated by forward-looking statements include, among other things: uncertainties as to the timing of the Takeover Offer; uncertainties as to how many of the Companys stockholders will tender their stock in the Takeover Offer; the possibility that competing offers will be made; the possibility that various conditions for the Takeover Offer may not be satisfied or waived, including that a governmental entity may prohibit, delay or refuse to grant approval for the consummation of the Takeover Offer; the effects of the Takeover Offer on relationships with employees, other business partners or governmental entities; that the Bidder and Novartis AG may not realize the potential benefits of the Takeover Offer; transaction costs associated with the Takeover Offer; that the Companys expectations may be incorrect; the inherent uncertainties associated with competitive developments, clinical trial and product development activities and regulatory approval requirements; the Company's reliance on collaborations with third parties; estimating the commercial potential of the Companys development programs; and other risks indicated in the risk factors included in the Companys filings with the SEC, including the Companys Annual Report on Form 20-F, as well as the Solicitation/Recommendation Statement on Schedule 14D-9 to be filed by the Company and the Tender Offer Statement on Schedule TO and related Takeover Offer Documents to be filed by the Bidder and Novartis AG. Given these uncertainties, the reader is advised not to place any undue reliance on such forward-looking statements. These forward-looking statements speak only as of the date of publication of this communication. The Company and the Bidder expressly disclaim any obligation to update any such forward-looking statements in this communication to reflect any change in its expectations with regard thereto or any change in events, conditions or circumstances on which any such statement is based or that may affect the likelihood that actual results will differ from those set forth in the forward-looking statements, unless specifically required by law or regulation. View source version on businesswire.com: https://www.businesswire.com/news/home/20240313374964/en/ Media Contacts: Thomas Biegi Senior Vice President, Corporate Affairs Tel.: +49 (0)89 / 899 27 26079 thomas.biegi@morphosys.com Eamonn Nolan Senior Director, Corporate Communications & Investor Relations Tel: +1 617-548-9271 eamonn.nolan@morphosys.com Investor Contacts: Dr. Julia Neugebauer Vice President, Global Investor Relations Tel: +49 (0)89 / 899 27 179 julia.neugebauer@morphosys.com Source: MorphoSys AG What was the offer price per share in cash in the Business Combination Agreement with Novartis? The offer price per share in cash in the Business Combination Agreement with Novartis was  68.00. What were the Monjuvi U.S. net product sales for the fourth quarter of 2023? The Monjuvi U.S. net product sales were US$ 24.1 million for the fourth quarter of 2023. How much cash and other financial assets did MorphoSys have as of December 31, 2023? MorphoSys had  680.5 million in cash and other financial assets as of December 31, 2023. What significant event related to tafasitamab occurred on February 5, 2024? On February 5, 2024, MorphoSys entered into a Purchase Agreement to sell and transfer all rights worldwide related to tafasitamab to Incyte for US$ 25 million. What financial guidance for 2024 was revoked by MorphoSys? MorphoSys revoked its 2024 financial guidance published on January 30, 2024, due to the sale and transfer of tafasitamab to Incyte."
Outset Medical Announces Appointment of Medical Technology Veteran Brent D. Lang to its Board of Directors,2024-03-13T20:02:00.000Z,Low,Very Positive,"Outset Medical, Inc. (OM) appoints medical technology veteran Brent D. Lang to its board of directors. Mr. Lang brings extensive healthcare expertise, including growing software-enabled business models. Katie M. Szyman steps down to prepare for a new role. Mr. Lang's background in leadership positions at Vocera and other companies makes him a valuable addition to the Outset board.","Outset Medical Announces Appointment of Medical Technology Veteran Brent D. Lang to its Board of Directors Rhea-AI Impact (Low) Rhea-AI Sentiment (Very Positive) Tags management Rhea-AI Summary Outset Medical, Inc. (OM) appoints medical technology veteran Brent D. Lang to its board of directors. Mr. Lang brings extensive healthcare expertise, including growing software-enabled business models. Katie M. Szyman steps down to prepare for a new role. Mr. Lang's background in leadership positions at Vocera and other companies makes him a valuable addition to the Outset board. Positive None. Negative None. 03/13/2024 - 04:02 PM SAN JOSE, Calif.--(BUSINESS WIRE)-- Outset Medical, Inc. (Nasdaq: OM) (Outset), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced the appointment of medical technology veteran Brent D. Lang to its board of directors. Mr. Lang most recently served as Chairman and Chief Executive Officer of Vocera Communications, a global provider of clinical communication and workflow solutions, until its acquisition by Stryker for $3 billion in 2022. Brent brings a wealth of healthcare expertise to the Outset board, including in growing and scaling software-enabled business models, which is well-aligned with our recurring revenue model, said Leslie Trigg, Chair and Chief Executive Officer. He is an ideal board member to help guide our continued growth and with a vision to improve the lives of patients that fits perfectly with Outsets moral mission. Concurrent with Mr. Langs appointment, Katie M. Szyman has stepped down from the Outset board in preparation for her pending role as Chief Executive Officer of Edwards Lifesciences Critical Care spinoff. As we welcome Brent, we want to also thank Katie for her service to the Outset board during a period of growth and change following our public offering, added Ms. Trigg. We wish her well as she begins an exciting new phase of her career journey. Mr. Lang will serve on the Audit Committee of the Outset board. He is Chairman of the Movella Holdings Inc. board, a company specializing in movement digitization, and a member of the Thriveworks board, a private company that provides mental health services. Including his role as Chairman and CEO, Mr. Lang spent more than 20 years in various leadership positions at Vocera, including President and Chief Operating Officer and Vice President of Marketing and Business Development. Earlier in his career, he held various roles at 3Com Corporation, a networking company, and worked as a strategy consultant for Monitor Company, Inc., a consulting firm advising Fortune 500 companies. Mr. Lang holds a B.S. from the University of Michigan and an M.B.A. from the Stanford University Graduate School of Business. He was also a gold medalist member of the 1988 U.S. Olympic swimming team. I look forward to joining such an accomplished board, and a company that is having a direct and profound impact on the lives of dialysis patients and providers, said Mr. Lang. The Outset team has surrounded its innovative Tablo platform with a highly differentiated software and service ecosystem that provide clear opportunities for growth well into the future. About Outset Medical, Inc. Outset is a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis. The Tablo Hemodialysis System, FDA cleared for use from the hospital to the home, represents a significant technological advancement that transforms the dialysis experience for patients and operationally simplifies it for providers. Tablo serves as a single enterprise solution that can be utilized across the continuum of care, allowing dialysis to be delivered anytime, anywhere and by anyone. The integration of water purification and on-demand dialysate production enables Tablo to serve as a dialysis clinic on wheels, with 2-way wireless data transmission and a proprietary data analytics platform powering a new holistic approach to dialysis care. Tablo is a registered trademark of Outset Medical, Inc. View source version on businesswire.com: https://www.businesswire.com/news/home/20240313305443/en/ Jim Mazzola Investor Relations jmazzola@outsetmedical.com Source: Outset Medical, Inc. Who has Outset Medical appointed to its board of directors? Outset Medical has appointed Brent D. Lang to its board of directors. What is Brent D. Lang's background in the medical technology field? Brent D. Lang has extensive experience in healthcare, including leadership roles at Vocera Communications and other companies. Why did Katie M. Szyman step down from the Outset board? Katie M. Szyman stepped down from the Outset board in preparation for her pending role as Chief Executive Officer of Edwards Lifesciences Critical Care spinoff. What role will Brent D. Lang serve on the Outset board? Brent D. Lang will serve on the Audit Committee of the Outset board. What is Mr. Lang's vision for Outset Medical? Mr. Lang aims to guide Outset's growth and improve the lives of dialysis patients and providers with the innovative Tablo platform."
"Corvus Pharmaceuticals to Provide Business Update and Fourth Quarter and Full Year 2023 Financial Results on March 19, 2024",2024-03-13T20:02:00.000Z,Neutral,Neutral,"Corvus Pharmaceuticals, Inc. (CRVS) will host a conference call and webcast on March 19, 2024, to discuss business updates and report financial results for Q4 and full year 2023.","Corvus Pharmaceuticals to Provide Business Update and Fourth Quarter and Full Year 2023 Financial Results on March 19, 2024 Rhea-AI Impact (Neutral) Rhea-AI Sentiment (Neutral) Tags earnings Rhea-AI Summary Corvus Pharmaceuticals, Inc. (CRVS) will host a conference call and webcast on March 19, 2024, to discuss business updates and report financial results for Q4 and full year 2023. Positive None. Negative None. 03/13/2024 - 04:02 PM Company to host conference call and webcast at 4:30 pm ET / 1:30 pm PTBURLINGAME, Calif., March 13, 2024 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS), a clinical-stage biopharmaceutical company, today announced that the company will host a conference call and webcast on March 19, 2024 at 4:30 pm ET (1:30 pm PT) to provide a business update and report fourth quarter and full year 2023 financial results. The conference call can be accessed by dialing 1-877-407-0784 (toll-free domestic) or 1-201-689-8560 (international) or by clicking on this link for instant telephone access to the event. The live webcast may be accessed via the investor relations section of the Corvus website. A replay of the webcast will be available on Corvus website for 90 days. About Corvus PharmaceuticalsCorvus Pharmaceuticals is a clinical-stage biopharmaceutical company pioneering the development of ITK inhibition as a new approach to immunotherapy for a broad range of cancer and immune diseases. The Companys lead product candidate is soquelitinib, an investigational, oral, small molecule drug that selectively inhibits ITK. Corvus plans to initiate a Phase 3 registrational clinical trial for soquelitinib in patients with relapsed peripheral T cell lymphoma. Its other clinical-stage candidates are being developed for a variety of cancer indications. For more information, visit www.corvuspharma.com. INVESTOR CONTACT:Leiv LeaChief Financial OfficerCorvus Pharmaceuticals, Inc.+1-650-900-4522llea@corvuspharma.com MEDIA CONTACT:Sheryl SeapyReal Chemistry+1-949-903-4750sseapy@realchemistry.com When will Corvus Pharmaceuticals host a conference call and webcast? Corvus Pharmaceuticals will host a conference call and webcast on March 19, 2024. What is the ticker symbol for Corvus Pharmaceuticals? The ticker symbol for Corvus Pharmaceuticals is CRVS. What will be discussed during the conference call and webcast? During the conference call and webcast, Corvus Pharmaceuticals will provide a business update and report fourth quarter and full year 2023 financial results. How can one access the conference call? The conference call can be accessed by dialing 1-877-407-0784 for toll-free domestic access or 1-201-689-8560 for international access. Alternatively, participants can click on the provided link for instant telephone access to the event. Where can the live webcast be accessed? The live webcast may be accessed via the investor relations section of the Corvus website. Will there be a replay of the webcast available? Yes, a replay of the webcast will be available on Corvus website for 90 days."
AGNC Investment Corp. Declares Monthly Common Stock Dividend of $0.12 per Common Share for March 2024,2024-03-13T20:01:00.000Z,Low,Neutral,"AGNC Investment Corp. declares a cash dividend of $0.12 per share for March 2024, payable on April 9, 2024. Record date is March 29, 2024.","AGNC Investment Corp. Declares Monthly Common Stock Dividend of $0.12 per Common Share for March 2024 Rhea-AI Impact (Low) Rhea-AI Sentiment (Neutral) Tags dividends Rhea-AI Summary AGNC Investment Corp. declares a cash dividend of $0.12 per share for March 2024, payable on April 9, 2024. Record date is March 29, 2024. Positive None. Negative None. Financial Analyst The declaration of a cash dividend of $0.12 per share by AGNC Investment Corp. reflects the company's current financial health and its ability to generate sufficient cash flow to return value to shareholders. Dividend announcements are closely monitored by investors as they provide insights into a company's profitability and its board's confidence in future earnings. This specific dividend payment could indicate a stable income stream for investors, particularly those with a focus on income-generating assets.However, it's crucial to compare the dividend yield and payout ratio to industry benchmarks to assess sustainability. A payout ratio that is too high might suggest that the company is not reinvesting enough back into its operations, which could impact long-term growth. Conversely, a yield that is significantly higher than peers might indicate a higher risk profile or a potential red flag that the market expects future dividends to decrease. Market Research Analyst AGNC Investment Corp.'s dividend announcement can serve as an indicator of market positioning within the real estate investment trust (REIT) sector. REITs are typically expected to pay out a majority of their taxable income as dividends and thus they are often part of income-focused investment strategies. The amount of $0.12 per share should be contextualized within the historical dividend payments of AGNC and the broader market trends.Investors should consider the consistency of AGNC's dividend payments, as well as any historical changes in the amount, to gauge the reliability of the income stream. Additionally, external economic factors such as interest rate changes can affect the performance of REITs and subsequently their ability to maintain or raise dividends. Understanding the relationship between these factors and AGNC's financial performance is essential for a comprehensive market analysis. 03/13/2024 - 04:01 PM BETHESDA, Md., March 13, 2024 /PRNewswire/ -- AGNC Investment Corp. (Nasdaq: AGNC) announced today that its Board of Directors has declared a cash dividend of $0.12 per share of common stock for March 2024. The dividend is payable on April 9, 2024 to common stockholders of record as of March 29, 2024. For further information or questions, please contact Investor Relations at (301) 968-9300 or IR@AGNC.com. ABOUT AGNC INVESTMENT CORP.Founded in 2008, AGNC Investment Corp. (Nasdaq: AGNC) is a leading investor in Agency residential mortgage-backed securities (Agency MBS), which benefit from a guarantee against credit losses by Fannie Mae, Freddie Mac, or Ginnie Mae. We invest on a leveraged basis, financing our Agency MBS assets primarily through repurchase agreements, and utilize dynamic risk management strategies intended to protect the value of our portfolio from interest rate and other market risks. AGNC has a track record of providing favorable long-term returns for our stockholders through substantial monthly dividend income, with over $12 billion of common stock dividends paid since inception. Our business is a significant source of private capital for the U.S. residential housing market, and our team has extensive experience managing mortgage assets across market cycles. To learn more about The Premier Agency Residential Mortgage REIT, please visit www.AGNC.com, follow us on LinkedIn, and Sign Up for Investor Alerts. View original content:https://www.prnewswire.com/news-releases/agnc-investment-corp-declares-monthly-common-stock-dividend-of-0-12-per-common-share-for-march-2024--302088526.html SOURCE AGNC Investment Corp. What dividend has AGNC Investment Corp. declared for March 2024? AGNC Investment Corp. has declared a cash dividend of $0.12 per share for March 2024. When is the dividend payable for AGNC Investment Corp.? The dividend declared by AGNC Investment Corp. is payable on April 9, 2024. What is the record date for the dividend declared by AGNC Investment Corp.? The record date for the dividend declared by AGNC Investment Corp. is March 29, 2024."
Spruce Biosciences Announces Topline Results from CAHmelia-203 in Adult Classic CAH and CAHptain-205 in Pediatric Classic CAH,2024-03-13T20:01:00.000Z,Moderate,Neutral,"Spruce Biosciences, Inc. (Nasdaq: SPRB) announced topline results from its CAHmelia-203 and CAHptain-205 studies of tildacerfont in adult and pediatric classic congenital adrenal hyperplasia (CAH). While CAHmelia-203 did not meet its primary efficacy endpoint, CAHptain-205 showed promising results. The company plans to meet regulatory authorities for a potential registrational program.","Spruce Biosciences Announces Topline Results from CAHmelia-203 in Adult Classic CAH and CAHptain-205 in Pediatric Classic CAH Rhea-AI Impact (Moderate) Rhea-AI Sentiment (Neutral) Tags clinical trial Rhea-AI Summary Spruce Biosciences, Inc. (Nasdaq: SPRB) announced topline results from its CAHmelia-203 and CAHptain-205 studies of tildacerfont in adult and pediatric classic congenital adrenal hyperplasia (CAH). While CAHmelia-203 did not meet its primary efficacy endpoint, CAHptain-205 showed promising results. The company plans to meet regulatory authorities for a potential registrational program. Positive Positive topline results from CAHmelia-203 and CAHptain-205 studies. Tildacerfont showed safety and tolerability in adult and pediatric CAH patients. Significant unmet medical need in CAH addressed by Spruce Biosciences. Cost-saving initiatives and workforce reduction to extend cash runway. Plans to meet with regulatory authorities for potential registrational program. Negative CAHmelia-203 did not achieve the primary efficacy endpoint. Low compliance with study medication and GC in CAHmelia-203. Tildacerfont clearance differences between adult and pediatric patients. Workforce reduction of approximately 21% implemented by the company. Medical Research Analyst The failure of the CAHmelia-203 study to meet its primary efficacy endpoint is a significant setback for Spruce Biosciences. The study's inability to demonstrate a statistically significant reduction in androstenedione levels in adults with severe hyperandrogenemia indicates that tildacerfont may not be effective for this particular patient subset. This outcome necessitates a reassessment of the drug's development strategy and could impact investor confidence, given that the drug's efficacy is crucial for regulatory approval and market success. Furthermore, the low compliance rate with study medication and glucocorticoid therapy observed in the trial raises concerns about patient adherence in real-world settings, which is essential for achieving therapeutic outcomes.From a medical research perspective, the result highlights the complexity of treating severe hyperandrogenemia in CAH and underscores the need for therapies that can be more easily integrated into patients' lives to enhance compliance. The safety profile of tildacerfont, however, remains a positive aspect, with no serious adverse events reported, which could be a key consideration for future clinical trials and potential market adoption if efficacy can be proven in other studies. Pediatric Endocrinologist The positive preliminary findings from the CAHptain-205 study in pediatric patients present a glimmer of hope for a new treatment option for children with CAH. The ability of tildacerfont to reduce androgen levels and potentially decrease the required dose of glucocorticoids could represent a significant advancement in managing CAH in pediatric patients. Glucocorticoid therapy, while essential, is associated with adverse effects like growth suppression and obesity, which can profoundly affect children's development and quality of life.The reported rapid clearance of tildacerfont in children compared to adults is an interesting pharmacokinetic consideration, suggesting that dosing strategies may need to be tailored differently for pediatric populations. The anticipation of further dose-ranging studies to inform the registrational program indicates a commitment to optimizing treatment for this demographic. The potential to improve long-term clinical outcomes by balancing androgen suppression and glucocorticoid use is an exciting prospect for pediatric endocrinology. Financial Analyst The announcement by Spruce Biosciences regarding the CAHmelia-203 study's results and the CAHptain-205 study's progress has mixed implications for the company's financial outlook. The negative outcome of the CAHmelia-203 trial could potentially lead to volatility in the company's stock price as investors reassess the drug's commercial viability. However, the extended cash runway through the end of 2025, due to cost reduction measures, including workforce reduction and termination of the CAHmelia-203 study, may provide some reassurance to investors about the company's financial stability in the short term.The company's future now hinges more heavily on the outcomes of the ongoing CAHmelia-204 and CAHptain-205 studies. Positive results from these could reinvigorate investor interest and provide a path forward for regulatory approval. The strategic decision to engage with the FDA and comparable foreign regulatory authorities, assuming positive results, demonstrates proactive planning. It will be crucial to monitor the company's cash burn rate and any changes in its clinical development strategy that could affect its financial position. 03/13/2024 - 04:01 PM CAHmelia-203 Study of Tildacerfont in Adult Classic Congenital Adrenal Hyperplasia (CAH) with Severe Hyperandrogenemia Did Not Meet Primary Efficacy Endpoint Positive Data from CAHptain-205 Study of Tildacerfont in Pediatric Classic CAH Supports Further Dose-Ranging Across Additional Dosing Cohorts Topline Results from CAHmelia-204 Study of Tildacerfont in Adult Classic CAH Evaluating Glucocorticoid (GC) Reduction Anticipated in Third Quarter of 2024 Resource Prioritization and Cost Reductions Extend Cash Runway Through End of 2025 Conference Call Today at 4:30 p.m. ET SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- Spruce Biosciences, Inc. (Nasdaq: SPRB), a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders with significant unmet medical need, today announced topline results from its CAHmelia-203 study of tildacerfont in adult classic congenital adrenal hyperplasia (CAH) and its CAHptain-205 study of tildacerfont in pediatric classic CAH. Spruce is investigating tildacerfont, a second generation, once-daily oral antagonist of the CRF1 receptor, for the treatment of classic CAH. The global CAHmelia program in adult classic CAH is comprised of two Phase 2b studies designed to address the unmet medical needs of two distinct populations of adult CAH patients. CAHmelia-203 assesses androstenedione (A4) reduction in adult CAH patients with severe hyperandrogenemia, while CAHmelia-204 assesses glucocorticoid (GC) reduction, a potentially registrational endpoint, in adult CAH patients on supraphysiologic GC doses with normal or near normal levels of A4. The Phase 2 CAHptain-205 study is focused on addressing the unmet medical need in pediatric CAH patients, which represents approximately 25% of the total patient population. The CAHmelia and CAHptain programs seek to address the unmet medical need across the entire spectrum of the CAH patient community, which has not seen a new standard of care since GCs were introduced in the 1950s. CAHmelia-203 Study of Tildacerfont in Adult Classic CAH CAHmelia-203 enrolled 96 subjects with a mean baseline A4 level of 1,151 ng/dL, which is more than five times above the upper limit of normal (ULN). Data Highlights The clinical trial did not achieve the primary efficacy endpoint of the assessment of dose response for the change in A4 from baseline to week 12. 200mg QD of tildacerfont demonstrated a placebo-adjusted reduction from baseline in A4 of -2.6% at week 12 with a non-significant p-value. Compliance with study medication and GC was low with approximately 50% of patients reporting 80% or greater compliance, resulting in lower-than-expected tildacerfont exposure. Tildacerfont was generally safe and well tolerated at all doses with no treatment-related serious adverse events (SAEs). Most adverse events were reported as mild to moderate. We are grateful to all the patients, families, study team and investigators who supported the CAHmelia-203 clinical trial, said Javier Szwarcberg, M.D., M.P.H., Chief Executive Officer, Spruce Biosciences. CAHmelia-203 is the first study of its kind to address a difficult-to-treat CAH patient population with severe and more refractory hyperandrogenemia, which is often attributed to challenging real-life compliance with daily GCs. We garnered important data from this study which will inform ongoing development of tildacerfont in adult classic CAH. Dr. Szwarcberg added, Looking ahead to the third quarter of 2024, we are eager to report topline results from CAHmelia-204, which is focused on assessing GC reduction, a potentially registrational endpoint, in a different population of adult CAH patients with relatively controlled A4 levels and historically better adherence to GC therapy. Assuming positive results from CAHmelia-204 and CAHptain-205, we plan to meet with the U.S. Food and Drug Administration (FDA) and comparable foreign regulatory authorities to outline the design of a registrational clinical program in adult and pediatric classic CAH. CAHmelia-203 and 204 Baseline Characteristics Highlight Two Distinct Patient Populations in Adult CAH with Differing Disease Status and Treatment Goals Patients in CAHmelia-203 enrolled with severe hyperandrogenemia, as indicated with mean baseline A4 levels more than five times above the ULN. By contrast, patients in CAHmelia-204 enrolled with a mean baseline A4 value of 224 ng/dL, which is approximately the ULN, with 66% of patients enrolled with androgenic control, which is defined as having A4 values below the ULN at baseline. Study Characteristics CAHmelia-203 (N = 96) CAHmelia-204 (N = 100) Male/Female (Proportion of Total Subjects) 47% Male 53% Female 47% Male 53% Female Average Age Age Ranges 32 Years Old (18  65 Years Old) 33 Years Old (18  64 Years Old) Average Baseline Glucocorticoid (GC) Dose1 27 mg/day (14 mg/m2/day) 37 mg/day (20 mg/m2/day) Average Baseline Androstenedione (A4) Level2 1,151 ng/dL (>5x ULN) 224 ng/dL (~ULN) Average Baseline 17-Hydroxyprogesterone (17-OHP) Level2 16,653 ng/dL (>80x ULN) 5,675 ng/dL (>28x ULN) Average Baseline Adrenocorticotropic (ACTH) Level2 435 pg/dL (>6x ULN) 168 pg/dL (>2x ULN) Body Mass Index (BMI) 50% Obese (BMI  30 kg/m2) 53% Obese (BMI  30 kg/m2) 1 In hydrocortisone equivalents (HCe) 2 Pre-GC dose. The CAHmelia-203 results underscore the complexities inherent in managing a patient group with challenges related to androgenic control and GC compliance, said Irina Bancos, M.D., Principal Investigator and Associate Professor of Medicine and Endocrinologist at the Mayo Clinic. Based on my clinical experience, patients within this group may face difficulties adhering to any therapeutic interventions, potentially impacting treatment outcomes. Dr. Bancos continued, Patients with higher glucocorticoid doses and normal or near normal androgen levels, such as those enrolled in CAHmelia-204, are generally more consistent with GC therapy and easier to manage due to lower ACTH overdrive of the adrenal gland but carry higher risk of glucocorticoid-associated comorbidities. I look forward to reviewing results from CAHmelia-204, which will provide a more complete picture into the therapeutic potential of tildacerfont. CAHptain-205 Study of Tildacerfont in Pediatric Classic CAH CAHptain-205 enrolled 30 children between two and 17 years of age with a mean baseline GC dose of 14 mg/m2/day and mean baseline A4 level of 372 ng/dL. The study characterized the safety and pharmacokinetic profiles of tildacerfont, as well as changes in androgen levels over 12 weeks of treatment, and the ability to reduce daily GC dose upon A4 normalization. Data Highlights Tildacerfont was generally safe and well tolerated at all dose ranges with no treatment-related SAEs reported. Preliminary pharmacokinetic analysis suggests that tildacerfont is cleared more rapidly in children than in adult CAH patients. 73% of all patients (22 of 30 patients) met the efficacy endpoint of A4 or GC reduction from baseline at 12 weeks of treatment with tildacerfont. 70% of patients with elevated baseline A4 values (16 of 23 patients) demonstrated an A4 reduction at week 4. As a pediatric endocrinologist, Ive witnessed first-hand the significant unmet medical need and lack of treatment options for children and adolescents living with CAH, said Will Charlton, M.D., M.A.S., Chief Medical Officer, Spruce Biosciences. The CAHptain-205 study results demonstrate safety and tolerability in pediatric CAH patients with weight-adjusted tildacerfont doses up to 200mg daily. While we are encouraged by the therapeutic activity of doses investigated in the study, we plan to continue dose-ranging across additional cohorts to evaluate dose selection to inform our registrational program. We anticipate topline results in the fourth quarter of 2024. Im encouraged by the initial results from the CAHptain-205 study and the potential of tildacerfont to shift the treatment paradigm for pediatric classic CAH to a more balanced approach between androgens and GCs, said Paul Thornton, M.B.B.S., Principal Investigator and Medical Director of the Endocrine and Diabetes Program at a CAH Center of Excellence. These data suggest that tildacerfont may enable clinically meaningful reduction of A4 and GC levels in children and adolescents. This may improve long-term clinical outcomes, such as short stature and obesity, which are related to both androgen excess and exposure to chronic supraphysiologic GC doses. Business and Financial Update The company intends to implement cost savings initiatives, including termination of the CAHmelia-203 study and a workforce reduction of approximately 21%. The company currently has over $81 million in cash and cash equivalents, which is anticipated to fund its current operating plan through the end of 2025, including through the CAHmelia-204 topline results and CAHptain-205 topline results from additional dosing cohorts. Conference Call Details Spruces management team and key study investigators will host a conference call today at 4:30 p.m. ET to discuss the topline results of the CAHmelia-203 and CAHptain-205 clinical studies. Analysts and investors can participate in the conference call by registering here or dialing (866) 777-2509. An archived copy of the call will be available on the events section of the companys investor relations website for approximately 90 days. About CAHmelia-203 CAHmelia-203 is a randomized, double-blind, placebo-controlled, dose-ranging Phase 2b clinical trial evaluating the safety and efficacy of tildacerfont in 96 adults with classic CAH and highly elevated levels of A4 at baseline while on stable glucocorticoid dosing. For the first six weeks, patients received blinded placebo to assess their adherence to their existing glucocorticoid therapy. Patients who continued to meet all eligibility criteria at the end of this period and where compliant with therapy entered a three-part treatment period. During the placebo-controlled treatment period, patients randomized in a blinded manner to receive placebo, 50mg, 100mg, or 200mg tildacerfont once daily. Dosing in the placebo-controlled treatment period continued for 12 weeks. The primary endpoint of the clinical trial was the assessment of dose response for the change in A4 from baseline to week 12. Following the placebo-controlled treatment period, all patients received tildacerfont following a dose-escalation protocol that allowed dose increase to 200mg once daily over 12 weeks. Following the 12-week dose-escalation period, all patients continued receiving tildacerfont at 200mg once daily for an additional 46 weeks. Patients who achieved control of A4 while on supraphysiologic glucocorticoid treatment had the opportunity to reduce their glucocorticoid dosing in the open-label period according to a pre-specified algorithm in the protocol. For more information about the CAHmelia program, please visit https://www.sprucebio.com/cahmelia. About CAHmelia-204 CAHmelia-204 is a randomized, double-blind, placebo-controlled Phase 2b clinical trial to evaluate the safety and efficacy of tildacerfont in reducing glucocorticoid usage in 100 adults with classic CAH on supraphysiologic doses of glucocorticoids with normal or near normal levels of A4 at baseline. This clinical trial is designed in two parts. In the first part of the clinical trial, patients will be randomized to receive 200mg tildacerfont once daily or placebo for 24 weeks. During the second part of the clinical trial, all patients will receive open-label 200mg tildacerfont once daily for 52 weeks. Throughout the trial, tapering of glucocorticoids will be guided according to a pre-specified algorithm and continue to the lowest level possible (physiologic replacement levels), as long as patients remain well controlled based on standard biomarkers and clinical assessments. The primary endpoint of this clinical trial is the absolute change in daily glucocorticoid dose from baseline at week 24. For more information about the CAHmelia program, please visit https://www.sprucebio.com/cahmelia. About CAHptain-205 CAHptain-205 is a Phase 2 open-label clinical trial, which utilized a sequential three cohort design, to evaluate the safety, efficacy, and pharmacokinetics of tildacerfont in children two to 17 years of age. The study will also characterize changes in androgen levels over 12 weeks of treatment, and the ability to reduce daily glucocorticoid dose based on A4 normalization. An optional open-label extension period will provide additional open-label treatment with tildacerfont to provide long-term safety data for up to two years. Cohort 1 enrolled five participants between the ages of 11 and 17 years of age, who received a weight-adjusted, adult dose equivalent of 50mg QD of tildacerfont. Cohort 2 enrolled seven participants between the ages of 11 and 17 years of age, who received a weight-adjusted, adult dose equivalent of 200mg QD of tildacerfont. Cohort 3 enrolled 18 participants between the ages of two and 10 years of age, who received a weight-adjusted, adult dose equivalent of 200mg QD of tildacerfont. The primary endpoint of this clinical trial is safety. Additional secondary endpoints include the proportion of subjects who achieve reduction in A4 or daily glucocorticoid dosing at week 12 and the proportion of subjects with elevated A4 at baseline who achieve a reduction in A4 at week 4. For more information about the CAHptain program, please visit https://www.sprucebio.com/cahptain. About Congenital Adrenal Hyperplasia (CAH) CAH is an autosomal recessive disease, driven by a mutation in the gene that encodes an enzyme necessary for the synthesis of key adrenal hormones. In CAH patients, the body is not able to produce cortisol, leading to serious health consequences. The absence of cortisol alters the normal feedback cycle of the hypothalamic-pituitary-adrenal (HPA) axis and leads to excess secretion of adrenocorticotropic hormone (ACTH), hyperplasia of the adrenal gland, and consequently high levels of adrenal androgen production. As a result, CAH patients may suffer from premature puberty, impaired fertility, hirsutism, acne, the development of adrenal rest tumors, and an impaired quality of life, and additionally for females, virilized genitalia and menstrual irregularities. Currently, the only way to downregulate the production of excess androgens in CAH patients is to administer supraphysiologic doses of glucocorticoids, which present specific side effects, including increased risks of developing diabetes, cardiovascular disease, stunted growth, osteoporosis, thin skin, gastrointestinal disorders, and decreased lifespan. About Tildacerfont Tildacerfont is a potent and highly selective, non-steroidal, once-daily oral antagonist of the CRF1 receptor, which is the receptor for corticotropin-releasing factor (CRF), a hormone that is secreted by the hypothalamus. The CRF1 receptor is abundantly expressed in the pituitary gland where it is the primary regulator of the HPA axis. By blocking the CRF1 receptor, tildacerfont has the potential to address the uncontrolled cortisol feedback regulatory pathway in CAH, and in turn reduce the production of ACTH in the pituitary, limiting the amount of androgen produced downstream from the adrenal gland. By controlling excess adrenal androgens through an independent mechanism, tildacerfont has the potential to reduce the unwanted clinical symptoms associated with high androgen exposure and could also enable treating physicians to lower the supraphysiologic glucocorticoid doses given to CAH patients to near physiologic levels. No drug-related serious adverse events have been reported related to tildacerfont treatment in completed studies. About Spruce Biosciences Spruce Biosciences is a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders with significant unmet medical need. Spruce is initially developing its wholly-owned product candidate, tildacerfont, as the potential first non-steroidal, once-daily therapy for patients suffering from classic congenital adrenal hyperplasia (CAH) and other endocrine disorders. To learn more, visit www.sprucebio.com and follow us on X, LinkedIn, Facebook, and YouTube. Forward-Looking Statements Statements contained in this press release regarding matters that are not historical facts are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements include statements regarding, among other things, the design, results, conduct, progress and timing of Spruces clinical trials; tildacerfonts potential to be a novel treatment option that improves long-term health outcomes for patients with CAH; the implications of the different patient population in CAHmelia-204 compared with CAHmelia-203; Spruces expectations regarding reporting results of its clinical trials in 2024; Spruces plans to meet with the FDA and comparable foreign regulatory authorities to discuss the potential registrational path forward of tildacerfont for adult and pediatric classic CAH; the impact of cost savings initiatives and the length of Spruces anticipated cash runway; and Spruces product candidate, strategy and regulatory matters. Because such statements are subject to risks and uncertainties, actual results may differ materially from those expressed or implied by such forward-looking statements. Words such as anticipate, will, potential, plan and similar expressions are intended to identify forward-looking statements. These forward-looking statements are based upon Spruces current expectations and involve assumptions that may never materialize or may prove to be incorrect. Actual results could differ materially from those anticipated in such forward-looking statements as a result of various risks and uncertainties, which include, without limitation, risks and uncertainties associated with Spruces business in general, the impact of geopolitical and macroeconomic events, and the other risks described in Spruces filings with the U.S. Securities and Exchange Commission. All forward-looking statements contained in this press release speak only as of the date on which they were made and are based on managements assumptions and estimates as of such date. Spruce undertakes no obligation to update such statements to reflect events that occur or circumstances that exist after the date on which they were made, except as required by law. View source version on businesswire.com: https://www.businesswire.com/news/home/20240313147623/en/ Media Will Zasadny Inizio Evoke Comms (619) 961-8848 will.zasadny@inizioevoke.com media@sprucebio.com Investors Samir Gharib President and CFO Spruce Biosciences, Inc. investors@sprucebio.com Source: Spruce Biosciences, Inc. What are the topline results from the CAHmelia-203 and CAHptain-205 studies by Spruce Biosciences? The topline results showed positive outcomes from the studies of tildacerfont in adult and pediatric classic CAH patients. What is the primary efficacy endpoint outcome of the CAHmelia-203 study? The CAHmelia-203 study did not meet its primary efficacy endpoint. What initiatives did Spruce Biosciences announce to extend its cash runway? The company intends to implement cost-saving measures and a workforce reduction of about 21%. What is the ticker symbol for Spruce Biosciences, Inc.? The ticker symbol for Spruce Biosciences, Inc. is SPRB. When does Spruce Biosciences plan to meet with regulatory authorities for a potential registrational program? Spruce Biosciences plans to meet with regulatory authorities after obtaining positive results from CAHmelia-204 and CAHptain-205."
Spero Therapeutics Announces Fourth Quarter and Full Year 2023 Operating Results and Provides a Business Update,2024-03-13T20:01:00.000Z,Neutral,Neutral,"Spero Therapeutics, Inc. (SPRO) announces financial results for Q4 and full year 2023, along with updates on SPR720 Phase 2a trial, Tebipenem HBr Phase 3 trial, and IND submission for SPR206. The company reiterates expected cash runway into late 2025.","Spero Therapeutics Announces Fourth Quarter and Full Year 2023 Operating Results and Provides a Business Update Rhea-AI Impact (Neutral) Rhea-AI Sentiment (Neutral) Tags earnings Rhea-AI Summary Spero Therapeutics, Inc. (SPRO) announces financial results for Q4 and full year 2023, along with updates on SPR720 Phase 2a trial, Tebipenem HBr Phase 3 trial, and IND submission for SPR206. The company reiterates expected cash runway into late 2025. Positive None. Negative None. Financial Analyst The announcement by Spero Therapeutics regarding their financial results and pipeline progress presents a multifaceted picture for stakeholders. The reported net income of $51.2 million for Q4 2023 and an overall net income of $22.8 million for the year is a significant turnaround from the net loss of $(46.4) million in the previous year. This improvement is primarily attributed to the collaboration revenue from partnerships with GSK and Pfizer, underscoring the value of strategic alliances in the biopharmaceutical industry. The milestone payments from GSK, including the recent $23.8 million tranche, enhance the company's cash position, extending the cash runway into late 2025, which is crucial for sustaining operations and funding ongoing clinical trials.However, the increase in research and development expenses, albeit offset by personnel cost savings, indicates an uptick in clinical activity which investors should monitor as it could impact future financials. The anticipated data from the SPR720 Phase 2a trial and the progress of the PIVOT-PO Phase 3 trial for tebipenem HBr are pivotal events that could influence the company's valuation and stock performance. Positive outcomes could lead to potential FDA approval and commercialization, whereas any setbacks may have adverse effects on investor confidence and the company's financial health. Medical Research Analyst The therapeutic pipeline updates provided by Spero Therapeutics have significant implications for the treatment of rare diseases and multi-drug resistant infections. SPR720, being an oral treatment for NTM-PD, represents a novel approach in a space with limited options. The upcoming top-line data from the Phase 2a trial will be critical in determining its efficacy and safety, which, if positive, could lead to a new standard of care and provide a substantial market opportunity for Spero.Similarly, tebipenem HBr has the potential to be a game-changer for patients with cUTI by providing an oral treatment alternative to intravenous therapies, potentially reducing hospital stays and healthcare costs. The Phase 3 PIVOT-PO trial, backed by an FDA Special Protocol Assessment, indicates a clear regulatory path forward, which could expedite the approval process upon successful trial outcomes. The unique value proposition of tebipenem HBr, as the first oral broad-spectrum carbapenem in the United States, could significantly impact treatment protocols and market dynamics upon approval. Infectious Disease Expert From an infectious disease perspective, the development of SPR206 is particularly noteworthy due to its activity against MDR Gram-negative pathogens, which are a growing public health concern due to limited treatment options. The advancement into a Phase 2 trial for hospital-acquired or ventilator-associated bacterial pneumonia could address a critical need in hospital settings. The published preclinical and Phase 1 study results provide a scientific basis for its potential efficacy and safety profile. The support from government agencies like the Department of Defense and the National Institute of Allergy and Infectious Diseases underscores the importance of SPR206's target indications and the need for innovative treatments in combating antibiotic resistance. 03/13/2024 - 04:01 PM On track for topline data from SPR720 Phase 2a proof-of-concept trial in treatment-naive and treatment-experienced non-refractory NTM-PD patients, expected in 2H 2024Initiated enrollment in PIVOT-PO, a pivotal Phase 3 clinical trial of oral Tebipenem HBr in cUTI Submitted IND for SPR206 and received FDA clearance to proceed with Phase 2 clinical trialReiterate expected cash runway into late 2025Conference call and webcast at 4:30pm ET today CAMBRIDGE, Mass., March 13, 2024 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq: SPRO), a multi-asset clinical-stage biopharmaceutical company, focused on identifying and developing novel treatments for rare diseases and multi-drug resistant (MDR) bacterial infections, today announced financial results for the fourth quarter and full year ended December 31, 2023, and provided a business update. 2023 was a productive year for Spero and we have been focused on execution across our programs, said Sath Shukla, President, and Chief Executive Officer of Spero. We are well poised to unveil top-line data for SPR720 Phase 2a, which is expected in 2H 2024, and our excitement is fueled by the hope it may bring for the rare disease community grappling with nontuberculous mycobacterial pulmonary disease (NTM-PD). On tebipenem HBr, engaging with the FDA and in collaboration with our partner, GSK, we are actively enrolling patients globally in our Phase 3 PIVOT-PO clinical trial. Positioned as the first oral broad-spectrum carbapenem in the United States for cUTI, we believe this product has the potential to change the treatment paradigm for these patients and underscores Speros commitment to innovation. We reiterate our expected cash runway into late 2025 based on our year-end cash balance, along with tebipenem HBr development milestone payments from GSK and our disciplined capital allocation. Pipeline Update SPR720 SPR720 is an investigational novel, oral, first-line treatment for NTM-PD. Top-line data from the Phase 2a proof-of-concept clinical trial in treatment-naive and treatment-experienced non-refractory NTM-PD patients is expected in 2H 2024. The trial is expected to enroll treatment-nave or treatment-experienced participants with non-refractory NTM-PD due to Mycobacterium avium complex. The primary endpoint evaluates changes in bacterial load in sputum samples from baseline to the end of the 56-day treatment period. Key secondary endpoints include assessments of clinical response, quality of life, pharmacokinetics, and safety and tolerability. For more information on the trial, see ClinicalTrials.gov identifier NCT05496374.A paper Efficacy of SPR720 in murine models of non-tuberculous mycobacterial pulmonary infection (Nicole Cotroneo et al) was published in Journal of Antimicrobial Chemotherapy in February 2024.A paper Nontuberculous mycobacterial pulmonary disease and the potential role of SPR720 (Kevin Winthrop et al) was published in Expert Review of Anti-infective Therapy in October 2023. Tebipenem HBr Tebipenem HBr is an investigational oral carbapenem antibiotic being developed for the treatment of complicated urinary tract infection (cUTI) including acute pyelonephritis (AP) to help patients avoid hospitalizations or reduce duration of in-patient therapy. Spero commenced enrollment in PIVOT-PO, a global, randomized, double-blind, Phase 3 clinical trial of tebipenem HBr in patients with cUTI, including AP in December 2023. The trial compares oral tebipenem HBr with intravenous imipenem cilastatin, in hospitalized adult patients with cUTI/AP. The primary endpoint is the number of patients with overall response (a combination of clinical cure and favorable microbiological response) at the Test-of-Cure (TOC) visit. The trial is expected to enroll approximately 2,648 patients, with enrollment completion anticipated in 2H 2025. For more information on PIVOT-PO, refer to ClinicalTrials.gov ID NCT06059846. In July 2023, Spero received written agreement from the U.S. Food and Drug Administration (FDA), under a Special Protocol Assessment (SPA), on the design and size of PIVOT-PO. The FDA has indicated that positive and persuasive results from PIVOT-PO, supported with confirmatory evidence of efficacy, could be sufficient to support approval of tebipenem HBr as a treatment for cUTI, including pyelonephritis, for a limited use indication. Under the terms of its license agreement with GSK, in December 2023, upon dosing the first patient, Spero earned $95 million in development milestones payable in four equal installments over two years. Spero also received a $30 million development milestone payment following the SPA. Further details on the agreement with GSK can be found here. SPR206 SPR206 is an innovative, investigational IV-administered direct-acting next generation polymyxin that has shown antibiotic activity against MDR Gram-negative pathogens, including carbapenem-resistant Enterobacteriaceae, Acinetobacter baumannii and Pseudomonas aeruginosa in preclinical studies. An Investigational New Drug (IND) application has been cleared by the FDA to advance SPR206, to treat MDR Gram-negative bacterial infections, into a Phase 2 clinical trial in participants with hospital-acquired or ventilator-associated bacterial pneumonia.The results from the Phase 1 bronchoalveolar lavage (BAL) study of SPR206 were published in a paper Pharmacokinetics of SPR206 in Plasma, Pulmonary Epithelial Lining Fluid, and Alveolar Macrophages following Intravenous Administration to Healthy Adult Subjects (Keith Rodvold et al) in Antimicrobials and Chemotherapy in July 2023. A paper Safety and pharmacokinetics of SPR206 in subjects with varying degrees of renal impairment (Jon B. Bruss et al) was published in Antimicrobials and Chemotherapy in October 2023. Corporate Highlights Satyavrat Sath Shukla successfully transitioned to President and Chief Executive Officer (CEO) of the company, and a member of the Board of Directors in August 2023. Mr. Shukla had previously been Chief Financial Officer and Treasurer of the company. Mr. Shukla succeeded Speros prior CEO and President, Ankit Mahadevia, M.D., who became Chair of the Board of Directors in August 2023.Esther Rajavelu was appointed as Chief Financial Officer, Chief Business Officer, and Treasurer in November 2023. Ms. Rajavelu brings over 20 years of experience working in the biotech and financial sectors focused on growth strategy, M&A, and financing. Fourth Quarter and Full Year 2023 Financial Results Spero reported net income of $51.2 million for the fourth quarter and an overall net income of $22.8 million, for the year ended December 31, 2023, or a diluted net income per share of common stock of $0.96 and $0.43, respectively. Net income for the fourth quarter and net loss for the year ended December 31, 2022, was $26.8 million and $(46.4) million, or $0.55 and $(1.23) per share of common stock, respectively.Total revenue for the fourth quarter of 2023 was $73.5 million, compared with total revenue of $47.4 million for the fourth quarter of 2022. The revenue increase for the fourth quarter of 2023 was primarily due to $71.8 million in collaboration revenue related to our agreements with GSK and Pfizer. Total revenue for the year ended December 31, 2023 was $103.8 million, compared to $53.5 million for the year ended December 31, 2022. The revenue increase for the year ended December 31, 2023, was primarily due to the aforementioned collaboration revenue related to our agreements with GSK and Pfizer.Research and development expenses for the fourth quarter of 2023 were $16.6 million, compared to $15.1 million of research and development expenses for the same period in 2022. Research and development expenses for the year ended December 31, 2023 were $51.4 million, compared to $47.6 million for the year ended December 31, 2022. The increase in research and development expenses year-over-year was primarily due to increased clinical activity during the period related to the ongoing Phase 2a clinical trial of SPR720, offset by personnel-related costs.General and administrative expenses for the fourth quarter of 2023 were $6.4 million, compared to $6.5 million of general and administrative expenses for the same period in 2022. This year-over-year decrease was primarily due to changes in personnel-related costs, offset by increased professional and consulting fees. General and administrative expenses for the year ended December 31, 2023, were $25.6 million, compared to $36.5 million for the year ended December 31, 2022, with lower expenses in 2023 compared to 2022 primarily due to decreases in both personnel-related costs and professional and consulting fees.As of December 31, 2023, Spero had cash and cash equivalents of $76.3 million. Since the year-end closing of financials, the company received $23.8 million, the first tranche of the $95.0 million in development milestones from GSK. Based on its current operating plans, Spero expects that its cash and cash equivalents, together with other non-dilutive funding commitments, will be sufficient to fund its operating expenses and capital expenditure requirements into late 2025. For further details on Speros financials, refer to Speros Annual Report on Form 10-K, filed with the U.S. Securities and Exchange Commission (SEC) today. Conference Call and Live Webcast Today at 4:30 pm EST Spero will host a conference call and webcast today at 4:30 p.m. ET. To access the call, please dial 1-877-704-4453 (domestic) or 1-201-389-0920 (international) and refer to conference ID 13744458 or click on this Link and request a return call. The conference call will also be webcast live and can be accessed through this website link, and on Spero's website at www.sperotherapeutics.com on the ""Events and Presentations"" page under the ""Connect"" tab. An archived webcast will be available on Spero's website for 30 days following the presentation. Tebipenem HBr Research SupportSelect tebipenem HBr studies have been funded in part with federal funds from the Department of Health and Human Services; Administration for Strategic Preparedness and Response; Biomedical Advanced Research and Development Authority, under contract number HHSO100201800015C. Government Agency Research Support The views expressed in this press release are those of the authors and may not reflect the official policy or position of the Department of the Army, Department of Defense, or the U.S. Government. Department of Defense Select SPR206 studies are supported by the Office of the Assistant Secretary of Defense for Health Affairs, through the Joint Warfighter Medical Research Program under Award No. W81XWH 19 1 0295. Opinions, interpretations, conclusions, and recommendations are those of the author and are not necessarily endorsed by the Department of Defense. National Institute of Allergy and Infectious Disease Select SPR206 studies have been funded in whole or in part with Federal funds from the National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services, under Contract No. 75N93021C00022. About Spero TherapeuticsSpero Therapeutics, headquartered in Cambridge, Massachusetts, is a multi-asset clinical-stage biopharmaceutical company focused on identifying and developing novel treatments for rare diseases and MDR bacterial infections with high unmet need. For more information, visit www.sperotherapeutics.com. Forward Looking Statements This press release may contain forward-looking statements. These statements include, but are not limited to, statements about the design, initiation, timing, progress and results of Spero's preclinical studies and clinical trials and its research and development programs, as well as the regulatory path forward for tebipenem HBr and potential FDA approval, the potential commercialization of tebipenem HBr, the potential receipt under the GSK license agreement of milestone payments and royalties on future sales of tebipenem HBr, and Speros cash runway. In some cases, forward-looking statements can be identified by terms such as ""may,"" ""will,"" ""should,"" ""expect,"" ""plan,"" ""aim,"" ""anticipate,"" ""could,"" ""intent,"" ""target,"" ""project,"" ""contemplate,"" ""believe,"" ""estimate,"" ""predict,"" ""potential"" or ""continue"" or the negative of these terms or other similar expressions. Actual results may differ materially from those indicated by such forward-looking statements as a result of various important factors, including whether tebipenem HBr, SPR720 and SPR206 will advance through the clinical trial process on a timely basis, or at all, taking into account the effects of possible regulatory delays, slower than anticipated patient enrollment, manufacturing challenges, clinical trial design and clinical outcomes; whether the results of such trials will warrant submission for approval from the FDA or equivalent foreign regulatory agencies; whether the FDA will ultimately approve tebipenem HBr and, if so, the timing of any such approval; whether the FDA will require any additional clinical data or place labeling restrictions on the use of tebipenem HBr that would delay approval and/or reduce the commercial prospects of tebipenem HBr; whether a successful commercial launch can be achieved and market acceptance of tebipenem HBr can be established; whether results obtained in preclinical studies and clinical trials will be indicative of results obtained in future clinical trials; Spero's reliance on third parties to manufacture, develop, and commercialize its product candidates, if approved; Speros need for additional funding; the ability to commercialize Spero's product candidates, if approved; Spero's ability to retain key personnel; Speros ongoing leadership transitions; whether Spero's cash resources will be sufficient to fund its continuing operations for the periods and/or trials anticipated; and other factors discussed in the ""Risk Factors"" set forth in filings that Spero periodically makes with the SEC. The forward-looking statements included in this press release represent Spero's views as of the date of this press release. Spero anticipates that subsequent events and developments will cause its views to change. However, while Spero may elect to update these forward-looking statements at some point in the future, it specifically disclaims any obligation to do so. These forward-looking statements should not be relied upon as representing Spero's views as of any date subsequent to the date of this press release. Investor Relations Contact:Ashley R. RobinsonManaging Director, LifeSci Advisors, LLCarr@lifesciadvisors.com(617) 775-5956 Media Inquiries: media@sperotherapeutics.com Spero Therapeutics, Inc.Condensed Consolidated Balance Sheet Data(in thousands)(Unaudited) December 31, December 31, 2023 2022 ChangeCash, cash equivalents and marketable securities $76,333 $109,107 $(32,774)Other assets 106,057 15,695 90,362 Total assets $ 182,390 $ 124,802 $ 57,588 Total liabilities $75,496 $48,868 $26,628 Total stockholder's equity 106,894 75,934 30,960 Total liabilities and stockholders' equity $ 182,390 $ 124,802 $ 57,588 Spero Therapeutics, Inc.Condensed Consolidated Statements of Operations(in thousands, except share and per share data)(unaudited) Three Months Ended December 31, Year Ended December 31, 2023 2022 2023 2022 Revenues: Grant revenue $1,698 $1,087 $7,046 $4,930 Collaboration revenue - related party 71,603 46,076 95,802 46,076 Collaboration revenue 223 278 933 2,503 Total revenues 73,524 47,441 103,781 53,509 Operating expenses: Research and development 16,558 15,089 51,440 47,593 General and administrative 6,433 6,495 25,554 36,483 Impairment of long-term asset   5,306  Restructuring  (67)  11,630 Total operating expenses 22,991 21,517 82,300 95,706 Loss from operations 50,533 25,924 21,481 (42,197)Other income (expense) 1,046 847 3,923 (4,218)Net income (loss) before income taxes 51,579 26,771 25,404 (46,415)Income tax expense (387)  (2,598)  Net income (loss) attributable to common shareholders of Spero Therapeutics, Inc. $51,192 $26,771 $22,806 $(46,415) Net loss per share attributable to common shareholders per share, basic $0.97 $0.55 $0.43 $(1.23)Net loss per share attributable to common shareholders per share, diluted $0.96 $0.55 $0.43 $(1.23) Weighted average shares outstanding, basic: 52,999,491 48,715,409 52,703,467 37,585,075 Weighted average shares outstanding, diluted: 53,108,270 48,942,616 52,989,030 37,585,075 When is the expected topline data from the SPR720 Phase 2a trial? The topline data from the SPR720 Phase 2a trial is expected in 2H 2024. What is the primary endpoint of the SPR720 Phase 2a trial? The primary endpoint of the SPR720 Phase 2a trial evaluates changes in bacterial load in sputum samples from baseline to the end of the 56-day treatment period. What is the purpose of the PIVOT-PO trial? The PIVOT-PO trial is a pivotal Phase 3 clinical trial of oral Tebipenem HBr in patients with complicated urinary tract infection (cUTI). What is the primary endpoint of the PIVOT-PO trial? The primary endpoint of the PIVOT-PO trial is the number of patients with overall response at the Test-of-Cure (TOC) visit. What milestone payments did Spero receive from GSK in December 2023? Spero received $95 million in development milestones payable in four equal installments over two years and a $30 million development milestone payment following the SPA. Who was appointed as Chief Financial Officer, Chief Business Officer, and Treasurer in November 2023? Esther Rajavelu was appointed as Chief Financial Officer, Chief Business Officer, and Treasurer in November 2023. What were Spero's net income and diluted net income per share for the year ended December 31, 2023? Spero reported a net income of $22.8 million and a diluted net income per share of common stock of $0.43 for the year ended December 31, 2023. What was the total revenue for the fourth quarter of 2023? The total revenue for the fourth quarter of 2023 was $73.5 million. What were Spero's research and development expenses for the year ended December 31, 2023? Spero's research and development expenses for the year ended December 31, 2023 were $51.4 million. How much cash and cash equivalents did Spero have as of December 31, 2023? As of December 31, 2023, Spero had cash and cash equivalents of $76.3 million."
Cue Health Reports Fourth Quarter 2023 Financial Results,2024-03-13T20:01:00.000Z,Moderate,Negative,Cue Health Inc. reports $18.8 million in Q4 revenue and $70.9 million in full-year 2023 revenue. The company submitted clinical data for RSV and Flu A/B tests to the FDA. Cue is in late-stage development of Herpes + Mpox Multiplex Molecular Test. They executed cost reduction plans saving $200 million annually. Fourth quarter revenue breakdown shows private sector revenue at $17.0 million and public sector revenue at $1.8 million. Cue reported a GAAP net loss of $148.4 million in Q4 2023.,"Cue Health Reports Fourth Quarter 2023 Financial Results Rhea-AI Impact (Moderate) Rhea-AI Sentiment (Negative) Tags earnings Rhea-AI Summary Cue Health Inc. reports $18.8 million in Q4 revenue and $70.9 million in full-year 2023 revenue. The company submitted clinical data for RSV and Flu A/B tests to the FDA. Cue is in late-stage development of Herpes + Mpox Multiplex Molecular Test. They executed cost reduction plans saving $200 million annually. Fourth quarter revenue breakdown shows private sector revenue at $17.0 million and public sector revenue at $1.8 million. Cue reported a GAAP net loss of $148.4 million in Q4 2023. Positive None. Negative - Cue Health Inc. reported a GAAP net loss of $148.4 million in the fourth quarter of 2023, indicating significant financial challenges despite revenue growth. - Cue's adjusted net loss for the full year 2023 was $267.2 million, reflecting continued financial struggles. - The company's GAAP product gross profit showed a loss of $62.9 million for the full year 2023, highlighting profitability concerns. - Cue's adjusted EBITDA was a loss of $24.4 million in the fourth quarter of 2023, indicating operational inefficiencies. - Despite revenue growth, Cue Health Inc. faces substantial financial losses, with a GAAP net loss of $373.5 million for the full year 2023. Financial Analyst The financial results reported by Cue Health Inc. for the fourth quarter and full year 2023 reflect a challenging period for the company, with significant net losses and operating costs. The reported net loss of $148.4 million for the fourth quarter and $373.5 million for the full year indicate substantial financial pressure, exacerbated by one-time inventory charges and impairment of long-lived assets. The adjusted EBITDA loss of $24.4 million for the quarter and $163.8 million for the year further underscores the need for stringent cost management and operational efficiency.From an investment perspective, the company's cost reduction plans, which are projected to save approximately $200 million annually, could be a strategic move to improve financial health. However, investors should closely monitor the company's ability to generate revenue from its pipeline of diagnostic tests and the expansion of its Integrated Care Platform. The anticipated launch of new products, such as the Herpes + Mpox Multiplex Molecular Test, could provide additional revenue streams, but the success of these launches is not guaranteed.The guidance for the first quarter of 2024, with revenues projected between $9 million to $11 million, suggests a continued downward trend in revenue, which could be a point of concern for stakeholders. The company's current cash reserves of $80.9 million, with no debt obligations, provide some buffer, but the burn rate will be a critical factor to watch in the coming quarters. Market Research Analyst Examining Cue Health Inc.'s performance within the broader healthcare technology market, the company's focus on developing multiplex molecular tests for various diseases positions it within a competitive and high-growth potential segment. The demand for accurate, rapid diagnostic solutions, especially for conditions like Flu, RSV and COVID-19, is likely to remain high in the post-pandemic era.However, the company's significant gross profit losses, both GAAP and adjusted, indicate pricing pressures or inefficiencies in the cost of goods sold. The private sector revenue, constituting 91% of total revenue, suggests a strong reliance on this segment, which could be both an opportunity and a risk, depending on the market dynamics and competition.Given the anticipated product launches and the expansion of the Integrated Care Platform, the company's ability to capture market share and establish a strong customer base will be crucial. The 49% decrease in adjusted operating costs year-over-year is a positive sign of cost control, but it is essential to balance this with investments in marketing and sales to drive revenue growth. Medical Research Analyst From a medical research and regulatory standpoint, Cue Health's progress in submitting additional clinical samples and stability data for RSV and Flu A/B to the FDA is a critical step towards expanding its product portfolio. The de novo submission process is a rigorous FDA pathway for novel devices that can be lengthy and uncertain, but successful authorization can significantly enhance the company's market presence.The development of a Herpes + Mpox Multiplex Molecular Test is particularly noteworthy, as it addresses emerging healthcare needs. The planned submission for Emergency Use Authorization (EUA) in the second quarter of 2024 could expedite the test's availability, which is essential during public health emergencies.It is important to note that the company has already secured two FDA authorizations for its COVID-19 and Mpox Molecular Tests, which demonstrates a track record of regulatory success. However, the financial investment required for research and development, as well as the regulatory approval process, must be weighed against the potential market demand and revenue generation capabilities of these new products. 03/13/2024 - 04:01 PM SAN DIEGO--(BUSINESS WIRE)-- Cue Health Inc. (""Cue"" or the Company) (Nasdaq: HLTH), a healthcare technology company, today reported financial results for the fourth quarter and full-year 2023. Recent Highlights Reported fourth quarter total revenue of $18.8 million. Full-year 2023 total revenue was $70.9 million Submitted additional clinical samples and stability data for RSV to the FDA in support of de novo submission Submitted additional clinical samples and gathering additional stability data for Flu A/B to the FDA in support of de novo submission In late stage development of Herpes + Mpox Multiplex Molecular Test with plan to submit for EUA in 2Q24 Executed cost reduction plans, resulting in cash savings of approximately $200 million on an annualized basis, while prioritizing near-term revenue generating opportunities Reported cash and cash equivalents of $80.9 million as of December 31, 2023 We made progress executing on our strategic priorities in 2023. We obtained two FDA authorizations including a de novo approval for our COVID-19 Molecular Test and an EUA for our Mpox Molecular Test, and made two de novo submissions for our RSV and Flu standalone molecular tests. We also drove significant development progress on our all-in-one Flu + COVID-19 + RSV test, our Herpes + Mpox multiplex test, and we expanded our Integrated Care Platform with a new suite of at-home diagnostics tests and treatments, all while streamlining our cost structure, said Ayub Khattak, Chairman and CEO of Cue. We believe that these successes have positioned us well for 2024. Fourth Quarter 2023 Financial Results Revenue was $18.8 million for the fourth quarter of 2023. Private sector revenue was $17.0 million or 91% of total revenue with strong ordering from existing customers. Public sector revenue was $1.8 million and disposable test cartridge revenue was $15.5 million. GAAP product gross profit was a loss of $18.4 million in the fourth quarter of 2023. Adjusted product gross profit was a loss of $2.7 million after excluding one-time $15.7 million inventory charges. GAAP operating costs and expenses in the fourth quarter of 2023 were $132.0 million, excluding cost of product revenue. GAAP operating costs and expenses includes $83.6 million of impairment of long-lived assets. Adjusted operating costs and expenses were $48.3 million in the fourth quarter of 2023, a 49% decrease from $94.6 million in the fourth quarter of 2022. GAAP net loss in the fourth quarter of 2023 was $148.4 million and earnings per diluted share was a loss of $0.96. Cue's adjusted net loss, which excludes the one-time inventory and impairment charges, was $49.1 million and adjusted earnings per diluted share was a loss of $0.32. Adjusted EBITDA was a loss of $24.4 million. Full-Year 2023 Financial Results Revenue was $70.9 million for the full year of 2023. Private sector revenue was $63.0 million, or 89% of total revenue. Public sector revenue was 11% of total revenue or $7.9 million. Disposable test cartridge revenue was $58.5 million for the full year 2023. GAAP product gross profit was a loss of $62.9 million for the full year 2023. Adjusted product gross profit was a loss of $35.2 million after excluding a $12.0 million disputed vendor payment and the one-time inventory charges of $15.7 million. GAAP operating costs and expenses for the full year 2023 were $338.7 million, excluding cost of product revenue. GAAP operating costs and expenses includes $83.6 million of impairment of long-lived assets and $14.5 million of restructuring expense. Adjusted operating costs and expenses for the full year 2023 were $240.6 million. GAAP net loss for the full year 2023 was $373.5 million and earnings per diluted share was a loss of $2.44. Cue's Adjusted net loss was $267.2 million and adjusted earnings per diluted share was a loss of $1.75. Adjusted EBITDA was a loss of $163.8 million. Cash and cash equivalents were $80.9 million as of December 31, 2023 and Cue continues to operate with no debt obligations. Guidance Cue expects first quarter 2024 revenues in the range of $9 million to $11 million. Webcast and Conference Call Information Cue will host a conference call to discuss the fourth quarter and full year 2023 financial results, after market close on Wednesday, March 13, 2024, at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time. To access the live call via telephone, please register in advance using the link here. Upon registering, each participant will receive an email confirmation with dial-in numbers and a unique personal PIN that can be used to join the call. The live webinar may be accessed by visiting the Events section of the Companys website at investors.cuehealth.com. A replay of the webinar will be available on the Companys website shortly after the conclusion of the call. About Cue Cue Health Inc. (Nasdaq: HLTH) is a healthcare technology company that uses diagnostic-enabled care to empower people to live their healthiest lives. Cues platform offers individuals and healthcare providers convenient and personalized access to lab-quality diagnostic tests at home and at the point-of-care, as well as on-demand telehealth consultations and treatment options for a wide range of health and wellness needs. Cues customers include federal and state public sector agencies and the private sector, which includes healthcare providers, enterprises, and individual consumers. Cue received De Novo authorization from the U.S. Food and Drug Administration (FDA) for its COVID-19 test, which became the first home use respiratory test to receive this FDA approval. Cue also received Emergency Use Authorization from the FDA for its molecular Mpox test at the point-of-care and, to expand its test menu, Cue has a number of other submissions under review by the FDA. Cue, founded in 2010, owns over 100 patents and is headquartered in San Diego. For more information, please visit www.cuehealth.com. Forward-Looking Statements Statements in this press release about future expectations, plans and prospects, including statements related to the submission of any FDA applications and expectations around receiving clearance and authorization and timing of such clearance, authorization and submissions, growth in our customer base, expectations regarding production capacity and product launches, potential technology enhancements, expectations related to availability of our programs and testing volumes, the ability to achieve growth in the future, and future results of operations and performance and our guidance, including first quarter 2024 guidance, as well as any other statements regarding matters that are not historical facts, may constitute forward-looking statements. The words, without limitation, continue, estimate, expect, intend, may, plan, potential, would, develop, pave, seek, offer, grow, expand, look forward, believe, design and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these or similar identifying words. Actual results may differ materially from those indicated by such forward-looking statements as a result of various important factors, including those related to expectations around FDA submissions, applications, authorizations and timing, the expected capabilities of the flu A/B standalone, flu A/B + COVID multiplex, RSV test, Strep Throat test, Mpox test and Chlamydia + Gonorrhea multiplex test, the expansion of Cue Care, our ability to maintain customer growth rates, our ability to increase private sector revenue, our ability maintain or replace the revenue historically generated from our government contracts, our ability to effectively scale our manufacturing capacity to meet contractual obligations with our customers and market demand, our ability to realize operating expense annualized savings as a result of the previously announced cost reduction program, and the factors discussed in the ""Risk Factors"" section of Cues Annual Report on Form 10-K for the year ended December 31, 2023, to be filed with the SEC. Any forward-looking statements contained in this press release are based on the current expectations of Cues management team and speak only as of the date hereof, and Cue specifically disclaims any obligation to update any forward-looking statement, whether as a result of new information, future events or otherwise. The Cue Mpox (Monkeypox) Molecular Test has not been FDA cleared or approved, but has been authorized for emergency use by FDA under an EUA. This product has been authorized only for the detection of nucleic acid from monkeypox virus, not for any other viruses or pathogens. The emergency use of this product is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of infection with the monkeypox virus, including in vitro diagnostics that detect and/or diagnose infection with non-variola Orthopoxvirus, under Section 564(b)(1) of the Federal Food, Drug, and Cosmetic Act, 21 U.S.C.  360bbb-3(b)(1), unless the declaration is terminated or authorization is revoked sooner. Use of Non-GAAP Financial Measures To supplement our financial information presented in accordance with GAAP, we consider certain financial measures that are not prepared in accordance with GAAP, including Adjusted Product Gross Profit (Loss) Margin, Adjusted Operating Expenses, Adjusted Net Loss, Adjusted Diluted EPS and Adjusted EBITDA (loss). We use these financial measures in conjunction with GAAP measures as part of our overall assessment of our performance, including the preparation of our annual operating budget and quarterly forecasts, to evaluate the effectiveness of our business strategies and to communicate with our board of directors concerning our business and financial performance. We believe that these non-GAAP financial measures provide useful information to investors about our business and financial performance, enhance their overall understanding of our past performance and future prospects, and allow for greater transparency with respect to metrics used by our management in their financial and operational decision making. We are presenting these non-GAAP financial measures to assist investors in seeing our business and financial performance through the eyes of management, and because we believe that these non-GAAP financial measures provide an additional tool for investors to use in comparing results of operations of our business over multiple periods with other companies in our industry. Adjusted EBITDA is defined as net loss before interest income, interest expense, income tax expense (benefit), depreciation and amortization, stock-based compensation, impairment of long-lived assets, restructuring expense, tax credits, disputed vendor payment, inventory charges, U.S. Department of Defense (the DoD) deferred revenue release. Adjusted product gross profit (loss) is defined as product gross profit (loss), before DoD deferred revenue release, disputed vendor payment, inventory charges. Adjusted operating costs and expenses is defined as operating costs and expenses before cost of product revenue, impairment of long-lived assets, restructuring expense. Adjusted net loss is defined as Net loss, before impairment of long-lived assets, restructuring expense, tax credits, disputed vendor payment, inventory charges and tax effects. Adjusted diluted EPS is defined as Diluted EPS before impairment of long-lived assets, restructuring expense, tax credits, disputed vendor payment, inventory charges and tax effects. Our definitions may differ from the definitions used by other companies and therefore comparability may be limited. In addition, other companies may not publish these or similar metrics. Further, these metrics have certain limitations in that they do not include the impact of certain expenses that are reflected in our consolidated statements of operations. Thus, these non-GAAP metrics should be considered in addition to, not as substitutes for, or in isolation from, measures prepared in accordance with GAAP. For reconciliations of these non-GAAP financial measures to their most directly comparable GAAP financial measures see the financial tables below. CONSOLIDATED STATEMENTS OF OPERATIONS (In thousands, except share data) Three Months Ended December 31, Twelve Months Ended December 31, 2023 2022 2023 2022 Revenue Product revenue $ 17,381 $ 145,701 $ 64,223 $ 474,166 Grant and other revenue 1,417 1,076 6,713 9,310 Total revenue 18,798 146,777 70,936 483,476 Operating costs and expenses: Cost of product revenue 35,742 90,783 127,091 329,973 Sales and marketing 6,226 19,312 32,584 88,580 Research and development 32,248 56,149 150,620 171,452 General and administrative 9,866 19,157 57,355 97,103 Impairment of long-lived assets 83,639  83,639  Restructuring expense (18 )  14,500 2,020 Total operating costs and expenses 167,703 185,401 465,789 689,128 Loss from operations (148,905 ) (38,624 ) (394,853 ) (205,652 ) Interest income 1,084 1,988 6,240 3,328 Interest expense (344 ) (232 ) (1,159 ) (645 ) Tax credits   20,939  Other income (expense), net (207 ) 46 162 (835 ) Net loss before income taxes (148,372 ) (36,821 ) (368,671 ) (203,804 ) Income tax expense (benefit) 60 (5,315 ) 4,793 (9,748 ) Net loss $ (148,432 ) $ (31,506 ) $ (373,464 ) $ (194,056 ) Net loss per share  basic & diluted $ (0.96 ) $ (0.21 ) $ (2.44 ) $ (1.31 ) Weighted-average number of shares used in computation of net loss per share  basic & diluted 154,807,021 149,711,419 152,877,306 148,024,749 CONSOLIDATED BALANCE SHEETS (In thousands, except share amounts and share data) December 31, 2023 December 31, 2022 Assets Current assets: Cash and cash equivalents $ 80,889 $ 241,530 Restricted cash 800 800 Accounts receivable, net 1,352 18,751 Inventories, net - current 14,039 82,210 Prepaid expenses 8,479 15,728 Other current assets 4,803 12,134 Total current assets 110,362 371,153 Non-current inventories, net 56,273 25,436 Property and equipment, net 72,096 189,275 Operating lease right-of-use assets 78,519 85,321 Intangible assets, net 19,644 16,867 Other non-current assets 2,893 6,528 Total assets $ 339,787 $ 694,580 Liabilities and Stockholders Equity Current liabilities: Accounts payable $ 7,705 $ 7,150 Accrued liabilities and other current liabilities 29,300 52,378 Deferred revenue, current 162 1,566 Operating lease liabilities, current 5,142 7,739 Finance lease liabilities, current 1,157 2,362 Total current liabilities 43,466 71,195 Operating leases liabilities, net of current portion 41,640 44,045 Finance lease liabilities, net of current portion  849 Other non-current liabilities 4,429 1,997 Total liabilities 89,535 118,086 Stockholders Equity Common stock 2 1 Additional paid-in-capital 841,788 794,567 Accumulated deficit (591,538 ) (218,074 ) Total stockholders equity 250,252 576,494 Total liabilities and stockholders equity $ 339,787 $ 694,580 Non-GAAP Measures (In thousands, except share data) The following table presents the reconciliation of Net loss to Adjusted EBITDA, for the periods presented: Three Months Ended December 31, Twelve Months Ended December 31, 2023 2022 2023 2022 Net loss $ (148,432 ) $ (31,506 ) $ (373,464 ) $ (194,056 ) Interest income (1,084 ) (1,988 ) (6,240 ) (3,328 ) Interest expense 344 232 1,159 645 Income tax expense (benefit) 60 (5,315 ) 4,793 (9,748 ) Depreciation and amortization 15,219 14,337 56,278 48,972 Stock-based compensation 10,138 15,776 48,735 64,291 Impairment of long-lived assets 83,639  83,639  Restructuring expense (18 )  14,500 2,020 Tax credits   (20,939 )  Disputed vendor payment   12,000  Inventory charges 15,705 47,352 15,705 92,806 DoD deferred revenue release  (92,448 )  (92,448 ) Adjusted EBITDA $ (24,429 ) $ (53,560 ) $ (163,834 ) $ (90,846 ) The following table presents the reconciliation of Product gross profit (loss) margin to Adjusted product gross profit (loss) margin, for the periods presented: Three Months Ended December 31, Twelve Months Ended December 31, 2023 2022 2023 2022 Product revenue $ 17,381 $ 145,701 $ 64,223 $ 474,166 Cost of product revenue 35,742 90,783 127,091 329,973 Product gross profit (loss) $ (18,361 ) $ 54,918 $ (62,868 ) $ 144,193 Product gross profit (loss) margin (106 )% 38 % (98 )% 30 % DoD deferred revenue release  (92,448 )  (92,448 ) Adjusted product revenue 17,381 53,253 64,223 381,718 Disputed vendor payment   12,000  Inventory charges 15,705 47,352 15,705 92,806 Adjusted product gross profit (loss) $ (2,656 ) $ 9,822 $ (35,163 ) $ 144,551 Adjusted product gross profit (loss) margin (15 )% 18 % (55 )% 38 % The following table presents the reconciliation of Operating costs and expenses to Adjusted operating costs and expenses, for the periods presented: Three Months Ended December 31, Twelve Months Ended December 31, 2023 2022 2023 2022 Operating costs and expenses $ 167,703 $ 185,401 $ 465,789 $ 689,128 Cost of product revenue 35,742 90,783 127,091 329,973 Operating costs and expenses excluding cost of product revenue 131,961 94,618 338,698 359,155 Impairment of long-lived assets 83,639  83,639  Restructuring expense (18 )  14,500 2,020 Adjusted operating costs and expenses $ 48,340 $ 94,618 $ 240,559 $ 357,135 The following table presents the reconciliation of Net loss / diluted EPS to Adjusted net loss / diluted EPS, for the periods presented: Three Months Ended December 31, Twelve Months Ended December 31, 2023 2023 Dollar Amount Per Diluted Share Dollar Amount Per Diluted Share Net loss / diluted EPS $ (148,432 ) $ (0.96 ) $ (373,464 ) $ (2.44 ) Impairment of long-lived assets 83,639 0.54 83,639 0.55 Restructuring expense (18 )  14,500 0.09 Tax credits   (20,939 ) (0.14 ) Disputed vendor payment   12,000 0.08 Inventory charges 15,705 0.10 15,705 0.10 Tax effects 40  1,364 0.01 Adjusted net loss / diluted EPS $ (49,066 ) $ (0.32 ) $ (267,195 ) $ (1.75 ) View source version on businesswire.com: https://www.businesswire.com/news/home/20240313695867/en/ Press Cue Health press@cuehealth.com Investors ICR Westwicke Caroline Corner +1-415-202-5678 caroline.corner@westwicke.com Source: Cue Health Inc. What was Cue Health Inc.'s total revenue for the fourth quarter of 2023? Cue Health Inc. reported total revenue of $18.8 million for the fourth quarter of 2023. What was Cue Health Inc.'s total revenue for full-year 2023? Cue Health Inc. reported total revenue of $70.9 million for full-year 2023. What clinical data did Cue Health Inc. submit to the FDA? Cue Health Inc. submitted additional clinical samples and stability data for RSV and Flu A/B tests to the FDA. What is Cue Health Inc. in late-stage development of? Cue Health Inc. is in late-stage development of Herpes + Mpox Multiplex Molecular Test. What cost reduction plans did Cue Health Inc. execute? Cue Health Inc. executed cost reduction plans resulting in cash savings of approximately $200 million on an annualized basis. What was Cue Health Inc.'s GAAP net loss in the fourth quarter of 2023? Cue Health Inc.'s GAAP net loss in the fourth quarter of 2023 was $148.4 million."
"Coherus BioSciences Reports Fourth Quarter, Full Year 2023 Financial Resultsand Provides Current Business Update",2024-03-13T20:01:00.000Z,Neutral,Neutral,"Coherus BioSciences, Inc. (CHRS) reports strong financial results for Q4 2023 and FY 2023, with net revenue of $91.5 million and $257.2 million, respectively. Key highlights include UDENYCA net sales of $36.2 million and CIMERLI net sales of $52.4 million in Q4. The company successfully launched LOQTORZI and UDENYCA ONBODY in Q1 2024. However, a 30% workforce reduction for 2024 was initiated on March 7, 2024.","Coherus BioSciences Reports Fourth Quarter, Full Year 2023 Financial Results and Provides Current Business Update Rhea-AI Impact (Neutral) Rhea-AI Sentiment (Neutral) Tags earnings Rhea-AI Summary Coherus BioSciences, Inc. (CHRS) reports strong financial results for Q4 2023 and FY 2023, with net revenue of $91.5 million and $257.2 million, respectively. Key highlights include UDENYCA net sales of $36.2 million and CIMERLI net sales of $52.4 million in Q4. The company successfully launched LOQTORZI and UDENYCA ONBODY in Q1 2024. However, a 30% workforce reduction for 2024 was initiated on March 7, 2024. Positive Strong net revenue of $91.5 million in Q4 2023 and $257.2 million in FY 2023. UDENYCA net sales reached $36.2 million in Q4, with CIMERLI net sales at $52.4 million. Successful launch of LOQTORZI and UDENYCA ONBODY in Q1 2024. Corporate restructuring with the divestiture of the ophthalmology franchise to Sandoz for $170 million. Initiation of a 30% workforce reduction for 2024 on March 7, 2024. Plan to prepay $175 million of the $250 million term loan balance with Pharmakon Advisors LP by April 1, 2024. Negative Workforce reduction may impact company morale and productivity. Partial prepayment of term loan may lead to increased financial pressure in the future. Financial Analyst The reported net revenue of $91.5 million for the fourth quarter and $257.2 million for the full fiscal year indicates a stable financial performance by Coherus BioSciences. The breakdown into specific product sales such as UDENYCA and CIMERLI provides a clear picture of the company's revenue streams. The successful launch of LOQTORZI and UDENYCA ONBODY could signify the company's potential for growth and diversification in its product portfolio. However, it's crucial to understand how these new products will affect future revenue projections and the competitive landscape.The divestiture of the ophthalmology franchise and the subsequent debt prepayment plan showcase a strategic shift towards strengthening the company's focus on oncology, which may resonate well with investors focusing on specialized biotech firms. The reduction in the workforce by 30% is a significant cost-cutting measure that could improve operational efficiency but may also raise concerns about the company's ability to sustain growth and innovation. The impact of these changes on Coherus's stock will depend on the market's perception of the company's long-term strategy and its execution. Market Research Analyst The divestiture of the ophthalmology franchise to Sandoz for a notable $170 million upfront plus additional considerations suggests a strategic pivot for Coherus BioSciences. This move could be perceived positively by the market as it allows the company to streamline its focus on oncology, a sector with high growth potential. The prepayment of the substantial portion of debt to Pharmakon Advisors LP indicates fiscal prudence and may lead to reduced interest expenses, improving the company's net income in the long run. This financial maneuvering reflects a proactive approach to balance sheet management that is often well-regarded by investors.However, the impact of the workforce reduction on the company's morale and productivity cannot be ignored. While the immediate financial benefits are clear, the long-term effects on innovation and company culture are less certain. Investors will likely monitor how these changes influence the company's ability to maintain a competitive edge in the biopharmaceutical industry. Pharmaceutical Industry Analyst Coherus BioSciences' focus on the oncology sector following the divestiture of their ophthalmology franchise is a strategic decision that capitalizes on the growing demand for cancer treatments. The oncology market is known for its high barriers to entry due to the complexity of drug development and regulatory approvals, but it also offers substantial rewards for successful entrants. The successful launches of LOQTORZI and UDENYCA ONBODY could potentially enhance Coherus's market positioning within this lucrative sector.The financial results reflect a company in transition, with significant changes in its operational structure. The reduction in workforce, while a difficult decision, may be necessary for the company to align its resources with its strategic focus and to remain competitive in the high-stakes oncology market. Stakeholders should monitor how these changes affect the company's research and development pipeline and its ability to bring new, innovative treatments to market. 03/13/2024 - 04:01 PM  Net revenue of $91.5 million in the fourth quarter and $257.2 million in FY 2023   UDENYCA net sales of $36.2 million in the fourth quarter and $127.1 million in FY 2023   CIMERLI net sales of $52.4 million in the fourth quarter and $125.4 million in FY 2023   LOQTORZI and UDENYCA ONBODY successfully launched in Q1 2024   Reduction of work force of 30% for 2024 initiated on March 7, 2024   Conference call today at 5:00 p.m. Eastern Time  REDWOOD CITY, Calif., March 13, 2024 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (Coherus, Nasdaq: CHRS), today reported financial results for its fiscal fourth quarter and full year ended December 31, 2023 and recent business highlights: RECENT BUSINESS HIGHLIGHTS CORPORATE RESTRUCTURING SOLIDIFIES FOCUS ON ONCOLOGY On March 1, 2024, Coherus closed the divestiture of the ophthalmology franchise to Sandoz for upfront, all-cash consideration of $170 million plus an additional $17.8 million for CIMERLI product inventory and prepaid manufacturing assets.On or before April 1, 2024, Coherus plans to prepay $175 million of the $250 million principal balance of its term loan with Pharmakon Advisors LP (Pharmakon), leaving a residual balance of $75 million and reducing projected annualized Pharmakon related interest payments by about 70%.The sharpened focus in oncology and a subsequent restructuring is expected to result in a reduction in workforce of 30% by the end of 2024, including 35 employees associated with the ophthalmology divestiture, for an estimated annualized cost savings of more than $25 million.Expected SG&A and R&D expenses for 2024 reduced from $301.5 million in 2023 to $250-265 million representing at least a 12% decrease year over year.The $25 million toripalimab NPC approval milestone due to be paid to Junshi Biosciences in Q1 2024 has been restructured such that $12.5 million will be paid in Q2 2024 and the remainder in Q1 2025, potentially adjusted downward for proceeds from Canadian rights. UDENYCA RESULTS and ONBODY LAUNCH UPDATE UDENYCA net product sales increased 10% in the fourth quarter 2023 to $36.2 million compared to $33.0 million in the third quarter. Total unit demand grew 7% quarter over quarter. UDENYCA Autoinjector presentation unit demand grew 129% quarter over quarter. Since commercial launch in May 2023, more than 727 accounts have ordered the Autoinjector presentation.UDENYCA ONBODY, a novel and proprietary state-of-the-art delivery system for pegfilgrastim-cbqv, was launched in February 2024. High customer demand coupled with confirmed payer coverage, drove robust uptake with 138 accounts ordering ONBODY within the first four weeks of launch.Based on data from IQVIA, rolling 4-week UDENYCA market share as of March 1 was 26%. LOQTORZI LAUNCH UPDATE LOQTORZI is the first and only FDA-approved treatment for recurrent or metastatic NPC in all lines of therapy with commercial launch commencing on January 2, 2024.NCCN Guidelines recommend LOQTORZI as the only immunotherapeutic agent with Preferred Category 1 status in first-line treatment for adults with metastatic or recurrent locally advanced NPC in combination with chemotherapy; LOQTORZI monotherapy is also recommended in NCCN guidelines as the only preferred regimen in subsequent lines of therapy. Category 1 represents the highest level of evidence and uniformity among panel members in terms of agreement that translates into ease of reimbursement and the ability to establish a new standard of care for these patients.Payer coverage for LOQTORZI has been confirmed across Medicare Fee for Service, as well as national and regional commercial health plans.Early demand uptake tracking to expectations, with over 59 NPC targeted accounts ordering the product since launch. NOVEL IMMUNO-ONCOLOGY PIPELINE ADVANCES In January 2024, Coherus entered into a clinical collaboration with INOVIO to evaluate LOQTORZI (toripalimab-tpzi) in combination with INO-3112 in a Phase 3 clinical trial as a potential treatment for patients with locoregionally advanced, high-risk, HPV16/18 positive oropharyngeal squamous cell carcinoma (OPSCC), a type of head and neck cancer commonly known as throat cancer.Coherus presented new Phase 1b/2 clinical data for casdozokitug, a first-in-class IL-27 antagonist at the 2023 ESMO IO Congress in December and 2024 ASCO Gastrointestinal Cancers Symposium in January. Results show encouraging signs of antitumor activity and an acceptable safety profile for casdozokitug alone and in combination with PD-(L)1 inhibitors with or without bevacizumab in HCC and NSCLC respectively. Importantly, responses were associated with IL-27 related biomarkers and data support planned clinical trials with casdozokitug/ toripalimab-tpzi in NSCLC and HCC.New preclinical data for CHS-1000 has been selected for a poster presentation at the upcoming 2024 AACR Annual Meeting being held April 5-10, 2024, in San Diego.Coherus plans to file an Investigational New Drug (IND) application in second quarter of 2024 for CHS-1000, a novel ILT4-targeted antibody. Throughout 2023, Coherus demonstrated significant progress in transforming the Companys business model and product portfolio for long-term sustainable growth, said Denny Lanfear, Coherus Chairman and Chief Executive Officer. We are clearly focused on driving our revenues, reducing our costs, and advancing our pipeline, with constant attention to long-term shareholder value. The divestiture of CIMERLI and debt paydown improves our capital structure and sharpens our focus on oncology. With a robust portfolio of FDA-approved products and a promising immuno-oncology pipeline, we are now better positioned than ever to execute on our mission of extending the lives of cancer patients. FOURTH QUARTER and FULL YEAR 2023 FINANCIAL RESULTS Net revenue was $91.5 million during the three months ended December 31, 2023 and included $36.2 million of net sales of UDENYCA, $52.4 million of net sales of CIMERLI, $2.2 million of net sales of YUSIMRY which was launched in July 2023 and $0.6 million of net sales of LOQTORZI which began shipping to distributors in December 2023 in preparation for launch. Net revenue was $45.4 million during the three months ended December 31, 2022. For the twelve months ended December 31, 2023 and 2022, net revenue was $257.2 million and $211.0 million, respectively. The increases in total net revenues were driven by the launches of CIMERLI and YUSIMRY and by the return to growth of UDENYCA throughout 2023. Cost of goods sold (COGS) was $84.6 million and $14.2 million during the three months ended December 31, 2023 and 2022, respectively, and $159.0 million and $70.1 million during the full year ended December 31, 2023 and 2022, respectively. The increases in COGS for the three month and the annual periods each included a $47.0 million charge for the write-down of slow moving YUSIMRY inventory and the related partial recognition of certain firm purchase commitments. Increases in COGS also included $19.4 million and $47.5 million in royalty costs compared to the quarterly and annual periods in the prior year, respectively and increases in product costs of $11.5 million and $25.0 million, respectively, primarily driven by CIMERLI sales. The increase in the year over year COGS was partially offset by a $26.0 million write-down in the third quarter 2022 of inventory at risk of expiration and due to the sale in the second half 2023 of certain of those UDENYCA units having a total original cost of $9.9 million but no carrying value following the write-down. UDENYCA COGS includes a mid-single digit royalty on net sales payable through the first half of 2024, and CIMERLI COGS includes a low to mid 50% royalty on gross profits. Research and development (R&D) expense for the three months ended December 31, 2023 and 2022 was $26.4 million and $29.0 million, respectively. For the full year ended December 31, 2023 and 2022, R&D expense was $109.4 million and $199.4 million, respectively. The decline compared to the prior year periods primarily resulted from the reduction in scope of the toripalimab collaboration and from the recognition in the first quarter of 2022 of the $35.0 million option exercise fee paid to Junshi Biosciences to license CHS-006. R&D expense for the full year of 2022 also included development costs for additional presentations of UDENYCA and certain manufacturing expenses for YUSIMRY which began to be capitalized in mid-2022. Selling, general and administrative (SG&A) expense was $49.5 million and $53.6 million during the three months ended December 31, 2023 and 2022, respectively, and $192.0 million and $198.5 million during the full year ended December 31, 2023 and 2022, respectively. The decline in SG&A expense in both periods compared to the prior year periods primarily reflects lower headcount, partially offset by transaction costs associated with the Surface acquisition. Net loss for the fourth quarter of 2023 was $79.7 million, or $(0.71) per share on a basic and diluted basis, compared to a net loss of $58.9 million, or $(0.76) per share on a basic and diluted basis for the same period in 2022. Net loss for the full year of 2023 was $237.9 million, or $(2.53) per share on a basic and diluted basis, compared to a net loss of $291.8 million, or $(3.76) per share on a basic and diluted basis for the full year of 2022. Non-GAAP net loss for the fourth quarter of 2023 was $68.9 million, or $(0.62) per share on a basic and diluted basis, compared to non-GAAP net loss of $47.1 million, or $(0.60) per share on a basic and diluted basis for the same period in 2022. Non-GAAP net loss for the full year of 2023 was $186.2 million, or $(1.98) per share on a basic and diluted basis, compared to non-GAAP net loss of $234.8 million, or $(3.02) per share on a basic and diluted basis for the full year of 2022. See Non-GAAP Financial Measures below for a discussion on how Coherus calculates non-GAAP net loss and a reconciliation to the most directly comparable GAAP measures. Cash, cash equivalents and investments in marketable securities were $117.7 million as of December 31, 2023, compared to $191.7 million at December 31, 2022. 2024 R&D and SG&A Expense Guidance Coherus is introducing a guidance range of combined 2024 R&D and SG&A expenses from $250 to $265 million. This guidance includes approximately $40 million of stock-based compensation expense and excludes the effects of strategic acquisitions, collaborations or investments, the exercise of rights or options related to collaboration programs, and any other transactions or circumstances not yet identified or quantified. This guidance is subject to a number of risks and uncertainties. See Forward-Looking Statements described in the section below. Conference Call Information When: Wednesday, March 13, 2024, starting at 5:00 p.m. Eastern Time To access the conference call, please register through the following link to receive dial-in information and a personal PIN to access the live call: https://register.vevent.com/register/BI41e6b8f8ab024eefafe43493f6fd0cdf Please dial-in 15 minutes early to ensure a timely connection to the call. Webcast: https://edge.media-server.com/mmc/p/7c7bss7i An archived webcast will be available on the Investors section of the Coherus website at https://investors.coherus.com/events-presentations. About Coherus BioSciences Coherus is a commercial-stage biopharmaceutical company focused on the research, development and commercialization of innovative immunotherapies to treat cancer. Coherus is developing an innovative immuno-oncology pipeline that will be synergistic with its proven commercial capabilities in oncology. Coherus immuno-oncology pipeline includes multiple antibody immunotherapy candidates focused on enhancing the innate and adaptive immune responses to enable a robust immunologic response and enhance outcomes for patients with cancer. Casdozokitug is a novel anti-IL-27 antibody currently being evaluated in two ongoing clinical studies: a Phase 1/2 study in advanced solid tumors and a Phase 2 study in hepatocellular carcinoma. CHS-114 is a highly selective, competitively positioned, ADCC-enhanced anti-CCR8 antibody currently in a Phase 1/2 study as a monotherapy in patients with advanced solid tumors. CHS-1000 is a preclinical candidate targeting immune-suppressive mechanisms via the novel pathway ILT4 with an IND filing planned in the first half of 2024. Coherus markets LOQTORZI (toripalimab-tpzi), a novel next generation PD-1 inhibitor, UDENYCA (pegfilgrastim-cbqv), a biosimilar of Neulasta, and YUSIMRY (adalimumab-aqvh), a biosimilar of Humira. Neulasta is a registered trademark of Amgen, Inc. Humira is a registered trademark of AbbVie Inc. Forward-Looking Statements Except for the historical information contained herein, the matters set forth in this press release are forward-looking statements within the meaning of the ""safe harbor"" provisions of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements regarding Coherus ability to identify synergies between its I-O pipeline and its commercial operations; Coherus expected timing for filing an IND for CHS-1000; Coherus future projections for R&D expense and SG&A expense; Coherus expectations for timing, principal paid and interest payment reductions for its term loan with Pharmakon Advisors, LP; the size of the reduction of workforce in 2024; and Coherus expectations that it will be able to realize value in the future from its pipeline. Such forward-looking statements involve substantial risks and uncertainties that could cause Coherus actual results, performance or achievements to differ significantly from any future results, performance or achievements expressed or implied by the forward-looking statements. Such risks and uncertainties include, among others, the risks and uncertainties inherent in the clinical drug development process; risks related to Coherus existing and potential collaboration partners; risks of Coherus competitive position; the risks and uncertainties of the regulatory approval process, including the speed of regulatory review and the timing of Coherus regulatory filings; the risk of FDA review issues; the risks of competition; the risk that Coherus is unable to complete commercial transactions and other matters that could affect the availability or commercial potential of Coherus products and product candidates; and the risks and uncertainties of possible litigation. All forward-looking statements contained in this press release speak only as of the date of this press release. Coherus undertakes no obligation to update or revise any forward-looking statements. For a further description of the significant risks and uncertainties that could cause actual results to differ from those expressed in these forward-looking statements, as well as risks relating to Coherus business in general, see Coherus Annual Report on Form 10-K for the fiscal year ended December 31, 2023 filed with the Securities and Exchange Commission on or about the date of this press release, including the section therein captioned Risk Factors and in other documents Coherus files with the Securities and Exchange Commission. Coherus results for the fiscal year ended December 31, 2023 are not necessarily indicative of its operating results for any future periods. UDENYCA, UDENYCA ONBODY, YUSIMRY and LOQTORZI, whether or not appearing in large print or with the trademark symbol, are trademarks of Coherus, its affiliates, related companies or its licensors or joint venture partners unless otherwise noted. Trademarks and trade names of other companies appearing in this press release are, to the knowledge of Coherus, the property of their respective owners. Coherus Contact Information:For Investors:Jami TaylorHead of Investor RelationsIR@coherus.com For Media:Jodi SieversVP, Corporate Communicationsmedia@coherus.com Coherus BioSciences, Inc.Condensed Consolidated Statements of Operations(in thousands, except share and per share data)(unaudited) Three Months Ended Year Ended December 31, December 31, 2023 2022 2023 2022 Net revenue $91,524 $45,352 $257,244 $211,042 Costs and expenses: Cost of goods sold 84,567 14,202 158,992 70,083 Research and development 26,368 29,022 109,436 199,358 Selling, general and administrative 49,494 53,621 192,015 198,481 Total costs and expenses 160,429 96,845 460,443 467,922 Loss from operations (68,905) (51,493) (203,199) (256,880)Interest expense (10,619) (9,385) (40,542) (32,474)Loss on debt extinguishment    (6,222)Other income (expense), net (129) 2,008 5,469 3,822 Loss before income taxes (79,653) (58,870) (238,272) (291,754)Income tax provision (benefit)   (380)  Net loss $(79,653) $(58,870) $(237,892) $(291,754) Basic and diluted net loss per share $(0.71) $(0.76) $(2.53) $(3.76) Weighted-average number of shares used in computing basic and diluted net loss per share 111,492,596 77,955,769 94,162,637 77,630,020 Coherus BioSciences, Inc.Condensed Consolidated Balance Sheets(in thousands)(unaudited) December 31, December 31, 2023 2022 Assets Cash and cash equivalents $102,891 $63,547 Investments in marketable securities 14,857 128,134 Trade receivables, net 260,522 109,964 Inventory 130,100 115,051 Intangible assets, net 71,673 5,931 Other assets 49,561 58,220 Total assets $629,604 $480,847 Liabilities and Stockholders Deficit Accrued rebates, fees and reserve $169,645 $54,461 Term loans 246,481 245,483 Convertible notes 226,888 225,575 Other liabilities 180,015 92,746 Total stockholders' deficit (193,425) (137,418)Total liabilities and stockholders deficit $629, 604 $480,847 Coherus BioSciences, Inc.Condensed Consolidated Statements of Cash Flows(in thousands)(unaudited) Three Months Ended Year Ended December 31, December 31, 2023 2022 2023 2022 Cash, cash equivalents and restricted cash at beginning of the period $80,711 $287,245 $63,987 $417,635 Net cash used in operating activities (12,937) (99,953) (174,884) (241,124) Purchases of investments in marketable securities  (127,382) (19,507) (127,382)Proceeds from maturities of investments in marketable securities 36,212  144,360  Proceeds from sale of investments in marketable securities   13,282  Cash and cash equivalents acquired from Surface Acquisition   6,997  Option payment to Junshi Biosciences    (35,000)Milestone based license fee payments (1,051) (2,429) (1,051) (2,429)Other investing activities, net 42 (87) 559 (2,039)Net cash provided by (used in) investing activities 35,203 (129,898) 144,640 (166,850) Proceeds from 2027 Term Loans, net of debt discount & issuance costs    240,679 Proceeds from issuance of common stock under ATM Offering, net of issuance costs (105) 6,358 18,093 6,358 Proceeds from issuance of common stock under Public Offering, net of issuance costs   53,625  Proceeds from issuance of common stock upon exercise of stock options 524 60 694 691 Proceeds from purchase under the employee stock purchase plan 472 665 1,809 2,320 Taxes paid related to net share settlement (326) (123) (3,587) (3,744)Repayment of 2022 Convertible Notes and premiums    (109,000)Repayment of 2025 Term Loan, premiums and exit fees    (81,750)Other financing activities (199) (367) (1,034) (1,228)Net cash provided by financing activities 366 6,593 69,600 54,326 Net increase (decrease) in cash, cash equivalents and restricted cash 22,632 (223,258) 39,356 (353,648) Cash, cash equivalents and restricted cash at end of the period $103,343 $63,987 $103,343 $63,987 Reconciliation of cash, cash equivalents, and restricted cash Cash and cash equivalents $102,891 $63,547 $102,891 $63,547 Restricted cash balance 452 440 452 440 Cash, cash equivalents and restricted cash $103,343 $63,987 $103,343 $63,987 Non-GAAP Financial Measures To supplement the financial results presented in accordance with GAAP, Coherus has also included in this press release non-GAAP net loss, and the related per share measures, which exclude from net loss, and the related per share measures, stock-based compensation expense, certain acquisition-related expenses, amortization of intangible assets, contingent consideration, loss on debt extinguishment and restructuring charges related to our reduction in workforce. These non-GAAP financial measures are not prepared in accordance with GAAP, do not serve as an alternative to GAAP and may be calculated differently than similar non-GAAP financial information disclosed by other companies. Coherus encourages investors to carefully consider its results under GAAP, as well as its supplemental non-GAAP financial information and the reconciliation between these presentations set forth below, to more fully understand Coherus business. Coherus believes that the presentation of these non-GAAP financial measures provides useful supplemental information to, and facilitates additional analysis by, investors. In particular, Coherus believes that these non-GAAP financial measures, when considered together with its financial information prepared in accordance with GAAP, can enhance investors and analysts ability to meaningfully compare Coherus results from period to period, and to identify operating trends in Coherus business. Coherus also regularly uses these non-GAAP financial measures internally to understand, manage and evaluate its business and to make operating decisions. Coherus BioSciences, Inc.Reconciliation of GAAP Net Loss to Non-GAAP Net Loss(in thousands, except share and per share data)(unaudited) Three Months Ended Year Ended December 31, December 31, 2023 2022 2023 2022 GAAP net loss $(79,653) $(58,870) $(237,892) $(291,754)Adjustments: Stock-based compensation expense(1) 10,797 11,726 42,161 50,737 Loss on debt extinguishment    6,222 Restructuring charges related to reduction in workforce(1)   4,876  Acquisition-related costs(2) 545  5,093  Contingent consideration (920)  (920)  Amortization of intangible assets 313  456  Non-GAAP net loss $(68,918) $(47,144) $(186,226) $(234,795) GAAP net loss per share, basic and diluted $(0.71) $(0.76) $(2.53) $(3.76)Non-GAAP net loss per share, basic and diluted $(0.62) $(0.60) $(1.98) $(3.02)Shares used in computing basic and diluted net loss per share 111,492,596 77,955,769 94,162,637 77,630,020 (1) In the year ended December 31, 2023, stock-based compensation of $1.0 million was classified within Restructuring charges related to reduction in workforce. (2) Beginning in the third quarter of 2023, the Company began excluding acquisition-related costs in its non-GAAP financial information. To conform to this change, $1.9 million of acquisition-related costs incurred during the quarter ended June 30, 2023 has been excluded from SG&A expense for the year ended December 31, 2023. What was Coherus BioSciences' net revenue in Q4 2023? Coherus BioSciences reported a net revenue of $91.5 million in Q4 2023. How much were UDENYCA net sales in Q4? UDENYCA net sales reached $36.2 million in Q4. What corporate restructuring did Coherus undertake recently? Coherus divested its ophthalmology franchise to Sandoz for $170 million. When did Coherus initiate a workforce reduction for 2024? Coherus initiated a 30% workforce reduction on March 7, 2024. What is Coherus' plan regarding its term loan with Pharmakon Advisors LP? Coherus plans to prepay $175 million of the $250 million term loan balance by April 1, 2024."
"VPT Announces Release of the New 1600W, GaN-based SGRBX DC-DC Converter",2024-03-13T18:07:00.000Z,Low,Neutral,"VPT, Inc., a HEICO company, introduces the SGRBX, a configurable box solution with GaN technology, offering up to 1600 watts of output power. The SGRBX features low noise, integrated EMI filter, high efficiency up to 96%, and radiation-hardened design for space applications.","VPT Announces Release of the New 1600W, GaN-based SGRBX DC-DC Converter Rhea-AI Impact (Low) Rhea-AI Sentiment (Neutral) Tags Rhea-AI Summary VPT, Inc., a HEICO company, introduces the SGRBX, a configurable box solution with GaN technology, offering up to 1600 watts of output power. The SGRBX features low noise, integrated EMI filter, high efficiency up to 96%, and radiation-hardened design for space applications. Positive None. Negative None. Electrical Engineer The introduction of VPT Inc.'s SGRBX configurable box solution represents a significant advancement in power conversion technology for space applications. The use of GaN (Gallium Nitride) technology is a notable development, as GaN is known for its high efficiency and ability to handle higher voltages and temperatures compared to traditional silicon-based technologies. This translates to power converters that are not only more efficient but also more reliable and suitable for the harsh conditions of space.The SGRBX's capability to deliver up to 1600 watts of output power and its scalability through paralleling multiple units to achieve even higher power levels is a testament to its versatility. The integration of an EMI filter and its radiation-hardened design, which includes guaranteed Total Ionizing Dose (TID) performance and Single Event Effects (SEE) performance, ensures that the SGRBX meets the stringent requirements of commercial, scientific and military space missions. This could potentially lead to increased demand for VPT's products in the space sector, impacting the company's market share and revenue in this niche market. Market Research Analyst From a market perspective, the release of the SGRBX could position VPT and by extension HEICO, as a leader in the space-rated power conversion market. The emphasis on high efficiency and low noise is particularly relevant for space applications where power efficiency is critical due to limited energy resources. As space exploration and commercial space ventures continue to grow, the demand for advanced components that can withstand space conditions is expected to rise. VPT's innovation in this area may give it a competitive edge and could be a driver for growth, potentially affecting HEICO's stock performance.It is also important to note that the space technology market is subject to stringent regulations and export license restrictions. As such, VPT's ability to navigate these regulations successfully will be crucial in determining the global reach and adoption of the SGRBX. The announcement of the immediate availability of the SGRBX for sale suggests a readiness to meet market demand, which could have positive implications for the company's short-term sales performance. Financial Analyst Analyzing the financial implications, the development and release of a new product like the SGRBX can lead to substantial R&D expenses. However, these costs are often offset by the potential for significant returns on investment in the high-margin aerospace and defense industry. The SGRBX's unique selling points, such as its radiation-hardened design and high efficiency, are likely to appeal to a wide range of customers within the space sector.Investors should monitor the adoption rate of the SGRBX post-release, as initial sales figures will provide valuable insights into the product's market acceptance. A successful launch, coupled with strong sales, could positively influence HEICO's financial performance and stock price. Conversely, any production or regulatory setbacks could hinder expected revenues and should be watched closely by stakeholders. 03/13/2024 - 02:07 PM BLACKSBURG, Va., March 13, 2024 /PRNewswire/ -- VPT, Inc., a HEICO company (NYSE:HEI.A) (NYSE: HEI), announces the release of the first-ever configurable box solution featuring state-of-the-art GaN technology: the SGRBX. Housing up to four award-winning SGRB DC-DC converter slices within its framework, the SGRBX delivers up to 1600 watts of output power. Utilizing the SGRB's advanced fixed frequency, reduced voltage switching topology, the SGRBX has extremely low input and output noise. In addition, the SGRBX features an integrated EMI filter, guaranteed TID performance to 100 krad(Si) including ELDRS, SEE performance to 85 MeV/mg/cm2, and high efficiency up to 96%. Multiple SGRBX boxes can be paralleled to reach higher power levels depending on program requirements. A technology-leading solution for space-rated DC-DC power conversion, the SGRB Series, including the SGRBX have been designed to thrive in the most demanding commercial, scientific, and military space environments. With GaN-based technology, its radiation hardened design ensures long-term reliability, making it the perfect choice for a wide range of space applications that require high efficiency and low noise. ""The SGRBX was developed to give our customers access to the same GaN-based technology found in our award-winning SGRB Series, but for applications that require significantly higher power levels."" VPT's Engineering Manager, John Evans, said. ""Leveraging VPT's extensive space flight heritage and proven performance, the SGRBX ensures high-reliability performance for the most demanding space missions."" ""We are pleased to announce the latest addition to our GaN-based SGRB Series with the SGRBX. Designed with our customer's needs in mind, this configurable solution allows users to parallel various SGRB units, tailoring output voltages and power levels to meet specific application requirements."" VPT's Vice President of North American Sales, Paul Andersen stated. ""It is the perfect choice for programs where high efficiency and low noise are imperative, such as space payloads, primary spacecraft bus, and space station applications. This marks another step in VPT's ongoing commitment to innovation within the GaN space. There will be more to come."" VPT is formally introducing the SGRBX at Satellite 2024 March 18th-21st in Washington, DC, featuring an SGRBX demo box solution at VPT's booth, #2755. The SGRBX is available for immediate sale. Sales are subject to all applicable U.S. export license restrictions and regulations. Additional information can be obtained by contacting a local VPT distributor. About VPT and HEICOVPT, Inc., part of the HEICO Electronic Technologies Group, is a global provider of innovative DC-DC power converters, EMI filters, and custom engineering services for avionics, military, space, and industrial applications. Every day, organizations like NASA, Lockheed Martin, Boeing, BAE Systems, Thales, and many more depend on high-reliability solutions from VPT to power critical systems. For more information about VPT, please visit www.vptpower.com. HEICO Corporation (NYSE:HEI.A) (NYSE:HEI) is engaged primarily in niche segments of the aviation, defense, space, and electronics industries through its Hollywood, FL based HEICO Aerospace Holdings Corp. subsidiary and its Miami, FL-based HEICO Electronic Technologies Corp. subsidiary. For more information about HEICO, please visit www.heico.com. Products described in this communication are subject to all export license restrictions and regulations which may include but are not limited to ITAR (International Traffic in Arms Regulations) and the Export Administration and Foreign Assets Control Regulations. Further restrictions may apply. The information provided is considered accurate at time of publication, errors or omissions excepted. VPT, Inc. reserves the right to make changes to products or services without prior notification and advises customers to obtain the latest version of all relevant technical information from VPT to verify data prior to placing orders. VPT, its logo and tagline are registered trademarks in the U.S. Patent and Trademark Office. All other names, product names and trade names may be trademarks or registered trademarks of their respective holders. View original content to download multimedia:https://www.prnewswire.com/news-releases/vpt-announces-release-of-the-new-1600w-gan-based-sgrbx-dc-dc-converter-302088406.html SOURCE VPT, Inc. What is the latest product announced by VPT, Inc.? The latest product announced by VPT, Inc. is the SGRBX, a configurable box solution featuring state-of-the-art GaN technology. What is the output power delivered by the SGRBX? The SGRBX delivers up to 1600 watts of output power. What are the key features of the SGRBX? The key features of the SGRBX include low input and output noise, integrated EMI filter, high efficiency up to 96%, and radiation-hardened design for space applications. Where can the SGRBX be seen for demonstration? The SGRBX can be seen for demonstration at VPT's booth, #2755, during Satellite 2024 in Washington, DC. When will the SGRBX be formally introduced? The SGRBX will be formally introduced at Satellite 2024 on March 18th-21st in Washington, DC."
Andean Precious Metals Announces Filing of Articles of Continuance,2024-03-13T18:07:00.000Z,Neutral,Neutral,"Andean Precious Metals Corp. (ANPMF) has filed articles of continuance to move from British Columbia to Ontario, effective March 8, 2024. The Continuance was approved at a shareholder meeting in August 2023. Details are outlined in the management information circular available on SEDAR+.","Andean Precious Metals Announces Filing of Articles of Continuance Rhea-AI Impact (Neutral) Rhea-AI Sentiment (Neutral) Tags Rhea-AI Summary Andean Precious Metals Corp. (ANPMF) has filed articles of continuance to move from British Columbia to Ontario, effective March 8, 2024. The Continuance was approved at a shareholder meeting in August 2023. Details are outlined in the management information circular available on SEDAR+. Positive None. Negative None. 03/13/2024 - 02:07 PM Toronto, Ontario--(Newsfile Corp. - March 13, 2024) - Andean Precious Metals Corp. (TSXV: APM) (OTCQX: ANPMF) (""Andean"" or the ""Company"") today announced that the Company has filed articles of continuance to continue out of the jurisdiction of the Business Corporations Act (British Columbia) and into the jurisdiction of the Business Corporations Act (Ontario), effective March 8, 2024 (the ""Continuance""). The Continuance was approved at the Company's annual general and special meeting of shareholders held on August 31, 2023. The principal effects of the Continuance are detailed in the management information circular dated July 19, 2023. The management information circular and constating documents of the Company following the Continuance are available under the Company's profile on SEDAR+ (www.sedarplus.ca).About Andean Precious Metals Corp.Andean is a growing precious metals producer focused on top-tier jurisdictions in the Americas. The Company owns and operates the San Bartolom processing facility in Potos, Bolivia and the Soledad Mountain mine in Kern County, California, and is well-funded to act on future growth opportunities. Andean's leadership team is committed to creating value; fostering safe, sustainable and responsible operations; and achieving our ambition to be a mid-tier precious metals producer. For more information, please contact:Trish Moran VP Investor Relationstmoran@andeanpm.comT: +1 416 564 4290 Neither the TSX Venture Exchange, Inc. nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.To view the source version of this press release, please visit https://www.newsfilecorp.com/release/201603 When did Andean Precious Metals Corp. file articles of continuance? Andean Precious Metals Corp. filed articles of continuance on March 8, 2024. Where is Andean Precious Metals Corp. moving to? Andean Precious Metals Corp. is moving from British Columbia to Ontario. When was the Continuance approved? The Continuance was approved at the Company's annual general and special meeting of shareholders held on August 31, 2023. Where can the management information circular following the Continuance be found? The management information circular and constating documents of the Company following the Continuance are available under the Company's profile on SEDAR+ (www.sedarplus.ca)."
Avila Energy Announces Change in Auditor and Appointment on New CFO,2024-03-13T18:30:00.000Z,Moderate,Neutral,"Avila Energy Corporation appoints KMSS as independent auditor and Donica Ingot-Candia as new CFO. KMSS replaces WDM as auditors effective March 5, 2024. Ms. Igot-Candia brings over ten years of finance and leadership experience.","Avila Energy Announces Change in Auditor and Appointment on New CFO Rhea-AI Impact (Moderate) Rhea-AI Sentiment (Neutral) Tags Rhea-AI Summary Avila Energy Corporation appoints KMSS as independent auditor and Donica Ingot-Candia as new CFO. KMSS replaces WDM as auditors effective March 5, 2024. Ms. Igot-Candia brings over ten years of finance and leadership experience. Positive None. Negative None. 03/13/2024 - 02:30 PM CALGARY, AB / ACCESSWIRE / March 13, 2024 / Avila Energy Corporation (""AVILA"" or the ""Company"") announces that it has appointed Kenway Mack Slusarchuk Stewart LLP Chartered Professional Accountants (""""KMSS"") as the Company's independent auditor to hold office until the next Annual General Meeting of Shareholders.Change in auditor.Effective March 5, 2024, at the request of the Company, Avila's predecessor WDM Chartered Professional Accountants (""WDM"") resigned as auditors and KMSS was appointed to fill their vacancy for the fiscal year ended December 31, 2023.In accordance with the requirements of National Instrument 51-102, a notice of change in auditor (""Notice of Change"") dated March 5,2024, with an effective date of March 5, 2024, was sent to KMSS and WDM, each of whom have provided a letter confirming their agreement with the statement in the Notice of Change.Appointment of new Chief Financial OfficerThe Company is also pleased to announce the appointment of Donica Ingot-Candia, CPA (Philippines) as Avila's new Chief Financial Officer.Ms. Igot-Candia brings over ten years of combined experience in finance and leadership experience. She was formerly a controller with a private Company in Calgary Alberta and has held various accounting positions with companies in the Philippines. Her areas of expertise include corporate finance, M&A, modeling, capital markets, financial reporting, and strategic planning.About Avila Energy CorporationThe Company is an emerging CSE listed corporation trading under the symbol (VIK'), and in combination with an expanding portfolio of 100% Owned and Operated oil and natural gas production, pipelines and facilities is a licensed producer, explorer, and developer of Energy in Canada. The Company's long-term vision is to achieve through the implementation of a closed system of carbon capture and sequestration, an established path towards the material reduction of Tier 1, Tier 2 and Tier 3 emissions and continues to work towards becoming a vertically integrated Carbon Neutral Energy Producer. The Company's goals are to be achieved by focusing on the application of proven geological, geophysical, engineering, and production techniques in combination with the delivery of Direct-to Consumer energy sales to both residential and commercial consumers.For further information, please contact: Leonard B. Van Betuw, President & CEO leonard.v@avilaenergy.com Peter Nesveda, Investor Relations, International peter@intuitiveaustralia.com.auON BEHALF OF THE BOARDLeonard B. Van BetuwPresident & CEOContact Phone Number: 1-403-451-2786Abbreviationsbbls/d - barrels per dayBOE/d- barrels oil equivalent per day NGLs - Natural Gas LiquidsMboe - Thousands of barrels of oil equivalent MMboe - Millions of barrels of oil equivalent PDP - Proved Developed ProducingTP - Total Proved ReservesTPP - Total Proved and Probable ReservesIFRS - International Financial Reporting Standards as issued by the International Accounting Standards BoardWTI - West Texas Intermediate, the reference price paid in U.S. dollars at Cushing, Oklahoma for the crude oil standard gradeForward-Looking Information & Forward-Looking Statements Cautionary StatementCertain information in this news release, including the operations at the Company's properties, constitute forward-looking statements under applicable securities laws. Although Avila Energy Corporation believes that the expectations reflected in these forward-looking statements are reasonable, undue reliance should not be placed on them because Avila Energy Corporation can give no assurance that they will prove to be correct. Since forward-looking statements address future events and conditions, by their very nature they involve inherentrisks and uncertainties. The forward-looking statements contained in this news releaseare made as at the date of this news release and the Company does not undertake any obligation to update publicly or to revise any of the included forward-looking statements, whether as a resultof new information, future eventsor otherwise, exceptas may be required by applicable securities laws. This release includescertain statements that may be deemed ""forward-looking statements."" All statements in this release, other than statements of historical facts, that address future production, reserve potential, exploration drilling, exploitation activities and eventsor developments that the Companyexpects are forwardlooking statements. Although the Company believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and actual resultsor developments may differ materially from those in the forward-looking statements. Factors that could cause actual results to differ materially from those in forward looking statements include market prices, exploitation, and exploration successes, continued availability of capital and financing, and general economic, market or business conditions. It should not be assumed that theestimates of net present value of future net revenue attributable to the Company'sreserves presented aboverepresent the fair market value of the reserves. The recovery and reserve estimates of the Company's oil, NGL, and natural gas reserves provided herein are estimates only and there is no guarantee that the estimated reserves will be recovered. Further, there is no assurance that the forecast prices and cost assumptions will be attained, and variances couldbe material. Investors are cautioned that any such statements are not guarantees of future performance and those actualresults or developments may differ materially from those projected in the forward-looking statements. Barrel(""bbl"") of oil equivalent (""boe"") amounts may be misleading particularly if used in isolation. All boe conversions in this report are calculated using a conversion of six thousand cubic feet of natural gas to one equivalent barrel of oil (6 mcf=1 bbl) and is based on an energyconversion method primarily applicable at the burner tip and does not represent a value equivalency at the well head. This news release shall not constitute an offer to sell or the solicitation of any offer to buy, nor shall there be any sale of these securities in any jurisdiction in which such offer, solicitation or sale would be unlawful. The securities offered have not been and will not be registered under the U.S. Securities Act of 1933, as amended,and may not be offeredor sold in the United States absent registration or applicable exemption from the registration requirements of the U.S. Securities Act and applicable state securities laws. Trading in the securities of Avila Energy Corporation should be considered highly speculative. Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Stock Exchange) accepts responsibility for the adequacy or accuracy of this release. For more information on the Company, Investors should review the Company's registered filings which are available at www.sedarplus.ca.SOURCE: Avila Energy CorporationView the original press release on accesswire.com Who is the new independent auditor appointed by Avila Energy Corporation? Avila Energy Corporation has appointed Kenway Mack Slusarchuk Stewart LLP Chartered Professional Accountants (KMSS) as the new independent auditor. When did Avila Energy Corporation make the change in auditors? Avila Energy Corporation made the change in auditors effective March 5, 2024, replacing WDM Chartered Professional Accountants with KMSS. Who is the new Chief Financial Officer of Avila Energy Corporation? Donica Ingot-Candia, CPA (Philippines), is the new Chief Financial Officer of Avila Energy Corporation. What is Donica Ingot-Candia's background and experience? Donica Ingot-Candia brings over ten years of combined experience in finance and leadership. She has held various accounting positions with companies in the Philippines and was formerly a controller with a private Company in Calgary Alberta."
CORRECTION: Hypercharge Selected by Trotman Auto Group for DC Fast Charging Stations in Metro Vancouver,2024-03-13T18:11:00.000Z,No impact,Neutral,"Hypercharge Networks Corp. partners with Trotman Auto Group to install DC fast charging stations at three dealerships in British Columbia, Canada, aiming to promote EV adoption.","CORRECTION: Hypercharge Selected by Trotman Auto Group for DC Fast Charging Stations in Metro Vancouver Rhea-AI Impact (No impact) Rhea-AI Sentiment (Neutral) Tags Rhea-AI Summary Hypercharge Networks Corp. partners with Trotman Auto Group to install DC fast charging stations at three dealerships in British Columbia, Canada, aiming to promote EV adoption. Positive None. Negative None. 03/13/2024 - 02:11 PM Early Adopter of Dealership Charging Solutions Continues Support of EV AdoptionThis press release is being re-issued to correct and replace the press release that was issued earlier today. The text of the ticker was inadvertently changed from the original Cboe CA: HC to CBOE: HC. No other changes were required in the body of the release. The corrected press release follows in full below:Vancouver, British Columbia--(Newsfile Corp. - March 13, 2024) - Hypercharge Networks Corp. (Cboe CA: HC) (OTCQB: HCNWF) (FSE: PB7) (the ""Company"" or ""Hypercharge""), a leading, smart electric vehicle (EV) charging solutions provider, today announced it has signed an agreement with the Trotman Auto Group (""TAG""), an industry-leading, diversified dealer group, to supply three DC fast charging stations at three of its dealerships in the Lower Mainland of British Columbia, Canada.Recognized as one of the most innovative dealer groups in Canada, Trotman Auto Group is an industry-leading, diversified dealer group representing 12 major original equipment manufacturer (OEM) brands across 11 dealerships located across British Columbia.Under the agreement, one of Hypercharge's Preferred Partners, Nightingale Electrical Ltd., will install three 200kW DC fast charging stations at TAG's Abbotsford Chrysler, Langley Chrysler, and Mainland Ford dealerships, with installation due to be completed in Q2 2024.""Our collaboration with TAG is part of their ongoing strategy and leadership to help promote greater EV and hybrid adoption by offering fast, convenient, and reliable charging stations at its dealerships throughout British Columbia,"" said Chris Koch, Head of Growth & Partnerships at Hypercharge. ""Our ability to provide Level 2 and DC fast charging stations, networking services, carbon credits, and assistance with rebate programs continues to provide us opportunities to work with pioneering auto groups like TAG to serve customers and communities. We look forward to continuing our work with TAG to make EV charging faster and more convenient for consumers in British Columbia, and drive the adoption of zero emission vehicles.""About HyperchargeHypercharge Networks Corp. (Cboe CA: HC) (OTCQB: HCNWF) (FSE: PB7) is a leading provider of smart electric vehicle (EV) charging solutions that offers turnkey technology to residential and commercial buildings, fleet operations, and other rapidly growing sectors. Driven by its mission to accelerate EV adoption and enable the shift towards a carbon neutral economy, Hypercharge is committed to providing seamless, simple charging solutions by offering industry-leading equipment and a robust network of public and private charging stations. Learn more: https://hypercharge.com/. On behalf of the company,Hypercharge Networks Corp.David Bibby, President & CEO ContactsInvestor Relations:Chris Tyson | Executive Vice President | MZ GroupHC@mzgroup.us | (949) 491-8235Media Contact:Kyle Kingsnorth | Head of Marketing | Hyperchargekyle.kingsnorth@hypercharge.comForward-Looking StatementsThis news release contains forward-looking statements and forward-looking information (collectively, ""forward-looking statements"") within the meaning of applicable securities laws. Any statements that are contained in this news release that are not statements of historical fact may be deemed to be forward-looking statements. Forward-looking statements are often identified by terms such as ""may"", ""should"", ""anticipate"", ""will"", ""estimates"", ""believes"", ""intends"", ""expects"" and similar expressions which are intended to identify forward-looking statements. More particularly and without limitation, this news release contains forward-looking statements regarding the expected installation of EV charging stations, contractual performance, and expected growth rates and trends in the EV market. Forward-looking statements are inherently uncertain, and the actual performance may be affected by a number of material factors, assumptions and expectations, many of which are beyond the control of the Company. Readers are cautioned that assumptions used in the preparation of any forward-looking statements may prove to be incorrect. Events or circumstances may cause actual results to differ materially from those predicted as a result of numerous known and unknown risks, uncertainties and other factors, many of which are beyond the control of the Company. Readers are further cautioned not to place undue reliance on any forward-looking statements, as such information, although considered reasonable by management of the Company at the time of preparation, may prove to be incorrect and actual results may differ materially from those anticipated.The forward-looking statements contained in this news release are made as of the date of this news release, and are expressly qualified by the foregoing cautionary statement. Except as expressly required by securities law, the Company undertakes no obligation to update publicly or to revise any of the included forward-looking statements, whether as a result of new information, future events or otherwise.Neither NEO Exchange Inc. nor its Market Regulator (as that term is defined in policies of NEO Exchange Inc.) accepts responsibility for the adequacy or accuracy of this news release.To view the source version of this press release, please visit https://www.newsfilecorp.com/release/201473 What is the partnership about between Hypercharge Networks Corp. and Trotman Auto Group? The partnership involves installing three 200kW DC fast charging stations at TAG's Abbotsford Chrysler, Langley Chrysler, and Mainland Ford dealerships in British Columbia, Canada. When will the installation of the charging stations be completed? The installation is scheduled to be completed in Q2 2024. What services will Hypercharge provide as part of the agreement? Hypercharge will provide Level 2 and DC fast charging stations, networking services, carbon credits, and assistance with rebate programs. What is the goal of the collaboration between Hypercharge Networks Corp. and Trotman Auto Group? The goal is to promote greater EV and hybrid adoption by offering fast, convenient, and reliable charging stations at TAG's dealerships in British Columbia. Who is the Head of Growth & Partnerships at Hypercharge Networks Corp.? Chris Koch is the Head of Growth & Partnerships at Hypercharge Networks Corp."
International Womens Day: Meet MPC Engineering Director Jeannette Jones,2024-03-13T18:45:00.000Z,Low,Positive,"MPC Engineering Director Jeannette Jones shares insights on International Women's Day in Denver, Colorado.","International Womens Day: Meet MPC Engineering Director Jeannette Jones Rhea-AI Impact (Low) Rhea-AI Sentiment (Positive) Tags Rhea-AI Summary MPC Engineering Director Jeannette Jones shares insights on International Women's Day in Denver, Colorado. Positive None. Negative None. 03/13/2024 - 02:45 PM In celebration of International Women's Day, hear from MPC Engineering Director Jeannette Jones in our Denver, Colorado, office on what excites her about her role and working in the energy industry and why more women should consider careers in engineeringNORTHAMPTON, MA / ACCESSWIRE / March 13, 2024 / Marathon Petroleum Corporation How she got started in engineeringJeannette earned a bachelor's degree in chemical and petroleum refining with a minor in environmental science from the Colorado School of Mines. She has nearly 30 years of engineering experience. ""I was the first in my family to attend college,"" she shared. ""My dad had an eighth-grade education, and my mom had a high school education, but they both knew the value of a college degree and strongly encouraged me to go to school and pursue a great career,"" she continued. ""My cousin also attended Colorado School of Mines, which influenced my decision to become an engineer, too.""What excites her about her role and the energy industryIn her role at MPC, she is responsible for identifying and driving the strategic vision of the technical services team to help execute the business plans of MPLX Gathering & Processing (G&P). ""What excites me the most about my role is getting to work with a group of engineers with diverse technical backgrounds, all coming together to support the technical operations of G&P,"" she shared. ""It's a lot of fun working with such a great team of people.""Jeannette also shared what excites her about the energy industry. ""Energy is a vital resource that makes people's lives better. The industry is always evolving through technological advancements, and we're continuing to find efficient ways to produce energy while protecting the environment. I'm excited to be part of the energy industry and enjoy attending conferences and networking with other experts in the sector and bringing those learnings back to my team.""Her perspective on why more women should consider a career in engineering""I'd encourage women to consider a career in engineering because there are many different types of engineering roles to explore. Engineers are often well compensated, and it's a lot of fun,"" she shared. ""Women also bring unique perspectives and experiences to the role to help strengthen companies and teams.""In 2020, women made up only 14 percent of the U.S. engineering workforce according to the Society of Women Engineers. ""I think engineering can oftentimes be portrayed as getting dirty and wearing steel-toed boots and hard hats, but if we're going to draw more middle school and high school girls into engineering and other STEM fields, we have to show them why it's fun,"" she shared.From an early age, Jeannette's parents gave her hands-on learning toys and encouraged STEM activities to show her that STEM learning can be fun. ""I recall playing with Lincoln Logs and engaging in activities where science meets nature, such as collecting rocks and growing crystals,"" she shared. ""My husband and I did the same for our children when they were younger by giving them old toolboxes and encouraging them to fix things or build things for their toys, whether it was a ramp for their Hot Wheels or a ramp for their Barbie doll to walk across the red carpet,"" she continued. ""We wanted them to know that problems can be fixed and problem-solving can be fun.""Her advice to women engineers who are early in their career""I'd encourage women engineers who are early in their career to believe in themselves and don't be afraid to fail. I'd also encourage them to find mentors that they can learn from and know that they don't have to have all the answers. It's okay to ask questions, learn and ask for help when needed.""Her involvement in MPC's Women's employee networkJeannette is a leader of our Women's employee network chapter in Denver, Colorado. ""Our Women's employee network chapter helps support the company's goals and provides women an opportunity to network with other MPC employees,"" she shared. ""Our network also supports leadership development opportunities and is a place for women and allies to share their personal and professional experiences. I'm excited about our network's momentum and would encourage employees to get involved in their local chapter.""Explore career opportunities at MPC.View additional multimedia and more ESG storytelling from Marathon Petroleum Corporation on 3blmedia.com.Contact Info:Spokesperson: Marathon Petroleum CorporationWebsite: https://www.3blmedia.com/profiles/marathon-petroleum-corporationEmail: info@3blmedia.comSOURCE: Marathon Petroleum CorporationView the original press release on accesswire.com Who is the MPC Engineering Director featured in the press release? Jeannette Jones Where is Jeannette Jones based? Denver, Colorado What event is being celebrated in the press release? International Women's Day What does Jeannette Jones do at MPC? Engineering Director What insights does Jeannette Jones share in the press release? Insights on International Women's Day"
DXC Technology Recognized as Leader in 2024 Gartner Magic Quadrant for Outsourced Digital Workplace Services,2024-03-13T16:30:00.000Z,No impact,Positive,"DXC Technology has been recognized by Gartner as a Leader in the Magic Quadrant for Outsourced Digital Workplace Services. The evaluation highlighted DXC's Modern Workplace Services, including Modern Device Management and Intelligent Collaboration. Andrew Wilson, General Manager, expressed pride in this recognition, emphasizing investments in AI-powered workplace solutions.","DXC Technology Recognized as Leader in 2024 Gartner Magic Quadrant for Outsourced Digital Workplace Services Rhea-AI Impact (No impact) Rhea-AI Sentiment (Positive) Tags Rhea-AI Summary DXC Technology has been recognized by Gartner as a Leader in the Magic Quadrant for Outsourced Digital Workplace Services. The evaluation highlighted DXC's Modern Workplace Services, including Modern Device Management and Intelligent Collaboration. Andrew Wilson, General Manager, expressed pride in this recognition, emphasizing investments in AI-powered workplace solutions. Positive None. Negative None. 03/13/2024 - 12:30 PM Recognized for Completeness of Vision and Ability to Execute ASHBURN, Va., March 13, 2024 /PRNewswire/ - DXC Technology (NYSE: DXC), a leading Fortune 500 global technology services provider, today announced it has been positioned by Gartner as a Leader in the Magic Quadrant for Outsourced Digital Workplace Services. The evaluation was based on specific criteria that analysed the company's overall completeness of vision and ability to execute. DXC's Modern Workplace Services include Modern Device Management, Digital Support Services, Intelligent Collaboration and Workplace Asset Management, all of which are underpinned by our Experience Platform DXC UPtime. ""We're proud to be recognized by Gartner as a Leader in the Magic Quadrant for another year,"" said Andrew Wilson, General Manager, Modern Workplace, DXC Technology. ""We believe this recognition reinforces our investments in the AI-powered, experience centric workplace and in our DXC UPtime platform. We are excited to bring this innovation to both our existing and new customers as we move forward."" Magic Quadrant reports are a culmination of rigorous, fact-based research in specific markets, providing a wide-angle view of the relative positions of the providers in markets where growth is high and provider differentiation is distinct. Providers are positioned into four quadrants: Leaders, Challengers, Visionaries and Niche Players. The research enables you to get the most from market analysis in alignment with your unique business and technology needs. View a complimentary copy of the Magic Quadrant report to learn more about DXC's strengths and cautions, among other provider offerings. Gartner DisclaimerGartner does not endorse any vendor, product or service depicted in our research publications, and does not advise technology users to select only those vendors with the highest ratings or other designation. Gartner research publications consist of the opinions of Gartner research organization and should not be construed as statements of fact. Gartner disclaims all warranties, expressed or implied, with respect to this research, including any warranties of merchantability or fitness for a particular purpose. About DXC TechnologyDXC Technology (NYSE: DXC) helps global companies run their mission-critical systems and operations while modernizing IT, optimizing data architectures, and ensuring security and scalability across public, private, and hybrid clouds. The world's largest companies and public sector organizations trust DXC to deploy services to drive new levels of performance, competitiveness, and customer experience across their IT estates. Learn more about how we deliver excellence for our customers and colleagues at DXC.com. View original content to download multimedia:https://www.prnewswire.com/news-releases/dxc-technology-recognized-as-leader-in-2024-gartner-magic-quadrant-for-outsourced-digital-workplace-services-302087571.html SOURCE DXC Technology Company What did Gartner recognize DXC Technology for? DXC Technology was recognized by Gartner as a Leader in the Magic Quadrant for Outsourced Digital Workplace Services. What are some of DXC's Modern Workplace Services mentioned in the PR? DXC's Modern Workplace Services include Modern Device Management, Digital Support Services, Intelligent Collaboration, and Workplace Asset Management. Who is the General Manager of Modern Workplace at DXC Technology? Andrew Wilson is the General Manager of Modern Workplace at DXC Technology. What is DXC UPtime? DXC UPtime is the Experience Platform that underpins DXC's Modern Workplace Services. How are providers positioned in Gartner's Magic Quadrant reports? Providers in Gartner's Magic Quadrant reports are positioned into four quadrants: Leaders, Challengers, Visionaries, and Niche Players."
Reyna Silver Announces Upsize to LIFE Offering and Concurrent Private Placement and Aggregate Closings of $4.6 Million,2024-03-13T18:45:00.000Z,Low,Neutral,"Reyna Silver Corp. increases its non-brokered private placement to approximately $4.6 million due to investor demand. The company closes the final tranche of the LIFE Offering and Concurrent Private Placement, issuing a total of 38,333,334 Units. Insiders participate in the Concurrent Private Placement. The proceeds will fund exploration projects and general corporate purposes.","Reyna Silver Announces Upsize to LIFE Offering and Concurrent Private Placement and Aggregate Closings of $4.6 Million Rhea-AI Impact (Low) Rhea-AI Sentiment (Neutral) Tags Rhea-AI Summary Reyna Silver Corp. increases its non-brokered private placement to approximately $4.6 million due to investor demand. The company closes the final tranche of the LIFE Offering and Concurrent Private Placement, issuing a total of 38,333,334 Units. Insiders participate in the Concurrent Private Placement. The proceeds will fund exploration projects and general corporate purposes. Positive None. Negative None. 03/13/2024 - 02:45 PM VANCOUVER, BC and HONG KONG / ACCESSWIRE / March 13, 2024 / Reyna Silver Corp. (TSXV:RSLV)(OTCQX:RSNVF)(FRA:4ZC) (""Reyna"" or the ""Company"") is pleased to announce that, due to investor demand, it is has increased the size of its non-brokered listed issuer financing exemption (LIFE) private placement (the ""LIFE Offering""), previously announced on February 14, 2024 and amended February 26, 2024 and March 6, 2024, and its previously announced concurrent non-brokered private placement (the ""Concurrent Private Placement"", and together with the LIFE Offering, the ""Offerings"") to purchasers pursuant to other applicable exemptions under NI 45-106. The amended LIFE Offering is for up to 26,666,667 units of the Company (""Units"") at a price of $0.12 per Unit (the ""Issue Price"") for gross proceeds of up to approximately $3,200,000, increased from $2,900,000. Each Unit will consist of one common share of the Company (a ""Common Share"") and one common share purchase warrant (a ""Warrant""). Each Warrant will entitle the holder thereof to acquire one Common Share at an exercise price of $0.20 for a period of 36 months from the date of issuance.""We are delighted to receive so much interest in the Offerings from both new and existing shareholders including significant participation from management and insiders,"" said Jorge Ramiro Monroy, CEO of Reyna Silver. ""We are excited to hit the ground running for our summer drill campaign at Gryphon.""The Offerings and Final ClosingsThe amended Concurrent Private Placement is for up to 12,500,000 Units for gross proceeds of up to approximately $1,500,000. Certain insiders of the Company are participating in the Concurrent Private Placement for 1,633,333 Units for gross proceeds of approximately $196,000. The participation of any insiders may be considered a related party transaction within the meaning of Multilateral Instrument 61-101 - Protection of Minority Security Holders in Special Transactions (""MI 61-101""). The Concurrent Private Placement will be exempt from the formal valuation and minority shareholder approval requirements of MI 61-101 as neither the fair market value of the securities issued to related parties nor the consideration for such securities will exceed 25% of the Company's market capitalization.The first closing of the LIFE Offering was completed on February 26, 2024. The second closing of the LIFE Offering and the first closing of the Concurrent Private Placement was completed on March 6, 2024. The Company completed a final closing of the LIFE Offering and of the Concurrent Private Placement today, on March 13, 2024, as discussed further below. The closings of the Offerings are subject to certain conditions including, but not limited to, the receipt of all necessary approvals, including final acceptance from the TSX Venture Exchange.Subject to compliance with applicable regulatory requirements and in accordance with National Instrument 45-106 - Prospectus Exemptions (""NI 45-106""), the LIFE Offering is being made pursuant to the listed issuer financing exemption under Part 5A of NI 45-106 (the ""Exemption""). The securities offered under the Exemption will not be subject to a hold period in accordance with applicable Canadian securities laws. There is a third amended and restated offering document relating to the LIFE Offering that can be accessed under the Company's profile at www.sedarplus.ca and on the Company's website at www.reynasilver.com. Prospective investors should read this amended and restated offering document before making an investment decision. All securities issued in connection with the Concurrent Private Placement will be subject to a statutory hold period of four months and one day following the date of issuance in accordance with applicable Canadian securities laws.The Company is also pleased to announce a third and final closing of the LIFE Offering of 3,673,358 Units for gross proceeds of approximately $440,803 and a second and final closing of the Concurrent Private Placement of 83,333 Units for gross proceeds of approximately $10,000.The Company closed the first tranche of the LIFE Offering on February 26, 2024 of 13,934,367 Units for gross proceeds of $1,672,124.04. On March 6, 2024, the Company (i) closed the second tranche of the LIFE Offering of 8,240,666 Units for gross proceeds of approximately $988,880 and (ii) closed the first tranche of the Concurrent Private Placement of 12,401,610 Units for gross proceeds of approximately $1,488,193.In the aggregate, including the closings announced today, the Company issued (i) 25,848,391 Units in the LIFE Offering for gross proceeds of approximately $3,101,807 and (ii) 12,484,943 Units in the Concurrent Private Placement for gross proceeds of approximately $1,498,193. Aggregating both the LIFE Offering and the Concurrent Private Placement, the Company issued 38,333,334 Units for gross proceeds of approximately $4,600,000.The Company has paid cash finder's fees equal to 7.0% on certain investments in the Offerings for aggregate fees to date of $265,627.44 and issued 2,213,569 Finder Warrants (as defined below) to eligible finders, including Red Cloud Securities Inc. and Canaccord Genuity Corp. The warrants issued to eligible finders (each, a ""Finder Warrant"") entitle the holder to acquire one Common Share at a price of $0.12 per Common Share for a period of 36 months from the date of issuance.The Company will use the net proceeds of the Offering and the Concurrent Private Placement for the exploration of the Company's Gryphon Summit Project, Guigui Project, Batopilas Project and Medicine Springs Project (as defined below), other exploration work and for general corporate and working capital purposes.Red Cloud and CEO.ca AgreementsThe Company is also pleased to announce that it has engaged Red Could Securities Inc. (""Red Cloud"") to provide a range of capital markets and transactional advisory services. Red Cloud is a Toronto-based investment bank and financial services company that assists mineral exploration and mining companies in accessing capital markets and enhancing their corporate profile. The Company will pay Red Cloud a work fee of $70,000 for an initial six-month engagement and, in certain circumstances, additional contingent consideration may be applicable in the event of a successful financing or corporate transaction.In addition, the Company has engaged CEO.ca Technologies Ltd. (""CEO.ca"") to provide certain advertising and communications services. CEO provides internet-based financial information and communications services through its website at ceo.ca. The Company will pay CEO.ca $70,000 for 12-month engagement.The engagement of Red Cloud and CEO.ca is subject to acceptance by the TSX Venture Exchange.For Further Information, Please Contact:Jorge Ramiro Monroy, Chief Executive Officerinfo@reynasilver.comwww.reynasilver.comAbout Reyna Silver Corp.Reyna Silver is a growth-oriented junior exploration and development company. The Company focuses on exploring for high-grade, district-scale silver deposits in Mexico and the United States. In Nevada USA, the Company has recently entered into an option to acquire 70% of the 10,300-hectare ""Gryphon Summit Project"" in a 50/50 partnership with Reyna Gold Corp. (TSXV:REYG). The Gryphon Project shows features indicating uniquely superimposed/overprinted Silver-Lead-Zinc-Copper Carbonate Replacement (CRD), Carlin Gold and Critical Metals mineralization. Also in Nevada, the Company is advancing its option to acquire 100% of the ""Medicine Springs Project"" where the Company is exploring a potentially significant Silver-Lead-Zinc-Copper CRD-skarn-Porphyry system. The Company's Mexican assets are 100% owned and include the ""Guigui Project"" and ""Batopilas Project"", both located in Chihuahua State. The Guigui Project covers the interpreted source area for the Santa Eulalia Carbonate Replacement Deposit District and Batopilas covers most of Mexico's historically highest-grade silver system.Forward Looking InformationThis release may contain forward-looking statements. Forward-looking statements are statements that are not historical facts and are generally, but not always, identified by the words ""expects"", ""plans"", ""anticipates"", ""believes"", ""intends"", ""estimates"", ""projects"", ""potential"" and similar expressions, or that events or conditions ""will"", ""would"", ""may"", ""could"" or ""should"" occur. Forward-looking statements may include, without limitation, statements relating to the Offerings and the use of proceeds therefrom. The forward-looking statements contained in this press release are expressly qualified in their entirety by this cautionary statement. All forward-looking statements in this press release are made as of the date of this press release. The forward-looking statements contained herein are also subject generally to assumptions and risks and uncertainties that are described from time to time in the Company's public securities filings with the Canadian securities commissions. Although the Company believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and actual results may differ materially from those in forward looking statements. The Company expressly disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise.This news release does not constitute an offer to sell or a solicitation of an offer to buy any securities in the United States or any other jurisdiction. No securities may be offered or sold in the United States or in any other jurisdiction in which such offer or sale would be unlawful absent registration under the U.S. Securities Act of 1933, as amended, or an exemption therefrom or qualification under the securities laws of such other jurisdiction or an exemption therefrom.Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES.SOURCE: Reyna Silver Corp.View the original press release on accesswire.com What is the ticker symbol for Reyna Silver Corp.? The ticker symbol for Reyna Silver Corp. is RSNVF. How much was the size of the non-brokered private placement increased to? The size of the non-brokered private placement was increased to approximately $4.6 million. What is the Issue Price of each Unit in the private placement? The Issue Price of each Unit in the private placement is $0.12. What projects will the net proceeds of the private placement fund? The net proceeds will fund the exploration of Gryphon Summit Project, Guigui Project, Batopilas Project, and Medicine Springs Project. Who are the companies engaged by Reyna Silver Corp. for advisory services? Reyna Silver Corp. has engaged Red Cloud Securities Inc. and CEO.ca Technologies Ltd. for advisory services."
BMO Hosts First Obesity Summit on Future of Obesity Care Market,2024-03-13T18:16:00.000Z,Low,Neutral,"BMO to host inaugural Obesity Summit in New York City to discuss trends in obesity treatment and medical weight-management therapeutics. The conference will feature panels and presentations on various topics, including the emerging therapeutic landscape, patient perspectives, care delivery, metabolic research, and coverage and access.","BMO Hosts First Obesity Summit on Future of Obesity Care Market Rhea-AI Impact (Low) Rhea-AI Sentiment (Neutral) Tags Rhea-AI Summary BMO to host inaugural Obesity Summit in New York City to discuss trends in obesity treatment and medical weight-management therapeutics. The conference will feature panels and presentations on various topics, including the emerging therapeutic landscape, patient perspectives, care delivery, metabolic research, and coverage and access. Positive None. Negative None. 03/13/2024 - 02:16 PM Healthcare industry experts and leaders will convene at inaugural BMO Obesity Summit to examine outlook and trends in obesity treatmentNEW YORK, March 13, 2024 /PRNewswire/ - BMO will host its first Obesity Summit on March 20, 2024 in New York City. The conference will target buy-side investors who want to hear from leading biotech and pharmaceutical companies developing medical weight-management therapeutics and stakeholders across the continuum of care and delivery. Topics straight from the headlines will be discussed via panels and presentations, including: A panel on the emerging therapeutic landscapeThe Patient's Voice: a conversation with patients on GLP-1+ therapyObesity 101 with Intellihealth, featuring Dr Katherine SaundersCare delivery featuring Beth Israel Lahey Health, Weight Watchers, and IntellihealthA key opinion leader's insights on metabolic research, featuring Weill Cornell Medical College's Dr Louis J. AronneA payors panel addressing coverage and access, featuring Prime Therapeutics""Important conversations need to happen around the development and delivery of obesity care,"" said Evan Seigerman, Senior Biotechnology & Pharmaceuticals Analyst, BMO. ""This summit is about having those discussions and sharing ideas and solutions from thought leaders and experts who can move the dial to meet challenges to deliver care for patients with obesity and metabolic disease."" BMO analysts, including Evan Seigerman, will host discussions with leading life sciences companies, including: AltimmuneAmgenCapital RxCorbus PharmaceuticalsEli Lilly & Co.Novo NordiskIntellihealthPrime TherapeuticsScholar RockStructure TherapeuticsTerns PharmaceuticalsWeight WatchersFor more information or to request an interview with one of BMO's equity research analysts, please contact BMO Media Relations using the contact details below. Note: There are restrictions for media on access to presentations and certain speakers. About BMO Financial Group BMO Financial Group is the eighth largest bank in North America by assets, with total assets of $1.3 trillion as of January 31, 2024. Serving customers for 200 years and counting, BMO is a diverse team of highly engaged employees providing a broad range of personal and commercial banking, wealth management, global markets and investment banking products and services to 13 million customers across Canada, the United States, and in select markets globally. Driven by a single purpose, to Boldly Grow the Good in business and life, BMO is committed to driving positive change in the world, and making progress for a thriving economy, sustainable future, and inclusive society. View original content:https://www.prnewswire.com/news-releases/bmo-hosts-first-obesity-summit-on-future-of-obesity-care-market-302088442.html SOURCE BMO Financial Group When and where will the BMO Obesity Summit take place? The BMO Obesity Summit will be held on March 20, 2024, in New York City. Who is the target audience for the summit? The conference will target buy-side investors and stakeholders involved in the development and delivery of medical weight-management therapeutics. What topics will be discussed at the summit? The summit will cover various topics, including the emerging therapeutic landscape, patient perspectives on GLP-1+ therapy, care delivery, metabolic research, and coverage and access. Who are some of the featured speakers at the summit? Speakers at the summit include Dr. Katherine Saunders from Intellihealth, Beth Israel Lahey Health, Weight Watchers, Dr. Louis J. Aronne from Weill Cornell Medical College, and Prime Therapeutics. Why is the summit important? The summit aims to facilitate important conversations around the development and delivery of obesity care, addressing key issues in the industry."
,,,,,
"Worthington Steel Joint Venture, TWB Company, Signs Licensing Agreement with ArcelorMittal Tailored Blanks for Patented Ablation Technology",2024-03-13T20:00:00.000Z,High,Very Positive,"Worthington Steel, Inc. (NYSE: WS) announces a licensing agreement with ArcelorMittal Tailored Blanks for ablation technology, enhancing hot formed tailored blanks production. The innovative technology allows for welding advanced high-strength steel, improving strength, crash performance, and reducing weight for automotive applications.","Worthington Steel Joint Venture, TWB Company, Signs Licensing Agreement with ArcelorMittal Tailored Blanks for Patented Ablation Technology Rhea-AI Impact (High) Rhea-AI Sentiment (Very Positive) Tags Rhea-AI Summary Worthington Steel, Inc. (NYSE: WS) announces a licensing agreement with ArcelorMittal Tailored Blanks for ablation technology, enhancing hot formed tailored blanks production. The innovative technology allows for welding advanced high-strength steel, improving strength, crash performance, and reducing weight for automotive applications. Positive Licensing agreement signed with ArcelorMittal Tailored Blanks for ablation technology. Enhancement of hot formed tailored blanks production capabilities in North America. Installation of fully automated ablation line at Monroe, Michigan facility. Ablation process removes aluminum silicon coating on weld edge of tailored blank. Hot forming process enables stamping of advanced high-strength steel for safety critical applications. TWB Company plans to invest in supporting customers embracing the technology. Negative None. Market Research Analyst The licensing agreement between TWB Company, LLC and ArcelorMittal Tailored Blanks to utilize patented ablation technology signifies a strategic move in the steel industry, particularly within the automotive sector. This move is poised to enhance Worthington Steel's competitive edge by expanding its product offerings to include hot formed tailored blanksa segment that is experiencing rapid growth due to the automotive industry's increasing demand for advanced high-strength steel (AHSS).The introduction of ablation technology, which facilitates the welding of AHSS, is expected to yield benefits such as improved crash performance and weight reduction in vehicles, which are critical factors for automotive manufacturers aiming to meet stringent safety and fuel efficiency standards. The adoption of this technology by TWB could lead to increased market share and potentially higher revenues for Worthington Steel, given the technology's relevance in producing components for safety and weight-critical applications. Financial Analyst From a financial perspective, the investment in a fully automated ablation line represents a significant capital expenditure for Worthington Steel. However, it also indicates a forward-looking approach to capitalizing on emerging market trends. The 12-15 month OEM qualification period suggests a medium-term horizon before revenue generation from this technology begins. Investors should monitor the progress of this qualification phase, as it will be a critical determinant of the timeline for financial returns on the investment.Furthermore, the exclusive nature of the licensing agreement could provide TWB with a competitive moat in North America, potentially leading to pricing power and improved profit margins. The impact on Worthington Steel's stock will depend on the successful integration of the technology and the market's reception of the enhanced product offerings. The company's ability to leverage this technology to secure contracts with automotive OEMs will be a key factor to watch. Automotive Industry Expert The integration of ablation technology in the production of hot formed tailored blanks addresses the automotive industry's push towards lightweighting and safety enhancements. Ablation technology's ability to remove aluminum silicon coating on weld edges is a nuanced but significant advancement, allowing for the welding of press hardened materials. This process is integral to manufacturing components that contribute to vehicle safety and efficiency.Given the automotive industry's trajectory towards electrification and stricter emissions regulations, TWB's expansion in AHSS capabilities may lead to greater collaboration with automotive manufacturers. As these manufacturers increasingly seek out suppliers who can provide innovative solutions for lightweight and safe vehicle structures, TWB's early adoption of this technology could position it as a preferred supplier and drive long-term growth for Worthington Steel. 03/13/2024 - 04:00 PM COLUMBUS, Ohio--(BUSINESS WIRE)-- Worthington Steel, Inc. (NYSE: WS) announced today that its tailor welded blanking joint venture, TWB Company, LLC (TWB), has signed a licensing agreement with ArcelorMittal Tailored Blanks for use of its patented ablation technology in the production of hot formed tailored blanks. This technology expands TWBs hot formed tailored blanking capabilities in North America. Along with this agreement, TWB plans to install a fully automated ablation line at its Monroe, Michigan, facility. Were excited to be one of two companies in North America to offer ablation technology and hot formed tailored blanks to our customers, said Worthington Steel president and CEO Geoff Gilmore. As one of the fastest growing segments in the tailored blank market, this innovative technology allows for welding of advanced high-strength steel, enhancing strength, crash performance and reducing weight for automotive applications. Specifically, the ablation process allows for the removal of aluminum silicon coating on the weld edge of a tailored blank, which is required before the press hardened material can be welded. The hot forming process allows this advanced high-strength steel to be stamped into a variety of safety and weight-critical applications. As more of our customers embrace this technology and the market continues to grow, we look forward to investing and supporting our customers efforts in this area, said TWB Company president Ivan Meltzer. TWB plans to install the new fully automated ablation line in its flagship facility in Monroe, Michigan. The 300,000 square foot facility currently produces traditional tailored blanks, tailored aluminum blanks and tailor welded coils. Following the ablation line installation, the company expects to spend 12-15 months undergoing OEM qualifications before beginning full production. About TWB Company TWB is North Americas market leader for tailor welded products with 11 locations in Kentucky, Michigan, Ohio, Tennessee, Ontario and Mexico. Formed in 1992, TWB Company is a joint venture between Worthington Steel and BAOSteel. Worthington Steel holds majority ownership and serves as managing partner. More information about TWB can be found at www.TWBCompany.com. About Worthington Steel Worthington Steel (NYSE:WS) is a metals processor that partners with customers to deliver highly technical and customized solutions. Worthington Steels expertise in carbon flat-roll steel processing, electrical steel laminations and tailor welded solutions are driving steel toward a more sustainable future. As one of the most trusted metals processors in North America, Worthington Steel and its 4,600 employees harness the power of steel to advance our customers visions through value-added processing capabilities including galvanizing, pickling, configured blanking, specialty cold reduction, lightweighting and electrical lamination. Headquartered in Columbus, Ohio, Worthington operates 32 facilities in seven states and six countries. Following a people-first Philosophy, commitment to sustainability and proven business system, Worthington Steels purpose is to generate positive returns by providing trusted and innovative solutions for customers, creating opportunities for employees, and strengthening its communities. Safe Harbor Statement Worthington Steel wishes to take advantage of the Safe Harbor provisions included in the Private Securities Litigation Reform Act of 1995 (the Act""). Statements by Worthington Steel which are not historical information constitute ""forward looking statements"" within the meaning of the Act. All forward-looking statements are subject to risks and uncertainties which could cause actual results to differ from those projected. Factors that could cause actual results to differ materially include risks, uncertainties and impacts described from time to time in Worthington Steels filings with the Securities and Exchange Commission. View source version on businesswire.com: https://www.businesswire.com/news/home/20240313232277/en/ Melissa Dykstra Vice President Corporate Communications and Investor Relations Phone: 614-840-4144 Melissa.Dykstra@worthingtonsteel.com Source: Worthington Steel, Inc. What is the significance of the licensing agreement between Worthington Steel, Inc. (WS) and ArcelorMittal Tailored Blanks? The licensing agreement aims to enhance hot formed tailored blanks production capabilities by utilizing ablation technology for welding advanced high-strength steel, improving strength, crash performance, and reducing weight for automotive applications. Where will TWB Company install the fully automated ablation line? TWB Company plans to install the new fully automated ablation line at its flagship facility in Monroe, Michigan. What does the ablation process involve in the production of tailored blanks? The ablation process involves the removal of aluminum silicon coating on the weld edge of a tailored blank, which is necessary before the press hardened material can be welded. What are the expected outcomes of installing the ablation line at TWB Company's facility? Following the installation of the ablation line, TWB Company expects to undergo OEM qualifications for 12-15 months before commencing full production. How does the hot forming process benefit the production of advanced high-strength steel? The hot forming process enables the stamping of advanced high-strength steel into various safety and weight-critical applications. What are the future plans of TWB Company regarding the technology investment? TWB Company plans to invest in and support customers embracing the technology as the market grows."
scPharmaceuticals Inc. Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Business Update,2024-03-13T20:01:00.000Z,Neutral,Neutral,"scPharmaceuticals Inc. (SCPH) reported strong financial results for Q4 2023 with net FUROSCIX revenue of $6.1 million, a 61% sequential growth. Full-year revenue reached $13.6 million. The company ended 2023 with $76 million in cash. scPharmaceuticals plans to expand FUROSCIX indications, including a pivotal PK study and an sNDA submission to the FDA. Despite revenue growth, the company reported a net loss of $13.8 million in Q4 and $54.8 million for the full year 2023.","scPharmaceuticals Inc. Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Business Update Rhea-AI Impact (Neutral) Rhea-AI Sentiment (Neutral) Tags earnings Rhea-AI Summary scPharmaceuticals Inc. (SCPH) reported strong financial results for Q4 2023 with net FUROSCIX revenue of $6.1 million, a 61% sequential growth. Full-year revenue reached $13.6 million. The company ended 2023 with $76 million in cash. scPharmaceuticals plans to expand FUROSCIX indications, including a pivotal PK study and an sNDA submission to the FDA. Despite revenue growth, the company reported a net loss of $13.8 million in Q4 and $54.8 million for the full year 2023. Positive Strong net FUROSCIX revenue of $6.1 million in Q4 2023, a 61% sequential growth Full-year net FUROSCIX revenue reached $13.6 million Ended 2023 with $76 million in cash, cash equivalents, and short-term investments Plans to expand FUROSCIX indications with a pivotal PK study and sNDA submission to the FDA Reported a net loss of $13.8 million in Q4 2023 and $54.8 million for the full year 2023 Negative Net loss of $13.8 million in Q4 2023 and $54.8 million for the full year 2023 Increase in selling, general, and administrative expenses compared to the previous year Decrease in cash, cash equivalents, and short-term investments from $118.4 million in 2022 to $76 million in 2023 Financial Analyst The reported fourth-quarter revenue growth of 61% for scPharmaceuticals' FUROSCIX is a strong indicator of the product's market acceptance and growing sales momentum. The sequential increase from $3.8 million in the third quarter to $6.1 million in the fourth quarter suggests robust demand and effective market penetration strategies. The gross-to-net discount improvement from 21% to 18% indicates a favorable pricing dynamic, which could lead to improved margins over time. However, the expectation of an increasing discount due to contracting efforts may temper the margin expansion outlook.Investors should note the increase in selling, general and administrative expenses, which more than doubled from the previous year, reflecting heightened commercial activity and possibly an expanded workforce. While necessary for growth, this increase in expenses has contributed to a net full-year loss of $54.8 million, deepening from $36.8 million in the previous year. The company's cash position of $76 million, while lower than the previous year-end, appears sufficient to support ongoing operations and R&D efforts in the near term. Medical Research Analyst scPharmaceuticals' strategic focus on lifecycle management and expansion of FUROSCIX's indications, such as the potential inclusion for NYHA Class IV heart failure patients and chronic kidney disease, is an important aspect for investors to consider. The initiation of a pivotal pharmacokinetic study for an 80mg/1mL auto-injector represents innovation in drug delivery systems, potentially enhancing patient adherence and expanding the addressable market. The sNDA submissions and formulary inclusion with a large government retiree payer are key regulatory and market access milestones that could significantly impact future revenue streams.It is also critical to monitor the clinical and regulatory developments, such as the FDA's review of the sNDA for expanding FUROSCIX's indication. Positive outcomes in these areas could further validate the product's efficacy and safety, leading to broader market adoption and potentially impacting stock valuation positively. Market Research Analyst The reported metrics such as the number of FUROSCIX doses written and filled, the increase in unique prescribers and completed in-services provide a quantitative measure of market engagement and adoption among healthcare providers. The 44% sequential increase in filled doses and the 52% increase in unique prescribers from the previous quarter are particularly encouraging, as they suggest a growing prescriber base and user acceptance. The addition of 1.1 million lives with preferred access to FUROSCIX through formulary placement is a significant market expansion that can drive future revenue growth.Furthermore, the company's sales to integrated delivery networks, including a large order to one of the largest closed IDNs in the United States, demonstrates the product's penetration into key healthcare networks, which is often a critical factor for sustained growth in the pharmaceutical sector. 03/13/2024 - 04:01 PM Generated 4Q 2023 net FUROSCIX revenue of $6.1 million, at the upper end of the range provided in January and representing sequential growth of 61% from $3.8 million in 3Q 2023 Generated full-year net FUROSCIX revenue of $13.6 million, at the upper end of the range provided in January Ended 2023 with cash, cash equivalents and short-term investments of $76 million Company to host investor conference call and webcast today, Wednesday, March 13, at 4:30pm ET BURLINGTON, Mass., March 13, 2024 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care, and reduce healthcare costs, today announced financial results for the fourth quarter and full-year ended December 31, 2023, and provided a business update. Business Update For the fourth quarter ended December 31, 2023, scPharmaceuticals reports: Net FUROSCIX revenue of $6.1 million, up 61% sequentially as compared to $3.8 million in the third quarter of 202313,542 total FUROSCIX doses written, up 56% sequentially as compared to 8,676 in the third quarter of 2023 7,016 FUROSCIX doses filled, up 44% sequentially from 4,861 in the third quarter of 20234,592 written doses payer cleared or pending 5.9 doses per prescription1,696 unique prescribers of FUROSCIX from launch through end of the year, up 52% from 1,119 from launch through the end of the third quarter2,331 FUROSCIX in-services completed from launch through end of the year, up from 1,806 from launch through the end of the third quarterGross-to-net discount of 18% from launch through the end of the year, as compared to 21% from launch through the end of third quarterInventory levels at specialty pharmacy partners remained consistent from September 30, 2023 levels Reported that, as of November 1, FUROSCIX is on formulary as a preferred brand with one of the largest government retiree payer formularies, increasing the number of lives with preferred access to FUROSCIX by an additional 1.1 million lives.Continued to see sales of FUROSCIX to integrated delivery networks (IDNs), including a large direct order in late Q4 to one of the largest closed IDN in the United Sates.On track to initiate a pivotal pharmacokinetic (PK) study in Q2 to support development of an 80mg/1mL auto-injector. If successful, scPharmaceuticals plans to submit a New Drug Application (NDA) to the FDA by the end of 2024.Advanced plans to submit an sNDA to the FDA next month seeking expansion of the FUROSCIX indication to include patients suffering from chronic kidney disease (CKD).Announced that the Companys sNDA submission to the FDA seeking to expand the FUROSCIX indication to include New York Heart Association Class IV heart failure patients is currently under review by the FDA.Ended the fourth quarter of 2023 with cash, cash equivalents and short-term investments of $76.0 million. We ended 2023 on a strong note, generating net FUROSCIX sequential revenue growth of 61%, which we believe reflects growing awareness and acceptance of FUROSCIX as a key component of a new heart failure treatment paradigm, stated John Tucker, President, and Chief Executive Officer of scPharmaceuticals. Our reported gross-to-net discount of 18% declined from launch through the end of Q4 as compared to 21% from launch through the end of Q3. However, we continue to anticipate that the GTN discount will increase over time as our contracting efforts continue to evolve and mature. Also, during the fourth quarter, we continued to advance the life cycle management and long-term growth initiatives for FUROSCIX that we previewed last quarter. These include the potential expansion of the FUROSCIX indication to include NYHA Class IV heart failure patients, which is currently under review by FDA, an additional indication in chronic kidney disease, for which we plan to file with the FDA next month , and the development of an auto-injector that would complement the current on-body infusor, a PK study for which we plan to initiate in the next few weeks. We continue to advance these initiatives while at the same time successfully driving uptake of FUROSCIX, and both our fourth quarter results and leading indicators confirm that FUROSCIX acceptance and utilization among heart failure specialists is accelerating, Mr. Tucker concluded. Fourth Quarter and Full-Year 2023 Financial Results and Financial Guidance Fourth Quarter 2023 Product revenues were $6.1 million, and cost of product revenues were $1.8 million for the fourth quarter of 2023. Research and development expenses were $3.3 million for the fourth quarter of 2023, compared to $2.3 million for the fourth quarter of 2022. The increase in research and development expenses for the quarter ended December 31, 2023, was primarily due to an increase in device and pharmaceutical development costs and clinical study costs. The increase was partially offset by a decrease in employee related costs. Selling, general and administrative expenses were $16.2 million for the fourth quarter of 2023, compared to $7.2 million for the fourth quarter of 2022. The increase in selling, general and administrative expenses for the quarter ended December 31, 2023, was primarily due to an increase in employee related costs and commercial costs. scPharmaceuticals reported a net loss of $13.8 million for the fourth quarter of 2023, compared to $9.2 million for the fourth quarter of 2022. Full-Year 2023 Product revenues were $13.6 million, and cost of product revenues were $3.8 million for the full-year 2023. Research and development expenses were $11.8 million for the full-year 2023, compared to $15.5 million for the full-year 2022. The decrease in research and development expenses for the full-year 2023 was primarily due to a decrease in clinical study and medical affairs costs, employee related costs, quality and regulatory consulting costs, and patent costs. The decrease was partially offset by an increase in pharmaceutical development costs. Selling, general and administrative expenses were $53.4 million for the full year 2023, compared to $20.6 million for the full-year 2022. The increase in selling, general and administrative expenses for the full-year 2023 was primarily due to an increase in employee related costs and commercial preparation costs, operations, quality and regulatory costs, and legal costs. The increase was partially offset by a decrease in insurance related costs. scPharmaceuticals reported a net loss of $54.8 million for the full-year 2023, compared to $36.8 million for the full-year 2022. scPharmaceuticals ended 2023 with $76 million in cash, cash equivalents and short-term investments, compared to $118.4 million as of December 31, 2022. As of December 31, 2023, scPharmaceuticals total shares outstanding was 35,968,510. Conference call and webcast information scPharmaceuticals management will host a conference call and webcast to review the Companys fourth quarter and full-year 2023 results today, Wednesday, March 13, at 4:30 p.m. ET. Participants should dial 1-877-407-9208 (domestic) or 1-201-493-6784 (international) with the conference code 13744172. To access the Call me feature, which avoids having to wait for an operator, click here. A link to the live webcast can be found here. Following the live webcast, a replay of the event will be archived on scPharmaceuticals website for one year. FUROSCIX (furosemide injection) 80 mg/10mL for subcutaneous use FUROSCIX is indicated for the treatment of congestion due to fluid overload in adult patients with New York Heart Association (NYHA) Class II and Class III chronic heart failure. FUROSCIX is not indicated for use in emergency situations or in patients with acute pulmonary edema. The On-Body Infusor will deliver only an 80-mg dose of FUROSCIX. IMPORTANT SAFETY INFORMATION FUROSCIX is contraindicated in patients with anuria, patients with a history of hypersensitivity to furosemide or medical adhesives and in patients with hepatic cirrhosis or ascites. Furosemide may cause fluid, electrolyte, and metabolic abnormalities, particularly in patients receiving higher doses, patients with inadequate oral electrolyte intake, and in elderly patients. Serum electrolytes, CO2, BUN, creatinine, glucose, and uric acid should be monitored frequently during furosemide therapy. Excessive diuresis may cause dehydration and blood volume reduction with circulatory collapse and possibly vascular thrombosis and embolism, particularly in elderly patients. In patients with hepatic cirrhosis and ascites, sudden alterations of fluid and electrolyte balance may precipitate hepatic encephalopathy and coma. Treatment in such patients is best initiated in the hospital. Furosemide can cause dehydration and azotemia. If increasing azotemia and oliguria occur during treatment of severe progressive renal disease, furosemide should be discontinued. Cases of tinnitus and reversible or irreversible hearing impairment and deafness have been reported with furosemide. Reports usually indicate that furosemide ototoxicity is associated with rapid injection, severe renal impairment, the use of higher than recommended doses, hypoproteinemia or concomitant therapy with aminoglycoside antibiotics, ethacrynic acid, or other ototoxic drugs. In patients with severe symptoms of urinary retention (because of bladder emptying disorders, prostatic hyperplasia, urethral narrowing), the administration of furosemide can cause acute urinary retention related to increased production and retention of urine. These patients require careful monitoring, especially during the initial stages of treatment. The most common adverse reactions with FUROSCIX administration in clinical trials were site and skin reactions including erythema, bruising, edema, and injection site pain. For more details, please read the full Prescribing Information at FUROSCIX.com/prescribing-information.pdf and Instructions for Use at FUROSCIX.com/instructions-for-use.pdf. About scPharmaceuticals scPharmaceuticals is a pharmaceutical company focused on developing and commercializing products that are designed to reduce healthcare costs and improve health outcomes. The Company develops, internally and through strategic partnerships, innovative products and solutions that aim to expand and advance the outpatient care of select acute conditions. The Companys lead programs focus on the subcutaneous, self-administration of IV-strength treatments in heart failure and infectious disease. scPharmaceuticals is headquartered in Burlington, MA. For more information, please visit www.scPharmaceuticals.com. Forward-Looking Statements This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements contained in this press release that do not relate to matters of historical fact should be considered forward-looking statements, including, but not limited to, statements regarding the potential market impact and benefits of FUROSCIX and the success of the commercialization of FUROSCIX, the trial initiation, anticipated results, clinical design, potential regulatory submissions, approvals and timing thereof of the PK study, the potential expansion of the FUROSCIX indication to include NYHA Class IV heart failure patients and the timing thereof, the potential for continued sales of FUROSCIX to IDNs, the potential expansion of the FUROSCIX indication to include treatment of edema in patients with chronic kidney disease, and participation in upcoming events and presentations. Any forward-looking statements in this press release are based on managements current expectations of future events and are subject to a number of risks and uncertainties that could cause actual results to differ materially and adversely from those set forth in or implied by such forward-looking statements. These risks and uncertainties include but are not limited to, our dependence on the commercial success of FUROSCIX and, if approved, our other product candidates, risks related to the receipt of regulatory approval for our product candidates, risks related to our ability to manufacture, or the ability of third parties to deliver, sufficient product for commercialization of FUROSCIX or any of our product candidates, if approved , risks related to our history of operating losses, and the risk that global economic factors and uncertainties will impact the Companys operations. For a discussion of these and other risks and uncertainties, and other important factors, any of which could cause our actual results to differ from those contained in the forward-looking statements, see the sections entitled Risk Factors in the Companys Annual Report on Form 10-K for the year ended December 31, 2023, on file with the Securities and Exchange Commission, available at the Securities and Exchange Commissions website at www.sec.gov, as well as discussions of potential risks, uncertainties and other important factors in the Companys subsequent filings with the Securities and Exchange Commission. All information in this press release is as of the date of the release, and the Company undertakes no duty to update this information unless required by law. Katherine MirandascPharmaceuticals Inc., 781-301-6869kmiranda@scpharma.com Investors:PJ KelleherLifeSci Advisors, 617-430-7579pkelleher@lifesciadvisors.com scPharmaceuticals Inc. Consolidated Statements of Operations (in thousands, except share and per share data) THREE MONTHS ENDED DECEMBER 31, YEAR ENDED DECEMBER 31, 2022 2023 2022 2023 Product revenues, net$- $6,096 $- $13,593 Operating expenses: Cost of product revenues$- $1,773 $- $3,811 Research and development 2,326 3,338 15,533 11,809 Selling, general and administrative 7,176 16,242 20,624 53,369 Total operating expenses 9,502 21,353 36,157 68,989 Loss from operations (9,502) (15,257) (36,157) (55,396)Other (expense) income 1,363 2,412 1,418 3,605 Interest income 850 1,125 1,203 5,104 Interest expense (1,959) (2,092) (3,302) (8,123)Net loss$(9,248) $(13,812) $(36,838) $(54,810)Net loss per share, basic and diluted$(0.30) $(0.35) $(1.30) $(1.42)Weightedaverage common shares outstanding, basic and diluted 31,253,909 38,786,956 28,358,502 38,513,747 scPharmaceuticals Inc. Consolidated Balance Sheet Data (in thousands) AS OF DECEMBER 31, 2022 2023 Cash, cash equivalents, restricted cash and investments $118,368 $76,013 Working capital 115,892 79,804 Total assets 124,195 94,479 Term loan 36,794 38,811 Accumulated deficit (226,536) (281,346)Total stockholders equity 72,433 37,218 What was scPharmaceuticals' (SCPH) net FUROSCIX revenue for Q4 2023? scPharmaceuticals reported net FUROSCIX revenue of $6.1 million for Q4 2023. How much cash did scPharmaceuticals (SCPH) end 2023 with? scPharmaceuticals ended 2023 with $76 million in cash, cash equivalents, and short-term investments. What plans does scPharmaceuticals (SCPH) have for expanding FUROSCIX indications? scPharmaceuticals plans to conduct a pivotal PK study and submit an sNDA to the FDA for expanding FUROSCIX indications. What was scPharmaceuticals' (SCPH) net loss for Q4 2023? scPharmaceuticals reported a net loss of $13.8 million for Q4 2023. What was scPharmaceuticals' (SCPH) full-year net FUROSCIX revenue for 2023? scPharmaceuticals reported full-year net FUROSCIX revenue of $13.6 million for 2023."
Core Molding Technologies to Participate in the 36th Annual Roth Conference,2024-03-13T20:01:00.000Z,Low,Neutral,"Core Molding Technologies, Inc. (CMT) executives to participate in the 36th Annual Roth Conference. The company specializes in molded structural products for various industries across North America.","Core Molding Technologies to Participate in the 36th Annual Roth Conference Rhea-AI Impact (Low) Rhea-AI Sentiment (Neutral) Tags conferences Rhea-AI Summary Core Molding Technologies, Inc. (CMT) executives to participate in the 36th Annual Roth Conference. The company specializes in molded structural products for various industries across North America. Positive None. Negative None. 03/13/2024 - 04:01 PM COLUMBUS, Ohio, March 13, 2024 (GLOBE NEWSWIRE) -- Core Molding Technologies, Inc. (NYSE American: CMT) (Core Molding, Core or the Company), a leading engineered materials company specializing in molded structural products, principally in building products, industrial and utilities, medium and heavy-duty truck and powersports industries across the United States, Canada and Mexico today announced that David Duvall, President and CEO, and John Zimmer, EVP and CFO, will participate in the upcoming 36th Annual Roth Conference on March 18-19, 2024 in Laguna Niguel, CA. Investors interested in arranging a one-on-one meeting should contact your conference representative or the Companys investor relations contacts listed below. About Core Molding Technologies, Inc. Core Molding Technologies is a leading engineered materials company specializing in molded structural products, principally in building products, utilities, transportation and powersports industries across North America. The Company operates in one operating segment as a molder of thermoplastic and thermoset structural products. The Companys operating segment consists of one reporting unit, Core Molding Technologies. The Company offers customers a wide range of manufacturing processes to fit various program volume and investment requirements. These thermoset processes include compression molding of sheet molding compound (SMC), resin transfer molding (RTM), liquid molding of dicyclopentadiene (DCPD), spray-up and hand-lay-up. The thermoplastic processes include direct long-fiber thermoplastics (DLFT) and structural foam and structural web injection molding. Core Molding Technologies serves a wide variety of markets, including the medium and heavy-duty truck, marine, automotive, agriculture, construction, and other commercial products. The demand for Core Molding Technologies products is affected by economic conditions in the United States, Mexico, and Canada. Core Molding Technologies operations may change proportionately more than revenues from operations. For more information, please refer to the Companys website at coremt.com. Company Contact: Core Molding Technologies, Inc.John ZimmerExecutive Vice President & Chief Financial Officerjzimmer@coremt.com Investor Relations Contact: Three Part Advisors, LLCSandy Martin or Steven Hooser214-616-2207 When is the 36th Annual Roth Conference taking place? The 36th Annual Roth Conference is scheduled for March 18-19, 2024. Who are the executives from Core Molding Technologies participating in the conference? David Duvall, President and CEO, and John Zimmer, EVP and CFO, will represent Core Molding Technologies at the event. What industries does Core Molding Technologies specialize in? Core Molding Technologies specializes in molded structural products for building products, industrial, utilities, medium and heavy-duty truck, and powersports industries across the United States, Canada, and Mexico. Where is the 36th Annual Roth Conference being held? The 36th Annual Roth Conference will take place in Laguna Niguel, CA. How can investors arrange a one-on-one meeting with Core Molding Technologies executives? Investors interested in arranging a one-on-one meeting should contact their conference representative or the Companys investor relations contacts."
Majority of Asia Pacific Real Estate Companies and Investment Funds Aim To Achieve Net Zero by 2050: CBRE Survey,2024-03-13T19:55:00.000Z,No impact,Positive,"CBRE's survey reveals rising interest in sustainable portfolios in Asia Pacific, with Chief Sustainability Officer role gaining importance.","Majority of Asia Pacific Real Estate Companies and Investment Funds Aim To Achieve Net Zero by 2050: CBRE Survey Rhea-AI Impact (No impact) Rhea-AI Sentiment (Positive) Tags Rhea-AI Summary CBRE's survey reveals rising interest in sustainable portfolios in Asia Pacific, with Chief Sustainability Officer role gaining importance. Positive None. Negative None. 03/13/2024 - 03:55 PM Nearly Two-Thirds of the Respondents Expect At Least 80% of Their Portfolios To Be Green-Certified in Next Three YearsASIA PACIFIC / ACCESSWIRE / March 13, 2024 / The role of Chief Sustainability Officer (CSO*) is rapidly gaining prominence among the Asia Pacific region as investors display increased appetite for sustainable portfolios, according to CBRE's Asia Pacific Real Estate Chief Sustainability Officer Survey.In collaboration with the U.S. Green Building Council (USGBC), CBRE conducted a survey among real estate companies and investment funds in Asia Pacific to understand how they perceive the role of CSO, their Environmental, Social & Governance (ESG) strategies and challenges, and prospect for achieving net zero.About half of surveyed asset owners named 2050 as their target to achieve net zero, largely aligning with the targets set by their government. However, many multinational occupiers are aiming to reach net zero by 2030. The discrepancy is primarily because building materials and construction activity are carbon-intensive for asset owners, particularly developers, while service sector tenants are asset-light and mainly focusing on operational emissions.""Asset owners have to be aware of the much more aggressive net zero target among occupiers. Both parties must collaborate and drive a common sustainability agenda,"" said Ada Choi, Head of Occupier Research, Asia Pacific, for CBRE. ""We expect projects that could result in cost and energy savings will be prioritised, while investors are advised to increase the use of green finance.""The survey reveals that about half of the CSO roles in Asia Pacific were created within the past three years, with 60% of them as full-time positions. With new regulations requiring sustainability disclosures, the key responsibility of CSOs is to conduct ESG monitoring and reporting, and to implement related projects. CSOs are also responsible for fostering cultural change within the company to achieve sustainability goals.""The path to decarbonization involves significant regulatory change and policy support,"" said David Fogarty, Head of ESG Consulting Services, Singapore & Southeast Asia, for CBRE. ""In view of a complex sustainability landscape, it is crucial for occupiers and investors to develop a strategic blueprint to navigate evolving regulations and achieve progress on decarbonization and net zero goals.""To read the full report, click here.* Chief Sustainability Officer, or Head of ESG, is an executive tasked with overseeing ESG / sustainability initiatives. These positions are playing a crucial part in guiding companies towards achieving carbon neutrality and implementing sustainable practices.ENDFollow us on Twitter: @cbreasia LinkedIn: company/cbre-asia-pacificAbout the U.S. Green Building CouncilUSGBC is committed to a prosperous and sustainable future through cost-efficient and energy-saving green buildings. USGBC's mission is ""to transform the way buildings and communities are designed, built and operated, enabling an environmentally and socially responsible, healthy, and prosperous environment that improves the quality of life.""USGBC builds on this vision through the development and improvement of the LEED rating system, the LEED professional credentials, robust educational offerings, an international network of local community leaders and USGBC member organizations, the annual Greenbuild International Conference & Expo, the Center for Green Schools and other USGBC initiatives, as well as through advocacy and outreach that encourages and enables green buildings and communities. For more information: USGBC.org.About CBRE Group, Inc. CBRE Group, Inc. (NYSE:CBRE), a Fortune 500 and S&P 500 company headquartered in Dallas, is the world's largest commercial real estate services and investment firm (based on 2023 revenue). The company has more than 130,000 employees (including Turner & Townsend employees) serving clients in more than 100 countries. CBRE serves a diverse range of clients with an integrated suite of services, including facilities, transaction and project management; property management; investment management; appraisal and valuation; property leasing; strategic consulting; property sales; mortgage services and development services. Please visit our website at cbre.comInternational WELL Building Institute The International WELL Building Institute (IWBI) is a public benefit corporation and the world's leading organization focused on deploying people-first places to advance a global culture of health. IWBI mobilizes its community through the administration of the WELL Building Standard (WELL) and WELL ratings and certifications, management of the WELL AP credential, the pursuit of applicable research, the development of educational resources and advocacy for policies that promote health and well-being everywhere. More information on WELL can be found here.View additional multimedia and more ESG storytelling from CBRE Group, Inc. on 3blmedia.com.Contact Info:Spokesperson: CBRE Group, Inc.Website: https://www.3blmedia.com/profiles/cbre-group-incEmail: info@3blmedia.comSOURCE: CBRE Group, Inc.View the original press release on accesswire.com What is the significance of CBRE's survey results in Asia Pacific? CBRE's survey highlights the increasing interest in sustainable portfolios in the region, with the Chief Sustainability Officer role gaining prominence. Who collaborated with CBRE for the survey in Asia Pacific? CBRE collaborated with the U.S. Green Building Council (USGBC) for the survey in Asia Pacific. What was the focus of the survey conducted by CBRE in Asia Pacific? The survey aimed to understand the perception of real estate companies and investment funds regarding the Chief Sustainability Officer role, ESG strategies, challenges, and prospects for achieving net zero."
Carowinds Announces New Summer Music Festival Amplified by Coke Studio,2024-03-13T15:00:00.000Z,Low,Very Positive,"Carowinds announces the Carowinds Summer Music Fest, featuring renowned artists like Flo Rida and LeAnn Rimes. The festival promises exhilarating live music experiences with free shows included in park admission. Season passholders can enjoy unlimited visits and free parking through Labor Day.","Carowinds Announces New Summer Music Festival Amplified by Coke Studio Rhea-AI Impact (Low) Rhea-AI Sentiment (Very Positive) Tags Rhea-AI Summary Carowinds announces the Carowinds Summer Music Fest, featuring renowned artists like Flo Rida and LeAnn Rimes. The festival promises exhilarating live music experiences with free shows included in park admission. Season passholders can enjoy unlimited visits and free parking through Labor Day. Positive None. Negative None. 03/13/2024 - 11:00 AM Experience Flo Rida, LeAnn Rimes and more included with park admission CHARLOTTE, N.C., March 13, 2024 /PRNewswire/ -- Carowinds is thrilled to announce a live music festival series this summer. Live music will remix the park experience with the new Carowinds Summer Music Fest amplified by Coke Studio.Exhilarating live music will remix the entire park experience with the new Carowinds Summer Music Fest amplified by Coke Studio. This multi-weekend music festival promises a memorable experience with headline performances at the Paladium, the iconic on-site amphitheater, and local bands and emerging artists performing throughout Carowinds. The festival features a star-studded lineup with renowned artists including Flo Rida, two-time GRAMMY Award winner LeAnn Rimes, two-time GRAMMY Award-nominated Skillet, and more artist announcements coming in the following weeks. In partnership with Coca-Cola, guests will find all-new music-related activations each weekend of the summer music festival with more than 30 artists set to perform. ""As the ultimate destination for fun in the Carolinas, we're gearing up for an exhilarating summer of music and thrills with the all-new Carowinds Summer Music Fest amplified by Coke Studio,"" Manny Gonzalez, Carowinds vice president and general manager, said. ""Get ready for 10 days of sensational performances that will make Carowinds the place to be this summer. What's more, these incredible shows are free with your park admission, guaranteeing a summer filled with entertainment and iconic thrills."" The Carowinds Paladium, the iconic on-site amphitheater, will come alive to host the series of concerts on five select weekends. The venue will again be the heart of entertainment at the park. Since its inception in 1975, the Paladium has welcomed cultural icons such as Billy Joel, Bob Dylan, Charlie Daniels, James Taylor, Mary J. Blige and the Temptations. Carowinds was among the first amusement parks to establish a permanent concert facility. In 1991, an expansion project transformed the amphitheater into a standalone concert venue. The Carowinds Summer Music Fest, amplified by Coke Studio, will be included with park admission. Season passholders can enjoy all these performances as part of their pass benefits. The 2024 Silver Season Pass offers unlimited visits to Carowinds, including access to Carolina Harbor Waterpark and free parking through Labor Day, September 2. ""Coca-Cola is thrilled to partner with Carowinds to bring this exciting and entertaining experience to Carolina music fans,"" Valencia Bivens, senior vice president, strategic partnerships, Coca-Cola North America, said. For more information about the Carowinds Summer Music Fest amplified by Coke Studio, please visit Carowinds.com. About The Coca-Cola CompanyThe Coca-Cola Company is a total beverage company with products sold in more than 200 countries and territories. Our company's purpose is to refresh the world and make a difference. We sell multiple billion-dollar brands across several beverage categories worldwide. Our portfolio of sparkling soft drink brands includes Coca Cola, Sprite and Fanta. Our hydration, sports, coffee and tea brands include Dasani, smartwater, vitaminwater, Topo Chico, BODYARMOR, Powerade, Costa, Georgia, Gold Peak and Ayataka. Our nutrition, juice, dairy and plant-based beverage brands include Minute Maid, Simply, innocent, Del Valle, fairlife and AdeS. We're constantly transforming our portfolio, from reducing sugar in our drinks to bringing innovative new products to market. We seek to positively impact people's lives, communities and the planet through water replenishment, packaging recycling, sustainable sourcing practices and carbon emissions reductions across our value chain. Together with our bottling partners, we employ more than 700,000 people, helping bring economic opportunity to local communities worldwide. Learn more at www.coca-colacompany.com and follow us on Instagram, Facebook and LinkedIn. About CarowindsCarowinds, a 400-acre amusement park located on the North Carolina-South Carolina state line, is home to top-rated roller coasters, including Fury 325, the world's tallest and fastest giga coaster, as well as more than 58 rides, attractions, and live stage shows. Carolina Harbor, a 26-acre water park, features a variety of water slides, wave pools, large play structures and a three-acre children's play area. Carowinds Camp Wilderness and SpringHill Suites by Marriott at Carowinds are guest accommodations located on-site. For information on attractions and accommodations at Carowinds, visit www.carowinds.com or call 704.588.2600. Carowinds is owned and operated by Cedar Fair Entertainment Company (NYSE: FUN), one of the largest regional amusement-resort operators in the world, and is a publicly traded partnership headquartered in Sandusky, Ohio. Focused on its mission to make people happy by providing fun, immersive, and memorable experiences, the Company owns and operates 13 properties, consisting of 11 amusement parks, four separately gated outdoor water parks, and resort accommodations totaling more than 2,300 rooms and more than 600 luxury RV sites. Cedar Fair's parks are located in Ohio, California, North Carolina, South Carolina, Virginia, Pennsylvania, Minnesota, Missouri, Michigan, Texas and Toronto, Ontario. Contact: Courtney C. McGarry Weber Director, Communications 704.587.9048 (o) Courtney.Weber@Carowinds.com View original content to download multimedia:https://www.prnewswire.com/news-releases/carowinds-announces-new-summer-music-festival-amplified-by-coke-studio-302088209.html SOURCE Carowinds Who are some of the artists performing at the Carowinds Summer Music Fest? Renowned artists like Flo Rida, LeAnn Rimes, Skillet, and more will be performing at the festival. What is included in park admission for the Carowinds Summer Music Fest? The festival is included with park admission, offering free shows with headline performances at the Paladium and local bands performing throughout Carowinds. What benefits do season passholders receive for the 2024 Silver Season Pass? Season passholders can enjoy unlimited visits to Carowinds, access to Carolina Harbor Waterpark, and free parking through Labor Day with the 2024 Silver Season Pass. Who is the vice president and general manager of Carowinds? Manny Gonzalez is the vice president and general manager of Carowinds. Which iconic amphitheater will host the Carowinds Summer Music Fest concerts? The Carowinds Paladium, the on-site amphitheater, will host the series of concerts on five select weekends."
Weekly share repurchase program transaction details,2024-03-13T17:35:00.000Z,Low,Neutral,"SBM Offshore reports details of EUR65 million share repurchase program. The program aims to reduce share capital. From March 7 to March 13, 2024, the company repurchased 110,201 shares at an average price of EUR 13.85.","Weekly share repurchase program transaction details Rhea-AI Impact (Low) Rhea-AI Sentiment (Neutral) Tags buyback Rhea-AI Summary SBM Offshore reports details of EUR65 million share repurchase program. The program aims to reduce share capital. From March 7 to March 13, 2024, the company repurchased 110,201 shares at an average price of EUR 13.85. Positive SBM Offshore discloses specifics of its EUR65 million share repurchase initiative. The company aims to diminish share capital through the buyback program. Between March 7 and March 13, 2024, SBM Offshore repurchased 110,201 shares at an average price of EUR 13.85. Negative None. 03/13/2024 - 01:35 PM March 13, 2024 SBM Offshore reports the transaction details related to its EUR65 million (c. US$70 million) share repurchase program for the period March 7, 2024 through March 13, 2024. The repurchases were made under the EUR65 million share repurchase program announced on February 29, 2024 and effective from March 1, 2024. The objective of the program is to reduce share capital. Information regarding the progress of the share repurchase program and the aggregate of the transactions (calculated on a daily basis) for the period March 1, 2024 through March 13, 2024 can be found in the top half of the table below. Further detailed information regarding both the progress of the share repurchase program and all individual transactions can be accessed via the Investors section of the Companys website. Share Repurchase Program Overall progress Share Repurchase Program: Total Repurchase Amount EUR 65,000,000 Cumulative Repurchase Amount EUR 2,739,686 Cumulative Quantity Repurchased 199,106 Cumulative Average Repurchase Price EUR 13.76 Start Date March 1, 2024 Percentage of program completed as of March 13, 20244.21% Overview of details of last 5 trading days: Trade DateQuantity RepurchasedAverage Purchase PriceSettlement Amount March 7, 2024 21,981 EUR 13.88EUR 305,167 March 8, 2024 21,934 EUR 13.91EUR 305,129 March 11, 2024 22,102 EUR 13.81EUR 305,159 March 12, 2024 22,091 EUR 13.81EUR 305,182 March 13, 2024 22,093 EUR 13.81EUR 305,175 Total110,201EUR 13.85EUR 1,525,812 1All shares purchased via Euronext Amsterdam, CBOE DXE and or Turquoise This press release contains information which is to be made publicly available under the Market Abuse Regulation (nr. 596/2014). The information concerns a regular update of the transactions conducted under SBM Offshores current share repurchase program, as announced by the Company on February 29, 2024, details of which are available on its website. Corporate Profile SBM Offshore designs, builds, installs and operates offshore floating facilities for the offshore energy industry. As a leading technology provider, we put our marine expertise at the service of a responsible energy transition by reducing emissions from fossil fuel production, while developing cleaner solutions for alternative energy sources. More than 7,400 SBMers worldwide are committed to sharing their experience to deliver safe, sustainable and affordable energy from the oceans for generations to come. For further information, please visit our website at www.sbmoffshore.com. Financial Calendar DateYearAnnual General Meeting April 122024First Quarter 2024 Trading Update May 82024Half Year 2024 Earnings August 82024Third Quarter 2024 Trading Update November 142024Full Year 2024 Earnings February 202025 For further information, please contact: Investor Relations Wouter HoltiesCorporate Finance & Investor Relations Manager Mobile:+31 (0) 6 23 34 37 64E-mail:wouter.holties@sbmoffshore.comWebsite:www.sbmoffshore.com Media Relations Evelyn Tachau BrownGroup Communications & Change Director Mobile:+377 (0) 6 40 62 30 34E-mail:evelyn.tachau-brown@sbmoffshore.comWebsite:www.sbmoffshore.com Market Abuse RegulationThis press release may contain inside information within the meaning of Article 7(1) of the EU Market Abuse Regulation. DisclaimerSome of the statements contained in this release that are not historical facts are statements of future expectations and other forward-looking statements based on managements current views and assumptions and involve known and unknown risks and uncertainties that could cause actual results, performance, or events to differ materially from those in such statements. These statements may be identified by words such as expect, should, could, shall and similar expressions. Such forward-looking statements are subject to various risks and uncertainties. The principal risks which could affect the future operations of SBM Offshore N.V. are described in the Impact, Risk and Opportunity Management section of the 2023 Annual Report. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results and performance of the Companys business may vary materially and adversely from the forward-looking statements described in this release. SBM Offshore does not intend and does not assume any obligation to update any industry information or forward-looking statements set forth in this release to reflect new information, subsequent events or otherwise.Nothing in this release shall be deemed an offer to sell, or a solicitation of an offer to buy, any securities. The companies in which SBM Offshore N.V. directly and indirectly owns investments are separate legal entities. In this release SBM Offshore and SBM are sometimes used for convenience where references are made to SBM Offshore N.V. and its subsidiaries in general. These expressions are also used where no useful purpose is served by identifying the particular company or companies. ""SBM Offshore"", the SBM logomark, Fast4Ward, emissionZERO and Float4Wind are proprietary marks owned by SBM Offshore. Attachment Press Release Week 10&11 - March 7 to March 13, 2024 How much was the total repurchase amount for SBM Offshore's share repurchase program? The total repurchase amount for SBM Offshore's share repurchase program was EUR 65,000,000. What was the cumulative quantity of shares repurchased by SBM Offshore? SBM Offshore repurchased a cumulative quantity of 199,106 shares. What was the average repurchase price per share for SBM Offshore? The average repurchase price per share for SBM Offshore was EUR 13.76. What was the percentage of the share repurchase program completed as of March 13, 2024? As of March 13, 2024, SBM Offshore had completed 4.21% of the share repurchase program. Where can detailed information about SBM Offshore's share repurchase program be accessed? Detailed information about SBM Offshore's share repurchase program can be accessed via the Investors section of the Companys website."
Robert Half to Host First Virtual Event of 2024: Overcoming Hiring and Retention Hurdles in Today's Complex Labor Market,2024-03-13T15:30:00.000Z,Low,Neutral,Robert Half to host virtual events focusing on hiring and retention strategies for professionals; highlighting challenges in the labor market.,"Robert Half to Host First Virtual Event of 2024: Overcoming Hiring and Retention Hurdles in Today's Complex Labor Market Rhea-AI Impact (Low) Rhea-AI Sentiment (Neutral) Tags conferences Rhea-AI Summary Robert Half to host virtual events focusing on hiring and retention strategies for professionals; highlighting challenges in the labor market. Positive None. Negative None. 03/13/2024 - 11:30 AM Event to feature retention strategies for remote, hybrid and in-office workers; how to avoid common hiring pitfalls; and AI's impact on the hiring and job search processMENLO PARK, Calif., March 13, 2024 /PRNewswire/ -- Global talent solutions and business consulting firm Robert Half will host a series of free virtual events in 2024 designed specifically for hiring managers and experienced professionals. These sessions will cater to the diverse needs and interests of both seasoned workers and those leading the charge in the hiring landscape. The first of these exclusive events, Overcoming Hiring and Retention Hurdles in Today's Complex Labor Market, is scheduled for March 20, 2024. According to new Robert Half research, 90% of hiring managers report difficulty finding skilled professionals, and 58% said it takes longer to hire for open roles compared to a year ago. Having the right hiring plan in place is key to getting ahead of the competition. This event will feature an interactive discussion with leading industry experts about the current employment landscape and how smart businesses are adapting. Learn about the latest hiring and retention best practices, how companies are implementing these strategies, and how AI and advanced technologies are having an impact. During this event, you'll hear from a panel of leading experts: Trisha Plovie, senior vice president of future of work at Robert HalfMegan Slabinski, district president for technology solutions at Robert HalfTrey Barnette, regional vice president at Robert HalfPeter Morada, head of brand creative at Premera Blue CrossClick here to register for this free event and for additional details. About Robert HalfRobert Half (NYSE: RHI) is the world's first and largest specialized talent solutions firm that connects opportunities at great companies with highly skilled job seekers. Offering contract talent and permanent placement solutions in the fields of finance and accounting, technology, administrative and customer support, legal, and marketing and creative, Robert Half has more than 400 locations worldwide, including nearly 100 locations in 18 countries outside the United States. Robert Half is the parent company of Protiviti, a global consulting firm that provides internal audit, risk, business and technology consulting solutions. Robert Half, including Protiviti, has been named one of the Fortune Most Admired Companies and 100 Best Companies to Work For and is a Forbes Best Employer for Diversity. Explore our comprehensive solutions, research and insights at RobertHalf.com. View original content to download multimedia:https://www.prnewswire.com/news-releases/robert-half-to-host-first-virtual-event-of-2024-overcoming-hiring-and-retention-hurdles-in-todays-complex-labor-market-302088223.html SOURCE Robert Half What is the focus of the virtual events hosted by Robert Half in 2024? The virtual events will focus on hiring and retention strategies for professionals. When is the first exclusive event, Overcoming Hiring and Retention Hurdles in Today's Complex Labor Market, scheduled to take place? The first exclusive event is scheduled for March 20, 2024. What percentage of hiring managers report difficulty finding skilled professionals according to Robert Half research? According to Robert Half research, 90% of hiring managers report difficulty finding skilled professionals. What percentage of hiring managers said it takes longer to hire for open roles compared to a year ago? 58% of hiring managers said it takes longer to hire for open roles compared to a year ago."
Nel ASA: Receives additional USD 75 million in support for Michigan facility,2024-03-13T17:53:00.000Z,Low,Very Positive,"Nel ASA (Nel) receives USD 75 million in incentives and grants from the US Department of Energy and the state of Michigan for a new electrolyser production facility. The support aims to create green industrial jobs and contribute to the energy transition. Nel also secures USD 50 million from DOE for a new gigafactory and workforce development initiatives, along with USD 25 million from Michigan. The total support amounts to approximately USD 125 million, with plans for a 4 GW production capacity in Michigan.","Nel ASA: Receives additional USD 75 million in support for Michigan facility Rhea-AI Impact (Low) Rhea-AI Sentiment (Very Positive) Tags Rhea-AI Summary Nel ASA (Nel) receives USD 75 million in incentives and grants from the US Department of Energy and the state of Michigan for a new electrolyser production facility. The support aims to create green industrial jobs and contribute to the energy transition. Nel also secures USD 50 million from DOE for a new gigafactory and workforce development initiatives, along with USD 25 million from Michigan. The total support amounts to approximately USD 125 million, with plans for a 4 GW production capacity in Michigan. Positive None. Negative None. 03/13/2024 - 01:53 PM OSLO, Norway, March 13, 2024 /PRNewswire/ -- Nel ASA (Nel) (OSE: NEL) - The US Department of Energy (DOE) and the state of Michigan have awarded a collective USD 75 million in cash incentives and grants for Nel's next electrolyser production facility in Michigan. ""The support from the Department of Energy and the state of Michigan is crucial for realizing our factory, which will create new green industrial jobs and be a significant contribution to the energy transition,"" says Nel's President and CEO, Hkon Volldal. ""It is encouraging to see the Department of Energy taking these strategic steps to stimulate a clean energy economy, and we appreciate their long-time support to take our products from R&D to commercial products,"" he says. On 13 March, the Department of Energy announced that they have granted Nel USD 50 million in direct investment support for the company's planned new US gigafactory and workforce development initiatives in the Detroit region. Partnering with General Motors, Macomb Community College, Wayne State University's College of Engineering, and others, DOE's investment will further enhance domestic electrolyser manufacturing production capacity while building a robust clean hydrogen value chain and an industrialized manufacturing training program. In parallel, the state of Michigan awarded USD 25 million in direct investment support to lead the nation in the clean energy transition. ""By harnessing our Make it in Michigan Competitiveness Fund and partnering with the Biden-Harris Administration, we are creating more than 500 good-paying, high-tech jobs in Plymouth,"" says Governor Whitmer. ""Today's investment in Nel Hydrogen will create a hydrogen production facility and ensure we stay on the cutting-edge of clean energy production and advanced manufacturing. Let's keep working together to bring jobs and projects home as we grow our economy and deliver for Michigan families."" ""Today's announcement is another example of how Michigan is leading America's technology and clean energy future,"" says Lieutenant Governor Garlin Gilchrist II. ""Because of a matching investment from the Michigan Competitiveness Fund, this federal grant will enable our partners to create more than 500 good-paying, high-tech jobs in Plymouth. Governor Whitmer and I will keep working to create jobs and win projects that will grow our economy and help more people `make it' in Michigan."" Nel has previously been awarded approximately USD 50 million from the state of Michigan in support of this electrolyser production facility (see the press release issued on 8 July 2023). Total support from federal and state authorities amounts to approximately USD 125 million. Fully built out, the Michigan site is expected to have an annual nameplate production capacity of 4 GW. In the planned new facility, Nel will manufacture its next-generation electrolyser technologies: the PEM stacks currently being developed together with General Motors, and pressurized alkaline stacks. A final investment decision has not yet been made and depends on market demand for electrolysers. For additional information, please contact: Kjell Christian Bjrnsen, CFO, +47 917 02 097 Lars Nermoen, Head of Communications, +47 902 40 153 About Nel ASA | www.nelhydrogen.com Nel has a history tracing back to 1927 and is today a leading pure play hydrogen technology company with a global presence. The company specializes in electrolyser technology for production of renewable hydrogen, and hydrogen fueling equipment for road-going vehicles. Nel's product offerings are key enablers for a green hydrogen economy, making it possible to decarbonize various industries such as transportation, refining, steel, and ammonia. This information is subject to a duty of disclosure pursuant to Section 5-12 of the Norwegian Securities Trading Act. This information was issued as inside information pursuant to the EU Market Abuse Regulation, and was published by Kjell Christian Bjrnsen, Chief Financial Officer, at NEL ASA on the date and time provided. Forward-looking statements: This announcement contains certain forward-looking statements. By their nature, forward-looking statements involve risk and uncertainty because they reflect the company's current expectations and assumptions as to future events and circumstances that may not prove accurate. A number of material factors could cause actual results and developments to differ materially from those expressed or implied by these forward-looking statements. This information was brought to you by Cision http://news.cision.com https://news.cision.com/nel-asa/r/nel-asa--receives-additional-usd-75-million-in-support-for-michigan-facility,c3945534 The following files are available for download: https://mb.cision.com/Main/115/3945534/2667786.pdf Release View original content:https://www.prnewswire.com/news-releases/nel-asa-receives-additional-usd-75-million-in-support-for-michigan-facility-302088416.html SOURCE NEL ASA What incentives and grants did Nel ASA receive? Nel ASA received USD 75 million in incentives and grants from the US Department of Energy and the state of Michigan for a new electrolyser production facility. How much support did Nel ASA secure from the Department of Energy for a new gigafactory? Nel ASA secured USD 50 million from the Department of Energy for a new gigafactory and workforce development initiatives in the Detroit region. What is the total amount of support received by Nel ASA from federal and state authorities? The total support from federal and state authorities amounts to approximately USD 125 million for Nel ASA. What is the expected annual production capacity of the Michigan site for Nel ASA? Fully built out, the Michigan site is expected to have an annual nameplate production capacity of 4 GW for Nel ASA. What electrolyser technologies will Nel ASA manufacture in the planned new facility? In the planned new facility, Nel ASA will manufacture its next-generation electrolyser technologies: the PEM stacks currently being developed together with General Motors, and pressurized alkaline stacks."
"Paychex, Inc. Schedules Third Quarter Fiscal 2024 Earnings Conference Call for March 27, 2024",2024-03-13T18:00:00.000Z,Low,Neutral,"Paychex, Inc. (PAYX) will announce its fiscal 2024 third-quarter financial results on February 29, 2024. The company will host a conference call on March 27, 2024, featuring John Gibson and Bob Schrader. Investors can access the live broadcast on the Paychex Investor Relations portal.","Paychex, Inc. Schedules Third Quarter Fiscal 2024 Earnings Conference Call for March 27, 2024 Rhea-AI Impact (Low) Rhea-AI Sentiment (Neutral) Tags earnings Rhea-AI Summary Paychex, Inc. (PAYX) will announce its fiscal 2024 third-quarter financial results on February 29, 2024. The company will host a conference call on March 27, 2024, featuring John Gibson and Bob Schrader. Investors can access the live broadcast on the Paychex Investor Relations portal. Positive None. Negative None. 03/13/2024 - 02:00 PM ROCHESTER, N.Y.--(BUSINESS WIRE)-- Paychex, Inc. (Nasdaq: PAYX) will release financial results for its fiscal 2024 third quarter ended February 29, 2024. Paychex will deliver results via Business Wire before the financial markets open on Wednesday, March 27, 2024. The company will host a conference call at 9:30 a.m. ET on Wednesday, March 27, 2024, to review the results for the quarter. Participating in this call will be John Gibson, president and CEO, and Bob Schrader, senior vice president and CFO. The conference call will be available online as a live broadcast on the Paychex Investor Relations portal. Listeners should access the site before the live call to ensure proper configuration. After the live call, an on-demand webcast will be archived and available for replay for approximately 90 days. About Paychex Paychex, Inc. (Nasdaq:PAYX) is an industry-leading HCM company delivering a full suite of technology and advisory services in human resources, employee benefit solutions, insurance, and payroll. The company serves approximately 740,000 customers in the U.S. and Europe and pays one out of every 12 American private sector employees. The more than 16,000 people at Paychex are committed to helping businesses succeed and building thriving communities where they work and live. To learn more, visit paychex.com. Paychex, Inc.s news releases, current financial information, SEC filings, and investor presentations are accessible on the Paychex Investor Relations portal. View source version on businesswire.com: https://www.businesswire.com/news/home/20240313384321/en/ Investor Relations: Jason Harbes, Director, Investor Relations Phil Nicosia, Manager, Investor Relations (800) 828-4411 investors@paychex.com Media Inquiries: Tracy Volkmann Manager, Public Relations (585) 387-6705 tvolkmann@paychex.com Source: Paychex, Inc. When will Paychex announce its fiscal 2024 third-quarter financial results? Paychex will release its fiscal 2024 third-quarter financial results on February 29, 2024. Who will be participating in the conference call on March 27, 2024? John Gibson, president and CEO, and Bob Schrader, senior vice president and CFO, will participate in the conference call on March 27, 2024. Where can investors access the live broadcast of the conference call? Investors can access the live broadcast of the conference call on the Paychex Investor Relations portal."
Tilray Wellness Introduces New Superfood Products Powered by Hemp at Expo West,2024-03-13T17:10:00.000Z,Low,Very Positive,"Manitoba Harvest, a leader in hemp-based foods and a subsidiary of Tilray Brands, will debut new superfood breakfast staples at Expo West 2024. The company aims to revolutionize healthy breakfast options with innovative products like Superseed Oatmeal and Bioactive Fiber. Manitoba Harvest's focus on sustainable, nutrient-powered innovation positions them as a key player in the global market for hemp foods.","Tilray Wellness Introduces New Superfood Products Powered by Hemp at Expo West Rhea-AI Impact (Low) Rhea-AI Sentiment (Very Positive) Tags Rhea-AI Summary Manitoba Harvest, a leader in hemp-based foods and a subsidiary of Tilray Brands, will debut new superfood breakfast staples at Expo West 2024. The company aims to revolutionize healthy breakfast options with innovative products like Superseed Oatmeal and Bioactive Fiber. Manitoba Harvest's focus on sustainable, nutrient-powered innovation positions them as a key player in the global market for hemp foods. Positive None. Negative None. 03/13/2024 - 01:10 PM Manitoba Harvest, Pioneers in Hemp and Natural Foods, Will Present New Superfood Breakfast Staples at Expo West March 13-15, 2024NEW YORK and WINNIPEG, Manitoba, March 13, 2024 (GLOBE NEWSWIRE) -- Manitoba Harvest Hemp Foods, a leader in hemp-based foods and a wholly-owned subsidiary of Tilray Brands, Inc. (NASDAQ: TLRY; TSX: TLRY), will showcase groundbreaking innovation at this years Natural Products Expo West, to be held in Anaheim, CA on March 13-15, 2024. Revolutionizing healthy breakfast, Manitoba Harvest will inspire attendees to fuel your day with hemp while sampling their new Superseed Oatmeal and debuting their new Bioactive Fiber for gut-health and regularity. The breakfast category is filled with unsustainable sources of energy, such as caffeine and sugar, states Sam Garfinkel, SVP of Commercial Operations & Strategy at Manitoba Harvest. What consumers want most is healthy, long-lasting sources of energy to fuel active lifestyles. Our latest innovation empowers holistic health with unprecedented nutritional benefits in familiar and delicious formats that the whole family will love. As the global market leader in hemp foods, with retail acceleration spanning from natural channel leader Whole Foods Markets to conventional grocery leader Walmart, Manitoba Harvest is an important staple of the annual Natural Products Expo West and represents the future of sustainable, nutrient-powered innovation. Manitoba Harvest is a Certified B Corp, certified CarbonZero and has pioneered Regenerative Agriculture practices in Hemp. Experience New Innovation from Manitoba Harvest Hemp Foods: Organic Bioactive Fiber: A complete fiber solution with 6g of fiber per serving. Fiber supports healthy digestion and bowel regularity while helping to feel full for longer. In collaboration with Bioactives company Brightseed, this proprietary powder is powered by Brightseed Bio Gut Fiber, an organic, prebiotic hemp fiber that actively supports gut health.*Original Superseed Oatmeal: This hemp hearts, oats and flax super seed blend is good source of 10 essential vitamins and minerals. Boost your breakfast with 10g of Protein, 4g of Fiber and 9g of Omegas 3 & 6 per serving.Apple & Cinnamon Superseed Oatmeal: Packed with apple pieces and warm cinnamon, this super seed blend puts a wholesome twist on a familiar favorite. Boost your breakfast with 10g of Protein, 4g of Fiber and 8g of Omegas 3 & 6 per serving.Maple & Brown Sugar Superseed Oatmeal: This nostalgic childhood standby with craveable maple flakes gives you the fuel you need to look forward to mornings. Boost your breakfast with 10g of Protein, 4g of Fiber and 9g of Omegas 3 & 6 per serving. Find Manitoba Harvest and sample the new Superseed Oatmeal at booth #N805 in the North Hall, Level 1. Full event details are available here. To learn more about Manitoba Harvest, visit manitobaharvest.com. *These statements have not been evaluated by the food and drug administration. This product is not intended to diagnose, treat, cure or prevent any disease. About Manitoba HarvestManitoba Harvest is a pioneer and leader in branded hemp-based foods, and is recognized as a Certified B Corporation and the first Canadian food company to attain a Carbonzero Certification. Taking the seed-to-shelf approach since 1998, Manitoba Harvest is committed to quality, sustainability, and consumer wellness. With an extensive product portfolio of Hemp Hearts (shelled hemp seed), Hemp Protein, Hemp Protein Blends, Hemp Granola, and Hemp Oil, Manitoba Harvest products are sold globally and in approximately 17,000 retail stores across North America. To learn more about Manitoba Harvest and shop, visit www.manitobaharvest.com and follow @manitobaharvest across all social platforms. About Tilray BrandsTilray Brands, Inc. (Nasdaq: TLRY; TSX: TLRY), is a leading global cannabis lifestyle and consumer packaged goods company with operations in Canada, the United States, Europe, Australia, and Latin America that is changing people's lives for the better  one person at a time  by inspiring and empowering a worldwide community to live their very best life, enhanced by moments of connection and wellbeing. Tilrays mission is to be the most responsible, trusted, and market-leading cannabis and consumer products company in the world with a portfolio of innovative, high-quality, and beloved brands that address the needs of the consumers, customers, and patients we serve. A pioneer in cannabis research, cultivation, and distribution, Tilrays unprecedented production platform supports over 20 brands in over 20 countries, including comprehensive cannabis offerings, hemp-based foods, and craft beverages. For more information on how we open a world of well-being, visit www.Tilray.com and follow @tilray on all social platforms. About BrightseedBrightseed is a pioneer in biosciences and artificial intelligence that illuminates nature to restore human health. Brightseeds Forager AI platform accelerates bioactive discovery, biological validation and ingredient formulation from years to months, rapidly revealing new connections between nature and humanity. Brightseed produces clinically proven bioactives for dietary supplements, food & beverage CPG, specialty nutrition and medical foods to power proactive health worldwide. Learn more at brightseedbio.com. Forward-Looking StatementsCertain statements in this communication that are not historical facts constitute forward-looking information or forward-looking statements (together, forward-looking statements) under Canadian securities laws and within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, that are intended to be subject to the safe harbor created by those sections and other applicable laws. Forward-looking statements can be identified by words such as forecast, future, should, could, enable, potential, contemplate, believe, anticipate, estimate, plan, expect, intend, may, project, will, would and the negative of these terms or similar expressions, although not all forward-looking statements contain these identifying words. Certain material factors, estimates, goals, projections or assumptions were used in drawing the conclusions contained in the forward-looking statements throughout this communication. Forward-looking statements include statements regarding our intentions, beliefs, projections, outlook, analyses or current expectations. Many factors could cause actual results, performance or achievement to be materially different from any forward-looking statements, and other risks and uncertainties not presently known to the Tilray or that the Tilray deems immaterial could also cause actual results or events to differ materially from those expressed in the forward-looking statements contained herein. For a more detailed discussion of these risks and other factors, see the most recently filed annual information form of Tilray and the Annual Report on Form 10-K (and other periodic reports filed with the SEC) of Tilray made with the SEC and available on EDGAR. The forward-looking statements included in this communication are made as of the date of this communication and the Tilray does not undertake any obligation to publicly update such forward-looking statements to reflect new information and subsequent events. To Contact Manitoba Harvest: Media: tilraywellness@diffusionpr.com or info@manitobaharvest.com Photos accompanying this announcement are available at: https://www.globenewswire.com/NewsRoom/AttachmentNg/20bd7320-7521-4790-a132-efcc78b600e2 https://www.globenewswire.com/NewsRoom/AttachmentNg/bd556f8a-9ba8-417d-afe2-4f873f2d970f What new products will Manitoba Harvest showcase at Expo West 2024? Manitoba Harvest will present new Superseed Oatmeal and debut their new Bioactive Fiber for gut-health and regularity. What are the key features of Manitoba Harvest's Organic Bioactive Fiber? The Organic Bioactive Fiber offers 6g of fiber per serving, supporting healthy digestion, bowel regularity, and prolonged satiety. What makes Manitoba Harvest's Superseed Oatmeal unique? Manitoba Harvest's Superseed Oatmeal is a blend of hemp hearts, oats, and flax, providing 10 essential vitamins and minerals, 10g of protein, 4g of fiber, and 9g of Omegas 3 & 6 per serving. Where can attendees find Manitoba Harvest at Expo West 2024? Attendees can visit Manitoba Harvest at booth #N805 in the North Hall, Level 1. What certifications does Manitoba Harvest hold? Manitoba Harvest is a Certified B Corp, certified CarbonZero, and has pioneered Regenerative Agriculture practices in Hemp."
Nel ASA: Nel and partners receive about USD 90 million in funding from DoE,2024-03-13T19:28:00.000Z,Low,Neutral,Nel and partners secure $90 million from the Department of Energy for research and development projects.,"Nel ASA: Nel and partners receive about USD 90 million in funding from DoE Rhea-AI Impact (Low) Rhea-AI Sentiment (Neutral) Tags Rhea-AI Summary Nel and partners secure $90 million from the Department of Energy for research and development projects. Positive None. Negative None. 03/13/2024 - 03:28 PM OSE-FILING OSLO, Norway, March 13, 2024 /PRNewswire/ -- Nel, (OSE:NEL). Today, Nel and its partners received around 90 USD million from the Department of Energy (DoE) for seven research and development projects. Nel is the leading partner on one of the projects. About 10 % of the work under the R&D programs will be undertaken by Nel. ""We are thankful for the support from the Department of Energy, which will help accelerate our research and development while solving key challenges for the future of the hydrogen industry,"" says Nel's Vice President for Research and Development, Kathy Ayers. DoE has awarded funding to the following projects in which Nel is one of the partners: Low-Cost, Clean AEM Electrolysis through Transport Property Understanding, Manufacturing Scale-up, and Optimization of Electrodes and Their Interfaces (Nel in lead)Advanced Porous Transport Layer Design and Manufacturing for PEM ElectrolyzersDurable, Low-Cost, Manufacturable AEM Electolyzer ComponentsOxygen Evolution Reaction Catalyst Scale-Up and Validation for Proton Exchange Membrane Water ElectrolyzersPrecious-Metal Free Coatings for PPG PTL AssembliesHigh Performance non-PFSA Membranes for Next-Generation Proton Exchange Membrane (PEM) ElectrolyzersH2CIRC: Circular Recycling for the Hydrogen EconomyLink to the press release from the Department of Energy: https://www.energy.gov/eere/fuelcells/bipartisan-infrastructure-law-clean-hydrogen-electrolysis-manufacturing-and-0?source=email. For additional information, please contact: Kjell Christian Bjrnsen, CFO, +47 917 02 097 Lars Nermoen, Head of Communications, +47 902 40 153 About Nel ASA | www.nelhydrogen.com Nel has a history tracing back to 1927 and is today a leading pure play hydrogen technology company with a global presence. The company specializes in electrolyser technology for production of renewable hydrogen, and hydrogen fueling equipment for road-going vehicles. Nel's product offerings are key enablers for a green hydrogen economy, making it possible to decarbonize various industries such as transportation, refining, steel, and ammonia. This information is subject to a duty of disclosure pursuant to Section 5-12 of the Norwegian Securities Trading Act. This information was issued as inside information pursuant to the EU Market Abuse Regulation, and was published by Kjell Christian Bjrnsen, Chief Financial Officer, at NEL ASA on the date and time provided. Forward-looking statements: This announcement contains certain forward-looking statements. By their nature, forward-looking statements involve risk and uncertainty because they reflect the company's current expectations and assumptions as to future events and circumstances that may not prove accurate. A number of material factors could cause actual results and developments to differ materially from those expressed or implied by these forward-looking statements. This information was brought to you by Cision http://news.cision.com https://news.cision.com/nel-asa/r/nel-asa--nel-and-partners-receive-about-usd-90-million-in-funding-from-doe,c3945629 View original content:https://www.prnewswire.com/news-releases/nel-asa-nel-and-partners-receive-about-usd-90-million-in-funding-from-doe-302088514.html SOURCE NEL ASA How much funding did Nel and its partners receive from the Department of Energy? Nel and its partners received around $90 million from the Department of Energy for seven research and development projects. Who is the leading partner on one of the projects funded by the Department of Energy? Nel is the leading partner on one of the projects funded by the Department of Energy."
Hearing Date Set for Brookfield Reinsurance Acquisition of AEL,2024-03-13T19:42:00.000Z,Low,Neutral,"Brookfield Reinsurance (BNRE) to acquire American Equity Investment Life Holding Company (AEL) with a hearing date set for April 5, 2024. CEO Sachin Shah expresses excitement about the transaction, aiming to strengthen AEL in the U.S. annuity markets.","Hearing Date Set for Brookfield Reinsurance Acquisition of AEL Rhea-AI Impact (Low) Rhea-AI Sentiment (Neutral) Tags acquisition Rhea-AI Summary Brookfield Reinsurance (BNRE) to acquire American Equity Investment Life Holding Company (AEL) with a hearing date set for April 5, 2024. CEO Sachin Shah expresses excitement about the transaction, aiming to strengthen AEL in the U.S. annuity markets. Positive None. Negative None. Market Research Analyst The announcement of the confirmation of a hearing date for the acquisition of American Equity Investment Life Holding Company by Brookfield Reinsurance represents a significant milestone in a transaction that could reshape the competitive landscape of the U.S. annuity markets. This acquisition, if approved, could potentially increase Brookfield Reinsurance's market share and influence in the insurance sector, particularly in annuity products which are a cornerstone for retirement planning in the United States.From a market research perspective, the integration of AEL into Brookfield's operations could result in synergies that enhance product offerings and customer service. Furthermore, the acquisition may lead to cost efficiencies through economies of scale and the consolidation of administrative processes. It's important to monitor how this acquisition might affect Brookfield's financial performance, as well as the potential market reactions in terms of stock price volatility in the short-term following the closure of the deal. Financial Analyst Investors should closely observe the financial metrics and terms of the deal, such as the acquisition price, the method of financing and the expected return on investment. The deal's effect on Brookfield Reinsurance's balance sheet, including any changes in debt levels or cash flows, will be a key area of focus. The long-term success of the acquisition will largely depend on Brookfield's ability to effectively integrate AEL's operations and realize the projected financial benefits.Additionally, the exchangeability of shares between Brookfield Reinsurance and Brookfield Corporation adds a layer of complexity for shareholders to consider. The impact of the acquisition on share value and the potential for dilution of ownership should be analyzed. Shareholders of both companies should evaluate the strategic rationale behind the acquisition and how it aligns with their investment thesis. Legal Expert The regulatory aspect of the acquisition, with the Iowa Insurance Division setting a hearing date, is a crucial step in the process. Regulatory approval is required to ensure that the acquisition does not violate antitrust laws and that it is in the best interest of policyholders and the insurance market as a whole. The outcome of the hearing will be pivotal in determining whether the transaction proceeds.It is also essential to assess the potential legal and regulatory risks associated with the acquisition, including compliance with insurance regulations and the integration of AEL's policies and contracts. Any conditions or restrictions imposed by the regulatory authorities could influence the final structure of the deal and its operational implications for Brookfield Reinsurance. 03/13/2024 - 03:42 PM BROOKFIELD, NEWS, March 13, 2024 (GLOBE NEWSWIRE) -- Brookfield Reinsurance (NYSE, TSX: BNRE) today announced that the Iowa Insurance Division has confirmed a hearing date of April 5, 2024 for the Brookfield Reinsurance acquisition of American Equity Investment Life Holding Company (NYSE: AEL) (AEL). Sachin Shah, CEO of Brookfield Reinsurance said, We are excited to move toward closing this transaction and begin the work of building AEL into a leader in the U.S. annuity markets. We look forward to working with all stakeholders to drive the business forward, and to make a positive impact in the Des Moines community and on AELs policyholders and employees. Brookfield Reinsurance and AEL announced the acquisition on July 5, 2023. The transaction is expected to close shortly after the hearing. Brookfield Reinsurance Ltd. (NYSE, TSX: BNRE, BNRE.A) operates a leading capital solutions business providing insurance and reinsurance services to individuals and institutions. Each class A exchangeable limited voting share and each class A-1 exchangeable non-voting share of Brookfield Reinsurance are exchangeable on a one-for-one basis with a class A limited voting share of Brookfield Corporation. (NYSE/TSX: BN). For more information, please contact: Communications & MediaInvestor RelationsKerrie McHughRachel PowellTel: (212) 618-3469Tel: (416) 956-5141Email: kerrie.mchugh@brookfield.comEmail: Rachel.powell@brookfield.com Cautionary Notice Regarding Forward-Looking Statements Except for historical information, all other information in this press release contains forward-looking information and forward-looking statements within the meaning of applicable Canadian securities laws and the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements related to the proposed acquisition of AEL and the anticipated timing, results, and benefits thereof, and statements regarding managements expectations and beliefs. These forward-looking statements use words and terms such as anticipate, assume, believe, can, continue, could, enable, estimate, expect, foreseeable, goal, improve, intend, likely, may, model, objective, opportunity, outlook, plan, potential, project, remain, risk, seek, should, strategy, target, will, would, and other words and terms of similar meaning or that are otherwise tied to future periods or future performance, in each case in all forms of speech and derivative forms, or similar words, as well as any projections of future events or results. These forward-looking statements, and related oral statements that Brookfield Reinsurance may make, are subject to risks and uncertainties, many of which are beyond Brookfield Reinsurances control, that could cause actual results to differ materially from those projected, anticipated, or implied. For example, (i) conditions to the closing of the transactions may not be satisfied, (ii) the timing of completion of transactions is uncertain, (iii) the business of Brookfield Reinsurance may suffer as a result of uncertainty surrounding the transactions, (iv) events, changes or other circumstances could occur that could give rise to the termination of the merger agreement, (v) there are risks related to disruption of managements attention from the ongoing business operations of Brookfield Reinsurance due to the transactions, (vi) the pendency of the transactions could affect the relationships of Brookfield Reinsurance with its clients, operating results and business generally, including on Brookfield Reinsurances ability to retain employees, (vii) the pendency or consummation of the transactions may have negative effects on Brookfield Reinsurances operating results, (viii) the outcome of any legal proceedings initiated against Brookfield Reinsurance during the pendency of the transactions could adversely affect Brookfield Reinsurance, including its ability to consummate the transactions, (ix) the failure to realize the expected benefit of the transactions and significant transaction costs and/or unknown or inestimable liabilities, (x) the risk that AELs business will not be integrated successfully or that integration may be more difficult, time-consuming or costly than expected and (xi) Brookfield Reinsurance may be adversely affected by other economic, business, and/or competitive factors as well as managements response to any of the aforementioned factors. The foregoing review of important factors should not be construed as exhaustive and should be read in conjunction with the other cautionary statements that are included herein or elsewhere, including the risk factors included in Brookfield Reinsurances Form 20-F and other documents of Brookfield Reinsurance on file with, or furnished to, the SEC. When is the hearing date for Brookfield Reinsurance's acquisition of AEL? The hearing date for the Brookfield Reinsurance acquisition of American Equity Investment Life Holding Company (AEL) is set for April 5, 2024. What is the ticker symbol for Brookfield Reinsurance? The ticker symbol for Brookfield Reinsurance is BNRE. Who is the CEO of Brookfield Reinsurance? Sachin Shah is the CEO of Brookfield Reinsurance. What type of business does Brookfield Reinsurance operate? Brookfield Reinsurance operates a leading capital solutions business providing insurance and reinsurance services to individuals and institutions. When was the acquisition of AEL announced? Brookfield Reinsurance and AEL announced the acquisition on July 5, 2023."
"Toll Brothers Announces Last Chance to Purchase in Diamond Canyon Community in Pleasanton, California",2024-03-13T19:41:00.000Z,No impact,Very Positive,"Toll Brothers, Inc. announces the final opportunity to purchase in Diamond Canyon, a luxury home community in Pleasanton, California. The community offers estate-sized single-family homes with various luxury features starting at $3.34 million.","Toll Brothers Announces Last Chance to Purchase in Diamond Canyon Community in Pleasanton, California Rhea-AI Impact (No impact) Rhea-AI Sentiment (Very Positive) Tags Rhea-AI Summary Toll Brothers, Inc. announces the final opportunity to purchase in Diamond Canyon, a luxury home community in Pleasanton, California. The community offers estate-sized single-family homes with various luxury features starting at $3.34 million. Positive None. Negative None. 03/13/2024 - 03:41 PM PLEASANTON, Calif., March 13, 2024 (GLOBE NEWSWIRE) -- Toll Brothers, Inc. (NYSE:TOL), the nations leading builder of luxury homes, today announced the final opportunity to purchase in Diamond Canyon, an exclusive community of luxurious estate-sized single-family homes located in the charming city of Pleasanton, California. Only six homes remain available at Diamond Canyon, a highly sought-after community nestled within an established tree-lined neighborhood. The community streetscape showcases an array of unmatched architectural designs of estate-sized two-story single-family homes. Toll Brothers homes in Diamond Canyon feature approximately 4,000 to 4,600+ square feet of luxury living space with 5 bedrooms, 5.5 bathrooms, and 3-car garages on expansive home sites. Flexible options are available including multigenerational suites, home offices, alternate workspaces, cabanas, bonus rooms, primary bedroom suite decks, floating staircases, and multi-panel stacking doors in various locations to maximize seamless indoor/outdoor living opportunities. Homes are priced from $3.34 million. Diamond Canyon showcases the epitome of Toll Brothers luxury design, and only a few opportunities remain for our discerning home buyers seeking luxury estate-sized living in this prime Pleasanton neighborhood, said Todd Callahan, Regional President of Toll Brothers for the Pacific Region. Diamond Canyon offers residents an unbeatable location with access to public and private schools within the award-winning Pleasanton Unified School District. This community is situated near the charming downtown area of Pleasanton, providing easy access to local shopping, restaurants, arts and culture, golf courses, parks, and outdoor spaces for residents to enjoy. Commuting is made easy with the 680 and 580 Freeways nearby, and the Pleasanton/Dublin BART station just a short drive away. Home buyers will experience one-stop shopping at the Toll Brothers Design Studio. The state-of-the-art Design Studio allows home buyers to choose from a wide array of selections to personalize their dream home with the assistance of Toll Brothers professional Design Consultants. For more information and to schedule an appointment to tour Diamond Canyon and the Toll Brothers model home, call (844) 790-5263 or visit LiveDiamondCanyon.com. About Toll Brothers Toll Brothers, Inc., a Fortune 500 Company, is the nation's leading builder of luxury homes. The Company was founded 57 years ago in 1967 and became a public company in 1986. Its common stock is listed on the New York Stock Exchange under the symbol TOL. The Company serves first-time, move-up, empty-nester, active-adult, and second-home buyers, as well as urban and suburban renters. Toll Brothers builds in over 60 markets in 24 states: Arizona, California, Colorado, Connecticut, Delaware, Florida, Georgia, Idaho, Illinois, Maryland, Massachusetts, Michigan, Nevada, New Jersey, New York, North Carolina, Oregon, Pennsylvania, South Carolina, Tennessee, Texas, Utah, Virginia, and Washington, as well as in the District of Columbia. The Company operates its own architectural, engineering, mortgage, title, land development, smart home technology, and landscape subsidiaries. The Company also develops master-planned and golf course communities as well as operates its own lumber distribution, house component assembly, and manufacturing operations. In 2024, Toll Brothers marked 10 years in a row being named to the Fortune World's Most Admired Companies list. Toll Brothers has also been named Builder of the Year by Builder magazine and is the first two-time recipient of Builder of the Year from Professional Builder magazine. For more information visit TollBrothers.com. From Fortune, 2024 Fortune Media IP Limited. All rights reserved. Used under license. Contact: Andrea Meck | Toll Brothers, Director, Public Relations & Social Media | 215-938-8169 | ameck@tollbrothers.com Photos accompanying this announcement are available at: https://www.globenewswire.com/NewsRoom/AttachmentNg/f060e6a6-88b1-49f6-adc5-e5592be43ce7 https://www.globenewswire.com/NewsRoom/AttachmentNg/14263d67-7668-48f1-8deb-11fc3690423d Sent by Toll Brothers via Regional Globe Newswire (TOLL-REG) What is the name of the luxury home community mentioned in the press release? The luxury home community mentioned in the press release is Diamond Canyon. Where is Diamond Canyon located? Diamond Canyon is located in the charming city of Pleasanton, California. What are some features of the Toll Brothers homes in Diamond Canyon? Toll Brothers homes in Diamond Canyon feature approximately 4,000 to 4,600+ square feet of luxury living space with 5 bedrooms, 5.5 bathrooms, and 3-car garages on expansive home sites. What options are available for home buyers in Diamond Canyon? Flexible options available include multigenerational suites, home offices, alternate workspaces, cabanas, bonus rooms, primary bedroom suite decks, floating staircases, and multi-panel stacking doors. What is the starting price for homes in Diamond Canyon? Homes in Diamond Canyon are priced from $3.34 million."
BUSY PHILIPPS RETURNS TO LATE-NIGHT WITH 'BUSY THIS WEEK' EXCLUSIVELY ON QVC+,2024-03-13T15:00:00.000Z,Low,Positive,"QVC+ announces the debut of a new original series 'Busy This Week' featuring Busy Philipps, offering an unscripted take on relevant topics, celebrity interviews, and shoppable finds. The show aims to provide a late-night experience for women, premiering on May 8 with a split season format.","BUSY PHILIPPS RETURNS TO LATE-NIGHT WITH 'BUSY THIS WEEK' EXCLUSIVELY ON QVC+ Rhea-AI Impact (Low) Rhea-AI Sentiment (Positive) Tags Rhea-AI Summary QVC+ announces the debut of a new original series 'Busy This Week' featuring Busy Philipps, offering an unscripted take on relevant topics, celebrity interviews, and shoppable finds. The show aims to provide a late-night experience for women, premiering on May 8 with a split season format. Positive None. Negative None. 03/13/2024 - 11:00 AM Streaming service will debut new original series May 8 featuring unscripted take on relevant topics, celebrity guest interviews, must-have shoppable finds and more WEST CHESTER, Pa., March 13, 2024 /PRNewswire/ -- QVC+ today announced New York Times best-selling author, actor, activist and writer Busy Philipps is jumping back into the late-night talk show host seat with ""Busy This Week,"" a new original series exclusively on the QVC+ streaming experience. Executive produced by Busy Philipps, Caissie St. Onge and Michael Gleason, ""Busy This Week"" is the latest original series to join the growing roster of original lifestyle programming on QVC+. During each half-hour episode, viewers will join Busy on the couch to get an unscripted take on whatever has kept us busy this week. From celebrity guest interviews and laugh-out-loud moments to personal stories and her favorite curated shopping finds, Busy will give her audience a healthy dose of [retail] therapy. ""Busy This Week"" will premiere on QVC+ May 8 at 10:00 PM EDT as a split season. The first 10 episodes will be released weekly on Wednesdays, and then four holiday-themed episodes will premiere in November and December for a total of 14 episodes. ""Caissie and I wanted to create a late-night show experience where women feel seen and the topics, guests and products shared are always worthy of that sacred time of day when she finally gets to unwind,"" said Busy Philipps. ""When we tried to get a seat at the late-night table to bring this concept to life, there didn't seem to be any room for women. But when we came to QVC+, they immediately recognized this was something special and we recognized their platform was perfect for reaching our audience. Instead of just giving us a seat, they gave us the whole table."" Caissie St. Onge added: ""While late-night comedy shows have experienced a sea of change over the last few years, the one constant has been the lack of representation by women and for women in the category. There's an audience of women today who feel largely forgotten when it comes to late-night shows. That's why Busy and I wanted to create a show where they finally felt represented and could see themselves reflected in every episode."" Bringing an added unique layer to the show experience, ""Busy This Week"" will have a series show page featuring shoppable products from each episode including Busy and Caissie's weekly looks, set dcor and Busy's favorite new brands featured on the show, which viewers can easily shop through QVC.com. Busy is also no stranger to the QVC+ family having first debuted on the channel in December 2022 in the holiday special ""Busy for the Holidays"" where she shared her best tips, tricks, hacks and snacks to get through the season stress-free. ""We know our customers come to us for an escape from the never-ending demands in their daily lives. So, it's critical the content we create makes them feel like they belong  and creates an environment they want to be part of  through the connections they build with our hosts, guests, and the brands we offer,"" said Stacie Tedesco, VP, Interim Streaming GM, Qurate Retail Group. ""We're reimagining our streaming experience by focusing on highly curated, story-driven shoppable entertainment that not only inspires, but also earns her time. And that's exactly what our customers will experience every time they tune-in for 'Busy This Week' on QVC+ with host Busy Philipps."" The QVC+ and HSN+ combined streaming experience is available free in more than 100 million internet-connected homes across the U.S. and offers QVC and HSN's most robust, comprehensive video commerce experience, with live, on-demand and streaming-only content together in one, easy-to-use, fully shoppable app. Missed a show or episode? Not a problem. You can watch your favorite programs via the QVC+ and HSN+ streaming experience anytime with Video on Demand. Fans can also download QVC+ and HSN+ to their favorite streaming platforms and devices for free here. About Busy PhilippsBusy Philipps is a New York Times best-selling author, actor, activist and writer, and previously was the late-night talk show host of ""Busy Tonight"" which she executive produced with Tina Fey and Caissie St. Onge. She is best known for her current roles in the hit comedy series ""Girls5Eva"" opposite Sara Bareilles, and in ""Mean Girls,"" the feature adaptation of the Broadway smash ""Mean Girls: The Musical,"" where she plays the iconic role of 'Mrs. George' alongside Renee Rapp, Tina Fey and Jenna Fischer. In 2020, Busy launched her popular podcast ""Busy Philipps is Doing Her Best,"" produced and co-hosted by Caissie St. Onge. Fans can also read a collection of humorous autobiographical essays in Busy's New York Times Best Seller ""This Will Only Hurt a Little"" published by Simon and Schuster's Touchstone division. Additional film and TV credits include ""I Feel Pretty,"" ""The Gift,"" ""A Case of You,"" ""I Don't Know How She Does It,"" ""He's Just Not That into You,"" ""Made of Honor,"" ""Vice Principles,"" ""Cougar Town,"" ""Dawson's Creek"" and ""Freaks and Geeks."" About QVC+ and HSN+ Streaming ExperienceThe QVC+ and HSN+ combined streaming experience is available free in more than 100 million internet-connected homes across the U.S. and offers QVC and HSN's most robust, comprehensive video commerce experience, with live, on-demand and streaming-only content together in one, easy-to-use, fully shoppable app. QVC and HSN are world leaders in video commerce (""vCommerce""), which includes video-driven shopping across linear TV, ecommerce sites, digital streaming and social platforms. The QVC+ and HSN+ streaming experience combines streaming-only show episodes, five digital-only linear channels  Fashion Finds, In The Kitchen, a rotating seasonally-themed channel, QVC West and HSN West, and five linear broadcast channels  QVC, QVC2, QVC3, HSN and HSN2. Fans can download the QVC+ and HSN+ app to their favorite streaming devices for free here. The app is available on Roku; Comcast X1, Xfinity Flex and Xumo TV; Amazon Fire TV; LG; Apple TV; and Android TV, the Google Play Store, Google TV, Samsung Smart TV, Cox Contour and Contour Stream Player, and VIZIO Smart TV. For more information, visit: https://plus.qvc.com/ Qurate Retail, Inc. (NASDAQ: QRTEA, QRTEB, QRTEP) is a Fortune 500 company that includes the Qurate Retail GroupSM portfolio of brands as well as other minority interests. Qurate Retail Group is the largest player in vCommerce and comprises six leading retail brands  QVC, HSN, Ballard Designs, Frontgate, Garnet Hill and Grandin Road  all dedicated to providing a more human way to shop. For more information, visit qurateretailgroup.com or follow Qurate Retail Group on YouTube or LinkedIn. QVC and Q are registered service marks of ER Marks, Inc. View original content to download multimedia:https://www.prnewswire.com/news-releases/busy-philipps-returns-to-late-night-with-busy-this-week-exclusively-on-qvc-302088226.html SOURCE Qurate Retail Group When will 'Busy This Week' premiere on QVC+? 'Busy This Week' will premiere on QVC+ on May 8 at 10:00 PM EDT. Who are the executive producers of 'Busy This Week'? The executive producers of 'Busy This Week' are Busy Philipps, Caissie St. Onge, and Michael Gleason. What is the unique feature of 'Busy This Week' show page? The show page of 'Busy This Week' will feature shoppable products from each episode, including Busy and Caissie's looks, set dcor, and favorite brands. How can viewers watch 'Busy This Week' if they miss an episode? Viewers can watch 'Busy This Week' via Video on Demand on the QVC+ and HSN+ streaming experience if they miss an episode. Where is the QVC+ and HSN+ combined streaming experience available? The QVC+ and HSN+ combined streaming experience is available free in over 100 million internet-connected homes across the U.S."
Falcon Hires Centreline for Great Burnt Drilling,2024-03-13T14:30:00.000Z,Low,Positive,Falcon Gold Corp. awards drilling contract for Great Burnt Copper Project in Newfoundland. The Company plans to test geophysical anomalies with up to 1100 meters of drilling. Benton Resources Inc. recently optioned the Great Burnt Copper-Gold Project. Falcon holds potential in the Great Burnt Greenstone Belt for copper and gold. CEO expresses excitement for exploration drilling at the project.,"Falcon Hires Centreline for Great Burnt Drilling Rhea-AI Impact (Low) Rhea-AI Sentiment (Positive) Tags management Rhea-AI Summary Falcon Gold Corp. awards drilling contract for Great Burnt Copper Project in Newfoundland. The Company plans to test geophysical anomalies with up to 1100 meters of drilling. Benton Resources Inc. recently optioned the Great Burnt Copper-Gold Project. Falcon holds potential in the Great Burnt Greenstone Belt for copper and gold. CEO expresses excitement for exploration drilling at the project. Positive None. Negative None. 03/13/2024 - 10:30 AM VANCOUVER, BC / ACCESSWIRE / March 13, 2024 / Falcon Gold Corp. (FG:TSXV)(3FA:GR)(FGLDF:OTCQB); (""Falcon"" or the ""Company"") is pleased to announce that the Company has awarded a drilling contract to CentreLine Drilling of Newfoundland to conduct a diamond drilling program at its 100% owned Great Burnt Copper Project in Central Newfoundland. The Company initially plans to test up to ten geophysical anomalies with a maximum of 1100 metres of drilling. Falcon will provide further guidance on an estimated drill start date once logistics for the program are determined and remaining service providers are confirmed.Falcon holds 2,275 hectares in the Great Burnt camp, with licenses located north of, and contiguous to, Benton Resources Inc. - Spruce Ridge Resources Ltd. Great Burnt Copper-Gold joint venture (see Figure 1). Benton Resources Inc. (""Benton"") recently optioned the Great Burnt Copper-Gold Project from Spruce Ridge Resources Ltd. (""Spruce Ridge"") in an agreement that allows Benton to earn a 70% interest in the property (see press release dated August 17, 2023). The Benton-Spruce Ridge property is host to the Great Burnt Copper Zone, a deposit with an indicated resource of 381,300 tonnes at 2.68% Cu and inferred resources of 663,100 tonnes at 2.10% Cu (https://www.spruceridgeresources.com/great-burnt.php). Recent drilling by Benton at the Great Burnt Copper Deposit reported drill results that returned 7.20% Cu, 7.12 g/t Ag, and 0.05% Co over 12.30 metres (see press release dated December 5, 2023). Previous drilling in 2020 by Spruce Ridge reported 8.06% Cu over 27.2 m (TSXV: SHL press release dated March 18, 2021). The Great Burnt Greenstone Belt is prospective for copper and gold, and further hosts the South Pond A and South Pond B copper-gold zones, and the End Zone copper prospect along a 14 km mineralized corridor. The mineralized corridor occurs along a conductive trend, and this conductive trend continues into Falcon's Great Burnt Copper Property (see right-hand-side image in Figure 2). The presence of mineral occurrences within ground adjacent to Falcon's Great Burnt Copper Property cannot be used as an indication of mineralization within Falcon's property itself.Figure 1. Location of proposed drilling within Falcon's recent acquisition proximal to the Benton - Spruce Ridge Great Burnt Copper-Gold joint venture in Central Newfoundland. Karim Rayani, Chief Executive Officer, commented; ""We are very excited to move forward on our first phase of exploration drilling at our Great Burnt Copper Project. The Great Burnt camp is quickly becoming recognized for its high-grade copper tenor demonstrated by Benton Resources Inc.'s recent successful drilling (see Benton Resources Inc. press release dated January 30, 2024). Benton's success at Great Burnt and recent press releases from FireFly Metals Ltd that disclose plans to advance the high-grade Green Bay Copper-Gold project in the Rambler camp have put the copper potential of VMS Deposits in Newfoundland front and center. The Green Bay Copper-Gold project hosts a mineral inventory that includes aggregate measured, indicated and inferred resources of 39.2Mt @1.83% Cu (click here to view the report). We believe that Benton's recent success at Great Burnt is a testament to the untapped VMS potential of the Great Burnt area, and we are thrilled to hold an extensive strike extent of this unexplored, never-drilled horizon.""The Great Burnt Copper PropertyThe property is hosted within the Great Burnt Greenstone Belt (GBGB) which hosts massive sulphide deposits that have been interpreted as Besshi-type. These types of deposits generally occur as laterally extensive sheets of pyrrhotite- or pyrite-rich sulphide rock within mixed volcanic-sedimentary environments. Sulphide lenses can be several metres thick and extend for several kilometres. Besshi-type massive-sulphide deposits are generally copper dominant, commonly contain other lithophile elements like cobalt or lead, and can contain precious metals such as gold and silver. The property is also located four km west of the Crest Resources-Exploits Discovery joint venture project within the Exploits Subzone. The Exploits Subzone contains deep-seated gold-bearing structures of the Dog Bay-Appleton Fault-GRUB Line deformation corridor that contains the high-grade Keats Gold Zone of New Found Gold Corp.Figure 2. Great Burnt Copper Project area with Falcon claims in orange and Benton - Spruce Ridge Great Burnt Copper-Gold joint venture in blue. New claims cover conductive trends hosting copper and gold mineralization. Qualified PersonThe technical content of this news release has been reviewed and approved by Greg Robinson, P.Geo., who is a Qualified Person as defined by National Instrument 43-101, Standards of Disclosure for Mineral Projects.The QP and the Company have not completed sufficient work to verify the historical information on the properties comprising the Great Burnt Copper Property claim group, particularly regarding historical exploration, neighbouring companies, and government geological work. The QP and the Company further acknowledge that the presence of mineral occurrences within property adjacent to Falcon's Great Burnt Copper Property cannot be used as an indication for mineralization to occur within Falcon's property itself.About Falcon Gold Corp.Falcon is a Canadian mineral exploration company focused on generating, acquiring, and exploring opportunities in the Americas. Falcon's flagship project, the Central Canada Gold Mine, is approximately 20 km southeast of Agnico Eagle's Hammond Reef Gold Deposit which has currently an estimated 3.32 million ounces of gold (123.5 million tonnes grading 0.84 g/t gold) mineral reserves, and 2.3 million ounces of measured and indicated mineral resources (133.4 million tonnes grading 0.54 g/t gold). The Hammond Reef gold property lies on the Hammond shear zone, which is a northeast-trending splay off the Quetico Fault Zone (""QFZ"") and may be the control for the gold deposit. The Central Gold property lies on a similar major northeast-trending splay of the QFZ.The Company holds multiple additional projects: the Viernes and Area 51 Gold/Silver/Copper projects in the world class copper cluster located Antofagasta Chile; the Springpole West Property in the world-renowned Red Lake mining camp; a 49% interest in the Burton Gold property with Iamgold near Sudbury Ontario; the Spitfire-Sunny Boy, and Gaspard Gold claims in B.C.; the Great Burnt, and Golden Brook projects adjacent to First Mining, Matador, Benton-Sokoman's JV, and Marvel Discovery in Central Newfoundland; and most recently battery metals projects, Timmins West Nickel-Copper-Cobalt Property Ontario, Outarde Nickel-Copper-Cobalt Property, HSP Nickel -Copper property in northern Quebec and the Havre St. Pierre Anorthosite Complex respectively.CONTACT INFORMATION:Falcon Gold Corp.""Karim Rayani""Karim RayaniChief Executive Officer, DirectorTelephone: (604) 716-0551Email: info@falcongold.caCHF Capital MarketsCathy HumeChief Executive OfficerTelephone: (416) 868-1079 x 251Email: cathy@chfir.comWebsite: www.falcongold.ca Twitter: @FalconGoldCorpFacebook: @FalconGoldCorp LinkedIn: @FalconGoldCorpInstagram: @FalconGoldCorpNeither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.Cautionary Language and Forward-Looking StatementsThis news release may contain forward-looking statements including but not limited to comments regarding the timing and content of upcoming work programs, geological interpretations, receipt of property titles, etc. Forward-looking statements address future events and conditions and therefore, involve inherent risks and uncertainties. Actual results may differ materially from those currently anticipated in such statements.SOURCE: Falcon Gold CorpView the original press release on accesswire.com What project is Falcon Gold Corp. conducting a drilling program for? Falcon Gold Corp. is conducting a diamond drilling program at its 100% owned Great Burnt Copper Project in Central Newfoundland. Which company recently optioned the Great Burnt Copper-Gold Project? Benton Resources Inc. recently optioned the Great Burnt Copper-Gold Project from Spruce Ridge Resources Ltd. What are some of the mineralized zones in the Great Burnt Greenstone Belt? The Great Burnt Greenstone Belt hosts the South Pond A and South Pond B copper-gold zones, and the End Zone copper prospect along a 14 km mineralized corridor. What is the significance of Falcon's Great Burnt Copper Property in relation to mineral occurrences? The presence of mineral occurrences within ground adjacent to Falcon's Great Burnt Copper Property cannot be used as an indication of mineralization within Falcon's property itself. Who is the Qualified Person responsible for reviewing the technical content of the news release? Greg Robinson, P.Geo., is the Qualified Person responsible for reviewing the technical content of the news release."
loanDepots Toy Eng Named Top Producer on State of New York Mortgage Agencys 2023 Hall of Fame,2024-03-13T19:55:00.000Z,No impact,Very Positive,"loanDepot's loan originator Toy Eng earns top spot on SONYMA's 2023 Hall of Fame list for supporting first-time homebuyers, showcasing commitment to diverse communities and sustainable homeownership.","loanDepots Toy Eng Named Top Producer on State of New York Mortgage Agencys 2023 Hall of Fame Rhea-AI Impact (No impact) Rhea-AI Sentiment (Very Positive) Tags Rhea-AI Summary loanDepot's loan originator Toy Eng earns top spot on SONYMA's 2023 Hall of Fame list for supporting first-time homebuyers, showcasing commitment to diverse communities and sustainable homeownership. Positive None. Negative None. 03/13/2024 - 03:55 PM Honor recognizes loan originators commitment to serving the increasingly diverse communities of first-time homebuyers IRVINE, Calif.--(BUSINESS WIRE)-- loanDepot, Inc. (""LDI"" or ""Company"") (NYSE: LDI) originator Toy Eng earned the top spot on the State of New York Mortgage Agencys (SONYMA) 2023 Hall of Fame list recognizing loan officers who support the agencys mission to serve first-time homebuyers. loanDepot is a leading provider of home lending solutions that enables customers to achieve the dream of homeownership. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240313410462/en/loanDepot originator Toy Eng earned the top spot on the State of New York Mortgage Agencys (SONYMA) 2023 Hall of Fame list recognizing loan officers who support the agencys mission to serve first-time homebuyers. (Photo: Business Wire) SONYMA provides educational resources and access to affordable homeownership by removing many of the hurdles faced by first-time homebuyers. The agency offers low-interest mortgage loans to help qualified buyers purchase their first home, along with down payment assistance programs and specialized add-ons to support their unique needs. ""I got into this business after seeing what can happen to families who werent properly prepared for homeownership,"" said Eng. ""Achieving and maintaining homeownership involves so much more than just getting a mortgage  and Ive made it my personal mission to steward sustainable homeownership through thoughtful guidance and support for those who need it the most. Its such an honor to make it to the top of SONYMAs Hall of Fame list  and its even more rewarding to play a role in making homeownership a reality for underserved communities in my great state of New York."" Eng has dedicated her 15-year career as a loan consultant to empowering first-time homebuyers and advocating for sustainable homeownership. She's driven to guide aspiring homeowners towards stable homeownership, investing time in educating and counseling. She ensures her customers understand the intricacies of the homebuying process and homeownership journey, including budgeting and financial planning. ""Toy is a true champion for accessible and sustainable housing within her community, and she embodies loanDepots purpose-driven mission by going above and beyond for the increasingly diverse communities of first-time homebuyers,"" said loanDepot EVP John Bianchi. ""Her commitment to guiding families towards their dreams of owning a home is truly inspiring, and were proud to celebrate her well-deserved recognition."" Eng's commitment extends beyond her professional duties  she volunteers for organizations focused on supporting affordable housing including Community Housing Innovations and Yonkers Affordable Housing  where she generously offers her expertise to support underserved homebuyers in achieving their dreams of homeownership. Having first been honored by SONYMA at No. 15 in 2016, Eng's rise through the agencys Hall of Fame has steadily advanced each year, reaching the No. 2 spot in 2022. About loanDepot loanDepot (NYSE: LDI; NMLS # 174457) is an equal housing lender and digital commerce company committed to serving its customers throughout the home ownership journey. Since its launch in 2010, loanDepot has revolutionized the mortgage industry with a digital-first approach that makes it easier, faster and less stressful to purchase or refinance a home. Today, as one of the nation's largest non-bank retail mortgage lenders, loanDepot enables customers to achieve the American dream of homeownership through a broad suite of lending and real estate services that simplify one of life's most complex transactions. With headquarters in Southern California and offices nationwide, loanDepot is committed to serving the communities in which its team lives and works through a variety of local, regional and national philanthropic efforts. View source version on businesswire.com: https://www.businesswire.com/news/home/20240313410462/en/ Jonathan Fine VP, Public Relations (781) 248-3963 jfine@loandepot.com Source: loanDepot, Inc. Who earned the top spot on SONYMA's 2023 Hall of Fame list? loanDepot's loan originator Toy Eng. What is loanDepot's ticker symbol? LDI. What is SONYMA's mission? SONYMA's mission is to serve first-time homebuyers by providing educational resources and access to affordable homeownership. How long has Toy Eng been in the loan consultant career? Toy Eng has dedicated her 15-year career as a loan consultant to empowering first-time homebuyers. What organizations does Toy Eng volunteer for? Toy Eng volunteers for organizations focused on supporting affordable housing, including Community Housing Innovations and Yonkers Affordable Housing."
Gaxos.ai Inc. Announces $3.5 Million Private Placement Priced At-The-Market under Nasdaq Rules,2024-03-13T19:07:00.000Z,Neutral,Neutral,"Gaxos.ai Inc. (NASDAQ: GXAI) announced a private placement of common stock and warrants, totaling 628,367 shares, at a purchase price of $5.57 per share. The series A and short-term series B warrants have exercise prices of $5.50 per share and expire at different intervals. The private placement is set to close soon.","Gaxos.ai Inc. Announces $3.5 Million Private Placement Priced At-The-Market under Nasdaq Rules Rhea-AI Impact (Neutral) Rhea-AI Sentiment (Neutral) Tags AI Rhea-AI Summary Gaxos.ai Inc. (NASDAQ: GXAI) announced a private placement of common stock and warrants, totaling 628,367 shares, at a purchase price of $5.57 per share. The series A and short-term series B warrants have exercise prices of $5.50 per share and expire at different intervals. The private placement is set to close soon. Positive None. Negative None. Financial Analyst The private placement of common stock and warrants by Gaxos.ai Inc. represents a strategic move to raise capital, likely aimed at funding ongoing operations or expanding their AI technology development. The capital infusion, priced at $5.57 per share, is in line with market regulations, which suggests a fair valuation and adherence to market rules. However, it's critical to assess the dilutive impact on existing shareholders. The immediate exercisability of the warrants could lead to a potential increase in the number of shares outstanding, which may depress the stock price in the short term if the market perceives the terms as unfavorable.From a long-term perspective, the use of the raised funds is paramount. If the capital is allocated efficiently towards projects with high return potential, it could lead to future growth and profitability, thereby offsetting the initial dilution. Investors should closely monitor the company's deployment of the raised capital and any subsequent earnings guidance. Market Research Analyst Gaxos.ai's engagement in a private placement transaction signals a proactive approach to capital management. Given the competitive nature of the AI sector, raising capital through such means is not uncommon. It is essential to understand the market sentiment towards Gaxos.ai's growth prospects and how this capital raise aligns with its strategic initiatives. The exercise price of $5.50 for both series A and B warrants is slightly below the purchase price, which could be perceived as an incentive for investors to exercise these warrants, potentially leading to increased investor confidence.However, the market's response to the private placement will largely depend on Gaxos.ai's current market positioning, its technological edge over competitors and the clarity of its growth strategy. Investors would benefit from a comparative analysis of Gaxos.ai's performance metrics against industry benchmarks to gauge the potential impact of this transaction on the company's market value. Legal Expert The structuring of Gaxos.ai's private placement, including the issuance of series A and B warrants, must comply with the Nasdaq rules governing at-the-market offerings. This compliance ensures that the transaction meets regulatory standards, which is crucial for investor protection. The details regarding the exercisability and expiration of the warrants are significant, as they define the timeframe in which investors can potentially influence the company's share structure. Legal transparency in such transactions is essential to maintain investor trust and to prevent any potential legal disputes related to securities law.Investors should also consider the governance implications of such a transaction. The addition of new investors through a private placement could alter the balance of power among shareholders, especially if the new shares represent a significant proportion of the company's equity. It is advisable for investors to review the terms of the agreement in detail to understand their rights and any changes to shareholder voting dynamics. 03/13/2024 - 03:07 PM Roseland, NJ, March 13, 2024 (GLOBE NEWSWIRE) -- Gaxos.ai Inc. (NASDAQ: GXAI), (Gaxos or the Company), a company developing artificial intelligence applications across various sectors, today announced that it has entered into definitive agreements for the purchase and sale of an aggregate of 628,367 shares of common stock (or pre-funded warrant in lieu thereof), series A warrants to purchase up to 628,367 shares of common stock and short-term series B warrants to purchase up to 628,367 shares of common stock at a purchase price of $5.57 per share (or per pre-funded warrant in lieu thereof) and accompanying warrants, in a private placement priced at-the-market under Nasdaq rules. The series A warrants and short-term series B warrants will have an exercise price of $5.50 per share and will be exercisable immediately upon issuance. The series A warrants will expire five and one-half years from the date of issuance and the short-term series B warrants will expire twenty-four months from the date of issuance. The private placement is expected to close on or about March 15, 2024, subject to the satisfaction of customary closing conditions. H.C. Wainwright & Co. is acting as the exclusive placement agent for the offering. The gross proceeds from the offering are expected to be approximately $3.5 million, prior to deducting placement agents fees and other offering expenses payable by Gaxos. Gaxos intends to use the net proceeds from the offering for working capital and other general corporate purposes. The securities described above are being offered in a private placement under Section 4(a)(2) of the Securities Act of 1933, as amended (the Securities Act), and/or Regulation D promulgated thereunder and, along with the shares of common stock underlying the warrants, have not been registered under the Securities Act, or applicable state securities laws. Accordingly, the warrants and underlying shares of common stock may not be offered or sold in the United States except pursuant to an effective registration statement or an applicable exemption from the registration requirements of the Securities Act and such applicable state securities laws. Pursuant to a registration rights agreement with investors, the Company has agreed to file a resale registration statement covering the securities described above. This press release shall not constitute an offer to sell or a solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or other jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such state or other jurisdiction. About Gaxos.ai Inc. Gaxos.ai isnt just developing applications; its aim is to redefine the human-AI relationship. Our offerings are being expanded to include health and wellness, as well as gaming. Were committed to addressing health, longevity, and entertainment, through AI solutions. Forward-Looking Statements All statements other than statements of historical fact in this announcement are forward-looking statements that involve known and unknown risks and uncertainties and are based on current expectations and projections about future events and financial trends that the Company believes may affect its financial condition, results of operations, business strategy, and financial needs and are subject to market and other conditions. Investors can identify these forward-looking statements by words or phrases such as may, will, expect, anticipate, aim, estimate, intend, plan, believe, potential, continue, is/are likely to or other similar expressions. Forward-looking statements include statements regarding, the ability of the Company to consummation of the private placement, the satisfaction of the closing conditions of the private placement and the use of proceeds therefrom. The Company undertakes no obligation to update forward-looking statements to reflect subsequent occurring events or circumstances, or changes in its expectations, except as may be required by law. Although the Company believes that the expectations expressed in these forward-looking statements are reasonable, it cannot assure you that such expectations will turn out to be correct, and the Company cautions investors that actual results may differ materially from the anticipated results and encourages investors to review other factors that may affect its future results in the Companys filings with the SEC. Gaxos.ai Inc. Company Contact Investor Relations E: ir@gaxos.ai T: 1-888-319-2499 What did Gaxos.ai Inc. (GXAI) announce? Gaxos.ai Inc. announced a private placement of common stock and warrants. How many shares were involved in the private placement? A total of 628,367 shares were part of the private placement. At what price were the shares sold? The shares were sold at a price of $5.57 per share. What are the exercise prices for the warrants? The series A warrants and short-term series B warrants have exercise prices of $5.50 per share. When do the series A warrants expire? The series A warrants will expire five and a half years from the date of issuance. When do the short-term series B warrants expire? The short-term series B warrants will expire twenty-four months from the date of issuance. When is the private placement expected to close? The private placement is expected to close soon."
Yangaroo Announces Appointment of CFO,2024-03-13T15:20:00.000Z,Low,Neutral,"YANGAROO Inc. appoints Mr. Frank Guo as Chief Financial Officer, bringing extensive finance experience and expertise to enhance financial strategies and operations.","Yangaroo Announces Appointment of CFO Rhea-AI Impact (Low) Rhea-AI Sentiment (Neutral) Tags management Rhea-AI Summary YANGAROO Inc. appoints Mr. Frank Guo as Chief Financial Officer, bringing extensive finance experience and expertise to enhance financial strategies and operations. Positive None. Negative None. 03/13/2024 - 11:20 AM Toronto, Ontario--(Newsfile Corp. - March 13, 2024) - YANGAROO Inc. (TSXV: YOO) (OTC PINK: YOOIF) (the ""Company""), a software leader in media asset workflow solutions for the advertising and entertainment industries, is pleased to announce the appointment of Mr. Frank Guo as the Company's Chief Financial Officer, effective March 13, 2024.Mr. Guo is a seasoned finance executive with over ten years of experience in enhancing financial and accounting frameworks to support organizational objectives. He holds the designations of Chartered Financial Analyst (CFA) and Certified Public Accountant (CPA), in addition to an MBA from the Ivey School of Business. Mr. Guo's extensive background includes roles in which he was instrumental in refining financial strategies and operations. His expertise in financial modeling, strategic planning, and stakeholder engagement, combined with a solid foundation in ASPE, IFRS, and US GAAP financial reporting, positions him well to lead the Company's financial team. In his previous roles, Mr. Guo demonstrated a strong capability in navigating companies through growth and transition phases, making significant contributions towards operational efficiencies and financial stability.Grant Schuetrumpf, Chief Executive Officer of the Company, commented ""We look forward to Mr. Guo's leadership in financial management as we continue to pursue our strategic objectives and aim to deliver value to our shareholders.""About YANGAROO:Yangaroo is a software leader in media asset workflow and distribution solutions for the advertising, music, and awards industries. YANGAROO's patented Digital Media Distribution System is a leading secure business-to-business cloud-based solution that incorporates production services, traffic, clearance, delivery, analytics, and secure API integration for the industry's various video and audio workflow challenges.YANGAROO has offices in Toronto, New York, and Los Angeles. YANGAROO trades on the TSX Venture Exchange (TSXV) under the symbol YOO and in the U.S. under OTCBB: YOOIF.###For YANGAROO Investor Inquiries:Grant SchuetrumpfPhone: (416) 534-0607investors@yangaroo.comCautionary Note Regarding Forward-looking Statements This news release contains certain forward-looking statements and forward-looking information (collectively referred to herein as ""forward-looking statements"") within the meaning of applicable Canadian securities laws. All statements other than statements of present or historical fact are forward-looking statements. Forward-looking statements are often, but not always, identified by the use of words such as ""anticipate"", ""achieve"", ""could"", ""believe"", ""plan"", ""intend"", ""objective"", ""continuous"", ""ongoing"", ""estimate"", ""outlook"", ""expect"", ""may"", ""will"", ""project"", ""should"" or similar words, including negatives thereof, suggesting future outcomes. Forward looking statements are subject to both known and unknown risks, uncertainties and other factors, many of which are beyond the control of YANGAROO, that may cause the actual results, level of activity, performance or achievements of YANGAROO to be materially different from those expressed or implied by such forward looking statements. Although YANGAROO has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking statements, there may be other factors that cause results not to be as anticipated, estimated or intended. The Company is making forward-looking statements with respect to, including but not limited to, the impact on the Company of the CFO appointment. Forward-looking statements are not a guarantee of future performance and involve a number of risks and uncertainties, some of which are described herein. Such forward-looking statements necessarily involve known and unknown risks and uncertainties, which may cause YANGAROO's actual performance and results to differ materially from any projections of future performance or results expressed or implied by such forward-looking statements. Any forward-looking statements are made as of the date hereof and, except as required by law, neither YANGAROO assumes no obligation to publicly update or revise such statements to reflect new information, subsequent or otherwise.To view the source version of this press release, please visit https://www.newsfilecorp.com/release/201556 Who is the new Chief Financial Officer of YANGAROO Inc.? Mr. Frank Guo is the new Chief Financial Officer of YANGAROO Inc. What are Mr. Frank Guo's qualifications? Mr. Frank Guo holds the designations of Chartered Financial Analyst (CFA) and Certified Public Accountant (CPA), in addition to an MBA from the Ivey School of Business. What is Mr. Frank Guo's expertise? Mr. Frank Guo has expertise in financial modeling, strategic planning, stakeholder engagement, and financial reporting standards such as ASPE, IFRS, and US GAAP. What did Grant Schuetrumpf, the CEO, say about Mr. Frank Guo's appointment? Grant Schuetrumpf, the CEO, expressed anticipation for Mr. Guo's leadership in financial management to achieve strategic objectives and deliver value to shareholders."
PNC Names Michael Thomas Head of Corporate & Institutional Banking,2024-03-13T18:04:00.000Z,Low,Neutral,"PNC Bank appoints Michael Thomas as head of Corporate & Institutional Banking, succeeding Michael P. Lyons. Thomas brings extensive experience and strong performance to the role, overseeing key areas like debt capital markets and real estate banking. PNC's C&IB business offers a range of financial products and services to clients in the U.S. and Canada, positioning PNC as a leading financial institution in the region.","PNC Names Michael Thomas Head of Corporate & Institutional Banking Rhea-AI Impact (Low) Rhea-AI Sentiment (Neutral) Tags Rhea-AI Summary PNC Bank appoints Michael Thomas as head of Corporate & Institutional Banking, succeeding Michael P. Lyons. Thomas brings extensive experience and strong performance to the role, overseeing key areas like debt capital markets and real estate banking. PNC's C&IB business offers a range of financial products and services to clients in the U.S. and Canada, positioning PNC as a leading financial institution in the region. Positive None. Negative None. 03/13/2024 - 02:04 PM PITTSBURGH, March 13, 2024 /PRNewswire/ -- PNC Bank today announced that Michael Thomas has been named head of Corporate & Institutional Banking (C&IB), effective immediately. Based in Pittsburgh, Thomas will report to Michael P. Lyons, president. Thomas succeeds Lyons in the role, after Lyons was appointed president Feb. 20, 2024. ""Mike brings a unique depth and breadth of experience and a history of strong performance and collaboration to his new role,"" said Lyons. ""I am confident the C&IB business will continue to flourish under his leadership."" During his 27-year career at PNC, Thomas has held progressive leadership roles in Debt Capital Markets and Real Estate Banking. Since 2020, he has served as head of PNC's Real Estate business, where he has played a key role in accelerating technology investments at PNC's Midland Loan Services unit, integrating BBVA USA, driving PNC's affordable housing and tax credit investments business and leading Real Estate Banking through a challenging market environment. In 2023, Thomas also assumed responsibility for the Corporate Strategy group, supporting the research, planning and execution of strategic initiatives across PNC's three lines of business. Prior to joining PNC, Thomas worked at JPMorgan Chase. He is a graduate of Yale University. PNC's C&IB business provides a complete set of value-added lending, treasury management, advisory and capital marketsrelated products and services to companies, governments and nonprofits across the U.S. and Canada. It is one of the largest commercial and industrial and commercial real estate lenders and one of the top treasury management providers in the U.S. PNC Bank, National Association, is a member of The PNC Financial Services Group, Inc. (NYSE: PNC). PNC is one of the largest diversified financial services institutions in the United States, organized around its customers and communities for strong relationships and local delivery of retail and business banking including a full range of lending products; specialized services for corporations and government entities, including corporate banking, real estate finance and asset-based lending; wealth management and asset management. For information about PNC, visit www.pnc.com. CONTACTS: MEDIA:Timothy Miller(412) 762-4550media.relations@pnc.com INVESTORS:Bryan Gill(412) 768-4143investor.relations@pnc.com View original content to download multimedia:https://www.prnewswire.com/news-releases/pnc-names-michael-thomas-head-of-corporate--institutional-banking-302088429.html SOURCE PNC Bank Who has been named head of Corporate & Institutional Banking at PNC Bank? Michael Thomas has been named head of Corporate & Institutional Banking at PNC Bank. What are Michael Thomas's key responsibilities in his new role? Michael Thomas will oversee areas such as Debt Capital Markets and Real Estate Banking in his new role. What is PNC's C&IB business known for providing? PNC's C&IB business offers a complete set of lending, treasury management, advisory, and capital markets-related products and services to companies, governments, and nonprofits in the U.S. and Canada. What is PNC's position in the financial services industry? PNC is one of the largest diversified financial services institutions in the United States, offering retail and business banking, lending products, specialized services for corporations and government entities, wealth management, and asset management."
"Comerica Bank to hold Sixth Annual Prom Dress Drive, Benefiting Jackets for Jobs",2024-03-13T16:58:00.000Z,Low,Positive,"Comerica Bank launches its sixth annual Prom Dress Drive in partnership with Jackets for Jobs, aiming to collect new or gently used dresses and accessories for southeast Michigan students. The drive will run from March 18 to April 12 at ten Comerica locations, with donations benefiting local teens who may not afford prom attire. Comerica has collected over 7,700 dresses in the past five years, with a record of 2,200 dresses last year.","Comerica Bank to hold Sixth Annual Prom Dress Drive, Benefiting Jackets for Jobs Rhea-AI Impact (Low) Rhea-AI Sentiment (Positive) Tags Rhea-AI Summary Comerica Bank launches its sixth annual Prom Dress Drive in partnership with Jackets for Jobs, aiming to collect new or gently used dresses and accessories for southeast Michigan students. The drive will run from March 18 to April 12 at ten Comerica locations, with donations benefiting local teens who may not afford prom attire. Comerica has collected over 7,700 dresses in the past five years, with a record of 2,200 dresses last year. Positive None. Negative None. 03/13/2024 - 12:58 PM Public encouraged to drop-off dresses and accessories at select Comerica locations March 18-April 12 DETROIT, March 13, 2024 /PRNewswire/ -- Comerica Bank is welcoming donations for its sixth annual Prom Dress Drive beginning Monday, March 18, and continuing through Friday, April 12, in support of community partner Jackets for Jobs. Individuals and businesses alike can drop off new or gently used dresses, along with accessories, such as jewelry, shoes, purses, and wraps, at participating Comerica locations to benefit southeast Michigan students. Ten Comerica Bank banking centers and offices throughout Metro Detroit will serve as collection sites. For the first time, Comerica will be accepting the donations of dresses and accessories over a four-week span, the longest donation period since Comerica's Prom Dress Drive first began in 2017. For the second consecutive year, Comerica will supply the donated dresses and accessories to Jackets for Jobs, a Detroit-based nonprofit that focuses on career development and removes barriers by providing high-quality clothing that makes clients look and feel professional to support workplace success. ""Teaming up with Jackets for Jobs was incredibly successful last year. We appreciate the passion of Alison Vaughn and her team in their commitment to reach and positively impact our youth during this very impressionable and important time in their lives,"" said Steve Davis, Comerica Bank Michigan Market President. ""Each year, we are truly grateful for the support we receive from our customers and communities throughout the Metro Detroit area during this effort. Their generosity makes our Prom Dress Drive possible."" Cumulatively across its last five Prom Dress Drives, Comerica has collected more than 7,700 dresses  including a record of over 2,200 last year  to benefit local teens who may not otherwise be able to afford formal attire and experience the high school tradition of prom. ""Our mission is to empower others to achieve great things by providing them with the resources to help overcome barriers that exist,"" said Alison Vaughn, Jackets for Jobs Founder and Executive Director. ""Clothing and attire, whether for workplace or special events, can stand in the way of meaningful experiences and achievements. Our goal in partnering with Comerica is to open the door for success. Teens are vulnerable, and we hope that our boutique can offer them excitement and inspiration as they look forward to some of their most special moments of their teen years without some of challenges than may persist."" Donation LocationsIndividuals and local businesses, including bridal and dress shops from surrounding areas, seeking to donate dresses and accessories to the Comerica Prom Dress drive can do so at locations in the following nine metro Detroit communities: Ann Arbor, Bloomfield Hills, Dearborn, Detroit, Grosse Pointe, New Baltimore, Northville, Novi and Rochester Hills. The following Comerica Bank locations will accept donations: Comerica Banking Centers Ann Arbor | Stadium Blvd.-Pauline: 1969 W. Stadium Blvd., Ann Arbor, MI 48103Bloomfield Hills | Woodward-Hunter: 36440 Woodward Ave., Bloomfield Hills, MI 48304Bloomfield Hills | Telegraph-Long Lake: 3910 Telegraph Rd., Ste. 100, Bloomfield Hills, MI 48302Dearborn | Michigan-American: 16150 Michigan Ave., Dearborn, MI 48126Grosse Pointe | Fisher-St. Paul: 415 Fisher Rd., Grosse Pointe, MI 48230New Baltimore | Gratiot-Cotton: 50300 Gratiot Ave., New Baltimore, MI 48051Northville | Northville: 129 E. Main St., Northville, MI 48167Novi | Grand River and Beck: 47440 Grand River, Novi, MI 48374Rochester Hills | Walton-Adamas: 3021 Walton Blvd, Rochester Hills, MI 48309Comerica OfficesThose donating dresses and accessories to the Comerica Prom Dress Drive in Detroit can do so by dropping off items in the main lobby of the Comerica Bank Center. Detroit | Comerica Bank Center: 411 W. Lafayette St., Detroit, MI 48226Jackets for Jobs Prom Dress BoutiqueThis year's Jackets for Jobs Prom Dress Boutique will take place Friday, April 19 through Sunday, April 21 at the Samaritan Center (5555 Conner St.) in Detroit. Schools, organizations or families with teens in need can contact Jackets for Jobs at (313) 579-9160 for more information. Celebrating 175 YearsThis year, Comerica Bank is celebrating 175 years of serving its communities, making it Michigan's longest-serving bank. Comerica was founded in 1849 in Detroit during a time when all banks in the city were exclusive to the business community. This was the motivation behind Comerica's decision to gear its banking for the people and for those who wanted to secure their personal and financial future. Since its inception, Comerica has grown in Michigan and throughout the country by focusing on the customer first and offering personal, small business and commercial banking services, as well as wealth management services. Throughout its history, Comerica has partnered with nonprofit and community organizations to improve financial education, support critical community needs and provide colleagues with volunteer opportunities. About Comerica BankComerica Bank, a subsidiary of Comerica Incorporated, has served Michigan longer than any other bank with a continuous presence dating back 175 years to its Detroit founding in 1849. It is the largest bank employer in metro Detroit and has approximately 4,500 employees (FTE) statewide. With one of the largest banking center networks in Michigan, Comerica nurtures lifelong relationships with unwavering integrity and financial prudence. Comerica positively impacts the lives of Michigan residents by helping customers be successful, providing financial support that assists hundreds of charitable organizations, and actively participating in Detroit's downtown revitalization. Comerica Incorporated (NYSE: CMA) is a financial services company strategically aligned by three business segments: The Commercial Bank, The Retail Bank, and Wealth Management. Follow on Facebook: www.facebook.com/Comerica, X (formerly known as Twitter): @ComericaBank and Instagram: @comerica_bank. About Jackets for JobsJackets for Jobs is an award-winning non-profit organization that provides career clothing for metro Detroit job seekers. For over two decades, we have assisted over 35,000 job seekers put their best foot forward to obtain employment. For people experiencing barriers to employment and independence, clothing insecurity is real. It can mean not having anything to wear or not having the right thing to wear. Both are barriers to advancement. Jackets for Jobs provides a stable source of well-maintained and displayed clothing that is suitable for any need, from casual to workwear. View original content to download multimedia:https://www.prnewswire.com/news-releases/comerica-bank-to-hold-sixth-annual-prom-dress-drive-benefiting-jackets-for-jobs-302088356.html SOURCE Comerica Bank Where can individuals and businesses donate dresses and accessories for the Comerica Prom Dress Drive? Individuals and businesses can donate dresses and accessories at select Comerica Bank locations in nine metro Detroit communities, including Ann Arbor, Bloomfield Hills, Dearborn, Detroit, Grosse Pointe, New Baltimore, Northville, Novi, and Rochester Hills. What is the duration of the donation period for the Comerica Prom Dress Drive? The donation period for the Comerica Prom Dress Drive runs from March 18 to April 12, spanning over four weeks. Who will benefit from the donated dresses and accessories collected by Comerica? Local southeast Michigan students who may not afford formal attire, particularly for prom, will benefit from the dresses and accessories collected by Comerica. What is the objective of Jackets for Jobs, the community partner of Comerica in this initiative? Jackets for Jobs focuses on career development and providing high-quality clothing to remove barriers and support workplace success by empowering individuals to achieve great things. When and where will the Jackets for Jobs Prom Dress Boutique take place? The Jackets for Jobs Prom Dress Boutique will be held from April 19 to April 21 at the Samaritan Center in Detroit. Schools, organizations, or families with teens in need can contact Jackets for Jobs for more information."
Keysight and Q-CTRL Team Up to Accelerate Infrastructure Quantum Software,2024-03-13T15:00:00.000Z,Low,Very Positive,"Keysight Technologies, Inc. (KEYS) partners with Q-CTRL to integrate quantum infrastructure software, enhancing quantum processor development and optimization. The collaboration aims to provide advanced AI/ML tools for complex design spaces, automate device optimization, accelerate quantum design cycles, and enable customizable experiments. The joint solution combines Keysight's Quantum Control System (QCS) with Q-CTRL's Boulder Opal hardware optimization to empower quantum developers in scaling both processor quantity and quality.","Keysight and Q-CTRL Team Up to Accelerate Infrastructure Quantum Software Rhea-AI Impact (Low) Rhea-AI Sentiment (Very Positive) Tags Rhea-AI Summary Keysight Technologies, Inc. (KEYS) partners with Q-CTRL to integrate quantum infrastructure software, enhancing quantum processor development and optimization. The collaboration aims to provide advanced AI/ML tools for complex design spaces, automate device optimization, accelerate quantum design cycles, and enable customizable experiments. The joint solution combines Keysight's Quantum Control System (QCS) with Q-CTRL's Boulder Opal hardware optimization to empower quantum developers in scaling both processor quantity and quality. Positive None. Negative None. Quantum Computing Expert The partnership between Keysight Technologies and Q-CTRL represents a significant stride in the quantum computing industry. The integration of advanced software for quantum processor development and optimization is poised to address some of the most pressing challenges faced by quantum hardware developers, such as the complexity of design cycles and the need for efficient characterization of quantum processors.Quantum processors operate on qubits, which unlike classical bits, can exist in multiple states simultaneously, allowing for a massive parallel computation. As the number of qubits increases, the complexity of managing and optimizing these systems also grows exponentially. This complexity barrier is one of the key hindrances to the scalability of quantum computers. By providing AI/ML tools to navigate this complexity and automate device optimization, the partnership aims to streamline the quantum design cycle and enhance the performance and reliability of quantum processors.The implications for stakeholders are substantial. For businesses investing in quantum computing, reduced characterization time and improved device uptime could translate into accelerated research and development timelines, potentially leading to quicker commercialization of quantum technologies. In the long-term, this could catalyze new breakthroughs in fields where quantum computing is expected to have a transformative impact, such as cryptography, materials science and complex system modeling. AI/ML Specialist The incorporation of advanced AI/ML tools into the quantum development process is a noteworthy development. By leveraging machine learning algorithms, the partnership aims to efficiently determine the optimal settings for quantum control systems (QCS) and navigate the high-dimensional space that characterizes quantum processor configurations. This is essential because the relationship between Hamiltonian parameters, which dictate the behavior of quantum systems and hardware settings, is highly non-linear and complex.AI/ML's role in automating device optimization and providing customizable experiments will likely lead to a more iterative and rapid prototyping approach in quantum processor development. This could result in a significant reduction in the time and resources required for quantum processor calibration and characterization, thereby enhancing the productivity of researchers and developers in the quantum field.For the stock market and investors, this partnership signals an advancement in quantum technology that could potentially lead to a competitive edge for companies like Keysight Technologies. The ability to offer enhanced quantum processor capabilities could open up new markets and applications, ultimately impacting the company's financial performance and stock valuation. Market Research Analyst From a market perspective, the collaboration between Keysight Technologies and Q-CTRL is strategically aligned with the growing demand for quantum computing solutions. As industries anticipate the advantages of quantum computing, such as solving complex optimization problems and simulating molecular interactions for drug discovery, there is a clear market opportunity for companies that can lower the entry barriers to quantum computing adoption.The partnership's focus on accelerating the quantum design cycle and enabling more use case development is likely to attract attention from sectors that are closely monitoring quantum computing advancements, such as pharmaceuticals, finance and cybersecurity. By enhancing exploration and innovation for quantum scientists and engineers, Keysight and Q-CTRL are positioning themselves as enablers of the next wave of quantum applications, which could have a ripple effect on the broader technology sector and its associated businesses.Investors should note that the quantum computing market is still in its nascent stage and while the potential is vast, the timeline for widespread commercialization remains uncertain. However, partnerships like this one are crucial indicators of progress and can serve as a bellwether for the maturity of the quantum computing industry. 03/13/2024 - 11:00 AM Partnership to provide an integrated solution enabling quantum developers to effectively scale both quantum processor quantity and quality Enhanced capability in quantum processor characterization and optimization to accelerate quantum development SANTA ROSA, Calif.--(BUSINESS WIRE)-- Keysight Technologies, Inc. (NYSE: KEYS) and Q-CTRL, a pioneer of quantum infrastructure software to make quantum technologies useful, are partnering to integrate key infrastructure quantum software to accelerate quantum processor development, characterization, and key proof of principle scientific demonstrations. An interesting feature of quantum computation is that as qubits are added to a quantum processor, the computational space available to the end user expands exponentially. However, as quantum systems grow exponentially, they become increasingly more complex to design, test, and operate. This means quantum hardware developers face a slow and complex design cycle as current software tools require users to exhaustively test and calibrate an ever-growing number of configurations and combinations. To address these design challenges, Keysight and Q-CTRL are partnering to provide an integrated solution enabling quantum developers to effectively scale both quantum processor quantity and quality. The solution will integrate Q-CTRLs Boulder Opal hardware optimization and automation functionality into Keysights Quantum Control System (QCS) providing enhanced capability in quantum processor characterization and optimization to rapidly decrease characterization time and improve device up-time. To accelerate quantum development, the joint solution will: Help navigate complexity  Provide advanced AI/ML tools to navigate complex design and characterization spaces. Automate device optimization  Enable closed loop, autonomous agents to efficiently determine the relationship between Hamiltonian parameters and QCS hardware settings. Accelerate the quantum design cycle  Less time calibrating and characterizing a quantum processor means faster development cycles and more use case development time available. Customizable experiments  Allow users to program and optimize experiments specific to their quantum device. Enhanced exploration  Enable more avenues of exploration and innovation for quantum scientists and engineers. The Keysight QCS combines dedicated quantum control hardware and full-stack software capabilities to provide an easy-to-use solution for the control and readout of quantum devices. Q-CTRL Boulder Opal delivers cloud-accelerated hardware design, AI-based automation, and quantum control optimization, giving professional teams everything they need to get ahead of the competition. Alex Shih, Head of Product, Q-CTRL, said: ""We are delighted to be working with Keysight to bring Q-CTRLs hardware characterization and optimization capabilities to their end users and empowering experimentalists and researchers to build and scale real quantum systems. We designed our products to be easily integrated and interoperable across hardware and software architectures, and we are proud to see this help activate the quantum ecosystem. To us, making quantum technology useful relies on not just developing new technologies, but supporting researchers to easily leverage them in building and scaling their quantum systems. Eric T. Holland, Director of Strategic Initiatives, Quantum at Keysight, said: ""Customer success is at the core of all that we do at Keysight. We are continually seeking feedback from our quantum users to drive our roadmap and spur innovation. This collaboration with Q-CTRL comes from such feedback and we are thrilled to begin our journey to improve the end-user experience and capabilities for our customers."" About Keysight At Keysight (NYSE: KEYS), we inspire and empower innovators to bring world-changing technologies to life. As an S&P 500 company, we're delivering market-leading design, emulation, and test solutions to help engineers develop and deploy faster, with less risk, throughout the entire product life cycle. We're a global innovation partner enabling customers in quantum, communications, industrial automation, aerospace and defense, automotive, semiconductor, and general electronics markets to accelerate innovation to connect and secure the world. Learn more at Keysight Newsroom and www.keysight.com. View source version on businesswire.com: https://www.businesswire.com/news/home/20240313371338/en/ Keysight Media Contacts Paul Erwin Americas +1 248 430 9075 paul.erwin@keysight.com Fusako Dohi Asia +81 42 660-2162 fusako_dohi@keysight.com Jenny Gallacher Europe +44 (0) 7800 737 982 jenny.gallacher@keysight.com Source: Keysight Technologies, Inc. What is the partnership between Keysight Technologies and Q-CTRL about? Keysight Technologies and Q-CTRL are partnering to integrate key infrastructure quantum software to accelerate quantum processor development, characterization, and key proof of principle scientific demonstrations. What are the main features of the joint solution between Keysight and Q-CTRL? The joint solution aims to help navigate complexity in quantum design spaces, automate device optimization, accelerate the quantum design cycle, allow customizable experiments specific to quantum devices, and enable enhanced exploration for quantum scientists and engineers. What does Q-CTRL's Boulder Opal bring to the collaboration? Q-CTRL's Boulder Opal delivers cloud-accelerated hardware design, AI-based automation, and quantum control optimization, providing professional teams with tools to stay ahead of the competition. Who is the Head of Product at Q-CTRL and what did they say about the partnership? Alex Shih, Head of Product at Q-CTRL, expressed delight in working with Keysight to bring Q-CTRLs hardware characterization and optimization capabilities to end users, empowering experimentalists and researchers in building and scaling real quantum systems. What is the focus of Keysight Technologies in collaborating with Q-CTRL? Keysight Technologies aims to improve the end-user experience and capabilities for their customers by integrating Q-CTRLs hardware optimization and automation functionality into their Quantum Control System (QCS)."
FTC Solar Announces Fourth Quarter 2023 Financial Results,2024-03-13T20:01:00.000Z,Neutral,Neutral,"FTC Solar, Inc. reported fourth-quarter revenue of $23.2 million, with an addition of approximately $213 million to backlog since November 8. The company aims to lower the breakeven revenue level and improve gross margin potential. They are actively searching for a new CEO. Fourth-quarter financial results showed a decrease in revenue compared to the prior quarter. The company expects revenue to be lower in the first quarter of 2024 but anticipates sequential growth for the rest of the year, aiming for profitability in the fourth quarter.","FTC Solar Announces Fourth Quarter 2023 Financial Results Rhea-AI Impact (Neutral) Rhea-AI Sentiment (Neutral) Tags earnings Rhea-AI Summary FTC Solar, Inc. reported fourth-quarter revenue of $23.2 million, with an addition of approximately $213 million to backlog since November 8. The company aims to lower the breakeven revenue level and improve gross margin potential. They are actively searching for a new CEO. Fourth-quarter financial results showed a decrease in revenue compared to the prior quarter. The company expects revenue to be lower in the first quarter of 2024 but anticipates sequential growth for the rest of the year, aiming for profitability in the fourth quarter. Positive FTC Solar reported fourth-quarter revenue of $23.2 million. Approximately $213 million was added to backlog since November 8. The company aims to lower the breakeven revenue level and improve gross margin potential. FTC Solar is actively searching for a new CEO. Fourth-quarter financial results showed a decrease in revenue compared to the prior quarter. The company expects revenue to be lower in the first quarter of 2024 but anticipates sequential growth for the rest of the year. FTC Solar aims for profitability in the fourth quarter of 2024. Negative None. Financial Analyst The reported fourth-quarter revenue of $23.2 million signifies a notable 11.5% year-over-year decline for FTC Solar, Inc., which is a concerning trend for investors focused on growth trajectories. The company's gross margin improvement from negative to positive is a silver lining, indicating some success in cost reduction efforts. However, the reported GAAP net loss of $11.2 million, though improved from the previous year's $20.5 million, still reflects challenges in achieving profitability.FTC Solar's guidance for Q1 2024 projects a further revenue decline, which could be alarming for stakeholders. The anticipated breakeven on an Adjusted EBITDA basis by Q3 and profitability in Q4 offers a potential turnaround point, but these projections hinge on the successful execution of the company's initiatives and market conditions. The addition of $213 million to the backlog suggests a solid pipeline, but the ability to convert this backlog into revenue efficiently will be critical for the company's financial health. Market Research Analyst The solar industry is experiencing increased competition and price sensitivity, which places emphasis on FTC Solar's strategic moves to improve customer engagement and enhance their product portfolio. The company's focus on operating efficiencies to lower the breakeven revenue level is in response to industry pressures for cost optimization. The backlog growth indicates market demand, but the company's ability to capitalize on this demand through accelerated project delivery will be a key factor in future performance.Investor sentiment may be influenced by the CEO succession plan, as leadership stability is often linked to strategic continuity and investor confidence. The search for a CEO with potential for a long tenure suggests a strategic pivot or sustained growth focus, which will be closely monitored by the market. The company's performance in the upcoming quarters will be pivotal in validating the effectiveness of its strategic initiatives and operational improvements. Legal Expert FTC Solar's financial disclosures reveal a reliance on non-GAAP measures such as adjusted EBITDA to convey a more favorable view of financial health. It is crucial for investors to understand the implications of these adjustments, as they exclude stock-based compensation and other non-cash items that impact the company's actual cash flow. Transparency in financial reporting is essential for investor trust and the company's disclosures should be scrutinized to ensure they accurately represent the company's operational and financial position.The appointment of a new Chairman of the Customer Advisory Board does not directly impact financial performance but can influence strategic customer relations and potentially lead to revenue growth through improved engagement. The legal and regulatory compliance of the succession process for the CEO will also be an area of interest, ensuring that it aligns with corporate governance standards. 03/13/2024 - 04:01 PM Fourth Quarter Highlights and Recent DevelopmentsFourth quarter revenue of $23.2 millionContinue to improve cost structure to lower break-even revenue levelAdded approximately $213 million to backlog1 since Nov. 8; acceleration in contracted projectsAnthony Carroll appointed Chairman of Customer Advisory Board AUSTIN, Texas, March 13, 2024 (GLOBE NEWSWIRE) -- FTC Solar, Inc. (Nasdaq: FTCI), a leading provider of solar tracker systems, software and engineering services, today announced financial results for the fourth quarter ended December 31, 2023. Fourth Quarter ResultsThe company's fourth-quarter results were in line with our targets, said Shaker Sadasivam, Chairman of the Board of FTC Solar. Along with those results, the company is making good progress advancing key initiatives that will support the companys future growth and profitability. These include: Accelerating contracted projects through improved customer engagement and an enhanced product portfolio;Improving gross margin potential by reducing product cost;Further lowering the breakeven revenue level through continued operating efficiencies; andImproving business processes across the business with particular emphasis on customer engagement, customer satisfaction, and purchase orders. As it relates to our CEO succession plan, we have begun searching for our next CEO and have seen great interest. The Board is focusing the processes on highly qualified candidates both within the industry and adjacent industries to identify a CEO capable of leading the company for a long tenure. We have a shortlist of excellent candidates and will plan to name a successor at the appropriate time when the process has concluded. Approximately $213 million has been added to backlog1 since November 8, with total backlog now standing at approximately $1.7 billion. Summary Financial Performance: Q4 2023 compared to Q4 2022 U.S. GAAP Non-GAAP Three months ended December 31, (in thousands, except per share data) 2023 2022 2023 2022 Revenue $23,201 $26,220 $23,201 $26,220 Gross margin percentage 3.0% (7.3%) 4.8% (3.4%)Total operating expenses $12,428 $17,947 $10,848 $9,971 Loss from operations(a) $(11,736) $(19,861) $(10,050) $(10,976)Net loss $(11,177) $(20,501) $(9,657) $(11,499)Diluted loss per share $(0.09) $(0.20) $(0.08) $(0.11) (a) Adjusted EBITDA for Non-GAAP Total fourth-quarter revenue was $23.2 million, coming in at the mid-point of our target range. This revenue level represents a decrease of 24.1% compared to the prior quarter, on both lower product and logistics volumes. Compared to the year-earlier quarter, revenue decreased 11.5%, driven by lower logistics volumes. GAAP gross profit was $0.7 million, or 3.0% of revenue, compared to gross profit of $3.4 million, or 11.1% of revenue, in the prior quarter. Non-GAAP gross profit was $1.1 million or 4.8% of revenue. The result for this quarter compares to a non-GAAP gross loss of $0.9 million in the prior-year period, with the difference driven primarily by significantly improved product direct margins and lower warranty, retrofit and other indirect costs. GAAP operating expenses were $12.4 million. On a non-GAAP basis, excluding stock-based compensation and certain other costs, operating expenses were $10.8 million. This result compares to operating expenses of $10.0 million in the year-ago quarter. GAAP net loss was $11.2 million or $0.09 per share, compared to a loss of $16.9 million or $0.14 per share in the prior quarter and a net loss of $20.5 million or $0.20 per share in the year-ago quarter. Adjusted EBITDA loss, which excludes approximately $1.1 million, including stock-based compensation expense and other non-cash items, was $10.1 million, compared to losses of $9.7 million in the prior quarter and $11.0 million in the year-ago quarter. OutlookWe expect first quarter 2024 revenue to be down from the fourth quarter and represent the trough in revenue for the year. Beyond the first quarter, we expect to see continued sequential revenue growth for the remainder of the year, with revenue being weighted toward the second half of the year. We expect to approximate breakeven on an Adjusted EBITDA basis in the third quarter and be profitable in the fourth quarter. 4Q'23 4Q'23 1Q'24 (in millions)Guidance Actual GuidanceRevenue$18.0  $28.0 $23.2 $10.0  $15.0Non-GAAP Gross Profit$(1.3)  $2.0 $1.1 $(3.8)  $(1.8)Non-GAAP Gross Margin(7%)  7% 4.8% (38%)  (12%)Non-GAAP operating expenses$10  $11 $10.8 $8.0  $8.9Non-GAAP adjusted EBITDA$(13.0)  $(2.5) $(10.1) $(12.6)  $(9.8) Fourth Quarter 2023 Earnings Conference CallFTC Solars senior management will host a conference call for members of the investment community at 5:00 p.m. E.T. today, during which the company will discuss its fourth quarter results, its outlook and other business items. This call will be webcast and can be accessed within the Investor Relations section of FTC Solar's website at investor.ftcsolar.com. A replay of the conference call will also be available on the website for 30 days following the webcast. About FTC Solar Inc. Founded in 2017 by a group of renewable energy industry veterans, FTC Solar is a leading provider of solar tracker systems, technology, software, and engineering services. Solar trackers significantly increase energy production at solar power installations by dynamically optimizing solar panel orientation to the sun. FTC Solars innovative tracker designs provide compelling performance and reliability, with an industry-leading installation cost-per-watt advantage. Footnotes1. The term backlog or contracted and awarded refers to the combination of our executed contracts and awarded orders, which are orders that have been documented and signed through a contract, where we are in the process of documenting a contract but for which a contract has not yet been signed, or that have been awarded in writing or verbally with a mutual understanding that the order will be contracted in the future. In the case of certain projects, including those that are scheduled for delivery on later dates, we have not locked in binding pricing with customers, and we instead use estimated average selling price to calculate the revenue included in our contracted and awarded orders for such projects. Actual revenue for these projects could differ once contracts with binding pricing are executed, and there is also a risk that a contract may never be executed for an awarded but uncontracted project, or that a contract may be executed for an awarded but uncontracted project at a date that is later than anticipated, or that a contract once executed may be subsequently amended, supplemented, rescinded, cancelled or breached, including in a manner that impacts the timing and amounts of payments due thereunder, thus reducing anticipated revenues. Please refer to our SEC filings, including our Form 10-K, for more information on our contracted and awarded orders, including risk factors. Forward-Looking StatementsThis press release contains forward looking statements. These statements are not historical facts but rather are based on our current expectations and projections regarding our business, operations and other factors relating thereto. Words such as may, will, could, would, should, anticipate, predict, potential, continue, expects, intends, plans, projects, believes, estimates and similar expressions are used to identify these forward-looking statements. These statements are only predictions and as such are not guarantees of future performance and involve risks, uncertainties and assumptions that are difficult to predict. You should not rely on our forward-looking statements as predictions of future events, as actual results may differ materially from those in the forward-looking statements because of several factors, including those described in more detail above and in our filings with the U.S. Securities and Exchange Commission, including the section entitled Risk Factors contained therein. FTC Solar undertakes no duty or obligation to update any forward-looking statements contained in this release as a result of new information, future events or changes in its expectations, except as required by law. FTC Solar Investor Contact:Bill Michalek Vice President, Investor Relations FTC SolarT: (737) 241-8618 E: IR@FTCSolar.com FTC Solar, Inc.Condensed Consolidated Statements of Comprehensive Loss(unaudited) Three months ended December 31, Year ended December 31, (in thousands, except shares and per share data) 2023 2022 2023 2022 Revenue: Product $20,945 $20,083 $101,872 $63,760 Service 2,256 6,137 25,130 59,306 Total revenue 23,201 26,220 127,002 123,066 Cost of revenue: Product 19,620 21,966 93,314 84,766 Service 2,889 6,168 25,381 65,528 Total cost of revenue 22,509 28,134 118,695 150,294 Gross profit (loss) 692 (1,914) 8,307 (27,228)Operating expenses Research and development 1,450 2,411 7,166 9,949 Selling and marketing 4,924 1,766 14,811 8,659 General and administrative 6,054 13,770 37,107 53,736 Total operating expenses 12,428 17,947 59,084 72,344 Loss from operations (11,736) (19,861) (50,777) (99,572)Interest expense, net (59) (96) (253) (978)Gain from disposal of investment in unconsolidated subsidiary 421  1,319 1,745 Other income (expense), net 8 (124) (257) (373)Loss from unconsolidated subsidiary (324)  (660)  Loss before income taxes (11,690) (20,081) (50,628) (99,178)(Provision for) benefit from income taxes 513 (420) 338 (435)Net loss (11,177) (20,501) (50,290) (99,613)Other comprehensive income (loss): Foreign currency translation adjustments 219 289 (232) (68)Comprehensive loss $(10,958) $(20,212) $(50,522) $(99,681)Net loss per share: Basic and diluted $(0.09) $(0.20) $(0.44) $(0.98)Weighted-average common shares outstanding: Basic and diluted 125,107,426 103,869,160 115,546,150 101,408,263 FTC Solar, Inc.Condensed Consolidated Balance Sheets(unaudited) (in thousands, except shares and per share data) December 31, 2023 December 31, 2022 ASSETS Current assets Cash and cash equivalents $25,235 $44,385 Accounts receivable, net 65,279 49,052 Inventories 3,905 14,949 Prepaid and other current assets 14,089 10,304 Total current assets 108,508 118,690 Operating lease right-of-use assets 1,819 1,154 Property and equipment, net 1,823 1,702 Intangible assets, net 542 1,113 Goodwill 7,353 7,538 Equity method investment 240  Other assets 2,785 4,201 Total assets $123,070 $134,398 LIABILITIES AND STOCKHOLDERS' EQUITY Current liabilities Accounts payable $7,979 $15,801 Accrued expenses 34,848 23,896 Income taxes payable 88 443 Deferred revenue 3,612 11,316 Other current liabilities 8,138 8,884 Total current liabilities 54,665 60,340 Operating lease liability, net of current portion 1,124 786 Other non-current liabilities 4,810 6,822 Total liabilities 60,599 67,948 Commitments and contingencies Stockholders equity Preferred stock par value of $0.0001 per share, 10,000,000 shares authorized; none issued as of December 31, 2023 and December 31, 2022   Common stock par value of $0.0001 per share, 850,000,000 shares authorized; 125,445,325 and 105,032,588 shares issued and outstanding as of December 31, 2023 and December 31, 2022 13 11 Treasury stock, at cost; 10,762,566 shares as of December 31, 2023 and December 31, 2022   Additional paid-in capital 361,886 315,345 Accumulated other comprehensive loss (293) (61)Accumulated deficit (299,135) (248,845)Total stockholders equity 62,471 66,450 Total liabilities and stockholders equity $123,070 $134,398 FTC Solar, Inc.Condensed Consolidated Statements of Cash Flows(unaudited) Year ended December 31, (in thousands) 2023 2022 Cash flows from operating activities Net loss $(50,290) $(99,613)Adjustments to reconcile net loss to cash used in operating activities: Stock-based compensation 8,295 20,303 Depreciation and amortization 1,375 900 (Gain) loss from sale of property and equipment (2) 183 Amortization of debt issue costs 709 703 Provision for litigation settlement  4,493 Provision for obsolete and slow-moving inventory 706 1,813 Loss from unconsolidated subsidiary 660  Gain from disposal of investment in unconsolidated subsidiary (1,319) (1,745)Gain on extinguishment of debt   Warranty and remediation provisions 4,310 8,228 Warranty recoverable from manufacturer 90 (302)Credit losses and bad debt expense 7,373 1,159 Deferred income taxes 138 (135)Lease expense and other 996 705 Impact on cash from changes in operating assets and liabilities: Accounts receivable (23,600) 57,337 Inventories 10,338 (7,902)Prepaid and other current assets (3,681) 7,189 Other assets 383 (1,019)Accounts payable (7,960) (22,940)Accruals and other current liabilities 10,582 (32,670)Deferred revenue (7,704) 9,895 Other non-current liabilities (3,083) (599)Lease payments and other, net (972) (493)Net cash used in operations (52,656) (54,510)Cash flows from investing activities: Purchases of property and equipment (816) (985)Proceeds from sale of property and equipment  86 Equity method investment in Alpha Steel (900)  Acquisitions, net of cash acquired  (5,093)Proceeds from disposal of investment in unconsolidated subsidiary 1,319 1,745 Net cash provided by (used in) investing activities (397) (4,247)Cash flows from financing activities: Sale of common stock 34,007  Stock offering costs paid (283)  Proceeds from stock option exercises 226 903 Net cash provided by financing activities 33,950 903 Effect of exchange rate changes on cash and cash equivalents (47) 54 Decrease in cash and cash equivalents (19,150) (57,800)Cash and cash equivalents at beginning of period 44,385 102,185 Cash and cash equivalents at end of period $25,235 $44,385 Notes to Reconciliations of Non-GAAP Financial Measures to Nearest Comparable GAAP Measures We present Non-GAAP gross profit (loss), Non-GAAP operating expense, Adjusted EBITDA, Adjusted Net Loss and Adjusted EPS as supplemental measures of our performance. We define Adjusted EBITDA as net loss plus (i) provision for (benefit from) income taxes, (ii) interest expense, net (iii) depreciation expense, (iv) amortization of intangibles, (v) stock-based compensation, and (vi) non-routine legal fees, severance and certain other costs (credits). We also deduct the contingent gains from the disposal of our investment in an unconsolidated subsidiary from net loss in arriving at Adjusted EBITDA. We define Adjusted Net Loss as net loss plus (i) amortization of debt issue costs and intangibles, (ii) stock-based compensation, (iii) non-routine legal fees, severance and certain other costs (credits), and (iv) the income tax expense (benefit) of those adjustments, if any. We also deduct the contingent gains from the disposal of our investment in an unconsolidated subsidiary from net loss in arriving at Adjusted Net Loss. Adjusted EPS is defined as Adjusted Net Loss on a per share basis using our weighted average diluted shares outstanding. Non-GAAP gross profit (loss), Non-GAAP operating expense, Adjusted EBITDA, Adjusted Net Loss and Adjusted EPS are intended as supplemental measures of performance that are neither required by, nor presented in accordance with, U.S. generally accepted accounting principles (GAAP). We present these non-GAAP measures, many of which are commonly used by investors and analysts, because we believe they assist those investors and analysts in comparing our performance across reporting periods on an ongoing basis by excluding items that we do not believe are indicative of our core operating performance. In addition, we use Adjusted EBITDA, Adjusted Net Loss and Adjusted EPS to evaluate the effectiveness of our business strategies. Non-GAAP gross profit (loss), Non-GAAP operating expense, Adjusted EBITDA, Adjusted Net Loss and Adjusted EPS should not be considered in isolation or as substitutes for performance measures calculated in accordance with GAAP, and you should not rely on any single financial measure to evaluate our business. These Non-GAAP financial measures, when presented, are reconciled to the most closely applicable GAAP measure as disclosed below. The following table reconciles Non-GAAP gross profit (loss) to the most closely related GAAP measure for the three and twelve months ended December 31, 2023 and 2022, respectively: Three months ended December 31, Year ended December 31, (in thousands, except percentages) 2023 2022 2023 2022 U.S. GAAP revenue $23,201 $26,220 $127,002 $123,066 U.S. GAAP gross profit (loss) $692 $(1,914) $8,307 $(27,228)Depreciation expense 139 117 478 389 Stock-based compensation 283 771 1,596 3,292 Severance  145 252 145 Other costs    102 Non-GAAP gross profit (loss) $1,114 $(881) $10,633 $(23,300)Non-GAAP gross margin percentage 4.8% (3.4%) 8.4% (18.9%) The following table reconciles Non-GAAP operating expenses to the most closely related GAAP measure for the three and twelve months ended December 31, 2023 and 2022, respectively: Three months ended December 31, Year ended December 31, (in thousands) 2023 2022 2023 2022 U.S. GAAP operating expenses $12,428 $17,947 $59,084 $72,344 Depreciation expense (99) (67) (355) (242)Amortization expense (133) (134) (542) (269)Stock-based compensation 1,032 (4,277) (6,699) (17,011)Non-routine legal fees (33) (2,753) (214) (8,495)Severance (2,347) (296) (4,170) (1,333)Other (costs) credits  (449) (3,241) (2,251)Non-GAAP operating expenses $10,848 $9,971 $43,863 $42,743 The following table reconciles Non-GAAP Adjusted EBITDA to the related GAAP measure of loss from operations for the three and twelve months ended December 31, 2023 and 2022, respectively: Three months ended December 31, Year ended December 31, (in thousands) 2023 2022 2023 2022 U.S. GAAP loss from operations $(11,736) $(19,861) $(50,777) $(99,572)Depreciation expense 238 184 833 631 Amortization expense 133 134 542 269 Stock-based compensation (749) 5,048 8,295 20,303 Non-routine legal fees 33 2,753 214 8,495 Severance 2,347 441 4,422 1,478 Other costs  449 3,241 2,353 Other income (expense), net 8 (124) (257) (373)Loss from unconsolidated subsidiary (324)  (660)  Adjusted EBITDA $(10,050) $(10,976) $(34,147) $(66,416) The following table reconciles Non-GAAP Adjusted EBITDA and Adjusted Net Loss to the related GAAP measure of net loss for the three months ended December 31, 2023 and 2022, respectively: Three months ended December 31, 2023 2022 (in thousands, except shares and per share data) Adjusted EBITDA Adjusted Net Loss Adjusted EBITDA Adjusted Net Loss Net loss per U.S. GAAP $(11,177) $(11,177) $(20,501) $(20,501)Reconciling items - Provision for (benefit from) income taxes (513)  420  Interest expense, net 59  96  Amortization of debt issue costs in interest expense  177  177 Depreciation expense 238  184  Amortization of intangibles 133 133 134 134 Stock-based compensation (749) (749) 5,048 5,048 Gain from disposal of investment in unconsolidated subsidiary(a) (421) (421)   Non-routine legal fees(b) 33 33 2,753 2,753 Severance(c) 2,347 2,347 441 441 Other costs(d)   449 449 Adjusted Non-GAAP amounts $(10,050) $(9,657) $(10,976) $(11,499) Adjusted Non-GAAP net loss per share (Adjusted EPS): Basic and diluted N/A $(0.08) N/A $(0.11) Weighted-average common shares outstanding: Basic and diluted N/A 125,107,426 N/A 103,869,160 (a)Our management excludes the gain from collections of contingent contractual amounts from the sale in 2021 of our investment in an unconsolidated subsidiary.(b)Non-routine legal fees represent legal fees and other costs incurred for specific matters that were not ordinary or routine to the operations of the business.(c)Severance costs were incurred in 2023 and 2022 due to restructuring changes involving executive turnover and a headcount reduction event.(d)Other costs in 2022 included the write-off of deferred costs relating to certain uncompleted transactions. What was FTC Solar's fourth-quarter revenue for 2023? FTC Solar reported fourth-quarter revenue of $23.2 million. How much was added to FTC Solar's backlog since November 8? Approximately $213 million was added to backlog since November 8. What is FTC Solar aiming to improve? FTC Solar aims to lower the breakeven revenue level and improve gross margin potential. Is FTC Solar looking for a new CEO? Yes, FTC Solar is actively searching for a new CEO. What was the trend in FTC Solar's revenue in the fourth quarter of 2023? Fourth-quarter financial results showed a decrease in revenue compared to the prior quarter. What are FTC Solar's revenue expectations for the first quarter of 2024? FTC Solar expects revenue to be lower in the first quarter of 2024. When does FTC Solar aim to achieve profitability? FTC Solar aims for profitability in the fourth quarter of 2024."
ESGEN Acquisition Corp. and Sunergy Renewables Complete Business Combination,2024-03-13T18:59:00.000Z,Low,Neutral,"ESGEN Acquisition Corp. completes its business combination with Sunergy Renewables, forming Zeo Energy Corp. The company will trade on Nasdaq under the ticker symbols 'ZEO' and 'ZEOWW'. Zeo aims to accelerate growth in the residential solar industry, leveraging Sunergy's expertise. The merger is expected to position Zeo favorably in the transition to a decarbonized economy, with gross proceeds of around $18 million.","ESGEN Acquisition Corp. and Sunergy Renewables Complete Business Combination Rhea-AI Impact (Low) Rhea-AI Sentiment (Neutral) Tags acquisition Rhea-AI Summary ESGEN Acquisition Corp. completes its business combination with Sunergy Renewables, forming Zeo Energy Corp. The company will trade on Nasdaq under the ticker symbols 'ZEO' and 'ZEOWW'. Zeo aims to accelerate growth in the residential solar industry, leveraging Sunergy's expertise. The merger is expected to position Zeo favorably in the transition to a decarbonized economy, with gross proceeds of around $18 million. Positive None. Negative None. Market Research Analyst The completion of the business combination between ESGEN Acquisition Corp. and Sunergy Renewables, resulting in the newly formed Zeo Energy Corp., represents a significant development in the renewable energy sector. The transaction, which culminates in Zeo's listing on the Nasdaq, is poised to inject approximately $18 million in gross proceeds into the company. This capital infusion is critical for Zeo's operational funding and growth strategy, which could potentially enhance its market position.From a market research perspective, the shift towards renewable energy solutions is a trend with increasing consumer demand and governmental support. Zeo's focus on residential solar systems places it in a rapidly expanding market segment. The company's strategy to accelerate growth through this merger could lead to increased market share and heightened competitive advantage, especially considering the current emphasis on sustainable and eco-friendly energy solutions. Financial Analyst Financially, the merger between ESGEN and Sunergy, now operating as Zeo Energy Corp., is a strategic move that could result in economies of scale, synergies and improved financial performance. The $18 million in gross proceeds earmarked for operational and growth strategies indicates a forward-looking approach to capital allocation. Investors should monitor Zeo's subsequent financial statements for evidence of growth and profitability, which could impact the company's stock performance.Additionally, the dual listing of common stock and warrants under the ticker symbols 'ZEO' and 'ZEOWW' provides investors with different vehicles to invest in Zeo's future. Warrants, in particular, offer a leveraged opportunity with a potentially higher risk-reward profile, which might attract a specific investor demographic. Energy Sector Analyst The energy sector is undergoing a significant transformation, with renewable energy at the forefront of this change. Zeo Energy Corp.'s emergence as a publicly traded entity in the residential solar market is indicative of the sector's growth trajectory. The company's strategic focus on partnering with industry players and serving a growing customer base seeking renewable energy solutions is aligned with the broader industry's move towards decarbonization and energy transition.It is also important to consider the regulatory environment and technological advancements that could influence Zeo's operations. As an energy sector analyst, one should assess the potential regulatory incentives or barriers that could affect the adoption of residential solar systems and the company's ability to capitalize on these trends. 03/13/2024 - 02:59 PM Zeo Energy Corp. to Begin Trading on Nasdaq Under the Ticker Symbols ZEO and ZEOWW Beginning Thursday, March 14th Company to Ring Nasdaq Closing Bell on Wednesday, March 13th DALLAS and NEW PORT RICHEY, Fla. , March 13, 2024 (GLOBE NEWSWIRE) -- ESGEN Acquisition Corp. (ESGEN), a publicly-traded special purpose acquisition company, today announced the completion of its business combination (the Business Combination) with Sunergy Renewables, LLC (Sunergy), a leading Florida-based provider of residential solar and energy efficiency solutions. At the closing, ESGEN changed its name to Zeo Energy Corp. (Zeo), and will be led by Sunergys senior management. The Board of Directors of Zeo will include members from both Sunergy and ESGEN. Commencing at the open of trading on March 14, 2024, Zeos common stock and warrants are expected to trade on the Nasdaq Capital Market under the new ticker symbols ZEO and ZEOWW, respectively. Becoming a publicly traded company is an extraordinary milestone for our employees, our shareholders, and for the residential solar industry, said Zeo CEO Tim Bridgewater. We are confident that this merger with ESGEN enables us to accelerate our growth strategy, partner with industry players, and serve more customers seeking renewable energy solutions to meet their power and energy storage needs. Weve worked hard to build our strong financial performance track record in recent years and look forward to delivering continued growth and profitability through Sunergys approach to selling residential solar systems. From the beginning, we set out to partner with a scalable and profitable company dedicated to advancing the energy transition, said ESGEN CEO Andrejka Bernatova. Were confident that Tim and the Sunergy team are the ideal partner, and that the combined company will be attractively positioned in the secular shift towards a distributed, decarbonized economy. We also focused on building a supportive and cohesive investor base, and carefully structured this transaction to best position the combined company for growth and flexibility moving forward. We look forward to our continued partnership working with Tim and his exceptional team in their next chapter of growth. The transaction will result in gross proceeds of approximately $18 million to Zeo. Funds from the transaction are expected to fund Zeos operations and growth strategy and pay certain expenses related to the Business Combination. Nasdaq Opening Bell CeremonyDate: Wednesday, March 13, 2024Location: New York, NYEvent Details: Select members of Zeos leadership team will join CEO Tim Bridgewater to ring the Nasdaq Opening Bell. The ceremony will be held at the Nasdaq MarketSite in New York City and will be webcast live starting at 3:45 p.m. ET and will be available for replay via the following link: Livestream For more information, please visit Zeos investor relations website at investors.zeoenergy.com. AdvisorsCohen & Company Capital Markets, a division of J.V.B. Financial Group, LLC (CCM), served as exclusive financial advisor and lead capital markets advisor to ESGEN. Kirkland & Ellis LLP served as legal counsel to ESGEN. Eversheds Sutherland (US) LLP and Ellenoff Grossman & Schole LLP served as legal counsel to Sunergy. About SunergySunergy is a Florida-based regional provider of residential solar, distributed energy, and energy efficiency solutions focused on high growth markets with limited competitive saturation. With its differentiated sales approach and vertically integrated offerings, Sunergy serves customers who desire to reduce high energy bills and contribute to a more sustainable future. About ESGEN Acquisition Corp.ESGEN was a blank check company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities. ESGEN was led by Chief Executive Officer, Andrejka Bernatova and Chief Financial Officer, Nader Daylami, and was affiliated with Energy Spectrum Capital, a Dallas-based private investment firm with long-standing experience building companies across the energy infrastructure landscape over multiple decades. Forward-Looking StatementsThis news release contains forward-looking statements within the meaning of section 27A of the Securities Act of 1933, as amended (the Securities Act), and Section 21E of the Exchange Act of 1934, as amended, that are based on beliefs and assumptions and on information currently available to Zeo, ESGEN and Sunergy. Forward-looking statements include, but are not limited to, statements relating to the listing and anticipated commencement of trading of Zeo and its future operations, growth and financial results. The words anticipate, intend, plan, goal, seek, believe, project, estimate, expect, strategy, future, likely, may, should, will and similar references to future periods may identify forward-looking statements, but the absence of these words does not mean that a statement is not forward-looking. Forward-looking statements may include, for example, statements about the benefits of the Business Combination; the future financial performance of Zeo following the Business Combination; changes in Zeos strategy, future operations, financial position, estimated revenues and losses, projected costs, prospects, the ability to raise additional funds and plans and objectives of management. These forward-looking statements are based on information available as of the date of this news release, and current expectations, forecasts and assumptions, and involve a number of judgments, risks and uncertainties. Accordingly, forward-looking statements should not be relied upon as representing Zeo, ESGEN or Sunergys views as of any subsequent date, and none of Zeo, ESGEN or Sunergy undertakes any obligation to update forward-looking statements to reflect events or circumstances after the date they were made, whether as a result of new information, future events or otherwise, except as may be required under applicable securities laws. You should not place undue reliance on these forward-looking statements. As a result of a number of known and unknown risks and uncertainties, Zeo, ESGEN and Sunergys actual results or performance may be materially different from those expressed or implied by these forward-looking statements. Some factors that could cause actual results to differ include: (i) the outcome of any legal proceedings that may be instituted against Zeo, ESGEN, Sunergy or others following the Business Combination; (ii) Zeos success in retaining or recruiting, or changes required in, its officers, key employees or directors following the Business Combination; (iii) Zeos ability to maintain the listing of its common stock and warrants on the Nasdaq following the Business Combination; (iv) the risk that the Business Combination disrupts current plans and operations of Zeo; (v) the ability to recognize the anticipated benefits of the Business Combination; (vi) unexpected costs related to the Business Combination; (vii) the management and board composition of Zeo following the Business Combination; (viii) limited liquidity and trading of Zeos securities; (ix) geopolitical risk and changes in applicable laws or regulations; (x) the possibility that Zeo may be adversely affected by other economic, business, and/or competitive factors; (xi) operational risk; (xii) litigation and regulatory enforcement risks, including the diversion of management time and attention and the additional costs and demands on Zeos resources; and (xiii) other risks and uncertainties, including those included under the heading Risk Factors in the Registration Statement filed by ESGEN with the SEC. In light of the significant uncertainties in these forward-looking statements, you should not regard these statements as a representation or warranty by Zeo, ESGEN, Sunergy, their respective directors, officers or employees or any other person that Zeo will achieve its objectives and plans in any specified time frame, or at all. The forward-looking statements in this news release represent the views of Zeo, ESGEN and Sunergy as of the date of this news release. Subsequent events and developments may cause that view to change. However, while Zeo, ESGEN and Sunergy may elect to update these forward-looking statements at some point in the future, there is no current intention to do so, except to the extent required by applicable law. You should, therefore, not rely on these forward-looking statements as representing the views of Zeo, ESGEN or Sunergy as of any date subsequent to the date of this news release. Sunergy Contacts For Investors:Cody Slach and Tom ColtonGateway GroupZEO@gateway-grp.com ESGEN Acquisition Corp. Contacts For Media & Investors: Nader Daylaminader@esgen-spac.com When will Zeo Energy Corp. begin trading on Nasdaq and under what ticker symbols? Zeo Energy Corp. will commence trading on Nasdaq on March 14, 2024, under the ticker symbols 'ZEO' and 'ZEOWW'. Who is leading Zeo Energy Corp. after the business combination with Sunergy Renewables? Zeo Energy Corp. will be led by Sunergy's senior management team following the business combination. What are the expected benefits of the merger between ESGEN Acquisition Corp. and Sunergy Renewables? The merger aims to accelerate growth strategy, partner with industry players, and serve more customers seeking renewable energy solutions. How much gross proceeds are expected from the transaction involving Zeo Energy Corp.? The transaction is expected to result in gross proceeds of approximately $18 million for Zeo Energy Corp. Who served as the exclusive financial advisor and lead capital markets advisor to ESGEN Acquisition Corp. in the business combination with Sunergy Renewables? Cohen & Company Capital Markets, a division of J.V.B. Financial Group, LLC (CCM), served as the exclusive financial advisor and lead capital markets advisor to ESGEN."
Textron Aviation Special Missions Cessna Grand Caravans to be Acquired to Aid in Horn of Africa Security,2024-03-13T15:00:00.000Z,Neutral,Neutral,Textron Aviation secures a contract with the U.S. Army to deliver two Cessna Grand Caravan EX aircraft to the Djiboutian Air Force. The contract is part of a $100 million IDIQ agreement for Textron Aviation aircraft over five years.,"Textron Aviation Special Missions Cessna Grand Caravans to be Acquired to Aid in Horn of Africa Security Rhea-AI Impact (Neutral) Rhea-AI Sentiment (Neutral) Tags acquisition Rhea-AI Summary Textron Aviation secures a contract with the U.S. Army to deliver two Cessna Grand Caravan EX aircraft to the Djiboutian Air Force. The contract is part of a $100 million IDIQ agreement for Textron Aviation aircraft over five years. Positive None. Negative None. Defense Industry Analyst The recent contract awarded to Textron Aviation by the U.S. Army Contracting Command for the delivery of two Cessna Grand Caravan EX aircraft to the Djiboutian Air Force signifies a strategic expansion of Textron's footprint in the military sector. The significance of this contract lies in its contribution to the company's revenue stream and the strengthening of its position as a key supplier of military aircraft, particularly in the light attack and reconnaissance segment.The indefinite delivery, indefinite quantity (IDIQ) contract model is particularly beneficial for Textron as it provides a more stable and predictable revenue forecast. With the potential of reaching up to $100 million over five years, this contract could represent a substantial portion of Textron's defense-related sales. It's crucial to note that such contracts often come with additional support and maintenance agreements, which can lead to further long-term revenue.The geopolitical importance of Djibouti, located in the Horn of Africa and its proximity to conflict-prone areas, necessitates a robust defense capability. This deal not only supports U.S. foreign policy and national security objectives but also suggests confidence in Textron's Cessna Grand Caravan EX for special missions. From an investor's perspective, this deal could be seen as a positive indicator of Textron's market competitiveness and its ability to secure recurring government contracts. Market Research Analyst Textron Aviation's announcement of the delivery order for two Cessna Grand Caravan EX aircraft tailored for intelligence, surveillance and reconnaissance (ISR) missions reflects a growing trend in the defense sector towards versatile, cost-effective solutions. The increasing demand for Commercial off the Shelf (COTS) aircraft, which are non-developmental items (NDI) readily available for purchase, highlights a shift in military procurement preferences.Market trends suggest that there is a burgeoning market for ISR-equipped aircraft, driven by the need for enhanced border security and military intelligence capabilities. The Cessna Grand Caravan EX's adaptability to special missions underscores the aircraft's appeal to both military and civilian operators. The ability of companies like Textron to quickly modify and deliver such aircraft is a competitive advantage that aligns with the current fast-paced procurement environment.For stakeholders, the contract's implications extend beyond immediate financial gains. It may also influence Textron's stock market performance, as defense contracts tend to provide a buffer against market volatility. Additionally, successful delivery and operation of these aircraft can lead to repeat orders and bolster Textron's reputation as a reliable government contractor, potentially impacting future stock valuations positively. Financial Analyst The announcement of Textron Aviation's contract with the U.S. Army Contracting Command represents a noteworthy development for Textron Inc. (NYSE:TXT) shareholders. The financial implications of this contract are multifaceted. Initially, the contract for two Cessna Grand Caravan EX aircraft may not appear to be a significant financial event when compared to Textron's overall revenue. However, the long-term potential of the IDIQ contract, which could amount to $100 million over five years, provides a more substantial outlook.Investors should consider the incremental nature of such contracts. While the initial order might have a marginal impact on the company's financials, the cumulative effect of subsequent orders can lead to significant revenue growth. Furthermore, the emphasis on ISR capabilities indicates a strategic investment in high-demand defense technologies, which could enhance Textron's profit margins due to the specialized nature of these products.The contract also serves as a barometer for Textron's future performance in the defense sector. A successful execution of this contract could lead to further orders under the IDIQ agreement and cement Textron's role as a preferred supplier for the U.S. government and allied forces. This could have positive implications for the company's stock, as consistent government contracts are typically viewed favorably by the market. 03/13/2024 - 11:00 AM WICHITA, Kan.--(BUSINESS WIRE)-- Textron Aviation today announced the award of a contract by the U.S. Army Contracting Command, Redstone Arsenal, AL, for two Cessna Grand Caravan EX turboprop aircraft. The aircraft will be owned and operated by the Djiboutian Air Force (DAF). This acquisition is the third delivery order under a recently established indefinite delivery, indefinite quantity (IDIQ) contract that allows up to $100 million U.S. dollars for the acquisition of Textron Aviation aircraft over a five-year period. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240313335405/en/Two Cessna Grand Caravan EX aircraft will be equipped to ensure the border sovereignty of the country of Djibouti (Photo: Business Wire) The Cessna Grand Caravan EX is designed and manufactured by Textron Aviation Inc., a Textron Inc. (NYSE:TXT) company. The two special missions Cessna Grand Caravan EX aircraft will be Intelligence, Surveillance, and Reconnaissance equipped to ensure the border sovereignty of the country of Djibouti, said Bob Gibbs, vice president, Special Mission Sales for Textron Aviation. This multiyear contract allows the U.S. Army Security Assistance Command to rapidly procure Commercial off the Shelf (COTS) aircraft and modifications from Textron Aviation for our Foreign Military Sale allies and partner nations. We are honored to assist in advancing U.S. national security and foreign policy interests by providing our solutions under the IDIQ and we look forward to further cooperation with the U.S. Army. This order follows the recent placement of delivery orders for three Beechcraft King Air 360ER aircraft two destined for the Peruvian Naval Aviation Force (Fuerza de Aviacin Naval) and one the Ecuadorian Naval Aviation (Aviacin Naval Ecuatoriana). With the addition of the two Cessna Grand Caravan EX for the Djiboutian Air Force, five aircraft have been ordered under the IDIQ contract. About the Cessna Grand Caravan EX The Cessna Caravan platform has seen more than 3,000 aircraft delivered that are certified in 100 countries with nearly 24 million flight hours amassed worldwide since the aircraft was introduced. Caravans fulfill roles for multiple missions, ranging from flight training to recreation, commuter airlines to VIP transport, cargo carriers and humanitarian missions. The Grand Caravan EX aircraft is known for its dependable and efficient performance by regional airlines, charter operators, cargo carriers and special missions operators worldwide. The aircraft offers an impressive output of 867 horsepower and a rate of climb of 1,275 feet per minute. Endless Special Missions Possibilities When government, military and commercial customers want airborne solutions for critical missions, they turn to Textron Aviation. The companys aviation solutions provide the high performance and flight characteristics required to address the unique challenges of special missions operations. With unparalleled quality, versatility and low operating costs, Textron Aviation products are chosen for air ambulance, ISR, utility transport, aerial survey, flight inspection, training and a number of other special operations. About Textron Aviation We inspire the journey of flight. For more than 95 years, Textron Aviation has empowered our collective talent across the Beechcraft, Cessna and Hawker brands to design and deliver the best aviation experience for our customers. With a range that includes everything from business jets, turboprops, and high-performance pistons, to special missions, military trainer and defense products, Textron Aviation has the most versatile and comprehensive aviation product portfolio in the world and a workforce that has produced more than half of all general aviation aircraft worldwide. Customers in more than 170 countries rely on our legendary performance, reliability and versatility, along with our trusted global customer service network, for affordable, productive and flexible flight. For more information, visit www.txtav.com | defense.txtav.com | scorpion.txtav.com. About Textron Textron is a multi-industry company that leverages its global network of aircraft, defense, industrial and finance businesses to provide customers with innovative solutions and services. Textron is known around the world for its powerful brands such as Bell, Cessna, Beechcraft, Pipistrel, Jacobsen, Kautex, Lycoming, E-Z-GO, Arctic Cat, and Textron Systems. For more information, visit: www.textron.com. Certain statements in this press release are forward-looking statements which may project revenues or describe strategies, goals, outlook or other non-historical matters; these statements speak only as of the date on which they are made, and we undertake no obligation to update or revise any forward-looking statements. These statements are subject to known and unknown risks, uncertainties, and other factors that may cause our actual results to differ materially from those expressed or implied by such forward-looking statements, including, but not limited to, changes in aircraft delivery schedules or cancellations or deferrals of orders. View source version on businesswire.com: https://www.businesswire.com/news/home/20240313335405/en/ Media: Doug Scott +1.316.347.0116 dscott2@txtav.com txtav.com Source: Textron Aviation Inc. What contract did Textron Aviation secure with the U.S. Army? Textron Aviation secured a contract with the U.S. Army Contracting Command, Redstone Arsenal, AL, for two Cessna Grand Caravan EX turboprop aircraft. Who will own and operate the two Cessna Grand Caravan EX aircraft? The Djiboutian Air Force (DAF) will own and operate the two Cessna Grand Caravan EX aircraft. What is the total value of the IDIQ contract for Textron Aviation aircraft? The IDIQ contract allows up to $100 million U.S. dollars for the acquisition of Textron Aviation aircraft over a five-year period. Who is the manufacturer of the Cessna Grand Caravan EX aircraft? Textron Aviation Inc., a Textron Inc. (NYSE:TXT) company, is the manufacturer of the Cessna Grand Caravan EX aircraft. What are the two special missions for the Cessna Grand Caravan EX aircraft? The two special missions for the Cessna Grand Caravan EX aircraft are Intelligence, Surveillance, and Reconnaissance to ensure the border sovereignty of Djibouti. How many aircraft have been ordered under the IDIQ contract so far? With the addition of the two Cessna Grand Caravan EX aircraft for the Djiboutian Air Force, five aircraft have been ordered under the IDIQ contract."
"Samsonite International S.A. Announces Final Results for the Year Ended December 31, 2023",2024-03-13T16:45:00.000Z,Low,Neutral,"Samsonite International S.A. reports a 30.4% increase in consolidated net sales year-on-year, driven by growth in all regions and core brands. The company also saw significant expansion in gross profit margin and Adjusted EBITDA margin in 2023, with a focus on the Asia region and Tumi brand. Samsonite continued to reduce its debt levels, achieving the lowest net leverage ratio since 2016.","Samsonite International S.A. Announces Final Results for the Year Ended December 31, 2023 Rhea-AI Impact (Low) Rhea-AI Sentiment (Neutral) Tags Rhea-AI Summary Samsonite International S.A. reports a 30.4% increase in consolidated net sales year-on-year, driven by growth in all regions and core brands. The company also saw significant expansion in gross profit margin and Adjusted EBITDA margin in 2023, with a focus on the Asia region and Tumi brand. Samsonite continued to reduce its debt levels, achieving the lowest net leverage ratio since 2016. Positive None. Negative None. 03/13/2024 - 12:45 PM Consolidated net sales increased by 30.4%1, 2 year-on-year driven by strong growth across all regions and core brands Gross profit margin and Adjusted EBITDA margin3 expanded significantly in 2023, driven by increased net sales contribution from higher-margin Asia region and Tumi brand as well as benefits from our more efficient cost structure Continued to deleverage balance sheet, driven by strong profit growth and Free Cash Flow4 with net leverage ratio5 at lowest level since 2016 acquisition of Tumi HONG KONG, March 13, 2024 /PRNewswire/ -- Samsonite International S.A. (""Samsonite"" or ""the Company"", together with its consolidated subsidiaries, ""the Group""; SEHK stock code: 1910), a leader in the global lifestyle bag industry and the world's best-known and largest travel luggage company, today published its final results for the year ended December 31, 2023. In this press release, certain financial results for the year ended December 31, 2023, are compared to both the year ended December 31, 2022, and the year ended December 31, 2019. Comparisons to the year ended December 31, 2019, are provided because it is the most recent comparable year during which the Company's results were not affected by COVID-19. OverviewCommenting on the results, Mr. Kyle Gendreau, Chief Executive Officer, said, ""2023 marked another impressive year for Samsonite. We achieved outstanding results, and we are well positioned to continue to outpace the market backed by our portfolio of leading brands, unrivalled global sourcing and distribution infrastructure, and ability to invest in product innovation and marketing. Supported by strategic investments in marketing, we successfully capitalized on the continued recovery and growth in leisure and business travel worldwide, particularly in Asia, to deliver strong year-on-year net sales gains across all regions and core brands, with significant improvements in profitability."" ""During 2023 the Group registered strong double-digit net sales growth year-on-year, while its gross profit margin and Adjusted EBITDA margin3 both reached record highs, reflecting our efficient cost structure and the increased net sales contribution from our higher-margin Asia region and Tumi brand. As a result, our Adjusted EBITDA6 increased by 50.2% on net sales that grew by 30.4%1, 2 in 2023 compared to 2022, a notable achievement that underscores Samsonite's fundamentally transformed profitability. With strong profits and prudent cash management, we generated strong Free Cash Flow4 in 2023, part of which we used to further reduce our debt. We ended the year with a net leverage ratio5 of 1.53x, the lowest level since our acquisition of Tumi in 2016, as well as substantial liquidity of US$1.6 billion7. Considering our strong performance and financial position, the Board decided to resume annual cash distributions in 2024, recommending a cash distribution of US$150.0 million to the Company's shareholders. This represents an increase of US$25.0 million, or 20.0%, compared to the cash distribution of US$125.0 million paid in 2019."" ""We intensified our efforts to embed sustainability into the business in 2023. Among other accomplishments, we increased the share of Samsonite's net sales that came from products made at least in part from recycled materials to approximately 34%, up from about 23% in 2022. We also achieved 100% renewable electricity usage in all our own operations, two years earlier than our 2025 target date. We will continue to advance Samsonite's ""Our Responsible Journey"" sustainability initiatives, leveraging our scale to lead the transformation of the luggage industry to become more sustainable."" Mr. Gendreau continued, ""Looking to 2024, global travel and tourism growth is expected to remain healthy. Asia is expected to continue to see robust travel growth in 2024, as outbound travel from China continues to improve. In markets that reopened earlier, including North America and Europe, travel is expected to see steady growth closer to historical trends, with relatively stronger prospects in Europe from the ongoing return of Chinese travelers."" ""We will continue to invest in our core brands in 2024, focusing on product innovation, sustainability initiatives and further enhancements to our global retail store network, all supported by increased investment in marketing. We are targeting 2024 marketing spend of approximately 7.0% of net sales, and we are confident that, with the amazing new products and exciting advertising campaigns planned for 2024, the Group will continue to deliver robust net sales growth, with strength in the higher-margin Asia region and Tumi brand."" Mr. Gendreau concluded, ""We will continue to be vigilant in limiting promotional discounts to sustain our improved gross profit margin. We will also maintain discipline in managing expenses, especially our fixed SG&A expenses, to drive operating leverage and deliver sustained bottom-line growth. At the same time, we will maintain focus on cash management to sustain strong Free Cash Flow4 generation, further enhancing Samsonite's flexibility in capital allocation to continue to deleverage our balance sheet, invest in organic growth, and return cash to our shareholders."" Table 1: Key Financial Highlights for the Three Months Ended December 31, 2023 Expressed in US$ millions, except per share data Three monthsendedDecember 31, 2023 Three monthsendedDecember 31, 2022 Percentage increase (decrease) 2023 vs. 2022 Percentage increase (decrease) 2023 vs. 2022 excl. foreign currency effects1 Net sales 948.5 818.5 15.9 % 15.8 % Gross profit 568.3 462.9 22.8 % 22.9 % Gross profit margin 59.9 % 56.5 % Operating profit8 248.9 210.5 18.3 % 18.6 % Operating profit excluding total non-cash impairment reversals and restructuring (reversals) charges8, 9 164.6 128.0 28.6 % 29.1 % Profit attributable to the equity holders 149.2 198.2 (24.8) % (27.7) % Adjusted Net Income10 95.8 147.8 (35.2) % (39.2) % Adjusted EBITDA6 181.0 142.5 27.0 % 27.4 % Adjusted EBITDA margin3 19.1 % 17.4 % Basic earnings per share Expressed in US$ per share 0.103 0.138 (25.2) % (28.1) % Diluted earnings per share Expressed in US$ per share 0.102 0.137 (25.6) % (28.6) % Adjusted basic earnings per share11  Expressed in US$ per share 0.066 0.103 (35.6) % (39.5) % Adjusted diluted earnings per share11  Expressed in US$ per share 0.066 0.102 (36.0) % (39.9) % 2023 Fourth Quarter HighlightsFor the three months ended December 31, 2023, Samsonite registered consolidated net sales of US$948.5 million, an increase of 15.8%1 year-on-year, notwithstanding travel growth in markets that reopened earlier, including North America and Europe, beginning to normalize. The net sales increase during the fourth quarter of 2023 was driven primarily by Asia where the Group registered net sales growth of 40.6%1 year-on-year. During the fourth quarter of 2023, net sales in the direct-to-consumer (""DTC"") channel in North America increased by 7.7%1 year-on-year driven by the Tumi and Samsonite brands. This was offset by wholesale channel net sales decreasing by 8.0%1 year-on-year during the fourth quarter of 2023, primarily due to a shift in timing of shipments to certain wholesale customers following strong year-on-year wholesale net sales growth during the first nine months of 2023. Overall, net sales in North America for the fourth quarter of 2023 were flat1 year-on-year. Net sales in Europe and Latin America for the fourth quarter of 2023 increased by 5.8%1 and 32.9%1 year-on-year, respectively. The Samsonite, Tumi and American Tourister brands recorded year-on-year net sales growth of 14.6%1, 18.7%1 and 14.6%1 for the fourth quarter of 2023, respectively. The Group's gross profit margin expanded to 59.9% in the fourth quarter of 2023, an increase of 340 basis points year-on-year, driven mainly by year-on-year gross profit margin improvements in all regions and Asia, the region with the highest gross profit margin, increasing its share of net sales, as well as overall lower promotional discounts. The Group increased its investment in marketing as planned, with marketing expenses rising to 7.2% of net sales in the fourth quarter of 2023 compared to 6.5% of net sales in the fourth quarter of 2022. The team remained disciplined in managing fixed selling, general and administrative (""SG&A"") expenses, enabling Samsonite to achieve a 27.0% increase in Adjusted EBITDA6 to US$181.0 million and a 170-basis point expansion in Adjusted EBITDA margin3 to 19.1% for the fourth quarter of 2023, year-on-year. The Group recorded an income tax expense of US$52.4 million for the three months ended December 31, 2023, compared to an income tax benefit of US$25.7 million for the fourth quarter of 2022, primarily due to year-on-year changes in unrecognized deferred tax assets. As a result, the Group's profit attributable to the equity holders decreased by US$49.1 million year-on-year to US$149.2 million for the three months ended December 31, 2023. The Group's Adjusted Net Income10 decreased by US$52.0 million year-on-year to US$95.8 million for the three months ended December 31, 2023. Compared to the corresponding period in 2019, Samsonite's net sales for the fourth quarter of 2023 increased by 15.1%1, 2, 12; gross profit margin increased by 580 basis points; Adjusted EBITDA6 and Adjusted EBITDA margin3 increased by 25.0% and 400 basis points, respectively; and Adjusted Net Income10 increased by 68.4%; despite marketing spend as a percentage of net sales rising by 290 basis points. This remarkable improvement from 2019 highlights the Group's strong operating leverage and fundamentally enhanced margin profile as net sales continued to grow. Table 2: Key Financial Highlights for the Year Ended December 31, 2023 Expressed in US$ millions, except per share data Year endedDecember 31, 2023 Year endedDecember 31, 2022 Percentage increase (decrease) 2023 vs. 2022 Percentage increase (decrease) 2023 vs. 2022 excl. foreign currency effects1 Net sales 3,682.4 2,879.6 27.9 % 30.0 % Gross profit 2,182.8 1,605.4 36.0 % 38.4 % Gross profit margin 59.3 % 55.8 % Operating profit8 743.7 492.1 51.1 % 53.6 % Operating profit excluding total non-cash impairment reversals and restructuring (reversals) charges8, 9 659.1 421.2 56.5 % 59.4 % Profit attributable to the equity holders 417.0 312.7 33.3 % 34.6 % Adjusted Net Income10 392.4 296.0 32.5 % 33.8 % Adjusted EBITDA6 709.3 472.3 50.2 % 54.0 % Adjusted EBITDA margin3 19.3 % 16.4 % Basic earnings per share Expressed in US$ per share 0.289 0.218 32.7 % 33.9 % Diluted earnings per share Expressed in US$ per share 0.287 0.217 32.1 % 33.3 % Adjusted basic earnings per share11  Expressed in US$ per share 0.272 0.206 31.9 % 33.2 % Adjusted diluted earnings per share11  Expressed in US$ per share 0.270 0.206 31.3 % 32.6 % Results for the Year Ended December 31, 2023The Group's performance for the year ended December 31, 2023, is discussed in greater detail below. Net SalesThe Group's net sales increase was driven by the continued recovery and growth in leisure and business travel globally and the resulting increased demand for the Group's products. Supported by substantial investments in marketing behind Samsonite's industry-leading brands and product assortments, as well as the strength of the Group's direct-to-consumer business, the Group achieved double-digit year-on-year net sales growth in all regions in 2023. Year Ended December 31, 2023, vs. Year Ended December 31, 2022For the year ended December 31, 2023, the Group recorded net sales of US$3,682.4 million, an increase of 30.0%1 compared to the US$2,879.6 million recorded in 2022. When excluding the net sales in Russia, the Group's net sales increased by US$812.5 million, or 30.4%1, 2, year-on-year, in 2023. Year Ended December 31, 2023, vs. Year Ended December 31, 2019Compared to 2019, the Group's net sales for the year ended December 31, 2023, increased by 11.5%1, and by 17.5%1, 2, 12 when excluding the net sales in Russia and by Speck. Net Sales Performance by Region Table 3: Net Sales by Region Region13 Year endedDecember 31, 2023 US$ millions Year endedDecember 31, 2022 US$ millions Percentage increase (decrease) 2023 vs. 2022 Percentage increase (decrease) 2023 vs. 2022 excl. foreign currency effects1 Asia 1,427.8 916.4 55.8 % 61.7 % North America 1,267.2 1,117.3 13.4 % 13.7 % Europe14 776.9 675.7 15.0 % 15.1 % Latin America 209.5 168.8 24.1 % 25.7 % Corporate 1.1 1.5 (27.2) % (27.2) % Net sales15 3,682.4 2,879.6 27.9 % 30.0 % AsiaYear Ended December 31, 2023, vs. Year Ended December 31, 2022For the year ended December 31, 2023, the Group recorded net sales of US$1,427.8 million in Asia, an increase of US$511.4 million, or 61.7%1, compared to 2022. The share of total net sales in Asia, the Group's most profitable region, increased to 38.8% in 2023 versus 31.8% in 2022. Net sales in China increased by 88.4%1 year-on-year in 2023, driven by a strong rebound in travel, particularly domestic travel, following the lifting of travel restrictions and social distancing measures at the beginning of the year. During 2023 the Group's net sales in India increased by 25.5%1, in Japan by 68.4%1, in South Korea by 52.2%1 and in Hong Kong16 by 96.1%1, year-on-year. Year Ended December 31, 2023, vs. Year Ended December 31, 2019Compared to 2019, the Group's net sales in Asia for the year ended December 31, 2023, increased by 20.1%1. The Group's net sales in China for 2023 were in line1 with 2019, a meaningful improvement versus 2022 when net sales were down by 47.0%1 compared to 2019. Net sales for 2023 in India and Japan increased by 75.7%1 and 13.0%1, respectively, compared to 2019. Net sales trends in South Korea and Hong Kong16 also noticeably improved in 2023. Compared to 2019, net sales in South Korea decreased by 1.2%1 in 2023 (versus a decline of 34.8%1 in 2022 compared to 2019), while net sales in Hong Kong16 decreased by 24.3%1 in 2023 (versus a decline of 61.4%1 in 2022 compared to 2019). North AmericaYear Ended December 31, 2023, vs. Year Ended December 31, 2022For the year ended December 31, 2023, the Group recorded net sales of US$1,267.2 million in North America, an increase of US$149.9 million, or 13.7%1, compared to 2022. The Group's net sales in the United States and Canada increased by 12.6%1 and 33.5%1, respectively, year-on-year. Year Ended December 31, 2023, vs. Year Ended December 31, 2019For the year ended December 31, 2023, the Group's net sales in North America declined by 7.0%1 compared to 2019. When excluding the net sales by Speck, the Group recorded a net sales increase of 2.3%1, 12 in North America in 2023 when compared to 2019. Further adjusting for the discontinuation of unprofitable third-party brand sales on the ebags e-commerce platform in 2020, net sales in North America in 2023 increased by 8.0%1, 12 compared to 2019. For the year ended December 31, 2023, the Group's net sales in the United States declined by 8.3%1 compared to 2019. When excluding the net sales by Speck, the Group recorded a net sales increase of 1.3%1, 12 in the United States compared to 2019. Further adjusting for the discontinuation of unprofitable third-party brand sales on the ebags e-commerce platform in 2020, net sales in the United States in 2023 increased by 7.3%1, 12 compared to 2019. Net sales in Canada increased by 20.8%1 during 2023 compared to 2019. EuropeYear Ended December 31, 2023, vs. Year Ended December 31, 2022For the year ended December 31, 2023, the Group recorded net sales of US$776.9 million in Europe, an increase of US$101.2 million, or 15.1%1, compared to 2022. When excluding the net sales in Russia, net sales in Europe increased by 16.8%1, 2 year-on-year. During 2023 the Group's net sales in Germany increased by 25.2%1, in Italy by 19.8%1, in France by 11.4%1, in the United Kingdom17 by 6.6%1, and in Spain by 16.0%1, year-on-year. Year Ended December 31, 2023, vs. Year Ended December 31, 2019For the year ended December 31, 2023, the Group's net sales in Europe were 16.7%1 higher than in 2019 (or 26.3%1, 2 higher when excluding the net sales in Russia). Net sales for most of the Group's key markets in Europe fully recovered to pre-pandemic levels in 2023, including Spain (up 20.0%1 versus 2019), Italy (up 3.9%1 versus 2019), and France (flat1 versus 2019). Net sales trends in Germany and the United Kingdom17 also noticeably improved in 2023. Compared to 2019, net sales in Germany decreased by 5.4%1 in 2023 (versus a decline of 24.1%1 in 2022 compared to 2019), while net sales in the United Kingdom17 decreased by 1.0%1 in 2023 (versus a decline of 6.9%1 in 2022 compared to 2019). Latin AmericaYear Ended December 31, 2023, vs. Year Ended December 31, 2022For the year ended December 31, 2023, the Group recorded net sales of US$209.5 million in Latin America, an increase of US$40.7 million, or 25.7%1, compared to 2022, driven by year-on-year net sales increases of 29.4%1 in Mexico, 11.1%1 in Chile, and 11.2%1 in Brazil. Year Ended December 31, 2023, vs. Year Ended December 31, 2019For the year ended December 31, 2023, Samsonite's net sales in Latin America increased by 71.6%1 compared to 2019, with all key markets recording net sales increases for 2023 when compared to 2019, including: Mexico (up 15.7%1), Chile (up 31.1%1), and Brazil (up 81.0%1). Net Sales Performance by Brand Table 4: Net Sales by Brand Brand Year endedDecember 31, 2023 US$ millions Year endedDecember 31, 2022 US$ millions Percentage increase (decrease) 2023 vs. 2022 Percentage increase (decrease) 2023 vs. 2022 excl. foreign currency effects1 Samsonite 1,849.0 1,444.3 28.0 % 30.1 % Tumi 878.6 654.2 34.3 % 35.8 % American Tourister 654.5 519.4 26.0 % 28.7 % Other18 300.3 261.7 14.8 % 17.0 % Net sales 3,682.4 2,879.6 27.9 % 30.0 % The Group's core brands all achieved strong net sales gains during 2023 driven by the continued recovery and growth in leisure and business travel globally and the resulting increased demand for the Group's products. For the year ended December 31, 2023, net sales of the Samsonite brand increased by US$404.7 million, or 30.1%1, year-on-year, with strong growth across all regions: Asia (up US$248.4 million, or 71.5%1), Europe (up US$79.8 million, or 18.1%1), North America (up US$61.6 million, or 11.7%1) and Latin America (up US$14.8 million, or 24.2%1). Net sales of the Tumi brand increased by US$224.4 million, or 35.8%1, year-on-year during 2023, with strong growth across all regions: Asia (up US$105.0 million, or 67.6%1), North America (up US$91.5 million, or 22.6%1), Europe (up US$22.2 million, or 33.4%1) and Latin America (up US$5.6 million, or 71.2%1). As a result, the Tumi brand's share of the Group's total net sales increased to 23.9% in 2023 from 22.7% in 2022. Net sales of the American Tourister brand increased by US$135.2 million, or 28.7%1, year-on-year during 2023, mainly driven by strong growth in Asia (up US$137.1 million, or 57.5%1), with Latin America (up US$7.4 million, or 29.4%1) also recording year-on-year net sales growth. Net sales of the American Tourister brand in Europe decreased slightly by US$0.2 million, or 1.1%1, in 2023 compared to 2022. Net sales of the American Tourister brand in North America decreased by US$9.2 million, or 8.2%1, year-on-year, due to a shift in timing of shipments to certain wholesale customers. Net Sales Performance by Product Category Table 5: Net Sales by Product Category Product Category Year endedDecember 31, 2023 US$ millions Year endedDecember 31, 2022 US$ millions Percentage increase (decrease) 2023 vs. 2022 Percentage increase (decrease) 2023 vs. 2022 excl. foreign currency effects1 Travel 2,435.9 1,891.8 28.8 % 30.7 % Non-travel19 1,246.5 987.8 26.2 % 28.5 % Net sales 3,682.4 2,879.6 27.9 % 30.0 % The Group's net sales in the travel product category continued to improve driven mainly by the continued recovery and growth in leisure and business travel and increased demand for the Group's products. Net sales in the travel product category increased by 30.7%1 year-on-year and accounted for 66.2% of total net sales in 2023 compared to 65.7% of total net sales in 2022. Total non-travel product category19 net sales increased by 28.5%1 year-on-year and accounted for 33.8% of total net sales in 2023 compared to 34.3% of total net sales in 2022. Net Sales Performance by Distribution Channel Table 6: Net Sales by Distribution Channel Distribution Channel Year endedDecember 31, 2023 US$ millions Year endedDecember 31, 2022 US$ millions Percentage increase (decrease) 2023 vs. 2022 Percentage increase (decrease) 2023 vs. 2022 excl. foreign currency effects1 Wholesale 2,247.2 1,794.1 25.3 % 27.4 % DTC 1,433.9 1,083.8 32.3 % 34.2 % Other20 1.3 1.6 (21.6) % (21.6) % Total net sales 3,682.4 2,879.6 27.9 % 30.0 % The Group's wholesale net sales increased by 27.4%1 to US$2,247.2 million (representing 61.0% of net sales) for the year ended December 31, 2023, from US$1,794.1 million (representing 62.3% of net sales) in 2022. Net sales to e-retailers, which are included in the Group's wholesale channel, increased by US$52.8 million, or 25.8%1, in 2023 compared to 2022. For the year ended December 31, 2023, the Group's net sales in the direct-to-consumer (""DTC"") channel, which includes company-operated bricks-and-mortar retail stores and e-commerce sites operated by the Group, increased by US$350.0 million, or 34.2%1, to US$1,433.9 million (representing 38.9% of net sales) from US$1,083.8 million (representing 37.6% of net sales) in 2022. During the year ended December 31, 2023, the Group added 96 company-operated retail stores, partially offset by the permanent closure of 29 company-operated retail stores. This resulted in a net increase of 67 company-operated retail stores in 2023, compared to a net reduction of 20 company-operated retail stores in 2022. The total number of company-operated retail stores was 1,052 as of December 31, 2023, compared to 985 at the end of 2022. During the year ended December 31, 2023, the Group's DTC retail net sales increased by US$253.0 million, or 34.3%1, to US$1,035.4 million (representing 28.1% of net sales), compared to US$782.4 million (representing 27.2% of net sales) in 2022. Compared to 2019, the Group's DTC retail net sales for 2023 increased by 24.4%1, 2, despite a significantly lower retail store count versus 2019 (as of December 31, 2019, the Group had 1,294 company-operated retail stores worldwide, including 45 company-operated retail stores in Russia). The Group's DTC e-commerce channel also experienced strong growth, with net sales increasing by US$97.1 million, or 34.2%1, to US$398.5 million (representing 10.8% of net sales) in 2023 compared to US$301.4 million (representing 10.5% of net sales) in 2022. Adjusting for the discontinuation of unprofitable third-party brand sales on the ebags e-commerce platform in 2020, the Group's 2023 DTC e-commerce net sales increased by 39.6%1, 2 compared to 2019. Gross ProfitThe Group's gross profit increased by US$577.3 million, or 36.0%, to US$2,182.8 million for the year ended December 31, 2023, from US$1,605.4 million in 2022. Gross profit margin increased by 350 basis points to 59.3% for 2023 from 55.8% for 2022. The increase in gross profit margin was driven mainly by year-on-year gross profit margin improvements in all regions and Asia, the region with the highest gross profit margin, increasing its share of net sales to 38.8% in 2023 from 31.8% in 2022. This increase in gross profit margin was also driven by an increased proportion of total net sales attributable to the Tumi brand to 23.9% in 2023 from 22.7% in 2022, an increased proportion of total net sales attributable to direct-to-consumer net sales of 38.9% in 2023 versus 37.6% in 2022, and overall reduced promotional discounts. Investment in MarketingThe Group substantially increased marketing activities as planned, spending US$241.5 million during the year ended December 31, 2023, an increase of US$85.5 million, or 54.8%, compared to US$156.0 million in 2022. As a percentage of net sales, marketing expenses increased by 120 basis points to 6.6% of net sales in 2023 from 5.4% in 2022. Distribution ExpensesDistribution expenses increased by US$220.3 million, or 27.3%, to US$1,027.6 million for the year ended December 31, 2023, from US$807.3 million in 2022. As a percentage of net sales, distribution expenses remained relatively consistent at 27.9% of net sales in 2023 versus 28.0% of net sales in 2022. General and Administrative Expenses General and administrative expenses increased by US$28.3 million, or 12.7%, to US$250.2 million for year ended December 31, 2023, from US$221.9 million in 2022. As a percentage of net sales, general and administrative expenses improved to 6.8% of net sales in 2023 compared to 7.7% in 2022, reflecting the increase in net sales year-on-year as well as disciplined expense management, partially offset by inflationary pressures. Operating ProfitThe Group reported an operating profit of US$743.7 million for the year ended December 31, 2023, an improvement of US$251.5 million, or 51.1%, compared to the US$492.1 million for 2022. The Group recorded an operating profit of US$659.1 million8, 9 for the year ended December 31, 2023, an increase of US$237.9 million, or 56.5%, compared to an operating profit of US$421.2 million8, 9 for 2022, when excluding total restructuring reversals (charges)8 and total non-cash impairment reversals8 recorded during the respective years. Profit Attributable to the Equity HoldersThe Group reported profit attributable to the equity holders of US$417.0 million for the year ended December 31, 2023, an increase of US$104.3 million, or 33.3%, from the US$312.7 million in 2022. The Group recorded profit attributable to the equity holders of US$356.3 million8, 9 for the year ended December 31, 2023, an increase of US$95.1 million, or 36.4%, compared to profit attributable to the equity holders of US$261.2 million8, 9 for 2022, when excluding total restructuring reversals (charges)8 and total non-cash impairment reversals8 recorded during the respective years, as well as the derecognition of deferred financing costs associated with a refinancing on the Group's credit facilities during 2023. Adjusted EBITDA and Adjusted Net IncomeYear Ended December 31, 2023, vs. Year Ended December 31, 2022For the year ended December 31, 2023, the Group recorded Adjusted EBITDA6 of US$709.3 million, an increase of US$237.0 million, or 50.2%, compared to US$472.3 million in 2022. For the year ended December 31, 2023, the Group's net sales rose by US$802.8 million year-on-year to US$3,682.4 million, but fixed SG&A expenses only increased by US$140.7 million to US$836.0 million due to the Group's disciplined expense management. As a result, fixed SG&A expenses amounted to 22.7% of net sales in 2023, 140 basis points lower than the 24.1% during 2022. Together with the 350-basis point year-on-year increase in gross profit margin, Samsonite's Adjusted EBITDA margin3 expanded by 290 basis points to 19.3% for the year ended December 31, 2023, from 16.4% during the corresponding period in 2022, despite marketing spend as a percentage of net sales increasing by 120 basis points year-on-year. Adjusted Net Income10 increased by US$96.3 million, or 32.5%, to US$392.4 million for the year ended December 31, 2023, compared to US$296.0 million for 2022, primarily due to improved net sales and gross profit margin, as well as disciplined expense management. Year Ended December 31, 2023, vs. Year Ended December 31, 2019Comparing the year ended December 31, 2023, against year ended December 31, 2019, Samsonite's gross profit margin increased by 390 basis points from 55.4% to 59.3%, marketing expenses as a percentage of sales increased by 140 basis points from 5.2% to 6.6%, and fixed SG&A expenses as a percentage of net sales decreased by 460 basis points from 27.3% to 22.7%, resulting in the Group's Adjusted EBITDA margin3 increasing by 580 basis points from 13.5% to 19.3%. In US dollar terms, the Group's Adjusted EBITDA6 for the year ended December 31, 2023, increased by US$217.1 million to US$709.3 million from the US$492.2 million recorded in 2019, despite reported net sales only rising by US$43.6 million in 2023 compared to 2019. Adjusted Net Income10 was US$176.5 million higher than the US$215.9 million in 2019. This remarkable improvement from 2019 highlights the Group's strong operating leverage and fundamentally enhanced margin profile. Working CapitalThe Group continued to optimize its working capital, particularly inventories, to support net sales growth. At US$695.9 million as of December 31, 2023, inventories were US$44.5 million lower than the US$740.4 million as of June 30, 2023, and just US$8.2 million higher than the US$687.6 million at the end of 2022, as the Group gradually reduced inventories with continued strong net sales and tapering product purchases during the second half of 2023, while maintaining a healthy level of inventories to meet ongoing growth in demand. Trade and other receivables increased by US$28.7 million to US$319.6 million as of December 31, 2023, compared to US$290.9 million at the end of 2022. Meanwhile, accounts payable decreased by US$82.9 million to US$500.4 million as of December 31, 2023, from US$583.3 million at the end of 2022. As a result, net working capital was US$515.1 million as of December 31, 2023, an increase of US$119.8 million from US$395.3 million as of December 31, 2022. However, with the Group's strong net sales performance, net working capital efficiency21 was a healthy 14.0% as of December 31, 2023, and the Group will continue to prudently manage its working capital in 2024. Total Capital ExpendituresAs the business recovers, the Group is prudently increasing its spending on total capital expenditures towards retail expansion in key markets and refreshing its retail store fleet after a few years of tight control. During the year ended December 31, 2023, the Group selectively opened 96 new retail stores, particularly in Asia. In comparison, the Group opened 50 new retail stores in 2022. As a result, the Group's total capital expenditures were US$110.1 million22 during the year ended December 31, 2023, an increase of US$47.3 million compared to US$62.8 million22 in 2022. The Group intends to continue to spend on total capital expenditures to upgrade and expand its retail store fleet, as well as to invest in core strategic functions to support continued sales growth. Balance Sheet and Free Cash FlowThe Group continued to focus on cash management and debt reduction. With strong profits and prudent cash management, Samsonite generated strong Free Cash Flow4 of US$284.5 million during the year ended December 31, 2023, compared to US$83.5 million in 2022, an increase of US$201.0 million, or 240.6%. The Group utilized part of its Free Cash Flow4 to further deleverage its balance sheet, repaying US$125.9 million of outstanding borrowings during the year ended December 31, 2023, consisting of US$100.0 million in voluntary payments and US$25.9 million in required quarterly amortization payments. As a result, the Group had net debt of US$1,107.4 million 23 as of December 31, 2023, compared to US$1,383.7 million23 at the end of 2022. The reduction in net debt, together with the strong growth in Adjusted EBITDA6, enabled the Group to significantly lower its net leverage ratio5 to 1.53x as of December 31, 2023, a meaningful improvement compared to 2.85x at the end of 2022, and the lowest level since the acquisition of Tumi in 2016. The Group had total liquidity of US$1,562.0 million7 as of December 31, 2023, compared to US$1,481.3 million7 at the end of 2022. 2023 Final Results  Briefing for Analysts and Investors: Date: Thursday, March 14, 2024 Time: 09:00 Hong Kong Venue: Nathan Room, Lower Lobby, Conrad Hong Kong, Pacific Place, 88 Queensway, Admiralty, Hong Kong Webcast Link: https://edge.media-server.com/mmc/p/552xejae About SamsoniteWith a heritage dating back to 1910, Samsonite International S.A. (""Samsonite"" or the ""Company"", together with its consolidated subsidiaries the ""Group""), is a leader in the global lifestyle bag industry and is the world's best-known and largest travel luggage company. The Group is principally engaged in the design, manufacture, sourcing and distribution of luggage, business and computer bags, outdoor and casual bags and travel accessories throughout the world, primarily under the Samsonite, Tumi, American Tourister, Gregory, High Sierra, Lipault and Hartmann brand names as well as other owned and licensed brand names. The Company's ordinary shares are listed on the Main Board of The Stock Exchange of Hong Kong Limited (""SEHK""). For more information, please contact: Samsonite International S.A.  Hong Kong Branch Tel: +852 2422 2611 William Yue Email: william.yue@samsonite.com Helena Sau Email: helena.sau@samsonite.com United States  Joele Frank, Wilkinson Brimmer Katcher Michael Freitag / Tim Ragones / Ed Trissel Tel: Tel: +1 212 355 4449 Notes 1 Results stated on a constant currency basis, a non-International Financial Reporting Standards (""IFRS"") Accounting Standards measure, are calculated by applying the average exchange rate of the quarter/year under comparison to current period local currency results. 2 On March 14, 2022, the Group suspended all commercial activities in Russia due to the armed conflict in Ukraine, and the Group subsequently completed the disposition of its Russian operations on July 1, 2022. As such, when comparing the Group's net sales for the three months and year ended December 31, 2023, with its net sales for the three months and years ended December 31, 2022, and December 31, 2019, net sales of the Group's former Russian operations in the respective quarters/years under comparison are excluded. 3 Adjusted EBITDA margin, a non-IFRS measure, is calculated by dividing adjusted earnings before interest, taxes, depreciation and amortization of intangible assets (""Adjusted EBITDA"") by net sales. 4 Free Cash Flow is defined as net cash generated from (used in) operating activities less (i) purchases of property, plant and equipment and software (""total capital expenditures"") and (ii) principal payments on lease liabilities (each as set forth on the consolidated statements of cash flows). 5 The total net leverage ratio is calculated by dividing total consolidated net debt minus the aggregate amount of unrestricted cash by the consolidated Adjusted EBITDA for the trailing four fiscal quarters on a pro forma basis as defined in the credit agreement. 6 Adjusted EBITDA, a non-IFRS measure, eliminates the effect of a number of costs, charges and credits and certain other non-cash charges. The Group believes these measures provide additional information that is useful in gaining a more complete understanding of its operational performance and of the underlying trends of its business. 7 Total liquidity is calculated as the sum of cash and cash equivalents per the consolidated statements of financial position plus available capacity under the Group's revolving credit facility. As of December 31, 2023, the Group had total liquidity of US$1,562.0 million, comprising cash and cash equivalents of US$716.6 million and US$845.4 million available to be borrowed on the Group's revolving credit facility. In comparison, as of December 31, 2022, the Group had total liquidity of US$1,481.3 million, comprising cash and cash equivalents of US$635.9 million and US$845.4 million available to be borrowed on the Group's revolving credit facility. 8 Results for the three months ended December 31, 2023, included total restructuring reversals of US$0.3 million and total non-cash impairment reversals of US$84.0 million. Results for the three months ended December 31, 2022, included total restructuring charges of US$0.5 million and total non-cash impairment reversals of US$81.7 million. Results for the year ended December 31, 2023, included total restructuring reversals of US$0.6 million and total non-cash impairment reversals of US$84.0 million. Results for the year ended December 31, 2022, included total restructuring charges of US$1.3 million and total non-cash impairment reversals of US$72.2 million. 9 Operating profit and profit attributable to the equity holders, both excluding total non-cash impairment reversals and restructuring reversals (charges), are non-IFRS measures and, as calculated herein, may not be comparable to similarly named measures used by other companies and should not be considered comparable to operating profit and profit attributable to the equity holders in the Group's consolidated statements of income. 10 Adjusted Net Income, a non-IFRS measure, eliminates the effect of a number of costs, charges and credits and certain other non-cash charges, along with their respective tax effects, that impact the Group's reported profit attributable to the equity holders, which the Group believes helps to give securities analysts, investors and other interested parties a more complete understanding of the Group's underlying financial performance. 11 Adjusted basic and diluted earnings per share, both non-IFRS measures, are calculated by dividing Adjusted Net Income by the weighted average number of shares used in the basic and diluted earnings per share calculations, respectively. 12 On July 30, 2021, a wholly-owned subsidiary of the Company sold Speculative Product Design, LLC (""Speck""), including the Speck brand. As such, when comparing the Group's net sales for the three months and year ended December 31, 2023, with its net sales for the three months and year ended December 31, 2019, net sales by Speck in 2019 are excluded. 13 The geographic location of the Group's net sales generally reflects the country/territory from which its products were sold and does not necessarily indicate the country/territory in which its end customers were actually located. 14 When excluding the Group's net sales in Russia, net sales in Europe increased by US$110.9 million, or 16.7% (+16.8% constant currency), for the year ended December 31, 2023, compared to the previous year. 15 When excluding the Group's net sales in Russia, consolidated net sales increased by US$812.5 million, or 28.3% (+30.4% constant currency), for the year ended December 31, 2023, compared to the previous year. 16 Net sales reported for Hong Kong include net sales made in the domestic Hong Kong market, in Macau, and to distributors in certain other Asian markets. 17 Net sales reported for the United Kingdom include net sales made in Ireland. 18 Other includes certain other non-core brands owned by the Group, such as Gregory, High Sierra, Kamiliant, ebags, Xtrem, Lipault, Hartmann, Saxoline and Secret. 19 The non-travel product category includes business, casual, accessories and other products. 20 ""Other"" primarily consists of licensing revenue. 21 Net working capital efficiency is calculated as net working capital (the sum of inventories and trade and other receivables, minus accounts payable) divided by annualized net sales. 22 For the year ended December 31, 2023, the Group spent US$99.3 million for the purchase of property, plant and equipment and US$10.8 million for software purchases. In comparison, for the year ended December 31, 2022, the Group spent US$51.6 million for the purchase of property, plant and equipment and US$11.2 million for software purchases. 23 As of December 31, 2023, the Group had US$716.6 million in cash and cash equivalents and outstanding financial debt of US$1,824.0 million (excluding deferred financing costs of US$17.0 million), resulting in a net debt position of US$1,107.4 million. In comparison, as of December 31, 2022, the Group had cash and cash equivalents of US$635.9 million and outstanding financial debt of US$2,019.6 million (excluding deferred financing costs of US$7.8 million), resulting in a net debt position of US$1,383.7 million. Non-IFRS MeasuresThe Company has presented certain non-IFRS measures in this press release because each of these measures provides additional information that management believes is useful for securities analysts, investors and other interested parties to gain a more complete understanding of the Group's operational performance and of the trends impacting its business. These non-IFRS measures, as calculated herein, may not be comparable to similarly named measures used by other companies, and should not be considered comparable to IFRS measures. Refer to the relevant announcement/report published by the Company for the corresponding period for reconciliations of the Group's non-IFRS Accounting Standards financial information. Non-IFRS measures have limitations as an analytical tool and should not be considered in isolation from, or as a substitute for, an analysis of the Group's financial results as reported under IFRS Accounting Standards. Forward-looking StatementsThis press release contains forward-looking statements. Forward-looking statements reflect the Company's current views with respect to future events and performance. These statements may discuss, among other things, the Company's net sales, gross profit margin, operating profit, Adjusted Net Income, Adjusted EBITDA, Adjusted EBITDA margin, cash flow, liquidity and capital resources, potential impairments, growth, strategies, plans, achievements, distributions, organizational structure, future store openings or closings, market opportunities and general market and industry conditions. The Company generally identifies forward-looking statements by words such as ""expect"", ""seek"", ""believe"", ""plan"", ""intend"", ""estimate"", ""project"", ""anticipate"", ""may"", ""will"", ""would"" and ""could"" or similar words or statements. Forward-looking statements are based on beliefs and assumptions made by management using currently available information. These statements are only predictions and are not guarantees of future performance, actions or events. Forward-looking statements are subject to risks and uncertainties. If one or more of these risks or uncertainties materialize, or if management's underlying beliefs and assumptions prove incorrect, actual results may differ materially from those contemplated by a forward-looking statement. Among the factors that could cause actual results to differ materially are: the effect of worldwide economic conditions; the effect of political or social unrest and armed conflict; the effects of inflation; a general economic downturn or generally reduced consumer spending; significant changes in consumer spending patterns or preferences; competition; interruptions or delays in the supply of finished goods or key components; the performance of the Group's products within the prevailing retail environment; and financial difficulties encountered by customers and related bankruptcy and collection issues. Forward-looking statements speak only as of the date on which they are made. The Company's shareholders, potential investors and other interested parties should not place undue reliance on these forward-looking statements. The Company expressly disclaims any obligation to update or revise any forward-looking statement, whether as a result of new information, future events or otherwise, except as required by applicable securities laws and regulations. RoundingCertain amounts presented in this press release have been rounded up or down to the nearest tenth of a million, unless otherwise indicated. There may therefore be discrepancies between the actual totals of the individual amounts in the tables and the totals shown, between the amounts in the tables and the amounts given in the corresponding analyses in the text of this press release and between amounts in this press release and other publicly available documents. All percentages and key figures were calculated using the underlying data in whole US Dollars. View original content:https://www.prnewswire.com/news-releases/samsonite-international-sa-announces-final-results-for-the-year-ended-december-31-2023-302088332.html SOURCE Samsonite What was the percentage increase in consolidated net sales for Samsonite International S.A. in 2023? Samsonite International S.A. reported a 30.4% increase in consolidated net sales year-on-year in 2023. What contributed to the significant expansion of gross profit margin and Adjusted EBITDA margin for Samsonite in 2023? The expansion in gross profit margin and Adjusted EBITDA margin for Samsonite in 2023 was driven by increased net sales contribution from the higher-margin Asia region and Tumi brand, as well as benefits from a more efficient cost structure. How did Samsonite reduce its debt levels in 2023? Samsonite reduced its debt levels in 2023 by generating strong Free Cash Flow, part of which was used to further reduce debt. The company ended the year with a net leverage ratio of 1.53x, the lowest level since the acquisition of Tumi in 2016. What was the cash distribution recommended by the Board of Samsonite for its shareholders in 2024? The Board of Samsonite recommended a cash distribution of US$150.0 million to the Company's shareholders in 2024, representing an increase of US$25.0 million, or 20.0%, compared to the cash distribution in 2019. What percentage of Samsonite's net sales in 2023 came from products made from recycled materials? Approximately 34% of Samsonite's net sales in 2023 came from products made at least in part from recycled materials."
Bluerock Homes Trust (BHM) Announces Key Dates For 2024 Annual Meeting Of Stockholders,2024-03-13T19:06:00.000Z,Low,Neutral,"Bluerock Homes Trust, Inc. sets the date for its 2024 annual stockholders meeting on June 13, 2024, with a record date of April 12, 2024.","Bluerock Homes Trust (BHM) Announces Key Dates For 2024 Annual Meeting Of Stockholders Rhea-AI Impact (Low) Rhea-AI Sentiment (Neutral) Tags Rhea-AI Summary Bluerock Homes Trust, Inc. sets the date for its 2024 annual stockholders meeting on June 13, 2024, with a record date of April 12, 2024. Positive None. Negative None. 03/13/2024 - 03:06 PM NEW YORK, March 13, 2024 /PRNewswire/ -- Bluerock Homes Trust, Inc. (NYSE American: BHM) (the ""Company"") today announced that its Board of Directors has established June 13, 2024 as the date of its 2024 annual meeting of stockholders. The Board of Directors has established April 12, 2024 as the record date for the determination of stockholders entitled to vote at the meeting. About Bluerock Homes Trust, Inc.Bluerock Homes Trust, Inc. (NYSE American: BHM), headquartered in New York, New York, is an externally managed REIT that owns and operates high-quality single-family properties located in attractive markets with a focus on the knowledge-economy and high quality of life regions of the Sunbelt and high growth areas of the Western United States. BHM's principal objective is to generate attractive risk-adjusted investment returns by assembling a portfolio of pre-existing single-family rental homes and developing build-to-rent communities. BHM properties are located across a diverse group of growth markets and will seek to target a growing pool of middle-market renters seeking the single-family lifestyle without the upfront and ongoing investments associated with home ownership. For more information, please visit bluerockhomes.com. Forward Looking StatementsThis press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and other federal securities laws. These forward-looking statements are based upon the Company's present expectations, but these statements are not guaranteed to occur. Furthermore, the Company disclaims any obligation to publicly update or revise any forward-looking statement to reflect changes in underlying assumptions or factors, of new information, data or methods, future events or other changes. Investors should not place undue reliance upon forward-looking statements. For further discussion of the factors that could affect outcomes, please refer to the risk factors set forth in Item 1A of the Company's Annual Report on Form 10-K filed by the Company with the U.S. Securities and Exchange Commission (""SEC"") on March 12, 2024, and subsequent filings by the Company with the SEC. The Company claims the safe harbor protection for forward looking statements contained in the Private Securities Litigation Reform Act of 1995. View original content to download multimedia:https://www.prnewswire.com/news-releases/bluerock-homes-trust-bhm-announces-key-dates-for-2024-annual-meeting-of-stockholders-302088291.html SOURCE Bluerock Homes Trust, Inc. When is Bluerock Homes Trust, Inc.'s 2024 annual stockholders meeting scheduled? Bluerock Homes Trust, Inc.'s 2024 annual stockholders meeting is scheduled for June 13, 2024. What is the record date for Bluerock Homes Trust, Inc.'s 2024 annual stockholders meeting? The record date for Bluerock Homes Trust, Inc.'s 2024 annual stockholders meeting is April 12, 2024."
Sinclair and APTS Announce Free Virtual Channel Hosting for Public Television Stations Not Yet Transmitting in ATSC 3.0,2024-03-13T15:00:00.000Z,Low,Very Positive,"Sinclair Broadcast Group partners with Americas Public Television Stations to offer free carriage of virtual channels on NEXTGEN Broadcasting Service, enhancing video quality for viewers with HDR technology.","Sinclair and APTS Announce Free Virtual Channel Hosting for Public Television Stations Not Yet Transmitting in ATSC 3.0 Rhea-AI Impact (Low) Rhea-AI Sentiment (Very Positive) Tags Rhea-AI Summary Sinclair Broadcast Group partners with Americas Public Television Stations to offer free carriage of virtual channels on NEXTGEN Broadcasting Service, enhancing video quality for viewers with HDR technology. Positive None. Negative None. Broadcast Technology Expert The announcement by Sinclair Broadcast Group to provide carriage of virtual channels for public television stations in NEXTGEN TV markets is a significant development in the broadcast industry. The adoption of ATSC 3.0, also known as NEXTGEN Broadcast Service, represents a major leap in television technology, offering enhanced features such as high dynamic range (HDR) and interactive content. By hosting these virtual channels at no cost, Sinclair is removing a financial barrier for public television stations, potentially accelerating the adoption of ATSC 3.0.From a technical standpoint, this collaboration could lead to increased viewer engagement due to the improved picture quality and interactive services. Moreover, the ability to access channels seamlessly over the Internet bridges traditional broadcast with modern streaming habits. This hybrid model may prove to be a strategic move as broadcasters seek to retain viewership in an increasingly fragmented media landscape. Media Industry Analyst Strategically, Sinclair's initiative to support public television stations may enhance its competitive position in the broadcasting sector. By facilitating the transition to NEXTGEN TV, Sinclair is likely to gain goodwill among public broadcasters and viewers alike, which can translate into stronger industry partnerships and potentially increased viewership. Furthermore, the initiative may set a precedent for other private broadcasters to support public television, leading to a more collaborative industry environment.In terms of market impact, this move could signal Sinclair's commitment to innovation and leadership in broadcasting technology, which might be reflected in investor confidence. As more markets embrace ATSC 3.0, Sinclair could benefit from first-mover advantages, such as establishing standards for broadcasting and advertising models that leverage the new technology's capabilities. Financial Analyst For investors, the implications of Sinclair's announcement are twofold. Firstly, the investment in NEXTGEN TV infrastructure suggests a long-term strategic vision that could lead to new revenue streams, such as targeted advertising and interactive content services. Secondly, the cost implications of providing free carriage to public television stations must be considered. While this may initially impact Sinclair's financials, the potential market expansion and viewer base growth could offset these costs in the long run.It is essential to monitor how this technology adoption impacts Sinclair's operating expenses and whether the increased market presence translates to tangible financial gains. Investors should also consider the potential for regulatory changes as broadcasting technology evolves, which could affect Sinclair's business model and the broader industry. 03/13/2024 - 11:00 AM Primes the Pump for NEXTGEN Broadcasting HUNT VALLEY, Md. & ARLINGTON, Va.--(BUSINESS WIRE)-- Sinclair Broadcast Group, LLC, a subsidiary of Sinclair, Inc. (NASDAQ: SBGI) and Americas Public Television Stations (APTS) today announced that, in markets where Sinclair has deployed NEXTGEN Broadcast Service (ATSC 3.0) and a public television station has not, Sinclair will provide free carriage of a virtual channel from that public television station. Carriage of a broadcast-enabled virtual channel involves transmitting programming data within the NEXTGEN signal that allows over-the-air viewers with NEXTGEN TVs to see and select the channel in their programming guide and access the channel seamlessly over the Internet. Under this arrangement, Sinclair will provide hosting at no cost to the public television station. The public television stations will also have the option to pass through programming in high dynamic range (HDR), significantly enhancing the video quality to the viewers. Technologies such as Advanced HDR by Technicolor will allow content to be visually enhanced on NEXTGEN TVs that support the improved picture format. Americas Public Television Stations are pleased to partner with Sinclair to offer more NEXTGEN service to more public television viewers, said Patrick Butler, president and CEO of APTS. We are proud to have helped public television stations in almost 30 markets make the transition to the NEXTGEN TV broadcast standard. This partnership with Sinclair will help serve local communities while we work with other public television stations to transition to NEXTGEN TV to advance their public service missions. We are thrilled to continue our partnership with Americas Public Television Stations to help bring the next generation of television to all viewers, said Rob Weisbord, Sinclairs Chief Operating Officer and President of Broadcast. For public television stations that face challenges in launching NEXTGEN service, we hope that this offer will help get them in the advanced TV game and set the stage for their eventual launch of this spectacular service over the air. ATSC 3.0 is a revolutionary over-the-air digital broadcast technology that uses the Internet and digital applications powered by the ATSC 3.0 broadcast standards to present viewers with more news and entertainment choices while providing broadcasters with a more compelling and interactive way to deliver their content. To date, Sinclair has launched ATSC 3.0 service in 43 markets, 36 of which do not yet have a public television station transmitting in ATSC 3.0. Public television stations interested in this offer can work directly with APTS to learn more. About Sinclair Broadcast Group: Sinclair Broadcast Group is a subsidiary of Sinclair Inc., (Nasdaq: SBGI) a diversified media company and a leading provider of local news and sports. The Company owns, operates and/or provides services to 185 television stations in 86 markets affiliated with all the major broadcast networks; owns Tennis Channel and multicast networks Comet, CHARGE!, TBD., and The Nest; and owns and provides services to 21 regional sports network brands. Sinclairs content is delivered via multiple platforms, including over-the-air, multi-channel video program distributors, and the nations largest streaming aggregator of local news content, NewsON. The Company regularly uses its website as a key source of Company information which can be accessed at www.sbgi.net. About Americas Public Television Stations: America's Public Television Stations (APTS) is a nonprofit membership organization ensuring a strong and financially sound public television system and helping member stations provide essential public services in education, public safety and civic leadership to the American people. For more information, visit www.apts.org. Category: General View source version on businesswire.com: https://www.businesswire.com/news/home/20240313410762/en/ Jessica Bellucci, jbellucci-c@sbgtv.com Stacey Karp, skarp@apts.org Source: Sinclair, Inc. What is the partnership between Sinclair Broadcast Group and Americas Public Television Stations about? The partnership involves Sinclair providing free carriage of virtual channels from public television stations in markets where Sinclair has deployed NEXTGEN Broadcast Service. What technology is used to enhance video quality for viewers in the partnership? Technologies such as Advanced HDR by Technicolor are used to pass through programming in high dynamic range (HDR) for improved video quality on NEXTGEN TVs. How many markets has Sinclair launched ATSC 3.0 service in? Sinclair has launched ATSC 3.0 service in 43 markets, with 36 of them not yet having a public television station transmitting in ATSC 3.0. What is the goal of the partnership between Sinclair and APTS? The goal is to help public television stations transition to the NEXTGEN TV broadcast standard to offer more advanced TV services to viewers."
Nordson EFD Opens New Latin America Tech Center for Customer Training and Application Tests,2024-03-13T17:15:00.000Z,Low,Neutral,"Nordson EFD, a precision fluid dispensing systems manufacturer, launches a new Latin America Tech Center in Quertaro, Mexico, offering timely feedback on fluid dispensing equipment. The lab provides a range of Nordson EFD systems and training sessions for manufacturers in the region.","Nordson EFD Opens New Latin America Tech Center for Customer Training and Application Tests Rhea-AI Impact (Low) Rhea-AI Sentiment (Neutral) Tags Rhea-AI Summary Nordson EFD, a precision fluid dispensing systems manufacturer, launches a new Latin America Tech Center in Quertaro, Mexico, offering timely feedback on fluid dispensing equipment. The lab provides a range of Nordson EFD systems and training sessions for manufacturers in the region. Positive None. Negative None. 03/13/2024 - 01:15 PM Manufacturers can now send their assembly fluids and parts to this lab based in Quertaro, Mexico and get timely feedback on the best fluid dispensing equipment for their applications EAST PROVIDENCE, R.I.--(BUSINESS WIRE)-- Nordson EFD, a Nordson company (NASDAQ: NDSN) and leading precision fluid dispensing systems manufacturer, introduces a new Latin America Tech Center based in Quertaro, Mexico. This new lab allows manufacturers in the region to get timely feedback on the best fluid dispensing equipment for their assembly fluid, parts, substrates, and production requirements. Customers can either travel to the lab or ship assembly assets to the lab, which is equipped with the latest fluid dispensing technology including the full range of Nordson EFDs automated dispensing systems, valves, controllers, progressive cavity pumps, jetting systems, and syringe dispensers. Customers can also learn how to operate EFD systems during product training sessions. The lab is equipped with a 3D printer, scales, and other measurement equipment to determine the correct fluid dispensing equipment for each customers unique application requirements. With the new lab in Quertaro, Mexico, customers will see a quicker turnaround time on their application test, said Bill Binkley, Latin America Sales Manager, Nordson EFD. The new lab will give customers the assurance that their application can be completed via a video or a visit to the lab to witness their application test being completed. Reach out to a local Nordson EFD representative to set up an application test with industry-leading fluid dispensing systems today. To find a local representative visit this contact directory in English or Spanish. About Nordson EFD Nordson EFD designs and manufactures precision fluid dispensing systems for benchtop assembly processes and automated assembly lines. By enabling manufacturers to apply the same amount of adhesive, lubricant or other assembly fluid to every part, every time, EFD dispensing systems are helping companies in a wide variety of industries increase throughput, improve quality, and lower their production costs. Other fluid management capabilities include high-quality syringe barrels and cartridges for packaging one- and two-component materials. The company is also a leading formulator of specialty solder pastes for dispensing and printing applications in the electronics industry. About Nordson Corporation Nordson engineers, manufactures, and markets differentiated products and systems used for dispensing and processing adhesives, coatings, polymers, sealants and biomaterials; and for managing fluids, testing and inspecting for quality, treating surfaces and curing. These products are supported with extensive application expertise and direct global sales and service. We serve a wide variety of consumer non-durable, consumer durable and technology end markets including packaging, nonwovens, electronics, medical, appliances, energy, transportation, building and construction, and general product assembly and finishing. Founded in 1954 and headquartered in Westlake, Ohio, the company has operations and support offices in more than 30 countries. Visit Nordson on the web at nordson.com. View source version on businesswire.com: https://www.businesswire.com/news/home/20240227771287/en/ Nicole Paquet Senior Marketing Specialist +1-401-431-7100 (USA) nicole.paquet@nordsonefd.com Nordson EFD Global Natalie Tomasso +1-401-431-7173; natalie.tomasso@nordsonefd.com Europe +44 (0) 1582 666334; infoefd.europe@nordsonefd.com China +86 (21) 3866 9006; china@nordsonefd.com Japan +81 (03) 5762 2760; japan@nordsonefd.com Korea +82 (31) 7368321; korea@nordsonefd.com SEAsia +65 6796 9522; sin-mal@nordsonefd.com India +91 80 4021 3600; india@nordsonefd.com Source: Nordson EFD What is the new lab introduced by Nordson EFD in Quertaro, Mexico? Nordson EFD has launched a new Latin America Tech Center in Quertaro, Mexico. What kind of feedback can manufacturers get at the new lab in Quertaro? Manufacturers can receive timely feedback on the best fluid dispensing equipment for their applications. What equipment is available at the lab in Quertaro, Mexico? The lab is equipped with Nordson EFD's automated dispensing systems, valves, controllers, pumps, jetting systems, and syringe dispensers. How can customers interact with the lab in Quertaro, Mexico? Customers can either travel to the lab or ship assembly assets to receive feedback on fluid dispensing equipment. Who is the Latin America Sales Manager at Nordson EFD? Bill Binkley is the Latin America Sales Manager at Nordson EFD."
Lincoln Financial Earns DALBAR Award for Excellence in Annuity Illustrations,2024-03-13T14:07:00.000Z,Low,Neutral,"Lincoln Financial Group has been recognized by DALBAR, Inc. for the 5th consecutive year for providing exceptional annuity illustrations to advisors. The firm's illustrations offer clear depictions of protected income and utilize color to highlight key values and performance under various market conditions, setting them apart from competitors. Lincoln's easy-to-understand projections and illustration assumptions have earned them this prestigious recognition.","Lincoln Financial Earns DALBAR Award for Excellence in Annuity Illustrations Rhea-AI Impact (Low) Rhea-AI Sentiment (Neutral) Tags Rhea-AI Summary Lincoln Financial Group has been recognized by DALBAR, Inc. for the 5th consecutive year for providing exceptional annuity illustrations to advisors. The firm's illustrations offer clear depictions of protected income and utilize color to highlight key values and performance under various market conditions, setting them apart from competitors. Lincoln's easy-to-understand projections and illustration assumptions have earned them this prestigious recognition. Positive None. Negative None. 03/13/2024 - 10:07 AM MARLBOROUGH, Mass.--(BUSINESS WIRE)-- DALBAR, Inc. is recognizing Lincoln Financial Group for a 5th consecutive year for arming advisors with a vital tool for use in their sales process. The firm sets the standard with annuity illustrations that speak to current and prospective clients with a complete and highly comprehensible picture of how an annuity can address their needs. Lincoln Financials illustrations feature clear depictions of protected income and use color generously to highlight key values and performance under different market conditions. This provider stands apart from competitors and many out-of-the-box illustration tools that rely on numerous pages of data-driven tables and lack the color, visuals and organization of Lincolns easy-to-digest projections and illustration assumptions. We are honored to once again earn this recognition, which reinforces our commitment to providing a superior annuity experience, said Daniel Herr, senior vice president of Annuity Product at Lincoln Financial Group. The attention and detail placed on our annuity illustrations is just one of the many ways Lincoln arms its current and future clients with the tools they need to be confident in their financial futures. DALBARs review of annuity illustrations included 11 leading annuity firms and rated illustrations based on 17 categories, ranging from the display of key contract and illustration details to the overall design and format. About DALBAR, Inc. DALBAR, Inc. has a 46-year history and is recognized by the industry and government as an independent third-party expert in the business of providing audits, evaluations, ratings, and due diligence certifications. About Lincoln Financial Group Lincoln Financial Group helps people to plan, protect and retire with confidence. As of December 31, 2023, approximately 17 million customers trust our guidance and solutions across four core businesses  annuities, life insurance, group protection, and retirement plan services. As of December 31, 2023, the company had approximately $295 billion in end-of-period account balances, net of reinsurance. Headquartered in Radnor, Pa., Lincoln Financial Group is the marketing name for Lincoln National Corporation (NYSE: LNC) and its affiliates. Learn more at LincolnFinancial.com. For more information visit www.dalbar.com or contact us at info@DALBAR.com View source version on businesswire.com: https://www.businesswire.com/news/home/20240313826482/en/ Media: Emily Kunka 617.624.7136 ekunka@dalbar.com Source: DALBAR, Inc. What has Lincoln Financial Group been recognized for by DALBAR, Inc.? Lincoln Financial Group has been recognized for providing exceptional annuity illustrations to advisors for the 5th consecutive year. How do Lincoln Financial Group's illustrations stand out from competitors? Lincoln Financial Group's illustrations offer clear depictions of protected income and use color to highlight key values and performance under different market conditions, setting them apart from competitors. Who is the senior vice president of Annuity Product at Lincoln Financial Group? Daniel Herr is the senior vice president of Annuity Product at Lincoln Financial Group. How many leading annuity firms were included in DALBAR's review of annuity illustrations? DALBAR's review of annuity illustrations included 11 leading annuity firms. What are some of the categories based on which illustrations were rated in DALBAR's review? Illustrations were rated based on 17 categories, ranging from the display of key contract and illustration details to the overall design and format."
Expedia Group Welcomes New Partners to its Global Travel Ecosystem,2024-03-13T14:55:00.000Z,Low,Very Positive,Expedia Group announces new partnerships to enhance personalized travel experiences and expand global reach through innovative technology and supply solutions.,"Expedia Group Welcomes New Partners to its Global Travel Ecosystem Rhea-AI Impact (Low) Rhea-AI Sentiment (Very Positive) Tags Rhea-AI Summary Expedia Group announces new partnerships to enhance personalized travel experiences and expand global reach through innovative technology and supply solutions. Positive None. Negative None. Market Research Analyst The announcement by Expedia Group regarding the expansion of strategic partnerships and the utilization of its technology solutions like Rapid API and White Label Template represents a significant move in the travel and tourism industry. These partnerships indicate a strategic push to capture increased market share in a post-pandemic landscape where travel demand is surging. The integration of these technologies allows for a more seamless and personalized customer experience, potentially increasing customer loyalty and repeat business.Expedia's collaborations with airlines such as Alaska Airlines and United Airlines to create integrated travel platforms could lead to an increase in bookings through the convenience of one-stop shopping for consumers. This integration could also drive ancillary revenue for the airlines through the sale of additional travel services. Furthermore, the partnerships with tourism boards and the emphasis on sustainable tourism and cultural experiences align with the growing consumer trend towards responsible and enriching travel.From a stock market perspective, these developments could be seen as positive indicators for Expedia's future revenue growth and market position. The expansion of its technological capabilities and global partnerships could attract more investors, potentially leading to an uptick in stock prices if the market perceives these moves as likely to drive long-term growth and profitability. Financial Analyst Expedia Group's announcement reflects an aggressive investment in technology and partnerships to drive growth. The use of Expedia's Rapid API by various international partners, including Ikyu in Japan and Top Town Travel in China, allows these companies to offer a wider range of lodging options and could lead to an increase in transaction volumes on Expedia's platform.Furthermore, the focus on loyalty programs, such as the integration with Alaska Airlines Mileage Plan and United Airlines MileagePlus, is a strategic move to lock in customer bases and encourage repeat usage. This could lead to higher customer lifetime values and increased revenue per user. The financial implications for Expedia may include improved margins due to the scalability of their technology solutions and the potential for increased commission income from partner sales.Investors should monitor the effectiveness of these partnerships in driving additional traffic and bookings, as well as the operational costs associated with expanding and maintaining these technological solutions. The balance between growth-driven expenditures and the resulting revenue will be pivotal in assessing Expedia's financial health and its impact on the stock market. Sustainability Expert Expedia's partnership with regional tourism boards in Australia to promote sustainable tourism is particularly noteworthy. As global awareness of environmental issues grows, travel companies are increasingly expected to demonstrate a commitment to sustainability. By enhancing travelers' experiences while simultaneously improving sustainable tourism practices, Expedia could strengthen its brand reputation and appeal to a demographic of environmentally conscious consumers.This approach could also mitigate potential regulatory risks associated with environmental impact, as governments worldwide are starting to impose stricter regulations on the tourism industry. By proactively addressing sustainability, Expedia may gain a competitive advantage and attract investors who are increasingly looking to support companies with strong environmental, social and governance (ESG) practices.However, the long-term success of these initiatives will depend on their tangible impact on local ecosystems and communities. Stakeholders will be interested in the measurable outcomes of these partnerships, such as reductions in carbon footprint, conservation efforts and benefits to local economies. An authentic and effective sustainability strategy could lead to increased customer loyalty and potentially justify premium pricing for responsible travel options. 03/13/2024 - 10:55 AM Responding to growing travel demand, Expedia Group unveils today new partnerships fuelling further personalized travel experiences, with supply and tech. SEATTLE, March 13, 2024 /PRNewswire/ -- Expedia Group continues to power travel for everyone, everywhere by broadening its global reach through a series of new and expanded partnerships underpinned by one of the world's best in travel technology and supply. ""Our purpose-built technology is transforming the travel industry, and we continue to invest in this space to bring new capabilities to our partners and expand their opportunities to reach travelers within our global ecosystem,"" said Alfonso Paredes, President of Private Label Solutions. ""This translates to unparalleled travel options, competitive pricing, and unique experiences for travelers, while simultaneously unlocking growth for all."" ""We're constantly deepening relationships with established global travel brands and providing startups and entrepreneurs the scale needed to propel their growth,"" said Greg Schulze, President of Travel Partners and Media. ""Combined with Expedia Group's transformative technology, our valuable media network inspires travelers across our global brands, while creating significant value for our partners."" Partners in Asia Pacific explore new opportunities with Expedia Group as travel peaks in best post-pandemic year: Uncover more down under: Tourism and Events Queensland, Tourism Tropical North Queensland, Tourism Northern Territory, and Brisbane Economic Development Agency entered strategic partnerships with Expedia Group Media Solutions to enhance travelers' experiences, help improve sustainable tourism, and showcase Australia's unique culture, landmarks, and millennia-old history. Together, these organizations are elevating the region's market share by capturing more interest with Expedia Group advertising solutions such as native, PassportAds and YouTube video.A world of luxury for Japan: Ikyu, a Japanese online booking service specializing in luxury hotels and restaurants, implements Expedia Group's Rapid API solution, unlocking access to lodging supply and providing more than 20,000 additional properties worldwide to guests on a newly revamped international site, along with the ability to earn points to apply toward future bookings.Expanded horizons: Established in 2000, Top Town Travel, an IATA member, provides professional travel services for inbound and outbound travelers in China. Top Town Travel will now use Expedia Group's quality hotel supply via Rapid API to offer an extensive array of hotel room types to travelers.North American travel providers work with Expedia Group to capitalize on rising demand via brand, tech, and advertising partnerships: More rewarding memories: Alaska Airlines launched a one-stop travel portal called ""Alaska Vacations,"" powered by Expedia Group's cutting-edge White Label Template. This platform seamlessly integrates flights, car rentals, and access to thousands of properties worldwide into customizable packages, so travelers can book their entire journey with ease. Alaska Airlines Mileage Plan Members will earn miles for every package booked via Alaska Vacations, on top of the normal flight miles earned. In addition, Alaska Airlines Visa cardholders earn 3 miles per $1 spent on their eligible Alaska Vacations packages when using their card to book1.Upgraded experiences: Following successful launches in Brazil, China, France, Germany, Japan, and Mexico in December 2023, United Airlines is upgrading their United Hotels platform, harnessing the power of Expedia Group's White Label Template technology. MileagePlus members have the flexibility to earn miles or use miles on nearly 700,000 hotels and vacation rentals. Eligible MileagePlus Premier members and Chase Cardmembers will receive exceptional service and perks when staying at select VIP Access properties.Access to quality demand: New Orleans Jazz & Heritage Festival named Expedia Group as the Official Travel Partner for the 2024 festival, which includes an Expedia Live Jazz Fest Travel Hub that showcases partners of our Travel Partner Program in front of a valuable demand channel.Business travelers hit the road: Stockotels, now offering an enhanced experience through Expedia Group's Rapid API, provides professional clients with a curated selection of luxurious to budget-friendly accommodations across 130 countries and 800,000 hotels.Fostering an entrepreneurial spirit: Through a new partnership with Expedia Travel Agent Affiliate Program (TAAP), independent travel agents in the TRAVELSAVERS network can now offer Expedia Group's extensive supply and competitive rates to their clients. Local expertise with global reach: One of Brazil's largest host agencies, Uniao Nacional das Agencias de Viagens (UNAV), is partnering with Expedia TAAP to provide their members with access to Expedia Group's global travel offerings, streamlining the booking process for agents.Enhanced corporate travel: Paytrack is a complete solution for expense and corporate travel management based in Brazil. Using Expedia Group's Rapid API solution, Paytrack is now able to offer its business travel customers access to the company's lodging supply, including special amenities, discounts and more.As unprecedented demand awaits Europe and the Middle East, Expedia Group's partners focus on ensuring travelers' experiences are worthy of gold medals: Unlocking wider travels: IAG Loyalty signed a new long-term agreement with Expedia Group to unlock the power of its Rapid API technology solution. The partnership will bolster the expansion of British Airways Executive Club and other loyalty programs in the International Airlines Group portfolio. Travelers using IAG Loyalty's Avios currency will have access to competitive rates and supply in 25,000 destinations and at 700,000 properties worldwide.Capturing ""footy"" demand: Radisson Hotels and Expedia Group have teamed up to offer unparalleled benefits to fans of Liverpool Football Club. Reds supporters who book one of the nine participating Radisson Hotels properties through the Expedia Live microsite will receive unique perks and better availability. The collaboration helps make matchday better at home and away, underscoring Expedia Group's unwavering commitment to Liverpool FC as their Official Travel Partner. The perks of luxury: Dubai's iconic Burj Al Arab Jumeirah, an architectural marvel that has put Dubai on the global map, is now part of Expedia Group's VIP Access program. This alliance elevates the guest experience for travelers with perks such as room upgrades, early check-in/late checkout, and enticing offerings at food and beverage outlets. Hotels enrolled in the VIP Access program tend to attract travelers who stay longer and spend more compared to non-participating properties.2 More hotel options: Hirondelle, an Italy-based travel company that offers tours, business travel trips, and travel agency services to their global client base, launched Book For Work, a rapidly growing B2B hotel booking website that transforms accommodation booking into a strategic advantage for both corporate travel and travel agencies. Book For Work is now offering an extensive array of global hotel options to their customers using Expedia Group's Rapid API solution.A rising travel destination: Visit Qatar is working with Expedia Group to drive interest and demand to Qatar as a tourism destination on a global scale, including building creative campaigns with the company's in-house creative team, Media Studio, to showcase the wonders of Qatar and creating a tailor-built data dashboard to share insights. Visit Qatar will also leverage travel agent support through the Expedia TAAP agency and extend its reach to additional global travelers through Expedia Group's B2B partnership network.For more information about how Expedia Group is empowering partners to succeed in the evolving world of travel, please click here. About Expedia Group Expedia Group, Inc. brands power travel for everyone, everywhere through our global platform. Driven by the core belief that travel is a force for good, we help people experience the world in new ways and build lasting connections. We provide industry-leading technology solutions to fuel partner growth and success, while facilitating memorable experiences for travelers. Our organization is made up of three pillars: Expedia Brands, housing all our consumer brands; Expedia Product & Technology, focused on the group's product and technical strategy and offerings; and Expedia for Business, consisting of business-to-business solutions and relationships throughout the travel ecosystem. Expedia Group's three flagship consumer brands includes: Expedia, Hotels.com, and Vrbo. One Key is our comprehensive loyalty program that unifies Expedia, Hotels.com and Vrbo into one simple, flexible travel rewards experience. To enroll in One Key, download Expedia, Hotels.com and Vrbo mobile apps for free on iOS and Android devices. One Key is currently available in the U.S. and will become available globally soon. For more information, visit www.expediagroup.com. Follow us on Twitter @expediagroup and check out our LinkedIn www.linkedin.com/company/expedia.  2024 Expedia, Inc., an Expedia Group company. All rights reserved. Trademarks and logos are the property of their respective owners. CST: 2029030-50 1 Information checked on March 12th, 2024. See the Alaska Airline Mileage Plan Terms and Conditions for more information.2 Expedia Group data, approximate incrementality for VIP Access vs. non-VIP Access properties, 2022 View original content to download multimedia:https://www.prnewswire.com/news-releases/expedia-group-welcomes-new-partners-to-its-global-travel-ecosystem-302088224.html SOURCE Expedia, Inc. What new partnerships has Expedia Group unveiled? Expedia Group has announced new partnerships to enhance personalized travel experiences and expand its global reach. How is Expedia Group broadening its global reach? Expedia Group is broadening its global reach through a series of new and expanded partnerships underpinned by innovative travel technology and supply solutions. What are some key highlights of the partnerships in Asia Pacific? Partnerships in Asia Pacific involve organizations like Tourism and Events Queensland, Tourism Tropical North Queensland, Tourism Northern Territory, and Brisbane Economic Development Agency, enhancing travelers' experiences and showcasing Australia's unique culture and landmarks. Which North American travel providers are working with Expedia Group? Alaska Airlines and United Airlines are partnering with Expedia Group to offer enhanced travel experiences and benefits to their customers. What partnership is Expedia Group fostering with independent travel agents? Expedia Group is partnering with independent travel agents in the TRAVELSAVERS network to provide access to its global travel offerings. How is Expedia Group enhancing corporate travel management in Brazil? Expedia Group is collaborating with Paytrack to offer business travel customers access to lodging supply, special amenities, and discounts in Brazil. What new agreement has Expedia Group signed for Europe and the Middle East? Expedia Group has signed a new long-term agreement with IAG Loyalty to expand British Airways Executive Club and other loyalty programs in the International Airlines Group portfolio. What collaboration has Expedia Group established with Radisson Hotels? Expedia Group has teamed up with Radisson Hotels to offer benefits to fans of Liverpool Football Club through unique perks and better availability. Which iconic Dubai hotel has joined Expedia Group's VIP Access program? Dubai's iconic Burj Al Arab Jumeirah has joined Expedia Group's VIP Access program to elevate the guest experience with exclusive perks. How is Expedia Group working with Visit Qatar to drive tourism interest? Expedia Group is collaborating with Visit Qatar to drive interest and demand to Qatar as a tourism destination on a global scale."
This Company Is Making Freight Transportation Cleaner,2024-03-13T15:00:00.000Z,Neutral,Neutral,"SAP's partner Randoncorp's company, Suspensys, introduces the Hybrid R Line, an innovative electric traction system that boosts fuel savings up to 25% through energy recovery. Randoncorp focuses on materials research, nanotechnology, and electromobility, with a recent upgrade to SAP S/4HANA for enhanced ERP performance.","This Company Is Making Freight Transportation Cleaner Rhea-AI Impact (Neutral) Rhea-AI Sentiment (Neutral) Tags Rhea-AI Summary SAP's partner Randoncorp's company, Suspensys, introduces the Hybrid R Line, an innovative electric traction system that boosts fuel savings up to 25% through energy recovery. Randoncorp focuses on materials research, nanotechnology, and electromobility, with a recent upgrade to SAP S/4HANA for enhanced ERP performance. Positive None. Negative None. Automotive Industry Analyst With the introduction of the Hybrid R Line by Suspensys, a subsidiary of Randoncorp, the automotive sector sees a significant innovation in electric traction systems. This development is poised to enhance the efficiency of heavy vehicles, offering up to 25% fuel savings depending on various factors such as application, road conditions and cargo type. This technological advancement is likely to be of interest to manufacturers and fleet operators seeking to reduce operational costs and adhere to stricter environmental regulations.Furthermore, the system's ability to reduce component wear and environmental waste aligns with the growing trend of sustainability in the automotive industry. By incorporating intelligent algorithms for energy recovery, Suspensys is not only contributing to operational efficiency but also to the circular economy. Companies investing in such technologies could see an increase in their market competitiveness and potentially their stock valuation due to investor interest in sustainable and innovative business practices. Environmental Sustainability Expert The environmental implications of the Hybrid R Line are noteworthy. By optimizing energy use and reducing fuel consumption, Suspensys is directly contributing to the reduction of carbon emissions associated with freight transport. This aligns with global efforts to combat climate change and can significantly bolster Randoncorp's environmental, social and governance (ESG) credentials.Investors and consumers increasingly factor in a company's environmental impact when making decisions. As such, Randoncorp's commitment to research in materials, nanotechnology and electromobility, coupled with the digitalization efforts facilitated by the upgrade to SAP S/4HANA, indicates a strategic pivot towards sustainability that could attract ESG-focused investments and improve brand reputation. Technology Investment Analyst The strategic upgrade to SAP S/4HANA is a critical move for Randoncorp, enhancing their enterprise resource planning (ERP) capabilities. This transition to a more advanced ERP system is indicative of the company's commitment to digital transformation, which is essential for data-driven decision-making and operational agility in today's fast-paced market.Investors should note that the integration of advanced analytics into Randoncorp's operations could lead to improved financial performance through better resource management and predictive insights. Companies that effectively leverage such technologies can often outperform their peers, suggesting potential for long-term growth and a positive impact on stock performance. 03/13/2024 - 11:00 AM NORTHAMPTON, MA / ACCESSWIRE / March 13, 2024 / SAPBy Judith MagyarOriginally published by ForbesSuspensys, one of Randoncorp's companies, developed the Hybrid R Line, an exclusive electric traction system that uses an auxiliary system of intelligent algorithms to recover energy generated during braking and descents, enabling the trailer to help the truck to climb uphill more effectively and safely.Depending on the application, the road conditions and the type of cargo transported, the new system generates fuel savings that can reach up to 25%, also providing less wear on the components and less waste in the environment.Randoncorp also promotes research in materials, nanotechnology and electromobility. Digitalization plays a key role in all these areas. The company is a long-term SAP customer and has recently undergone a major upgrade to SAP S/4HANA to accelerate ERP performance and leverage the system's built-in analytics.Continue reading hereView additional multimedia and more ESG storytelling from SAP on 3blmedia.com.Contact Info:Spokesperson: SAPWebsite: https://www.3blmedia.com/profiles/sap Email: info@3blmedia.comSOURCE: SAPView the original press release on accesswire.com What is the name of the partner company mentioned in the press release? The partner company mentioned is Randoncorp. What is the product introduced by Suspensys? Suspensys introduced the Hybrid R Line, an electric traction system. How much fuel savings can the new system generate? The new system can generate fuel savings up to 25%. What areas does Randoncorp focus on in terms of research? Randoncorp focuses on materials, nanotechnology, and electromobility. What recent upgrade did Randoncorp undergo with SAP? Randoncorp recently upgraded to SAP S/4HANA for improved ERP performance."
PulteGroup Design Team Reveals Top Home Trends for 2024,2024-03-13T15:47:00.000Z,Low,Very Positive,"PulteGroup Inc. (PHM) presents 2024 design and color trends for homebuilding, emphasizing authentic materials, sustainability, highly textured elements, new-traditional styling, and vibrant colors. The company's Interior Design Team recommends using clay, stone, wood, upcycled materials, textured accents, and matte finishes to create a modern and luxurious living space.","PulteGroup Design Team Reveals Top Home Trends for 2024 Rhea-AI Impact (Low) Rhea-AI Sentiment (Very Positive) Tags Rhea-AI Summary PulteGroup Inc. (PHM) presents 2024 design and color trends for homebuilding, emphasizing authentic materials, sustainability, highly textured elements, new-traditional styling, and vibrant colors. The company's Interior Design Team recommends using clay, stone, wood, upcycled materials, textured accents, and matte finishes to create a modern and luxurious living space. Positive None. Negative None. 03/13/2024 - 11:47 AM Elevate your space this year with sophistication and a touch of the avant-garde ATLANTA--(BUSINESS WIRE)-- Drawing on the expertise of a dedicated design team that serves the most trusted brands in homebuilding, PulteGroup Inc. (NYSE: PHM), the nation's third-largest homebuilder, is presenting prospective buyers with its unique perspective on national design and color trends for 2024. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240313005537/en/Skyline (Photo: PulteGroup) A new year means a new chance to create a home where you and your family can live out your dreams, said Angela Nuessle, Vice President of Interior Design at PulteGroup. From the growing popularity of mixed-era styling to pops of vibrant colors coupled with natural textured elements, the PulteGroup design team has the pulse of the latest national trends. Through our design centers, industry experts and interactive design tools, we can guide you through an easy step-by-step process to meet your unique needs and stay a step ahead of whats hot in home design and decor. 2024 Design and Color Trends Home design is both an art and a science. Through precision and experimentation, you can achieve a healthy and aesthetically pleasing space that sets the tone for how you and your visitors feel in your new home. With an emphasis on casual luxury and curated styling, paired with natural elements and warm undertones, PulteGroups Interior Design Team recommends some of the most compelling design possibilities for the year ahead. Top Design Trends Authentic Materials: Clay, Stone, Wood  Natures neutrals are having a moment, as homeowners celebrate the innate beauty of earthy elements. A mix and match of these materials creates an understated yet elegant vibe that can be applied to any room. Sustainability with Upcycled Materials and Repurposed Furniture  Revive the timeless beauty in evergreen pieces that have may have been passed down through generations or hidden gems found at second-hand stores, including real wood dining tables, ornate hutches and unique buffets. Highly Textured Materials  A textured accent wall, plaster painting and micro cement  a thin, cement-based decorative coating -- offers a tactile component that adds depth and character. Chunky, woven accents and throw blankets, velvet and boucle accent pillows, and woolen and woven area rugs are taking center stage and allow for effortless style. The New-Traditional  Traditional design styling is back in a fresh and modernized way; look for classic design paired with new-age approaches in furniture and patterned upholstery. Matte and High Gloss Finishes  Multi-dimensional finishes make a big statement in 2024; from raw woods to matte and high-gloss paint and furniture coatings, visual interest will be achieved through even the smallest of details. Top Color Trends Vibrant and Saturated Colors  Deep blues, kelly green and yellow are injecting personalities into interiors, while dark aquamarine creates a feeling of stylish sophistication. Saturated and vibrant colors will appear in many forms in 2024. Neutrals and Earth Tones  Conventional sand and beige neutrals, along with gold and earthy tones, including mocha and taupe, warm charcoal and rich caramel bring a coziness into the interiors of your home. Black a Bold Staple  Black is such a versatile and stylish choice for any home! Whether it's used as an accent color in paint, lighting, fixtures, or even in soft furnishings, the boldness and warmth it brings to a space will always be a timeless design staple. For more 2024 design trends and ideas please visit our latest design trends blog. To learn more about the technology-powered design tools PulteGroup provides to new homeowners, visit www.pulte.com/design/design-center. For added inspiration, follow Pulte Interiors on Instagram. About PulteGroup PulteGroup, Inc. (NYSE: PHM), based in Atlanta, Georgia, is one of Americas largest homebuilding companies with operations in more than 45 markets throughout the country. Through its brand portfolio that includes Centex, Pulte Homes, Del Webb, DiVosta Homes, American West and John Wieland Homes and Neighborhoods, the company is one of the industrys most versatile homebuilders able to meet the needs of multiple buyer groups and respond to changing consumer demand. PulteGroups purpose is building incredible places where people can live their dreams. For more information about PulteGroup, Inc. and PulteGroup brands, go to pultegroup.com; pulte.com; centex.com; delwebb.com; divosta.com; jwhomes.com; and americanwesthomes.com. Follow PulteGroup, Inc. on Twitter: @PulteGroupNews. View source version on businesswire.com: https://www.businesswire.com/news/home/20240313005537/en/ Tim Chatlos Office: 404-464-9041 Timothy.Chatlos@PulteGroup.com Source: PulteGroup, Inc. What are the top design trends for 2024 according to PulteGroup Inc. (PHM)? PulteGroup Inc. (PHM) suggests using authentic materials like clay, stone, wood, sustainability with upcycled materials, highly textured elements, new-traditional styling, and matte finishes for home design trends in 2024. Which colors are recommended for interiors in 2024 by PulteGroup Inc. (PHM)? PulteGroup Inc. (PHM) recommends using vibrant and saturated colors like deep blues, kelly green, and yellow, neutrals and earth tones such as sand, beige, gold, mocha, taupe, charcoal, caramel, and black as a bold staple for interiors in 2024. Who is the Vice President of Interior Design at PulteGroup Inc. (PHM)? The Vice President of Interior Design at PulteGroup Inc. (PHM) is Angela Nuessle, who emphasizes creating homes that reflect the latest national design and color trends for 2024."
"Phio Pharmaceuticals Announces Addition of Clinical Trial Sites at Banner MD Anderson Cancer Center, The George Washington University, and Integrity Research",2024-03-13T18:00:00.000Z,Neutral,Positive,"Phio Pharmaceuticals Corp. announced the addition of three clinical trial sites for its Phase 1b study of PH-762, an INTASYL compound silencing PD-1 to enhance T cells' ability to kill cancer cells. The study aims to evaluate safety, tolerability, tumor response, and dosing for patients with skin cancers.","Phio Pharmaceuticals Announces Addition of Clinical Trial Sites at Banner MD Anderson Cancer Center, The George Washington University, and Integrity Research Rhea-AI Impact (Neutral) Rhea-AI Sentiment (Positive) Tags clinical trial Rhea-AI Summary Phio Pharmaceuticals Corp. announced the addition of three clinical trial sites for its Phase 1b study of PH-762, an INTASYL compound silencing PD-1 to enhance T cells' ability to kill cancer cells. The study aims to evaluate safety, tolerability, tumor response, and dosing for patients with skin cancers. Positive None. Negative None. Oncology Doctor The expansion of clinical trial sites for Phio Pharmaceuticals' Phase 1b study of PH-762 is a significant development in the field of immuno-oncology. PH-762 is an innovative INTASYL compound that targets PD-1, a crucial checkpoint inhibitor that, when silenced, can enhance the ability of T cells to combat tumor cells. This mechanism is particularly relevant for cutaneous squamous cell carcinoma, melanoma and Merkel cell carcinoma, which are the focus of this trial.From a clinical perspective, the inclusion of multiple reputable institutions in the study ensures a diverse patient population, which is critical for assessing the safety and efficacy of PH-762 across different demographics. The neoadjuvant setting of the trial is also noteworthy, as treatments given prior to the main treatment can shrink tumors and may improve surgical outcomes. The outcomes of this study have the potential to shape future therapeutic strategies and contribute to personalized medicine in oncology. Medical Research Analyst As a Medical Research Analyst, it's important to emphasize the strategic importance of broadening the geographic reach of a clinical trial. By engaging additional sites, Phio Pharmaceuticals is likely to accelerate patient enrollment and enhance the statistical power of the study. This is crucial for a Phase 1b trial, which aims to determine the optimal dose for further research.Moreover, the study's design to evaluate tumor response and safety profiles will provide valuable data for subsequent phases of clinical development. The ability to silence PD-1 intratumorally could represent a significant advancement over existing systemic therapies, potentially reducing side effects and improving patient outcomes. Investors and stakeholders will be closely monitoring the results for indications of PH-762's efficacy and tolerability, which could have a profound impact on the company's valuation and future prospects. Market Research Analyst From a market perspective, advancements in gene silencing technologies like INTASYL have the potential to disrupt the oncology treatment landscape. The successful development and eventual approval of PH-762 could position Phio Pharmaceuticals as a key player in a market that is increasingly focused on precision medicine and targeted therapies. As the trial progresses, positive data could attract partnership opportunities and increase investor confidence.However, it is essential to consider the competitive environment. The immuno-oncology space is crowded, with many companies vying for a share of the market. The success of PH-762 will depend not only on its clinical efficacy but also on its ability to differentiate itself from other therapies. Analysts will need to monitor the evolving landscape and consider how emerging data from PH-762's trials stack up against alternative treatments in terms of efficacy, safety and cost-effectiveness. 03/13/2024 - 02:00 PM --Four sites across the U.S. are now engaged in the Phase1b studyMARLBOROUGH, Mass., March 13, 2024 (GLOBE NEWSWIRE) -- Phio Pharmaceuticals Corp. (Nasdaq: PHIO), a clinical stage biotechnology company whose proprietary INTASYL siRNA gene silencing technology is designed to make immune cells more effective in killing tumor cells, today announced the addition of three clinical trial sites for its Phase 1b study of PH-762: The George Washington UniversityMedical Faculty Associates in Washington, D.C.Banner MD Anderson Cancer Center in Gilbert, ArizonaIntegrity Research Clinical Associates in Delray Beach, Florida These sites join Centricity Research in Dublin, Ohio, which enrolled the studys first patient in November. The principal investigator at the George Washington University trial is Vishal Patel, M.D. and Mark Gimbel, M.D. at the Banner MD Anderson Cancer Center trial site. Kevin Donnelly MD is principal investigator at Centricity Research. We are delighted to be able to include these sites, all of whom have an interest in immuno-oncology and an exceptional reputation in conducting trials in skin cancer, said Robert Bitterman, CEO of Phio Pharmaceuticals. Additionally, their inclusion expands our geographic reach facilitating broader patient inclusion in the clinical trial. PH-762 is an INTASYL compound that silences PD-1, a protein that inhibits T cells ability to kill cancer cells. The Phase 1b trial is a non-comparative study of neoadjuvant monotherapy using PH-762 in adult patients with cutaneous squamous cell carcinoma, melanoma, or Merkel cell carcinoma. The study is designed to evaluate the safety and tolerability of neoadjuvant use of intratumorally injected PH-762, assess the tumor response, and determine the dose or dose range for continued study of PH-762 in patients with cutaneous squamous cell carcinoma, melanoma, or Merkel cell carcinoma. More information about this clinical trial is available at clinicaltrials.gov (identifier: NCT06014086). About Phio Pharmaceuticals Corp.Phio Pharmaceuticals Corp. (Nasdaq: PHIO) is a clinical stage biotechnology company whose proprietary INTASYL siRNA gene silencing technology is designed to make immune cells more effective in killing tumor cells. INTASYL is the only self-delivering RNAi technology focused on immuno-oncology therapeutics. INTASYL drugs precisely target specific proteins that reduce the bodys ability to fight cancer, without the need for specialized formulations or drug delivery systems. For additional information, visit the Companys website, www.phiopharma.com. Forward Looking Statements This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements can be identified by words such as ""intends,"" ""believes,"" ""anticipates,"" ""indicates,"" ""plans,"" ""expects,"" ""suggests,"" ""may,"" ""would,"" ""should,"" ""potential,"" ""designed to,"" ""will,"" ""ongoing,"" ""estimate,"" ""forecast,"" ""target,"" ""predict,"" ""could"" and similar references, although not all forward-looking statements contain these words. These statements are based only on our current beliefs, expectations and assumptions and are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict and many of which are outside of our control. Examples of forward-looking statements include statements regarding the timing of, as well as the progress of, and data reported from, this Phase 1b clinical trial and the therapeutic potential of PH-762 to treat patients with cutaneous squamous cell carcinoma, melanoma, or Merkel cell carcinoma. Our actual results may differ materially from those indicated in the forward-looking statements as a result of a number of important factors, including, but not limited to, the impact to our business and operations by inflationary pressures, rising interest rates, recession fears, the development of our product candidates, results from our preclinical and clinical activities, our ability to execute on business strategies, our ability to develop our product candidates with collaboration partners, and the success of any such collaborations, the timeline and duration for advancing our product candidates into clinical development, the timing or likelihood of regulatory filings and approvals, the success of our efforts to commercialize our product candidates if approved, our ability to manufacture and supply our product candidates for clinical activities, and for commercial use if approved, the scope of protection we are able to establish and maintain for intellectual property rights covering our technology platform, our ability to obtain future financing, market and other conditions and those identified in our Annual Report on Form 10-K and subsequent Quarterly Reports on Form 10-Q under the caption ""Risk Factors"" and in other filings the Company periodically makes with the SEC. Readers are urged to review these risk factors and to not act in reliance on any forward-looking statements, as actual results may differ from those contemplated by our forward-looking statements. Phio does not undertake to update forward-looking statements to reflect a change in its views, events or circumstances that occur after the date of this release, except as required by law. Contact:Phio Pharmaceuticals Corp.ir@phiopharma.com PR ContactMichael AdamsBridge View Mediaadams@bridgeviewmedia.com What is the purpose of Phio Pharmaceuticals Corp.'s Phase 1b study for PH-762? The Phase 1b study aims to evaluate the safety, tolerability, tumor response, and dosing of PH-762, an INTASYL compound that silences PD-1 to enhance T cells' ability to kill cancer cells, in patients with cutaneous squamous cell carcinoma, melanoma, or Merkel cell carcinoma. Which sites have been added to the Phase 1b study of PH-762 by Phio Pharmaceuticals Corp.? The three new clinical trial sites added are The George Washington UniversityMedical Faculty Associates in Washington, D.C., Banner MD Anderson Cancer Center in Gilbert, Arizona, and Integrity Research Clinical Associates in Delray Beach, Florida. Who are the principal investigators at the George Washington University and Banner MD Anderson Cancer Center trial sites? The principal investigator at the George Washington University trial is Vishal Patel, M.D., and Mark Gimbel, M.D. is the principal investigator at the Banner MD Anderson Cancer Center trial site. What is the role of Centricity Research in the Phase 1b study of PH-762? Centricity Research in Dublin, Ohio, enrolled the study's first patient in November, with Kevin Donnelly, MD, as the principal investigator. What is the target of PH-762 in the Phase 1b study? PH-762 targets PD-1, a protein that inhibits T cells' ability to kill cancer cells, in adult patients with cutaneous squamous cell carcinoma, melanoma, or Merkel cell carcinoma."
"Blend to Announce Fourth Quarter and Full Year 2023 Financial Results on March 14, 2024",2024-03-13T18:04:00.000Z,Neutral,Neutral,"Blend Labs, Inc. (NYSE: BLND) will host a conference call to discuss its Q4 and full-year 2023 financial results. The call will take place on March 14, 2024, at 4:30 pm ET. Investors can access the press release and financial information on the company's investor website.","Blend to Announce Fourth Quarter and Full Year 2023 Financial Results on March 14, 2024 Rhea-AI Impact (Neutral) Rhea-AI Sentiment (Neutral) Tags earnings Rhea-AI Summary Blend Labs, Inc. (NYSE: BLND) will host a conference call to discuss its Q4 and full-year 2023 financial results. The call will take place on March 14, 2024, at 4:30 pm ET. Investors can access the press release and financial information on the company's investor website. Positive None. Negative None. 03/13/2024 - 02:04 PM SAN FRANCISCO--(BUSINESS WIRE)-- Blend Labs, Inc. (NYSE: BLND), a leader in cloud banking software, today announced that the Company will host a conference call on Thursday, March 14, 2024, at 4:30 pm ET to discuss its fourth quarter and full year 2023 financial results. A press release, with accompanying financial information, will be posted prior to the discussion on the Companys investor website at https://investor.blend.com. A link to the live discussion will be made available on the Company's investor relations website at https://investor.blend.com. A replay will also be made available following the discussion at the same website. About Blend Blend is the infrastructure powering the future of banking. Financial providersfrom large banks, fintechs, and credit unions to community and independent mortgage banksuse Blends platform to transform banking experiences for their customers. Blend powers billions of dollars in financial transactions every day. To learn more, visit blend.com. View source version on businesswire.com: https://www.businesswire.com/news/home/20240313376166/en/ Investor Contact: ir@blend.com Media Contact: press@blend.com Source: Blend When will Blend Labs, Inc. (BLND) host a conference call to discuss its financial results? Blend Labs, Inc. (NYSE: BLND) will host a conference call on Thursday, March 14, 2024, at 4:30 pm ET to discuss its fourth quarter and full year 2023 financial results. Where can investors find the press release and financial information for Blend Labs, Inc. (BLND)? Investors can access the press release and financial information on the company's investor website at https://investor.blend.com. Will there be a replay available for the discussion of Blend Labs, Inc. (BLND) financial results? Yes, a replay will be made available following the discussion on the same website."
Cintas Corporation Announces Webcast for Third Quarter Fiscal Year 2024 Results,2024-03-13T14:59:00.000Z,Low,Neutral,"Cintas Corporation (CTAS) will release fiscal year 2024 third quarter results on March 27, 2024. A conference call will address the financial results, with a live webcast available to investors and the public.","Cintas Corporation Announces Webcast for Third Quarter Fiscal Year 2024 Results Rhea-AI Impact (Low) Rhea-AI Sentiment (Neutral) Tags earnings Rhea-AI Summary Cintas Corporation (CTAS) will release fiscal year 2024 third quarter results on March 27, 2024. A conference call will address the financial results, with a live webcast available to investors and the public. Positive None. Negative None. 03/13/2024 - 10:59 AM CINCINNATI--(BUSINESS WIRE)-- Cintas Corporation (Nasdaq: CTAS) today announced that it will release fiscal year 2024 third quarter results on Wednesday, March 27, 2024. The Company will conduct a conference call to address the financial results. A live webcast of the call will be available to individual investors and the public beginning at 10:00 a.m., Eastern Time, on Wednesday, March 27, 2024. The webcast will be available at www.Cintas.com. Click on the webcast icon and then follow instructions. For those unable to listen to the live webcast, a replay will be available on the Company's website beginning approximately two hours after the completion of the live call and will remain available for two weeks. About Cintas Corporation Cintas Corporation helps more than one million businesses of all types and sizes get Ready to open their doors with confidence every day by providing products and services that help keep their customers facilities and employees clean, safe, and looking their best. With offerings including uniforms, mats, mops, restroom supplies, first aid and safety products, fire extinguishers and testing, and safety training, Cintas helps customers get Ready for the Workday. Headquartered in Cincinnati, Cintas is a publicly held Fortune 500 company traded over the Nasdaq Global Select Market under the symbol CTAS and is a component of both the Standard & Poors 500 Index and Nasdaq-100 Index. View source version on businesswire.com: https://www.businesswire.com/news/home/20240313053338/en/ Questions concerning the webcast or conference call should be directed to: Leisha Smith (513) 972-2688 smithle@cintas.com Source: Cintas Corporation When will Cintas Corporation release its fiscal year 2024 third quarter results? Cintas Corporation (CTAS) will release its fiscal year 2024 third quarter results on Wednesday, March 27, 2024. What time will the live webcast of the conference call be available? The live webcast of the conference call will be available at 10:00 a.m., Eastern Time, on Wednesday, March 27, 2024. Where can individual investors and the public access the webcast? Individual investors and the public can access the webcast at www.Cintas.com by clicking on the webcast icon and following instructions. How long will the replay of the webcast be available on the Company's website? The replay of the webcast will be available on the Company's website for two weeks, starting approximately two hours after the live call."
"Chemours Supports 35th Annual Salem County, New Jersey Science Fair",2024-03-13T14:45:00.000Z,Low,Very Positive,"Chemours Company sponsors 35th annual Salem County Science Fair, benefiting STEM education. Over 200 students from 11 schools participated, focusing on topics like plant growth, moon phases, and SPF effectiveness. Winners received $2,500. Chemours' $275,000 Vibrant Community grant supports STEM learning initiatives in partnership with local schools and colleges.","Chemours Supports 35th Annual Salem County, New Jersey Science Fair Rhea-AI Impact (Low) Rhea-AI Sentiment (Very Positive) Tags Rhea-AI Summary Chemours Company sponsors 35th annual Salem County Science Fair, benefiting STEM education. Over 200 students from 11 schools participated, focusing on topics like plant growth, moon phases, and SPF effectiveness. Winners received $2,500. Chemours' $275,000 Vibrant Community grant supports STEM learning initiatives in partnership with local schools and colleges. Positive None. Negative None. 03/13/2024 - 10:45 AM NORTHAMPTON, MA / ACCESSWIRE / March 13, 2024 / The Chemours CompanyMarch 6th marked an exciting time in Salem County, New Jersey where our Chambers Works manufacturing site is centrally located. Nearly 200 fifth through twelfth graders from eleven different schools participated in the 35th annual Salem County Science Fair which Chambers Works has sponsored for more than three decades. The Science Fair, hosted at Salem Community College (SCC), allows students to apply what they have learned in science, technology, engineering, and math (STEM) education in hopes of advancing to the Delaware Valley Science Fair and beyond.Participants concentrate on an area of special interest, collecting and analyzing data while following the scientific method and present their findings to volunteer judges. Some of the 2024 topics examined:How does positive reinforcement affect plant growth?How does the phase of the moon affect the number of visible stars in the sky?What SPF is the most effective at blocking UV rays?The various winners received a total of $2,500 from Chemours. This event sponsorship is part of a broader $275,000 Vibrant Community grant where the Chambers Works team partners with Salem Community College and the local middle schools to support hands-on learning opportunities to instill a lifelong love of STEM.In response to the support from Chemours, Joe Sarbello, Elsinboro Science Teacher and SCC partnership lead, shared, ""I believe it's such a valuable experience for the kids to get interviewed and communicate what they did to the judges. I love the support Chemours gives to all the schools for the Science Fair and STEM in general! We are so very lucky to have a company that's committed to partnering with the schools and community.""Brian Boettler, Chemours Environmental, Health, and Safety Senior Consultant, leads the partnership on the site's behalf. ""Partnering with the local schools and community college is rewarding. We all contribute in our own way to help support the next generation, and that is on full display at the Science Fair.""Chambers Works plant manager Troy Blanchard participated as one of the volunteer judges, speaking with various entrants about their hypotheses and conclusions. Blanchard shared, ""This event continues to remind me that the future of STEM is in Salem County, New Jersey, and that's why this partnership is so valuable."" He added ""I may have met some future Chambers Works employees, too.""View additional multimedia and more ESG storytelling from The Chemours Company on 3blmedia.com.Contact Info:Spokesperson: The Chemours CompanyWebsite: https://www.3blmedia.com/profiles/chemours-companyEmail: info@3blmedia.comSOURCE: The Chemours CompanyView the original press release on accesswire.com What event did Chemours sponsor in Salem County, New Jersey? Chemours sponsored the 35th annual Salem County Science Fair. How many students participated in the Science Fair? Nearly 200 students from fifth through twelfth grade from 11 different schools participated. What were some of the topics examined by participants in the 2024 Science Fair? Participants examined topics like the effect of positive reinforcement on plant growth, the impact of moon phases on visible stars, and the effectiveness of SPF in blocking UV rays. How much money did the winners receive from Chemours? The winners received a total of $2,500 from Chemours. What is the purpose of Chemours' $275,000 Vibrant Community grant? The grant supports hands-on STEM learning opportunities to instill a lifelong love of STEM in partnership with local schools and colleges."
Greene Concepts BE WATER 6-Packs Now Available at Camping World,2024-03-13T14:15:00.000Z,Moderate,Very Positive,"Greene Concepts Inc. (OTC PINK:INKW) introduces BE WATER artesian spring water in a new six-pack configuration at Camping World, enhancing accessibility and customer convenience. CEO Lenny Greene expresses gratitude for the partnership, highlighting increased sales potential and customer demand. The product will be available nationwide in time for the upcoming spring and summer seasons.","Greene Concepts BE WATER 6-Packs Now Available at Camping World Rhea-AI Impact (Moderate) Rhea-AI Sentiment (Very Positive) Tags Rhea-AI Summary Greene Concepts Inc. (OTC PINK:INKW) introduces BE WATER artesian spring water in a new six-pack configuration at Camping World, enhancing accessibility and customer convenience. CEO Lenny Greene expresses gratitude for the partnership, highlighting increased sales potential and customer demand. The product will be available nationwide in time for the upcoming spring and summer seasons. Positive None. Negative None. 03/13/2024 - 10:15 AM MARION, NC / ACCESSWIRE / March 13, 2024 / Greene Concepts Inc. (OTC PINK:INKW) is pleased to announce that its BE WATER artesian spring water is now available at your local Camping World in a six-pack configuration along with our 24-pack configuration.This new configuration offers easier maneuverability, storage, and presentation. 6-pack bottles will still arrive at Camping World as 24 bottles per case but now come packaged as four six-packs for easy six-pack display and sale.Lenny Greene, CEO of Greene Concepts, states, ""We are incredibly grateful to Camping World for their trust in us and in our BE WATER brand by allowing us to bring our six-packs to their stores. This is a win-win as it results in greater sales and increased demand through easier store positioning and customer transport. Store managers may choose between receiving six-packs or our legacy 24-pack configurations depending on their preference and sales history. Camping World, our first large-scale national retailer, has been nothing but first-rate to us since we first became a vendor partner with them in 2021. The six-packs will be available in all Camping World locations just in time for the spring and summer months and I encourage each of you pick up a case of our fresh artesian spring water soonest."" About Greene Concepts, Inc.Greene Concepts, Inc. (http://www.greeneconcepts.com) is a publicly traded company whose purpose is to provide the world with high-quality, healthy and enhanced beverage choices that meet the nutritional needs of its consumers while refreshing their mind, body and spirit. The Company's flagship product, BE WATER, is a premium artesian bottled water that supports total body health and wellness. Greene Concepts' beverage and bottling plant is located in Marion, North Carolina, and their water is ethically sourced from spring and artesian wells that are fed from a natural aquifer located deep beneath the Blue Ridge Mountains. Greene Concepts continues to develop and market premium beverage brands designed to enhance the daily lives of consumers.Safe Harbor: This Press Release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements are based on the current plans and expectations of management and are subject to a few uncertainties and risks that could significantly affect the company's current plans and expectations, as well as future results of operations and financial condition. A more extensive listing of risks and factors that may affect the company's business prospects and cause actual results to differ materially from those described in the forward-looking statements can be found in the reports and other documents filed by the company with the Securities and Exchange Commission and OTC Markets, Inc. OTC Disclosure and News Service. The company undertakes no obligation to publicly update or revise any forward-looking statements, because of new information, future events or otherwise.CONTACT:Greene Concepts, Inc.Investor RelationsIR@greeneconcepts.comSOURCE: Greene Concepts, Inc.View the original press release on accesswire.com Where can I find Greene Concepts Inc.'s BE WATER artesian spring water in the new six-pack configuration? You can find the BE WATER artesian spring water in the new six-pack configuration at your local Camping World store. What are the benefits of the new six-pack configuration for BE WATER artesian spring water? The new six-pack configuration offers easier maneuverability, storage, and presentation, making it more convenient for customers. Who is the CEO of Greene Concepts Inc.? Lenny Greene is the CEO of Greene Concepts Inc. When will the six-pack configuration of BE WATER artesian spring water be available at Camping World locations? The six-pack configuration will be available in all Camping World locations just in time for the spring and summer months."
"UTI, Inc. to Participate in the 36th Annual ROTH Conference",2024-03-13T16:32:00.000Z,Low,Neutral,"UTI, Inc. management will provide a company overview and discuss strategic progress at the 36th Annual ROTH Conference. The CEO and CFO will highlight growth, diversification, and optimization strategies for the first fiscal quarter of 2024 and beyond.","UTI, Inc. to Participate in the 36th Annual ROTH Conference Rhea-AI Impact (Low) Rhea-AI Sentiment (Neutral) Tags conferences Rhea-AI Summary UTI, Inc. management will provide a company overview and discuss strategic progress at the 36th Annual ROTH Conference. The CEO and CFO will highlight growth, diversification, and optimization strategies for the first fiscal quarter of 2024 and beyond. Positive None. Negative None. 03/13/2024 - 12:32 PM Management to Provide a Company Overview and Highlight Strategic Progress on Growth, Diversification, and Optimization PHOENIX, March 13, 2024 /PRNewswire/ -- UTI, Inc. (NYSE: UTI) (the ""Company""), a leading workforce solutions provider of transportation, skilled trades and healthcare education programs, is scheduled to participate in the 36th Annual ROTH Conference, which is being held in Dana Point, CA from March 17-19, 2024. The Company's CEO, Jerome Grant and CFO, Troy Anderson will be hosting one-on-one investor meetings throughout March 18th and 19th. In their remarks, management will offer an overview of the Company and highlight progress on the Company's growth, diversification, and optimization strategy through the first fiscal quarter of 2024, along with the expectations for the remainder of the year. To receive additional information, request an invitation, or schedule a one-on-one meeting with management, please contact your ROTH representative or the Company's investor relations team at UTI@gateway-grp.com. The Company's most recent investor presentation can be found here. About UTI, Inc. UTI, Inc. (NYSE: UTI) was founded in 1965 and is a leading workforce solutions provider of transportation, skilled trades and healthcare education programs, whose mission is to serve students, partners, and communities by providing quality education and support services for in-demand careers across a number of highly-skilled fields. The Company is comprised of two divisions: Universal Technical Institute (""UTI"") and Concorde Career Colleges (""Concorde""). UTI operates 16 campuses located in 9 states and offers a wide range of transportation and skilled trades technical training programs under brands such as UTI, MIAT College of Technology, Motorcycle Mechanics Institute, Marine Mechanics Institute and NASCAR Technical Institute. Concorde operates across 17 campuses in 8 states and online, offering programs in the Allied Health, Dental, Nursing, Patient Care and Diagnostic fields. For more information, visit www.uti.edu or www.concorde.edu, or visit us on LinkedIn at @UniversalTechnicalInstitute and @Concorde Career Colleges or on X (formerly Twitter) @news_UTI or @ConcordeCareer. Investor Relations Contact:Matt Glover and Jackie KeshnerGateway Group, Inc.(949) 574-3860UTI@gateway-grp.com Media Contact:Susan AspeyCorporate AffairsUniversal Technical Institute, Inc.saspey@uti.edu View original content to download multimedia:https://www.prnewswire.com/news-releases/uti-inc-to-participate-in-the-36th-annual-roth-conference-302088333.html SOURCE Universal Technical Institute, Inc. What event is UTI, Inc. participating in to discuss strategic progress? UTI, Inc. is participating in the 36th Annual ROTH Conference. Who will be hosting one-on-one investor meetings at the conference? CEO Jerome Grant and CFO Troy Anderson will be hosting one-on-one investor meetings. What will management highlight in their remarks at the conference? Management will offer an overview of the Company and discuss progress on growth, diversification, and optimization strategies. Where can additional information about the conference be found? To receive additional information or request a meeting, contact ROTH representative or UTI's investor relations team at UTI@gateway-grp.com."
"Fresenius Medical Care appoints Jrg Hring as new Management Board member responsible for Legal, Compliance and Human Resources",2024-03-13T14:00:00.000Z,Low,Very Positive,"Fresenius Medical Care appoints Jrg Hring as Global Head of Legal, Compliance, and Human Resources, effective June 1, 2024. Hring brings extensive expertise in corporate governance and legal matters from his previous roles in the energy and healthcare sectors.","Fresenius Medical Care appoints Jrg Hring as new Management Board member responsible for Legal, Compliance and Human Resources Rhea-AI Impact (Low) Rhea-AI Sentiment (Very Positive) Tags management Rhea-AI Summary Fresenius Medical Care appoints Jrg Hring as Global Head of Legal, Compliance, and Human Resources, effective June 1, 2024. Hring brings extensive expertise in corporate governance and legal matters from his previous roles in the energy and healthcare sectors. Positive None. Negative None. 03/13/2024 - 10:00 AM Effective June 1, the Legal, Compliance, and Human Resources functions will be combined in a new Management Board roleJrg Hring contributes his extensive expertise from the energy, industry, and healthcare sectorsBAD HOMBURG, Germany, March 13, 2024 /PRNewswire/ -- Fresenius Medical Care, the world's leading provider of products and services for individuals with renal diseases, has announced today the appointment of Jrg Hring (54) as its new Global Head of Legal, Compliance and Human Resources. Hring, who will join the company as a member of the Management Board, will start on June 1, 2024, and also assume the role of Labor Director. Michael Sen, Chairman of the Supervisory Board of Fresenius Medical Care AG, said: ""We are delighted to welcome Jrg Hring to the Management Board of Fresenius Medical Care. With his international experience and expertise in corporate governance and legal matters, he perfectly adds to the existing Management Board team. With his proven track record of successful growth and transformation projects at multinational companies he will play a crucial role in the company's further turnaround."" Jrg Hring is currently a member of the Management Committee, Chief Legal & Assurance Officer, and General Secretary at the Spanish oil company Compaa Espaola de Petrleos (CEPSA), with global responsibility for Legal, Corporate Audit, Risk, and Compliance. Previously, he spent more than 20 years with the Siemens Group, among others as General Counsel for almost 13 years, with a wide range of regional and industry responsibilities. Hring brings excellent knowledge and a broad experience in Corporate Governance. Prior to joining Siemens in 2002, Hring worked at the law firm Cleary, Gottlieb, Steen & Hamilton, based in Frankfurt and Brussels. He holds a PhD in law and a degree in economics from the University of Tbingen (Germany) and has been admitted lawyer to the bar by Munich District Court II. Helen Giza, CEO and Chair of the Management Board of Fresenius Medical Care AG, said: ""Jrg joins Fresenius Medical Care with more than two decades of career experience as a senior legal executive and corporate leader in the energy and healthcare sectors. He combines strong business knowledge with great functional expertise, people skills and a focus on corporate culture. He will support our cultural change with inspiration and determination. I look forward to working with him on our transformational journey."" ""It's an honor and a privilege to become Head of Legal, Compliance and Human Resources at Fresenius Medical Care and to lead these functions and the people strategy to the next phase in the company's transformation. I'm very proud to partner with the employees and leaders as we work to transform the organization to serve our employees, shareholders and further stakeholders,"" said Jrg Hring. About Fresenius Medical Care:Fresenius Medical Care is the world's leading provider of products and services for individuals with renal diseases of which around 3.9 million patients worldwide regularly undergo dialysis treatment. Through its network of 4,000 dialysis clinics, Fresenius Medical Care provides dialysis treatments for approximately 332,000 patients around the globe and is the leading provider of dialysis products such as dialysis machines and dialyzers. Fresenius Medical Care is listed on the Frankfurt Stock Exchange (FME) and on the New York Stock Exchange (FMS). For more information visit the Company's website at www.freseniusmedicalcare.com. Disclaimer:This release contains forward-looking statements that are subject to various risks and uncertainties. Actual results could differ materially from those described in these forward-looking statements due to various factors, including, but not limited to, changes in business, economic and competitive conditions, legal changes, regulatory approvals, impacts related to the COVID-19 pandemic results of clinical studies, foreign exchange rate fluctuations, uncertainties in litigation or investigative proceedings, and the availability of financing. These and other risks and uncertainties are detailed in Fresenius Medical Care's reports filed with the U.S. Securities and Exchange Commission. Fresenius Medical Care does not undertake any responsibility to update the forward-looking statements in this release. Media contactChristine Peters T +49 160 60 66 770christine.peters@freseniusmedicalcare.com Contact for analysts and investorsDr. Dominik HegerT +49 6172 609 2601dominik.heger@freseniusmedicalcare.com www.freseniusmedicalcare.com View original content to download multimedia:https://www.prnewswire.com/news-releases/fresenius-medical-care-appoints-jorg-haring-as-new-management-board-member-responsible-for-legal-compliance-and-human-resources-302088171.html SOURCE Fresenius Medical Care Holdings, Inc. Who is the new Global Head of Legal, Compliance, and Human Resources at Fresenius Medical Care? Jrg Hring has been appointed as the new Global Head of Legal, Compliance, and Human Resources at Fresenius Medical Care. When will Jrg Hring start his new role at Fresenius Medical Care? Jrg Hring will start his new role at Fresenius Medical Care on June 1, 2024. What is Jrg Hring's background and expertise? Jrg Hring has extensive experience in corporate governance and legal matters from his previous roles in the energy and healthcare sectors. What is Jrg Hring's current position and responsibilities? Jrg Hring is currently a member of the Management Committee, Chief Legal & Assurance Officer, and General Secretary at CEPSA, with global responsibility for Legal, Corporate Audit, Risk, and Compliance. What is Jrg Hring's educational background? Jrg Hring holds a PhD in law and a degree in economics from the University of Tbingen (Germany) and has been admitted as a lawyer to the bar by Munich District Court II. What are the expectations from Jrg Hring in his new role at Fresenius Medical Care? Jrg Hring is expected to play a crucial role in the company's further turnaround with his proven track record of successful growth and transformation projects at multinational companies."
"Lifeway Foods to Report Fourth Quarter and Full Year 2023 Results on March 20, 2024",2024-03-13T14:30:00.000Z,Low,Neutral,"Lifeway Foods, Inc. (Nasdaq: LWAY) will announce its financial results for Q4 and full year 2023 on March 20, 2024. The announcement will include a conference call and webcast with Lifeway's CEO, Julie Smolyansky.","Lifeway Foods to Report Fourth Quarter and Full Year 2023 Results on March 20, 2024 Rhea-AI Impact (Low) Rhea-AI Sentiment (Neutral) Tags conferences earnings Rhea-AI Summary Lifeway Foods, Inc. (Nasdaq: LWAY) will announce its financial results for Q4 and full year 2023 on March 20, 2024. The announcement will include a conference call and webcast with Lifeway's CEO, Julie Smolyansky. Positive None. Negative None. 03/13/2024 - 10:30 AM MORTON GROVE, Ill., March 13, 2024 /PRNewswire/ -- Lifeway Foods, Inc. (Nasdaq: LWAY) (""Lifeway"" or ""the Company""), a leading U.S. supplier of kefir and fermented probiotic products to support the microbiome, today announced it will report financial results for the fourth quarter and full year ended December 31, 2023 on March 20, 2024 before market hours. A pre-recorded conference call and webcast with Julie Smolyanksy, Lifeway's President and Chief Executive Officer, discussing these results with additional comments and details will be made available through the ""Investor Relations"" section of the Company's website at https://lifewaykefir.com/webinars-reports/ upon dissemination of the fourth quarter and full year results on March 20, 2024 before market hours. About Lifeway Foods, Inc.Lifeway Foods, Inc., which has been recognized as one of Forbes' Best Small Companies, is America's leading supplier of the probiotic, fermented beverage known as kefir. In addition to its line of drinkable kefir, the company also produces a variety of cheeses and a ProBugs line for kids. Lifeway's tart and tangy fermented dairy products are now sold across the United States, Mexico, Ireland and France. Learn how Lifeway is good for more than just you at lifewayfoods.com. Media:Derek Miller Vice President of Communications, Lifeway FoodsEmail: derekm@lifeway.net General inquiries:Lifeway Foods, Inc.Phone: 847-967-1010Email: info@lifeway.net View original content to download multimedia:https://www.prnewswire.com/news-releases/lifeway-foods-to-report-fourth-quarter-and-full-year-2023-results-on-march-20-2024-302087700.html SOURCE Lifeway Foods, Inc. When will Lifeway Foods, Inc. announce its financial results for Q4 and full year 2023? Lifeway Foods, Inc. will announce its financial results for Q4 and full year 2023 on March 20, 2024. Who will be discussing the financial results during the conference call and webcast? Julie Smolyansky, Lifeway's President and CEO, will be discussing the financial results during the conference call and webcast. Where can investors access the conference call and webcast? Investors can access the conference call and webcast through the 'Investor Relations' section of Lifeway Foods, Inc.'s website at https://lifewaykefir.com/webinars-reports/."
Ally Financial schedules release of first quarter financial results,2024-03-13T14:00:00.000Z,Low,Neutral,"Ally Financial Inc. to Release First Quarter Financial Results on April 18, 2024","Ally Financial schedules release of first quarter financial results Rhea-AI Impact (Low) Rhea-AI Sentiment (Neutral) Tags earnings Rhea-AI Summary Ally Financial Inc. to Release First Quarter Financial Results on April 18, 2024 Positive None. Negative None. 03/13/2024 - 10:00 AM CHARLOTTE, N.C., March 13, 2024 /PRNewswire/ -- Ally Financial Inc. (NYSE: ALLY) has scheduled the release of its first quarter financial results for Thursday, April 18, 2024, at approximately 7:30 a.m. ET. The results will be available on the Ally Press Room website (http://media.ally.com). Ally will host a conference call at 9 a.m. ET to review the company's performance. You may listen to the call via webcast or dial-in. The webcast will be live on Ally's Investor Relations website in the Events & Presentations section (http://www.ally.com/about/investor/events-presentations/index.html). To join the conference via dial-in, please pre-register via the following link at least 15 minutes before the call begins: https://register.vevent.com/register/BI9b99352331674e528800b642e7e862a0. Upon registration, you will be provided with the conference dial-in number as well as a unique registrant ID. The presentation and financial supplement will be posted in the Events & Presentations section of Ally's Investor Relations website on April 18, 2024, at approximately 7:30 a.m. ET. A replay of the call will be available via webcast on the Ally Investor Relations website. About Ally FinancialAlly Financial Inc. (NYSE: ALLY) is a financial services company with the nation's largest all-digital bank and an industry-leading auto financing business, driven by a mission to ""Do It Right"" and be a relentless ally for customers and communities. The company serves approximately 11 million customers through a full range of online banking services (including deposits, mortgage, and credit card products) and securities brokerage and investment advisory services. The company also includes a robust corporate finance business that offers capital for equity sponsors and middle-market companies, as well as auto financing and insurance offerings. For more information, please visit www.ally.com. For more information and disclosures about Ally, visit https://www.ally.com/#disclosures. For further images and news on Ally, please visit http://media.ally.com. Contacts: Sean LearyAlly Investor Relations 704-444-4830sean.leary@ally.com Jackie HartzellAlly Communications (Media)980-270-4244jackie.hartzell@ally.com View original content to download multimedia:https://www.prnewswire.com/news-releases/ally-financial-schedules-release-of-first-quarter-financial-results-302088096.html SOURCE Ally Financial When is Ally Financial Inc. releasing its first quarter financial results? Ally Financial Inc. is scheduled to release its first quarter financial results on Thursday, April 18, 2024, at approximately 7:30 a.m. ET. Where can I access the first quarter financial results of Ally Financial Inc.? The results will be available on the Ally Press Room website at http://media.ally.com. What time is the conference call to review Ally Financial Inc.'s performance? Ally Financial Inc. will host a conference call at 9 a.m. ET to review the company's performance. How can I listen to the conference call by Ally Financial Inc.? You may listen to the call via webcast or dial-in. The webcast will be live on Ally's Investor Relations website in the Events & Presentations section."
Exploring the Multidimensional Energy Transition: S&P Global Unveils its Latest Look Forward Journal,2024-03-13T14:05:00.000Z,Low,Neutral,"S&P Global published the sixth edition of its Look Forward research series, focusing on the multidimensional energy transition. The report highlights the challenges and opportunities in the global energy landscape, emphasizing the importance of energy security, climate policies, and investments in renewable energy sources.","Exploring the Multidimensional Energy Transition: S&P Global Unveils its Latest Look Forward Journal Rhea-AI Impact (Low) Rhea-AI Sentiment (Neutral) Tags Rhea-AI Summary S&P Global published the sixth edition of its Look Forward research series, focusing on the multidimensional energy transition. The report highlights the challenges and opportunities in the global energy landscape, emphasizing the importance of energy security, climate policies, and investments in renewable energy sources. Positive The report emphasizes the need for energy security to ensure a steady and scalable energy transition. Climate policies and investments in developed countries alone are insufficient to address global climate change issues, requiring engagement with developing economies. The electrification of the world's vehicle fleet is progressing in select markets, while the role of natural gas in decarbonization is highlighted as crucial. The report calls for a significant increase in renewable energy capacity globally to meet climate goals, and highlights the importance of AI in managing the complexity of renewable energy integration. Negative None. Energy Market Analyst An integral aspect of the energy sector's future is the alignment of energy security with the progression of the energy transition. The report's emphasis on the necessity of a secure energy supply as a foundational element for a steady transition underlines the sector's vulnerability to geopolitical and market risks. The observation that current climate policies in the Global North are insufficient to address global climate issues accentuates the need for inclusive strategies engaging the Global South, potentially leading to new market opportunities and investment requirements.Furthermore, the report's projection of a doubling in the annual addition of renewable capacity to meet international pledges suggests a significant scaling up of industry operations. This could imply increased demand for capital, advancements in technology and a surge in employment opportunities within the sector. However, it also presents challenges in terms of supply chain management, resource availability and the need for supportive regulatory frameworks. Technology Innovation Analyst The inclusion of artificial intelligence in the energy transition narrative is particularly noteworthy. AI's role in managing the complexities introduced by a higher share of renewables in the energy mix could be a game-changer. The ability to process vast amounts of data and optimize decision-making can lead to more efficient grid management and integration of intermittent energy sources. This technological integration may also stimulate investment in AI-driven startups and R&D within established energy firms, potentially leading to a wave of innovation in energy sector operations. Environmental Policy Analyst The report's nod to the role of gas as a bridge fuel highlights a pragmatic approach to decarbonization. The immediate deployment of natural gas as a substitute for coal can offer a relatively quick reduction in carbon emissions. However, this strategy must be carefully balanced with long-term goals to avoid locking in fossil fuel dependency. Policymakers will need to consider the implications of such transitional policies on environmental targets and the investment landscape, ensuring that they do not stifle the growth of renewable energy technologies.Additionally, the momentum in vehicle electrification, while concentrated in specific markets, indicates a sectoral shift that could have far-reaching consequences for oil demand, electric grid requirements and the automotive industry. This shift may necessitate new infrastructure investments and could lead to changes in consumer behavior, urban planning and energy consumption patterns. 03/13/2024 - 10:05 AM NEW YORK, March 13, 2024 /PRNewswire/ -- S&P Global (NYSE: SPGI) today published the sixth edition of its Look Forward research series, providing in-depth analysis of the major geopolitical, technological, financial and regulatory drivers that are shaping the direction and pace of the multidimensional energy transition. Developments over the last three years have shaken expectations of a linear global transition as climate goals compete with economic development, energy access, energy security and affordability. This research, titled Look Forward: Multidimensional Transition, explores expectations for a multispeed, multifueled and multi-technology transition  with different road maps and end points for different countries. ""We are at a pivotal moment in the energy transition. Sweeping financial investments have set the stage for a decade of deployment,"" said Saugata Saha, President, S&P Global Commodity Insights. ""Thousands of new projects and new technologies will enter the world's energy ecosystem, from hydrogen to carbon capture and more. In addition, artificial intelligence is transforming capabilities in data processing and decision-making that will impact the energy industry."" Key findings from Look Forward: Multidimensional Transition include: Ensuring energy security is a high priority: events in recent years have demonstrated that the energy transition depends on energy security to proceed at a steady pace and at scale.Climate policies and investments in the Global North alone are not sufficient to solve climate change issues worldwide - effective solutions will need to engage the developing economies of the Global South.Wars, polarization and political divides will challenge governments and the private sector to secure energy supplies while also navigating investments for energy transition.Electrification of the world's vehicle fleet is gaining momentum, yet progress remains concentrated on select markets. Gas in its various forms needs to be part of the environmental policy toolkit - the immediate push of natural gas can help achieve fast decarbonization by accelerating the phaseout of coal with a proven alternative technology.At least 1,000 GW of new renewables capacity are needed globally each year  or more than double today's levels  to meet the COP28 pledge to triple renewables capacity.Energy transition dynamics may incentivize, or even require, companies to test and use AI to manage the increased complexity created by more renewable generation in the energy mix.For more insights from Look Forward: Multidimensional Transition (Volume 6 | March 2024), please visit: https://www.spglobal.com/en/research-insights/featured/special-editorial/look-forward/look-forward-volume-3-2024 This is the sixth volume of the Look Forward research series from the S&P Global Research Council. For more information about S&P Global Research Council, please visit: https://www.spglobal.com/en/research-insights/featured/research-council About S&P Global S&P Global (NYSE: SPGI) provides essential intelligence. We enable governments, businesses and individuals with the right data, expertise and connected technology so that they can make decisions with conviction. From helping our customers assess new investments to guiding them through ESG and energy transition across supply chains, we unlock new opportunities, solve challenges and accelerate progress for the world. We are widely sought after by many of the world's leading organizations to provide credit ratings, benchmarks, analytics and workflow solutions in the global capital, commodity and automotive markets. With every one of our offerings, we help the world's leading organizations plan for tomorrow, today. Media ContactJoanna Vickers S&P Global Corporate Communications Tel: +44 207 260 224 Joanna.vickers@spglobal.com View original content:https://www.prnewswire.com/news-releases/exploring-the-multidimensional-energy-transition-sp-global-unveils-its-latest-look-forward-journal-302088179.html SOURCE S&P Global What is the focus of the Look Forward research series? The Look Forward research series from S&P Global focuses on the multidimensional energy transition and its impact on the global energy landscape. Why is energy security important in the energy transition? Energy security is crucial for ensuring a steady and scalable energy transition, as highlighted in the report. What role does natural gas play in decarbonization? The report emphasizes that natural gas can help achieve fast decarbonization by accelerating the phaseout of coal with proven alternative technology. How much new renewables capacity is needed globally each year according to the report? The report suggests that at least 1,000 GW of new renewables capacity are needed annually to meet climate goals, more than double current levels. Why is AI important in the energy transition? AI is highlighted as crucial in managing the increased complexity created by more renewable generation in the energy mix, as per the report."
U.S. Public Sector Adapts to Change by Modernizing HCM,2024-03-13T14:00:00.000Z,Low,Neutral,"The 2023 ISG Provider Lens report highlights the accelerated adoption of advanced human capital management (HCM) software platforms by U.S. public sector agencies due to workforce changes, retirements, and new expectations. Agencies are centralizing HCM to address talent retention, diversity, equity, and inclusion challenges, seeking efficiency and modernization.","U.S. Public Sector Adapts to Change by Modernizing HCM Rhea-AI Impact (Low) Rhea-AI Sentiment (Neutral) Tags Rhea-AI Summary The 2023 ISG Provider Lens report highlights the accelerated adoption of advanced human capital management (HCM) software platforms by U.S. public sector agencies due to workforce changes, retirements, and new expectations. Agencies are centralizing HCM to address talent retention, diversity, equity, and inclusion challenges, seeking efficiency and modernization. Positive None. Negative None. Human Resources Technology Expert The integration of advanced human capital management (HCM) platforms within U.S. public sector agencies signifies a pivotal shift in how these entities approach workforce management. The move towards these systems is indicative of a broader trend where organizations, in response to dynamic work environments and evolving employee expectations, are leveraging technology to gain a strategic edge in talent acquisition and retention. Advanced HCM platforms offer a suite of tools that not only streamline HR operations but also provide valuable analytics to inform decision-making processes.From a technological standpoint, the adoption of such platforms can lead to increased efficiency and productivity. The ability to automate routine tasks frees up HR professionals to focus on more strategic initiatives, such as workforce planning and employee development. Moreover, the use of analytics can help identify trends and patterns within the workforce, allowing for more informed decisions regarding talent management and potentially enhancing diversity, equity and inclusion efforts. Public Sector Management Analyst The report's findings on the U.S. public sector's adoption of HCM platforms underscore a critical response to an aging workforce and the subsequent talent shortages. As retirements surge, the need to attract younger, tech-savvy professionals becomes more acute. Public agencies are recognizing the necessity of modernizing their HR systems not only to manage their current workforce more effectively but also to appeal to the next generation of employees who expect digital proficiency in their work environments.Furthermore, the standardization on centralized HCM platforms reflects a strategic move to mitigate risks associated with decentralized and outdated HR systems. By centralizing HR functions, agencies can ensure a more consistent application of policies and procedures across the board, which is crucial for maintaining compliance with new regulations and standards. This transition is a significant undertaking for the public sector, which often operates within tight budgetary constraints and faces scrutiny regarding the allocation of resources. Financial Analyst The financial implications of public sector agencies adopting modern HCM platforms are multifaceted. Initially, there is a significant investment required not only for the software purchase but also for the implementation and ongoing maintenance. Most agencies opt to outsource these services due to a lack of internal resources, which can add to the cost. However, the long-term financial benefits may justify the upfront expenses. Enhanced HR operations can lead to cost savings through improved efficiency, reduced turnover and better management of human resources.Investors and stakeholders in companies that provide these HCM solutions should monitor the adoption rates and satisfaction levels within the public sector, as these could be indicators of future market growth and potential revenue streams. The report suggests a growing market for HCM platforms in the public sector, which could have positive implications for the stock performance of companies in this industry. 03/13/2024 - 10:00 AM Agencies roiled by retirements, talent shortages and new regulations standardize on modern, centralized HCM platforms, ISG Provider Lens report says STAMFORD, Conn.--(BUSINESS WIRE)-- U.S. public sector agencies have accelerated their adoption of advanced human capital management (HCM) software platforms in the face of multiple changes that have impacted the sector in the past few years, according to a new research report published today by Information Services Group (ISG) (Nasdaq: III), a leading global technology research and advisory firm. The 2023 ISG Provider Lens HCM Technology Platforms report for the U.S. Public Sector finds that changes in the composition and location of workforces, new employee and constituent expectations and a wave of retirements have forced agencies to modernize human resource management. Two of the steepest challenges today are attracting and retaining talent and promoting diversity, equity and inclusion, but agencies recognize other challenges will emerge. Public sector organizations are turning to centralized HCM platforms so they can take a more holistic approach to staff management, said Nathan Frey, partner and lead, ISG Public Sector, in the U.S. What affects one aspect of human resources can influence others, and they want the agility to address future needs. State and local governments and educational organizations in the U.S. are seeking improvements in HR operations, management and efficiency, the report says. Their goals span several functional areas, many of which have languished in these organizations due to outdated systems, tools and interfaces. Typically, public agencies begin by buying and implementing a core HCM platform, which may be decades ahead of the systems it replaces but still have limited built-in capabilities, ISG says. Later, the agencies add modules for specific functions. Many projects involve purchasing software and then outsourcing implementation and maintenance, for which most agencies lack the resources. To address challenges around talent, organizations are implementing solutions that automate processes and use analytics to make data-driven decisions about recruitment and retention, the report says. In payroll management, new HCM solutions are automating routine tasks and providing better oversight and regulatory compliance, reducing the risk of costly errors and penalties. Transparency is critical for taxpayer-funded organizations, said Jan Erik Aase, partner and global leader, ISG Provider Lens Research. New HCM platforms provide real-time access to data, which can help agencies increase accountability and public trust. The report also explores other HCM trends in the U.S. public sector, including the rising importance of remote workforce management and mobile access to HR data for employees and administrators. For more insights into the HCM challenges facing the U.S. public sector, including talent shortages and diversity mandates, and ISGs advice for addressing them, see the ISG Provider Lens Focal Points briefing here. The 2023 ISG Provider Lens HCM Technology Platforms report for the U.S. Public Sector evaluates the capabilities of 36 providers across three quadrants: Core HCM Platforms Plus Talent Management, Payroll Management Solutions and Recruiting and Retention Solutions. The report names CGI, Infor, Oracle, SAP SuccessFactors and Workday as Leaders in all three quadrants. It names ADP, CivicPlus and HR Acuity as Leaders in one quadrant each. In addition, Circa, Dayforce and NEOGOV are named as Rising Stars  companies with a promising portfolio and high future potential by ISGs definition  in one quadrant each. A customized version of the report is available from CGI. The 2023 ISG Provider Lens HCM Technology Platforms report for the U.S. Public Sector is available to subscribers or for one-time purchase on this webpage. About ISG Provider Lens Research The ISG Provider Lens Quadrant research series is the only service provider evaluation of its kind to combine empirical, data-driven research and market analysis with the real-world experience and observations of ISG's global advisory team. Enterprises will find a wealth of detailed data and market analysis to help guide their selection of appropriate sourcing partners, while ISG advisors use the reports to validate their own market knowledge and make recommendations to ISG's enterprise clients. The research currently covers providers offering their services globally, across Europe, as well as in the U.S., Canada, Brazil, the U.K., France, Benelux, Germany, Switzerland, the Nordics, Australia and Singapore/Malaysia, with additional markets to be added in the future. For more information about ISG Provider Lens research, please visit this webpage. A companion research series, the ISG Provider Lens Archetype reports, offer a first-of-its-kind evaluation of providers from the perspective of specific buyer types. About ISG ISG (Information Services Group) (Nasdaq: III) is a leading global technology research and advisory firm. A trusted business partner to more than 900 clients, including more than 75 of the worlds top 100 enterprises, ISG is committed to helping corporations, public sector organizations, and service and technology providers achieve operational excellence and faster growth. The firm specializes in digital transformation services, including automation, cloud and data analytics; sourcing advisory; managed governance and risk services; network carrier services; strategy and operations design; change management; market intelligence and technology research and analysis. Founded in 2006, and based in Stamford, Conn., ISG employs more than 1,600 digital-ready professionals operating in more than 20 countriesa global team known for its innovative thinking, market influence, deep industry and technology expertise, and world-class research and analytical capabilities based on the industrys most comprehensive marketplace data. For more information, visit www.isg-one.com. View source version on businesswire.com: https://www.businesswire.com/news/home/20240313968242/en/ Press: Will Thoretz, ISG +1 203 517 3119 will.thoretz@isg-one.com Julianna Sheridan, Matter Communications for ISG +1 978-518-4520 isg@matternow.com Source: Information Services Group, Inc. Why are U.S. public sector agencies adopting advanced HCM software platforms? U.S. public sector agencies are adopting advanced HCM software platforms due to workforce changes, retirements, and new expectations. What challenges are public sector organizations facing in terms of HR management? Public sector organizations are facing challenges in attracting and retaining talent, promoting diversity, equity, and inclusion, and addressing future needs. What are the goals of state and local governments and educational organizations in the U.S. regarding HR operations? State and local governments and educational organizations in the U.S. are seeking improvements in HR operations, management, and efficiency. How do public agencies typically approach the implementation of HCM platforms? Public agencies typically start by buying and implementing a core HCM platform and later add modules for specific functions. What solutions are organizations implementing to address talent challenges? Organizations are implementing solutions that automate processes and use analytics to make data-driven decisions to address talent challenges."
Sekur Private Data Outlines Business Data Cyber Risks from Bad Actor States During U.S. Election Year - Offers Countermeasures,2024-03-13T14:30:00.000Z,Moderate,Negative,"Sekur Private Data Ltd. offers robust cybersecurity solutions to protect businesses from cyber threats, particularly ransomware attacks, during the crucial US presidential election year. With a focus on secure and private communications, Sekur provides encrypted emails, secure messengers, and communication tools to safeguard sensitive data. The company's CEO emphasizes the need for impenetrable security solutions against state-actor cyber threats, highlighting the escalating risks faced by businesses. Sekur's proprietary technology and Swiss-hosted servers ensure secure communications without relying on big tech infrastructure or data mining. The company's SekurRelay Enterprise Email Solution and SekurVPN set new industry standards by prioritizing data protection and privacy, adhering to stringent Swiss privacy laws. SekurMessenger introduces innovative features like 'Chat-By-Invite' to facilitate private and secure communication without compromising user data. Overall, Sekur's comprehensive suite of security solutions positions it as a leader in the fight against cyber threats.","Sekur Private Data Outlines Business Data Cyber Risks from Bad Actor States During U.S. Election Year - Offers Countermeasures Rhea-AI Impact (Moderate) Rhea-AI Sentiment (Negative) Tags Rhea-AI Summary Sekur Private Data Ltd. offers robust cybersecurity solutions to protect businesses from cyber threats, particularly ransomware attacks, during the crucial US presidential election year. With a focus on secure and private communications, Sekur provides encrypted emails, secure messengers, and communication tools to safeguard sensitive data. The company's CEO emphasizes the need for impenetrable security solutions against state-actor cyber threats, highlighting the escalating risks faced by businesses. Sekur's proprietary technology and Swiss-hosted servers ensure secure communications without relying on big tech infrastructure or data mining. The company's SekurRelay Enterprise Email Solution and SekurVPN set new industry standards by prioritizing data protection and privacy, adhering to stringent Swiss privacy laws. SekurMessenger introduces innovative features like 'Chat-By-Invite' to facilitate private and secure communication without compromising user data. Overall, Sekur's comprehensive suite of security solutions positions it as a leader in the fight against cyber threats. Positive Sekur Private Data Ltd. offers comprehensive cybersecurity solutions to protect businesses from cyber threats. The company focuses on secure and private communications, providing encrypted emails, secure messengers, and communication tools. Sekur's CEO highlights the escalating risks faced by businesses due to state-actor cyber threats, emphasizing the need for impenetrable security solutions. The company's proprietary technology and Swiss-hosted servers ensure secure communications without relying on big tech infrastructure or data mining. Sekur's SekurRelay Enterprise Email Solution and SekurVPN prioritize data protection and privacy, adhering to stringent Swiss privacy laws. SekurMessenger introduces innovative features like 'Chat-By-Invite' to facilitate private and secure communication without compromising user data. Overall, Sekur's security solutions position it as a leader in the fight against cyber threats. Negative None. 03/13/2024 - 10:30 AM Miami, Florida and Toronto, Ontario--(Newsfile Corp. - March 13, 2024) - Sekur Private Data Ltd. (OTCQB: SWISF) (CSE: SKUR) (FSE: GDT0) (""Sekur"" or the ""Company""), a leading Swiss hosted secure and private communications platform, outlines solutions to protect enterprise and small to medium-sized business (SMB) owners from the growing menace of bad actor cyber threats. With statistics indicating the escalating costs of ransomware attacks on businesses, during the crucial US presidential election year, Sekur Private Data is committed to providing robust and comprehensive security solutions.Recent incidents, such as the alleged exploitation of Google accounts via OAuth2 functionality and the high-profile hacking of Microsoft's corporate network from a Russian hacking group, highlights the critical need for robust cybersecurity and data privacy measures. In this environment, Sekur remains at the forefront of the battle against state-actor cyber threats, equipping enterprises and SMB owners with impenetrable security solutions.According to recent studies, ransomware attacks have inflicted staggering financial losses on businesses, amounting to billions of dollars annually. Sekur Private Data's comprehensive suite of encrypted emails, secure messengers, and communication tools offers a formidable defense against these escalating threats.Alain Ghiai, the CEO of Sekur Private Data Ltd., commented, ""As bad actor states continue to escalate their cyber threats, especially in the USA and during a presidential election year, businesses are facing unprecedented risks and soaring costs, as these rogue states and bad actors are doing everything to disrupt the U.S. economy. At Sekur, we provide robust solutions that safeguard sensitive data, empowering SMBs, enterprises and governments to stay one step ahead of these evolving threats and challenges. We are happy to be able to provide these solutions, as we can offer the only Swiss-hosted, proprietary, private and secure communications platform that does not rely on big tech infrastructure, open-source coding or data mining, therefore reducing exponentially the risk of cyber penetration. Our prime directive is to provide private and secure communications for everyone, by offering a truly independent, private and secure means of communications, without any data mining, through our proprietary technology and our secure private servers based in Switzerland.""SekurRelay Enterprise Email Solution, a vital component of the Sekur Enterprise suite, empowers corporate executives and management to effortlessly implement enhanced security measures for their company's email domain. By leveraging SekurSend/SekurReply features and other Swiss-hosted privacy solutions, SekurRelay ensures that sensitive communications remain secure without necessitating a complete migration of the entire workforce. This breakthrough eliminates a significant hurdle to mass adoption within large corporations and government agencies.Additionally, SekurVPN sets new industry standards by utilizing its proprietary infrastructure and abstaining from hyperscaler or Big Tech hosting providers. Unlike other VPNs, SekurVPN exclusively employs its private Swiss cloud infrastructure, offering Swiss-hosted VPN services with Swiss IPs only. This guarantees unparalleled data protection, as the service solely relies on SekurVPN's own servers and routing. By adhering to the stringent regulations of FADP Swiss privacy laws, SekurVPN treats users' IP addresses as private property, making data harvesting a criminal offense under Swiss legislation.SekurMessenger comes with a proprietary feature and technology called ""Chat-By-Invite."" This feature allows a SekurMessenger user (""SM user"") to invite via email or SMS a non-SM user, or a group of non-SM users, to chat in a fully private and secure way without the recipient ever having to register to SekurMessenger or download the app. Additionally, SekurMessenger uses a strict vetting system that prevents non vetted users from spamming and hacking your account, as it does not collect the user's phone number and does not harvest any data or phone contact from SekurMessenger users.Sekur's Data privacy solutions are all hosted in Switzerland, protecting users' data from any outside data intrusion requests. In Switzerland, the right to privacy is guaranteed in article 13 of the Swiss Federal Constitution. The Federal Act on Data Protection (""FADP"") of 19 June 1992 (in force since 1993) has set up a strict protection of privacy by prohibiting virtually any processing of personal data which is not expressly authorized by the data subjects. The protection is subject to the authority of the Federal Data Protection and Information Commissioner.Under Swiss federal law, it is a crime to publish information based on leaked ""secret official discussions."" In 2010, the Federal Supreme Court of Switzerland found that IP addresses are personal information and that under Swiss privacy laws they may not be used to track internet usage without the knowledge of the individuals involved.About Sekur Private Data Ltd.Sekur Private Data Ltd. is a cybersecurity and Internet privacy provider of Swiss hosted solutions for secure and private communications. The Company distributes a suite of encrypted e-mails, secure messengers and secure communication tools. Sekur Private Data Ltd. sells its products through its own website, https://www.sekur.com, approved distributors and telecommunications companies worldwide. Sekur Private Data Ltd. serves consumers, businesses and governments worldwide.Follow us on Twitter: https://twitter.com/sekurprivate On behalf of ManagementSEKUR PRIVATE DATA LTD.Alain GhiaiPresident and Chief Executive Officercorporate@sekurprivatedata.comFor more information, please contact Sekur Private Data at corporate@sekurprivatedata.com or visit us at https://www.sekurprivatedata.comFor more information on Sekur visit us at: https://www.sekur.comForward-Looking InformationThis news release contains certain forward-looking information within the meaning of applicable Canadian securities laws (""forward-looking statements""). All statements other than statements of present or historical fact are forward-looking statements. Forward-looking statements are often, but not always, identified by the use of words such as ""anticipate"", ""achieve"", ""could"", ""believe"", ""plan"", ""intend"", ""objective"", ""continuous"", ""ongoing"", ""estimate"", ""outlook"", ""expect"", ""project"" and similar words, including negatives thereof, suggesting future outcomes or that certain events or conditions ""may"" or ""will"" occur. These statements are only predictions. These statements reflect management's current estimates, beliefs, intentions and expectations; they are not guaranteeing future performance. Sekur cautions that all forward-looking statements are inherently uncertain and that actual performance may be affected by a number of material factors, many of which are beyond Sekur's control. Such factors include, among other things: risks and uncertainties relating to the future of the Company's business; the success of marketing and sales efforts of the Company; the projections prepared in house and projections delivered by channel partners; the Company's ability to complete the necessary software updates; increases in sales as a result of investments software development technology; consumer interest in the Products; future sales plans and strategies; reliance on large channel partners and expectations of renewals to ongoing agreements with these partners; anticipated events and trends; the economy and other future conditions; and other risks and uncertainties, including those described in Sekur's prospectus dated May 8, 2019, filed with the Canadian Securities Administrators and available on www.sedarplus.ca. Accordingly, actual and future events, conditions and results may differ materially from the estimates, beliefs, intentions and expectations expressed or implied in the forward-looking information. Except as required under applicable securities legislation, Sekur undertakes no obligation to publicly update or revise forward-looking information.To view the source version of this press release, please visit https://www.newsfilecorp.com/release/201523 What cybersecurity solutions does Sekur Private Data Ltd. offer to protect businesses? Sekur Private Data Ltd. offers comprehensive cybersecurity solutions, including encrypted emails, secure messengers, and communication tools, to safeguard sensitive data from cyber threats. How does Sekur prioritize data protection and privacy in its services? Sekur prioritizes data protection and privacy by using proprietary technology and Swiss-hosted servers, adhering to stringent Swiss privacy laws to ensure secure communications without relying on big tech infrastructure or data mining. What innovative feature does SekurMessenger introduce to facilitate private communication? SekurMessenger introduces 'Chat-By-Invite,' allowing users to invite non-users to chat in a fully private and secure way without the need for recipients to register or download the app."
ADM Tronics CEO Presents Vet-Sonotron Veterinary Therapy Device at Medical Device Industry Webinar,2024-03-13T14:30:00.000Z,Neutral,Positive,"ADM Tronics CEO presents Vet-Sonotron non-invasive therapy device at MDG Premium webinar. The device offers innovative pain management solutions for small animals, showcasing significant efficacy in treating musculoskeletal conditions. The webinar highlighted the device's development, testing, and positive results, emphasizing its potential in veterinary care.","ADM Tronics CEO Presents Vet-Sonotron Veterinary Therapy Device at Medical Device Industry Webinar Rhea-AI Impact (Neutral) Rhea-AI Sentiment (Positive) Tags Rhea-AI Summary ADM Tronics CEO presents Vet-Sonotron non-invasive therapy device at MDG Premium webinar. The device offers innovative pain management solutions for small animals, showcasing significant efficacy in treating musculoskeletal conditions. The webinar highlighted the device's development, testing, and positive results, emphasizing its potential in veterinary care. Positive None. Negative None. 03/13/2024 - 10:30 AM NORTHVALE, NJ / ACCESSWIRE / March 13, 2024 / ADM Tronics, an innovator of electronic medical device technologies, is pleased to announce that its CEO, Andre DiMino, presented the groundbreaking Vet-Sonotron non-invasive veterinary therapy device at an exclusive, interactive MDG Premium webinar. The webinar provided an in-depth exploration of the development, testing, and outstanding efficacy of the Vet-Sonotron in treating musculoskeletal pain conditions in small animals, including dogs as well as horses. View the webinar here: https://tinyurl.com/yb28txjkThe Vet-Sonotron represents a significant advancement in veterinary care, offering a non-invasive solution for managing pain and promoting healing in animals. Developed and tested over the past several years, this cutting-edge device utilizes proprietary non-invasive therapeutic technology to deliver targeted therapy with excellent results.During the webinar, Mr. DiMino shared insights into the development process of the Vet-Sonotron, highlighting the extensive research and engineering development involved in bringing this innovative device to fruition. He emphasized the device's ability to address a critical need in veterinary medicine by offering a safe, effective alternative to traditional treatments for musculoskeletal pain.""We are proud to introduce the Vet-Sonotron to the medical device community through this webinar,"" said Mr. DiMino. ""This device has significant potential in the way pain management is approached in small animals and in horses, providing veterinarians with a powerful tool to improve the quality of life for their patients.""The webinar included an overview of the testing conducted to assess the efficacy of the Vet-Sonotron. Results demonstrated the device's ability to significantly reduce pain and inflammation, accelerate healing, and improve mobility in dogs and horses suffering from both acute and chronic musculoskeletal conditions.The webinar was hosted by Joe Hage, Chair of MDG Premium and leader of the Medical Devices Group (medicaldevicesgroup.net), with over 350,000 members in the medical device and related industries. Attendees of the webinar, members of MDG Premium, including medical device professionals, researchers, and industry experts, had the opportunity to engage with Mr. DiMino during a Q&A session following the presentation. The lively discussion delved into various aspects of the Vet-Sonotron technology, its applications, and the future development of a human medical version of the technology.As ADM Tronics continues to advance the field of veterinary therapeutics with innovative solutions like the Vet-Sonotron, the company remains committed to advancing its research and development of electronic medical devices, both for its own products as well as on a contract engineering and manufacturing basis for customers at its FDA-Registered and ISO-13485 Certified medical device facility. With its proven efficacy and non-invasive approach, the Vet-Sonotron stands poised to make a lasting impact on veterinary care, offering new hope for animals suffering from musculoskeletal conditions.For more information about the Vet-Sonotron and contract medical device development and manufacturing services by ADM Tronics, visit www.admtronics.com.About ADMTADMT is a diversified, technology-based developer and manufacturer of innovative technologies and products. ADMT has three areas of activity: Proprietary Electronic Medical Devices; Engineering, Regulatory and Manufacturing Services; and, Eco-Friendly, Water-Based Formulations. The Company's headquarters, laboratories, and FDA-Registered medical device manufacturing operations are in Northvale, NJ. ADMT's multi-disciplinary team of engineers, researchers and technologists utilize advanced technology infrastructure, for research, development and commercialization of diversified technologies.ADMT welcomes inquiries for its medical device services at www.admteng.com.Investor Relations:Howard Isaacs 562-987-4939 HISAACS@EARTHLINK.NETRichard Cavalli 303-956-1777 RICHARDACAVALLI@GMAIL.COMExcept for historical information contained herein, the matters set forth in this news release are ""forward-looking"" statements (as defined in the Private Securities Litigation Reform Act of 1995), including statements regarding future revenue growth and performance. Although ADMT believes the expectations reflected in such forward-looking statements are based upon reasonable assumptions, there can be no assurance that its expectations will be realized. Forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from expectations. Factors that could contribute to such differences include those described from time to time in ADMT's filings with the SEC, news releases and other communications. The Company assumes no obligation to update the information contained in this news release.SOURCE: ADM Tronics Unlimited, Inc.View the original press release on accesswire.com What did ADM Tronics CEO present at the MDG Premium webinar? ADM Tronics CEO presented the Vet-Sonotron non-invasive therapy device at the MDG Premium webinar. What is the Vet-Sonotron device designed for? The Vet-Sonotron device is designed for managing pain and promoting healing in small animals, including dogs and horses. Who hosted the webinar where the Vet-Sonotron was presented? The webinar was hosted by Joe Hage, Chair of MDG Premium and leader of the Medical Devices Group. What were the results of the testing conducted on the Vet-Sonotron? Results showed that the Vet-Sonotron significantly reduced pain and inflammation, accelerated healing, and improved mobility in dogs and horses with musculoskeletal conditions. What is ADM Tronics committed to in terms of research and development? ADM Tronics is committed to advancing the field of veterinary therapeutics with innovative solutions like the Vet-Sonotron, along with developing electronic medical devices for its own products and on a contract basis for customers."
"Liberty All-Star Growth Fund, Inc. February 2024 Monthly Update",2024-03-13T17:06:00.000Z,Low,Neutral,"The Liberty All-Star Growth Fund, Inc. (ASG) released its February 2024 Monthly Update, showcasing a diversified investment approach with three growth style managers focusing on small, mid, and large-cap stocks. The top 20 holdings include well-known companies like Amazon, Microsoft, and Visa. The monthly performance saw a 5.31% increase in NAV and a 3.44% increase in market price, with a 9.1% discount at the end of the month. The fund's net assets stood at $354.9 million, with a sector breakdown showing a significant allocation to Information Technology and Health Care.","Liberty All-Star Growth Fund, Inc. February 2024 Monthly Update Rhea-AI Impact (Low) Rhea-AI Sentiment (Neutral) Tags Rhea-AI Summary The Liberty All-Star Growth Fund, Inc. (ASG) released its February 2024 Monthly Update, showcasing a diversified investment approach with three growth style managers focusing on small, mid, and large-cap stocks. The top 20 holdings include well-known companies like Amazon, Microsoft, and Visa. The monthly performance saw a 5.31% increase in NAV and a 3.44% increase in market price, with a 9.1% discount at the end of the month. The fund's net assets stood at $354.9 million, with a sector breakdown showing a significant allocation to Information Technology and Health Care. Positive None. Negative None. Financial Analyst An examination of the Liberty All-Star Growth Fund's monthly update reveals a noteworthy increase in NAV from $5.65 to $5.95, paired with a market price rise from $5.23 to $5.41. This indicates a performance uptick for the month, with a 5.31% return on NAV and a 3.44% return on market price. However, the widening of the discount from -7.4% to -9.1% suggests a growing discrepancy between market valuation and the underlying assets, which could potentially signal investor concerns or a market undervaluation of the fund.From a sector allocation perspective, the fund's significant exposure to Information Technology and Health Care sectors, comprising 23.0% and 22.1% of the equity portfolio respectively, aligns with trends in all-cap growth strategies that favor sectors with high growth potential. The addition of new holdings such as CECO Environmental Corp. and Waste Management, Inc. indicates strategic portfolio adjustments, likely aimed at capitalizing on specific industry trends or diversifying risks. Market Research Analyst In the context of the current market environment, the fund's strategy of combining managers with different capitalization focuses could be advantageous. This approach allows for diversification across market segments, potentially reducing volatility and improving risk-adjusted returns. The fund's high percentage invested, 98.7%, suggests an aggressive strategy that seeks to fully capitalize on market opportunities, which could appeal to investors with a higher risk tolerance.The sector breakdown, with a heavy emphasis on Information Technology and Health Care, is indicative of a growth-oriented investment philosophy. These sectors are generally known for their dynamic nature and potential for innovation-driven growth, which is consistent with the fund's all-cap growth style. Investors and analysts alike might scrutinize the fund's performance against broader market indices to gauge its competitive edge in achieving superior growth. Economist The fund's performance should be contextualized within the broader economic landscape. Factors such as interest rate changes, inflationary pressures and economic cycles can significantly impact growth-focused investment strategies. For instance, sectors like Information Technology and Health Care may react differently to macroeconomic shifts, which could affect the fund's performance. The fund's ability to navigate these economic variables while maintaining a growth trajectory is crucial for long-term success.Additionally, the fund's discount widening may reflect broader market sentiment or specific concerns about the fund's asset valuation. It is important to consider that closed-end funds like this one can trade at significant premiums or discounts to NAV, which can be influenced by investor sentiment, distribution rates and fund management performance. 03/13/2024 - 01:06 PM BOSTON, March 13, 2024 /PRNewswire/ -- Below is the February 2024 Monthly Update for the Liberty All-Star Growth Fund, Inc. (NYSE: ASG) Liberty All-Star Growth Fund, Inc.Ticker: ASGMonthly Update, February, 2024 Investment Approach:Fund Style: All-Cap GrowthFund Strategy: Combines three growth style investment managers, each with a distinct capitalization focus (small-, mid- and large-cap) selected and continuously monitored by the Fund's Investment Advisor. Investment Managers: Weatherbie Capital, LLCSmall-Cap GrowthCongress Asset Management Company, LLPMid-Cap GrowthSustainable Growth Advisers, LPLarge-Cap Growth Top 20 Holdings at Month-End (32.4% of equity portfolio) 1 SPS Commerce, Inc. 2.5 % 2 Amazon.com, Inc. 2.2 % 3 Microsoft Corp. 2.2 % 4 Vertex, Inc. 1.9 % 5 FirstService Corp. 1.8 % 6 Casella Waste Systems, Inc. 1.8 % 7 Visa, Inc. 1.8 % 8 Natera, Inc. 1.6 % 9 UnitedHealth Group, Inc. 1.5 % 10 SiteOne Landscape Supply, Inc. 1.5 % 11 Danaher Corp. 1.5 % 12 StepStone Group, Inc. 1.5 % 13 Progyny, Inc. 1.4 % 14 EMCOR Group, Inc. 1.4 % 15 Ollie's Bargain Outlet Holdings, Inc. 1.4 % 16 Saia, Inc. 1.3 % 17 Glaukos Corp. 1.3 % 18 S&P Global, Inc. 1.3 % 19 Deckers Outdoor Corp. 1.3 % 20 Canadian Pacific Kansas City, Ltd. 1.2 % Holdings are subject to change. Monthly Performance Performance NAV Market Price Discount Beginning of month value $5.65 $5.23 -7.4 % End of month value $5.95 $5.41 -9.1 % Performance for month 5.31 % 3.44 % Performance year-to-date 5.59 % 4.56 % Net Assets at Month-End ($millions) Total $354.9 Equities $350.1 Percent Invested 98.7 % Sector Breakdown (% of equity portfolio)* Information Technology 23.0 % Health Care 22.1 % Industrials 17.9 % Financials 13.0 % Consumer Discretionary 11.8 % Materials 3.6 % Communication Services 2.9 % Real Estate 2.9 % Consumer Staples 1.5 % Energy 1.3 % Total Market Value 100.0 % *Based on Standard & Poor's and MSCI Global Industry Classification Standard (GICS). New HoldingsCECO Environmental Corp.DoubleVerify Holdings, Inc.Waste Management, Inc. Holdings LiquidatedSun Communities, Inc. The net asset value (NAV) of a closed-end fund is the market value of the underlying investments (i.e., stocks and bonds) in the Fund's portfolio, minus liabilities, divided by the total number of Fund shares outstanding. However, the Fund also has a market price; the value at which it trades on an exchange. If the market price is above the NAV the Fund is trading at a premium. If the market price is below the NAV the Fund is trading at a discount. Performance returns for the Fund are total returns, which includes dividends, and are net of management fees and other Fund expenses. Returns are calculated assuming that a shareholder reinvested all distributions. Past performance cannot predict future investment results. Performance will fluctuate with changes in market conditions. Current performance may be lower or higher than the performance data shown. Performance information shown does not reflect the deduction of taxes that shareholders would pay on Fund distributions or the sale of Fund shares. Shareholders must be willing to tolerate significant fluctuations in the value of their investment. An investment in the Fund involves risk, including loss of principal. Sources of distributions to shareholders may include ordinary dividends, long-term capital gains and return of capital. The final determination of the source of all distributions in 2024 for tax reporting purposes will be made after year end. The actual amounts and sources of the amounts for tax reporting purposes will depend upon the Fund's investment experience during its fiscal year and may be subject to changes based on tax regulations. Based on current estimates a portion of the distributions consist of a return of capital. These estimates may not match the final tax characterization (for the full year's distributions) contained in shareholder 1099-DIV forms after the end of the year. All data is as of February 29, 2024 unless otherwise noted. Liberty All-Star Growth Fund, Inc.1-800-241-1850www.all-starfunds.comlibinfo@alpsinc.com View original content to download multimedia:https://www.prnewswire.com/news-releases/liberty-all-star-growth-fund-inc-february-2024-monthly-update-302088364.html SOURCE Liberty All-Star Growth Fund, Inc. What is the ticker symbol for Liberty All-Star Growth Fund, Inc.? The ticker symbol for Liberty All-Star Growth Fund, Inc. is ASG. What was the beginning of month value for the fund's NAV in February 2024? The beginning of month value for the fund's NAV in February 2024 was $5.65. What was the total net assets of the fund at the end of February 2024? The total net assets of the fund at the end of February 2024 were $354.9 million. Which sectors had the highest allocation in the fund's equity portfolio? The sectors with the highest allocation in the fund's equity portfolio were Information Technology and Health Care. What was the performance year-to-date for the fund in February 2024? The performance year-to-date for the fund in February 2024 was 5.59%."
"Fueled by Growth, Global Fintech Adyen Doubles Down on North American Presence With New 150,000-Square-Foot Office in Downtown San Francisco",2024-03-13T17:02:00.000Z,Low,Very Positive,"Adyen, a global financial technology platform, has signed a new sublease for a 150,000-square-foot office building in San Francisco, extending through December 2032. The new office will house over 300 employees, fostering collaboration and innovation. Adyen's North America revenues grew by 27% year on year, with a strong presence in key cities like Chicago, New York, and Toronto.","Fueled by Growth, Global Fintech Adyen Doubles Down on North American Presence With New 150,000-Square-Foot Office in Downtown San Francisco Rhea-AI Impact (Low) Rhea-AI Sentiment (Very Positive) Tags Rhea-AI Summary Adyen, a global financial technology platform, has signed a new sublease for a 150,000-square-foot office building in San Francisco, extending through December 2032. The new office will house over 300 employees, fostering collaboration and innovation. Adyen's North America revenues grew by 27% year on year, with a strong presence in key cities like Chicago, New York, and Toronto. Positive None. Negative None. 03/13/2024 - 01:02 PM SAN FRANCISCO, March 13, 2024 /PRNewswire/ -- Adyen, the global financial technology platform of choice for leading businesses, has signed a new sublease to a 150,000-square-foot office building at 505 Brannan Street. The lease will extend through December 2032, subject to all appropriate regulatory approvals, and Adyen's offices will span all six floors of the building. This new office will provide a vibrant commercial and tech hub for the company's San Francisco team of more than 300 employees. The space is thoughtfully designed to foster collaboration, innovation, and a positive work environment. It is also strategically located in close proximity to many of Adyen's North American clients that are also based in San Francisco. ""We're proud to expand our footprint in San Francisco as a dedicated member of the local business community,"" said Davi Strazza, president of North America, Adyen. ""We've been investing in North America for over a decade, and this lease represents our future ambitions and growth in the market. We're honored to work with so many leading U.S. companies, including McDonald's, Microsoft, Uber and Etsy, and look forward to bringing our best-in-class fintech platform to even more organizations."" San Francisco serves as Adyen's North American headquarters, and the company has significant presences in Chicago, New York and Toronto. As reported in Adyen's latest half-year results, North America was the company's fastest growing region, with net revenues up 27% year on year. Adyen opened its first San Francisco office in 2012 with a diverse, international team and has continued to steadily increase its presence ever since. Recently, Adyen was named as one of Built In's Best Places to Work in San Francisco. About Adyen Adyen (AMS: ADYEN) is the financial technology platform of choice for leading companies. By providing end-to-end payments capabilities, data-driven insights, and financial products in a single global solution, Adyen helps businesses achieve their ambitions faster. With offices around the world, Adyen works with the likes of Meta, Uber, H&M, eBay, and Microsoft. For more information, visit Adyen.com. View original content to download multimedia:https://www.prnewswire.com/news-releases/fueled-by-growth-global-fintech-adyen-doubles-down-on-north-american-presence-with-new-150-000-square-foot-office-in-downtown-san-francisco-302088362.html SOURCE Adyen What is the new office space leased by Adyen in San Francisco? Adyen has signed a new sublease for a 150,000-square-foot office building at 505 Brannan Street. How long will the lease for the new office space in San Francisco extend? The lease will extend through December 2032. Which region experienced the fastest revenue growth for Adyen according to their latest results? North America was the company's fastest growing region, with net revenues up 27% year on year. What are some of the key cities where Adyen has significant presence in North America? Adyen has significant presences in Chicago, New York, and Toronto. Which companies does Adyen work with in the U.S.? Adyen works with leading U.S. companies like McDonald's, Microsoft, Uber, and Etsy."
The Maximus Foundation Supports Connecting Individuals With Nonprofits in Need of Volunteers,2024-03-13T14:00:00.000Z,Low,Positive,"Volunteer Hampton Roads, a nonprofit organization in Virginia, fosters volunteerism, community engagement, and support for local nonprofits. They connect volunteers with opportunities, support nonprofits in optimizing their programs, and organize community events like Family Volunteer Day. In 2023, they recruited over 13,000 volunteers, assisted 150 nonprofit organizations, and helped 50 companies develop community engagement plans.","The Maximus Foundation Supports Connecting Individuals With Nonprofits in Need of Volunteers Rhea-AI Impact (Low) Rhea-AI Sentiment (Positive) Tags Rhea-AI Summary Volunteer Hampton Roads, a nonprofit organization in Virginia, fosters volunteerism, community engagement, and support for local nonprofits. They connect volunteers with opportunities, support nonprofits in optimizing their programs, and organize community events like Family Volunteer Day. In 2023, they recruited over 13,000 volunteers, assisted 150 nonprofit organizations, and helped 50 companies develop community engagement plans. Positive None. Negative None. 03/13/2024 - 10:00 AM NORTHAMPTON, MA / ACCESSWIRE / March 13, 2024 / MaximusVolunteer Hampton Roads is a nonprofit organization dedicated to fostering a culture of volunteerism and community engagement in the Hampton Roads region of Virginia. The organization serves as a bridge between volunteers and local nonprofit organizations, identifying and coordinating volunteer initiatives that address pressing community needs. Through their platform, volunteers can easily find opportunities that align with their skills, interests, and availability, making it accessible for people from all walks of life to contribute to their community.Besides facilitating these partnerships and collaborations, Volunteer Hampton Roads provides valuable resources and support to nonprofit organizations to help them achieve their missions. This includes helping to optimize their volunteer programs and effectively build their capacity by providing training, facilitating volunteerism, and coordinating large-scale projects.Family Volunteer Day is one of their significant community events, held yearly just before Thanksgiving. It brings together community members for a day of service supporting community nonprofits. An excellent opportunity to coordinate a large-scale volunteer effort to support the community, it also presents community members with the satisfaction of giving back while forming a connection with nonprofits they can help on an ongoing basis.In 2023, Volunteer Hampton Roads recruited over 13,000 volunteers to give back to local nonprofits and reached 150 nonprofit organizations to provide crucial support to enhance their operations.Additionally, Volunteer Hampton Roads played a key role in assisting more than 50 area companies in developing a community engagement plan, identifying organizations for partnerships, and working with their employees to match them with volunteer opportunities. These volunteer opportunities include nonprofit boards and training to fill that role effectively.Grant funding from the Maximus Foundation allowed Volunteer Hampton Roads to allocate additional resources to recruit volunteers to serve local nonprofit organizations further. It also allowed them to waive membership fees for smaller nonprofit organizations needing assistance, specifically minority-led organizations and groups with small operational budgets. This resulted in several nonprofits growing their outreach to the number of people they served and how many times they could offer their services.With a mission to connect individuals and groups with meaningful opportunities to make a positive impact, Volunteer Hampton Roads plays a pivotal role in building a stronger and more compassionate community in Hampton Roads, Virginia. Learn more about Volunteer Hampton Roads.Giving back to the communities we serveThe Maximus Foundation is one of the ways Maximus employees are doing something greater together. Established by the Maximus Board of Directors in 2000, the Maximus Foundation is an independent, employee-led, 501(c)(3) nonprofit organization. Employee donors pool their charitable contributions together through the Foundation, double their impact on the grantmaking program through Maximus' dollar-for-dollar matching pledge, and make their voices heard by nominating and voting for future grantee partners. Though the Foundation focuses its giving strategy on grantmaking, it also helps coordinate corporate-wide humanitarian efforts and empowers employees to donate their time and skills to nonprofits. Their inspired giving and volunteerism help accelerate the missions of nonprofits on the front lines of the communities we serve. Learn more at maximus.com/foundation.Group of Volunteer Hampton Roads volunteers making a difference View additional multimedia and more ESG storytelling from Maximus on 3blmedia.com.Contact Info:Spokesperson: MaximusWebsite: https://www.3blmedia.com/profiles/maximusEmail: info@3blmedia.comSOURCE: MaximusView the original press release on accesswire.com What is the mission of Volunteer Hampton Roads? Volunteer Hampton Roads aims to foster volunteerism, community engagement, and support for local nonprofits in the Hampton Roads region of Virginia. How many volunteers did Volunteer Hampton Roads recruit in 2023? In 2023, Volunteer Hampton Roads recruited over 13,000 volunteers to give back to local nonprofits. What is Family Volunteer Day? Family Volunteer Day is a significant community event organized by Volunteer Hampton Roads yearly just before Thanksgiving, bringing together community members for a day of service supporting community nonprofits. How did Volunteer Hampton Roads assist area companies? Volunteer Hampton Roads played a key role in assisting more than 50 area companies in developing a community engagement plan, identifying organizations for partnerships, and matching their employees with volunteer opportunities. What role did the Maximus Foundation play in supporting Volunteer Hampton Roads? Grant funding from the Maximus Foundation allowed Volunteer Hampton Roads to allocate additional resources to recruit volunteers, waive membership fees for smaller nonprofit organizations, and support minority-led organizations and groups with small operational budgets."
Keurig Reimagines Single Serve Coffee with the Unveil of its Next-Generation Coffee and Brewer Innovation,2024-03-13T17:00:00.000Z,Moderate,Very Positive,"Keurig Dr Pepper (KDP) unveils a groundbreaking innovation agenda featuring plastic- and aluminum-free coffee pods and a visionary new brewer, the Keurig Alta. The K-Rounds plastic-free pods, made from expertly roasted coffee beans with a protective plant-based coating, eliminate the need for plastic or aluminum, offering consumers a wide range of barista-style beverages. The Keurig Alta brewer allows for brewing at high or low pressure, catering to a variety of coffee preferences. Consumers can expect compostable pods and the option to brew existing K-Cup pods. The development is the result of a multi-year innovation project, including a partnership with Delica Switzerland for proprietary technology.","Keurig Reimagines Single Serve Coffee with the Unveil of its Next-Generation Coffee and Brewer Innovation Rhea-AI Impact (Moderate) Rhea-AI Sentiment (Very Positive) Tags Rhea-AI Summary Keurig Dr Pepper (KDP) unveils a groundbreaking innovation agenda featuring plastic- and aluminum-free coffee pods and a visionary new brewer, the Keurig Alta. The K-Rounds plastic-free pods, made from expertly roasted coffee beans with a protective plant-based coating, eliminate the need for plastic or aluminum, offering consumers a wide range of barista-style beverages. The Keurig Alta brewer allows for brewing at high or low pressure, catering to a variety of coffee preferences. Consumers can expect compostable pods and the option to brew existing K-Cup pods. The development is the result of a multi-year innovation project, including a partnership with Delica Switzerland for proprietary technology. Positive None. Negative None. Market Research Analyst The unveiling of Keurig Dr Pepper's K-Rounds plastic-free pods and the Keurig Alta brewer represents a significant strategic move within the home coffee brewing market. This innovation addresses the growing consumer demand for sustainable and convenient coffee solutions. The shift towards eco-friendly products is not just a trend but a long-term market transformation as consumers become more environmentally conscious. The introduction of these products could potentially disrupt the market by setting a new standard for sustainability in single-serve coffee systems.Furthermore, the ability to use the new K-Rounds pods with the Keurig Alta brewer, which also accommodates traditional K-Cup pods, suggests a keen understanding of market segmentation. This dual compatibility caters to both eco-conscious consumers and those resistant to change, mitigating the risk of alienating existing customers. The differentiation of pod sizes for various beverages and the brewer's automatic code reading for optimal brewing pressure could enhance the user experience and create a competitive edge. Sustainability Expert Keurig Dr Pepper's commitment to sustainability is evident in the development of the K-Rounds plastic-free pods. The move away from plastic and aluminum, materials traditionally associated with environmental concerns due to their contribution to waste and recycling challenges, is a significant step towards reducing the company's environmental footprint. The expected compostability of the K-Rounds pods could resonate well with the increasing number of consumers seeking environmentally responsible products, potentially boosting brand loyalty and market share.However, the success of this initiative hinges on the certification process for compostability and the actual performance of the pods in composting environments. The company's collaboration with Delica Switzerland and the acquisition of a perpetual license for their proprietary plant-based coating technology could provide a solid foundation for these sustainability claims, but the long-term impact will depend on consumer acceptance and practical use. Financial Analyst Keurig Dr Pepper's (NASDAQ: KDP) announcement could influence its financial performance and stock market valuation. The development and launch of innovative products like the K-Rounds and Keurig Alta brewer typically involve substantial R&D expenditures. However, if these products capture a significant share of the eco-conscious consumer segment, they could lead to increased revenue streams and potentially higher profit margins due to the premium nature of sustainable products.Investors should monitor the consumer feedback from the beta testing phases, as it will be critical in determining the potential market acceptance and success of the new system. Additionally, strategic engagement with retailers and coffee brand partners will be crucial for distribution and market penetration. The company's stock could see fluctuations based on the market's reception of these innovations and their perceived impact on KDP's future growth trajectory. 03/13/2024 - 01:00 PM Plastic- and aluminum-free coffee pods and visionary new brewer will lead the future of home coffee brewing BURLINGTON, Mass. and FRISCO, Texas, March 13, 2024 /PRNewswire/ -- Keurig Dr Pepper (NASDAQ: KDP) today introduced a multi-year innovation agenda for its Keurig single serve brewing system, including a completely reimagined coffee system and a portfolio of new products and technologies designed to meet the needs of today's and tomorrow's coffee consumer (see also: ""Introducing the Next Chapter of the Keurig K-Cup Pod System Product Portfolio""). Experience the full interactive Multichannel News Release here: https://www.multivu.com/players/English/9255651-keurig-unveils-k-rounds-plastic-and-aluminum-free-coffee-pods/ The foundation of the Company's future vision is K-Rounds plastic-free pods, a revolutionary new form of single serve coffee. K-Rounds pods are created from expertly roasted coffee beans that are ground, pressed and wrapped in a proprietary, protective plant-based coating preserving the coffee's flavor and aroma, eliminating the need for plastic or aluminum. K-Rounds plastic-free pods will work in the new Keurig Alta brewer as part of a reimagined Keurig system that allows consumers to make a variety of hot and cold barista-style beverages  from a bold espresso with velvety crema, to an aroma-rich cup of hot coffee or a refreshingly chilled cold coffee  without having to master complex brewing techniques. As the Company pursues its vision, consumers will have the opportunity to provide essential feedback in the ongoing development of the Keurig Alta system in various beta testing phases with the first starting as early as fall 2024. Keurig will leverage learnings from these trials, as well as strategic engagement with and insights from its retailer and coffee brand partners, to refine and optimize the system before making it available for broader sale to consumers. Chairman and CEO Bob Gamgort shared, ""Thirty years ago, Keurig changed the way consumers brewed coffee, with the introduction of the K-Cup pod single serve coffee system. Today, we are applying all our expertise to create a revolutionary new system that will redefine how consumers will brew coffee for decades to come. Our ambitious agenda reflects our commitment to providing variety, quality, value, and sustainability to the 45 million North American coffee consumers who currently use Keurig brewers and the millions of potential new households who will discover the benefits of a perfect cup of coffee prepared effortlessly in their home."" The unique plastic- and aluminum- free design of K-Rounds allows for brewing at both high pressure for espresso-based drinks and low pressure for drip coffee, cold or hot, so consumers can enjoy a variety of coffeehouse drinks without coffeehouse prices. K-Rounds plastic-free pods will come in different sizes for specific types of coffee beverages and will be marked with a code that the Keurig Alta brewer automatically reads to determine the pressure and extraction profile needed to get the full flavor, aroma and richness of each coffee variety. After brewing, K-Rounds plastic free pods can be disposed of like coffee grounds and are expected to be certified compostable, as the Company is currently working through the certification process. The new Keurig Alta brewer will also provide the option to brew existing K-Cup pods so that users can enjoy the 500+ varieties offered through the Keurig family of brands. The development of the Keurig Alta brewer and K-Rounds plastic-free pods is the result of a multi-year innovation project which incorporates significant intellectual property in beverage, pod, appliance and manufacturing design and processes. As part of this intellectual property portfolio, KDP has acquired a perpetual license to know-how and technology invented by Delica Switzerland for their CoffeeB system in Europe, including a proprietary plant-based coating and application processes. KDP's partnership with Delica grants Keurig exclusive rights to use and build upon these technologies for consumers across the U.S., Canada and Mexico. Keurig previewed more background about its reimagined single serve system in a launch video  ""Reimagining Keurig: From the Ground Up."" Consumers are invited to visit www.keurig.com/krounds to sign-up to receive exclusive updates about Keurig's future innovation, including the potential to be selected as a Beta tester of a Keurig Alta brewer prototype as early as this fall. About Keurig Dr PepperKeurig Dr Pepper (KDP) is a leading beverage company in North America, with annual revenue of more than $14 billion and approximately 28,000 employees. KDP holds leadership positions in liquid refreshment beverages, including soft drinks, specialty coffee and tea, water, juice and juice drinks and mixers, and markets the #1 single serve coffee brewing system in the U.S. and Canada. The Company's portfolio of more than 125 owned, licensed and partner brands is designed to satisfy virtually any consumer need, any time, and includes Keurig, Dr Pepper, Canada Dry, Clamato, CORE, Green Mountain Coffee Roasters, Mott's, Snapple, and The Original Donut Shop. Through its powerful sales and distribution network, KDP can deliver its portfolio of hot and cold beverages to nearly every point of purchase for consumers. The Company's Drink Well. Do Good. corporate responsibility platform is focused on the greatest opportunities for impact in the environment, its supply chain, the health and well-being of consumers and with its people and communities. For more information, visit www.keurigdrpepper.com. Forward-Looking StatementsCertain statements contained herein are ""forward-looking statements"" within the meaning of applicable securities laws and regulations. These forward-looking statements can generally be identified by the use of words such as ""outlook,"" ""guidance,"" ""anticipate,"" ""expect,"" ""believe,"" ""could,"" ""estimate,"" ""feel,"" ""forecast,"" ""intend,"" ""may,"" ""plan,"" ""potential,"" ""project,"" ""should,"" ""target,"" ""will,"" ""would,"" and similar words. Forward-looking statements by their nature address matters that are, to different degrees, uncertain. These statements are based on the current expectations of our management, are not predictions of actual performance, and actual results may differ materially. Forward-looking statements are subject to a number of risks and uncertainties, including the factors disclosed in our Annual Report on Form 10-K and subsequent filings with the SEC. We are under no obligation to update, modify or withdraw any forward-looking statements, except as required by applicable law. Investor Contacts:Jane GelfandT: 888-340-5287 / jane.gelfand@kdrp.com Chethan MallelaT: 888-340-5287 / chethan.mallela@kdrp.com Media Contact:Katie GilroyT: 781-418-3345 / katie.gilroy@kdrp.com View original content:https://www.prnewswire.com/news-releases/keurig-reimagines-single-serve-coffee-with-the-unveil-of-its-next-generation-coffee-and-brewer-innovation-302087411.html SOURCE Keurig Dr Pepper What is the innovative product introduced by Keurig Dr Pepper (KDP)? Keurig Dr Pepper (KDP) has introduced K-Rounds plastic-free pods and the Keurig Alta brewer. What are K-Rounds plastic-free pods made of? K-Rounds plastic-free pods are made from expertly roasted coffee beans with a protective plant-based coating. What are the key features of the Keurig Alta brewer? The Keurig Alta brewer allows for brewing at high or low pressure, catering to a variety of coffee preferences. Are the K-Rounds plastic-free pods compostable? The K-Rounds plastic-free pods are expected to be certified compostable. What is the result of Keurig Dr Pepper's partnership with Delica Switzerland? The partnership with Delica Switzerland grants Keurig exclusive rights to use and build upon proprietary technologies for consumers in the U.S., Canada, and Mexico."
Transaction in Own Shares,2024-03-13T18:02:00.000Z,Low,Neutral,"Shell plc announces the purchase and cancellation of a significant number of its own shares as part of its existing share buy-back program. The transactions were made on various trading venues at different prices, contributing to the company's ongoing capital management strategy.","Transaction in Own Shares Rhea-AI Impact (Low) Rhea-AI Sentiment (Neutral) Tags Rhea-AI Summary Shell plc announces the purchase and cancellation of a significant number of its own shares as part of its existing share buy-back program. The transactions were made on various trading venues at different prices, contributing to the company's ongoing capital management strategy. Positive None. Negative None. Financial Analyst The share buyback announcement by Shell plc represents a strategic financial decision, potentially signaling the company's confidence in its intrinsic value and a commitment to enhancing shareholder value. From a financial perspective, the reduction in the number of shares outstanding can lead to an increase in earnings per share (EPS), assuming net income remains constant. This can make the stock more attractive to investors, as it may indicate improved financial ratios and a stronger financial position.However, the cost of the buyback must be considered against other potential uses of capital, such as investment in growth opportunities or debt reduction. The decision to execute a buyback also suggests that the company views its stock as undervalued or that it is seeking to return capital to shareholders in a tax-efficient manner. Investors will be interested in how this buyback aligns with the company's long-term strategy and capital allocation priorities. Market Research Analyst The execution of Shell's share buyback program within the parameters of market regulations, such as EU MAR and UK MAR, indicates compliance with market abuse prevention standards. The involvement of Citigroup Global Markets Limited to independently make trading decisions on behalf of Shell suggests an effort to maintain market integrity and transparency. Market participants will monitor the impact of these buybacks on share liquidity and market volatility.Additionally, the geographical split in the buyback across different trading venues and currencies points to a strategic approach to capital management across Shell's investor base. This also reflects the company's global footprint and the need to balance market activities across different regulatory environments. Legal Expert Shell's adherence to the complex regulatory frameworks governing share buybacks, such as EU MAR, UK MAR and the EU MAR Delegated Regulation, is crucial for legal compliance. The detailed disclosure of the buyback transactions and the involvement of an independent trading entity align with the transparency requirements set forth by these regulations. Legal scrutiny in such cases ensures that the company's actions do not contravene market abuse laws and that shareholders are treated fairly.It is important for investors to understand that such regulatory compliance also serves to protect their interests by mitigating the risk of market manipulation. The legal intricacies of these transactions reflect the company's obligation to operate within a tightly controlled legal framework, which can have significant implications for corporate governance and shareholder rights. 03/13/2024 - 02:02 PM Transaction in Own Shares 13 March, 2024                 Shell plc (the Company) announces that on 13 March 2024 it purchased the following number of Shares for cancellation. Aggregated information on Shares purchased according to trading venue: Date of purchaseNumber of Shares purchasedHighest price paid Lowest price paid Volume weighted average price paid per shareVenueCurrency13/03/2024665,170 25.310024.905025.0872LSEGBP13/03/2024- 0.00000.00000.0000Chi-X (CXE)GBP13/03/2024- 0.00000.00000.0000BATS (BXE)GBP13/03/2024612,055 29.910029.460029.6736XAMSEUR13/03/2024- 0.00000.00000.0000CBOE DXEEUR13/03/2024- 0.00000.00000.0000TQEXEUR These share purchases form part of the on- and off-market limbs of the Company's existing share buy-back programme previously announced on 1 February 2024. In respect of this programme, Citigroup Global Markets Limited will make trading decisions in relation to the securities independently of the Company for a period from 1 February 2024 up to and including 26 April 2024. The on-market limb will be effected within certain pre-set parameters and in accordance with the Companys general authority to repurchase shares on-market. The off-market limb will be effected in accordance with the Companys general authority to repurchase shares off-market pursuant to the off-market buyback contract approved by its shareholders and the pre-set parameters set out therein. The programme will be conducted in accordance with Chapter 12 of the Listing Rules and Article 5 of the Market Abuse Regulation 596/2014/EU dealing with buy-back programmes (EU MAR) and EU MAR as onshored into UK law from the end of the Brexit transition period (at 11:00 pm on 31 December 2020) through the European Union (Withdrawal) Act 2018 (as amended by the European Union (Withdrawal Agreement) Act 2020), and as amended, supplemented, restated, novated, substituted or replaced by the Financial Services Act, 2021 and relevant statutory instruments (including, The Market Abuse (Amendment) (EU Exit) Regulations (SI 2019/310)), from time to time (UK MAR) and the Commission Delegated Regulation (EU) 2016/1052 (the EU MAR Delegated Regulation) and the EU MAR Delegated Regulation as onshored into UK law from the end of the Brexit transition period (at 11:00 pm on 31 December 2020) through the European Union (Withdrawal) Act 2018 (as amended by the European Union (Withdrawal Agreement) Act 2020), and as amended, supplemented, restated, novated, substituted or replaced by the Financial Services Act, 2021 and relevant statutory instruments (including, The Market Abuse (Amendment) (EU Exit) Regulations (SI 2019/310)), from time to time. In accordance with EU MAR and UK MAR, a breakdown of the individual trades made by Citigroup Global Markets Limited on behalf of the Company as a part of the buy-back programme is detailed below. Enquiries Media International: +44 (0) 207 934 5550 Media Americas: +1 832 337 4335 LEI number of Shell plc: 21380068P1DRHMJ8KU70 Classification: Acquisition or disposal of the issuers own shares Attachment Shell Share Buyback RNS - 13-Mar-24 complete How many shares did Shell plc purchase for cancellation on 13th March 2024? Shell plc purchased 1,277,225 shares for cancellation on 13th March 2024. What was the highest price paid per share by Shell plc on 13th March 2024? The highest price paid per share by Shell plc on 13th March 2024 was 25.3100 on the London Stock Exchange (LSE). Which trading venues did Shell plc make share purchases on 13th March 2024? Shell plc made share purchases on the London Stock Exchange (LSE), Chi-X (CXE), BATS (BXE), and XAMS. Who will make trading decisions for Shell plc's share buy-back program until 26th April 2024? Citigroup Global Markets Limited will make trading decisions for Shell plc's share buy-back program until 26th April 2024. Under which regulations is Shell plc's share buy-back program being conducted? Shell plc's share buy-back program is being conducted in accordance with Chapter 12 of the Listing Rules, EU MAR, and UK MAR."
KBRA Assigns Preliminary Ratings to EverBright Solar Trust 2024-A,2024-03-13T17:04:00.000Z,Low,Neutral,"KBRA assigns preliminary ratings to two classes of notes totaling $288.49 million issued by EverBright Solar Trust 2024-A, backed by residential solar contracts originated by EverBright, LLC, a subsidiary of NextEra Energy, Inc. The securitization is collateralized by prime quality solar receivables with balances ranging from $10,000 to $150,000, original terms of 10 to 25 years, and interest rates of 3.99% to 10.99%. KBRA applied various methodologies to analyze the asset-backed securities, EverBright's portfolio pool data, and proposed capital structure under stressed cash flow assumptions.","KBRA Assigns Preliminary Ratings to EverBright Solar Trust 2024-A Rhea-AI Impact (Low) Rhea-AI Sentiment (Neutral) Tags Rhea-AI Summary KBRA assigns preliminary ratings to two classes of notes totaling $288.49 million issued by EverBright Solar Trust 2024-A, backed by residential solar contracts originated by EverBright, LLC, a subsidiary of NextEra Energy, Inc. The securitization is collateralized by prime quality solar receivables with balances ranging from $10,000 to $150,000, original terms of 10 to 25 years, and interest rates of 3.99% to 10.99%. KBRA applied various methodologies to analyze the asset-backed securities, EverBright's portfolio pool data, and proposed capital structure under stressed cash flow assumptions. Positive None. Negative None. Financial Analyst The preliminary ratings assigned by KBRA to EverBright Solar Trust's asset-backed securitization are indicative of the confidence in the underlying assets, which in this case are residential solar retail installment contracts. The affiliation with NextEra Energy, a well-established energy company, provides a backdrop of stability and industry experience. It's important to note that the solar industry is seen as a growth sector and this securitization allows EverBright to leverage its customer receivables into capital for further expansion.Investors should be aware of the interest rates on these receivables, which range from 3.99% to 10.99%. These rates are competitive within the consumer finance sector and suggest a balanced approach to risk, catering to 'prime quality' customers. The long-term nature of the contracts (10 - 25 years) also suggests a stable cash flow for investors, although this is counterbalanced by the inherent risk of default over such periods.From a financial perspective, the capital raised through this securitization could impact EverBright's and NextEra's ability to invest in new technologies and expand market share in the competitive renewable energy sector, potentially affecting their stock performance positively if managed effectively. However, the complexity of the securitization and the reliance on consumer creditworthiness are factors that require careful scrutiny. Market Research Analyst The residential solar market is growing, driven by consumer interest in renewable energy and supportive government policies. EverBright's securitization of solar receivables is a strategic move to capitalize on this trend. By pooling the receivables and offering them as an investment vehicle, EverBright is not only diversifying its funding sources but also tapping into the appetite for green investments among institutional investors.The involvement of KBRA and the application of its rating methodologies, including an ESG Global Rating Methodology, underscore the increasing importance of environmental, social and governance factors in investment decisions. This could attract a broader range of investors, potentially increasing liquidity and lowering capital costs for EverBright.For stakeholders, the key consideration will be the performance of the solar assets and the creditworthiness of the customers. The prime quality of the customers is reassuring, but the solar industry's sensitivity to policy changes and technological advancements can introduce volatility to the underlying asset performance. Environmental, Social and Governance (ESG) Analyst The explicit inclusion of an ESG Global Rating Methodology by KBRA in their assessment process for EverBright Solar Trust's securitization reflects a broader shift in the investment community towards sustainable and responsible investments. The focus on residential solar power generation aligns with global efforts to transition to cleaner energy sources, which is a positive sign for investors concerned with long-term sustainability issues.Investors looking at the long-term impact of their portfolios on the environment will view EverBright's initiative as an opportunity to contribute to the reduction of carbon emissions. The securitization's success could set a precedent for similar financial instruments in the renewable energy sector, potentially influencing the flow of capital towards more sustainable projects.However, the ESG impact is not without risks. Regulatory changes, technological disruptions and shifts in consumer behavior towards solar energy adoption are factors that can affect the performance of these securities. The alignment of EverBright's business model with ESG principles will be critical in managing these risks and ensuring long-term value creation for stakeholders. 03/13/2024 - 01:04 PM NEW YORK--(BUSINESS WIRE)-- KBRA assigns preliminary ratings to two classes of notes totaling $288.49 million issued by EverBright Solar Trust 2024-A (EVBRT 2024-A), an asset-backed securitization collateralized by a pool of residential solar retail installment contracts originated by EverBright, LLC (""EverBright"" or the ""Company""). Headquartered in Juno Beach, FL, EverBright was founded and organized as a limited liability company in Delaware in 2021 and fully launched its receivables origination program in early 2022. The Company is a subsidiary of NextEra Energy, Inc, which has been an energy producer since 1925 and is publicly listed on the New York Stock Exchange (NYSE: NEE) with a market cap of over $115 billion and total assets of $177 billion as of December 31, 2023. EVBRT 2024-A is collateralized by a pool of solar receivables that are made to mostly prime quality customers to finance residential solar power generation and/or storage systems, including solar panels and any additional products, equipment or services related to installation. Currently, EverBright offers solar receivables with balances of $10,000 - $150,000, original terms of 10 - 25 years and interest rates of 3.99% - 10.99%. KBRA applied its General Global Rating Methodology for Asset-Backed Securities as well as its Consumer Loan ABS Global Rating Methodology, Global Structured Finance Counterparty Methodology and ESG Global Rating Methodology. In applying the methodologies, KBRA analyzed EverBrights portfolio pool data, underlying collateral pool and proposed capital structure under stressed cash flow assumptions. KBRA considered its operational review of EverBright, as well as periodic update calls with the Company. Operative agreements and legal opinions will be reviewed prior to closing. To access rating and relevant documents, click here. Click here to view the report. Methodologies ABS: General Global Rating Methodology for Asset Backed Securities ABS: Consumer Loan ABS Global Rating Methodology Structured Finance: Global Structured Finance Counterparty Methodology ESG Global Rating Methodology Disclosures Further information on key credit considerations, sensitivity analyses that consider what factors can affect these credit ratings and how they could lead to an upgrade or a downgrade, and ESG factors (where they are a key driver behind the change to the credit rating or rating outlook) can be found in the full rating report referenced above. A description of all substantially material sources that were used to prepare the credit rating and information on the methodology(ies) (inclusive of any material models and sensitivity analyses of the relevant key rating assumptions, as applicable) used in determining the credit rating is available in the Information Disclosure Form(s) located here. Information on the meaning of each rating category can be located here. Further disclosures relating to this rating action are available in the Information Disclosure Form(s) referenced above. Additional information regarding KBRA policies, methodologies, rating scales and disclosures are available at www.kbra.com. About KBRA Kroll Bond Rating Agency, LLC (KBRA) is a full-service credit rating agency registered with the U.S. Securities and Exchange Commission as an NRSRO. Kroll Bond Rating Agency Europe Limited is registered as a CRA with the European Securities and Markets Authority. Kroll Bond Rating Agency UK Limited is registered as a CRA with the UK Financial Conduct Authority. In addition, KBRA is designated as a designated rating organization by the Ontario Securities Commission for issuers of asset-backed securities to file a short form prospectus or shelf prospectus. KBRA is also recognized by the National Association of Insurance Commissioners as a Credit Rating Provider. Doc ID: 1003120 View source version on businesswire.com: https://www.businesswire.com/news/home/20240313079374/en/ Analytical Contacts Melvin Zhou, Managing Director (Lead Analyst) +1 646-731-2412 melvin.zhou@kbra.com Michael Polvere, Associate Director +1 646-731-3339 michael.polvere@kbra.com Vicky Xiao, Analyst +1 646-731-1422 vicky.xiao@kbra.com Eric Neglia, Head of Commercial and Consumer ABS (Rating Committee Chair) +1 646-731-2456 eric.neglia@kbra.com Business Development Contact Arielle Smelkinson, Senior Director +1 646-731-2369 arielle.smelkinson@kbra.com Source: Kroll Bond Rating Agency, LLC What is the ticker symbol for NextEra Energy, Inc.? The ticker symbol for NextEra Energy, Inc. is NEE. What is the total market cap of NextEra Energy, Inc. as of December 31, 2023? NextEra Energy, Inc. has a market cap of over $115 billion as of December 31, 2023. What are the interest rates offered by EverBright for solar receivables? EverBright offers interest rates of 3.99% to 10.99% for solar receivables. What types of solar products are financed by EverBright's receivables? EverBright's receivables finance residential solar power generation and/or storage systems, including solar panels and related products, equipment, or services. What methodologies did KBRA apply to analyze EverBright's asset-backed securities? KBRA applied its General Global Rating Methodology for Asset-Backed Securities, Consumer Loan ABS Global Rating Methodology, Global Structured Finance Counterparty Methodology, and ESG Global Rating Methodology."
Energy Finders Selected to Present at Inaugural 3rd Coast Venture Summit in New Orleans,2024-03-13T16:46:00.000Z,Low,Positive,"Energy Finders, Inc. (EGYF) selected to present at the inaugural 3rd Coast Venture Summit in New Orleans, showcasing innovative renewable technologies. The summit aims to accelerate Gulf Coast startups, providing networking opportunities for founders and investors.","Energy Finders Selected to Present at Inaugural 3rd Coast Venture Summit in New Orleans Rhea-AI Impact (Low) Rhea-AI Sentiment (Positive) Tags conferences Rhea-AI Summary Energy Finders, Inc. (EGYF) selected to present at the inaugural 3rd Coast Venture Summit in New Orleans, showcasing innovative renewable technologies. The summit aims to accelerate Gulf Coast startups, providing networking opportunities for founders and investors. Positive None. Negative None. 03/13/2024 - 12:46 PM GERMANTOWN, Md., March 13, 2024 /PRNewswire/ -- Energy Finders, Inc. (OTC PINK: EGYF) - (""Energy Finders, Inc"" or the ""Company"")  Energy Finders Inc a US based company developing groundbreaking renewable technologies, (Stock Symbol: EGYF) selected to present at the inaugural 3rd Coast Venture Summit in New Orleans. Energy Finders is pleased to announce its selection to present at the inaugural 3rd Coast Venture Summit in New Orleans, taking place from March 13-15, 2024. Chosen from a competitive selection pool, Energy Finders will be at the forefront of this premier event that unites Gulf South startup founders, nationwide investors, business leaders, and corporate partners. Event Overview: The 3rd Coast Venture Summit is set against the backdrop of the vibrant Gulf South startup ecosystem, encompassing Texas, Louisiana, Mississippi, Alabama, and Florida. This burgeoning hub converges top talent and world-class resources, fostering innovative solutions and propelling forward-thinking ventures. Energy Finders, joining other trailblazing innovators, will be positioned to connect with nationwide investors, business leaders, and corporate partners, creating a dynamic collision of ventures. This three-day summit aims to accelerate the growth of Gulf Coast startups, providing increased deal flow and showcasing some of the best regional technology within the venture ecosystem. Networking Opportunities: Founders will engage in valuable networking, set up one-on-one meetings with investors, and seize the chance to pitch on the 3CVS stage. Participating companies are innovators serving new markets, incorporating technology for problem-solving, and offering revolutionary business models. The summit focuses on innovative Seed to Series A companies with proven traction and connectivity to the Gulf South region. Investor Engagement: For investors seeking Investable opportunities along the 3rd Coast, the summit offers an unparalleled chance to meet and engage with Seed to Series A startups and Entrepreneurs addressing global issues. Investor tickets provide access to networking opportunities, one-on-one meetings with founders, and the chance to witness the best of the 3rd Coast pitching on the 3CVS stage. Sponsorship and Core Committee: The summit is made possible through the support of key committee members and sponsors, including JP Morgan Chase & Co, Halliburton Labs, Entergy, Benson Capital, Tulane Innovation Institute, Ochsner Health and The Idea Village. Energy Finders is excited to be part of this groundbreaking event, contributing to the vibrant entrepreneurial landscape of the Gulf South and forging valuable connections within the startup ecosystem. Mohammed ZulfiquarCEO & FounderEnergy Finders, Inc. About Energy Finders: Energy Finders (EGYF), is a leading off-grid renewable energy innovation company. To Find Out More: Please bookmark our BETA website and subscribe to our email alert platform at www.energyfinders.us for future real time updates from @Energy Finders via our new automated email alert system. View original content:https://www.prnewswire.com/news-releases/energy-finders-selected-to-present-at-inaugural-3rd-coast-venture-summit-in-new-orleans-302088347.html SOURCE Energy Finders, Inc What event did Energy Finders, Inc. (EGYF) get selected to present at? Energy Finders, Inc. was selected to present at the inaugural 3rd Coast Venture Summit in New Orleans. When is the 3rd Coast Venture Summit taking place? The summit is scheduled to take place from March 13-15, 2024. Which regions does the Gulf South startup ecosystem encompass? The Gulf South startup ecosystem includes Texas, Louisiana, Mississippi, Alabama, and Florida. What opportunities does the summit offer for founders? Founders can engage in valuable networking, set up one-on-one meetings with investors, and pitch on the 3CVS stage. Who are some of the key sponsors of the 3rd Coast Venture Summit? Key sponsors include JP Morgan Chase & Co, Halliburton Labs, Entergy, Benson Capital, Tulane Innovation Institute, Ochsner Health, and The Idea Village."
"CUEN  Cuentas, Inc. Unveils Fintech Offering Advancements, Spotlighting Rapid Expansion in Core Services and Products Tailored to Captivate the Thriving Hispanic Diaspora Market",2024-03-13T16:37:00.000Z,Neutral,Positive,"Cuentas, Inc. releases a shareholder letter detailing improvements in core fintech services, upcoming product launches, and market expansion. The company highlights the successful performance in the last quarter, the launch of new prepaid cards, mobile app enhancements, and the revolutionary eSIM offering. They also discuss the upcoming financial filing, potential divestment opportunities in Tampa, and the positive impact on shareholder value.","CUEN  Cuentas, Inc. Unveils Fintech Offering Advancements, Spotlighting Rapid Expansion in Core Services and Products Tailored to Captivate the Thriving Hispanic Diaspora Market Rhea-AI Impact (Neutral) Rhea-AI Sentiment (Positive) Tags Rhea-AI Summary Cuentas, Inc. releases a shareholder letter detailing improvements in core fintech services, upcoming product launches, and market expansion. The company highlights the successful performance in the last quarter, the launch of new prepaid cards, mobile app enhancements, and the revolutionary eSIM offering. They also discuss the upcoming financial filing, potential divestment opportunities in Tampa, and the positive impact on shareholder value. Positive None. Negative None. Financial Analyst The strategic transition of Cuentas Inc. to a new services platform within its Fintech division, Cuentas Money, signifies a pivotal change aimed at increasing the company's operational agility and feature customization. The introduction of the Cuentas Visa Single Load Prepaid card is a strategic move to capture a larger share of the financial services market within the Hispanic community. This demographic is often underserved by traditional banking institutions and the company's targeted approach could lead to an uptick in customer acquisition, given the minimal barriers to onboarding. Additionally, the financial implications of the upcoming 10K filing are crucial for evaluating the company's fiscal health and operational efficiency. The filing is expected to provide investors with insights into the company's profitability and growth trajectory, which could influence investor sentiment and stock performance. Market Research Analyst The expansion of Cuentas Mobile through robust distribution agreements and the launch of the eSIM offering are indicative of the company's commitment to innovation and market penetration. The eSIM technology is a disruptive force in the telecommunications industry that offers a seamless user experience and compatibility across devices. Cuentas Inc.'s focus on the Hispanic demographic in the United States positions it favorably within a niche market. The company's ability to understand and cater to the specific needs of this group could lead to a competitive advantage, fostering brand loyalty and potentially leading to increased market share. The integration of additional features and benefits to the eSIM service will likely enhance the user experience, potentially driving further adoption. Real Estate Investment Analyst The development in Tampa represents a strategic real estate investment venture for Cuentas Inc. Considering the divestiture of this asset in a fast-growing market could result in a significant return on investment. The real estate market's dynamics, particularly in burgeoning areas like Tampa, are critical in assessing the potential financial gain from such a transaction. The company's refinancing and extension of its line of credit suggest a strengthened financial position, which provides more flexibility in exploring divestiture opportunities. The sale of the property would not only result in a cash infusion but also allow for the reallocation of capital towards marketing and expanding the company's core fintech and mobile offerings, potentially enhancing its overall market presence. 03/13/2024 - 12:37 PM Cuentas, Inc. Unleashes Shareholder Letter, Sharing Dynamic Improvements in Core Fintech Services and Exciting Feature Additions and the Current Status of its Upcoming Filing. MIAMI BEACH, FL, March 13, 2024 (GLOBE NEWSWIRE) -- Cuentas, Inc. (OTC: CUEN & CUENW) (CUEN or the Company), a pioneer driving the seamless integration of financial services, telecommunications, and real estate for the unbanked and underbanked Hispanic demographic, is delighted to announce the release of a shareholder letter from its Chief Executive Officer, Mr. Arik Maimon. This communication offers a comprehensive update on the company's core services commercial offer and market expansion, evaluation of strategic initiatives, and a forthcoming filing update. Dear Fellow Shareholders, It brings me great pleasure to share our latest shareholder newsletter, designed to provide you with a thorough overview of the strides and strategic initiatives being undertaken by Cuentas to bolster revenues, profitability, and overall shareholder value. Our steadfast dedication to achieving unparalleled growth and profitability, as outlined in our 2023 roadmap, remains resolute. The exceptional performance witnessed in the last quarter, surpassing our growth projections, serves as a testament to our unwavering commitment and focus. Our Fintech division, Cuentas Money, is currently in the midst of a transformative transition to a new services platform. This transition will provide us with enhanced agility and customizable features. We are launching our Cuentas Visa Single Load Prepaid card, a significant milestone in expanding essential financial services to millions within the Hispanic community. With streamlined onboarding processes and minimal compliance friction, we anticipate a notable increase in our customers. Simultaneously, we are in the final stages of launching our Cuentas Visa GPR (General Purpose Reloadable) card and enhancing the user experience and features of our mobile app. We are committed to keeping all our shareholders abreast of these imminent product releases and strategic technology agreements. Cuentas Mobile, bolstered by robust distribution agreements, continues its rapid expansion. Our pioneering eSIM offering is revolutionizing the mobile market landscape, facilitating deeper market penetration. The eSIM, a digital iteration of the traditional SIM card, simplifies connectivity by enabling remote programmability and compatibility with a wide array of devices. This transformative innovation will soon be scaled nationwide, complemented by the integration of additional features and benefits. Our service portfolio, carefully tailored for the United States Hispanic demographic, encompasses a comprehensive suite of cellular services and both virtual and traditional fintech solutions. We take immense pride in being the primary provider of such indispensable services to these communities, offering affordable and efficient solutions. Preparations are currently underway for our upcoming financial 10K filing, underscoring our diligent financial stewardship and foresight. Expected to be filed by the end of March, these results will reaffirm our unwavering commitment to profitability and growth in 2024 and beyond. The ongoing development in Tampa marks a pivotal moment for Cuentas. We are currently considering several options to divest for an attractive ROI. Recent refinancing and extensions of our line of credit have fortified our financial position, empowering us to explore these opportunities judiciously. As we evaluate various offers for this project, situated in one of the nation's fastest-growing real estate markets, we remain dedicated to maximizing returns for our shareholders. Our management team is diligently reviewing offers and will make a prompt decision to divest our real estate property if the terms of the offer are deemed adequate. The sale of this property will inject a substantial cash infusion into Cuentas, strengthening our marketing efforts and amplifying our Cuentas Fintech and Cuentas Mobile offerings through both online and offline distribution channels. I am committed to providing you with regular updates on our progress and accomplishments. Additionally, a comprehensive management report, in conjunction with our 10K filing, will provide detailed insights into our strategic trajectory and performance. Thank you for your ongoing trust and support as we navigate the path to sustained success and the enhancement of shareholder value. Warm regards, Arik MaimonChairman and CEOAbout Cuentas Cuentas, Inc. (OTC: CUEN & CUENW) is creating an alternative financial ecosystem for the growing global population who do not have access to traditional financial alternatives. The Companys proprietary technologies help to integrate FinTech (Financial Technology), e-finance and e-commerce services into solutions that deliver next generation digital financial services to the unbanked, under-banked and underserved populations nationally in the USA. The Cuentas Platform integrates Cuentas Mobile, the Companys Mobile Telecommunications solution, with its core financial services offerings to help entire communities enter the modern financial marketplace. Cuentas has launched its General Purpose Reloadable (GPR) Card, which includes a digital wallet, discounts for purchases at major physical and online retailers, rewards, and the ability to purchase digital content. LINK: https://cuentas.com AND https://cuentasmobile.com For additional media and information, please follow us on: Twitter Instagram YouTube LinkedIn Forward-Looking Statements This news release contains ""forward-looking statements,"" as that term is defined in section 27a of the United States Securities Act of 1933, as amended, and section 21e of the United States Securities Exchange Act of 1934, as amended. These forward-looking statements involve substantial uncertainties and risks and are based upon our current expectations, estimates and projections and reflect our beliefs and assumptions based upon information available to us at the date of this release. We caution readers that forward-looking statements are predictions based on our current expectations about future events. These forward-looking statements are not guarantees of future performance and are subject to risks, uncertainties and assumptions that are difficult to predict. Our actual results, performance or achievements could differ materially from those expressed or implied by the forward-looking statements as a result of a number of factors, including, but not limited to, OTC and shareholder approval of the proposed transaction, our ability to manage our research and development programs that are based on novel technologies, our ability to successfully integrate WHEN operations and product offerings, the sufficiency of working capital to realize our business plans and our ability to raise additional capital, market acceptance, the going concern qualification in our financial statements, our ability to retain key employees, our competitors developing better or cheaper alternatives to our products, risks relating to legal proceedings against us and the risks and uncertainties discussed under the heading ""RISK FACTORS"" in Item 1A of our Annual Report on Form 10-K for the fiscal year ended December 31, 2022, and in our other filings with the Securities and Exchange Commission. We undertake no obligation to revise or update any forward-looking statement for any reason. Contact Information: Arik Maimon CEO at Cuentas Inc Cuentas Inc. (OTC:CUEN) Phone: 800-611-3622 Mobile: 786-774-2835 Web: www.cuentas.com Email: arik@cuentas.com What does Cuentas, Inc. announce in their shareholder letter? Cuentas, Inc. announces dynamic improvements in core fintech services, upcoming product launches, market expansion, and strategic initiatives in their shareholder letter. What is the ticker symbol for Cuentas, Inc.? The ticker symbol for Cuentas, Inc. is 'CUEN'. What new prepaid card is Cuentas, Inc. launching? Cuentas, Inc. is launching the Cuentas Visa Single Load Prepaid card. What innovative offering is revolutionizing the mobile market landscape according to the shareholder letter? The eSIM offering by Cuentas, Inc. is revolutionizing the mobile market landscape. When is Cuentas, Inc. expected to file their financial 10K? Cuentas, Inc. is expected to file their financial 10K by the end of March. What opportunities is Cuentas, Inc. considering in Tampa? Cuentas, Inc. is considering divesting for an attractive ROI in Tampa. How will the sale of the real estate property impact Cuentas, Inc.? The sale of the real estate property will inject a substantial cash infusion into Cuentas, Inc., strengthening their marketing efforts and amplifying their fintech and mobile offerings."
Marsh McLennan Declares Quarterly Cash Dividend,2024-03-13T14:00:00.000Z,Low,Neutral,"Marsh McLennan (MMC) announces a quarterly dividend of $0.710 per share for stockholders, payable on May 15, 2024.","Marsh McLennan Declares Quarterly Cash Dividend Rhea-AI Impact (Low) Rhea-AI Sentiment (Neutral) Tags dividends Rhea-AI Summary Marsh McLennan (MMC) announces a quarterly dividend of $0.710 per share for stockholders, payable on May 15, 2024. Positive None. Negative None. 03/13/2024 - 10:00 AM NEW YORK--(BUSINESS WIRE)-- The Board of Directors of Marsh McLennan (NYSE: MMC) today declared a quarterly dividend of $0.710 per share on outstanding common stock, payable on May 15, 2024 to stockholders of record on April 4, 2024. About Marsh McLennan Marsh McLennan (NYSE: MMC) is the worlds leading professional services firm in the areas of risk, strategy and people. The Companys more than 85,000 colleagues advise clients in over 130 countries. With annual revenue of $23 billion, Marsh McLennan helps clients navigate an increasingly dynamic and complex environment through four market-leading businesses. Marsh provides data-driven risk advisory services and insurance solutions to commercial and consumer clients. Guy Carpenter develops advanced risk, reinsurance and capital strategies that help clients grow profitably and pursue emerging opportunities. Mercer delivers advice and technology-driven solutions that help organizations redefine the world of work, reshape retirement and investment outcomes, and unlock health and wellbeing for a changing workforce. Oliver Wyman serves as a critical strategic, economic and brand advisor to private sector and governmental clients. For more information, visit marshmclennan.com, or follow us on LinkedIn and X. View source version on businesswire.com: https://www.businesswire.com/news/home/20240313771551/en/ Media Contact: Erick Gustafson Marsh McLennan +1 202 263 7788 Erick.gustafson@mmc.com Investor Contact: Sarah DeWitt Marsh McLennan +1 212 345 6750 Sarah.dewitt@mmc.com Source: Marsh McLennan What dividend has Marsh McLennan (MMC) declared per share? Marsh McLennan (MMC) has declared a quarterly dividend of $0.710 per share. When will the dividend be payable to stockholders? The dividend will be payable on May 15, 2024, to stockholders of record on April 4, 2024."
"KVH Industries to Host Fourth Quarter/Year-end Conference Call on March 15, 2024",2024-03-13T13:42:00.000Z,Low,Neutral,"KVH Industries, Inc. (KVHI) will announce its financial results for Q4 and fiscal year 2023 on March 15, 2024. The investor conference call will be hosted by CEO Brent Bruun and CFO Roger Kuebel.","KVH Industries to Host Fourth Quarter/Year-end Conference Call on March 15, 2024 Rhea-AI Impact (Low) Rhea-AI Sentiment (Neutral) Tags conferences Rhea-AI Summary KVH Industries, Inc. (KVHI) will announce its financial results for Q4 and fiscal year 2023 on March 15, 2024. The investor conference call will be hosted by CEO Brent Bruun and CFO Roger Kuebel. Positive None. Negative None. 03/13/2024 - 09:42 AM MIDDLETOWN, R.I., March 13, 2024 (GLOBE NEWSWIRE) -- KVH Industries, Inc. (Nasdaq: KVHI), will announce its financial results for the fourth quarter and fiscal year that ended on December 31, 2023, on Friday, March 15, 2024. In conjunction with the release, the company will conduct its investor conference call at 9:00 a.m. ET, hosted by Mr. Brent Bruun, CEO and Mr. Roger Kuebel, CFO. A live broadcast of the call will be available online at investors.kvh.com. In addition, an audio replay of the conference call will be available on the website for at least two weeks. To listen to the replay, visit investors.kvh.com starting three hours following the conclusion of the call. Investors who wish to submit questions during or following the call may do so to IR@kvh.com. About KVH Industries, Inc. KVH Industries, Inc. is a global leader in mobile connectivity and maritime VSAT delivered via the KVH ONE network. The company, founded in 1982, is based in Middletown, RI, with research, development, and manufacturing operations in Middletown, RI, and more than a dozen offices around the globe. KVH provides connectivity solutions for commercial maritime, leisure marine, military/government, and land mobile applications on vessels and vehicles, including the TracNet, TracPhone, and TracVision product lines, the KVH ONE OpenNet Program for non-KVH antennas, AgilePlans Connectivity as a Service (CaaS), and the KVH Link crew wellbeing content service. Contact: Chris WatsonVP, Marketing/CommunicationsKVH Industries, Inc.401-845-2441cwatson@kvh.com When will KVH Industries, Inc. announce its financial results for Q4 and fiscal year 2023? KVH Industries, Inc. will announce its financial results for Q4 and fiscal year 2023 on March 15, 2024. Who will host the investor conference call for KVH Industries, Inc.? The investor conference call for KVH Industries, Inc. will be hosted by CEO Brent Bruun and CFO Roger Kuebel. Where can investors listen to the live broadcast of the conference call? Investors can listen to the live broadcast of the conference call online at investors.kvh.com. How long will the audio replay of the conference call be available on the website? The audio replay of the conference call will be available on the website for at least two weeks. How can investors submit questions during or following the conference call? Investors can submit questions during or following the conference call to IR@kvh.com."
Air France-KLM - state aid appeal,2024-03-13T17:00:00.000Z,Low,Neutral,Air France-KLM and Air France have lodged appeals before the Court of Justice of the European Union regarding two judgments annulling Commission decisions approving French State aid measures during the Covid 19 crisis. They have fully refunded all State aid received.,"Air France-KLM - state aid appeal Rhea-AI Impact (Low) Rhea-AI Sentiment (Neutral) Tags Rhea-AI Summary Air France-KLM and Air France have lodged appeals before the Court of Justice of the European Union regarding two judgments annulling Commission decisions approving French State aid measures during the Covid 19 crisis. They have fully refunded all State aid received. Positive None. Negative None. 03/13/2024 - 01:00 PM Paris, March 13, 2024 Air France-KLM and Air France confirm having lodged two appeals before the Court of Justice of the European Union of two judgments of the General Court of the European Union rendered in December 2023, annulling a 2020 Commission decision and a 2021 Commission decision which approved various French State aid measures during the Covid 19 crisis. Air France-KLM reminds that Air France-KLM and Air France have fully refunded all State aid received, in accordance with the applicable legal framework. Investor Relations Michiel Klinkers Marouane Mami michiel.klinkers@airfranceklm.com marouane.mami@airfranceklm.com Website: www.airfranceklm.com Attachment Air France KLM - state aid appeal What appeals have Air France-KLM and Air France lodged before the Court of Justice of the European Union? Air France-KLM and Air France have lodged appeals regarding two judgments annulling Commission decisions approving French State aid measures during the Covid 19 crisis. What Commission decisions were annulled by the General Court of the European Union in December 2023? The General Court of the European Union annulled a 2020 Commission decision and a 2021 Commission decision which approved various French State aid measures. Have Air France-KLM and Air France refunded all State aid received? Yes, Air France-KLM and Air France have fully refunded all State aid received in accordance with the applicable legal framework."
Liberty All-Star Equity Fund February 2024 Monthly Update,2024-03-13T17:22:00.000Z,Low,Neutral,"The Liberty All-Star Equity Fund (USA) released its February 2024 Monthly Update, showcasing a Large-Cap Core Fund style with a mix of value and growth managers. The top holdings include Microsoft, NVIDIA, and Alphabet. The fund's performance for the month was 4.03%, with a year-to-date performance of 5.91%. Net assets stood at $1,947.4 million, with a sector breakdown dominated by Information Technology and Financials.","Liberty All-Star Equity Fund February 2024 Monthly Update Rhea-AI Impact (Low) Rhea-AI Sentiment (Neutral) Tags Rhea-AI Summary The Liberty All-Star Equity Fund (USA) released its February 2024 Monthly Update, showcasing a Large-Cap Core Fund style with a mix of value and growth managers. The top holdings include Microsoft, NVIDIA, and Alphabet. The fund's performance for the month was 4.03%, with a year-to-date performance of 5.91%. Net assets stood at $1,947.4 million, with a sector breakdown dominated by Information Technology and Financials. Positive None. Negative None. Financial Analyst The disclosed monthly performance data for the Liberty All-Star Equity Fund, with a net asset value (NAV) increase and a market price movement, provides a snapshot of the fund's health and trajectory. The fund's performance relative to its NAV is particularly noteworthy, as it indicates the market's valuation of the fund's assets compared to the fund's own accounting. A widening discount could signal investor concerns or a potential buying opportunity if the market underestimates the underlying value.The sector breakdown reveals a strategic allocation with a strong emphasis on Information Technology and Financials, which aligns with broader market trends favoring these sectors. The addition and liquidation of holdings suggest active management in response to market conditions or a reevaluation of company prospects.For stakeholders, the year-to-date performance figures are crucial, as they provide insights into the fund's short-term efficacy in capital growth. However, it's important to consider that past performance is not indicative of future results and the fund's volatility must be acknowledged as an inherent investment risk. Market Research Analyst Understanding the top holdings of the Liberty All-Star Equity Fund is essential for assessing its potential risk and return profile. The concentration of investments in leading technology and healthcare companies, such as Microsoft and UnitedHealth Group, suggests exposure to sectors with high growth potential but also to industry-specific risks. The fund's diversification across various sectors, however, may mitigate systemic risks.The fund's new holdings and liquidated positions indicate a strategic shift that could be based on macroeconomic factors, sector outlooks, or company-specific developments. Investors should monitor these changes as they may impact the fund's future performance.Lastly, the fund's distribution sources, including ordinary dividends and potential return of capital, are a key consideration for investors seeking income, as well as for the tax implications of these distributions. Economist The Liberty All-Star Equity Fund's performance and investment approach can be reflective of broader economic conditions. A strong emphasis on large-cap core equities is a sign of confidence in established companies during uncertain economic times. The fund's active management style, involving both value and growth strategies, aims to capitalize on market inefficiencies and could be particularly effective in periods of economic volatility.Investors should also consider the implications of the fund's sector allocations in the context of economic cycles. For instance, an overweight position in Information Technology and Financials might be advantageous during expansionary phases but could pose greater risks during economic downturns.The fund's discount to NAV is also an important economic indicator, as it may reflect broader market sentiment and investor expectations regarding future economic and market conditions. 03/13/2024 - 01:22 PM BOSTON, March 13, 2024 /PRNewswire/ -- Below is the February 2024 Monthly Update for the Liberty All-Star Equity Fund. (NYSE: USA) Liberty All-Star Equity FundTicker: USA Monthly Update, February, 2024 Investment Approach: Fund Style: Large-Cap Core Fund Strategy: Combines three value-style and two growth-style investment managers. Those selected demonstrate a consistent investment philosophy, decision making process, continuity of key people and above-average long-term results compared to managers with similar styles. Investment Managers: Value Managers: Aristotle Capital Management, LLC Fiduciary Management, Inc. Pzena Investment Management, LLC Growth Managers: Sustainable Growth Advisers, LP TCW Investment Management Company Top 20 Holdings at Month-End (34.2% of equity portfolio) 1 Microsoft Corp. 3.9 % 2 NVIDIA Corp. 3.0 % 3 Alphabet, Inc. 2.9 % 4 Amazon.com, Inc. 2.8 % 5 UnitedHealth Group, Inc. 2.1 % 6 Visa, Inc. 2.1 % 7 ServiceNow, Inc. 1.9 % 8 S&P Global, Inc. 1.4 % 9 Salesforce, Inc. 1.4 % 10 Danaher Corp. 1.4 % 11 Charles Schwab Corp. 1.3 % 12 Adobe, Inc. 1.2 % 13 Capital One Financial Corp. 1.2 % 14 Sony Group Corp. 1.2 % 15 Ecolab, Inc. 1.2 % 16 Ferguson PLC 1.1 % 17 Autodesk, Inc. 1.1 % 18 Dollar General Corp. 1.1 % 19 Berkshire Hathaway, Inc. 1.0 % 20 Wells Fargo & Co. 0.9 % Holdings are subject to change. Monthly Performance: Performance NAV Market Price Discount Beginning of month value $6.70 $6.57 -1.9 % End of month value $6.97 $6.75 -3.2 % Performance for month 4.03 % 2.74 % Performance year-to-date 5.91 % 8.52 % Net Assets at Month-End ($millions) Total $1,947.4 Equities $1,906.9 Percent Invested 97.9 % Sector Breakdown (% of equity portfolio)* Information Technology 21.5 % Financials 21.3 % Health Care 14.2 % Consumer Discretionary 12.9 % Industrials 8.0 % Communication Services 6.0 % Materials 5.8 % Consumer Staples 5.3 % Energy 1.9 % Real Estate 1.8 % Utilities 1.3 % Total Market Value 100.0 % *Based on Standard & Poor's and MSCI Global Industry Classification Standard (GICS). New HoldingsLowe's Companies, Inc.Meta Platforms, Inc.TotalEnergies SEWaste Management, Inc. Holdings LiquidatedCardinal Health, Inc.General Electric Co.Phillips 66 The net asset value (NAV) of a closed-end fund is the market value of the underlying investments (i.e., stocks and bonds) in the Fund's portfolio, minus liabilities, divided by the total number of Fund shares outstanding. However, the Fund also has a market price; the value at which it trades on an exchange. If the market price is above the NAV the Fund is trading at a premium. If the market price is below the NAV the Fund is trading at a discount. Performance returns for the Fund are total returns, which includes dividends, and are net of management fees and other Fund expenses. Returns are calculated assuming that a shareholder reinvested all distributions. Past performance cannot predict future investment results. Performance will fluctuate with changes in market conditions. Current performance may be lower or higher than the performance data shown. Performance information shown does not reflect the deduction of taxes that shareholders would pay on Fund distributions or the sale of Fund shares. Shareholders must be willing to tolerate significant fluctuations in the value of their investment. An investment in the Fund involves risk, including loss of principal. Sources of distributions to shareholders may include ordinary dividends, long-term capital gains and return of capital. The final determination of the source of all distributions in 2024 for tax reporting purposes will be made after year end. The actual amounts and sources of the amounts for tax reporting purposes will depend upon the Fund's investment experience during its fiscal year and may be subject to changes based on tax regulations. Based on current estimates a portion of the distributions consist of a return of capital. These estimates may not match the final tax characterization (for the full year's distributions) contained in shareholder 1099-DIV forms after the end of the year. All data is as of February 29, 2024 unless otherwise noted. Liberty All-Star Equity Fund1-800-241-1850www.all-starfunds.com libinfo@alpsinc.com View original content to download multimedia:https://www.prnewswire.com/news-releases/liberty-all-star-equity-fund-february-2024-monthly-update-302088375.html SOURCE Liberty All-Star Equity Fund What is the investment approach of the Liberty All-Star Equity Fund (USA)? The fund follows a Large-Cap Core Fund style and combines three value-style and two growth-style investment managers. Who are the top three holdings of the Liberty All-Star Equity Fund (USA)? The top three holdings are Microsoft Corp. at 3.9%, NVIDIA Corp. at 3.0%, and Alphabet, Inc. at 2.9%. What was the fund's performance for the month of February 2024? The fund's performance for the month was 4.03%. What are the net assets of the Liberty All-Star Equity Fund (USA) at the end of February 2024? The net assets stood at $1,947.4 million. Which sectors dominate the sector breakdown of the Liberty All-Star Equity Fund (USA)? The sector breakdown is dominated by Information Technology at 21.5% and Financials at 21.3%."
Vishay Intertechnology Upgrades TFBS4xx and TFDU4xx Series IR Transceiver Modules With Longer Link Distance and Improved ESD Robustness,2024-03-13T15:00:00.000Z,Low,Neutral,"Vishay Intertechnology, Inc. (NYSE: VSH) upgrades its TFBS4xx and TFDU4xx series of IR transceiver modules for IrDA applications, offering 20% longer link distance and improved ESD robustness. The devices support data rates up to 115.2 kbit/s, with low power consumption for extended battery life. Compliant with IrDA specifications, the modules are drop-in replacements, saving costs by eliminating PCB redesigns. Vishay's latest IC and emitter chip technology ensures long-term availability. The devices are RoHS-compliant, halogen-free, and offered in various package sizes. Samples and production quantities are available now.","Vishay Intertechnology Upgrades TFBS4xx and TFDU4xx Series IR Transceiver Modules With Longer Link Distance and Improved ESD Robustness Rhea-AI Impact (Low) Rhea-AI Sentiment (Neutral) Tags Rhea-AI Summary Vishay Intertechnology, Inc. (NYSE: VSH) upgrades its TFBS4xx and TFDU4xx series of IR transceiver modules for IrDA applications, offering 20% longer link distance and improved ESD robustness. The devices support data rates up to 115.2 kbit/s, with low power consumption for extended battery life. Compliant with IrDA specifications, the modules are drop-in replacements, saving costs by eliminating PCB redesigns. Vishay's latest IC and emitter chip technology ensures long-term availability. The devices are RoHS-compliant, halogen-free, and offered in various package sizes. Samples and production quantities are available now. Positive None. Negative None. Market Research Analyst The announcement by Vishay Intertechnology regarding their upgraded infrared (IR) transceiver modules marks a significant development in the semiconductor industry. The improved features, such as a 20% longer link distance and enhanced Electrostatic Discharge (ESD) robustness, directly cater to the growing demand for reliable and efficient wireless communication in various sectors. This enhancement could potentially increase the competitiveness of Vishay's products in the market, especially in applications like energy meters, industrial automation and medical equipment where data integrity and transmission range are crucial.From a market perspective, the ability of these modules to act as drop-in replacements for existing solutions could lead to increased adoption rates, as it reduces the costs and complexities associated with system upgrades. This ease of integration, combined with the low power consumption feature, positions Vishay favorably in markets with a focus on energy efficiency and longer battery life, such as mobile and portable devices. Financial Analyst Vishay Intertechnology's stock market position, as reflected by its NYSE listing under VSH, could see an impact from this product upgrade. Investors often look for companies that demonstrate innovation and the ability to maintain or expand their market share. The introduction of in-house IC and surface emitter chip technology suggests a strategic move towards self-reliance and could signal to investors a long-term commitment to product development and customer satisfaction. This could be viewed positively by the market, potentially influencing the company's stock performance.Furthermore, the financial implications of manufacturing cost reductions due to the modules' compatibility as drop-in replacements could improve profit margins. This operational efficiency, if reflected in the upcoming financial reports, may result in a favorable response from investors seeking companies with strong cost management strategies. Electronics Engineer The technical advancements in Vishay's IR transceiver modules, such as the extended link distance and the improved ESD robustness to 2 kV, are indicative of the company's commitment to quality and innovation. For professionals in the field of electronics engineering, the use of Vishays latest in-house IC and surface emitter chip technology is a testament to the company's capabilities in semiconductor design and manufacturing. The operational voltage range and temperature specifications suggest that these components are versatile and robust, suitable for a wide range of environmental conditions, which is essential for the reliability of electronic devices in diverse applications.The low power consumption and the significantly reduced idle supply current are critical for battery-operated devices and these improvements could lead to longer device lifecycles and reduced maintenance costs. For the industry, this could mean a shift in standards for IR transceiver modules, pushing competitors to innovate similarly. 03/13/2024 - 11:00 AM Offering Drop-in Replacements for Existing Solutions, IrDA-Compliant Devices Feature New In-House IC and Surface Emitter Chip TechnologyMALVERN, Pa., March 13, 2024 (GLOBE NEWSWIRE) -- Vishay Intertechnology, Inc. (NYSE: VSH) today announced that it has upgraded its TFBS4xx and TFDU4xx series of infrared (IR) transceiver modules for IrDA applications to offer 20 % longer link distance and improved ESD robustness to 2 kV. With support for data rates up to 115.2 kbit/s (SIR) and link distances of 1 meter, the devices are intended for wireless communication and data transmission in energy meters and monitors, industrial automation controls, mobile phones, and medical equipment. To increase battery life in portable devices, the modules offer low power consumption with an idle supply current of < 70 A, down to < 1 A in shutdown mode. Devices in the Vishay Semiconductors TFBS4xxx and TFDU4xxx series each consist of a PIN photodiode, infrared emitter (IRED), and low power control IC in a single package. By upgrading the IR transceivers with Vishays latest in-house IC and surface emitter chip technology, the company is assuring the long term availability of IRDC products for its customers. And as drop-in replacements for existing devices, the modules help save costs by eliminating the need for PCB redesigns. Compliant with the latest IrDA physical layer specification, TFBS4xxx and TFDU4xxx series devices are backward-compatible and are offered in top- and side-view surface-mount packages. The enhanced solutions provide drop-in, plug and play replacements for existing devices in the series. RoHS-compliant, halogen-free, and Vishay Green, the devices are offered in a variety of package sizes and feature a wide operating voltage range from 2.4 V to 5.5 V and an operating temperature range from -25 C to +85 C. Device Size Table: Part #Dimensions (mm)TFBS46501.6 by 6.8 by 2.8TFBS46521.6 by 6.8 by 2.8TFBS47111.9 by 6 by 3TFDU41014 by 9.7 by 4.7TFDU43013.1 by 8.5 by 2.5 Samples and production quantities of the upgraded IR transceiver modules are available now. Vishay manufactures one of the worlds largest portfolios of discrete semiconductors and passive electronic components that are essential to innovative designs in the automotive, industrial, computing, consumer, telecommunications, military, aerospace, and medical markets. Serving customers worldwide, Vishay is The DNA of tech. Vishay Intertechnology, Inc. is a Fortune 1,000 Company listed on the NYSE (VSH). More on Vishay at www.Vishay.com. The DNA of tech is a registered trademark of Vishay Intertechnology. Vishay on Facebook: http://www.facebook.com/VishayIntertechnology Vishay Twitter feed: http://twitter.com/vishayindust Links to product datasheets:http://www.vishay.com/ppg?84672 (TFBS4650)http://www.vishay.com/ppg?84671 (TFBS4652)http://www.vishay.com/ppg?82633 (TFBS4711)http://www.vishay.com/ppg?81288 (TFDU4101)http://www.vishay.com/ppg?81965 (TFDU4301) Link to product photo:https://www.flickr.com/photos/vishay/albums/72177720315374596 For more information please contact:Vishay IntertechnologyPeter Henrici, +1 408 567-8400peter.henrici@vishay.com orRedpinesBob Decker, +1 415 409-0233bob.decker@redpinesgroup.com What are the key upgrades in Vishay Intertechnology's TFBS4xx and TFDU4xx series of IR transceiver modules for IrDA applications? Vishay Intertechnology has upgraded its TFBS4xx and TFDU4xx series of IR transceiver modules to offer 20% longer link distance and improved ESD robustness. What data rates are supported by the IR transceiver modules? The devices support data rates up to 115.2 kbit/s. What is the power consumption of the modules for extended battery life? The modules offer low power consumption with an idle supply current of < 70 A, down to < 1 A in shutdown mode. Are the IR transceiver modules drop-in replacements for existing devices? Yes, the modules are drop-in replacements, saving costs by eliminating the need for PCB redesigns. What technology ensures the long-term availability of IRDC products? Vishay upgraded the IR transceivers with its latest in-house IC and surface emitter chip technology to ensure long-term availability."
"With Basic Needs Met, Students Can Soar",2024-03-13T13:45:00.000Z,Neutral,Neutral,"Aflac Incorporated's Employee Engagement Team's Philanthropy Committee at PLADS launched the Closet of Care initiative to support local students in need by providing essential supplies. The program aims to reduce stress levels in students, improve academic performance, and maintain their dignity. PLADS employees in Connecticut and Florida locations contributed generously, leading to positive impacts on the schools and recognition for their efforts.","With Basic Needs Met, Students Can Soar Rhea-AI Impact (Neutral) Rhea-AI Sentiment (Neutral) Tags Rhea-AI Summary Aflac Incorporated's Employee Engagement Team's Philanthropy Committee at PLADS launched the Closet of Care initiative to support local students in need by providing essential supplies. The program aims to reduce stress levels in students, improve academic performance, and maintain their dignity. PLADS employees in Connecticut and Florida locations contributed generously, leading to positive impacts on the schools and recognition for their efforts. Positive None. Negative None. 03/13/2024 - 09:45 AM NORTHAMPTON, MA / ACCESSWIRE / March 13, 2024 / Aflac IncorporatedOriginally published on Aflac NewsroomCommunity giving, close to home - that's what the Employee Engagement Team's Philanthropy Committee at Aflac's Premier Life, Absence and Disability Solutions (PLADS) wanted. And they made it happen, streamlining the donation process so that they could more quickly get needed items in the hands of local students in need.From vision to reality: Closet of Care takes shapeEmployees in both the Connecticut and Florida PLADS locations rallied behind this mission. The offices in Farmington, Connecticut, and Plantation, Florida, each identified a nearby public high school with a high number of at-need students and began collecting school supplies, hygiene products, toiletries, snacks and clothing.In that moment, the Closet of Care was born.Since delivering the first batch of supplies to the schools in November 2022, the Philanthropy Committee developed a process to track inventory. Using it - and with continued, generous donations from PLADS employees - they continue to keep school shelves stocked.No-shame participationCloset of Care addresses studies showing children are better able to meet academic and achievement standards when not distracted by stress.1 With basic needs met - and discreetly - stress levels decrease, and students can devote their energy to academics and social development.Focused equally on preserving students' sense of dignity and respecting their privacy, the schools created space for supplies and communicated to students that help was available free of charge.As the partnership between PLADS and local schools grew, a faster and even more efficient delivery of supplies was needed. Now, PLADS employees can access Amazon Wish Lists for Bulkeley High School in Connecticut and Flanagan High school in Florida from their personal devices to order and ship requested supplies directly to the schools.Both locations are seeing positive impact from the Closet of Care - in fact, Florida school representatives felt the program was so impactful that they nominated Randy Olivo, manager, Group Proposition Development, who assisted with the local program, for a countywide Community Involvement Award in the School-Based Partnership Category.Learn more about how Aflac gives back to the community at Aflac.com.1Education Library, ""Maslow's Hierarchy Of Needs In Education."" Accessed on Feb. 1, 2024. https://educationlibrary.org/maslows-hierarchy-of-needs-in-education/.Premier Life, Absence and Disability Services (PLADS): Group life, disability, and absence services are administered by Continental American Insurance Company (CAIC), a proud member of the Aflac family of insurers. CAIC is not licensed to solicit business in New York, Guam, Puerto Rico, or the Virgin Islands.Continental American Insurance Company | Columbia, SCAGC2400201View additional multimedia and more ESG storytelling from Aflac Incorporated on 3blmedia.com.Contact Info:Spokesperson: Aflac IncorporatedWebsite: https://www.3blmedia.com/profiles/aflac-incorporatedEmail: info@3blmedia.comSOURCE: Aflac IncorporatedView the original press release on accesswire.com What is the name of the initiative launched by Aflac's Employee Engagement Team at PLADS to support local students? The initiative is called Closet of Care. What type of items were collected by PLADS employees for the Closet of Care initiative? PLADS employees collected school supplies, hygiene products, toiletries, snacks, and clothing for the initiative. How do studies show the Closet of Care initiative can benefit students? Studies indicate that when basic needs are met through initiatives like Closet of Care, stress levels decrease, allowing students to focus more on academics and social development. How can PLADS employees contribute to the Closet of Care initiative? PLADS employees can access Amazon Wish Lists for Bulkeley High School in Connecticut and Flanagan High School in Florida from their personal devices to order and ship requested supplies directly to the schools. What recognition did PLADS receive for the Closet of Care initiative? Florida school representatives nominated Randy Olivo, manager, Group Proposition Development, for a countywide Community Involvement Award in the School-Based Partnership Category due to the impactful nature of the program."
Browning West Addresses Recent Media Reports That Highlight the Gildan Activewear Boards Diligence Failures and Poor Judgement When Appointing Vince Tyra as CEO,2024-03-13T17:05:00.000Z,Low,Negative,"The press release highlights concerns regarding the Board's oversight of Mr. Tyra, potential conflicts, and risks for Gildan. It also criticizes the Board's PR efforts and attempts to deflect blame onto Browning West and shareholders.","Browning West Addresses Recent Media Reports That Highlight the Gildan Activewear Boards Diligence Failures and Poor Judgement When Appointing Vince Tyra as CEO Rhea-AI Impact (Low) Rhea-AI Sentiment (Negative) Tags Rhea-AI Summary The press release highlights concerns regarding the Board's oversight of Mr. Tyra, potential conflicts, and risks for Gildan. It also criticizes the Board's PR efforts and attempts to deflect blame onto Browning West and shareholders. Positive None. Negative Potential conflicts and risks for Gildan due to the Board's oversight of Mr. Tyra Criticism of the Board's PR strategy and blame-shifting tactics onto Browning West and shareholders 03/13/2024 - 01:05 PM Believes the Board Either Failed in its Diligence of Mr. Tyra or Willfully Overlooked His Concerning Prior Behavior, Which Has Created Undue Conflicts and Risks for Gildan Exposes the Boards Effort to Ramp Up its PR Machine and Shift Blame onto Browning West and Shareholders, Who Have Every Right to be Concerned About Their Investment and Scrutinize the Selection of a Questionable CEO Urges the Board and Mr. Tyra to Immediately Commence an Orderly Resignation Process and to Work Expeditiously with Browning West to Substantially Reconstitute the Board LOS ANGELES--(BUSINESS WIRE)-- Browning West, LP (together with its affiliates, Browning West or we), which is a long-term shareholder of Gildan Activewear Inc. (NYSE: GIL) (TSX: GIL) (Gildan or the Company) and beneficially owns approximately 5.0% of the Companys outstanding shares, today issued the below statement. Recent media coverage and an independent research report suggest the Board has presided over an egregious failure of due care and judgement by overlooking Mr. Tyras seemingly inappropriate relationship with a subordinate  who is currently an executive at Gildan  during his time as CEO of Broder Bros. We question if the Board uncovered this deeply troubling information during its CEO search process and how the sitting directors got comfortable appointing and retaining a CEO who felt it was acceptable to maintain such a relationship with someone who worked under him. We also question if the Board considered that the historical relationship between these two executives creates undue conflicts and risk for Gildan shareholders and employees. No amount of deflecting and downplaying will allow the Board to succeed in sweeping this inexplicable lapse in diligence and judgement under the rug. To be clear, Browning West had absolutely no role in the independent research report referenced in recent media coverage and will pursue legal action against any parties that claim otherwise. We believe it is important to emphasize this point given that the Board has ramped up its PR machine and is proactively contacting media in an effort to push blame onto Browning West and shareholders, who have every right to be concerned about their investments in Gildan and to scrutinize the selection of a seemingly unfit CEO. We urge Chairman Donald Berg and the Board, as well as Mr. Tyra, to recognize that it is in the best interest of all Gildan stakeholders to commence an orderly resignation process and work with Browning West to reconstitute the majority of the Board. The current directors have clearly failed in their assessment of Mr. Tyra in light of his record of value destruction, lack of critical manufacturing experience, and apparent decision to carry on a relationship with a subordinate while he was CEO of Border Bros. Now is the time for Gildan to agree to appoint all of the highly qualified director candidates proposed by Browning West to the Board, so that this unfortunate chapter in the Companys history can end. This will allow for Gildan to once again focus on growing and strengthening its business and creating value for all of its shareholders. Disclaimer for Forward-Looking Information Certain information in this news release may constitute forward-looking information within the meaning of applicable securities legislation. Forward-looking statements and information generally can be identified by the use of forward-looking terminology such as outlook, objective, may, will, expect, intend, estimate, anticipate, believe, should, plans, continue, or similar expressions suggesting future outcomes or events. Forward-looking information in this news release may include, but is not limited to, statements of Browning West regarding (i) how Browning West intends to exercise its legal rights as a shareholder of the Company, and (ii) its plans to make changes at the Board and management of the Company. Although Browning West believes that the expectations reflected in any such forward-looking information are reasonable, there can be no assurance that such expectations will prove to be correct. Such forward-looking statements are subject to risks and uncertainties that may cause actual results, performance or developments to differ materially from those contained in the statements including, without limitation, the risks that (i) the Company may use tactics to thwart the rights of Browning West as a shareholder and (ii) the actions being proposed and the changes being demanded by Browning West, may not take place for any reason whatsoever. Except as required by law, Browning West does not intend to update these forward-looking statements. Advisors Olshan Frome Wolosky LLP is serving as legal counsel, Goodmans LLP is serving as Canadian legal counsel, and IMK is serving as Quebec legal counsel. Longacre Square Partners is serving as strategic advisor and Pelican PR is serving as public relations advisor. Carson Proxy is serving as proxy advisor. About Browning West, LP Browning West is an independent investment partnership based in Los Angeles, California. The partnership employs a concentrated, long-term, and fundamental approach to investing and focuses primarily on investments in North America and Western Europe. Browning West seeks to identify and invest in a limited number of high-quality businesses and to hold these investments for multiple years. Backed by a select group of leading foundations, family offices, and university endowments, Browning Wests unique capital base allows it to focus on long-term value creation at its portfolio companies. View source version on businesswire.com: https://www.businesswire.com/news/home/20240313795990/en/ Browning West info@browningwest.com 310-984-7600 Longacre Square Partners Greg Marose / Scott Deveau, 646-386-0091 browningwest@longacresquare.com Pelican PR Lyla Radmanovich / Mlanie Tardif, 514-845-8763 media@rppelican.ca Carson Proxy Christine Carson, 416-804-0825 christine@carsonproxy.com Source: Browning West, LP What conflicts and risks are highlighted in the press release regarding Gildan? The press release mentions concerns about conflicts and risks due to the Board's oversight of Mr. Tyra. Who is criticized for blame-shifting in the PR? The Board is criticized for its PR efforts and attempts to shift blame onto Browning West and shareholders. What is the main focus of the press release regarding Gildan? The press release focuses on the Board's oversight of Mr. Tyra and the associated conflicts and risks for Gildan. Why are shareholders concerned according to the PR? Shareholders are concerned due to the Board's actions and the potential risks highlighted in the press release."
